*********** PTASSAMj00 ******** FILEIN user.vek ../../CSA/PIK_SPRITE/ ULMN 3 2wwt_o00 INTRACELLULAR SUBTILISIN PROTEASE user 1 3 # 1 A 49 ASP A 56 ASP~? 11.59 C21 2PE A 148 A 86 HIS A 115 HIS~? 12.27 C21 2PE A 148 A 250 ALA A 51 ALA~? 7.23 CD MLY D 135 coo 18.89 -28.09 25.11 19.05 -26.61 23.60 -16.01 45.89 15.64 -15.93 44.31 14.23 coo 21.50 -24.76 21.11 19.82 -23.58 21.50 -13.18 48.35 10.37 -12.55 46.36 10.33 coo 16.40 -19.57 19.82 17.00 -20.87 19.22 -20.65 48.85 8.75 -21.19 47.91 7.68 ULMN 3 2wwt_o00 INTRACELLULAR SUBTILISIN PROTEASE user 2 3 # 2 A 49 ASP A 87 ASP.? 8.49 C6 PGE A 147 A 86 HIS A 88 HIS^? 4.20 CH2 MLY D 135 A 250 ALA A 51 ALA~? 7.23 CD MLY D 135 coo 18.89 -28.09 25.11 19.05 -26.61 23.60 -23.17 58.67 3.55 -22.34 59.17 1.69 coo 21.50 -24.76 21.11 19.82 -23.58 21.50 -23.95 56.87 7.77 -24.14 54.98 6.86 coo 16.40 -19.57 19.82 17.00 -20.87 19.22 -20.65 48.85 8.75 -21.19 47.91 7.68 ULMN 3 2wwt_o00 INTRACELLULAR SUBTILISIN PROTEASE user 3 3 # 3 A 49 ASP B 56 ASP~? 11.45 C20 PE8 B 148 A 86 HIS B 115 HIS~? 12.48 C18 PE8 B 148 A 250 ALA B 51 ALA~? 7.25 CG MLY C 135 coo 18.89 -28.09 25.11 19.05 -26.61 23.60 6.80 78.21 26.00 8.47 79.07 25.03 coo 21.50 -24.76 21.11 19.82 -23.58 21.50 11.86 77.76 30.05 12.70 77.49 28.15 coo 16.40 -19.57 19.82 17.00 -20.87 19.22 9.29 84.92 31.07 10.11 86.09 30.55 ULMN 3 2wwt_o00 INTRACELLULAR SUBTILISIN PROTEASE user 4 3 # 4 A 49 ASP B 87 ASP.? 8.94 O4 PGE B 147 A 86 HIS B 88 HIS^? 4.29 CH1 MLY C 135 A 250 ALA B 51 ALA~? 7.25 CG MLY C 135 coo 18.89 -28.09 25.11 19.05 -26.61 23.60 9.49 87.97 42.02 11.31 87.98 43.09 coo 21.50 -24.76 21.11 19.82 -23.58 21.50 6.15 87.00 38.94 7.35 87.96 37.51 coo 16.40 -19.57 19.82 17.00 -20.87 19.22 9.29 84.92 31.07 10.11 86.09 30.55 ULMN 3 2wwt_o00 INTRACELLULAR SUBTILISIN PROTEASE user 5 3 # 5 A 49 ASP C 56 ASP~? 9.09 N MLZ C 114 A 86 HIS C 115 HIS~? 4.72 C MLZ C 114 A 250 ALA C 51 ALA~? 7.46 CD MLY B 135 coo 18.89 -28.09 25.11 19.05 -26.61 23.60 -16.40 94.43 66.11 -17.63 93.56 67.58 coo 21.50 -24.76 21.11 19.82 -23.58 21.50 -12.99 90.00 69.08 -14.38 90.57 70.54 coo 16.40 -19.57 19.82 17.00 -20.87 19.22 -16.25 86.28 63.34 -17.35 85.28 63.69 ULMN 3 2wwt_o00 INTRACELLULAR SUBTILISIN PROTEASE user 6 3 # 6 A 49 ASP C 87 ASP.? 8.84 O1 PGE C 147 A 86 HIS C 88 HIS^? 3.86 CD MLY B 135 A 250 ALA C 51 ALA~? 7.46 CD MLY B 135 coo 18.89 -28.09 25.11 19.05 -26.61 23.60 -9.03 79.00 58.44 -8.21 77.39 59.55 coo 21.50 -24.76 21.11 19.82 -23.58 21.50 -11.00 83.03 57.18 -12.69 82.43 58.26 coo 16.40 -19.57 19.82 17.00 -20.87 19.22 -16.25 86.28 63.34 -17.35 85.28 63.69 ULMN 3 2wwt_o00 INTRACELLULAR SUBTILISIN PROTEASE user 7 3 # 7 A 49 ASP D 56 ASP~? 11.46 C21 2PE D 146 A 86 HIS D 115 HIS~? 12.18 C21 2PE D 146 A 250 ALA D 51 ALA~? 6.92 CG MLY A 135 coo 18.89 -28.09 25.11 19.05 -26.61 23.60 -41.85 87.81 13.66 -41.61 89.58 14.80 coo 21.50 -24.76 21.11 19.82 -23.58 21.50 -36.28 90.32 11.92 -37.49 91.98 12.35 coo 16.40 -19.57 19.82 17.00 -20.87 19.22 -34.62 86.43 18.27 -34.28 87.19 19.52 ULMN 3 2wwt_o00 INTRACELLULAR SUBTILISIN PROTEASE user 8 3 # 8 A 49 ASP D 87 ASP.? 7.26 C16 1PE B 150 A 86 HIS D 88 HIS^? 4.38 CH1 MLY A 135 A 250 ALA D 51 ALA~? 6.92 CG MLY A 135 coo 18.89 -28.09 25.11 19.05 -26.61 23.60 -24.70 80.89 17.41 -22.90 81.94 17.31 coo 21.50 -24.76 21.11 19.82 -23.58 21.50 -29.18 79.71 17.63 -29.43 81.25 19.03 coo 16.40 -19.57 19.82 17.00 -20.87 19.22 -34.62 86.43 18.27 -34.28 87.19 19.52 2wwt_o00 source 2WWT INTRACELLULAR SUBTILISIN PROTEASE : 8 hits 2wwt_o00 naa= 3 ULMN 5 1uqr_c02 3-DEHYDROQUINATE DEHYDRATASE user 1 5 # 1 C 11 ASN A 28 ASN^? 3.50 CL CL A 145s C 18 ARG A 124 ARG^? 8.18 C1 GOL A 150 C 98 GLU A 93 GLU^? 3.90 NZ MLY A 67 C 100 HIS A 25 HIS^? 6.06 C MLZ A 129 C 107 ARG A 127 ARG^? 7.47 N MLZ A 129 coo 11.41 35.14 -4.52 9.49 35.87 -3.92 -22.13 61.51 13.69 -20.95 60.87 15.35 coo 13.36 36.57 -12.40 15.16 35.96 -9.99 -17.35 69.10 10.18 -16.14 69.37 7.36 coo 22.12 38.29 5.10 21.08 39.95 5.91 -27.37 60.67 25.57 -29.32 61.09 26.31 coo 21.01 39.76 0.48 19.58 39.56 2.00 -27.47 64.89 22.81 -29.24 64.17 23.67 coo 17.86 45.51 -4.92 15.68 43.42 -5.43 -18.44 68.25 24.06 -17.70 68.37 27.04 ULMN 5 1uqr_c02 3-DEHYDROQUINATE DEHYDRATASE user 2 5 # 2 C 11 ASN B 28 ASN^? 3.43 CL CL B 143s C 18 ARG B 124 ARG^? 8.02 O2 GOL B 149 C 98 GLU B 93 GLU^? 4.01 CE MLZ B 67 C 100 HIS B 25 HIS^? 5.55 C6 PG4 C 145 C 107 ARG B 127 ARG^? 9.26 O4 SO4 A 144 coo 11.41 35.14 -4.52 9.49 35.87 -3.92 0.96 81.77 41.38 0.26 80.18 40.18 coo 13.36 36.57 -12.40 15.16 35.96 -9.99 3.96 78.02 49.67 6.79 78.26 50.86 coo 22.12 38.29 5.10 21.08 39.95 5.91 -11.20 80.89 36.50 -12.93 82.08 36.76 coo 21.01 39.76 0.48 19.58 39.56 2.00 -10.19 81.59 41.51 -11.58 82.85 40.58 coo 17.86 45.51 -4.92 15.68 43.42 -5.43 -7.64 72.55 44.16 -9.78 70.52 43.36 ULMN 5 1uqr_c02 3-DEHYDROQUINATE DEHYDRATASE user 3 5 # 3 C 11 ASN C 28 ASN^? 3.42 CL CL C 144s C 18 ARG C 124 ARG^? 7.92 C3 GOL C 149 C 98 GLU C 93 GLU^? -3.82 CH2 MLY C 67s C 100 HIS C 25 HIS^? 5.68 C3 PG4 C 145 C 107 ARG C 127 ARG^? 7.44 N MLZ C 129 coo 11.41 35.14 -4.52 9.49 35.87 -3.92 -6.06 88.35 54.50 -6.05 90.38 55.16 coo 13.36 36.57 -12.40 15.16 35.96 -9.99 2.87 85.20 55.95 3.74 82.90 57.81 coo 22.12 38.29 5.10 21.08 39.95 5.91 -9.46 98.26 46.68 -9.97 98.34 44.62 coo 21.01 39.76 0.48 19.58 39.56 2.00 -5.80 94.82 45.56 -7.26 95.23 44.11 coo 17.86 45.51 -4.92 15.68 43.42 -5.43 1.53 98.09 50.88 2.14 101.05 50.40 ULMN 5 1uqr_c02 3-DEHYDROQUINATE DEHYDRATASE user 4 5 # 4 C 11 ASN D 28 ASN^? 3.51 CL CL D 143s C 18 ARG D 124 ARG^? 7.97 C3 GOL D 147 C 98 GLU D 93 GLU^? -3.68 CE MLY D 67s C 100 HIS D 25 HIS^? 5.64 C8 PG4 D 144 C 107 ARG D 127 ARG^? 9.31 O3 PGE A 147 coo 11.41 35.14 -4.52 9.49 35.87 -3.92 -31.24 74.87 11.89 -33.01 75.13 10.75 coo 13.36 36.57 -12.40 15.16 35.96 -9.99 -24.04 74.20 5.58 -21.67 76.16 5.44 coo 22.12 38.29 5.10 21.08 39.95 5.91 -41.50 66.77 12.62 -41.92 65.02 13.75 coo 21.01 39.76 0.48 19.58 39.56 2.00 -36.75 65.22 11.65 -37.83 64.18 13.11 coo 17.86 45.51 -4.92 15.68 43.42 -5.43 -35.94 67.72 2.28 -38.25 66.55 0.66 1uqr_c02 source 1uqr 3-DEHYDROQUINATE DEHYDRATASE : 4 hits 1uqr_c02 naa= 5 ULMN 5 1uqr_c06 3-DEHYDROQUINATE DEHYDRATASE user 1 5 # 1 G 11 ASN A 28 ASN^? 3.50 CL CL A 145s G 18 ARG A 124 ARG^? 8.18 C1 GOL A 150 G 98 GLU A 93 GLU^? 3.90 NZ MLY A 67 G 100 HIS A 25 HIS^? 6.06 C MLZ A 129 G 107 ARG A 127 ARG^? 7.47 N MLZ A 129 coo 18.60 62.21 42.24 16.60 61.66 41.77 -22.13 61.51 13.69 -20.95 60.87 15.35 coo 23.24 55.80 44.07 24.07 58.56 43.02 -17.35 69.10 10.18 -16.14 69.37 7.36 coo 24.29 72.38 32.90 22.99 71.88 31.32 -27.37 60.67 25.57 -29.32 61.09 26.31 coo 25.26 67.64 33.89 23.36 68.46 33.64 -27.47 64.89 22.81 -29.24 64.17 23.67 coo 24.52 59.60 31.94 22.78 59.24 34.44 -18.44 68.25 24.06 -17.70 68.37 27.04 ULMN 5 1uqr_c06 3-DEHYDROQUINATE DEHYDRATASE user 2 5 # 2 G 11 ASN B 28 ASN^? 3.43 CL CL B 143s G 18 ARG B 124 ARG^? 8.02 O2 GOL B 149 G 98 GLU B 93 GLU^? 4.01 CE MLZ B 67 G 100 HIS B 25 HIS^? 5.55 C6 PG4 C 145 G 107 ARG B 127 ARG^? 9.26 O4 SO4 A 144 coo 18.60 62.21 42.24 16.60 61.66 41.77 0.96 81.77 41.38 0.26 80.18 40.18 coo 23.24 55.80 44.07 24.07 58.56 43.02 3.96 78.02 49.67 6.79 78.26 50.86 coo 24.29 72.38 32.90 22.99 71.88 31.32 -11.20 80.89 36.50 -12.93 82.08 36.76 coo 25.26 67.64 33.89 23.36 68.46 33.64 -10.19 81.59 41.51 -11.58 82.85 40.58 coo 24.52 59.60 31.94 22.78 59.24 34.44 -7.64 72.55 44.16 -9.78 70.52 43.36 ULMN 5 1uqr_c06 3-DEHYDROQUINATE DEHYDRATASE user 3 5 # 3 G 11 ASN C 28 ASN^? 3.42 CL CL C 144s G 18 ARG C 124 ARG^? 7.92 C3 GOL C 149 G 98 GLU C 93 GLU^? -3.82 CH2 MLY C 67s G 100 HIS C 25 HIS^? 5.68 C3 PG4 C 145 G 107 ARG C 127 ARG^? 7.44 N MLZ C 129 coo 18.60 62.21 42.24 16.60 61.66 41.77 -6.06 88.35 54.50 -6.05 90.38 55.16 coo 23.24 55.80 44.07 24.07 58.56 43.02 2.87 85.20 55.95 3.74 82.90 57.81 coo 24.29 72.38 32.90 22.99 71.88 31.32 -9.46 98.26 46.68 -9.97 98.34 44.62 coo 25.26 67.64 33.89 23.36 68.46 33.64 -5.80 94.82 45.56 -7.26 95.23 44.11 coo 24.52 59.60 31.94 22.78 59.24 34.44 1.53 98.09 50.88 2.14 101.05 50.40 ULMN 5 1uqr_c06 3-DEHYDROQUINATE DEHYDRATASE user 4 5 # 4 G 11 ASN D 28 ASN^? 3.51 CL CL D 143s G 18 ARG D 124 ARG^? 7.97 C3 GOL D 147 G 98 GLU D 93 GLU^? -3.68 CE MLY D 67s G 100 HIS D 25 HIS^? 5.64 C8 PG4 D 144 G 107 ARG D 127 ARG^? 9.31 O3 PGE A 147 coo 18.60 62.21 42.24 16.60 61.66 41.77 -31.24 74.87 11.89 -33.01 75.13 10.75 coo 23.24 55.80 44.07 24.07 58.56 43.02 -24.04 74.20 5.58 -21.67 76.16 5.44 coo 24.29 72.38 32.90 22.99 71.88 31.32 -41.50 66.77 12.62 -41.92 65.02 13.75 coo 25.26 67.64 33.89 23.36 68.46 33.64 -36.75 65.22 11.65 -37.83 64.18 13.11 coo 24.52 59.60 31.94 22.78 59.24 34.44 -35.94 67.72 2.28 -38.25 66.55 0.66 1uqr_c06 source 1uqr 3-DEHYDROQUINATE DEHYDRATASE : 4 hits 1uqr_c06 naa= 5 ULMN 5 1uqr_c07 3-DEHYDROQUINATE DEHYDRATASE user 1 5 # 1 H 11 ASN A 28 ASN^? 3.50 CL CL A 145s H 18 ARG A 124 ARG^? 8.18 C1 GOL A 150 H 98 GLU A 93 GLU^? 3.90 NZ MLY A 67 H 100 HIS A 25 HIS^? 6.06 C MLZ A 129 H 107 ARG A 127 ARG^? 7.47 N MLZ A 129 coo -4.52 62.91 38.35 -3.82 64.81 37.70 -22.13 61.51 13.69 -20.95 60.87 15.35 coo -12.53 61.56 36.54 -10.23 59.58 36.95 -17.35 69.10 10.18 -16.14 69.37 7.36 coo 4.93 51.81 35.14 5.72 52.60 33.35 -27.37 60.67 25.57 -29.32 61.09 26.31 coo 0.30 52.85 33.49 2.03 54.01 33.67 -27.47 64.89 22.81 -29.24 64.17 23.67 coo -4.94 56.38 27.94 -5.36 58.57 30.04 -18.44 68.25 24.06 -17.70 68.37 27.04 ULMN 5 1uqr_c07 3-DEHYDROQUINATE DEHYDRATASE user 2 5 # 2 H 11 ASN B 28 ASN^? 3.43 CL CL B 143s H 18 ARG B 124 ARG^? 8.02 O2 GOL B 149 H 98 GLU B 93 GLU^? 4.01 CE MLZ B 67 H 100 HIS B 25 HIS^? 5.55 C6 PG4 C 145 H 107 ARG B 127 ARG^? 9.26 O4 SO4 A 144 coo -4.52 62.91 38.35 -3.82 64.81 37.70 0.96 81.77 41.38 0.26 80.18 40.18 coo -12.53 61.56 36.54 -10.23 59.58 36.95 3.96 78.02 49.67 6.79 78.26 50.86 coo 4.93 51.81 35.14 5.72 52.60 33.35 -11.20 80.89 36.50 -12.93 82.08 36.76 coo 0.30 52.85 33.49 2.03 54.01 33.67 -10.19 81.59 41.51 -11.58 82.85 40.58 coo -4.94 56.38 27.94 -5.36 58.57 30.04 -7.64 72.55 44.16 -9.78 70.52 43.36 ULMN 5 1uqr_c07 3-DEHYDROQUINATE DEHYDRATASE user 3 5 # 3 H 11 ASN C 28 ASN^? 3.42 CL CL C 144s H 18 ARG C 124 ARG^? 7.92 C3 GOL C 149 H 98 GLU C 93 GLU^? -3.82 CH2 MLY C 67s H 100 HIS C 25 HIS^? 5.68 C3 PG4 C 145 H 107 ARG C 127 ARG^? 7.44 N MLZ C 129 coo -4.52 62.91 38.35 -3.82 64.81 37.70 -6.06 88.35 54.50 -6.05 90.38 55.16 coo -12.53 61.56 36.54 -10.23 59.58 36.95 2.87 85.20 55.95 3.74 82.90 57.81 coo 4.93 51.81 35.14 5.72 52.60 33.35 -9.46 98.26 46.68 -9.97 98.34 44.62 coo 0.30 52.85 33.49 2.03 54.01 33.67 -5.80 94.82 45.56 -7.26 95.23 44.11 coo -4.94 56.38 27.94 -5.36 58.57 30.04 1.53 98.09 50.88 2.14 101.05 50.40 ULMN 5 1uqr_c07 3-DEHYDROQUINATE DEHYDRATASE user 4 5 # 4 H 11 ASN D 28 ASN^? 3.51 CL CL D 143s H 18 ARG D 124 ARG^? 7.97 C3 GOL D 147 H 98 GLU D 93 GLU^? -3.68 CE MLY D 67s H 100 HIS D 25 HIS^? 5.64 C8 PG4 D 144 H 107 ARG D 127 ARG^? 9.31 O3 PGE A 147 coo -4.52 62.91 38.35 -3.82 64.81 37.70 -31.24 74.87 11.89 -33.01 75.13 10.75 coo -12.53 61.56 36.54 -10.23 59.58 36.95 -24.04 74.20 5.58 -21.67 76.16 5.44 coo 4.93 51.81 35.14 5.72 52.60 33.35 -41.50 66.77 12.62 -41.92 65.02 13.75 coo 0.30 52.85 33.49 2.03 54.01 33.67 -36.75 65.22 11.65 -37.83 64.18 13.11 coo -4.94 56.38 27.94 -5.36 58.57 30.04 -35.94 67.72 2.28 -38.25 66.55 0.66 1uqr_c07 source 1uqr 3-DEHYDROQUINATE DEHYDRATASE : 4 hits 1uqr_c07 naa= 5 ULMN 4 1amy_c02 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 1 4 # 1 92 HIS A 4 HIS.? -3.92 C2 GOL A 150s 179 ASP A 122 ASP^? 7.46 C1 GOL A 150 204 GLU A 84 GLU.? 10.45 C3 GOL D 147 289 ASP A 83 ASP.? 8.52 O3 GOL D 147 coo -4.11 71.56 34.64 -2.46 71.38 33.48 -11.85 68.18 8.83 -11.23 70.10 8.29 coo -0.62 65.95 29.97 0.31 67.47 31.05 -15.41 64.92 4.51 -15.09 66.83 5.33 coo 4.34 62.44 32.05 4.22 64.48 32.53 -21.01 70.22 3.12 -21.10 71.95 4.30 coo 9.42 68.07 30.27 7.35 68.27 30.10 -19.46 70.43 -3.04 -19.06 72.28 -2.05 ULMN 4 1amy_c02 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 2 4 # 2 92 HIS B 4 HIS.? -3.86 O2 GOL B 149s 179 ASP B 122 ASP^? 7.33 O2 GOL B 149 204 GLU B 84 GLU.? 10.31 O3 GOL C 149 289 ASP B 83 ASP.? 9.40 O3 GOL C 149 coo -4.11 71.56 34.64 -2.46 71.38 33.48 8.07 73.88 49.16 8.30 73.43 51.19 coo -0.62 65.95 29.97 0.31 67.47 31.05 10.89 79.68 47.57 9.75 78.80 49.16 coo 4.34 62.44 32.05 4.22 64.48 32.53 7.66 84.31 53.13 6.13 83.49 54.35 coo 9.42 68.07 30.27 7.35 68.27 30.10 13.62 86.10 55.23 12.83 84.59 56.49 ULMN 4 1amy_c02 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 3 4 # 3 92 HIS C 4 HIS.? -3.73 C3 GOL C 149s 179 ASP C 122 ASP^? 7.22 C3 GOL C 149 204 GLU C 84 GLU.? 10.77 O2 GOL B 149 289 ASP C 83 ASP.? 8.65 O3 GOL B 149 coo -4.11 71.56 34.64 -2.46 71.38 33.48 4.88 85.81 61.42 6.80 85.00 61.18 coo -0.62 65.95 29.97 0.31 67.47 31.05 0.27 81.12 61.60 2.07 81.54 60.53 coo 4.34 62.44 32.05 4.22 64.48 32.53 2.34 77.12 55.01 3.46 78.21 53.60 coo 9.42 68.07 30.27 7.35 68.27 30.10 3.02 71.86 58.06 4.88 72.49 57.24 ULMN 4 1amy_c02 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 4 4 # 4 92 HIS D 4 HIS.? 4.07 C3 GOL D 147 179 ASP D 122 ASP^? 7.49 C3 GOL D 147 204 GLU D 84 GLU.? 10.79 C1 GOL A 150 289 ASP D 83 ASP.? 8.76 O1 GOL A 150 coo -4.11 71.56 34.64 -2.46 71.38 33.48 -23.57 78.63 1.94 -22.01 77.96 0.72 coo -0.62 65.95 29.97 0.31 67.47 31.05 -21.82 80.90 7.85 -21.38 79.32 6.51 coo 4.34 62.44 32.05 4.22 64.48 32.53 -17.40 74.78 10.23 -17.69 72.96 9.24 coo 9.42 68.07 30.27 7.35 68.27 30.10 -12.54 78.43 10.94 -12.46 77.06 9.29 1amy_c02 source 1amy ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE (ALPHA-AMY: 4 hits 1amy_c02 naa= 4 ULMN 4 1amy_c03 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 1 4 # 1 179 ASP A 83 ASP.? 8.52 O3 GOL D 147 204 GLU A 84 GLU.? 10.45 C3 GOL D 147 206 TRP A 86 TRP.? 11.27 C5 PGE A 147 289 ASP A 122 ASP^? 7.46 C1 GOL A 150 coo -0.62 65.95 29.97 0.31 67.47 31.05 -19.46 70.43 -3.04 -19.06 72.28 -2.05 coo 4.34 62.44 32.05 4.22 64.48 32.53 -21.01 70.22 3.12 -21.10 71.95 4.30 coo 9.53 62.76 36.39 10.06 65.94 34.23 -23.97 66.49 5.70 -20.10 66.49 6.06 coo 9.42 68.07 30.27 7.35 68.27 30.10 -15.41 64.92 4.51 -15.09 66.83 5.33 ULMN 4 1amy_c03 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 2 4 # 2 179 ASP B 83 ASP.? 9.40 O3 GOL C 149 204 GLU B 84 GLU.? 10.31 O3 GOL C 149 206 TRP B 86 TRP.? 11.40 C6 PGE B 147 289 ASP B 122 ASP^? 7.33 O2 GOL B 149 coo -0.62 65.95 29.97 0.31 67.47 31.05 13.62 86.10 55.23 12.83 84.59 56.49 coo 4.34 62.44 32.05 4.22 64.48 32.53 7.66 84.31 53.13 6.13 83.49 54.35 coo 9.53 62.76 36.39 10.06 65.94 34.23 5.15 86.32 48.71 6.70 82.77 48.58 coo 9.42 68.07 30.27 7.35 68.27 30.10 10.89 79.68 47.57 9.75 78.80 49.16 ULMN 4 1amy_c03 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 3 4 # 3 179 ASP C 83 ASP.? 8.65 O3 GOL B 149 204 GLU C 84 GLU.? 10.77 O2 GOL B 149 206 TRP C 86 TRP.? 11.30 C1 PGE C 147 289 ASP C 122 ASP^? 7.22 C3 GOL C 149 coo -0.62 65.95 29.97 0.31 67.47 31.05 3.02 71.86 58.06 4.88 72.49 57.24 coo 4.34 62.44 32.05 4.22 64.48 32.53 2.34 77.12 55.01 3.46 78.21 53.60 coo 9.53 62.76 36.39 10.06 65.94 34.23 -2.64 79.47 53.33 -0.76 80.96 56.37 coo 9.42 68.07 30.27 7.35 68.27 30.10 0.27 81.12 61.60 2.07 81.54 60.53 ULMN 4 1amy_c03 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 4 4 # 4 179 ASP D 83 ASP.? 8.76 O1 GOL A 150 204 GLU D 84 GLU.? 10.79 C1 GOL A 150 206 TRP D 86 TRP.? 10.59 OH7 1PE B 150 289 ASP D 122 ASP^? 7.49 C3 GOL D 147 coo -0.62 65.95 29.97 0.31 67.47 31.05 -12.54 78.43 10.94 -12.46 77.06 9.29 coo 4.34 62.44 32.05 4.22 64.48 32.53 -17.40 74.78 10.23 -17.69 72.96 9.24 coo 9.53 62.76 36.39 10.06 65.94 34.23 -21.83 74.25 13.71 -22.24 76.29 10.42 coo 9.42 68.07 30.27 7.35 68.27 30.10 -21.82 80.90 7.85 -21.38 79.32 6.51 1amy_c03 source 1amy ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE (ALPHA-AMY: 4 hits 1amy_c03 naa= 4 ULMN 4 1b8f_c00 HISTIDINE AMMONIA-LYASE user 1 4 # 1 A 142 ALA A 47 ALA~? 9.02 CD MLY D 135 A 144 GLY A 46 GLY~? 12.01 CD MLY D 135 A 280 TYR B 94 TYR^? -5.06 CL CL B 143s A 414 GLU A 48 GLU~? 14.04 CG MLY D 135 coo 8.90 -17.98 11.65 7.53 -18.34 11.16 -20.21 51.63 3.44 -21.40 51.48 2.53 coo 11.65 -18.01 12.88 11.72 -18.24 12.53 -16.75 52.82 2.36 -17.28 52.20 2.20 coo -3.84 22.59 11.63 -6.55 23.25 11.72 -6.97 76.65 35.26 -4.34 77.53 35.11 coo 7.29 -23.46 8.78 9.26 -22.73 8.47 -19.52 46.65 2.13 -18.86 45.41 0.50 1b8f_c00 source 1b8f HISTIDINE AMMONIA-LYASE : 1 hits 1b8f_c00 naa= 4 ULMN 4 1bf2_c01 ISOAMYLASE user 1 4 # 1 375 ASP A 83 ASP.? 8.52 O3 GOL D 147 435 GLU A 84 GLU.? 10.45 C3 GOL D 147 437 TRP A 86 TRP.? 11.27 C5 PGE A 147 510 ASP A 122 ASP^? 7.46 C1 GOL A 150 coo 88.62 69.90 41.16 89.05 70.67 43.04 -19.46 70.43 -3.04 -19.06 72.28 -2.05 coo 89.52 76.11 40.17 89.01 75.16 41.97 -21.01 70.22 3.12 -21.10 71.95 4.30 coo 92.40 77.76 42.22 89.96 80.25 40.39 -23.97 66.49 5.70 -20.10 66.49 6.06 coo 84.89 77.60 46.67 85.63 75.79 46.03 -15.41 64.92 4.51 -15.09 66.83 5.33 ULMN 4 1bf2_c01 ISOAMYLASE user 2 4 # 2 375 ASP A 122 ASP^? 7.46 C1 GOL A 150 435 GLU A 84 GLU.? 10.45 C3 GOL D 147 437 TRP A 86 TRP.? 11.27 C5 PGE A 147 510 ASP A 83 ASP.? 8.52 O3 GOL D 147 coo 88.62 69.90 41.16 89.05 70.67 43.04 -15.41 64.92 4.51 -15.09 66.83 5.33 coo 89.52 76.11 40.17 89.01 75.16 41.97 -21.01 70.22 3.12 -21.10 71.95 4.30 coo 92.40 77.76 42.22 89.96 80.25 40.39 -23.97 66.49 5.70 -20.10 66.49 6.06 coo 84.89 77.60 46.67 85.63 75.79 46.03 -19.46 70.43 -3.04 -19.06 72.28 -2.05 ULMN 4 1bf2_c01 ISOAMYLASE user 3 4 # 3 375 ASP B 83 ASP.? 9.40 O3 GOL C 149 435 GLU B 84 GLU.? 10.31 O3 GOL C 149 437 TRP B 86 TRP.? 11.40 C6 PGE B 147 510 ASP B 122 ASP^? 7.33 O2 GOL B 149 coo 88.62 69.90 41.16 89.05 70.67 43.04 13.62 86.10 55.23 12.83 84.59 56.49 coo 89.52 76.11 40.17 89.01 75.16 41.97 7.66 84.31 53.13 6.13 83.49 54.35 coo 92.40 77.76 42.22 89.96 80.25 40.39 5.15 86.32 48.71 6.70 82.77 48.58 coo 84.89 77.60 46.67 85.63 75.79 46.03 10.89 79.68 47.57 9.75 78.80 49.16 ULMN 4 1bf2_c01 ISOAMYLASE user 4 4 # 4 375 ASP B 122 ASP^? 7.33 O2 GOL B 149 435 GLU B 84 GLU.? 10.31 O3 GOL C 149 437 TRP B 86 TRP.? 11.40 C6 PGE B 147 510 ASP B 83 ASP.? 9.40 O3 GOL C 149 coo 88.62 69.90 41.16 89.05 70.67 43.04 10.89 79.68 47.57 9.75 78.80 49.16 coo 89.52 76.11 40.17 89.01 75.16 41.97 7.66 84.31 53.13 6.13 83.49 54.35 coo 92.40 77.76 42.22 89.96 80.25 40.39 5.15 86.32 48.71 6.70 82.77 48.58 coo 84.89 77.60 46.67 85.63 75.79 46.03 13.62 86.10 55.23 12.83 84.59 56.49 ULMN 4 1bf2_c01 ISOAMYLASE user 5 4 # 5 375 ASP C 83 ASP.? 8.65 O3 GOL B 149 435 GLU C 84 GLU.? 10.77 O2 GOL B 149 437 TRP C 86 TRP.? 11.30 C1 PGE C 147 510 ASP C 122 ASP^? 7.22 C3 GOL C 149 coo 88.62 69.90 41.16 89.05 70.67 43.04 3.02 71.86 58.06 4.88 72.49 57.24 coo 89.52 76.11 40.17 89.01 75.16 41.97 2.34 77.12 55.01 3.46 78.21 53.60 coo 92.40 77.76 42.22 89.96 80.25 40.39 -2.64 79.47 53.33 -0.76 80.96 56.37 coo 84.89 77.60 46.67 85.63 75.79 46.03 0.27 81.12 61.60 2.07 81.54 60.53 ULMN 4 1bf2_c01 ISOAMYLASE user 6 4 # 6 375 ASP C 122 ASP^? 7.22 C3 GOL C 149 435 GLU C 84 GLU.? 10.77 O2 GOL B 149 437 TRP C 86 TRP.? 11.30 C1 PGE C 147 510 ASP C 83 ASP.? 8.65 O3 GOL B 149 coo 88.62 69.90 41.16 89.05 70.67 43.04 0.27 81.12 61.60 2.07 81.54 60.53 coo 89.52 76.11 40.17 89.01 75.16 41.97 2.34 77.12 55.01 3.46 78.21 53.60 coo 92.40 77.76 42.22 89.96 80.25 40.39 -2.64 79.47 53.33 -0.76 80.96 56.37 coo 84.89 77.60 46.67 85.63 75.79 46.03 3.02 71.86 58.06 4.88 72.49 57.24 ULMN 4 1bf2_c01 ISOAMYLASE user 7 4 # 7 375 ASP D 83 ASP.? 8.76 O1 GOL A 150 435 GLU D 84 GLU.? 10.79 C1 GOL A 150 437 TRP D 86 TRP.? 10.59 OH7 1PE B 150 510 ASP D 122 ASP^? 7.49 C3 GOL D 147 coo 88.62 69.90 41.16 89.05 70.67 43.04 -12.54 78.43 10.94 -12.46 77.06 9.29 coo 89.52 76.11 40.17 89.01 75.16 41.97 -17.40 74.78 10.23 -17.69 72.96 9.24 coo 92.40 77.76 42.22 89.96 80.25 40.39 -21.83 74.25 13.71 -22.24 76.29 10.42 coo 84.89 77.60 46.67 85.63 75.79 46.03 -21.82 80.90 7.85 -21.38 79.32 6.51 ULMN 4 1bf2_c01 ISOAMYLASE user 8 4 # 8 375 ASP D 122 ASP^? 7.49 C3 GOL D 147 435 GLU D 84 GLU.? 10.79 C1 GOL A 150 437 TRP D 86 TRP.? 10.59 OH7 1PE B 150 510 ASP D 83 ASP.? 8.76 O1 GOL A 150 coo 88.62 69.90 41.16 89.05 70.67 43.04 -21.82 80.90 7.85 -21.38 79.32 6.51 coo 89.52 76.11 40.17 89.01 75.16 41.97 -17.40 74.78 10.23 -17.69 72.96 9.24 coo 92.40 77.76 42.22 89.96 80.25 40.39 -21.83 74.25 13.71 -22.24 76.29 10.42 coo 84.89 77.60 46.67 85.63 75.79 46.03 -12.54 78.43 10.94 -12.46 77.06 9.29 1bf2_c01 source 1bf2 ISOAMYLASE : 8 hits 1bf2_c01 naa= 4 ULMN 4 1bf2_c03 ISOAMYLASE user 1 4 # 1 297 HIS A 4 HIS.? -3.92 C2 GOL A 150s 375 ASP A 122 ASP^? 7.46 C1 GOL A 150 435 GLU A 84 GLU.? 10.45 C3 GOL D 147 510 ASP A 83 ASP.? 8.52 O3 GOL D 147 coo 93.30 65.32 45.77 91.38 65.92 46.37 -11.85 68.18 8.83 -11.23 70.10 8.29 coo 88.62 69.90 41.16 89.05 70.67 43.04 -15.41 64.92 4.51 -15.09 66.83 5.33 coo 89.52 76.11 40.17 89.01 75.16 41.97 -21.01 70.22 3.12 -21.10 71.95 4.30 coo 84.89 77.60 46.67 85.63 75.79 46.03 -19.46 70.43 -3.04 -19.06 72.28 -2.05 ULMN 4 1bf2_c03 ISOAMYLASE user 2 4 # 2 297 HIS B 4 HIS.? -3.86 O2 GOL B 149s 375 ASP B 122 ASP^? 7.33 O2 GOL B 149 435 GLU B 84 GLU.? 10.31 O3 GOL C 149 510 ASP B 83 ASP.? 9.40 O3 GOL C 149 coo 93.30 65.32 45.77 91.38 65.92 46.37 8.07 73.88 49.16 8.30 73.43 51.19 coo 88.62 69.90 41.16 89.05 70.67 43.04 10.89 79.68 47.57 9.75 78.80 49.16 coo 89.52 76.11 40.17 89.01 75.16 41.97 7.66 84.31 53.13 6.13 83.49 54.35 coo 84.89 77.60 46.67 85.63 75.79 46.03 13.62 86.10 55.23 12.83 84.59 56.49 ULMN 4 1bf2_c03 ISOAMYLASE user 3 4 # 3 297 HIS C 4 HIS.? -3.73 C3 GOL C 149s 375 ASP C 122 ASP^? 7.22 C3 GOL C 149 435 GLU C 84 GLU.? 10.77 O2 GOL B 149 510 ASP C 83 ASP.? 8.65 O3 GOL B 149 coo 93.30 65.32 45.77 91.38 65.92 46.37 4.88 85.81 61.42 6.80 85.00 61.18 coo 88.62 69.90 41.16 89.05 70.67 43.04 0.27 81.12 61.60 2.07 81.54 60.53 coo 89.52 76.11 40.17 89.01 75.16 41.97 2.34 77.12 55.01 3.46 78.21 53.60 coo 84.89 77.60 46.67 85.63 75.79 46.03 3.02 71.86 58.06 4.88 72.49 57.24 ULMN 4 1bf2_c03 ISOAMYLASE user 4 4 # 4 297 HIS D 4 HIS.? 4.07 C3 GOL D 147 375 ASP D 122 ASP^? 7.49 C3 GOL D 147 435 GLU D 84 GLU.? 10.79 C1 GOL A 150 510 ASP D 83 ASP.? 8.76 O1 GOL A 150 coo 93.30 65.32 45.77 91.38 65.92 46.37 -23.57 78.63 1.94 -22.01 77.96 0.72 coo 88.62 69.90 41.16 89.05 70.67 43.04 -21.82 80.90 7.85 -21.38 79.32 6.51 coo 89.52 76.11 40.17 89.01 75.16 41.97 -17.40 74.78 10.23 -17.69 72.96 9.24 coo 84.89 77.60 46.67 85.63 75.79 46.03 -12.54 78.43 10.94 -12.46 77.06 9.29 1bf2_c03 source 1bf2 ISOAMYLASE : 4 hits 1bf2_c03 naa= 4 ULMN 4 1bvz_c02 ALPHA-AMYLASE II user 1 4 # 1 A 325 ASP A 83 ASP.? 8.52 O3 GOL D 147 A 354 GLU A 84 GLU.? 10.45 C3 GOL D 147 A 356 TRP A 86 TRP.? 11.27 C5 PGE A 147 A 421 ASP A 122 ASP^? 7.46 C1 GOL A 150 coo 31.05 49.37 64.51 31.97 51.11 63.85 -19.46 70.43 -3.04 -19.06 72.28 -2.05 coo 29.07 50.42 58.36 29.02 52.18 59.49 -21.01 70.22 3.12 -21.10 71.95 4.30 coo 32.40 51.51 54.93 28.61 52.36 55.13 -23.97 66.49 5.70 -20.10 66.49 6.06 coo 30.82 59.76 58.47 31.12 59.02 60.40 -15.41 64.92 4.51 -15.09 66.83 5.33 ULMN 4 1bvz_c02 ALPHA-AMYLASE II user 2 4 # 2 A 325 ASP B 83 ASP.? 9.40 O3 GOL C 149 A 354 GLU B 84 GLU.? 10.31 O3 GOL C 149 A 356 TRP B 86 TRP.? 11.40 C6 PGE B 147 A 421 ASP B 122 ASP^? 7.33 O2 GOL B 149 coo 31.05 49.37 64.51 31.97 51.11 63.85 13.62 86.10 55.23 12.83 84.59 56.49 coo 29.07 50.42 58.36 29.02 52.18 59.49 7.66 84.31 53.13 6.13 83.49 54.35 coo 32.40 51.51 54.93 28.61 52.36 55.13 5.15 86.32 48.71 6.70 82.77 48.58 coo 30.82 59.76 58.47 31.12 59.02 60.40 10.89 79.68 47.57 9.75 78.80 49.16 ULMN 4 1bvz_c02 ALPHA-AMYLASE II user 3 4 # 3 A 325 ASP C 83 ASP.? 8.65 O3 GOL B 149 A 354 GLU C 84 GLU.? 10.77 O2 GOL B 149 A 356 TRP C 86 TRP.? 11.30 C1 PGE C 147 A 421 ASP C 122 ASP^? 7.22 C3 GOL C 149 coo 31.05 49.37 64.51 31.97 51.11 63.85 3.02 71.86 58.06 4.88 72.49 57.24 coo 29.07 50.42 58.36 29.02 52.18 59.49 2.34 77.12 55.01 3.46 78.21 53.60 coo 32.40 51.51 54.93 28.61 52.36 55.13 -2.64 79.47 53.33 -0.76 80.96 56.37 coo 30.82 59.76 58.47 31.12 59.02 60.40 0.27 81.12 61.60 2.07 81.54 60.53 ULMN 4 1bvz_c02 ALPHA-AMYLASE II user 4 4 # 4 A 325 ASP D 83 ASP.? 8.76 O1 GOL A 150 A 354 GLU D 84 GLU.? 10.79 C1 GOL A 150 A 356 TRP D 86 TRP.? 10.59 OH7 1PE B 150 A 421 ASP D 122 ASP^? 7.49 C3 GOL D 147 coo 31.05 49.37 64.51 31.97 51.11 63.85 -12.54 78.43 10.94 -12.46 77.06 9.29 coo 29.07 50.42 58.36 29.02 52.18 59.49 -17.40 74.78 10.23 -17.69 72.96 9.24 coo 32.40 51.51 54.93 28.61 52.36 55.13 -21.83 74.25 13.71 -22.24 76.29 10.42 coo 30.82 59.76 58.47 31.12 59.02 60.40 -21.82 80.90 7.85 -21.38 79.32 6.51 1bvz_c02 source 1bvz ALPHA-AMYLASE II : 4 hits 1bvz_c02 naa= 4 ULMN 4 1bvz_c03 ALPHA-AMYLASE II user 1 4 # 1 B 325 ASP A 83 ASP.? 8.52 O3 GOL D 147 B 354 GLU A 84 GLU.? 10.45 C3 GOL D 147 B 356 TRP A 86 TRP.? 11.27 C5 PGE A 147 B 421 ASP A 87 ASP.? 8.49 C6 PGE A 147 coo 25.90 8.19 53.87 25.36 6.97 52.29 -19.46 70.43 -3.04 -19.06 72.28 -2.05 coo 27.87 10.66 47.95 27.82 8.60 48.27 -21.01 70.22 3.12 -21.10 71.95 4.30 coo 24.60 10.88 44.33 28.44 10.20 44.29 -23.97 66.49 5.70 -20.10 66.49 6.06 coo 26.02 1.87 43.38 25.90 1.97 45.49 -23.17 58.67 3.55 -22.34 59.17 1.69 ULMN 4 1bvz_c03 ALPHA-AMYLASE II user 2 4 # 2 B 325 ASP B 83 ASP.? 9.40 O3 GOL C 149 B 354 GLU B 84 GLU.? 10.31 O3 GOL C 149 B 356 TRP B 86 TRP.? 11.40 C6 PGE B 147 B 421 ASP B 87 ASP.? 8.94 O4 PGE B 147 coo 25.90 8.19 53.87 25.36 6.97 52.29 13.62 86.10 55.23 12.83 84.59 56.49 coo 27.87 10.66 47.95 27.82 8.60 48.27 7.66 84.31 53.13 6.13 83.49 54.35 coo 24.60 10.88 44.33 28.44 10.20 44.29 5.15 86.32 48.71 6.70 82.77 48.58 coo 26.02 1.87 43.38 25.90 1.97 45.49 9.49 87.97 42.02 11.31 87.98 43.09 ULMN 4 1bvz_c03 ALPHA-AMYLASE II user 3 4 # 3 B 325 ASP C 83 ASP.? 8.65 O3 GOL B 149 B 354 GLU C 84 GLU.? 10.77 O2 GOL B 149 B 356 TRP C 86 TRP.? 11.30 C1 PGE C 147 B 421 ASP C 87 ASP.? 8.84 O1 PGE C 147 coo 25.90 8.19 53.87 25.36 6.97 52.29 3.02 71.86 58.06 4.88 72.49 57.24 coo 27.87 10.66 47.95 27.82 8.60 48.27 2.34 77.12 55.01 3.46 78.21 53.60 coo 24.60 10.88 44.33 28.44 10.20 44.29 -2.64 79.47 53.33 -0.76 80.96 56.37 coo 26.02 1.87 43.38 25.90 1.97 45.49 -9.03 79.00 58.44 -8.21 77.39 59.55 ULMN 4 1bvz_c03 ALPHA-AMYLASE II user 4 4 # 4 B 325 ASP D 83 ASP.? 8.76 O1 GOL A 150 B 354 GLU D 84 GLU.? 10.79 C1 GOL A 150 B 356 TRP D 86 TRP.? 10.59 OH7 1PE B 150 B 421 ASP D 87 ASP.? 7.26 C16 1PE B 150 coo 25.90 8.19 53.87 25.36 6.97 52.29 -12.54 78.43 10.94 -12.46 77.06 9.29 coo 27.87 10.66 47.95 27.82 8.60 48.27 -17.40 74.78 10.23 -17.69 72.96 9.24 coo 24.60 10.88 44.33 28.44 10.20 44.29 -21.83 74.25 13.71 -22.24 76.29 10.42 coo 26.02 1.87 43.38 25.90 1.97 45.49 -24.70 80.89 17.41 -22.90 81.94 17.31 1bvz_c03 source 1bvz ALPHA-AMYLASE II : 4 hits 1bvz_c03 naa= 4 ULMN 4 1bvz_c07 ALPHA-AMYLASE II user 1 4 # 1 B 244 HIS B 4 HIS.? -3.86 O2 GOL B 149s B 325 ASP B 122 ASP^? 7.33 O2 GOL B 149 B 354 GLU B 121 GLU^? 8.74 O2 PEG B 144 B 421 ASP B 83 ASP.? 9.40 O3 GOL C 149 coo 18.86 7.90 56.29 20.11 7.10 54.89 8.07 73.88 49.16 8.30 73.43 51.19 coo 25.90 8.19 53.87 25.36 6.97 52.29 10.89 79.68 47.57 9.75 78.80 49.16 coo 27.87 10.66 47.95 27.82 8.60 48.27 15.37 80.83 45.64 16.23 82.69 46.15 coo 26.02 1.87 43.38 25.90 1.97 45.49 13.62 86.10 55.23 12.83 84.59 56.49 ULMN 4 1bvz_c07 ALPHA-AMYLASE II user 2 4 # 2 B 244 HIS C 4 HIS.? -3.73 C3 GOL C 149s B 325 ASP C 122 ASP^? 7.22 C3 GOL C 149 B 354 GLU C 121 GLU^? 12.40 C3 GOL C 149 B 421 ASP C 83 ASP.? 8.65 O3 GOL B 149 coo 18.86 7.90 56.29 20.11 7.10 54.89 4.88 85.81 61.42 6.80 85.00 61.18 coo 25.90 8.19 53.87 25.36 6.97 52.29 0.27 81.12 61.60 2.07 81.54 60.53 coo 27.87 10.66 47.95 27.82 8.60 48.27 -1.98 78.69 65.48 -2.54 76.71 65.06 coo 26.02 1.87 43.38 25.90 1.97 45.49 3.02 71.86 58.06 4.88 72.49 57.24 1bvz_c07 source 1bvz ALPHA-AMYLASE II : 2 hits 1bvz_c07 naa= 4 ULMN 4 1c17_c11 ATP SYNTHASE SUBUNIT C user 1 4 # 1 A 61 ASP A 87 ASP.? 8.49 C6 PGE A 147 M 206 SER A 96 SER~? 7.38 O1 SO4 A 144 M 210 ARG A 127 ARG^? 7.47 N MLZ A 129 M 214 ASN A 18 ASN~? 7.05 CM MLZ A 129 coo 2.15 -17.14 -6.89 2.91 -15.59 -8.10 -23.17 58.67 3.55 -22.34 59.17 1.69 coo -2.55 -23.32 19.81 -3.48 -21.59 18.38 -20.86 61.67 30.54 -19.56 59.85 31.49 coo 1.98 -17.11 17.69 1.79 -15.15 15.33 -18.44 68.25 24.06 -17.70 68.37 27.04 coo 8.13 -16.73 20.92 6.75 -15.93 19.51 -15.51 71.08 28.46 -17.41 71.81 28.97 ULMN 4 1c17_c11 ATP SYNTHASE SUBUNIT C user 2 4 # 2 A 61 ASP B 87 ASP.? 8.94 O4 PGE B 147 M 206 SER B 96 SER~? 7.21 O4 SO4 A 144 M 210 ARG B 127 ARG^? 9.26 O4 SO4 A 144 M 214 ASN B 18 ASN~? 7.46 O3 PGE C 147 coo 2.15 -17.14 -6.89 2.91 -15.59 -8.10 9.49 87.97 42.02 11.31 87.98 43.09 coo -2.55 -23.32 19.81 -3.48 -21.59 18.38 -12.28 72.78 35.88 -11.90 71.42 33.88 coo 1.98 -17.11 17.69 1.79 -15.15 15.33 -7.64 72.55 44.16 -9.78 70.52 43.36 coo 8.13 -16.73 20.92 6.75 -15.93 19.51 -10.56 67.47 45.50 -12.09 68.82 46.03 ULMN 4 1c17_c11 ATP SYNTHASE SUBUNIT C user 3 4 # 3 A 61 ASP B 106 ASP~? 11.87 OH2 1PE B 150 M 206 SER A 57 SER~? 3.96 C21 2PE A 148 M 210 ARG A 116 ARG~? 4.70 C15 2PE A 148 M 214 ASN A 28 ASN^? 3.50 CL CL A 145s coo 2.15 -17.14 -6.89 2.91 -15.59 -8.10 -0.30 70.27 27.08 -0.10 70.78 25.05 coo -2.55 -23.32 19.81 -3.48 -21.59 18.38 -17.83 49.34 18.20 -18.57 51.11 16.71 coo 1.98 -17.11 17.69 1.79 -15.15 15.33 -15.13 57.15 12.87 -15.00 60.01 11.67 coo 8.13 -16.73 20.92 6.75 -15.93 19.51 -22.13 61.51 13.69 -20.95 60.87 15.35 ULMN 4 1c17_c11 ATP SYNTHASE SUBUNIT C user 4 4 # 4 A 61 ASP C 87 ASP.? 8.84 O1 PGE C 147 M 206 SER C 96 SER~? 11.39 N MLY C 67 M 210 ARG C 127 ARG^? 7.44 N MLZ C 129 M 214 ASN C 18 ASN~? 7.71 C3 PGE B 147 coo 2.15 -17.14 -6.89 2.91 -15.59 -8.10 -9.03 79.00 58.44 -8.21 77.39 59.55 coo -2.55 -23.32 19.81 -3.48 -21.59 18.38 -5.29 104.57 49.79 -6.22 106.17 51.38 coo 1.98 -17.11 17.69 1.79 -15.15 15.33 1.53 98.09 50.88 2.14 101.05 50.40 coo 8.13 -16.73 20.92 6.75 -15.93 19.51 5.53 102.64 50.54 5.25 102.39 48.47 ULMN 4 1c17_c11 ATP SYNTHASE SUBUNIT C user 5 4 # 5 A 61 ASP D 87 ASP.? 7.26 C16 1PE B 150 M 206 SER D 96 SER~? 11.44 N MLY D 67 M 210 ARG D 127 ARG^? 9.31 O3 PGE A 147 M 214 ASN D 18 ASN~? 7.72 O4 PGE A 147 coo 2.15 -17.14 -6.89 2.91 -15.59 -8.10 -24.70 80.89 17.41 -22.90 81.94 17.31 coo -2.55 -23.32 19.81 -3.48 -21.59 18.38 -44.97 67.48 5.17 -46.83 69.00 4.60 coo 1.98 -17.11 17.69 1.79 -15.15 15.33 -35.94 67.72 2.28 -38.25 66.55 0.66 coo 8.13 -16.73 20.92 6.75 -15.93 19.51 -37.88 65.32 -2.95 -37.84 63.53 -1.86 1c17_c11 source 1c17 ATP SYNTHASE SUBUNIT C : 5 hits 1c17_c11 naa= 4 ULMN 4 1cd5_c00 GLUCOSAMINE 6-PHOSPHATE DEAMINASE user 1 4 # 1 A 72 ASP A 40 ASP.? 18.50 C9 2PE A 148 A 141 ASP A 56 ASP~? 11.59 C21 2PE A 148 A 143 HIS A 115 HIS~? 12.27 C21 2PE A 148 A 148 GLU A 111 GLU~? 12.48 C11 2PE A 148 coo 86.21 51.78 11.27 86.87 50.27 12.61 -5.23 45.83 3.63 -5.09 44.63 5.33 coo 77.92 48.13 25.32 78.70 49.17 23.61 -16.01 45.89 15.64 -15.93 44.31 14.23 coo 79.83 48.98 19.95 81.76 49.72 20.33 -13.18 48.35 10.37 -12.55 46.36 10.33 coo 76.11 54.71 19.44 77.75 55.81 18.59 -8.13 46.06 17.22 -6.45 46.46 15.98 ULMN 4 1cd5_c00 GLUCOSAMINE 6-PHOSPHATE DEAMINASE user 2 4 # 2 A 72 ASP B 40 ASP.? 11.67 O1 PEG B 144 A 141 ASP B 56 ASP~? 11.45 C20 PE8 B 148 A 143 HIS B 115 HIS~? 12.48 C18 PE8 B 148 A 148 GLU B 111 GLU~? 12.54 O7 PE8 B 148 coo 86.21 51.78 11.27 86.87 50.27 12.61 22.51 72.75 29.32 21.02 74.20 28.79 coo 77.92 48.13 25.32 78.70 49.17 23.61 6.80 78.21 26.00 8.47 79.07 25.03 coo 79.83 48.98 19.95 81.76 49.72 20.33 11.86 77.76 30.05 12.70 77.49 28.15 coo 76.11 54.71 19.44 77.75 55.81 18.59 9.41 70.70 25.55 11.25 69.94 26.27 ULMN 4 1cd5_c00 GLUCOSAMINE 6-PHOSPHATE DEAMINASE user 3 4 # 3 A 72 ASP D 40 ASP.? 18.38 C9 2PE D 146 A 141 ASP D 56 ASP~? 11.46 C21 2PE D 146 A 143 HIS D 115 HIS~? 12.18 C21 2PE D 146 A 148 GLU D 111 GLU~? 11.88 C9 2PE D 146 coo 86.21 51.78 11.27 86.87 50.27 12.61 -32.95 100.50 7.54 -33.10 99.69 9.54 coo 77.92 48.13 25.32 78.70 49.17 23.61 -41.85 87.81 13.66 -41.61 89.58 14.80 coo 79.83 48.98 19.95 81.76 49.72 20.33 -36.28 90.32 11.92 -37.49 91.98 12.35 coo 76.11 54.71 19.44 77.75 55.81 18.59 -43.22 91.45 6.64 -41.92 92.74 5.57 1cd5_c00 source 1cd5 GLUCOSAMINE 6-PHOSPHATE DEAMINASE : 3 hits 1cd5_c00 naa= 4 ULMN 4 1cdg_c03 CYCLODEXTRIN GLYCOSYLTRANSFERASE (E.user 1 4 # 1 140 HIS A 4 HIS.? -3.92 C2 GOL A 150s 229 ASP A 122 ASP^? 7.46 C1 GOL A 150 257 GLU A 84 GLU.? 10.45 C3 GOL D 147 328 ASP A 83 ASP.? 8.52 O3 GOL D 147 coo 44.94 80.12 51.43 44.17 80.95 49.66 -11.85 68.18 8.83 -11.23 70.10 8.29 coo 45.62 80.42 43.69 45.65 82.01 45.07 -15.41 64.92 4.51 -15.09 66.83 5.33 coo 48.97 85.16 40.39 47.18 86.25 40.47 -21.01 70.22 3.12 -21.10 71.95 4.30 coo 45.39 90.72 40.63 45.07 89.14 41.90 -19.46 70.43 -3.04 -19.06 72.28 -2.05 ULMN 4 1cdg_c03 CYCLODEXTRIN GLYCOSYLTRANSFERASE (E.user 2 4 # 2 140 HIS B 4 HIS.? -3.86 O2 GOL B 149s 229 ASP B 122 ASP^? 7.33 O2 GOL B 149 257 GLU B 84 GLU.? 10.31 O3 GOL C 149 328 ASP B 83 ASP.? 9.40 O3 GOL C 149 coo 44.94 80.12 51.43 44.17 80.95 49.66 8.07 73.88 49.16 8.30 73.43 51.19 coo 45.62 80.42 43.69 45.65 82.01 45.07 10.89 79.68 47.57 9.75 78.80 49.16 coo 48.97 85.16 40.39 47.18 86.25 40.47 7.66 84.31 53.13 6.13 83.49 54.35 coo 45.39 90.72 40.63 45.07 89.14 41.90 13.62 86.10 55.23 12.83 84.59 56.49 ULMN 4 1cdg_c03 CYCLODEXTRIN GLYCOSYLTRANSFERASE (E.user 3 4 # 3 140 HIS C 4 HIS.? -3.73 C3 GOL C 149s 229 ASP C 122 ASP^? 7.22 C3 GOL C 149 257 GLU C 84 GLU.? 10.77 O2 GOL B 149 328 ASP C 83 ASP.? 8.65 O3 GOL B 149 coo 44.94 80.12 51.43 44.17 80.95 49.66 4.88 85.81 61.42 6.80 85.00 61.18 coo 45.62 80.42 43.69 45.65 82.01 45.07 0.27 81.12 61.60 2.07 81.54 60.53 coo 48.97 85.16 40.39 47.18 86.25 40.47 2.34 77.12 55.01 3.46 78.21 53.60 coo 45.39 90.72 40.63 45.07 89.14 41.90 3.02 71.86 58.06 4.88 72.49 57.24 ULMN 4 1cdg_c03 CYCLODEXTRIN GLYCOSYLTRANSFERASE (E.user 4 4 # 4 140 HIS D 4 HIS.? 4.07 C3 GOL D 147 229 ASP D 122 ASP^? 7.49 C3 GOL D 147 257 GLU D 84 GLU.? 10.79 C1 GOL A 150 328 ASP D 83 ASP.? 8.76 O1 GOL A 150 coo 44.94 80.12 51.43 44.17 80.95 49.66 -23.57 78.63 1.94 -22.01 77.96 0.72 coo 45.62 80.42 43.69 45.65 82.01 45.07 -21.82 80.90 7.85 -21.38 79.32 6.51 coo 48.97 85.16 40.39 47.18 86.25 40.47 -17.40 74.78 10.23 -17.69 72.96 9.24 coo 45.39 90.72 40.63 45.07 89.14 41.90 -12.54 78.43 10.94 -12.46 77.06 9.29 1cdg_c03 source 1cdg CYCLODEXTRIN GLYCOSYLTRANSFERASE (E.C.2.4.1.19: 4 hits 1cdg_c03 naa= 4 ULMN 4 1ddj_c04 PLASMINOGEN user 1 4 # 1 A 603 HIS A 88 HIS^? 4.20 CH2 MLY D 135 A 646 ASP A 87 ASP.? 8.49 C6 PGE A 147 A 741 ALA A 47 ALA~? 9.02 CD MLY D 135 A 742 GLY A 46 GLY~? 12.01 CD MLY D 135 coo 17.92 60.45 -3.51 16.63 61.88 -2.68 -23.95 56.87 7.77 -24.14 54.98 6.86 coo 18.60 56.26 -8.31 18.53 57.26 -6.47 -23.17 58.67 3.55 -22.34 59.17 1.69 coo 15.76 55.12 -0.44 16.10 56.60 -0.54 -20.21 51.63 3.44 -21.40 51.48 2.53 coo 18.59 52.82 -1.50 17.88 52.53 -1.22 -16.75 52.82 2.36 -17.28 52.20 2.20 ULMN 4 1ddj_c04 PLASMINOGEN user 2 4 # 2 A 603 HIS A 115 HIS~? 12.27 C21 2PE A 148 A 646 ASP A 56 ASP~? 11.59 C21 2PE A 148 A 741 ALA A 51 ALA~? 7.23 CD MLY D 135 A 742 GLY A 54 GLY~? 5.80 C21 2PE A 148 coo 17.92 60.45 -3.51 16.63 61.88 -2.68 -13.18 48.35 10.37 -12.55 46.36 10.33 coo 18.60 56.26 -8.31 18.53 57.26 -6.47 -16.01 45.89 15.64 -15.93 44.31 14.23 coo 15.76 55.12 -0.44 16.10 56.60 -0.54 -20.65 48.85 8.75 -21.19 47.91 7.68 coo 18.59 52.82 -1.50 17.88 52.53 -1.22 -20.41 50.07 13.76 -19.88 49.43 13.69 ULMN 4 1ddj_c04 PLASMINOGEN user 3 4 # 3 A 603 HIS B 88 HIS^? 4.29 CH1 MLY C 135 A 646 ASP B 87 ASP.? 8.94 O4 PGE B 147 A 741 ALA B 47 ALA~? 9.27 CD MLY C 135 A 742 GLY B 46 GLY~? 9.70 O1 PEG B 144 coo 17.92 60.45 -3.51 16.63 61.88 -2.68 6.15 87.00 38.94 7.35 87.96 37.51 coo 18.60 56.26 -8.31 18.53 57.26 -6.47 9.49 87.97 42.02 11.31 87.98 43.09 coo 15.76 55.12 -0.44 16.10 56.60 -0.54 13.13 86.65 35.42 13.34 88.15 35.52 coo 18.59 52.82 -1.50 17.88 52.53 -1.22 15.35 83.93 36.97 15.42 84.55 36.41 ULMN 4 1ddj_c04 PLASMINOGEN user 4 4 # 4 A 603 HIS B 115 HIS~? 12.48 C18 PE8 B 148 A 646 ASP B 56 ASP~? 11.45 C20 PE8 B 148 A 741 ALA B 51 ALA~? 7.25 CG MLY C 135 A 742 GLY B 54 GLY~? 5.68 C20 PE8 B 148 coo 17.92 60.45 -3.51 16.63 61.88 -2.68 11.86 77.76 30.05 12.70 77.49 28.15 coo 18.60 56.26 -8.31 18.53 57.26 -6.47 6.80 78.21 26.00 8.47 79.07 25.03 coo 15.76 55.12 -0.44 16.10 56.60 -0.54 9.29 84.92 31.07 10.11 86.09 30.55 coo 18.59 52.82 -1.50 17.88 52.53 -1.22 5.02 82.24 30.45 5.51 81.90 29.87 ULMN 4 1ddj_c04 PLASMINOGEN user 5 4 # 5 A 603 HIS C 88 HIS^? 3.86 CD MLY B 135 A 646 ASP C 87 ASP.? 8.84 O1 PGE C 147 A 741 ALA C 47 ALA~? 8.78 CD MLY B 135 A 742 GLY C 46 GLY~? 10.04 O MLZ C 114 coo 17.92 60.45 -3.51 16.63 61.88 -2.68 -11.00 83.03 57.18 -12.69 82.43 58.26 coo 18.60 56.26 -8.31 18.53 57.26 -6.47 -9.03 79.00 58.44 -8.21 77.39 59.55 coo 15.76 55.12 -0.44 16.10 56.60 -0.54 -13.73 80.92 64.16 -14.51 79.74 63.61 coo 18.59 52.82 -1.50 17.88 52.53 -1.22 -10.91 80.74 66.75 -11.70 80.52 66.65 ULMN 4 1ddj_c04 PLASMINOGEN user 6 4 # 6 A 603 HIS C 115 HIS~? 4.72 C MLZ C 114 A 646 ASP C 56 ASP~? 9.09 N MLZ C 114 A 741 ALA C 51 ALA~? 7.46 CD MLY B 135 A 742 GLY C 54 GLY~? 6.00 CH2 MLY B 135 coo 17.92 60.45 -3.51 16.63 61.88 -2.68 -12.99 90.00 69.08 -14.38 90.57 70.54 coo 18.60 56.26 -8.31 18.53 57.26 -6.47 -16.40 94.43 66.11 -17.63 93.56 67.58 coo 15.76 55.12 -0.44 16.10 56.60 -0.54 -16.25 86.28 63.34 -17.35 85.28 63.69 coo 18.59 52.82 -1.50 17.88 52.53 -1.22 -15.22 90.72 61.35 -15.47 90.98 62.07 ULMN 4 1ddj_c04 PLASMINOGEN user 7 4 # 7 A 603 HIS D 88 HIS^? 4.38 CH1 MLY A 135 A 646 ASP D 87 ASP.? 7.26 C16 1PE B 150 A 741 ALA D 47 ALA~? 9.03 CG MLY A 135 A 742 GLY D 46 GLY~? 12.21 CD MLY A 135 coo 17.92 60.45 -3.51 16.63 61.88 -2.68 -29.18 79.71 17.63 -29.43 81.25 19.03 coo 18.60 56.26 -8.31 18.53 57.26 -6.47 -24.70 80.89 17.41 -22.90 81.94 17.31 coo 15.76 55.12 -0.44 16.10 56.60 -0.54 -28.68 87.42 18.40 -28.00 87.29 19.73 coo 18.59 52.82 -1.50 17.88 52.53 -1.22 -27.16 89.12 15.33 -27.37 89.29 16.11 ULMN 4 1ddj_c04 PLASMINOGEN user 8 4 # 8 A 603 HIS D 115 HIS~? 12.18 C21 2PE D 146 A 646 ASP D 56 ASP~? 11.46 C21 2PE D 146 A 741 ALA D 51 ALA~? 6.92 CG MLY A 135 A 742 GLY D 54 GLY~? 5.81 C23 2PE D 146 coo 17.92 60.45 -3.51 16.63 61.88 -2.68 -36.28 90.32 11.92 -37.49 91.98 12.35 coo 18.60 56.26 -8.31 18.53 57.26 -6.47 -41.85 87.81 13.66 -41.61 89.58 14.80 coo 15.76 55.12 -0.44 16.10 56.60 -0.54 -34.62 86.43 18.27 -34.28 87.19 19.52 coo 18.59 52.82 -1.50 17.88 52.53 -1.22 -38.01 83.52 15.98 -38.33 84.28 15.84 1ddj_c04 source 1ddj PLASMINOGEN : 8 hits 1ddj_c04 naa= 4 ULMN 4 1ddj_c05 PLASMINOGEN user 1 4 # 1 B 603 HIS A 88 HIS^? 4.20 CH2 MLY D 135 B 646 ASP A 87 ASP.? 8.49 C6 PGE A 147 B 741 ALA A 47 ALA~? 9.02 CD MLY D 135 B 742 GLY A 46 GLY~? 12.01 CD MLY D 135 coo -28.76 37.11 -20.75 -29.48 38.32 -19.19 -23.95 56.87 7.77 -24.14 54.98 6.86 coo -23.42 34.83 -23.78 -25.09 36.03 -23.31 -23.17 58.67 3.55 -22.34 59.17 1.69 coo -27.00 42.91 -23.45 -27.89 42.02 -22.58 -20.21 51.63 3.44 -21.40 51.48 2.53 coo -26.52 41.43 -26.94 -26.21 42.13 -26.73 -16.75 52.82 2.36 -17.28 52.20 2.20 ULMN 4 1ddj_c05 PLASMINOGEN user 2 4 # 2 B 603 HIS A 115 HIS~? 12.27 C21 2PE A 148 B 646 ASP A 56 ASP~? 11.59 C21 2PE A 148 B 741 ALA A 51 ALA~? 7.23 CD MLY D 135 B 742 GLY A 54 GLY~? 5.80 C21 2PE A 148 coo -28.76 37.11 -20.75 -29.48 38.32 -19.19 -13.18 48.35 10.37 -12.55 46.36 10.33 coo -23.42 34.83 -23.78 -25.09 36.03 -23.31 -16.01 45.89 15.64 -15.93 44.31 14.23 coo -27.00 42.91 -23.45 -27.89 42.02 -22.58 -20.65 48.85 8.75 -21.19 47.91 7.68 coo -26.52 41.43 -26.94 -26.21 42.13 -26.73 -20.41 50.07 13.76 -19.88 49.43 13.69 ULMN 4 1ddj_c05 PLASMINOGEN user 3 4 # 3 B 603 HIS B 88 HIS^? 4.29 CH1 MLY C 135 B 646 ASP B 87 ASP.? 8.94 O4 PGE B 147 B 741 ALA B 47 ALA~? 9.27 CD MLY C 135 B 742 GLY B 46 GLY~? 9.70 O1 PEG B 144 coo -28.76 37.11 -20.75 -29.48 38.32 -19.19 6.15 87.00 38.94 7.35 87.96 37.51 coo -23.42 34.83 -23.78 -25.09 36.03 -23.31 9.49 87.97 42.02 11.31 87.98 43.09 coo -27.00 42.91 -23.45 -27.89 42.02 -22.58 13.13 86.65 35.42 13.34 88.15 35.52 coo -26.52 41.43 -26.94 -26.21 42.13 -26.73 15.35 83.93 36.97 15.42 84.55 36.41 ULMN 4 1ddj_c05 PLASMINOGEN user 4 4 # 4 B 603 HIS B 115 HIS~? 12.48 C18 PE8 B 148 B 646 ASP B 56 ASP~? 11.45 C20 PE8 B 148 B 741 ALA B 51 ALA~? 7.25 CG MLY C 135 B 742 GLY B 54 GLY~? 5.68 C20 PE8 B 148 coo -28.76 37.11 -20.75 -29.48 38.32 -19.19 11.86 77.76 30.05 12.70 77.49 28.15 coo -23.42 34.83 -23.78 -25.09 36.03 -23.31 6.80 78.21 26.00 8.47 79.07 25.03 coo -27.00 42.91 -23.45 -27.89 42.02 -22.58 9.29 84.92 31.07 10.11 86.09 30.55 coo -26.52 41.43 -26.94 -26.21 42.13 -26.73 5.02 82.24 30.45 5.51 81.90 29.87 ULMN 4 1ddj_c05 PLASMINOGEN user 5 4 # 5 B 603 HIS C 88 HIS^? 3.86 CD MLY B 135 B 646 ASP C 87 ASP.? 8.84 O1 PGE C 147 B 741 ALA C 47 ALA~? 8.78 CD MLY B 135 B 742 GLY C 46 GLY~? 10.04 O MLZ C 114 coo -28.76 37.11 -20.75 -29.48 38.32 -19.19 -11.00 83.03 57.18 -12.69 82.43 58.26 coo -23.42 34.83 -23.78 -25.09 36.03 -23.31 -9.03 79.00 58.44 -8.21 77.39 59.55 coo -27.00 42.91 -23.45 -27.89 42.02 -22.58 -13.73 80.92 64.16 -14.51 79.74 63.61 coo -26.52 41.43 -26.94 -26.21 42.13 -26.73 -10.91 80.74 66.75 -11.70 80.52 66.65 ULMN 4 1ddj_c05 PLASMINOGEN user 6 4 # 6 B 603 HIS C 115 HIS~? 4.72 C MLZ C 114 B 646 ASP C 56 ASP~? 9.09 N MLZ C 114 B 741 ALA C 51 ALA~? 7.46 CD MLY B 135 B 742 GLY C 54 GLY~? 6.00 CH2 MLY B 135 coo -28.76 37.11 -20.75 -29.48 38.32 -19.19 -12.99 90.00 69.08 -14.38 90.57 70.54 coo -23.42 34.83 -23.78 -25.09 36.03 -23.31 -16.40 94.43 66.11 -17.63 93.56 67.58 coo -27.00 42.91 -23.45 -27.89 42.02 -22.58 -16.25 86.28 63.34 -17.35 85.28 63.69 coo -26.52 41.43 -26.94 -26.21 42.13 -26.73 -15.22 90.72 61.35 -15.47 90.98 62.07 ULMN 4 1ddj_c05 PLASMINOGEN user 7 4 # 7 B 603 HIS D 88 HIS^? 4.38 CH1 MLY A 135 B 646 ASP D 87 ASP.? 7.26 C16 1PE B 150 B 741 ALA D 47 ALA~? 9.03 CG MLY A 135 B 742 GLY D 46 GLY~? 12.21 CD MLY A 135 coo -28.76 37.11 -20.75 -29.48 38.32 -19.19 -29.18 79.71 17.63 -29.43 81.25 19.03 coo -23.42 34.83 -23.78 -25.09 36.03 -23.31 -24.70 80.89 17.41 -22.90 81.94 17.31 coo -27.00 42.91 -23.45 -27.89 42.02 -22.58 -28.68 87.42 18.40 -28.00 87.29 19.73 coo -26.52 41.43 -26.94 -26.21 42.13 -26.73 -27.16 89.12 15.33 -27.37 89.29 16.11 ULMN 4 1ddj_c05 PLASMINOGEN user 8 4 # 8 B 603 HIS D 115 HIS~? 12.18 C21 2PE D 146 B 646 ASP D 56 ASP~? 11.46 C21 2PE D 146 B 741 ALA D 51 ALA~? 6.92 CG MLY A 135 B 742 GLY D 54 GLY~? 5.81 C23 2PE D 146 coo -28.76 37.11 -20.75 -29.48 38.32 -19.19 -36.28 90.32 11.92 -37.49 91.98 12.35 coo -23.42 34.83 -23.78 -25.09 36.03 -23.31 -41.85 87.81 13.66 -41.61 89.58 14.80 coo -27.00 42.91 -23.45 -27.89 42.02 -22.58 -34.62 86.43 18.27 -34.28 87.19 19.52 coo -26.52 41.43 -26.94 -26.21 42.13 -26.73 -38.01 83.52 15.98 -38.33 84.28 15.84 1ddj_c05 source 1ddj PLASMINOGEN : 8 hits 1ddj_c05 naa= 4 ULMN 4 1ddj_c06 PLASMINOGEN user 1 4 # 1 C 603 HIS A 88 HIS^? 4.20 CH2 MLY D 135 C 646 ASP A 87 ASP.? 8.49 C6 PGE A 147 C 741 ALA A 47 ALA~? 9.02 CD MLY D 135 C 742 GLY A 46 GLY~? 12.01 CD MLY D 135 coo 15.33 59.81 59.60 13.98 60.99 60.69 -23.95 56.87 7.77 -24.14 54.98 6.86 coo 16.06 55.72 54.73 15.97 56.49 56.70 -23.17 58.67 3.55 -22.34 59.17 1.69 coo 13.55 54.01 62.74 13.86 55.50 62.79 -20.21 51.63 3.44 -21.40 51.48 2.53 coo 16.36 51.81 61.40 15.69 51.50 61.72 -16.75 52.82 2.36 -17.28 52.20 2.20 ULMN 4 1ddj_c06 PLASMINOGEN user 2 4 # 2 C 603 HIS A 115 HIS~? 12.27 C21 2PE A 148 C 646 ASP A 56 ASP~? 11.59 C21 2PE A 148 C 741 ALA A 51 ALA~? 7.23 CD MLY D 135 C 742 GLY A 54 GLY~? 5.80 C21 2PE A 148 coo 15.33 59.81 59.60 13.98 60.99 60.69 -13.18 48.35 10.37 -12.55 46.36 10.33 coo 16.06 55.72 54.73 15.97 56.49 56.70 -16.01 45.89 15.64 -15.93 44.31 14.23 coo 13.55 54.01 62.74 13.86 55.50 62.79 -20.65 48.85 8.75 -21.19 47.91 7.68 coo 16.36 51.81 61.40 15.69 51.50 61.72 -20.41 50.07 13.76 -19.88 49.43 13.69 ULMN 4 1ddj_c06 PLASMINOGEN user 3 4 # 3 C 603 HIS B 88 HIS^? 4.29 CH1 MLY C 135 C 646 ASP B 87 ASP.? 8.94 O4 PGE B 147 C 741 ALA B 47 ALA~? 9.27 CD MLY C 135 C 742 GLY B 46 GLY~? 9.70 O1 PEG B 144 coo 15.33 59.81 59.60 13.98 60.99 60.69 6.15 87.00 38.94 7.35 87.96 37.51 coo 16.06 55.72 54.73 15.97 56.49 56.70 9.49 87.97 42.02 11.31 87.98 43.09 coo 13.55 54.01 62.74 13.86 55.50 62.79 13.13 86.65 35.42 13.34 88.15 35.52 coo 16.36 51.81 61.40 15.69 51.50 61.72 15.35 83.93 36.97 15.42 84.55 36.41 ULMN 4 1ddj_c06 PLASMINOGEN user 4 4 # 4 C 603 HIS B 115 HIS~? 12.48 C18 PE8 B 148 C 646 ASP B 56 ASP~? 11.45 C20 PE8 B 148 C 741 ALA B 51 ALA~? 7.25 CG MLY C 135 C 742 GLY B 54 GLY~? 5.68 C20 PE8 B 148 coo 15.33 59.81 59.60 13.98 60.99 60.69 11.86 77.76 30.05 12.70 77.49 28.15 coo 16.06 55.72 54.73 15.97 56.49 56.70 6.80 78.21 26.00 8.47 79.07 25.03 coo 13.55 54.01 62.74 13.86 55.50 62.79 9.29 84.92 31.07 10.11 86.09 30.55 coo 16.36 51.81 61.40 15.69 51.50 61.72 5.02 82.24 30.45 5.51 81.90 29.87 ULMN 4 1ddj_c06 PLASMINOGEN user 5 4 # 5 C 603 HIS C 88 HIS^? 3.86 CD MLY B 135 C 646 ASP C 87 ASP.? 8.84 O1 PGE C 147 C 741 ALA C 47 ALA~? 8.78 CD MLY B 135 C 742 GLY C 46 GLY~? 10.04 O MLZ C 114 coo 15.33 59.81 59.60 13.98 60.99 60.69 -11.00 83.03 57.18 -12.69 82.43 58.26 coo 16.06 55.72 54.73 15.97 56.49 56.70 -9.03 79.00 58.44 -8.21 77.39 59.55 coo 13.55 54.01 62.74 13.86 55.50 62.79 -13.73 80.92 64.16 -14.51 79.74 63.61 coo 16.36 51.81 61.40 15.69 51.50 61.72 -10.91 80.74 66.75 -11.70 80.52 66.65 ULMN 4 1ddj_c06 PLASMINOGEN user 6 4 # 6 C 603 HIS C 115 HIS~? 4.72 C MLZ C 114 C 646 ASP C 56 ASP~? 9.09 N MLZ C 114 C 741 ALA C 51 ALA~? 7.46 CD MLY B 135 C 742 GLY C 54 GLY~? 6.00 CH2 MLY B 135 coo 15.33 59.81 59.60 13.98 60.99 60.69 -12.99 90.00 69.08 -14.38 90.57 70.54 coo 16.06 55.72 54.73 15.97 56.49 56.70 -16.40 94.43 66.11 -17.63 93.56 67.58 coo 13.55 54.01 62.74 13.86 55.50 62.79 -16.25 86.28 63.34 -17.35 85.28 63.69 coo 16.36 51.81 61.40 15.69 51.50 61.72 -15.22 90.72 61.35 -15.47 90.98 62.07 ULMN 4 1ddj_c06 PLASMINOGEN user 7 4 # 7 C 603 HIS D 88 HIS^? 4.38 CH1 MLY A 135 C 646 ASP D 87 ASP.? 7.26 C16 1PE B 150 C 741 ALA D 47 ALA~? 9.03 CG MLY A 135 C 742 GLY D 46 GLY~? 12.21 CD MLY A 135 coo 15.33 59.81 59.60 13.98 60.99 60.69 -29.18 79.71 17.63 -29.43 81.25 19.03 coo 16.06 55.72 54.73 15.97 56.49 56.70 -24.70 80.89 17.41 -22.90 81.94 17.31 coo 13.55 54.01 62.74 13.86 55.50 62.79 -28.68 87.42 18.40 -28.00 87.29 19.73 coo 16.36 51.81 61.40 15.69 51.50 61.72 -27.16 89.12 15.33 -27.37 89.29 16.11 ULMN 4 1ddj_c06 PLASMINOGEN user 8 4 # 8 C 603 HIS D 115 HIS~? 12.18 C21 2PE D 146 C 646 ASP D 56 ASP~? 11.46 C21 2PE D 146 C 741 ALA D 51 ALA~? 6.92 CG MLY A 135 C 742 GLY D 54 GLY~? 5.81 C23 2PE D 146 coo 15.33 59.81 59.60 13.98 60.99 60.69 -36.28 90.32 11.92 -37.49 91.98 12.35 coo 16.06 55.72 54.73 15.97 56.49 56.70 -41.85 87.81 13.66 -41.61 89.58 14.80 coo 13.55 54.01 62.74 13.86 55.50 62.79 -34.62 86.43 18.27 -34.28 87.19 19.52 coo 16.36 51.81 61.40 15.69 51.50 61.72 -38.01 83.52 15.98 -38.33 84.28 15.84 1ddj_c06 source 1ddj PLASMINOGEN : 8 hits 1ddj_c06 naa= 4 ULMN 4 1ddj_c07 PLASMINOGEN user 1 4 # 1 D 603 HIS A 88 HIS^? 4.20 CH2 MLY D 135 D 646 ASP A 87 ASP.? 8.49 C6 PGE A 147 D 741 ALA A 47 ALA~? 9.02 CD MLY D 135 D 742 GLY A 46 GLY~? 12.01 CD MLY D 135 coo -30.51 33.83 43.05 -30.50 33.12 45.03 -23.95 56.87 7.77 -24.14 54.98 6.86 coo -25.73 33.05 39.28 -27.50 34.05 39.88 -23.17 58.67 3.55 -22.34 59.17 1.69 coo -29.58 40.72 40.37 -30.29 39.69 41.25 -20.21 51.63 3.44 -21.40 51.48 2.53 coo -29.22 39.61 36.72 -28.92 40.32 37.00 -16.75 52.82 2.36 -17.28 52.20 2.20 ULMN 4 1ddj_c07 PLASMINOGEN user 2 4 # 2 D 603 HIS A 115 HIS~? 12.27 C21 2PE A 148 D 646 ASP A 56 ASP~? 11.59 C21 2PE A 148 D 741 ALA A 51 ALA~? 7.23 CD MLY D 135 D 742 GLY A 54 GLY~? 5.80 C21 2PE A 148 coo -30.51 33.83 43.05 -30.50 33.12 45.03 -13.18 48.35 10.37 -12.55 46.36 10.33 coo -25.73 33.05 39.28 -27.50 34.05 39.88 -16.01 45.89 15.64 -15.93 44.31 14.23 coo -29.58 40.72 40.37 -30.29 39.69 41.25 -20.65 48.85 8.75 -21.19 47.91 7.68 coo -29.22 39.61 36.72 -28.92 40.32 37.00 -20.41 50.07 13.76 -19.88 49.43 13.69 ULMN 4 1ddj_c07 PLASMINOGEN user 3 4 # 3 D 603 HIS B 88 HIS^? 4.29 CH1 MLY C 135 D 646 ASP B 87 ASP.? 8.94 O4 PGE B 147 D 741 ALA B 47 ALA~? 9.27 CD MLY C 135 D 742 GLY B 46 GLY~? 9.70 O1 PEG B 144 coo -30.51 33.83 43.05 -30.50 33.12 45.03 6.15 87.00 38.94 7.35 87.96 37.51 coo -25.73 33.05 39.28 -27.50 34.05 39.88 9.49 87.97 42.02 11.31 87.98 43.09 coo -29.58 40.72 40.37 -30.29 39.69 41.25 13.13 86.65 35.42 13.34 88.15 35.52 coo -29.22 39.61 36.72 -28.92 40.32 37.00 15.35 83.93 36.97 15.42 84.55 36.41 ULMN 4 1ddj_c07 PLASMINOGEN user 4 4 # 4 D 603 HIS B 115 HIS~? 12.48 C18 PE8 B 148 D 646 ASP B 56 ASP~? 11.45 C20 PE8 B 148 D 741 ALA B 51 ALA~? 7.25 CG MLY C 135 D 742 GLY B 54 GLY~? 5.68 C20 PE8 B 148 coo -30.51 33.83 43.05 -30.50 33.12 45.03 11.86 77.76 30.05 12.70 77.49 28.15 coo -25.73 33.05 39.28 -27.50 34.05 39.88 6.80 78.21 26.00 8.47 79.07 25.03 coo -29.58 40.72 40.37 -30.29 39.69 41.25 9.29 84.92 31.07 10.11 86.09 30.55 coo -29.22 39.61 36.72 -28.92 40.32 37.00 5.02 82.24 30.45 5.51 81.90 29.87 ULMN 4 1ddj_c07 PLASMINOGEN user 5 4 # 5 D 603 HIS C 88 HIS^? 3.86 CD MLY B 135 D 646 ASP C 87 ASP.? 8.84 O1 PGE C 147 D 741 ALA C 47 ALA~? 8.78 CD MLY B 135 D 742 GLY C 46 GLY~? 10.04 O MLZ C 114 coo -30.51 33.83 43.05 -30.50 33.12 45.03 -11.00 83.03 57.18 -12.69 82.43 58.26 coo -25.73 33.05 39.28 -27.50 34.05 39.88 -9.03 79.00 58.44 -8.21 77.39 59.55 coo -29.58 40.72 40.37 -30.29 39.69 41.25 -13.73 80.92 64.16 -14.51 79.74 63.61 coo -29.22 39.61 36.72 -28.92 40.32 37.00 -10.91 80.74 66.75 -11.70 80.52 66.65 ULMN 4 1ddj_c07 PLASMINOGEN user 6 4 # 6 D 603 HIS C 115 HIS~? 4.72 C MLZ C 114 D 646 ASP C 56 ASP~? 9.09 N MLZ C 114 D 741 ALA C 51 ALA~? 7.46 CD MLY B 135 D 742 GLY C 54 GLY~? 6.00 CH2 MLY B 135 coo -30.51 33.83 43.05 -30.50 33.12 45.03 -12.99 90.00 69.08 -14.38 90.57 70.54 coo -25.73 33.05 39.28 -27.50 34.05 39.88 -16.40 94.43 66.11 -17.63 93.56 67.58 coo -29.58 40.72 40.37 -30.29 39.69 41.25 -16.25 86.28 63.34 -17.35 85.28 63.69 coo -29.22 39.61 36.72 -28.92 40.32 37.00 -15.22 90.72 61.35 -15.47 90.98 62.07 ULMN 4 1ddj_c07 PLASMINOGEN user 7 4 # 7 D 603 HIS D 88 HIS^? 4.38 CH1 MLY A 135 D 646 ASP D 87 ASP.? 7.26 C16 1PE B 150 D 741 ALA D 47 ALA~? 9.03 CG MLY A 135 D 742 GLY D 46 GLY~? 12.21 CD MLY A 135 coo -30.51 33.83 43.05 -30.50 33.12 45.03 -29.18 79.71 17.63 -29.43 81.25 19.03 coo -25.73 33.05 39.28 -27.50 34.05 39.88 -24.70 80.89 17.41 -22.90 81.94 17.31 coo -29.58 40.72 40.37 -30.29 39.69 41.25 -28.68 87.42 18.40 -28.00 87.29 19.73 coo -29.22 39.61 36.72 -28.92 40.32 37.00 -27.16 89.12 15.33 -27.37 89.29 16.11 ULMN 4 1ddj_c07 PLASMINOGEN user 8 4 # 8 D 603 HIS D 115 HIS~? 12.18 C21 2PE D 146 D 646 ASP D 56 ASP~? 11.46 C21 2PE D 146 D 741 ALA D 51 ALA~? 6.92 CG MLY A 135 D 742 GLY D 54 GLY~? 5.81 C23 2PE D 146 coo -30.51 33.83 43.05 -30.50 33.12 45.03 -36.28 90.32 11.92 -37.49 91.98 12.35 coo -25.73 33.05 39.28 -27.50 34.05 39.88 -41.85 87.81 13.66 -41.61 89.58 14.80 coo -29.58 40.72 40.37 -30.29 39.69 41.25 -34.62 86.43 18.27 -34.28 87.19 19.52 coo -29.22 39.61 36.72 -28.92 40.32 37.00 -38.01 83.52 15.98 -38.33 84.28 15.84 1ddj_c07 source 1ddj PLASMINOGEN : 8 hits 1ddj_c07 naa= 4 ULMN 4 1dl2_c00 CLASS I ALPHA-1,2-MANNOSIDASE user 1 4 # 1 A 132 GLU A 102 GLU~? 6.28 O2 SO4 A 143 A 136 ARG A 105 ARG~? -3.04 O2 SO4 A 143s A 275 ASP A 19 ASP.? -3.59 O4 SO4 A 144s A 435 GLU B 102 GLU~? 6.18 O4 SO4 A 143 coo -6.23 53.40 -2.33 -7.38 55.09 -1.77 -14.00 55.24 30.65 -12.08 54.69 31.20 coo -4.99 57.22 1.82 -7.93 56.43 2.21 -8.78 56.32 28.12 -7.90 58.53 30.04 coo -12.63 61.87 -10.13 -11.95 60.35 -8.79 -15.01 66.98 32.71 -14.52 68.02 34.44 coo -13.69 65.25 -3.58 -13.46 63.85 -2.01 -7.10 67.86 29.77 -6.34 66.05 29.12 1dl2_c00 source 1dl2 CLASS I ALPHA-1,2-MANNOSIDASE : 1 hits 1dl2_c00 naa= 4 ULMN 4 1f75_c00 UNDECAPRENYL PYROPHOSPHATE SYNTHETASuser 1 4 # 1 A 33 ARG A 16 ARG~? -2.82 O4 SO4 A 143s A 42 ARG B 16 ARG~? -3.64 O1 SO4 A 143s A 197 ARG A 20 ARG.? 4.64 CB MLZ A 129 A 203 ARG A 127 ARG^? 7.47 N MLZ A 129 coo 23.24 19.51 21.94 24.57 16.76 21.61 -9.29 63.37 28.06 -8.90 62.24 30.90 coo 16.08 17.48 28.78 19.09 16.85 28.49 -4.85 63.18 38.40 -7.23 62.95 36.44 coo 28.26 9.63 19.68 28.71 10.56 22.55 -20.19 69.79 30.19 -22.38 67.97 29.03 coo 33.62 12.31 23.18 30.84 12.90 24.36 -18.44 68.25 24.06 -17.70 68.37 27.04 ULMN 4 1f75_c00 UNDECAPRENYL PYROPHOSPHATE SYNTHETASuser 2 4 # 2 A 33 ARG B 16 ARG~? -3.64 O1 SO4 A 143s A 42 ARG A 16 ARG~? -2.82 O4 SO4 A 143s A 197 ARG B 20 ARG.? 7.28 C1 PEG B 146 A 203 ARG B 127 ARG^? 9.26 O4 SO4 A 144 coo 23.24 19.51 21.94 24.57 16.76 21.61 -4.85 63.18 38.40 -7.23 62.95 36.44 coo 16.08 17.48 28.78 19.09 16.85 28.49 -9.29 63.37 28.06 -8.90 62.24 30.90 coo 28.26 9.63 19.68 28.71 10.56 22.55 -14.05 70.97 43.62 -13.60 73.76 42.39 coo 33.62 12.31 23.18 30.84 12.90 24.36 -7.64 72.55 44.16 -9.78 70.52 43.36 ULMN 4 1f75_c00 UNDECAPRENYL PYROPHOSPHATE SYNTHETASuser 3 4 # 3 A 33 ARG B 16 ARG~? -3.64 O1 SO4 A 143s A 42 ARG A 16 ARG~? -2.82 O4 SO4 A 143s A 197 ARG B 127 ARG^? 9.26 O4 SO4 A 144 A 203 ARG B 20 ARG.? 7.28 C1 PEG B 146 coo 23.24 19.51 21.94 24.57 16.76 21.61 -4.85 63.18 38.40 -7.23 62.95 36.44 coo 16.08 17.48 28.78 19.09 16.85 28.49 -9.29 63.37 28.06 -8.90 62.24 30.90 coo 28.26 9.63 19.68 28.71 10.56 22.55 -7.64 72.55 44.16 -9.78 70.52 43.36 coo 33.62 12.31 23.18 30.84 12.90 24.36 -14.05 70.97 43.62 -13.60 73.76 42.39 1f75_c00 source 1f75 UNDECAPRENYL PYROPHOSPHATE SYNTHETASE : 3 hits 1f75_c00 naa= 4 ULMN 4 1f75_c01 UNDECAPRENYL PYROPHOSPHATE SYNTHETASuser 1 4 # 1 B 33 ARG A 16 ARG~? -2.82 O4 SO4 A 143s B 42 ARG A 110 ARG~? -3.66 O1 2PE A 148s B 197 ARG A 127 ARG^? 7.47 N MLZ A 129 B 203 ARG A 20 ARG.? 4.64 CB MLZ A 129 coo 42.69 1.07 -0.40 42.64 1.65 2.61 -9.29 63.37 28.06 -8.90 62.24 30.90 coo 53.37 -3.67 -3.96 53.38 -5.27 -1.33 -6.91 52.41 21.82 -5.61 55.22 21.43 coo 40.75 3.79 10.50 41.03 0.76 9.97 -18.44 68.25 24.06 -17.70 68.37 27.04 coo 36.15 -1.87 10.26 38.18 -1.23 8.01 -20.19 69.79 30.19 -22.38 67.97 29.03 ULMN 4 1f75_c01 UNDECAPRENYL PYROPHOSPHATE SYNTHETASuser 2 4 # 2 B 33 ARG B 16 ARG~? -3.64 O1 SO4 A 143s B 42 ARG A 105 ARG~? -3.04 O2 SO4 A 143s B 197 ARG B 20 ARG.? 7.28 C1 PEG B 146 B 203 ARG B 127 ARG^? 9.26 O4 SO4 A 144 coo 42.69 1.07 -0.40 42.64 1.65 2.61 -4.85 63.18 38.40 -7.23 62.95 36.44 coo 53.37 -3.67 -3.96 53.38 -5.27 -1.33 -8.78 56.32 28.12 -7.90 58.53 30.04 coo 40.75 3.79 10.50 41.03 0.76 9.97 -14.05 70.97 43.62 -13.60 73.76 42.39 coo 36.15 -1.87 10.26 38.18 -1.23 8.01 -7.64 72.55 44.16 -9.78 70.52 43.36 ULMN 4 1f75_c01 UNDECAPRENYL PYROPHOSPHATE SYNTHETASuser 3 4 # 3 B 33 ARG B 16 ARG~? -3.64 O1 SO4 A 143s B 42 ARG B 110 ARG~? 10.12 O7 PE8 B 148 B 197 ARG B 127 ARG^? 9.26 O4 SO4 A 144 B 203 ARG B 20 ARG.? 7.28 C1 PEG B 146 coo 42.69 1.07 -0.40 42.64 1.65 2.61 -4.85 63.18 38.40 -7.23 62.95 36.44 coo 53.37 -3.67 -3.96 53.38 -5.27 -1.33 4.56 66.25 30.54 5.81 64.43 28.32 coo 40.75 3.79 10.50 41.03 0.76 9.97 -7.64 72.55 44.16 -9.78 70.52 43.36 coo 36.15 -1.87 10.26 38.18 -1.23 8.01 -14.05 70.97 43.62 -13.60 73.76 42.39 ULMN 4 1f75_c01 UNDECAPRENYL PYROPHOSPHATE SYNTHETASuser 4 4 # 4 B 33 ARG B 16 ARG~? -3.64 O1 SO4 A 143s B 42 ARG B 127 ARG^? 9.26 O4 SO4 A 144 B 197 ARG A 16 ARG~? -2.82 O4 SO4 A 143s B 203 ARG A 105 ARG~? -3.04 O2 SO4 A 143s coo 42.69 1.07 -0.40 42.64 1.65 2.61 -4.85 63.18 38.40 -7.23 62.95 36.44 coo 53.37 -3.67 -3.96 53.38 -5.27 -1.33 -7.64 72.55 44.16 -9.78 70.52 43.36 coo 40.75 3.79 10.50 41.03 0.76 9.97 -9.29 63.37 28.06 -8.90 62.24 30.90 coo 36.15 -1.87 10.26 38.18 -1.23 8.01 -8.78 56.32 28.12 -7.90 58.53 30.04 ULMN 4 1f75_c01 UNDECAPRENYL PYROPHOSPHATE SYNTHETASuser 5 4 # 5 B 33 ARG C 16 ARG~? -2.96 O3 SO4 C 143s B 42 ARG C 110 ARG~? -6.90 CM MLZ C 114s B 197 ARG C 127 ARG^? 7.44 N MLZ C 129 B 203 ARG C 20 ARG.? 4.54 CB MLZ C 129 coo 42.69 1.07 -0.40 42.64 1.65 2.61 1.87 105.73 59.26 1.00 108.67 58.94 coo 53.37 -3.67 -3.96 53.38 -5.27 -1.33 -6.95 102.53 68.25 -6.50 103.08 71.25 coo 40.75 3.79 10.50 41.03 0.76 9.97 1.53 98.09 50.88 2.14 101.05 50.40 coo 36.15 -1.87 10.26 38.18 -1.23 8.01 2.03 103.13 46.63 -0.64 101.63 46.15 ULMN 4 1f75_c01 UNDECAPRENYL PYROPHOSPHATE SYNTHETASuser 6 4 # 6 B 33 ARG D 16 ARG~? -9.70 O1 2PE D 146s B 42 ARG D 110 ARG~? 8.08 C9 2PE D 146 B 197 ARG D 127 ARG^? 9.31 O3 PGE A 147 B 203 ARG D 20 ARG.? 10.31 C3 PEG D 145 coo 42.69 1.07 -0.40 42.64 1.65 2.61 -42.18 74.28 -4.52 -45.10 73.30 -4.28 coo 53.37 -3.67 -3.96 53.38 -5.27 -1.33 -43.46 85.72 1.13 -42.23 87.94 -0.73 coo 40.75 3.79 10.50 41.03 0.76 9.97 -35.94 67.72 2.28 -38.25 66.55 0.66 coo 36.15 -1.87 10.26 38.18 -1.23 8.01 -40.03 62.67 1.01 -40.08 63.13 4.08 1f75_c01 source 1f75 UNDECAPRENYL PYROPHOSPHATE SYNTHETASE : 6 hits 1f75_c01 naa= 4 ULMN 4 1gox_c01 GLYCOLATE OXIDASE user 1 4 # 1 129 TYR B 50 TYR~? 5.52 CH1 MLY C 135 157 ASP B 56 ASP~? 11.45 C20 PE8 B 148 254 HIS B 115 HIS~? 12.48 C18 PE8 B 148 257 ARG B 42 ARG.? 12.70 O1 PEG B 144 coo 42.78 52.38 24.86 44.83 53.69 23.54 8.51 83.11 35.90 5.93 82.51 36.84 coo 49.25 58.21 29.45 50.12 57.23 27.75 6.80 78.21 26.00 8.47 79.07 25.03 coo 50.92 56.96 24.04 49.24 56.15 23.09 11.86 77.76 30.05 12.70 77.49 28.15 coo 53.31 58.10 18.81 51.90 57.61 16.26 19.61 78.53 29.44 17.94 76.42 28.00 ULMN 4 1gox_c01 GLYCOLATE OXIDASE user 2 4 # 2 129 TYR D 50 TYR~? 5.61 CH1 MLY A 135 157 ASP D 56 ASP~? 11.46 C21 2PE D 146 254 HIS D 115 HIS~? 12.18 C21 2PE D 146 257 ARG D 42 ARG.? 16.60 C9 2PE D 146 coo 42.78 52.38 24.86 44.83 53.69 23.54 -31.54 83.73 14.98 -32.20 81.17 14.09 coo 49.25 58.21 29.45 50.12 57.23 27.75 -41.85 87.81 13.66 -41.61 89.58 14.80 coo 50.92 56.96 24.04 49.24 56.15 23.09 -36.28 90.32 11.92 -37.49 91.98 12.35 coo 53.31 58.10 18.81 51.90 57.61 16.26 -32.78 97.24 12.74 -35.35 96.85 11.13 1gox_c01 source 1gox GLYCOLATE OXIDASE : 2 hits 1gox_c01 naa= 4 ULMN 4 1hpl_c00 LIPASE (E.C.3.1.1.3) (TRIACYLGLYCEROuser 1 4 # 1 A 77 PHE A 90 PHE^? 4.08 CH1 MLY D 135 A 153 LEU A 29 LEU^? 11.10 CH2 MLY D 135 A 176 ASP A 87 ASP.? 8.49 C6 PGE A 147 A 263 HIS A 88 HIS^? 4.20 CH2 MLY D 135 coo 49.46 51.93 11.85 50.12 53.23 14.23 -25.59 59.02 13.87 -22.88 58.27 14.15 coo 48.47 51.01 3.83 49.10 52.90 2.99 -22.17 65.57 9.39 -23.57 67.10 10.05 coo 40.04 48.33 9.02 39.08 50.19 9.48 -23.17 58.67 3.55 -22.34 59.17 1.69 coo 43.45 51.20 11.32 44.32 50.94 9.50 -23.95 56.87 7.77 -24.14 54.98 6.86 ULMN 4 1hpl_c00 LIPASE (E.C.3.1.1.3) (TRIACYLGLYCEROuser 2 4 # 2 A 77 PHE B 90 PHE^? 3.94 CH1 MLY C 135 A 153 LEU B 29 LEU^? 11.04 CH1 MLY C 135 A 176 ASP B 87 ASP.? 8.94 O4 PGE B 147 A 263 HIS B 88 HIS^? 4.29 CH1 MLY C 135 coo 49.46 51.93 11.85 50.12 53.23 14.23 -0.26 85.08 38.94 1.10 82.78 38.09 coo 48.47 51.01 3.83 49.10 52.90 2.99 3.15 83.14 46.68 1.48 83.85 47.90 coo 40.04 48.33 9.02 39.08 50.19 9.48 9.49 87.97 42.02 11.31 87.98 43.09 coo 43.45 51.20 11.32 44.32 50.94 9.50 6.15 87.00 38.94 7.35 87.96 37.51 ULMN 4 1hpl_c00 LIPASE (E.C.3.1.1.3) (TRIACYLGLYCEROuser 3 4 # 3 A 77 PHE C 90 PHE^? 3.87 CH1 MLY B 135 A 153 LEU C 29 LEU^? 11.06 CH1 MLY B 135 A 176 ASP C 87 ASP.? 8.84 O1 PGE C 147 A 263 HIS C 88 HIS^? 3.86 CD MLY B 135 coo 49.46 51.93 11.85 50.12 53.23 14.23 -9.96 87.99 52.84 -9.24 88.98 55.39 coo 48.47 51.01 3.83 49.10 52.90 2.99 -2.52 83.62 53.99 -1.90 83.60 51.86 coo 40.04 48.33 9.02 39.08 50.19 9.48 -9.03 79.00 58.44 -8.21 77.39 59.55 coo 43.45 51.20 11.32 44.32 50.94 9.50 -11.00 83.03 57.18 -12.69 82.43 58.26 ULMN 4 1hpl_c00 LIPASE (E.C.3.1.1.3) (TRIACYLGLYCEROuser 4 4 # 4 A 77 PHE D 90 PHE^? 4.00 CH1 MLY A 135 A 153 LEU D 29 LEU^? 11.09 CH1 MLY A 135 A 176 ASP D 87 ASP.? 7.26 C16 1PE B 150 A 263 HIS D 88 HIS^? 4.38 CH1 MLY A 135 coo 49.46 51.93 11.85 50.12 53.23 14.23 -32.92 74.43 15.81 -33.53 76.42 13.90 coo 48.47 51.01 3.83 49.10 52.90 2.99 -25.48 74.16 11.37 -25.10 72.01 11.66 coo 40.04 48.33 9.02 39.08 50.19 9.48 -24.70 80.89 17.41 -22.90 81.94 17.31 coo 43.45 51.20 11.32 44.32 50.94 9.50 -29.18 79.71 17.63 -29.43 81.25 19.03 1hpl_c00 source 1hpl LIPASE (E.C.3.1.1.3) (TRIACYLGLYCEROL HYDROLAS: 4 hits 1hpl_c00 naa= 4 ULMN 4 1hpl_c01 LIPASE (E.C.3.1.1.3) (TRIACYLGLYCEROuser 1 4 # 1 B 77 PHE A 90 PHE^? 4.08 CH1 MLY D 135 B 153 LEU A 29 LEU^? 11.10 CH2 MLY D 135 B 176 ASP A 87 ASP.? 8.49 C6 PGE A 147 B 263 HIS A 88 HIS^? 4.20 CH2 MLY D 135 coo 29.53 52.84 46.76 28.82 54.35 44.53 -25.59 59.02 13.87 -22.88 58.27 14.15 coo 30.35 52.10 54.81 29.94 54.08 55.45 -22.17 65.57 9.39 -23.57 67.10 10.05 coo 38.97 49.40 49.54 39.78 51.32 48.96 -23.17 58.67 3.55 -22.34 59.17 1.69 coo 35.23 51.95 47.14 34.55 51.97 49.04 -23.95 56.87 7.77 -24.14 54.98 6.86 ULMN 4 1hpl_c01 LIPASE (E.C.3.1.1.3) (TRIACYLGLYCEROuser 2 4 # 2 B 77 PHE B 90 PHE^? 3.94 CH1 MLY C 135 B 153 LEU B 29 LEU^? 11.04 CH1 MLY C 135 B 176 ASP B 87 ASP.? 8.94 O4 PGE B 147 B 263 HIS B 88 HIS^? 4.29 CH1 MLY C 135 coo 29.53 52.84 46.76 28.82 54.35 44.53 -0.26 85.08 38.94 1.10 82.78 38.09 coo 30.35 52.10 54.81 29.94 54.08 55.45 3.15 83.14 46.68 1.48 83.85 47.90 coo 38.97 49.40 49.54 39.78 51.32 48.96 9.49 87.97 42.02 11.31 87.98 43.09 coo 35.23 51.95 47.14 34.55 51.97 49.04 6.15 87.00 38.94 7.35 87.96 37.51 ULMN 4 1hpl_c01 LIPASE (E.C.3.1.1.3) (TRIACYLGLYCEROuser 3 4 # 3 B 77 PHE C 90 PHE^? 3.87 CH1 MLY B 135 B 153 LEU C 29 LEU^? 11.06 CH1 MLY B 135 B 176 ASP C 87 ASP.? 8.84 O1 PGE C 147 B 263 HIS C 88 HIS^? 3.86 CD MLY B 135 coo 29.53 52.84 46.76 28.82 54.35 44.53 -9.96 87.99 52.84 -9.24 88.98 55.39 coo 30.35 52.10 54.81 29.94 54.08 55.45 -2.52 83.62 53.99 -1.90 83.60 51.86 coo 38.97 49.40 49.54 39.78 51.32 48.96 -9.03 79.00 58.44 -8.21 77.39 59.55 coo 35.23 51.95 47.14 34.55 51.97 49.04 -11.00 83.03 57.18 -12.69 82.43 58.26 ULMN 4 1hpl_c01 LIPASE (E.C.3.1.1.3) (TRIACYLGLYCEROuser 4 4 # 4 B 77 PHE D 90 PHE^? 4.00 CH1 MLY A 135 B 153 LEU D 29 LEU^? 11.09 CH1 MLY A 135 B 176 ASP D 87 ASP.? 7.26 C16 1PE B 150 B 263 HIS D 88 HIS^? 4.38 CH1 MLY A 135 coo 29.53 52.84 46.76 28.82 54.35 44.53 -32.92 74.43 15.81 -33.53 76.42 13.90 coo 30.35 52.10 54.81 29.94 54.08 55.45 -25.48 74.16 11.37 -25.10 72.01 11.66 coo 38.97 49.40 49.54 39.78 51.32 48.96 -24.70 80.89 17.41 -22.90 81.94 17.31 coo 35.23 51.95 47.14 34.55 51.97 49.04 -29.18 79.71 17.63 -29.43 81.25 19.03 1hpl_c01 source 1hpl LIPASE (E.C.3.1.1.3) (TRIACYLGLYCEROL HYDROLAS: 4 hits 1hpl_c01 naa= 4 ULMN 4 1i8t_c02 UDP-GALACTOPYRANOSE MUTASE user 1 4 # 1 A 170 ARG A 116 ARG~? 4.70 C15 2PE A 148 A 278 ARG A 16 ARG~? -2.82 O4 SO4 A 143s A 298 GLU B 102 GLU~? 6.18 O4 SO4 A 143 A 348 ASP A 106 ASP~? 11.93 O22 2PE A 148 coo -23.99 -12.72 0.77 -26.03 -13.46 2.92 -15.13 57.15 12.87 -15.00 60.01 11.67 coo -18.98 -3.88 -14.05 -18.01 -5.56 -11.69 -9.29 63.37 28.06 -8.90 62.24 30.90 coo -18.09 -5.55 -18.88 -17.66 -5.99 -16.85 -7.10 67.86 29.77 -6.34 66.05 29.12 coo -11.04 -13.38 -5.15 -13.10 -12.92 -5.14 -12.71 50.36 24.83 -13.06 48.30 25.05 ULMN 4 1i8t_c02 UDP-GALACTOPYRANOSE MUTASE user 2 4 # 2 A 170 ARG B 16 ARG~? -3.64 O1 SO4 A 143s A 278 ARG B 63 ARG~? -8.01 OH2 1PE B 150s A 298 GLU A 10 GLU~? 8.70 C6 2PE A 148 A 348 ASP A 19 ASP.? -3.59 O4 SO4 A 144s coo -23.99 -12.72 0.77 -26.03 -13.46 2.92 -4.85 63.18 38.40 -7.23 62.95 36.44 coo -18.98 -3.88 -14.05 -18.01 -5.56 -11.69 -5.18 74.17 22.68 -2.11 73.83 22.90 coo -18.09 -5.55 -18.88 -17.66 -5.99 -16.85 -3.10 70.57 20.07 -2.45 69.30 18.38 coo -11.04 -13.38 -5.15 -13.10 -12.92 -5.14 -15.01 66.98 32.71 -14.52 68.02 34.44 ULMN 4 1i8t_c02 UDP-GALACTOPYRANOSE MUTASE user 3 4 # 3 A 170 ARG B 63 ARG~? -8.01 OH2 1PE B 150s A 278 ARG A 105 ARG~? -3.04 O2 SO4 A 143s A 298 GLU A 102 GLU~? 6.28 O2 SO4 A 143 A 348 ASP A 6 ASP.? -3.91 C9 2PE A 148s coo -23.99 -12.72 0.77 -26.03 -13.46 2.92 -5.18 74.17 22.68 -2.11 73.83 22.90 coo -18.98 -3.88 -14.05 -18.01 -5.56 -11.69 -8.78 56.32 28.12 -7.90 58.53 30.04 coo -18.09 -5.55 -18.88 -17.66 -5.99 -16.85 -14.00 55.24 30.65 -12.08 54.69 31.20 coo -11.04 -13.38 -5.15 -13.10 -12.92 -5.14 -8.66 61.41 13.34 -8.76 59.35 12.80 1i8t_c02 source 1i8t UDP-GALACTOPYRANOSE MUTASE : 3 hits 1i8t_c02 naa= 4 ULMN 4 1i8t_c03 UDP-GALACTOPYRANOSE MUTASE user 1 4 # 1 B 170 ARG A 116 ARG~? 4.70 C15 2PE A 148 B 278 ARG A 16 ARG~? -2.82 O4 SO4 A 143s B 298 GLU B 102 GLU~? 6.18 O4 SO4 A 143 B 348 ASP A 106 ASP~? 11.93 O22 2PE A 148 coo -8.10 23.98 3.08 -8.58 21.04 2.27 -15.13 57.15 12.87 -15.00 60.01 11.67 coo -19.09 15.00 16.26 -16.38 15.21 14.84 -9.29 63.37 28.06 -8.90 62.24 30.90 coo -19.42 16.58 21.15 -18.01 16.20 19.59 -7.10 67.86 29.77 -6.34 66.05 29.12 coo -3.61 14.95 13.27 -5.31 15.62 12.23 -12.71 50.36 24.83 -13.06 48.30 25.05 ULMN 4 1i8t_c03 UDP-GALACTOPYRANOSE MUTASE user 2 4 # 2 B 170 ARG B 63 ARG~? -8.01 OH2 1PE B 150s B 278 ARG A 105 ARG~? -3.04 O2 SO4 A 143s B 298 GLU A 102 GLU~? 6.28 O2 SO4 A 143 B 348 ASP A 6 ASP.? -3.91 C9 2PE A 148s coo -8.10 23.98 3.08 -8.58 21.04 2.27 -5.18 74.17 22.68 -2.11 73.83 22.90 coo -19.09 15.00 16.26 -16.38 15.21 14.84 -8.78 56.32 28.12 -7.90 58.53 30.04 coo -19.42 16.58 21.15 -18.01 16.20 19.59 -14.00 55.24 30.65 -12.08 54.69 31.20 coo -3.61 14.95 13.27 -5.31 15.62 12.23 -8.66 61.41 13.34 -8.76 59.35 12.80 ULMN 4 1i8t_c03 UDP-GALACTOPYRANOSE MUTASE user 3 4 # 3 B 170 ARG B 105 ARG~? -3.01 O4 SO4 A 143s B 278 ARG A 127 ARG^? 7.47 N MLZ A 129 B 298 GLU D 75 GLU.? -3.59 CB MLZ A 129s B 348 ASP B 19 ASP.? -3.77 O3 SO4 A 144s coo -8.10 23.98 3.08 -8.58 21.04 2.27 -2.68 64.28 31.62 -4.52 62.28 32.99 coo -19.09 15.00 16.26 -16.38 15.21 14.84 -18.44 68.25 24.06 -17.70 68.37 27.04 coo -19.42 16.58 21.15 -18.01 16.20 19.59 -21.02 72.19 24.99 -21.34 70.79 26.58 coo -3.61 14.95 13.27 -5.31 15.62 12.23 -12.63 65.75 40.21 -14.11 64.30 40.60 1i8t_c03 source 1i8t UDP-GALACTOPYRANOSE MUTASE : 3 hits 1i8t_c03 naa= 4 ULMN 4 1m53_c02 ISOMALTULOSE SYNTHASE user 1 4 # 1 A 145 HIS A 4 HIS.? -3.92 C2 GOL A 150s A 241 ASP A 122 ASP^? 7.46 C1 GOL A 150 A 295 GLU A 84 GLU.? 10.45 C3 GOL D 147 A 369 ASP A 83 ASP.? 8.52 O3 GOL D 147 coo 5.03 36.88 76.44 6.25 36.30 78.05 -11.85 68.18 8.83 -11.23 70.10 8.29 coo 11.74 38.14 80.19 10.63 36.40 80.65 -15.41 64.92 4.51 -15.09 66.83 5.33 coo 16.11 33.72 80.99 14.10 33.54 81.63 -21.01 70.22 3.12 -21.10 71.95 4.30 coo 12.19 31.08 87.29 11.13 32.66 86.38 -19.46 70.43 -3.04 -19.06 72.28 -2.05 ULMN 4 1m53_c02 ISOMALTULOSE SYNTHASE user 2 4 # 2 A 145 HIS B 4 HIS.? -3.86 O2 GOL B 149s A 241 ASP B 122 ASP^? 7.33 O2 GOL B 149 A 295 GLU B 84 GLU.? 10.31 O3 GOL C 149 A 369 ASP B 83 ASP.? 9.40 O3 GOL C 149 coo 5.03 36.88 76.44 6.25 36.30 78.05 8.07 73.88 49.16 8.30 73.43 51.19 coo 11.74 38.14 80.19 10.63 36.40 80.65 10.89 79.68 47.57 9.75 78.80 49.16 coo 16.11 33.72 80.99 14.10 33.54 81.63 7.66 84.31 53.13 6.13 83.49 54.35 coo 12.19 31.08 87.29 11.13 32.66 86.38 13.62 86.10 55.23 12.83 84.59 56.49 ULMN 4 1m53_c02 ISOMALTULOSE SYNTHASE user 3 4 # 3 A 145 HIS C 4 HIS.? -3.73 C3 GOL C 149s A 241 ASP C 122 ASP^? 7.22 C3 GOL C 149 A 295 GLU C 84 GLU.? 10.77 O2 GOL B 149 A 369 ASP C 83 ASP.? 8.65 O3 GOL B 149 coo 5.03 36.88 76.44 6.25 36.30 78.05 4.88 85.81 61.42 6.80 85.00 61.18 coo 11.74 38.14 80.19 10.63 36.40 80.65 0.27 81.12 61.60 2.07 81.54 60.53 coo 16.11 33.72 80.99 14.10 33.54 81.63 2.34 77.12 55.01 3.46 78.21 53.60 coo 12.19 31.08 87.29 11.13 32.66 86.38 3.02 71.86 58.06 4.88 72.49 57.24 ULMN 4 1m53_c02 ISOMALTULOSE SYNTHASE user 4 4 # 4 A 145 HIS D 4 HIS.? 4.07 C3 GOL D 147 A 241 ASP D 122 ASP^? 7.49 C3 GOL D 147 A 295 GLU D 84 GLU.? 10.79 C1 GOL A 150 A 369 ASP D 83 ASP.? 8.76 O1 GOL A 150 coo 5.03 36.88 76.44 6.25 36.30 78.05 -23.57 78.63 1.94 -22.01 77.96 0.72 coo 11.74 38.14 80.19 10.63 36.40 80.65 -21.82 80.90 7.85 -21.38 79.32 6.51 coo 16.11 33.72 80.99 14.10 33.54 81.63 -17.40 74.78 10.23 -17.69 72.96 9.24 coo 12.19 31.08 87.29 11.13 32.66 86.38 -12.54 78.43 10.94 -12.46 77.06 9.29 1m53_c02 source 1m53 ISOMALTULOSE SYNTHASE : 4 hits 1m53_c02 naa= 4 ULMN 4 1p4r_c00 BIFUNCTIONAL PURINE BIOSYNTHESIS PROuser 1 4 # 1 A 266 LYS A 114 LYS~? 11.27 C9 2PE A 148 A 267 HIS A 115 HIS~? 12.27 C21 2PE A 148 A 431 ASN A 28 ASN^? 3.50 CL CL A 145s A 592 HIS A 88 HIS^? 4.20 CH2 MLY D 135 coo 0.26 22.09 34.68 -3.45 19.36 33.12 -9.49 51.50 12.13 -4.59 48.44 14.69 coo 2.87 18.25 32.93 2.17 16.30 33.22 -13.18 48.35 10.37 -12.55 46.36 10.33 coo 11.44 27.50 23.30 13.30 27.55 22.28 -22.13 61.51 13.69 -20.95 60.87 15.35 coo 15.28 24.00 30.62 14.74 24.27 28.61 -23.95 56.87 7.77 -24.14 54.98 6.86 ULMN 4 1p4r_c00 BIFUNCTIONAL PURINE BIOSYNTHESIS PROuser 2 4 # 2 A 266 LYS B 114 LYS~? 11.34 O7 PE8 B 148 A 267 HIS B 115 HIS~? 12.48 C18 PE8 B 148 A 431 ASN B 28 ASN^? 3.43 CL CL B 143s A 592 HIS B 88 HIS^? 4.29 CH1 MLY C 135 coo 0.26 22.09 34.68 -3.45 19.36 33.12 11.35 73.22 32.47 12.65 68.43 28.61 coo 2.87 18.25 32.93 2.17 16.30 33.22 11.86 77.76 30.05 12.70 77.49 28.15 coo 11.44 27.50 23.30 13.30 27.55 22.28 0.96 81.77 41.38 0.26 80.18 40.18 coo 15.28 24.00 30.62 14.74 24.27 28.61 6.15 87.00 38.94 7.35 87.96 37.51 ULMN 4 1p4r_c00 BIFUNCTIONAL PURINE BIOSYNTHESIS PROuser 3 4 # 3 A 266 LYS D 114 LYS~? 10.81 C9 2PE D 146 A 267 HIS D 115 HIS~? 12.18 C21 2PE D 146 A 431 ASN D 28 ASN^? 3.51 CL CL D 143s A 592 HIS D 88 HIS^? 4.38 CH1 MLY A 135 coo 0.26 22.09 34.68 -3.45 19.36 33.12 -35.88 89.56 6.78 -39.69 93.33 3.49 coo 2.87 18.25 32.93 2.17 16.30 33.22 -36.28 90.32 11.92 -37.49 91.98 12.35 coo 11.44 27.50 23.30 13.30 27.55 22.28 -31.24 74.87 11.89 -33.01 75.13 10.75 coo 15.28 24.00 30.62 14.74 24.27 28.61 -29.18 79.71 17.63 -29.43 81.25 19.03 1p4r_c00 source 1p4r BIFUNCTIONAL PURINE BIOSYNTHESIS PROTEIN PURH : 3 hits 1p4r_c00 naa= 4 ULMN 4 1p4r_c01 BIFUNCTIONAL PURINE BIOSYNTHESIS PROuser 1 4 # 1 B 266 LYS A 114 LYS~? 11.27 C9 2PE A 148 B 267 HIS A 115 HIS~? 12.27 C21 2PE A 148 B 431 ASN A 28 ASN^? 3.50 CL CL A 145s B 592 HIS A 88 HIS^? 4.20 CH2 MLY D 135 coo 16.46 21.36 21.89 16.46 24.95 18.59 -9.49 51.50 12.13 -4.59 48.44 14.69 coo 15.13 24.90 25.09 15.98 26.81 24.92 -13.18 48.35 10.37 -12.55 46.36 10.33 coo 2.00 16.40 28.58 0.63 16.55 30.19 -22.13 61.51 13.69 -20.95 60.87 15.35 coo 8.34 17.88 34.80 6.52 18.00 33.76 -23.95 56.87 7.77 -24.14 54.98 6.86 ULMN 4 1p4r_c01 BIFUNCTIONAL PURINE BIOSYNTHESIS PROuser 2 4 # 2 B 266 LYS B 114 LYS~? 11.34 O7 PE8 B 148 B 267 HIS B 115 HIS~? 12.48 C18 PE8 B 148 B 431 ASN B 28 ASN^? 3.43 CL CL B 143s B 592 HIS B 88 HIS^? 4.29 CH1 MLY C 135 coo 16.46 21.36 21.89 16.46 24.95 18.59 11.35 73.22 32.47 12.65 68.43 28.61 coo 15.13 24.90 25.09 15.98 26.81 24.92 11.86 77.76 30.05 12.70 77.49 28.15 coo 2.00 16.40 28.58 0.63 16.55 30.19 0.96 81.77 41.38 0.26 80.18 40.18 coo 8.34 17.88 34.80 6.52 18.00 33.76 6.15 87.00 38.94 7.35 87.96 37.51 ULMN 4 1p4r_c01 BIFUNCTIONAL PURINE BIOSYNTHESIS PROuser 3 4 # 3 B 266 LYS D 114 LYS~? 10.81 C9 2PE D 146 B 267 HIS D 115 HIS~? 12.18 C21 2PE D 146 B 431 ASN D 28 ASN^? 3.51 CL CL D 143s B 592 HIS D 88 HIS^? 4.38 CH1 MLY A 135 coo 16.46 21.36 21.89 16.46 24.95 18.59 -35.88 89.56 6.78 -39.69 93.33 3.49 coo 15.13 24.90 25.09 15.98 26.81 24.92 -36.28 90.32 11.92 -37.49 91.98 12.35 coo 2.00 16.40 28.58 0.63 16.55 30.19 -31.24 74.87 11.89 -33.01 75.13 10.75 coo 8.34 17.88 34.80 6.52 18.00 33.76 -29.18 79.71 17.63 -29.43 81.25 19.03 1p4r_c01 source 1p4r BIFUNCTIONAL PURINE BIOSYNTHESIS PROTEIN PURH : 3 hits 1p4r_c01 naa= 4 ULMN 4 1pix_c01 GLUTACONYL-COA DECARBOXYLASE A SUBUNuser 1 4 # 1 B 151 VAL A 97 VAL~? 7.02 O1 SO4 A 144 B 194 GLY A 22 GLY.? 4.28 C3 PEG A 146 B 417 ILE C 24 ILE^? 6.70 N MLZ C 129 B 457 ALA C 92 ALA^? 3.74 CL CL C 144 coo 52.95 126.71 13.21 51.34 125.24 13.19 -17.68 62.89 28.92 -16.58 64.71 28.66 coo 50.40 126.23 20.48 50.46 127.00 20.75 -24.67 65.84 32.25 -23.92 65.53 31.96 coo 68.38 85.45 19.33 67.41 85.52 20.41 -3.07 99.27 49.17 -2.85 100.13 50.32 coo 65.50 91.13 17.77 64.65 89.88 18.00 -9.27 93.54 50.71 -9.15 93.80 52.25 1pix_c01 source 1pix GLUTACONYL-COA DECARBOXYLASE A SUBUNIT : 1 hits 1pix_c01 naa= 4 ULMN 4 1pix_c02 GLUTACONYL-COA DECARBOXYLASE A SUBUNuser 1 4 # 1 A 457 ALA A 49 ALA~? 12.15 CD MLY D 135 A 458 ALA A 47 ALA~? 9.02 CD MLY D 135 B 193 ALA A 52 ALA~? 11.32 CD MLY D 135 B 194 GLY A 54 GLY~? 5.80 C21 2PE A 148 coo 43.27 124.32 20.47 43.79 125.29 21.53 -16.03 49.47 6.19 -14.84 50.27 5.67 coo 39.57 123.53 20.89 38.42 124.25 20.20 -20.21 51.63 3.44 -21.40 51.48 2.53 coo 47.95 129.15 20.31 47.81 128.95 18.79 -17.75 46.92 10.26 -16.48 46.44 9.51 coo 50.40 126.23 20.48 50.46 127.00 20.75 -20.41 50.07 13.76 -19.88 49.43 13.69 ULMN 4 1pix_c02 GLUTACONYL-COA DECARBOXYLASE A SUBUNuser 2 4 # 2 A 457 ALA A 49 ALA~? 12.15 CD MLY D 135 A 458 ALA A 119 ALA~? 10.88 CH2 MLY D 135 B 193 ALA A 51 ALA~? 7.23 CD MLY D 135 B 194 GLY A 54 GLY~? 5.80 C21 2PE A 148 coo 43.27 124.32 20.47 43.79 125.29 21.53 -16.03 49.47 6.19 -14.84 50.27 5.67 coo 39.57 123.53 20.89 38.42 124.25 20.20 -14.35 54.52 5.55 -15.48 54.02 6.43 coo 47.95 129.15 20.31 47.81 128.95 18.79 -20.65 48.85 8.75 -21.19 47.91 7.68 coo 50.40 126.23 20.48 50.46 127.00 20.75 -20.41 50.07 13.76 -19.88 49.43 13.69 ULMN 4 1pix_c02 GLUTACONYL-COA DECARBOXYLASE A SUBUNuser 3 4 # 3 A 457 ALA A 49 ALA~? 12.15 CD MLY D 135 A 458 ALA A 119 ALA~? 10.88 CH2 MLY D 135 B 193 ALA A 52 ALA~? 11.32 CD MLY D 135 B 194 GLY A 54 GLY~? 5.80 C21 2PE A 148 coo 43.27 124.32 20.47 43.79 125.29 21.53 -16.03 49.47 6.19 -14.84 50.27 5.67 coo 39.57 123.53 20.89 38.42 124.25 20.20 -14.35 54.52 5.55 -15.48 54.02 6.43 coo 47.95 129.15 20.31 47.81 128.95 18.79 -17.75 46.92 10.26 -16.48 46.44 9.51 coo 50.40 126.23 20.48 50.46 127.00 20.75 -20.41 50.07 13.76 -19.88 49.43 13.69 ULMN 4 1pix_c02 GLUTACONYL-COA DECARBOXYLASE A SUBUNuser 4 4 # 4 A 457 ALA A 51 ALA~? 7.23 CD MLY D 135 A 458 ALA A 52 ALA~? 11.32 CD MLY D 135 B 193 ALA A 47 ALA~? 9.02 CD MLY D 135 B 194 GLY A 46 GLY~? 12.01 CD MLY D 135 coo 43.27 124.32 20.47 43.79 125.29 21.53 -20.65 48.85 8.75 -21.19 47.91 7.68 coo 39.57 123.53 20.89 38.42 124.25 20.20 -17.75 46.92 10.26 -16.48 46.44 9.51 coo 47.95 129.15 20.31 47.81 128.95 18.79 -20.21 51.63 3.44 -21.40 51.48 2.53 coo 50.40 126.23 20.48 50.46 127.00 20.75 -16.75 52.82 2.36 -17.28 52.20 2.20 ULMN 4 1pix_c02 GLUTACONYL-COA DECARBOXYLASE A SUBUNuser 5 4 # 5 A 457 ALA B 49 ALA~? 10.91 O1 PEG B 144 A 458 ALA B 47 ALA~? 9.27 CD MLY C 135 B 193 ALA B 52 ALA~? 11.30 CE MLY C 135 B 194 GLY B 54 GLY~? 5.68 C20 PE8 B 148 coo 43.27 124.32 20.47 43.79 125.29 21.53 13.56 82.06 32.43 14.35 81.13 33.34 coo 39.57 123.53 20.89 38.42 124.25 20.20 13.13 86.65 35.42 13.34 88.15 35.52 coo 47.95 129.15 20.31 47.81 128.95 18.79 10.17 82.02 28.78 11.54 81.34 28.64 coo 50.40 126.23 20.48 50.46 127.00 20.75 5.02 82.24 30.45 5.51 81.90 29.87 ULMN 4 1pix_c02 GLUTACONYL-COA DECARBOXYLASE A SUBUNuser 6 4 # 6 A 457 ALA B 49 ALA~? 10.91 O1 PEG B 144 A 458 ALA B 119 ALA~? 10.71 O16 PE8 B 148 B 193 ALA B 51 ALA~? 7.25 CG MLY C 135 B 194 GLY B 54 GLY~? 5.68 C20 PE8 B 148 coo 43.27 124.32 20.47 43.79 125.29 21.53 13.56 82.06 32.43 14.35 81.13 33.34 coo 39.57 123.53 20.89 38.42 124.25 20.20 13.47 80.03 37.47 12.33 80.66 36.69 coo 47.95 129.15 20.31 47.81 128.95 18.79 9.29 84.92 31.07 10.11 86.09 30.55 coo 50.40 126.23 20.48 50.46 127.00 20.75 5.02 82.24 30.45 5.51 81.90 29.87 ULMN 4 1pix_c02 GLUTACONYL-COA DECARBOXYLASE A SUBUNuser 7 4 # 7 A 457 ALA B 49 ALA~? 10.91 O1 PEG B 144 A 458 ALA B 119 ALA~? 10.71 O16 PE8 B 148 B 193 ALA B 52 ALA~? 11.30 CE MLY C 135 B 194 GLY B 54 GLY~? 5.68 C20 PE8 B 148 coo 43.27 124.32 20.47 43.79 125.29 21.53 13.56 82.06 32.43 14.35 81.13 33.34 coo 39.57 123.53 20.89 38.42 124.25 20.20 13.47 80.03 37.47 12.33 80.66 36.69 coo 47.95 129.15 20.31 47.81 128.95 18.79 10.17 82.02 28.78 11.54 81.34 28.64 coo 50.40 126.23 20.48 50.46 127.00 20.75 5.02 82.24 30.45 5.51 81.90 29.87 ULMN 4 1pix_c02 GLUTACONYL-COA DECARBOXYLASE A SUBUNuser 8 4 # 8 A 457 ALA B 51 ALA~? 7.25 CG MLY C 135 A 458 ALA B 52 ALA~? 11.30 CE MLY C 135 B 193 ALA B 47 ALA~? 9.27 CD MLY C 135 B 194 GLY B 46 GLY~? 9.70 O1 PEG B 144 coo 43.27 124.32 20.47 43.79 125.29 21.53 9.29 84.92 31.07 10.11 86.09 30.55 coo 39.57 123.53 20.89 38.42 124.25 20.20 10.17 82.02 28.78 11.54 81.34 28.64 coo 47.95 129.15 20.31 47.81 128.95 18.79 13.13 86.65 35.42 13.34 88.15 35.52 coo 50.40 126.23 20.48 50.46 127.00 20.75 15.35 83.93 36.97 15.42 84.55 36.41 ULMN 4 1pix_c02 GLUTACONYL-COA DECARBOXYLASE A SUBUNuser 9 4 # 9 A 457 ALA C 49 ALA~? 6.49 O MLZ C 114 A 458 ALA C 47 ALA~? 8.78 CD MLY B 135 B 193 ALA C 52 ALA~? 7.88 C MLZ C 114 B 194 GLY C 54 GLY~? 6.00 CH2 MLY B 135 coo 43.27 124.32 20.47 43.79 125.29 21.53 -13.48 85.10 67.69 -12.20 84.83 68.50 coo 39.57 123.53 20.89 38.42 124.25 20.20 -13.73 80.92 64.16 -14.51 79.74 63.61 coo 47.95 129.15 20.31 47.81 128.95 18.79 -16.51 88.80 66.17 -16.23 88.55 67.66 coo 50.40 126.23 20.48 50.46 127.00 20.75 -15.22 90.72 61.35 -15.47 90.98 62.07 ULMN 4 1pix_c02 GLUTACONYL-COA DECARBOXYLASE A SUBUNuser 10 4 # 10 A 457 ALA C 49 ALA~? 6.49 O MLZ C 114 A 458 ALA C 119 ALA~? 6.80 O MLZ C 114 B 193 ALA C 51 ALA~? 7.46 CD MLY B 135 B 194 GLY C 54 GLY~? 6.00 CH2 MLY B 135 coo 43.27 124.32 20.47 43.79 125.29 21.53 -13.48 85.10 67.69 -12.20 84.83 68.50 coo 39.57 123.53 20.89 38.42 124.25 20.20 -8.25 84.08 66.89 -9.22 84.66 65.88 coo 47.95 129.15 20.31 47.81 128.95 18.79 -16.25 86.28 63.34 -17.35 85.28 63.69 coo 50.40 126.23 20.48 50.46 127.00 20.75 -15.22 90.72 61.35 -15.47 90.98 62.07 ULMN 4 1pix_c02 GLUTACONYL-COA DECARBOXYLASE A SUBUNuser 11 4 # 11 A 457 ALA C 49 ALA~? 6.49 O MLZ C 114 A 458 ALA C 119 ALA~? 6.80 O MLZ C 114 B 193 ALA C 52 ALA~? 7.88 C MLZ C 114 B 194 GLY C 54 GLY~? 6.00 CH2 MLY B 135 coo 43.27 124.32 20.47 43.79 125.29 21.53 -13.48 85.10 67.69 -12.20 84.83 68.50 coo 39.57 123.53 20.89 38.42 124.25 20.20 -8.25 84.08 66.89 -9.22 84.66 65.88 coo 47.95 129.15 20.31 47.81 128.95 18.79 -16.51 88.80 66.17 -16.23 88.55 67.66 coo 50.40 126.23 20.48 50.46 127.00 20.75 -15.22 90.72 61.35 -15.47 90.98 62.07 ULMN 4 1pix_c02 GLUTACONYL-COA DECARBOXYLASE A SUBUNuser 12 4 # 12 A 457 ALA C 51 ALA~? 7.46 CD MLY B 135 A 458 ALA C 52 ALA~? 7.88 C MLZ C 114 B 193 ALA C 47 ALA~? 8.78 CD MLY B 135 B 194 GLY C 46 GLY~? 10.04 O MLZ C 114 coo 43.27 124.32 20.47 43.79 125.29 21.53 -16.25 86.28 63.34 -17.35 85.28 63.69 coo 39.57 123.53 20.89 38.42 124.25 20.20 -16.51 88.80 66.17 -16.23 88.55 67.66 coo 47.95 129.15 20.31 47.81 128.95 18.79 -13.73 80.92 64.16 -14.51 79.74 63.61 coo 50.40 126.23 20.48 50.46 127.00 20.75 -10.91 80.74 66.75 -11.70 80.52 66.65 ULMN 4 1pix_c02 GLUTACONYL-COA DECARBOXYLASE A SUBUNuser 13 4 # 13 A 457 ALA D 49 ALA~? 12.11 CE MLY A 135 A 458 ALA D 47 ALA~? 9.03 CG MLY A 135 B 193 ALA D 52 ALA~? 11.20 CE MLY A 135 B 194 GLY D 54 GLY~? 5.81 C23 2PE D 146 coo 43.27 124.32 20.47 43.79 125.29 21.53 -32.13 89.91 15.13 -31.19 90.29 13.98 coo 39.57 123.53 20.89 38.42 124.25 20.20 -28.68 87.42 18.40 -28.00 87.29 19.73 coo 47.95 129.15 20.31 47.81 128.95 18.79 -36.92 88.76 16.36 -36.55 90.11 15.77 coo 50.40 126.23 20.48 50.46 127.00 20.75 -38.01 83.52 15.98 -38.33 84.28 15.84 ULMN 4 1pix_c02 GLUTACONYL-COA DECARBOXYLASE A SUBUNuser 14 4 # 14 A 457 ALA D 49 ALA~? 12.11 CE MLY A 135 A 458 ALA D 119 ALA~? 10.88 C18 2PE D 146 B 193 ALA D 51 ALA~? 6.92 CG MLY A 135 B 194 GLY D 54 GLY~? 5.81 C23 2PE D 146 coo 43.27 124.32 20.47 43.79 125.29 21.53 -32.13 89.91 15.13 -31.19 90.29 13.98 coo 39.57 123.53 20.89 38.42 124.25 20.20 -28.73 87.90 11.52 -29.74 87.21 12.41 coo 47.95 129.15 20.31 47.81 128.95 18.79 -34.62 86.43 18.27 -34.28 87.19 19.52 coo 50.40 126.23 20.48 50.46 127.00 20.75 -38.01 83.52 15.98 -38.33 84.28 15.84 ULMN 4 1pix_c02 GLUTACONYL-COA DECARBOXYLASE A SUBUNuser 15 4 # 15 A 457 ALA D 49 ALA~? 12.11 CE MLY A 135 A 458 ALA D 119 ALA~? 10.88 C18 2PE D 146 B 193 ALA D 52 ALA~? 11.20 CE MLY A 135 B 194 GLY D 54 GLY~? 5.81 C23 2PE D 146 coo 43.27 124.32 20.47 43.79 125.29 21.53 -32.13 89.91 15.13 -31.19 90.29 13.98 coo 39.57 123.53 20.89 38.42 124.25 20.20 -28.73 87.90 11.52 -29.74 87.21 12.41 coo 47.95 129.15 20.31 47.81 128.95 18.79 -36.92 88.76 16.36 -36.55 90.11 15.77 coo 50.40 126.23 20.48 50.46 127.00 20.75 -38.01 83.52 15.98 -38.33 84.28 15.84 ULMN 4 1pix_c02 GLUTACONYL-COA DECARBOXYLASE A SUBUNuser 16 4 # 16 A 457 ALA D 51 ALA~? 6.92 CG MLY A 135 A 458 ALA D 52 ALA~? 11.20 CE MLY A 135 B 193 ALA D 47 ALA~? 9.03 CG MLY A 135 B 194 GLY D 46 GLY~? 12.21 CD MLY A 135 coo 43.27 124.32 20.47 43.79 125.29 21.53 -34.62 86.43 18.27 -34.28 87.19 19.52 coo 39.57 123.53 20.89 38.42 124.25 20.20 -36.92 88.76 16.36 -36.55 90.11 15.77 coo 47.95 129.15 20.31 47.81 128.95 18.79 -28.68 87.42 18.40 -28.00 87.29 19.73 coo 50.40 126.23 20.48 50.46 127.00 20.75 -27.16 89.12 15.33 -27.37 89.29 16.11 1pix_c02 source 1pix GLUTACONYL-COA DECARBOXYLASE A SUBUNIT : 16 hits 1pix_c02 naa= 4 ULMN 4 1pix_c03 GLUTACONYL-COA DECARBOXYLASE A SUBUNuser 1 4 # 1 A 193 ALA A 47 ALA~? 9.02 CD MLY D 135 A 194 GLY A 46 GLY~? 12.01 CD MLY D 135 B 457 ALA A 51 ALA~? 7.23 CD MLY D 135 B 458 ALA A 52 ALA~? 11.32 CD MLY D 135 coo 61.89 87.20 13.50 62.59 88.00 12.38 -20.21 51.63 3.44 -21.40 51.48 2.53 coo 59.34 89.99 13.88 59.24 89.18 13.73 -16.75 52.82 2.36 -17.28 52.20 2.20 coo 65.50 91.13 17.77 64.65 89.88 18.00 -20.65 48.85 8.75 -21.19 47.91 7.68 coo 68.56 91.15 20.03 69.95 90.68 19.64 -17.75 46.92 10.26 -16.48 46.44 9.51 ULMN 4 1pix_c03 GLUTACONYL-COA DECARBOXYLASE A SUBUNuser 2 4 # 2 A 193 ALA A 51 ALA~? 7.23 CD MLY D 135 A 194 GLY A 54 GLY~? 5.80 C21 2PE A 148 B 457 ALA A 49 ALA~? 12.15 CD MLY D 135 B 458 ALA A 119 ALA~? 10.88 CH2 MLY D 135 coo 61.89 87.20 13.50 62.59 88.00 12.38 -20.65 48.85 8.75 -21.19 47.91 7.68 coo 59.34 89.99 13.88 59.24 89.18 13.73 -20.41 50.07 13.76 -19.88 49.43 13.69 coo 65.50 91.13 17.77 64.65 89.88 18.00 -16.03 49.47 6.19 -14.84 50.27 5.67 coo 68.56 91.15 20.03 69.95 90.68 19.64 -14.35 54.52 5.55 -15.48 54.02 6.43 ULMN 4 1pix_c03 GLUTACONYL-COA DECARBOXYLASE A SUBUNuser 3 4 # 3 A 193 ALA A 52 ALA~? 11.32 CD MLY D 135 A 194 GLY A 54 GLY~? 5.80 C21 2PE A 148 B 457 ALA A 49 ALA~? 12.15 CD MLY D 135 B 458 ALA A 47 ALA~? 9.02 CD MLY D 135 coo 61.89 87.20 13.50 62.59 88.00 12.38 -17.75 46.92 10.26 -16.48 46.44 9.51 coo 59.34 89.99 13.88 59.24 89.18 13.73 -20.41 50.07 13.76 -19.88 49.43 13.69 coo 65.50 91.13 17.77 64.65 89.88 18.00 -16.03 49.47 6.19 -14.84 50.27 5.67 coo 68.56 91.15 20.03 69.95 90.68 19.64 -20.21 51.63 3.44 -21.40 51.48 2.53 ULMN 4 1pix_c03 GLUTACONYL-COA DECARBOXYLASE A SUBUNuser 4 4 # 4 A 193 ALA A 52 ALA~? 11.32 CD MLY D 135 A 194 GLY A 54 GLY~? 5.80 C21 2PE A 148 B 457 ALA A 49 ALA~? 12.15 CD MLY D 135 B 458 ALA A 119 ALA~? 10.88 CH2 MLY D 135 coo 61.89 87.20 13.50 62.59 88.00 12.38 -17.75 46.92 10.26 -16.48 46.44 9.51 coo 59.34 89.99 13.88 59.24 89.18 13.73 -20.41 50.07 13.76 -19.88 49.43 13.69 coo 65.50 91.13 17.77 64.65 89.88 18.00 -16.03 49.47 6.19 -14.84 50.27 5.67 coo 68.56 91.15 20.03 69.95 90.68 19.64 -14.35 54.52 5.55 -15.48 54.02 6.43 ULMN 4 1pix_c03 GLUTACONYL-COA DECARBOXYLASE A SUBUNuser 5 4 # 5 A 193 ALA B 47 ALA~? 9.27 CD MLY C 135 A 194 GLY B 46 GLY~? 9.70 O1 PEG B 144 B 457 ALA B 51 ALA~? 7.25 CG MLY C 135 B 458 ALA B 52 ALA~? 11.30 CE MLY C 135 coo 61.89 87.20 13.50 62.59 88.00 12.38 13.13 86.65 35.42 13.34 88.15 35.52 coo 59.34 89.99 13.88 59.24 89.18 13.73 15.35 83.93 36.97 15.42 84.55 36.41 coo 65.50 91.13 17.77 64.65 89.88 18.00 9.29 84.92 31.07 10.11 86.09 30.55 coo 68.56 91.15 20.03 69.95 90.68 19.64 10.17 82.02 28.78 11.54 81.34 28.64 ULMN 4 1pix_c03 GLUTACONYL-COA DECARBOXYLASE A SUBUNuser 6 4 # 6 A 193 ALA B 51 ALA~? 7.25 CG MLY C 135 A 194 GLY B 54 GLY~? 5.68 C20 PE8 B 148 B 457 ALA B 49 ALA~? 10.91 O1 PEG B 144 B 458 ALA B 119 ALA~? 10.71 O16 PE8 B 148 coo 61.89 87.20 13.50 62.59 88.00 12.38 9.29 84.92 31.07 10.11 86.09 30.55 coo 59.34 89.99 13.88 59.24 89.18 13.73 5.02 82.24 30.45 5.51 81.90 29.87 coo 65.50 91.13 17.77 64.65 89.88 18.00 13.56 82.06 32.43 14.35 81.13 33.34 coo 68.56 91.15 20.03 69.95 90.68 19.64 13.47 80.03 37.47 12.33 80.66 36.69 ULMN 4 1pix_c03 GLUTACONYL-COA DECARBOXYLASE A SUBUNuser 7 4 # 7 A 193 ALA B 52 ALA~? 11.30 CE MLY C 135 A 194 GLY B 54 GLY~? 5.68 C20 PE8 B 148 B 457 ALA B 49 ALA~? 10.91 O1 PEG B 144 B 458 ALA B 47 ALA~? 9.27 CD MLY C 135 coo 61.89 87.20 13.50 62.59 88.00 12.38 10.17 82.02 28.78 11.54 81.34 28.64 coo 59.34 89.99 13.88 59.24 89.18 13.73 5.02 82.24 30.45 5.51 81.90 29.87 coo 65.50 91.13 17.77 64.65 89.88 18.00 13.56 82.06 32.43 14.35 81.13 33.34 coo 68.56 91.15 20.03 69.95 90.68 19.64 13.13 86.65 35.42 13.34 88.15 35.52 ULMN 4 1pix_c03 GLUTACONYL-COA DECARBOXYLASE A SUBUNuser 8 4 # 8 A 193 ALA B 52 ALA~? 11.30 CE MLY C 135 A 194 GLY B 54 GLY~? 5.68 C20 PE8 B 148 B 457 ALA B 49 ALA~? 10.91 O1 PEG B 144 B 458 ALA B 119 ALA~? 10.71 O16 PE8 B 148 coo 61.89 87.20 13.50 62.59 88.00 12.38 10.17 82.02 28.78 11.54 81.34 28.64 coo 59.34 89.99 13.88 59.24 89.18 13.73 5.02 82.24 30.45 5.51 81.90 29.87 coo 65.50 91.13 17.77 64.65 89.88 18.00 13.56 82.06 32.43 14.35 81.13 33.34 coo 68.56 91.15 20.03 69.95 90.68 19.64 13.47 80.03 37.47 12.33 80.66 36.69 ULMN 4 1pix_c03 GLUTACONYL-COA DECARBOXYLASE A SUBUNuser 9 4 # 9 A 193 ALA C 47 ALA~? 8.78 CD MLY B 135 A 194 GLY C 46 GLY~? 10.04 O MLZ C 114 B 457 ALA C 51 ALA~? 7.46 CD MLY B 135 B 458 ALA C 52 ALA~? 7.88 C MLZ C 114 coo 61.89 87.20 13.50 62.59 88.00 12.38 -13.73 80.92 64.16 -14.51 79.74 63.61 coo 59.34 89.99 13.88 59.24 89.18 13.73 -10.91 80.74 66.75 -11.70 80.52 66.65 coo 65.50 91.13 17.77 64.65 89.88 18.00 -16.25 86.28 63.34 -17.35 85.28 63.69 coo 68.56 91.15 20.03 69.95 90.68 19.64 -16.51 88.80 66.17 -16.23 88.55 67.66 ULMN 4 1pix_c03 GLUTACONYL-COA DECARBOXYLASE A SUBUNuser 10 4 # 10 A 193 ALA C 51 ALA~? 7.46 CD MLY B 135 A 194 GLY C 54 GLY~? 6.00 CH2 MLY B 135 B 457 ALA C 49 ALA~? 6.49 O MLZ C 114 B 458 ALA C 119 ALA~? 6.80 O MLZ C 114 coo 61.89 87.20 13.50 62.59 88.00 12.38 -16.25 86.28 63.34 -17.35 85.28 63.69 coo 59.34 89.99 13.88 59.24 89.18 13.73 -15.22 90.72 61.35 -15.47 90.98 62.07 coo 65.50 91.13 17.77 64.65 89.88 18.00 -13.48 85.10 67.69 -12.20 84.83 68.50 coo 68.56 91.15 20.03 69.95 90.68 19.64 -8.25 84.08 66.89 -9.22 84.66 65.88 ULMN 4 1pix_c03 GLUTACONYL-COA DECARBOXYLASE A SUBUNuser 11 4 # 11 A 193 ALA C 52 ALA~? 7.88 C MLZ C 114 A 194 GLY C 54 GLY~? 6.00 CH2 MLY B 135 B 457 ALA C 49 ALA~? 6.49 O MLZ C 114 B 458 ALA C 47 ALA~? 8.78 CD MLY B 135 coo 61.89 87.20 13.50 62.59 88.00 12.38 -16.51 88.80 66.17 -16.23 88.55 67.66 coo 59.34 89.99 13.88 59.24 89.18 13.73 -15.22 90.72 61.35 -15.47 90.98 62.07 coo 65.50 91.13 17.77 64.65 89.88 18.00 -13.48 85.10 67.69 -12.20 84.83 68.50 coo 68.56 91.15 20.03 69.95 90.68 19.64 -13.73 80.92 64.16 -14.51 79.74 63.61 ULMN 4 1pix_c03 GLUTACONYL-COA DECARBOXYLASE A SUBUNuser 12 4 # 12 A 193 ALA C 52 ALA~? 7.88 C MLZ C 114 A 194 GLY C 54 GLY~? 6.00 CH2 MLY B 135 B 457 ALA C 49 ALA~? 6.49 O MLZ C 114 B 458 ALA C 119 ALA~? 6.80 O MLZ C 114 coo 61.89 87.20 13.50 62.59 88.00 12.38 -16.51 88.80 66.17 -16.23 88.55 67.66 coo 59.34 89.99 13.88 59.24 89.18 13.73 -15.22 90.72 61.35 -15.47 90.98 62.07 coo 65.50 91.13 17.77 64.65 89.88 18.00 -13.48 85.10 67.69 -12.20 84.83 68.50 coo 68.56 91.15 20.03 69.95 90.68 19.64 -8.25 84.08 66.89 -9.22 84.66 65.88 ULMN 4 1pix_c03 GLUTACONYL-COA DECARBOXYLASE A SUBUNuser 13 4 # 13 A 193 ALA D 47 ALA~? 9.03 CG MLY A 135 A 194 GLY D 46 GLY~? 12.21 CD MLY A 135 B 457 ALA D 51 ALA~? 6.92 CG MLY A 135 B 458 ALA D 52 ALA~? 11.20 CE MLY A 135 coo 61.89 87.20 13.50 62.59 88.00 12.38 -28.68 87.42 18.40 -28.00 87.29 19.73 coo 59.34 89.99 13.88 59.24 89.18 13.73 -27.16 89.12 15.33 -27.37 89.29 16.11 coo 65.50 91.13 17.77 64.65 89.88 18.00 -34.62 86.43 18.27 -34.28 87.19 19.52 coo 68.56 91.15 20.03 69.95 90.68 19.64 -36.92 88.76 16.36 -36.55 90.11 15.77 ULMN 4 1pix_c03 GLUTACONYL-COA DECARBOXYLASE A SUBUNuser 14 4 # 14 A 193 ALA D 51 ALA~? 6.92 CG MLY A 135 A 194 GLY D 54 GLY~? 5.81 C23 2PE D 146 B 457 ALA D 49 ALA~? 12.11 CE MLY A 135 B 458 ALA D 119 ALA~? 10.88 C18 2PE D 146 coo 61.89 87.20 13.50 62.59 88.00 12.38 -34.62 86.43 18.27 -34.28 87.19 19.52 coo 59.34 89.99 13.88 59.24 89.18 13.73 -38.01 83.52 15.98 -38.33 84.28 15.84 coo 65.50 91.13 17.77 64.65 89.88 18.00 -32.13 89.91 15.13 -31.19 90.29 13.98 coo 68.56 91.15 20.03 69.95 90.68 19.64 -28.73 87.90 11.52 -29.74 87.21 12.41 ULMN 4 1pix_c03 GLUTACONYL-COA DECARBOXYLASE A SUBUNuser 15 4 # 15 A 193 ALA D 52 ALA~? 11.20 CE MLY A 135 A 194 GLY D 54 GLY~? 5.81 C23 2PE D 146 B 457 ALA D 49 ALA~? 12.11 CE MLY A 135 B 458 ALA D 47 ALA~? 9.03 CG MLY A 135 coo 61.89 87.20 13.50 62.59 88.00 12.38 -36.92 88.76 16.36 -36.55 90.11 15.77 coo 59.34 89.99 13.88 59.24 89.18 13.73 -38.01 83.52 15.98 -38.33 84.28 15.84 coo 65.50 91.13 17.77 64.65 89.88 18.00 -32.13 89.91 15.13 -31.19 90.29 13.98 coo 68.56 91.15 20.03 69.95 90.68 19.64 -28.68 87.42 18.40 -28.00 87.29 19.73 ULMN 4 1pix_c03 GLUTACONYL-COA DECARBOXYLASE A SUBUNuser 16 4 # 16 A 193 ALA D 52 ALA~? 11.20 CE MLY A 135 A 194 GLY D 54 GLY~? 5.81 C23 2PE D 146 B 457 ALA D 49 ALA~? 12.11 CE MLY A 135 B 458 ALA D 119 ALA~? 10.88 C18 2PE D 146 coo 61.89 87.20 13.50 62.59 88.00 12.38 -36.92 88.76 16.36 -36.55 90.11 15.77 coo 59.34 89.99 13.88 59.24 89.18 13.73 -38.01 83.52 15.98 -38.33 84.28 15.84 coo 65.50 91.13 17.77 64.65 89.88 18.00 -32.13 89.91 15.13 -31.19 90.29 13.98 coo 68.56 91.15 20.03 69.95 90.68 19.64 -28.73 87.90 11.52 -29.74 87.21 12.41 1pix_c03 source 1pix GLUTACONYL-COA DECARBOXYLASE A SUBUNIT : 16 hits 1pix_c03 naa= 4 ULMN 4 1qho_c03 ALPHA-AMYLASE user 1 4 # 1 A 132 HIS A 4 HIS.? -3.92 C2 GOL A 150s A 228 ASP A 122 ASP^? 7.46 C1 GOL A 150 A 256 GLU A 84 GLU.? 10.45 C3 GOL D 147 A 329 ASP A 83 ASP.? 8.52 O3 GOL D 147 coo 30.47 73.42 20.05 31.26 72.46 21.74 -11.85 68.18 8.83 -11.23 70.10 8.29 coo 28.46 69.88 26.74 30.40 70.70 26.53 -15.41 64.92 4.51 -15.09 66.83 5.33 coo 30.54 71.65 32.58 31.73 72.26 30.92 -21.01 70.22 3.12 -21.10 71.95 4.30 coo 37.87 70.12 31.80 36.61 69.74 30.15 -19.46 70.43 -3.04 -19.06 72.28 -2.05 ULMN 4 1qho_c03 ALPHA-AMYLASE user 2 4 # 2 A 132 HIS B 4 HIS.? -3.86 O2 GOL B 149s A 228 ASP B 122 ASP^? 7.33 O2 GOL B 149 A 256 GLU B 84 GLU.? 10.31 O3 GOL C 149 A 329 ASP B 83 ASP.? 9.40 O3 GOL C 149 coo 30.47 73.42 20.05 31.26 72.46 21.74 8.07 73.88 49.16 8.30 73.43 51.19 coo 28.46 69.88 26.74 30.40 70.70 26.53 10.89 79.68 47.57 9.75 78.80 49.16 coo 30.54 71.65 32.58 31.73 72.26 30.92 7.66 84.31 53.13 6.13 83.49 54.35 coo 37.87 70.12 31.80 36.61 69.74 30.15 13.62 86.10 55.23 12.83 84.59 56.49 ULMN 4 1qho_c03 ALPHA-AMYLASE user 3 4 # 3 A 132 HIS C 4 HIS.? -3.73 C3 GOL C 149s A 228 ASP C 122 ASP^? 7.22 C3 GOL C 149 A 256 GLU C 84 GLU.? 10.77 O2 GOL B 149 A 329 ASP C 83 ASP.? 8.65 O3 GOL B 149 coo 30.47 73.42 20.05 31.26 72.46 21.74 4.88 85.81 61.42 6.80 85.00 61.18 coo 28.46 69.88 26.74 30.40 70.70 26.53 0.27 81.12 61.60 2.07 81.54 60.53 coo 30.54 71.65 32.58 31.73 72.26 30.92 2.34 77.12 55.01 3.46 78.21 53.60 coo 37.87 70.12 31.80 36.61 69.74 30.15 3.02 71.86 58.06 4.88 72.49 57.24 ULMN 4 1qho_c03 ALPHA-AMYLASE user 4 4 # 4 A 132 HIS D 4 HIS.? 4.07 C3 GOL D 147 A 228 ASP D 122 ASP^? 7.49 C3 GOL D 147 A 256 GLU D 84 GLU.? 10.79 C1 GOL A 150 A 329 ASP D 83 ASP.? 8.76 O1 GOL A 150 coo 30.47 73.42 20.05 31.26 72.46 21.74 -23.57 78.63 1.94 -22.01 77.96 0.72 coo 28.46 69.88 26.74 30.40 70.70 26.53 -21.82 80.90 7.85 -21.38 79.32 6.51 coo 30.54 71.65 32.58 31.73 72.26 30.92 -17.40 74.78 10.23 -17.69 72.96 9.24 coo 37.87 70.12 31.80 36.61 69.74 30.15 -12.54 78.43 10.94 -12.46 77.06 9.29 1qho_c03 source 1qho ALPHA-AMYLASE : 4 hits 1qho_c03 naa= 4 ULMN 4 1uok_c02 OLIGO-1,6-GLUCOSIDASE user 1 4 # 1 103 HIS A 4 HIS.? -3.92 C2 GOL A 150s 199 ASP A 122 ASP^? 7.46 C1 GOL A 150 255 GLU A 84 GLU.? 10.45 C3 GOL D 147 329 ASP A 83 ASP.? 8.52 O3 GOL D 147 coo 49.45 28.31 18.34 50.63 29.96 17.82 -11.85 68.18 8.83 -11.23 70.10 8.29 coo 49.16 35.16 15.19 51.08 34.43 15.65 -15.41 64.92 4.51 -15.09 66.83 5.33 coo 52.57 37.12 10.17 53.37 35.95 11.75 -21.01 70.22 3.12 -21.10 71.95 4.30 coo 59.16 37.82 13.95 57.63 37.03 15.12 -19.46 70.43 -3.04 -19.06 72.28 -2.05 ULMN 4 1uok_c02 OLIGO-1,6-GLUCOSIDASE user 2 4 # 2 103 HIS B 4 HIS.? -3.86 O2 GOL B 149s 199 ASP B 122 ASP^? 7.33 O2 GOL B 149 255 GLU B 84 GLU.? 10.31 O3 GOL C 149 329 ASP B 83 ASP.? 9.40 O3 GOL C 149 coo 49.45 28.31 18.34 50.63 29.96 17.82 8.07 73.88 49.16 8.30 73.43 51.19 coo 49.16 35.16 15.19 51.08 34.43 15.65 10.89 79.68 47.57 9.75 78.80 49.16 coo 52.57 37.12 10.17 53.37 35.95 11.75 7.66 84.31 53.13 6.13 83.49 54.35 coo 59.16 37.82 13.95 57.63 37.03 15.12 13.62 86.10 55.23 12.83 84.59 56.49 ULMN 4 1uok_c02 OLIGO-1,6-GLUCOSIDASE user 3 4 # 3 103 HIS C 4 HIS.? -3.73 C3 GOL C 149s 199 ASP C 122 ASP^? 7.22 C3 GOL C 149 255 GLU C 84 GLU.? 10.77 O2 GOL B 149 329 ASP C 83 ASP.? 8.65 O3 GOL B 149 coo 49.45 28.31 18.34 50.63 29.96 17.82 4.88 85.81 61.42 6.80 85.00 61.18 coo 49.16 35.16 15.19 51.08 34.43 15.65 0.27 81.12 61.60 2.07 81.54 60.53 coo 52.57 37.12 10.17 53.37 35.95 11.75 2.34 77.12 55.01 3.46 78.21 53.60 coo 59.16 37.82 13.95 57.63 37.03 15.12 3.02 71.86 58.06 4.88 72.49 57.24 ULMN 4 1uok_c02 OLIGO-1,6-GLUCOSIDASE user 4 4 # 4 103 HIS D 4 HIS.? 4.07 C3 GOL D 147 199 ASP D 122 ASP^? 7.49 C3 GOL D 147 255 GLU D 84 GLU.? 10.79 C1 GOL A 150 329 ASP D 83 ASP.? 8.76 O1 GOL A 150 coo 49.45 28.31 18.34 50.63 29.96 17.82 -23.57 78.63 1.94 -22.01 77.96 0.72 coo 49.16 35.16 15.19 51.08 34.43 15.65 -21.82 80.90 7.85 -21.38 79.32 6.51 coo 52.57 37.12 10.17 53.37 35.95 11.75 -17.40 74.78 10.23 -17.69 72.96 9.24 coo 59.16 37.82 13.95 57.63 37.03 15.12 -12.54 78.43 10.94 -12.46 77.06 9.29 1uok_c02 source 1uok OLIGO-1,6-GLUCOSIDASE : 4 hits 1uok_c02 naa= 4 ULMN 4 2amg_c04 1,4-ALPHA-D-GLUCAN MALTOTETRAHYDROLAuser 1 4 # 1 193 ASP B 83 ASP.? 9.40 O3 GOL C 149 219 GLU B 84 GLU.? 10.31 O3 GOL C 149 221 TRP B 86 TRP.? 11.40 C6 PGE B 147 294 ASP B 122 ASP^? 7.33 O2 GOL B 149 coo 27.89 102.52 14.98 29.35 101.92 13.57 13.62 86.10 55.23 12.83 84.59 56.49 coo 25.84 105.87 9.06 27.86 105.55 8.74 7.66 84.31 53.13 6.13 83.49 54.35 coo 26.57 103.90 2.48 30.28 105.00 3.20 5.15 86.32 48.71 6.70 82.77 48.58 coo 33.16 106.80 7.72 33.34 104.87 6.92 10.89 79.68 47.57 9.75 78.80 49.16 2amg_c04 source 2amg 1,4-ALPHA-D-GLUCAN MALTOTETRAHYDROLASE : 1 hits 2amg_c04 naa= 4 ULMN 3 12as_c00 ASPARAGINE SYNTHETASE user 1 3 # 1 A 46 ASP A 19 ASP.? -3.59 O4 SO4 A 144s A 100 ARG A 16 ARG~? -2.82 O4 SO4 A 143s A 116 GLN A 14 GLN~? 4.09 C14 1PE B 150 coo 32.24 20.09 5.34 30.38 19.04 5.27 -15.01 66.98 32.71 -14.52 68.02 34.44 coo 26.40 25.34 6.28 26.15 22.33 7.25 -9.29 63.37 28.06 -8.90 62.24 30.90 coo 26.74 21.94 13.78 27.57 20.97 12.08 -9.40 72.50 23.82 -9.67 73.73 22.10 ULMN 3 12as_c00 ASPARAGINE SYNTHETASE user 2 3 # 2 A 46 ASP A 19 ASP.? -3.59 O4 SO4 A 144s A 100 ARG A 127 ARG^? 7.47 N MLZ A 129 A 116 GLN A 14 GLN~? 4.09 C14 1PE B 150 coo 32.24 20.09 5.34 30.38 19.04 5.27 -15.01 66.98 32.71 -14.52 68.02 34.44 coo 26.40 25.34 6.28 26.15 22.33 7.25 -18.44 68.25 24.06 -17.70 68.37 27.04 coo 26.74 21.94 13.78 27.57 20.97 12.08 -9.40 72.50 23.82 -9.67 73.73 22.10 ULMN 3 12as_c00 ASPARAGINE SYNTHETASE user 3 3 # 3 A 46 ASP B 19 ASP.? -3.77 O3 SO4 A 144s A 100 ARG B 16 ARG~? -3.64 O1 SO4 A 143s A 116 GLN B 14 GLN~? 3.86 C4 PGE C 147 coo 32.24 20.09 5.34 30.38 19.04 5.27 -12.63 65.75 40.21 -14.11 64.30 40.60 coo 26.40 25.34 6.28 26.15 22.33 7.25 -4.85 63.18 38.40 -7.23 62.95 36.44 coo 26.74 21.94 13.78 27.57 20.97 12.08 -4.26 64.23 48.43 -3.20 64.97 50.12 ULMN 3 12as_c00 ASPARAGINE SYNTHETASE user 4 3 # 4 A 46 ASP B 19 ASP.? -3.77 O3 SO4 A 144s A 100 ARG B 127 ARG^? 9.26 O4 SO4 A 144 A 116 GLN B 14 GLN~? 3.86 C4 PGE C 147 coo 32.24 20.09 5.34 30.38 19.04 5.27 -12.63 65.75 40.21 -14.11 64.30 40.60 coo 26.40 25.34 6.28 26.15 22.33 7.25 -7.64 72.55 44.16 -9.78 70.52 43.36 coo 26.74 21.94 13.78 27.57 20.97 12.08 -4.26 64.23 48.43 -3.20 64.97 50.12 ULMN 3 12as_c00 ASPARAGINE SYNTHETASE user 5 3 # 5 A 46 ASP C 19 ASP.? 9.43 O3 SO4 C 143 A 100 ARG C 127 ARG^? 7.44 N MLZ C 129 A 116 GLN C 14 GLN~? 4.10 C4 PGE B 147 coo 32.24 20.09 5.34 30.38 19.04 5.27 2.21 107.45 51.42 3.36 109.08 50.82 coo 26.40 25.34 6.28 26.15 22.33 7.25 1.53 98.09 50.88 2.14 101.05 50.40 coo 26.74 21.94 13.78 27.57 20.97 12.08 9.82 99.77 56.17 10.76 97.86 56.11 ULMN 3 12as_c00 ASPARAGINE SYNTHETASE user 6 3 # 6 A 46 ASP D 19 ASP.? -13.24 C2 PGE A 147s A 100 ARG D 16 ARG~? -9.70 O1 2PE D 146s A 116 GLN D 14 GLN~? 4.36 C3 PGE A 147 coo 32.24 20.09 5.34 30.38 19.04 5.27 -43.72 66.33 -2.80 -44.54 65.10 -4.29 coo 26.40 25.34 6.28 26.15 22.33 7.25 -42.18 74.28 -4.52 -45.10 73.30 -4.28 coo 26.74 21.94 13.78 27.57 20.97 12.08 -33.25 70.00 -6.94 -31.12 69.90 -6.76 ULMN 3 12as_c00 ASPARAGINE SYNTHETASE user 7 3 # 7 A 46 ASP D 19 ASP.? -13.24 C2 PGE A 147s A 100 ARG D 127 ARG^? 9.31 O3 PGE A 147 A 116 GLN D 14 GLN~? 4.36 C3 PGE A 147 coo 32.24 20.09 5.34 30.38 19.04 5.27 -43.72 66.33 -2.80 -44.54 65.10 -4.29 coo 26.40 25.34 6.28 26.15 22.33 7.25 -35.94 67.72 2.28 -38.25 66.55 0.66 coo 26.74 21.94 13.78 27.57 20.97 12.08 -33.25 70.00 -6.94 -31.12 69.90 -6.76 12as_c00 source 12as ASPARAGINE SYNTHETASE : 7 hits 12as_c00 naa= 3 ULMN 3 12as_c01 ASPARAGINE SYNTHETASE user 1 3 # 1 B 46 ASP A 19 ASP.? -3.59 O4 SO4 A 144s B 100 ARG A 16 ARG~? -2.82 O4 SO4 A 143s B 116 GLN A 14 GLN~? 4.09 C14 1PE B 150 coo 32.18 48.37 12.48 33.96 49.46 12.97 -15.01 66.98 32.71 -14.52 68.02 34.44 coo 39.04 43.25 11.37 38.30 45.35 13.56 -9.29 63.37 28.06 -8.90 62.24 30.90 coo 37.43 42.63 19.41 36.76 44.08 17.97 -9.40 72.50 23.82 -9.67 73.73 22.10 ULMN 3 12as_c01 ASPARAGINE SYNTHETASE user 2 3 # 2 B 46 ASP A 19 ASP.? -3.59 O4 SO4 A 144s B 100 ARG A 127 ARG^? 7.47 N MLZ A 129 B 116 GLN A 14 GLN~? 4.09 C14 1PE B 150 coo 32.18 48.37 12.48 33.96 49.46 12.97 -15.01 66.98 32.71 -14.52 68.02 34.44 coo 39.04 43.25 11.37 38.30 45.35 13.56 -18.44 68.25 24.06 -17.70 68.37 27.04 coo 37.43 42.63 19.41 36.76 44.08 17.97 -9.40 72.50 23.82 -9.67 73.73 22.10 ULMN 3 12as_c01 ASPARAGINE SYNTHETASE user 3 3 # 3 B 46 ASP B 19 ASP.? -3.77 O3 SO4 A 144s B 100 ARG B 16 ARG~? -3.64 O1 SO4 A 143s B 116 GLN B 14 GLN~? 3.86 C4 PGE C 147 coo 32.18 48.37 12.48 33.96 49.46 12.97 -12.63 65.75 40.21 -14.11 64.30 40.60 coo 39.04 43.25 11.37 38.30 45.35 13.56 -4.85 63.18 38.40 -7.23 62.95 36.44 coo 37.43 42.63 19.41 36.76 44.08 17.97 -4.26 64.23 48.43 -3.20 64.97 50.12 ULMN 3 12as_c01 ASPARAGINE SYNTHETASE user 4 3 # 4 B 46 ASP B 19 ASP.? -3.77 O3 SO4 A 144s B 100 ARG B 127 ARG^? 9.26 O4 SO4 A 144 B 116 GLN B 14 GLN~? 3.86 C4 PGE C 147 coo 32.18 48.37 12.48 33.96 49.46 12.97 -12.63 65.75 40.21 -14.11 64.30 40.60 coo 39.04 43.25 11.37 38.30 45.35 13.56 -7.64 72.55 44.16 -9.78 70.52 43.36 coo 37.43 42.63 19.41 36.76 44.08 17.97 -4.26 64.23 48.43 -3.20 64.97 50.12 ULMN 3 12as_c01 ASPARAGINE SYNTHETASE user 5 3 # 5 B 46 ASP C 19 ASP.? 9.43 O3 SO4 C 143 B 100 ARG C 127 ARG^? 7.44 N MLZ C 129 B 116 GLN C 14 GLN~? 4.10 C4 PGE B 147 coo 32.18 48.37 12.48 33.96 49.46 12.97 2.21 107.45 51.42 3.36 109.08 50.82 coo 39.04 43.25 11.37 38.30 45.35 13.56 1.53 98.09 50.88 2.14 101.05 50.40 coo 37.43 42.63 19.41 36.76 44.08 17.97 9.82 99.77 56.17 10.76 97.86 56.11 ULMN 3 12as_c01 ASPARAGINE SYNTHETASE user 6 3 # 6 B 46 ASP D 19 ASP.? -13.24 C2 PGE A 147s B 100 ARG D 16 ARG~? -9.70 O1 2PE D 146s B 116 GLN D 14 GLN~? 4.36 C3 PGE A 147 coo 32.18 48.37 12.48 33.96 49.46 12.97 -43.72 66.33 -2.80 -44.54 65.10 -4.29 coo 39.04 43.25 11.37 38.30 45.35 13.56 -42.18 74.28 -4.52 -45.10 73.30 -4.28 coo 37.43 42.63 19.41 36.76 44.08 17.97 -33.25 70.00 -6.94 -31.12 69.90 -6.76 ULMN 3 12as_c01 ASPARAGINE SYNTHETASE user 7 3 # 7 B 46 ASP D 19 ASP.? -13.24 C2 PGE A 147s B 100 ARG D 127 ARG^? 9.31 O3 PGE A 147 B 116 GLN D 14 GLN~? 4.36 C3 PGE A 147 coo 32.18 48.37 12.48 33.96 49.46 12.97 -43.72 66.33 -2.80 -44.54 65.10 -4.29 coo 39.04 43.25 11.37 38.30 45.35 13.56 -35.94 67.72 2.28 -38.25 66.55 0.66 coo 37.43 42.63 19.41 36.76 44.08 17.97 -33.25 70.00 -6.94 -31.12 69.90 -6.76 12as_c01 source 12as ASPARAGINE SYNTHETASE : 7 hits 12as_c01 naa= 3 ULMN 3 1a05_c00 3-ISOPROPYLMALATE DEHYDROGENASE user 1 3 # 1 A 140 TYR A 50 TYR~? 5.51 CH2 MLY D 135 B 190 LYS A 114 LYS~? 11.27 C9 2PE A 148 B 222 ASP A 56 ASP~? 11.59 C21 2PE A 148 coo 7.17 16.59 41.26 8.01 19.20 40.73 -19.50 53.98 8.67 -20.18 55.72 10.74 coo 13.38 20.00 35.06 11.43 22.49 39.53 -9.49 51.50 12.13 -4.59 48.44 14.69 coo 9.76 26.58 38.10 11.63 25.78 38.76 -16.01 45.89 15.64 -15.93 44.31 14.23 ULMN 3 1a05_c00 3-ISOPROPYLMALATE DEHYDROGENASE user 2 3 # 2 A 140 TYR A 109 TYR~? -5.64 O16 2PE A 148s B 190 LYS A 114 LYS~? 11.27 C9 2PE A 148 B 222 ASP A 6 ASP.? -3.91 C9 2PE A 148s coo 7.17 16.59 41.26 8.01 19.20 40.73 -13.81 52.60 20.09 -14.53 54.76 18.49 coo 13.38 20.00 35.06 11.43 22.49 39.53 -9.49 51.50 12.13 -4.59 48.44 14.69 coo 9.76 26.58 38.10 11.63 25.78 38.76 -8.66 61.41 13.34 -8.76 59.35 12.80 ULMN 3 1a05_c00 3-ISOPROPYLMALATE DEHYDROGENASE user 3 3 # 3 A 140 TYR B 50 TYR~? 5.52 CH1 MLY C 135 B 190 LYS B 114 LYS~? 11.34 O7 PE8 B 148 B 222 ASP B 56 ASP~? 11.45 C20 PE8 B 148 coo 7.17 16.59 41.26 8.01 19.20 40.73 8.51 83.11 35.90 5.93 82.51 36.84 coo 13.38 20.00 35.06 11.43 22.49 39.53 11.35 73.22 32.47 12.65 68.43 28.61 coo 9.76 26.58 38.10 11.63 25.78 38.76 6.80 78.21 26.00 8.47 79.07 25.03 ULMN 3 1a05_c00 3-ISOPROPYLMALATE DEHYDROGENASE user 4 3 # 4 A 140 TYR B 109 TYR~? -5.65 O13 PE8 B 148s B 190 LYS B 114 LYS~? 11.34 O7 PE8 B 148 B 222 ASP B 6 ASP.? -3.99 C6 PE8 B 148s coo 7.17 16.59 41.26 8.01 19.20 40.73 2.41 73.03 30.76 2.68 74.03 33.35 coo 13.38 20.00 35.06 11.43 22.49 39.53 11.35 73.22 32.47 12.65 68.43 28.61 coo 9.76 26.58 38.10 11.63 25.78 38.76 7.95 70.39 41.39 8.88 71.08 39.61 ULMN 3 1a05_c00 3-ISOPROPYLMALATE DEHYDROGENASE user 5 3 # 5 A 140 TYR D 50 TYR~? 5.61 CH1 MLY A 135 B 190 LYS D 114 LYS~? 10.81 C9 2PE D 146 B 222 ASP D 56 ASP~? 11.46 C21 2PE D 146 coo 7.17 16.59 41.26 8.01 19.20 40.73 -31.54 83.73 14.98 -32.20 81.17 14.09 coo 13.38 20.00 35.06 11.43 22.49 39.53 -35.88 89.56 6.78 -39.69 93.33 3.49 coo 9.76 26.58 38.10 11.63 25.78 38.76 -41.85 87.81 13.66 -41.61 89.58 14.80 ULMN 3 1a05_c00 3-ISOPROPYLMALATE DEHYDROGENASE user 6 3 # 6 A 140 TYR D 109 TYR~? -5.82 O16 2PE D 146s B 190 LYS D 114 LYS~? 10.81 C9 2PE D 146 B 222 ASP D 6 ASP.? -3.77 C8 2PE D 146s coo 7.17 16.59 41.26 8.01 19.20 40.73 -41.76 82.56 7.21 -39.24 81.41 7.29 coo 13.38 20.00 35.06 11.43 22.49 39.53 -35.88 89.56 6.78 -39.69 93.33 3.49 coo 9.76 26.58 38.10 11.63 25.78 38.76 -31.03 82.87 1.04 -31.83 84.41 2.29 1a05_c00 source 1a05 3-ISOPROPYLMALATE DEHYDROGENASE : 6 hits 1a05_c00 naa= 3 ULMN 3 1a05_c01 3-ISOPROPYLMALATE DEHYDROGENASE user 1 3 # 1 A 190 LYS A 114 LYS~? 11.27 C9 2PE A 148 A 222 ASP A 56 ASP~? 11.59 C21 2PE A 148 B 140 TYR A 50 TYR~? 5.51 CH2 MLY D 135 coo -4.61 20.12 30.34 -2.74 22.65 25.95 -9.49 51.50 12.13 -4.59 48.44 14.69 coo -1.04 26.60 27.37 -2.94 25.93 26.69 -16.01 45.89 15.64 -15.93 44.31 14.23 coo 1.51 16.60 24.17 0.82 19.23 24.79 -19.50 53.98 8.67 -20.18 55.72 10.74 ULMN 3 1a05_c01 3-ISOPROPYLMALATE DEHYDROGENASE user 2 3 # 2 A 190 LYS B 114 LYS~? 11.34 O7 PE8 B 148 A 222 ASP B 6 ASP.? -3.99 C6 PE8 B 148s B 140 TYR B 109 TYR~? -5.65 O13 PE8 B 148s coo -4.61 20.12 30.34 -2.74 22.65 25.95 11.35 73.22 32.47 12.65 68.43 28.61 coo -1.04 26.60 27.37 -2.94 25.93 26.69 7.95 70.39 41.39 8.88 71.08 39.61 coo 1.51 16.60 24.17 0.82 19.23 24.79 2.41 73.03 30.76 2.68 74.03 33.35 ULMN 3 1a05_c01 3-ISOPROPYLMALATE DEHYDROGENASE user 3 3 # 3 A 190 LYS B 114 LYS~? 11.34 O7 PE8 B 148 A 222 ASP B 56 ASP~? 11.45 C20 PE8 B 148 B 140 TYR B 50 TYR~? 5.52 CH1 MLY C 135 coo -4.61 20.12 30.34 -2.74 22.65 25.95 11.35 73.22 32.47 12.65 68.43 28.61 coo -1.04 26.60 27.37 -2.94 25.93 26.69 6.80 78.21 26.00 8.47 79.07 25.03 coo 1.51 16.60 24.17 0.82 19.23 24.79 8.51 83.11 35.90 5.93 82.51 36.84 ULMN 3 1a05_c01 3-ISOPROPYLMALATE DEHYDROGENASE user 4 3 # 4 A 190 LYS D 114 LYS~? 10.81 C9 2PE D 146 A 222 ASP D 56 ASP~? 11.46 C21 2PE D 146 B 140 TYR D 50 TYR~? 5.61 CH1 MLY A 135 coo -4.61 20.12 30.34 -2.74 22.65 25.95 -35.88 89.56 6.78 -39.69 93.33 3.49 coo -1.04 26.60 27.37 -2.94 25.93 26.69 -41.85 87.81 13.66 -41.61 89.58 14.80 coo 1.51 16.60 24.17 0.82 19.23 24.79 -31.54 83.73 14.98 -32.20 81.17 14.09 1a05_c01 source 1a05 3-ISOPROPYLMALATE DEHYDROGENASE : 4 hits 1a05_c01 naa= 3 ULMN 3 1a0j_c12 TRYPSIN user 1 3 # 1 A 57 HIS A 88 HIS^? 4.20 CH2 MLY D 135 A 102 ASP A 87 ASP.? 8.49 C6 PGE A 147 A 193 GLY A 54 GLY~? 5.80 C21 2PE A 148 coo 25.57 41.22 61.68 24.18 39.98 62.50 -23.95 56.87 7.77 -24.14 54.98 6.86 coo 22.33 45.48 59.73 23.35 43.67 60.06 -23.17 58.67 3.55 -22.34 59.17 1.69 coo 22.57 32.23 64.13 21.98 32.82 64.22 -20.41 50.07 13.76 -19.88 49.43 13.69 ULMN 3 1a0j_c12 TRYPSIN user 2 3 # 2 A 57 HIS A 88 HIS^? 4.20 CH2 MLY D 135 A 102 ASP A 87 ASP.? 8.49 C6 PGE A 147 A 193 GLY D 134 GLY.? 2.47 N MLY D 135 coo 25.57 41.22 61.68 24.18 39.98 62.50 -23.95 56.87 7.77 -24.14 54.98 6.86 coo 22.33 45.48 59.73 23.35 43.67 60.06 -23.17 58.67 3.55 -22.34 59.17 1.69 coo 22.57 32.23 64.13 21.98 32.82 64.22 -31.46 51.06 14.18 -31.60 51.74 13.54 ULMN 3 1a0j_c12 TRYPSIN user 3 3 # 3 A 57 HIS A 115 HIS~? 12.27 C21 2PE A 148 A 102 ASP A 56 ASP~? 11.59 C21 2PE A 148 A 193 GLY A 46 GLY~? 12.01 CD MLY D 135 coo 25.57 41.22 61.68 24.18 39.98 62.50 -13.18 48.35 10.37 -12.55 46.36 10.33 coo 22.33 45.48 59.73 23.35 43.67 60.06 -16.01 45.89 15.64 -15.93 44.31 14.23 coo 22.57 32.23 64.13 21.98 32.82 64.22 -16.75 52.82 2.36 -17.28 52.20 2.20 ULMN 3 1a0j_c12 TRYPSIN user 4 3 # 4 A 57 HIS B 88 HIS^? 4.29 CH1 MLY C 135 A 102 ASP B 87 ASP.? 8.94 O4 PGE B 147 A 193 GLY B 54 GLY~? 5.68 C20 PE8 B 148 coo 25.57 41.22 61.68 24.18 39.98 62.50 6.15 87.00 38.94 7.35 87.96 37.51 coo 22.33 45.48 59.73 23.35 43.67 60.06 9.49 87.97 42.02 11.31 87.98 43.09 coo 22.57 32.23 64.13 21.98 32.82 64.22 5.02 82.24 30.45 5.51 81.90 29.87 ULMN 3 1a0j_c12 TRYPSIN user 5 3 # 5 A 57 HIS B 88 HIS^? 4.29 CH1 MLY C 135 A 102 ASP B 87 ASP.? 8.94 O4 PGE B 147 A 193 GLY C 134 GLY.? 2.48 N MLY C 135 coo 25.57 41.22 61.68 24.18 39.98 62.50 6.15 87.00 38.94 7.35 87.96 37.51 coo 22.33 45.48 59.73 23.35 43.67 60.06 9.49 87.97 42.02 11.31 87.98 43.09 coo 22.57 32.23 64.13 21.98 32.82 64.22 -1.36 91.26 31.44 -1.10 91.64 32.26 ULMN 3 1a0j_c12 TRYPSIN user 6 3 # 6 A 57 HIS B 115 HIS~? 12.48 C18 PE8 B 148 A 102 ASP B 56 ASP~? 11.45 C20 PE8 B 148 A 193 GLY B 46 GLY~? 9.70 O1 PEG B 144 coo 25.57 41.22 61.68 24.18 39.98 62.50 11.86 77.76 30.05 12.70 77.49 28.15 coo 22.33 45.48 59.73 23.35 43.67 60.06 6.80 78.21 26.00 8.47 79.07 25.03 coo 22.57 32.23 64.13 21.98 32.82 64.22 15.35 83.93 36.97 15.42 84.55 36.41 ULMN 3 1a0j_c12 TRYPSIN user 7 3 # 7 A 57 HIS C 88 HIS^? 3.86 CD MLY B 135 A 102 ASP C 87 ASP.? 8.84 O1 PGE C 147 A 193 GLY B 134 GLY.? 2.46 N MLY B 135 coo 25.57 41.22 61.68 24.18 39.98 62.50 -11.00 83.03 57.18 -12.69 82.43 58.26 coo 22.33 45.48 59.73 23.35 43.67 60.06 -9.03 79.00 58.44 -8.21 77.39 59.55 coo 22.57 32.23 64.13 21.98 32.82 64.22 -19.59 87.32 51.84 -18.97 86.72 51.66 ULMN 3 1a0j_c12 TRYPSIN user 8 3 # 8 A 57 HIS C 88 HIS^? 3.86 CD MLY B 135 A 102 ASP C 87 ASP.? 8.84 O1 PGE C 147 A 193 GLY C 54 GLY~? 6.00 CH2 MLY B 135 coo 25.57 41.22 61.68 24.18 39.98 62.50 -11.00 83.03 57.18 -12.69 82.43 58.26 coo 22.33 45.48 59.73 23.35 43.67 60.06 -9.03 79.00 58.44 -8.21 77.39 59.55 coo 22.57 32.23 64.13 21.98 32.82 64.22 -15.22 90.72 61.35 -15.47 90.98 62.07 ULMN 3 1a0j_c12 TRYPSIN user 9 3 # 9 A 57 HIS C 115 HIS~? 4.72 C MLZ C 114 A 102 ASP C 56 ASP~? 9.09 N MLZ C 114 A 193 GLY C 46 GLY~? 10.04 O MLZ C 114 coo 25.57 41.22 61.68 24.18 39.98 62.50 -12.99 90.00 69.08 -14.38 90.57 70.54 coo 22.33 45.48 59.73 23.35 43.67 60.06 -16.40 94.43 66.11 -17.63 93.56 67.58 coo 22.57 32.23 64.13 21.98 32.82 64.22 -10.91 80.74 66.75 -11.70 80.52 66.65 ULMN 3 1a0j_c12 TRYPSIN user 10 3 # 10 A 57 HIS D 88 HIS^? 4.38 CH1 MLY A 135 A 102 ASP D 87 ASP.? 7.26 C16 1PE B 150 A 193 GLY A 134 GLY.? 2.47 N MLY A 135 coo 25.57 41.22 61.68 24.18 39.98 62.50 -29.18 79.71 17.63 -29.43 81.25 19.03 coo 22.33 45.48 59.73 23.35 43.67 60.06 -24.70 80.89 17.41 -22.90 81.94 17.31 coo 22.57 32.23 64.13 21.98 32.82 64.22 -37.57 76.13 24.20 -36.67 75.88 24.22 ULMN 3 1a0j_c12 TRYPSIN user 11 3 # 11 A 57 HIS D 88 HIS^? 4.38 CH1 MLY A 135 A 102 ASP D 87 ASP.? 7.26 C16 1PE B 150 A 193 GLY D 54 GLY~? 5.81 C23 2PE D 146 coo 25.57 41.22 61.68 24.18 39.98 62.50 -29.18 79.71 17.63 -29.43 81.25 19.03 coo 22.33 45.48 59.73 23.35 43.67 60.06 -24.70 80.89 17.41 -22.90 81.94 17.31 coo 22.57 32.23 64.13 21.98 32.82 64.22 -38.01 83.52 15.98 -38.33 84.28 15.84 ULMN 3 1a0j_c12 TRYPSIN user 12 3 # 12 A 57 HIS D 115 HIS~? 12.18 C21 2PE D 146 A 102 ASP D 56 ASP~? 11.46 C21 2PE D 146 A 193 GLY D 46 GLY~? 12.21 CD MLY A 135 coo 25.57 41.22 61.68 24.18 39.98 62.50 -36.28 90.32 11.92 -37.49 91.98 12.35 coo 22.33 45.48 59.73 23.35 43.67 60.06 -41.85 87.81 13.66 -41.61 89.58 14.80 coo 22.57 32.23 64.13 21.98 32.82 64.22 -27.16 89.12 15.33 -27.37 89.29 16.11 1a0j_c12 source 1a0j TRYPSIN : 12 hits 1a0j_c12 naa= 3 ULMN 3 1a0j_c13 TRYPSIN user 1 3 # 1 B 57 HIS A 88 HIS^? 4.20 CH2 MLY D 135 B 102 ASP A 87 ASP.? 8.49 C6 PGE A 147 B 193 GLY A 54 GLY~? 5.80 C21 2PE A 148 coo 44.08 45.58 52.81 45.86 46.55 52.85 -23.95 56.87 7.77 -24.14 54.98 6.86 coo 43.04 44.75 47.18 43.31 45.51 49.13 -23.17 58.67 3.55 -22.34 59.17 1.69 coo 50.46 51.91 56.90 50.65 51.62 56.14 -20.41 50.07 13.76 -19.88 49.43 13.69 ULMN 3 1a0j_c13 TRYPSIN user 2 3 # 2 B 57 HIS A 88 HIS^? 4.20 CH2 MLY D 135 B 102 ASP A 87 ASP.? 8.49 C6 PGE A 147 B 193 GLY D 134 GLY.? 2.47 N MLY D 135 coo 44.08 45.58 52.81 45.86 46.55 52.85 -23.95 56.87 7.77 -24.14 54.98 6.86 coo 43.04 44.75 47.18 43.31 45.51 49.13 -23.17 58.67 3.55 -22.34 59.17 1.69 coo 50.46 51.91 56.90 50.65 51.62 56.14 -31.46 51.06 14.18 -31.60 51.74 13.54 ULMN 3 1a0j_c13 TRYPSIN user 3 3 # 3 B 57 HIS A 115 HIS~? 12.27 C21 2PE A 148 B 102 ASP A 56 ASP~? 11.59 C21 2PE A 148 B 193 GLY A 46 GLY~? 12.01 CD MLY D 135 coo 44.08 45.58 52.81 45.86 46.55 52.85 -13.18 48.35 10.37 -12.55 46.36 10.33 coo 43.04 44.75 47.18 43.31 45.51 49.13 -16.01 45.89 15.64 -15.93 44.31 14.23 coo 50.46 51.91 56.90 50.65 51.62 56.14 -16.75 52.82 2.36 -17.28 52.20 2.20 ULMN 3 1a0j_c13 TRYPSIN user 4 3 # 4 B 57 HIS B 88 HIS^? 4.29 CH1 MLY C 135 B 102 ASP B 87 ASP.? 8.94 O4 PGE B 147 B 193 GLY B 54 GLY~? 5.68 C20 PE8 B 148 coo 44.08 45.58 52.81 45.86 46.55 52.85 6.15 87.00 38.94 7.35 87.96 37.51 coo 43.04 44.75 47.18 43.31 45.51 49.13 9.49 87.97 42.02 11.31 87.98 43.09 coo 50.46 51.91 56.90 50.65 51.62 56.14 5.02 82.24 30.45 5.51 81.90 29.87 ULMN 3 1a0j_c13 TRYPSIN user 5 3 # 5 B 57 HIS B 88 HIS^? 4.29 CH1 MLY C 135 B 102 ASP B 87 ASP.? 8.94 O4 PGE B 147 B 193 GLY C 134 GLY.? 2.48 N MLY C 135 coo 44.08 45.58 52.81 45.86 46.55 52.85 6.15 87.00 38.94 7.35 87.96 37.51 coo 43.04 44.75 47.18 43.31 45.51 49.13 9.49 87.97 42.02 11.31 87.98 43.09 coo 50.46 51.91 56.90 50.65 51.62 56.14 -1.36 91.26 31.44 -1.10 91.64 32.26 ULMN 3 1a0j_c13 TRYPSIN user 6 3 # 6 B 57 HIS B 115 HIS~? 12.48 C18 PE8 B 148 B 102 ASP B 56 ASP~? 11.45 C20 PE8 B 148 B 193 GLY B 46 GLY~? 9.70 O1 PEG B 144 coo 44.08 45.58 52.81 45.86 46.55 52.85 11.86 77.76 30.05 12.70 77.49 28.15 coo 43.04 44.75 47.18 43.31 45.51 49.13 6.80 78.21 26.00 8.47 79.07 25.03 coo 50.46 51.91 56.90 50.65 51.62 56.14 15.35 83.93 36.97 15.42 84.55 36.41 ULMN 3 1a0j_c13 TRYPSIN user 7 3 # 7 B 57 HIS C 88 HIS^? 3.86 CD MLY B 135 B 102 ASP C 87 ASP.? 8.84 O1 PGE C 147 B 193 GLY B 134 GLY.? 2.46 N MLY B 135 coo 44.08 45.58 52.81 45.86 46.55 52.85 -11.00 83.03 57.18 -12.69 82.43 58.26 coo 43.04 44.75 47.18 43.31 45.51 49.13 -9.03 79.00 58.44 -8.21 77.39 59.55 coo 50.46 51.91 56.90 50.65 51.62 56.14 -19.59 87.32 51.84 -18.97 86.72 51.66 ULMN 3 1a0j_c13 TRYPSIN user 8 3 # 8 B 57 HIS C 88 HIS^? 3.86 CD MLY B 135 B 102 ASP C 87 ASP.? 8.84 O1 PGE C 147 B 193 GLY C 54 GLY~? 6.00 CH2 MLY B 135 coo 44.08 45.58 52.81 45.86 46.55 52.85 -11.00 83.03 57.18 -12.69 82.43 58.26 coo 43.04 44.75 47.18 43.31 45.51 49.13 -9.03 79.00 58.44 -8.21 77.39 59.55 coo 50.46 51.91 56.90 50.65 51.62 56.14 -15.22 90.72 61.35 -15.47 90.98 62.07 ULMN 3 1a0j_c13 TRYPSIN user 9 3 # 9 B 57 HIS C 115 HIS~? 4.72 C MLZ C 114 B 102 ASP C 56 ASP~? 9.09 N MLZ C 114 B 193 GLY C 46 GLY~? 10.04 O MLZ C 114 coo 44.08 45.58 52.81 45.86 46.55 52.85 -12.99 90.00 69.08 -14.38 90.57 70.54 coo 43.04 44.75 47.18 43.31 45.51 49.13 -16.40 94.43 66.11 -17.63 93.56 67.58 coo 50.46 51.91 56.90 50.65 51.62 56.14 -10.91 80.74 66.75 -11.70 80.52 66.65 ULMN 3 1a0j_c13 TRYPSIN user 10 3 # 10 B 57 HIS D 88 HIS^? 4.38 CH1 MLY A 135 B 102 ASP D 87 ASP.? 7.26 C16 1PE B 150 B 193 GLY A 134 GLY.? 2.47 N MLY A 135 coo 44.08 45.58 52.81 45.86 46.55 52.85 -29.18 79.71 17.63 -29.43 81.25 19.03 coo 43.04 44.75 47.18 43.31 45.51 49.13 -24.70 80.89 17.41 -22.90 81.94 17.31 coo 50.46 51.91 56.90 50.65 51.62 56.14 -37.57 76.13 24.20 -36.67 75.88 24.22 ULMN 3 1a0j_c13 TRYPSIN user 11 3 # 11 B 57 HIS D 88 HIS^? 4.38 CH1 MLY A 135 B 102 ASP D 87 ASP.? 7.26 C16 1PE B 150 B 193 GLY D 54 GLY~? 5.81 C23 2PE D 146 coo 44.08 45.58 52.81 45.86 46.55 52.85 -29.18 79.71 17.63 -29.43 81.25 19.03 coo 43.04 44.75 47.18 43.31 45.51 49.13 -24.70 80.89 17.41 -22.90 81.94 17.31 coo 50.46 51.91 56.90 50.65 51.62 56.14 -38.01 83.52 15.98 -38.33 84.28 15.84 ULMN 3 1a0j_c13 TRYPSIN user 12 3 # 12 B 57 HIS D 115 HIS~? 12.18 C21 2PE D 146 B 102 ASP D 56 ASP~? 11.46 C21 2PE D 146 B 193 GLY D 46 GLY~? 12.21 CD MLY A 135 coo 44.08 45.58 52.81 45.86 46.55 52.85 -36.28 90.32 11.92 -37.49 91.98 12.35 coo 43.04 44.75 47.18 43.31 45.51 49.13 -41.85 87.81 13.66 -41.61 89.58 14.80 coo 50.46 51.91 56.90 50.65 51.62 56.14 -27.16 89.12 15.33 -27.37 89.29 16.11 1a0j_c13 source 1a0j TRYPSIN : 12 hits 1a0j_c13 naa= 3 ULMN 3 1a0j_c14 TRYPSIN user 1 3 # 1 C 57 HIS A 88 HIS^? 4.20 CH2 MLY D 135 C 102 ASP A 87 ASP.? 8.49 C6 PGE A 147 C 193 GLY A 54 GLY~? 5.80 C21 2PE A 148 coo 34.37 41.18 73.21 34.04 43.09 73.87 -23.95 56.87 7.77 -24.14 54.98 6.86 coo 34.89 38.34 78.12 35.11 39.59 76.42 -23.17 58.67 3.55 -22.34 59.17 1.69 coo 35.43 51.03 72.12 35.20 50.72 72.87 -20.41 50.07 13.76 -19.88 49.43 13.69 ULMN 3 1a0j_c14 TRYPSIN user 2 3 # 2 C 57 HIS A 88 HIS^? 4.20 CH2 MLY D 135 C 102 ASP A 87 ASP.? 8.49 C6 PGE A 147 C 193 GLY D 134 GLY.? 2.47 N MLY D 135 coo 34.37 41.18 73.21 34.04 43.09 73.87 -23.95 56.87 7.77 -24.14 54.98 6.86 coo 34.89 38.34 78.12 35.11 39.59 76.42 -23.17 58.67 3.55 -22.34 59.17 1.69 coo 35.43 51.03 72.12 35.20 50.72 72.87 -31.46 51.06 14.18 -31.60 51.74 13.54 ULMN 3 1a0j_c14 TRYPSIN user 3 3 # 3 C 57 HIS A 115 HIS~? 12.27 C21 2PE A 148 C 102 ASP A 56 ASP~? 11.59 C21 2PE A 148 C 193 GLY A 46 GLY~? 12.01 CD MLY D 135 coo 34.37 41.18 73.21 34.04 43.09 73.87 -13.18 48.35 10.37 -12.55 46.36 10.33 coo 34.89 38.34 78.12 35.11 39.59 76.42 -16.01 45.89 15.64 -15.93 44.31 14.23 coo 35.43 51.03 72.12 35.20 50.72 72.87 -16.75 52.82 2.36 -17.28 52.20 2.20 ULMN 3 1a0j_c14 TRYPSIN user 4 3 # 4 C 57 HIS B 88 HIS^? 4.29 CH1 MLY C 135 C 102 ASP B 87 ASP.? 8.94 O4 PGE B 147 C 193 GLY B 54 GLY~? 5.68 C20 PE8 B 148 coo 34.37 41.18 73.21 34.04 43.09 73.87 6.15 87.00 38.94 7.35 87.96 37.51 coo 34.89 38.34 78.12 35.11 39.59 76.42 9.49 87.97 42.02 11.31 87.98 43.09 coo 35.43 51.03 72.12 35.20 50.72 72.87 5.02 82.24 30.45 5.51 81.90 29.87 ULMN 3 1a0j_c14 TRYPSIN user 5 3 # 5 C 57 HIS B 88 HIS^? 4.29 CH1 MLY C 135 C 102 ASP B 87 ASP.? 8.94 O4 PGE B 147 C 193 GLY C 134 GLY.? 2.48 N MLY C 135 coo 34.37 41.18 73.21 34.04 43.09 73.87 6.15 87.00 38.94 7.35 87.96 37.51 coo 34.89 38.34 78.12 35.11 39.59 76.42 9.49 87.97 42.02 11.31 87.98 43.09 coo 35.43 51.03 72.12 35.20 50.72 72.87 -1.36 91.26 31.44 -1.10 91.64 32.26 ULMN 3 1a0j_c14 TRYPSIN user 6 3 # 6 C 57 HIS B 115 HIS~? 12.48 C18 PE8 B 148 C 102 ASP B 56 ASP~? 11.45 C20 PE8 B 148 C 193 GLY B 46 GLY~? 9.70 O1 PEG B 144 coo 34.37 41.18 73.21 34.04 43.09 73.87 11.86 77.76 30.05 12.70 77.49 28.15 coo 34.89 38.34 78.12 35.11 39.59 76.42 6.80 78.21 26.00 8.47 79.07 25.03 coo 35.43 51.03 72.12 35.20 50.72 72.87 15.35 83.93 36.97 15.42 84.55 36.41 ULMN 3 1a0j_c14 TRYPSIN user 7 3 # 7 C 57 HIS C 88 HIS^? 3.86 CD MLY B 135 C 102 ASP C 87 ASP.? 8.84 O1 PGE C 147 C 193 GLY B 134 GLY.? 2.46 N MLY B 135 coo 34.37 41.18 73.21 34.04 43.09 73.87 -11.00 83.03 57.18 -12.69 82.43 58.26 coo 34.89 38.34 78.12 35.11 39.59 76.42 -9.03 79.00 58.44 -8.21 77.39 59.55 coo 35.43 51.03 72.12 35.20 50.72 72.87 -19.59 87.32 51.84 -18.97 86.72 51.66 ULMN 3 1a0j_c14 TRYPSIN user 8 3 # 8 C 57 HIS C 88 HIS^? 3.86 CD MLY B 135 C 102 ASP C 87 ASP.? 8.84 O1 PGE C 147 C 193 GLY C 54 GLY~? 6.00 CH2 MLY B 135 coo 34.37 41.18 73.21 34.04 43.09 73.87 -11.00 83.03 57.18 -12.69 82.43 58.26 coo 34.89 38.34 78.12 35.11 39.59 76.42 -9.03 79.00 58.44 -8.21 77.39 59.55 coo 35.43 51.03 72.12 35.20 50.72 72.87 -15.22 90.72 61.35 -15.47 90.98 62.07 ULMN 3 1a0j_c14 TRYPSIN user 9 3 # 9 C 57 HIS C 115 HIS~? 4.72 C MLZ C 114 C 102 ASP C 56 ASP~? 9.09 N MLZ C 114 C 193 GLY C 46 GLY~? 10.04 O MLZ C 114 coo 34.37 41.18 73.21 34.04 43.09 73.87 -12.99 90.00 69.08 -14.38 90.57 70.54 coo 34.89 38.34 78.12 35.11 39.59 76.42 -16.40 94.43 66.11 -17.63 93.56 67.58 coo 35.43 51.03 72.12 35.20 50.72 72.87 -10.91 80.74 66.75 -11.70 80.52 66.65 ULMN 3 1a0j_c14 TRYPSIN user 10 3 # 10 C 57 HIS D 88 HIS^? 4.38 CH1 MLY A 135 C 102 ASP D 87 ASP.? 7.26 C16 1PE B 150 C 193 GLY A 134 GLY.? 2.47 N MLY A 135 coo 34.37 41.18 73.21 34.04 43.09 73.87 -29.18 79.71 17.63 -29.43 81.25 19.03 coo 34.89 38.34 78.12 35.11 39.59 76.42 -24.70 80.89 17.41 -22.90 81.94 17.31 coo 35.43 51.03 72.12 35.20 50.72 72.87 -37.57 76.13 24.20 -36.67 75.88 24.22 ULMN 3 1a0j_c14 TRYPSIN user 11 3 # 11 C 57 HIS D 88 HIS^? 4.38 CH1 MLY A 135 C 102 ASP D 87 ASP.? 7.26 C16 1PE B 150 C 193 GLY D 54 GLY~? 5.81 C23 2PE D 146 coo 34.37 41.18 73.21 34.04 43.09 73.87 -29.18 79.71 17.63 -29.43 81.25 19.03 coo 34.89 38.34 78.12 35.11 39.59 76.42 -24.70 80.89 17.41 -22.90 81.94 17.31 coo 35.43 51.03 72.12 35.20 50.72 72.87 -38.01 83.52 15.98 -38.33 84.28 15.84 ULMN 3 1a0j_c14 TRYPSIN user 12 3 # 12 C 57 HIS D 115 HIS~? 12.18 C21 2PE D 146 C 102 ASP D 56 ASP~? 11.46 C21 2PE D 146 C 193 GLY D 46 GLY~? 12.21 CD MLY A 135 coo 34.37 41.18 73.21 34.04 43.09 73.87 -36.28 90.32 11.92 -37.49 91.98 12.35 coo 34.89 38.34 78.12 35.11 39.59 76.42 -41.85 87.81 13.66 -41.61 89.58 14.80 coo 35.43 51.03 72.12 35.20 50.72 72.87 -27.16 89.12 15.33 -27.37 89.29 16.11 1a0j_c14 source 1a0j TRYPSIN : 12 hits 1a0j_c14 naa= 3 ULMN 3 1a0j_c15 TRYPSIN user 1 3 # 1 D 57 HIS A 88 HIS^? 4.20 CH2 MLY D 135 D 102 ASP A 87 ASP.? 8.49 C6 PGE A 147 D 193 GLY A 54 GLY~? 5.80 C21 2PE A 148 coo 8.19 15.01 95.72 7.78 16.53 97.01 -23.95 56.87 7.77 -24.14 54.98 6.86 coo 13.53 16.28 93.98 11.45 16.21 94.40 -23.17 58.67 3.55 -22.34 59.17 1.69 coo 1.80 21.25 100.04 2.61 21.42 100.18 -20.41 50.07 13.76 -19.88 49.43 13.69 ULMN 3 1a0j_c15 TRYPSIN user 2 3 # 2 D 57 HIS A 88 HIS^? 4.20 CH2 MLY D 135 D 102 ASP A 87 ASP.? 8.49 C6 PGE A 147 D 193 GLY D 134 GLY.? 2.47 N MLY D 135 coo 8.19 15.01 95.72 7.78 16.53 97.01 -23.95 56.87 7.77 -24.14 54.98 6.86 coo 13.53 16.28 93.98 11.45 16.21 94.40 -23.17 58.67 3.55 -22.34 59.17 1.69 coo 1.80 21.25 100.04 2.61 21.42 100.18 -31.46 51.06 14.18 -31.60 51.74 13.54 ULMN 3 1a0j_c15 TRYPSIN user 3 3 # 3 D 57 HIS A 115 HIS~? 12.27 C21 2PE A 148 D 102 ASP A 56 ASP~? 11.59 C21 2PE A 148 D 193 GLY A 46 GLY~? 12.01 CD MLY D 135 coo 8.19 15.01 95.72 7.78 16.53 97.01 -13.18 48.35 10.37 -12.55 46.36 10.33 coo 13.53 16.28 93.98 11.45 16.21 94.40 -16.01 45.89 15.64 -15.93 44.31 14.23 coo 1.80 21.25 100.04 2.61 21.42 100.18 -16.75 52.82 2.36 -17.28 52.20 2.20 ULMN 3 1a0j_c15 TRYPSIN user 4 3 # 4 D 57 HIS B 88 HIS^? 4.29 CH1 MLY C 135 D 102 ASP B 87 ASP.? 8.94 O4 PGE B 147 D 193 GLY B 54 GLY~? 5.68 C20 PE8 B 148 coo 8.19 15.01 95.72 7.78 16.53 97.01 6.15 87.00 38.94 7.35 87.96 37.51 coo 13.53 16.28 93.98 11.45 16.21 94.40 9.49 87.97 42.02 11.31 87.98 43.09 coo 1.80 21.25 100.04 2.61 21.42 100.18 5.02 82.24 30.45 5.51 81.90 29.87 ULMN 3 1a0j_c15 TRYPSIN user 5 3 # 5 D 57 HIS B 88 HIS^? 4.29 CH1 MLY C 135 D 102 ASP B 87 ASP.? 8.94 O4 PGE B 147 D 193 GLY C 134 GLY.? 2.48 N MLY C 135 coo 8.19 15.01 95.72 7.78 16.53 97.01 6.15 87.00 38.94 7.35 87.96 37.51 coo 13.53 16.28 93.98 11.45 16.21 94.40 9.49 87.97 42.02 11.31 87.98 43.09 coo 1.80 21.25 100.04 2.61 21.42 100.18 -1.36 91.26 31.44 -1.10 91.64 32.26 ULMN 3 1a0j_c15 TRYPSIN user 6 3 # 6 D 57 HIS B 115 HIS~? 12.48 C18 PE8 B 148 D 102 ASP B 56 ASP~? 11.45 C20 PE8 B 148 D 193 GLY B 46 GLY~? 9.70 O1 PEG B 144 coo 8.19 15.01 95.72 7.78 16.53 97.01 11.86 77.76 30.05 12.70 77.49 28.15 coo 13.53 16.28 93.98 11.45 16.21 94.40 6.80 78.21 26.00 8.47 79.07 25.03 coo 1.80 21.25 100.04 2.61 21.42 100.18 15.35 83.93 36.97 15.42 84.55 36.41 ULMN 3 1a0j_c15 TRYPSIN user 7 3 # 7 D 57 HIS C 88 HIS^? 3.86 CD MLY B 135 D 102 ASP C 87 ASP.? 8.84 O1 PGE C 147 D 193 GLY B 134 GLY.? 2.46 N MLY B 135 coo 8.19 15.01 95.72 7.78 16.53 97.01 -11.00 83.03 57.18 -12.69 82.43 58.26 coo 13.53 16.28 93.98 11.45 16.21 94.40 -9.03 79.00 58.44 -8.21 77.39 59.55 coo 1.80 21.25 100.04 2.61 21.42 100.18 -19.59 87.32 51.84 -18.97 86.72 51.66 ULMN 3 1a0j_c15 TRYPSIN user 8 3 # 8 D 57 HIS C 88 HIS^? 3.86 CD MLY B 135 D 102 ASP C 87 ASP.? 8.84 O1 PGE C 147 D 193 GLY C 54 GLY~? 6.00 CH2 MLY B 135 coo 8.19 15.01 95.72 7.78 16.53 97.01 -11.00 83.03 57.18 -12.69 82.43 58.26 coo 13.53 16.28 93.98 11.45 16.21 94.40 -9.03 79.00 58.44 -8.21 77.39 59.55 coo 1.80 21.25 100.04 2.61 21.42 100.18 -15.22 90.72 61.35 -15.47 90.98 62.07 ULMN 3 1a0j_c15 TRYPSIN user 9 3 # 9 D 57 HIS C 115 HIS~? 4.72 C MLZ C 114 D 102 ASP C 56 ASP~? 9.09 N MLZ C 114 D 193 GLY C 46 GLY~? 10.04 O MLZ C 114 coo 8.19 15.01 95.72 7.78 16.53 97.01 -12.99 90.00 69.08 -14.38 90.57 70.54 coo 13.53 16.28 93.98 11.45 16.21 94.40 -16.40 94.43 66.11 -17.63 93.56 67.58 coo 1.80 21.25 100.04 2.61 21.42 100.18 -10.91 80.74 66.75 -11.70 80.52 66.65 ULMN 3 1a0j_c15 TRYPSIN user 10 3 # 10 D 57 HIS D 88 HIS^? 4.38 CH1 MLY A 135 D 102 ASP D 87 ASP.? 7.26 C16 1PE B 150 D 193 GLY A 134 GLY.? 2.47 N MLY A 135 coo 8.19 15.01 95.72 7.78 16.53 97.01 -29.18 79.71 17.63 -29.43 81.25 19.03 coo 13.53 16.28 93.98 11.45 16.21 94.40 -24.70 80.89 17.41 -22.90 81.94 17.31 coo 1.80 21.25 100.04 2.61 21.42 100.18 -37.57 76.13 24.20 -36.67 75.88 24.22 ULMN 3 1a0j_c15 TRYPSIN user 11 3 # 11 D 57 HIS D 88 HIS^? 4.38 CH1 MLY A 135 D 102 ASP D 87 ASP.? 7.26 C16 1PE B 150 D 193 GLY D 54 GLY~? 5.81 C23 2PE D 146 coo 8.19 15.01 95.72 7.78 16.53 97.01 -29.18 79.71 17.63 -29.43 81.25 19.03 coo 13.53 16.28 93.98 11.45 16.21 94.40 -24.70 80.89 17.41 -22.90 81.94 17.31 coo 1.80 21.25 100.04 2.61 21.42 100.18 -38.01 83.52 15.98 -38.33 84.28 15.84 ULMN 3 1a0j_c15 TRYPSIN user 12 3 # 12 D 57 HIS D 115 HIS~? 12.18 C21 2PE D 146 D 102 ASP D 56 ASP~? 11.46 C21 2PE D 146 D 193 GLY D 46 GLY~? 12.21 CD MLY A 135 coo 8.19 15.01 95.72 7.78 16.53 97.01 -36.28 90.32 11.92 -37.49 91.98 12.35 coo 13.53 16.28 93.98 11.45 16.21 94.40 -41.85 87.81 13.66 -41.61 89.58 14.80 coo 1.80 21.25 100.04 2.61 21.42 100.18 -27.16 89.12 15.33 -27.37 89.29 16.11 1a0j_c15 source 1a0j TRYPSIN : 12 hits 1a0j_c15 naa= 3 ULMN 3 1a41_c01 TOPOISOMERASE I user 1 3 # 1 223 ARG A 31 ARG^? 11.10 C1 GOL A 150 265 HIS A 4 HIS.? -3.92 C2 GOL A 150s 274 TYR A 53 TYR~? -4.55 C21 2PE A 148s coo -15.18 55.46 8.55 -14.82 52.98 10.38 -18.51 63.86 1.13 -18.37 66.66 2.58 coo -14.48 45.59 11.18 -14.02 47.49 10.42 -11.85 68.18 8.83 -11.23 70.10 8.29 coo 0.94 52.26 9.16 1.95 54.78 9.91 -16.76 52.42 13.05 -16.88 54.33 15.10 ULMN 3 1a41_c01 TOPOISOMERASE I user 2 3 # 2 223 ARG A 31 ARG^? 11.10 C1 GOL A 150 265 HIS A 88 HIS^? 4.20 CH2 MLY D 135 274 TYR A 38 TYR.? 14.78 C11 2PE A 148 coo -15.18 55.46 8.55 -14.82 52.98 10.38 -18.51 63.86 1.13 -18.37 66.66 2.58 coo -14.48 45.59 11.18 -14.02 47.49 10.42 -23.95 56.87 7.77 -24.14 54.98 6.86 coo 0.94 52.26 9.16 1.95 54.78 9.91 -8.94 48.99 5.06 -11.42 48.37 6.17 ULMN 3 1a41_c01 TOPOISOMERASE I user 3 3 # 3 223 ARG A 127 ARG^? 7.47 N MLZ A 129 265 HIS A 25 HIS^? 6.06 C MLZ A 129 274 TYR A 109 TYR~? -5.64 O16 2PE A 148s coo -15.18 55.46 8.55 -14.82 52.98 10.38 -18.44 68.25 24.06 -17.70 68.37 27.04 coo -14.48 45.59 11.18 -14.02 47.49 10.42 -27.47 64.89 22.81 -29.24 64.17 23.67 coo 0.94 52.26 9.16 1.95 54.78 9.91 -13.81 52.60 20.09 -14.53 54.76 18.49 ULMN 3 1a41_c01 TOPOISOMERASE I user 4 3 # 4 223 ARG B 31 ARG^? 11.02 C6 PGE B 147 265 HIS B 4 HIS.? -3.86 O2 GOL B 149s 274 TYR B 53 TYR~? -4.63 C18 PE8 B 148s coo -15.18 55.46 8.55 -14.82 52.98 10.38 12.15 83.61 47.77 10.36 84.10 50.21 coo -14.48 45.59 11.18 -14.02 47.49 10.42 8.07 73.88 49.16 8.30 73.43 51.19 coo 0.94 52.26 9.16 1.95 54.78 9.91 6.73 78.96 33.00 4.51 77.73 34.14 ULMN 3 1a41_c01 TOPOISOMERASE I user 5 3 # 5 223 ARG B 31 ARG^? 11.02 C6 PGE B 147 265 HIS B 88 HIS^? 4.29 CH1 MLY C 135 274 TYR B 38 TYR.? 9.60 O1 PEG B 144 coo -15.18 55.46 8.55 -14.82 52.98 10.38 12.15 83.61 47.77 10.36 84.10 50.21 coo -14.48 45.59 11.18 -14.02 47.49 10.42 6.15 87.00 38.94 7.35 87.96 37.51 coo 0.94 52.26 9.16 1.95 54.78 9.91 18.19 76.55 32.34 16.15 78.24 31.46 ULMN 3 1a41_c01 TOPOISOMERASE I user 6 3 # 6 223 ARG B 127 ARG^? 9.26 O4 SO4 A 144 265 HIS B 25 HIS^? 5.55 C6 PG4 C 145 274 TYR B 109 TYR~? -5.65 O13 PE8 B 148s coo -15.18 55.46 8.55 -14.82 52.98 10.38 -7.64 72.55 44.16 -9.78 70.52 43.36 coo -14.48 45.59 11.18 -14.02 47.49 10.42 -10.19 81.59 41.51 -11.58 82.85 40.58 coo 0.94 52.26 9.16 1.95 54.78 9.91 2.41 73.03 30.76 2.68 74.03 33.35 ULMN 3 1a41_c01 TOPOISOMERASE I user 7 3 # 7 223 ARG C 31 ARG^? 11.22 C3 GOL C 149 265 HIS C 4 HIS.? -3.73 C3 GOL C 149s 274 TYR C 53 TYR~? -4.98 C18 PE8 C 148s coo -15.18 55.46 8.55 -14.82 52.98 10.38 -2.17 77.49 60.72 0.17 78.08 58.83 coo -14.48 45.59 11.18 -14.02 47.49 10.42 4.88 85.81 61.42 6.80 85.00 61.18 coo 0.94 52.26 9.16 1.95 54.78 9.91 -11.26 90.80 63.43 -9.63 92.35 61.80 ULMN 3 1a41_c01 TOPOISOMERASE I user 8 3 # 8 223 ARG C 31 ARG^? 11.22 C3 GOL C 149 265 HIS C 88 HIS^? 3.86 CD MLY B 135 274 TYR C 38 TYR.? 5.20 O MLZ C 114 coo -15.18 55.46 8.55 -14.82 52.98 10.38 -2.17 77.49 60.72 0.17 78.08 58.83 coo -14.48 45.59 11.18 -14.02 47.49 10.42 -11.00 83.03 57.18 -12.69 82.43 58.26 coo 0.94 52.26 9.16 1.95 54.78 9.91 -10.37 86.21 74.10 -12.04 86.61 71.91 ULMN 3 1a41_c01 TOPOISOMERASE I user 9 3 # 9 223 ARG C 127 ARG^? 7.44 N MLZ C 129 265 HIS C 25 HIS^? 5.68 C3 PG4 C 145 274 TYR C 109 TYR~? -5.91 C14 PE8 C 148s coo -15.18 55.46 8.55 -14.82 52.98 10.38 1.53 98.09 50.88 2.14 101.05 50.40 coo -14.48 45.59 11.18 -14.02 47.49 10.42 -5.80 94.82 45.56 -7.26 95.23 44.11 coo 0.94 52.26 9.16 1.95 54.78 9.91 -9.64 98.32 63.33 -8.13 96.27 62.21 ULMN 3 1a41_c01 TOPOISOMERASE I user 10 3 # 10 223 ARG D 31 ARG^? 10.57 OH7 1PE B 150 265 HIS D 4 HIS.? 4.07 C3 GOL D 147 274 TYR D 53 TYR~? -4.60 C21 2PE D 146s coo -15.18 55.46 8.55 -14.82 52.98 10.38 -19.64 81.34 12.02 -19.24 78.87 10.07 coo -14.48 45.59 11.18 -14.02 47.49 10.42 -23.57 78.63 1.94 -22.01 77.96 0.72 coo 0.94 52.26 9.16 1.95 54.78 9.91 -36.08 84.35 12.01 -36.58 82.07 10.49 ULMN 3 1a41_c01 TOPOISOMERASE I user 11 3 # 11 223 ARG D 31 ARG^? 10.57 OH7 1PE B 150 265 HIS D 88 HIS^? 4.38 CH1 MLY A 135 274 TYR D 38 TYR.? 14.74 C9 2PE D 146 coo -15.18 55.46 8.55 -14.82 52.98 10.38 -19.64 81.34 12.02 -19.24 78.87 10.07 coo -14.48 45.59 11.18 -14.02 47.49 10.42 -29.18 79.71 17.63 -29.43 81.25 19.03 coo 0.94 52.26 9.16 1.95 54.78 9.91 -31.57 94.95 9.95 -32.83 93.25 11.77 ULMN 3 1a41_c01 TOPOISOMERASE I user 12 3 # 12 223 ARG D 127 ARG^? 9.31 O3 PGE A 147 265 HIS D 25 HIS^? 5.64 C8 PG4 D 144 274 TYR D 109 TYR~? -5.82 O16 2PE D 146s coo -15.18 55.46 8.55 -14.82 52.98 10.38 -35.94 67.72 2.28 -38.25 66.55 0.66 coo -14.48 45.59 11.18 -14.02 47.49 10.42 -36.75 65.22 11.65 -37.83 64.18 13.11 coo 0.94 52.26 9.16 1.95 54.78 9.91 -41.76 82.56 7.21 -39.24 81.41 7.29 1a41_c01 source 1a41 TOPOISOMERASE I : 12 hits 1a41_c01 naa= 3 ULMN 3 1aa6_c01 FORMATE DEHYDROGENASE H user 1 3 # 1 44 LYS A 114 LYS~? 11.27 C9 2PE A 148 141 HIS A 85 HIS.? 6.69 C5 PGE A 147 333 ARG A 31 ARG^? 11.10 C1 GOL A 150 coo 69.56 26.03 31.04 72.53 30.39 31.84 -9.49 51.50 12.13 -4.59 48.44 14.69 coo 85.95 39.62 33.57 84.70 40.34 35.09 -23.05 64.43 -0.55 -21.68 63.00 -1.25 coo 87.31 36.08 32.89 89.57 36.58 34.95 -18.51 63.86 1.13 -18.37 66.66 2.58 ULMN 3 1aa6_c01 FORMATE DEHYDROGENASE H user 2 3 # 2 44 LYS B 114 LYS~? 11.34 O7 PE8 B 148 141 HIS B 85 HIS.? 6.66 C6 PGE B 147 333 ARG B 31 ARG^? 11.02 C6 PGE B 147 coo 69.56 26.03 31.04 72.53 30.39 31.84 11.35 73.22 32.47 12.65 68.43 28.61 coo 85.95 39.62 33.57 84.70 40.34 35.09 11.11 88.86 48.90 12.76 88.34 47.73 coo 87.31 36.08 32.89 89.57 36.58 34.95 12.15 83.61 47.77 10.36 84.10 50.21 ULMN 3 1aa6_c01 FORMATE DEHYDROGENASE H user 3 3 # 3 44 LYS D 114 LYS~? 10.81 C9 2PE D 146 141 HIS D 85 HIS.? 4.73 OH7 1PE B 150 333 ARG D 31 ARG^? 10.57 OH7 1PE B 150 coo 69.56 26.03 31.04 72.53 30.39 31.84 -35.88 89.56 6.78 -39.69 93.33 3.49 coo 85.95 39.62 33.57 84.70 40.34 35.09 -18.08 79.12 16.04 -18.14 81.21 15.79 coo 87.31 36.08 32.89 89.57 36.58 34.95 -19.64 81.34 12.02 -19.24 78.87 10.07 1aa6_c01 source 1aa6 FORMATE DEHYDROGENASE H : 3 hits 1aa6_c01 naa= 3 ULMN 3 1aam_c01 ASPARTATE AMINOTRANSFERASE user 1 3 # 1 142 TRP A 86 TRP.? 11.27 C5 PGE A 147 223 ASP A 87 ASP.? 8.49 C6 PGE A 147 258 LYS D 129 LYS^? 7.63 C4 PEG D 145 coo 127.19 33.46 26.14 126.78 36.79 28.15 -23.97 66.49 5.70 -20.10 66.49 6.06 coo 126.95 41.66 23.38 128.48 40.72 24.51 -23.17 58.67 3.55 -22.34 59.17 1.69 coo 138.83 37.95 25.17 133.50 36.37 26.52 -36.12 61.83 6.50 -39.41 57.83 4.09 ULMN 3 1aam_c01 ASPARTATE AMINOTRANSFERASE user 2 3 # 2 142 TRP C 86 TRP.? 11.30 C1 PGE C 147 223 ASP C 87 ASP.? 8.84 O1 PGE C 147 258 LYS B 129 LYS^? 7.64 C2 PEG B 146 coo 127.19 33.46 26.14 126.78 36.79 28.15 -2.64 79.47 53.33 -0.76 80.96 56.37 coo 126.95 41.66 23.38 128.48 40.72 24.51 -9.03 79.00 58.44 -8.21 77.39 59.55 coo 138.83 37.95 25.17 133.50 36.37 26.52 -12.78 77.45 45.34 -17.39 74.89 47.84 1aam_c01 source 1aam ASPARTATE AMINOTRANSFERASE : 2 hits 1aam_c01 naa= 3 ULMN 3 1ab4_c00 GYRASE A user 1 3 # 1 32 ARG A 127 ARG^? 7.47 N MLZ A 129 78 HIS A 25 HIS^? 6.06 C MLZ A 129 122 TYR D 53 TYR~? -4.60 C21 2PE D 146s coo 48.32 72.26 30.89 48.69 69.28 31.53 -18.44 68.25 24.06 -17.70 68.37 27.04 coo 53.63 68.24 34.99 53.08 69.10 33.16 -27.47 64.89 22.81 -29.24 64.17 23.67 coo 75.01 61.87 32.93 75.34 59.26 31.96 -36.08 84.35 12.01 -36.58 82.07 10.49 ULMN 3 1ab4_c00 GYRASE A user 2 3 # 2 32 ARG A 127 ARG^? 7.47 N MLZ A 129 78 HIS A 25 HIS^? 6.06 C MLZ A 129 122 TYR D 94 TYR^? -4.97 CL CL D 143s coo 48.32 72.26 30.89 48.69 69.28 31.53 -18.44 68.25 24.06 -17.70 68.37 27.04 coo 53.63 68.24 34.99 53.08 69.10 33.16 -27.47 64.89 22.81 -29.24 64.17 23.67 coo 75.01 61.87 32.93 75.34 59.26 31.96 -41.68 71.74 9.13 -40.22 73.97 9.96 ULMN 3 1ab4_c00 GYRASE A user 3 3 # 3 32 ARG B 127 ARG^? 9.26 O4 SO4 A 144 78 HIS B 25 HIS^? 5.55 C6 PG4 C 145 122 TYR C 53 TYR~? -4.98 C18 PE8 C 148s coo 48.32 72.26 30.89 48.69 69.28 31.53 -7.64 72.55 44.16 -9.78 70.52 43.36 coo 53.63 68.24 34.99 53.08 69.10 33.16 -10.19 81.59 41.51 -11.58 82.85 40.58 coo 75.01 61.87 32.93 75.34 59.26 31.96 -11.26 90.80 63.43 -9.63 92.35 61.80 ULMN 3 1ab4_c00 GYRASE A user 4 3 # 4 32 ARG B 127 ARG^? 9.26 O4 SO4 A 144 78 HIS B 25 HIS^? 5.55 C6 PG4 C 145 122 TYR C 94 TYR^? 5.01 CL CL C 144s coo 48.32 72.26 30.89 48.69 69.28 31.53 -7.64 72.55 44.16 -9.78 70.52 43.36 coo 53.63 68.24 34.99 53.08 69.10 33.16 -10.19 81.59 41.51 -11.58 82.85 40.58 coo 75.01 61.87 32.93 75.34 59.26 31.96 -8.07 99.17 52.54 -8.69 97.12 54.34 ULMN 3 1ab4_c00 GYRASE A user 5 3 # 5 32 ARG C 127 ARG^? 7.44 N MLZ C 129 78 HIS C 25 HIS^? 5.68 C3 PG4 C 145 122 TYR B 94 TYR^? -5.06 CL CL B 143s coo 48.32 72.26 30.89 48.69 69.28 31.53 1.53 98.09 50.88 2.14 101.05 50.40 coo 53.63 68.24 34.99 53.08 69.10 33.16 -5.80 94.82 45.56 -7.26 95.23 44.11 coo 75.01 61.87 32.93 75.34 59.26 31.96 -6.97 76.65 35.26 -4.34 77.53 35.11 ULMN 3 1ab4_c00 GYRASE A user 6 3 # 6 32 ARG D 127 ARG^? 9.31 O3 PGE A 147 78 HIS D 25 HIS^? 5.64 C8 PG4 D 144 122 TYR A 53 TYR~? -4.55 C21 2PE A 148s coo 48.32 72.26 30.89 48.69 69.28 31.53 -35.94 67.72 2.28 -38.25 66.55 0.66 coo 53.63 68.24 34.99 53.08 69.10 33.16 -36.75 65.22 11.65 -37.83 64.18 13.11 coo 75.01 61.87 32.93 75.34 59.26 31.96 -16.76 52.42 13.05 -16.88 54.33 15.10 ULMN 3 1ab4_c00 GYRASE A user 7 3 # 7 32 ARG D 127 ARG^? 9.31 O3 PGE A 147 78 HIS D 25 HIS^? 5.64 C8 PG4 D 144 122 TYR A 94 TYR^? 4.94 CL CL A 145s coo 48.32 72.26 30.89 48.69 69.28 31.53 -35.94 67.72 2.28 -38.25 66.55 0.66 coo 53.63 68.24 34.99 53.08 69.10 33.16 -36.75 65.22 11.65 -37.83 64.18 13.11 coo 75.01 61.87 32.93 75.34 59.26 31.96 -21.59 58.91 24.53 -21.03 57.83 22.04 1ab4_c00 source 1ab4 GYRASE A : 7 hits 1ab4_c00 naa= 3 ULMN 3 1aj0_c00 DIHYDROPTEROATE SYNTHASE user 1 3 # 1 22 ASN A 28 ASN^? 3.50 CL CL A 145s 63 ARG A 116 ARG~? 4.70 C15 2PE A 148 255 ARG A 124 ARG^? 8.18 C1 GOL A 150 coo 42.10 13.02 11.14 41.85 11.12 10.23 -22.13 61.51 13.69 -20.95 60.87 15.35 coo 44.36 11.24 3.39 41.81 12.78 4.00 -15.13 57.15 12.87 -15.00 60.01 11.67 coo 38.40 3.83 10.26 40.02 6.30 9.25 -17.35 69.10 10.18 -16.14 69.37 7.36 ULMN 3 1aj0_c00 DIHYDROPTEROATE SYNTHASE user 2 3 # 2 22 ASN A 28 ASN^? 3.50 CL CL A 145s 63 ARG A 124 ARG^? 8.18 C1 GOL A 150 255 ARG A 116 ARG~? 4.70 C15 2PE A 148 coo 42.10 13.02 11.14 41.85 11.12 10.23 -22.13 61.51 13.69 -20.95 60.87 15.35 coo 44.36 11.24 3.39 41.81 12.78 4.00 -17.35 69.10 10.18 -16.14 69.37 7.36 coo 38.40 3.83 10.26 40.02 6.30 9.25 -15.13 57.15 12.87 -15.00 60.01 11.67 ULMN 3 1aj0_c00 DIHYDROPTEROATE SYNTHASE user 3 3 # 3 22 ASN B 28 ASN^? 3.43 CL CL B 143s 63 ARG B 116 ARG~? 4.93 C12 PE8 B 148 255 ARG B 124 ARG^? 8.02 O2 GOL B 149 coo 42.10 13.02 11.14 41.85 11.12 10.23 0.96 81.77 41.38 0.26 80.18 40.18 coo 44.36 11.24 3.39 41.81 12.78 4.00 6.23 77.16 37.54 6.11 77.30 40.64 coo 38.40 3.83 10.26 40.02 6.30 9.25 3.96 78.02 49.67 6.79 78.26 50.86 ULMN 3 1aj0_c00 DIHYDROPTEROATE SYNTHASE user 4 3 # 4 22 ASN C 28 ASN^? 3.42 CL CL C 144s 63 ARG C 116 ARG~? 4.72 C15 PE8 C 148 255 ARG C 124 ARG^? 7.92 C3 GOL C 149 coo 42.10 13.02 11.14 41.85 11.12 10.23 -6.06 88.35 54.50 -6.05 90.38 55.16 coo 44.36 11.24 3.39 41.81 12.78 4.00 -6.64 90.12 62.40 -4.04 88.84 61.33 coo 38.40 3.83 10.26 40.02 6.30 9.25 2.87 85.20 55.95 3.74 82.90 57.81 ULMN 3 1aj0_c00 DIHYDROPTEROATE SYNTHASE user 5 3 # 5 22 ASN C 28 ASN^? 3.42 CL CL C 144s 63 ARG C 124 ARG^? 7.92 C3 GOL C 149 255 ARG C 116 ARG~? 4.72 C15 PE8 C 148 coo 42.10 13.02 11.14 41.85 11.12 10.23 -6.06 88.35 54.50 -6.05 90.38 55.16 coo 44.36 11.24 3.39 41.81 12.78 4.00 2.87 85.20 55.95 3.74 82.90 57.81 coo 38.40 3.83 10.26 40.02 6.30 9.25 -6.64 90.12 62.40 -4.04 88.84 61.33 ULMN 3 1aj0_c00 DIHYDROPTEROATE SYNTHASE user 6 3 # 6 22 ASN D 28 ASN^? 3.51 CL CL D 143s 63 ARG D 116 ARG~? 4.73 C15 2PE D 146 255 ARG D 124 ARG^? 7.97 C3 GOL D 147 coo 42.10 13.02 11.14 41.85 11.12 10.23 -31.24 74.87 11.89 -33.01 75.13 10.75 coo 44.36 11.24 3.39 41.81 12.78 4.00 -33.13 82.22 8.73 -30.63 80.83 7.52 coo 38.40 3.83 10.26 40.02 6.30 9.25 -24.04 74.20 5.58 -21.67 76.16 5.44 ULMN 3 1aj0_c00 DIHYDROPTEROATE SYNTHASE user 7 3 # 7 22 ASN D 28 ASN^? 3.51 CL CL D 143s 63 ARG D 124 ARG^? 7.97 C3 GOL D 147 255 ARG D 116 ARG~? 4.73 C15 2PE D 146 coo 42.10 13.02 11.14 41.85 11.12 10.23 -31.24 74.87 11.89 -33.01 75.13 10.75 coo 44.36 11.24 3.39 41.81 12.78 4.00 -24.04 74.20 5.58 -21.67 76.16 5.44 coo 38.40 3.83 10.26 40.02 6.30 9.25 -33.13 82.22 8.73 -30.63 80.83 7.52 1aj0_c00 source 1aj0 DIHYDROPTEROATE SYNTHASE : 7 hits 1aj0_c00 naa= 3 ULMN 3 1ald_c00 ALDOLASE A (E.C.4.1.2.13) user 1 3 # 1 33 ASP A 87 ASP.? 8.49 C6 PGE A 147 187 GLU A 75 GLU.? -8.03 O4 PGE A 147s 229 LYS D 129 LYS^? 7.63 C4 PEG D 145 coo -52.57 56.60 47.75 -51.52 54.87 46.95 -23.17 58.67 3.55 -22.34 59.17 1.69 coo -45.08 48.37 46.81 -46.53 49.74 45.96 -34.40 63.01 2.19 -36.49 63.07 2.67 coo -47.40 44.36 48.48 -50.80 49.18 46.20 -36.12 61.83 6.50 -39.41 57.83 4.09 ULMN 3 1ald_c00 ALDOLASE A (E.C.4.1.2.13) user 2 3 # 2 33 ASP B 19 ASP.? -3.77 O3 SO4 A 144s 187 GLU C 75 GLU.? -8.81 O1 PGE C 147s 229 LYS B 129 LYS^? 7.64 C2 PEG B 146 coo -52.57 56.60 47.75 -51.52 54.87 46.95 -12.63 65.75 40.21 -14.11 64.30 40.60 coo -45.08 48.37 46.81 -46.53 49.74 45.96 -10.84 73.75 47.59 -11.85 73.47 45.72 coo -47.40 44.36 48.48 -50.80 49.18 46.20 -12.78 77.45 45.34 -17.39 74.89 47.84 ULMN 3 1ald_c00 ALDOLASE A (E.C.4.1.2.13) user 3 3 # 3 33 ASP C 87 ASP.? 8.84 O1 PGE C 147 187 GLU C 75 GLU.? -8.81 O1 PGE C 147s 229 LYS B 129 LYS^? 7.64 C2 PEG B 146 coo -52.57 56.60 47.75 -51.52 54.87 46.95 -9.03 79.00 58.44 -8.21 77.39 59.55 coo -45.08 48.37 46.81 -46.53 49.74 45.96 -10.84 73.75 47.59 -11.85 73.47 45.72 coo -47.40 44.36 48.48 -50.80 49.18 46.20 -12.78 77.45 45.34 -17.39 74.89 47.84 ULMN 3 1ald_c00 ALDOLASE A (E.C.4.1.2.13) user 4 3 # 4 33 ASP D 19 ASP.? -13.24 C2 PGE A 147s 187 GLU A 75 GLU.? -8.03 O4 PGE A 147s 229 LYS D 129 LYS^? 7.63 C4 PEG D 145 coo -52.57 56.60 47.75 -51.52 54.87 46.95 -43.72 66.33 -2.80 -44.54 65.10 -4.29 coo -45.08 48.37 46.81 -46.53 49.74 45.96 -34.40 63.01 2.19 -36.49 63.07 2.67 coo -47.40 44.36 48.48 -50.80 49.18 46.20 -36.12 61.83 6.50 -39.41 57.83 4.09 1ald_c00 source 1ald ALDOLASE A (E.C.4.1.2.13) : 4 hits 1ald_c00 naa= 3 ULMN 3 1am5_c04 PEPSIN user 1 3 # 1 32 ASP A 19 ASP.? -3.59 O4 SO4 A 144s 35 SER B 96 SER~? 7.21 O4 SO4 A 144 215 ASP B 19 ASP.? -3.77 O3 SO4 A 144s coo -7.18 8.92 145.10 -8.77 8.81 143.59 -15.01 66.98 32.71 -14.52 68.02 34.44 coo -12.30 10.35 145.24 -10.75 8.55 145.88 -12.28 72.78 35.88 -11.90 71.42 33.88 coo -8.20 12.64 138.30 -8.86 10.97 139.38 -12.63 65.75 40.21 -14.11 64.30 40.60 1am5_c04 source 1am5 PEPSIN : 1 hits 1am5_c04 naa= 3 ULMN 3 1amy_c01 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 1 3 # 1 179 ASP A 6 ASP.? -3.91 C9 2PE A 148s 214 ASP D 6 ASP.? -3.77 C8 2PE D 146s 289 ASP A 122 ASP^? 7.46 C1 GOL A 150 coo -0.62 65.95 29.97 0.31 67.47 31.05 -8.66 61.41 13.34 -8.76 59.35 12.80 coo 26.86 59.76 46.36 25.42 58.23 45.92 -31.03 82.87 1.04 -31.83 84.41 2.29 coo 9.42 68.07 30.27 7.35 68.27 30.10 -15.41 64.92 4.51 -15.09 66.83 5.33 ULMN 3 1amy_c01 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 2 3 # 2 179 ASP A 56 ASP~? 11.59 C21 2PE A 148 214 ASP B 106 ASP~? 11.87 OH2 1PE B 150 289 ASP A 106 ASP~? 11.93 O22 2PE A 148 coo -0.62 65.95 29.97 0.31 67.47 31.05 -16.01 45.89 15.64 -15.93 44.31 14.23 coo 26.86 59.76 46.36 25.42 58.23 45.92 -0.30 70.27 27.08 -0.10 70.78 25.05 coo 9.42 68.07 30.27 7.35 68.27 30.10 -12.71 50.36 24.83 -13.06 48.30 25.05 ULMN 3 1amy_c01 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 3 3 # 3 179 ASP A 122 ASP^? 7.46 C1 GOL A 150 214 ASP B 56 ASP~? 11.45 C20 PE8 B 148 289 ASP A 6 ASP.? -3.91 C9 2PE A 148s coo -0.62 65.95 29.97 0.31 67.47 31.05 -15.41 64.92 4.51 -15.09 66.83 5.33 coo 26.86 59.76 46.36 25.42 58.23 45.92 6.80 78.21 26.00 8.47 79.07 25.03 coo 9.42 68.07 30.27 7.35 68.27 30.10 -8.66 61.41 13.34 -8.76 59.35 12.80 ULMN 3 1amy_c01 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 4 3 # 4 179 ASP B 6 ASP.? -3.99 C6 PE8 B 148s 214 ASP C 6 ASP.? -4.04 C8 PE8 C 148s 289 ASP B 122 ASP^? 7.33 O2 GOL B 149 coo -0.62 65.95 29.97 0.31 67.47 31.05 7.95 70.39 41.39 8.88 71.08 39.61 coo 26.86 59.76 46.36 25.42 58.23 45.92 0.53 91.96 65.64 -1.31 91.68 66.68 coo 9.42 68.07 30.27 7.35 68.27 30.10 10.89 79.68 47.57 9.75 78.80 49.16 ULMN 3 1amy_c01 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 5 3 # 5 179 ASP B 56 ASP~? 11.45 C20 PE8 B 148 214 ASP A 106 ASP~? 11.93 O22 2PE A 148 289 ASP B 106 ASP~? 11.87 OH2 1PE B 150 coo -0.62 65.95 29.97 0.31 67.47 31.05 6.80 78.21 26.00 8.47 79.07 25.03 coo 26.86 59.76 46.36 25.42 58.23 45.92 -12.71 50.36 24.83 -13.06 48.30 25.05 coo 9.42 68.07 30.27 7.35 68.27 30.10 -0.30 70.27 27.08 -0.10 70.78 25.05 ULMN 3 1amy_c01 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 6 3 # 6 179 ASP B 122 ASP^? 7.33 O2 GOL B 149 214 ASP A 19 ASP.? -3.59 O4 SO4 A 144s 289 ASP B 6 ASP.? -3.99 C6 PE8 B 148s coo -0.62 65.95 29.97 0.31 67.47 31.05 10.89 79.68 47.57 9.75 78.80 49.16 coo 26.86 59.76 46.36 25.42 58.23 45.92 -15.01 66.98 32.71 -14.52 68.02 34.44 coo 9.42 68.07 30.27 7.35 68.27 30.10 7.95 70.39 41.39 8.88 71.08 39.61 ULMN 3 1amy_c01 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 7 3 # 7 179 ASP C 6 ASP.? -4.04 C8 PE8 C 148s 214 ASP B 6 ASP.? -3.99 C6 PE8 B 148s 289 ASP C 122 ASP^? 7.22 C3 GOL C 149 coo -0.62 65.95 29.97 0.31 67.47 31.05 0.53 91.96 65.64 -1.31 91.68 66.68 coo 26.86 59.76 46.36 25.42 58.23 45.92 7.95 70.39 41.39 8.88 71.08 39.61 coo 9.42 68.07 30.27 7.35 68.27 30.10 0.27 81.12 61.60 2.07 81.54 60.53 ULMN 3 1amy_c01 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 8 3 # 8 179 ASP D 6 ASP.? -3.77 C8 2PE D 146s 214 ASP A 6 ASP.? -3.91 C9 2PE A 148s 289 ASP D 122 ASP^? 7.49 C3 GOL D 147 coo -0.62 65.95 29.97 0.31 67.47 31.05 -31.03 82.87 1.04 -31.83 84.41 2.29 coo 26.86 59.76 46.36 25.42 58.23 45.92 -8.66 61.41 13.34 -8.76 59.35 12.80 coo 9.42 68.07 30.27 7.35 68.27 30.10 -21.82 80.90 7.85 -21.38 79.32 6.51 ULMN 3 1amy_c01 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 9 3 # 9 179 ASP D 122 ASP^? 7.49 C3 GOL D 147 214 ASP B 56 ASP~? 11.45 C20 PE8 B 148 289 ASP D 83 ASP.? 8.76 O1 GOL A 150 coo -0.62 65.95 29.97 0.31 67.47 31.05 -21.82 80.90 7.85 -21.38 79.32 6.51 coo 26.86 59.76 46.36 25.42 58.23 45.92 6.80 78.21 26.00 8.47 79.07 25.03 coo 9.42 68.07 30.27 7.35 68.27 30.10 -12.54 78.43 10.94 -12.46 77.06 9.29 1amy_c01 source 1amy ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE (ALPHA-AMY: 9 hits 1amy_c01 naa= 3 ULMN 3 1amy_c05 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 1 3 # 1 179 ASP A 83 ASP.? 8.52 O3 GOL D 147 204 GLU A 84 GLU.? 10.45 C3 GOL D 147 289 ASP A 122 ASP^? 7.46 C1 GOL A 150 coo -0.62 65.95 29.97 0.31 67.47 31.05 -19.46 70.43 -3.04 -19.06 72.28 -2.05 coo 4.34 62.44 32.05 4.22 64.48 32.53 -21.01 70.22 3.12 -21.10 71.95 4.30 coo 9.42 68.07 30.27 7.35 68.27 30.10 -15.41 64.92 4.51 -15.09 66.83 5.33 ULMN 3 1amy_c05 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 2 3 # 2 179 ASP A 122 ASP^? 7.46 C1 GOL A 150 204 GLU A 84 GLU.? 10.45 C3 GOL D 147 289 ASP A 83 ASP.? 8.52 O3 GOL D 147 coo -0.62 65.95 29.97 0.31 67.47 31.05 -15.41 64.92 4.51 -15.09 66.83 5.33 coo 4.34 62.44 32.05 4.22 64.48 32.53 -21.01 70.22 3.12 -21.10 71.95 4.30 coo 9.42 68.07 30.27 7.35 68.27 30.10 -19.46 70.43 -3.04 -19.06 72.28 -2.05 ULMN 3 1amy_c05 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 3 3 # 3 179 ASP B 83 ASP.? 9.40 O3 GOL C 149 204 GLU B 84 GLU.? 10.31 O3 GOL C 149 289 ASP B 122 ASP^? 7.33 O2 GOL B 149 coo -0.62 65.95 29.97 0.31 67.47 31.05 13.62 86.10 55.23 12.83 84.59 56.49 coo 4.34 62.44 32.05 4.22 64.48 32.53 7.66 84.31 53.13 6.13 83.49 54.35 coo 9.42 68.07 30.27 7.35 68.27 30.10 10.89 79.68 47.57 9.75 78.80 49.16 ULMN 3 1amy_c05 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 4 3 # 4 179 ASP B 122 ASP^? 7.33 O2 GOL B 149 204 GLU B 84 GLU.? 10.31 O3 GOL C 149 289 ASP B 83 ASP.? 9.40 O3 GOL C 149 coo -0.62 65.95 29.97 0.31 67.47 31.05 10.89 79.68 47.57 9.75 78.80 49.16 coo 4.34 62.44 32.05 4.22 64.48 32.53 7.66 84.31 53.13 6.13 83.49 54.35 coo 9.42 68.07 30.27 7.35 68.27 30.10 13.62 86.10 55.23 12.83 84.59 56.49 ULMN 3 1amy_c05 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 5 3 # 5 179 ASP C 56 ASP~? 9.09 N MLZ C 114 204 GLU C 111 GLU~? 3.06 NZ MLZ C 114 289 ASP C 106 ASP~? 12.11 C21 PE8 C 148 coo -0.62 65.95 29.97 0.31 67.47 31.05 -16.40 94.43 66.11 -17.63 93.56 67.58 coo 4.34 62.44 32.05 4.22 64.48 32.53 -12.41 98.44 71.96 -11.17 97.70 73.52 coo 9.42 68.07 30.27 7.35 68.27 30.10 -11.06 103.55 63.77 -13.00 104.00 64.35 ULMN 3 1amy_c05 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 6 3 # 6 179 ASP C 83 ASP.? 8.65 O3 GOL B 149 204 GLU C 84 GLU.? 10.77 O2 GOL B 149 289 ASP C 122 ASP^? 7.22 C3 GOL C 149 coo -0.62 65.95 29.97 0.31 67.47 31.05 3.02 71.86 58.06 4.88 72.49 57.24 coo 4.34 62.44 32.05 4.22 64.48 32.53 2.34 77.12 55.01 3.46 78.21 53.60 coo 9.42 68.07 30.27 7.35 68.27 30.10 0.27 81.12 61.60 2.07 81.54 60.53 ULMN 3 1amy_c05 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 7 3 # 7 179 ASP C 122 ASP^? 7.22 C3 GOL C 149 204 GLU C 84 GLU.? 10.77 O2 GOL B 149 289 ASP C 83 ASP.? 8.65 O3 GOL B 149 coo -0.62 65.95 29.97 0.31 67.47 31.05 0.27 81.12 61.60 2.07 81.54 60.53 coo 4.34 62.44 32.05 4.22 64.48 32.53 2.34 77.12 55.01 3.46 78.21 53.60 coo 9.42 68.07 30.27 7.35 68.27 30.10 3.02 71.86 58.06 4.88 72.49 57.24 ULMN 3 1amy_c05 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 8 3 # 8 179 ASP D 56 ASP~? 11.46 C21 2PE D 146 204 GLU D 111 GLU~? 11.88 C9 2PE D 146 289 ASP D 106 ASP~? 11.82 O22 2PE D 146 coo -0.62 65.95 29.97 0.31 67.47 31.05 -41.85 87.81 13.66 -41.61 89.58 14.80 coo 4.34 62.44 32.05 4.22 64.48 32.53 -43.22 91.45 6.64 -41.92 92.74 5.57 coo 9.42 68.07 30.27 7.35 68.27 30.10 -46.82 82.57 5.87 -48.37 83.43 7.00 ULMN 3 1amy_c05 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 9 3 # 9 179 ASP D 83 ASP.? 8.76 O1 GOL A 150 204 GLU D 84 GLU.? 10.79 C1 GOL A 150 289 ASP D 122 ASP^? 7.49 C3 GOL D 147 coo -0.62 65.95 29.97 0.31 67.47 31.05 -12.54 78.43 10.94 -12.46 77.06 9.29 coo 4.34 62.44 32.05 4.22 64.48 32.53 -17.40 74.78 10.23 -17.69 72.96 9.24 coo 9.42 68.07 30.27 7.35 68.27 30.10 -21.82 80.90 7.85 -21.38 79.32 6.51 ULMN 3 1amy_c05 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 10 3 # 10 179 ASP D 122 ASP^? 7.49 C3 GOL D 147 204 GLU D 84 GLU.? 10.79 C1 GOL A 150 289 ASP D 83 ASP.? 8.76 O1 GOL A 150 coo -0.62 65.95 29.97 0.31 67.47 31.05 -21.82 80.90 7.85 -21.38 79.32 6.51 coo 4.34 62.44 32.05 4.22 64.48 32.53 -17.40 74.78 10.23 -17.69 72.96 9.24 coo 9.42 68.07 30.27 7.35 68.27 30.10 -12.54 78.43 10.94 -12.46 77.06 9.29 1amy_c05 source 1amy ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE (ALPHA-AMY: 10 hits 1amy_c05 naa= 3 ULMN 3 1amy_c06 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 1 3 # 1 179 ASP A 83 ASP.? 8.52 O3 GOL D 147 227 GLU A 75 GLU.? -8.03 O4 PGE A 147s 289 ASP A 122 ASP^? 7.46 C1 GOL A 150 coo -0.62 65.95 29.97 0.31 67.47 31.05 -19.46 70.43 -3.04 -19.06 72.28 -2.05 coo 3.96 55.76 41.24 4.83 57.69 41.17 -34.40 63.01 2.19 -36.49 63.07 2.67 coo 9.42 68.07 30.27 7.35 68.27 30.10 -15.41 64.92 4.51 -15.09 66.83 5.33 ULMN 3 1amy_c06 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 2 3 # 2 179 ASP B 83 ASP.? 9.40 O3 GOL C 149 227 GLU B 75 GLU.? -3.56 CB MLZ C 129s 289 ASP B 122 ASP^? 7.33 O2 GOL B 149 coo -0.62 65.95 29.97 0.31 67.47 31.05 13.62 86.10 55.23 12.83 84.59 56.49 coo 3.96 55.76 41.24 4.83 57.69 41.17 3.68 97.59 46.60 2.29 99.21 46.53 coo 9.42 68.07 30.27 7.35 68.27 30.10 10.89 79.68 47.57 9.75 78.80 49.16 ULMN 3 1amy_c06 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 3 3 # 3 179 ASP C 83 ASP.? 8.65 O3 GOL B 149 227 GLU C 75 GLU.? -8.81 O1 PGE C 147s 289 ASP C 122 ASP^? 7.22 C3 GOL C 149 coo -0.62 65.95 29.97 0.31 67.47 31.05 3.02 71.86 58.06 4.88 72.49 57.24 coo 3.96 55.76 41.24 4.83 57.69 41.17 -10.84 73.75 47.59 -11.85 73.47 45.72 coo 9.42 68.07 30.27 7.35 68.27 30.10 0.27 81.12 61.60 2.07 81.54 60.53 ULMN 3 1amy_c06 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 4 3 # 4 179 ASP D 83 ASP.? 8.76 O1 GOL A 150 227 GLU D 75 GLU.? -3.59 CB MLZ A 129s 289 ASP D 122 ASP^? 7.49 C3 GOL D 147 coo -0.62 65.95 29.97 0.31 67.47 31.05 -12.54 78.43 10.94 -12.46 77.06 9.29 coo 3.96 55.76 41.24 4.83 57.69 41.17 -21.02 72.19 24.99 -21.34 70.79 26.58 coo 9.42 68.07 30.27 7.35 68.27 30.10 -21.82 80.90 7.85 -21.38 79.32 6.51 1amy_c06 source 1amy ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE (ALPHA-AMY: 4 hits 1amy_c06 naa= 3 ULMN 3 1apt_c04 ISOVALERYL (IVA)-VAL-VAL-LYSTA-O-ET user 1 3 # 1 E 33 ASP A 19 ASP.? -3.59 O4 SO4 A 144s E 36 SER B 96 SER~? 7.21 O4 SO4 A 144 E 213 ASP B 19 ASP.? -3.77 O3 SO4 A 144s coo 26.30 12.96 16.78 25.46 12.99 18.72 -15.01 66.98 32.71 -14.52 68.02 34.44 coo 28.33 15.15 21.27 28.70 13.12 19.97 -12.28 72.78 35.88 -11.90 71.42 33.88 coo 20.15 16.04 19.79 21.65 14.49 19.86 -12.63 65.75 40.21 -14.11 64.30 40.60 1apt_c04 source 1apt ISOVALERYL (IVA)-VAL-VAL-LYSTA-O-ET (LYSTA IS : 1 hits 1apt_c04 naa= 3 ULMN 3 1aql_c02 BILE-SALT ACTIVATED LIPASE user 1 3 # 1 A 194 SER A 123 SER^? 7.34 C15 2PE A 148 A 292 ASP A 56 ASP~? 11.59 C21 2PE A 148 A 322 HIS D 4 HIS.? 4.07 C3 GOL D 147 coo 36.34 32.23 39.60 36.43 34.62 39.93 -17.01 64.19 8.64 -15.43 63.06 10.12 coo 19.73 19.18 41.39 21.50 18.65 40.34 -16.01 45.89 15.64 -15.93 44.31 14.23 coo 41.69 45.14 46.60 41.78 47.19 46.18 -23.57 78.63 1.94 -22.01 77.96 0.72 ULMN 3 1aql_c02 BILE-SALT ACTIVATED LIPASE user 2 3 # 2 A 194 SER A 123 SER^? 7.34 C15 2PE A 148 A 292 ASP A 56 ASP~? 11.59 C21 2PE A 148 A 322 HIS D 85 HIS.? 4.73 OH7 1PE B 150 coo 36.34 32.23 39.60 36.43 34.62 39.93 -17.01 64.19 8.64 -15.43 63.06 10.12 coo 19.73 19.18 41.39 21.50 18.65 40.34 -16.01 45.89 15.64 -15.93 44.31 14.23 coo 41.69 45.14 46.60 41.78 47.19 46.18 -18.08 79.12 16.04 -18.14 81.21 15.79 ULMN 3 1aql_c02 BILE-SALT ACTIVATED LIPASE user 3 3 # 3 A 194 SER A 123 SER^? 7.34 C15 2PE A 148 A 292 ASP D 87 ASP.? 7.26 C16 1PE B 150 A 322 HIS A 115 HIS~? 12.27 C21 2PE A 148 coo 36.34 32.23 39.60 36.43 34.62 39.93 -17.01 64.19 8.64 -15.43 63.06 10.12 coo 19.73 19.18 41.39 21.50 18.65 40.34 -24.70 80.89 17.41 -22.90 81.94 17.31 coo 41.69 45.14 46.60 41.78 47.19 46.18 -13.18 48.35 10.37 -12.55 46.36 10.33 ULMN 3 1aql_c02 BILE-SALT ACTIVATED LIPASE user 4 3 # 4 A 194 SER B 61 SER~? -3.13 O22 PE8 B 148s A 292 ASP D 83 ASP.? 8.76 O1 GOL A 150 A 322 HIS B 88 HIS^? 4.29 CH1 MLY C 135 coo 36.34 32.23 39.60 36.43 34.62 39.93 -3.39 77.64 29.23 -3.48 78.95 31.25 coo 19.73 19.18 41.39 21.50 18.65 40.34 -12.54 78.43 10.94 -12.46 77.06 9.29 coo 41.69 45.14 46.60 41.78 47.19 46.18 6.15 87.00 38.94 7.35 87.96 37.51 ULMN 3 1aql_c02 BILE-SALT ACTIVATED LIPASE user 5 3 # 5 A 194 SER B 123 SER^? 7.43 C12 PE8 B 148 A 292 ASP B 56 ASP~? 11.45 C20 PE8 B 148 A 322 HIS C 4 HIS.? -3.73 C3 GOL C 149s coo 36.34 32.23 39.60 36.43 34.62 39.93 6.88 79.31 45.54 6.79 77.45 43.98 coo 19.73 19.18 41.39 21.50 18.65 40.34 6.80 78.21 26.00 8.47 79.07 25.03 coo 41.69 45.14 46.60 41.78 47.19 46.18 4.88 85.81 61.42 6.80 85.00 61.18 ULMN 3 1aql_c02 BILE-SALT ACTIVATED LIPASE user 6 3 # 6 A 194 SER B 123 SER^? 7.43 C12 PE8 B 148 A 292 ASP B 56 ASP~? 11.45 C20 PE8 B 148 A 322 HIS C 85 HIS.? 6.34 C1 PGE C 147 coo 36.34 32.23 39.60 36.43 34.62 39.93 6.88 79.31 45.54 6.79 77.45 43.98 coo 19.73 19.18 41.39 21.50 18.65 40.34 6.80 78.21 26.00 8.47 79.07 25.03 coo 41.69 45.14 46.60 41.78 47.19 46.18 -4.08 74.18 57.17 -4.69 74.12 59.17 ULMN 3 1aql_c02 BILE-SALT ACTIVATED LIPASE user 7 3 # 7 A 194 SER B 123 SER^? 7.43 C12 PE8 B 148 A 292 ASP C 87 ASP.? 8.84 O1 PGE C 147 A 322 HIS B 115 HIS~? 12.48 C18 PE8 B 148 coo 36.34 32.23 39.60 36.43 34.62 39.93 6.88 79.31 45.54 6.79 77.45 43.98 coo 19.73 19.18 41.39 21.50 18.65 40.34 -9.03 79.00 58.44 -8.21 77.39 59.55 coo 41.69 45.14 46.60 41.78 47.19 46.18 11.86 77.76 30.05 12.70 77.49 28.15 ULMN 3 1aql_c02 BILE-SALT ACTIVATED LIPASE user 8 3 # 8 A 194 SER C 123 SER^? 7.65 C15 PE8 C 148 A 292 ASP B 87 ASP.? 8.94 O4 PGE B 147 A 322 HIS C 115 HIS~? 4.72 C MLZ C 114 coo 36.34 32.23 39.60 36.43 34.62 39.93 -1.16 84.64 59.13 -1.43 86.65 60.45 coo 19.73 19.18 41.39 21.50 18.65 40.34 9.49 87.97 42.02 11.31 87.98 43.09 coo 41.69 45.14 46.60 41.78 47.19 46.18 -12.99 90.00 69.08 -14.38 90.57 70.54 ULMN 3 1aql_c02 BILE-SALT ACTIVATED LIPASE user 9 3 # 9 A 194 SER C 123 SER^? 7.65 C15 PE8 C 148 A 292 ASP C 56 ASP~? 9.09 N MLZ C 114 A 322 HIS B 4 HIS.? -3.86 O2 GOL B 149s coo 36.34 32.23 39.60 36.43 34.62 39.93 -1.16 84.64 59.13 -1.43 86.65 60.45 coo 19.73 19.18 41.39 21.50 18.65 40.34 -16.40 94.43 66.11 -17.63 93.56 67.58 coo 41.69 45.14 46.60 41.78 47.19 46.18 8.07 73.88 49.16 8.30 73.43 51.19 ULMN 3 1aql_c02 BILE-SALT ACTIVATED LIPASE user 10 3 # 10 A 194 SER C 123 SER^? 7.65 C15 PE8 C 148 A 292 ASP C 56 ASP~? 9.09 N MLZ C 114 A 322 HIS B 85 HIS.? 6.66 C6 PGE B 147 coo 36.34 32.23 39.60 36.43 34.62 39.93 -1.16 84.64 59.13 -1.43 86.65 60.45 coo 19.73 19.18 41.39 21.50 18.65 40.34 -16.40 94.43 66.11 -17.63 93.56 67.58 coo 41.69 45.14 46.60 41.78 47.19 46.18 11.11 88.86 48.90 12.76 88.34 47.73 ULMN 3 1aql_c02 BILE-SALT ACTIVATED LIPASE user 11 3 # 11 A 194 SER D 123 SER^? 7.59 C15 2PE D 146 A 292 ASP A 87 ASP.? 8.49 C6 PGE A 147 A 322 HIS D 115 HIS~? 12.18 C21 2PE D 146 coo 36.34 32.23 39.60 36.43 34.62 39.93 -25.59 78.45 8.19 -27.49 79.37 6.96 coo 19.73 19.18 41.39 21.50 18.65 40.34 -23.17 58.67 3.55 -22.34 59.17 1.69 coo 41.69 45.14 46.60 41.78 47.19 46.18 -36.28 90.32 11.92 -37.49 91.98 12.35 ULMN 3 1aql_c02 BILE-SALT ACTIVATED LIPASE user 12 3 # 12 A 194 SER D 123 SER^? 7.59 C15 2PE D 146 A 292 ASP D 56 ASP~? 11.46 C21 2PE D 146 A 322 HIS A 4 HIS.? -3.92 C2 GOL A 150s coo 36.34 32.23 39.60 36.43 34.62 39.93 -25.59 78.45 8.19 -27.49 79.37 6.96 coo 19.73 19.18 41.39 21.50 18.65 40.34 -41.85 87.81 13.66 -41.61 89.58 14.80 coo 41.69 45.14 46.60 41.78 47.19 46.18 -11.85 68.18 8.83 -11.23 70.10 8.29 ULMN 3 1aql_c02 BILE-SALT ACTIVATED LIPASE user 13 3 # 13 A 194 SER D 123 SER^? 7.59 C15 2PE D 146 A 292 ASP D 56 ASP~? 11.46 C21 2PE D 146 A 322 HIS A 85 HIS.? 6.69 C5 PGE A 147 coo 36.34 32.23 39.60 36.43 34.62 39.93 -25.59 78.45 8.19 -27.49 79.37 6.96 coo 19.73 19.18 41.39 21.50 18.65 40.34 -41.85 87.81 13.66 -41.61 89.58 14.80 coo 41.69 45.14 46.60 41.78 47.19 46.18 -23.05 64.43 -0.55 -21.68 63.00 -1.25 1aql_c02 source 1aql BILE-SALT ACTIVATED LIPASE : 13 hits 1aql_c02 naa= 3 ULMN 3 1aql_c03 BILE-SALT ACTIVATED LIPASE user 1 3 # 1 B 194 SER A 61 SER~? -2.92 O25 2PE A 148s B 292 ASP B 19 ASP.? -3.77 O3 SO4 A 144s B 322 HIS A 88 HIS^? 4.20 CH2 MLY D 135 coo 35.42 71.28 22.94 36.24 69.06 22.37 -20.68 51.98 23.20 -22.01 53.58 22.10 coo 24.74 78.07 5.59 24.32 79.03 7.46 -12.63 65.75 40.21 -14.11 64.30 40.60 coo 48.81 64.16 26.34 49.30 62.16 26.73 -23.95 56.87 7.77 -24.14 54.98 6.86 ULMN 3 1aql_c03 BILE-SALT ACTIVATED LIPASE user 2 3 # 2 B 194 SER A 61 SER~? -2.92 O25 2PE A 148s B 292 ASP B 19 ASP.? -3.77 O3 SO4 A 144s B 322 HIS A 115 HIS~? 12.27 C21 2PE A 148 coo 35.42 71.28 22.94 36.24 69.06 22.37 -20.68 51.98 23.20 -22.01 53.58 22.10 coo 24.74 78.07 5.59 24.32 79.03 7.46 -12.63 65.75 40.21 -14.11 64.30 40.60 coo 48.81 64.16 26.34 49.30 62.16 26.73 -13.18 48.35 10.37 -12.55 46.36 10.33 ULMN 3 1aql_c03 BILE-SALT ACTIVATED LIPASE user 3 3 # 3 B 194 SER A 123 SER^? 7.34 C15 2PE A 148 B 292 ASP A 56 ASP~? 11.59 C21 2PE A 148 B 322 HIS D 4 HIS.? 4.07 C3 GOL D 147 coo 35.42 71.28 22.94 36.24 69.06 22.37 -17.01 64.19 8.64 -15.43 63.06 10.12 coo 24.74 78.07 5.59 24.32 79.03 7.46 -16.01 45.89 15.64 -15.93 44.31 14.23 coo 48.81 64.16 26.34 49.30 62.16 26.73 -23.57 78.63 1.94 -22.01 77.96 0.72 ULMN 3 1aql_c03 BILE-SALT ACTIVATED LIPASE user 4 3 # 4 B 194 SER A 123 SER^? 7.34 C15 2PE A 148 B 292 ASP A 56 ASP~? 11.59 C21 2PE A 148 B 322 HIS D 85 HIS.? 4.73 OH7 1PE B 150 coo 35.42 71.28 22.94 36.24 69.06 22.37 -17.01 64.19 8.64 -15.43 63.06 10.12 coo 24.74 78.07 5.59 24.32 79.03 7.46 -16.01 45.89 15.64 -15.93 44.31 14.23 coo 48.81 64.16 26.34 49.30 62.16 26.73 -18.08 79.12 16.04 -18.14 81.21 15.79 ULMN 3 1aql_c03 BILE-SALT ACTIVATED LIPASE user 5 3 # 5 B 194 SER A 123 SER^? 7.34 C15 2PE A 148 B 292 ASP D 87 ASP.? 7.26 C16 1PE B 150 B 322 HIS A 115 HIS~? 12.27 C21 2PE A 148 coo 35.42 71.28 22.94 36.24 69.06 22.37 -17.01 64.19 8.64 -15.43 63.06 10.12 coo 24.74 78.07 5.59 24.32 79.03 7.46 -24.70 80.89 17.41 -22.90 81.94 17.31 coo 48.81 64.16 26.34 49.30 62.16 26.73 -13.18 48.35 10.37 -12.55 46.36 10.33 ULMN 3 1aql_c03 BILE-SALT ACTIVATED LIPASE user 6 3 # 6 B 194 SER B 57 SER~? 3.95 C20 PE8 B 148 B 292 ASP D 83 ASP.? 8.76 O1 GOL A 150 B 322 HIS B 88 HIS^? 4.29 CH1 MLY C 135 coo 35.42 71.28 22.94 36.24 69.06 22.37 2.89 78.00 28.42 3.14 79.13 30.54 coo 24.74 78.07 5.59 24.32 79.03 7.46 -12.54 78.43 10.94 -12.46 77.06 9.29 coo 48.81 64.16 26.34 49.30 62.16 26.73 6.15 87.00 38.94 7.35 87.96 37.51 ULMN 3 1aql_c03 BILE-SALT ACTIVATED LIPASE user 7 3 # 7 B 194 SER B 61 SER~? -3.13 O22 PE8 B 148s B 292 ASP A 6 ASP.? -3.91 C9 2PE A 148s B 322 HIS B 25 HIS^? 5.55 C6 PG4 C 145 coo 35.42 71.28 22.94 36.24 69.06 22.37 -3.39 77.64 29.23 -3.48 78.95 31.25 coo 24.74 78.07 5.59 24.32 79.03 7.46 -8.66 61.41 13.34 -8.76 59.35 12.80 coo 48.81 64.16 26.34 49.30 62.16 26.73 -10.19 81.59 41.51 -11.58 82.85 40.58 ULMN 3 1aql_c03 BILE-SALT ACTIVATED LIPASE user 8 3 # 8 B 194 SER B 61 SER~? -3.13 O22 PE8 B 148s B 292 ASP D 83 ASP.? 8.76 O1 GOL A 150 B 322 HIS B 88 HIS^? 4.29 CH1 MLY C 135 coo 35.42 71.28 22.94 36.24 69.06 22.37 -3.39 77.64 29.23 -3.48 78.95 31.25 coo 24.74 78.07 5.59 24.32 79.03 7.46 -12.54 78.43 10.94 -12.46 77.06 9.29 coo 48.81 64.16 26.34 49.30 62.16 26.73 6.15 87.00 38.94 7.35 87.96 37.51 ULMN 3 1aql_c03 BILE-SALT ACTIVATED LIPASE user 9 3 # 9 B 194 SER B 123 SER^? 7.43 C12 PE8 B 148 B 292 ASP B 56 ASP~? 11.45 C20 PE8 B 148 B 322 HIS C 4 HIS.? -3.73 C3 GOL C 149s coo 35.42 71.28 22.94 36.24 69.06 22.37 6.88 79.31 45.54 6.79 77.45 43.98 coo 24.74 78.07 5.59 24.32 79.03 7.46 6.80 78.21 26.00 8.47 79.07 25.03 coo 48.81 64.16 26.34 49.30 62.16 26.73 4.88 85.81 61.42 6.80 85.00 61.18 ULMN 3 1aql_c03 BILE-SALT ACTIVATED LIPASE user 10 3 # 10 B 194 SER B 123 SER^? 7.43 C12 PE8 B 148 B 292 ASP B 56 ASP~? 11.45 C20 PE8 B 148 B 322 HIS C 85 HIS.? 6.34 C1 PGE C 147 coo 35.42 71.28 22.94 36.24 69.06 22.37 6.88 79.31 45.54 6.79 77.45 43.98 coo 24.74 78.07 5.59 24.32 79.03 7.46 6.80 78.21 26.00 8.47 79.07 25.03 coo 48.81 64.16 26.34 49.30 62.16 26.73 -4.08 74.18 57.17 -4.69 74.12 59.17 ULMN 3 1aql_c03 BILE-SALT ACTIVATED LIPASE user 11 3 # 11 B 194 SER B 123 SER^? 7.43 C12 PE8 B 148 B 292 ASP C 87 ASP.? 8.84 O1 PGE C 147 B 322 HIS B 115 HIS~? 12.48 C18 PE8 B 148 coo 35.42 71.28 22.94 36.24 69.06 22.37 6.88 79.31 45.54 6.79 77.45 43.98 coo 24.74 78.07 5.59 24.32 79.03 7.46 -9.03 79.00 58.44 -8.21 77.39 59.55 coo 48.81 64.16 26.34 49.30 62.16 26.73 11.86 77.76 30.05 12.70 77.49 28.15 ULMN 3 1aql_c03 BILE-SALT ACTIVATED LIPASE user 12 3 # 12 B 194 SER C 123 SER^? 7.65 C15 PE8 C 148 B 292 ASP B 87 ASP.? 8.94 O4 PGE B 147 B 322 HIS C 115 HIS~? 4.72 C MLZ C 114 coo 35.42 71.28 22.94 36.24 69.06 22.37 -1.16 84.64 59.13 -1.43 86.65 60.45 coo 24.74 78.07 5.59 24.32 79.03 7.46 9.49 87.97 42.02 11.31 87.98 43.09 coo 48.81 64.16 26.34 49.30 62.16 26.73 -12.99 90.00 69.08 -14.38 90.57 70.54 ULMN 3 1aql_c03 BILE-SALT ACTIVATED LIPASE user 13 3 # 13 B 194 SER D 123 SER^? 7.59 C15 2PE D 146 B 292 ASP A 87 ASP.? 8.49 C6 PGE A 147 B 322 HIS D 115 HIS~? 12.18 C21 2PE D 146 coo 35.42 71.28 22.94 36.24 69.06 22.37 -25.59 78.45 8.19 -27.49 79.37 6.96 coo 24.74 78.07 5.59 24.32 79.03 7.46 -23.17 58.67 3.55 -22.34 59.17 1.69 coo 48.81 64.16 26.34 49.30 62.16 26.73 -36.28 90.32 11.92 -37.49 91.98 12.35 ULMN 3 1aql_c03 BILE-SALT ACTIVATED LIPASE user 14 3 # 14 B 194 SER D 123 SER^? 7.59 C15 2PE D 146 B 292 ASP D 56 ASP~? 11.46 C21 2PE D 146 B 322 HIS A 4 HIS.? -3.92 C2 GOL A 150s coo 35.42 71.28 22.94 36.24 69.06 22.37 -25.59 78.45 8.19 -27.49 79.37 6.96 coo 24.74 78.07 5.59 24.32 79.03 7.46 -41.85 87.81 13.66 -41.61 89.58 14.80 coo 48.81 64.16 26.34 49.30 62.16 26.73 -11.85 68.18 8.83 -11.23 70.10 8.29 ULMN 3 1aql_c03 BILE-SALT ACTIVATED LIPASE user 15 3 # 15 B 194 SER D 123 SER^? 7.59 C15 2PE D 146 B 292 ASP D 56 ASP~? 11.46 C21 2PE D 146 B 322 HIS A 85 HIS.? 6.69 C5 PGE A 147 coo 35.42 71.28 22.94 36.24 69.06 22.37 -25.59 78.45 8.19 -27.49 79.37 6.96 coo 24.74 78.07 5.59 24.32 79.03 7.46 -41.85 87.81 13.66 -41.61 89.58 14.80 coo 48.81 64.16 26.34 49.30 62.16 26.73 -23.05 64.43 -0.55 -21.68 63.00 -1.25 1aql_c03 source 1aql BILE-SALT ACTIVATED LIPASE : 15 hits 1aql_c03 naa= 3 ULMN 3 1asy_c00 TRANSFER RIBONUCLEIC ACID (TRNAASP) user 1 3 # 1 B 325 ARG A 16 ARG~? -2.82 O4 SO4 A 143s B 342 ASP B 19 ASP.? -3.77 O3 SO4 A 144s B 531 ARG A 20 ARG.? 4.64 CB MLZ A 129 coo 68.60 41.07 -12.62 69.17 40.45 -9.67 -9.29 63.37 28.06 -8.90 62.24 30.90 coo 73.51 47.41 -3.97 72.62 46.48 -5.62 -12.63 65.75 40.21 -14.11 64.30 40.60 coo 59.93 41.82 -5.59 61.38 39.13 -5.79 -20.19 69.79 30.19 -22.38 67.97 29.03 ULMN 3 1asy_c00 TRANSFER RIBONUCLEIC ACID (TRNAASP) user 2 3 # 2 B 325 ARG A 16 ARG~? -2.82 O4 SO4 A 143s B 342 ASP B 106 ASP~? 11.87 OH2 1PE B 150 B 531 ARG B 16 ARG~? -3.64 O1 SO4 A 143s coo 68.60 41.07 -12.62 69.17 40.45 -9.67 -9.29 63.37 28.06 -8.90 62.24 30.90 coo 73.51 47.41 -3.97 72.62 46.48 -5.62 -0.30 70.27 27.08 -0.10 70.78 25.05 coo 59.93 41.82 -5.59 61.38 39.13 -5.79 -4.85 63.18 38.40 -7.23 62.95 36.44 ULMN 3 1asy_c00 TRANSFER RIBONUCLEIC ACID (TRNAASP) user 3 3 # 3 B 325 ARG A 20 ARG.? 4.64 CB MLZ A 129 B 342 ASP B 19 ASP.? -3.77 O3 SO4 A 144s B 531 ARG A 16 ARG~? -2.82 O4 SO4 A 143s coo 68.60 41.07 -12.62 69.17 40.45 -9.67 -20.19 69.79 30.19 -22.38 67.97 29.03 coo 73.51 47.41 -3.97 72.62 46.48 -5.62 -12.63 65.75 40.21 -14.11 64.30 40.60 coo 59.93 41.82 -5.59 61.38 39.13 -5.79 -9.29 63.37 28.06 -8.90 62.24 30.90 ULMN 3 1asy_c00 TRANSFER RIBONUCLEIC ACID (TRNAASP) user 4 3 # 4 B 325 ARG A 33 ARG.? 10.19 C3 GOL A 150 B 342 ASP A 6 ASP.? -3.91 C9 2PE A 148s B 531 ARG A 31 ARG^? 11.10 C1 GOL A 150 coo 68.60 41.07 -12.62 69.17 40.45 -9.67 -11.76 56.72 1.51 -9.97 59.19 1.86 coo 73.51 47.41 -3.97 72.62 46.48 -5.62 -8.66 61.41 13.34 -8.76 59.35 12.80 coo 59.93 41.82 -5.59 61.38 39.13 -5.79 -18.51 63.86 1.13 -18.37 66.66 2.58 ULMN 3 1asy_c00 TRANSFER RIBONUCLEIC ACID (TRNAASP) user 5 3 # 5 B 325 ARG A 110 ARG~? -3.66 O1 2PE A 148s B 342 ASP A 6 ASP.? -3.91 C9 2PE A 148s B 531 ARG A 16 ARG~? -2.82 O4 SO4 A 143s coo 68.60 41.07 -12.62 69.17 40.45 -9.67 -6.91 52.41 21.82 -5.61 55.22 21.43 coo 73.51 47.41 -3.97 72.62 46.48 -5.62 -8.66 61.41 13.34 -8.76 59.35 12.80 coo 59.93 41.82 -5.59 61.38 39.13 -5.79 -9.29 63.37 28.06 -8.90 62.24 30.90 ULMN 3 1asy_c00 TRANSFER RIBONUCLEIC ACID (TRNAASP) user 6 3 # 6 B 325 ARG A 116 ARG~? 4.70 C15 2PE A 148 B 342 ASP A 87 ASP.? 8.49 C6 PGE A 147 B 531 ARG A 124 ARG^? 8.18 C1 GOL A 150 coo 68.60 41.07 -12.62 69.17 40.45 -9.67 -15.13 57.15 12.87 -15.00 60.01 11.67 coo 73.51 47.41 -3.97 72.62 46.48 -5.62 -23.17 58.67 3.55 -22.34 59.17 1.69 coo 59.93 41.82 -5.59 61.38 39.13 -5.79 -17.35 69.10 10.18 -16.14 69.37 7.36 ULMN 3 1asy_c00 TRANSFER RIBONUCLEIC ACID (TRNAASP) user 7 3 # 7 B 325 ARG A 124 ARG^? 8.18 C1 GOL A 150 B 342 ASP A 6 ASP.? -3.91 C9 2PE A 148s B 531 ARG A 31 ARG^? 11.10 C1 GOL A 150 coo 68.60 41.07 -12.62 69.17 40.45 -9.67 -17.35 69.10 10.18 -16.14 69.37 7.36 coo 73.51 47.41 -3.97 72.62 46.48 -5.62 -8.66 61.41 13.34 -8.76 59.35 12.80 coo 59.93 41.82 -5.59 61.38 39.13 -5.79 -18.51 63.86 1.13 -18.37 66.66 2.58 ULMN 3 1asy_c00 TRANSFER RIBONUCLEIC ACID (TRNAASP) user 8 3 # 8 B 325 ARG A 124 ARG^? 8.18 C1 GOL A 150 B 342 ASP A 87 ASP.? 8.49 C6 PGE A 147 B 531 ARG D 124 ARG^? 7.97 C3 GOL D 147 coo 68.60 41.07 -12.62 69.17 40.45 -9.67 -17.35 69.10 10.18 -16.14 69.37 7.36 coo 73.51 47.41 -3.97 72.62 46.48 -5.62 -23.17 58.67 3.55 -22.34 59.17 1.69 coo 59.93 41.82 -5.59 61.38 39.13 -5.79 -24.04 74.20 5.58 -21.67 76.16 5.44 ULMN 3 1asy_c00 TRANSFER RIBONUCLEIC ACID (TRNAASP) user 9 3 # 9 B 325 ARG A 124 ARG^? 8.18 C1 GOL A 150 B 342 ASP D 83 ASP.? 8.76 O1 GOL A 150 B 531 ARG D 124 ARG^? 7.97 C3 GOL D 147 coo 68.60 41.07 -12.62 69.17 40.45 -9.67 -17.35 69.10 10.18 -16.14 69.37 7.36 coo 73.51 47.41 -3.97 72.62 46.48 -5.62 -12.54 78.43 10.94 -12.46 77.06 9.29 coo 59.93 41.82 -5.59 61.38 39.13 -5.79 -24.04 74.20 5.58 -21.67 76.16 5.44 ULMN 3 1asy_c00 TRANSFER RIBONUCLEIC ACID (TRNAASP) user 10 3 # 10 B 325 ARG B 16 ARG~? -3.64 O1 SO4 A 143s B 342 ASP A 19 ASP.? -3.59 O4 SO4 A 144s B 531 ARG A 105 ARG~? -3.04 O2 SO4 A 143s coo 68.60 41.07 -12.62 69.17 40.45 -9.67 -4.85 63.18 38.40 -7.23 62.95 36.44 coo 73.51 47.41 -3.97 72.62 46.48 -5.62 -15.01 66.98 32.71 -14.52 68.02 34.44 coo 59.93 41.82 -5.59 61.38 39.13 -5.79 -8.78 56.32 28.12 -7.90 58.53 30.04 ULMN 3 1asy_c00 TRANSFER RIBONUCLEIC ACID (TRNAASP) user 11 3 # 11 B 325 ARG B 16 ARG~? -3.64 O1 SO4 A 143s B 342 ASP A 19 ASP.? -3.59 O4 SO4 A 144s B 531 ARG B 127 ARG^? 9.26 O4 SO4 A 144 coo 68.60 41.07 -12.62 69.17 40.45 -9.67 -4.85 63.18 38.40 -7.23 62.95 36.44 coo 73.51 47.41 -3.97 72.62 46.48 -5.62 -15.01 66.98 32.71 -14.52 68.02 34.44 coo 59.93 41.82 -5.59 61.38 39.13 -5.79 -7.64 72.55 44.16 -9.78 70.52 43.36 ULMN 3 1asy_c00 TRANSFER RIBONUCLEIC ACID (TRNAASP) user 12 3 # 12 B 325 ARG B 33 ARG.? -3.91 C3 PEG B 144s B 342 ASP B 6 ASP.? -3.99 C6 PE8 B 148s B 531 ARG B 31 ARG^? 11.02 C6 PGE B 147 coo 68.60 41.07 -12.62 69.17 40.45 -9.67 17.31 79.39 40.81 17.39 77.24 43.00 coo 73.51 47.41 -3.97 72.62 46.48 -5.62 7.95 70.39 41.39 8.88 71.08 39.61 coo 59.93 41.82 -5.59 61.38 39.13 -5.79 12.15 83.61 47.77 10.36 84.10 50.21 ULMN 3 1asy_c00 TRANSFER RIBONUCLEIC ACID (TRNAASP) user 13 3 # 13 B 325 ARG B 105 ARG~? -3.01 O4 SO4 A 143s B 342 ASP A 19 ASP.? -3.59 O4 SO4 A 144s B 531 ARG A 105 ARG~? -3.04 O2 SO4 A 143s coo 68.60 41.07 -12.62 69.17 40.45 -9.67 -2.68 64.28 31.62 -4.52 62.28 32.99 coo 73.51 47.41 -3.97 72.62 46.48 -5.62 -15.01 66.98 32.71 -14.52 68.02 34.44 coo 59.93 41.82 -5.59 61.38 39.13 -5.79 -8.78 56.32 28.12 -7.90 58.53 30.04 ULMN 3 1asy_c00 TRANSFER RIBONUCLEIC ACID (TRNAASP) user 14 3 # 14 B 325 ARG B 105 ARG~? -3.01 O4 SO4 A 143s B 342 ASP B 19 ASP.? -3.77 O3 SO4 A 144s B 531 ARG A 105 ARG~? -3.04 O2 SO4 A 143s coo 68.60 41.07 -12.62 69.17 40.45 -9.67 -2.68 64.28 31.62 -4.52 62.28 32.99 coo 73.51 47.41 -3.97 72.62 46.48 -5.62 -12.63 65.75 40.21 -14.11 64.30 40.60 coo 59.93 41.82 -5.59 61.38 39.13 -5.79 -8.78 56.32 28.12 -7.90 58.53 30.04 ULMN 3 1asy_c00 TRANSFER RIBONUCLEIC ACID (TRNAASP) user 15 3 # 15 B 325 ARG B 110 ARG~? 10.12 O7 PE8 B 148 B 342 ASP B 6 ASP.? -3.99 C6 PE8 B 148s B 531 ARG B 16 ARG~? -3.64 O1 SO4 A 143s coo 68.60 41.07 -12.62 69.17 40.45 -9.67 4.56 66.25 30.54 5.81 64.43 28.32 coo 73.51 47.41 -3.97 72.62 46.48 -5.62 7.95 70.39 41.39 8.88 71.08 39.61 coo 59.93 41.82 -5.59 61.38 39.13 -5.79 -4.85 63.18 38.40 -7.23 62.95 36.44 ULMN 3 1asy_c00 TRANSFER RIBONUCLEIC ACID (TRNAASP) user 16 3 # 16 B 325 ARG B 116 ARG~? 4.93 C12 PE8 B 148 B 342 ASP B 56 ASP~? 11.45 C20 PE8 B 148 B 531 ARG B 110 ARG~? 10.12 O7 PE8 B 148 coo 68.60 41.07 -12.62 69.17 40.45 -9.67 6.23 77.16 37.54 6.11 77.30 40.64 coo 73.51 47.41 -3.97 72.62 46.48 -5.62 6.80 78.21 26.00 8.47 79.07 25.03 coo 59.93 41.82 -5.59 61.38 39.13 -5.79 4.56 66.25 30.54 5.81 64.43 28.32 ULMN 3 1asy_c00 TRANSFER RIBONUCLEIC ACID (TRNAASP) user 17 3 # 17 B 325 ARG B 116 ARG~? 4.93 C12 PE8 B 148 B 342 ASP B 87 ASP.? 8.94 O4 PGE B 147 B 531 ARG B 124 ARG^? 8.02 O2 GOL B 149 coo 68.60 41.07 -12.62 69.17 40.45 -9.67 6.23 77.16 37.54 6.11 77.30 40.64 coo 73.51 47.41 -3.97 72.62 46.48 -5.62 9.49 87.97 42.02 11.31 87.98 43.09 coo 59.93 41.82 -5.59 61.38 39.13 -5.79 3.96 78.02 49.67 6.79 78.26 50.86 ULMN 3 1asy_c00 TRANSFER RIBONUCLEIC ACID (TRNAASP) user 18 3 # 18 B 325 ARG B 124 ARG^? 8.02 O2 GOL B 149 B 342 ASP B 6 ASP.? -3.99 C6 PE8 B 148s B 531 ARG B 31 ARG^? 11.02 C6 PGE B 147 coo 68.60 41.07 -12.62 69.17 40.45 -9.67 3.96 78.02 49.67 6.79 78.26 50.86 coo 73.51 47.41 -3.97 72.62 46.48 -5.62 7.95 70.39 41.39 8.88 71.08 39.61 coo 59.93 41.82 -5.59 61.38 39.13 -5.79 12.15 83.61 47.77 10.36 84.10 50.21 ULMN 3 1asy_c00 TRANSFER RIBONUCLEIC ACID (TRNAASP) user 19 3 # 19 B 325 ARG B 124 ARG^? 8.02 O2 GOL B 149 B 342 ASP B 87 ASP.? 8.94 O4 PGE B 147 B 531 ARG C 124 ARG^? 7.92 C3 GOL C 149 coo 68.60 41.07 -12.62 69.17 40.45 -9.67 3.96 78.02 49.67 6.79 78.26 50.86 coo 73.51 47.41 -3.97 72.62 46.48 -5.62 9.49 87.97 42.02 11.31 87.98 43.09 coo 59.93 41.82 -5.59 61.38 39.13 -5.79 2.87 85.20 55.95 3.74 82.90 57.81 ULMN 3 1asy_c00 TRANSFER RIBONUCLEIC ACID (TRNAASP) user 20 3 # 20 B 325 ARG B 124 ARG^? 8.02 O2 GOL B 149 B 342 ASP C 83 ASP.? 8.65 O3 GOL B 149 B 531 ARG C 124 ARG^? 7.92 C3 GOL C 149 coo 68.60 41.07 -12.62 69.17 40.45 -9.67 3.96 78.02 49.67 6.79 78.26 50.86 coo 73.51 47.41 -3.97 72.62 46.48 -5.62 3.02 71.86 58.06 4.88 72.49 57.24 coo 59.93 41.82 -5.59 61.38 39.13 -5.79 2.87 85.20 55.95 3.74 82.90 57.81 ULMN 3 1asy_c00 TRANSFER RIBONUCLEIC ACID (TRNAASP) user 21 3 # 21 B 325 ARG C 33 ARG.? 10.55 C1 GOL C 149 B 342 ASP C 6 ASP.? -4.04 C8 PE8 C 148s B 531 ARG C 31 ARG^? 11.22 C3 GOL C 149 coo 68.60 41.07 -12.62 69.17 40.45 -9.67 -5.11 80.73 69.28 -2.11 81.22 69.57 coo 73.51 47.41 -3.97 72.62 46.48 -5.62 0.53 91.96 65.64 -1.31 91.68 66.68 coo 59.93 41.82 -5.59 61.38 39.13 -5.79 -2.17 77.49 60.72 0.17 78.08 58.83 ULMN 3 1asy_c00 TRANSFER RIBONUCLEIC ACID (TRNAASP) user 22 3 # 22 B 325 ARG C 110 ARG~? -6.90 CM MLZ C 114s B 342 ASP C 6 ASP.? -4.04 C8 PE8 C 148s B 531 ARG C 16 ARG~? -2.96 O3 SO4 C 143s coo 68.60 41.07 -12.62 69.17 40.45 -9.67 -6.95 102.53 68.25 -6.50 103.08 71.25 coo 73.51 47.41 -3.97 72.62 46.48 -5.62 0.53 91.96 65.64 -1.31 91.68 66.68 coo 59.93 41.82 -5.59 61.38 39.13 -5.79 1.87 105.73 59.26 1.00 108.67 58.94 ULMN 3 1asy_c00 TRANSFER RIBONUCLEIC ACID (TRNAASP) user 23 3 # 23 B 325 ARG C 116 ARG~? 4.72 C15 PE8 C 148 B 342 ASP C 87 ASP.? 8.84 O1 PGE C 147 B 531 ARG C 124 ARG^? 7.92 C3 GOL C 149 coo 68.60 41.07 -12.62 69.17 40.45 -9.67 -6.64 90.12 62.40 -4.04 88.84 61.33 coo 73.51 47.41 -3.97 72.62 46.48 -5.62 -9.03 79.00 58.44 -8.21 77.39 59.55 coo 59.93 41.82 -5.59 61.38 39.13 -5.79 2.87 85.20 55.95 3.74 82.90 57.81 ULMN 3 1asy_c00 TRANSFER RIBONUCLEIC ACID (TRNAASP) user 24 3 # 24 B 325 ARG C 124 ARG^? 7.92 C3 GOL C 149 B 342 ASP B 83 ASP.? 9.40 O3 GOL C 149 B 531 ARG B 124 ARG^? 8.02 O2 GOL B 149 coo 68.60 41.07 -12.62 69.17 40.45 -9.67 2.87 85.20 55.95 3.74 82.90 57.81 coo 73.51 47.41 -3.97 72.62 46.48 -5.62 13.62 86.10 55.23 12.83 84.59 56.49 coo 59.93 41.82 -5.59 61.38 39.13 -5.79 3.96 78.02 49.67 6.79 78.26 50.86 ULMN 3 1asy_c00 TRANSFER RIBONUCLEIC ACID (TRNAASP) user 25 3 # 25 B 325 ARG C 124 ARG^? 7.92 C3 GOL C 149 B 342 ASP C 6 ASP.? -4.04 C8 PE8 C 148s B 531 ARG C 31 ARG^? 11.22 C3 GOL C 149 coo 68.60 41.07 -12.62 69.17 40.45 -9.67 2.87 85.20 55.95 3.74 82.90 57.81 coo 73.51 47.41 -3.97 72.62 46.48 -5.62 0.53 91.96 65.64 -1.31 91.68 66.68 coo 59.93 41.82 -5.59 61.38 39.13 -5.79 -2.17 77.49 60.72 0.17 78.08 58.83 ULMN 3 1asy_c00 TRANSFER RIBONUCLEIC ACID (TRNAASP) user 26 3 # 26 B 325 ARG C 124 ARG^? 7.92 C3 GOL C 149 B 342 ASP C 87 ASP.? 8.84 O1 PGE C 147 B 531 ARG B 124 ARG^? 8.02 O2 GOL B 149 coo 68.60 41.07 -12.62 69.17 40.45 -9.67 2.87 85.20 55.95 3.74 82.90 57.81 coo 73.51 47.41 -3.97 72.62 46.48 -5.62 -9.03 79.00 58.44 -8.21 77.39 59.55 coo 59.93 41.82 -5.59 61.38 39.13 -5.79 3.96 78.02 49.67 6.79 78.26 50.86 ULMN 3 1asy_c00 TRANSFER RIBONUCLEIC ACID (TRNAASP) user 27 3 # 27 B 325 ARG D 33 ARG.? 10.45 C1 GOL D 147 B 342 ASP D 6 ASP.? -3.77 C8 2PE D 146s B 531 ARG D 31 ARG^? 10.57 OH7 1PE B 150 coo 68.60 41.07 -12.62 69.17 40.45 -9.67 -24.75 89.49 9.81 -23.48 88.88 7.05 coo 73.51 47.41 -3.97 72.62 46.48 -5.62 -31.03 82.87 1.04 -31.83 84.41 2.29 coo 59.93 41.82 -5.59 61.38 39.13 -5.79 -19.64 81.34 12.02 -19.24 78.87 10.07 ULMN 3 1asy_c00 TRANSFER RIBONUCLEIC ACID (TRNAASP) user 28 3 # 28 B 325 ARG D 110 ARG~? 8.08 C9 2PE D 146 B 342 ASP D 6 ASP.? -3.77 C8 2PE D 146s B 531 ARG D 16 ARG~? -9.70 O1 2PE D 146s coo 68.60 41.07 -12.62 69.17 40.45 -9.67 -43.46 85.72 1.13 -42.23 87.94 -0.73 coo 73.51 47.41 -3.97 72.62 46.48 -5.62 -31.03 82.87 1.04 -31.83 84.41 2.29 coo 59.93 41.82 -5.59 61.38 39.13 -5.79 -42.18 74.28 -4.52 -45.10 73.30 -4.28 ULMN 3 1asy_c00 TRANSFER RIBONUCLEIC ACID (TRNAASP) user 29 3 # 29 B 325 ARG D 116 ARG~? 4.73 C15 2PE D 146 B 342 ASP D 87 ASP.? 7.26 C16 1PE B 150 B 531 ARG D 124 ARG^? 7.97 C3 GOL D 147 coo 68.60 41.07 -12.62 69.17 40.45 -9.67 -33.13 82.22 8.73 -30.63 80.83 7.52 coo 73.51 47.41 -3.97 72.62 46.48 -5.62 -24.70 80.89 17.41 -22.90 81.94 17.31 coo 59.93 41.82 -5.59 61.38 39.13 -5.79 -24.04 74.20 5.58 -21.67 76.16 5.44 ULMN 3 1asy_c00 TRANSFER RIBONUCLEIC ACID (TRNAASP) user 30 3 # 30 B 325 ARG D 124 ARG^? 7.97 C3 GOL D 147 B 342 ASP A 83 ASP.? 8.52 O3 GOL D 147 B 531 ARG A 124 ARG^? 8.18 C1 GOL A 150 coo 68.60 41.07 -12.62 69.17 40.45 -9.67 -24.04 74.20 5.58 -21.67 76.16 5.44 coo 73.51 47.41 -3.97 72.62 46.48 -5.62 -19.46 70.43 -3.04 -19.06 72.28 -2.05 coo 59.93 41.82 -5.59 61.38 39.13 -5.79 -17.35 69.10 10.18 -16.14 69.37 7.36 ULMN 3 1asy_c00 TRANSFER RIBONUCLEIC ACID (TRNAASP) user 31 3 # 31 B 325 ARG D 124 ARG^? 7.97 C3 GOL D 147 B 342 ASP D 6 ASP.? -3.77 C8 2PE D 146s B 531 ARG D 31 ARG^? 10.57 OH7 1PE B 150 coo 68.60 41.07 -12.62 69.17 40.45 -9.67 -24.04 74.20 5.58 -21.67 76.16 5.44 coo 73.51 47.41 -3.97 72.62 46.48 -5.62 -31.03 82.87 1.04 -31.83 84.41 2.29 coo 59.93 41.82 -5.59 61.38 39.13 -5.79 -19.64 81.34 12.02 -19.24 78.87 10.07 ULMN 3 1asy_c00 TRANSFER RIBONUCLEIC ACID (TRNAASP) user 32 3 # 32 B 325 ARG D 124 ARG^? 7.97 C3 GOL D 147 B 342 ASP D 87 ASP.? 7.26 C16 1PE B 150 B 531 ARG A 124 ARG^? 8.18 C1 GOL A 150 coo 68.60 41.07 -12.62 69.17 40.45 -9.67 -24.04 74.20 5.58 -21.67 76.16 5.44 coo 73.51 47.41 -3.97 72.62 46.48 -5.62 -24.70 80.89 17.41 -22.90 81.94 17.31 coo 59.93 41.82 -5.59 61.38 39.13 -5.79 -17.35 69.10 10.18 -16.14 69.37 7.36 1asy_c00 source 1asy TRANSFER RIBONUCLEIC ACID (TRNAASP) : 32 hits 1asy_c00 naa= 3 ULMN 3 1asy_c01 TRANSFER RIBONUCLEIC ACID (TRNAASP) user 1 3 # 1 A 325 ARG A 16 ARG~? -2.82 O4 SO4 A 143s A 342 ASP A 6 ASP.? -3.91 C9 2PE A 148s A 531 ARG A 127 ARG^? 7.47 N MLZ A 129 coo 73.40 61.96 -24.99 72.46 63.92 -22.84 -9.29 63.37 28.06 -8.90 62.24 30.90 coo 66.77 64.93 -14.03 68.02 64.49 -15.66 -8.66 61.41 13.34 -8.76 59.35 12.80 coo 80.46 68.51 -18.35 79.98 68.55 -21.36 -18.44 68.25 24.06 -17.70 68.37 27.04 ULMN 3 1asy_c01 TRANSFER RIBONUCLEIC ACID (TRNAASP) user 2 3 # 2 A 325 ARG A 16 ARG~? -2.82 O4 SO4 A 143s A 342 ASP A 6 ASP.? -3.91 C9 2PE A 148s A 531 ARG B 63 ARG~? -8.01 OH2 1PE B 150s coo 73.40 61.96 -24.99 72.46 63.92 -22.84 -9.29 63.37 28.06 -8.90 62.24 30.90 coo 66.77 64.93 -14.03 68.02 64.49 -15.66 -8.66 61.41 13.34 -8.76 59.35 12.80 coo 80.46 68.51 -18.35 79.98 68.55 -21.36 -5.18 74.17 22.68 -2.11 73.83 22.90 ULMN 3 1asy_c01 TRANSFER RIBONUCLEIC ACID (TRNAASP) user 3 3 # 3 A 325 ARG A 16 ARG~? -2.82 O4 SO4 A 143s A 342 ASP B 19 ASP.? -3.77 O3 SO4 A 144s A 531 ARG A 20 ARG.? 4.64 CB MLZ A 129 coo 73.40 61.96 -24.99 72.46 63.92 -22.84 -9.29 63.37 28.06 -8.90 62.24 30.90 coo 66.77 64.93 -14.03 68.02 64.49 -15.66 -12.63 65.75 40.21 -14.11 64.30 40.60 coo 80.46 68.51 -18.35 79.98 68.55 -21.36 -20.19 69.79 30.19 -22.38 67.97 29.03 ULMN 3 1asy_c01 TRANSFER RIBONUCLEIC ACID (TRNAASP) user 4 3 # 4 A 325 ARG A 16 ARG~? -2.82 O4 SO4 A 143s A 342 ASP B 106 ASP~? 11.87 OH2 1PE B 150 A 531 ARG B 16 ARG~? -3.64 O1 SO4 A 143s coo 73.40 61.96 -24.99 72.46 63.92 -22.84 -9.29 63.37 28.06 -8.90 62.24 30.90 coo 66.77 64.93 -14.03 68.02 64.49 -15.66 -0.30 70.27 27.08 -0.10 70.78 25.05 coo 80.46 68.51 -18.35 79.98 68.55 -21.36 -4.85 63.18 38.40 -7.23 62.95 36.44 ULMN 3 1asy_c01 TRANSFER RIBONUCLEIC ACID (TRNAASP) user 5 3 # 5 A 325 ARG A 20 ARG.? 4.64 CB MLZ A 129 A 342 ASP B 19 ASP.? -3.77 O3 SO4 A 144s A 531 ARG A 16 ARG~? -2.82 O4 SO4 A 143s coo 73.40 61.96 -24.99 72.46 63.92 -22.84 -20.19 69.79 30.19 -22.38 67.97 29.03 coo 66.77 64.93 -14.03 68.02 64.49 -15.66 -12.63 65.75 40.21 -14.11 64.30 40.60 coo 80.46 68.51 -18.35 79.98 68.55 -21.36 -9.29 63.37 28.06 -8.90 62.24 30.90 ULMN 3 1asy_c01 TRANSFER RIBONUCLEIC ACID (TRNAASP) user 6 3 # 6 A 325 ARG A 33 ARG.? 10.19 C3 GOL A 150 A 342 ASP A 6 ASP.? -3.91 C9 2PE A 148s A 531 ARG A 31 ARG^? 11.10 C1 GOL A 150 coo 73.40 61.96 -24.99 72.46 63.92 -22.84 -11.76 56.72 1.51 -9.97 59.19 1.86 coo 66.77 64.93 -14.03 68.02 64.49 -15.66 -8.66 61.41 13.34 -8.76 59.35 12.80 coo 80.46 68.51 -18.35 79.98 68.55 -21.36 -18.51 63.86 1.13 -18.37 66.66 2.58 ULMN 3 1asy_c01 TRANSFER RIBONUCLEIC ACID (TRNAASP) user 7 3 # 7 A 325 ARG A 110 ARG~? -3.66 O1 2PE A 148s A 342 ASP A 6 ASP.? -3.91 C9 2PE A 148s A 531 ARG A 16 ARG~? -2.82 O4 SO4 A 143s coo 73.40 61.96 -24.99 72.46 63.92 -22.84 -6.91 52.41 21.82 -5.61 55.22 21.43 coo 66.77 64.93 -14.03 68.02 64.49 -15.66 -8.66 61.41 13.34 -8.76 59.35 12.80 coo 80.46 68.51 -18.35 79.98 68.55 -21.36 -9.29 63.37 28.06 -8.90 62.24 30.90 ULMN 3 1asy_c01 TRANSFER RIBONUCLEIC ACID (TRNAASP) user 8 3 # 8 A 325 ARG A 116 ARG~? 4.70 C15 2PE A 148 A 342 ASP A 87 ASP.? 8.49 C6 PGE A 147 A 531 ARG A 124 ARG^? 8.18 C1 GOL A 150 coo 73.40 61.96 -24.99 72.46 63.92 -22.84 -15.13 57.15 12.87 -15.00 60.01 11.67 coo 66.77 64.93 -14.03 68.02 64.49 -15.66 -23.17 58.67 3.55 -22.34 59.17 1.69 coo 80.46 68.51 -18.35 79.98 68.55 -21.36 -17.35 69.10 10.18 -16.14 69.37 7.36 ULMN 3 1asy_c01 TRANSFER RIBONUCLEIC ACID (TRNAASP) user 9 3 # 9 A 325 ARG A 124 ARG^? 8.18 C1 GOL A 150 A 342 ASP A 6 ASP.? -3.91 C9 2PE A 148s A 531 ARG A 31 ARG^? 11.10 C1 GOL A 150 coo 73.40 61.96 -24.99 72.46 63.92 -22.84 -17.35 69.10 10.18 -16.14 69.37 7.36 coo 66.77 64.93 -14.03 68.02 64.49 -15.66 -8.66 61.41 13.34 -8.76 59.35 12.80 coo 80.46 68.51 -18.35 79.98 68.55 -21.36 -18.51 63.86 1.13 -18.37 66.66 2.58 ULMN 3 1asy_c01 TRANSFER RIBONUCLEIC ACID (TRNAASP) user 10 3 # 10 A 325 ARG B 16 ARG~? -3.64 O1 SO4 A 143s A 342 ASP A 19 ASP.? -3.59 O4 SO4 A 144s A 531 ARG A 105 ARG~? -3.04 O2 SO4 A 143s coo 73.40 61.96 -24.99 72.46 63.92 -22.84 -4.85 63.18 38.40 -7.23 62.95 36.44 coo 66.77 64.93 -14.03 68.02 64.49 -15.66 -15.01 66.98 32.71 -14.52 68.02 34.44 coo 80.46 68.51 -18.35 79.98 68.55 -21.36 -8.78 56.32 28.12 -7.90 58.53 30.04 ULMN 3 1asy_c01 TRANSFER RIBONUCLEIC ACID (TRNAASP) user 11 3 # 11 A 325 ARG B 16 ARG~? -3.64 O1 SO4 A 143s A 342 ASP A 19 ASP.? -3.59 O4 SO4 A 144s A 531 ARG B 127 ARG^? 9.26 O4 SO4 A 144 coo 73.40 61.96 -24.99 72.46 63.92 -22.84 -4.85 63.18 38.40 -7.23 62.95 36.44 coo 66.77 64.93 -14.03 68.02 64.49 -15.66 -15.01 66.98 32.71 -14.52 68.02 34.44 coo 80.46 68.51 -18.35 79.98 68.55 -21.36 -7.64 72.55 44.16 -9.78 70.52 43.36 ULMN 3 1asy_c01 TRANSFER RIBONUCLEIC ACID (TRNAASP) user 12 3 # 12 A 325 ARG B 16 ARG~? -3.64 O1 SO4 A 143s A 342 ASP B 6 ASP.? -3.99 C6 PE8 B 148s A 531 ARG B 127 ARG^? 9.26 O4 SO4 A 144 coo 73.40 61.96 -24.99 72.46 63.92 -22.84 -4.85 63.18 38.40 -7.23 62.95 36.44 coo 66.77 64.93 -14.03 68.02 64.49 -15.66 7.95 70.39 41.39 8.88 71.08 39.61 coo 80.46 68.51 -18.35 79.98 68.55 -21.36 -7.64 72.55 44.16 -9.78 70.52 43.36 ULMN 3 1asy_c01 TRANSFER RIBONUCLEIC ACID (TRNAASP) user 13 3 # 13 A 325 ARG B 16 ARG~? -3.64 O1 SO4 A 143s A 342 ASP B 106 ASP~? 11.87 OH2 1PE B 150 A 531 ARG A 105 ARG~? -3.04 O2 SO4 A 143s coo 73.40 61.96 -24.99 72.46 63.92 -22.84 -4.85 63.18 38.40 -7.23 62.95 36.44 coo 66.77 64.93 -14.03 68.02 64.49 -15.66 -0.30 70.27 27.08 -0.10 70.78 25.05 coo 80.46 68.51 -18.35 79.98 68.55 -21.36 -8.78 56.32 28.12 -7.90 58.53 30.04 ULMN 3 1asy_c01 TRANSFER RIBONUCLEIC ACID (TRNAASP) user 14 3 # 14 A 325 ARG B 105 ARG~? -3.01 O4 SO4 A 143s A 342 ASP A 19 ASP.? -3.59 O4 SO4 A 144s A 531 ARG A 105 ARG~? -3.04 O2 SO4 A 143s coo 73.40 61.96 -24.99 72.46 63.92 -22.84 -2.68 64.28 31.62 -4.52 62.28 32.99 coo 66.77 64.93 -14.03 68.02 64.49 -15.66 -15.01 66.98 32.71 -14.52 68.02 34.44 coo 80.46 68.51 -18.35 79.98 68.55 -21.36 -8.78 56.32 28.12 -7.90 58.53 30.04 ULMN 3 1asy_c01 TRANSFER RIBONUCLEIC ACID (TRNAASP) user 15 3 # 15 A 325 ARG B 105 ARG~? -3.01 O4 SO4 A 143s A 342 ASP A 19 ASP.? -3.59 O4 SO4 A 144s A 531 ARG B 63 ARG~? -8.01 OH2 1PE B 150s coo 73.40 61.96 -24.99 72.46 63.92 -22.84 -2.68 64.28 31.62 -4.52 62.28 32.99 coo 66.77 64.93 -14.03 68.02 64.49 -15.66 -15.01 66.98 32.71 -14.52 68.02 34.44 coo 80.46 68.51 -18.35 79.98 68.55 -21.36 -5.18 74.17 22.68 -2.11 73.83 22.90 ULMN 3 1asy_c01 TRANSFER RIBONUCLEIC ACID (TRNAASP) user 16 3 # 16 A 325 ARG B 105 ARG~? -3.01 O4 SO4 A 143s A 342 ASP B 19 ASP.? -3.77 O3 SO4 A 144s A 531 ARG A 105 ARG~? -3.04 O2 SO4 A 143s coo 73.40 61.96 -24.99 72.46 63.92 -22.84 -2.68 64.28 31.62 -4.52 62.28 32.99 coo 66.77 64.93 -14.03 68.02 64.49 -15.66 -12.63 65.75 40.21 -14.11 64.30 40.60 coo 80.46 68.51 -18.35 79.98 68.55 -21.36 -8.78 56.32 28.12 -7.90 58.53 30.04 ULMN 3 1asy_c01 TRANSFER RIBONUCLEIC ACID (TRNAASP) user 17 3 # 17 A 325 ARG B 110 ARG~? 10.12 O7 PE8 B 148 A 342 ASP B 6 ASP.? -3.99 C6 PE8 B 148s A 531 ARG B 16 ARG~? -3.64 O1 SO4 A 143s coo 73.40 61.96 -24.99 72.46 63.92 -22.84 4.56 66.25 30.54 5.81 64.43 28.32 coo 66.77 64.93 -14.03 68.02 64.49 -15.66 7.95 70.39 41.39 8.88 71.08 39.61 coo 80.46 68.51 -18.35 79.98 68.55 -21.36 -4.85 63.18 38.40 -7.23 62.95 36.44 ULMN 3 1asy_c01 TRANSFER RIBONUCLEIC ACID (TRNAASP) user 18 3 # 18 A 325 ARG B 116 ARG~? 4.93 C12 PE8 B 148 A 342 ASP B 56 ASP~? 11.45 C20 PE8 B 148 A 531 ARG B 110 ARG~? 10.12 O7 PE8 B 148 coo 73.40 61.96 -24.99 72.46 63.92 -22.84 6.23 77.16 37.54 6.11 77.30 40.64 coo 66.77 64.93 -14.03 68.02 64.49 -15.66 6.80 78.21 26.00 8.47 79.07 25.03 coo 80.46 68.51 -18.35 79.98 68.55 -21.36 4.56 66.25 30.54 5.81 64.43 28.32 ULMN 3 1asy_c01 TRANSFER RIBONUCLEIC ACID (TRNAASP) user 19 3 # 19 A 325 ARG B 116 ARG~? 4.93 C12 PE8 B 148 A 342 ASP B 87 ASP.? 8.94 O4 PGE B 147 A 531 ARG B 124 ARG^? 8.02 O2 GOL B 149 coo 73.40 61.96 -24.99 72.46 63.92 -22.84 6.23 77.16 37.54 6.11 77.30 40.64 coo 66.77 64.93 -14.03 68.02 64.49 -15.66 9.49 87.97 42.02 11.31 87.98 43.09 coo 80.46 68.51 -18.35 79.98 68.55 -21.36 3.96 78.02 49.67 6.79 78.26 50.86 ULMN 3 1asy_c01 TRANSFER RIBONUCLEIC ACID (TRNAASP) user 20 3 # 20 A 325 ARG B 124 ARG^? 8.02 O2 GOL B 149 A 342 ASP B 6 ASP.? -3.99 C6 PE8 B 148s A 531 ARG B 31 ARG^? 11.02 C6 PGE B 147 coo 73.40 61.96 -24.99 72.46 63.92 -22.84 3.96 78.02 49.67 6.79 78.26 50.86 coo 66.77 64.93 -14.03 68.02 64.49 -15.66 7.95 70.39 41.39 8.88 71.08 39.61 coo 80.46 68.51 -18.35 79.98 68.55 -21.36 12.15 83.61 47.77 10.36 84.10 50.21 ULMN 3 1asy_c01 TRANSFER RIBONUCLEIC ACID (TRNAASP) user 21 3 # 21 A 325 ARG C 110 ARG~? -6.90 CM MLZ C 114s A 342 ASP C 6 ASP.? -4.04 C8 PE8 C 148s A 531 ARG C 16 ARG~? -2.96 O3 SO4 C 143s coo 73.40 61.96 -24.99 72.46 63.92 -22.84 -6.95 102.53 68.25 -6.50 103.08 71.25 coo 66.77 64.93 -14.03 68.02 64.49 -15.66 0.53 91.96 65.64 -1.31 91.68 66.68 coo 80.46 68.51 -18.35 79.98 68.55 -21.36 1.87 105.73 59.26 1.00 108.67 58.94 ULMN 3 1asy_c01 TRANSFER RIBONUCLEIC ACID (TRNAASP) user 22 3 # 22 A 325 ARG C 116 ARG~? 4.72 C15 PE8 C 148 A 342 ASP C 87 ASP.? 8.84 O1 PGE C 147 A 531 ARG C 124 ARG^? 7.92 C3 GOL C 149 coo 73.40 61.96 -24.99 72.46 63.92 -22.84 -6.64 90.12 62.40 -4.04 88.84 61.33 coo 66.77 64.93 -14.03 68.02 64.49 -15.66 -9.03 79.00 58.44 -8.21 77.39 59.55 coo 80.46 68.51 -18.35 79.98 68.55 -21.36 2.87 85.20 55.95 3.74 82.90 57.81 ULMN 3 1asy_c01 TRANSFER RIBONUCLEIC ACID (TRNAASP) user 23 3 # 23 A 325 ARG C 124 ARG^? 7.92 C3 GOL C 149 A 342 ASP C 6 ASP.? -4.04 C8 PE8 C 148s A 531 ARG C 31 ARG^? 11.22 C3 GOL C 149 coo 73.40 61.96 -24.99 72.46 63.92 -22.84 2.87 85.20 55.95 3.74 82.90 57.81 coo 66.77 64.93 -14.03 68.02 64.49 -15.66 0.53 91.96 65.64 -1.31 91.68 66.68 coo 80.46 68.51 -18.35 79.98 68.55 -21.36 -2.17 77.49 60.72 0.17 78.08 58.83 ULMN 3 1asy_c01 TRANSFER RIBONUCLEIC ACID (TRNAASP) user 24 3 # 24 A 325 ARG D 33 ARG.? 10.45 C1 GOL D 147 A 342 ASP D 6 ASP.? -3.77 C8 2PE D 146s A 531 ARG D 31 ARG^? 10.57 OH7 1PE B 150 coo 73.40 61.96 -24.99 72.46 63.92 -22.84 -24.75 89.49 9.81 -23.48 88.88 7.05 coo 66.77 64.93 -14.03 68.02 64.49 -15.66 -31.03 82.87 1.04 -31.83 84.41 2.29 coo 80.46 68.51 -18.35 79.98 68.55 -21.36 -19.64 81.34 12.02 -19.24 78.87 10.07 ULMN 3 1asy_c01 TRANSFER RIBONUCLEIC ACID (TRNAASP) user 25 3 # 25 A 325 ARG D 110 ARG~? 8.08 C9 2PE D 146 A 342 ASP D 6 ASP.? -3.77 C8 2PE D 146s A 531 ARG D 16 ARG~? -9.70 O1 2PE D 146s coo 73.40 61.96 -24.99 72.46 63.92 -22.84 -43.46 85.72 1.13 -42.23 87.94 -0.73 coo 66.77 64.93 -14.03 68.02 64.49 -15.66 -31.03 82.87 1.04 -31.83 84.41 2.29 coo 80.46 68.51 -18.35 79.98 68.55 -21.36 -42.18 74.28 -4.52 -45.10 73.30 -4.28 ULMN 3 1asy_c01 TRANSFER RIBONUCLEIC ACID (TRNAASP) user 26 3 # 26 A 325 ARG D 116 ARG~? 4.73 C15 2PE D 146 A 342 ASP D 56 ASP~? 11.46 C21 2PE D 146 A 531 ARG D 110 ARG~? 8.08 C9 2PE D 146 coo 73.40 61.96 -24.99 72.46 63.92 -22.84 -33.13 82.22 8.73 -30.63 80.83 7.52 coo 66.77 64.93 -14.03 68.02 64.49 -15.66 -41.85 87.81 13.66 -41.61 89.58 14.80 coo 80.46 68.51 -18.35 79.98 68.55 -21.36 -43.46 85.72 1.13 -42.23 87.94 -0.73 ULMN 3 1asy_c01 TRANSFER RIBONUCLEIC ACID (TRNAASP) user 27 3 # 27 A 325 ARG D 116 ARG~? 4.73 C15 2PE D 146 A 342 ASP D 87 ASP.? 7.26 C16 1PE B 150 A 531 ARG D 124 ARG^? 7.97 C3 GOL D 147 coo 73.40 61.96 -24.99 72.46 63.92 -22.84 -33.13 82.22 8.73 -30.63 80.83 7.52 coo 66.77 64.93 -14.03 68.02 64.49 -15.66 -24.70 80.89 17.41 -22.90 81.94 17.31 coo 80.46 68.51 -18.35 79.98 68.55 -21.36 -24.04 74.20 5.58 -21.67 76.16 5.44 ULMN 3 1asy_c01 TRANSFER RIBONUCLEIC ACID (TRNAASP) user 28 3 # 28 A 325 ARG D 124 ARG^? 7.97 C3 GOL D 147 A 342 ASP D 6 ASP.? -3.77 C8 2PE D 146s A 531 ARG D 31 ARG^? 10.57 OH7 1PE B 150 coo 73.40 61.96 -24.99 72.46 63.92 -22.84 -24.04 74.20 5.58 -21.67 76.16 5.44 coo 66.77 64.93 -14.03 68.02 64.49 -15.66 -31.03 82.87 1.04 -31.83 84.41 2.29 coo 80.46 68.51 -18.35 79.98 68.55 -21.36 -19.64 81.34 12.02 -19.24 78.87 10.07 1asy_c01 source 1asy TRANSFER RIBONUCLEIC ACID (TRNAASP) : 28 hits 1asy_c01 naa= 3 ULMN 3 1avf_c04 GASTRICSIN user 1 3 # 1 A 32 ASP A 122 ASP^? 7.46 C1 GOL A 150 A 35 SER A 123 SER^? 7.34 C15 2PE A 148 A 217 ASP A 87 ASP.? 8.49 C6 PGE A 147 coo -10.06 2.54 49.69 -8.83 3.73 50.96 -15.41 64.92 4.51 -15.09 66.83 5.33 coo -11.96 5.74 52.90 -10.55 6.74 51.22 -17.01 64.19 8.64 -15.43 63.06 10.12 coo -5.22 1.43 56.08 -5.36 2.84 54.49 -23.17 58.67 3.55 -22.34 59.17 1.69 ULMN 3 1avf_c04 GASTRICSIN user 2 3 # 2 A 32 ASP B 122 ASP^? 7.33 O2 GOL B 149 A 35 SER B 123 SER^? 7.43 C12 PE8 B 148 A 217 ASP B 87 ASP.? 8.94 O4 PGE B 147 coo -10.06 2.54 49.69 -8.83 3.73 50.96 10.89 79.68 47.57 9.75 78.80 49.16 coo -11.96 5.74 52.90 -10.55 6.74 51.22 6.88 79.31 45.54 6.79 77.45 43.98 coo -5.22 1.43 56.08 -5.36 2.84 54.49 9.49 87.97 42.02 11.31 87.98 43.09 ULMN 3 1avf_c04 GASTRICSIN user 3 3 # 3 A 32 ASP C 122 ASP^? 7.22 C3 GOL C 149 A 35 SER C 123 SER^? 7.65 C15 PE8 C 148 A 217 ASP C 87 ASP.? 8.84 O1 PGE C 147 coo -10.06 2.54 49.69 -8.83 3.73 50.96 0.27 81.12 61.60 2.07 81.54 60.53 coo -11.96 5.74 52.90 -10.55 6.74 51.22 -1.16 84.64 59.13 -1.43 86.65 60.45 coo -5.22 1.43 56.08 -5.36 2.84 54.49 -9.03 79.00 58.44 -8.21 77.39 59.55 ULMN 3 1avf_c04 GASTRICSIN user 4 3 # 4 A 32 ASP D 122 ASP^? 7.49 C3 GOL D 147 A 35 SER D 123 SER^? 7.59 C15 2PE D 146 A 217 ASP D 87 ASP.? 7.26 C16 1PE B 150 coo -10.06 2.54 49.69 -8.83 3.73 50.96 -21.82 80.90 7.85 -21.38 79.32 6.51 coo -11.96 5.74 52.90 -10.55 6.74 51.22 -25.59 78.45 8.19 -27.49 79.37 6.96 coo -5.22 1.43 56.08 -5.36 2.84 54.49 -24.70 80.89 17.41 -22.90 81.94 17.31 1avf_c04 source 1avf GASTRICSIN : 4 hits 1avf_c04 naa= 3 ULMN 3 1ay4_c02 AROMATIC AMINO ACID AMINOTRANSFERASEuser 1 3 # 1 A 140 TRP A 86 TRP.? 11.27 C5 PGE A 147 A 222 ASP A 87 ASP.? 8.49 C6 PGE A 147 A 258 LYS D 129 LYS^? 7.63 C4 PEG D 145 coo 89.83 15.40 0.01 90.61 18.86 1.71 -23.97 66.49 5.70 -20.10 66.49 6.06 coo 82.92 20.43 2.47 84.82 20.45 1.55 -23.17 58.67 3.55 -22.34 59.17 1.69 coo 89.09 24.00 -8.81 89.39 20.33 -4.16 -36.12 61.83 6.50 -39.41 57.83 4.09 ULMN 3 1ay4_c02 AROMATIC AMINO ACID AMINOTRANSFERASEuser 2 3 # 2 A 140 TRP C 86 TRP.? 11.30 C1 PGE C 147 A 222 ASP C 87 ASP.? 8.84 O1 PGE C 147 A 258 LYS B 129 LYS^? 7.64 C2 PEG B 146 coo 89.83 15.40 0.01 90.61 18.86 1.71 -2.64 79.47 53.33 -0.76 80.96 56.37 coo 82.92 20.43 2.47 84.82 20.45 1.55 -9.03 79.00 58.44 -8.21 77.39 59.55 coo 89.09 24.00 -8.81 89.39 20.33 -4.16 -12.78 77.45 45.34 -17.39 74.89 47.84 1ay4_c02 source 1ay4 AROMATIC AMINO ACID AMINOTRANSFERASE : 2 hits 1ay4_c02 naa= 3 ULMN 3 1ay4_c03 AROMATIC AMINO ACID AMINOTRANSFERASEuser 1 3 # 1 B 140 TRP A 86 TRP.? 11.27 C5 PGE A 147 B 222 ASP A 87 ASP.? 8.49 C6 PGE A 147 B 258 LYS D 129 LYS^? 7.63 C4 PEG D 145 coo 103.45 44.39 16.20 102.66 41.02 14.32 -23.97 66.49 5.70 -20.10 66.49 6.06 coo 110.10 38.66 15.58 108.40 39.41 14.53 -23.17 58.67 3.55 -22.34 59.17 1.69 coo 107.51 45.54 4.76 105.41 44.51 10.25 -36.12 61.83 6.50 -39.41 57.83 4.09 ULMN 3 1ay4_c03 AROMATIC AMINO ACID AMINOTRANSFERASEuser 2 3 # 2 B 140 TRP C 86 TRP.? 11.30 C1 PGE C 147 B 222 ASP C 87 ASP.? 8.84 O1 PGE C 147 B 258 LYS B 129 LYS^? 7.64 C2 PEG B 146 coo 103.45 44.39 16.20 102.66 41.02 14.32 -2.64 79.47 53.33 -0.76 80.96 56.37 coo 110.10 38.66 15.58 108.40 39.41 14.53 -9.03 79.00 58.44 -8.21 77.39 59.55 coo 107.51 45.54 4.76 105.41 44.51 10.25 -12.78 77.45 45.34 -17.39 74.89 47.84 1ay4_c03 source 1ay4 AROMATIC AMINO ACID AMINOTRANSFERASE : 2 hits 1ay4_c03 naa= 3 ULMN 3 1b2m_c01 5'-R(*GP*(CH2)U)-3' user 1 3 # 1 B 40 HIS A 85 HIS.? 6.69 C5 PGE A 147 B 58 GLU A 84 GLU.? 10.45 C3 GOL D 147 B 92 HIS A 4 HIS.? -3.92 C2 GOL A 150s coo 10.74 36.24 16.20 9.81 34.52 16.97 -23.05 64.43 -0.55 -21.68 63.00 -1.25 coo 5.02 36.40 17.74 5.55 34.41 17.37 -21.01 70.22 3.12 -21.10 71.95 4.30 coo 0.68 29.04 20.43 2.46 29.56 19.46 -11.85 68.18 8.83 -11.23 70.10 8.29 ULMN 3 1b2m_c01 5'-R(*GP*(CH2)U)-3' user 2 3 # 2 B 40 HIS A 85 HIS.? 6.69 C5 PGE A 147 B 58 GLU A 84 GLU.? 10.45 C3 GOL D 147 B 92 HIS D 4 HIS.? 4.07 C3 GOL D 147 coo 10.74 36.24 16.20 9.81 34.52 16.97 -23.05 64.43 -0.55 -21.68 63.00 -1.25 coo 5.02 36.40 17.74 5.55 34.41 17.37 -21.01 70.22 3.12 -21.10 71.95 4.30 coo 0.68 29.04 20.43 2.46 29.56 19.46 -23.57 78.63 1.94 -22.01 77.96 0.72 ULMN 3 1b2m_c01 5'-R(*GP*(CH2)U)-3' user 3 3 # 3 B 40 HIS B 85 HIS.? 6.66 C6 PGE B 147 B 58 GLU B 84 GLU.? 10.31 O3 GOL C 149 B 92 HIS C 4 HIS.? -3.73 C3 GOL C 149s coo 10.74 36.24 16.20 9.81 34.52 16.97 11.11 88.86 48.90 12.76 88.34 47.73 coo 5.02 36.40 17.74 5.55 34.41 17.37 7.66 84.31 53.13 6.13 83.49 54.35 coo 0.68 29.04 20.43 2.46 29.56 19.46 4.88 85.81 61.42 6.80 85.00 61.18 ULMN 3 1b2m_c01 5'-R(*GP*(CH2)U)-3' user 4 3 # 4 B 40 HIS C 85 HIS.? 6.34 C1 PGE C 147 B 58 GLU C 84 GLU.? 10.77 O2 GOL B 149 B 92 HIS B 4 HIS.? -3.86 O2 GOL B 149s coo 10.74 36.24 16.20 9.81 34.52 16.97 -4.08 74.18 57.17 -4.69 74.12 59.17 coo 5.02 36.40 17.74 5.55 34.41 17.37 2.34 77.12 55.01 3.46 78.21 53.60 coo 0.68 29.04 20.43 2.46 29.56 19.46 8.07 73.88 49.16 8.30 73.43 51.19 ULMN 3 1b2m_c01 5'-R(*GP*(CH2)U)-3' user 5 3 # 5 B 40 HIS D 85 HIS.? 4.73 OH7 1PE B 150 B 58 GLU D 84 GLU.? 10.79 C1 GOL A 150 B 92 HIS A 4 HIS.? -3.92 C2 GOL A 150s coo 10.74 36.24 16.20 9.81 34.52 16.97 -18.08 79.12 16.04 -18.14 81.21 15.79 coo 5.02 36.40 17.74 5.55 34.41 17.37 -17.40 74.78 10.23 -17.69 72.96 9.24 coo 0.68 29.04 20.43 2.46 29.56 19.46 -11.85 68.18 8.83 -11.23 70.10 8.29 1b2m_c01 source 1b2m 5'-R(*GP*(CH2)U)-3' : 5 hits 1b2m_c01 naa= 3 ULMN 3 1b57_c00 FRUCTOSE-BISPHOSPHATE ALDOLASE II user 1 3 # 1 A 109 ASP A 19 ASP.? -3.59 O4 SO4 A 144s A 182 GLU A 21 GLU.? -3.95 C2 PEG A 146s A 286 ASN A 18 ASN~? 7.05 CM MLZ A 129 coo 26.03 44.66 108.90 25.67 42.61 108.82 -15.01 66.98 32.71 -14.52 68.02 34.44 coo 18.06 44.02 105.38 18.08 45.37 107.03 -23.01 65.38 36.24 -23.03 64.85 38.31 coo 25.47 38.28 112.06 27.26 39.30 111.54 -15.51 71.08 28.46 -17.41 71.81 28.97 ULMN 3 1b57_c00 FRUCTOSE-BISPHOSPHATE ALDOLASE II user 2 3 # 2 A 109 ASP A 19 ASP.? -3.59 O4 SO4 A 144s A 182 GLU B 21 GLU.? -4.32 C4 PEG B 146s A 286 ASN A 18 ASN~? 7.05 CM MLZ A 129 coo 26.03 44.66 108.90 25.67 42.61 108.82 -15.01 66.98 32.71 -14.52 68.02 34.44 coo 18.06 44.02 105.38 18.08 45.37 107.03 -19.10 71.22 37.43 -20.67 70.39 36.27 coo 25.47 38.28 112.06 27.26 39.30 111.54 -15.51 71.08 28.46 -17.41 71.81 28.97 ULMN 3 1b57_c00 FRUCTOSE-BISPHOSPHATE ALDOLASE II user 3 3 # 3 A 109 ASP B 19 ASP.? -3.77 O3 SO4 A 144s A 182 GLU B 21 GLU.? -4.32 C4 PEG B 146s A 286 ASN B 18 ASN~? 7.46 O3 PGE C 147 coo 26.03 44.66 108.90 25.67 42.61 108.82 -12.63 65.75 40.21 -14.11 64.30 40.60 coo 18.06 44.02 105.38 18.08 45.37 107.03 -19.10 71.22 37.43 -20.67 70.39 36.27 coo 25.47 38.28 112.06 27.26 39.30 111.54 -10.56 67.47 45.50 -12.09 68.82 46.03 ULMN 3 1b57_c00 FRUCTOSE-BISPHOSPHATE ALDOLASE II user 4 3 # 4 A 109 ASP C 19 ASP.? 9.43 O3 SO4 C 143 A 182 GLU C 21 GLU.? -6.38 O2 PEG C 146s A 286 ASN C 18 ASN~? 7.71 C3 PGE B 147 coo 26.03 44.66 108.90 25.67 42.61 108.82 2.21 107.45 51.42 3.36 109.08 50.82 coo 18.06 44.02 105.38 18.08 45.37 107.03 -3.17 108.79 44.43 -3.64 110.82 43.98 coo 25.47 38.28 112.06 27.26 39.30 111.54 5.53 102.64 50.54 5.25 102.39 48.47 ULMN 3 1b57_c00 FRUCTOSE-BISPHOSPHATE ALDOLASE II user 5 3 # 5 A 109 ASP D 19 ASP.? -13.24 C2 PGE A 147s A 182 GLU D 21 GLU.? -13.48 O4 PEG D 145s A 286 ASN D 18 ASN~? 7.72 O4 PGE A 147 coo 26.03 44.66 108.90 25.67 42.61 108.82 -43.72 66.33 -2.80 -44.54 65.10 -4.29 coo 18.06 44.02 105.38 18.08 45.37 107.03 -47.50 61.07 3.30 -49.50 60.44 2.88 coo 25.47 38.28 112.06 27.26 39.30 111.54 -37.88 65.32 -2.95 -37.84 63.53 -1.86 1b57_c00 source 1b57 FRUCTOSE-BISPHOSPHATE ALDOLASE II : 5 hits 1b57_c00 naa= 3 ULMN 3 1b57_c01 FRUCTOSE-BISPHOSPHATE ALDOLASE II user 1 3 # 1 B 109 ASP A 19 ASP.? -3.59 O4 SO4 A 144s B 182 GLU A 21 GLU.? -3.95 C2 PEG A 146s B 286 ASN A 18 ASN~? 7.05 CM MLZ A 129 coo 13.82 69.26 132.27 11.87 70.14 132.51 -15.01 66.98 32.71 -14.52 68.02 34.44 coo 8.74 63.05 136.42 9.87 62.19 134.79 -23.01 65.38 36.24 -23.03 64.85 38.31 coo 8.26 72.60 129.22 10.14 73.45 129.80 -15.51 71.08 28.46 -17.41 71.81 28.97 ULMN 3 1b57_c01 FRUCTOSE-BISPHOSPHATE ALDOLASE II user 2 3 # 2 B 109 ASP B 19 ASP.? -3.77 O3 SO4 A 144s B 182 GLU B 21 GLU.? -4.32 C4 PEG B 146s B 286 ASN B 18 ASN~? 7.46 O3 PGE C 147 coo 13.82 69.26 132.27 11.87 70.14 132.51 -12.63 65.75 40.21 -14.11 64.30 40.60 coo 8.74 63.05 136.42 9.87 62.19 134.79 -19.10 71.22 37.43 -20.67 70.39 36.27 coo 8.26 72.60 129.22 10.14 73.45 129.80 -10.56 67.47 45.50 -12.09 68.82 46.03 ULMN 3 1b57_c01 FRUCTOSE-BISPHOSPHATE ALDOLASE II user 3 3 # 3 B 109 ASP C 19 ASP.? 9.43 O3 SO4 C 143 B 182 GLU C 21 GLU.? -6.38 O2 PEG C 146s B 286 ASN C 18 ASN~? 7.71 C3 PGE B 147 coo 13.82 69.26 132.27 11.87 70.14 132.51 2.21 107.45 51.42 3.36 109.08 50.82 coo 8.74 63.05 136.42 9.87 62.19 134.79 -3.17 108.79 44.43 -3.64 110.82 43.98 coo 8.26 72.60 129.22 10.14 73.45 129.80 5.53 102.64 50.54 5.25 102.39 48.47 ULMN 3 1b57_c01 FRUCTOSE-BISPHOSPHATE ALDOLASE II user 4 3 # 4 B 109 ASP D 19 ASP.? -13.24 C2 PGE A 147s B 182 GLU D 21 GLU.? -13.48 O4 PEG D 145s B 286 ASN D 18 ASN~? 7.72 O4 PGE A 147 coo 13.82 69.26 132.27 11.87 70.14 132.51 -43.72 66.33 -2.80 -44.54 65.10 -4.29 coo 8.74 63.05 136.42 9.87 62.19 134.79 -47.50 61.07 3.30 -49.50 60.44 2.88 coo 8.26 72.60 129.22 10.14 73.45 129.80 -37.88 65.32 -2.95 -37.84 63.53 -1.86 1b57_c01 source 1b57 FRUCTOSE-BISPHOSPHATE ALDOLASE II : 4 hits 1b57_c01 naa= 3 ULMN 3 1b6t_c00 PHOSPHOPANTETHEINE ADENYLYLTRANSFERAuser 1 3 # 1 A 18 HIS A 115 HIS~? 12.27 C21 2PE A 148 A 91 ARG A 55 ARG~? 10.23 CD MLY D 135 A 129 SER A 57 SER~? 3.96 C21 2PE A 148 coo 24.39 47.01 49.70 26.42 47.04 49.21 -13.18 48.35 10.37 -12.55 46.36 10.33 coo 25.98 44.20 42.23 28.53 42.98 43.43 -19.70 43.33 11.87 -20.69 44.07 9.04 coo 30.00 49.76 45.68 28.73 48.72 47.47 -17.83 49.34 18.20 -18.57 51.11 16.71 ULMN 3 1b6t_c00 PHOSPHOPANTETHEINE ADENYLYLTRANSFERAuser 2 3 # 2 A 18 HIS B 115 HIS~? 12.48 C18 PE8 B 148 A 91 ARG B 55 ARG~? 9.33 CG MLY C 135 A 129 SER B 57 SER~? 3.95 C20 PE8 B 148 coo 24.39 47.01 49.70 26.42 47.04 49.21 11.86 77.76 30.05 12.70 77.49 28.15 coo 25.98 44.20 42.23 28.53 42.98 43.43 8.78 84.29 24.99 10.39 86.20 26.77 coo 30.00 49.76 45.68 28.73 48.72 47.47 2.89 78.00 28.42 3.14 79.13 30.54 ULMN 3 1b6t_c00 PHOSPHOPANTETHEINE ADENYLYLTRANSFERAuser 3 3 # 3 A 18 HIS C 115 HIS~? 4.72 C MLZ C 114 A 91 ARG C 55 ARG~? 9.18 O MLY B 135 A 129 SER C 57 SER~? 4.15 C20 PE8 C 148 coo 24.39 47.01 49.70 26.42 47.04 49.21 -12.99 90.00 69.08 -14.38 90.57 70.54 coo 25.98 44.20 42.23 28.53 42.98 43.43 -21.06 89.68 64.73 -20.37 86.74 65.24 coo 30.00 49.76 45.68 28.73 48.72 47.47 -14.48 95.85 62.27 -13.19 94.01 61.32 ULMN 3 1b6t_c00 PHOSPHOPANTETHEINE ADENYLYLTRANSFERAuser 4 3 # 4 A 18 HIS D 115 HIS~? 12.18 C21 2PE D 146 A 91 ARG D 55 ARG~? 9.16 CG MLY A 135 A 129 SER D 57 SER~? 3.84 C21 2PE D 146 coo 24.39 47.01 49.70 26.42 47.04 49.21 -36.28 90.32 11.92 -37.49 91.98 12.35 coo 25.98 44.20 42.23 28.53 42.98 43.43 -39.98 89.02 19.79 -37.17 89.06 21.03 coo 30.00 49.76 45.68 28.73 48.72 47.47 -42.08 83.25 12.68 -39.78 82.38 12.84 1b6t_c00 source 1b6t PHOSPHOPANTETHEINE ADENYLYLTRANSFERASE : 4 hits 1b6t_c00 naa= 3 ULMN 3 1b6t_c01 PHOSPHOPANTETHEINE ADENYLYLTRANSFERAuser 1 3 # 1 B 18 HIS A 115 HIS~? 12.27 C21 2PE A 148 B 91 ARG A 55 ARG~? 10.23 CD MLY D 135 B 129 SER A 57 SER~? 3.96 C21 2PE A 148 coo 18.19 17.03 40.71 18.55 17.18 38.64 -13.18 48.35 10.37 -12.55 46.36 10.33 coo 25.60 21.10 38.54 23.57 20.93 36.25 -19.70 43.33 11.87 -20.69 44.07 9.04 coo 21.33 14.29 34.62 19.25 14.88 35.71 -17.83 49.34 18.20 -18.57 51.11 16.71 ULMN 3 1b6t_c01 PHOSPHOPANTETHEINE ADENYLYLTRANSFERAuser 2 3 # 2 B 18 HIS A 115 HIS~? 12.27 C21 2PE A 148 B 91 ARG A 116 ARG~? 4.70 C15 2PE A 148 B 129 SER A 57 SER~? 3.96 C21 2PE A 148 coo 18.19 17.03 40.71 18.55 17.18 38.64 -13.18 48.35 10.37 -12.55 46.36 10.33 coo 25.60 21.10 38.54 23.57 20.93 36.25 -15.13 57.15 12.87 -15.00 60.01 11.67 coo 21.33 14.29 34.62 19.25 14.88 35.71 -17.83 49.34 18.20 -18.57 51.11 16.71 ULMN 3 1b6t_c01 PHOSPHOPANTETHEINE ADENYLYLTRANSFERAuser 3 3 # 3 B 18 HIS B 4 HIS.? -3.86 O2 GOL B 149s B 91 ARG B 31 ARG^? 11.02 C6 PGE B 147 B 129 SER B 123 SER^? 7.43 C12 PE8 B 148 coo 18.19 17.03 40.71 18.55 17.18 38.64 8.07 73.88 49.16 8.30 73.43 51.19 coo 25.60 21.10 38.54 23.57 20.93 36.25 12.15 83.61 47.77 10.36 84.10 50.21 coo 21.33 14.29 34.62 19.25 14.88 35.71 6.88 79.31 45.54 6.79 77.45 43.98 ULMN 3 1b6t_c01 PHOSPHOPANTETHEINE ADENYLYLTRANSFERAuser 4 3 # 4 B 18 HIS B 115 HIS~? 12.48 C18 PE8 B 148 B 91 ARG B 55 ARG~? 9.33 CG MLY C 135 B 129 SER B 57 SER~? 3.95 C20 PE8 B 148 coo 18.19 17.03 40.71 18.55 17.18 38.64 11.86 77.76 30.05 12.70 77.49 28.15 coo 25.60 21.10 38.54 23.57 20.93 36.25 8.78 84.29 24.99 10.39 86.20 26.77 coo 21.33 14.29 34.62 19.25 14.88 35.71 2.89 78.00 28.42 3.14 79.13 30.54 ULMN 3 1b6t_c01 PHOSPHOPANTETHEINE ADENYLYLTRANSFERAuser 5 3 # 5 B 18 HIS B 115 HIS~? 12.48 C18 PE8 B 148 B 91 ARG B 116 ARG~? 4.93 C12 PE8 B 148 B 129 SER B 57 SER~? 3.95 C20 PE8 B 148 coo 18.19 17.03 40.71 18.55 17.18 38.64 11.86 77.76 30.05 12.70 77.49 28.15 coo 25.60 21.10 38.54 23.57 20.93 36.25 6.23 77.16 37.54 6.11 77.30 40.64 coo 21.33 14.29 34.62 19.25 14.88 35.71 2.89 78.00 28.42 3.14 79.13 30.54 ULMN 3 1b6t_c01 PHOSPHOPANTETHEINE ADENYLYLTRANSFERAuser 6 3 # 6 B 18 HIS C 115 HIS~? 4.72 C MLZ C 114 B 91 ARG C 55 ARG~? 9.18 O MLY B 135 B 129 SER C 57 SER~? 4.15 C20 PE8 C 148 coo 18.19 17.03 40.71 18.55 17.18 38.64 -12.99 90.00 69.08 -14.38 90.57 70.54 coo 25.60 21.10 38.54 23.57 20.93 36.25 -21.06 89.68 64.73 -20.37 86.74 65.24 coo 21.33 14.29 34.62 19.25 14.88 35.71 -14.48 95.85 62.27 -13.19 94.01 61.32 ULMN 3 1b6t_c01 PHOSPHOPANTETHEINE ADENYLYLTRANSFERAuser 7 3 # 7 B 18 HIS C 115 HIS~? 4.72 C MLZ C 114 B 91 ARG C 116 ARG~? 4.72 C15 PE8 C 148 B 129 SER C 57 SER~? 4.15 C20 PE8 C 148 coo 18.19 17.03 40.71 18.55 17.18 38.64 -12.99 90.00 69.08 -14.38 90.57 70.54 coo 25.60 21.10 38.54 23.57 20.93 36.25 -6.64 90.12 62.40 -4.04 88.84 61.33 coo 21.33 14.29 34.62 19.25 14.88 35.71 -14.48 95.85 62.27 -13.19 94.01 61.32 ULMN 3 1b6t_c01 PHOSPHOPANTETHEINE ADENYLYLTRANSFERAuser 8 3 # 8 B 18 HIS D 115 HIS~? 12.18 C21 2PE D 146 B 91 ARG D 55 ARG~? 9.16 CG MLY A 135 B 129 SER D 57 SER~? 3.84 C21 2PE D 146 coo 18.19 17.03 40.71 18.55 17.18 38.64 -36.28 90.32 11.92 -37.49 91.98 12.35 coo 25.60 21.10 38.54 23.57 20.93 36.25 -39.98 89.02 19.79 -37.17 89.06 21.03 coo 21.33 14.29 34.62 19.25 14.88 35.71 -42.08 83.25 12.68 -39.78 82.38 12.84 ULMN 3 1b6t_c01 PHOSPHOPANTETHEINE ADENYLYLTRANSFERAuser 9 3 # 9 B 18 HIS D 115 HIS~? 12.18 C21 2PE D 146 B 91 ARG D 116 ARG~? 4.73 C15 2PE D 146 B 129 SER D 57 SER~? 3.84 C21 2PE D 146 coo 18.19 17.03 40.71 18.55 17.18 38.64 -36.28 90.32 11.92 -37.49 91.98 12.35 coo 25.60 21.10 38.54 23.57 20.93 36.25 -33.13 82.22 8.73 -30.63 80.83 7.52 coo 21.33 14.29 34.62 19.25 14.88 35.71 -42.08 83.25 12.68 -39.78 82.38 12.84 1b6t_c01 source 1b6t PHOSPHOPANTETHEINE ADENYLYLTRANSFERASE : 9 hits 1b6t_c01 naa= 3 ULMN 3 1b9h_c02 3-AMINO-5-HYDROXYBENZOIC ACID SYNTHAuser 1 3 # 1 A 88 PHE A 90 PHE^? 4.08 CH1 MLY D 135 A 159 ASP A 87 ASP.? 8.49 C6 PGE A 147 A 188 LYS D 129 LYS^? 7.63 C4 PEG D 145 coo 13.91 34.58 14.67 12.95 36.00 12.47 -25.59 59.02 13.87 -22.88 58.27 14.15 coo 20.97 28.40 16.26 20.19 30.15 15.34 -23.17 58.67 3.55 -22.34 59.17 1.69 coo 22.55 41.65 15.60 18.92 37.20 14.63 -36.12 61.83 6.50 -39.41 57.83 4.09 ULMN 3 1b9h_c02 3-AMINO-5-HYDROXYBENZOIC ACID SYNTHAuser 2 3 # 2 A 88 PHE B 15 PHE~? 8.85 C11 PE8 B 148 A 159 ASP B 19 ASP.? -3.77 O3 SO4 A 144s A 188 LYS B 129 LYS^? 7.64 C2 PEG B 146 coo 13.91 34.58 14.67 12.95 36.00 12.47 -4.97 69.26 41.83 -5.66 71.31 40.07 coo 20.97 28.40 16.26 20.19 30.15 15.34 -12.63 65.75 40.21 -14.11 64.30 40.60 coo 22.55 41.65 15.60 18.92 37.20 14.63 -12.78 77.45 45.34 -17.39 74.89 47.84 ULMN 3 1b9h_c02 3-AMINO-5-HYDROXYBENZOIC ACID SYNTHAuser 3 3 # 3 A 88 PHE B 100 PHE~? 5.44 CL CL B 143 A 159 ASP B 19 ASP.? -3.77 O3 SO4 A 144s A 188 LYS B 129 LYS^? 7.64 C2 PEG B 146 coo 13.91 34.58 14.67 12.95 36.00 12.47 -4.47 72.85 36.74 -1.98 73.56 37.79 coo 20.97 28.40 16.26 20.19 30.15 15.34 -12.63 65.75 40.21 -14.11 64.30 40.60 coo 22.55 41.65 15.60 18.92 37.20 14.63 -12.78 77.45 45.34 -17.39 74.89 47.84 ULMN 3 1b9h_c02 3-AMINO-5-HYDROXYBENZOIC ACID SYNTHAuser 4 3 # 4 A 88 PHE D 15 PHE~? 8.99 C14 2PE D 146 A 159 ASP D 19 ASP.? -13.24 C2 PGE A 147s A 188 LYS D 129 LYS^? 7.63 C4 PEG D 145 coo 13.91 34.58 14.67 12.95 36.00 12.47 -37.50 71.61 -0.03 -38.77 71.49 2.45 coo 20.97 28.40 16.26 20.19 30.15 15.34 -43.72 66.33 -2.80 -44.54 65.10 -4.29 coo 22.55 41.65 15.60 18.92 37.20 14.63 -36.12 61.83 6.50 -39.41 57.83 4.09 ULMN 3 1b9h_c02 3-AMINO-5-HYDROXYBENZOIC ACID SYNTHAuser 5 3 # 5 A 88 PHE D 100 PHE~? 5.42 CL CL D 143 A 159 ASP D 19 ASP.? -13.24 C2 PGE A 147s A 188 LYS D 129 LYS^? 7.63 C4 PEG D 145 coo 13.91 34.58 14.67 12.95 36.00 12.47 -40.31 73.86 4.98 -37.99 75.35 5.35 coo 20.97 28.40 16.26 20.19 30.15 15.34 -43.72 66.33 -2.80 -44.54 65.10 -4.29 coo 22.55 41.65 15.60 18.92 37.20 14.63 -36.12 61.83 6.50 -39.41 57.83 4.09 1b9h_c02 source 1b9h 3-AMINO-5-HYDROXYBENZOIC ACID SYNTHASE : 5 hits 1b9h_c02 naa= 3 ULMN 3 1bd3_c00 URACIL PHOSPHORIBOSYLTRANSFERASE user 1 3 # 1 A 137 ARG A 33 ARG.? 10.19 C3 GOL A 150 A 141 THR A 2 THR.? -3.85 C1 GOL A 150s A 235 ASP A 40 ASP.? 18.50 C9 2PE A 148 coo 6.21 93.81 36.58 4.58 96.33 37.17 -11.76 56.72 1.51 -9.97 59.19 1.86 coo 6.80 92.87 28.33 4.91 92.74 27.40 -8.70 65.75 2.39 -7.33 67.47 2.56 coo 12.98 90.36 47.57 11.26 89.62 46.62 -5.23 45.83 3.63 -5.09 44.63 5.33 ULMN 3 1bd3_c00 URACIL PHOSPHORIBOSYLTRANSFERASE user 2 3 # 2 A 137 ARG A 33 ARG.? 10.19 C3 GOL A 150 A 141 THR A 44 THR.? 15.68 CD MLY D 135 A 235 ASP A 6 ASP.? -3.91 C9 2PE A 148s coo 6.21 93.81 36.58 4.58 96.33 37.17 -11.76 56.72 1.51 -9.97 59.19 1.86 coo 6.80 92.87 28.33 4.91 92.74 27.40 -14.40 47.15 0.15 -14.28 46.10 2.04 coo 12.98 90.36 47.57 11.26 89.62 46.62 -8.66 61.41 13.34 -8.76 59.35 12.80 ULMN 3 1bd3_c00 URACIL PHOSPHORIBOSYLTRANSFERASE user 3 3 # 3 A 137 ARG A 33 ARG.? 10.19 C3 GOL A 150 A 141 THR A 45 THR~? 13.61 CD MLY D 135 A 235 ASP A 6 ASP.? -3.91 C9 2PE A 148s coo 6.21 93.81 36.58 4.58 96.33 37.17 -11.76 56.72 1.51 -9.97 59.19 1.86 coo 6.80 92.87 28.33 4.91 92.74 27.40 -16.83 50.00 -0.15 -18.74 49.27 -0.79 coo 12.98 90.36 47.57 11.26 89.62 46.62 -8.66 61.41 13.34 -8.76 59.35 12.80 ULMN 3 1bd3_c00 URACIL PHOSPHORIBOSYLTRANSFERASE user 4 3 # 4 A 137 ARG B 33 ARG.? -3.91 C3 PEG B 144s A 141 THR B 2 THR.? -5.25 O2 GOL B 149s A 235 ASP B 40 ASP.? 11.67 O1 PEG B 144 coo 6.21 93.81 36.58 4.58 96.33 37.17 17.31 79.39 40.81 17.39 77.24 43.00 coo 6.80 92.87 28.33 4.91 92.74 27.40 15.86 75.03 48.92 16.49 73.66 50.59 coo 12.98 90.36 47.57 11.26 89.62 46.62 22.51 72.75 29.32 21.02 74.20 28.79 ULMN 3 1bd3_c00 URACIL PHOSPHORIBOSYLTRANSFERASE user 5 3 # 5 A 137 ARG B 33 ARG.? -3.91 C3 PEG B 144s A 141 THR B 44 THR.? 10.05 O1 PEG B 144 A 235 ASP B 6 ASP.? -3.99 C6 PE8 B 148s coo 6.21 93.81 36.58 4.58 96.33 37.17 17.31 79.39 40.81 17.39 77.24 43.00 coo 6.80 92.87 28.33 4.91 92.74 27.40 20.30 83.81 32.42 18.64 82.72 31.47 coo 12.98 90.36 47.57 11.26 89.62 46.62 7.95 70.39 41.39 8.88 71.08 39.61 ULMN 3 1bd3_c00 URACIL PHOSPHORIBOSYLTRANSFERASE user 6 3 # 6 A 137 ARG B 33 ARG.? -3.91 C3 PEG B 144s A 141 THR B 45 THR~? 11.55 O1 PEG B 144 A 235 ASP B 6 ASP.? -3.99 C6 PE8 B 148s coo 6.21 93.81 36.58 4.58 96.33 37.17 17.31 79.39 40.81 17.39 77.24 43.00 coo 6.80 92.87 28.33 4.91 92.74 27.40 18.24 85.54 35.10 17.92 87.63 34.59 coo 12.98 90.36 47.57 11.26 89.62 46.62 7.95 70.39 41.39 8.88 71.08 39.61 ULMN 3 1bd3_c00 URACIL PHOSPHORIBOSYLTRANSFERASE user 7 3 # 7 A 137 ARG B 63 ARG~? -8.01 OH2 1PE B 150s A 141 THR A 8 THR~? 7.49 C5 2PE A 148 A 235 ASP B 56 ASP~? 11.45 C20 PE8 B 148 coo 6.21 93.81 36.58 4.58 96.33 37.17 -5.18 74.17 22.68 -2.11 73.83 22.90 coo 6.80 92.87 28.33 4.91 92.74 27.40 -6.50 66.30 16.74 -6.53 68.38 16.05 coo 12.98 90.36 47.57 11.26 89.62 46.62 6.80 78.21 26.00 8.47 79.07 25.03 ULMN 3 1bd3_c00 URACIL PHOSPHORIBOSYLTRANSFERASE user 8 3 # 8 A 137 ARG C 33 ARG.? 10.55 C1 GOL C 149 A 141 THR C 2 THR.? 5.13 C3 GOL C 149 A 235 ASP C 40 ASP.? 9.64 O MLZ C 114 coo 6.21 93.81 36.58 4.58 96.33 37.17 -5.11 80.73 69.28 -2.11 81.22 69.57 coo 6.80 92.87 28.33 4.91 92.74 27.40 4.42 80.53 66.93 6.02 81.13 68.31 coo 12.98 90.36 47.57 11.26 89.62 46.62 -10.62 87.43 80.17 -12.01 86.84 78.68 ULMN 3 1bd3_c00 URACIL PHOSPHORIBOSYLTRANSFERASE user 9 3 # 9 A 137 ARG C 33 ARG.? 10.55 C1 GOL C 149 A 141 THR C 44 THR.? 9.97 O MLZ C 114 A 235 ASP C 6 ASP.? -4.04 C8 PE8 C 148s coo 6.21 93.81 36.58 4.58 96.33 37.17 -5.11 80.73 69.28 -2.11 81.22 69.57 coo 6.80 92.87 28.33 4.91 92.74 27.40 -14.57 80.11 72.30 -14.71 82.29 72.07 coo 12.98 90.36 47.57 11.26 89.62 46.62 0.53 91.96 65.64 -1.31 91.68 66.68 ULMN 3 1bd3_c00 URACIL PHOSPHORIBOSYLTRANSFERASE user 10 3 # 10 A 137 ARG C 33 ARG.? 10.55 C1 GOL C 149 A 141 THR C 45 THR~? 13.44 CD MLY B 135 A 235 ASP C 6 ASP.? -4.04 C8 PE8 C 148s coo 6.21 93.81 36.58 4.58 96.33 37.17 -5.11 80.73 69.28 -2.11 81.22 69.57 coo 6.80 92.87 28.33 4.91 92.74 27.40 -13.32 78.78 68.97 -14.95 77.79 67.94 coo 12.98 90.36 47.57 11.26 89.62 46.62 0.53 91.96 65.64 -1.31 91.68 66.68 ULMN 3 1bd3_c00 URACIL PHOSPHORIBOSYLTRANSFERASE user 11 3 # 11 A 137 ARG D 33 ARG.? 10.45 C1 GOL D 147 A 141 THR D 2 THR.? -5.15 C3 GOL D 147s A 235 ASP D 40 ASP.? 18.38 C9 2PE D 146 coo 6.21 93.81 36.58 4.58 96.33 37.17 -24.75 89.49 9.81 -23.48 88.88 7.05 coo 6.80 92.87 28.33 4.91 92.74 27.40 -19.31 85.21 3.09 -18.35 85.33 1.06 coo 12.98 90.36 47.57 11.26 89.62 46.62 -32.95 100.50 7.54 -33.10 99.69 9.54 ULMN 3 1bd3_c00 URACIL PHOSPHORIBOSYLTRANSFERASE user 12 3 # 12 A 137 ARG D 33 ARG.? 10.45 C1 GOL D 147 A 141 THR D 44 THR.? 15.16 CG MLY A 135 A 235 ASP D 6 ASP.? -3.77 C8 2PE D 146s coo 6.21 93.81 36.58 4.58 96.33 37.17 -24.75 89.49 9.81 -23.48 88.88 7.05 coo 6.80 92.87 28.33 4.91 92.74 27.40 -28.30 95.53 16.66 -30.17 94.47 16.62 coo 12.98 90.36 47.57 11.26 89.62 46.62 -31.03 82.87 1.04 -31.83 84.41 2.29 ULMN 3 1bd3_c00 URACIL PHOSPHORIBOSYLTRANSFERASE user 13 3 # 13 A 137 ARG D 33 ARG.? 10.45 C1 GOL D 147 A 141 THR D 45 THR~? 13.42 CG MLY A 135 A 235 ASP D 6 ASP.? -3.77 C8 2PE D 146s coo 6.21 93.81 36.58 4.58 96.33 37.17 -24.75 89.49 9.81 -23.48 88.88 7.05 coo 6.80 92.87 28.33 4.91 92.74 27.40 -26.69 92.19 17.49 -26.72 91.85 19.63 coo 12.98 90.36 47.57 11.26 89.62 46.62 -31.03 82.87 1.04 -31.83 84.41 2.29 1bd3_c00 source 1bd3 URACIL PHOSPHORIBOSYLTRANSFERASE : 13 hits 1bd3_c00 naa= 3 ULMN 3 1bd3_c01 URACIL PHOSPHORIBOSYLTRANSFERASE user 1 3 # 1 D 137 ARG A 33 ARG.? 10.19 C3 GOL A 150 D 141 THR A 2 THR.? -3.85 C1 GOL A 150s D 235 ASP A 40 ASP.? 18.50 C9 2PE A 148 coo -8.33 92.80 100.06 -7.71 95.33 98.44 -11.76 56.72 1.51 -9.97 59.19 1.86 coo -9.24 93.49 108.77 -7.37 94.21 109.61 -8.70 65.75 2.39 -7.33 67.47 2.56 coo -14.64 87.74 89.51 -12.89 87.43 90.65 -5.23 45.83 3.63 -5.09 44.63 5.33 ULMN 3 1bd3_c01 URACIL PHOSPHORIBOSYLTRANSFERASE user 2 3 # 2 D 137 ARG A 33 ARG.? 10.19 C3 GOL A 150 D 141 THR A 44 THR.? 15.68 CD MLY D 135 D 235 ASP A 6 ASP.? -3.91 C9 2PE A 148s coo -8.33 92.80 100.06 -7.71 95.33 98.44 -11.76 56.72 1.51 -9.97 59.19 1.86 coo -9.24 93.49 108.77 -7.37 94.21 109.61 -14.40 47.15 0.15 -14.28 46.10 2.04 coo -14.64 87.74 89.51 -12.89 87.43 90.65 -8.66 61.41 13.34 -8.76 59.35 12.80 ULMN 3 1bd3_c01 URACIL PHOSPHORIBOSYLTRANSFERASE user 3 3 # 3 D 137 ARG A 33 ARG.? 10.19 C3 GOL A 150 D 141 THR A 45 THR~? 13.61 CD MLY D 135 D 235 ASP A 6 ASP.? -3.91 C9 2PE A 148s coo -8.33 92.80 100.06 -7.71 95.33 98.44 -11.76 56.72 1.51 -9.97 59.19 1.86 coo -9.24 93.49 108.77 -7.37 94.21 109.61 -16.83 50.00 -0.15 -18.74 49.27 -0.79 coo -14.64 87.74 89.51 -12.89 87.43 90.65 -8.66 61.41 13.34 -8.76 59.35 12.80 ULMN 3 1bd3_c01 URACIL PHOSPHORIBOSYLTRANSFERASE user 4 3 # 4 D 137 ARG B 33 ARG.? -3.91 C3 PEG B 144s D 141 THR B 2 THR.? -5.25 O2 GOL B 149s D 235 ASP B 40 ASP.? 11.67 O1 PEG B 144 coo -8.33 92.80 100.06 -7.71 95.33 98.44 17.31 79.39 40.81 17.39 77.24 43.00 coo -9.24 93.49 108.77 -7.37 94.21 109.61 15.86 75.03 48.92 16.49 73.66 50.59 coo -14.64 87.74 89.51 -12.89 87.43 90.65 22.51 72.75 29.32 21.02 74.20 28.79 ULMN 3 1bd3_c01 URACIL PHOSPHORIBOSYLTRANSFERASE user 5 3 # 5 D 137 ARG B 33 ARG.? -3.91 C3 PEG B 144s D 141 THR B 44 THR.? 10.05 O1 PEG B 144 D 235 ASP B 6 ASP.? -3.99 C6 PE8 B 148s coo -8.33 92.80 100.06 -7.71 95.33 98.44 17.31 79.39 40.81 17.39 77.24 43.00 coo -9.24 93.49 108.77 -7.37 94.21 109.61 20.30 83.81 32.42 18.64 82.72 31.47 coo -14.64 87.74 89.51 -12.89 87.43 90.65 7.95 70.39 41.39 8.88 71.08 39.61 ULMN 3 1bd3_c01 URACIL PHOSPHORIBOSYLTRANSFERASE user 6 3 # 6 D 137 ARG B 33 ARG.? -3.91 C3 PEG B 144s D 141 THR B 45 THR~? 11.55 O1 PEG B 144 D 235 ASP B 6 ASP.? -3.99 C6 PE8 B 148s coo -8.33 92.80 100.06 -7.71 95.33 98.44 17.31 79.39 40.81 17.39 77.24 43.00 coo -9.24 93.49 108.77 -7.37 94.21 109.61 18.24 85.54 35.10 17.92 87.63 34.59 coo -14.64 87.74 89.51 -12.89 87.43 90.65 7.95 70.39 41.39 8.88 71.08 39.61 ULMN 3 1bd3_c01 URACIL PHOSPHORIBOSYLTRANSFERASE user 7 3 # 7 D 137 ARG B 63 ARG~? -8.01 OH2 1PE B 150s D 141 THR A 8 THR~? 7.49 C5 2PE A 148 D 235 ASP B 56 ASP~? 11.45 C20 PE8 B 148 coo -8.33 92.80 100.06 -7.71 95.33 98.44 -5.18 74.17 22.68 -2.11 73.83 22.90 coo -9.24 93.49 108.77 -7.37 94.21 109.61 -6.50 66.30 16.74 -6.53 68.38 16.05 coo -14.64 87.74 89.51 -12.89 87.43 90.65 6.80 78.21 26.00 8.47 79.07 25.03 ULMN 3 1bd3_c01 URACIL PHOSPHORIBOSYLTRANSFERASE user 8 3 # 8 D 137 ARG C 33 ARG.? 10.55 C1 GOL C 149 D 141 THR C 2 THR.? 5.13 C3 GOL C 149 D 235 ASP C 40 ASP.? 9.64 O MLZ C 114 coo -8.33 92.80 100.06 -7.71 95.33 98.44 -5.11 80.73 69.28 -2.11 81.22 69.57 coo -9.24 93.49 108.77 -7.37 94.21 109.61 4.42 80.53 66.93 6.02 81.13 68.31 coo -14.64 87.74 89.51 -12.89 87.43 90.65 -10.62 87.43 80.17 -12.01 86.84 78.68 ULMN 3 1bd3_c01 URACIL PHOSPHORIBOSYLTRANSFERASE user 9 3 # 9 D 137 ARG C 33 ARG.? 10.55 C1 GOL C 149 D 141 THR C 44 THR.? 9.97 O MLZ C 114 D 235 ASP C 6 ASP.? -4.04 C8 PE8 C 148s coo -8.33 92.80 100.06 -7.71 95.33 98.44 -5.11 80.73 69.28 -2.11 81.22 69.57 coo -9.24 93.49 108.77 -7.37 94.21 109.61 -14.57 80.11 72.30 -14.71 82.29 72.07 coo -14.64 87.74 89.51 -12.89 87.43 90.65 0.53 91.96 65.64 -1.31 91.68 66.68 ULMN 3 1bd3_c01 URACIL PHOSPHORIBOSYLTRANSFERASE user 10 3 # 10 D 137 ARG C 33 ARG.? 10.55 C1 GOL C 149 D 141 THR C 45 THR~? 13.44 CD MLY B 135 D 235 ASP C 6 ASP.? -4.04 C8 PE8 C 148s coo -8.33 92.80 100.06 -7.71 95.33 98.44 -5.11 80.73 69.28 -2.11 81.22 69.57 coo -9.24 93.49 108.77 -7.37 94.21 109.61 -13.32 78.78 68.97 -14.95 77.79 67.94 coo -14.64 87.74 89.51 -12.89 87.43 90.65 0.53 91.96 65.64 -1.31 91.68 66.68 ULMN 3 1bd3_c01 URACIL PHOSPHORIBOSYLTRANSFERASE user 11 3 # 11 D 137 ARG D 33 ARG.? 10.45 C1 GOL D 147 D 141 THR D 2 THR.? -5.15 C3 GOL D 147s D 235 ASP D 40 ASP.? 18.38 C9 2PE D 146 coo -8.33 92.80 100.06 -7.71 95.33 98.44 -24.75 89.49 9.81 -23.48 88.88 7.05 coo -9.24 93.49 108.77 -7.37 94.21 109.61 -19.31 85.21 3.09 -18.35 85.33 1.06 coo -14.64 87.74 89.51 -12.89 87.43 90.65 -32.95 100.50 7.54 -33.10 99.69 9.54 ULMN 3 1bd3_c01 URACIL PHOSPHORIBOSYLTRANSFERASE user 12 3 # 12 D 137 ARG D 33 ARG.? 10.45 C1 GOL D 147 D 141 THR D 44 THR.? 15.16 CG MLY A 135 D 235 ASP D 6 ASP.? -3.77 C8 2PE D 146s coo -8.33 92.80 100.06 -7.71 95.33 98.44 -24.75 89.49 9.81 -23.48 88.88 7.05 coo -9.24 93.49 108.77 -7.37 94.21 109.61 -28.30 95.53 16.66 -30.17 94.47 16.62 coo -14.64 87.74 89.51 -12.89 87.43 90.65 -31.03 82.87 1.04 -31.83 84.41 2.29 ULMN 3 1bd3_c01 URACIL PHOSPHORIBOSYLTRANSFERASE user 13 3 # 13 D 137 ARG D 33 ARG.? 10.45 C1 GOL D 147 D 141 THR D 45 THR~? 13.42 CG MLY A 135 D 235 ASP D 6 ASP.? -3.77 C8 2PE D 146s coo -8.33 92.80 100.06 -7.71 95.33 98.44 -24.75 89.49 9.81 -23.48 88.88 7.05 coo -9.24 93.49 108.77 -7.37 94.21 109.61 -26.69 92.19 17.49 -26.72 91.85 19.63 coo -14.64 87.74 89.51 -12.89 87.43 90.65 -31.03 82.87 1.04 -31.83 84.41 2.29 1bd3_c01 source 1bd3 URACIL PHOSPHORIBOSYLTRANSFERASE : 13 hits 1bd3_c01 naa= 3 ULMN 3 1bd3_c02 URACIL PHOSPHORIBOSYLTRANSFERASE user 1 3 # 1 C 137 ARG A 33 ARG.? 10.19 C3 GOL A 150 C 141 THR A 2 THR.? -3.85 C1 GOL A 150s C 235 ASP A 40 ASP.? 18.50 C9 2PE A 148 coo -5.79 67.26 36.83 -4.57 64.58 37.74 -11.76 56.72 1.51 -9.97 59.19 1.86 coo -6.81 68.31 28.28 -4.82 68.47 27.57 -8.70 65.75 2.39 -7.33 67.47 2.56 coo -13.01 70.96 47.58 -11.44 71.65 46.34 -5.23 45.83 3.63 -5.09 44.63 5.33 ULMN 3 1bd3_c02 URACIL PHOSPHORIBOSYLTRANSFERASE user 2 3 # 2 C 137 ARG A 33 ARG.? 10.19 C3 GOL A 150 C 141 THR A 44 THR.? 15.68 CD MLY D 135 C 235 ASP A 6 ASP.? -3.91 C9 2PE A 148s coo -5.79 67.26 36.83 -4.57 64.58 37.74 -11.76 56.72 1.51 -9.97 59.19 1.86 coo -6.81 68.31 28.28 -4.82 68.47 27.57 -14.40 47.15 0.15 -14.28 46.10 2.04 coo -13.01 70.96 47.58 -11.44 71.65 46.34 -8.66 61.41 13.34 -8.76 59.35 12.80 ULMN 3 1bd3_c02 URACIL PHOSPHORIBOSYLTRANSFERASE user 3 3 # 3 C 137 ARG A 33 ARG.? 10.19 C3 GOL A 150 C 141 THR A 45 THR~? 13.61 CD MLY D 135 C 235 ASP A 6 ASP.? -3.91 C9 2PE A 148s coo -5.79 67.26 36.83 -4.57 64.58 37.74 -11.76 56.72 1.51 -9.97 59.19 1.86 coo -6.81 68.31 28.28 -4.82 68.47 27.57 -16.83 50.00 -0.15 -18.74 49.27 -0.79 coo -13.01 70.96 47.58 -11.44 71.65 46.34 -8.66 61.41 13.34 -8.76 59.35 12.80 ULMN 3 1bd3_c02 URACIL PHOSPHORIBOSYLTRANSFERASE user 4 3 # 4 C 137 ARG B 33 ARG.? -3.91 C3 PEG B 144s C 141 THR B 2 THR.? -5.25 O2 GOL B 149s C 235 ASP B 40 ASP.? 11.67 O1 PEG B 144 coo -5.79 67.26 36.83 -4.57 64.58 37.74 17.31 79.39 40.81 17.39 77.24 43.00 coo -6.81 68.31 28.28 -4.82 68.47 27.57 15.86 75.03 48.92 16.49 73.66 50.59 coo -13.01 70.96 47.58 -11.44 71.65 46.34 22.51 72.75 29.32 21.02 74.20 28.79 ULMN 3 1bd3_c02 URACIL PHOSPHORIBOSYLTRANSFERASE user 5 3 # 5 C 137 ARG B 33 ARG.? -3.91 C3 PEG B 144s C 141 THR B 44 THR.? 10.05 O1 PEG B 144 C 235 ASP B 6 ASP.? -3.99 C6 PE8 B 148s coo -5.79 67.26 36.83 -4.57 64.58 37.74 17.31 79.39 40.81 17.39 77.24 43.00 coo -6.81 68.31 28.28 -4.82 68.47 27.57 20.30 83.81 32.42 18.64 82.72 31.47 coo -13.01 70.96 47.58 -11.44 71.65 46.34 7.95 70.39 41.39 8.88 71.08 39.61 ULMN 3 1bd3_c02 URACIL PHOSPHORIBOSYLTRANSFERASE user 6 3 # 6 C 137 ARG B 33 ARG.? -3.91 C3 PEG B 144s C 141 THR B 45 THR~? 11.55 O1 PEG B 144 C 235 ASP B 6 ASP.? -3.99 C6 PE8 B 148s coo -5.79 67.26 36.83 -4.57 64.58 37.74 17.31 79.39 40.81 17.39 77.24 43.00 coo -6.81 68.31 28.28 -4.82 68.47 27.57 18.24 85.54 35.10 17.92 87.63 34.59 coo -13.01 70.96 47.58 -11.44 71.65 46.34 7.95 70.39 41.39 8.88 71.08 39.61 ULMN 3 1bd3_c02 URACIL PHOSPHORIBOSYLTRANSFERASE user 7 3 # 7 C 137 ARG B 63 ARG~? -8.01 OH2 1PE B 150s C 141 THR A 8 THR~? 7.49 C5 2PE A 148 C 235 ASP B 56 ASP~? 11.45 C20 PE8 B 148 coo -5.79 67.26 36.83 -4.57 64.58 37.74 -5.18 74.17 22.68 -2.11 73.83 22.90 coo -6.81 68.31 28.28 -4.82 68.47 27.57 -6.50 66.30 16.74 -6.53 68.38 16.05 coo -13.01 70.96 47.58 -11.44 71.65 46.34 6.80 78.21 26.00 8.47 79.07 25.03 ULMN 3 1bd3_c02 URACIL PHOSPHORIBOSYLTRANSFERASE user 8 3 # 8 C 137 ARG C 33 ARG.? 10.55 C1 GOL C 149 C 141 THR C 2 THR.? 5.13 C3 GOL C 149 C 235 ASP C 40 ASP.? 9.64 O MLZ C 114 coo -5.79 67.26 36.83 -4.57 64.58 37.74 -5.11 80.73 69.28 -2.11 81.22 69.57 coo -6.81 68.31 28.28 -4.82 68.47 27.57 4.42 80.53 66.93 6.02 81.13 68.31 coo -13.01 70.96 47.58 -11.44 71.65 46.34 -10.62 87.43 80.17 -12.01 86.84 78.68 ULMN 3 1bd3_c02 URACIL PHOSPHORIBOSYLTRANSFERASE user 9 3 # 9 C 137 ARG C 33 ARG.? 10.55 C1 GOL C 149 C 141 THR C 44 THR.? 9.97 O MLZ C 114 C 235 ASP C 6 ASP.? -4.04 C8 PE8 C 148s coo -5.79 67.26 36.83 -4.57 64.58 37.74 -5.11 80.73 69.28 -2.11 81.22 69.57 coo -6.81 68.31 28.28 -4.82 68.47 27.57 -14.57 80.11 72.30 -14.71 82.29 72.07 coo -13.01 70.96 47.58 -11.44 71.65 46.34 0.53 91.96 65.64 -1.31 91.68 66.68 ULMN 3 1bd3_c02 URACIL PHOSPHORIBOSYLTRANSFERASE user 10 3 # 10 C 137 ARG C 33 ARG.? 10.55 C1 GOL C 149 C 141 THR C 45 THR~? 13.44 CD MLY B 135 C 235 ASP C 6 ASP.? -4.04 C8 PE8 C 148s coo -5.79 67.26 36.83 -4.57 64.58 37.74 -5.11 80.73 69.28 -2.11 81.22 69.57 coo -6.81 68.31 28.28 -4.82 68.47 27.57 -13.32 78.78 68.97 -14.95 77.79 67.94 coo -13.01 70.96 47.58 -11.44 71.65 46.34 0.53 91.96 65.64 -1.31 91.68 66.68 ULMN 3 1bd3_c02 URACIL PHOSPHORIBOSYLTRANSFERASE user 11 3 # 11 C 137 ARG D 33 ARG.? 10.45 C1 GOL D 147 C 141 THR D 2 THR.? -5.15 C3 GOL D 147s C 235 ASP D 40 ASP.? 18.38 C9 2PE D 146 coo -5.79 67.26 36.83 -4.57 64.58 37.74 -24.75 89.49 9.81 -23.48 88.88 7.05 coo -6.81 68.31 28.28 -4.82 68.47 27.57 -19.31 85.21 3.09 -18.35 85.33 1.06 coo -13.01 70.96 47.58 -11.44 71.65 46.34 -32.95 100.50 7.54 -33.10 99.69 9.54 ULMN 3 1bd3_c02 URACIL PHOSPHORIBOSYLTRANSFERASE user 12 3 # 12 C 137 ARG D 33 ARG.? 10.45 C1 GOL D 147 C 141 THR D 44 THR.? 15.16 CG MLY A 135 C 235 ASP D 6 ASP.? -3.77 C8 2PE D 146s coo -5.79 67.26 36.83 -4.57 64.58 37.74 -24.75 89.49 9.81 -23.48 88.88 7.05 coo -6.81 68.31 28.28 -4.82 68.47 27.57 -28.30 95.53 16.66 -30.17 94.47 16.62 coo -13.01 70.96 47.58 -11.44 71.65 46.34 -31.03 82.87 1.04 -31.83 84.41 2.29 ULMN 3 1bd3_c02 URACIL PHOSPHORIBOSYLTRANSFERASE user 13 3 # 13 C 137 ARG D 33 ARG.? 10.45 C1 GOL D 147 C 141 THR D 45 THR~? 13.42 CG MLY A 135 C 235 ASP D 6 ASP.? -3.77 C8 2PE D 146s coo -5.79 67.26 36.83 -4.57 64.58 37.74 -24.75 89.49 9.81 -23.48 88.88 7.05 coo -6.81 68.31 28.28 -4.82 68.47 27.57 -26.69 92.19 17.49 -26.72 91.85 19.63 coo -13.01 70.96 47.58 -11.44 71.65 46.34 -31.03 82.87 1.04 -31.83 84.41 2.29 1bd3_c02 source 1bd3 URACIL PHOSPHORIBOSYLTRANSFERASE : 13 hits 1bd3_c02 naa= 3 ULMN 3 1bd3_c03 URACIL PHOSPHORIBOSYLTRANSFERASE user 1 3 # 1 B 137 ARG A 33 ARG.? 10.19 C3 GOL A 150 B 141 THR A 2 THR.? -3.85 C1 GOL A 150s B 235 ASP A 40 ASP.? 18.50 C9 2PE A 148 coo 8.13 67.41 100.27 7.18 68.35 97.45 -11.76 56.72 1.51 -9.97 59.19 1.86 coo 8.28 67.78 108.81 6.22 67.65 109.43 -8.70 65.75 2.39 -7.33 67.47 2.56 coo 14.55 73.52 89.47 12.81 73.95 90.56 -5.23 45.83 3.63 -5.09 44.63 5.33 ULMN 3 1bd3_c03 URACIL PHOSPHORIBOSYLTRANSFERASE user 2 3 # 2 B 137 ARG A 33 ARG.? 10.19 C3 GOL A 150 B 141 THR A 44 THR.? 15.68 CD MLY D 135 B 235 ASP A 6 ASP.? -3.91 C9 2PE A 148s coo 8.13 67.41 100.27 7.18 68.35 97.45 -11.76 56.72 1.51 -9.97 59.19 1.86 coo 8.28 67.78 108.81 6.22 67.65 109.43 -14.40 47.15 0.15 -14.28 46.10 2.04 coo 14.55 73.52 89.47 12.81 73.95 90.56 -8.66 61.41 13.34 -8.76 59.35 12.80 ULMN 3 1bd3_c03 URACIL PHOSPHORIBOSYLTRANSFERASE user 3 3 # 3 B 137 ARG A 33 ARG.? 10.19 C3 GOL A 150 B 141 THR A 45 THR~? 13.61 CD MLY D 135 B 235 ASP A 6 ASP.? -3.91 C9 2PE A 148s coo 8.13 67.41 100.27 7.18 68.35 97.45 -11.76 56.72 1.51 -9.97 59.19 1.86 coo 8.28 67.78 108.81 6.22 67.65 109.43 -16.83 50.00 -0.15 -18.74 49.27 -0.79 coo 14.55 73.52 89.47 12.81 73.95 90.56 -8.66 61.41 13.34 -8.76 59.35 12.80 ULMN 3 1bd3_c03 URACIL PHOSPHORIBOSYLTRANSFERASE user 4 3 # 4 B 137 ARG B 33 ARG.? -3.91 C3 PEG B 144s B 141 THR B 2 THR.? -5.25 O2 GOL B 149s B 235 ASP B 40 ASP.? 11.67 O1 PEG B 144 coo 8.13 67.41 100.27 7.18 68.35 97.45 17.31 79.39 40.81 17.39 77.24 43.00 coo 8.28 67.78 108.81 6.22 67.65 109.43 15.86 75.03 48.92 16.49 73.66 50.59 coo 14.55 73.52 89.47 12.81 73.95 90.56 22.51 72.75 29.32 21.02 74.20 28.79 ULMN 3 1bd3_c03 URACIL PHOSPHORIBOSYLTRANSFERASE user 5 3 # 5 B 137 ARG B 33 ARG.? -3.91 C3 PEG B 144s B 141 THR B 44 THR.? 10.05 O1 PEG B 144 B 235 ASP B 6 ASP.? -3.99 C6 PE8 B 148s coo 8.13 67.41 100.27 7.18 68.35 97.45 17.31 79.39 40.81 17.39 77.24 43.00 coo 8.28 67.78 108.81 6.22 67.65 109.43 20.30 83.81 32.42 18.64 82.72 31.47 coo 14.55 73.52 89.47 12.81 73.95 90.56 7.95 70.39 41.39 8.88 71.08 39.61 ULMN 3 1bd3_c03 URACIL PHOSPHORIBOSYLTRANSFERASE user 6 3 # 6 B 137 ARG B 33 ARG.? -3.91 C3 PEG B 144s B 141 THR B 45 THR~? 11.55 O1 PEG B 144 B 235 ASP B 6 ASP.? -3.99 C6 PE8 B 148s coo 8.13 67.41 100.27 7.18 68.35 97.45 17.31 79.39 40.81 17.39 77.24 43.00 coo 8.28 67.78 108.81 6.22 67.65 109.43 18.24 85.54 35.10 17.92 87.63 34.59 coo 14.55 73.52 89.47 12.81 73.95 90.56 7.95 70.39 41.39 8.88 71.08 39.61 ULMN 3 1bd3_c03 URACIL PHOSPHORIBOSYLTRANSFERASE user 7 3 # 7 B 137 ARG B 63 ARG~? -8.01 OH2 1PE B 150s B 141 THR A 8 THR~? 7.49 C5 2PE A 148 B 235 ASP B 56 ASP~? 11.45 C20 PE8 B 148 coo 8.13 67.41 100.27 7.18 68.35 97.45 -5.18 74.17 22.68 -2.11 73.83 22.90 coo 8.28 67.78 108.81 6.22 67.65 109.43 -6.50 66.30 16.74 -6.53 68.38 16.05 coo 14.55 73.52 89.47 12.81 73.95 90.56 6.80 78.21 26.00 8.47 79.07 25.03 ULMN 3 1bd3_c03 URACIL PHOSPHORIBOSYLTRANSFERASE user 8 3 # 8 B 137 ARG C 33 ARG.? 10.55 C1 GOL C 149 B 141 THR C 2 THR.? 5.13 C3 GOL C 149 B 235 ASP C 40 ASP.? 9.64 O MLZ C 114 coo 8.13 67.41 100.27 7.18 68.35 97.45 -5.11 80.73 69.28 -2.11 81.22 69.57 coo 8.28 67.78 108.81 6.22 67.65 109.43 4.42 80.53 66.93 6.02 81.13 68.31 coo 14.55 73.52 89.47 12.81 73.95 90.56 -10.62 87.43 80.17 -12.01 86.84 78.68 ULMN 3 1bd3_c03 URACIL PHOSPHORIBOSYLTRANSFERASE user 9 3 # 9 B 137 ARG C 33 ARG.? 10.55 C1 GOL C 149 B 141 THR C 44 THR.? 9.97 O MLZ C 114 B 235 ASP C 6 ASP.? -4.04 C8 PE8 C 148s coo 8.13 67.41 100.27 7.18 68.35 97.45 -5.11 80.73 69.28 -2.11 81.22 69.57 coo 8.28 67.78 108.81 6.22 67.65 109.43 -14.57 80.11 72.30 -14.71 82.29 72.07 coo 14.55 73.52 89.47 12.81 73.95 90.56 0.53 91.96 65.64 -1.31 91.68 66.68 ULMN 3 1bd3_c03 URACIL PHOSPHORIBOSYLTRANSFERASE user 10 3 # 10 B 137 ARG C 33 ARG.? 10.55 C1 GOL C 149 B 141 THR C 45 THR~? 13.44 CD MLY B 135 B 235 ASP C 6 ASP.? -4.04 C8 PE8 C 148s coo 8.13 67.41 100.27 7.18 68.35 97.45 -5.11 80.73 69.28 -2.11 81.22 69.57 coo 8.28 67.78 108.81 6.22 67.65 109.43 -13.32 78.78 68.97 -14.95 77.79 67.94 coo 14.55 73.52 89.47 12.81 73.95 90.56 0.53 91.96 65.64 -1.31 91.68 66.68 ULMN 3 1bd3_c03 URACIL PHOSPHORIBOSYLTRANSFERASE user 11 3 # 11 B 137 ARG D 33 ARG.? 10.45 C1 GOL D 147 B 141 THR D 2 THR.? -5.15 C3 GOL D 147s B 235 ASP D 40 ASP.? 18.38 C9 2PE D 146 coo 8.13 67.41 100.27 7.18 68.35 97.45 -24.75 89.49 9.81 -23.48 88.88 7.05 coo 8.28 67.78 108.81 6.22 67.65 109.43 -19.31 85.21 3.09 -18.35 85.33 1.06 coo 14.55 73.52 89.47 12.81 73.95 90.56 -32.95 100.50 7.54 -33.10 99.69 9.54 ULMN 3 1bd3_c03 URACIL PHOSPHORIBOSYLTRANSFERASE user 12 3 # 12 B 137 ARG D 33 ARG.? 10.45 C1 GOL D 147 B 141 THR D 44 THR.? 15.16 CG MLY A 135 B 235 ASP D 6 ASP.? -3.77 C8 2PE D 146s coo 8.13 67.41 100.27 7.18 68.35 97.45 -24.75 89.49 9.81 -23.48 88.88 7.05 coo 8.28 67.78 108.81 6.22 67.65 109.43 -28.30 95.53 16.66 -30.17 94.47 16.62 coo 14.55 73.52 89.47 12.81 73.95 90.56 -31.03 82.87 1.04 -31.83 84.41 2.29 ULMN 3 1bd3_c03 URACIL PHOSPHORIBOSYLTRANSFERASE user 13 3 # 13 B 137 ARG D 33 ARG.? 10.45 C1 GOL D 147 B 141 THR D 45 THR~? 13.42 CG MLY A 135 B 235 ASP D 6 ASP.? -3.77 C8 2PE D 146s coo 8.13 67.41 100.27 7.18 68.35 97.45 -24.75 89.49 9.81 -23.48 88.88 7.05 coo 8.28 67.78 108.81 6.22 67.65 109.43 -26.69 92.19 17.49 -26.72 91.85 19.63 coo 14.55 73.52 89.47 12.81 73.95 90.56 -31.03 82.87 1.04 -31.83 84.41 2.29 1bd3_c03 source 1bd3 URACIL PHOSPHORIBOSYLTRANSFERASE : 13 hits 1bd3_c03 naa= 3 ULMN 3 1be1_c02 GLUTAMATE MUTASE user 1 3 # 1 14 ASP A 56 ASP~? 11.59 C21 2PE A 148 16 HIS A 115 HIS~? 12.27 C21 2PE A 148 67 GLY A 3 GLY.? -5.02 C3 GOL A 150s coo -11.04 -6.46 -7.27 -10.57 -4.40 -7.48 -16.01 45.89 15.64 -15.93 44.31 14.23 coo -6.73 -11.42 -7.86 -5.41 -11.61 -6.26 -13.18 48.35 10.37 -12.55 46.36 10.33 coo 10.06 -0.59 -9.79 9.66 -0.34 -9.05 -11.64 65.89 4.76 -10.88 65.57 4.96 ULMN 3 1be1_c02 GLUTAMATE MUTASE user 2 3 # 2 14 ASP A 56 ASP~? 11.59 C21 2PE A 148 16 HIS A 115 HIS~? 12.27 C21 2PE A 148 67 GLY D 80 GLY.? 7.47 C2 GOL A 150 coo -11.04 -6.46 -7.27 -10.57 -4.40 -7.48 -16.01 45.89 15.64 -15.93 44.31 14.23 coo -6.73 -11.42 -7.86 -5.41 -11.61 -6.26 -13.18 48.35 10.37 -12.55 46.36 10.33 coo 10.06 -0.59 -9.79 9.66 -0.34 -9.05 -13.78 69.07 11.78 -13.14 69.11 12.34 ULMN 3 1be1_c02 GLUTAMATE MUTASE user 3 3 # 3 14 ASP A 87 ASP.? 8.49 C6 PGE A 147 16 HIS A 85 HIS.? 6.69 C5 PGE A 147 67 GLY D 3 GLY.? 4.87 C3 GOL D 147 coo -11.04 -6.46 -7.27 -10.57 -4.40 -7.48 -23.17 58.67 3.55 -22.34 59.17 1.69 coo -6.73 -11.42 -7.86 -5.41 -11.61 -6.26 -23.05 64.43 -0.55 -21.68 63.00 -1.25 coo 10.06 -0.59 -9.79 9.66 -0.34 -9.05 -21.40 82.14 3.97 -21.80 82.75 3.64 ULMN 3 1be1_c02 GLUTAMATE MUTASE user 4 3 # 4 14 ASP A 87 ASP.? 8.49 C6 PGE A 147 16 HIS A 85 HIS.? 6.69 C5 PGE A 147 67 GLY D 22 GLY.? 9.04 C3 PEG D 145 coo -11.04 -6.46 -7.27 -10.57 -4.40 -7.48 -23.17 58.67 3.55 -22.34 59.17 1.69 coo -6.73 -11.42 -7.86 -5.41 -11.61 -6.26 -23.05 64.43 -0.55 -21.68 63.00 -1.25 coo 10.06 -0.59 -9.79 9.66 -0.34 -9.05 -43.93 61.79 5.73 -43.90 62.56 5.37 ULMN 3 1be1_c02 GLUTAMATE MUTASE user 5 3 # 5 14 ASP A 87 ASP.? 8.49 C6 PGE A 147 16 HIS A 88 HIS^? 4.20 CH2 MLY D 135 67 GLY D 22 GLY.? 9.04 C3 PEG D 145 coo -11.04 -6.46 -7.27 -10.57 -4.40 -7.48 -23.17 58.67 3.55 -22.34 59.17 1.69 coo -6.73 -11.42 -7.86 -5.41 -11.61 -6.26 -23.95 56.87 7.77 -24.14 54.98 6.86 coo 10.06 -0.59 -9.79 9.66 -0.34 -9.05 -43.93 61.79 5.73 -43.90 62.56 5.37 ULMN 3 1be1_c02 GLUTAMATE MUTASE user 6 3 # 6 14 ASP A 87 ASP.? 8.49 C6 PGE A 147 16 HIS A 88 HIS^? 4.20 CH2 MLY D 135 67 GLY D 72 GLY.? 3.28 O MLZ A 129 coo -11.04 -6.46 -7.27 -10.57 -4.40 -7.48 -23.17 58.67 3.55 -22.34 59.17 1.69 coo -6.73 -11.42 -7.86 -5.41 -11.61 -6.26 -23.95 56.87 7.77 -24.14 54.98 6.86 coo 10.06 -0.59 -9.79 9.66 -0.34 -9.05 -28.40 71.61 21.66 -28.57 72.28 21.25 ULMN 3 1be1_c02 GLUTAMATE MUTASE user 7 3 # 7 14 ASP A 122 ASP^? 7.46 C1 GOL A 150 16 HIS A 4 HIS.? -3.92 C2 GOL A 150s 67 GLY D 72 GLY.? 3.28 O MLZ A 129 coo -11.04 -6.46 -7.27 -10.57 -4.40 -7.48 -15.41 64.92 4.51 -15.09 66.83 5.33 coo -6.73 -11.42 -7.86 -5.41 -11.61 -6.26 -11.85 68.18 8.83 -11.23 70.10 8.29 coo 10.06 -0.59 -9.79 9.66 -0.34 -9.05 -28.40 71.61 21.66 -28.57 72.28 21.25 ULMN 3 1be1_c02 GLUTAMATE MUTASE user 8 3 # 8 14 ASP B 6 ASP.? -3.99 C6 PE8 B 148s 16 HIS B 4 HIS.? -3.86 O2 GOL B 149s 67 GLY B 72 GLY.? 3.37 O MLZ C 129 coo -11.04 -6.46 -7.27 -10.57 -4.40 -7.48 7.95 70.39 41.39 8.88 71.08 39.61 coo -6.73 -11.42 -7.86 -5.41 -11.61 -6.26 8.07 73.88 49.16 8.30 73.43 51.19 coo 10.06 -0.59 -9.79 9.66 -0.34 -9.05 -0.49 92.37 42.04 0.02 91.83 41.70 ULMN 3 1be1_c02 GLUTAMATE MUTASE user 9 3 # 9 14 ASP B 6 ASP.? -3.99 C6 PE8 B 148s 16 HIS B 4 HIS.? -3.86 O2 GOL B 149s 67 GLY C 72 GLY.? 8.73 CH1 MLY B 135 coo -11.04 -6.46 -7.27 -10.57 -4.40 -7.48 7.95 70.39 41.39 8.88 71.08 39.61 coo -6.73 -11.42 -7.86 -5.41 -11.61 -6.26 8.07 73.88 49.16 8.30 73.43 51.19 coo 10.06 -0.59 -9.79 9.66 -0.34 -9.05 -11.64 81.75 48.16 -11.60 81.98 48.95 ULMN 3 1be1_c02 GLUTAMATE MUTASE user 10 3 # 10 14 ASP B 56 ASP~? 11.45 C20 PE8 B 148 16 HIS B 115 HIS~? 12.48 C18 PE8 B 148 67 GLY B 3 GLY.? 4.53 O2 GOL B 149 coo -11.04 -6.46 -7.27 -10.57 -4.40 -7.48 6.80 78.21 26.00 8.47 79.07 25.03 coo -6.73 -11.42 -7.86 -5.41 -11.61 -6.26 11.86 77.76 30.05 12.70 77.49 28.15 coo 10.06 -0.59 -9.79 9.66 -0.34 -9.05 12.20 75.96 48.73 12.53 75.45 48.19 ULMN 3 1be1_c02 GLUTAMATE MUTASE user 11 3 # 11 14 ASP B 56 ASP~? 11.45 C20 PE8 B 148 16 HIS B 115 HIS~? 12.48 C18 PE8 B 148 67 GLY C 80 GLY.? 7.77 O2 GOL B 149 coo -11.04 -6.46 -7.27 -10.57 -4.40 -7.48 6.80 78.21 26.00 8.47 79.07 25.03 coo -6.73 -11.42 -7.86 -5.41 -11.61 -6.26 11.86 77.76 30.05 12.70 77.49 28.15 coo 10.06 -0.59 -9.79 9.66 -0.34 -9.05 4.31 74.26 49.15 4.26 73.42 48.97 ULMN 3 1be1_c02 GLUTAMATE MUTASE user 12 3 # 12 14 ASP B 87 ASP.? 8.94 O4 PGE B 147 16 HIS B 85 HIS.? 6.66 C6 PGE B 147 67 GLY C 3 GLY.? -4.72 C3 GOL C 149s coo -11.04 -6.46 -7.27 -10.57 -4.40 -7.48 9.49 87.97 42.02 11.31 87.98 43.09 coo -6.73 -11.42 -7.86 -5.41 -11.61 -6.26 11.11 88.86 48.90 12.76 88.34 47.73 coo 10.06 -0.59 -9.79 9.66 -0.34 -9.05 2.92 82.34 64.00 3.08 82.77 64.68 ULMN 3 1be1_c02 GLUTAMATE MUTASE user 13 3 # 13 14 ASP B 87 ASP.? 8.94 O4 PGE B 147 16 HIS B 85 HIS.? 6.66 C6 PGE B 147 67 GLY C 22 GLY.? 6.89 CD MLZ C 129 coo -11.04 -6.46 -7.27 -10.57 -4.40 -7.48 9.49 87.97 42.02 11.31 87.98 43.09 coo -6.73 -11.42 -7.86 -5.41 -11.61 -6.26 11.11 88.86 48.90 12.76 88.34 47.73 coo 10.06 -0.59 -9.79 9.66 -0.34 -9.05 -3.53 104.38 44.27 -3.45 104.39 45.13 ULMN 3 1be1_c02 GLUTAMATE MUTASE user 14 3 # 14 14 ASP B 87 ASP.? 8.94 O4 PGE B 147 16 HIS B 88 HIS^? 4.29 CH1 MLY C 135 67 GLY C 22 GLY.? 6.89 CD MLZ C 129 coo -11.04 -6.46 -7.27 -10.57 -4.40 -7.48 9.49 87.97 42.02 11.31 87.98 43.09 coo -6.73 -11.42 -7.86 -5.41 -11.61 -6.26 6.15 87.00 38.94 7.35 87.96 37.51 coo 10.06 -0.59 -9.79 9.66 -0.34 -9.05 -3.53 104.38 44.27 -3.45 104.39 45.13 ULMN 3 1be1_c02 GLUTAMATE MUTASE user 15 3 # 15 14 ASP B 87 ASP.? 8.94 O4 PGE B 147 16 HIS B 88 HIS^? 4.29 CH1 MLY C 135 67 GLY C 72 GLY.? 8.73 CH1 MLY B 135 coo -11.04 -6.46 -7.27 -10.57 -4.40 -7.48 9.49 87.97 42.02 11.31 87.98 43.09 coo -6.73 -11.42 -7.86 -5.41 -11.61 -6.26 6.15 87.00 38.94 7.35 87.96 37.51 coo 10.06 -0.59 -9.79 9.66 -0.34 -9.05 -11.64 81.75 48.16 -11.60 81.98 48.95 ULMN 3 1be1_c02 GLUTAMATE MUTASE user 16 3 # 16 14 ASP B 122 ASP^? 7.33 O2 GOL B 149 16 HIS B 4 HIS.? -3.86 O2 GOL B 149s 67 GLY C 72 GLY.? 8.73 CH1 MLY B 135 coo -11.04 -6.46 -7.27 -10.57 -4.40 -7.48 10.89 79.68 47.57 9.75 78.80 49.16 coo -6.73 -11.42 -7.86 -5.41 -11.61 -6.26 8.07 73.88 49.16 8.30 73.43 51.19 coo 10.06 -0.59 -9.79 9.66 -0.34 -9.05 -11.64 81.75 48.16 -11.60 81.98 48.95 ULMN 3 1be1_c02 GLUTAMATE MUTASE user 17 3 # 17 14 ASP C 56 ASP~? 9.09 N MLZ C 114 16 HIS C 115 HIS~? 4.72 C MLZ C 114 67 GLY B 80 GLY.? 7.38 C3 GOL C 149 coo -11.04 -6.46 -7.27 -10.57 -4.40 -7.48 -16.40 94.43 66.11 -17.63 93.56 67.58 coo -6.73 -11.42 -7.86 -5.41 -11.61 -6.26 -12.99 90.00 69.08 -14.38 90.57 70.54 coo 10.06 -0.59 -9.79 9.66 -0.34 -9.05 4.67 87.66 58.38 5.02 88.38 58.71 ULMN 3 1be1_c02 GLUTAMATE MUTASE user 18 3 # 18 14 ASP C 56 ASP~? 9.09 N MLZ C 114 16 HIS C 115 HIS~? 4.72 C MLZ C 114 67 GLY C 3 GLY.? -4.72 C3 GOL C 149s coo -11.04 -6.46 -7.27 -10.57 -4.40 -7.48 -16.40 94.43 66.11 -17.63 93.56 67.58 coo -6.73 -11.42 -7.86 -5.41 -11.61 -6.26 -12.99 90.00 69.08 -14.38 90.57 70.54 coo 10.06 -0.59 -9.79 9.66 -0.34 -9.05 2.92 82.34 64.00 3.08 82.77 64.68 ULMN 3 1be1_c02 GLUTAMATE MUTASE user 19 3 # 19 14 ASP C 87 ASP.? 8.84 O1 PGE C 147 16 HIS C 85 HIS.? 6.34 C1 PGE C 147 67 GLY B 3 GLY.? 4.53 O2 GOL B 149 coo -11.04 -6.46 -7.27 -10.57 -4.40 -7.48 -9.03 79.00 58.44 -8.21 77.39 59.55 coo -6.73 -11.42 -7.86 -5.41 -11.61 -6.26 -4.08 74.18 57.17 -4.69 74.12 59.17 coo 10.06 -0.59 -9.79 9.66 -0.34 -9.05 12.20 75.96 48.73 12.53 75.45 48.19 ULMN 3 1be1_c02 GLUTAMATE MUTASE user 20 3 # 20 14 ASP C 87 ASP.? 8.84 O1 PGE C 147 16 HIS C 85 HIS.? 6.34 C1 PGE C 147 67 GLY B 22 GLY.? 4.26 C1 PEG B 146 coo -11.04 -6.46 -7.27 -10.57 -4.40 -7.48 -9.03 79.00 58.44 -8.21 77.39 59.55 coo -6.73 -11.42 -7.86 -5.41 -11.61 -6.26 -4.08 74.18 57.17 -4.69 74.12 59.17 coo 10.06 -0.59 -9.79 9.66 -0.34 -9.05 -16.69 74.52 39.34 -16.05 74.06 39.06 ULMN 3 1be1_c02 GLUTAMATE MUTASE user 21 3 # 21 14 ASP C 87 ASP.? 8.84 O1 PGE C 147 16 HIS C 88 HIS^? 3.86 CD MLY B 135 67 GLY B 22 GLY.? 4.26 C1 PEG B 146 coo -11.04 -6.46 -7.27 -10.57 -4.40 -7.48 -9.03 79.00 58.44 -8.21 77.39 59.55 coo -6.73 -11.42 -7.86 -5.41 -11.61 -6.26 -11.00 83.03 57.18 -12.69 82.43 58.26 coo 10.06 -0.59 -9.79 9.66 -0.34 -9.05 -16.69 74.52 39.34 -16.05 74.06 39.06 ULMN 3 1be1_c02 GLUTAMATE MUTASE user 22 3 # 22 14 ASP C 87 ASP.? 8.84 O1 PGE C 147 16 HIS C 88 HIS^? 3.86 CD MLY B 135 67 GLY B 72 GLY.? 3.37 O MLZ C 129 coo -11.04 -6.46 -7.27 -10.57 -4.40 -7.48 -9.03 79.00 58.44 -8.21 77.39 59.55 coo -6.73 -11.42 -7.86 -5.41 -11.61 -6.26 -11.00 83.03 57.18 -12.69 82.43 58.26 coo 10.06 -0.59 -9.79 9.66 -0.34 -9.05 -0.49 92.37 42.04 0.02 91.83 41.70 ULMN 3 1be1_c02 GLUTAMATE MUTASE user 23 3 # 23 14 ASP C 122 ASP^? 7.22 C3 GOL C 149 16 HIS C 4 HIS.? -3.73 C3 GOL C 149s 67 GLY B 72 GLY.? 3.37 O MLZ C 129 coo -11.04 -6.46 -7.27 -10.57 -4.40 -7.48 0.27 81.12 61.60 2.07 81.54 60.53 coo -6.73 -11.42 -7.86 -5.41 -11.61 -6.26 4.88 85.81 61.42 6.80 85.00 61.18 coo 10.06 -0.59 -9.79 9.66 -0.34 -9.05 -0.49 92.37 42.04 0.02 91.83 41.70 ULMN 3 1be1_c02 GLUTAMATE MUTASE user 24 3 # 24 14 ASP D 56 ASP~? 11.46 C21 2PE D 146 16 HIS D 115 HIS~? 12.18 C21 2PE D 146 67 GLY A 80 GLY.? 7.76 C1 GOL D 147 coo -11.04 -6.46 -7.27 -10.57 -4.40 -7.48 -41.85 87.81 13.66 -41.61 89.58 14.80 coo -6.73 -11.42 -7.86 -5.41 -11.61 -6.26 -36.28 90.32 11.92 -37.49 91.98 12.35 coo 10.06 -0.59 -9.79 9.66 -0.34 -9.05 -25.41 75.48 2.13 -25.84 75.58 1.39 ULMN 3 1be1_c02 GLUTAMATE MUTASE user 25 3 # 25 14 ASP D 56 ASP~? 11.46 C21 2PE D 146 16 HIS D 115 HIS~? 12.18 C21 2PE D 146 67 GLY D 3 GLY.? 4.87 C3 GOL D 147 coo -11.04 -6.46 -7.27 -10.57 -4.40 -7.48 -41.85 87.81 13.66 -41.61 89.58 14.80 coo -6.73 -11.42 -7.86 -5.41 -11.61 -6.26 -36.28 90.32 11.92 -37.49 91.98 12.35 coo 10.06 -0.59 -9.79 9.66 -0.34 -9.05 -21.40 82.14 3.97 -21.80 82.75 3.64 ULMN 3 1be1_c02 GLUTAMATE MUTASE user 26 3 # 26 14 ASP D 83 ASP.? 8.76 O1 GOL A 150 16 HIS D 85 HIS.? 4.73 OH7 1PE B 150 67 GLY B 58 GLY~? 4.95 C24 PE8 B 148 coo -11.04 -6.46 -7.27 -10.57 -4.40 -7.48 -12.54 78.43 10.94 -12.46 77.06 9.29 coo -6.73 -11.42 -7.86 -5.41 -11.61 -6.26 -18.08 79.12 16.04 -18.14 81.21 15.79 coo 10.06 -0.59 -9.79 9.66 -0.34 -9.05 0.41 80.81 27.68 0.49 80.12 27.29 ULMN 3 1be1_c02 GLUTAMATE MUTASE user 27 3 # 27 14 ASP D 83 ASP.? 8.76 O1 GOL A 150 16 HIS D 85 HIS.? 4.73 OH7 1PE B 150 67 GLY B 66 GLY.? -2.40 N MLZ B 67s coo -11.04 -6.46 -7.27 -10.57 -4.40 -7.48 -12.54 78.43 10.94 -12.46 77.06 9.29 coo -6.73 -11.42 -7.86 -5.41 -11.61 -6.26 -18.08 79.12 16.04 -18.14 81.21 15.79 coo 10.06 -0.59 -9.79 9.66 -0.34 -9.05 -6.97 79.43 31.86 -7.37 79.83 31.22 ULMN 3 1be1_c02 GLUTAMATE MUTASE user 28 3 # 28 14 ASP D 87 ASP.? 7.26 C16 1PE B 150 16 HIS D 85 HIS.? 4.73 OH7 1PE B 150 67 GLY A 3 GLY.? -5.02 C3 GOL A 150s coo -11.04 -6.46 -7.27 -10.57 -4.40 -7.48 -24.70 80.89 17.41 -22.90 81.94 17.31 coo -6.73 -11.42 -7.86 -5.41 -11.61 -6.26 -18.08 79.12 16.04 -18.14 81.21 15.79 coo 10.06 -0.59 -9.79 9.66 -0.34 -9.05 -11.64 65.89 4.76 -10.88 65.57 4.96 ULMN 3 1be1_c02 GLUTAMATE MUTASE user 29 3 # 29 14 ASP D 87 ASP.? 7.26 C16 1PE B 150 16 HIS D 85 HIS.? 4.73 OH7 1PE B 150 67 GLY A 22 GLY.? 4.28 C3 PEG A 146 coo -11.04 -6.46 -7.27 -10.57 -4.40 -7.48 -24.70 80.89 17.41 -22.90 81.94 17.31 coo -6.73 -11.42 -7.86 -5.41 -11.61 -6.26 -18.08 79.12 16.04 -18.14 81.21 15.79 coo 10.06 -0.59 -9.79 9.66 -0.34 -9.05 -24.67 65.84 32.25 -23.92 65.53 31.96 ULMN 3 1be1_c02 GLUTAMATE MUTASE user 30 3 # 30 14 ASP D 87 ASP.? 7.26 C16 1PE B 150 16 HIS D 85 HIS.? 4.73 OH7 1PE B 150 67 GLY B 66 GLY.? -2.40 N MLZ B 67s coo -11.04 -6.46 -7.27 -10.57 -4.40 -7.48 -24.70 80.89 17.41 -22.90 81.94 17.31 coo -6.73 -11.42 -7.86 -5.41 -11.61 -6.26 -18.08 79.12 16.04 -18.14 81.21 15.79 coo 10.06 -0.59 -9.79 9.66 -0.34 -9.05 -6.97 79.43 31.86 -7.37 79.83 31.22 ULMN 3 1be1_c02 GLUTAMATE MUTASE user 31 3 # 31 14 ASP D 87 ASP.? 7.26 C16 1PE B 150 16 HIS D 88 HIS^? 4.38 CH1 MLY A 135 67 GLY A 22 GLY.? 4.28 C3 PEG A 146 coo -11.04 -6.46 -7.27 -10.57 -4.40 -7.48 -24.70 80.89 17.41 -22.90 81.94 17.31 coo -6.73 -11.42 -7.86 -5.41 -11.61 -6.26 -29.18 79.71 17.63 -29.43 81.25 19.03 coo 10.06 -0.59 -9.79 9.66 -0.34 -9.05 -24.67 65.84 32.25 -23.92 65.53 31.96 ULMN 3 1be1_c02 GLUTAMATE MUTASE user 32 3 # 32 14 ASP D 87 ASP.? 7.26 C16 1PE B 150 16 HIS D 88 HIS^? 4.38 CH1 MLY A 135 67 GLY A 72 GLY.? 8.27 O MLY D 135 coo -11.04 -6.46 -7.27 -10.57 -4.40 -7.48 -24.70 80.89 17.41 -22.90 81.94 17.31 coo -6.73 -11.42 -7.86 -5.41 -11.61 -6.26 -29.18 79.71 17.63 -29.43 81.25 19.03 coo 10.06 -0.59 -9.79 9.66 -0.34 -9.05 -31.88 60.72 9.60 -31.18 60.35 9.56 ULMN 3 1be1_c02 GLUTAMATE MUTASE user 33 3 # 33 14 ASP D 122 ASP^? 7.49 C3 GOL D 147 16 HIS D 4 HIS.? 4.07 C3 GOL D 147 67 GLY A 72 GLY.? 8.27 O MLY D 135 coo -11.04 -6.46 -7.27 -10.57 -4.40 -7.48 -21.82 80.90 7.85 -21.38 79.32 6.51 coo -6.73 -11.42 -7.86 -5.41 -11.61 -6.26 -23.57 78.63 1.94 -22.01 77.96 0.72 coo 10.06 -0.59 -9.79 9.66 -0.34 -9.05 -31.88 60.72 9.60 -31.18 60.35 9.56 1be1_c02 source 1be1 GLUTAMATE MUTASE : 33 hits 1be1_c02 naa= 3 ULMN 3 1bf2_c00 ISOAMYLASE user 1 3 # 1 375 ASP A 56 ASP~? 11.59 C21 2PE A 148 435 GLU A 111 GLU~? 12.48 C11 2PE A 148 510 ASP A 106 ASP~? 11.93 O22 2PE A 148 coo 88.62 69.90 41.16 89.05 70.67 43.04 -16.01 45.89 15.64 -15.93 44.31 14.23 coo 89.52 76.11 40.17 89.01 75.16 41.97 -8.13 46.06 17.22 -6.45 46.46 15.98 coo 84.89 77.60 46.67 85.63 75.79 46.03 -12.71 50.36 24.83 -13.06 48.30 25.05 ULMN 3 1bf2_c00 ISOAMYLASE user 2 3 # 2 375 ASP A 83 ASP.? 8.52 O3 GOL D 147 435 GLU A 84 GLU.? 10.45 C3 GOL D 147 510 ASP A 122 ASP^? 7.46 C1 GOL A 150 coo 88.62 69.90 41.16 89.05 70.67 43.04 -19.46 70.43 -3.04 -19.06 72.28 -2.05 coo 89.52 76.11 40.17 89.01 75.16 41.97 -21.01 70.22 3.12 -21.10 71.95 4.30 coo 84.89 77.60 46.67 85.63 75.79 46.03 -15.41 64.92 4.51 -15.09 66.83 5.33 ULMN 3 1bf2_c00 ISOAMYLASE user 3 3 # 3 375 ASP A 122 ASP^? 7.46 C1 GOL A 150 435 GLU A 84 GLU.? 10.45 C3 GOL D 147 510 ASP A 83 ASP.? 8.52 O3 GOL D 147 coo 88.62 69.90 41.16 89.05 70.67 43.04 -15.41 64.92 4.51 -15.09 66.83 5.33 coo 89.52 76.11 40.17 89.01 75.16 41.97 -21.01 70.22 3.12 -21.10 71.95 4.30 coo 84.89 77.60 46.67 85.63 75.79 46.03 -19.46 70.43 -3.04 -19.06 72.28 -2.05 ULMN 3 1bf2_c00 ISOAMYLASE user 4 3 # 4 375 ASP A 122 ASP^? 7.46 C1 GOL A 150 435 GLU A 121 GLU^? 12.41 C1 GOL A 150 510 ASP A 87 ASP.? 8.49 C6 PGE A 147 coo 88.62 69.90 41.16 89.05 70.67 43.04 -15.41 64.92 4.51 -15.09 66.83 5.33 coo 89.52 76.11 40.17 89.01 75.16 41.97 -13.98 61.53 0.93 -15.14 61.60 -0.79 coo 84.89 77.60 46.67 85.63 75.79 46.03 -23.17 58.67 3.55 -22.34 59.17 1.69 ULMN 3 1bf2_c00 ISOAMYLASE user 5 3 # 5 375 ASP B 56 ASP~? 11.45 C20 PE8 B 148 435 GLU B 111 GLU~? 12.54 O7 PE8 B 148 510 ASP B 106 ASP~? 11.87 OH2 1PE B 150 coo 88.62 69.90 41.16 89.05 70.67 43.04 6.80 78.21 26.00 8.47 79.07 25.03 coo 89.52 76.11 40.17 89.01 75.16 41.97 9.41 70.70 25.55 11.25 69.94 26.27 coo 84.89 77.60 46.67 85.63 75.79 46.03 -0.30 70.27 27.08 -0.10 70.78 25.05 ULMN 3 1bf2_c00 ISOAMYLASE user 6 3 # 6 375 ASP B 83 ASP.? 9.40 O3 GOL C 149 435 GLU B 84 GLU.? 10.31 O3 GOL C 149 510 ASP B 122 ASP^? 7.33 O2 GOL B 149 coo 88.62 69.90 41.16 89.05 70.67 43.04 13.62 86.10 55.23 12.83 84.59 56.49 coo 89.52 76.11 40.17 89.01 75.16 41.97 7.66 84.31 53.13 6.13 83.49 54.35 coo 84.89 77.60 46.67 85.63 75.79 46.03 10.89 79.68 47.57 9.75 78.80 49.16 ULMN 3 1bf2_c00 ISOAMYLASE user 7 3 # 7 375 ASP B 122 ASP^? 7.33 O2 GOL B 149 435 GLU B 84 GLU.? 10.31 O3 GOL C 149 510 ASP B 83 ASP.? 9.40 O3 GOL C 149 coo 88.62 69.90 41.16 89.05 70.67 43.04 10.89 79.68 47.57 9.75 78.80 49.16 coo 89.52 76.11 40.17 89.01 75.16 41.97 7.66 84.31 53.13 6.13 83.49 54.35 coo 84.89 77.60 46.67 85.63 75.79 46.03 13.62 86.10 55.23 12.83 84.59 56.49 ULMN 3 1bf2_c00 ISOAMYLASE user 8 3 # 8 375 ASP B 122 ASP^? 7.33 O2 GOL B 149 435 GLU B 121 GLU^? 8.74 O2 PEG B 144 510 ASP B 87 ASP.? 8.94 O4 PGE B 147 coo 88.62 69.90 41.16 89.05 70.67 43.04 10.89 79.68 47.57 9.75 78.80 49.16 coo 89.52 76.11 40.17 89.01 75.16 41.97 15.37 80.83 45.64 16.23 82.69 46.15 coo 84.89 77.60 46.67 85.63 75.79 46.03 9.49 87.97 42.02 11.31 87.98 43.09 ULMN 3 1bf2_c00 ISOAMYLASE user 9 3 # 9 375 ASP C 56 ASP~? 9.09 N MLZ C 114 435 GLU C 111 GLU~? 3.06 NZ MLZ C 114 510 ASP C 106 ASP~? 12.11 C21 PE8 C 148 coo 88.62 69.90 41.16 89.05 70.67 43.04 -16.40 94.43 66.11 -17.63 93.56 67.58 coo 89.52 76.11 40.17 89.01 75.16 41.97 -12.41 98.44 71.96 -11.17 97.70 73.52 coo 84.89 77.60 46.67 85.63 75.79 46.03 -11.06 103.55 63.77 -13.00 104.00 64.35 ULMN 3 1bf2_c00 ISOAMYLASE user 10 3 # 10 375 ASP C 83 ASP.? 8.65 O3 GOL B 149 435 GLU C 84 GLU.? 10.77 O2 GOL B 149 510 ASP C 122 ASP^? 7.22 C3 GOL C 149 coo 88.62 69.90 41.16 89.05 70.67 43.04 3.02 71.86 58.06 4.88 72.49 57.24 coo 89.52 76.11 40.17 89.01 75.16 41.97 2.34 77.12 55.01 3.46 78.21 53.60 coo 84.89 77.60 46.67 85.63 75.79 46.03 0.27 81.12 61.60 2.07 81.54 60.53 ULMN 3 1bf2_c00 ISOAMYLASE user 11 3 # 11 375 ASP C 122 ASP^? 7.22 C3 GOL C 149 435 GLU C 84 GLU.? 10.77 O2 GOL B 149 510 ASP C 83 ASP.? 8.65 O3 GOL B 149 coo 88.62 69.90 41.16 89.05 70.67 43.04 0.27 81.12 61.60 2.07 81.54 60.53 coo 89.52 76.11 40.17 89.01 75.16 41.97 2.34 77.12 55.01 3.46 78.21 53.60 coo 84.89 77.60 46.67 85.63 75.79 46.03 3.02 71.86 58.06 4.88 72.49 57.24 ULMN 3 1bf2_c00 ISOAMYLASE user 12 3 # 12 375 ASP C 122 ASP^? 7.22 C3 GOL C 149 435 GLU C 121 GLU^? 12.40 C3 GOL C 149 510 ASP C 87 ASP.? 8.84 O1 PGE C 147 coo 88.62 69.90 41.16 89.05 70.67 43.04 0.27 81.12 61.60 2.07 81.54 60.53 coo 89.52 76.11 40.17 89.01 75.16 41.97 -1.98 78.69 65.48 -2.54 76.71 65.06 coo 84.89 77.60 46.67 85.63 75.79 46.03 -9.03 79.00 58.44 -8.21 77.39 59.55 ULMN 3 1bf2_c00 ISOAMYLASE user 13 3 # 13 375 ASP D 56 ASP~? 11.46 C21 2PE D 146 435 GLU D 111 GLU~? 11.88 C9 2PE D 146 510 ASP D 106 ASP~? 11.82 O22 2PE D 146 coo 88.62 69.90 41.16 89.05 70.67 43.04 -41.85 87.81 13.66 -41.61 89.58 14.80 coo 89.52 76.11 40.17 89.01 75.16 41.97 -43.22 91.45 6.64 -41.92 92.74 5.57 coo 84.89 77.60 46.67 85.63 75.79 46.03 -46.82 82.57 5.87 -48.37 83.43 7.00 ULMN 3 1bf2_c00 ISOAMYLASE user 14 3 # 14 375 ASP D 83 ASP.? 8.76 O1 GOL A 150 435 GLU D 84 GLU.? 10.79 C1 GOL A 150 510 ASP D 122 ASP^? 7.49 C3 GOL D 147 coo 88.62 69.90 41.16 89.05 70.67 43.04 -12.54 78.43 10.94 -12.46 77.06 9.29 coo 89.52 76.11 40.17 89.01 75.16 41.97 -17.40 74.78 10.23 -17.69 72.96 9.24 coo 84.89 77.60 46.67 85.63 75.79 46.03 -21.82 80.90 7.85 -21.38 79.32 6.51 ULMN 3 1bf2_c00 ISOAMYLASE user 15 3 # 15 375 ASP D 122 ASP^? 7.49 C3 GOL D 147 435 GLU D 84 GLU.? 10.79 C1 GOL A 150 510 ASP D 83 ASP.? 8.76 O1 GOL A 150 coo 88.62 69.90 41.16 89.05 70.67 43.04 -21.82 80.90 7.85 -21.38 79.32 6.51 coo 89.52 76.11 40.17 89.01 75.16 41.97 -17.40 74.78 10.23 -17.69 72.96 9.24 coo 84.89 77.60 46.67 85.63 75.79 46.03 -12.54 78.43 10.94 -12.46 77.06 9.29 ULMN 3 1bf2_c00 ISOAMYLASE user 16 3 # 16 375 ASP D 122 ASP^? 7.49 C3 GOL D 147 435 GLU D 121 GLU^? 11.70 OH7 1PE B 150 510 ASP D 87 ASP.? 7.26 C16 1PE B 150 coo 88.62 69.90 41.16 89.05 70.67 43.04 -21.82 80.90 7.85 -21.38 79.32 6.51 coo 89.52 76.11 40.17 89.01 75.16 41.97 -20.91 85.61 9.48 -19.44 85.70 10.98 coo 84.89 77.60 46.67 85.63 75.79 46.03 -24.70 80.89 17.41 -22.90 81.94 17.31 1bf2_c00 source 1bf2 ISOAMYLASE : 16 hits 1bf2_c00 naa= 3 ULMN 3 1bfd_c00 BENZOYLFORMATE DECARBOXYLASE user 1 3 # 1 28 GLU C 93 GLU^? -3.82 CH2 MLY C 67s 70 HIS C 25 HIS^? 5.68 C3 PG4 C 145 281 HIS D 85 HIS.? 4.73 OH7 1PE B 150 coo 66.09 46.17 155.81 66.77 48.19 155.70 -9.46 98.26 46.68 -9.97 98.34 44.62 coo 69.05 50.55 157.03 68.00 52.29 156.51 -5.80 94.82 45.56 -7.26 95.23 44.11 coo 100.93 36.73 156.02 100.47 38.42 157.18 -18.08 79.12 16.04 -18.14 81.21 15.79 ULMN 3 1bfd_c00 BENZOYLFORMATE DECARBOXYLASE user 2 3 # 2 28 GLU D 84 GLU.? 10.79 C1 GOL A 150 70 HIS D 85 HIS.? 4.73 OH7 1PE B 150 281 HIS B 115 HIS~? 12.48 C18 PE8 B 148 coo 66.09 46.17 155.81 66.77 48.19 155.70 -17.40 74.78 10.23 -17.69 72.96 9.24 coo 69.05 50.55 157.03 68.00 52.29 156.51 -18.08 79.12 16.04 -18.14 81.21 15.79 coo 100.93 36.73 156.02 100.47 38.42 157.18 11.86 77.76 30.05 12.70 77.49 28.15 1bfd_c00 source 1bfd BENZOYLFORMATE DECARBOXYLASE : 2 hits 1bfd_c00 naa= 3 ULMN 3 1bhg_c04 BETA-GLUCURONIDASE user 1 3 # 1 A 382 ARG A 20 ARG.? 4.64 CB MLZ A 129 A 451 GLU A 21 GLU.? -3.95 C2 PEG A 146s A 540 GLU B 21 GLU.? -4.32 C4 PEG B 146s coo 79.04 80.20 80.81 79.58 81.40 83.63 -20.19 69.79 30.19 -22.38 67.97 29.03 coo 81.34 87.29 87.22 82.36 86.09 88.61 -23.01 65.38 36.24 -23.03 64.85 38.31 coo 79.94 80.46 88.84 81.11 81.36 87.27 -19.10 71.22 37.43 -20.67 70.39 36.27 1bhg_c04 source 1bhg BETA-GLUCURONIDASE : 1 hits 1bhg_c04 naa= 3 ULMN 3 1bhg_c05 BETA-GLUCURONIDASE user 1 3 # 1 B 382 ARG A 20 ARG.? 4.64 CB MLZ A 129 B 451 GLU A 21 GLU.? -3.95 C2 PEG A 146s B 540 GLU B 21 GLU.? -4.32 C4 PEG B 146s coo 82.21 41.07 119.14 83.95 40.66 116.59 -20.19 69.79 30.19 -22.38 67.97 29.03 coo 86.52 35.28 112.74 87.08 36.38 110.99 -23.01 65.38 36.24 -23.03 64.85 38.31 coo 83.38 41.19 112.55 85.47 40.59 112.72 -19.10 71.22 37.43 -20.67 70.39 36.27 1bhg_c05 source 1bhg BETA-GLUCURONIDASE : 1 hits 1bhg_c05 naa= 3 ULMN 3 1bib_c00 BIRA BIFUNCTIONAL PROTEIN (ACTS AS Buser 1 3 # 1 118 ARG A 55 ARG~? 10.23 CD MLY D 135 183 LYS A 114 LYS~? 11.27 C9 2PE A 148 317 ARG A 31 ARG^? 11.10 C1 GOL A 150 coo 76.57 109.19 73.41 73.86 110.26 72.16 -19.70 43.33 11.87 -20.69 44.07 9.04 coo 82.09 117.51 66.37 80.60 114.32 71.44 -9.49 51.50 12.13 -4.59 48.44 14.69 coo 65.21 120.62 58.76 63.62 123.14 59.66 -18.51 63.86 1.13 -18.37 66.66 2.58 ULMN 3 1bib_c00 BIRA BIFUNCTIONAL PROTEIN (ACTS AS Buser 2 3 # 2 118 ARG A 110 ARG~? -3.66 O1 2PE A 148s 183 LYS A 9 LYS~? 8.68 C6 2PE A 148 317 ARG A 20 ARG.? 4.64 CB MLZ A 129 coo 76.57 109.19 73.41 73.86 110.26 72.16 -6.91 52.41 21.82 -5.61 55.22 21.43 coo 82.09 117.51 66.37 80.60 114.32 71.44 -4.77 65.74 20.08 0.46 67.29 18.98 coo 65.21 120.62 58.76 63.62 123.14 59.66 -20.19 69.79 30.19 -22.38 67.97 29.03 ULMN 3 1bib_c00 BIRA BIFUNCTIONAL PROTEIN (ACTS AS Buser 3 3 # 3 118 ARG A 110 ARG~? -3.66 O1 2PE A 148s 183 LYS A 9 LYS~? 8.68 C6 2PE A 148 317 ARG B 16 ARG~? -3.64 O1 SO4 A 143s coo 76.57 109.19 73.41 73.86 110.26 72.16 -6.91 52.41 21.82 -5.61 55.22 21.43 coo 82.09 117.51 66.37 80.60 114.32 71.44 -4.77 65.74 20.08 0.46 67.29 18.98 coo 65.21 120.62 58.76 63.62 123.14 59.66 -4.85 63.18 38.40 -7.23 62.95 36.44 ULMN 3 1bib_c00 BIRA BIFUNCTIONAL PROTEIN (ACTS AS Buser 4 3 # 4 118 ARG B 42 ARG.? 12.70 O1 PEG B 144 183 LYS B 114 LYS~? 11.34 O7 PE8 B 148 317 ARG B 31 ARG^? 11.02 C6 PGE B 147 coo 76.57 109.19 73.41 73.86 110.26 72.16 19.61 78.53 29.44 17.94 76.42 28.00 coo 82.09 117.51 66.37 80.60 114.32 71.44 11.35 73.22 32.47 12.65 68.43 28.61 coo 65.21 120.62 58.76 63.62 123.14 59.66 12.15 83.61 47.77 10.36 84.10 50.21 ULMN 3 1bib_c00 BIRA BIFUNCTIONAL PROTEIN (ACTS AS Buser 5 3 # 5 118 ARG B 55 ARG~? 9.33 CG MLY C 135 183 LYS B 114 LYS~? 11.34 O7 PE8 B 148 317 ARG B 31 ARG^? 11.02 C6 PGE B 147 coo 76.57 109.19 73.41 73.86 110.26 72.16 8.78 84.29 24.99 10.39 86.20 26.77 coo 82.09 117.51 66.37 80.60 114.32 71.44 11.35 73.22 32.47 12.65 68.43 28.61 coo 65.21 120.62 58.76 63.62 123.14 59.66 12.15 83.61 47.77 10.36 84.10 50.21 ULMN 3 1bib_c00 BIRA BIFUNCTIONAL PROTEIN (ACTS AS Buser 6 3 # 6 118 ARG B 110 ARG~? 10.12 O7 PE8 B 148 183 LYS B 9 LYS~? 8.12 C3 PE8 B 148 317 ARG B 20 ARG.? 7.28 C1 PEG B 146 coo 76.57 109.19 73.41 73.86 110.26 72.16 4.56 66.25 30.54 5.81 64.43 28.32 coo 82.09 117.51 66.37 80.60 114.32 71.44 3.06 63.14 43.18 6.71 59.02 44.53 coo 65.21 120.62 58.76 63.62 123.14 59.66 -14.05 70.97 43.62 -13.60 73.76 42.39 ULMN 3 1bib_c00 BIRA BIFUNCTIONAL PROTEIN (ACTS AS Buser 7 3 # 7 118 ARG D 42 ARG.? 16.60 C9 2PE D 146 183 LYS D 114 LYS~? 10.81 C9 2PE D 146 317 ARG D 31 ARG^? 10.57 OH7 1PE B 150 coo 76.57 109.19 73.41 73.86 110.26 72.16 -32.78 97.24 12.74 -35.35 96.85 11.13 coo 82.09 117.51 66.37 80.60 114.32 71.44 -35.88 89.56 6.78 -39.69 93.33 3.49 coo 65.21 120.62 58.76 63.62 123.14 59.66 -19.64 81.34 12.02 -19.24 78.87 10.07 ULMN 3 1bib_c00 BIRA BIFUNCTIONAL PROTEIN (ACTS AS Buser 8 3 # 8 118 ARG D 55 ARG~? 9.16 CG MLY A 135 183 LYS D 114 LYS~? 10.81 C9 2PE D 146 317 ARG D 31 ARG^? 10.57 OH7 1PE B 150 coo 76.57 109.19 73.41 73.86 110.26 72.16 -39.98 89.02 19.79 -37.17 89.06 21.03 coo 82.09 117.51 66.37 80.60 114.32 71.44 -35.88 89.56 6.78 -39.69 93.33 3.49 coo 65.21 120.62 58.76 63.62 123.14 59.66 -19.64 81.34 12.02 -19.24 78.87 10.07 ULMN 3 1bib_c00 BIRA BIFUNCTIONAL PROTEIN (ACTS AS Buser 9 3 # 9 118 ARG D 110 ARG~? 8.08 C9 2PE D 146 183 LYS D 9 LYS~? 7.95 C5 2PE D 146 317 ARG D 20 ARG.? 10.31 C3 PEG D 145 coo 76.57 109.19 73.41 73.86 110.26 72.16 -43.46 85.72 1.13 -42.23 87.94 -0.73 coo 82.09 117.51 66.37 80.60 114.32 71.44 -34.17 79.01 -6.33 -32.19 82.24 -10.69 coo 65.21 120.62 58.76 63.62 123.14 59.66 -40.03 62.67 1.01 -40.08 63.13 4.08 ULMN 3 1bib_c00 BIRA BIFUNCTIONAL PROTEIN (ACTS AS Buser 10 3 # 10 118 ARG D 110 ARG~? 8.08 C9 2PE D 146 183 LYS D 114 LYS~? 10.81 C9 2PE D 146 317 ARG D 124 ARG^? 7.97 C3 GOL D 147 coo 76.57 109.19 73.41 73.86 110.26 72.16 -43.46 85.72 1.13 -42.23 87.94 -0.73 coo 82.09 117.51 66.37 80.60 114.32 71.44 -35.88 89.56 6.78 -39.69 93.33 3.49 coo 65.21 120.62 58.76 63.62 123.14 59.66 -24.04 74.20 5.58 -21.67 76.16 5.44 1bib_c00 source 1bib BIRA BIFUNCTIONAL PROTEIN (ACTS AS BIOTIN OPER: 10 hits 1bib_c00 naa= 3 ULMN 3 1bmt_c04 METHIONINE SYNTHASE (B12-BINDING DOMuser 1 3 # 1 A 757 ASP A 56 ASP~? 11.59 C21 2PE A 148 A 759 HIS A 115 HIS~? 12.27 C21 2PE A 148 A 810 SER A 57 SER~? 3.96 C21 2PE A 148 coo 30.11 61.02 29.12 29.36 59.77 27.63 -16.01 45.89 15.64 -15.93 44.31 14.23 coo 30.94 56.62 25.28 29.94 54.94 26.14 -13.18 48.35 10.37 -12.55 46.36 10.33 coo 25.05 62.74 29.97 26.88 61.45 29.19 -17.83 49.34 18.20 -18.57 51.11 16.71 ULMN 3 1bmt_c04 METHIONINE SYNTHASE (B12-BINDING DOMuser 2 3 # 2 A 757 ASP B 56 ASP~? 11.45 C20 PE8 B 148 A 759 HIS B 115 HIS~? 12.48 C18 PE8 B 148 A 810 SER B 57 SER~? 3.95 C20 PE8 B 148 coo 30.11 61.02 29.12 29.36 59.77 27.63 6.80 78.21 26.00 8.47 79.07 25.03 coo 30.94 56.62 25.28 29.94 54.94 26.14 11.86 77.76 30.05 12.70 77.49 28.15 coo 25.05 62.74 29.97 26.88 61.45 29.19 2.89 78.00 28.42 3.14 79.13 30.54 ULMN 3 1bmt_c04 METHIONINE SYNTHASE (B12-BINDING DOMuser 3 3 # 3 A 757 ASP C 56 ASP~? 9.09 N MLZ C 114 A 759 HIS C 115 HIS~? 4.72 C MLZ C 114 A 810 SER C 57 SER~? 4.15 C20 PE8 C 148 coo 30.11 61.02 29.12 29.36 59.77 27.63 -16.40 94.43 66.11 -17.63 93.56 67.58 coo 30.94 56.62 25.28 29.94 54.94 26.14 -12.99 90.00 69.08 -14.38 90.57 70.54 coo 25.05 62.74 29.97 26.88 61.45 29.19 -14.48 95.85 62.27 -13.19 94.01 61.32 ULMN 3 1bmt_c04 METHIONINE SYNTHASE (B12-BINDING DOMuser 4 3 # 4 A 757 ASP D 56 ASP~? 11.46 C21 2PE D 146 A 759 HIS D 115 HIS~? 12.18 C21 2PE D 146 A 810 SER D 57 SER~? 3.84 C21 2PE D 146 coo 30.11 61.02 29.12 29.36 59.77 27.63 -41.85 87.81 13.66 -41.61 89.58 14.80 coo 30.94 56.62 25.28 29.94 54.94 26.14 -36.28 90.32 11.92 -37.49 91.98 12.35 coo 25.05 62.74 29.97 26.88 61.45 29.19 -42.08 83.25 12.68 -39.78 82.38 12.84 1bmt_c04 source 1bmt METHIONINE SYNTHASE (B12-BINDING DOMAINS) (E.C: 4 hits 1bmt_c04 naa= 3 ULMN 3 1bmt_c05 METHIONINE SYNTHASE (B12-BINDING DOMuser 1 3 # 1 B 757 ASP A 56 ASP~? 11.59 C21 2PE A 148 B 759 HIS A 115 HIS~? 12.27 C21 2PE A 148 B 810 SER A 57 SER~? 3.96 C21 2PE A 148 coo -2.30 64.08 6.41 -0.36 64.72 6.26 -16.01 45.89 15.64 -15.93 44.31 14.23 coo 1.96 66.39 3.07 2.10 68.48 3.58 -13.18 48.35 10.37 -12.55 46.36 10.33 coo -1.50 63.90 11.86 -1.31 64.33 9.52 -17.83 49.34 18.20 -18.57 51.11 16.71 ULMN 3 1bmt_c05 METHIONINE SYNTHASE (B12-BINDING DOMuser 2 3 # 2 B 757 ASP B 56 ASP~? 11.45 C20 PE8 B 148 B 759 HIS B 115 HIS~? 12.48 C18 PE8 B 148 B 810 SER B 57 SER~? 3.95 C20 PE8 B 148 coo -2.30 64.08 6.41 -0.36 64.72 6.26 6.80 78.21 26.00 8.47 79.07 25.03 coo 1.96 66.39 3.07 2.10 68.48 3.58 11.86 77.76 30.05 12.70 77.49 28.15 coo -1.50 63.90 11.86 -1.31 64.33 9.52 2.89 78.00 28.42 3.14 79.13 30.54 ULMN 3 1bmt_c05 METHIONINE SYNTHASE (B12-BINDING DOMuser 3 3 # 3 B 757 ASP C 56 ASP~? 9.09 N MLZ C 114 B 759 HIS C 115 HIS~? 4.72 C MLZ C 114 B 810 SER C 57 SER~? 4.15 C20 PE8 C 148 coo -2.30 64.08 6.41 -0.36 64.72 6.26 -16.40 94.43 66.11 -17.63 93.56 67.58 coo 1.96 66.39 3.07 2.10 68.48 3.58 -12.99 90.00 69.08 -14.38 90.57 70.54 coo -1.50 63.90 11.86 -1.31 64.33 9.52 -14.48 95.85 62.27 -13.19 94.01 61.32 ULMN 3 1bmt_c05 METHIONINE SYNTHASE (B12-BINDING DOMuser 4 3 # 4 B 757 ASP D 56 ASP~? 11.46 C21 2PE D 146 B 759 HIS D 115 HIS~? 12.18 C21 2PE D 146 B 810 SER D 57 SER~? 3.84 C21 2PE D 146 coo -2.30 64.08 6.41 -0.36 64.72 6.26 -41.85 87.81 13.66 -41.61 89.58 14.80 coo 1.96 66.39 3.07 2.10 68.48 3.58 -36.28 90.32 11.92 -37.49 91.98 12.35 coo -1.50 63.90 11.86 -1.31 64.33 9.52 -42.08 83.25 12.68 -39.78 82.38 12.84 1bmt_c05 source 1bmt METHIONINE SYNTHASE (B12-BINDING DOMAINS) (E.C: 4 hits 1bmt_c05 naa= 3 ULMN 3 1boo_c00 N-4 CYTOSINE-SPECIFIC METHYLTRANSFERuser 1 3 # 1 A 53 SER A 57 SER~? 3.96 C21 2PE A 148 A 54 PRO A 59 PRO~? 7.19 O28 2PE A 148 A 96 ASP A 56 ASP~? 11.59 C21 2PE A 148 coo -9.03 45.15 44.45 -7.51 43.26 44.28 -17.83 49.34 18.20 -18.57 51.11 16.71 coo -12.82 46.62 43.11 -11.69 44.75 42.79 -20.58 44.93 20.55 -20.99 46.94 21.43 coo -5.86 47.39 44.34 -4.55 46.60 42.83 -16.01 45.89 15.64 -15.93 44.31 14.23 ULMN 3 1boo_c00 N-4 CYTOSINE-SPECIFIC METHYLTRANSFERuser 2 3 # 2 A 53 SER B 57 SER~? 3.95 C20 PE8 B 148 A 54 PRO B 59 PRO~? 7.49 O25 PE8 B 148 A 96 ASP B 56 ASP~? 11.45 C20 PE8 B 148 coo -9.03 45.15 44.45 -7.51 43.26 44.28 2.89 78.00 28.42 3.14 79.13 30.54 coo -12.82 46.62 43.11 -11.69 44.75 42.79 0.87 79.96 23.42 -0.66 79.61 25.02 coo -5.86 47.39 44.34 -4.55 46.60 42.83 6.80 78.21 26.00 8.47 79.07 25.03 ULMN 3 1boo_c00 N-4 CYTOSINE-SPECIFIC METHYLTRANSFERuser 3 3 # 3 A 53 SER C 57 SER~? 4.15 C20 PE8 C 148 A 54 PRO C 59 PRO~? 7.89 O25 PE8 C 148 A 96 ASP C 56 ASP~? 9.09 N MLZ C 114 coo -9.03 45.15 44.45 -7.51 43.26 44.28 -14.48 95.85 62.27 -13.19 94.01 61.32 coo -12.82 46.62 43.11 -11.69 44.75 42.79 -19.61 98.03 61.38 -18.12 98.37 59.73 coo -5.86 47.39 44.34 -4.55 46.60 42.83 -16.40 94.43 66.11 -17.63 93.56 67.58 ULMN 3 1boo_c00 N-4 CYTOSINE-SPECIFIC METHYLTRANSFERuser 4 3 # 4 A 53 SER D 57 SER~? 3.84 C21 2PE D 146 A 54 PRO D 59 PRO~? 6.81 O28 2PE D 146 A 96 ASP D 56 ASP~? 11.46 C21 2PE D 146 coo -9.03 45.15 44.45 -7.51 43.26 44.28 -42.08 83.25 12.68 -39.78 82.38 12.84 coo -12.82 46.62 43.11 -11.69 44.75 42.79 -46.49 83.49 16.21 -46.05 81.53 15.29 coo -5.86 47.39 44.34 -4.55 46.60 42.83 -41.85 87.81 13.66 -41.61 89.58 14.80 1boo_c00 source 1boo N-4 CYTOSINE-SPECIFIC METHYLTRANSFERASE PVU II: 4 hits 1boo_c00 naa= 3 ULMN 3 1bp2_c00 PHOSPHOLIPASE A2 (E.C.3.1.1.4) (PHOSuser 1 3 # 1 30 GLY A 46 GLY~? 12.01 CD MLY D 135 48 HIS A 115 HIS~? 12.27 C21 2PE A 148 99 ASP A 56 ASP~? 11.59 C21 2PE A 148 coo 12.38 5.55 24.25 13.27 5.59 24.39 -16.75 52.82 2.36 -17.28 52.20 2.20 coo 18.80 12.68 24.53 17.69 13.54 26.08 -13.18 48.35 10.37 -12.55 46.36 10.33 coo 17.07 18.51 26.62 16.67 17.07 28.09 -16.01 45.89 15.64 -15.93 44.31 14.23 ULMN 3 1bp2_c00 PHOSPHOLIPASE A2 (E.C.3.1.1.4) (PHOSuser 2 3 # 2 30 GLY A 54 GLY~? 5.80 C21 2PE A 148 48 HIS A 88 HIS^? 4.20 CH2 MLY D 135 99 ASP A 87 ASP.? 8.49 C6 PGE A 147 coo 12.38 5.55 24.25 13.27 5.59 24.39 -20.41 50.07 13.76 -19.88 49.43 13.69 coo 18.80 12.68 24.53 17.69 13.54 26.08 -23.95 56.87 7.77 -24.14 54.98 6.86 coo 17.07 18.51 26.62 16.67 17.07 28.09 -23.17 58.67 3.55 -22.34 59.17 1.69 ULMN 3 1bp2_c00 PHOSPHOLIPASE A2 (E.C.3.1.1.4) (PHOSuser 3 3 # 3 30 GLY A 134 GLY.? 2.47 N MLY A 135 48 HIS D 88 HIS^? 4.38 CH1 MLY A 135 99 ASP D 87 ASP.? 7.26 C16 1PE B 150 coo 12.38 5.55 24.25 13.27 5.59 24.39 -37.57 76.13 24.20 -36.67 75.88 24.22 coo 18.80 12.68 24.53 17.69 13.54 26.08 -29.18 79.71 17.63 -29.43 81.25 19.03 coo 17.07 18.51 26.62 16.67 17.07 28.09 -24.70 80.89 17.41 -22.90 81.94 17.31 ULMN 3 1bp2_c00 PHOSPHOLIPASE A2 (E.C.3.1.1.4) (PHOSuser 4 3 # 4 30 GLY B 46 GLY~? 9.70 O1 PEG B 144 48 HIS B 115 HIS~? 12.48 C18 PE8 B 148 99 ASP B 56 ASP~? 11.45 C20 PE8 B 148 coo 12.38 5.55 24.25 13.27 5.59 24.39 15.35 83.93 36.97 15.42 84.55 36.41 coo 18.80 12.68 24.53 17.69 13.54 26.08 11.86 77.76 30.05 12.70 77.49 28.15 coo 17.07 18.51 26.62 16.67 17.07 28.09 6.80 78.21 26.00 8.47 79.07 25.03 ULMN 3 1bp2_c00 PHOSPHOLIPASE A2 (E.C.3.1.1.4) (PHOSuser 5 3 # 5 30 GLY B 54 GLY~? 5.68 C20 PE8 B 148 48 HIS B 88 HIS^? 4.29 CH1 MLY C 135 99 ASP B 87 ASP.? 8.94 O4 PGE B 147 coo 12.38 5.55 24.25 13.27 5.59 24.39 5.02 82.24 30.45 5.51 81.90 29.87 coo 18.80 12.68 24.53 17.69 13.54 26.08 6.15 87.00 38.94 7.35 87.96 37.51 coo 17.07 18.51 26.62 16.67 17.07 28.09 9.49 87.97 42.02 11.31 87.98 43.09 ULMN 3 1bp2_c00 PHOSPHOLIPASE A2 (E.C.3.1.1.4) (PHOSuser 6 3 # 6 30 GLY B 134 GLY.? 2.46 N MLY B 135 48 HIS C 88 HIS^? 3.86 CD MLY B 135 99 ASP C 87 ASP.? 8.84 O1 PGE C 147 coo 12.38 5.55 24.25 13.27 5.59 24.39 -19.59 87.32 51.84 -18.97 86.72 51.66 coo 18.80 12.68 24.53 17.69 13.54 26.08 -11.00 83.03 57.18 -12.69 82.43 58.26 coo 17.07 18.51 26.62 16.67 17.07 28.09 -9.03 79.00 58.44 -8.21 77.39 59.55 ULMN 3 1bp2_c00 PHOSPHOLIPASE A2 (E.C.3.1.1.4) (PHOSuser 7 3 # 7 30 GLY C 46 GLY~? 10.04 O MLZ C 114 48 HIS C 115 HIS~? 4.72 C MLZ C 114 99 ASP C 56 ASP~? 9.09 N MLZ C 114 coo 12.38 5.55 24.25 13.27 5.59 24.39 -10.91 80.74 66.75 -11.70 80.52 66.65 coo 18.80 12.68 24.53 17.69 13.54 26.08 -12.99 90.00 69.08 -14.38 90.57 70.54 coo 17.07 18.51 26.62 16.67 17.07 28.09 -16.40 94.43 66.11 -17.63 93.56 67.58 ULMN 3 1bp2_c00 PHOSPHOLIPASE A2 (E.C.3.1.1.4) (PHOSuser 8 3 # 8 30 GLY C 54 GLY~? 6.00 CH2 MLY B 135 48 HIS C 88 HIS^? 3.86 CD MLY B 135 99 ASP C 87 ASP.? 8.84 O1 PGE C 147 coo 12.38 5.55 24.25 13.27 5.59 24.39 -15.22 90.72 61.35 -15.47 90.98 62.07 coo 18.80 12.68 24.53 17.69 13.54 26.08 -11.00 83.03 57.18 -12.69 82.43 58.26 coo 17.07 18.51 26.62 16.67 17.07 28.09 -9.03 79.00 58.44 -8.21 77.39 59.55 ULMN 3 1bp2_c00 PHOSPHOLIPASE A2 (E.C.3.1.1.4) (PHOSuser 9 3 # 9 30 GLY C 134 GLY.? 2.48 N MLY C 135 48 HIS B 88 HIS^? 4.29 CH1 MLY C 135 99 ASP B 87 ASP.? 8.94 O4 PGE B 147 coo 12.38 5.55 24.25 13.27 5.59 24.39 -1.36 91.26 31.44 -1.10 91.64 32.26 coo 18.80 12.68 24.53 17.69 13.54 26.08 6.15 87.00 38.94 7.35 87.96 37.51 coo 17.07 18.51 26.62 16.67 17.07 28.09 9.49 87.97 42.02 11.31 87.98 43.09 ULMN 3 1bp2_c00 PHOSPHOLIPASE A2 (E.C.3.1.1.4) (PHOSuser 10 3 # 10 30 GLY D 46 GLY~? 12.21 CD MLY A 135 48 HIS D 115 HIS~? 12.18 C21 2PE D 146 99 ASP D 56 ASP~? 11.46 C21 2PE D 146 coo 12.38 5.55 24.25 13.27 5.59 24.39 -27.16 89.12 15.33 -27.37 89.29 16.11 coo 18.80 12.68 24.53 17.69 13.54 26.08 -36.28 90.32 11.92 -37.49 91.98 12.35 coo 17.07 18.51 26.62 16.67 17.07 28.09 -41.85 87.81 13.66 -41.61 89.58 14.80 ULMN 3 1bp2_c00 PHOSPHOLIPASE A2 (E.C.3.1.1.4) (PHOSuser 11 3 # 11 30 GLY D 54 GLY~? 5.81 C23 2PE D 146 48 HIS D 88 HIS^? 4.38 CH1 MLY A 135 99 ASP D 87 ASP.? 7.26 C16 1PE B 150 coo 12.38 5.55 24.25 13.27 5.59 24.39 -38.01 83.52 15.98 -38.33 84.28 15.84 coo 18.80 12.68 24.53 17.69 13.54 26.08 -29.18 79.71 17.63 -29.43 81.25 19.03 coo 17.07 18.51 26.62 16.67 17.07 28.09 -24.70 80.89 17.41 -22.90 81.94 17.31 ULMN 3 1bp2_c00 PHOSPHOLIPASE A2 (E.C.3.1.1.4) (PHOSuser 12 3 # 12 30 GLY D 134 GLY.? 2.47 N MLY D 135 48 HIS A 88 HIS^? 4.20 CH2 MLY D 135 99 ASP A 87 ASP.? 8.49 C6 PGE A 147 coo 12.38 5.55 24.25 13.27 5.59 24.39 -31.46 51.06 14.18 -31.60 51.74 13.54 coo 18.80 12.68 24.53 17.69 13.54 26.08 -23.95 56.87 7.77 -24.14 54.98 6.86 coo 17.07 18.51 26.62 16.67 17.07 28.09 -23.17 58.67 3.55 -22.34 59.17 1.69 1bp2_c00 source 1bp2 PHOSPHOLIPASE A2 (E.C.3.1.1.4) (PHOSPHATIDE AC: 12 hits 1bp2_c00 naa= 3 ULMN 3 1bs4_c00 PEPTIDE DEFORMYLASE user 1 3 # 1 A 50 GLN A 14 GLN~? 4.09 C14 1PE B 150 A 91 LEU B 64 LEU~? 7.06 OH4 1PE B 150 A 133 GLU A 10 GLU~? 8.70 C6 2PE A 148 coo 43.58 43.67 66.73 42.32 42.78 68.15 -9.40 72.50 23.82 -9.67 73.73 22.10 coo 38.58 45.09 70.44 38.28 45.21 72.59 -6.99 74.17 28.56 -6.11 72.35 27.70 coo 44.05 36.87 70.65 43.15 38.64 69.97 -3.10 70.57 20.07 -2.45 69.30 18.38 1bs4_c00 source 1bs4 PEPTIDE DEFORMYLASE : 1 hits 1bs4_c00 naa= 3 ULMN 3 1bs4_c01 PEPTIDE DEFORMYLASE user 1 3 # 1 B 550 GLN A 14 GLN~? 4.09 C14 1PE B 150 B 591 LEU B 64 LEU~? 7.06 OH4 1PE B 150 B 633 GLU A 10 GLU~? 8.70 C6 2PE A 148 coo 88.06 44.34 57.19 89.06 45.53 55.74 -9.40 72.50 23.82 -9.67 73.73 22.10 coo 86.70 48.66 52.61 87.15 48.69 50.51 -6.99 74.17 28.56 -6.11 72.35 27.70 coo 95.42 44.52 54.43 93.46 45.31 54.70 -3.10 70.57 20.07 -2.45 69.30 18.38 1bs4_c01 source 1bs4 PEPTIDE DEFORMYLASE : 1 hits 1bs4_c01 naa= 3 ULMN 3 1bs4_c02 PEPTIDE DEFORMYLASE user 1 3 # 1 C1050 GLN A 14 GLN~? 4.09 C14 1PE B 150 C1091 LEU B 64 LEU~? 7.06 OH4 1PE B 150 C1133 GLU A 10 GLU~? 8.70 C6 2PE A 148 coo 68.29 34.44 43.03 66.67 34.74 44.37 -9.40 72.50 23.82 -9.67 73.73 22.10 coo 65.83 38.95 47.05 65.46 38.90 49.20 -6.99 74.17 28.56 -6.11 72.35 27.70 coo 63.14 29.39 46.25 63.84 31.31 45.74 -3.10 70.57 20.07 -2.45 69.30 18.38 1bs4_c02 source 1bs4 PEPTIDE DEFORMYLASE : 1 hits 1bs4_c02 naa= 3 ULMN 3 1bsj_c00 PEPTIDE DEFORMYLASE user 1 3 # 1 A 50 GLN A 14 GLN~? 4.09 C14 1PE B 150 A 91 LEU B 64 LEU~? 7.06 OH4 1PE B 150 A 133 GLU A 10 GLU~? 8.70 C6 2PE A 148 coo 38.23 53.34 67.59 38.84 53.87 69.56 -9.40 72.50 23.82 -9.67 73.73 22.10 coo 35.40 53.22 73.30 35.37 54.87 74.74 -6.99 74.17 28.56 -6.11 72.35 27.70 coo 45.08 56.04 70.60 43.15 55.19 70.77 -3.10 70.57 20.07 -2.45 69.30 18.38 1bsj_c00 source 1bsj PEPTIDE DEFORMYLASE : 1 hits 1bsj_c00 naa= 3 ULMN 3 1bvz_c08 ALPHA-AMYLASE II user 1 3 # 1 A 325 ASP A 56 ASP~? 11.59 C21 2PE A 148 A 354 GLU A 111 GLU~? 12.48 C11 2PE A 148 A 421 ASP A 106 ASP~? 11.93 O22 2PE A 148 coo 31.05 49.37 64.51 31.97 51.11 63.85 -16.01 45.89 15.64 -15.93 44.31 14.23 coo 29.07 50.42 58.36 29.02 52.18 59.49 -8.13 46.06 17.22 -6.45 46.46 15.98 coo 30.82 59.76 58.47 31.12 59.02 60.40 -12.71 50.36 24.83 -13.06 48.30 25.05 ULMN 3 1bvz_c08 ALPHA-AMYLASE II user 2 3 # 2 A 325 ASP A 83 ASP.? 8.52 O3 GOL D 147 A 354 GLU A 84 GLU.? 10.45 C3 GOL D 147 A 421 ASP A 122 ASP^? 7.46 C1 GOL A 150 coo 31.05 49.37 64.51 31.97 51.11 63.85 -19.46 70.43 -3.04 -19.06 72.28 -2.05 coo 29.07 50.42 58.36 29.02 52.18 59.49 -21.01 70.22 3.12 -21.10 71.95 4.30 coo 30.82 59.76 58.47 31.12 59.02 60.40 -15.41 64.92 4.51 -15.09 66.83 5.33 ULMN 3 1bvz_c08 ALPHA-AMYLASE II user 3 3 # 3 A 325 ASP A 122 ASP^? 7.46 C1 GOL A 150 A 354 GLU A 121 GLU^? 12.41 C1 GOL A 150 A 421 ASP A 83 ASP.? 8.52 O3 GOL D 147 coo 31.05 49.37 64.51 31.97 51.11 63.85 -15.41 64.92 4.51 -15.09 66.83 5.33 coo 29.07 50.42 58.36 29.02 52.18 59.49 -13.98 61.53 0.93 -15.14 61.60 -0.79 coo 30.82 59.76 58.47 31.12 59.02 60.40 -19.46 70.43 -3.04 -19.06 72.28 -2.05 ULMN 3 1bvz_c08 ALPHA-AMYLASE II user 4 3 # 4 A 325 ASP A 122 ASP^? 7.46 C1 GOL A 150 A 354 GLU A 121 GLU^? 12.41 C1 GOL A 150 A 421 ASP A 87 ASP.? 8.49 C6 PGE A 147 coo 31.05 49.37 64.51 31.97 51.11 63.85 -15.41 64.92 4.51 -15.09 66.83 5.33 coo 29.07 50.42 58.36 29.02 52.18 59.49 -13.98 61.53 0.93 -15.14 61.60 -0.79 coo 30.82 59.76 58.47 31.12 59.02 60.40 -23.17 58.67 3.55 -22.34 59.17 1.69 ULMN 3 1bvz_c08 ALPHA-AMYLASE II user 5 3 # 5 A 325 ASP B 56 ASP~? 11.45 C20 PE8 B 148 A 354 GLU B 111 GLU~? 12.54 O7 PE8 B 148 A 421 ASP B 106 ASP~? 11.87 OH2 1PE B 150 coo 31.05 49.37 64.51 31.97 51.11 63.85 6.80 78.21 26.00 8.47 79.07 25.03 coo 29.07 50.42 58.36 29.02 52.18 59.49 9.41 70.70 25.55 11.25 69.94 26.27 coo 30.82 59.76 58.47 31.12 59.02 60.40 -0.30 70.27 27.08 -0.10 70.78 25.05 ULMN 3 1bvz_c08 ALPHA-AMYLASE II user 6 3 # 6 A 325 ASP B 83 ASP.? 9.40 O3 GOL C 149 A 354 GLU B 84 GLU.? 10.31 O3 GOL C 149 A 421 ASP B 122 ASP^? 7.33 O2 GOL B 149 coo 31.05 49.37 64.51 31.97 51.11 63.85 13.62 86.10 55.23 12.83 84.59 56.49 coo 29.07 50.42 58.36 29.02 52.18 59.49 7.66 84.31 53.13 6.13 83.49 54.35 coo 30.82 59.76 58.47 31.12 59.02 60.40 10.89 79.68 47.57 9.75 78.80 49.16 ULMN 3 1bvz_c08 ALPHA-AMYLASE II user 7 3 # 7 A 325 ASP B 122 ASP^? 7.33 O2 GOL B 149 A 354 GLU B 121 GLU^? 8.74 O2 PEG B 144 A 421 ASP B 83 ASP.? 9.40 O3 GOL C 149 coo 31.05 49.37 64.51 31.97 51.11 63.85 10.89 79.68 47.57 9.75 78.80 49.16 coo 29.07 50.42 58.36 29.02 52.18 59.49 15.37 80.83 45.64 16.23 82.69 46.15 coo 30.82 59.76 58.47 31.12 59.02 60.40 13.62 86.10 55.23 12.83 84.59 56.49 ULMN 3 1bvz_c08 ALPHA-AMYLASE II user 8 3 # 8 A 325 ASP B 122 ASP^? 7.33 O2 GOL B 149 A 354 GLU B 121 GLU^? 8.74 O2 PEG B 144 A 421 ASP B 87 ASP.? 8.94 O4 PGE B 147 coo 31.05 49.37 64.51 31.97 51.11 63.85 10.89 79.68 47.57 9.75 78.80 49.16 coo 29.07 50.42 58.36 29.02 52.18 59.49 15.37 80.83 45.64 16.23 82.69 46.15 coo 30.82 59.76 58.47 31.12 59.02 60.40 9.49 87.97 42.02 11.31 87.98 43.09 ULMN 3 1bvz_c08 ALPHA-AMYLASE II user 9 3 # 9 A 325 ASP C 56 ASP~? 9.09 N MLZ C 114 A 354 GLU C 111 GLU~? 3.06 NZ MLZ C 114 A 421 ASP C 106 ASP~? 12.11 C21 PE8 C 148 coo 31.05 49.37 64.51 31.97 51.11 63.85 -16.40 94.43 66.11 -17.63 93.56 67.58 coo 29.07 50.42 58.36 29.02 52.18 59.49 -12.41 98.44 71.96 -11.17 97.70 73.52 coo 30.82 59.76 58.47 31.12 59.02 60.40 -11.06 103.55 63.77 -13.00 104.00 64.35 ULMN 3 1bvz_c08 ALPHA-AMYLASE II user 10 3 # 10 A 325 ASP C 83 ASP.? 8.65 O3 GOL B 149 A 354 GLU C 84 GLU.? 10.77 O2 GOL B 149 A 421 ASP C 122 ASP^? 7.22 C3 GOL C 149 coo 31.05 49.37 64.51 31.97 51.11 63.85 3.02 71.86 58.06 4.88 72.49 57.24 coo 29.07 50.42 58.36 29.02 52.18 59.49 2.34 77.12 55.01 3.46 78.21 53.60 coo 30.82 59.76 58.47 31.12 59.02 60.40 0.27 81.12 61.60 2.07 81.54 60.53 ULMN 3 1bvz_c08 ALPHA-AMYLASE II user 11 3 # 11 A 325 ASP C 122 ASP^? 7.22 C3 GOL C 149 A 354 GLU C 121 GLU^? 12.40 C3 GOL C 149 A 421 ASP C 83 ASP.? 8.65 O3 GOL B 149 coo 31.05 49.37 64.51 31.97 51.11 63.85 0.27 81.12 61.60 2.07 81.54 60.53 coo 29.07 50.42 58.36 29.02 52.18 59.49 -1.98 78.69 65.48 -2.54 76.71 65.06 coo 30.82 59.76 58.47 31.12 59.02 60.40 3.02 71.86 58.06 4.88 72.49 57.24 ULMN 3 1bvz_c08 ALPHA-AMYLASE II user 12 3 # 12 A 325 ASP C 122 ASP^? 7.22 C3 GOL C 149 A 354 GLU C 121 GLU^? 12.40 C3 GOL C 149 A 421 ASP C 87 ASP.? 8.84 O1 PGE C 147 coo 31.05 49.37 64.51 31.97 51.11 63.85 0.27 81.12 61.60 2.07 81.54 60.53 coo 29.07 50.42 58.36 29.02 52.18 59.49 -1.98 78.69 65.48 -2.54 76.71 65.06 coo 30.82 59.76 58.47 31.12 59.02 60.40 -9.03 79.00 58.44 -8.21 77.39 59.55 ULMN 3 1bvz_c08 ALPHA-AMYLASE II user 13 3 # 13 A 325 ASP D 56 ASP~? 11.46 C21 2PE D 146 A 354 GLU D 111 GLU~? 11.88 C9 2PE D 146 A 421 ASP D 106 ASP~? 11.82 O22 2PE D 146 coo 31.05 49.37 64.51 31.97 51.11 63.85 -41.85 87.81 13.66 -41.61 89.58 14.80 coo 29.07 50.42 58.36 29.02 52.18 59.49 -43.22 91.45 6.64 -41.92 92.74 5.57 coo 30.82 59.76 58.47 31.12 59.02 60.40 -46.82 82.57 5.87 -48.37 83.43 7.00 ULMN 3 1bvz_c08 ALPHA-AMYLASE II user 14 3 # 14 A 325 ASP D 83 ASP.? 8.76 O1 GOL A 150 A 354 GLU D 84 GLU.? 10.79 C1 GOL A 150 A 421 ASP D 122 ASP^? 7.49 C3 GOL D 147 coo 31.05 49.37 64.51 31.97 51.11 63.85 -12.54 78.43 10.94 -12.46 77.06 9.29 coo 29.07 50.42 58.36 29.02 52.18 59.49 -17.40 74.78 10.23 -17.69 72.96 9.24 coo 30.82 59.76 58.47 31.12 59.02 60.40 -21.82 80.90 7.85 -21.38 79.32 6.51 ULMN 3 1bvz_c08 ALPHA-AMYLASE II user 15 3 # 15 A 325 ASP D 122 ASP^? 7.49 C3 GOL D 147 A 354 GLU D 121 GLU^? 11.70 OH7 1PE B 150 A 421 ASP D 83 ASP.? 8.76 O1 GOL A 150 coo 31.05 49.37 64.51 31.97 51.11 63.85 -21.82 80.90 7.85 -21.38 79.32 6.51 coo 29.07 50.42 58.36 29.02 52.18 59.49 -20.91 85.61 9.48 -19.44 85.70 10.98 coo 30.82 59.76 58.47 31.12 59.02 60.40 -12.54 78.43 10.94 -12.46 77.06 9.29 1bvz_c08 source 1bvz ALPHA-AMYLASE II : 15 hits 1bvz_c08 naa= 3 ULMN 3 1bvz_c09 ALPHA-AMYLASE II user 1 3 # 1 B 325 ASP A 56 ASP~? 11.59 C21 2PE A 148 B 354 GLU A 111 GLU~? 12.48 C11 2PE A 148 B 421 ASP A 106 ASP~? 11.93 O22 2PE A 148 coo 25.90 8.19 53.87 25.36 6.97 52.29 -16.01 45.89 15.64 -15.93 44.31 14.23 coo 27.87 10.66 47.95 27.82 8.60 48.27 -8.13 46.06 17.22 -6.45 46.46 15.98 coo 26.02 1.87 43.38 25.90 1.97 45.49 -12.71 50.36 24.83 -13.06 48.30 25.05 ULMN 3 1bvz_c09 ALPHA-AMYLASE II user 2 3 # 2 B 325 ASP A 83 ASP.? 8.52 O3 GOL D 147 B 354 GLU A 84 GLU.? 10.45 C3 GOL D 147 B 421 ASP A 87 ASP.? 8.49 C6 PGE A 147 coo 25.90 8.19 53.87 25.36 6.97 52.29 -19.46 70.43 -3.04 -19.06 72.28 -2.05 coo 27.87 10.66 47.95 27.82 8.60 48.27 -21.01 70.22 3.12 -21.10 71.95 4.30 coo 26.02 1.87 43.38 25.90 1.97 45.49 -23.17 58.67 3.55 -22.34 59.17 1.69 ULMN 3 1bvz_c09 ALPHA-AMYLASE II user 3 3 # 3 B 325 ASP B 56 ASP~? 11.45 C20 PE8 B 148 B 354 GLU B 111 GLU~? 12.54 O7 PE8 B 148 B 421 ASP B 106 ASP~? 11.87 OH2 1PE B 150 coo 25.90 8.19 53.87 25.36 6.97 52.29 6.80 78.21 26.00 8.47 79.07 25.03 coo 27.87 10.66 47.95 27.82 8.60 48.27 9.41 70.70 25.55 11.25 69.94 26.27 coo 26.02 1.87 43.38 25.90 1.97 45.49 -0.30 70.27 27.08 -0.10 70.78 25.05 ULMN 3 1bvz_c09 ALPHA-AMYLASE II user 4 3 # 4 B 325 ASP B 83 ASP.? 9.40 O3 GOL C 149 B 354 GLU B 84 GLU.? 10.31 O3 GOL C 149 B 421 ASP B 87 ASP.? 8.94 O4 PGE B 147 coo 25.90 8.19 53.87 25.36 6.97 52.29 13.62 86.10 55.23 12.83 84.59 56.49 coo 27.87 10.66 47.95 27.82 8.60 48.27 7.66 84.31 53.13 6.13 83.49 54.35 coo 26.02 1.87 43.38 25.90 1.97 45.49 9.49 87.97 42.02 11.31 87.98 43.09 ULMN 3 1bvz_c09 ALPHA-AMYLASE II user 5 3 # 5 B 325 ASP B 122 ASP^? 7.33 O2 GOL B 149 B 354 GLU B 121 GLU^? 8.74 O2 PEG B 144 B 421 ASP B 83 ASP.? 9.40 O3 GOL C 149 coo 25.90 8.19 53.87 25.36 6.97 52.29 10.89 79.68 47.57 9.75 78.80 49.16 coo 27.87 10.66 47.95 27.82 8.60 48.27 15.37 80.83 45.64 16.23 82.69 46.15 coo 26.02 1.87 43.38 25.90 1.97 45.49 13.62 86.10 55.23 12.83 84.59 56.49 ULMN 3 1bvz_c09 ALPHA-AMYLASE II user 6 3 # 6 B 325 ASP C 56 ASP~? 9.09 N MLZ C 114 B 354 GLU C 111 GLU~? 3.06 NZ MLZ C 114 B 421 ASP C 106 ASP~? 12.11 C21 PE8 C 148 coo 25.90 8.19 53.87 25.36 6.97 52.29 -16.40 94.43 66.11 -17.63 93.56 67.58 coo 27.87 10.66 47.95 27.82 8.60 48.27 -12.41 98.44 71.96 -11.17 97.70 73.52 coo 26.02 1.87 43.38 25.90 1.97 45.49 -11.06 103.55 63.77 -13.00 104.00 64.35 ULMN 3 1bvz_c09 ALPHA-AMYLASE II user 7 3 # 7 B 325 ASP C 83 ASP.? 8.65 O3 GOL B 149 B 354 GLU C 84 GLU.? 10.77 O2 GOL B 149 B 421 ASP C 87 ASP.? 8.84 O1 PGE C 147 coo 25.90 8.19 53.87 25.36 6.97 52.29 3.02 71.86 58.06 4.88 72.49 57.24 coo 27.87 10.66 47.95 27.82 8.60 48.27 2.34 77.12 55.01 3.46 78.21 53.60 coo 26.02 1.87 43.38 25.90 1.97 45.49 -9.03 79.00 58.44 -8.21 77.39 59.55 ULMN 3 1bvz_c09 ALPHA-AMYLASE II user 8 3 # 8 B 325 ASP C 122 ASP^? 7.22 C3 GOL C 149 B 354 GLU C 121 GLU^? 12.40 C3 GOL C 149 B 421 ASP C 83 ASP.? 8.65 O3 GOL B 149 coo 25.90 8.19 53.87 25.36 6.97 52.29 0.27 81.12 61.60 2.07 81.54 60.53 coo 27.87 10.66 47.95 27.82 8.60 48.27 -1.98 78.69 65.48 -2.54 76.71 65.06 coo 26.02 1.87 43.38 25.90 1.97 45.49 3.02 71.86 58.06 4.88 72.49 57.24 ULMN 3 1bvz_c09 ALPHA-AMYLASE II user 9 3 # 9 B 325 ASP D 56 ASP~? 11.46 C21 2PE D 146 B 354 GLU D 111 GLU~? 11.88 C9 2PE D 146 B 421 ASP D 106 ASP~? 11.82 O22 2PE D 146 coo 25.90 8.19 53.87 25.36 6.97 52.29 -41.85 87.81 13.66 -41.61 89.58 14.80 coo 27.87 10.66 47.95 27.82 8.60 48.27 -43.22 91.45 6.64 -41.92 92.74 5.57 coo 26.02 1.87 43.38 25.90 1.97 45.49 -46.82 82.57 5.87 -48.37 83.43 7.00 ULMN 3 1bvz_c09 ALPHA-AMYLASE II user 10 3 # 10 B 325 ASP D 83 ASP.? 8.76 O1 GOL A 150 B 354 GLU D 84 GLU.? 10.79 C1 GOL A 150 B 421 ASP D 87 ASP.? 7.26 C16 1PE B 150 coo 25.90 8.19 53.87 25.36 6.97 52.29 -12.54 78.43 10.94 -12.46 77.06 9.29 coo 27.87 10.66 47.95 27.82 8.60 48.27 -17.40 74.78 10.23 -17.69 72.96 9.24 coo 26.02 1.87 43.38 25.90 1.97 45.49 -24.70 80.89 17.41 -22.90 81.94 17.31 1bvz_c09 source 1bvz ALPHA-AMYLASE II : 10 hits 1bvz_c09 naa= 3 ULMN 3 1c54_c00 RIBONUCLEASE SA user 1 3 # 1 A 54 GLU A 48 GLU~? 14.04 CG MLY D 135 A 65 ARG A 42 ARG.? 16.81 C11 2PE A 148 A 85 HIS A 115 HIS~? 12.27 C21 2PE A 148 coo -3.75 5.08 -16.45 -4.49 7.03 -16.67 -19.52 46.65 2.13 -18.86 45.41 0.50 coo -11.31 0.89 -21.51 -13.74 2.37 -20.15 -8.57 45.71 4.07 -9.11 44.76 6.92 coo -11.98 -0.40 -12.41 -12.65 1.37 -13.15 -13.18 48.35 10.37 -12.55 46.36 10.33 ULMN 3 1c54_c00 RIBONUCLEASE SA user 2 3 # 2 A 54 GLU A 48 GLU~? 14.04 CG MLY D 135 A 65 ARG A 55 ARG~? 10.23 CD MLY D 135 A 85 HIS A 115 HIS~? 12.27 C21 2PE A 148 coo -3.75 5.08 -16.45 -4.49 7.03 -16.67 -19.52 46.65 2.13 -18.86 45.41 0.50 coo -11.31 0.89 -21.51 -13.74 2.37 -20.15 -19.70 43.33 11.87 -20.69 44.07 9.04 coo -11.98 -0.40 -12.41 -12.65 1.37 -13.15 -13.18 48.35 10.37 -12.55 46.36 10.33 ULMN 3 1c54_c00 RIBONUCLEASE SA user 3 3 # 3 A 54 GLU B 48 GLU~? 13.73 O1 PEG B 144 A 65 ARG B 42 ARG.? 12.70 O1 PEG B 144 A 85 HIS B 115 HIS~? 12.48 C18 PE8 B 148 coo -3.75 5.08 -16.45 -4.49 7.03 -16.67 16.05 87.39 31.22 18.08 87.70 30.57 coo -11.31 0.89 -21.51 -13.74 2.37 -20.15 19.61 78.53 29.44 17.94 76.42 28.00 coo -11.98 -0.40 -12.41 -12.65 1.37 -13.15 11.86 77.76 30.05 12.70 77.49 28.15 ULMN 3 1c54_c00 RIBONUCLEASE SA user 4 3 # 4 A 54 GLU B 48 GLU~? 13.73 O1 PEG B 144 A 65 ARG B 55 ARG~? 9.33 CG MLY C 135 A 85 HIS B 115 HIS~? 12.48 C18 PE8 B 148 coo -3.75 5.08 -16.45 -4.49 7.03 -16.67 16.05 87.39 31.22 18.08 87.70 30.57 coo -11.31 0.89 -21.51 -13.74 2.37 -20.15 8.78 84.29 24.99 10.39 86.20 26.77 coo -11.98 -0.40 -12.41 -12.65 1.37 -13.15 11.86 77.76 30.05 12.70 77.49 28.15 ULMN 3 1c54_c00 RIBONUCLEASE SA user 5 3 # 5 A 54 GLU C 48 GLU~? 14.22 O MLZ C 114 A 65 ARG C 42 ARG.? 7.63 O MLZ C 114 A 85 HIS C 115 HIS~? 4.72 C MLZ C 114 coo -3.75 5.08 -16.45 -4.49 7.03 -16.67 -17.56 80.63 67.68 -18.20 79.53 69.43 coo -11.31 0.89 -21.51 -13.74 2.37 -20.15 -13.55 84.90 75.42 -13.77 88.03 75.38 coo -11.98 -0.40 -12.41 -12.65 1.37 -13.15 -12.99 90.00 69.08 -14.38 90.57 70.54 ULMN 3 1c54_c00 RIBONUCLEASE SA user 6 3 # 6 A 54 GLU C 48 GLU~? 14.22 O MLZ C 114 A 65 ARG C 55 ARG~? 9.18 O MLY B 135 A 85 HIS C 115 HIS~? 4.72 C MLZ C 114 coo -3.75 5.08 -16.45 -4.49 7.03 -16.67 -17.56 80.63 67.68 -18.20 79.53 69.43 coo -11.31 0.89 -21.51 -13.74 2.37 -20.15 -21.06 89.68 64.73 -20.37 86.74 65.24 coo -11.98 -0.40 -12.41 -12.65 1.37 -13.15 -12.99 90.00 69.08 -14.38 90.57 70.54 ULMN 3 1c54_c00 RIBONUCLEASE SA user 7 3 # 7 A 54 GLU D 48 GLU~? 13.85 CG MLY A 135 A 65 ARG D 42 ARG.? 16.60 C9 2PE D 146 A 85 HIS D 115 HIS~? 12.18 C21 2PE D 146 coo -3.75 5.08 -16.45 -4.49 7.03 -16.67 -30.39 91.81 20.65 -29.75 93.83 21.10 coo -11.31 0.89 -21.51 -13.74 2.37 -20.15 -32.78 97.24 12.74 -35.35 96.85 11.13 coo -11.98 -0.40 -12.41 -12.65 1.37 -13.15 -36.28 90.32 11.92 -37.49 91.98 12.35 ULMN 3 1c54_c00 RIBONUCLEASE SA user 8 3 # 8 A 54 GLU D 48 GLU~? 13.85 CG MLY A 135 A 65 ARG D 55 ARG~? 9.16 CG MLY A 135 A 85 HIS D 115 HIS~? 12.18 C21 2PE D 146 coo -3.75 5.08 -16.45 -4.49 7.03 -16.67 -30.39 91.81 20.65 -29.75 93.83 21.10 coo -11.31 0.89 -21.51 -13.74 2.37 -20.15 -39.98 89.02 19.79 -37.17 89.06 21.03 coo -11.98 -0.40 -12.41 -12.65 1.37 -13.15 -36.28 90.32 11.92 -37.49 91.98 12.35 1c54_c00 source 1c54 RIBONUCLEASE SA : 8 hits 1c54_c00 naa= 3 ULMN 3 1c82_c01 HYALURONATE LYASE user 1 3 # 1 A 399 HIS A 115 HIS~? 12.27 C21 2PE A 148 A 408 TYR A 53 TYR~? -4.55 C21 2PE A 148s A 462 ARG A 55 ARG~? 10.23 CD MLY D 135 coo 13.02 -18.02 35.24 12.75 -16.25 34.15 -13.18 48.35 10.37 -12.55 46.36 10.33 coo 7.81 -17.82 32.55 9.60 -15.69 32.78 -16.76 52.42 13.05 -16.88 54.33 15.10 coo 10.34 -11.56 38.02 10.61 -11.96 35.00 -19.70 43.33 11.87 -20.69 44.07 9.04 ULMN 3 1c82_c01 HYALURONATE LYASE user 2 3 # 2 A 399 HIS B 115 HIS~? 12.48 C18 PE8 B 148 A 408 TYR B 53 TYR~? -4.63 C18 PE8 B 148s A 462 ARG B 55 ARG~? 9.33 CG MLY C 135 coo 13.02 -18.02 35.24 12.75 -16.25 34.15 11.86 77.76 30.05 12.70 77.49 28.15 coo 7.81 -17.82 32.55 9.60 -15.69 32.78 6.73 78.96 33.00 4.51 77.73 34.14 coo 10.34 -11.56 38.02 10.61 -11.96 35.00 8.78 84.29 24.99 10.39 86.20 26.77 ULMN 3 1c82_c01 HYALURONATE LYASE user 3 3 # 3 A 399 HIS C 115 HIS~? 4.72 C MLZ C 114 A 408 TYR C 53 TYR~? -4.98 C18 PE8 C 148s A 462 ARG C 55 ARG~? 9.18 O MLY B 135 coo 13.02 -18.02 35.24 12.75 -16.25 34.15 -12.99 90.00 69.08 -14.38 90.57 70.54 coo 7.81 -17.82 32.55 9.60 -15.69 32.78 -11.26 90.80 63.43 -9.63 92.35 61.80 coo 10.34 -11.56 38.02 10.61 -11.96 35.00 -21.06 89.68 64.73 -20.37 86.74 65.24 ULMN 3 1c82_c01 HYALURONATE LYASE user 4 3 # 4 A 399 HIS D 115 HIS~? 12.18 C21 2PE D 146 A 408 TYR D 53 TYR~? -4.60 C21 2PE D 146s A 462 ARG D 55 ARG~? 9.16 CG MLY A 135 coo 13.02 -18.02 35.24 12.75 -16.25 34.15 -36.28 90.32 11.92 -37.49 91.98 12.35 coo 7.81 -17.82 32.55 9.60 -15.69 32.78 -36.08 84.35 12.01 -36.58 82.07 10.49 coo 10.34 -11.56 38.02 10.61 -11.96 35.00 -39.98 89.02 19.79 -37.17 89.06 21.03 1c82_c01 source 1c82 HYALURONATE LYASE : 4 hits 1c82_c01 naa= 3 ULMN 3 1c82_c02 HYALURONATE LYASE user 1 3 # 1 A 399 HIS A 115 HIS~? 12.27 C21 2PE A 148 A 408 TYR A 53 TYR~? -4.55 C21 2PE A 148s A 480 ARG A 105 ARG~? -3.04 O2 SO4 A 143s coo 13.02 -18.02 35.24 12.75 -16.25 34.15 -13.18 48.35 10.37 -12.55 46.36 10.33 coo 7.81 -17.82 32.55 9.60 -15.69 32.78 -16.76 52.42 13.05 -16.88 54.33 15.10 coo -6.46 -13.31 26.85 -4.21 -11.25 27.13 -8.78 56.32 28.12 -7.90 58.53 30.04 ULMN 3 1c82_c02 HYALURONATE LYASE user 2 3 # 2 A 399 HIS A 115 HIS~? 12.27 C21 2PE A 148 A 408 TYR A 53 TYR~? -4.55 C21 2PE A 148s A 480 ARG A 124 ARG^? 8.18 C1 GOL A 150 coo 13.02 -18.02 35.24 12.75 -16.25 34.15 -13.18 48.35 10.37 -12.55 46.36 10.33 coo 7.81 -17.82 32.55 9.60 -15.69 32.78 -16.76 52.42 13.05 -16.88 54.33 15.10 coo -6.46 -13.31 26.85 -4.21 -11.25 27.13 -17.35 69.10 10.18 -16.14 69.37 7.36 ULMN 3 1c82_c02 HYALURONATE LYASE user 3 3 # 3 A 399 HIS B 115 HIS~? 12.48 C18 PE8 B 148 A 408 TYR B 53 TYR~? -4.63 C18 PE8 B 148s A 480 ARG B 105 ARG~? -3.01 O4 SO4 A 143s coo 13.02 -18.02 35.24 12.75 -16.25 34.15 11.86 77.76 30.05 12.70 77.49 28.15 coo 7.81 -17.82 32.55 9.60 -15.69 32.78 6.73 78.96 33.00 4.51 77.73 34.14 coo -6.46 -13.31 26.85 -4.21 -11.25 27.13 -2.68 64.28 31.62 -4.52 62.28 32.99 ULMN 3 1c82_c02 HYALURONATE LYASE user 4 3 # 4 A 399 HIS B 115 HIS~? 12.48 C18 PE8 B 148 A 408 TYR B 53 TYR~? -4.63 C18 PE8 B 148s A 480 ARG B 124 ARG^? 8.02 O2 GOL B 149 coo 13.02 -18.02 35.24 12.75 -16.25 34.15 11.86 77.76 30.05 12.70 77.49 28.15 coo 7.81 -17.82 32.55 9.60 -15.69 32.78 6.73 78.96 33.00 4.51 77.73 34.14 coo -6.46 -13.31 26.85 -4.21 -11.25 27.13 3.96 78.02 49.67 6.79 78.26 50.86 ULMN 3 1c82_c02 HYALURONATE LYASE user 5 3 # 5 A 399 HIS C 115 HIS~? 4.72 C MLZ C 114 A 408 TYR C 53 TYR~? -4.98 C18 PE8 C 148s A 480 ARG C 105 ARG~? -3.12 O1 SO4 C 143s coo 13.02 -18.02 35.24 12.75 -16.25 34.15 -12.99 90.00 69.08 -14.38 90.57 70.54 coo 7.81 -17.82 32.55 9.60 -15.69 32.78 -11.26 90.80 63.43 -9.63 92.35 61.80 coo -6.46 -13.31 26.85 -4.21 -11.25 27.13 -3.93 106.64 63.12 -1.78 108.52 62.12 ULMN 3 1c82_c02 HYALURONATE LYASE user 6 3 # 6 A 399 HIS C 115 HIS~? 4.72 C MLZ C 114 A 408 TYR C 53 TYR~? -4.98 C18 PE8 C 148s A 480 ARG C 124 ARG^? 7.92 C3 GOL C 149 coo 13.02 -18.02 35.24 12.75 -16.25 34.15 -12.99 90.00 69.08 -14.38 90.57 70.54 coo 7.81 -17.82 32.55 9.60 -15.69 32.78 -11.26 90.80 63.43 -9.63 92.35 61.80 coo -6.46 -13.31 26.85 -4.21 -11.25 27.13 2.87 85.20 55.95 3.74 82.90 57.81 ULMN 3 1c82_c02 HYALURONATE LYASE user 7 3 # 7 A 399 HIS D 115 HIS~? 12.18 C21 2PE D 146 A 408 TYR D 53 TYR~? -4.60 C21 2PE D 146s A 480 ARG D 105 ARG~? -8.15 O1 2PE D 146s coo 13.02 -18.02 35.24 12.75 -16.25 34.15 -36.28 90.32 11.92 -37.49 91.98 12.35 coo 7.81 -17.82 32.55 9.60 -15.69 32.78 -36.08 84.35 12.01 -36.58 82.07 10.49 coo -6.46 -13.31 26.85 -4.21 -11.25 27.13 -46.14 79.22 -1.30 -46.45 77.32 -3.67 ULMN 3 1c82_c02 HYALURONATE LYASE user 8 3 # 8 A 399 HIS D 115 HIS~? 12.18 C21 2PE D 146 A 408 TYR D 53 TYR~? -4.60 C21 2PE D 146s A 480 ARG D 124 ARG^? 7.97 C3 GOL D 147 coo 13.02 -18.02 35.24 12.75 -16.25 34.15 -36.28 90.32 11.92 -37.49 91.98 12.35 coo 7.81 -17.82 32.55 9.60 -15.69 32.78 -36.08 84.35 12.01 -36.58 82.07 10.49 coo -6.46 -13.31 26.85 -4.21 -11.25 27.13 -24.04 74.20 5.58 -21.67 76.16 5.44 1c82_c02 source 1c82 HYALURONATE LYASE : 8 hits 1c82_c02 naa= 3 ULMN 3 1cb7_c06 GLUTAMATE MUTASE user 1 3 # 1 A 14 ASP A 56 ASP~? 11.59 C21 2PE A 148 A 16 HIS A 115 HIS~? 12.27 C21 2PE A 148 A 67 GLY A 58 GLY~? 4.50 C27 2PE A 148 coo 11.02 -13.08 77.25 10.70 -11.13 76.52 -16.01 45.89 15.64 -15.93 44.31 14.23 coo 7.44 -8.54 76.22 7.57 -7.67 78.12 -13.18 48.35 10.37 -12.55 46.36 10.33 coo 18.64 -11.26 77.99 18.99 -11.13 78.72 -21.53 48.90 19.09 -20.88 48.61 19.49 ULMN 3 1cb7_c06 GLUTAMATE MUTASE user 2 3 # 2 A 14 ASP A 83 ASP.? 8.52 O3 GOL D 147 A 16 HIS A 85 HIS.? 6.69 C5 PGE A 147 A 67 GLY A 80 GLY.? 7.76 C1 GOL D 147 coo 11.02 -13.08 77.25 10.70 -11.13 76.52 -19.46 70.43 -3.04 -19.06 72.28 -2.05 coo 7.44 -8.54 76.22 7.57 -7.67 78.12 -23.05 64.43 -0.55 -21.68 63.00 -1.25 coo 18.64 -11.26 77.99 18.99 -11.13 78.72 -25.41 75.48 2.13 -25.84 75.58 1.39 ULMN 3 1cb7_c06 GLUTAMATE MUTASE user 3 3 # 3 A 14 ASP A 87 ASP.? 8.49 C6 PGE A 147 A 16 HIS A 85 HIS.? 6.69 C5 PGE A 147 A 67 GLY A 46 GLY~? 12.01 CD MLY D 135 coo 11.02 -13.08 77.25 10.70 -11.13 76.52 -23.17 58.67 3.55 -22.34 59.17 1.69 coo 7.44 -8.54 76.22 7.57 -7.67 78.12 -23.05 64.43 -0.55 -21.68 63.00 -1.25 coo 18.64 -11.26 77.99 18.99 -11.13 78.72 -16.75 52.82 2.36 -17.28 52.20 2.20 ULMN 3 1cb7_c06 GLUTAMATE MUTASE user 4 3 # 4 A 14 ASP A 87 ASP.? 8.49 C6 PGE A 147 A 16 HIS A 88 HIS^? 4.20 CH2 MLY D 135 A 67 GLY A 46 GLY~? 12.01 CD MLY D 135 coo 11.02 -13.08 77.25 10.70 -11.13 76.52 -23.17 58.67 3.55 -22.34 59.17 1.69 coo 7.44 -8.54 76.22 7.57 -7.67 78.12 -23.95 56.87 7.77 -24.14 54.98 6.86 coo 18.64 -11.26 77.99 18.99 -11.13 78.72 -16.75 52.82 2.36 -17.28 52.20 2.20 ULMN 3 1cb7_c06 GLUTAMATE MUTASE user 5 3 # 5 A 14 ASP B 56 ASP~? 11.45 C20 PE8 B 148 A 16 HIS B 115 HIS~? 12.48 C18 PE8 B 148 A 67 GLY B 58 GLY~? 4.95 C24 PE8 B 148 coo 11.02 -13.08 77.25 10.70 -11.13 76.52 6.80 78.21 26.00 8.47 79.07 25.03 coo 7.44 -8.54 76.22 7.57 -7.67 78.12 11.86 77.76 30.05 12.70 77.49 28.15 coo 18.64 -11.26 77.99 18.99 -11.13 78.72 0.41 80.81 27.68 0.49 80.12 27.29 ULMN 3 1cb7_c06 GLUTAMATE MUTASE user 6 3 # 6 A 14 ASP B 83 ASP.? 9.40 O3 GOL C 149 A 16 HIS B 85 HIS.? 6.66 C6 PGE B 147 A 67 GLY B 80 GLY.? 7.38 C3 GOL C 149 coo 11.02 -13.08 77.25 10.70 -11.13 76.52 13.62 86.10 55.23 12.83 84.59 56.49 coo 7.44 -8.54 76.22 7.57 -7.67 78.12 11.11 88.86 48.90 12.76 88.34 47.73 coo 18.64 -11.26 77.99 18.99 -11.13 78.72 4.67 87.66 58.38 5.02 88.38 58.71 ULMN 3 1cb7_c06 GLUTAMATE MUTASE user 7 3 # 7 A 14 ASP B 87 ASP.? 8.94 O4 PGE B 147 A 16 HIS B 85 HIS.? 6.66 C6 PGE B 147 A 67 GLY B 46 GLY~? 9.70 O1 PEG B 144 coo 11.02 -13.08 77.25 10.70 -11.13 76.52 9.49 87.97 42.02 11.31 87.98 43.09 coo 7.44 -8.54 76.22 7.57 -7.67 78.12 11.11 88.86 48.90 12.76 88.34 47.73 coo 18.64 -11.26 77.99 18.99 -11.13 78.72 15.35 83.93 36.97 15.42 84.55 36.41 ULMN 3 1cb7_c06 GLUTAMATE MUTASE user 8 3 # 8 A 14 ASP B 87 ASP.? 8.94 O4 PGE B 147 A 16 HIS B 88 HIS^? 4.29 CH1 MLY C 135 A 67 GLY B 46 GLY~? 9.70 O1 PEG B 144 coo 11.02 -13.08 77.25 10.70 -11.13 76.52 9.49 87.97 42.02 11.31 87.98 43.09 coo 7.44 -8.54 76.22 7.57 -7.67 78.12 6.15 87.00 38.94 7.35 87.96 37.51 coo 18.64 -11.26 77.99 18.99 -11.13 78.72 15.35 83.93 36.97 15.42 84.55 36.41 ULMN 3 1cb7_c06 GLUTAMATE MUTASE user 9 3 # 9 A 14 ASP C 56 ASP~? 9.09 N MLZ C 114 A 16 HIS C 115 HIS~? 4.72 C MLZ C 114 A 67 GLY C 58 GLY~? 5.12 O25 PE8 C 148 coo 11.02 -13.08 77.25 10.70 -11.13 76.52 -16.40 94.43 66.11 -17.63 93.56 67.58 coo 7.44 -8.54 76.22 7.57 -7.67 78.12 -12.99 90.00 69.08 -14.38 90.57 70.54 coo 18.64 -11.26 77.99 18.99 -11.13 78.72 -16.70 95.68 59.15 -16.57 96.27 59.66 ULMN 3 1cb7_c06 GLUTAMATE MUTASE user 10 3 # 10 A 14 ASP C 83 ASP.? 8.65 O3 GOL B 149 A 16 HIS C 85 HIS.? 6.34 C1 PGE C 147 A 67 GLY C 80 GLY.? 7.77 O2 GOL B 149 coo 11.02 -13.08 77.25 10.70 -11.13 76.52 3.02 71.86 58.06 4.88 72.49 57.24 coo 7.44 -8.54 76.22 7.57 -7.67 78.12 -4.08 74.18 57.17 -4.69 74.12 59.17 coo 18.64 -11.26 77.99 18.99 -11.13 78.72 4.31 74.26 49.15 4.26 73.42 48.97 ULMN 3 1cb7_c06 GLUTAMATE MUTASE user 11 3 # 11 A 14 ASP C 87 ASP.? 8.84 O1 PGE C 147 A 16 HIS C 85 HIS.? 6.34 C1 PGE C 147 A 67 GLY C 46 GLY~? 10.04 O MLZ C 114 coo 11.02 -13.08 77.25 10.70 -11.13 76.52 -9.03 79.00 58.44 -8.21 77.39 59.55 coo 7.44 -8.54 76.22 7.57 -7.67 78.12 -4.08 74.18 57.17 -4.69 74.12 59.17 coo 18.64 -11.26 77.99 18.99 -11.13 78.72 -10.91 80.74 66.75 -11.70 80.52 66.65 ULMN 3 1cb7_c06 GLUTAMATE MUTASE user 12 3 # 12 A 14 ASP C 87 ASP.? 8.84 O1 PGE C 147 A 16 HIS C 88 HIS^? 3.86 CD MLY B 135 A 67 GLY C 46 GLY~? 10.04 O MLZ C 114 coo 11.02 -13.08 77.25 10.70 -11.13 76.52 -9.03 79.00 58.44 -8.21 77.39 59.55 coo 7.44 -8.54 76.22 7.57 -7.67 78.12 -11.00 83.03 57.18 -12.69 82.43 58.26 coo 18.64 -11.26 77.99 18.99 -11.13 78.72 -10.91 80.74 66.75 -11.70 80.52 66.65 ULMN 3 1cb7_c06 GLUTAMATE MUTASE user 13 3 # 13 A 14 ASP D 56 ASP~? 11.46 C21 2PE D 146 A 16 HIS D 115 HIS~? 12.18 C21 2PE D 146 A 67 GLY D 58 GLY~? 4.33 O28 2PE D 146 coo 11.02 -13.08 77.25 10.70 -11.13 76.52 -41.85 87.81 13.66 -41.61 89.58 14.80 coo 7.44 -8.54 76.22 7.57 -7.67 78.12 -36.28 90.32 11.92 -37.49 91.98 12.35 coo 18.64 -11.26 77.99 18.99 -11.13 78.72 -43.01 81.01 15.62 -43.47 81.37 15.05 ULMN 3 1cb7_c06 GLUTAMATE MUTASE user 14 3 # 14 A 14 ASP D 83 ASP.? 8.76 O1 GOL A 150 A 16 HIS D 85 HIS.? 4.73 OH7 1PE B 150 A 67 GLY D 80 GLY.? 7.47 C2 GOL A 150 coo 11.02 -13.08 77.25 10.70 -11.13 76.52 -12.54 78.43 10.94 -12.46 77.06 9.29 coo 7.44 -8.54 76.22 7.57 -7.67 78.12 -18.08 79.12 16.04 -18.14 81.21 15.79 coo 18.64 -11.26 77.99 18.99 -11.13 78.72 -13.78 69.07 11.78 -13.14 69.11 12.34 ULMN 3 1cb7_c06 GLUTAMATE MUTASE user 15 3 # 15 A 14 ASP D 87 ASP.? 7.26 C16 1PE B 150 A 16 HIS D 85 HIS.? 4.73 OH7 1PE B 150 A 67 GLY D 46 GLY~? 12.21 CD MLY A 135 coo 11.02 -13.08 77.25 10.70 -11.13 76.52 -24.70 80.89 17.41 -22.90 81.94 17.31 coo 7.44 -8.54 76.22 7.57 -7.67 78.12 -18.08 79.12 16.04 -18.14 81.21 15.79 coo 18.64 -11.26 77.99 18.99 -11.13 78.72 -27.16 89.12 15.33 -27.37 89.29 16.11 ULMN 3 1cb7_c06 GLUTAMATE MUTASE user 16 3 # 16 A 14 ASP D 87 ASP.? 7.26 C16 1PE B 150 A 16 HIS D 88 HIS^? 4.38 CH1 MLY A 135 A 67 GLY D 46 GLY~? 12.21 CD MLY A 135 coo 11.02 -13.08 77.25 10.70 -11.13 76.52 -24.70 80.89 17.41 -22.90 81.94 17.31 coo 7.44 -8.54 76.22 7.57 -7.67 78.12 -29.18 79.71 17.63 -29.43 81.25 19.03 coo 18.64 -11.26 77.99 18.99 -11.13 78.72 -27.16 89.12 15.33 -27.37 89.29 16.11 1cb7_c06 source 1cb7 GLUTAMATE MUTASE : 16 hits 1cb7_c06 naa= 3 ULMN 3 1cb7_c07 GLUTAMATE MUTASE user 1 3 # 1 C 14 ASP A 56 ASP~? 11.59 C21 2PE A 148 C 16 HIS A 115 HIS~? 12.27 C21 2PE A 148 C 67 GLY A 58 GLY~? 4.50 C27 2PE A 148 coo 10.04 44.27 88.44 9.47 42.32 89.03 -16.01 45.89 15.64 -15.93 44.31 14.23 coo 6.38 39.80 88.71 6.88 38.89 86.87 -13.18 48.35 10.37 -12.55 46.36 10.33 coo 17.63 42.50 89.25 18.11 42.29 88.64 -21.53 48.90 19.09 -20.88 48.61 19.49 ULMN 3 1cb7_c07 GLUTAMATE MUTASE user 2 3 # 2 C 14 ASP A 83 ASP.? 8.52 O3 GOL D 147 C 16 HIS A 85 HIS.? 6.69 C5 PGE A 147 C 67 GLY A 80 GLY.? 7.76 C1 GOL D 147 coo 10.04 44.27 88.44 9.47 42.32 89.03 -19.46 70.43 -3.04 -19.06 72.28 -2.05 coo 6.38 39.80 88.71 6.88 38.89 86.87 -23.05 64.43 -0.55 -21.68 63.00 -1.25 coo 17.63 42.50 89.25 18.11 42.29 88.64 -25.41 75.48 2.13 -25.84 75.58 1.39 ULMN 3 1cb7_c07 GLUTAMATE MUTASE user 3 3 # 3 C 14 ASP A 87 ASP.? 8.49 C6 PGE A 147 C 16 HIS A 85 HIS.? 6.69 C5 PGE A 147 C 67 GLY A 46 GLY~? 12.01 CD MLY D 135 coo 10.04 44.27 88.44 9.47 42.32 89.03 -23.17 58.67 3.55 -22.34 59.17 1.69 coo 6.38 39.80 88.71 6.88 38.89 86.87 -23.05 64.43 -0.55 -21.68 63.00 -1.25 coo 17.63 42.50 89.25 18.11 42.29 88.64 -16.75 52.82 2.36 -17.28 52.20 2.20 ULMN 3 1cb7_c07 GLUTAMATE MUTASE user 4 3 # 4 C 14 ASP A 87 ASP.? 8.49 C6 PGE A 147 C 16 HIS A 88 HIS^? 4.20 CH2 MLY D 135 C 67 GLY A 46 GLY~? 12.01 CD MLY D 135 coo 10.04 44.27 88.44 9.47 42.32 89.03 -23.17 58.67 3.55 -22.34 59.17 1.69 coo 6.38 39.80 88.71 6.88 38.89 86.87 -23.95 56.87 7.77 -24.14 54.98 6.86 coo 17.63 42.50 89.25 18.11 42.29 88.64 -16.75 52.82 2.36 -17.28 52.20 2.20 ULMN 3 1cb7_c07 GLUTAMATE MUTASE user 5 3 # 5 C 14 ASP B 56 ASP~? 11.45 C20 PE8 B 148 C 16 HIS B 115 HIS~? 12.48 C18 PE8 B 148 C 67 GLY B 58 GLY~? 4.95 C24 PE8 B 148 coo 10.04 44.27 88.44 9.47 42.32 89.03 6.80 78.21 26.00 8.47 79.07 25.03 coo 6.38 39.80 88.71 6.88 38.89 86.87 11.86 77.76 30.05 12.70 77.49 28.15 coo 17.63 42.50 89.25 18.11 42.29 88.64 0.41 80.81 27.68 0.49 80.12 27.29 ULMN 3 1cb7_c07 GLUTAMATE MUTASE user 6 3 # 6 C 14 ASP B 83 ASP.? 9.40 O3 GOL C 149 C 16 HIS B 85 HIS.? 6.66 C6 PGE B 147 C 67 GLY B 80 GLY.? 7.38 C3 GOL C 149 coo 10.04 44.27 88.44 9.47 42.32 89.03 13.62 86.10 55.23 12.83 84.59 56.49 coo 6.38 39.80 88.71 6.88 38.89 86.87 11.11 88.86 48.90 12.76 88.34 47.73 coo 17.63 42.50 89.25 18.11 42.29 88.64 4.67 87.66 58.38 5.02 88.38 58.71 ULMN 3 1cb7_c07 GLUTAMATE MUTASE user 7 3 # 7 C 14 ASP B 87 ASP.? 8.94 O4 PGE B 147 C 16 HIS B 85 HIS.? 6.66 C6 PGE B 147 C 67 GLY B 46 GLY~? 9.70 O1 PEG B 144 coo 10.04 44.27 88.44 9.47 42.32 89.03 9.49 87.97 42.02 11.31 87.98 43.09 coo 6.38 39.80 88.71 6.88 38.89 86.87 11.11 88.86 48.90 12.76 88.34 47.73 coo 17.63 42.50 89.25 18.11 42.29 88.64 15.35 83.93 36.97 15.42 84.55 36.41 ULMN 3 1cb7_c07 GLUTAMATE MUTASE user 8 3 # 8 C 14 ASP B 87 ASP.? 8.94 O4 PGE B 147 C 16 HIS B 88 HIS^? 4.29 CH1 MLY C 135 C 67 GLY B 46 GLY~? 9.70 O1 PEG B 144 coo 10.04 44.27 88.44 9.47 42.32 89.03 9.49 87.97 42.02 11.31 87.98 43.09 coo 6.38 39.80 88.71 6.88 38.89 86.87 6.15 87.00 38.94 7.35 87.96 37.51 coo 17.63 42.50 89.25 18.11 42.29 88.64 15.35 83.93 36.97 15.42 84.55 36.41 ULMN 3 1cb7_c07 GLUTAMATE MUTASE user 9 3 # 9 C 14 ASP C 56 ASP~? 9.09 N MLZ C 114 C 16 HIS C 115 HIS~? 4.72 C MLZ C 114 C 67 GLY C 58 GLY~? 5.12 O25 PE8 C 148 coo 10.04 44.27 88.44 9.47 42.32 89.03 -16.40 94.43 66.11 -17.63 93.56 67.58 coo 6.38 39.80 88.71 6.88 38.89 86.87 -12.99 90.00 69.08 -14.38 90.57 70.54 coo 17.63 42.50 89.25 18.11 42.29 88.64 -16.70 95.68 59.15 -16.57 96.27 59.66 ULMN 3 1cb7_c07 GLUTAMATE MUTASE user 10 3 # 10 C 14 ASP C 83 ASP.? 8.65 O3 GOL B 149 C 16 HIS C 85 HIS.? 6.34 C1 PGE C 147 C 67 GLY C 80 GLY.? 7.77 O2 GOL B 149 coo 10.04 44.27 88.44 9.47 42.32 89.03 3.02 71.86 58.06 4.88 72.49 57.24 coo 6.38 39.80 88.71 6.88 38.89 86.87 -4.08 74.18 57.17 -4.69 74.12 59.17 coo 17.63 42.50 89.25 18.11 42.29 88.64 4.31 74.26 49.15 4.26 73.42 48.97 ULMN 3 1cb7_c07 GLUTAMATE MUTASE user 11 3 # 11 C 14 ASP C 87 ASP.? 8.84 O1 PGE C 147 C 16 HIS C 85 HIS.? 6.34 C1 PGE C 147 C 67 GLY C 46 GLY~? 10.04 O MLZ C 114 coo 10.04 44.27 88.44 9.47 42.32 89.03 -9.03 79.00 58.44 -8.21 77.39 59.55 coo 6.38 39.80 88.71 6.88 38.89 86.87 -4.08 74.18 57.17 -4.69 74.12 59.17 coo 17.63 42.50 89.25 18.11 42.29 88.64 -10.91 80.74 66.75 -11.70 80.52 66.65 ULMN 3 1cb7_c07 GLUTAMATE MUTASE user 12 3 # 12 C 14 ASP C 87 ASP.? 8.84 O1 PGE C 147 C 16 HIS C 88 HIS^? 3.86 CD MLY B 135 C 67 GLY C 46 GLY~? 10.04 O MLZ C 114 coo 10.04 44.27 88.44 9.47 42.32 89.03 -9.03 79.00 58.44 -8.21 77.39 59.55 coo 6.38 39.80 88.71 6.88 38.89 86.87 -11.00 83.03 57.18 -12.69 82.43 58.26 coo 17.63 42.50 89.25 18.11 42.29 88.64 -10.91 80.74 66.75 -11.70 80.52 66.65 ULMN 3 1cb7_c07 GLUTAMATE MUTASE user 13 3 # 13 C 14 ASP D 56 ASP~? 11.46 C21 2PE D 146 C 16 HIS D 115 HIS~? 12.18 C21 2PE D 146 C 67 GLY D 58 GLY~? 4.33 O28 2PE D 146 coo 10.04 44.27 88.44 9.47 42.32 89.03 -41.85 87.81 13.66 -41.61 89.58 14.80 coo 6.38 39.80 88.71 6.88 38.89 86.87 -36.28 90.32 11.92 -37.49 91.98 12.35 coo 17.63 42.50 89.25 18.11 42.29 88.64 -43.01 81.01 15.62 -43.47 81.37 15.05 ULMN 3 1cb7_c07 GLUTAMATE MUTASE user 14 3 # 14 C 14 ASP D 83 ASP.? 8.76 O1 GOL A 150 C 16 HIS D 85 HIS.? 4.73 OH7 1PE B 150 C 67 GLY D 80 GLY.? 7.47 C2 GOL A 150 coo 10.04 44.27 88.44 9.47 42.32 89.03 -12.54 78.43 10.94 -12.46 77.06 9.29 coo 6.38 39.80 88.71 6.88 38.89 86.87 -18.08 79.12 16.04 -18.14 81.21 15.79 coo 17.63 42.50 89.25 18.11 42.29 88.64 -13.78 69.07 11.78 -13.14 69.11 12.34 ULMN 3 1cb7_c07 GLUTAMATE MUTASE user 15 3 # 15 C 14 ASP D 87 ASP.? 7.26 C16 1PE B 150 C 16 HIS D 85 HIS.? 4.73 OH7 1PE B 150 C 67 GLY D 46 GLY~? 12.21 CD MLY A 135 coo 10.04 44.27 88.44 9.47 42.32 89.03 -24.70 80.89 17.41 -22.90 81.94 17.31 coo 6.38 39.80 88.71 6.88 38.89 86.87 -18.08 79.12 16.04 -18.14 81.21 15.79 coo 17.63 42.50 89.25 18.11 42.29 88.64 -27.16 89.12 15.33 -27.37 89.29 16.11 ULMN 3 1cb7_c07 GLUTAMATE MUTASE user 16 3 # 16 C 14 ASP D 87 ASP.? 7.26 C16 1PE B 150 C 16 HIS D 88 HIS^? 4.38 CH1 MLY A 135 C 67 GLY D 46 GLY~? 12.21 CD MLY A 135 coo 10.04 44.27 88.44 9.47 42.32 89.03 -24.70 80.89 17.41 -22.90 81.94 17.31 coo 6.38 39.80 88.71 6.88 38.89 86.87 -29.18 79.71 17.63 -29.43 81.25 19.03 coo 17.63 42.50 89.25 18.11 42.29 88.64 -27.16 89.12 15.33 -27.37 89.29 16.11 1cb7_c07 source 1cb7 GLUTAMATE MUTASE : 16 hits 1cb7_c07 naa= 3 ULMN 3 1cb8_c00 CHONDROITINASE AC user 1 3 # 1 A 175 ASN A 28 ASN^? 3.50 CL CL A 145s A 225 HIS A 88 HIS^? 4.20 CH2 MLY D 135 A 234 TYR A 50 TYR~? 5.51 CH2 MLY D 135 coo 26.32 35.76 46.63 26.28 33.63 46.67 -22.13 61.51 13.69 -20.95 60.87 15.35 coo 27.04 28.61 41.75 26.86 28.65 43.84 -23.95 56.87 7.77 -24.14 54.98 6.86 coo 21.80 30.48 43.67 23.70 29.06 45.12 -19.50 53.98 8.67 -20.18 55.72 10.74 ULMN 3 1cb8_c00 CHONDROITINASE AC user 2 3 # 2 A 175 ASN B 28 ASN^? 3.43 CL CL B 143s A 225 HIS B 88 HIS^? 4.29 CH1 MLY C 135 A 234 TYR B 50 TYR~? 5.52 CH1 MLY C 135 coo 26.32 35.76 46.63 26.28 33.63 46.67 0.96 81.77 41.38 0.26 80.18 40.18 coo 27.04 28.61 41.75 26.86 28.65 43.84 6.15 87.00 38.94 7.35 87.96 37.51 coo 21.80 30.48 43.67 23.70 29.06 45.12 8.51 83.11 35.90 5.93 82.51 36.84 ULMN 3 1cb8_c00 CHONDROITINASE AC user 3 3 # 3 A 175 ASN C 28 ASN^? 3.42 CL CL C 144s A 225 HIS C 88 HIS^? 3.86 CD MLY B 135 A 234 TYR C 50 TYR~? 5.59 CE MLY B 135 coo 26.32 35.76 46.63 26.28 33.63 46.67 -6.06 88.35 54.50 -6.05 90.38 55.16 coo 27.04 28.61 41.75 26.86 28.65 43.84 -11.00 83.03 57.18 -12.69 82.43 58.26 coo 21.80 30.48 43.67 23.70 29.06 45.12 -11.27 85.65 61.91 -10.18 87.09 59.78 ULMN 3 1cb8_c00 CHONDROITINASE AC user 4 3 # 4 A 175 ASN D 28 ASN^? 3.51 CL CL D 143s A 225 HIS D 88 HIS^? 4.38 CH1 MLY A 135 A 234 TYR D 50 TYR~? 5.61 CH1 MLY A 135 coo 26.32 35.76 46.63 26.28 33.63 46.67 -31.24 74.87 11.89 -33.01 75.13 10.75 coo 27.04 28.61 41.75 26.86 28.65 43.84 -29.18 79.71 17.63 -29.43 81.25 19.03 coo 21.80 30.48 43.67 23.70 29.06 45.12 -31.54 83.73 14.98 -32.20 81.17 14.09 1cb8_c00 source 1cb8 CHONDROITINASE AC : 4 hits 1cb8_c00 naa= 3 ULMN 3 1cb8_c01 CHONDROITINASE AC user 1 3 # 1 A 225 HIS A 115 HIS~? 12.27 C21 2PE A 148 A 234 TYR A 53 TYR~? -4.55 C21 2PE A 148s A 288 ARG A 55 ARG~? 10.23 CD MLY D 135 coo 27.04 28.61 41.75 26.86 28.65 43.84 -13.18 48.35 10.37 -12.55 46.36 10.33 coo 21.80 30.48 43.67 23.70 29.06 45.12 -16.76 52.42 13.05 -16.88 54.33 15.10 coo 24.79 22.62 45.60 24.87 25.42 46.81 -19.70 43.33 11.87 -20.69 44.07 9.04 ULMN 3 1cb8_c01 CHONDROITINASE AC user 2 3 # 2 A 225 HIS B 115 HIS~? 12.48 C18 PE8 B 148 A 234 TYR B 53 TYR~? -4.63 C18 PE8 B 148s A 288 ARG B 55 ARG~? 9.33 CG MLY C 135 coo 27.04 28.61 41.75 26.86 28.65 43.84 11.86 77.76 30.05 12.70 77.49 28.15 coo 21.80 30.48 43.67 23.70 29.06 45.12 6.73 78.96 33.00 4.51 77.73 34.14 coo 24.79 22.62 45.60 24.87 25.42 46.81 8.78 84.29 24.99 10.39 86.20 26.77 ULMN 3 1cb8_c01 CHONDROITINASE AC user 3 3 # 3 A 225 HIS C 115 HIS~? 4.72 C MLZ C 114 A 234 TYR C 53 TYR~? -4.98 C18 PE8 C 148s A 288 ARG C 55 ARG~? 9.18 O MLY B 135 coo 27.04 28.61 41.75 26.86 28.65 43.84 -12.99 90.00 69.08 -14.38 90.57 70.54 coo 21.80 30.48 43.67 23.70 29.06 45.12 -11.26 90.80 63.43 -9.63 92.35 61.80 coo 24.79 22.62 45.60 24.87 25.42 46.81 -21.06 89.68 64.73 -20.37 86.74 65.24 ULMN 3 1cb8_c01 CHONDROITINASE AC user 4 3 # 4 A 225 HIS D 115 HIS~? 12.18 C21 2PE D 146 A 234 TYR D 53 TYR~? -4.60 C21 2PE D 146s A 288 ARG D 55 ARG~? 9.16 CG MLY A 135 coo 27.04 28.61 41.75 26.86 28.65 43.84 -36.28 90.32 11.92 -37.49 91.98 12.35 coo 21.80 30.48 43.67 23.70 29.06 45.12 -36.08 84.35 12.01 -36.58 82.07 10.49 coo 24.79 22.62 45.60 24.87 25.42 46.81 -39.98 89.02 19.79 -37.17 89.06 21.03 1cb8_c01 source 1cb8 CHONDROITINASE AC : 4 hits 1cb8_c01 naa= 3 ULMN 3 1cbx_c01 CARBOXYPEPTIDASE A (E.C.3.4.17.1) COuser 1 3 # 1 71 ARG A 16 ARG~? -2.82 O4 SO4 A 143s 127 ARG B 105 ARG~? -3.01 O4 SO4 A 143s 270 GLU A 10 GLU~? 8.70 C6 2PE A 148 coo -0.83 25.63 1.57 0.97 28.05 0.90 -9.29 63.37 28.06 -8.90 62.24 30.90 coo 2.68 26.75 -2.61 1.18 28.07 -5.02 -2.68 64.28 31.62 -4.52 62.28 32.99 coo -7.78 30.85 -7.94 -6.11 29.80 -7.25 -3.10 70.57 20.07 -2.45 69.30 18.38 ULMN 3 1cbx_c01 CARBOXYPEPTIDASE A (E.C.3.4.17.1) COuser 2 3 # 2 71 ARG A 20 ARG.? 4.64 CB MLZ A 129 127 ARG A 127 ARG^? 7.47 N MLZ A 129 270 GLU A 93 GLU^? 3.90 NZ MLY A 67 coo -0.83 25.63 1.57 0.97 28.05 0.90 -20.19 69.79 30.19 -22.38 67.97 29.03 coo 2.68 26.75 -2.61 1.18 28.07 -5.02 -18.44 68.25 24.06 -17.70 68.37 27.04 coo -7.78 30.85 -7.94 -6.11 29.80 -7.25 -27.37 60.67 25.57 -29.32 61.09 26.31 ULMN 3 1cbx_c01 CARBOXYPEPTIDASE A (E.C.3.4.17.1) COuser 3 3 # 3 71 ARG A 20 ARG.? 4.64 CB MLZ A 129 127 ARG A 127 ARG^? 7.47 N MLZ A 129 270 GLU B 102 GLU~? 6.18 O4 SO4 A 143 coo -0.83 25.63 1.57 0.97 28.05 0.90 -20.19 69.79 30.19 -22.38 67.97 29.03 coo 2.68 26.75 -2.61 1.18 28.07 -5.02 -18.44 68.25 24.06 -17.70 68.37 27.04 coo -7.78 30.85 -7.94 -6.11 29.80 -7.25 -7.10 67.86 29.77 -6.34 66.05 29.12 ULMN 3 1cbx_c01 CARBOXYPEPTIDASE A (E.C.3.4.17.1) COuser 4 3 # 4 71 ARG A 127 ARG^? 7.47 N MLZ A 129 127 ARG A 20 ARG.? 4.64 CB MLZ A 129 270 GLU A 93 GLU^? 3.90 NZ MLY A 67 coo -0.83 25.63 1.57 0.97 28.05 0.90 -18.44 68.25 24.06 -17.70 68.37 27.04 coo 2.68 26.75 -2.61 1.18 28.07 -5.02 -20.19 69.79 30.19 -22.38 67.97 29.03 coo -7.78 30.85 -7.94 -6.11 29.80 -7.25 -27.37 60.67 25.57 -29.32 61.09 26.31 ULMN 3 1cbx_c01 CARBOXYPEPTIDASE A (E.C.3.4.17.1) COuser 5 3 # 5 71 ARG A 127 ARG^? 7.47 N MLZ A 129 127 ARG A 20 ARG.? 4.64 CB MLZ A 129 270 GLU B 102 GLU~? 6.18 O4 SO4 A 143 coo -0.83 25.63 1.57 0.97 28.05 0.90 -18.44 68.25 24.06 -17.70 68.37 27.04 coo 2.68 26.75 -2.61 1.18 28.07 -5.02 -20.19 69.79 30.19 -22.38 67.97 29.03 coo -7.78 30.85 -7.94 -6.11 29.80 -7.25 -7.10 67.86 29.77 -6.34 66.05 29.12 ULMN 3 1cbx_c01 CARBOXYPEPTIDASE A (E.C.3.4.17.1) COuser 6 3 # 6 71 ARG B 20 ARG.? 7.28 C1 PEG B 146 127 ARG B 127 ARG^? 9.26 O4 SO4 A 144 270 GLU B 93 GLU^? 4.01 CE MLZ B 67 coo -0.83 25.63 1.57 0.97 28.05 0.90 -14.05 70.97 43.62 -13.60 73.76 42.39 coo 2.68 26.75 -2.61 1.18 28.07 -5.02 -7.64 72.55 44.16 -9.78 70.52 43.36 coo -7.78 30.85 -7.94 -6.11 29.80 -7.25 -11.20 80.89 36.50 -12.93 82.08 36.76 ULMN 3 1cbx_c01 CARBOXYPEPTIDASE A (E.C.3.4.17.1) COuser 7 3 # 7 71 ARG B 105 ARG~? -3.01 O4 SO4 A 143s 127 ARG A 16 ARG~? -2.82 O4 SO4 A 143s 270 GLU A 10 GLU~? 8.70 C6 2PE A 148 coo -0.83 25.63 1.57 0.97 28.05 0.90 -2.68 64.28 31.62 -4.52 62.28 32.99 coo 2.68 26.75 -2.61 1.18 28.07 -5.02 -9.29 63.37 28.06 -8.90 62.24 30.90 coo -7.78 30.85 -7.94 -6.11 29.80 -7.25 -3.10 70.57 20.07 -2.45 69.30 18.38 ULMN 3 1cbx_c01 CARBOXYPEPTIDASE A (E.C.3.4.17.1) COuser 8 3 # 8 71 ARG B 105 ARG~? -3.01 O4 SO4 A 143s 127 ARG B 16 ARG~? -3.64 O1 SO4 A 143s 270 GLU A 102 GLU~? 6.28 O2 SO4 A 143 coo -0.83 25.63 1.57 0.97 28.05 0.90 -2.68 64.28 31.62 -4.52 62.28 32.99 coo 2.68 26.75 -2.61 1.18 28.07 -5.02 -4.85 63.18 38.40 -7.23 62.95 36.44 coo -7.78 30.85 -7.94 -6.11 29.80 -7.25 -14.00 55.24 30.65 -12.08 54.69 31.20 ULMN 3 1cbx_c01 CARBOXYPEPTIDASE A (E.C.3.4.17.1) COuser 9 3 # 9 71 ARG B 105 ARG~? -3.01 O4 SO4 A 143s 127 ARG B 110 ARG~? 10.12 O7 PE8 B 148 270 GLU A 10 GLU~? 8.70 C6 2PE A 148 coo -0.83 25.63 1.57 0.97 28.05 0.90 -2.68 64.28 31.62 -4.52 62.28 32.99 coo 2.68 26.75 -2.61 1.18 28.07 -5.02 4.56 66.25 30.54 5.81 64.43 28.32 coo -7.78 30.85 -7.94 -6.11 29.80 -7.25 -3.10 70.57 20.07 -2.45 69.30 18.38 ULMN 3 1cbx_c01 CARBOXYPEPTIDASE A (E.C.3.4.17.1) COuser 10 3 # 10 71 ARG B 110 ARG~? 10.12 O7 PE8 B 148 127 ARG B 105 ARG~? -3.01 O4 SO4 A 143s 270 GLU A 10 GLU~? 8.70 C6 2PE A 148 coo -0.83 25.63 1.57 0.97 28.05 0.90 4.56 66.25 30.54 5.81 64.43 28.32 coo 2.68 26.75 -2.61 1.18 28.07 -5.02 -2.68 64.28 31.62 -4.52 62.28 32.99 coo -7.78 30.85 -7.94 -6.11 29.80 -7.25 -3.10 70.57 20.07 -2.45 69.30 18.38 ULMN 3 1cbx_c01 CARBOXYPEPTIDASE A (E.C.3.4.17.1) COuser 11 3 # 11 71 ARG B 127 ARG^? 9.26 O4 SO4 A 144 127 ARG B 20 ARG.? 7.28 C1 PEG B 146 270 GLU B 93 GLU^? 4.01 CE MLZ B 67 coo -0.83 25.63 1.57 0.97 28.05 0.90 -7.64 72.55 44.16 -9.78 70.52 43.36 coo 2.68 26.75 -2.61 1.18 28.07 -5.02 -14.05 70.97 43.62 -13.60 73.76 42.39 coo -7.78 30.85 -7.94 -6.11 29.80 -7.25 -11.20 80.89 36.50 -12.93 82.08 36.76 ULMN 3 1cbx_c01 CARBOXYPEPTIDASE A (E.C.3.4.17.1) COuser 12 3 # 12 71 ARG C 20 ARG.? 4.54 CB MLZ C 129 127 ARG C 127 ARG^? 7.44 N MLZ C 129 270 GLU C 93 GLU^? -3.82 CH2 MLY C 67s coo -0.83 25.63 1.57 0.97 28.05 0.90 2.03 103.13 46.63 -0.64 101.63 46.15 coo 2.68 26.75 -2.61 1.18 28.07 -5.02 1.53 98.09 50.88 2.14 101.05 50.40 coo -7.78 30.85 -7.94 -6.11 29.80 -7.25 -9.46 98.26 46.68 -9.97 98.34 44.62 ULMN 3 1cbx_c01 CARBOXYPEPTIDASE A (E.C.3.4.17.1) COuser 13 3 # 13 71 ARG C 127 ARG^? 7.44 N MLZ C 129 127 ARG C 20 ARG.? 4.54 CB MLZ C 129 270 GLU C 93 GLU^? -3.82 CH2 MLY C 67s coo -0.83 25.63 1.57 0.97 28.05 0.90 1.53 98.09 50.88 2.14 101.05 50.40 coo 2.68 26.75 -2.61 1.18 28.07 -5.02 2.03 103.13 46.63 -0.64 101.63 46.15 coo -7.78 30.85 -7.94 -6.11 29.80 -7.25 -9.46 98.26 46.68 -9.97 98.34 44.62 ULMN 3 1cbx_c01 CARBOXYPEPTIDASE A (E.C.3.4.17.1) COuser 14 3 # 14 71 ARG D 20 ARG.? 10.31 C3 PEG D 145 127 ARG D 127 ARG^? 9.31 O3 PGE A 147 270 GLU D 93 GLU^? -3.68 CE MLY D 67s coo -0.83 25.63 1.57 0.97 28.05 0.90 -40.03 62.67 1.01 -40.08 63.13 4.08 coo 2.68 26.75 -2.61 1.18 28.07 -5.02 -35.94 67.72 2.28 -38.25 66.55 0.66 coo -7.78 30.85 -7.94 -6.11 29.80 -7.25 -41.50 66.77 12.62 -41.92 65.02 13.75 ULMN 3 1cbx_c01 CARBOXYPEPTIDASE A (E.C.3.4.17.1) COuser 15 3 # 15 71 ARG D 127 ARG^? 9.31 O3 PGE A 147 127 ARG D 20 ARG.? 10.31 C3 PEG D 145 270 GLU D 93 GLU^? -3.68 CE MLY D 67s coo -0.83 25.63 1.57 0.97 28.05 0.90 -35.94 67.72 2.28 -38.25 66.55 0.66 coo 2.68 26.75 -2.61 1.18 28.07 -5.02 -40.03 62.67 1.01 -40.08 63.13 4.08 coo -7.78 30.85 -7.94 -6.11 29.80 -7.25 -41.50 66.77 12.62 -41.92 65.02 13.75 1cbx_c01 source 1cbx CARBOXYPEPTIDASE A (E.C.3.4.17.1) COMPLEX WITH: 15 hits 1cbx_c01 naa= 3 ULMN 3 1cdg_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE (E.user 1 3 # 1 229 ASP A 122 ASP^? 7.46 C1 GOL A 150 264 GLU A 10 GLU~? 8.70 C6 2PE A 148 328 ASP A 6 ASP.? -3.91 C9 2PE A 148s coo 45.62 80.42 43.69 45.65 82.01 45.07 -15.41 64.92 4.51 -15.09 66.83 5.33 coo 59.69 92.71 39.85 58.53 92.03 41.47 -3.10 70.57 20.07 -2.45 69.30 18.38 coo 45.39 90.72 40.63 45.07 89.14 41.90 -8.66 61.41 13.34 -8.76 59.35 12.80 ULMN 3 1cdg_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE (E.user 2 3 # 2 229 ASP A 122 ASP^? 7.46 C1 GOL A 150 264 GLU A 48 GLU~? 14.04 CG MLY D 135 328 ASP A 87 ASP.? 8.49 C6 PGE A 147 coo 45.62 80.42 43.69 45.65 82.01 45.07 -15.41 64.92 4.51 -15.09 66.83 5.33 coo 59.69 92.71 39.85 58.53 92.03 41.47 -19.52 46.65 2.13 -18.86 45.41 0.50 coo 45.39 90.72 40.63 45.07 89.14 41.90 -23.17 58.67 3.55 -22.34 59.17 1.69 ULMN 3 1cdg_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE (E.user 3 3 # 3 229 ASP B 122 ASP^? 7.33 O2 GOL B 149 264 GLU B 10 GLU~? 8.46 C3 PE8 B 148 328 ASP B 6 ASP.? -3.99 C6 PE8 B 148s coo 45.62 80.42 43.69 45.65 82.01 45.07 10.89 79.68 47.57 9.75 78.80 49.16 coo 59.69 92.71 39.85 58.53 92.03 41.47 2.64 60.90 47.80 4.72 61.28 47.03 coo 45.39 90.72 40.63 45.07 89.14 41.90 7.95 70.39 41.39 8.88 71.08 39.61 ULMN 3 1cdg_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE (E.user 4 3 # 4 229 ASP B 122 ASP^? 7.33 O2 GOL B 149 264 GLU B 48 GLU~? 13.73 O1 PEG B 144 328 ASP B 87 ASP.? 8.94 O4 PGE B 147 coo 45.62 80.42 43.69 45.65 82.01 45.07 10.89 79.68 47.57 9.75 78.80 49.16 coo 59.69 92.71 39.85 58.53 92.03 41.47 16.05 87.39 31.22 18.08 87.70 30.57 coo 45.39 90.72 40.63 45.07 89.14 41.90 9.49 87.97 42.02 11.31 87.98 43.09 ULMN 3 1cdg_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE (E.user 5 3 # 5 229 ASP C 122 ASP^? 7.22 C3 GOL C 149 264 GLU C 48 GLU~? 14.22 O MLZ C 114 328 ASP C 87 ASP.? 8.84 O1 PGE C 147 coo 45.62 80.42 43.69 45.65 82.01 45.07 0.27 81.12 61.60 2.07 81.54 60.53 coo 59.69 92.71 39.85 58.53 92.03 41.47 -17.56 80.63 67.68 -18.20 79.53 69.43 coo 45.39 90.72 40.63 45.07 89.14 41.90 -9.03 79.00 58.44 -8.21 77.39 59.55 ULMN 3 1cdg_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE (E.user 6 3 # 6 229 ASP D 122 ASP^? 7.49 C3 GOL D 147 264 GLU D 48 GLU~? 13.85 CG MLY A 135 328 ASP D 87 ASP.? 7.26 C16 1PE B 150 coo 45.62 80.42 43.69 45.65 82.01 45.07 -21.82 80.90 7.85 -21.38 79.32 6.51 coo 59.69 92.71 39.85 58.53 92.03 41.47 -30.39 91.81 20.65 -29.75 93.83 21.10 coo 45.39 90.72 40.63 45.07 89.14 41.90 -24.70 80.89 17.41 -22.90 81.94 17.31 1cdg_c00 source 1cdg CYCLODEXTRIN GLYCOSYLTRANSFERASE (E.C.2.4.1.19: 6 hits 1cdg_c00 naa= 3 ULMN 3 1cdg_c04 CYCLODEXTRIN GLYCOSYLTRANSFERASE (E.user 1 3 # 1 229 ASP A 83 ASP.? 8.52 O3 GOL D 147 257 GLU A 84 GLU.? 10.45 C3 GOL D 147 328 ASP A 122 ASP^? 7.46 C1 GOL A 150 coo 45.62 80.42 43.69 45.65 82.01 45.07 -19.46 70.43 -3.04 -19.06 72.28 -2.05 coo 48.97 85.16 40.39 47.18 86.25 40.47 -21.01 70.22 3.12 -21.10 71.95 4.30 coo 45.39 90.72 40.63 45.07 89.14 41.90 -15.41 64.92 4.51 -15.09 66.83 5.33 ULMN 3 1cdg_c04 CYCLODEXTRIN GLYCOSYLTRANSFERASE (E.user 2 3 # 2 229 ASP A 122 ASP^? 7.46 C1 GOL A 150 257 GLU A 84 GLU.? 10.45 C3 GOL D 147 328 ASP A 83 ASP.? 8.52 O3 GOL D 147 coo 45.62 80.42 43.69 45.65 82.01 45.07 -15.41 64.92 4.51 -15.09 66.83 5.33 coo 48.97 85.16 40.39 47.18 86.25 40.47 -21.01 70.22 3.12 -21.10 71.95 4.30 coo 45.39 90.72 40.63 45.07 89.14 41.90 -19.46 70.43 -3.04 -19.06 72.28 -2.05 ULMN 3 1cdg_c04 CYCLODEXTRIN GLYCOSYLTRANSFERASE (E.user 3 3 # 3 229 ASP B 83 ASP.? 9.40 O3 GOL C 149 257 GLU B 84 GLU.? 10.31 O3 GOL C 149 328 ASP B 122 ASP^? 7.33 O2 GOL B 149 coo 45.62 80.42 43.69 45.65 82.01 45.07 13.62 86.10 55.23 12.83 84.59 56.49 coo 48.97 85.16 40.39 47.18 86.25 40.47 7.66 84.31 53.13 6.13 83.49 54.35 coo 45.39 90.72 40.63 45.07 89.14 41.90 10.89 79.68 47.57 9.75 78.80 49.16 ULMN 3 1cdg_c04 CYCLODEXTRIN GLYCOSYLTRANSFERASE (E.user 4 3 # 4 229 ASP B 122 ASP^? 7.33 O2 GOL B 149 257 GLU B 84 GLU.? 10.31 O3 GOL C 149 328 ASP B 83 ASP.? 9.40 O3 GOL C 149 coo 45.62 80.42 43.69 45.65 82.01 45.07 10.89 79.68 47.57 9.75 78.80 49.16 coo 48.97 85.16 40.39 47.18 86.25 40.47 7.66 84.31 53.13 6.13 83.49 54.35 coo 45.39 90.72 40.63 45.07 89.14 41.90 13.62 86.10 55.23 12.83 84.59 56.49 ULMN 3 1cdg_c04 CYCLODEXTRIN GLYCOSYLTRANSFERASE (E.user 5 3 # 5 229 ASP C 83 ASP.? 8.65 O3 GOL B 149 257 GLU C 84 GLU.? 10.77 O2 GOL B 149 328 ASP C 122 ASP^? 7.22 C3 GOL C 149 coo 45.62 80.42 43.69 45.65 82.01 45.07 3.02 71.86 58.06 4.88 72.49 57.24 coo 48.97 85.16 40.39 47.18 86.25 40.47 2.34 77.12 55.01 3.46 78.21 53.60 coo 45.39 90.72 40.63 45.07 89.14 41.90 0.27 81.12 61.60 2.07 81.54 60.53 ULMN 3 1cdg_c04 CYCLODEXTRIN GLYCOSYLTRANSFERASE (E.user 6 3 # 6 229 ASP C 122 ASP^? 7.22 C3 GOL C 149 257 GLU C 84 GLU.? 10.77 O2 GOL B 149 328 ASP C 83 ASP.? 8.65 O3 GOL B 149 coo 45.62 80.42 43.69 45.65 82.01 45.07 0.27 81.12 61.60 2.07 81.54 60.53 coo 48.97 85.16 40.39 47.18 86.25 40.47 2.34 77.12 55.01 3.46 78.21 53.60 coo 45.39 90.72 40.63 45.07 89.14 41.90 3.02 71.86 58.06 4.88 72.49 57.24 ULMN 3 1cdg_c04 CYCLODEXTRIN GLYCOSYLTRANSFERASE (E.user 7 3 # 7 229 ASP D 83 ASP.? 8.76 O1 GOL A 150 257 GLU D 84 GLU.? 10.79 C1 GOL A 150 328 ASP D 122 ASP^? 7.49 C3 GOL D 147 coo 45.62 80.42 43.69 45.65 82.01 45.07 -12.54 78.43 10.94 -12.46 77.06 9.29 coo 48.97 85.16 40.39 47.18 86.25 40.47 -17.40 74.78 10.23 -17.69 72.96 9.24 coo 45.39 90.72 40.63 45.07 89.14 41.90 -21.82 80.90 7.85 -21.38 79.32 6.51 ULMN 3 1cdg_c04 CYCLODEXTRIN GLYCOSYLTRANSFERASE (E.user 8 3 # 8 229 ASP D 122 ASP^? 7.49 C3 GOL D 147 257 GLU D 84 GLU.? 10.79 C1 GOL A 150 328 ASP D 83 ASP.? 8.76 O1 GOL A 150 coo 45.62 80.42 43.69 45.65 82.01 45.07 -21.82 80.90 7.85 -21.38 79.32 6.51 coo 48.97 85.16 40.39 47.18 86.25 40.47 -17.40 74.78 10.23 -17.69 72.96 9.24 coo 45.39 90.72 40.63 45.07 89.14 41.90 -12.54 78.43 10.94 -12.46 77.06 9.29 1cdg_c04 source 1cdg CYCLODEXTRIN GLYCOSYLTRANSFERASE (E.C.2.4.1.19: 8 hits 1cdg_c04 naa= 3 ULMN 3 1chm_c01 CREATINE AMIDINOHYDROLASE (E.C.3.5.3user 1 3 # 1 B 232 HIS A 4 HIS.? -3.92 C2 GOL A 150s B 262 GLU A 84 GLU.? 10.45 C3 GOL D 147 B 358 GLU D 84 GLU.? 10.79 C1 GOL A 150 coo 44.98 77.01 48.39 44.42 78.67 47.18 -11.85 68.18 8.83 -11.23 70.10 8.29 coo 41.60 83.57 54.16 42.46 83.24 52.25 -21.01 70.22 3.12 -21.10 71.95 4.30 coo 44.05 87.61 48.73 43.15 85.67 48.52 -17.40 74.78 10.23 -17.69 72.96 9.24 ULMN 3 1chm_c01 CREATINE AMIDINOHYDROLASE (E.C.3.5.3user 2 3 # 2 B 232 HIS A 4 HIS.? -3.92 C2 GOL A 150s B 262 GLU D 84 GLU.? 10.79 C1 GOL A 150 B 358 GLU A 84 GLU.? 10.45 C3 GOL D 147 coo 44.98 77.01 48.39 44.42 78.67 47.18 -11.85 68.18 8.83 -11.23 70.10 8.29 coo 41.60 83.57 54.16 42.46 83.24 52.25 -17.40 74.78 10.23 -17.69 72.96 9.24 coo 44.05 87.61 48.73 43.15 85.67 48.52 -21.01 70.22 3.12 -21.10 71.95 4.30 ULMN 3 1chm_c01 CREATINE AMIDINOHYDROLASE (E.C.3.5.3user 3 3 # 3 B 232 HIS B 4 HIS.? -3.86 O2 GOL B 149s B 262 GLU B 84 GLU.? 10.31 O3 GOL C 149 B 358 GLU C 84 GLU.? 10.77 O2 GOL B 149 coo 44.98 77.01 48.39 44.42 78.67 47.18 8.07 73.88 49.16 8.30 73.43 51.19 coo 41.60 83.57 54.16 42.46 83.24 52.25 7.66 84.31 53.13 6.13 83.49 54.35 coo 44.05 87.61 48.73 43.15 85.67 48.52 2.34 77.12 55.01 3.46 78.21 53.60 ULMN 3 1chm_c01 CREATINE AMIDINOHYDROLASE (E.C.3.5.3user 4 3 # 4 B 232 HIS B 4 HIS.? -3.86 O2 GOL B 149s B 262 GLU C 84 GLU.? 10.77 O2 GOL B 149 B 358 GLU B 84 GLU.? 10.31 O3 GOL C 149 coo 44.98 77.01 48.39 44.42 78.67 47.18 8.07 73.88 49.16 8.30 73.43 51.19 coo 41.60 83.57 54.16 42.46 83.24 52.25 2.34 77.12 55.01 3.46 78.21 53.60 coo 44.05 87.61 48.73 43.15 85.67 48.52 7.66 84.31 53.13 6.13 83.49 54.35 ULMN 3 1chm_c01 CREATINE AMIDINOHYDROLASE (E.C.3.5.3user 5 3 # 5 B 232 HIS C 4 HIS.? -3.73 C3 GOL C 149s B 262 GLU B 84 GLU.? 10.31 O3 GOL C 149 B 358 GLU C 84 GLU.? 10.77 O2 GOL B 149 coo 44.98 77.01 48.39 44.42 78.67 47.18 4.88 85.81 61.42 6.80 85.00 61.18 coo 41.60 83.57 54.16 42.46 83.24 52.25 7.66 84.31 53.13 6.13 83.49 54.35 coo 44.05 87.61 48.73 43.15 85.67 48.52 2.34 77.12 55.01 3.46 78.21 53.60 ULMN 3 1chm_c01 CREATINE AMIDINOHYDROLASE (E.C.3.5.3user 6 3 # 6 B 232 HIS C 4 HIS.? -3.73 C3 GOL C 149s B 262 GLU C 84 GLU.? 10.77 O2 GOL B 149 B 358 GLU B 84 GLU.? 10.31 O3 GOL C 149 coo 44.98 77.01 48.39 44.42 78.67 47.18 4.88 85.81 61.42 6.80 85.00 61.18 coo 41.60 83.57 54.16 42.46 83.24 52.25 2.34 77.12 55.01 3.46 78.21 53.60 coo 44.05 87.61 48.73 43.15 85.67 48.52 7.66 84.31 53.13 6.13 83.49 54.35 ULMN 3 1chm_c01 CREATINE AMIDINOHYDROLASE (E.C.3.5.3user 7 3 # 7 B 232 HIS D 4 HIS.? 4.07 C3 GOL D 147 B 262 GLU A 84 GLU.? 10.45 C3 GOL D 147 B 358 GLU D 84 GLU.? 10.79 C1 GOL A 150 coo 44.98 77.01 48.39 44.42 78.67 47.18 -23.57 78.63 1.94 -22.01 77.96 0.72 coo 41.60 83.57 54.16 42.46 83.24 52.25 -21.01 70.22 3.12 -21.10 71.95 4.30 coo 44.05 87.61 48.73 43.15 85.67 48.52 -17.40 74.78 10.23 -17.69 72.96 9.24 ULMN 3 1chm_c01 CREATINE AMIDINOHYDROLASE (E.C.3.5.3user 8 3 # 8 B 232 HIS D 4 HIS.? 4.07 C3 GOL D 147 B 262 GLU D 84 GLU.? 10.79 C1 GOL A 150 B 358 GLU A 84 GLU.? 10.45 C3 GOL D 147 coo 44.98 77.01 48.39 44.42 78.67 47.18 -23.57 78.63 1.94 -22.01 77.96 0.72 coo 41.60 83.57 54.16 42.46 83.24 52.25 -17.40 74.78 10.23 -17.69 72.96 9.24 coo 44.05 87.61 48.73 43.15 85.67 48.52 -21.01 70.22 3.12 -21.10 71.95 4.30 1chm_c01 source 1chm CREATINE AMIDINOHYDROLASE (E.C.3.5.3.3) : 8 hits 1chm_c01 naa= 3 ULMN 3 1cjy_c00 CYTOSOLIC PHOSPHOLIPASE A2 user 1 3 # 1 A 198 GLY A 80 GLY.? 7.76 C1 GOL D 147 A 228 SER D 123 SER^? 7.59 C15 2PE D 146 A 549 ASP D 122 ASP^? 7.49 C3 GOL D 147 coo 43.62 -9.31 54.06 43.04 -9.29 54.58 -25.41 75.48 2.13 -25.84 75.58 1.39 coo 45.99 -4.81 58.63 47.02 -6.84 57.75 -25.59 78.45 8.19 -27.49 79.37 6.96 coo 51.69 -5.84 58.91 49.67 -6.52 58.93 -21.82 80.90 7.85 -21.38 79.32 6.51 ULMN 3 1cjy_c00 CYTOSOLIC PHOSPHOLIPASE A2 user 2 3 # 2 A 198 GLY B 22 GLY.? 4.26 C1 PEG B 146 A 228 SER B 96 SER~? 7.21 O4 SO4 A 144 A 549 ASP A 19 ASP.? -3.59 O4 SO4 A 144s coo 43.62 -9.31 54.06 43.04 -9.29 54.58 -16.69 74.52 39.34 -16.05 74.06 39.06 coo 45.99 -4.81 58.63 47.02 -6.84 57.75 -12.28 72.78 35.88 -11.90 71.42 33.88 coo 51.69 -5.84 58.91 49.67 -6.52 58.93 -15.01 66.98 32.71 -14.52 68.02 34.44 ULMN 3 1cjy_c00 CYTOSOLIC PHOSPHOLIPASE A2 user 3 3 # 3 A 198 GLY B 80 GLY.? 7.38 C3 GOL C 149 A 228 SER C 123 SER^? 7.65 C15 PE8 C 148 A 549 ASP C 122 ASP^? 7.22 C3 GOL C 149 coo 43.62 -9.31 54.06 43.04 -9.29 54.58 4.67 87.66 58.38 5.02 88.38 58.71 coo 45.99 -4.81 58.63 47.02 -6.84 57.75 -1.16 84.64 59.13 -1.43 86.65 60.45 coo 51.69 -5.84 58.91 49.67 -6.52 58.93 0.27 81.12 61.60 2.07 81.54 60.53 ULMN 3 1cjy_c00 CYTOSOLIC PHOSPHOLIPASE A2 user 4 3 # 4 A 198 GLY C 80 GLY.? 7.77 O2 GOL B 149 A 228 SER B 123 SER^? 7.43 C12 PE8 B 148 A 549 ASP B 122 ASP^? 7.33 O2 GOL B 149 coo 43.62 -9.31 54.06 43.04 -9.29 54.58 4.31 74.26 49.15 4.26 73.42 48.97 coo 45.99 -4.81 58.63 47.02 -6.84 57.75 6.88 79.31 45.54 6.79 77.45 43.98 coo 51.69 -5.84 58.91 49.67 -6.52 58.93 10.89 79.68 47.57 9.75 78.80 49.16 ULMN 3 1cjy_c00 CYTOSOLIC PHOSPHOLIPASE A2 user 5 3 # 5 A 198 GLY D 80 GLY.? 7.47 C2 GOL A 150 A 228 SER A 123 SER^? 7.34 C15 2PE A 148 A 549 ASP A 122 ASP^? 7.46 C1 GOL A 150 coo 43.62 -9.31 54.06 43.04 -9.29 54.58 -13.78 69.07 11.78 -13.14 69.11 12.34 coo 45.99 -4.81 58.63 47.02 -6.84 57.75 -17.01 64.19 8.64 -15.43 63.06 10.12 coo 51.69 -5.84 58.91 49.67 -6.52 58.93 -15.41 64.92 4.51 -15.09 66.83 5.33 1cjy_c00 source 1cjy CYTOSOLIC PHOSPHOLIPASE A2 : 5 hits 1cjy_c00 naa= 3 ULMN 3 1cjy_c01 CYTOSOLIC PHOSPHOLIPASE A2 user 1 3 # 1 B1198 GLY A 22 GLY.? 4.28 C3 PEG A 146 B1228 SER A 96 SER~? 7.38 O1 SO4 A 144 B1549 ASP A 19 ASP.? -3.59 O4 SO4 A 144s coo 126.34 72.75 125.66 125.95 73.27 126.11 -24.67 65.84 32.25 -23.92 65.53 31.96 coo 131.65 74.68 129.41 130.31 72.73 128.82 -20.86 61.67 30.54 -19.56 59.85 31.49 coo 134.72 69.43 130.42 133.03 70.65 130.08 -15.01 66.98 32.71 -14.52 68.02 34.44 ULMN 3 1cjy_c01 CYTOSOLIC PHOSPHOLIPASE A2 user 2 3 # 2 B1198 GLY A 80 GLY.? 7.76 C1 GOL D 147 B1228 SER D 123 SER^? 7.59 C15 2PE D 146 B1549 ASP D 122 ASP^? 7.49 C3 GOL D 147 coo 126.34 72.75 125.66 125.95 73.27 126.11 -25.41 75.48 2.13 -25.84 75.58 1.39 coo 131.65 74.68 129.41 130.31 72.73 128.82 -25.59 78.45 8.19 -27.49 79.37 6.96 coo 134.72 69.43 130.42 133.03 70.65 130.08 -21.82 80.90 7.85 -21.38 79.32 6.51 ULMN 3 1cjy_c01 CYTOSOLIC PHOSPHOLIPASE A2 user 3 3 # 3 B1198 GLY B 22 GLY.? 4.26 C1 PEG B 146 B1228 SER B 96 SER~? 7.21 O4 SO4 A 144 B1549 ASP A 19 ASP.? -3.59 O4 SO4 A 144s coo 126.34 72.75 125.66 125.95 73.27 126.11 -16.69 74.52 39.34 -16.05 74.06 39.06 coo 131.65 74.68 129.41 130.31 72.73 128.82 -12.28 72.78 35.88 -11.90 71.42 33.88 coo 134.72 69.43 130.42 133.03 70.65 130.08 -15.01 66.98 32.71 -14.52 68.02 34.44 ULMN 3 1cjy_c01 CYTOSOLIC PHOSPHOLIPASE A2 user 4 3 # 4 B1198 GLY B 80 GLY.? 7.38 C3 GOL C 149 B1228 SER C 123 SER^? 7.65 C15 PE8 C 148 B1549 ASP C 122 ASP^? 7.22 C3 GOL C 149 coo 126.34 72.75 125.66 125.95 73.27 126.11 4.67 87.66 58.38 5.02 88.38 58.71 coo 131.65 74.68 129.41 130.31 72.73 128.82 -1.16 84.64 59.13 -1.43 86.65 60.45 coo 134.72 69.43 130.42 133.03 70.65 130.08 0.27 81.12 61.60 2.07 81.54 60.53 ULMN 3 1cjy_c01 CYTOSOLIC PHOSPHOLIPASE A2 user 5 3 # 5 B1198 GLY C 22 GLY.? 6.89 CD MLZ C 129 B1228 SER C 96 SER~? 11.39 N MLY C 67 B1549 ASP C 19 ASP.? 9.43 O3 SO4 C 143 coo 126.34 72.75 125.66 125.95 73.27 126.11 -3.53 104.38 44.27 -3.45 104.39 45.13 coo 131.65 74.68 129.41 130.31 72.73 128.82 -5.29 104.57 49.79 -6.22 106.17 51.38 coo 134.72 69.43 130.42 133.03 70.65 130.08 2.21 107.45 51.42 3.36 109.08 50.82 ULMN 3 1cjy_c01 CYTOSOLIC PHOSPHOLIPASE A2 user 6 3 # 6 B1198 GLY C 80 GLY.? 7.77 O2 GOL B 149 B1228 SER B 123 SER^? 7.43 C12 PE8 B 148 B1549 ASP B 122 ASP^? 7.33 O2 GOL B 149 coo 126.34 72.75 125.66 125.95 73.27 126.11 4.31 74.26 49.15 4.26 73.42 48.97 coo 131.65 74.68 129.41 130.31 72.73 128.82 6.88 79.31 45.54 6.79 77.45 43.98 coo 134.72 69.43 130.42 133.03 70.65 130.08 10.89 79.68 47.57 9.75 78.80 49.16 ULMN 3 1cjy_c01 CYTOSOLIC PHOSPHOLIPASE A2 user 7 3 # 7 B1198 GLY D 22 GLY.? 9.04 C3 PEG D 145 B1228 SER D 96 SER~? 11.44 N MLY D 67 B1549 ASP D 19 ASP.? -13.24 C2 PGE A 147s coo 126.34 72.75 125.66 125.95 73.27 126.11 -43.93 61.79 5.73 -43.90 62.56 5.37 coo 131.65 74.68 129.41 130.31 72.73 128.82 -44.97 67.48 5.17 -46.83 69.00 4.60 coo 134.72 69.43 130.42 133.03 70.65 130.08 -43.72 66.33 -2.80 -44.54 65.10 -4.29 ULMN 3 1cjy_c01 CYTOSOLIC PHOSPHOLIPASE A2 user 8 3 # 8 B1198 GLY D 80 GLY.? 7.47 C2 GOL A 150 B1228 SER A 123 SER^? 7.34 C15 2PE A 148 B1549 ASP A 122 ASP^? 7.46 C1 GOL A 150 coo 126.34 72.75 125.66 125.95 73.27 126.11 -13.78 69.07 11.78 -13.14 69.11 12.34 coo 131.65 74.68 129.41 130.31 72.73 128.82 -17.01 64.19 8.64 -15.43 63.06 10.12 coo 134.72 69.43 130.42 133.03 70.65 130.08 -15.41 64.92 4.51 -15.09 66.83 5.33 1cjy_c01 source 1cjy CYTOSOLIC PHOSPHOLIPASE A2 : 8 hits 1cjy_c01 naa= 3 ULMN 3 1cms_c04 CHYMOSIN B (FORMERLY KNOWN AS RENNINuser 1 3 # 1 34 ASP D 122 ASP^? 7.49 C3 GOL D 147 37 SER D 123 SER^? 7.59 C15 2PE D 146 216 ASP D 87 ASP.? 7.26 C16 1PE B 150 coo 16.90 26.20 29.49 16.22 24.50 28.41 -21.82 80.90 7.85 -21.38 79.32 6.51 coo 12.23 24.31 30.40 14.55 23.96 31.03 -25.59 78.45 8.19 -27.49 79.37 6.96 coo 13.93 25.52 22.10 14.75 24.44 23.75 -24.70 80.89 17.41 -22.90 81.94 17.31 1cms_c04 source 1cms CHYMOSIN B (FORMERLY KNOWN AS RENNIN) (E.C.3.4: 1 hits 1cms_c04 naa= 3 ULMN 3 1cns_c00 CHITINASE user 1 3 # 1 A 67 GLU A 84 GLU.? 10.45 C3 GOL D 147 A 89 GLU A 121 GLU^? 12.41 C1 GOL A 150 A 120 SER A 123 SER^? 7.34 C15 2PE A 148 coo -24.35 9.53 67.64 -25.07 11.29 68.60 -21.01 70.22 3.12 -21.10 71.95 4.30 coo -31.18 6.91 75.60 -32.39 8.51 74.91 -13.98 61.53 0.93 -15.14 61.60 -0.79 coo -34.73 8.57 68.21 -33.63 9.08 70.28 -17.01 64.19 8.64 -15.43 63.06 10.12 ULMN 3 1cns_c00 CHITINASE user 2 3 # 2 A 67 GLU A 84 GLU.? 10.45 C3 GOL D 147 A 89 GLU D 84 GLU.? 10.79 C1 GOL A 150 A 120 SER D 123 SER^? 7.59 C15 2PE D 146 coo -24.35 9.53 67.64 -25.07 11.29 68.60 -21.01 70.22 3.12 -21.10 71.95 4.30 coo -31.18 6.91 75.60 -32.39 8.51 74.91 -17.40 74.78 10.23 -17.69 72.96 9.24 coo -34.73 8.57 68.21 -33.63 9.08 70.28 -25.59 78.45 8.19 -27.49 79.37 6.96 ULMN 3 1cns_c00 CHITINASE user 3 3 # 3 A 67 GLU A 121 GLU^? 12.41 C1 GOL A 150 A 89 GLU A 84 GLU.? 10.45 C3 GOL D 147 A 120 SER A 123 SER^? 7.34 C15 2PE A 148 coo -24.35 9.53 67.64 -25.07 11.29 68.60 -13.98 61.53 0.93 -15.14 61.60 -0.79 coo -31.18 6.91 75.60 -32.39 8.51 74.91 -21.01 70.22 3.12 -21.10 71.95 4.30 coo -34.73 8.57 68.21 -33.63 9.08 70.28 -17.01 64.19 8.64 -15.43 63.06 10.12 ULMN 3 1cns_c00 CHITINASE user 4 3 # 4 A 67 GLU B 84 GLU.? 10.31 O3 GOL C 149 A 89 GLU B 121 GLU^? 8.74 O2 PEG B 144 A 120 SER B 123 SER^? 7.43 C12 PE8 B 148 coo -24.35 9.53 67.64 -25.07 11.29 68.60 7.66 84.31 53.13 6.13 83.49 54.35 coo -31.18 6.91 75.60 -32.39 8.51 74.91 15.37 80.83 45.64 16.23 82.69 46.15 coo -34.73 8.57 68.21 -33.63 9.08 70.28 6.88 79.31 45.54 6.79 77.45 43.98 ULMN 3 1cns_c00 CHITINASE user 5 3 # 5 A 67 GLU B 84 GLU.? 10.31 O3 GOL C 149 A 89 GLU C 84 GLU.? 10.77 O2 GOL B 149 A 120 SER C 123 SER^? 7.65 C15 PE8 C 148 coo -24.35 9.53 67.64 -25.07 11.29 68.60 7.66 84.31 53.13 6.13 83.49 54.35 coo -31.18 6.91 75.60 -32.39 8.51 74.91 2.34 77.12 55.01 3.46 78.21 53.60 coo -34.73 8.57 68.21 -33.63 9.08 70.28 -1.16 84.64 59.13 -1.43 86.65 60.45 ULMN 3 1cns_c00 CHITINASE user 6 3 # 6 A 67 GLU B 121 GLU^? 8.74 O2 PEG B 144 A 89 GLU B 84 GLU.? 10.31 O3 GOL C 149 A 120 SER B 123 SER^? 7.43 C12 PE8 B 148 coo -24.35 9.53 67.64 -25.07 11.29 68.60 15.37 80.83 45.64 16.23 82.69 46.15 coo -31.18 6.91 75.60 -32.39 8.51 74.91 7.66 84.31 53.13 6.13 83.49 54.35 coo -34.73 8.57 68.21 -33.63 9.08 70.28 6.88 79.31 45.54 6.79 77.45 43.98 ULMN 3 1cns_c00 CHITINASE user 7 3 # 7 A 67 GLU C 84 GLU.? 10.77 O2 GOL B 149 A 89 GLU B 84 GLU.? 10.31 O3 GOL C 149 A 120 SER B 123 SER^? 7.43 C12 PE8 B 148 coo -24.35 9.53 67.64 -25.07 11.29 68.60 2.34 77.12 55.01 3.46 78.21 53.60 coo -31.18 6.91 75.60 -32.39 8.51 74.91 7.66 84.31 53.13 6.13 83.49 54.35 coo -34.73 8.57 68.21 -33.63 9.08 70.28 6.88 79.31 45.54 6.79 77.45 43.98 ULMN 3 1cns_c00 CHITINASE user 8 3 # 8 A 67 GLU C 84 GLU.? 10.77 O2 GOL B 149 A 89 GLU C 121 GLU^? 12.40 C3 GOL C 149 A 120 SER C 123 SER^? 7.65 C15 PE8 C 148 coo -24.35 9.53 67.64 -25.07 11.29 68.60 2.34 77.12 55.01 3.46 78.21 53.60 coo -31.18 6.91 75.60 -32.39 8.51 74.91 -1.98 78.69 65.48 -2.54 76.71 65.06 coo -34.73 8.57 68.21 -33.63 9.08 70.28 -1.16 84.64 59.13 -1.43 86.65 60.45 ULMN 3 1cns_c00 CHITINASE user 9 3 # 9 A 67 GLU C 121 GLU^? 12.40 C3 GOL C 149 A 89 GLU C 84 GLU.? 10.77 O2 GOL B 149 A 120 SER C 123 SER^? 7.65 C15 PE8 C 148 coo -24.35 9.53 67.64 -25.07 11.29 68.60 -1.98 78.69 65.48 -2.54 76.71 65.06 coo -31.18 6.91 75.60 -32.39 8.51 74.91 2.34 77.12 55.01 3.46 78.21 53.60 coo -34.73 8.57 68.21 -33.63 9.08 70.28 -1.16 84.64 59.13 -1.43 86.65 60.45 ULMN 3 1cns_c00 CHITINASE user 10 3 # 10 A 67 GLU D 84 GLU.? 10.79 C1 GOL A 150 A 89 GLU A 84 GLU.? 10.45 C3 GOL D 147 A 120 SER A 123 SER^? 7.34 C15 2PE A 148 coo -24.35 9.53 67.64 -25.07 11.29 68.60 -17.40 74.78 10.23 -17.69 72.96 9.24 coo -31.18 6.91 75.60 -32.39 8.51 74.91 -21.01 70.22 3.12 -21.10 71.95 4.30 coo -34.73 8.57 68.21 -33.63 9.08 70.28 -17.01 64.19 8.64 -15.43 63.06 10.12 ULMN 3 1cns_c00 CHITINASE user 11 3 # 11 A 67 GLU D 84 GLU.? 10.79 C1 GOL A 150 A 89 GLU D 121 GLU^? 11.70 OH7 1PE B 150 A 120 SER D 123 SER^? 7.59 C15 2PE D 146 coo -24.35 9.53 67.64 -25.07 11.29 68.60 -17.40 74.78 10.23 -17.69 72.96 9.24 coo -31.18 6.91 75.60 -32.39 8.51 74.91 -20.91 85.61 9.48 -19.44 85.70 10.98 coo -34.73 8.57 68.21 -33.63 9.08 70.28 -25.59 78.45 8.19 -27.49 79.37 6.96 ULMN 3 1cns_c00 CHITINASE user 12 3 # 12 A 67 GLU D 121 GLU^? 11.70 OH7 1PE B 150 A 89 GLU D 84 GLU.? 10.79 C1 GOL A 150 A 120 SER D 123 SER^? 7.59 C15 2PE D 146 coo -24.35 9.53 67.64 -25.07 11.29 68.60 -20.91 85.61 9.48 -19.44 85.70 10.98 coo -31.18 6.91 75.60 -32.39 8.51 74.91 -17.40 74.78 10.23 -17.69 72.96 9.24 coo -34.73 8.57 68.21 -33.63 9.08 70.28 -25.59 78.45 8.19 -27.49 79.37 6.96 1cns_c00 source 1cns CHITINASE : 12 hits 1cns_c00 naa= 3 ULMN 3 1cns_c01 CHITINASE user 1 3 # 1 B 67 GLU A 10 GLU~? 8.70 C6 2PE A 148 B 89 GLU B 62 GLU~? 5.14 OH2 1PE B 150 B 120 SER B 57 SER~? 3.95 C20 PE8 B 148 coo 9.89 -17.65 45.79 9.28 -17.39 43.77 -3.10 70.57 20.07 -2.45 69.30 18.38 coo 19.53 -19.89 39.46 19.21 -18.09 38.37 -5.99 81.74 25.38 -5.29 83.68 24.76 coo 18.32 -11.51 42.26 16.65 -12.32 40.69 2.89 78.00 28.42 3.14 79.13 30.54 ULMN 3 1cns_c01 CHITINASE user 2 3 # 2 B 67 GLU A 10 GLU~? 8.70 C6 2PE A 148 B 89 GLU B 102 GLU~? 6.18 O4 SO4 A 143 B 120 SER B 61 SER~? -3.13 O22 PE8 B 148s coo 9.89 -17.65 45.79 9.28 -17.39 43.77 -3.10 70.57 20.07 -2.45 69.30 18.38 coo 19.53 -19.89 39.46 19.21 -18.09 38.37 -7.10 67.86 29.77 -6.34 66.05 29.12 coo 18.32 -11.51 42.26 16.65 -12.32 40.69 -3.39 77.64 29.23 -3.48 78.95 31.25 ULMN 3 1cns_c01 CHITINASE user 3 3 # 3 B 67 GLU A 10 GLU~? 8.70 C6 2PE A 148 B 89 GLU B 111 GLU~? 12.54 O7 PE8 B 148 B 120 SER B 57 SER~? 3.95 C20 PE8 B 148 coo 9.89 -17.65 45.79 9.28 -17.39 43.77 -3.10 70.57 20.07 -2.45 69.30 18.38 coo 19.53 -19.89 39.46 19.21 -18.09 38.37 9.41 70.70 25.55 11.25 69.94 26.27 coo 18.32 -11.51 42.26 16.65 -12.32 40.69 2.89 78.00 28.42 3.14 79.13 30.54 ULMN 3 1cns_c01 CHITINASE user 4 3 # 4 B 67 GLU A 75 GLU.? -8.03 O4 PGE A 147s B 89 GLU D 21 GLU.? -13.48 O4 PEG D 145s B 120 SER D 96 SER~? 11.44 N MLY D 67 coo 9.89 -17.65 45.79 9.28 -17.39 43.77 -34.40 63.01 2.19 -36.49 63.07 2.67 coo 19.53 -19.89 39.46 19.21 -18.09 38.37 -47.50 61.07 3.30 -49.50 60.44 2.88 coo 18.32 -11.51 42.26 16.65 -12.32 40.69 -44.97 67.48 5.17 -46.83 69.00 4.60 ULMN 3 1cns_c01 CHITINASE user 5 3 # 5 B 67 GLU A 75 GLU.? -8.03 O4 PGE A 147s B 89 GLU D 93 GLU^? -3.68 CE MLY D 67s B 120 SER D 96 SER~? 11.44 N MLY D 67 coo 9.89 -17.65 45.79 9.28 -17.39 43.77 -34.40 63.01 2.19 -36.49 63.07 2.67 coo 19.53 -19.89 39.46 19.21 -18.09 38.37 -41.50 66.77 12.62 -41.92 65.02 13.75 coo 18.32 -11.51 42.26 16.65 -12.32 40.69 -44.97 67.48 5.17 -46.83 69.00 4.60 ULMN 3 1cns_c01 CHITINASE user 6 3 # 6 B 67 GLU A 84 GLU.? 10.45 C3 GOL D 147 B 89 GLU A 121 GLU^? 12.41 C1 GOL A 150 B 120 SER A 123 SER^? 7.34 C15 2PE A 148 coo 9.89 -17.65 45.79 9.28 -17.39 43.77 -21.01 70.22 3.12 -21.10 71.95 4.30 coo 19.53 -19.89 39.46 19.21 -18.09 38.37 -13.98 61.53 0.93 -15.14 61.60 -0.79 coo 18.32 -11.51 42.26 16.65 -12.32 40.69 -17.01 64.19 8.64 -15.43 63.06 10.12 ULMN 3 1cns_c01 CHITINASE user 7 3 # 7 B 67 GLU B 75 GLU.? -3.56 CB MLZ C 129s B 89 GLU C 21 GLU.? -6.38 O2 PEG C 146s B 120 SER C 96 SER~? 11.39 N MLY C 67 coo 9.89 -17.65 45.79 9.28 -17.39 43.77 3.68 97.59 46.60 2.29 99.21 46.53 coo 19.53 -19.89 39.46 19.21 -18.09 38.37 -3.17 108.79 44.43 -3.64 110.82 43.98 coo 18.32 -11.51 42.26 16.65 -12.32 40.69 -5.29 104.57 49.79 -6.22 106.17 51.38 ULMN 3 1cns_c01 CHITINASE user 8 3 # 8 B 67 GLU B 75 GLU.? -3.56 CB MLZ C 129s B 89 GLU C 93 GLU^? -3.82 CH2 MLY C 67s B 120 SER C 96 SER~? 11.39 N MLY C 67 coo 9.89 -17.65 45.79 9.28 -17.39 43.77 3.68 97.59 46.60 2.29 99.21 46.53 coo 19.53 -19.89 39.46 19.21 -18.09 38.37 -9.46 98.26 46.68 -9.97 98.34 44.62 coo 18.32 -11.51 42.26 16.65 -12.32 40.69 -5.29 104.57 49.79 -6.22 106.17 51.38 ULMN 3 1cns_c01 CHITINASE user 9 3 # 9 B 67 GLU B 84 GLU.? 10.31 O3 GOL C 149 B 89 GLU B 121 GLU^? 8.74 O2 PEG B 144 B 120 SER B 123 SER^? 7.43 C12 PE8 B 148 coo 9.89 -17.65 45.79 9.28 -17.39 43.77 7.66 84.31 53.13 6.13 83.49 54.35 coo 19.53 -19.89 39.46 19.21 -18.09 38.37 15.37 80.83 45.64 16.23 82.69 46.15 coo 18.32 -11.51 42.26 16.65 -12.32 40.69 6.88 79.31 45.54 6.79 77.45 43.98 ULMN 3 1cns_c01 CHITINASE user 10 3 # 10 B 67 GLU C 75 GLU.? -8.81 O1 PGE C 147s B 89 GLU B 21 GLU.? -4.32 C4 PEG B 146s B 120 SER B 96 SER~? 7.21 O4 SO4 A 144 coo 9.89 -17.65 45.79 9.28 -17.39 43.77 -10.84 73.75 47.59 -11.85 73.47 45.72 coo 19.53 -19.89 39.46 19.21 -18.09 38.37 -19.10 71.22 37.43 -20.67 70.39 36.27 coo 18.32 -11.51 42.26 16.65 -12.32 40.69 -12.28 72.78 35.88 -11.90 71.42 33.88 ULMN 3 1cns_c01 CHITINASE user 11 3 # 11 B 67 GLU C 75 GLU.? -8.81 O1 PGE C 147s B 89 GLU B 93 GLU^? 4.01 CE MLZ B 67 B 120 SER B 96 SER~? 7.21 O4 SO4 A 144 coo 9.89 -17.65 45.79 9.28 -17.39 43.77 -10.84 73.75 47.59 -11.85 73.47 45.72 coo 19.53 -19.89 39.46 19.21 -18.09 38.37 -11.20 80.89 36.50 -12.93 82.08 36.76 coo 18.32 -11.51 42.26 16.65 -12.32 40.69 -12.28 72.78 35.88 -11.90 71.42 33.88 ULMN 3 1cns_c01 CHITINASE user 12 3 # 12 B 67 GLU C 84 GLU.? 10.77 O2 GOL B 149 B 89 GLU C 121 GLU^? 12.40 C3 GOL C 149 B 120 SER C 123 SER^? 7.65 C15 PE8 C 148 coo 9.89 -17.65 45.79 9.28 -17.39 43.77 2.34 77.12 55.01 3.46 78.21 53.60 coo 19.53 -19.89 39.46 19.21 -18.09 38.37 -1.98 78.69 65.48 -2.54 76.71 65.06 coo 18.32 -11.51 42.26 16.65 -12.32 40.69 -1.16 84.64 59.13 -1.43 86.65 60.45 ULMN 3 1cns_c01 CHITINASE user 13 3 # 13 B 67 GLU D 75 GLU.? -3.59 CB MLZ A 129s B 89 GLU A 21 GLU.? -3.95 C2 PEG A 146s B 120 SER A 96 SER~? 7.38 O1 SO4 A 144 coo 9.89 -17.65 45.79 9.28 -17.39 43.77 -21.02 72.19 24.99 -21.34 70.79 26.58 coo 19.53 -19.89 39.46 19.21 -18.09 38.37 -23.01 65.38 36.24 -23.03 64.85 38.31 coo 18.32 -11.51 42.26 16.65 -12.32 40.69 -20.86 61.67 30.54 -19.56 59.85 31.49 ULMN 3 1cns_c01 CHITINASE user 14 3 # 14 B 67 GLU D 75 GLU.? -3.59 CB MLZ A 129s B 89 GLU A 93 GLU^? 3.90 NZ MLY A 67 B 120 SER A 96 SER~? 7.38 O1 SO4 A 144 coo 9.89 -17.65 45.79 9.28 -17.39 43.77 -21.02 72.19 24.99 -21.34 70.79 26.58 coo 19.53 -19.89 39.46 19.21 -18.09 38.37 -27.37 60.67 25.57 -29.32 61.09 26.31 coo 18.32 -11.51 42.26 16.65 -12.32 40.69 -20.86 61.67 30.54 -19.56 59.85 31.49 ULMN 3 1cns_c01 CHITINASE user 15 3 # 15 B 67 GLU D 84 GLU.? 10.79 C1 GOL A 150 B 89 GLU D 121 GLU^? 11.70 OH7 1PE B 150 B 120 SER D 123 SER^? 7.59 C15 2PE D 146 coo 9.89 -17.65 45.79 9.28 -17.39 43.77 -17.40 74.78 10.23 -17.69 72.96 9.24 coo 19.53 -19.89 39.46 19.21 -18.09 38.37 -20.91 85.61 9.48 -19.44 85.70 10.98 coo 18.32 -11.51 42.26 16.65 -12.32 40.69 -25.59 78.45 8.19 -27.49 79.37 6.96 1cns_c01 source 1cns CHITINASE : 15 hits 1cns_c01 naa= 3 ULMN 3 1cs1_c00 CYSTATHIONINE GAMMA-SYNTHASE user 1 3 # 1 A 101 TYR A 109 TYR~? -5.64 O16 2PE A 148s A 173 ASP A 56 ASP~? 11.59 C21 2PE A 148 C 48 ARG A 63 ARG~? 11.15 O28 2PE A 148 coo 25.00 -3.03 25.68 27.14 -4.51 26.75 -13.81 52.60 20.09 -14.53 54.76 18.49 coo 24.35 4.55 25.11 25.94 3.23 25.53 -16.01 45.89 15.64 -15.93 44.31 14.23 coo 29.84 -5.31 33.83 28.87 -5.97 30.97 -18.54 46.85 28.43 -16.64 46.31 26.03 ULMN 3 1cs1_c00 CYSTATHIONINE GAMMA-SYNTHASE user 2 3 # 2 A 101 TYR B 38 TYR.? 9.60 O1 PEG B 144 A 173 ASP B 40 ASP.? 11.67 O1 PEG B 144 C 48 ARG B 33 ARG.? -3.91 C3 PEG B 144s coo 25.00 -3.03 25.68 27.14 -4.51 26.75 18.19 76.55 32.34 16.15 78.24 31.46 coo 24.35 4.55 25.11 25.94 3.23 25.53 22.51 72.75 29.32 21.02 74.20 28.79 coo 29.84 -5.31 33.83 28.87 -5.97 30.97 17.31 79.39 40.81 17.39 77.24 43.00 ULMN 3 1cs1_c00 CYSTATHIONINE GAMMA-SYNTHASE user 3 3 # 3 A 101 TYR B 38 TYR.? 9.60 O1 PEG B 144 A 173 ASP B 40 ASP.? 11.67 O1 PEG B 144 C 48 ARG B 35 ARG.? 9.50 O1 PEG B 144 coo 25.00 -3.03 25.68 27.14 -4.51 26.75 18.19 76.55 32.34 16.15 78.24 31.46 coo 24.35 4.55 25.11 25.94 3.23 25.53 22.51 72.75 29.32 21.02 74.20 28.79 coo 29.84 -5.31 33.83 28.87 -5.97 30.97 22.76 84.08 36.32 22.81 87.07 35.45 ULMN 3 1cs1_c00 CYSTATHIONINE GAMMA-SYNTHASE user 4 3 # 4 A 101 TYR B 109 TYR~? -5.65 O13 PE8 B 148s A 173 ASP B 56 ASP~? 11.45 C20 PE8 B 148 C 48 ARG B 63 ARG~? -8.01 OH2 1PE B 150s coo 25.00 -3.03 25.68 27.14 -4.51 26.75 2.41 73.03 30.76 2.68 74.03 33.35 coo 24.35 4.55 25.11 25.94 3.23 25.53 6.80 78.21 26.00 8.47 79.07 25.03 coo 29.84 -5.31 33.83 28.87 -5.97 30.97 -5.18 74.17 22.68 -2.11 73.83 22.90 ULMN 3 1cs1_c00 CYSTATHIONINE GAMMA-SYNTHASE user 5 3 # 5 A 101 TYR C 38 TYR.? 5.20 O MLZ C 114 A 173 ASP C 40 ASP.? 9.64 O MLZ C 114 C 48 ARG C 33 ARG.? 10.55 C1 GOL C 149 coo 25.00 -3.03 25.68 27.14 -4.51 26.75 -10.37 86.21 74.10 -12.04 86.61 71.91 coo 24.35 4.55 25.11 25.94 3.23 25.53 -10.62 87.43 80.17 -12.01 86.84 78.68 coo 29.84 -5.31 33.83 28.87 -5.97 30.97 -5.11 80.73 69.28 -2.11 81.22 69.57 ULMN 3 1cs1_c00 CYSTATHIONINE GAMMA-SYNTHASE user 6 3 # 6 A 101 TYR C 109 TYR~? -5.91 C14 PE8 C 148s A 173 ASP C 56 ASP~? 9.09 N MLZ C 114 C 48 ARG C 63 ARG~? -11.70 O25 PE8 C 148s coo 25.00 -3.03 25.68 27.14 -4.51 26.75 -9.64 98.32 63.33 -8.13 96.27 62.21 coo 24.35 4.55 25.11 25.94 3.23 25.53 -16.40 94.43 66.11 -17.63 93.56 67.58 coo 29.84 -5.31 33.83 28.87 -5.97 30.97 -17.02 105.73 59.39 -16.53 104.08 61.96 ULMN 3 1cs1_c00 CYSTATHIONINE GAMMA-SYNTHASE user 7 3 # 7 A 101 TYR D 38 TYR.? 14.74 C9 2PE D 146 A 173 ASP D 40 ASP.? 18.38 C9 2PE D 146 C 48 ARG D 33 ARG.? 10.45 C1 GOL D 147 coo 25.00 -3.03 25.68 27.14 -4.51 26.75 -31.57 94.95 9.95 -32.83 93.25 11.77 coo 24.35 4.55 25.11 25.94 3.23 25.53 -32.95 100.50 7.54 -33.10 99.69 9.54 coo 29.84 -5.31 33.83 28.87 -5.97 30.97 -24.75 89.49 9.81 -23.48 88.88 7.05 ULMN 3 1cs1_c00 CYSTATHIONINE GAMMA-SYNTHASE user 8 3 # 8 A 101 TYR D 109 TYR~? -5.82 O16 2PE D 146s A 173 ASP D 56 ASP~? 11.46 C21 2PE D 146 C 48 ARG D 63 ARG~? -11.23 O28 2PE D 146s coo 25.00 -3.03 25.68 27.14 -4.51 26.75 -41.76 82.56 7.21 -39.24 81.41 7.29 coo 24.35 4.55 25.11 25.94 3.23 25.53 -41.85 87.81 13.66 -41.61 89.58 14.80 coo 29.84 -5.31 33.83 28.87 -5.97 30.97 -51.80 79.77 10.92 -50.17 82.42 10.63 1cs1_c00 source 1cs1 CYSTATHIONINE GAMMA-SYNTHASE : 8 hits 1cs1_c00 naa= 3 ULMN 3 1cs1_c01 CYSTATHIONINE GAMMA-SYNTHASE user 1 3 # 1 A 48 ARG A 63 ARG~? 11.15 O28 2PE A 148 C 101 TYR A 109 TYR~? -5.64 O16 2PE A 148s C 173 ASP A 56 ASP~? 11.59 C21 2PE A 148 coo 32.27 5.62 48.15 31.93 6.48 51.06 -18.54 46.85 28.43 -16.64 46.31 26.03 coo 29.64 3.64 57.39 31.22 5.14 55.65 -13.81 52.60 20.09 -14.53 54.76 18.49 coo 28.89 -3.78 58.23 30.38 -2.57 57.33 -16.01 45.89 15.64 -15.93 44.31 14.23 ULMN 3 1cs1_c01 CYSTATHIONINE GAMMA-SYNTHASE user 2 3 # 2 A 48 ARG B 33 ARG.? -3.91 C3 PEG B 144s C 101 TYR B 38 TYR.? 9.60 O1 PEG B 144 C 173 ASP B 40 ASP.? 11.67 O1 PEG B 144 coo 32.27 5.62 48.15 31.93 6.48 51.06 17.31 79.39 40.81 17.39 77.24 43.00 coo 29.64 3.64 57.39 31.22 5.14 55.65 18.19 76.55 32.34 16.15 78.24 31.46 coo 28.89 -3.78 58.23 30.38 -2.57 57.33 22.51 72.75 29.32 21.02 74.20 28.79 ULMN 3 1cs1_c01 CYSTATHIONINE GAMMA-SYNTHASE user 3 3 # 3 A 48 ARG B 35 ARG.? 9.50 O1 PEG B 144 C 101 TYR B 38 TYR.? 9.60 O1 PEG B 144 C 173 ASP B 40 ASP.? 11.67 O1 PEG B 144 coo 32.27 5.62 48.15 31.93 6.48 51.06 22.76 84.08 36.32 22.81 87.07 35.45 coo 29.64 3.64 57.39 31.22 5.14 55.65 18.19 76.55 32.34 16.15 78.24 31.46 coo 28.89 -3.78 58.23 30.38 -2.57 57.33 22.51 72.75 29.32 21.02 74.20 28.79 ULMN 3 1cs1_c01 CYSTATHIONINE GAMMA-SYNTHASE user 4 3 # 4 A 48 ARG B 63 ARG~? -8.01 OH2 1PE B 150s C 101 TYR B 109 TYR~? -5.65 O13 PE8 B 148s C 173 ASP B 56 ASP~? 11.45 C20 PE8 B 148 coo 32.27 5.62 48.15 31.93 6.48 51.06 -5.18 74.17 22.68 -2.11 73.83 22.90 coo 29.64 3.64 57.39 31.22 5.14 55.65 2.41 73.03 30.76 2.68 74.03 33.35 coo 28.89 -3.78 58.23 30.38 -2.57 57.33 6.80 78.21 26.00 8.47 79.07 25.03 ULMN 3 1cs1_c01 CYSTATHIONINE GAMMA-SYNTHASE user 5 3 # 5 A 48 ARG C 33 ARG.? 10.55 C1 GOL C 149 C 101 TYR C 38 TYR.? 5.20 O MLZ C 114 C 173 ASP C 40 ASP.? 9.64 O MLZ C 114 coo 32.27 5.62 48.15 31.93 6.48 51.06 -5.11 80.73 69.28 -2.11 81.22 69.57 coo 29.64 3.64 57.39 31.22 5.14 55.65 -10.37 86.21 74.10 -12.04 86.61 71.91 coo 28.89 -3.78 58.23 30.38 -2.57 57.33 -10.62 87.43 80.17 -12.01 86.84 78.68 ULMN 3 1cs1_c01 CYSTATHIONINE GAMMA-SYNTHASE user 6 3 # 6 A 48 ARG C 63 ARG~? -11.70 O25 PE8 C 148s C 101 TYR C 109 TYR~? -5.91 C14 PE8 C 148s C 173 ASP C 56 ASP~? 9.09 N MLZ C 114 coo 32.27 5.62 48.15 31.93 6.48 51.06 -17.02 105.73 59.39 -16.53 104.08 61.96 coo 29.64 3.64 57.39 31.22 5.14 55.65 -9.64 98.32 63.33 -8.13 96.27 62.21 coo 28.89 -3.78 58.23 30.38 -2.57 57.33 -16.40 94.43 66.11 -17.63 93.56 67.58 ULMN 3 1cs1_c01 CYSTATHIONINE GAMMA-SYNTHASE user 7 3 # 7 A 48 ARG D 33 ARG.? 10.45 C1 GOL D 147 C 101 TYR D 38 TYR.? 14.74 C9 2PE D 146 C 173 ASP D 40 ASP.? 18.38 C9 2PE D 146 coo 32.27 5.62 48.15 31.93 6.48 51.06 -24.75 89.49 9.81 -23.48 88.88 7.05 coo 29.64 3.64 57.39 31.22 5.14 55.65 -31.57 94.95 9.95 -32.83 93.25 11.77 coo 28.89 -3.78 58.23 30.38 -2.57 57.33 -32.95 100.50 7.54 -33.10 99.69 9.54 ULMN 3 1cs1_c01 CYSTATHIONINE GAMMA-SYNTHASE user 8 3 # 8 A 48 ARG D 63 ARG~? -11.23 O28 2PE D 146s C 101 TYR D 109 TYR~? -5.82 O16 2PE D 146s C 173 ASP D 56 ASP~? 11.46 C21 2PE D 146 coo 32.27 5.62 48.15 31.93 6.48 51.06 -51.80 79.77 10.92 -50.17 82.42 10.63 coo 29.64 3.64 57.39 31.22 5.14 55.65 -41.76 82.56 7.21 -39.24 81.41 7.29 coo 28.89 -3.78 58.23 30.38 -2.57 57.33 -41.85 87.81 13.66 -41.61 89.58 14.80 1cs1_c01 source 1cs1 CYSTATHIONINE GAMMA-SYNTHASE : 8 hits 1cs1_c01 naa= 3 ULMN 3 1cs1_c02 CYSTATHIONINE GAMMA-SYNTHASE user 1 3 # 1 B 48 ARG A 63 ARG~? 11.15 O28 2PE A 148 D 101 TYR A 109 TYR~? -5.64 O16 2PE A 148s D 173 ASP A 56 ASP~? 11.59 C21 2PE A 148 coo 69.08 8.58 32.60 69.70 10.81 30.58 -18.54 46.85 28.43 -16.64 46.31 26.03 coo 71.77 11.86 24.26 70.23 12.22 26.56 -13.81 52.60 20.09 -14.53 54.76 18.49 coo 71.60 6.14 19.25 70.26 6.87 20.69 -16.01 45.89 15.64 -15.93 44.31 14.23 ULMN 3 1cs1_c02 CYSTATHIONINE GAMMA-SYNTHASE user 2 3 # 2 B 48 ARG B 33 ARG.? -3.91 C3 PEG B 144s D 101 TYR B 38 TYR.? 9.60 O1 PEG B 144 D 173 ASP B 40 ASP.? 11.67 O1 PEG B 144 coo 69.08 8.58 32.60 69.70 10.81 30.58 17.31 79.39 40.81 17.39 77.24 43.00 coo 71.77 11.86 24.26 70.23 12.22 26.56 18.19 76.55 32.34 16.15 78.24 31.46 coo 71.60 6.14 19.25 70.26 6.87 20.69 22.51 72.75 29.32 21.02 74.20 28.79 ULMN 3 1cs1_c02 CYSTATHIONINE GAMMA-SYNTHASE user 3 3 # 3 B 48 ARG B 35 ARG.? 9.50 O1 PEG B 144 D 101 TYR B 38 TYR.? 9.60 O1 PEG B 144 D 173 ASP B 40 ASP.? 11.67 O1 PEG B 144 coo 69.08 8.58 32.60 69.70 10.81 30.58 22.76 84.08 36.32 22.81 87.07 35.45 coo 71.77 11.86 24.26 70.23 12.22 26.56 18.19 76.55 32.34 16.15 78.24 31.46 coo 71.60 6.14 19.25 70.26 6.87 20.69 22.51 72.75 29.32 21.02 74.20 28.79 ULMN 3 1cs1_c02 CYSTATHIONINE GAMMA-SYNTHASE user 4 3 # 4 B 48 ARG B 63 ARG~? -8.01 OH2 1PE B 150s D 101 TYR B 109 TYR~? -5.65 O13 PE8 B 148s D 173 ASP B 56 ASP~? 11.45 C20 PE8 B 148 coo 69.08 8.58 32.60 69.70 10.81 30.58 -5.18 74.17 22.68 -2.11 73.83 22.90 coo 71.77 11.86 24.26 70.23 12.22 26.56 2.41 73.03 30.76 2.68 74.03 33.35 coo 71.60 6.14 19.25 70.26 6.87 20.69 6.80 78.21 26.00 8.47 79.07 25.03 ULMN 3 1cs1_c02 CYSTATHIONINE GAMMA-SYNTHASE user 5 3 # 5 B 48 ARG C 33 ARG.? 10.55 C1 GOL C 149 D 101 TYR C 38 TYR.? 5.20 O MLZ C 114 D 173 ASP C 40 ASP.? 9.64 O MLZ C 114 coo 69.08 8.58 32.60 69.70 10.81 30.58 -5.11 80.73 69.28 -2.11 81.22 69.57 coo 71.77 11.86 24.26 70.23 12.22 26.56 -10.37 86.21 74.10 -12.04 86.61 71.91 coo 71.60 6.14 19.25 70.26 6.87 20.69 -10.62 87.43 80.17 -12.01 86.84 78.68 ULMN 3 1cs1_c02 CYSTATHIONINE GAMMA-SYNTHASE user 6 3 # 6 B 48 ARG C 63 ARG~? -11.70 O25 PE8 C 148s D 101 TYR C 109 TYR~? -5.91 C14 PE8 C 148s D 173 ASP C 56 ASP~? 9.09 N MLZ C 114 coo 69.08 8.58 32.60 69.70 10.81 30.58 -17.02 105.73 59.39 -16.53 104.08 61.96 coo 71.77 11.86 24.26 70.23 12.22 26.56 -9.64 98.32 63.33 -8.13 96.27 62.21 coo 71.60 6.14 19.25 70.26 6.87 20.69 -16.40 94.43 66.11 -17.63 93.56 67.58 ULMN 3 1cs1_c02 CYSTATHIONINE GAMMA-SYNTHASE user 7 3 # 7 B 48 ARG D 33 ARG.? 10.45 C1 GOL D 147 D 101 TYR D 38 TYR.? 14.74 C9 2PE D 146 D 173 ASP D 40 ASP.? 18.38 C9 2PE D 146 coo 69.08 8.58 32.60 69.70 10.81 30.58 -24.75 89.49 9.81 -23.48 88.88 7.05 coo 71.77 11.86 24.26 70.23 12.22 26.56 -31.57 94.95 9.95 -32.83 93.25 11.77 coo 71.60 6.14 19.25 70.26 6.87 20.69 -32.95 100.50 7.54 -33.10 99.69 9.54 ULMN 3 1cs1_c02 CYSTATHIONINE GAMMA-SYNTHASE user 8 3 # 8 B 48 ARG D 63 ARG~? -11.23 O28 2PE D 146s D 101 TYR D 109 TYR~? -5.82 O16 2PE D 146s D 173 ASP D 56 ASP~? 11.46 C21 2PE D 146 coo 69.08 8.58 32.60 69.70 10.81 30.58 -51.80 79.77 10.92 -50.17 82.42 10.63 coo 71.77 11.86 24.26 70.23 12.22 26.56 -41.76 82.56 7.21 -39.24 81.41 7.29 coo 71.60 6.14 19.25 70.26 6.87 20.69 -41.85 87.81 13.66 -41.61 89.58 14.80 1cs1_c02 source 1cs1 CYSTATHIONINE GAMMA-SYNTHASE : 8 hits 1cs1_c02 naa= 3 ULMN 3 1cs1_c03 CYSTATHIONINE GAMMA-SYNTHASE user 1 3 # 1 B 101 TYR A 109 TYR~? -5.64 O16 2PE A 148s B 173 ASP A 56 ASP~? 11.59 C21 2PE A 148 D 48 ARG A 63 ARG~? 11.15 O28 2PE A 148 coo 74.59 -12.57 45.75 72.37 -12.96 44.12 -13.81 52.60 20.09 -14.53 54.76 18.49 coo 76.00 -6.96 50.63 74.29 -7.61 49.57 -16.01 45.89 15.64 -15.93 44.31 14.23 coo 69.39 -8.90 38.17 70.70 -11.19 39.77 -18.54 46.85 28.43 -16.64 46.31 26.03 ULMN 3 1cs1_c03 CYSTATHIONINE GAMMA-SYNTHASE user 2 3 # 2 B 101 TYR B 38 TYR.? 9.60 O1 PEG B 144 B 173 ASP B 40 ASP.? 11.67 O1 PEG B 144 D 48 ARG B 33 ARG.? -3.91 C3 PEG B 144s coo 74.59 -12.57 45.75 72.37 -12.96 44.12 18.19 76.55 32.34 16.15 78.24 31.46 coo 76.00 -6.96 50.63 74.29 -7.61 49.57 22.51 72.75 29.32 21.02 74.20 28.79 coo 69.39 -8.90 38.17 70.70 -11.19 39.77 17.31 79.39 40.81 17.39 77.24 43.00 ULMN 3 1cs1_c03 CYSTATHIONINE GAMMA-SYNTHASE user 3 3 # 3 B 101 TYR B 38 TYR.? 9.60 O1 PEG B 144 B 173 ASP B 40 ASP.? 11.67 O1 PEG B 144 D 48 ARG B 35 ARG.? 9.50 O1 PEG B 144 coo 74.59 -12.57 45.75 72.37 -12.96 44.12 18.19 76.55 32.34 16.15 78.24 31.46 coo 76.00 -6.96 50.63 74.29 -7.61 49.57 22.51 72.75 29.32 21.02 74.20 28.79 coo 69.39 -8.90 38.17 70.70 -11.19 39.77 22.76 84.08 36.32 22.81 87.07 35.45 ULMN 3 1cs1_c03 CYSTATHIONINE GAMMA-SYNTHASE user 4 3 # 4 B 101 TYR B 109 TYR~? -5.65 O13 PE8 B 148s B 173 ASP B 56 ASP~? 11.45 C20 PE8 B 148 D 48 ARG B 63 ARG~? -8.01 OH2 1PE B 150s coo 74.59 -12.57 45.75 72.37 -12.96 44.12 2.41 73.03 30.76 2.68 74.03 33.35 coo 76.00 -6.96 50.63 74.29 -7.61 49.57 6.80 78.21 26.00 8.47 79.07 25.03 coo 69.39 -8.90 38.17 70.70 -11.19 39.77 -5.18 74.17 22.68 -2.11 73.83 22.90 ULMN 3 1cs1_c03 CYSTATHIONINE GAMMA-SYNTHASE user 5 3 # 5 B 101 TYR C 38 TYR.? 5.20 O MLZ C 114 B 173 ASP C 40 ASP.? 9.64 O MLZ C 114 D 48 ARG C 33 ARG.? 10.55 C1 GOL C 149 coo 74.59 -12.57 45.75 72.37 -12.96 44.12 -10.37 86.21 74.10 -12.04 86.61 71.91 coo 76.00 -6.96 50.63 74.29 -7.61 49.57 -10.62 87.43 80.17 -12.01 86.84 78.68 coo 69.39 -8.90 38.17 70.70 -11.19 39.77 -5.11 80.73 69.28 -2.11 81.22 69.57 ULMN 3 1cs1_c03 CYSTATHIONINE GAMMA-SYNTHASE user 6 3 # 6 B 101 TYR C 109 TYR~? -5.91 C14 PE8 C 148s B 173 ASP C 56 ASP~? 9.09 N MLZ C 114 D 48 ARG C 63 ARG~? -11.70 O25 PE8 C 148s coo 74.59 -12.57 45.75 72.37 -12.96 44.12 -9.64 98.32 63.33 -8.13 96.27 62.21 coo 76.00 -6.96 50.63 74.29 -7.61 49.57 -16.40 94.43 66.11 -17.63 93.56 67.58 coo 69.39 -8.90 38.17 70.70 -11.19 39.77 -17.02 105.73 59.39 -16.53 104.08 61.96 ULMN 3 1cs1_c03 CYSTATHIONINE GAMMA-SYNTHASE user 7 3 # 7 B 101 TYR D 38 TYR.? 14.74 C9 2PE D 146 B 173 ASP D 40 ASP.? 18.38 C9 2PE D 146 D 48 ARG D 33 ARG.? 10.45 C1 GOL D 147 coo 74.59 -12.57 45.75 72.37 -12.96 44.12 -31.57 94.95 9.95 -32.83 93.25 11.77 coo 76.00 -6.96 50.63 74.29 -7.61 49.57 -32.95 100.50 7.54 -33.10 99.69 9.54 coo 69.39 -8.90 38.17 70.70 -11.19 39.77 -24.75 89.49 9.81 -23.48 88.88 7.05 ULMN 3 1cs1_c03 CYSTATHIONINE GAMMA-SYNTHASE user 8 3 # 8 B 101 TYR D 109 TYR~? -5.82 O16 2PE D 146s B 173 ASP D 56 ASP~? 11.46 C21 2PE D 146 D 48 ARG D 63 ARG~? -11.23 O28 2PE D 146s coo 74.59 -12.57 45.75 72.37 -12.96 44.12 -41.76 82.56 7.21 -39.24 81.41 7.29 coo 76.00 -6.96 50.63 74.29 -7.61 49.57 -41.85 87.81 13.66 -41.61 89.58 14.80 coo 69.39 -8.90 38.17 70.70 -11.19 39.77 -51.80 79.77 10.92 -50.17 82.42 10.63 1cs1_c03 source 1cs1 CYSTATHIONINE GAMMA-SYNTHASE : 8 hits 1cs1_c03 naa= 3 ULMN 3 1ctn_c00 CHITINASE A (E.C.3.2.1.14) (PH 5.5, user 1 3 # 1 313 ASP A 122 ASP^? 7.46 C1 GOL A 150 315 GLU A 121 GLU^? 12.41 C1 GOL A 150 390 TYR A 50 TYR~? 5.51 CH2 MLY D 135 coo 32.46 99.13 19.34 30.94 100.38 20.07 -15.41 64.92 4.51 -15.09 66.83 5.33 coo 32.04 94.22 18.23 30.57 94.75 16.88 -13.98 61.53 0.93 -15.14 61.60 -0.79 coo 21.10 94.74 18.36 23.09 96.71 18.59 -19.50 53.98 8.67 -20.18 55.72 10.74 ULMN 3 1ctn_c00 CHITINASE A (E.C.3.2.1.14) (PH 5.5, user 2 3 # 2 313 ASP B 122 ASP^? 7.33 O2 GOL B 149 315 GLU B 121 GLU^? 8.74 O2 PEG B 144 390 TYR B 50 TYR~? 5.52 CH1 MLY C 135 coo 32.46 99.13 19.34 30.94 100.38 20.07 10.89 79.68 47.57 9.75 78.80 49.16 coo 32.04 94.22 18.23 30.57 94.75 16.88 15.37 80.83 45.64 16.23 82.69 46.15 coo 21.10 94.74 18.36 23.09 96.71 18.59 8.51 83.11 35.90 5.93 82.51 36.84 ULMN 3 1ctn_c00 CHITINASE A (E.C.3.2.1.14) (PH 5.5, user 3 3 # 3 313 ASP C 122 ASP^? 7.22 C3 GOL C 149 315 GLU C 121 GLU^? 12.40 C3 GOL C 149 390 TYR C 50 TYR~? 5.59 CE MLY B 135 coo 32.46 99.13 19.34 30.94 100.38 20.07 0.27 81.12 61.60 2.07 81.54 60.53 coo 32.04 94.22 18.23 30.57 94.75 16.88 -1.98 78.69 65.48 -2.54 76.71 65.06 coo 21.10 94.74 18.36 23.09 96.71 18.59 -11.27 85.65 61.91 -10.18 87.09 59.78 ULMN 3 1ctn_c00 CHITINASE A (E.C.3.2.1.14) (PH 5.5, user 4 3 # 4 313 ASP D 122 ASP^? 7.49 C3 GOL D 147 315 GLU D 121 GLU^? 11.70 OH7 1PE B 150 390 TYR D 50 TYR~? 5.61 CH1 MLY A 135 coo 32.46 99.13 19.34 30.94 100.38 20.07 -21.82 80.90 7.85 -21.38 79.32 6.51 coo 32.04 94.22 18.23 30.57 94.75 16.88 -20.91 85.61 9.48 -19.44 85.70 10.98 coo 21.10 94.74 18.36 23.09 96.71 18.59 -31.54 83.73 14.98 -32.20 81.17 14.09 1ctn_c00 source 1ctn CHITINASE A (E.C.3.2.1.14) (PH 5.5, 4 DEGREES : 4 hits 1ctn_c00 naa= 3 ULMN 3 1cwy_c00 AMYLOMALTASE user 1 3 # 1 A 293 ASP A 83 ASP.? 8.52 O3 GOL D 147 A 340 GLU A 84 GLU.? 10.45 C3 GOL D 147 A 395 ASP A 122 ASP^? 7.46 C1 GOL A 150 coo -48.00 -26.48 6.86 -46.51 -25.94 5.49 -19.46 70.43 -3.04 -19.06 72.28 -2.05 coo -43.58 -29.03 7.13 -42.45 -27.34 7.75 -21.01 70.22 3.12 -21.10 71.95 4.30 coo -42.28 -26.47 -1.32 -44.06 -25.60 -0.58 -15.41 64.92 4.51 -15.09 66.83 5.33 ULMN 3 1cwy_c00 AMYLOMALTASE user 2 3 # 2 A 293 ASP A 122 ASP^? 7.46 C1 GOL A 150 A 340 GLU A 121 GLU^? 12.41 C1 GOL A 150 A 395 ASP A 87 ASP.? 8.49 C6 PGE A 147 coo -48.00 -26.48 6.86 -46.51 -25.94 5.49 -15.41 64.92 4.51 -15.09 66.83 5.33 coo -43.58 -29.03 7.13 -42.45 -27.34 7.75 -13.98 61.53 0.93 -15.14 61.60 -0.79 coo -42.28 -26.47 -1.32 -44.06 -25.60 -0.58 -23.17 58.67 3.55 -22.34 59.17 1.69 ULMN 3 1cwy_c00 AMYLOMALTASE user 3 3 # 3 A 293 ASP B 83 ASP.? 9.40 O3 GOL C 149 A 340 GLU B 84 GLU.? 10.31 O3 GOL C 149 A 395 ASP B 122 ASP^? 7.33 O2 GOL B 149 coo -48.00 -26.48 6.86 -46.51 -25.94 5.49 13.62 86.10 55.23 12.83 84.59 56.49 coo -43.58 -29.03 7.13 -42.45 -27.34 7.75 7.66 84.31 53.13 6.13 83.49 54.35 coo -42.28 -26.47 -1.32 -44.06 -25.60 -0.58 10.89 79.68 47.57 9.75 78.80 49.16 ULMN 3 1cwy_c00 AMYLOMALTASE user 4 3 # 4 A 293 ASP B 122 ASP^? 7.33 O2 GOL B 149 A 340 GLU B 121 GLU^? 8.74 O2 PEG B 144 A 395 ASP B 87 ASP.? 8.94 O4 PGE B 147 coo -48.00 -26.48 6.86 -46.51 -25.94 5.49 10.89 79.68 47.57 9.75 78.80 49.16 coo -43.58 -29.03 7.13 -42.45 -27.34 7.75 15.37 80.83 45.64 16.23 82.69 46.15 coo -42.28 -26.47 -1.32 -44.06 -25.60 -0.58 9.49 87.97 42.02 11.31 87.98 43.09 ULMN 3 1cwy_c00 AMYLOMALTASE user 5 3 # 5 A 293 ASP C 83 ASP.? 8.65 O3 GOL B 149 A 340 GLU C 84 GLU.? 10.77 O2 GOL B 149 A 395 ASP C 122 ASP^? 7.22 C3 GOL C 149 coo -48.00 -26.48 6.86 -46.51 -25.94 5.49 3.02 71.86 58.06 4.88 72.49 57.24 coo -43.58 -29.03 7.13 -42.45 -27.34 7.75 2.34 77.12 55.01 3.46 78.21 53.60 coo -42.28 -26.47 -1.32 -44.06 -25.60 -0.58 0.27 81.12 61.60 2.07 81.54 60.53 ULMN 3 1cwy_c00 AMYLOMALTASE user 6 3 # 6 A 293 ASP C 122 ASP^? 7.22 C3 GOL C 149 A 340 GLU C 121 GLU^? 12.40 C3 GOL C 149 A 395 ASP C 87 ASP.? 8.84 O1 PGE C 147 coo -48.00 -26.48 6.86 -46.51 -25.94 5.49 0.27 81.12 61.60 2.07 81.54 60.53 coo -43.58 -29.03 7.13 -42.45 -27.34 7.75 -1.98 78.69 65.48 -2.54 76.71 65.06 coo -42.28 -26.47 -1.32 -44.06 -25.60 -0.58 -9.03 79.00 58.44 -8.21 77.39 59.55 ULMN 3 1cwy_c00 AMYLOMALTASE user 7 3 # 7 A 293 ASP D 83 ASP.? 8.76 O1 GOL A 150 A 340 GLU D 84 GLU.? 10.79 C1 GOL A 150 A 395 ASP D 122 ASP^? 7.49 C3 GOL D 147 coo -48.00 -26.48 6.86 -46.51 -25.94 5.49 -12.54 78.43 10.94 -12.46 77.06 9.29 coo -43.58 -29.03 7.13 -42.45 -27.34 7.75 -17.40 74.78 10.23 -17.69 72.96 9.24 coo -42.28 -26.47 -1.32 -44.06 -25.60 -0.58 -21.82 80.90 7.85 -21.38 79.32 6.51 ULMN 3 1cwy_c00 AMYLOMALTASE user 8 3 # 8 A 293 ASP D 122 ASP^? 7.49 C3 GOL D 147 A 340 GLU D 121 GLU^? 11.70 OH7 1PE B 150 A 395 ASP D 87 ASP.? 7.26 C16 1PE B 150 coo -48.00 -26.48 6.86 -46.51 -25.94 5.49 -21.82 80.90 7.85 -21.38 79.32 6.51 coo -43.58 -29.03 7.13 -42.45 -27.34 7.75 -20.91 85.61 9.48 -19.44 85.70 10.98 coo -42.28 -26.47 -1.32 -44.06 -25.60 -0.58 -24.70 80.89 17.41 -22.90 81.94 17.31 1cwy_c00 source 1cwy AMYLOMALTASE : 8 hits 1cwy_c00 naa= 3 ULMN 3 1d6o_c00 FK506-BINDING PROTEIN user 1 3 # 1 A 37 ASP A 6 ASP.? -3.91 C9 2PE A 148s A 56 ILE A 104 ILE~? -4.75 C12 2PE A 148s A 82 TYR A 109 TYR~? -5.64 O16 2PE A 148s coo 57.53 -0.59 -5.76 57.73 0.50 -3.97 -8.66 61.41 13.34 -8.76 59.35 12.80 coo 60.23 -10.38 -0.25 59.76 -9.69 -1.44 -12.17 57.15 22.11 -11.76 57.92 22.19 coo 54.60 -10.25 -2.46 55.96 -7.94 -1.62 -13.81 52.60 20.09 -14.53 54.76 18.49 ULMN 3 1d6o_c00 FK506-BINDING PROTEIN user 2 3 # 2 A 37 ASP B 6 ASP.? -3.99 C6 PE8 B 148s A 56 ILE B 104 ILE~? 4.89 C9 PE8 B 148 A 82 TYR B 109 TYR~? -5.65 O13 PE8 B 148s coo 57.53 -0.59 -5.76 57.73 0.50 -3.97 7.95 70.39 41.39 8.88 71.08 39.61 coo 60.23 -10.38 -0.25 59.76 -9.69 -1.44 -0.32 69.64 34.33 0.10 69.58 35.70 coo 54.60 -10.25 -2.46 55.96 -7.94 -1.62 2.41 73.03 30.76 2.68 74.03 33.35 ULMN 3 1d6o_c00 FK506-BINDING PROTEIN user 3 3 # 3 A 37 ASP C 6 ASP.? -4.04 C8 PE8 C 148s A 56 ILE C 104 ILE~? 4.50 O10 PE8 C 148 A 82 TYR C 109 TYR~? -5.91 C14 PE8 C 148s coo 57.53 -0.59 -5.76 57.73 0.50 -3.97 0.53 91.96 65.64 -1.31 91.68 66.68 coo 60.23 -10.38 -0.25 59.76 -9.69 -1.44 -4.71 100.60 61.61 -3.41 99.76 61.75 coo 54.60 -10.25 -2.46 55.96 -7.94 -1.62 -9.64 98.32 63.33 -8.13 96.27 62.21 ULMN 3 1d6o_c00 FK506-BINDING PROTEIN user 4 3 # 4 A 37 ASP D 6 ASP.? -3.77 C8 2PE D 146s A 56 ILE D 104 ILE~? 4.75 C12 2PE D 146 A 82 TYR D 109 TYR~? -5.82 O16 2PE D 146s coo 57.53 -0.59 -5.76 57.73 0.50 -3.97 -31.03 82.87 1.04 -31.83 84.41 2.29 coo 60.23 -10.38 -0.25 59.76 -9.69 -1.44 -40.79 79.54 3.08 -40.49 79.24 2.33 coo 54.60 -10.25 -2.46 55.96 -7.94 -1.62 -41.76 82.56 7.21 -39.24 81.41 7.29 1d6o_c00 source 1d6o FK506-BINDING PROTEIN : 4 hits 1d6o_c00 naa= 3 ULMN 3 1d6o_c01 FK506-BINDING PROTEIN user 1 3 # 1 B 37 ASP A 6 ASP.? -3.91 C9 2PE A 148s B 56 ILE A 104 ILE~? -4.75 C12 2PE A 148s B 82 TYR A 109 TYR~? -5.64 O16 2PE A 148s coo 60.36 -17.02 -33.28 60.59 -15.91 -31.49 -8.66 61.41 13.34 -8.76 59.35 12.80 coo 63.12 -26.85 -28.11 62.65 -26.16 -29.29 -12.17 57.15 22.11 -11.76 57.92 22.19 coo 57.53 -26.71 -30.24 58.93 -24.39 -29.50 -13.81 52.60 20.09 -14.53 54.76 18.49 ULMN 3 1d6o_c01 FK506-BINDING PROTEIN user 2 3 # 2 B 37 ASP B 6 ASP.? -3.99 C6 PE8 B 148s B 56 ILE B 104 ILE~? 4.89 C9 PE8 B 148 B 82 TYR B 109 TYR~? -5.65 O13 PE8 B 148s coo 60.36 -17.02 -33.28 60.59 -15.91 -31.49 7.95 70.39 41.39 8.88 71.08 39.61 coo 63.12 -26.85 -28.11 62.65 -26.16 -29.29 -0.32 69.64 34.33 0.10 69.58 35.70 coo 57.53 -26.71 -30.24 58.93 -24.39 -29.50 2.41 73.03 30.76 2.68 74.03 33.35 ULMN 3 1d6o_c01 FK506-BINDING PROTEIN user 3 3 # 3 B 37 ASP C 6 ASP.? -4.04 C8 PE8 C 148s B 56 ILE C 104 ILE~? 4.50 O10 PE8 C 148 B 82 TYR C 109 TYR~? -5.91 C14 PE8 C 148s coo 60.36 -17.02 -33.28 60.59 -15.91 -31.49 0.53 91.96 65.64 -1.31 91.68 66.68 coo 63.12 -26.85 -28.11 62.65 -26.16 -29.29 -4.71 100.60 61.61 -3.41 99.76 61.75 coo 57.53 -26.71 -30.24 58.93 -24.39 -29.50 -9.64 98.32 63.33 -8.13 96.27 62.21 ULMN 3 1d6o_c01 FK506-BINDING PROTEIN user 4 3 # 4 B 37 ASP D 6 ASP.? -3.77 C8 2PE D 146s B 56 ILE D 104 ILE~? 4.75 C12 2PE D 146 B 82 TYR D 109 TYR~? -5.82 O16 2PE D 146s coo 60.36 -17.02 -33.28 60.59 -15.91 -31.49 -31.03 82.87 1.04 -31.83 84.41 2.29 coo 63.12 -26.85 -28.11 62.65 -26.16 -29.29 -40.79 79.54 3.08 -40.49 79.24 2.33 coo 57.53 -26.71 -30.24 58.93 -24.39 -29.50 -41.76 82.56 7.21 -39.24 81.41 7.29 1d6o_c01 source 1d6o FK506-BINDING PROTEIN : 4 hits 1d6o_c01 naa= 3 ULMN 3 1ddj_c12 PLASMINOGEN user 1 3 # 1 A 603 HIS A 85 HIS.? 6.69 C5 PGE A 147 A 646 ASP A 83 ASP.? 8.52 O3 GOL D 147 A 739 GLY A 3 GLY.? -5.02 C3 GOL A 150s coo 17.92 60.45 -3.51 16.63 61.88 -2.68 -23.05 64.43 -0.55 -21.68 63.00 -1.25 coo 18.60 56.26 -8.31 18.53 57.26 -6.47 -19.46 70.43 -3.04 -19.06 72.28 -2.05 coo 11.37 50.89 2.29 11.05 51.63 2.25 -11.64 65.89 4.76 -10.88 65.57 4.96 ULMN 3 1ddj_c12 PLASMINOGEN user 2 3 # 2 A 603 HIS A 85 HIS.? 6.69 C5 PGE A 147 A 646 ASP A 87 ASP.? 8.49 C6 PGE A 147 A 739 GLY A 3 GLY.? -5.02 C3 GOL A 150s coo 17.92 60.45 -3.51 16.63 61.88 -2.68 -23.05 64.43 -0.55 -21.68 63.00 -1.25 coo 18.60 56.26 -8.31 18.53 57.26 -6.47 -23.17 58.67 3.55 -22.34 59.17 1.69 coo 11.37 50.89 2.29 11.05 51.63 2.25 -11.64 65.89 4.76 -10.88 65.57 4.96 ULMN 3 1ddj_c12 PLASMINOGEN user 3 3 # 3 A 603 HIS A 88 HIS^? 4.20 CH2 MLY D 135 A 646 ASP A 87 ASP.? 8.49 C6 PGE A 147 A 739 GLY D 134 GLY.? 2.47 N MLY D 135 coo 17.92 60.45 -3.51 16.63 61.88 -2.68 -23.95 56.87 7.77 -24.14 54.98 6.86 coo 18.60 56.26 -8.31 18.53 57.26 -6.47 -23.17 58.67 3.55 -22.34 59.17 1.69 coo 11.37 50.89 2.29 11.05 51.63 2.25 -31.46 51.06 14.18 -31.60 51.74 13.54 ULMN 3 1ddj_c12 PLASMINOGEN user 4 3 # 4 A 603 HIS B 85 HIS.? 6.66 C6 PGE B 147 A 646 ASP B 83 ASP.? 9.40 O3 GOL C 149 A 739 GLY B 3 GLY.? 4.53 O2 GOL B 149 coo 17.92 60.45 -3.51 16.63 61.88 -2.68 11.11 88.86 48.90 12.76 88.34 47.73 coo 18.60 56.26 -8.31 18.53 57.26 -6.47 13.62 86.10 55.23 12.83 84.59 56.49 coo 11.37 50.89 2.29 11.05 51.63 2.25 12.20 75.96 48.73 12.53 75.45 48.19 ULMN 3 1ddj_c12 PLASMINOGEN user 5 3 # 5 A 603 HIS B 85 HIS.? 6.66 C6 PGE B 147 A 646 ASP B 87 ASP.? 8.94 O4 PGE B 147 A 739 GLY B 3 GLY.? 4.53 O2 GOL B 149 coo 17.92 60.45 -3.51 16.63 61.88 -2.68 11.11 88.86 48.90 12.76 88.34 47.73 coo 18.60 56.26 -8.31 18.53 57.26 -6.47 9.49 87.97 42.02 11.31 87.98 43.09 coo 11.37 50.89 2.29 11.05 51.63 2.25 12.20 75.96 48.73 12.53 75.45 48.19 ULMN 3 1ddj_c12 PLASMINOGEN user 6 3 # 6 A 603 HIS B 88 HIS^? 4.29 CH1 MLY C 135 A 646 ASP B 87 ASP.? 8.94 O4 PGE B 147 A 739 GLY C 134 GLY.? 2.48 N MLY C 135 coo 17.92 60.45 -3.51 16.63 61.88 -2.68 6.15 87.00 38.94 7.35 87.96 37.51 coo 18.60 56.26 -8.31 18.53 57.26 -6.47 9.49 87.97 42.02 11.31 87.98 43.09 coo 11.37 50.89 2.29 11.05 51.63 2.25 -1.36 91.26 31.44 -1.10 91.64 32.26 ULMN 3 1ddj_c12 PLASMINOGEN user 7 3 # 7 A 603 HIS C 85 HIS.? 6.34 C1 PGE C 147 A 646 ASP C 83 ASP.? 8.65 O3 GOL B 149 A 739 GLY C 3 GLY.? -4.72 C3 GOL C 149s coo 17.92 60.45 -3.51 16.63 61.88 -2.68 -4.08 74.18 57.17 -4.69 74.12 59.17 coo 18.60 56.26 -8.31 18.53 57.26 -6.47 3.02 71.86 58.06 4.88 72.49 57.24 coo 11.37 50.89 2.29 11.05 51.63 2.25 2.92 82.34 64.00 3.08 82.77 64.68 ULMN 3 1ddj_c12 PLASMINOGEN user 8 3 # 8 A 603 HIS C 85 HIS.? 6.34 C1 PGE C 147 A 646 ASP C 87 ASP.? 8.84 O1 PGE C 147 A 739 GLY C 3 GLY.? -4.72 C3 GOL C 149s coo 17.92 60.45 -3.51 16.63 61.88 -2.68 -4.08 74.18 57.17 -4.69 74.12 59.17 coo 18.60 56.26 -8.31 18.53 57.26 -6.47 -9.03 79.00 58.44 -8.21 77.39 59.55 coo 11.37 50.89 2.29 11.05 51.63 2.25 2.92 82.34 64.00 3.08 82.77 64.68 ULMN 3 1ddj_c12 PLASMINOGEN user 9 3 # 9 A 603 HIS D 85 HIS.? 4.73 OH7 1PE B 150 A 646 ASP D 87 ASP.? 7.26 C16 1PE B 150 A 739 GLY D 3 GLY.? 4.87 C3 GOL D 147 coo 17.92 60.45 -3.51 16.63 61.88 -2.68 -18.08 79.12 16.04 -18.14 81.21 15.79 coo 18.60 56.26 -8.31 18.53 57.26 -6.47 -24.70 80.89 17.41 -22.90 81.94 17.31 coo 11.37 50.89 2.29 11.05 51.63 2.25 -21.40 82.14 3.97 -21.80 82.75 3.64 ULMN 3 1ddj_c12 PLASMINOGEN user 10 3 # 10 A 603 HIS D 88 HIS^? 4.38 CH1 MLY A 135 A 646 ASP D 87 ASP.? 7.26 C16 1PE B 150 A 739 GLY A 134 GLY.? 2.47 N MLY A 135 coo 17.92 60.45 -3.51 16.63 61.88 -2.68 -29.18 79.71 17.63 -29.43 81.25 19.03 coo 18.60 56.26 -8.31 18.53 57.26 -6.47 -24.70 80.89 17.41 -22.90 81.94 17.31 coo 11.37 50.89 2.29 11.05 51.63 2.25 -37.57 76.13 24.20 -36.67 75.88 24.22 1ddj_c12 source 1ddj PLASMINOGEN : 10 hits 1ddj_c12 naa= 3 ULMN 3 1ddj_c13 PLASMINOGEN user 1 3 # 1 B 603 HIS A 85 HIS.? 6.69 C5 PGE A 147 B 646 ASP A 87 ASP.? 8.49 C6 PGE A 147 B 739 GLY A 3 GLY.? -5.02 C3 GOL A 150s coo -28.76 37.11 -20.75 -29.48 38.32 -19.19 -23.05 64.43 -0.55 -21.68 63.00 -1.25 coo -23.42 34.83 -23.78 -25.09 36.03 -23.31 -23.17 58.67 3.55 -22.34 59.17 1.69 coo -24.60 49.24 -23.60 -24.80 48.99 -22.86 -11.64 65.89 4.76 -10.88 65.57 4.96 ULMN 3 1ddj_c13 PLASMINOGEN user 2 3 # 2 B 603 HIS A 88 HIS^? 4.20 CH2 MLY D 135 B 646 ASP A 87 ASP.? 8.49 C6 PGE A 147 B 739 GLY D 134 GLY.? 2.47 N MLY D 135 coo -28.76 37.11 -20.75 -29.48 38.32 -19.19 -23.95 56.87 7.77 -24.14 54.98 6.86 coo -23.42 34.83 -23.78 -25.09 36.03 -23.31 -23.17 58.67 3.55 -22.34 59.17 1.69 coo -24.60 49.24 -23.60 -24.80 48.99 -22.86 -31.46 51.06 14.18 -31.60 51.74 13.54 ULMN 3 1ddj_c13 PLASMINOGEN user 3 3 # 3 B 603 HIS B 85 HIS.? 6.66 C6 PGE B 147 B 646 ASP B 87 ASP.? 8.94 O4 PGE B 147 B 739 GLY B 3 GLY.? 4.53 O2 GOL B 149 coo -28.76 37.11 -20.75 -29.48 38.32 -19.19 11.11 88.86 48.90 12.76 88.34 47.73 coo -23.42 34.83 -23.78 -25.09 36.03 -23.31 9.49 87.97 42.02 11.31 87.98 43.09 coo -24.60 49.24 -23.60 -24.80 48.99 -22.86 12.20 75.96 48.73 12.53 75.45 48.19 ULMN 3 1ddj_c13 PLASMINOGEN user 4 3 # 4 B 603 HIS B 88 HIS^? 4.29 CH1 MLY C 135 B 646 ASP B 87 ASP.? 8.94 O4 PGE B 147 B 739 GLY C 134 GLY.? 2.48 N MLY C 135 coo -28.76 37.11 -20.75 -29.48 38.32 -19.19 6.15 87.00 38.94 7.35 87.96 37.51 coo -23.42 34.83 -23.78 -25.09 36.03 -23.31 9.49 87.97 42.02 11.31 87.98 43.09 coo -24.60 49.24 -23.60 -24.80 48.99 -22.86 -1.36 91.26 31.44 -1.10 91.64 32.26 ULMN 3 1ddj_c13 PLASMINOGEN user 5 3 # 5 B 603 HIS C 85 HIS.? 6.34 C1 PGE C 147 B 646 ASP C 87 ASP.? 8.84 O1 PGE C 147 B 739 GLY C 3 GLY.? -4.72 C3 GOL C 149s coo -28.76 37.11 -20.75 -29.48 38.32 -19.19 -4.08 74.18 57.17 -4.69 74.12 59.17 coo -23.42 34.83 -23.78 -25.09 36.03 -23.31 -9.03 79.00 58.44 -8.21 77.39 59.55 coo -24.60 49.24 -23.60 -24.80 48.99 -22.86 2.92 82.34 64.00 3.08 82.77 64.68 ULMN 3 1ddj_c13 PLASMINOGEN user 6 3 # 6 B 603 HIS D 85 HIS.? 4.73 OH7 1PE B 150 B 646 ASP D 87 ASP.? 7.26 C16 1PE B 150 B 739 GLY D 3 GLY.? 4.87 C3 GOL D 147 coo -28.76 37.11 -20.75 -29.48 38.32 -19.19 -18.08 79.12 16.04 -18.14 81.21 15.79 coo -23.42 34.83 -23.78 -25.09 36.03 -23.31 -24.70 80.89 17.41 -22.90 81.94 17.31 coo -24.60 49.24 -23.60 -24.80 48.99 -22.86 -21.40 82.14 3.97 -21.80 82.75 3.64 ULMN 3 1ddj_c13 PLASMINOGEN user 7 3 # 7 B 603 HIS D 88 HIS^? 4.38 CH1 MLY A 135 B 646 ASP D 87 ASP.? 7.26 C16 1PE B 150 B 739 GLY A 134 GLY.? 2.47 N MLY A 135 coo -28.76 37.11 -20.75 -29.48 38.32 -19.19 -29.18 79.71 17.63 -29.43 81.25 19.03 coo -23.42 34.83 -23.78 -25.09 36.03 -23.31 -24.70 80.89 17.41 -22.90 81.94 17.31 coo -24.60 49.24 -23.60 -24.80 48.99 -22.86 -37.57 76.13 24.20 -36.67 75.88 24.22 1ddj_c13 source 1ddj PLASMINOGEN : 7 hits 1ddj_c13 naa= 3 ULMN 3 1ddj_c14 PLASMINOGEN user 1 3 # 1 C 603 HIS A 85 HIS.? 6.69 C5 PGE A 147 C 646 ASP A 87 ASP.? 8.49 C6 PGE A 147 C 739 GLY A 3 GLY.? -5.02 C3 GOL A 150s coo 15.33 59.81 59.60 13.98 60.99 60.69 -23.05 64.43 -0.55 -21.68 63.00 -1.25 coo 16.06 55.72 54.73 15.97 56.49 56.70 -23.17 58.67 3.55 -22.34 59.17 1.69 coo 9.38 49.29 65.28 9.01 50.03 65.31 -11.64 65.89 4.76 -10.88 65.57 4.96 ULMN 3 1ddj_c14 PLASMINOGEN user 2 3 # 2 C 603 HIS A 88 HIS^? 4.20 CH2 MLY D 135 C 646 ASP A 87 ASP.? 8.49 C6 PGE A 147 C 739 GLY D 134 GLY.? 2.47 N MLY D 135 coo 15.33 59.81 59.60 13.98 60.99 60.69 -23.95 56.87 7.77 -24.14 54.98 6.86 coo 16.06 55.72 54.73 15.97 56.49 56.70 -23.17 58.67 3.55 -22.34 59.17 1.69 coo 9.38 49.29 65.28 9.01 50.03 65.31 -31.46 51.06 14.18 -31.60 51.74 13.54 ULMN 3 1ddj_c14 PLASMINOGEN user 3 3 # 3 C 603 HIS B 85 HIS.? 6.66 C6 PGE B 147 C 646 ASP B 83 ASP.? 9.40 O3 GOL C 149 C 739 GLY B 3 GLY.? 4.53 O2 GOL B 149 coo 15.33 59.81 59.60 13.98 60.99 60.69 11.11 88.86 48.90 12.76 88.34 47.73 coo 16.06 55.72 54.73 15.97 56.49 56.70 13.62 86.10 55.23 12.83 84.59 56.49 coo 9.38 49.29 65.28 9.01 50.03 65.31 12.20 75.96 48.73 12.53 75.45 48.19 ULMN 3 1ddj_c14 PLASMINOGEN user 4 3 # 4 C 603 HIS B 85 HIS.? 6.66 C6 PGE B 147 C 646 ASP B 87 ASP.? 8.94 O4 PGE B 147 C 739 GLY B 3 GLY.? 4.53 O2 GOL B 149 coo 15.33 59.81 59.60 13.98 60.99 60.69 11.11 88.86 48.90 12.76 88.34 47.73 coo 16.06 55.72 54.73 15.97 56.49 56.70 9.49 87.97 42.02 11.31 87.98 43.09 coo 9.38 49.29 65.28 9.01 50.03 65.31 12.20 75.96 48.73 12.53 75.45 48.19 ULMN 3 1ddj_c14 PLASMINOGEN user 5 3 # 5 C 603 HIS B 88 HIS^? 4.29 CH1 MLY C 135 C 646 ASP B 87 ASP.? 8.94 O4 PGE B 147 C 739 GLY C 134 GLY.? 2.48 N MLY C 135 coo 15.33 59.81 59.60 13.98 60.99 60.69 6.15 87.00 38.94 7.35 87.96 37.51 coo 16.06 55.72 54.73 15.97 56.49 56.70 9.49 87.97 42.02 11.31 87.98 43.09 coo 9.38 49.29 65.28 9.01 50.03 65.31 -1.36 91.26 31.44 -1.10 91.64 32.26 ULMN 3 1ddj_c14 PLASMINOGEN user 6 3 # 6 C 603 HIS C 85 HIS.? 6.34 C1 PGE C 147 C 646 ASP C 87 ASP.? 8.84 O1 PGE C 147 C 739 GLY C 3 GLY.? -4.72 C3 GOL C 149s coo 15.33 59.81 59.60 13.98 60.99 60.69 -4.08 74.18 57.17 -4.69 74.12 59.17 coo 16.06 55.72 54.73 15.97 56.49 56.70 -9.03 79.00 58.44 -8.21 77.39 59.55 coo 9.38 49.29 65.28 9.01 50.03 65.31 2.92 82.34 64.00 3.08 82.77 64.68 ULMN 3 1ddj_c14 PLASMINOGEN user 7 3 # 7 C 603 HIS D 85 HIS.? 4.73 OH7 1PE B 150 C 646 ASP D 87 ASP.? 7.26 C16 1PE B 150 C 739 GLY D 3 GLY.? 4.87 C3 GOL D 147 coo 15.33 59.81 59.60 13.98 60.99 60.69 -18.08 79.12 16.04 -18.14 81.21 15.79 coo 16.06 55.72 54.73 15.97 56.49 56.70 -24.70 80.89 17.41 -22.90 81.94 17.31 coo 9.38 49.29 65.28 9.01 50.03 65.31 -21.40 82.14 3.97 -21.80 82.75 3.64 1ddj_c14 source 1ddj PLASMINOGEN : 7 hits 1ddj_c14 naa= 3 ULMN 3 1ddj_c15 PLASMINOGEN user 1 3 # 1 D 603 HIS A 85 HIS.? 6.69 C5 PGE A 147 D 646 ASP A 87 ASP.? 8.49 C6 PGE A 147 D 739 GLY A 3 GLY.? -5.02 C3 GOL A 150s coo -30.51 33.83 43.05 -30.50 33.12 45.03 -23.05 64.43 -0.55 -21.68 63.00 -1.25 coo -25.73 33.05 39.28 -27.50 34.05 39.88 -23.17 58.67 3.55 -22.34 59.17 1.69 coo -27.66 47.32 40.66 -27.81 47.01 41.41 -11.64 65.89 4.76 -10.88 65.57 4.96 ULMN 3 1ddj_c15 PLASMINOGEN user 2 3 # 2 D 603 HIS A 88 HIS^? 4.20 CH2 MLY D 135 D 646 ASP A 87 ASP.? 8.49 C6 PGE A 147 D 739 GLY A 3 GLY.? -5.02 C3 GOL A 150s coo -30.51 33.83 43.05 -30.50 33.12 45.03 -23.95 56.87 7.77 -24.14 54.98 6.86 coo -25.73 33.05 39.28 -27.50 34.05 39.88 -23.17 58.67 3.55 -22.34 59.17 1.69 coo -27.66 47.32 40.66 -27.81 47.01 41.41 -11.64 65.89 4.76 -10.88 65.57 4.96 ULMN 3 1ddj_c15 PLASMINOGEN user 3 3 # 3 D 603 HIS B 85 HIS.? 6.66 C6 PGE B 147 D 646 ASP B 87 ASP.? 8.94 O4 PGE B 147 D 739 GLY B 3 GLY.? 4.53 O2 GOL B 149 coo -30.51 33.83 43.05 -30.50 33.12 45.03 11.11 88.86 48.90 12.76 88.34 47.73 coo -25.73 33.05 39.28 -27.50 34.05 39.88 9.49 87.97 42.02 11.31 87.98 43.09 coo -27.66 47.32 40.66 -27.81 47.01 41.41 12.20 75.96 48.73 12.53 75.45 48.19 ULMN 3 1ddj_c15 PLASMINOGEN user 4 3 # 4 D 603 HIS B 88 HIS^? 4.29 CH1 MLY C 135 D 646 ASP B 87 ASP.? 8.94 O4 PGE B 147 D 739 GLY B 3 GLY.? 4.53 O2 GOL B 149 coo -30.51 33.83 43.05 -30.50 33.12 45.03 6.15 87.00 38.94 7.35 87.96 37.51 coo -25.73 33.05 39.28 -27.50 34.05 39.88 9.49 87.97 42.02 11.31 87.98 43.09 coo -27.66 47.32 40.66 -27.81 47.01 41.41 12.20 75.96 48.73 12.53 75.45 48.19 ULMN 3 1ddj_c15 PLASMINOGEN user 5 3 # 5 D 603 HIS C 85 HIS.? 6.34 C1 PGE C 147 D 646 ASP C 87 ASP.? 8.84 O1 PGE C 147 D 739 GLY C 3 GLY.? -4.72 C3 GOL C 149s coo -30.51 33.83 43.05 -30.50 33.12 45.03 -4.08 74.18 57.17 -4.69 74.12 59.17 coo -25.73 33.05 39.28 -27.50 34.05 39.88 -9.03 79.00 58.44 -8.21 77.39 59.55 coo -27.66 47.32 40.66 -27.81 47.01 41.41 2.92 82.34 64.00 3.08 82.77 64.68 ULMN 3 1ddj_c15 PLASMINOGEN user 6 3 # 6 D 603 HIS C 88 HIS^? 3.86 CD MLY B 135 D 646 ASP C 87 ASP.? 8.84 O1 PGE C 147 D 739 GLY C 3 GLY.? -4.72 C3 GOL C 149s coo -30.51 33.83 43.05 -30.50 33.12 45.03 -11.00 83.03 57.18 -12.69 82.43 58.26 coo -25.73 33.05 39.28 -27.50 34.05 39.88 -9.03 79.00 58.44 -8.21 77.39 59.55 coo -27.66 47.32 40.66 -27.81 47.01 41.41 2.92 82.34 64.00 3.08 82.77 64.68 ULMN 3 1ddj_c15 PLASMINOGEN user 7 3 # 7 D 603 HIS D 85 HIS.? 4.73 OH7 1PE B 150 D 646 ASP D 87 ASP.? 7.26 C16 1PE B 150 D 739 GLY D 3 GLY.? 4.87 C3 GOL D 147 coo -30.51 33.83 43.05 -30.50 33.12 45.03 -18.08 79.12 16.04 -18.14 81.21 15.79 coo -25.73 33.05 39.28 -27.50 34.05 39.88 -24.70 80.89 17.41 -22.90 81.94 17.31 coo -27.66 47.32 40.66 -27.81 47.01 41.41 -21.40 82.14 3.97 -21.80 82.75 3.64 ULMN 3 1ddj_c15 PLASMINOGEN user 8 3 # 8 D 603 HIS D 88 HIS^? 4.38 CH1 MLY A 135 D 646 ASP D 87 ASP.? 7.26 C16 1PE B 150 D 739 GLY D 3 GLY.? 4.87 C3 GOL D 147 coo -30.51 33.83 43.05 -30.50 33.12 45.03 -29.18 79.71 17.63 -29.43 81.25 19.03 coo -25.73 33.05 39.28 -27.50 34.05 39.88 -24.70 80.89 17.41 -22.90 81.94 17.31 coo -27.66 47.32 40.66 -27.81 47.01 41.41 -21.40 82.14 3.97 -21.80 82.75 3.64 1ddj_c15 source 1ddj PLASMINOGEN : 8 hits 1ddj_c15 naa= 3 ULMN 3 1de6_c00 L-RHAMNOSE ISOMERASE user 1 3 # 1 A 236 LYS A 114 LYS~? 11.27 C9 2PE A 148 A 270 HIS A 115 HIS~? 12.27 C21 2PE A 148 A 302 ASP A 56 ASP~? 11.59 C21 2PE A 148 coo 31.95 29.75 57.34 28.52 26.19 61.27 -9.49 51.50 12.13 -4.59 48.44 14.69 coo 33.21 25.89 58.06 33.02 25.68 60.13 -13.18 48.35 10.37 -12.55 46.36 10.33 coo 28.85 22.90 58.20 30.22 22.78 59.84 -16.01 45.89 15.64 -15.93 44.31 14.23 ULMN 3 1de6_c00 L-RHAMNOSE ISOMERASE user 2 3 # 2 A 236 LYS B 114 LYS~? 11.34 O7 PE8 B 148 A 270 HIS B 115 HIS~? 12.48 C18 PE8 B 148 A 302 ASP B 56 ASP~? 11.45 C20 PE8 B 148 coo 31.95 29.75 57.34 28.52 26.19 61.27 11.35 73.22 32.47 12.65 68.43 28.61 coo 33.21 25.89 58.06 33.02 25.68 60.13 11.86 77.76 30.05 12.70 77.49 28.15 coo 28.85 22.90 58.20 30.22 22.78 59.84 6.80 78.21 26.00 8.47 79.07 25.03 ULMN 3 1de6_c00 L-RHAMNOSE ISOMERASE user 3 3 # 3 A 236 LYS D 114 LYS~? 10.81 C9 2PE D 146 A 270 HIS D 115 HIS~? 12.18 C21 2PE D 146 A 302 ASP D 56 ASP~? 11.46 C21 2PE D 146 coo 31.95 29.75 57.34 28.52 26.19 61.27 -35.88 89.56 6.78 -39.69 93.33 3.49 coo 33.21 25.89 58.06 33.02 25.68 60.13 -36.28 90.32 11.92 -37.49 91.98 12.35 coo 28.85 22.90 58.20 30.22 22.78 59.84 -41.85 87.81 13.66 -41.61 89.58 14.80 1de6_c00 source 1de6 L-RHAMNOSE ISOMERASE : 3 hits 1de6_c00 naa= 3 ULMN 3 1de6_c01 L-RHAMNOSE ISOMERASE user 1 3 # 1 B 236 LYS A 114 LYS~? 11.27 C9 2PE A 148 B 270 HIS A 115 HIS~? 12.27 C21 2PE A 148 B 302 ASP A 56 ASP~? 11.59 C21 2PE A 148 coo 38.57 31.68 38.20 37.57 30.37 32.27 -9.49 51.50 12.13 -4.59 48.44 14.69 coo 35.21 33.33 36.56 35.91 33.91 34.66 -13.18 48.35 10.37 -12.55 46.36 10.33 coo 33.27 29.36 33.58 33.68 31.25 32.69 -16.01 45.89 15.64 -15.93 44.31 14.23 ULMN 3 1de6_c01 L-RHAMNOSE ISOMERASE user 2 3 # 2 B 236 LYS B 114 LYS~? 11.34 O7 PE8 B 148 B 270 HIS B 115 HIS~? 12.48 C18 PE8 B 148 B 302 ASP B 56 ASP~? 11.45 C20 PE8 B 148 coo 38.57 31.68 38.20 37.57 30.37 32.27 11.35 73.22 32.47 12.65 68.43 28.61 coo 35.21 33.33 36.56 35.91 33.91 34.66 11.86 77.76 30.05 12.70 77.49 28.15 coo 33.27 29.36 33.58 33.68 31.25 32.69 6.80 78.21 26.00 8.47 79.07 25.03 ULMN 3 1de6_c01 L-RHAMNOSE ISOMERASE user 3 3 # 3 B 236 LYS D 114 LYS~? 10.81 C9 2PE D 146 B 270 HIS D 115 HIS~? 12.18 C21 2PE D 146 B 302 ASP D 56 ASP~? 11.46 C21 2PE D 146 coo 38.57 31.68 38.20 37.57 30.37 32.27 -35.88 89.56 6.78 -39.69 93.33 3.49 coo 35.21 33.33 36.56 35.91 33.91 34.66 -36.28 90.32 11.92 -37.49 91.98 12.35 coo 33.27 29.36 33.58 33.68 31.25 32.69 -41.85 87.81 13.66 -41.61 89.58 14.80 1de6_c01 source 1de6 L-RHAMNOSE ISOMERASE : 3 hits 1de6_c01 naa= 3 ULMN 3 1de6_c02 L-RHAMNOSE ISOMERASE user 1 3 # 1 C 236 LYS A 114 LYS~? 11.27 C9 2PE A 148 C 270 HIS A 115 HIS~? 12.27 C21 2PE A 148 C 302 ASP A 56 ASP~? 11.59 C21 2PE A 148 coo 14.14 13.22 49.33 13.72 16.13 54.74 -9.49 51.50 12.13 -4.59 48.44 14.69 coo 12.62 17.05 49.17 11.38 17.06 50.85 -13.18 48.35 10.37 -12.55 46.36 10.33 coo 15.59 19.87 52.59 13.47 19.78 52.76 -16.01 45.89 15.64 -15.93 44.31 14.23 ULMN 3 1de6_c02 L-RHAMNOSE ISOMERASE user 2 3 # 2 C 236 LYS B 114 LYS~? 11.34 O7 PE8 B 148 C 270 HIS B 115 HIS~? 12.48 C18 PE8 B 148 C 302 ASP B 56 ASP~? 11.45 C20 PE8 B 148 coo 14.14 13.22 49.33 13.72 16.13 54.74 11.35 73.22 32.47 12.65 68.43 28.61 coo 12.62 17.05 49.17 11.38 17.06 50.85 11.86 77.76 30.05 12.70 77.49 28.15 coo 15.59 19.87 52.59 13.47 19.78 52.76 6.80 78.21 26.00 8.47 79.07 25.03 ULMN 3 1de6_c02 L-RHAMNOSE ISOMERASE user 3 3 # 3 C 236 LYS D 114 LYS~? 10.81 C9 2PE D 146 C 270 HIS D 115 HIS~? 12.18 C21 2PE D 146 C 302 ASP D 56 ASP~? 11.46 C21 2PE D 146 coo 14.14 13.22 49.33 13.72 16.13 54.74 -35.88 89.56 6.78 -39.69 93.33 3.49 coo 12.62 17.05 49.17 11.38 17.06 50.85 -36.28 90.32 11.92 -37.49 91.98 12.35 coo 15.59 19.87 52.59 13.47 19.78 52.76 -41.85 87.81 13.66 -41.61 89.58 14.80 1de6_c02 source 1de6 L-RHAMNOSE ISOMERASE : 3 hits 1de6_c02 naa= 3 ULMN 3 1de6_c03 L-RHAMNOSE ISOMERASE user 1 3 # 1 D 236 LYS A 114 LYS~? 11.27 C9 2PE A 148 D 270 HIS A 115 HIS~? 12.27 C21 2PE A 148 D 302 ASP A 56 ASP~? 11.59 C21 2PE A 148 coo 22.81 12.92 30.93 27.72 14.83 27.49 -9.49 51.50 12.13 -4.59 48.44 14.69 coo 26.34 11.31 32.03 27.15 10.82 30.17 -13.18 48.35 10.37 -12.55 46.36 10.33 coo 29.89 15.23 31.62 30.32 13.38 30.56 -16.01 45.89 15.64 -15.93 44.31 14.23 ULMN 3 1de6_c03 L-RHAMNOSE ISOMERASE user 2 3 # 2 D 236 LYS B 114 LYS~? 11.34 O7 PE8 B 148 D 270 HIS B 115 HIS~? 12.48 C18 PE8 B 148 D 302 ASP B 56 ASP~? 11.45 C20 PE8 B 148 coo 22.81 12.92 30.93 27.72 14.83 27.49 11.35 73.22 32.47 12.65 68.43 28.61 coo 26.34 11.31 32.03 27.15 10.82 30.17 11.86 77.76 30.05 12.70 77.49 28.15 coo 29.89 15.23 31.62 30.32 13.38 30.56 6.80 78.21 26.00 8.47 79.07 25.03 ULMN 3 1de6_c03 L-RHAMNOSE ISOMERASE user 3 3 # 3 D 236 LYS D 114 LYS~? 10.81 C9 2PE D 146 D 270 HIS D 115 HIS~? 12.18 C21 2PE D 146 D 302 ASP D 56 ASP~? 11.46 C21 2PE D 146 coo 22.81 12.92 30.93 27.72 14.83 27.49 -35.88 89.56 6.78 -39.69 93.33 3.49 coo 26.34 11.31 32.03 27.15 10.82 30.17 -36.28 90.32 11.92 -37.49 91.98 12.35 coo 29.89 15.23 31.62 30.32 13.38 30.56 -41.85 87.81 13.66 -41.61 89.58 14.80 1de6_c03 source 1de6 L-RHAMNOSE ISOMERASE : 3 hits 1de6_c03 naa= 3 ULMN 3 1dhp_c00 DIHYDRODIPICOLINATE SYNTHASE user 1 3 # 1 A 133 TYR A 38 TYR.? 14.78 C11 2PE A 148 A 138 ARG A 33 ARG.? 10.19 C3 GOL A 150 A 161 LYS A 114 LYS~? 11.27 C9 2PE A 148 coo 29.03 88.95 86.80 28.09 90.57 84.75 -8.94 48.99 5.06 -11.42 48.37 6.17 coo 23.31 93.18 82.88 23.00 93.71 79.86 -11.76 56.72 1.51 -9.97 59.19 1.86 coo 33.83 91.15 88.62 31.07 91.06 83.02 -9.49 51.50 12.13 -4.59 48.44 14.69 ULMN 3 1dhp_c00 DIHYDRODIPICOLINATE SYNTHASE user 2 3 # 2 A 133 TYR A 53 TYR~? -4.55 C21 2PE A 148s A 138 ARG A 55 ARG~? 10.23 CD MLY D 135 A 161 LYS A 114 LYS~? 11.27 C9 2PE A 148 coo 29.03 88.95 86.80 28.09 90.57 84.75 -16.76 52.42 13.05 -16.88 54.33 15.10 coo 23.31 93.18 82.88 23.00 93.71 79.86 -19.70 43.33 11.87 -20.69 44.07 9.04 coo 33.83 91.15 88.62 31.07 91.06 83.02 -9.49 51.50 12.13 -4.59 48.44 14.69 ULMN 3 1dhp_c00 DIHYDRODIPICOLINATE SYNTHASE user 3 3 # 3 A 133 TYR B 53 TYR~? -4.63 C18 PE8 B 148s A 138 ARG B 55 ARG~? 9.33 CG MLY C 135 A 161 LYS B 114 LYS~? 11.34 O7 PE8 B 148 coo 29.03 88.95 86.80 28.09 90.57 84.75 6.73 78.96 33.00 4.51 77.73 34.14 coo 23.31 93.18 82.88 23.00 93.71 79.86 8.78 84.29 24.99 10.39 86.20 26.77 coo 33.83 91.15 88.62 31.07 91.06 83.02 11.35 73.22 32.47 12.65 68.43 28.61 ULMN 3 1dhp_c00 DIHYDRODIPICOLINATE SYNTHASE user 4 3 # 4 A 133 TYR D 38 TYR.? 14.74 C9 2PE D 146 A 138 ARG D 33 ARG.? 10.45 C1 GOL D 147 A 161 LYS D 114 LYS~? 10.81 C9 2PE D 146 coo 29.03 88.95 86.80 28.09 90.57 84.75 -31.57 94.95 9.95 -32.83 93.25 11.77 coo 23.31 93.18 82.88 23.00 93.71 79.86 -24.75 89.49 9.81 -23.48 88.88 7.05 coo 33.83 91.15 88.62 31.07 91.06 83.02 -35.88 89.56 6.78 -39.69 93.33 3.49 ULMN 3 1dhp_c00 DIHYDRODIPICOLINATE SYNTHASE user 5 3 # 5 A 133 TYR D 53 TYR~? -4.60 C21 2PE D 146s A 138 ARG D 55 ARG~? 9.16 CG MLY A 135 A 161 LYS D 114 LYS~? 10.81 C9 2PE D 146 coo 29.03 88.95 86.80 28.09 90.57 84.75 -36.08 84.35 12.01 -36.58 82.07 10.49 coo 23.31 93.18 82.88 23.00 93.71 79.86 -39.98 89.02 19.79 -37.17 89.06 21.03 coo 33.83 91.15 88.62 31.07 91.06 83.02 -35.88 89.56 6.78 -39.69 93.33 3.49 1dhp_c00 source 1dhp DIHYDRODIPICOLINATE SYNTHASE : 5 hits 1dhp_c00 naa= 3 ULMN 3 1dhp_c01 DIHYDRODIPICOLINATE SYNTHASE user 1 3 # 1 B 133 TYR A 38 TYR.? 14.78 C11 2PE A 148 B 138 ARG A 33 ARG.? 10.19 C3 GOL A 150 B 161 LYS A 114 LYS~? 11.27 C9 2PE A 148 coo 4.62 122.69 99.88 5.46 122.82 97.24 -8.94 48.99 5.06 -11.42 48.37 6.17 coo 10.44 122.27 94.08 11.02 123.87 91.53 -11.76 56.72 1.51 -9.97 59.19 1.86 coo -0.17 119.75 99.65 2.51 123.83 95.70 -9.49 51.50 12.13 -4.59 48.44 14.69 ULMN 3 1dhp_c01 DIHYDRODIPICOLINATE SYNTHASE user 2 3 # 2 B 133 TYR A 53 TYR~? -4.55 C21 2PE A 148s B 138 ARG A 55 ARG~? 10.23 CD MLY D 135 B 161 LYS A 114 LYS~? 11.27 C9 2PE A 148 coo 4.62 122.69 99.88 5.46 122.82 97.24 -16.76 52.42 13.05 -16.88 54.33 15.10 coo 10.44 122.27 94.08 11.02 123.87 91.53 -19.70 43.33 11.87 -20.69 44.07 9.04 coo -0.17 119.75 99.65 2.51 123.83 95.70 -9.49 51.50 12.13 -4.59 48.44 14.69 ULMN 3 1dhp_c01 DIHYDRODIPICOLINATE SYNTHASE user 3 3 # 3 B 133 TYR B 53 TYR~? -4.63 C18 PE8 B 148s B 138 ARG B 55 ARG~? 9.33 CG MLY C 135 B 161 LYS B 114 LYS~? 11.34 O7 PE8 B 148 coo 4.62 122.69 99.88 5.46 122.82 97.24 6.73 78.96 33.00 4.51 77.73 34.14 coo 10.44 122.27 94.08 11.02 123.87 91.53 8.78 84.29 24.99 10.39 86.20 26.77 coo -0.17 119.75 99.65 2.51 123.83 95.70 11.35 73.22 32.47 12.65 68.43 28.61 ULMN 3 1dhp_c01 DIHYDRODIPICOLINATE SYNTHASE user 4 3 # 4 B 133 TYR D 38 TYR.? 14.74 C9 2PE D 146 B 138 ARG D 33 ARG.? 10.45 C1 GOL D 147 B 161 LYS D 114 LYS~? 10.81 C9 2PE D 146 coo 4.62 122.69 99.88 5.46 122.82 97.24 -31.57 94.95 9.95 -32.83 93.25 11.77 coo 10.44 122.27 94.08 11.02 123.87 91.53 -24.75 89.49 9.81 -23.48 88.88 7.05 coo -0.17 119.75 99.65 2.51 123.83 95.70 -35.88 89.56 6.78 -39.69 93.33 3.49 ULMN 3 1dhp_c01 DIHYDRODIPICOLINATE SYNTHASE user 5 3 # 5 B 133 TYR D 53 TYR~? -4.60 C21 2PE D 146s B 138 ARG D 55 ARG~? 9.16 CG MLY A 135 B 161 LYS D 114 LYS~? 10.81 C9 2PE D 146 coo 4.62 122.69 99.88 5.46 122.82 97.24 -36.08 84.35 12.01 -36.58 82.07 10.49 coo 10.44 122.27 94.08 11.02 123.87 91.53 -39.98 89.02 19.79 -37.17 89.06 21.03 coo -0.17 119.75 99.65 2.51 123.83 95.70 -35.88 89.56 6.78 -39.69 93.33 3.49 1dhp_c01 source 1dhp DIHYDRODIPICOLINATE SYNTHASE : 5 hits 1dhp_c01 naa= 3 ULMN 3 1dhp_c02 DIHYDRODIPICOLINATE SYNTHASE user 1 3 # 1 A 44 THR A 44 THR.? 15.68 CD MLY D 135 A 45 THR A 45 THR~? 13.61 CD MLY D 135 A 161 LYS A 114 LYS~? 11.27 C9 2PE A 148 coo 26.16 88.25 79.16 25.22 89.47 80.71 -14.40 47.15 0.15 -14.28 46.10 2.04 coo 27.73 89.90 76.08 29.24 91.46 75.95 -16.83 50.00 -0.15 -18.74 49.27 -0.79 coo 33.83 91.15 88.62 31.07 91.06 83.02 -9.49 51.50 12.13 -4.59 48.44 14.69 ULMN 3 1dhp_c02 DIHYDRODIPICOLINATE SYNTHASE user 2 3 # 2 A 44 THR A 45 THR~? 13.61 CD MLY D 135 A 45 THR A 44 THR.? 15.68 CD MLY D 135 A 161 LYS A 114 LYS~? 11.27 C9 2PE A 148 coo 26.16 88.25 79.16 25.22 89.47 80.71 -16.83 50.00 -0.15 -18.74 49.27 -0.79 coo 27.73 89.90 76.08 29.24 91.46 75.95 -14.40 47.15 0.15 -14.28 46.10 2.04 coo 33.83 91.15 88.62 31.07 91.06 83.02 -9.49 51.50 12.13 -4.59 48.44 14.69 ULMN 3 1dhp_c02 DIHYDRODIPICOLINATE SYNTHASE user 3 3 # 3 A 44 THR B 44 THR.? 10.05 O1 PEG B 144 A 45 THR B 45 THR~? 11.55 O1 PEG B 144 A 161 LYS B 114 LYS~? 11.34 O7 PE8 B 148 coo 26.16 88.25 79.16 25.22 89.47 80.71 20.30 83.81 32.42 18.64 82.72 31.47 coo 27.73 89.90 76.08 29.24 91.46 75.95 18.24 85.54 35.10 17.92 87.63 34.59 coo 33.83 91.15 88.62 31.07 91.06 83.02 11.35 73.22 32.47 12.65 68.43 28.61 ULMN 3 1dhp_c02 DIHYDRODIPICOLINATE SYNTHASE user 4 3 # 4 A 44 THR B 45 THR~? 11.55 O1 PEG B 144 A 45 THR B 44 THR.? 10.05 O1 PEG B 144 A 161 LYS B 114 LYS~? 11.34 O7 PE8 B 148 coo 26.16 88.25 79.16 25.22 89.47 80.71 18.24 85.54 35.10 17.92 87.63 34.59 coo 27.73 89.90 76.08 29.24 91.46 75.95 20.30 83.81 32.42 18.64 82.72 31.47 coo 33.83 91.15 88.62 31.07 91.06 83.02 11.35 73.22 32.47 12.65 68.43 28.61 ULMN 3 1dhp_c02 DIHYDRODIPICOLINATE SYNTHASE user 5 3 # 5 A 44 THR D 44 THR.? 15.16 CG MLY A 135 A 45 THR D 45 THR~? 13.42 CG MLY A 135 A 161 LYS D 114 LYS~? 10.81 C9 2PE D 146 coo 26.16 88.25 79.16 25.22 89.47 80.71 -28.30 95.53 16.66 -30.17 94.47 16.62 coo 27.73 89.90 76.08 29.24 91.46 75.95 -26.69 92.19 17.49 -26.72 91.85 19.63 coo 33.83 91.15 88.62 31.07 91.06 83.02 -35.88 89.56 6.78 -39.69 93.33 3.49 ULMN 3 1dhp_c02 DIHYDRODIPICOLINATE SYNTHASE user 6 3 # 6 A 44 THR D 45 THR~? 13.42 CG MLY A 135 A 45 THR D 44 THR.? 15.16 CG MLY A 135 A 161 LYS D 114 LYS~? 10.81 C9 2PE D 146 coo 26.16 88.25 79.16 25.22 89.47 80.71 -26.69 92.19 17.49 -26.72 91.85 19.63 coo 27.73 89.90 76.08 29.24 91.46 75.95 -28.30 95.53 16.66 -30.17 94.47 16.62 coo 33.83 91.15 88.62 31.07 91.06 83.02 -35.88 89.56 6.78 -39.69 93.33 3.49 1dhp_c02 source 1dhp DIHYDRODIPICOLINATE SYNTHASE : 6 hits 1dhp_c02 naa= 3 ULMN 3 1dhp_c03 DIHYDRODIPICOLINATE SYNTHASE user 1 3 # 1 B 44 THR A 44 THR.? 15.68 CD MLY D 135 B 45 THR A 45 THR~? 13.61 CD MLY D 135 B 161 LYS A 114 LYS~? 11.27 C9 2PE A 148 coo 7.39 128.28 94.56 8.34 126.36 94.79 -14.40 47.15 0.15 -14.28 46.10 2.04 coo 5.75 129.25 91.25 4.29 128.16 90.07 -16.83 50.00 -0.15 -18.74 49.27 -0.79 coo -0.17 119.75 99.65 2.51 123.83 95.70 -9.49 51.50 12.13 -4.59 48.44 14.69 ULMN 3 1dhp_c03 DIHYDRODIPICOLINATE SYNTHASE user 2 3 # 2 B 44 THR A 45 THR~? 13.61 CD MLY D 135 B 45 THR A 44 THR.? 15.68 CD MLY D 135 B 161 LYS A 114 LYS~? 11.27 C9 2PE A 148 coo 7.39 128.28 94.56 8.34 126.36 94.79 -16.83 50.00 -0.15 -18.74 49.27 -0.79 coo 5.75 129.25 91.25 4.29 128.16 90.07 -14.40 47.15 0.15 -14.28 46.10 2.04 coo -0.17 119.75 99.65 2.51 123.83 95.70 -9.49 51.50 12.13 -4.59 48.44 14.69 ULMN 3 1dhp_c03 DIHYDRODIPICOLINATE SYNTHASE user 3 3 # 3 B 44 THR B 44 THR.? 10.05 O1 PEG B 144 B 45 THR B 45 THR~? 11.55 O1 PEG B 144 B 161 LYS B 114 LYS~? 11.34 O7 PE8 B 148 coo 7.39 128.28 94.56 8.34 126.36 94.79 20.30 83.81 32.42 18.64 82.72 31.47 coo 5.75 129.25 91.25 4.29 128.16 90.07 18.24 85.54 35.10 17.92 87.63 34.59 coo -0.17 119.75 99.65 2.51 123.83 95.70 11.35 73.22 32.47 12.65 68.43 28.61 ULMN 3 1dhp_c03 DIHYDRODIPICOLINATE SYNTHASE user 4 3 # 4 B 44 THR B 45 THR~? 11.55 O1 PEG B 144 B 45 THR B 44 THR.? 10.05 O1 PEG B 144 B 161 LYS B 114 LYS~? 11.34 O7 PE8 B 148 coo 7.39 128.28 94.56 8.34 126.36 94.79 18.24 85.54 35.10 17.92 87.63 34.59 coo 5.75 129.25 91.25 4.29 128.16 90.07 20.30 83.81 32.42 18.64 82.72 31.47 coo -0.17 119.75 99.65 2.51 123.83 95.70 11.35 73.22 32.47 12.65 68.43 28.61 ULMN 3 1dhp_c03 DIHYDRODIPICOLINATE SYNTHASE user 5 3 # 5 B 44 THR D 44 THR.? 15.16 CG MLY A 135 B 45 THR D 45 THR~? 13.42 CG MLY A 135 B 161 LYS D 114 LYS~? 10.81 C9 2PE D 146 coo 7.39 128.28 94.56 8.34 126.36 94.79 -28.30 95.53 16.66 -30.17 94.47 16.62 coo 5.75 129.25 91.25 4.29 128.16 90.07 -26.69 92.19 17.49 -26.72 91.85 19.63 coo -0.17 119.75 99.65 2.51 123.83 95.70 -35.88 89.56 6.78 -39.69 93.33 3.49 ULMN 3 1dhp_c03 DIHYDRODIPICOLINATE SYNTHASE user 6 3 # 6 B 44 THR D 45 THR~? 13.42 CG MLY A 135 B 45 THR D 44 THR.? 15.16 CG MLY A 135 B 161 LYS D 114 LYS~? 10.81 C9 2PE D 146 coo 7.39 128.28 94.56 8.34 126.36 94.79 -26.69 92.19 17.49 -26.72 91.85 19.63 coo 5.75 129.25 91.25 4.29 128.16 90.07 -28.30 95.53 16.66 -30.17 94.47 16.62 coo -0.17 119.75 99.65 2.51 123.83 95.70 -35.88 89.56 6.78 -39.69 93.33 3.49 1dhp_c03 source 1dhp DIHYDRODIPICOLINATE SYNTHASE : 6 hits 1dhp_c03 naa= 3 ULMN 3 1do8_c00 MALIC ENZYME user 1 3 # 1 A 112 TYR A 38 TYR.? 14.78 C11 2PE A 148 A 183 LYS A 114 LYS~? 11.27 C9 2PE A 148 A 278 ASP A 56 ASP~? 11.59 C21 2PE A 148 coo 19.43 18.53 42.32 17.66 18.80 40.15 -8.94 48.99 5.06 -11.42 48.37 6.17 coo 21.92 15.80 36.19 17.64 19.44 36.35 -9.49 51.50 12.13 -4.59 48.44 14.69 coo 15.46 19.03 31.40 15.01 18.25 33.31 -16.01 45.89 15.64 -15.93 44.31 14.23 ULMN 3 1do8_c00 MALIC ENZYME user 2 3 # 2 A 112 TYR A 53 TYR~? -4.55 C21 2PE A 148s A 183 LYS A 114 LYS~? 11.27 C9 2PE A 148 A 278 ASP A 6 ASP.? -3.91 C9 2PE A 148s coo 19.43 18.53 42.32 17.66 18.80 40.15 -16.76 52.42 13.05 -16.88 54.33 15.10 coo 21.92 15.80 36.19 17.64 19.44 36.35 -9.49 51.50 12.13 -4.59 48.44 14.69 coo 15.46 19.03 31.40 15.01 18.25 33.31 -8.66 61.41 13.34 -8.76 59.35 12.80 ULMN 3 1do8_c00 MALIC ENZYME user 3 3 # 3 A 112 TYR A 109 TYR~? -5.64 O16 2PE A 148s A 183 LYS A 114 LYS~? 11.27 C9 2PE A 148 A 278 ASP A 6 ASP.? -3.91 C9 2PE A 148s coo 19.43 18.53 42.32 17.66 18.80 40.15 -13.81 52.60 20.09 -14.53 54.76 18.49 coo 21.92 15.80 36.19 17.64 19.44 36.35 -9.49 51.50 12.13 -4.59 48.44 14.69 coo 15.46 19.03 31.40 15.01 18.25 33.31 -8.66 61.41 13.34 -8.76 59.35 12.80 ULMN 3 1do8_c00 MALIC ENZYME user 4 3 # 4 A 112 TYR B 38 TYR.? 9.60 O1 PEG B 144 A 183 LYS B 114 LYS~? 11.34 O7 PE8 B 148 A 278 ASP B 56 ASP~? 11.45 C20 PE8 B 148 coo 19.43 18.53 42.32 17.66 18.80 40.15 18.19 76.55 32.34 16.15 78.24 31.46 coo 21.92 15.80 36.19 17.64 19.44 36.35 11.35 73.22 32.47 12.65 68.43 28.61 coo 15.46 19.03 31.40 15.01 18.25 33.31 6.80 78.21 26.00 8.47 79.07 25.03 ULMN 3 1do8_c00 MALIC ENZYME user 5 3 # 5 A 112 TYR B 53 TYR~? -4.63 C18 PE8 B 148s A 183 LYS B 114 LYS~? 11.34 O7 PE8 B 148 A 278 ASP B 6 ASP.? -3.99 C6 PE8 B 148s coo 19.43 18.53 42.32 17.66 18.80 40.15 6.73 78.96 33.00 4.51 77.73 34.14 coo 21.92 15.80 36.19 17.64 19.44 36.35 11.35 73.22 32.47 12.65 68.43 28.61 coo 15.46 19.03 31.40 15.01 18.25 33.31 7.95 70.39 41.39 8.88 71.08 39.61 ULMN 3 1do8_c00 MALIC ENZYME user 6 3 # 6 A 112 TYR B 109 TYR~? -5.65 O13 PE8 B 148s A 183 LYS B 114 LYS~? 11.34 O7 PE8 B 148 A 278 ASP B 6 ASP.? -3.99 C6 PE8 B 148s coo 19.43 18.53 42.32 17.66 18.80 40.15 2.41 73.03 30.76 2.68 74.03 33.35 coo 21.92 15.80 36.19 17.64 19.44 36.35 11.35 73.22 32.47 12.65 68.43 28.61 coo 15.46 19.03 31.40 15.01 18.25 33.31 7.95 70.39 41.39 8.88 71.08 39.61 ULMN 3 1do8_c00 MALIC ENZYME user 7 3 # 7 A 112 TYR D 38 TYR.? 14.74 C9 2PE D 146 A 183 LYS D 114 LYS~? 10.81 C9 2PE D 146 A 278 ASP D 56 ASP~? 11.46 C21 2PE D 146 coo 19.43 18.53 42.32 17.66 18.80 40.15 -31.57 94.95 9.95 -32.83 93.25 11.77 coo 21.92 15.80 36.19 17.64 19.44 36.35 -35.88 89.56 6.78 -39.69 93.33 3.49 coo 15.46 19.03 31.40 15.01 18.25 33.31 -41.85 87.81 13.66 -41.61 89.58 14.80 ULMN 3 1do8_c00 MALIC ENZYME user 8 3 # 8 A 112 TYR D 53 TYR~? -4.60 C21 2PE D 146s A 183 LYS D 114 LYS~? 10.81 C9 2PE D 146 A 278 ASP D 6 ASP.? -3.77 C8 2PE D 146s coo 19.43 18.53 42.32 17.66 18.80 40.15 -36.08 84.35 12.01 -36.58 82.07 10.49 coo 21.92 15.80 36.19 17.64 19.44 36.35 -35.88 89.56 6.78 -39.69 93.33 3.49 coo 15.46 19.03 31.40 15.01 18.25 33.31 -31.03 82.87 1.04 -31.83 84.41 2.29 ULMN 3 1do8_c00 MALIC ENZYME user 9 3 # 9 A 112 TYR D 109 TYR~? -5.82 O16 2PE D 146s A 183 LYS D 114 LYS~? 10.81 C9 2PE D 146 A 278 ASP D 6 ASP.? -3.77 C8 2PE D 146s coo 19.43 18.53 42.32 17.66 18.80 40.15 -41.76 82.56 7.21 -39.24 81.41 7.29 coo 21.92 15.80 36.19 17.64 19.44 36.35 -35.88 89.56 6.78 -39.69 93.33 3.49 coo 15.46 19.03 31.40 15.01 18.25 33.31 -31.03 82.87 1.04 -31.83 84.41 2.29 1do8_c00 source 1do8 MALIC ENZYME : 9 hits 1do8_c00 naa= 3 ULMN 3 1do8_c01 MALIC ENZYME user 1 3 # 1 B 112 TYR A 38 TYR.? 14.78 C11 2PE A 148 B 183 LYS A 114 LYS~? 11.27 C9 2PE A 148 B 278 ASP A 56 ASP~? 11.59 C21 2PE A 148 coo 58.62 15.99 58.34 60.98 14.60 58.93 -8.94 48.99 5.06 -11.42 48.37 6.17 coo 60.11 10.60 53.63 62.59 10.74 58.67 -9.49 51.50 12.13 -4.59 48.44 14.69 coo 66.50 7.32 58.45 66.26 9.42 58.23 -16.01 45.89 15.64 -15.93 44.31 14.23 ULMN 3 1do8_c01 MALIC ENZYME user 2 3 # 2 B 112 TYR A 53 TYR~? -4.55 C21 2PE A 148s B 183 LYS A 114 LYS~? 11.27 C9 2PE A 148 B 278 ASP A 6 ASP.? -3.91 C9 2PE A 148s coo 58.62 15.99 58.34 60.98 14.60 58.93 -16.76 52.42 13.05 -16.88 54.33 15.10 coo 60.11 10.60 53.63 62.59 10.74 58.67 -9.49 51.50 12.13 -4.59 48.44 14.69 coo 66.50 7.32 58.45 66.26 9.42 58.23 -8.66 61.41 13.34 -8.76 59.35 12.80 ULMN 3 1do8_c01 MALIC ENZYME user 3 3 # 3 B 112 TYR A 109 TYR~? -5.64 O16 2PE A 148s B 183 LYS A 114 LYS~? 11.27 C9 2PE A 148 B 278 ASP A 6 ASP.? -3.91 C9 2PE A 148s coo 58.62 15.99 58.34 60.98 14.60 58.93 -13.81 52.60 20.09 -14.53 54.76 18.49 coo 60.11 10.60 53.63 62.59 10.74 58.67 -9.49 51.50 12.13 -4.59 48.44 14.69 coo 66.50 7.32 58.45 66.26 9.42 58.23 -8.66 61.41 13.34 -8.76 59.35 12.80 ULMN 3 1do8_c01 MALIC ENZYME user 4 3 # 4 B 112 TYR B 38 TYR.? 9.60 O1 PEG B 144 B 183 LYS B 114 LYS~? 11.34 O7 PE8 B 148 B 278 ASP B 56 ASP~? 11.45 C20 PE8 B 148 coo 58.62 15.99 58.34 60.98 14.60 58.93 18.19 76.55 32.34 16.15 78.24 31.46 coo 60.11 10.60 53.63 62.59 10.74 58.67 11.35 73.22 32.47 12.65 68.43 28.61 coo 66.50 7.32 58.45 66.26 9.42 58.23 6.80 78.21 26.00 8.47 79.07 25.03 ULMN 3 1do8_c01 MALIC ENZYME user 5 3 # 5 B 112 TYR B 53 TYR~? -4.63 C18 PE8 B 148s B 183 LYS B 114 LYS~? 11.34 O7 PE8 B 148 B 278 ASP B 6 ASP.? -3.99 C6 PE8 B 148s coo 58.62 15.99 58.34 60.98 14.60 58.93 6.73 78.96 33.00 4.51 77.73 34.14 coo 60.11 10.60 53.63 62.59 10.74 58.67 11.35 73.22 32.47 12.65 68.43 28.61 coo 66.50 7.32 58.45 66.26 9.42 58.23 7.95 70.39 41.39 8.88 71.08 39.61 ULMN 3 1do8_c01 MALIC ENZYME user 6 3 # 6 B 112 TYR B 109 TYR~? -5.65 O13 PE8 B 148s B 183 LYS B 114 LYS~? 11.34 O7 PE8 B 148 B 278 ASP B 6 ASP.? -3.99 C6 PE8 B 148s coo 58.62 15.99 58.34 60.98 14.60 58.93 2.41 73.03 30.76 2.68 74.03 33.35 coo 60.11 10.60 53.63 62.59 10.74 58.67 11.35 73.22 32.47 12.65 68.43 28.61 coo 66.50 7.32 58.45 66.26 9.42 58.23 7.95 70.39 41.39 8.88 71.08 39.61 ULMN 3 1do8_c01 MALIC ENZYME user 7 3 # 7 B 112 TYR D 38 TYR.? 14.74 C9 2PE D 146 B 183 LYS D 114 LYS~? 10.81 C9 2PE D 146 B 278 ASP D 56 ASP~? 11.46 C21 2PE D 146 coo 58.62 15.99 58.34 60.98 14.60 58.93 -31.57 94.95 9.95 -32.83 93.25 11.77 coo 60.11 10.60 53.63 62.59 10.74 58.67 -35.88 89.56 6.78 -39.69 93.33 3.49 coo 66.50 7.32 58.45 66.26 9.42 58.23 -41.85 87.81 13.66 -41.61 89.58 14.80 ULMN 3 1do8_c01 MALIC ENZYME user 8 3 # 8 B 112 TYR D 53 TYR~? -4.60 C21 2PE D 146s B 183 LYS D 114 LYS~? 10.81 C9 2PE D 146 B 278 ASP D 6 ASP.? -3.77 C8 2PE D 146s coo 58.62 15.99 58.34 60.98 14.60 58.93 -36.08 84.35 12.01 -36.58 82.07 10.49 coo 60.11 10.60 53.63 62.59 10.74 58.67 -35.88 89.56 6.78 -39.69 93.33 3.49 coo 66.50 7.32 58.45 66.26 9.42 58.23 -31.03 82.87 1.04 -31.83 84.41 2.29 ULMN 3 1do8_c01 MALIC ENZYME user 9 3 # 9 B 112 TYR D 109 TYR~? -5.82 O16 2PE D 146s B 183 LYS D 114 LYS~? 10.81 C9 2PE D 146 B 278 ASP D 6 ASP.? -3.77 C8 2PE D 146s coo 58.62 15.99 58.34 60.98 14.60 58.93 -41.76 82.56 7.21 -39.24 81.41 7.29 coo 60.11 10.60 53.63 62.59 10.74 58.67 -35.88 89.56 6.78 -39.69 93.33 3.49 coo 66.50 7.32 58.45 66.26 9.42 58.23 -31.03 82.87 1.04 -31.83 84.41 2.29 1do8_c01 source 1do8 MALIC ENZYME : 9 hits 1do8_c01 naa= 3 ULMN 3 1do8_c02 MALIC ENZYME user 1 3 # 1 C 112 TYR A 38 TYR.? 14.78 C11 2PE A 148 C 183 LYS A 114 LYS~? 11.27 C9 2PE A 148 C 278 ASP A 56 ASP~? 11.59 C21 2PE A 148 coo 76.02 -16.57 8.89 78.24 -15.17 9.87 -8.94 48.99 5.06 -11.42 48.37 6.17 coo 74.18 -11.17 13.22 79.08 -11.19 10.47 -9.49 51.50 12.13 -4.59 48.44 14.69 coo 82.27 -7.93 13.54 81.93 -10.04 13.72 -16.01 45.89 15.64 -15.93 44.31 14.23 ULMN 3 1do8_c02 MALIC ENZYME user 2 3 # 2 C 112 TYR A 53 TYR~? -4.55 C21 2PE A 148s C 183 LYS A 114 LYS~? 11.27 C9 2PE A 148 C 278 ASP A 6 ASP.? -3.91 C9 2PE A 148s coo 76.02 -16.57 8.89 78.24 -15.17 9.87 -16.76 52.42 13.05 -16.88 54.33 15.10 coo 74.18 -11.17 13.22 79.08 -11.19 10.47 -9.49 51.50 12.13 -4.59 48.44 14.69 coo 82.27 -7.93 13.54 81.93 -10.04 13.72 -8.66 61.41 13.34 -8.76 59.35 12.80 ULMN 3 1do8_c02 MALIC ENZYME user 3 3 # 3 C 112 TYR A 109 TYR~? -5.64 O16 2PE A 148s C 183 LYS A 114 LYS~? 11.27 C9 2PE A 148 C 278 ASP A 6 ASP.? -3.91 C9 2PE A 148s coo 76.02 -16.57 8.89 78.24 -15.17 9.87 -13.81 52.60 20.09 -14.53 54.76 18.49 coo 74.18 -11.17 13.22 79.08 -11.19 10.47 -9.49 51.50 12.13 -4.59 48.44 14.69 coo 82.27 -7.93 13.54 81.93 -10.04 13.72 -8.66 61.41 13.34 -8.76 59.35 12.80 ULMN 3 1do8_c02 MALIC ENZYME user 4 3 # 4 C 112 TYR B 38 TYR.? 9.60 O1 PEG B 144 C 183 LYS B 114 LYS~? 11.34 O7 PE8 B 148 C 278 ASP B 56 ASP~? 11.45 C20 PE8 B 148 coo 76.02 -16.57 8.89 78.24 -15.17 9.87 18.19 76.55 32.34 16.15 78.24 31.46 coo 74.18 -11.17 13.22 79.08 -11.19 10.47 11.35 73.22 32.47 12.65 68.43 28.61 coo 82.27 -7.93 13.54 81.93 -10.04 13.72 6.80 78.21 26.00 8.47 79.07 25.03 ULMN 3 1do8_c02 MALIC ENZYME user 5 3 # 5 C 112 TYR B 53 TYR~? -4.63 C18 PE8 B 148s C 183 LYS B 114 LYS~? 11.34 O7 PE8 B 148 C 278 ASP B 6 ASP.? -3.99 C6 PE8 B 148s coo 76.02 -16.57 8.89 78.24 -15.17 9.87 6.73 78.96 33.00 4.51 77.73 34.14 coo 74.18 -11.17 13.22 79.08 -11.19 10.47 11.35 73.22 32.47 12.65 68.43 28.61 coo 82.27 -7.93 13.54 81.93 -10.04 13.72 7.95 70.39 41.39 8.88 71.08 39.61 ULMN 3 1do8_c02 MALIC ENZYME user 6 3 # 6 C 112 TYR B 109 TYR~? -5.65 O13 PE8 B 148s C 183 LYS B 114 LYS~? 11.34 O7 PE8 B 148 C 278 ASP B 6 ASP.? -3.99 C6 PE8 B 148s coo 76.02 -16.57 8.89 78.24 -15.17 9.87 2.41 73.03 30.76 2.68 74.03 33.35 coo 74.18 -11.17 13.22 79.08 -11.19 10.47 11.35 73.22 32.47 12.65 68.43 28.61 coo 82.27 -7.93 13.54 81.93 -10.04 13.72 7.95 70.39 41.39 8.88 71.08 39.61 ULMN 3 1do8_c02 MALIC ENZYME user 7 3 # 7 C 112 TYR D 38 TYR.? 14.74 C9 2PE D 146 C 183 LYS D 114 LYS~? 10.81 C9 2PE D 146 C 278 ASP D 56 ASP~? 11.46 C21 2PE D 146 coo 76.02 -16.57 8.89 78.24 -15.17 9.87 -31.57 94.95 9.95 -32.83 93.25 11.77 coo 74.18 -11.17 13.22 79.08 -11.19 10.47 -35.88 89.56 6.78 -39.69 93.33 3.49 coo 82.27 -7.93 13.54 81.93 -10.04 13.72 -41.85 87.81 13.66 -41.61 89.58 14.80 ULMN 3 1do8_c02 MALIC ENZYME user 8 3 # 8 C 112 TYR D 53 TYR~? -4.60 C21 2PE D 146s C 183 LYS D 114 LYS~? 10.81 C9 2PE D 146 C 278 ASP D 6 ASP.? -3.77 C8 2PE D 146s coo 76.02 -16.57 8.89 78.24 -15.17 9.87 -36.08 84.35 12.01 -36.58 82.07 10.49 coo 74.18 -11.17 13.22 79.08 -11.19 10.47 -35.88 89.56 6.78 -39.69 93.33 3.49 coo 82.27 -7.93 13.54 81.93 -10.04 13.72 -31.03 82.87 1.04 -31.83 84.41 2.29 ULMN 3 1do8_c02 MALIC ENZYME user 9 3 # 9 C 112 TYR D 109 TYR~? -5.82 O16 2PE D 146s C 183 LYS D 114 LYS~? 10.81 C9 2PE D 146 C 278 ASP D 6 ASP.? -3.77 C8 2PE D 146s coo 76.02 -16.57 8.89 78.24 -15.17 9.87 -41.76 82.56 7.21 -39.24 81.41 7.29 coo 74.18 -11.17 13.22 79.08 -11.19 10.47 -35.88 89.56 6.78 -39.69 93.33 3.49 coo 82.27 -7.93 13.54 81.93 -10.04 13.72 -31.03 82.87 1.04 -31.83 84.41 2.29 1do8_c02 source 1do8 MALIC ENZYME : 9 hits 1do8_c02 naa= 3 ULMN 3 1do8_c03 MALIC ENZYME user 1 3 # 1 D 112 TYR A 38 TYR.? 14.78 C11 2PE A 148 D 183 LYS A 114 LYS~? 11.27 C9 2PE A 148 D 278 ASP A 56 ASP~? 11.59 C21 2PE A 148 coo 35.64 -19.32 -3.24 32.92 -19.55 -2.64 -8.94 48.99 5.06 -11.42 48.37 6.17 coo 33.51 -16.63 3.10 30.11 -20.23 0.26 -9.49 51.50 12.13 -4.59 48.44 14.69 coo 25.62 -19.94 2.86 26.44 -19.16 1.09 -16.01 45.89 15.64 -15.93 44.31 14.23 ULMN 3 1do8_c03 MALIC ENZYME user 2 3 # 2 D 112 TYR A 53 TYR~? -4.55 C21 2PE A 148s D 183 LYS A 114 LYS~? 11.27 C9 2PE A 148 D 278 ASP A 6 ASP.? -3.91 C9 2PE A 148s coo 35.64 -19.32 -3.24 32.92 -19.55 -2.64 -16.76 52.42 13.05 -16.88 54.33 15.10 coo 33.51 -16.63 3.10 30.11 -20.23 0.26 -9.49 51.50 12.13 -4.59 48.44 14.69 coo 25.62 -19.94 2.86 26.44 -19.16 1.09 -8.66 61.41 13.34 -8.76 59.35 12.80 ULMN 3 1do8_c03 MALIC ENZYME user 3 3 # 3 D 112 TYR A 109 TYR~? -5.64 O16 2PE A 148s D 183 LYS A 114 LYS~? 11.27 C9 2PE A 148 D 278 ASP A 6 ASP.? -3.91 C9 2PE A 148s coo 35.64 -19.32 -3.24 32.92 -19.55 -2.64 -13.81 52.60 20.09 -14.53 54.76 18.49 coo 33.51 -16.63 3.10 30.11 -20.23 0.26 -9.49 51.50 12.13 -4.59 48.44 14.69 coo 25.62 -19.94 2.86 26.44 -19.16 1.09 -8.66 61.41 13.34 -8.76 59.35 12.80 ULMN 3 1do8_c03 MALIC ENZYME user 4 3 # 4 D 112 TYR B 38 TYR.? 9.60 O1 PEG B 144 D 183 LYS B 114 LYS~? 11.34 O7 PE8 B 148 D 278 ASP B 56 ASP~? 11.45 C20 PE8 B 148 coo 35.64 -19.32 -3.24 32.92 -19.55 -2.64 18.19 76.55 32.34 16.15 78.24 31.46 coo 33.51 -16.63 3.10 30.11 -20.23 0.26 11.35 73.22 32.47 12.65 68.43 28.61 coo 25.62 -19.94 2.86 26.44 -19.16 1.09 6.80 78.21 26.00 8.47 79.07 25.03 ULMN 3 1do8_c03 MALIC ENZYME user 5 3 # 5 D 112 TYR B 53 TYR~? -4.63 C18 PE8 B 148s D 183 LYS B 114 LYS~? 11.34 O7 PE8 B 148 D 278 ASP B 6 ASP.? -3.99 C6 PE8 B 148s coo 35.64 -19.32 -3.24 32.92 -19.55 -2.64 6.73 78.96 33.00 4.51 77.73 34.14 coo 33.51 -16.63 3.10 30.11 -20.23 0.26 11.35 73.22 32.47 12.65 68.43 28.61 coo 25.62 -19.94 2.86 26.44 -19.16 1.09 7.95 70.39 41.39 8.88 71.08 39.61 ULMN 3 1do8_c03 MALIC ENZYME user 6 3 # 6 D 112 TYR B 109 TYR~? -5.65 O13 PE8 B 148s D 183 LYS B 114 LYS~? 11.34 O7 PE8 B 148 D 278 ASP B 6 ASP.? -3.99 C6 PE8 B 148s coo 35.64 -19.32 -3.24 32.92 -19.55 -2.64 2.41 73.03 30.76 2.68 74.03 33.35 coo 33.51 -16.63 3.10 30.11 -20.23 0.26 11.35 73.22 32.47 12.65 68.43 28.61 coo 25.62 -19.94 2.86 26.44 -19.16 1.09 7.95 70.39 41.39 8.88 71.08 39.61 ULMN 3 1do8_c03 MALIC ENZYME user 7 3 # 7 D 112 TYR D 38 TYR.? 14.74 C9 2PE D 146 D 183 LYS D 114 LYS~? 10.81 C9 2PE D 146 D 278 ASP D 56 ASP~? 11.46 C21 2PE D 146 coo 35.64 -19.32 -3.24 32.92 -19.55 -2.64 -31.57 94.95 9.95 -32.83 93.25 11.77 coo 33.51 -16.63 3.10 30.11 -20.23 0.26 -35.88 89.56 6.78 -39.69 93.33 3.49 coo 25.62 -19.94 2.86 26.44 -19.16 1.09 -41.85 87.81 13.66 -41.61 89.58 14.80 ULMN 3 1do8_c03 MALIC ENZYME user 8 3 # 8 D 112 TYR D 53 TYR~? -4.60 C21 2PE D 146s D 183 LYS D 114 LYS~? 10.81 C9 2PE D 146 D 278 ASP D 6 ASP.? -3.77 C8 2PE D 146s coo 35.64 -19.32 -3.24 32.92 -19.55 -2.64 -36.08 84.35 12.01 -36.58 82.07 10.49 coo 33.51 -16.63 3.10 30.11 -20.23 0.26 -35.88 89.56 6.78 -39.69 93.33 3.49 coo 25.62 -19.94 2.86 26.44 -19.16 1.09 -31.03 82.87 1.04 -31.83 84.41 2.29 ULMN 3 1do8_c03 MALIC ENZYME user 9 3 # 9 D 112 TYR D 109 TYR~? -5.82 O16 2PE D 146s D 183 LYS D 114 LYS~? 10.81 C9 2PE D 146 D 278 ASP D 6 ASP.? -3.77 C8 2PE D 146s coo 35.64 -19.32 -3.24 32.92 -19.55 -2.64 -41.76 82.56 7.21 -39.24 81.41 7.29 coo 33.51 -16.63 3.10 30.11 -20.23 0.26 -35.88 89.56 6.78 -39.69 93.33 3.49 coo 25.62 -19.94 2.86 26.44 -19.16 1.09 -31.03 82.87 1.04 -31.83 84.41 2.29 1do8_c03 source 1do8 MALIC ENZYME : 9 hits 1do8_c03 naa= 3 ULMN 3 1ds2_c02 PROTEINASE B (SGPB user 1 3 # 1 E 57 HIS A 88 HIS^? 4.20 CH2 MLY D 135 E 102 ASP A 87 ASP.? 8.49 C6 PGE A 147 E 193 GLY A 54 GLY~? 5.80 C21 2PE A 148 coo 11.39 26.86 25.95 9.85 26.64 27.36 -23.95 56.87 7.77 -24.14 54.98 6.86 coo 10.90 32.83 25.96 10.83 30.68 25.98 -23.17 58.67 3.55 -22.34 59.17 1.69 coo 4.57 20.60 30.29 4.74 21.36 30.66 -20.41 50.07 13.76 -19.88 49.43 13.69 ULMN 3 1ds2_c02 PROTEINASE B (SGPB user 2 3 # 2 E 57 HIS A 88 HIS^? 4.20 CH2 MLY D 135 E 102 ASP A 87 ASP.? 8.49 C6 PGE A 147 E 193 GLY D 134 GLY.? 2.47 N MLY D 135 coo 11.39 26.86 25.95 9.85 26.64 27.36 -23.95 56.87 7.77 -24.14 54.98 6.86 coo 10.90 32.83 25.96 10.83 30.68 25.98 -23.17 58.67 3.55 -22.34 59.17 1.69 coo 4.57 20.60 30.29 4.74 21.36 30.66 -31.46 51.06 14.18 -31.60 51.74 13.54 ULMN 3 1ds2_c02 PROTEINASE B (SGPB user 3 3 # 3 E 57 HIS A 115 HIS~? 12.27 C21 2PE A 148 E 102 ASP A 56 ASP~? 11.59 C21 2PE A 148 E 193 GLY A 46 GLY~? 12.01 CD MLY D 135 coo 11.39 26.86 25.95 9.85 26.64 27.36 -13.18 48.35 10.37 -12.55 46.36 10.33 coo 10.90 32.83 25.96 10.83 30.68 25.98 -16.01 45.89 15.64 -15.93 44.31 14.23 coo 4.57 20.60 30.29 4.74 21.36 30.66 -16.75 52.82 2.36 -17.28 52.20 2.20 ULMN 3 1ds2_c02 PROTEINASE B (SGPB user 4 3 # 4 E 57 HIS B 88 HIS^? 4.29 CH1 MLY C 135 E 102 ASP B 87 ASP.? 8.94 O4 PGE B 147 E 193 GLY B 54 GLY~? 5.68 C20 PE8 B 148 coo 11.39 26.86 25.95 9.85 26.64 27.36 6.15 87.00 38.94 7.35 87.96 37.51 coo 10.90 32.83 25.96 10.83 30.68 25.98 9.49 87.97 42.02 11.31 87.98 43.09 coo 4.57 20.60 30.29 4.74 21.36 30.66 5.02 82.24 30.45 5.51 81.90 29.87 ULMN 3 1ds2_c02 PROTEINASE B (SGPB user 5 3 # 5 E 57 HIS B 88 HIS^? 4.29 CH1 MLY C 135 E 102 ASP B 87 ASP.? 8.94 O4 PGE B 147 E 193 GLY C 134 GLY.? 2.48 N MLY C 135 coo 11.39 26.86 25.95 9.85 26.64 27.36 6.15 87.00 38.94 7.35 87.96 37.51 coo 10.90 32.83 25.96 10.83 30.68 25.98 9.49 87.97 42.02 11.31 87.98 43.09 coo 4.57 20.60 30.29 4.74 21.36 30.66 -1.36 91.26 31.44 -1.10 91.64 32.26 ULMN 3 1ds2_c02 PROTEINASE B (SGPB user 6 3 # 6 E 57 HIS B 115 HIS~? 12.48 C18 PE8 B 148 E 102 ASP B 56 ASP~? 11.45 C20 PE8 B 148 E 193 GLY B 46 GLY~? 9.70 O1 PEG B 144 coo 11.39 26.86 25.95 9.85 26.64 27.36 11.86 77.76 30.05 12.70 77.49 28.15 coo 10.90 32.83 25.96 10.83 30.68 25.98 6.80 78.21 26.00 8.47 79.07 25.03 coo 4.57 20.60 30.29 4.74 21.36 30.66 15.35 83.93 36.97 15.42 84.55 36.41 ULMN 3 1ds2_c02 PROTEINASE B (SGPB user 7 3 # 7 E 57 HIS C 88 HIS^? 3.86 CD MLY B 135 E 102 ASP C 87 ASP.? 8.84 O1 PGE C 147 E 193 GLY B 134 GLY.? 2.46 N MLY B 135 coo 11.39 26.86 25.95 9.85 26.64 27.36 -11.00 83.03 57.18 -12.69 82.43 58.26 coo 10.90 32.83 25.96 10.83 30.68 25.98 -9.03 79.00 58.44 -8.21 77.39 59.55 coo 4.57 20.60 30.29 4.74 21.36 30.66 -19.59 87.32 51.84 -18.97 86.72 51.66 ULMN 3 1ds2_c02 PROTEINASE B (SGPB user 8 3 # 8 E 57 HIS C 88 HIS^? 3.86 CD MLY B 135 E 102 ASP C 87 ASP.? 8.84 O1 PGE C 147 E 193 GLY C 54 GLY~? 6.00 CH2 MLY B 135 coo 11.39 26.86 25.95 9.85 26.64 27.36 -11.00 83.03 57.18 -12.69 82.43 58.26 coo 10.90 32.83 25.96 10.83 30.68 25.98 -9.03 79.00 58.44 -8.21 77.39 59.55 coo 4.57 20.60 30.29 4.74 21.36 30.66 -15.22 90.72 61.35 -15.47 90.98 62.07 ULMN 3 1ds2_c02 PROTEINASE B (SGPB user 9 3 # 9 E 57 HIS C 115 HIS~? 4.72 C MLZ C 114 E 102 ASP C 56 ASP~? 9.09 N MLZ C 114 E 193 GLY C 46 GLY~? 10.04 O MLZ C 114 coo 11.39 26.86 25.95 9.85 26.64 27.36 -12.99 90.00 69.08 -14.38 90.57 70.54 coo 10.90 32.83 25.96 10.83 30.68 25.98 -16.40 94.43 66.11 -17.63 93.56 67.58 coo 4.57 20.60 30.29 4.74 21.36 30.66 -10.91 80.74 66.75 -11.70 80.52 66.65 ULMN 3 1ds2_c02 PROTEINASE B (SGPB user 10 3 # 10 E 57 HIS D 88 HIS^? 4.38 CH1 MLY A 135 E 102 ASP D 87 ASP.? 7.26 C16 1PE B 150 E 193 GLY A 134 GLY.? 2.47 N MLY A 135 coo 11.39 26.86 25.95 9.85 26.64 27.36 -29.18 79.71 17.63 -29.43 81.25 19.03 coo 10.90 32.83 25.96 10.83 30.68 25.98 -24.70 80.89 17.41 -22.90 81.94 17.31 coo 4.57 20.60 30.29 4.74 21.36 30.66 -37.57 76.13 24.20 -36.67 75.88 24.22 ULMN 3 1ds2_c02 PROTEINASE B (SGPB user 11 3 # 11 E 57 HIS D 88 HIS^? 4.38 CH1 MLY A 135 E 102 ASP D 87 ASP.? 7.26 C16 1PE B 150 E 193 GLY D 54 GLY~? 5.81 C23 2PE D 146 coo 11.39 26.86 25.95 9.85 26.64 27.36 -29.18 79.71 17.63 -29.43 81.25 19.03 coo 10.90 32.83 25.96 10.83 30.68 25.98 -24.70 80.89 17.41 -22.90 81.94 17.31 coo 4.57 20.60 30.29 4.74 21.36 30.66 -38.01 83.52 15.98 -38.33 84.28 15.84 ULMN 3 1ds2_c02 PROTEINASE B (SGPB user 12 3 # 12 E 57 HIS D 115 HIS~? 12.18 C21 2PE D 146 E 102 ASP D 56 ASP~? 11.46 C21 2PE D 146 E 193 GLY D 46 GLY~? 12.21 CD MLY A 135 coo 11.39 26.86 25.95 9.85 26.64 27.36 -36.28 90.32 11.92 -37.49 91.98 12.35 coo 10.90 32.83 25.96 10.83 30.68 25.98 -41.85 87.81 13.66 -41.61 89.58 14.80 coo 4.57 20.60 30.29 4.74 21.36 30.66 -27.16 89.12 15.33 -27.37 89.29 16.11 1ds2_c02 source 1ds2 PROTEINASE B (SGPB : 12 hits 1ds2_c02 naa= 3 ULMN 3 1e3v_c02 STEROID DELTA-ISOMERASE user 1 3 # 1 A 16 TYR A 50 TYR~? 5.51 CH2 MLY D 135 A 40 ASP A 122 ASP^? 7.46 C1 GOL A 150 A 103 ASP A 87 ASP.? 8.49 C6 PGE A 147 coo 3.86 -20.80 85.74 4.58 -18.11 85.73 -19.50 53.98 8.67 -20.18 55.72 10.74 coo 8.98 -11.19 82.60 6.87 -11.00 82.49 -15.41 64.92 4.51 -15.09 66.83 5.33 coo 5.15 -17.92 79.35 5.03 -16.26 80.65 -23.17 58.67 3.55 -22.34 59.17 1.69 ULMN 3 1e3v_c02 STEROID DELTA-ISOMERASE user 2 3 # 2 A 16 TYR B 50 TYR~? 5.52 CH1 MLY C 135 A 40 ASP B 122 ASP^? 7.33 O2 GOL B 149 A 103 ASP B 87 ASP.? 8.94 O4 PGE B 147 coo 3.86 -20.80 85.74 4.58 -18.11 85.73 8.51 83.11 35.90 5.93 82.51 36.84 coo 8.98 -11.19 82.60 6.87 -11.00 82.49 10.89 79.68 47.57 9.75 78.80 49.16 coo 5.15 -17.92 79.35 5.03 -16.26 80.65 9.49 87.97 42.02 11.31 87.98 43.09 ULMN 3 1e3v_c02 STEROID DELTA-ISOMERASE user 3 3 # 3 A 16 TYR C 50 TYR~? 5.59 CE MLY B 135 A 40 ASP C 122 ASP^? 7.22 C3 GOL C 149 A 103 ASP C 87 ASP.? 8.84 O1 PGE C 147 coo 3.86 -20.80 85.74 4.58 -18.11 85.73 -11.27 85.65 61.91 -10.18 87.09 59.78 coo 8.98 -11.19 82.60 6.87 -11.00 82.49 0.27 81.12 61.60 2.07 81.54 60.53 coo 5.15 -17.92 79.35 5.03 -16.26 80.65 -9.03 79.00 58.44 -8.21 77.39 59.55 ULMN 3 1e3v_c02 STEROID DELTA-ISOMERASE user 4 3 # 4 A 16 TYR D 50 TYR~? 5.61 CH1 MLY A 135 A 40 ASP D 122 ASP^? 7.49 C3 GOL D 147 A 103 ASP D 87 ASP.? 7.26 C16 1PE B 150 coo 3.86 -20.80 85.74 4.58 -18.11 85.73 -31.54 83.73 14.98 -32.20 81.17 14.09 coo 8.98 -11.19 82.60 6.87 -11.00 82.49 -21.82 80.90 7.85 -21.38 79.32 6.51 coo 5.15 -17.92 79.35 5.03 -16.26 80.65 -24.70 80.89 17.41 -22.90 81.94 17.31 1e3v_c02 source 1e3v STEROID DELTA-ISOMERASE : 4 hits 1e3v_c02 naa= 3 ULMN 3 1e3v_c03 STEROID DELTA-ISOMERASE user 1 3 # 1 B 16 TYR A 50 TYR~? 5.51 CH2 MLY D 135 B 40 ASP A 122 ASP^? 7.46 C1 GOL A 150 B 103 ASP A 87 ASP.? 8.49 C6 PGE A 147 coo 4.95 -16.38 58.56 5.78 -19.05 58.68 -19.50 53.98 8.67 -20.18 55.72 10.74 coo 9.81 -26.10 62.11 7.73 -26.45 62.06 -15.41 64.92 4.51 -15.09 66.83 5.33 coo 5.71 -19.27 64.99 5.64 -20.90 63.63 -23.17 58.67 3.55 -22.34 59.17 1.69 ULMN 3 1e3v_c03 STEROID DELTA-ISOMERASE user 2 3 # 2 B 16 TYR B 50 TYR~? 5.52 CH1 MLY C 135 B 40 ASP B 122 ASP^? 7.33 O2 GOL B 149 B 103 ASP B 87 ASP.? 8.94 O4 PGE B 147 coo 4.95 -16.38 58.56 5.78 -19.05 58.68 8.51 83.11 35.90 5.93 82.51 36.84 coo 9.81 -26.10 62.11 7.73 -26.45 62.06 10.89 79.68 47.57 9.75 78.80 49.16 coo 5.71 -19.27 64.99 5.64 -20.90 63.63 9.49 87.97 42.02 11.31 87.98 43.09 ULMN 3 1e3v_c03 STEROID DELTA-ISOMERASE user 3 3 # 3 B 16 TYR C 50 TYR~? 5.59 CE MLY B 135 B 40 ASP C 122 ASP^? 7.22 C3 GOL C 149 B 103 ASP C 87 ASP.? 8.84 O1 PGE C 147 coo 4.95 -16.38 58.56 5.78 -19.05 58.68 -11.27 85.65 61.91 -10.18 87.09 59.78 coo 9.81 -26.10 62.11 7.73 -26.45 62.06 0.27 81.12 61.60 2.07 81.54 60.53 coo 5.71 -19.27 64.99 5.64 -20.90 63.63 -9.03 79.00 58.44 -8.21 77.39 59.55 ULMN 3 1e3v_c03 STEROID DELTA-ISOMERASE user 4 3 # 4 B 16 TYR D 50 TYR~? 5.61 CH1 MLY A 135 B 40 ASP D 122 ASP^? 7.49 C3 GOL D 147 B 103 ASP D 87 ASP.? 7.26 C16 1PE B 150 coo 4.95 -16.38 58.56 5.78 -19.05 58.68 -31.54 83.73 14.98 -32.20 81.17 14.09 coo 9.81 -26.10 62.11 7.73 -26.45 62.06 -21.82 80.90 7.85 -21.38 79.32 6.51 coo 5.71 -19.27 64.99 5.64 -20.90 63.63 -24.70 80.89 17.41 -22.90 81.94 17.31 1e3v_c03 source 1e3v STEROID DELTA-ISOMERASE : 4 hits 1e3v_c03 naa= 3 ULMN 3 1e7q_c01 GDP-FUCOSE SYNTHETASE user 1 3 # 1 A 107 ALA A 49 ALA~? 12.15 CD MLY D 135 A 136 TYR A 38 TYR.? 14.78 C11 2PE A 148 A 140 LYS A 114 LYS~? 11.27 C9 2PE A 148 coo 55.90 7.49 23.83 56.71 8.23 22.76 -16.03 49.47 6.19 -14.84 50.27 5.67 coo 59.38 10.02 17.51 59.95 9.89 20.21 -8.94 48.99 5.06 -11.42 48.37 6.17 coo 59.52 3.69 18.67 62.31 6.19 22.58 -9.49 51.50 12.13 -4.59 48.44 14.69 ULMN 3 1e7q_c01 GDP-FUCOSE SYNTHETASE user 2 3 # 2 A 107 ALA A 49 ALA~? 12.15 CD MLY D 135 A 136 TYR A 53 TYR~? -4.55 C21 2PE A 148s A 140 LYS A 114 LYS~? 11.27 C9 2PE A 148 coo 55.90 7.49 23.83 56.71 8.23 22.76 -16.03 49.47 6.19 -14.84 50.27 5.67 coo 59.38 10.02 17.51 59.95 9.89 20.21 -16.76 52.42 13.05 -16.88 54.33 15.10 coo 59.52 3.69 18.67 62.31 6.19 22.58 -9.49 51.50 12.13 -4.59 48.44 14.69 ULMN 3 1e7q_c01 GDP-FUCOSE SYNTHETASE user 3 3 # 3 A 107 ALA A 118 ALA~? 12.39 C11 2PE A 148 A 136 TYR A 53 TYR~? -4.55 C21 2PE A 148s A 140 LYS A 114 LYS~? 11.27 C9 2PE A 148 coo 55.90 7.49 23.83 56.71 8.23 22.76 -10.68 53.61 6.19 -10.55 52.09 6.11 coo 59.38 10.02 17.51 59.95 9.89 20.21 -16.76 52.42 13.05 -16.88 54.33 15.10 coo 59.52 3.69 18.67 62.31 6.19 22.58 -9.49 51.50 12.13 -4.59 48.44 14.69 ULMN 3 1e7q_c01 GDP-FUCOSE SYNTHETASE user 4 3 # 4 A 107 ALA A 119 ALA~? 10.88 CH2 MLY D 135 A 136 TYR A 38 TYR.? 14.78 C11 2PE A 148 A 140 LYS A 114 LYS~? 11.27 C9 2PE A 148 coo 55.90 7.49 23.83 56.71 8.23 22.76 -14.35 54.52 5.55 -15.48 54.02 6.43 coo 59.38 10.02 17.51 59.95 9.89 20.21 -8.94 48.99 5.06 -11.42 48.37 6.17 coo 59.52 3.69 18.67 62.31 6.19 22.58 -9.49 51.50 12.13 -4.59 48.44 14.69 ULMN 3 1e7q_c01 GDP-FUCOSE SYNTHETASE user 5 3 # 5 A 107 ALA A 119 ALA~? 10.88 CH2 MLY D 135 A 136 TYR A 53 TYR~? -4.55 C21 2PE A 148s A 140 LYS A 114 LYS~? 11.27 C9 2PE A 148 coo 55.90 7.49 23.83 56.71 8.23 22.76 -14.35 54.52 5.55 -15.48 54.02 6.43 coo 59.38 10.02 17.51 59.95 9.89 20.21 -16.76 52.42 13.05 -16.88 54.33 15.10 coo 59.52 3.69 18.67 62.31 6.19 22.58 -9.49 51.50 12.13 -4.59 48.44 14.69 ULMN 3 1e7q_c01 GDP-FUCOSE SYNTHETASE user 6 3 # 6 A 107 ALA B 49 ALA~? 10.91 O1 PEG B 144 A 136 TYR B 38 TYR.? 9.60 O1 PEG B 144 A 140 LYS B 114 LYS~? 11.34 O7 PE8 B 148 coo 55.90 7.49 23.83 56.71 8.23 22.76 13.56 82.06 32.43 14.35 81.13 33.34 coo 59.38 10.02 17.51 59.95 9.89 20.21 18.19 76.55 32.34 16.15 78.24 31.46 coo 59.52 3.69 18.67 62.31 6.19 22.58 11.35 73.22 32.47 12.65 68.43 28.61 ULMN 3 1e7q_c01 GDP-FUCOSE SYNTHETASE user 7 3 # 7 A 107 ALA B 49 ALA~? 10.91 O1 PEG B 144 A 136 TYR B 53 TYR~? -4.63 C18 PE8 B 148s A 140 LYS B 114 LYS~? 11.34 O7 PE8 B 148 coo 55.90 7.49 23.83 56.71 8.23 22.76 13.56 82.06 32.43 14.35 81.13 33.34 coo 59.38 10.02 17.51 59.95 9.89 20.21 6.73 78.96 33.00 4.51 77.73 34.14 coo 59.52 3.69 18.67 62.31 6.19 22.58 11.35 73.22 32.47 12.65 68.43 28.61 ULMN 3 1e7q_c01 GDP-FUCOSE SYNTHETASE user 8 3 # 8 A 107 ALA B 118 ALA~? 8.74 O1 PEG B 144 A 136 TYR B 53 TYR~? -4.63 C18 PE8 B 148s A 140 LYS B 114 LYS~? 11.34 O7 PE8 B 148 coo 55.90 7.49 23.83 56.71 8.23 22.76 15.05 76.70 36.40 15.62 76.90 35.00 coo 59.38 10.02 17.51 59.95 9.89 20.21 6.73 78.96 33.00 4.51 77.73 34.14 coo 59.52 3.69 18.67 62.31 6.19 22.58 11.35 73.22 32.47 12.65 68.43 28.61 ULMN 3 1e7q_c01 GDP-FUCOSE SYNTHETASE user 9 3 # 9 A 107 ALA B 119 ALA~? 10.71 O16 PE8 B 148 A 136 TYR B 38 TYR.? 9.60 O1 PEG B 144 A 140 LYS B 114 LYS~? 11.34 O7 PE8 B 148 coo 55.90 7.49 23.83 56.71 8.23 22.76 13.47 80.03 37.47 12.33 80.66 36.69 coo 59.38 10.02 17.51 59.95 9.89 20.21 18.19 76.55 32.34 16.15 78.24 31.46 coo 59.52 3.69 18.67 62.31 6.19 22.58 11.35 73.22 32.47 12.65 68.43 28.61 ULMN 3 1e7q_c01 GDP-FUCOSE SYNTHETASE user 10 3 # 10 A 107 ALA B 119 ALA~? 10.71 O16 PE8 B 148 A 136 TYR B 53 TYR~? -4.63 C18 PE8 B 148s A 140 LYS B 114 LYS~? 11.34 O7 PE8 B 148 coo 55.90 7.49 23.83 56.71 8.23 22.76 13.47 80.03 37.47 12.33 80.66 36.69 coo 59.38 10.02 17.51 59.95 9.89 20.21 6.73 78.96 33.00 4.51 77.73 34.14 coo 59.52 3.69 18.67 62.31 6.19 22.58 11.35 73.22 32.47 12.65 68.43 28.61 ULMN 3 1e7q_c01 GDP-FUCOSE SYNTHETASE user 11 3 # 11 A 107 ALA D 49 ALA~? 12.11 CE MLY A 135 A 136 TYR D 38 TYR.? 14.74 C9 2PE D 146 A 140 LYS D 114 LYS~? 10.81 C9 2PE D 146 coo 55.90 7.49 23.83 56.71 8.23 22.76 -32.13 89.91 15.13 -31.19 90.29 13.98 coo 59.38 10.02 17.51 59.95 9.89 20.21 -31.57 94.95 9.95 -32.83 93.25 11.77 coo 59.52 3.69 18.67 62.31 6.19 22.58 -35.88 89.56 6.78 -39.69 93.33 3.49 ULMN 3 1e7q_c01 GDP-FUCOSE SYNTHETASE user 12 3 # 12 A 107 ALA D 49 ALA~? 12.11 CE MLY A 135 A 136 TYR D 53 TYR~? -4.60 C21 2PE D 146s A 140 LYS D 114 LYS~? 10.81 C9 2PE D 146 coo 55.90 7.49 23.83 56.71 8.23 22.76 -32.13 89.91 15.13 -31.19 90.29 13.98 coo 59.38 10.02 17.51 59.95 9.89 20.21 -36.08 84.35 12.01 -36.58 82.07 10.49 coo 59.52 3.69 18.67 62.31 6.19 22.58 -35.88 89.56 6.78 -39.69 93.33 3.49 ULMN 3 1e7q_c01 GDP-FUCOSE SYNTHETASE user 13 3 # 13 A 107 ALA D 112 ALA~? 8.09 C21 2PE D 146 A 136 TYR D 53 TYR~? -4.60 C21 2PE D 146s A 140 LYS D 114 LYS~? 10.81 C9 2PE D 146 coo 55.90 7.49 23.83 56.71 8.23 22.76 -39.97 87.72 9.79 -40.62 86.60 10.56 coo 59.38 10.02 17.51 59.95 9.89 20.21 -36.08 84.35 12.01 -36.58 82.07 10.49 coo 59.52 3.69 18.67 62.31 6.19 22.58 -35.88 89.56 6.78 -39.69 93.33 3.49 ULMN 3 1e7q_c01 GDP-FUCOSE SYNTHETASE user 14 3 # 14 A 107 ALA D 118 ALA~? 12.42 C9 2PE D 146 A 136 TYR D 53 TYR~? -4.60 C21 2PE D 146s A 140 LYS D 114 LYS~? 10.81 C9 2PE D 146 coo 55.90 7.49 23.83 56.71 8.23 22.76 -29.78 90.27 8.72 -30.62 91.39 9.36 coo 59.38 10.02 17.51 59.95 9.89 20.21 -36.08 84.35 12.01 -36.58 82.07 10.49 coo 59.52 3.69 18.67 62.31 6.19 22.58 -35.88 89.56 6.78 -39.69 93.33 3.49 ULMN 3 1e7q_c01 GDP-FUCOSE SYNTHETASE user 15 3 # 15 A 107 ALA D 119 ALA~? 10.88 C18 2PE D 146 A 136 TYR D 38 TYR.? 14.74 C9 2PE D 146 A 140 LYS D 114 LYS~? 10.81 C9 2PE D 146 coo 55.90 7.49 23.83 56.71 8.23 22.76 -28.73 87.90 11.52 -29.74 87.21 12.41 coo 59.38 10.02 17.51 59.95 9.89 20.21 -31.57 94.95 9.95 -32.83 93.25 11.77 coo 59.52 3.69 18.67 62.31 6.19 22.58 -35.88 89.56 6.78 -39.69 93.33 3.49 ULMN 3 1e7q_c01 GDP-FUCOSE SYNTHETASE user 16 3 # 16 A 107 ALA D 119 ALA~? 10.88 C18 2PE D 146 A 136 TYR D 53 TYR~? -4.60 C21 2PE D 146s A 140 LYS D 114 LYS~? 10.81 C9 2PE D 146 coo 55.90 7.49 23.83 56.71 8.23 22.76 -28.73 87.90 11.52 -29.74 87.21 12.41 coo 59.38 10.02 17.51 59.95 9.89 20.21 -36.08 84.35 12.01 -36.58 82.07 10.49 coo 59.52 3.69 18.67 62.31 6.19 22.58 -35.88 89.56 6.78 -39.69 93.33 3.49 1e7q_c01 source 1e7q GDP-FUCOSE SYNTHETASE : 16 hits 1e7q_c01 naa= 3 ULMN 3 1eag_c04 PEPTIDE INHIBITOR user 1 3 # 1 A 32 ASP A 19 ASP.? -3.59 O4 SO4 A 144s A 35 SER B 96 SER~? 7.21 O4 SO4 A 144 A 218 ASP B 19 ASP.? -3.77 O3 SO4 A 144s coo 47.22 22.34 8.57 45.16 22.02 9.13 -15.01 66.98 32.71 -14.52 68.02 34.44 coo 43.58 20.85 5.15 44.62 23.01 5.76 -12.28 72.78 35.88 -11.90 71.42 33.88 coo 44.05 16.99 12.67 44.05 18.89 11.74 -12.63 65.75 40.21 -14.11 64.30 40.60 1eag_c04 source 1eag PEPTIDE INHIBITOR : 1 hits 1eag_c04 naa= 3 ULMN 3 1eed_c04 ENDOTHIAPEPSIN (E.C.3.4.23.22) COMPLuser 1 3 # 1 P 32 ASP A 19 ASP.? -3.59 O4 SO4 A 144s P 35 SER B 96 SER~? 7.21 O4 SO4 A 144 P 215 ASP B 19 ASP.? -3.77 O3 SO4 A 144s coo 10.15 33.41 11.98 7.98 33.66 12.07 -15.01 66.98 32.71 -14.52 68.02 34.44 coo 7.57 37.60 10.00 8.86 37.02 12.03 -12.28 72.78 35.88 -11.90 71.42 33.88 coo 4.04 29.97 8.82 4.78 31.15 10.46 -12.63 65.75 40.21 -14.11 64.30 40.60 1eed_c04 source 1eed ENDOTHIAPEPSIN (E.C.3.4.23.22) COMPLEX WITH TH: 1 hits 1eed_c04 naa= 3 ULMN 3 1ehy_c00 SOLUBLE EPOXIDE HYDROLASE user 1 3 # 1 A 107 ASP A 56 ASP~? 11.59 C21 2PE A 148 A 246 ASP A 40 ASP.? 18.50 C9 2PE A 148 A 275 HIS A 115 HIS~? 12.27 C21 2PE A 148 coo 28.44 37.56 46.79 26.87 37.11 48.10 -16.01 45.89 15.64 -15.93 44.31 14.23 coo 22.84 50.35 52.24 23.24 48.32 52.90 -5.23 45.83 3.63 -5.09 44.63 5.33 coo 26.67 42.94 48.26 27.49 41.07 48.73 -13.18 48.35 10.37 -12.55 46.36 10.33 ULMN 3 1ehy_c00 SOLUBLE EPOXIDE HYDROLASE user 2 3 # 2 A 107 ASP A 87 ASP.? 8.49 C6 PGE A 147 A 246 ASP A 83 ASP.? 8.52 O3 GOL D 147 A 275 HIS A 85 HIS.? 6.69 C5 PGE A 147 coo 28.44 37.56 46.79 26.87 37.11 48.10 -23.17 58.67 3.55 -22.34 59.17 1.69 coo 22.84 50.35 52.24 23.24 48.32 52.90 -19.46 70.43 -3.04 -19.06 72.28 -2.05 coo 26.67 42.94 48.26 27.49 41.07 48.73 -23.05 64.43 -0.55 -21.68 63.00 -1.25 ULMN 3 1ehy_c00 SOLUBLE EPOXIDE HYDROLASE user 3 3 # 3 A 107 ASP A 122 ASP^? 7.46 C1 GOL A 150 A 246 ASP D 83 ASP.? 8.76 O1 GOL A 150 A 275 HIS A 4 HIS.? -3.92 C2 GOL A 150s coo 28.44 37.56 46.79 26.87 37.11 48.10 -15.41 64.92 4.51 -15.09 66.83 5.33 coo 22.84 50.35 52.24 23.24 48.32 52.90 -12.54 78.43 10.94 -12.46 77.06 9.29 coo 26.67 42.94 48.26 27.49 41.07 48.73 -11.85 68.18 8.83 -11.23 70.10 8.29 ULMN 3 1ehy_c00 SOLUBLE EPOXIDE HYDROLASE user 4 3 # 4 A 107 ASP B 87 ASP.? 8.94 O4 PGE B 147 A 246 ASP B 83 ASP.? 9.40 O3 GOL C 149 A 275 HIS B 85 HIS.? 6.66 C6 PGE B 147 coo 28.44 37.56 46.79 26.87 37.11 48.10 9.49 87.97 42.02 11.31 87.98 43.09 coo 22.84 50.35 52.24 23.24 48.32 52.90 13.62 86.10 55.23 12.83 84.59 56.49 coo 26.67 42.94 48.26 27.49 41.07 48.73 11.11 88.86 48.90 12.76 88.34 47.73 ULMN 3 1ehy_c00 SOLUBLE EPOXIDE HYDROLASE user 5 3 # 5 A 107 ASP B 122 ASP^? 7.33 O2 GOL B 149 A 246 ASP C 83 ASP.? 8.65 O3 GOL B 149 A 275 HIS B 4 HIS.? -3.86 O2 GOL B 149s coo 28.44 37.56 46.79 26.87 37.11 48.10 10.89 79.68 47.57 9.75 78.80 49.16 coo 22.84 50.35 52.24 23.24 48.32 52.90 3.02 71.86 58.06 4.88 72.49 57.24 coo 26.67 42.94 48.26 27.49 41.07 48.73 8.07 73.88 49.16 8.30 73.43 51.19 ULMN 3 1ehy_c00 SOLUBLE EPOXIDE HYDROLASE user 6 3 # 6 A 107 ASP C 87 ASP.? 8.84 O1 PGE C 147 A 246 ASP C 83 ASP.? 8.65 O3 GOL B 149 A 275 HIS C 85 HIS.? 6.34 C1 PGE C 147 coo 28.44 37.56 46.79 26.87 37.11 48.10 -9.03 79.00 58.44 -8.21 77.39 59.55 coo 22.84 50.35 52.24 23.24 48.32 52.90 3.02 71.86 58.06 4.88 72.49 57.24 coo 26.67 42.94 48.26 27.49 41.07 48.73 -4.08 74.18 57.17 -4.69 74.12 59.17 ULMN 3 1ehy_c00 SOLUBLE EPOXIDE HYDROLASE user 7 3 # 7 A 107 ASP C 122 ASP^? 7.22 C3 GOL C 149 A 246 ASP B 83 ASP.? 9.40 O3 GOL C 149 A 275 HIS C 4 HIS.? -3.73 C3 GOL C 149s coo 28.44 37.56 46.79 26.87 37.11 48.10 0.27 81.12 61.60 2.07 81.54 60.53 coo 22.84 50.35 52.24 23.24 48.32 52.90 13.62 86.10 55.23 12.83 84.59 56.49 coo 26.67 42.94 48.26 27.49 41.07 48.73 4.88 85.81 61.42 6.80 85.00 61.18 ULMN 3 1ehy_c00 SOLUBLE EPOXIDE HYDROLASE user 8 3 # 8 A 107 ASP D 87 ASP.? 7.26 C16 1PE B 150 A 246 ASP D 83 ASP.? 8.76 O1 GOL A 150 A 275 HIS D 85 HIS.? 4.73 OH7 1PE B 150 coo 28.44 37.56 46.79 26.87 37.11 48.10 -24.70 80.89 17.41 -22.90 81.94 17.31 coo 22.84 50.35 52.24 23.24 48.32 52.90 -12.54 78.43 10.94 -12.46 77.06 9.29 coo 26.67 42.94 48.26 27.49 41.07 48.73 -18.08 79.12 16.04 -18.14 81.21 15.79 ULMN 3 1ehy_c00 SOLUBLE EPOXIDE HYDROLASE user 9 3 # 9 A 107 ASP D 122 ASP^? 7.49 C3 GOL D 147 A 246 ASP A 83 ASP.? 8.52 O3 GOL D 147 A 275 HIS D 4 HIS.? 4.07 C3 GOL D 147 coo 28.44 37.56 46.79 26.87 37.11 48.10 -21.82 80.90 7.85 -21.38 79.32 6.51 coo 22.84 50.35 52.24 23.24 48.32 52.90 -19.46 70.43 -3.04 -19.06 72.28 -2.05 coo 26.67 42.94 48.26 27.49 41.07 48.73 -23.57 78.63 1.94 -22.01 77.96 0.72 1ehy_c00 source 1ehy SOLUBLE EPOXIDE HYDROLASE : 9 hits 1ehy_c00 naa= 3 ULMN 3 1ehy_c01 SOLUBLE EPOXIDE HYDROLASE user 1 3 # 1 B 107 ASP A 56 ASP~? 11.59 C21 2PE A 148 B 246 ASP A 40 ASP.? 18.50 C9 2PE A 148 B 275 HIS A 115 HIS~? 12.27 C21 2PE A 148 coo 34.84 56.77 81.62 34.95 54.74 82.03 -16.01 45.89 15.64 -15.93 44.31 14.23 coo 43.18 49.30 68.39 44.75 49.87 69.78 -5.23 45.83 3.63 -5.09 44.63 5.33 coo 38.73 55.10 77.62 36.80 55.01 78.46 -13.18 48.35 10.37 -12.55 46.36 10.33 ULMN 3 1ehy_c01 SOLUBLE EPOXIDE HYDROLASE user 2 3 # 2 B 107 ASP B 56 ASP~? 11.45 C20 PE8 B 148 B 246 ASP B 40 ASP.? 11.67 O1 PEG B 144 B 275 HIS B 115 HIS~? 12.48 C18 PE8 B 148 coo 34.84 56.77 81.62 34.95 54.74 82.03 6.80 78.21 26.00 8.47 79.07 25.03 coo 43.18 49.30 68.39 44.75 49.87 69.78 22.51 72.75 29.32 21.02 74.20 28.79 coo 38.73 55.10 77.62 36.80 55.01 78.46 11.86 77.76 30.05 12.70 77.49 28.15 ULMN 3 1ehy_c01 SOLUBLE EPOXIDE HYDROLASE user 3 3 # 3 B 107 ASP C 56 ASP~? 9.09 N MLZ C 114 B 246 ASP C 40 ASP.? 9.64 O MLZ C 114 B 275 HIS C 115 HIS~? 4.72 C MLZ C 114 coo 34.84 56.77 81.62 34.95 54.74 82.03 -16.40 94.43 66.11 -17.63 93.56 67.58 coo 43.18 49.30 68.39 44.75 49.87 69.78 -10.62 87.43 80.17 -12.01 86.84 78.68 coo 38.73 55.10 77.62 36.80 55.01 78.46 -12.99 90.00 69.08 -14.38 90.57 70.54 ULMN 3 1ehy_c01 SOLUBLE EPOXIDE HYDROLASE user 4 3 # 4 B 107 ASP C 122 ASP^? 7.22 C3 GOL C 149 B 246 ASP B 83 ASP.? 9.40 O3 GOL C 149 B 275 HIS C 4 HIS.? -3.73 C3 GOL C 149s coo 34.84 56.77 81.62 34.95 54.74 82.03 0.27 81.12 61.60 2.07 81.54 60.53 coo 43.18 49.30 68.39 44.75 49.87 69.78 13.62 86.10 55.23 12.83 84.59 56.49 coo 38.73 55.10 77.62 36.80 55.01 78.46 4.88 85.81 61.42 6.80 85.00 61.18 ULMN 3 1ehy_c01 SOLUBLE EPOXIDE HYDROLASE user 5 3 # 5 B 107 ASP D 56 ASP~? 11.46 C21 2PE D 146 B 246 ASP D 40 ASP.? 18.38 C9 2PE D 146 B 275 HIS D 115 HIS~? 12.18 C21 2PE D 146 coo 34.84 56.77 81.62 34.95 54.74 82.03 -41.85 87.81 13.66 -41.61 89.58 14.80 coo 43.18 49.30 68.39 44.75 49.87 69.78 -32.95 100.50 7.54 -33.10 99.69 9.54 coo 38.73 55.10 77.62 36.80 55.01 78.46 -36.28 90.32 11.92 -37.49 91.98 12.35 1ehy_c01 source 1ehy SOLUBLE EPOXIDE HYDROLASE : 5 hits 1ehy_c01 naa= 3 ULMN 3 1ehy_c02 SOLUBLE EPOXIDE HYDROLASE user 1 3 # 1 C 107 ASP A 56 ASP~? 11.59 C21 2PE A 148 C 246 ASP A 6 ASP.? -3.91 C9 2PE A 148s C 275 HIS A 115 HIS~? 12.27 C21 2PE A 148 coo 1.90 35.26 72.76 3.20 35.74 71.18 -16.01 45.89 15.64 -15.93 44.31 14.23 coo 12.03 20.33 71.56 10.48 19.25 70.56 -8.66 61.41 13.34 -8.76 59.35 12.80 coo 3.92 29.96 71.75 4.22 31.96 72.31 -13.18 48.35 10.37 -12.55 46.36 10.33 ULMN 3 1ehy_c02 SOLUBLE EPOXIDE HYDROLASE user 2 3 # 2 C 107 ASP A 56 ASP~? 11.59 C21 2PE A 148 C 246 ASP A 40 ASP.? 18.50 C9 2PE A 148 C 275 HIS A 115 HIS~? 12.27 C21 2PE A 148 coo 1.90 35.26 72.76 3.20 35.74 71.18 -16.01 45.89 15.64 -15.93 44.31 14.23 coo 12.03 20.33 71.56 10.48 19.25 70.56 -5.23 45.83 3.63 -5.09 44.63 5.33 coo 3.92 29.96 71.75 4.22 31.96 72.31 -13.18 48.35 10.37 -12.55 46.36 10.33 ULMN 3 1ehy_c02 SOLUBLE EPOXIDE HYDROLASE user 3 3 # 3 C 107 ASP B 56 ASP~? 11.45 C20 PE8 B 148 C 246 ASP B 6 ASP.? -3.99 C6 PE8 B 148s C 275 HIS B 115 HIS~? 12.48 C18 PE8 B 148 coo 1.90 35.26 72.76 3.20 35.74 71.18 6.80 78.21 26.00 8.47 79.07 25.03 coo 12.03 20.33 71.56 10.48 19.25 70.56 7.95 70.39 41.39 8.88 71.08 39.61 coo 3.92 29.96 71.75 4.22 31.96 72.31 11.86 77.76 30.05 12.70 77.49 28.15 ULMN 3 1ehy_c02 SOLUBLE EPOXIDE HYDROLASE user 4 3 # 4 C 107 ASP B 56 ASP~? 11.45 C20 PE8 B 148 C 246 ASP B 40 ASP.? 11.67 O1 PEG B 144 C 275 HIS B 115 HIS~? 12.48 C18 PE8 B 148 coo 1.90 35.26 72.76 3.20 35.74 71.18 6.80 78.21 26.00 8.47 79.07 25.03 coo 12.03 20.33 71.56 10.48 19.25 70.56 22.51 72.75 29.32 21.02 74.20 28.79 coo 3.92 29.96 71.75 4.22 31.96 72.31 11.86 77.76 30.05 12.70 77.49 28.15 ULMN 3 1ehy_c02 SOLUBLE EPOXIDE HYDROLASE user 5 3 # 5 C 107 ASP C 56 ASP~? 9.09 N MLZ C 114 C 246 ASP C 6 ASP.? -4.04 C8 PE8 C 148s C 275 HIS C 115 HIS~? 4.72 C MLZ C 114 coo 1.90 35.26 72.76 3.20 35.74 71.18 -16.40 94.43 66.11 -17.63 93.56 67.58 coo 12.03 20.33 71.56 10.48 19.25 70.56 0.53 91.96 65.64 -1.31 91.68 66.68 coo 3.92 29.96 71.75 4.22 31.96 72.31 -12.99 90.00 69.08 -14.38 90.57 70.54 ULMN 3 1ehy_c02 SOLUBLE EPOXIDE HYDROLASE user 6 3 # 6 C 107 ASP C 56 ASP~? 9.09 N MLZ C 114 C 246 ASP C 40 ASP.? 9.64 O MLZ C 114 C 275 HIS C 115 HIS~? 4.72 C MLZ C 114 coo 1.90 35.26 72.76 3.20 35.74 71.18 -16.40 94.43 66.11 -17.63 93.56 67.58 coo 12.03 20.33 71.56 10.48 19.25 70.56 -10.62 87.43 80.17 -12.01 86.84 78.68 coo 3.92 29.96 71.75 4.22 31.96 72.31 -12.99 90.00 69.08 -14.38 90.57 70.54 ULMN 3 1ehy_c02 SOLUBLE EPOXIDE HYDROLASE user 7 3 # 7 C 107 ASP D 56 ASP~? 11.46 C21 2PE D 146 C 246 ASP D 6 ASP.? -3.77 C8 2PE D 146s C 275 HIS D 115 HIS~? 12.18 C21 2PE D 146 coo 1.90 35.26 72.76 3.20 35.74 71.18 -41.85 87.81 13.66 -41.61 89.58 14.80 coo 12.03 20.33 71.56 10.48 19.25 70.56 -31.03 82.87 1.04 -31.83 84.41 2.29 coo 3.92 29.96 71.75 4.22 31.96 72.31 -36.28 90.32 11.92 -37.49 91.98 12.35 ULMN 3 1ehy_c02 SOLUBLE EPOXIDE HYDROLASE user 8 3 # 8 C 107 ASP D 56 ASP~? 11.46 C21 2PE D 146 C 246 ASP D 40 ASP.? 18.38 C9 2PE D 146 C 275 HIS D 115 HIS~? 12.18 C21 2PE D 146 coo 1.90 35.26 72.76 3.20 35.74 71.18 -41.85 87.81 13.66 -41.61 89.58 14.80 coo 12.03 20.33 71.56 10.48 19.25 70.56 -32.95 100.50 7.54 -33.10 99.69 9.54 coo 3.92 29.96 71.75 4.22 31.96 72.31 -36.28 90.32 11.92 -37.49 91.98 12.35 1ehy_c02 source 1ehy SOLUBLE EPOXIDE HYDROLASE : 8 hits 1ehy_c02 naa= 3 ULMN 3 1ehy_c03 SOLUBLE EPOXIDE HYDROLASE user 1 3 # 1 D 107 ASP A 56 ASP~? 11.59 C21 2PE A 148 D 246 ASP A 40 ASP.? 18.50 C9 2PE A 148 D 275 HIS A 115 HIS~? 12.27 C21 2PE A 148 coo 37.41 19.89 81.58 37.64 21.98 81.53 -16.01 45.89 15.64 -15.93 44.31 14.23 coo 23.50 26.43 88.52 24.76 26.47 90.29 -5.23 45.83 3.63 -5.09 44.63 5.33 coo 33.16 21.44 85.29 34.07 21.53 83.40 -13.18 48.35 10.37 -12.55 46.36 10.33 ULMN 3 1ehy_c03 SOLUBLE EPOXIDE HYDROLASE user 2 3 # 2 D 107 ASP A 122 ASP^? 7.46 C1 GOL A 150 D 246 ASP D 83 ASP.? 8.76 O1 GOL A 150 D 275 HIS A 4 HIS.? -3.92 C2 GOL A 150s coo 37.41 19.89 81.58 37.64 21.98 81.53 -15.41 64.92 4.51 -15.09 66.83 5.33 coo 23.50 26.43 88.52 24.76 26.47 90.29 -12.54 78.43 10.94 -12.46 77.06 9.29 coo 33.16 21.44 85.29 34.07 21.53 83.40 -11.85 68.18 8.83 -11.23 70.10 8.29 ULMN 3 1ehy_c03 SOLUBLE EPOXIDE HYDROLASE user 3 3 # 3 D 107 ASP B 56 ASP~? 11.45 C20 PE8 B 148 D 246 ASP B 40 ASP.? 11.67 O1 PEG B 144 D 275 HIS B 115 HIS~? 12.48 C18 PE8 B 148 coo 37.41 19.89 81.58 37.64 21.98 81.53 6.80 78.21 26.00 8.47 79.07 25.03 coo 23.50 26.43 88.52 24.76 26.47 90.29 22.51 72.75 29.32 21.02 74.20 28.79 coo 33.16 21.44 85.29 34.07 21.53 83.40 11.86 77.76 30.05 12.70 77.49 28.15 ULMN 3 1ehy_c03 SOLUBLE EPOXIDE HYDROLASE user 4 3 # 4 D 107 ASP B 122 ASP^? 7.33 O2 GOL B 149 D 246 ASP C 83 ASP.? 8.65 O3 GOL B 149 D 275 HIS B 4 HIS.? -3.86 O2 GOL B 149s coo 37.41 19.89 81.58 37.64 21.98 81.53 10.89 79.68 47.57 9.75 78.80 49.16 coo 23.50 26.43 88.52 24.76 26.47 90.29 3.02 71.86 58.06 4.88 72.49 57.24 coo 33.16 21.44 85.29 34.07 21.53 83.40 8.07 73.88 49.16 8.30 73.43 51.19 ULMN 3 1ehy_c03 SOLUBLE EPOXIDE HYDROLASE user 5 3 # 5 D 107 ASP C 56 ASP~? 9.09 N MLZ C 114 D 246 ASP C 40 ASP.? 9.64 O MLZ C 114 D 275 HIS C 115 HIS~? 4.72 C MLZ C 114 coo 37.41 19.89 81.58 37.64 21.98 81.53 -16.40 94.43 66.11 -17.63 93.56 67.58 coo 23.50 26.43 88.52 24.76 26.47 90.29 -10.62 87.43 80.17 -12.01 86.84 78.68 coo 33.16 21.44 85.29 34.07 21.53 83.40 -12.99 90.00 69.08 -14.38 90.57 70.54 ULMN 3 1ehy_c03 SOLUBLE EPOXIDE HYDROLASE user 6 3 # 6 D 107 ASP C 122 ASP^? 7.22 C3 GOL C 149 D 246 ASP B 83 ASP.? 9.40 O3 GOL C 149 D 275 HIS C 4 HIS.? -3.73 C3 GOL C 149s coo 37.41 19.89 81.58 37.64 21.98 81.53 0.27 81.12 61.60 2.07 81.54 60.53 coo 23.50 26.43 88.52 24.76 26.47 90.29 13.62 86.10 55.23 12.83 84.59 56.49 coo 33.16 21.44 85.29 34.07 21.53 83.40 4.88 85.81 61.42 6.80 85.00 61.18 ULMN 3 1ehy_c03 SOLUBLE EPOXIDE HYDROLASE user 7 3 # 7 D 107 ASP D 56 ASP~? 11.46 C21 2PE D 146 D 246 ASP D 40 ASP.? 18.38 C9 2PE D 146 D 275 HIS D 115 HIS~? 12.18 C21 2PE D 146 coo 37.41 19.89 81.58 37.64 21.98 81.53 -41.85 87.81 13.66 -41.61 89.58 14.80 coo 23.50 26.43 88.52 24.76 26.47 90.29 -32.95 100.50 7.54 -33.10 99.69 9.54 coo 33.16 21.44 85.29 34.07 21.53 83.40 -36.28 90.32 11.92 -37.49 91.98 12.35 ULMN 3 1ehy_c03 SOLUBLE EPOXIDE HYDROLASE user 8 3 # 8 D 107 ASP D 122 ASP^? 7.49 C3 GOL D 147 D 246 ASP A 83 ASP.? 8.52 O3 GOL D 147 D 275 HIS D 4 HIS.? 4.07 C3 GOL D 147 coo 37.41 19.89 81.58 37.64 21.98 81.53 -21.82 80.90 7.85 -21.38 79.32 6.51 coo 23.50 26.43 88.52 24.76 26.47 90.29 -19.46 70.43 -3.04 -19.06 72.28 -2.05 coo 33.16 21.44 85.29 34.07 21.53 83.40 -23.57 78.63 1.94 -22.01 77.96 0.72 1ehy_c03 source 1ehy SOLUBLE EPOXIDE HYDROLASE : 8 hits 1ehy_c03 naa= 3 ULMN 3 1emd_c01 MALATE DEHYDROGENASE (E.C.1.1.1.37) user 1 3 # 1 150 ASP A 56 ASP~? 11.59 C21 2PE A 148 153 ARG A 55 ARG~? 10.23 CD MLY D 135 177 HIS A 115 HIS~? 12.27 C21 2PE A 148 coo 6.83 2.75 19.17 7.40 0.75 19.11 -16.01 45.89 15.64 -15.93 44.31 14.23 coo 1.78 0.50 17.43 2.55 -2.31 16.44 -19.70 43.33 11.87 -20.69 44.07 9.04 coo 9.81 -2.34 18.22 7.84 -2.69 17.56 -13.18 48.35 10.37 -12.55 46.36 10.33 ULMN 3 1emd_c01 MALATE DEHYDROGENASE (E.C.1.1.1.37) user 2 3 # 2 150 ASP B 56 ASP~? 11.45 C20 PE8 B 148 153 ARG B 55 ARG~? 9.33 CG MLY C 135 177 HIS B 115 HIS~? 12.48 C18 PE8 B 148 coo 6.83 2.75 19.17 7.40 0.75 19.11 6.80 78.21 26.00 8.47 79.07 25.03 coo 1.78 0.50 17.43 2.55 -2.31 16.44 8.78 84.29 24.99 10.39 86.20 26.77 coo 9.81 -2.34 18.22 7.84 -2.69 17.56 11.86 77.76 30.05 12.70 77.49 28.15 ULMN 3 1emd_c01 MALATE DEHYDROGENASE (E.C.1.1.1.37) user 3 3 # 3 150 ASP C 56 ASP~? 9.09 N MLZ C 114 153 ARG C 55 ARG~? 9.18 O MLY B 135 177 HIS C 115 HIS~? 4.72 C MLZ C 114 coo 6.83 2.75 19.17 7.40 0.75 19.11 -16.40 94.43 66.11 -17.63 93.56 67.58 coo 1.78 0.50 17.43 2.55 -2.31 16.44 -21.06 89.68 64.73 -20.37 86.74 65.24 coo 9.81 -2.34 18.22 7.84 -2.69 17.56 -12.99 90.00 69.08 -14.38 90.57 70.54 ULMN 3 1emd_c01 MALATE DEHYDROGENASE (E.C.1.1.1.37) user 4 3 # 4 150 ASP D 56 ASP~? 11.46 C21 2PE D 146 153 ARG D 55 ARG~? 9.16 CG MLY A 135 177 HIS D 115 HIS~? 12.18 C21 2PE D 146 coo 6.83 2.75 19.17 7.40 0.75 19.11 -41.85 87.81 13.66 -41.61 89.58 14.80 coo 1.78 0.50 17.43 2.55 -2.31 16.44 -39.98 89.02 19.79 -37.17 89.06 21.03 coo 9.81 -2.34 18.22 7.84 -2.69 17.56 -36.28 90.32 11.92 -37.49 91.98 12.35 1emd_c01 source 1emd MALATE DEHYDROGENASE (E.C.1.1.1.37) : 4 hits 1emd_c01 naa= 3 ULMN 3 1eo7_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE user 1 3 # 1 A 229 ALA A 17 ALA~? 6.78 C24 1PE B 150 A 257 ALA A 13 ALA~? 8.48 C3 2PE A 148 A 328 ASP B 106 ASP~? 11.87 OH2 1PE B 150 coo 39.84 24.12 8.44 38.50 24.23 9.11 -11.11 69.66 29.83 -10.38 70.82 29.22 coo 43.22 26.73 5.37 41.81 27.09 5.79 -7.72 67.72 25.29 -6.32 68.40 25.30 coo 38.17 34.10 6.67 37.72 32.06 6.84 -0.30 70.27 27.08 -0.10 70.78 25.05 ULMN 3 1eo7_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE user 2 3 # 2 A 229 ALA A 17 ALA~? 6.78 C24 1PE B 150 A 257 ALA B 98 ALA~? 5.85 O4 SO4 A 144 A 328 ASP B 19 ASP.? -3.77 O3 SO4 A 144s coo 39.84 24.12 8.44 38.50 24.23 9.11 -11.11 69.66 29.83 -10.38 70.82 29.22 coo 43.22 26.73 5.37 41.81 27.09 5.79 -9.66 68.53 34.34 -10.85 67.86 33.67 coo 38.17 34.10 6.67 37.72 32.06 6.84 -12.63 65.75 40.21 -14.11 64.30 40.60 ULMN 3 1eo7_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE user 3 3 # 3 A 229 ALA A 17 ALA~? 6.78 C24 1PE B 150 A 257 ALA B 99 ALA~? 8.23 C24 1PE B 150 A 328 ASP B 19 ASP.? -3.77 O3 SO4 A 144s coo 39.84 24.12 8.44 38.50 24.23 9.11 -11.11 69.66 29.83 -10.38 70.82 29.22 coo 43.22 26.73 5.37 41.81 27.09 5.79 -8.65 71.66 32.40 -9.35 73.01 32.38 coo 38.17 34.10 6.67 37.72 32.06 6.84 -12.63 65.75 40.21 -14.11 64.30 40.60 ULMN 3 1eo7_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE user 4 3 # 4 A 229 ALA A 17 ALA~? 6.78 C24 1PE B 150 A 257 ALA B 99 ALA~? 8.23 C24 1PE B 150 A 328 ASP B 106 ASP~? 11.87 OH2 1PE B 150 coo 39.84 24.12 8.44 38.50 24.23 9.11 -11.11 69.66 29.83 -10.38 70.82 29.22 coo 43.22 26.73 5.37 41.81 27.09 5.79 -8.65 71.66 32.40 -9.35 73.01 32.38 coo 38.17 34.10 6.67 37.72 32.06 6.84 -0.30 70.27 27.08 -0.10 70.78 25.05 ULMN 3 1eo7_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE user 5 3 # 5 A 229 ALA A 36 ALA.? 15.34 CD MLY D 135 A 257 ALA A 37 ALA.? 13.61 C3 GOL A 150 A 328 ASP A 40 ASP.? 18.50 C9 2PE A 148 coo 39.84 24.12 8.44 38.50 24.23 9.11 -12.29 52.26 1.54 -12.72 51.09 2.41 coo 43.22 26.73 5.37 41.81 27.09 5.79 -8.69 53.40 2.12 -8.36 54.91 2.11 coo 38.17 34.10 6.67 37.72 32.06 6.84 -5.23 45.83 3.63 -5.09 44.63 5.33 ULMN 3 1eo7_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE user 6 3 # 6 A 229 ALA A 36 ALA.? 15.34 CD MLY D 135 A 257 ALA A 118 ALA~? 12.39 C11 2PE A 148 A 328 ASP A 40 ASP.? 18.50 C9 2PE A 148 coo 39.84 24.12 8.44 38.50 24.23 9.11 -12.29 52.26 1.54 -12.72 51.09 2.41 coo 43.22 26.73 5.37 41.81 27.09 5.79 -10.68 53.61 6.19 -10.55 52.09 6.11 coo 38.17 34.10 6.67 37.72 32.06 6.84 -5.23 45.83 3.63 -5.09 44.63 5.33 ULMN 3 1eo7_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE user 7 3 # 7 A 229 ALA A 37 ALA.? 13.61 C3 GOL A 150 A 257 ALA A 36 ALA.? 15.34 CD MLY D 135 A 328 ASP A 40 ASP.? 18.50 C9 2PE A 148 coo 39.84 24.12 8.44 38.50 24.23 9.11 -8.69 53.40 2.12 -8.36 54.91 2.11 coo 43.22 26.73 5.37 41.81 27.09 5.79 -12.29 52.26 1.54 -12.72 51.09 2.41 coo 38.17 34.10 6.67 37.72 32.06 6.84 -5.23 45.83 3.63 -5.09 44.63 5.33 ULMN 3 1eo7_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE user 8 3 # 8 A 229 ALA A 37 ALA.? 13.61 C3 GOL A 150 A 257 ALA A 118 ALA~? 12.39 C11 2PE A 148 A 328 ASP A 40 ASP.? 18.50 C9 2PE A 148 coo 39.84 24.12 8.44 38.50 24.23 9.11 -8.69 53.40 2.12 -8.36 54.91 2.11 coo 43.22 26.73 5.37 41.81 27.09 5.79 -10.68 53.61 6.19 -10.55 52.09 6.11 coo 38.17 34.10 6.67 37.72 32.06 6.84 -5.23 45.83 3.63 -5.09 44.63 5.33 ULMN 3 1eo7_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE user 9 3 # 9 A 229 ALA A 49 ALA~? 12.15 CD MLY D 135 A 257 ALA A 36 ALA.? 15.34 CD MLY D 135 A 328 ASP A 40 ASP.? 18.50 C9 2PE A 148 coo 39.84 24.12 8.44 38.50 24.23 9.11 -16.03 49.47 6.19 -14.84 50.27 5.67 coo 43.22 26.73 5.37 41.81 27.09 5.79 -12.29 52.26 1.54 -12.72 51.09 2.41 coo 38.17 34.10 6.67 37.72 32.06 6.84 -5.23 45.83 3.63 -5.09 44.63 5.33 ULMN 3 1eo7_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE user 10 3 # 10 A 229 ALA A 49 ALA~? 12.15 CD MLY D 135 A 257 ALA A 47 ALA~? 9.02 CD MLY D 135 A 328 ASP A 87 ASP.? 8.49 C6 PGE A 147 coo 39.84 24.12 8.44 38.50 24.23 9.11 -16.03 49.47 6.19 -14.84 50.27 5.67 coo 43.22 26.73 5.37 41.81 27.09 5.79 -20.21 51.63 3.44 -21.40 51.48 2.53 coo 38.17 34.10 6.67 37.72 32.06 6.84 -23.17 58.67 3.55 -22.34 59.17 1.69 ULMN 3 1eo7_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE user 11 3 # 11 A 229 ALA A 49 ALA~? 12.15 CD MLY D 135 A 257 ALA A 51 ALA~? 7.23 CD MLY D 135 A 328 ASP A 56 ASP~? 11.59 C21 2PE A 148 coo 39.84 24.12 8.44 38.50 24.23 9.11 -16.03 49.47 6.19 -14.84 50.27 5.67 coo 43.22 26.73 5.37 41.81 27.09 5.79 -20.65 48.85 8.75 -21.19 47.91 7.68 coo 38.17 34.10 6.67 37.72 32.06 6.84 -16.01 45.89 15.64 -15.93 44.31 14.23 ULMN 3 1eo7_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE user 12 3 # 12 A 229 ALA A 49 ALA~? 12.15 CD MLY D 135 A 257 ALA A 118 ALA~? 12.39 C11 2PE A 148 A 328 ASP A 40 ASP.? 18.50 C9 2PE A 148 coo 39.84 24.12 8.44 38.50 24.23 9.11 -16.03 49.47 6.19 -14.84 50.27 5.67 coo 43.22 26.73 5.37 41.81 27.09 5.79 -10.68 53.61 6.19 -10.55 52.09 6.11 coo 38.17 34.10 6.67 37.72 32.06 6.84 -5.23 45.83 3.63 -5.09 44.63 5.33 ULMN 3 1eo7_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE user 13 3 # 13 A 229 ALA A 49 ALA~? 12.15 CD MLY D 135 A 257 ALA A 119 ALA~? 10.88 CH2 MLY D 135 A 328 ASP A 87 ASP.? 8.49 C6 PGE A 147 coo 39.84 24.12 8.44 38.50 24.23 9.11 -16.03 49.47 6.19 -14.84 50.27 5.67 coo 43.22 26.73 5.37 41.81 27.09 5.79 -14.35 54.52 5.55 -15.48 54.02 6.43 coo 38.17 34.10 6.67 37.72 32.06 6.84 -23.17 58.67 3.55 -22.34 59.17 1.69 ULMN 3 1eo7_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE user 14 3 # 14 A 229 ALA A 51 ALA~? 7.23 CD MLY D 135 A 257 ALA A 47 ALA~? 9.02 CD MLY D 135 A 328 ASP A 87 ASP.? 8.49 C6 PGE A 147 coo 39.84 24.12 8.44 38.50 24.23 9.11 -20.65 48.85 8.75 -21.19 47.91 7.68 coo 43.22 26.73 5.37 41.81 27.09 5.79 -20.21 51.63 3.44 -21.40 51.48 2.53 coo 38.17 34.10 6.67 37.72 32.06 6.84 -23.17 58.67 3.55 -22.34 59.17 1.69 ULMN 3 1eo7_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE user 15 3 # 15 A 229 ALA A 51 ALA~? 7.23 CD MLY D 135 A 257 ALA A 49 ALA~? 12.15 CD MLY D 135 A 328 ASP A 56 ASP~? 11.59 C21 2PE A 148 coo 39.84 24.12 8.44 38.50 24.23 9.11 -20.65 48.85 8.75 -21.19 47.91 7.68 coo 43.22 26.73 5.37 41.81 27.09 5.79 -16.03 49.47 6.19 -14.84 50.27 5.67 coo 38.17 34.10 6.67 37.72 32.06 6.84 -16.01 45.89 15.64 -15.93 44.31 14.23 ULMN 3 1eo7_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE user 16 3 # 16 A 229 ALA A 98 ALA~? 6.19 O1 SO4 A 144 A 257 ALA A 99 ALA~? 9.01 N MLY A 67 A 328 ASP A 106 ASP~? 11.93 O22 2PE A 148 coo 39.84 24.12 8.44 38.50 24.23 9.11 -15.92 60.15 30.86 -15.93 59.97 32.40 coo 43.22 26.73 5.37 41.81 27.09 5.79 -18.17 57.51 29.32 -19.70 57.46 29.31 coo 38.17 34.10 6.67 37.72 32.06 6.84 -12.71 50.36 24.83 -13.06 48.30 25.05 ULMN 3 1eo7_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE user 17 3 # 17 A 229 ALA A 99 ALA~? 9.01 N MLY A 67 A 257 ALA A 98 ALA~? 6.19 O1 SO4 A 144 A 328 ASP A 19 ASP.? -3.59 O4 SO4 A 144s coo 39.84 24.12 8.44 38.50 24.23 9.11 -18.17 57.51 29.32 -19.70 57.46 29.31 coo 43.22 26.73 5.37 41.81 27.09 5.79 -15.92 60.15 30.86 -15.93 59.97 32.40 coo 38.17 34.10 6.67 37.72 32.06 6.84 -15.01 66.98 32.71 -14.52 68.02 34.44 ULMN 3 1eo7_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE user 18 3 # 18 A 229 ALA A 118 ALA~? 12.39 C11 2PE A 148 A 257 ALA A 36 ALA.? 15.34 CD MLY D 135 A 328 ASP A 40 ASP.? 18.50 C9 2PE A 148 coo 39.84 24.12 8.44 38.50 24.23 9.11 -10.68 53.61 6.19 -10.55 52.09 6.11 coo 43.22 26.73 5.37 41.81 27.09 5.79 -12.29 52.26 1.54 -12.72 51.09 2.41 coo 38.17 34.10 6.67 37.72 32.06 6.84 -5.23 45.83 3.63 -5.09 44.63 5.33 ULMN 3 1eo7_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE user 19 3 # 19 A 229 ALA A 118 ALA~? 12.39 C11 2PE A 148 A 257 ALA A 37 ALA.? 13.61 C3 GOL A 150 A 328 ASP A 40 ASP.? 18.50 C9 2PE A 148 coo 39.84 24.12 8.44 38.50 24.23 9.11 -10.68 53.61 6.19 -10.55 52.09 6.11 coo 43.22 26.73 5.37 41.81 27.09 5.79 -8.69 53.40 2.12 -8.36 54.91 2.11 coo 38.17 34.10 6.67 37.72 32.06 6.84 -5.23 45.83 3.63 -5.09 44.63 5.33 ULMN 3 1eo7_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE user 20 3 # 20 A 229 ALA A 119 ALA~? 10.88 CH2 MLY D 135 A 257 ALA A 47 ALA~? 9.02 CD MLY D 135 A 328 ASP A 87 ASP.? 8.49 C6 PGE A 147 coo 39.84 24.12 8.44 38.50 24.23 9.11 -14.35 54.52 5.55 -15.48 54.02 6.43 coo 43.22 26.73 5.37 41.81 27.09 5.79 -20.21 51.63 3.44 -21.40 51.48 2.53 coo 38.17 34.10 6.67 37.72 32.06 6.84 -23.17 58.67 3.55 -22.34 59.17 1.69 ULMN 3 1eo7_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE user 21 3 # 21 A 229 ALA A 119 ALA~? 10.88 CH2 MLY D 135 A 257 ALA A 118 ALA~? 12.39 C11 2PE A 148 A 328 ASP A 6 ASP.? -3.91 C9 2PE A 148s coo 39.84 24.12 8.44 38.50 24.23 9.11 -14.35 54.52 5.55 -15.48 54.02 6.43 coo 43.22 26.73 5.37 41.81 27.09 5.79 -10.68 53.61 6.19 -10.55 52.09 6.11 coo 38.17 34.10 6.67 37.72 32.06 6.84 -8.66 61.41 13.34 -8.76 59.35 12.80 ULMN 3 1eo7_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE user 22 3 # 22 A 229 ALA B 36 ALA.? 7.02 O1 PEG B 144 A 257 ALA B 37 ALA.? 3.83 C2 PEG B 144 A 328 ASP B 40 ASP.? 11.67 O1 PEG B 144 coo 39.84 24.12 8.44 38.50 24.23 9.11 18.43 80.55 36.64 17.85 80.70 35.22 coo 43.22 26.73 5.37 41.81 27.09 5.79 19.38 76.93 37.51 19.13 76.38 38.92 coo 38.17 34.10 6.67 37.72 32.06 6.84 22.51 72.75 29.32 21.02 74.20 28.79 ULMN 3 1eo7_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE user 23 3 # 23 A 229 ALA B 49 ALA~? 10.91 O1 PEG B 144 A 257 ALA B 47 ALA~? 9.27 CD MLY C 135 A 328 ASP B 87 ASP.? 8.94 O4 PGE B 147 coo 39.84 24.12 8.44 38.50 24.23 9.11 13.56 82.06 32.43 14.35 81.13 33.34 coo 43.22 26.73 5.37 41.81 27.09 5.79 13.13 86.65 35.42 13.34 88.15 35.52 coo 38.17 34.10 6.67 37.72 32.06 6.84 9.49 87.97 42.02 11.31 87.98 43.09 ULMN 3 1eo7_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE user 24 3 # 24 A 229 ALA B 49 ALA~? 10.91 O1 PEG B 144 A 257 ALA B 51 ALA~? 7.25 CG MLY C 135 A 328 ASP B 56 ASP~? 11.45 C20 PE8 B 148 coo 39.84 24.12 8.44 38.50 24.23 9.11 13.56 82.06 32.43 14.35 81.13 33.34 coo 43.22 26.73 5.37 41.81 27.09 5.79 9.29 84.92 31.07 10.11 86.09 30.55 coo 38.17 34.10 6.67 37.72 32.06 6.84 6.80 78.21 26.00 8.47 79.07 25.03 ULMN 3 1eo7_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE user 25 3 # 25 A 229 ALA B 49 ALA~? 10.91 O1 PEG B 144 A 257 ALA B 119 ALA~? 10.71 O16 PE8 B 148 A 328 ASP B 87 ASP.? 8.94 O4 PGE B 147 coo 39.84 24.12 8.44 38.50 24.23 9.11 13.56 82.06 32.43 14.35 81.13 33.34 coo 43.22 26.73 5.37 41.81 27.09 5.79 13.47 80.03 37.47 12.33 80.66 36.69 coo 38.17 34.10 6.67 37.72 32.06 6.84 9.49 87.97 42.02 11.31 87.98 43.09 ULMN 3 1eo7_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE user 26 3 # 26 A 229 ALA B 51 ALA~? 7.25 CG MLY C 135 A 257 ALA B 47 ALA~? 9.27 CD MLY C 135 A 328 ASP B 87 ASP.? 8.94 O4 PGE B 147 coo 39.84 24.12 8.44 38.50 24.23 9.11 9.29 84.92 31.07 10.11 86.09 30.55 coo 43.22 26.73 5.37 41.81 27.09 5.79 13.13 86.65 35.42 13.34 88.15 35.52 coo 38.17 34.10 6.67 37.72 32.06 6.84 9.49 87.97 42.02 11.31 87.98 43.09 ULMN 3 1eo7_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE user 27 3 # 27 A 229 ALA B 51 ALA~? 7.25 CG MLY C 135 A 257 ALA B 49 ALA~? 10.91 O1 PEG B 144 A 328 ASP B 56 ASP~? 11.45 C20 PE8 B 148 coo 39.84 24.12 8.44 38.50 24.23 9.11 9.29 84.92 31.07 10.11 86.09 30.55 coo 43.22 26.73 5.37 41.81 27.09 5.79 13.56 82.06 32.43 14.35 81.13 33.34 coo 38.17 34.10 6.67 37.72 32.06 6.84 6.80 78.21 26.00 8.47 79.07 25.03 ULMN 3 1eo7_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE user 28 3 # 28 A 229 ALA B 98 ALA~? 5.85 O4 SO4 A 144 A 257 ALA B 99 ALA~? 8.23 C24 1PE B 150 A 328 ASP B 106 ASP~? 11.87 OH2 1PE B 150 coo 39.84 24.12 8.44 38.50 24.23 9.11 -9.66 68.53 34.34 -10.85 67.86 33.67 coo 43.22 26.73 5.37 41.81 27.09 5.79 -8.65 71.66 32.40 -9.35 73.01 32.38 coo 38.17 34.10 6.67 37.72 32.06 6.84 -0.30 70.27 27.08 -0.10 70.78 25.05 ULMN 3 1eo7_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE user 29 3 # 29 A 229 ALA B 99 ALA~? 8.23 C24 1PE B 150 A 257 ALA B 98 ALA~? 5.85 O4 SO4 A 144 A 328 ASP B 19 ASP.? -3.77 O3 SO4 A 144s coo 39.84 24.12 8.44 38.50 24.23 9.11 -8.65 71.66 32.40 -9.35 73.01 32.38 coo 43.22 26.73 5.37 41.81 27.09 5.79 -9.66 68.53 34.34 -10.85 67.86 33.67 coo 38.17 34.10 6.67 37.72 32.06 6.84 -12.63 65.75 40.21 -14.11 64.30 40.60 ULMN 3 1eo7_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE user 30 3 # 30 A 229 ALA B 118 ALA~? 8.74 O1 PEG B 144 A 257 ALA B 37 ALA.? 3.83 C2 PEG B 144 A 328 ASP B 40 ASP.? 11.67 O1 PEG B 144 coo 39.84 24.12 8.44 38.50 24.23 9.11 15.05 76.70 36.40 15.62 76.90 35.00 coo 43.22 26.73 5.37 41.81 27.09 5.79 19.38 76.93 37.51 19.13 76.38 38.92 coo 38.17 34.10 6.67 37.72 32.06 6.84 22.51 72.75 29.32 21.02 74.20 28.79 ULMN 3 1eo7_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE user 31 3 # 31 A 229 ALA B 118 ALA~? 8.74 O1 PEG B 144 A 257 ALA B 119 ALA~? 10.71 O16 PE8 B 148 A 328 ASP B 122 ASP^? 7.33 O2 GOL B 149 coo 39.84 24.12 8.44 38.50 24.23 9.11 15.05 76.70 36.40 15.62 76.90 35.00 coo 43.22 26.73 5.37 41.81 27.09 5.79 13.47 80.03 37.47 12.33 80.66 36.69 coo 38.17 34.10 6.67 37.72 32.06 6.84 10.89 79.68 47.57 9.75 78.80 49.16 ULMN 3 1eo7_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE user 32 3 # 32 A 229 ALA B 119 ALA~? 10.71 O16 PE8 B 148 A 257 ALA B 47 ALA~? 9.27 CD MLY C 135 A 328 ASP B 87 ASP.? 8.94 O4 PGE B 147 coo 39.84 24.12 8.44 38.50 24.23 9.11 13.47 80.03 37.47 12.33 80.66 36.69 coo 43.22 26.73 5.37 41.81 27.09 5.79 13.13 86.65 35.42 13.34 88.15 35.52 coo 38.17 34.10 6.67 37.72 32.06 6.84 9.49 87.97 42.02 11.31 87.98 43.09 ULMN 3 1eo7_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE user 33 3 # 33 A 229 ALA B 119 ALA~? 10.71 O16 PE8 B 148 A 257 ALA B 118 ALA~? 8.74 O1 PEG B 144 A 328 ASP B 6 ASP.? -3.99 C6 PE8 B 148s coo 39.84 24.12 8.44 38.50 24.23 9.11 13.47 80.03 37.47 12.33 80.66 36.69 coo 43.22 26.73 5.37 41.81 27.09 5.79 15.05 76.70 36.40 15.62 76.90 35.00 coo 38.17 34.10 6.67 37.72 32.06 6.84 7.95 70.39 41.39 8.88 71.08 39.61 ULMN 3 1eo7_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE user 34 3 # 34 A 229 ALA C 36 ALA.? 7.94 O MLZ C 114 A 257 ALA C 37 ALA.? 8.47 O MLZ C 114 A 328 ASP C 40 ASP.? 9.64 O MLZ C 114 coo 39.84 24.12 8.44 38.50 24.23 9.11 -9.24 81.26 70.91 -10.47 82.16 70.81 coo 43.22 26.73 5.37 41.81 27.09 5.79 -6.51 82.74 73.21 -5.03 82.52 72.86 coo 38.17 34.10 6.67 37.72 32.06 6.84 -10.62 87.43 80.17 -12.01 86.84 78.68 ULMN 3 1eo7_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE user 35 3 # 35 A 229 ALA C 36 ALA.? 7.94 O MLZ C 114 A 257 ALA C 118 ALA~? 3.71 O MLZ C 114 A 328 ASP C 40 ASP.? 9.64 O MLZ C 114 coo 39.84 24.12 8.44 38.50 24.23 9.11 -9.24 81.26 70.91 -10.47 82.16 70.81 coo 43.22 26.73 5.37 41.81 27.09 5.79 -7.16 85.94 70.06 -8.41 86.17 70.90 coo 38.17 34.10 6.67 37.72 32.06 6.84 -10.62 87.43 80.17 -12.01 86.84 78.68 ULMN 3 1eo7_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE user 36 3 # 36 A 229 ALA C 37 ALA.? 8.47 O MLZ C 114 A 257 ALA C 118 ALA~? 3.71 O MLZ C 114 A 328 ASP C 40 ASP.? 9.64 O MLZ C 114 coo 39.84 24.12 8.44 38.50 24.23 9.11 -6.51 82.74 73.21 -5.03 82.52 72.86 coo 43.22 26.73 5.37 41.81 27.09 5.79 -7.16 85.94 70.06 -8.41 86.17 70.90 coo 38.17 34.10 6.67 37.72 32.06 6.84 -10.62 87.43 80.17 -12.01 86.84 78.68 ULMN 3 1eo7_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE user 37 3 # 37 A 229 ALA C 49 ALA~? 6.49 O MLZ C 114 A 257 ALA C 47 ALA~? 8.78 CD MLY B 135 A 328 ASP C 87 ASP.? 8.84 O1 PGE C 147 coo 39.84 24.12 8.44 38.50 24.23 9.11 -13.48 85.10 67.69 -12.20 84.83 68.50 coo 43.22 26.73 5.37 41.81 27.09 5.79 -13.73 80.92 64.16 -14.51 79.74 63.61 coo 38.17 34.10 6.67 37.72 32.06 6.84 -9.03 79.00 58.44 -8.21 77.39 59.55 ULMN 3 1eo7_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE user 38 3 # 38 A 229 ALA C 49 ALA~? 6.49 O MLZ C 114 A 257 ALA C 51 ALA~? 7.46 CD MLY B 135 A 328 ASP C 56 ASP~? 9.09 N MLZ C 114 coo 39.84 24.12 8.44 38.50 24.23 9.11 -13.48 85.10 67.69 -12.20 84.83 68.50 coo 43.22 26.73 5.37 41.81 27.09 5.79 -16.25 86.28 63.34 -17.35 85.28 63.69 coo 38.17 34.10 6.67 37.72 32.06 6.84 -16.40 94.43 66.11 -17.63 93.56 67.58 ULMN 3 1eo7_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE user 39 3 # 39 A 229 ALA C 49 ALA~? 6.49 O MLZ C 114 A 257 ALA C 119 ALA~? 6.80 O MLZ C 114 A 328 ASP C 87 ASP.? 8.84 O1 PGE C 147 coo 39.84 24.12 8.44 38.50 24.23 9.11 -13.48 85.10 67.69 -12.20 84.83 68.50 coo 43.22 26.73 5.37 41.81 27.09 5.79 -8.25 84.08 66.89 -9.22 84.66 65.88 coo 38.17 34.10 6.67 37.72 32.06 6.84 -9.03 79.00 58.44 -8.21 77.39 59.55 ULMN 3 1eo7_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE user 40 3 # 40 A 229 ALA C 51 ALA~? 7.46 CD MLY B 135 A 257 ALA C 47 ALA~? 8.78 CD MLY B 135 A 328 ASP C 87 ASP.? 8.84 O1 PGE C 147 coo 39.84 24.12 8.44 38.50 24.23 9.11 -16.25 86.28 63.34 -17.35 85.28 63.69 coo 43.22 26.73 5.37 41.81 27.09 5.79 -13.73 80.92 64.16 -14.51 79.74 63.61 coo 38.17 34.10 6.67 37.72 32.06 6.84 -9.03 79.00 58.44 -8.21 77.39 59.55 ULMN 3 1eo7_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE user 41 3 # 41 A 229 ALA C 51 ALA~? 7.46 CD MLY B 135 A 257 ALA C 49 ALA~? 6.49 O MLZ C 114 A 328 ASP C 56 ASP~? 9.09 N MLZ C 114 coo 39.84 24.12 8.44 38.50 24.23 9.11 -16.25 86.28 63.34 -17.35 85.28 63.69 coo 43.22 26.73 5.37 41.81 27.09 5.79 -13.48 85.10 67.69 -12.20 84.83 68.50 coo 38.17 34.10 6.67 37.72 32.06 6.84 -16.40 94.43 66.11 -17.63 93.56 67.58 ULMN 3 1eo7_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE user 42 3 # 42 A 229 ALA C 98 ALA~? 7.68 O3 SO4 C 143 A 257 ALA C 99 ALA~? 8.97 N MLY C 67 A 328 ASP C 106 ASP~? 12.11 C21 PE8 C 148 coo 39.84 24.12 8.44 38.50 24.23 9.11 -4.20 106.61 54.48 -4.36 108.09 54.06 coo 43.22 26.73 5.37 41.81 27.09 5.79 -7.58 104.86 54.49 -8.41 104.39 53.32 coo 38.17 34.10 6.67 37.72 32.06 6.84 -11.06 103.55 63.77 -13.00 104.00 64.35 ULMN 3 1eo7_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE user 43 3 # 43 A 229 ALA C 99 ALA~? 8.97 N MLY C 67 A 257 ALA C 98 ALA~? 7.68 O3 SO4 C 143 A 328 ASP C 19 ASP.? 9.43 O3 SO4 C 143 coo 39.84 24.12 8.44 38.50 24.23 9.11 -7.58 104.86 54.49 -8.41 104.39 53.32 coo 43.22 26.73 5.37 41.81 27.09 5.79 -4.20 106.61 54.48 -4.36 108.09 54.06 coo 38.17 34.10 6.67 37.72 32.06 6.84 2.21 107.45 51.42 3.36 109.08 50.82 ULMN 3 1eo7_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE user 44 3 # 44 A 229 ALA C 118 ALA~? 3.71 O MLZ C 114 A 257 ALA C 37 ALA.? 8.47 O MLZ C 114 A 328 ASP C 40 ASP.? 9.64 O MLZ C 114 coo 39.84 24.12 8.44 38.50 24.23 9.11 -7.16 85.94 70.06 -8.41 86.17 70.90 coo 43.22 26.73 5.37 41.81 27.09 5.79 -6.51 82.74 73.21 -5.03 82.52 72.86 coo 38.17 34.10 6.67 37.72 32.06 6.84 -10.62 87.43 80.17 -12.01 86.84 78.68 ULMN 3 1eo7_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE user 45 3 # 45 A 229 ALA C 118 ALA~? 3.71 O MLZ C 114 A 257 ALA C 119 ALA~? 6.80 O MLZ C 114 A 328 ASP C 122 ASP^? 7.22 C3 GOL C 149 coo 39.84 24.12 8.44 38.50 24.23 9.11 -7.16 85.94 70.06 -8.41 86.17 70.90 coo 43.22 26.73 5.37 41.81 27.09 5.79 -8.25 84.08 66.89 -9.22 84.66 65.88 coo 38.17 34.10 6.67 37.72 32.06 6.84 0.27 81.12 61.60 2.07 81.54 60.53 ULMN 3 1eo7_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE user 46 3 # 46 A 229 ALA C 119 ALA~? 6.80 O MLZ C 114 A 257 ALA C 47 ALA~? 8.78 CD MLY B 135 A 328 ASP C 87 ASP.? 8.84 O1 PGE C 147 coo 39.84 24.12 8.44 38.50 24.23 9.11 -8.25 84.08 66.89 -9.22 84.66 65.88 coo 43.22 26.73 5.37 41.81 27.09 5.79 -13.73 80.92 64.16 -14.51 79.74 63.61 coo 38.17 34.10 6.67 37.72 32.06 6.84 -9.03 79.00 58.44 -8.21 77.39 59.55 ULMN 3 1eo7_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE user 47 3 # 47 A 229 ALA C 119 ALA~? 6.80 O MLZ C 114 A 257 ALA C 118 ALA~? 3.71 O MLZ C 114 A 328 ASP C 6 ASP.? -4.04 C8 PE8 C 148s coo 39.84 24.12 8.44 38.50 24.23 9.11 -8.25 84.08 66.89 -9.22 84.66 65.88 coo 43.22 26.73 5.37 41.81 27.09 5.79 -7.16 85.94 70.06 -8.41 86.17 70.90 coo 38.17 34.10 6.67 37.72 32.06 6.84 0.53 91.96 65.64 -1.31 91.68 66.68 ULMN 3 1eo7_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE user 48 3 # 48 A 229 ALA D 36 ALA.? 15.48 CE MLY A 135 A 257 ALA D 37 ALA.? 13.79 O1 GOL D 147 A 328 ASP D 40 ASP.? 18.38 C9 2PE D 146 coo 39.84 24.12 8.44 38.50 24.23 9.11 -26.77 92.45 12.28 -28.15 92.58 12.90 coo 43.22 26.73 5.37 41.81 27.09 5.79 -26.64 93.53 8.61 -25.72 92.76 7.63 coo 38.17 34.10 6.67 37.72 32.06 6.84 -32.95 100.50 7.54 -33.10 99.69 9.54 ULMN 3 1eo7_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE user 49 3 # 49 A 229 ALA D 36 ALA.? 15.48 CE MLY A 135 A 257 ALA D 118 ALA~? 12.42 C9 2PE D 146 A 328 ASP D 40 ASP.? 18.38 C9 2PE D 146 coo 39.84 24.12 8.44 38.50 24.23 9.11 -26.77 92.45 12.28 -28.15 92.58 12.90 coo 43.22 26.73 5.37 41.81 27.09 5.79 -29.78 90.27 8.72 -30.62 91.39 9.36 coo 38.17 34.10 6.67 37.72 32.06 6.84 -32.95 100.50 7.54 -33.10 99.69 9.54 ULMN 3 1eo7_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE user 50 3 # 50 A 229 ALA D 37 ALA.? 13.79 O1 GOL D 147 A 257 ALA D 118 ALA~? 12.42 C9 2PE D 146 A 328 ASP D 40 ASP.? 18.38 C9 2PE D 146 coo 39.84 24.12 8.44 38.50 24.23 9.11 -26.64 93.53 8.61 -25.72 92.76 7.63 coo 43.22 26.73 5.37 41.81 27.09 5.79 -29.78 90.27 8.72 -30.62 91.39 9.36 coo 38.17 34.10 6.67 37.72 32.06 6.84 -32.95 100.50 7.54 -33.10 99.69 9.54 ULMN 3 1eo7_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE user 51 3 # 51 A 229 ALA D 49 ALA~? 12.11 CE MLY A 135 A 257 ALA D 47 ALA~? 9.03 CG MLY A 135 A 328 ASP D 87 ASP.? 7.26 C16 1PE B 150 coo 39.84 24.12 8.44 38.50 24.23 9.11 -32.13 89.91 15.13 -31.19 90.29 13.98 coo 43.22 26.73 5.37 41.81 27.09 5.79 -28.68 87.42 18.40 -28.00 87.29 19.73 coo 38.17 34.10 6.67 37.72 32.06 6.84 -24.70 80.89 17.41 -22.90 81.94 17.31 ULMN 3 1eo7_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE user 52 3 # 52 A 229 ALA D 49 ALA~? 12.11 CE MLY A 135 A 257 ALA D 51 ALA~? 6.92 CG MLY A 135 A 328 ASP D 56 ASP~? 11.46 C21 2PE D 146 coo 39.84 24.12 8.44 38.50 24.23 9.11 -32.13 89.91 15.13 -31.19 90.29 13.98 coo 43.22 26.73 5.37 41.81 27.09 5.79 -34.62 86.43 18.27 -34.28 87.19 19.52 coo 38.17 34.10 6.67 37.72 32.06 6.84 -41.85 87.81 13.66 -41.61 89.58 14.80 ULMN 3 1eo7_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE user 53 3 # 53 A 229 ALA D 49 ALA~? 12.11 CE MLY A 135 A 257 ALA D 119 ALA~? 10.88 C18 2PE D 146 A 328 ASP D 87 ASP.? 7.26 C16 1PE B 150 coo 39.84 24.12 8.44 38.50 24.23 9.11 -32.13 89.91 15.13 -31.19 90.29 13.98 coo 43.22 26.73 5.37 41.81 27.09 5.79 -28.73 87.90 11.52 -29.74 87.21 12.41 coo 38.17 34.10 6.67 37.72 32.06 6.84 -24.70 80.89 17.41 -22.90 81.94 17.31 ULMN 3 1eo7_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE user 54 3 # 54 A 229 ALA D 51 ALA~? 6.92 CG MLY A 135 A 257 ALA D 47 ALA~? 9.03 CG MLY A 135 A 328 ASP D 87 ASP.? 7.26 C16 1PE B 150 coo 39.84 24.12 8.44 38.50 24.23 9.11 -34.62 86.43 18.27 -34.28 87.19 19.52 coo 43.22 26.73 5.37 41.81 27.09 5.79 -28.68 87.42 18.40 -28.00 87.29 19.73 coo 38.17 34.10 6.67 37.72 32.06 6.84 -24.70 80.89 17.41 -22.90 81.94 17.31 ULMN 3 1eo7_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE user 55 3 # 55 A 229 ALA D 51 ALA~? 6.92 CG MLY A 135 A 257 ALA D 49 ALA~? 12.11 CE MLY A 135 A 328 ASP D 56 ASP~? 11.46 C21 2PE D 146 coo 39.84 24.12 8.44 38.50 24.23 9.11 -34.62 86.43 18.27 -34.28 87.19 19.52 coo 43.22 26.73 5.37 41.81 27.09 5.79 -32.13 89.91 15.13 -31.19 90.29 13.98 coo 38.17 34.10 6.67 37.72 32.06 6.84 -41.85 87.81 13.66 -41.61 89.58 14.80 ULMN 3 1eo7_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE user 56 3 # 56 A 229 ALA D 98 ALA~? 13.95 O1 2PE D 146 A 257 ALA D 99 ALA~? 8.96 N MLY D 67 A 328 ASP D 106 ASP~? 11.82 O22 2PE D 146 coo 39.84 24.12 8.44 38.50 24.23 9.11 -46.16 71.18 1.80 -47.49 70.56 1.40 coo 43.22 26.73 5.37 41.81 27.09 5.79 -46.31 72.48 5.36 -46.32 71.68 6.65 coo 38.17 34.10 6.67 37.72 32.06 6.84 -46.82 82.57 5.87 -48.37 83.43 7.00 ULMN 3 1eo7_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE user 57 3 # 57 A 229 ALA D 99 ALA~? 8.96 N MLY D 67 A 257 ALA D 98 ALA~? 13.95 O1 2PE D 146 A 328 ASP D 19 ASP.? -13.24 C2 PGE A 147s coo 39.84 24.12 8.44 38.50 24.23 9.11 -46.31 72.48 5.36 -46.32 71.68 6.65 coo 43.22 26.73 5.37 41.81 27.09 5.79 -46.16 71.18 1.80 -47.49 70.56 1.40 coo 38.17 34.10 6.67 37.72 32.06 6.84 -43.72 66.33 -2.80 -44.54 65.10 -4.29 ULMN 3 1eo7_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE user 58 3 # 58 A 229 ALA D 118 ALA~? 12.42 C9 2PE D 146 A 257 ALA D 37 ALA.? 13.79 O1 GOL D 147 A 328 ASP D 40 ASP.? 18.38 C9 2PE D 146 coo 39.84 24.12 8.44 38.50 24.23 9.11 -29.78 90.27 8.72 -30.62 91.39 9.36 coo 43.22 26.73 5.37 41.81 27.09 5.79 -26.64 93.53 8.61 -25.72 92.76 7.63 coo 38.17 34.10 6.67 37.72 32.06 6.84 -32.95 100.50 7.54 -33.10 99.69 9.54 ULMN 3 1eo7_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE user 59 3 # 59 A 229 ALA D 119 ALA~? 10.88 C18 2PE D 146 A 257 ALA D 47 ALA~? 9.03 CG MLY A 135 A 328 ASP D 87 ASP.? 7.26 C16 1PE B 150 coo 39.84 24.12 8.44 38.50 24.23 9.11 -28.73 87.90 11.52 -29.74 87.21 12.41 coo 43.22 26.73 5.37 41.81 27.09 5.79 -28.68 87.42 18.40 -28.00 87.29 19.73 coo 38.17 34.10 6.67 37.72 32.06 6.84 -24.70 80.89 17.41 -22.90 81.94 17.31 ULMN 3 1eo7_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE user 60 3 # 60 A 229 ALA D 119 ALA~? 10.88 C18 2PE D 146 A 257 ALA D 118 ALA~? 12.42 C9 2PE D 146 A 328 ASP D 6 ASP.? -3.77 C8 2PE D 146s coo 39.84 24.12 8.44 38.50 24.23 9.11 -28.73 87.90 11.52 -29.74 87.21 12.41 coo 43.22 26.73 5.37 41.81 27.09 5.79 -29.78 90.27 8.72 -30.62 91.39 9.36 coo 38.17 34.10 6.67 37.72 32.06 6.84 -31.03 82.87 1.04 -31.83 84.41 2.29 1eo7_c00 source 1eo7 CYCLODEXTRIN GLYCOSYLTRANSFERASE : 60 hits 1eo7_c00 naa= 3 ULMN 3 1eyi_c00 FRUCTOSE-1,6-BISPHOSPHATASE user 1 3 # 1 A 68 ASP D 87 ASP.? 7.26 C16 1PE B 150 A 74 ASP D 122 ASP^? 7.49 C3 GOL D 147 A 98 GLU D 121 GLU^? 11.70 OH7 1PE B 150 coo 17.19 9.05 25.28 15.77 9.98 26.53 -24.70 80.89 17.41 -22.90 81.94 17.31 coo 15.99 8.54 17.36 14.96 7.80 19.05 -21.82 80.90 7.85 -21.38 79.32 6.51 coo 16.31 12.85 18.11 16.71 11.79 19.90 -20.91 85.61 9.48 -19.44 85.70 10.98 1eyi_c00 source 1eyi FRUCTOSE-1,6-BISPHOSPHATASE : 1 hits 1eyi_c00 naa= 3 ULMN 3 1f6d_c02 UDP-N-ACETYLGLUCOSAMINE 2-EPIMERASE user 1 3 # 1 C 95 ASP A 122 ASP^? 7.46 C1 GOL A 150 C 117 GLU A 84 GLU.? 10.45 C3 GOL D 147 C 131 GLU A 121 GLU^? 12.41 C1 GOL A 150 coo 68.01 56.37 72.57 68.42 56.10 70.51 -15.41 64.92 4.51 -15.09 66.83 5.33 coo 66.59 62.50 67.44 67.57 60.64 67.12 -21.01 70.22 3.12 -21.10 71.95 4.30 coo 69.24 52.27 71.96 69.91 50.26 71.89 -13.98 61.53 0.93 -15.14 61.60 -0.79 ULMN 3 1f6d_c02 UDP-N-ACETYLGLUCOSAMINE 2-EPIMERASE user 2 3 # 2 C 95 ASP B 122 ASP^? 7.33 O2 GOL B 149 C 117 GLU B 84 GLU.? 10.31 O3 GOL C 149 C 131 GLU B 121 GLU^? 8.74 O2 PEG B 144 coo 68.01 56.37 72.57 68.42 56.10 70.51 10.89 79.68 47.57 9.75 78.80 49.16 coo 66.59 62.50 67.44 67.57 60.64 67.12 7.66 84.31 53.13 6.13 83.49 54.35 coo 69.24 52.27 71.96 69.91 50.26 71.89 15.37 80.83 45.64 16.23 82.69 46.15 ULMN 3 1f6d_c02 UDP-N-ACETYLGLUCOSAMINE 2-EPIMERASE user 3 3 # 3 C 95 ASP C 122 ASP^? 7.22 C3 GOL C 149 C 117 GLU C 84 GLU.? 10.77 O2 GOL B 149 C 131 GLU C 121 GLU^? 12.40 C3 GOL C 149 coo 68.01 56.37 72.57 68.42 56.10 70.51 0.27 81.12 61.60 2.07 81.54 60.53 coo 66.59 62.50 67.44 67.57 60.64 67.12 2.34 77.12 55.01 3.46 78.21 53.60 coo 69.24 52.27 71.96 69.91 50.26 71.89 -1.98 78.69 65.48 -2.54 76.71 65.06 ULMN 3 1f6d_c02 UDP-N-ACETYLGLUCOSAMINE 2-EPIMERASE user 4 3 # 4 C 95 ASP D 122 ASP^? 7.49 C3 GOL D 147 C 117 GLU D 84 GLU.? 10.79 C1 GOL A 150 C 131 GLU D 121 GLU^? 11.70 OH7 1PE B 150 coo 68.01 56.37 72.57 68.42 56.10 70.51 -21.82 80.90 7.85 -21.38 79.32 6.51 coo 66.59 62.50 67.44 67.57 60.64 67.12 -17.40 74.78 10.23 -17.69 72.96 9.24 coo 69.24 52.27 71.96 69.91 50.26 71.89 -20.91 85.61 9.48 -19.44 85.70 10.98 1f6d_c02 source 1f6d UDP-N-ACETYLGLUCOSAMINE 2-EPIMERASE : 4 hits 1f6d_c02 naa= 3 ULMN 3 1f80_c03 ACYL CARRIER PROTEIN user 1 3 # 1 A 105 HIS A 85 HIS.? 6.69 C5 PGE A 147 C 62 LYS D 129 LYS^? 7.63 C4 PEG D 145 F 35 ASP A 87 ASP.? 8.49 C6 PGE A 147 coo 15.40 22.79 16.66 13.93 24.10 15.98 -23.05 64.43 -0.55 -21.68 63.00 -1.25 coo 19.95 18.98 4.81 18.82 20.94 10.49 -36.12 61.83 6.50 -39.41 57.83 4.09 coo 16.32 15.30 17.19 17.71 14.73 18.69 -23.17 58.67 3.55 -22.34 59.17 1.69 ULMN 3 1f80_c03 ACYL CARRIER PROTEIN user 2 3 # 2 A 105 HIS C 85 HIS.? 6.34 C1 PGE C 147 C 62 LYS B 129 LYS^? 7.64 C2 PEG B 146 F 35 ASP C 87 ASP.? 8.84 O1 PGE C 147 coo 15.40 22.79 16.66 13.93 24.10 15.98 -4.08 74.18 57.17 -4.69 74.12 59.17 coo 19.95 18.98 4.81 18.82 20.94 10.49 -12.78 77.45 45.34 -17.39 74.89 47.84 coo 16.32 15.30 17.19 17.71 14.73 18.69 -9.03 79.00 58.44 -8.21 77.39 59.55 1f80_c03 source 1f80 ACYL CARRIER PROTEIN : 2 hits 1f80_c03 naa= 3 ULMN 3 1f80_c04 ACYL CARRIER PROTEIN user 1 3 # 1 B 62 LYS B 129 LYS^? 7.64 C2 PEG B 146 C 105 HIS C 85 HIS.? 6.34 C1 PGE C 147 D 35 ASP C 87 ASP.? 8.84 O1 PGE C 147 coo 38.76 28.25 7.87 36.33 26.41 13.58 -12.78 77.45 45.34 -17.39 74.89 47.84 coo 34.93 19.72 17.37 34.72 18.17 15.98 -4.08 74.18 57.17 -4.69 74.12 59.17 coo 41.01 23.02 20.83 40.65 24.26 22.55 -9.03 79.00 58.44 -8.21 77.39 59.55 ULMN 3 1f80_c04 ACYL CARRIER PROTEIN user 2 3 # 2 B 62 LYS D 129 LYS^? 7.63 C4 PEG D 145 C 105 HIS A 85 HIS.? 6.69 C5 PGE A 147 D 35 ASP A 87 ASP.? 8.49 C6 PGE A 147 coo 38.76 28.25 7.87 36.33 26.41 13.58 -36.12 61.83 6.50 -39.41 57.83 4.09 coo 34.93 19.72 17.37 34.72 18.17 15.98 -23.05 64.43 -0.55 -21.68 63.00 -1.25 coo 41.01 23.02 20.83 40.65 24.26 22.55 -23.17 58.67 3.55 -22.34 59.17 1.69 1f80_c04 source 1f80 ACYL CARRIER PROTEIN : 2 hits 1f80_c04 naa= 3 ULMN 3 1f80_c05 ACYL CARRIER PROTEIN user 1 3 # 1 A 62 LYS B 129 LYS^? 7.64 C2 PEG B 146 B 105 HIS C 85 HIS.? 6.34 C1 PGE C 147 E 35 ASP C 87 ASP.? 8.84 O1 PGE C 147 coo 20.51 39.76 8.83 21.23 37.38 14.18 -12.78 77.45 45.34 -17.39 74.89 47.84 coo 27.18 37.56 20.68 29.07 38.28 20.13 -4.08 74.18 57.17 -4.69 74.12 59.17 coo 19.97 40.39 22.03 18.53 39.30 23.18 -9.03 79.00 58.44 -8.21 77.39 59.55 ULMN 3 1f80_c05 ACYL CARRIER PROTEIN user 2 3 # 2 A 62 LYS D 129 LYS^? 7.63 C4 PEG D 145 B 105 HIS A 85 HIS.? 6.69 C5 PGE A 147 E 35 ASP A 87 ASP.? 8.49 C6 PGE A 147 coo 20.51 39.76 8.83 21.23 37.38 14.18 -36.12 61.83 6.50 -39.41 57.83 4.09 coo 27.18 37.56 20.68 29.07 38.28 20.13 -23.05 64.43 -0.55 -21.68 63.00 -1.25 coo 19.97 40.39 22.03 18.53 39.30 23.18 -23.17 58.67 3.55 -22.34 59.17 1.69 1f80_c05 source 1f80 ACYL CARRIER PROTEIN : 2 hits 1f80_c05 naa= 3 ULMN 3 1fc4_c02 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 1 3 # 1 A 112 PHE A 90 PHE^? 4.08 CH1 MLY D 135 A 210 ASP A 87 ASP.? 8.49 C6 PGE A 147 A 244 LYS D 129 LYS^? 7.63 C4 PEG D 145 coo 9.23 46.77 25.11 11.48 48.39 24.76 -25.59 59.02 13.87 -22.88 58.27 14.15 coo 10.51 37.86 19.71 9.07 39.38 20.04 -23.17 58.67 3.55 -22.34 59.17 1.69 coo -1.20 42.34 17.67 3.19 45.13 19.06 -36.12 61.83 6.50 -39.41 57.83 4.09 ULMN 3 1fc4_c02 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 2 3 # 2 A 112 PHE B 15 PHE~? 8.85 C11 PE8 B 148 A 210 ASP B 19 ASP.? -3.77 O3 SO4 A 144s A 244 LYS B 129 LYS^? 7.64 C2 PEG B 146 coo 9.23 46.77 25.11 11.48 48.39 24.76 -4.97 69.26 41.83 -5.66 71.31 40.07 coo 10.51 37.86 19.71 9.07 39.38 20.04 -12.63 65.75 40.21 -14.11 64.30 40.60 coo -1.20 42.34 17.67 3.19 45.13 19.06 -12.78 77.45 45.34 -17.39 74.89 47.84 ULMN 3 1fc4_c02 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 3 3 # 3 A 112 PHE B 100 PHE~? 5.44 CL CL B 143 A 210 ASP B 19 ASP.? -3.77 O3 SO4 A 144s A 244 LYS B 129 LYS^? 7.64 C2 PEG B 146 coo 9.23 46.77 25.11 11.48 48.39 24.76 -4.47 72.85 36.74 -1.98 73.56 37.79 coo 10.51 37.86 19.71 9.07 39.38 20.04 -12.63 65.75 40.21 -14.11 64.30 40.60 coo -1.20 42.34 17.67 3.19 45.13 19.06 -12.78 77.45 45.34 -17.39 74.89 47.84 ULMN 3 1fc4_c02 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 4 3 # 4 A 112 PHE C 90 PHE^? 3.87 CH1 MLY B 135 A 210 ASP C 87 ASP.? 8.84 O1 PGE C 147 A 244 LYS B 129 LYS^? 7.64 C2 PEG B 146 coo 9.23 46.77 25.11 11.48 48.39 24.76 -9.96 87.99 52.84 -9.24 88.98 55.39 coo 10.51 37.86 19.71 9.07 39.38 20.04 -9.03 79.00 58.44 -8.21 77.39 59.55 coo -1.20 42.34 17.67 3.19 45.13 19.06 -12.78 77.45 45.34 -17.39 74.89 47.84 ULMN 3 1fc4_c02 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 5 3 # 5 A 112 PHE D 15 PHE~? 8.99 C14 2PE D 146 A 210 ASP D 19 ASP.? -13.24 C2 PGE A 147s A 244 LYS D 129 LYS^? 7.63 C4 PEG D 145 coo 9.23 46.77 25.11 11.48 48.39 24.76 -37.50 71.61 -0.03 -38.77 71.49 2.45 coo 10.51 37.86 19.71 9.07 39.38 20.04 -43.72 66.33 -2.80 -44.54 65.10 -4.29 coo -1.20 42.34 17.67 3.19 45.13 19.06 -36.12 61.83 6.50 -39.41 57.83 4.09 ULMN 3 1fc4_c02 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 6 3 # 6 A 112 PHE D 100 PHE~? 5.42 CL CL D 143 A 210 ASP D 19 ASP.? -13.24 C2 PGE A 147s A 244 LYS D 129 LYS^? 7.63 C4 PEG D 145 coo 9.23 46.77 25.11 11.48 48.39 24.76 -40.31 73.86 4.98 -37.99 75.35 5.35 coo 10.51 37.86 19.71 9.07 39.38 20.04 -43.72 66.33 -2.80 -44.54 65.10 -4.29 coo -1.20 42.34 17.67 3.19 45.13 19.06 -36.12 61.83 6.50 -39.41 57.83 4.09 1fc4_c02 source 1fc4 2-AMINO-3-KETOBUTYRATE CONENZYME A LIGASE : 6 hits 1fc4_c02 naa= 3 ULMN 3 1fc4_c03 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 1 3 # 1 B 112 PHE A 90 PHE^? 4.08 CH1 MLY D 135 B 210 ASP A 87 ASP.? 8.49 C6 PGE A 147 B 244 LYS D 129 LYS^? 7.63 C4 PEG D 145 coo 8.76 47.85 34.91 11.08 46.36 35.41 -25.59 59.02 13.87 -22.88 58.27 14.15 coo 9.06 56.85 40.30 7.71 55.27 39.90 -23.17 58.67 3.55 -22.34 59.17 1.69 coo -2.38 51.82 41.62 2.07 49.19 40.42 -36.12 61.83 6.50 -39.41 57.83 4.09 ULMN 3 1fc4_c03 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 2 3 # 2 B 112 PHE B 15 PHE~? 8.85 C11 PE8 B 148 B 210 ASP B 19 ASP.? -3.77 O3 SO4 A 144s B 244 LYS B 129 LYS^? 7.64 C2 PEG B 146 coo 8.76 47.85 34.91 11.08 46.36 35.41 -4.97 69.26 41.83 -5.66 71.31 40.07 coo 9.06 56.85 40.30 7.71 55.27 39.90 -12.63 65.75 40.21 -14.11 64.30 40.60 coo -2.38 51.82 41.62 2.07 49.19 40.42 -12.78 77.45 45.34 -17.39 74.89 47.84 ULMN 3 1fc4_c03 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 3 3 # 3 B 112 PHE B 100 PHE~? 5.44 CL CL B 143 B 210 ASP B 19 ASP.? -3.77 O3 SO4 A 144s B 244 LYS B 129 LYS^? 7.64 C2 PEG B 146 coo 8.76 47.85 34.91 11.08 46.36 35.41 -4.47 72.85 36.74 -1.98 73.56 37.79 coo 9.06 56.85 40.30 7.71 55.27 39.90 -12.63 65.75 40.21 -14.11 64.30 40.60 coo -2.38 51.82 41.62 2.07 49.19 40.42 -12.78 77.45 45.34 -17.39 74.89 47.84 ULMN 3 1fc4_c03 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 4 3 # 4 B 112 PHE C 90 PHE^? 3.87 CH1 MLY B 135 B 210 ASP C 87 ASP.? 8.84 O1 PGE C 147 B 244 LYS B 129 LYS^? 7.64 C2 PEG B 146 coo 8.76 47.85 34.91 11.08 46.36 35.41 -9.96 87.99 52.84 -9.24 88.98 55.39 coo 9.06 56.85 40.30 7.71 55.27 39.90 -9.03 79.00 58.44 -8.21 77.39 59.55 coo -2.38 51.82 41.62 2.07 49.19 40.42 -12.78 77.45 45.34 -17.39 74.89 47.84 ULMN 3 1fc4_c03 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 5 3 # 5 B 112 PHE D 15 PHE~? 8.99 C14 2PE D 146 B 210 ASP D 19 ASP.? -13.24 C2 PGE A 147s B 244 LYS D 129 LYS^? 7.63 C4 PEG D 145 coo 8.76 47.85 34.91 11.08 46.36 35.41 -37.50 71.61 -0.03 -38.77 71.49 2.45 coo 9.06 56.85 40.30 7.71 55.27 39.90 -43.72 66.33 -2.80 -44.54 65.10 -4.29 coo -2.38 51.82 41.62 2.07 49.19 40.42 -36.12 61.83 6.50 -39.41 57.83 4.09 ULMN 3 1fc4_c03 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 6 3 # 6 B 112 PHE D 100 PHE~? 5.42 CL CL D 143 B 210 ASP D 19 ASP.? -13.24 C2 PGE A 147s B 244 LYS D 129 LYS^? 7.63 C4 PEG D 145 coo 8.76 47.85 34.91 11.08 46.36 35.41 -40.31 73.86 4.98 -37.99 75.35 5.35 coo 9.06 56.85 40.30 7.71 55.27 39.90 -43.72 66.33 -2.80 -44.54 65.10 -4.29 coo -2.38 51.82 41.62 2.07 49.19 40.42 -36.12 61.83 6.50 -39.41 57.83 4.09 1fc4_c03 source 1fc4 2-AMINO-3-KETOBUTYRATE CONENZYME A LIGASE : 6 hits 1fc4_c03 naa= 3 ULMN 3 1fgj_c01 HYDROXYLAMINE OXIDOREDUCTASE user 1 3 # 1 B 267 ASP A 56 ASP~? 11.59 C21 2PE A 148 B 268 HIS A 115 HIS~? 12.27 C21 2PE A 148 B 334 TYR A 53 TYR~? -4.55 C21 2PE A 148s coo 34.92 32.34 -16.78 33.96 30.63 -15.98 -16.01 45.89 15.64 -15.93 44.31 14.23 coo 34.35 32.52 -12.02 33.62 30.54 -12.18 -13.18 48.35 10.37 -12.55 46.36 10.33 coo 31.28 36.97 -17.45 31.29 34.40 -16.38 -16.76 52.42 13.05 -16.88 54.33 15.10 ULMN 3 1fgj_c01 HYDROXYLAMINE OXIDOREDUCTASE user 2 3 # 2 B 267 ASP B 56 ASP~? 11.45 C20 PE8 B 148 B 268 HIS B 115 HIS~? 12.48 C18 PE8 B 148 B 334 TYR B 53 TYR~? -4.63 C18 PE8 B 148s coo 34.92 32.34 -16.78 33.96 30.63 -15.98 6.80 78.21 26.00 8.47 79.07 25.03 coo 34.35 32.52 -12.02 33.62 30.54 -12.18 11.86 77.76 30.05 12.70 77.49 28.15 coo 31.28 36.97 -17.45 31.29 34.40 -16.38 6.73 78.96 33.00 4.51 77.73 34.14 ULMN 3 1fgj_c01 HYDROXYLAMINE OXIDOREDUCTASE user 3 3 # 3 B 267 ASP C 56 ASP~? 9.09 N MLZ C 114 B 268 HIS C 115 HIS~? 4.72 C MLZ C 114 B 334 TYR C 53 TYR~? -4.98 C18 PE8 C 148s coo 34.92 32.34 -16.78 33.96 30.63 -15.98 -16.40 94.43 66.11 -17.63 93.56 67.58 coo 34.35 32.52 -12.02 33.62 30.54 -12.18 -12.99 90.00 69.08 -14.38 90.57 70.54 coo 31.28 36.97 -17.45 31.29 34.40 -16.38 -11.26 90.80 63.43 -9.63 92.35 61.80 ULMN 3 1fgj_c01 HYDROXYLAMINE OXIDOREDUCTASE user 4 3 # 4 B 267 ASP D 56 ASP~? 11.46 C21 2PE D 146 B 268 HIS D 115 HIS~? 12.18 C21 2PE D 146 B 334 TYR D 53 TYR~? -4.60 C21 2PE D 146s coo 34.92 32.34 -16.78 33.96 30.63 -15.98 -41.85 87.81 13.66 -41.61 89.58 14.80 coo 34.35 32.52 -12.02 33.62 30.54 -12.18 -36.28 90.32 11.92 -37.49 91.98 12.35 coo 31.28 36.97 -17.45 31.29 34.40 -16.38 -36.08 84.35 12.01 -36.58 82.07 10.49 1fgj_c01 source 1fgj HYDROXYLAMINE OXIDOREDUCTASE : 4 hits 1fgj_c01 naa= 3 ULMN 3 1foh_c00 PHENOL HYDROXYLASE user 1 3 # 1 A 54 ASP A 56 ASP~? 11.59 C21 2PE A 148 A 281 ARG A 55 ARG~? 10.23 CD MLY D 135 A 289 TYR A 50 TYR~? 5.51 CH2 MLY D 135 coo 54.86 40.00 47.23 55.57 38.60 48.67 -16.01 45.89 15.64 -15.93 44.31 14.23 coo 52.08 40.18 50.14 50.83 38.93 47.73 -19.70 43.33 11.87 -20.69 44.07 9.04 coo 57.82 31.70 50.73 57.94 34.00 49.17 -19.50 53.98 8.67 -20.18 55.72 10.74 1foh_c00 source 1foh PHENOL HYDROXYLASE : 1 hits 1foh_c00 naa= 3 ULMN 3 1foh_c01 PHENOL HYDROXYLASE user 1 3 # 1 B 54 ASP A 56 ASP~? 11.59 C21 2PE A 148 B 281 ARG A 55 ARG~? 10.23 CD MLY D 135 B 289 TYR A 50 TYR~? 5.51 CH2 MLY D 135 coo 90.56 80.24 98.04 90.36 81.53 96.34 -16.01 45.89 15.64 -15.93 44.31 14.23 coo 86.62 80.67 97.51 87.37 82.00 100.10 -19.70 43.33 11.87 -20.69 44.07 9.04 coo 91.83 88.28 92.88 92.60 85.93 94.14 -19.50 53.98 8.67 -20.18 55.72 10.74 1foh_c01 source 1foh PHENOL HYDROXYLASE : 1 hits 1foh_c01 naa= 3 ULMN 3 1foh_c02 PHENOL HYDROXYLASE user 1 3 # 1 C 54 ASP A 56 ASP~? 11.59 C21 2PE A 148 C 281 ARG A 55 ARG~? 10.23 CD MLY D 135 C 289 TYR A 50 TYR~? 5.51 CH2 MLY D 135 coo 42.34 76.83 49.10 43.06 78.59 50.01 -16.01 45.89 15.64 -15.93 44.31 14.23 coo 46.12 77.15 48.13 44.44 77.61 45.70 -19.70 43.33 11.87 -20.69 44.07 9.04 coo 42.69 86.18 51.69 41.59 83.63 51.54 -19.50 53.98 8.67 -20.18 55.72 10.74 1foh_c02 source 1foh PHENOL HYDROXYLASE : 1 hits 1foh_c02 naa= 3 ULMN 3 1fr8_c00 BETA 1,4 GALACTOSYLTRANSFERASE user 1 3 # 1 A 317 GLU A 102 GLU~? 6.28 O2 SO4 A 143 A 319 ASP A 106 ASP~? 11.93 O22 2PE A 148 A 359 ARG A 110 ARG~? -3.66 O1 2PE A 148s coo 14.41 12.40 16.42 12.92 13.74 15.71 -14.00 55.24 30.65 -12.08 54.69 31.20 coo 12.25 13.04 23.85 11.56 15.02 23.93 -12.71 50.36 24.83 -13.06 48.30 25.05 coo 10.89 14.95 28.28 12.39 12.53 29.31 -6.91 52.41 21.82 -5.61 55.22 21.43 ULMN 3 1fr8_c00 BETA 1,4 GALACTOSYLTRANSFERASE user 2 3 # 2 A 317 GLU A 111 GLU~? 12.48 C11 2PE A 148 A 319 ASP A 56 ASP~? 11.59 C21 2PE A 148 A 359 ARG A 55 ARG~? 10.23 CD MLY D 135 coo 14.41 12.40 16.42 12.92 13.74 15.71 -8.13 46.06 17.22 -6.45 46.46 15.98 coo 12.25 13.04 23.85 11.56 15.02 23.93 -16.01 45.89 15.64 -15.93 44.31 14.23 coo 10.89 14.95 28.28 12.39 12.53 29.31 -19.70 43.33 11.87 -20.69 44.07 9.04 ULMN 3 1fr8_c00 BETA 1,4 GALACTOSYLTRANSFERASE user 3 3 # 3 A 317 GLU B 102 GLU~? 6.18 O4 SO4 A 143 A 319 ASP A 19 ASP.? -3.59 O4 SO4 A 144s A 359 ARG A 20 ARG.? 4.64 CB MLZ A 129 coo 14.41 12.40 16.42 12.92 13.74 15.71 -7.10 67.86 29.77 -6.34 66.05 29.12 coo 12.25 13.04 23.85 11.56 15.02 23.93 -15.01 66.98 32.71 -14.52 68.02 34.44 coo 10.89 14.95 28.28 12.39 12.53 29.31 -20.19 69.79 30.19 -22.38 67.97 29.03 ULMN 3 1fr8_c00 BETA 1,4 GALACTOSYLTRANSFERASE user 4 3 # 4 A 317 GLU B 111 GLU~? 12.54 O7 PE8 B 148 A 319 ASP B 56 ASP~? 11.45 C20 PE8 B 148 A 359 ARG B 55 ARG~? 9.33 CG MLY C 135 coo 14.41 12.40 16.42 12.92 13.74 15.71 9.41 70.70 25.55 11.25 69.94 26.27 coo 12.25 13.04 23.85 11.56 15.02 23.93 6.80 78.21 26.00 8.47 79.07 25.03 coo 10.89 14.95 28.28 12.39 12.53 29.31 8.78 84.29 24.99 10.39 86.20 26.77 ULMN 3 1fr8_c00 BETA 1,4 GALACTOSYLTRANSFERASE user 5 3 # 5 A 317 GLU C 102 GLU~? 5.77 O1 SO4 C 143 A 319 ASP C 106 ASP~? 12.11 C21 PE8 C 148 A 359 ARG C 110 ARG~? -6.90 CM MLZ C 114s coo 14.41 12.40 16.42 12.92 13.74 15.71 -7.47 107.78 58.43 -6.93 108.85 60.16 coo 12.25 13.04 23.85 11.56 15.02 23.93 -11.06 103.55 63.77 -13.00 104.00 64.35 coo 10.89 14.95 28.28 12.39 12.53 29.31 -6.95 102.53 68.25 -6.50 103.08 71.25 ULMN 3 1fr8_c00 BETA 1,4 GALACTOSYLTRANSFERASE user 6 3 # 6 A 317 GLU C 111 GLU~? 3.06 NZ MLZ C 114 A 319 ASP C 56 ASP~? 9.09 N MLZ C 114 A 359 ARG C 55 ARG~? 9.18 O MLY B 135 coo 14.41 12.40 16.42 12.92 13.74 15.71 -12.41 98.44 71.96 -11.17 97.70 73.52 coo 12.25 13.04 23.85 11.56 15.02 23.93 -16.40 94.43 66.11 -17.63 93.56 67.58 coo 10.89 14.95 28.28 12.39 12.53 29.31 -21.06 89.68 64.73 -20.37 86.74 65.24 ULMN 3 1fr8_c00 BETA 1,4 GALACTOSYLTRANSFERASE user 7 3 # 7 A 317 GLU D 102 GLU~? 11.83 O1 2PE D 146 A 319 ASP D 106 ASP~? 11.82 O22 2PE D 146 A 359 ARG D 110 ARG~? 8.08 C9 2PE D 146 coo 14.41 12.40 16.42 12.92 13.74 15.71 -48.79 75.67 2.61 -49.51 76.91 1.13 coo 12.25 13.04 23.85 11.56 15.02 23.93 -46.82 82.57 5.87 -48.37 83.43 7.00 coo 10.89 14.95 28.28 12.39 12.53 29.31 -43.46 85.72 1.13 -42.23 87.94 -0.73 ULMN 3 1fr8_c00 BETA 1,4 GALACTOSYLTRANSFERASE user 8 3 # 8 A 317 GLU D 111 GLU~? 11.88 C9 2PE D 146 A 319 ASP D 56 ASP~? 11.46 C21 2PE D 146 A 359 ARG D 55 ARG~? 9.16 CG MLY A 135 coo 14.41 12.40 16.42 12.92 13.74 15.71 -43.22 91.45 6.64 -41.92 92.74 5.57 coo 12.25 13.04 23.85 11.56 15.02 23.93 -41.85 87.81 13.66 -41.61 89.58 14.80 coo 10.89 14.95 28.28 12.39 12.53 29.31 -39.98 89.02 19.79 -37.17 89.06 21.03 1fr8_c00 source 1fr8 BETA 1,4 GALACTOSYLTRANSFERASE : 8 hits 1fr8_c00 naa= 3 ULMN 3 1fr8_c01 BETA 1,4 GALACTOSYLTRANSFERASE user 1 3 # 1 B 317 GLU A 10 GLU~? 8.70 C6 2PE A 148 B 319 ASP B 106 ASP~? 11.87 OH2 1PE B 150 B 359 ARG B 105 ARG~? -3.01 O4 SO4 A 143s coo 10.77 13.13 40.94 11.03 14.73 39.51 -3.10 70.57 20.07 -2.45 69.30 18.38 coo 3.77 12.64 38.21 3.35 14.53 37.39 -0.30 70.27 27.08 -0.10 70.78 25.05 coo -1.16 15.32 35.60 -3.32 13.56 36.98 -2.68 64.28 31.62 -4.52 62.28 32.99 ULMN 3 1fr8_c01 BETA 1,4 GALACTOSYLTRANSFERASE user 2 3 # 2 B 317 GLU A 10 GLU~? 8.70 C6 2PE A 148 B 319 ASP B 106 ASP~? 11.87 OH2 1PE B 150 B 359 ARG B 110 ARG~? 10.12 O7 PE8 B 148 coo 10.77 13.13 40.94 11.03 14.73 39.51 -3.10 70.57 20.07 -2.45 69.30 18.38 coo 3.77 12.64 38.21 3.35 14.53 37.39 -0.30 70.27 27.08 -0.10 70.78 25.05 coo -1.16 15.32 35.60 -3.32 13.56 36.98 4.56 66.25 30.54 5.81 64.43 28.32 ULMN 3 1fr8_c01 BETA 1,4 GALACTOSYLTRANSFERASE user 3 3 # 3 B 317 GLU A 102 GLU~? 6.28 O2 SO4 A 143 B 319 ASP A 106 ASP~? 11.93 O22 2PE A 148 B 359 ARG A 110 ARG~? -3.66 O1 2PE A 148s coo 10.77 13.13 40.94 11.03 14.73 39.51 -14.00 55.24 30.65 -12.08 54.69 31.20 coo 3.77 12.64 38.21 3.35 14.53 37.39 -12.71 50.36 24.83 -13.06 48.30 25.05 coo -1.16 15.32 35.60 -3.32 13.56 36.98 -6.91 52.41 21.82 -5.61 55.22 21.43 ULMN 3 1fr8_c01 BETA 1,4 GALACTOSYLTRANSFERASE user 4 3 # 4 B 317 GLU A 111 GLU~? 12.48 C11 2PE A 148 B 319 ASP A 56 ASP~? 11.59 C21 2PE A 148 B 359 ARG A 55 ARG~? 10.23 CD MLY D 135 coo 10.77 13.13 40.94 11.03 14.73 39.51 -8.13 46.06 17.22 -6.45 46.46 15.98 coo 3.77 12.64 38.21 3.35 14.53 37.39 -16.01 45.89 15.64 -15.93 44.31 14.23 coo -1.16 15.32 35.60 -3.32 13.56 36.98 -19.70 43.33 11.87 -20.69 44.07 9.04 ULMN 3 1fr8_c01 BETA 1,4 GALACTOSYLTRANSFERASE user 5 3 # 5 B 317 GLU B 102 GLU~? 6.18 O4 SO4 A 143 B 319 ASP A 19 ASP.? -3.59 O4 SO4 A 144s B 359 ARG A 20 ARG.? 4.64 CB MLZ A 129 coo 10.77 13.13 40.94 11.03 14.73 39.51 -7.10 67.86 29.77 -6.34 66.05 29.12 coo 3.77 12.64 38.21 3.35 14.53 37.39 -15.01 66.98 32.71 -14.52 68.02 34.44 coo -1.16 15.32 35.60 -3.32 13.56 36.98 -20.19 69.79 30.19 -22.38 67.97 29.03 ULMN 3 1fr8_c01 BETA 1,4 GALACTOSYLTRANSFERASE user 6 3 # 6 B 317 GLU B 102 GLU~? 6.18 O4 SO4 A 143 B 319 ASP B 106 ASP~? 11.87 OH2 1PE B 150 B 359 ARG B 110 ARG~? 10.12 O7 PE8 B 148 coo 10.77 13.13 40.94 11.03 14.73 39.51 -7.10 67.86 29.77 -6.34 66.05 29.12 coo 3.77 12.64 38.21 3.35 14.53 37.39 -0.30 70.27 27.08 -0.10 70.78 25.05 coo -1.16 15.32 35.60 -3.32 13.56 36.98 4.56 66.25 30.54 5.81 64.43 28.32 ULMN 3 1fr8_c01 BETA 1,4 GALACTOSYLTRANSFERASE user 7 3 # 7 B 317 GLU B 111 GLU~? 12.54 O7 PE8 B 148 B 319 ASP B 56 ASP~? 11.45 C20 PE8 B 148 B 359 ARG B 55 ARG~? 9.33 CG MLY C 135 coo 10.77 13.13 40.94 11.03 14.73 39.51 9.41 70.70 25.55 11.25 69.94 26.27 coo 3.77 12.64 38.21 3.35 14.53 37.39 6.80 78.21 26.00 8.47 79.07 25.03 coo -1.16 15.32 35.60 -3.32 13.56 36.98 8.78 84.29 24.99 10.39 86.20 26.77 ULMN 3 1fr8_c01 BETA 1,4 GALACTOSYLTRANSFERASE user 8 3 # 8 B 317 GLU C 111 GLU~? 3.06 NZ MLZ C 114 B 319 ASP C 56 ASP~? 9.09 N MLZ C 114 B 359 ARG C 55 ARG~? 9.18 O MLY B 135 coo 10.77 13.13 40.94 11.03 14.73 39.51 -12.41 98.44 71.96 -11.17 97.70 73.52 coo 3.77 12.64 38.21 3.35 14.53 37.39 -16.40 94.43 66.11 -17.63 93.56 67.58 coo -1.16 15.32 35.60 -3.32 13.56 36.98 -21.06 89.68 64.73 -20.37 86.74 65.24 ULMN 3 1fr8_c01 BETA 1,4 GALACTOSYLTRANSFERASE user 9 3 # 9 B 317 GLU D 102 GLU~? 11.83 O1 2PE D 146 B 319 ASP D 106 ASP~? 11.82 O22 2PE D 146 B 359 ARG D 110 ARG~? 8.08 C9 2PE D 146 coo 10.77 13.13 40.94 11.03 14.73 39.51 -48.79 75.67 2.61 -49.51 76.91 1.13 coo 3.77 12.64 38.21 3.35 14.53 37.39 -46.82 82.57 5.87 -48.37 83.43 7.00 coo -1.16 15.32 35.60 -3.32 13.56 36.98 -43.46 85.72 1.13 -42.23 87.94 -0.73 ULMN 3 1fr8_c01 BETA 1,4 GALACTOSYLTRANSFERASE user 10 3 # 10 B 317 GLU D 111 GLU~? 11.88 C9 2PE D 146 B 319 ASP D 56 ASP~? 11.46 C21 2PE D 146 B 359 ARG D 55 ARG~? 9.16 CG MLY A 135 coo 10.77 13.13 40.94 11.03 14.73 39.51 -43.22 91.45 6.64 -41.92 92.74 5.57 coo 3.77 12.64 38.21 3.35 14.53 37.39 -41.85 87.81 13.66 -41.61 89.58 14.80 coo -1.16 15.32 35.60 -3.32 13.56 36.98 -39.98 89.02 19.79 -37.17 89.06 21.03 1fr8_c01 source 1fr8 BETA 1,4 GALACTOSYLTRANSFERASE : 10 hits 1fr8_c01 naa= 3 ULMN 3 1g8o_c01 N-ACETYLLACTOSAMINIDE ALPHA-1,3- GALuser 1 3 # 1 A 314 TRP A 86 TRP.? 11.27 C5 PGE A 147 A 317 GLU A 84 GLU.? 10.45 C3 GOL D 147 A 365 ARG D 127 ARG^? 9.31 O3 PGE A 147 coo 79.91 26.87 38.77 78.95 23.18 37.81 -23.97 66.49 5.70 -20.10 66.49 6.06 coo 85.55 26.30 41.25 85.59 24.97 39.65 -21.01 70.22 3.12 -21.10 71.95 4.30 coo 83.47 25.30 27.10 83.44 27.82 25.29 -35.94 67.72 2.28 -38.25 66.55 0.66 ULMN 3 1g8o_c01 N-ACETYLLACTOSAMINIDE ALPHA-1,3- GALuser 2 3 # 2 A 314 TRP B 86 TRP.? 11.40 C6 PGE B 147 A 317 GLU B 84 GLU.? 10.31 O3 GOL C 149 A 365 ARG C 127 ARG^? 7.44 N MLZ C 129 coo 79.91 26.87 38.77 78.95 23.18 37.81 5.15 86.32 48.71 6.70 82.77 48.58 coo 85.55 26.30 41.25 85.59 24.97 39.65 7.66 84.31 53.13 6.13 83.49 54.35 coo 83.47 25.30 27.10 83.44 27.82 25.29 1.53 98.09 50.88 2.14 101.05 50.40 ULMN 3 1g8o_c01 N-ACETYLLACTOSAMINIDE ALPHA-1,3- GALuser 3 3 # 3 A 314 TRP C 86 TRP.? 11.30 C1 PGE C 147 A 317 GLU C 84 GLU.? 10.77 O2 GOL B 149 A 365 ARG B 127 ARG^? 9.26 O4 SO4 A 144 coo 79.91 26.87 38.77 78.95 23.18 37.81 -2.64 79.47 53.33 -0.76 80.96 56.37 coo 85.55 26.30 41.25 85.59 24.97 39.65 2.34 77.12 55.01 3.46 78.21 53.60 coo 83.47 25.30 27.10 83.44 27.82 25.29 -7.64 72.55 44.16 -9.78 70.52 43.36 ULMN 3 1g8o_c01 N-ACETYLLACTOSAMINIDE ALPHA-1,3- GALuser 4 3 # 4 A 314 TRP D 86 TRP.? 10.59 OH7 1PE B 150 A 317 GLU D 84 GLU.? 10.79 C1 GOL A 150 A 365 ARG A 127 ARG^? 7.47 N MLZ A 129 coo 79.91 26.87 38.77 78.95 23.18 37.81 -21.83 74.25 13.71 -22.24 76.29 10.42 coo 85.55 26.30 41.25 85.59 24.97 39.65 -17.40 74.78 10.23 -17.69 72.96 9.24 coo 83.47 25.30 27.10 83.44 27.82 25.29 -18.44 68.25 24.06 -17.70 68.37 27.04 1g8o_c01 source 1g8o N-ACETYLLACTOSAMINIDE ALPHA-1,3- GALACTOSYLTRA: 4 hits 1g8o_c01 naa= 3 ULMN 3 1gim_c00 ADENYLOSUCCINATE SYNTHETASE user 1 3 # 1 13 ASP A 83 ASP.? 8.52 O3 GOL D 147 41 HIS A 85 HIS.? 6.69 C5 PGE A 147 224 GLN A 82 GLN.? 6.12 C4 PGE A 147 coo -3.80 50.71 49.48 -5.59 51.85 49.27 -19.46 70.43 -3.04 -19.06 72.28 -2.05 coo -6.45 47.32 41.99 -8.32 46.87 42.83 -23.05 64.43 -0.55 -21.68 63.00 -1.25 coo -12.35 49.13 49.89 -13.38 48.89 48.03 -26.22 72.35 -4.39 -27.71 71.44 -3.07 ULMN 3 1gim_c00 ADENYLOSUCCINATE SYNTHETASE user 2 3 # 2 13 ASP A 83 ASP.? 8.52 O3 GOL D 147 41 HIS D 4 HIS.? 4.07 C3 GOL D 147 224 GLN A 82 GLN.? 6.12 C4 PGE A 147 coo -3.80 50.71 49.48 -5.59 51.85 49.27 -19.46 70.43 -3.04 -19.06 72.28 -2.05 coo -6.45 47.32 41.99 -8.32 46.87 42.83 -23.57 78.63 1.94 -22.01 77.96 0.72 coo -12.35 49.13 49.89 -13.38 48.89 48.03 -26.22 72.35 -4.39 -27.71 71.44 -3.07 ULMN 3 1gim_c00 ADENYLOSUCCINATE SYNTHETASE user 3 3 # 3 13 ASP A 87 ASP.? 8.49 C6 PGE A 147 41 HIS A 85 HIS.? 6.69 C5 PGE A 147 224 GLN A 73 GLN.? 7.73 O4 PGE A 147 coo -3.80 50.71 49.48 -5.59 51.85 49.27 -23.17 58.67 3.55 -22.34 59.17 1.69 coo -6.45 47.32 41.99 -8.32 46.87 42.83 -23.05 64.43 -0.55 -21.68 63.00 -1.25 coo -12.35 49.13 49.89 -13.38 48.89 48.03 -32.06 58.76 3.71 -33.62 57.58 2.74 ULMN 3 1gim_c00 ADENYLOSUCCINATE SYNTHETASE user 4 3 # 4 13 ASP B 83 ASP.? 9.40 O3 GOL C 149 41 HIS B 85 HIS.? 6.66 C6 PGE B 147 224 GLN B 82 GLN.? 6.18 C4 PGE B 147 coo -3.80 50.71 49.48 -5.59 51.85 49.27 13.62 86.10 55.23 12.83 84.59 56.49 coo -6.45 47.32 41.99 -8.32 46.87 42.83 11.11 88.86 48.90 12.76 88.34 47.73 coo -12.35 49.13 49.89 -13.38 48.89 48.03 10.55 92.05 57.61 8.91 92.76 56.34 ULMN 3 1gim_c00 ADENYLOSUCCINATE SYNTHETASE user 5 3 # 5 13 ASP B 87 ASP.? 8.94 O4 PGE B 147 41 HIS B 85 HIS.? 6.66 C6 PGE B 147 224 GLN B 73 GLN.? 3.84 NZ MLZ C 129 coo -3.80 50.71 49.48 -5.59 51.85 49.27 9.49 87.97 42.02 11.31 87.98 43.09 coo -6.45 47.32 41.99 -8.32 46.87 42.83 11.11 88.86 48.90 12.76 88.34 47.73 coo -12.35 49.13 49.89 -13.38 48.89 48.03 4.86 95.50 42.11 5.28 97.49 41.31 ULMN 3 1gim_c00 ADENYLOSUCCINATE SYNTHETASE user 6 3 # 6 13 ASP C 83 ASP.? 8.65 O3 GOL B 149 41 HIS B 4 HIS.? -3.86 O2 GOL B 149s 224 GLN C 82 GLN.? 6.72 C3 PGE C 147 coo -3.80 50.71 49.48 -5.59 51.85 49.27 3.02 71.86 58.06 4.88 72.49 57.24 coo -6.45 47.32 41.99 -8.32 46.87 42.83 8.07 73.88 49.16 8.30 73.43 51.19 coo -12.35 49.13 49.89 -13.38 48.89 48.03 1.33 68.31 52.03 0.02 69.55 50.77 ULMN 3 1gim_c00 ADENYLOSUCCINATE SYNTHETASE user 7 3 # 7 13 ASP C 83 ASP.? 8.65 O3 GOL B 149 41 HIS C 85 HIS.? 6.34 C1 PGE C 147 224 GLN C 82 GLN.? 6.72 C3 PGE C 147 coo -3.80 50.71 49.48 -5.59 51.85 49.27 3.02 71.86 58.06 4.88 72.49 57.24 coo -6.45 47.32 41.99 -8.32 46.87 42.83 -4.08 74.18 57.17 -4.69 74.12 59.17 coo -12.35 49.13 49.89 -13.38 48.89 48.03 1.33 68.31 52.03 0.02 69.55 50.77 ULMN 3 1gim_c00 ADENYLOSUCCINATE SYNTHETASE user 8 3 # 8 13 ASP C 87 ASP.? 8.84 O1 PGE C 147 41 HIS C 85 HIS.? 6.34 C1 PGE C 147 224 GLN C 73 GLN.? 8.43 O1 PGE C 147 coo -3.80 50.71 49.48 -5.59 51.85 49.27 -9.03 79.00 58.44 -8.21 77.39 59.55 coo -6.45 47.32 41.99 -8.32 46.87 42.83 -4.08 74.18 57.17 -4.69 74.12 59.17 coo -12.35 49.13 49.89 -13.38 48.89 48.03 -13.34 76.53 51.01 -15.17 75.42 50.67 ULMN 3 1gim_c00 ADENYLOSUCCINATE SYNTHETASE user 9 3 # 9 13 ASP D 83 ASP.? 8.76 O1 GOL A 150 41 HIS A 4 HIS.? -3.92 C2 GOL A 150s 224 GLN D 82 GLN.? 6.38 C25 1PE B 150 coo -3.80 50.71 49.48 -5.59 51.85 49.27 -12.54 78.43 10.94 -12.46 77.06 9.29 coo -6.45 47.32 41.99 -8.32 46.87 42.83 -11.85 68.18 8.83 -11.23 70.10 8.29 coo -12.35 49.13 49.89 -13.38 48.89 48.03 -10.30 73.84 16.04 -11.87 72.70 17.06 ULMN 3 1gim_c00 ADENYLOSUCCINATE SYNTHETASE user 10 3 # 10 13 ASP D 83 ASP.? 8.76 O1 GOL A 150 41 HIS D 85 HIS.? 4.73 OH7 1PE B 150 224 GLN D 82 GLN.? 6.38 C25 1PE B 150 coo -3.80 50.71 49.48 -5.59 51.85 49.27 -12.54 78.43 10.94 -12.46 77.06 9.29 coo -6.45 47.32 41.99 -8.32 46.87 42.83 -18.08 79.12 16.04 -18.14 81.21 15.79 coo -12.35 49.13 49.89 -13.38 48.89 48.03 -10.30 73.84 16.04 -11.87 72.70 17.06 ULMN 3 1gim_c00 ADENYLOSUCCINATE SYNTHETASE user 11 3 # 11 13 ASP D 87 ASP.? 7.26 C16 1PE B 150 41 HIS D 85 HIS.? 4.73 OH7 1PE B 150 224 GLN D 73 GLN.? 4.19 NZ MLZ A 129 coo -3.80 50.71 49.48 -5.59 51.85 49.27 -24.70 80.89 17.41 -22.90 81.94 17.31 coo -6.45 47.32 41.99 -8.32 46.87 42.83 -18.08 79.12 16.04 -18.14 81.21 15.79 coo -12.35 49.13 49.89 -13.38 48.89 48.03 -24.70 75.63 24.63 -24.59 75.97 26.79 1gim_c00 source 1gim ADENYLOSUCCINATE SYNTHETASE : 11 hits 1gim_c00 naa= 3 ULMN 3 1grc_c03 GLYCINAMIDE RIBONUCLEOTIDE TRANSFORMuser 1 3 # 1 B 106 ASN A 28 ASN^? 3.50 CL CL A 145s B 108 HIS A 88 HIS^? 4.20 CH2 MLY D 135 B 144 ASP A 122 ASP^? 7.46 C1 GOL A 150 coo 36.64 101.02 13.15 38.55 101.84 12.78 -22.13 61.51 13.69 -20.95 60.87 15.35 coo 41.00 107.18 12.86 42.70 107.82 11.96 -23.95 56.87 7.77 -24.14 54.98 6.86 coo 31.60 110.69 6.14 29.69 109.74 5.94 -15.41 64.92 4.51 -15.09 66.83 5.33 ULMN 3 1grc_c03 GLYCINAMIDE RIBONUCLEOTIDE TRANSFORMuser 2 3 # 2 B 106 ASN B 28 ASN^? 3.43 CL CL B 143s B 108 HIS B 88 HIS^? 4.29 CH1 MLY C 135 B 144 ASP B 122 ASP^? 7.33 O2 GOL B 149 coo 36.64 101.02 13.15 38.55 101.84 12.78 0.96 81.77 41.38 0.26 80.18 40.18 coo 41.00 107.18 12.86 42.70 107.82 11.96 6.15 87.00 38.94 7.35 87.96 37.51 coo 31.60 110.69 6.14 29.69 109.74 5.94 10.89 79.68 47.57 9.75 78.80 49.16 ULMN 3 1grc_c03 GLYCINAMIDE RIBONUCLEOTIDE TRANSFORMuser 3 3 # 3 B 106 ASN C 28 ASN^? 3.42 CL CL C 144s B 108 HIS C 88 HIS^? 3.86 CD MLY B 135 B 144 ASP C 122 ASP^? 7.22 C3 GOL C 149 coo 36.64 101.02 13.15 38.55 101.84 12.78 -6.06 88.35 54.50 -6.05 90.38 55.16 coo 41.00 107.18 12.86 42.70 107.82 11.96 -11.00 83.03 57.18 -12.69 82.43 58.26 coo 31.60 110.69 6.14 29.69 109.74 5.94 0.27 81.12 61.60 2.07 81.54 60.53 ULMN 3 1grc_c03 GLYCINAMIDE RIBONUCLEOTIDE TRANSFORMuser 4 3 # 4 B 106 ASN D 28 ASN^? 3.51 CL CL D 143s B 108 HIS D 88 HIS^? 4.38 CH1 MLY A 135 B 144 ASP D 122 ASP^? 7.49 C3 GOL D 147 coo 36.64 101.02 13.15 38.55 101.84 12.78 -31.24 74.87 11.89 -33.01 75.13 10.75 coo 41.00 107.18 12.86 42.70 107.82 11.96 -29.18 79.71 17.63 -29.43 81.25 19.03 coo 31.60 110.69 6.14 29.69 109.74 5.94 -21.82 80.90 7.85 -21.38 79.32 6.51 1grc_c03 source 1grc GLYCINAMIDE RIBONUCLEOTIDE TRANSFORMYLASE (E.C: 4 hits 1grc_c03 naa= 3 ULMN 3 1gsa_c00 GLUTATHIONE SYNTHETASE user 1 3 # 1 160 LYS A 114 LYS~? 11.27 C9 2PE A 148 210 ARG A 16 ARG~? -2.82 O4 SO4 A 143s 225 ARG A 105 ARG~? -3.04 O2 SO4 A 143s coo 17.51 28.50 73.42 17.24 23.02 75.86 -9.49 51.50 12.13 -4.59 48.44 14.69 coo 24.74 11.56 73.05 25.29 14.32 71.80 -9.29 63.37 28.06 -8.90 62.24 30.90 coo 27.81 15.44 77.10 25.66 16.50 75.19 -8.78 56.32 28.12 -7.90 58.53 30.04 ULMN 3 1gsa_c00 GLUTATHIONE SYNTHETASE user 2 3 # 2 160 LYS B 114 LYS~? 11.34 O7 PE8 B 148 210 ARG B 16 ARG~? -3.64 O1 SO4 A 143s 225 ARG B 105 ARG~? -3.01 O4 SO4 A 143s coo 17.51 28.50 73.42 17.24 23.02 75.86 11.35 73.22 32.47 12.65 68.43 28.61 coo 24.74 11.56 73.05 25.29 14.32 71.80 -4.85 63.18 38.40 -7.23 62.95 36.44 coo 27.81 15.44 77.10 25.66 16.50 75.19 -2.68 64.28 31.62 -4.52 62.28 32.99 ULMN 3 1gsa_c00 GLUTATHIONE SYNTHETASE user 3 3 # 3 160 LYS C 132 LYS.? 10.46 CE MLZ C 129 210 ARG C 127 ARG^? 7.44 N MLZ C 129 225 ARG C 20 ARG.? 4.54 CB MLZ C 129 coo 17.51 28.50 73.42 17.24 23.02 75.86 -3.83 95.01 34.81 -4.64 100.66 32.21 coo 24.74 11.56 73.05 25.29 14.32 71.80 1.53 98.09 50.88 2.14 101.05 50.40 coo 27.81 15.44 77.10 25.66 16.50 75.19 2.03 103.13 46.63 -0.64 101.63 46.15 ULMN 3 1gsa_c00 GLUTATHIONE SYNTHETASE user 4 3 # 4 160 LYS D 114 LYS~? 10.81 C9 2PE D 146 210 ARG D 16 ARG~? -9.70 O1 2PE D 146s 225 ARG D 105 ARG~? -8.15 O1 2PE D 146s coo 17.51 28.50 73.42 17.24 23.02 75.86 -35.88 89.56 6.78 -39.69 93.33 3.49 coo 24.74 11.56 73.05 25.29 14.32 71.80 -42.18 74.28 -4.52 -45.10 73.30 -4.28 coo 27.81 15.44 77.10 25.66 16.50 75.19 -46.14 79.22 -1.30 -46.45 77.32 -3.67 ULMN 3 1gsa_c00 GLUTATHIONE SYNTHETASE user 5 3 # 5 160 LYS D 132 LYS.? -3.69 O4 PEG D 145s 210 ARG D 127 ARG^? 9.31 O3 PGE A 147 225 ARG D 20 ARG.? 10.31 C3 PEG D 145 coo 17.51 28.50 73.42 17.24 23.02 75.86 -35.99 54.44 13.45 -42.83 52.94 13.30 coo 24.74 11.56 73.05 25.29 14.32 71.80 -35.94 67.72 2.28 -38.25 66.55 0.66 coo 27.81 15.44 77.10 25.66 16.50 75.19 -40.03 62.67 1.01 -40.08 63.13 4.08 1gsa_c00 source 1gsa GLUTATHIONE SYNTHETASE : 5 hits 1gsa_c00 naa= 3 ULMN 3 1gtx_c00 4-AMINOBUTYRATE AMINOTRANSFERASE user 1 3 # 1 A 189 PHE B 15 PHE~? 8.85 C11 PE8 B 148 A 298 ASP B 19 ASP.? -3.77 O3 SO4 A 144s A 329 LYS B 129 LYS^? 7.64 C2 PEG B 146 coo 6.56 -4.17 18.88 9.26 -4.62 19.48 -4.97 69.26 41.83 -5.66 71.31 40.07 coo 2.59 0.29 25.55 4.65 0.18 25.07 -12.63 65.75 40.21 -14.11 64.30 40.60 coo 12.42 6.10 23.27 9.95 1.57 20.16 -12.78 77.45 45.34 -17.39 74.89 47.84 ULMN 3 1gtx_c00 4-AMINOBUTYRATE AMINOTRANSFERASE user 2 3 # 2 A 189 PHE D 15 PHE~? 8.99 C14 2PE D 146 A 298 ASP D 19 ASP.? -13.24 C2 PGE A 147s A 329 LYS D 129 LYS^? 7.63 C4 PEG D 145 coo 6.56 -4.17 18.88 9.26 -4.62 19.48 -37.50 71.61 -0.03 -38.77 71.49 2.45 coo 2.59 0.29 25.55 4.65 0.18 25.07 -43.72 66.33 -2.80 -44.54 65.10 -4.29 coo 12.42 6.10 23.27 9.95 1.57 20.16 -36.12 61.83 6.50 -39.41 57.83 4.09 1gtx_c00 source 1gtx 4-AMINOBUTYRATE AMINOTRANSFERASE : 2 hits 1gtx_c00 naa= 3 ULMN 3 1gtx_c01 4-AMINOBUTYRATE AMINOTRANSFERASE user 1 3 # 1 B 189 PHE B 15 PHE~? 8.85 C11 PE8 B 148 B 298 ASP B 19 ASP.? -3.77 O3 SO4 A 144s B 329 LYS B 129 LYS^? 7.64 C2 PEG B 146 coo 20.14 -12.51 41.29 18.81 -10.14 40.57 -4.97 69.26 41.83 -5.66 71.31 40.07 coo 25.22 -15.42 34.53 24.48 -13.46 34.89 -12.63 65.75 40.21 -14.11 64.30 40.60 coo 27.68 -4.10 35.68 24.39 -7.59 39.32 -12.78 77.45 45.34 -17.39 74.89 47.84 ULMN 3 1gtx_c01 4-AMINOBUTYRATE AMINOTRANSFERASE user 2 3 # 2 B 189 PHE D 15 PHE~? 8.99 C14 2PE D 146 B 298 ASP D 19 ASP.? -13.24 C2 PGE A 147s B 329 LYS D 129 LYS^? 7.63 C4 PEG D 145 coo 20.14 -12.51 41.29 18.81 -10.14 40.57 -37.50 71.61 -0.03 -38.77 71.49 2.45 coo 25.22 -15.42 34.53 24.48 -13.46 34.89 -43.72 66.33 -2.80 -44.54 65.10 -4.29 coo 27.68 -4.10 35.68 24.39 -7.59 39.32 -36.12 61.83 6.50 -39.41 57.83 4.09 1gtx_c01 source 1gtx 4-AMINOBUTYRATE AMINOTRANSFERASE : 2 hits 1gtx_c01 naa= 3 ULMN 3 1gtx_c02 4-AMINOBUTYRATE AMINOTRANSFERASE user 1 3 # 1 C 189 PHE B 15 PHE~? 8.85 C11 PE8 B 148 C 298 ASP B 19 ASP.? -3.77 O3 SO4 A 144s C 329 LYS B 129 LYS^? 7.64 C2 PEG B 146 coo 17.41 60.57 64.39 18.40 58.12 65.34 -4.97 69.26 41.83 -5.66 71.31 40.07 coo 24.10 66.43 63.33 24.18 64.30 63.40 -12.63 65.75 40.21 -14.11 64.30 40.60 coo 27.64 56.61 58.17 22.18 57.92 60.36 -12.78 77.45 45.34 -17.39 74.89 47.84 ULMN 3 1gtx_c02 4-AMINOBUTYRATE AMINOTRANSFERASE user 2 3 # 2 C 189 PHE D 15 PHE~? 8.99 C14 2PE D 146 C 298 ASP D 19 ASP.? -13.24 C2 PGE A 147s C 329 LYS D 129 LYS^? 7.63 C4 PEG D 145 coo 17.41 60.57 64.39 18.40 58.12 65.34 -37.50 71.61 -0.03 -38.77 71.49 2.45 coo 24.10 66.43 63.33 24.18 64.30 63.40 -43.72 66.33 -2.80 -44.54 65.10 -4.29 coo 27.64 56.61 58.17 22.18 57.92 60.36 -36.12 61.83 6.50 -39.41 57.83 4.09 1gtx_c02 source 1gtx 4-AMINOBUTYRATE AMINOTRANSFERASE : 2 hits 1gtx_c02 naa= 3 ULMN 3 1gtx_c03 4-AMINOBUTYRATE AMINOTRANSFERASE user 1 3 # 1 D 189 PHE B 15 PHE~? 8.85 C11 PE8 B 148 D 298 ASP B 19 ASP.? -3.77 O3 SO4 A 144s D 329 LYS B 129 LYS^? 7.64 C2 PEG B 146 coo 35.44 53.35 83.81 35.65 54.53 81.28 -4.97 69.26 41.83 -5.66 71.31 40.07 coo 29.72 46.46 83.60 30.79 47.36 81.99 -12.63 65.75 40.21 -14.11 64.30 40.60 coo 36.89 44.91 74.55 37.33 48.94 79.01 -12.78 77.45 45.34 -17.39 74.89 47.84 ULMN 3 1gtx_c03 4-AMINOBUTYRATE AMINOTRANSFERASE user 2 3 # 2 D 189 PHE D 15 PHE~? 8.99 C14 2PE D 146 D 298 ASP D 19 ASP.? -13.24 C2 PGE A 147s D 329 LYS D 129 LYS^? 7.63 C4 PEG D 145 coo 35.44 53.35 83.81 35.65 54.53 81.28 -37.50 71.61 -0.03 -38.77 71.49 2.45 coo 29.72 46.46 83.60 30.79 47.36 81.99 -43.72 66.33 -2.80 -44.54 65.10 -4.29 coo 36.89 44.91 74.55 37.33 48.94 79.01 -36.12 61.83 6.50 -39.41 57.83 4.09 1gtx_c03 source 1gtx 4-AMINOBUTYRATE AMINOTRANSFERASE : 2 hits 1gtx_c03 naa= 3 ULMN 3 1h19_c00 LEUKOTRIENE A-4 HYDROLASE user 1 3 # 1 A 271 GLN A 14 GLN~? 4.09 C14 1PE B 150 A 296 GLU A 10 GLU~? 8.70 C6 2PE A 148 A 383 TYR B 109 TYR~? -5.65 O13 PE8 B 148s coo 38.07 -1.37 3.28 36.21 -0.34 2.92 -9.40 72.50 23.82 -9.67 73.73 22.10 coo 40.93 4.45 2.36 38.91 3.75 2.26 -3.10 70.57 20.07 -2.45 69.30 18.38 coo 30.54 7.22 6.23 31.38 5.79 3.97 2.41 73.03 30.76 2.68 74.03 33.35 ULMN 3 1h19_c00 LEUKOTRIENE A-4 HYDROLASE user 2 3 # 2 A 271 GLN A 14 GLN~? 4.09 C14 1PE B 150 A 296 GLU B 102 GLU~? 6.18 O4 SO4 A 143 A 383 TYR B 94 TYR^? -5.06 CL CL B 143s coo 38.07 -1.37 3.28 36.21 -0.34 2.92 -9.40 72.50 23.82 -9.67 73.73 22.10 coo 40.93 4.45 2.36 38.91 3.75 2.26 -7.10 67.86 29.77 -6.34 66.05 29.12 coo 30.54 7.22 6.23 31.38 5.79 3.97 -6.97 76.65 35.26 -4.34 77.53 35.11 ULMN 3 1h19_c00 LEUKOTRIENE A-4 HYDROLASE user 3 3 # 3 A 271 GLN A 14 GLN~? 4.09 C14 1PE B 150 A 296 GLU B 102 GLU~? 6.18 O4 SO4 A 143 A 383 TYR B 109 TYR~? -5.65 O13 PE8 B 148s coo 38.07 -1.37 3.28 36.21 -0.34 2.92 -9.40 72.50 23.82 -9.67 73.73 22.10 coo 40.93 4.45 2.36 38.91 3.75 2.26 -7.10 67.86 29.77 -6.34 66.05 29.12 coo 30.54 7.22 6.23 31.38 5.79 3.97 2.41 73.03 30.76 2.68 74.03 33.35 1h19_c00 source 1h19 LEUKOTRIENE A-4 HYDROLASE : 3 hits 1h19_c00 naa= 3 ULMN 3 1hto_c00 GLUTAMINE SYNTHETASE user 1 3 # 1 A 50 ASP A 6 ASP.? -3.91 C9 2PE A 148s A 327 GLU B 84 GLU.? 10.31 O3 GOL C 149 A 339 ARG B 31 ARG^? 11.02 C6 PGE B 147 coo 85.81 57.99 116.01 86.03 55.86 115.89 -8.66 61.41 13.34 -8.76 59.35 12.80 coo 75.11 41.01 160.30 76.65 40.06 161.41 7.66 84.31 53.13 6.13 83.49 54.35 coo 82.23 40.35 159.87 85.09 40.67 161.01 12.15 83.61 47.77 10.36 84.10 50.21 ULMN 3 1hto_c00 GLUTAMINE SYNTHETASE user 2 3 # 2 A 50 ASP A 106 ASP~? 11.93 O22 2PE A 148 A 327 GLU B 84 GLU.? 10.31 O3 GOL C 149 A 339 ARG B 31 ARG^? 11.02 C6 PGE B 147 coo 85.81 57.99 116.01 86.03 55.86 115.89 -12.71 50.36 24.83 -13.06 48.30 25.05 coo 75.11 41.01 160.30 76.65 40.06 161.41 7.66 84.31 53.13 6.13 83.49 54.35 coo 82.23 40.35 159.87 85.09 40.67 161.01 12.15 83.61 47.77 10.36 84.10 50.21 ULMN 3 1hto_c00 GLUTAMINE SYNTHETASE user 3 3 # 3 A 50 ASP A 106 ASP~? 11.93 O22 2PE A 148 A 327 GLU B 84 GLU.? 10.31 O3 GOL C 149 A 339 ARG C 124 ARG^? 7.92 C3 GOL C 149 coo 85.81 57.99 116.01 86.03 55.86 115.89 -12.71 50.36 24.83 -13.06 48.30 25.05 coo 75.11 41.01 160.30 76.65 40.06 161.41 7.66 84.31 53.13 6.13 83.49 54.35 coo 82.23 40.35 159.87 85.09 40.67 161.01 2.87 85.20 55.95 3.74 82.90 57.81 ULMN 3 1hto_c00 GLUTAMINE SYNTHETASE user 4 3 # 4 A 50 ASP B 6 ASP.? -3.99 C6 PE8 B 148s A 327 GLU A 84 GLU.? 10.45 C3 GOL D 147 A 339 ARG A 31 ARG^? 11.10 C1 GOL A 150 coo 85.81 57.99 116.01 86.03 55.86 115.89 7.95 70.39 41.39 8.88 71.08 39.61 coo 75.11 41.01 160.30 76.65 40.06 161.41 -21.01 70.22 3.12 -21.10 71.95 4.30 coo 82.23 40.35 159.87 85.09 40.67 161.01 -18.51 63.86 1.13 -18.37 66.66 2.58 ULMN 3 1hto_c00 GLUTAMINE SYNTHETASE user 5 3 # 5 A 50 ASP B 6 ASP.? -3.99 C6 PE8 B 148s A 327 GLU A 84 GLU.? 10.45 C3 GOL D 147 A 339 ARG D 124 ARG^? 7.97 C3 GOL D 147 coo 85.81 57.99 116.01 86.03 55.86 115.89 7.95 70.39 41.39 8.88 71.08 39.61 coo 75.11 41.01 160.30 76.65 40.06 161.41 -21.01 70.22 3.12 -21.10 71.95 4.30 coo 82.23 40.35 159.87 85.09 40.67 161.01 -24.04 74.20 5.58 -21.67 76.16 5.44 ULMN 3 1hto_c00 GLUTAMINE SYNTHETASE user 6 3 # 6 A 50 ASP B 6 ASP.? -3.99 C6 PE8 B 148s A 327 GLU A 121 GLU^? 12.41 C1 GOL A 150 A 339 ARG A 33 ARG.? 10.19 C3 GOL A 150 coo 85.81 57.99 116.01 86.03 55.86 115.89 7.95 70.39 41.39 8.88 71.08 39.61 coo 75.11 41.01 160.30 76.65 40.06 161.41 -13.98 61.53 0.93 -15.14 61.60 -0.79 coo 82.23 40.35 159.87 85.09 40.67 161.01 -11.76 56.72 1.51 -9.97 59.19 1.86 ULMN 3 1hto_c00 GLUTAMINE SYNTHETASE user 7 3 # 7 A 50 ASP B 40 ASP.? 11.67 O1 PEG B 144 A 327 GLU A 121 GLU^? 12.41 C1 GOL A 150 A 339 ARG A 33 ARG.? 10.19 C3 GOL A 150 coo 85.81 57.99 116.01 86.03 55.86 115.89 22.51 72.75 29.32 21.02 74.20 28.79 coo 75.11 41.01 160.30 76.65 40.06 161.41 -13.98 61.53 0.93 -15.14 61.60 -0.79 coo 82.23 40.35 159.87 85.09 40.67 161.01 -11.76 56.72 1.51 -9.97 59.19 1.86 ULMN 3 1hto_c00 GLUTAMINE SYNTHETASE user 8 3 # 8 A 50 ASP B 83 ASP.? 9.40 O3 GOL C 149 A 327 GLU A 102 GLU~? 6.28 O2 SO4 A 143 A 339 ARG A 105 ARG~? -3.04 O2 SO4 A 143s coo 85.81 57.99 116.01 86.03 55.86 115.89 13.62 86.10 55.23 12.83 84.59 56.49 coo 75.11 41.01 160.30 76.65 40.06 161.41 -14.00 55.24 30.65 -12.08 54.69 31.20 coo 82.23 40.35 159.87 85.09 40.67 161.01 -8.78 56.32 28.12 -7.90 58.53 30.04 ULMN 3 1hto_c00 GLUTAMINE SYNTHETASE user 9 3 # 9 A 50 ASP B 122 ASP^? 7.33 O2 GOL B 149 A 327 GLU D 84 GLU.? 10.79 C1 GOL A 150 A 339 ARG A 124 ARG^? 8.18 C1 GOL A 150 coo 85.81 57.99 116.01 86.03 55.86 115.89 10.89 79.68 47.57 9.75 78.80 49.16 coo 75.11 41.01 160.30 76.65 40.06 161.41 -17.40 74.78 10.23 -17.69 72.96 9.24 coo 82.23 40.35 159.87 85.09 40.67 161.01 -17.35 69.10 10.18 -16.14 69.37 7.36 ULMN 3 1hto_c00 GLUTAMINE SYNTHETASE user 10 3 # 10 A 50 ASP B 122 ASP^? 7.33 O2 GOL B 149 A 327 GLU D 84 GLU.? 10.79 C1 GOL A 150 A 339 ARG D 31 ARG^? 10.57 OH7 1PE B 150 coo 85.81 57.99 116.01 86.03 55.86 115.89 10.89 79.68 47.57 9.75 78.80 49.16 coo 75.11 41.01 160.30 76.65 40.06 161.41 -17.40 74.78 10.23 -17.69 72.96 9.24 coo 82.23 40.35 159.87 85.09 40.67 161.01 -19.64 81.34 12.02 -19.24 78.87 10.07 ULMN 3 1hto_c00 GLUTAMINE SYNTHETASE user 11 3 # 11 A 50 ASP C 6 ASP.? -4.04 C8 PE8 C 148s A 327 GLU D 75 GLU.? -3.59 CB MLZ A 129s A 339 ARG A 20 ARG.? 4.64 CB MLZ A 129 coo 85.81 57.99 116.01 86.03 55.86 115.89 0.53 91.96 65.64 -1.31 91.68 66.68 coo 75.11 41.01 160.30 76.65 40.06 161.41 -21.02 72.19 24.99 -21.34 70.79 26.58 coo 82.23 40.35 159.87 85.09 40.67 161.01 -20.19 69.79 30.19 -22.38 67.97 29.03 ULMN 3 1hto_c00 GLUTAMINE SYNTHETASE user 12 3 # 12 A 50 ASP C 19 ASP.? 9.43 O3 SO4 C 143 A 327 GLU D 75 GLU.? -3.59 CB MLZ A 129s A 339 ARG A 20 ARG.? 4.64 CB MLZ A 129 coo 85.81 57.99 116.01 86.03 55.86 115.89 2.21 107.45 51.42 3.36 109.08 50.82 coo 75.11 41.01 160.30 76.65 40.06 161.41 -21.02 72.19 24.99 -21.34 70.79 26.58 coo 82.23 40.35 159.87 85.09 40.67 161.01 -20.19 69.79 30.19 -22.38 67.97 29.03 ULMN 3 1hto_c00 GLUTAMINE SYNTHETASE user 13 3 # 13 A 50 ASP C 87 ASP.? 8.84 O1 PGE C 147 A 327 GLU D 84 GLU.? 10.79 C1 GOL A 150 A 339 ARG D 31 ARG^? 10.57 OH7 1PE B 150 coo 85.81 57.99 116.01 86.03 55.86 115.89 -9.03 79.00 58.44 -8.21 77.39 59.55 coo 75.11 41.01 160.30 76.65 40.06 161.41 -17.40 74.78 10.23 -17.69 72.96 9.24 coo 82.23 40.35 159.87 85.09 40.67 161.01 -19.64 81.34 12.02 -19.24 78.87 10.07 ULMN 3 1hto_c00 GLUTAMINE SYNTHETASE user 14 3 # 14 A 50 ASP C 106 ASP~? 12.11 C21 PE8 C 148 A 327 GLU A 21 GLU.? -3.95 C2 PEG A 146s A 339 ARG A 20 ARG.? 4.64 CB MLZ A 129 coo 85.81 57.99 116.01 86.03 55.86 115.89 -11.06 103.55 63.77 -13.00 104.00 64.35 coo 75.11 41.01 160.30 76.65 40.06 161.41 -23.01 65.38 36.24 -23.03 64.85 38.31 coo 82.23 40.35 159.87 85.09 40.67 161.01 -20.19 69.79 30.19 -22.38 67.97 29.03 ULMN 3 1hto_c00 GLUTAMINE SYNTHETASE user 15 3 # 15 A 50 ASP D 6 ASP.? -3.77 C8 2PE D 146s A 327 GLU B 111 GLU~? 12.54 O7 PE8 B 148 A 339 ARG B 110 ARG~? 10.12 O7 PE8 B 148 coo 85.81 57.99 116.01 86.03 55.86 115.89 -31.03 82.87 1.04 -31.83 84.41 2.29 coo 75.11 41.01 160.30 76.65 40.06 161.41 9.41 70.70 25.55 11.25 69.94 26.27 coo 82.23 40.35 159.87 85.09 40.67 161.01 4.56 66.25 30.54 5.81 64.43 28.32 ULMN 3 1hto_c00 GLUTAMINE SYNTHETASE user 16 3 # 16 A 50 ASP D 19 ASP.? -13.24 C2 PGE A 147s A 327 GLU B 62 GLU~? 5.14 OH2 1PE B 150 A 339 ARG B 63 ARG~? -8.01 OH2 1PE B 150s coo 85.81 57.99 116.01 86.03 55.86 115.89 -43.72 66.33 -2.80 -44.54 65.10 -4.29 coo 75.11 41.01 160.30 76.65 40.06 161.41 -5.99 81.74 25.38 -5.29 83.68 24.76 coo 82.23 40.35 159.87 85.09 40.67 161.01 -5.18 74.17 22.68 -2.11 73.83 22.90 ULMN 3 1hto_c00 GLUTAMINE SYNTHETASE user 17 3 # 17 A 50 ASP D 19 ASP.? -13.24 C2 PGE A 147s A 327 GLU B 102 GLU~? 6.18 O4 SO4 A 143 A 339 ARG A 16 ARG~? -2.82 O4 SO4 A 143s coo 85.81 57.99 116.01 86.03 55.86 115.89 -43.72 66.33 -2.80 -44.54 65.10 -4.29 coo 75.11 41.01 160.30 76.65 40.06 161.41 -7.10 67.86 29.77 -6.34 66.05 29.12 coo 82.23 40.35 159.87 85.09 40.67 161.01 -9.29 63.37 28.06 -8.90 62.24 30.90 ULMN 3 1hto_c00 GLUTAMINE SYNTHETASE user 18 3 # 18 A 50 ASP D 40 ASP.? 18.38 C9 2PE D 146 A 327 GLU B 102 GLU~? 6.18 O4 SO4 A 143 A 339 ARG A 16 ARG~? -2.82 O4 SO4 A 143s coo 85.81 57.99 116.01 86.03 55.86 115.89 -32.95 100.50 7.54 -33.10 99.69 9.54 coo 75.11 41.01 160.30 76.65 40.06 161.41 -7.10 67.86 29.77 -6.34 66.05 29.12 coo 82.23 40.35 159.87 85.09 40.67 161.01 -9.29 63.37 28.06 -8.90 62.24 30.90 ULMN 3 1hto_c00 GLUTAMINE SYNTHETASE user 19 3 # 19 A 50 ASP D 83 ASP.? 8.76 O1 GOL A 150 A 327 GLU B 84 GLU.? 10.31 O3 GOL C 149 A 339 ARG C 124 ARG^? 7.92 C3 GOL C 149 coo 85.81 57.99 116.01 86.03 55.86 115.89 -12.54 78.43 10.94 -12.46 77.06 9.29 coo 75.11 41.01 160.30 76.65 40.06 161.41 7.66 84.31 53.13 6.13 83.49 54.35 coo 82.23 40.35 159.87 85.09 40.67 161.01 2.87 85.20 55.95 3.74 82.90 57.81 ULMN 3 1hto_c00 GLUTAMINE SYNTHETASE user 20 3 # 20 A 50 ASP D 87 ASP.? 7.26 C16 1PE B 150 A 327 GLU B 84 GLU.? 10.31 O3 GOL C 149 A 339 ARG B 31 ARG^? 11.02 C6 PGE B 147 coo 85.81 57.99 116.01 86.03 55.86 115.89 -24.70 80.89 17.41 -22.90 81.94 17.31 coo 75.11 41.01 160.30 76.65 40.06 161.41 7.66 84.31 53.13 6.13 83.49 54.35 coo 82.23 40.35 159.87 85.09 40.67 161.01 12.15 83.61 47.77 10.36 84.10 50.21 ULMN 3 1hto_c00 GLUTAMINE SYNTHETASE user 21 3 # 21 A 50 ASP D 87 ASP.? 7.26 C16 1PE B 150 A 327 GLU B 84 GLU.? 10.31 O3 GOL C 149 A 339 ARG C 124 ARG^? 7.92 C3 GOL C 149 coo 85.81 57.99 116.01 86.03 55.86 115.89 -24.70 80.89 17.41 -22.90 81.94 17.31 coo 75.11 41.01 160.30 76.65 40.06 161.41 7.66 84.31 53.13 6.13 83.49 54.35 coo 82.23 40.35 159.87 85.09 40.67 161.01 2.87 85.20 55.95 3.74 82.90 57.81 ULMN 3 1hto_c00 GLUTAMINE SYNTHETASE user 22 3 # 22 A 50 ASP D 87 ASP.? 7.26 C16 1PE B 150 A 327 GLU B 121 GLU^? 8.74 O2 PEG B 144 A 339 ARG B 33 ARG.? -3.91 C3 PEG B 144s coo 85.81 57.99 116.01 86.03 55.86 115.89 -24.70 80.89 17.41 -22.90 81.94 17.31 coo 75.11 41.01 160.30 76.65 40.06 161.41 15.37 80.83 45.64 16.23 82.69 46.15 coo 82.23 40.35 159.87 85.09 40.67 161.01 17.31 79.39 40.81 17.39 77.24 43.00 ULMN 3 1hto_c00 GLUTAMINE SYNTHETASE user 23 3 # 23 A 50 ASP D 106 ASP~? 11.82 O22 2PE D 146 A 327 GLU B 102 GLU~? 6.18 O4 SO4 A 143 A 339 ARG A 16 ARG~? -2.82 O4 SO4 A 143s coo 85.81 57.99 116.01 86.03 55.86 115.89 -46.82 82.57 5.87 -48.37 83.43 7.00 coo 75.11 41.01 160.30 76.65 40.06 161.41 -7.10 67.86 29.77 -6.34 66.05 29.12 coo 82.23 40.35 159.87 85.09 40.67 161.01 -9.29 63.37 28.06 -8.90 62.24 30.90 1hto_c00 source 1hto GLUTAMINE SYNTHETASE : 23 hits 1hto_c00 naa= 3 ULMN 3 1i29_c03 CSDB user 1 3 # 1 A 128 VAL A 97 VAL~? 7.02 O1 SO4 A 144 A 200 ASP A 106 ASP~? 11.93 O22 2PE A 148 A 226 LYS A 114 LYS~? 11.27 C9 2PE A 148 coo 19.13 38.05 1.41 19.72 38.80 -0.53 -17.68 62.89 28.92 -16.58 64.71 28.66 coo 24.51 43.28 11.18 25.17 44.50 9.58 -12.71 50.36 24.83 -13.06 48.30 25.05 coo 34.47 51.09 7.19 28.58 51.18 7.53 -9.49 51.50 12.13 -4.59 48.44 14.69 ULMN 3 1i29_c03 CSDB user 2 3 # 2 A 128 VAL A 97 VAL~? 7.02 O1 SO4 A 144 A 200 ASP B 19 ASP.? -3.77 O3 SO4 A 144s A 226 LYS B 129 LYS^? 7.64 C2 PEG B 146 coo 19.13 38.05 1.41 19.72 38.80 -0.53 -17.68 62.89 28.92 -16.58 64.71 28.66 coo 24.51 43.28 11.18 25.17 44.50 9.58 -12.63 65.75 40.21 -14.11 64.30 40.60 coo 34.47 51.09 7.19 28.58 51.18 7.53 -12.78 77.45 45.34 -17.39 74.89 47.84 ULMN 3 1i29_c03 CSDB user 3 3 # 3 A 128 VAL B 97 VAL~? 6.89 O4 SO4 A 144 A 200 ASP B 106 ASP~? 11.87 OH2 1PE B 150 A 226 LYS B 114 LYS~? 11.34 O7 PE8 B 148 coo 19.13 38.05 1.41 19.72 38.80 -0.53 -9.72 70.55 37.53 -9.53 69.49 39.41 coo 24.51 43.28 11.18 25.17 44.50 9.58 -0.30 70.27 27.08 -0.10 70.78 25.05 coo 34.47 51.09 7.19 28.58 51.18 7.53 11.35 73.22 32.47 12.65 68.43 28.61 ULMN 3 1i29_c03 CSDB user 4 3 # 4 A 128 VAL D 97 VAL~? 11.58 CL CL D 143 A 200 ASP D 106 ASP~? 11.82 O22 2PE D 146 A 226 LYS D 114 LYS~? 10.81 C9 2PE D 146 coo 19.13 38.05 1.41 19.72 38.80 -0.53 -42.96 69.31 2.56 -41.72 68.82 0.85 coo 24.51 43.28 11.18 25.17 44.50 9.58 -46.82 82.57 5.87 -48.37 83.43 7.00 coo 34.47 51.09 7.19 28.58 51.18 7.53 -35.88 89.56 6.78 -39.69 93.33 3.49 1i29_c03 source 1i29 CSDB : 4 hits 1i29_c03 naa= 3 ULMN 3 1ir3_c02 INSULIN RECEPTOR user 1 3 # 1 A1132 ASP A 19 ASP.? -3.59 O4 SO4 A 144s A1134 ALA A 17 ALA~? 6.78 C24 1PE B 150 A1137 ASN A 18 ASN~? 7.05 CM MLZ A 129 coo -27.05 34.58 17.12 -25.81 32.84 17.16 -15.01 66.98 32.71 -14.52 68.02 34.44 coo -20.53 36.39 15.81 -20.80 35.01 16.40 -11.11 69.66 29.83 -10.38 70.82 29.22 coo -23.72 34.69 12.49 -24.32 32.83 13.34 -15.51 71.08 28.46 -17.41 71.81 28.97 ULMN 3 1ir3_c02 INSULIN RECEPTOR user 2 3 # 2 A1132 ASP B 19 ASP.? -3.77 O3 SO4 A 144s A1134 ALA B 17 ALA~? 7.36 O3 PGE C 147 A1137 ASN B 18 ASN~? 7.46 O3 PGE C 147 coo -27.05 34.58 17.12 -25.81 32.84 17.16 -12.63 65.75 40.21 -14.11 64.30 40.60 coo -20.53 36.39 15.81 -20.80 35.01 16.40 -9.12 63.31 43.65 -8.56 62.72 44.91 coo -23.72 34.69 12.49 -24.32 32.83 13.34 -10.56 67.47 45.50 -12.09 68.82 46.03 ULMN 3 1ir3_c02 INSULIN RECEPTOR user 3 3 # 3 A1132 ASP C 19 ASP.? 9.43 O3 SO4 C 143 A1134 ALA C 17 ALA~? 7.50 C3 PGE B 147 A1137 ASN C 18 ASN~? 7.71 C3 PGE B 147 coo -27.05 34.58 17.12 -25.81 32.84 17.16 2.21 107.45 51.42 3.36 109.08 50.82 coo -20.53 36.39 15.81 -20.80 35.01 16.40 6.53 105.45 54.27 7.86 104.83 54.53 coo -23.72 34.69 12.49 -24.32 32.83 13.34 5.53 102.64 50.54 5.25 102.39 48.47 ULMN 3 1ir3_c02 INSULIN RECEPTOR user 4 3 # 4 A1132 ASP D 19 ASP.? -13.24 C2 PGE A 147s A1134 ALA D 17 ALA~? 7.68 C2 PGE A 147 A1137 ASN D 18 ASN~? 7.72 O4 PGE A 147 coo -27.05 34.58 17.12 -25.81 32.84 17.16 -43.72 66.33 -2.80 -44.54 65.10 -4.29 coo -20.53 36.39 15.81 -20.80 35.01 16.40 -39.79 68.17 -6.28 -38.60 68.14 -7.20 coo -23.72 34.69 12.49 -24.32 32.83 13.34 -37.88 65.32 -2.95 -37.84 63.53 -1.86 1ir3_c02 source 1ir3 INSULIN RECEPTOR : 4 hits 1ir3_c02 naa= 3 ULMN 3 1itx_c00 GLYCOSYL HYDROLASE user 1 3 # 1 A 202 ASP A 122 ASP^? 7.46 C1 GOL A 150 A 204 GLU A 121 GLU^? 12.41 C1 GOL A 150 A 279 TYR A 50 TYR~? 5.51 CH2 MLY D 135 coo 5.85 5.60 30.32 5.00 7.49 29.88 -15.41 64.92 4.51 -15.09 66.83 5.33 coo 7.79 1.83 27.81 9.08 3.25 26.92 -13.98 61.53 0.93 -15.14 61.60 -0.79 coo 8.22 7.77 18.64 7.58 8.47 21.28 -19.50 53.98 8.67 -20.18 55.72 10.74 ULMN 3 1itx_c00 GLYCOSYL HYDROLASE user 2 3 # 2 A 202 ASP B 122 ASP^? 7.33 O2 GOL B 149 A 204 GLU B 121 GLU^? 8.74 O2 PEG B 144 A 279 TYR B 50 TYR~? 5.52 CH1 MLY C 135 coo 5.85 5.60 30.32 5.00 7.49 29.88 10.89 79.68 47.57 9.75 78.80 49.16 coo 7.79 1.83 27.81 9.08 3.25 26.92 15.37 80.83 45.64 16.23 82.69 46.15 coo 8.22 7.77 18.64 7.58 8.47 21.28 8.51 83.11 35.90 5.93 82.51 36.84 ULMN 3 1itx_c00 GLYCOSYL HYDROLASE user 3 3 # 3 A 202 ASP C 122 ASP^? 7.22 C3 GOL C 149 A 204 GLU C 121 GLU^? 12.40 C3 GOL C 149 A 279 TYR C 50 TYR~? 5.59 CE MLY B 135 coo 5.85 5.60 30.32 5.00 7.49 29.88 0.27 81.12 61.60 2.07 81.54 60.53 coo 7.79 1.83 27.81 9.08 3.25 26.92 -1.98 78.69 65.48 -2.54 76.71 65.06 coo 8.22 7.77 18.64 7.58 8.47 21.28 -11.27 85.65 61.91 -10.18 87.09 59.78 ULMN 3 1itx_c00 GLYCOSYL HYDROLASE user 4 3 # 4 A 202 ASP D 122 ASP^? 7.49 C3 GOL D 147 A 204 GLU D 121 GLU^? 11.70 OH7 1PE B 150 A 279 TYR D 50 TYR~? 5.61 CH1 MLY A 135 coo 5.85 5.60 30.32 5.00 7.49 29.88 -21.82 80.90 7.85 -21.38 79.32 6.51 coo 7.79 1.83 27.81 9.08 3.25 26.92 -20.91 85.61 9.48 -19.44 85.70 10.98 coo 8.22 7.77 18.64 7.58 8.47 21.28 -31.54 83.73 14.98 -32.20 81.17 14.09 1itx_c00 source 1itx GLYCOSYL HYDROLASE : 4 hits 1itx_c00 naa= 3 ULMN 3 1j53_c00 DNA POLYMERASE III, EPSILON CHAIN user 1 3 # 1 A 14 GLU A 84 GLU.? 10.45 C3 GOL D 147 A 61 GLU A 121 GLU^? 12.41 C1 GOL A 150 A 162 HIS A 85 HIS.? 6.69 C5 PGE A 147 coo -1.50 25.58 -6.20 -2.54 26.76 -4.79 -21.01 70.22 3.12 -21.10 71.95 4.30 coo -4.89 20.85 5.22 -3.95 21.69 6.91 -13.98 61.53 0.93 -15.14 61.60 -0.79 coo -7.53 27.82 -3.33 -8.58 28.59 -1.68 -23.05 64.43 -0.55 -21.68 63.00 -1.25 ULMN 3 1j53_c00 DNA POLYMERASE III, EPSILON CHAIN user 2 3 # 2 A 14 GLU A 93 GLU^? 3.90 NZ MLY A 67 A 61 GLU D 75 GLU.? -3.59 CB MLZ A 129s A 162 HIS A 25 HIS^? 6.06 C MLZ A 129 coo -1.50 25.58 -6.20 -2.54 26.76 -4.79 -27.37 60.67 25.57 -29.32 61.09 26.31 coo -4.89 20.85 5.22 -3.95 21.69 6.91 -21.02 72.19 24.99 -21.34 70.79 26.58 coo -7.53 27.82 -3.33 -8.58 28.59 -1.68 -27.47 64.89 22.81 -29.24 64.17 23.67 ULMN 3 1j53_c00 DNA POLYMERASE III, EPSILON CHAIN user 3 3 # 3 A 14 GLU B 84 GLU.? 10.31 O3 GOL C 149 A 61 GLU B 121 GLU^? 8.74 O2 PEG B 144 A 162 HIS B 85 HIS.? 6.66 C6 PGE B 147 coo -1.50 25.58 -6.20 -2.54 26.76 -4.79 7.66 84.31 53.13 6.13 83.49 54.35 coo -4.89 20.85 5.22 -3.95 21.69 6.91 15.37 80.83 45.64 16.23 82.69 46.15 coo -7.53 27.82 -3.33 -8.58 28.59 -1.68 11.11 88.86 48.90 12.76 88.34 47.73 ULMN 3 1j53_c00 DNA POLYMERASE III, EPSILON CHAIN user 4 3 # 4 A 14 GLU B 93 GLU^? 4.01 CE MLZ B 67 A 61 GLU C 75 GLU.? -8.81 O1 PGE C 147s A 162 HIS B 25 HIS^? 5.55 C6 PG4 C 145 coo -1.50 25.58 -6.20 -2.54 26.76 -4.79 -11.20 80.89 36.50 -12.93 82.08 36.76 coo -4.89 20.85 5.22 -3.95 21.69 6.91 -10.84 73.75 47.59 -11.85 73.47 45.72 coo -7.53 27.82 -3.33 -8.58 28.59 -1.68 -10.19 81.59 41.51 -11.58 82.85 40.58 ULMN 3 1j53_c00 DNA POLYMERASE III, EPSILON CHAIN user 5 3 # 5 A 14 GLU C 84 GLU.? 10.77 O2 GOL B 149 A 61 GLU C 121 GLU^? 12.40 C3 GOL C 149 A 162 HIS C 85 HIS.? 6.34 C1 PGE C 147 coo -1.50 25.58 -6.20 -2.54 26.76 -4.79 2.34 77.12 55.01 3.46 78.21 53.60 coo -4.89 20.85 5.22 -3.95 21.69 6.91 -1.98 78.69 65.48 -2.54 76.71 65.06 coo -7.53 27.82 -3.33 -8.58 28.59 -1.68 -4.08 74.18 57.17 -4.69 74.12 59.17 ULMN 3 1j53_c00 DNA POLYMERASE III, EPSILON CHAIN user 6 3 # 6 A 14 GLU C 93 GLU^? -3.82 CH2 MLY C 67s A 61 GLU B 75 GLU.? -3.56 CB MLZ C 129s A 162 HIS C 25 HIS^? 5.68 C3 PG4 C 145 coo -1.50 25.58 -6.20 -2.54 26.76 -4.79 -9.46 98.26 46.68 -9.97 98.34 44.62 coo -4.89 20.85 5.22 -3.95 21.69 6.91 3.68 97.59 46.60 2.29 99.21 46.53 coo -7.53 27.82 -3.33 -8.58 28.59 -1.68 -5.80 94.82 45.56 -7.26 95.23 44.11 ULMN 3 1j53_c00 DNA POLYMERASE III, EPSILON CHAIN user 7 3 # 7 A 14 GLU D 84 GLU.? 10.79 C1 GOL A 150 A 61 GLU D 121 GLU^? 11.70 OH7 1PE B 150 A 162 HIS D 85 HIS.? 4.73 OH7 1PE B 150 coo -1.50 25.58 -6.20 -2.54 26.76 -4.79 -17.40 74.78 10.23 -17.69 72.96 9.24 coo -4.89 20.85 5.22 -3.95 21.69 6.91 -20.91 85.61 9.48 -19.44 85.70 10.98 coo -7.53 27.82 -3.33 -8.58 28.59 -1.68 -18.08 79.12 16.04 -18.14 81.21 15.79 ULMN 3 1j53_c00 DNA POLYMERASE III, EPSILON CHAIN user 8 3 # 8 A 14 GLU D 93 GLU^? -3.68 CE MLY D 67s A 61 GLU A 75 GLU.? -8.03 O4 PGE A 147s A 162 HIS D 25 HIS^? 5.64 C8 PG4 D 144 coo -1.50 25.58 -6.20 -2.54 26.76 -4.79 -41.50 66.77 12.62 -41.92 65.02 13.75 coo -4.89 20.85 5.22 -3.95 21.69 6.91 -34.40 63.01 2.19 -36.49 63.07 2.67 coo -7.53 27.82 -3.33 -8.58 28.59 -1.68 -36.75 65.22 11.65 -37.83 64.18 13.11 1j53_c00 source 1j53 DNA POLYMERASE III, EPSILON CHAIN : 8 hits 1j53_c00 naa= 3 ULMN 3 1jqn_c01 PHOSPHOENOLPYRUVATE CARBOXYLASE user 1 3 # 1 A 396 ARG B 33 ARG.? -3.91 C3 PEG B 144s A 581 ARG B 35 ARG.? 9.50 O1 PEG B 144 A 713 ARG B 42 ARG.? 12.70 O1 PEG B 144 coo 23.87 26.44 -10.48 23.95 28.93 -12.26 17.31 79.39 40.81 17.39 77.24 43.00 coo 27.15 35.19 -13.19 28.74 37.24 -14.84 22.76 84.08 36.32 22.81 87.07 35.45 coo 23.13 28.56 -19.97 22.88 27.45 -17.11 19.61 78.53 29.44 17.94 76.42 28.00 ULMN 3 1jqn_c01 PHOSPHOENOLPYRUVATE CARBOXYLASE user 2 3 # 2 A 396 ARG B 33 ARG.? -3.91 C3 PEG B 144s A 581 ARG B 42 ARG.? 12.70 O1 PEG B 144 A 713 ARG B 35 ARG.? 9.50 O1 PEG B 144 coo 23.87 26.44 -10.48 23.95 28.93 -12.26 17.31 79.39 40.81 17.39 77.24 43.00 coo 27.15 35.19 -13.19 28.74 37.24 -14.84 19.61 78.53 29.44 17.94 76.42 28.00 coo 23.13 28.56 -19.97 22.88 27.45 -17.11 22.76 84.08 36.32 22.81 87.07 35.45 ULMN 3 1jqn_c01 PHOSPHOENOLPYRUVATE CARBOXYLASE user 3 3 # 3 A 396 ARG B 35 ARG.? 9.50 O1 PEG B 144 A 581 ARG B 33 ARG.? -3.91 C3 PEG B 144s A 713 ARG B 42 ARG.? 12.70 O1 PEG B 144 coo 23.87 26.44 -10.48 23.95 28.93 -12.26 22.76 84.08 36.32 22.81 87.07 35.45 coo 27.15 35.19 -13.19 28.74 37.24 -14.84 17.31 79.39 40.81 17.39 77.24 43.00 coo 23.13 28.56 -19.97 22.88 27.45 -17.11 19.61 78.53 29.44 17.94 76.42 28.00 ULMN 3 1jqn_c01 PHOSPHOENOLPYRUVATE CARBOXYLASE user 4 3 # 4 A 396 ARG B 35 ARG.? 9.50 O1 PEG B 144 A 581 ARG B 42 ARG.? 12.70 O1 PEG B 144 A 713 ARG B 33 ARG.? -3.91 C3 PEG B 144s coo 23.87 26.44 -10.48 23.95 28.93 -12.26 22.76 84.08 36.32 22.81 87.07 35.45 coo 27.15 35.19 -13.19 28.74 37.24 -14.84 19.61 78.53 29.44 17.94 76.42 28.00 coo 23.13 28.56 -19.97 22.88 27.45 -17.11 17.31 79.39 40.81 17.39 77.24 43.00 ULMN 3 1jqn_c01 PHOSPHOENOLPYRUVATE CARBOXYLASE user 5 3 # 5 A 396 ARG B 42 ARG.? 12.70 O1 PEG B 144 A 581 ARG B 33 ARG.? -3.91 C3 PEG B 144s A 713 ARG B 35 ARG.? 9.50 O1 PEG B 144 coo 23.87 26.44 -10.48 23.95 28.93 -12.26 19.61 78.53 29.44 17.94 76.42 28.00 coo 27.15 35.19 -13.19 28.74 37.24 -14.84 17.31 79.39 40.81 17.39 77.24 43.00 coo 23.13 28.56 -19.97 22.88 27.45 -17.11 22.76 84.08 36.32 22.81 87.07 35.45 ULMN 3 1jqn_c01 PHOSPHOENOLPYRUVATE CARBOXYLASE user 6 3 # 6 A 396 ARG B 42 ARG.? 12.70 O1 PEG B 144 A 581 ARG B 35 ARG.? 9.50 O1 PEG B 144 A 713 ARG B 33 ARG.? -3.91 C3 PEG B 144s coo 23.87 26.44 -10.48 23.95 28.93 -12.26 19.61 78.53 29.44 17.94 76.42 28.00 coo 27.15 35.19 -13.19 28.74 37.24 -14.84 22.76 84.08 36.32 22.81 87.07 35.45 coo 23.13 28.56 -19.97 22.88 27.45 -17.11 17.31 79.39 40.81 17.39 77.24 43.00 1jqn_c01 source 1jqn PHOSPHOENOLPYRUVATE CARBOXYLASE : 6 hits 1jqn_c01 naa= 3 ULMN 3 1js4_c00 ENDO-EXOCELLULASE E4 user 1 3 # 1 A 55 ASP A 19 ASP.? -3.59 O4 SO4 A 144s A 58 ASP B 19 ASP.? -3.77 O3 SO4 A 144s A 424 GLU B 21 GLU.? -4.32 C4 PEG B 146s coo 58.42 47.76 20.67 58.01 49.10 19.12 -15.01 66.98 32.71 -14.52 68.02 34.44 coo 58.59 41.80 18.81 58.94 43.89 18.94 -12.63 65.75 40.21 -14.11 64.30 40.60 coo 52.85 46.34 13.34 54.09 44.97 14.42 -19.10 71.22 37.43 -20.67 70.39 36.27 ULMN 3 1js4_c00 ENDO-EXOCELLULASE E4 user 2 3 # 2 A 55 ASP B 19 ASP.? -3.77 O3 SO4 A 144s A 58 ASP A 19 ASP.? -3.59 O4 SO4 A 144s A 424 GLU A 21 GLU.? -3.95 C2 PEG A 146s coo 58.42 47.76 20.67 58.01 49.10 19.12 -12.63 65.75 40.21 -14.11 64.30 40.60 coo 58.59 41.80 18.81 58.94 43.89 18.94 -15.01 66.98 32.71 -14.52 68.02 34.44 coo 52.85 46.34 13.34 54.09 44.97 14.42 -23.01 65.38 36.24 -23.03 64.85 38.31 ULMN 3 1js4_c00 ENDO-EXOCELLULASE E4 user 3 3 # 3 A 55 ASP B 19 ASP.? -3.77 O3 SO4 A 144s A 58 ASP A 19 ASP.? -3.59 O4 SO4 A 144s A 424 GLU B 21 GLU.? -4.32 C4 PEG B 146s coo 58.42 47.76 20.67 58.01 49.10 19.12 -12.63 65.75 40.21 -14.11 64.30 40.60 coo 58.59 41.80 18.81 58.94 43.89 18.94 -15.01 66.98 32.71 -14.52 68.02 34.44 coo 52.85 46.34 13.34 54.09 44.97 14.42 -19.10 71.22 37.43 -20.67 70.39 36.27 1js4_c00 source 1js4 ENDO-EXOCELLULASE E4 : 3 hits 1js4_c00 naa= 3 ULMN 3 1js4_c01 ENDO-EXOCELLULASE E4 user 1 3 # 1 B 55 ASP A 19 ASP.? -3.59 O4 SO4 A 144s B 58 ASP B 19 ASP.? -3.77 O3 SO4 A 144s B 424 GLU B 21 GLU.? -4.32 C4 PEG B 146s coo 112.10 61.46 19.99 111.82 60.65 18.07 -15.01 66.98 32.71 -14.52 68.02 34.44 coo 117.85 63.62 21.08 115.96 63.25 20.18 -12.63 65.75 40.21 -14.11 64.30 40.60 coo 118.47 57.23 15.57 119.32 58.77 16.73 -19.10 71.22 37.43 -20.67 70.39 36.27 ULMN 3 1js4_c01 ENDO-EXOCELLULASE E4 user 2 3 # 2 B 55 ASP B 19 ASP.? -3.77 O3 SO4 A 144s B 58 ASP A 19 ASP.? -3.59 O4 SO4 A 144s B 424 GLU B 21 GLU.? -4.32 C4 PEG B 146s coo 112.10 61.46 19.99 111.82 60.65 18.07 -12.63 65.75 40.21 -14.11 64.30 40.60 coo 117.85 63.62 21.08 115.96 63.25 20.18 -15.01 66.98 32.71 -14.52 68.02 34.44 coo 118.47 57.23 15.57 119.32 58.77 16.73 -19.10 71.22 37.43 -20.67 70.39 36.27 1js4_c01 source 1js4 ENDO-EXOCELLULASE E4 : 2 hits 1js4_c01 naa= 3 ULMN 3 1k82_c00 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 1 3 # 1 A 2 GLU B 102 GLU~? 6.18 O4 SO4 A 143 A 56 LYS A 9 LYS~? 8.68 C6 2PE A 148 A 258 ARG A 127 ARG^? 7.47 N MLZ A 129 coo 42.33 1.56 26.99 42.38 2.91 28.66 -7.10 67.86 29.77 -6.34 66.05 29.12 coo 38.45 -0.44 19.89 37.36 0.90 25.90 -4.77 65.74 20.08 0.46 67.29 18.98 coo 36.54 -1.79 35.54 37.68 -1.44 32.69 -18.44 68.25 24.06 -17.70 68.37 27.04 ULMN 3 1k82_c00 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 2 3 # 2 A 2 GLU B 102 GLU~? 6.18 O4 SO4 A 143 A 56 LYS A 9 LYS~? 8.68 C6 2PE A 148 A 258 ARG B 110 ARG~? 10.12 O7 PE8 B 148 coo 42.33 1.56 26.99 42.38 2.91 28.66 -7.10 67.86 29.77 -6.34 66.05 29.12 coo 38.45 -0.44 19.89 37.36 0.90 25.90 -4.77 65.74 20.08 0.46 67.29 18.98 coo 36.54 -1.79 35.54 37.68 -1.44 32.69 4.56 66.25 30.54 5.81 64.43 28.32 1k82_c00 source 1k82 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE : 2 hits 1k82_c00 naa= 3 ULMN 3 1k82_c01 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 1 3 # 1 B 2 GLU B 102 GLU~? 6.18 O4 SO4 A 143 B 56 LYS A 9 LYS~? 8.68 C6 2PE A 148 B 258 ARG A 127 ARG^? 7.47 N MLZ A 129 coo -2.88 -2.27 26.18 -2.94 -3.40 27.96 -7.10 67.86 29.77 -6.34 66.05 29.12 coo 1.37 -0.44 19.19 2.21 -1.48 25.26 -4.77 65.74 20.08 0.46 67.29 18.98 coo 2.64 1.83 34.81 1.56 1.13 32.02 -18.44 68.25 24.06 -17.70 68.37 27.04 ULMN 3 1k82_c01 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 2 3 # 2 B 2 GLU B 102 GLU~? 6.18 O4 SO4 A 143 B 56 LYS A 9 LYS~? 8.68 C6 2PE A 148 B 258 ARG B 110 ARG~? 10.12 O7 PE8 B 148 coo -2.88 -2.27 26.18 -2.94 -3.40 27.96 -7.10 67.86 29.77 -6.34 66.05 29.12 coo 1.37 -0.44 19.19 2.21 -1.48 25.26 -4.77 65.74 20.08 0.46 67.29 18.98 coo 2.64 1.83 34.81 1.56 1.13 32.02 4.56 66.25 30.54 5.81 64.43 28.32 1k82_c01 source 1k82 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE : 2 hits 1k82_c01 naa= 3 ULMN 3 1k82_c02 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 1 3 # 1 C 2 GLU B 102 GLU~? 6.18 O4 SO4 A 143 C 56 LYS A 9 LYS~? 8.68 C6 2PE A 148 C 258 ARG A 127 ARG^? 7.47 N MLZ A 129 coo 43.38 -1.09 -22.48 43.25 -2.24 -24.24 -7.10 67.86 29.77 -6.34 66.05 29.12 coo 39.00 0.70 -15.53 38.30 -0.73 -21.58 -4.77 65.74 20.08 0.46 67.29 18.98 coo 37.62 2.54 -31.11 38.78 1.93 -28.33 -18.44 68.25 24.06 -17.70 68.37 27.04 ULMN 3 1k82_c02 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 2 3 # 2 C 2 GLU B 102 GLU~? 6.18 O4 SO4 A 143 C 56 LYS A 9 LYS~? 8.68 C6 2PE A 148 C 258 ARG B 110 ARG~? 10.12 O7 PE8 B 148 coo 43.38 -1.09 -22.48 43.25 -2.24 -24.24 -7.10 67.86 29.77 -6.34 66.05 29.12 coo 39.00 0.70 -15.53 38.30 -0.73 -21.58 -4.77 65.74 20.08 0.46 67.29 18.98 coo 37.62 2.54 -31.11 38.78 1.93 -28.33 4.56 66.25 30.54 5.81 64.43 28.32 1k82_c02 source 1k82 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE : 2 hits 1k82_c02 naa= 3 ULMN 3 1k82_c03 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 1 3 # 1 D 2 GLU B 102 GLU~? 6.18 O4 SO4 A 143 D 56 LYS A 9 LYS~? 8.68 C6 2PE A 148 D 258 ARG A 127 ARG^? 7.47 N MLZ A 129 coo -2.14 0.68 -23.29 -2.02 1.93 -25.00 -7.10 67.86 29.77 -6.34 66.05 29.12 coo 2.02 -1.43 -16.27 3.11 0.23 -22.16 -4.77 65.74 20.08 0.46 67.29 18.98 coo 4.06 -2.42 -31.79 2.79 -2.18 -28.99 -18.44 68.25 24.06 -17.70 68.37 27.04 ULMN 3 1k82_c03 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 2 3 # 2 D 2 GLU B 102 GLU~? 6.18 O4 SO4 A 143 D 56 LYS A 9 LYS~? 8.68 C6 2PE A 148 D 258 ARG B 110 ARG~? 10.12 O7 PE8 B 148 coo -2.14 0.68 -23.29 -2.02 1.93 -25.00 -7.10 67.86 29.77 -6.34 66.05 29.12 coo 2.02 -1.43 -16.27 3.11 0.23 -22.16 -4.77 65.74 20.08 0.46 67.29 18.98 coo 4.06 -2.42 -31.79 2.79 -2.18 -28.99 4.56 66.25 30.54 5.81 64.43 28.32 1k82_c03 source 1k82 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE : 2 hits 1k82_c03 naa= 3 ULMN 3 1kim_c00 THYMIDINE KINASE user 1 3 # 1 A 83 GLU A 84 GLU.? 10.45 C3 GOL D 147 A 163 ARG A 31 ARG^? 11.10 C1 GOL A 150 A 222 ARG A 124 ARG^? 8.18 C1 GOL A 150 coo 51.27 81.34 48.31 51.67 80.79 50.28 -21.01 70.22 3.12 -21.10 71.95 4.30 coo 48.06 78.22 50.94 48.51 78.27 53.98 -18.51 63.86 1.13 -18.37 66.66 2.58 coo 54.85 84.16 52.60 54.26 81.23 53.34 -17.35 69.10 10.18 -16.14 69.37 7.36 ULMN 3 1kim_c00 THYMIDINE KINASE user 2 3 # 2 A 83 GLU A 84 GLU.? 10.45 C3 GOL D 147 A 163 ARG D 124 ARG^? 7.97 C3 GOL D 147 A 222 ARG A 124 ARG^? 8.18 C1 GOL A 150 coo 51.27 81.34 48.31 51.67 80.79 50.28 -21.01 70.22 3.12 -21.10 71.95 4.30 coo 48.06 78.22 50.94 48.51 78.27 53.98 -24.04 74.20 5.58 -21.67 76.16 5.44 coo 54.85 84.16 52.60 54.26 81.23 53.34 -17.35 69.10 10.18 -16.14 69.37 7.36 ULMN 3 1kim_c00 THYMIDINE KINASE user 3 3 # 3 A 83 GLU A 121 GLU^? 12.41 C1 GOL A 150 A 163 ARG A 31 ARG^? 11.10 C1 GOL A 150 A 222 ARG A 33 ARG.? 10.19 C3 GOL A 150 coo 51.27 81.34 48.31 51.67 80.79 50.28 -13.98 61.53 0.93 -15.14 61.60 -0.79 coo 48.06 78.22 50.94 48.51 78.27 53.98 -18.51 63.86 1.13 -18.37 66.66 2.58 coo 54.85 84.16 52.60 54.26 81.23 53.34 -11.76 56.72 1.51 -9.97 59.19 1.86 ULMN 3 1kim_c00 THYMIDINE KINASE user 4 3 # 4 A 83 GLU A 121 GLU^? 12.41 C1 GOL A 150 A 163 ARG A 33 ARG.? 10.19 C3 GOL A 150 A 222 ARG A 31 ARG^? 11.10 C1 GOL A 150 coo 51.27 81.34 48.31 51.67 80.79 50.28 -13.98 61.53 0.93 -15.14 61.60 -0.79 coo 48.06 78.22 50.94 48.51 78.27 53.98 -11.76 56.72 1.51 -9.97 59.19 1.86 coo 54.85 84.16 52.60 54.26 81.23 53.34 -18.51 63.86 1.13 -18.37 66.66 2.58 ULMN 3 1kim_c00 THYMIDINE KINASE user 5 3 # 5 A 83 GLU B 84 GLU.? 10.31 O3 GOL C 149 A 163 ARG B 31 ARG^? 11.02 C6 PGE B 147 A 222 ARG B 124 ARG^? 8.02 O2 GOL B 149 coo 51.27 81.34 48.31 51.67 80.79 50.28 7.66 84.31 53.13 6.13 83.49 54.35 coo 48.06 78.22 50.94 48.51 78.27 53.98 12.15 83.61 47.77 10.36 84.10 50.21 coo 54.85 84.16 52.60 54.26 81.23 53.34 3.96 78.02 49.67 6.79 78.26 50.86 ULMN 3 1kim_c00 THYMIDINE KINASE user 6 3 # 6 A 83 GLU B 84 GLU.? 10.31 O3 GOL C 149 A 163 ARG C 124 ARG^? 7.92 C3 GOL C 149 A 222 ARG B 124 ARG^? 8.02 O2 GOL B 149 coo 51.27 81.34 48.31 51.67 80.79 50.28 7.66 84.31 53.13 6.13 83.49 54.35 coo 48.06 78.22 50.94 48.51 78.27 53.98 2.87 85.20 55.95 3.74 82.90 57.81 coo 54.85 84.16 52.60 54.26 81.23 53.34 3.96 78.02 49.67 6.79 78.26 50.86 ULMN 3 1kim_c00 THYMIDINE KINASE user 7 3 # 7 A 83 GLU B 102 GLU~? 6.18 O4 SO4 A 143 A 163 ARG A 16 ARG~? -2.82 O4 SO4 A 143s A 222 ARG B 105 ARG~? -3.01 O4 SO4 A 143s coo 51.27 81.34 48.31 51.67 80.79 50.28 -7.10 67.86 29.77 -6.34 66.05 29.12 coo 48.06 78.22 50.94 48.51 78.27 53.98 -9.29 63.37 28.06 -8.90 62.24 30.90 coo 54.85 84.16 52.60 54.26 81.23 53.34 -2.68 64.28 31.62 -4.52 62.28 32.99 ULMN 3 1kim_c00 THYMIDINE KINASE user 8 3 # 8 A 83 GLU B 102 GLU~? 6.18 O4 SO4 A 143 A 163 ARG B 105 ARG~? -3.01 O4 SO4 A 143s A 222 ARG A 16 ARG~? -2.82 O4 SO4 A 143s coo 51.27 81.34 48.31 51.67 80.79 50.28 -7.10 67.86 29.77 -6.34 66.05 29.12 coo 48.06 78.22 50.94 48.51 78.27 53.98 -2.68 64.28 31.62 -4.52 62.28 32.99 coo 54.85 84.16 52.60 54.26 81.23 53.34 -9.29 63.37 28.06 -8.90 62.24 30.90 ULMN 3 1kim_c00 THYMIDINE KINASE user 9 3 # 9 A 83 GLU B 121 GLU^? 8.74 O2 PEG B 144 A 163 ARG B 31 ARG^? 11.02 C6 PGE B 147 A 222 ARG B 33 ARG.? -3.91 C3 PEG B 144s coo 51.27 81.34 48.31 51.67 80.79 50.28 15.37 80.83 45.64 16.23 82.69 46.15 coo 48.06 78.22 50.94 48.51 78.27 53.98 12.15 83.61 47.77 10.36 84.10 50.21 coo 54.85 84.16 52.60 54.26 81.23 53.34 17.31 79.39 40.81 17.39 77.24 43.00 ULMN 3 1kim_c00 THYMIDINE KINASE user 10 3 # 10 A 83 GLU B 121 GLU^? 8.74 O2 PEG B 144 A 163 ARG B 33 ARG.? -3.91 C3 PEG B 144s A 222 ARG B 31 ARG^? 11.02 C6 PGE B 147 coo 51.27 81.34 48.31 51.67 80.79 50.28 15.37 80.83 45.64 16.23 82.69 46.15 coo 48.06 78.22 50.94 48.51 78.27 53.98 17.31 79.39 40.81 17.39 77.24 43.00 coo 54.85 84.16 52.60 54.26 81.23 53.34 12.15 83.61 47.77 10.36 84.10 50.21 ULMN 3 1kim_c00 THYMIDINE KINASE user 11 3 # 11 A 83 GLU C 84 GLU.? 10.77 O2 GOL B 149 A 163 ARG B 124 ARG^? 8.02 O2 GOL B 149 A 222 ARG C 124 ARG^? 7.92 C3 GOL C 149 coo 51.27 81.34 48.31 51.67 80.79 50.28 2.34 77.12 55.01 3.46 78.21 53.60 coo 48.06 78.22 50.94 48.51 78.27 53.98 3.96 78.02 49.67 6.79 78.26 50.86 coo 54.85 84.16 52.60 54.26 81.23 53.34 2.87 85.20 55.95 3.74 82.90 57.81 ULMN 3 1kim_c00 THYMIDINE KINASE user 12 3 # 12 A 83 GLU C 121 GLU^? 12.40 C3 GOL C 149 A 163 ARG C 31 ARG^? 11.22 C3 GOL C 149 A 222 ARG C 33 ARG.? 10.55 C1 GOL C 149 coo 51.27 81.34 48.31 51.67 80.79 50.28 -1.98 78.69 65.48 -2.54 76.71 65.06 coo 48.06 78.22 50.94 48.51 78.27 53.98 -2.17 77.49 60.72 0.17 78.08 58.83 coo 54.85 84.16 52.60 54.26 81.23 53.34 -5.11 80.73 69.28 -2.11 81.22 69.57 ULMN 3 1kim_c00 THYMIDINE KINASE user 13 3 # 13 A 83 GLU C 121 GLU^? 12.40 C3 GOL C 149 A 163 ARG C 33 ARG.? 10.55 C1 GOL C 149 A 222 ARG C 31 ARG^? 11.22 C3 GOL C 149 coo 51.27 81.34 48.31 51.67 80.79 50.28 -1.98 78.69 65.48 -2.54 76.71 65.06 coo 48.06 78.22 50.94 48.51 78.27 53.98 -5.11 80.73 69.28 -2.11 81.22 69.57 coo 54.85 84.16 52.60 54.26 81.23 53.34 -2.17 77.49 60.72 0.17 78.08 58.83 ULMN 3 1kim_c00 THYMIDINE KINASE user 14 3 # 14 A 83 GLU D 84 GLU.? 10.79 C1 GOL A 150 A 163 ARG A 124 ARG^? 8.18 C1 GOL A 150 A 222 ARG D 124 ARG^? 7.97 C3 GOL D 147 coo 51.27 81.34 48.31 51.67 80.79 50.28 -17.40 74.78 10.23 -17.69 72.96 9.24 coo 48.06 78.22 50.94 48.51 78.27 53.98 -17.35 69.10 10.18 -16.14 69.37 7.36 coo 54.85 84.16 52.60 54.26 81.23 53.34 -24.04 74.20 5.58 -21.67 76.16 5.44 ULMN 3 1kim_c00 THYMIDINE KINASE user 15 3 # 15 A 83 GLU D 84 GLU.? 10.79 C1 GOL A 150 A 163 ARG D 31 ARG^? 10.57 OH7 1PE B 150 A 222 ARG D 124 ARG^? 7.97 C3 GOL D 147 coo 51.27 81.34 48.31 51.67 80.79 50.28 -17.40 74.78 10.23 -17.69 72.96 9.24 coo 48.06 78.22 50.94 48.51 78.27 53.98 -19.64 81.34 12.02 -19.24 78.87 10.07 coo 54.85 84.16 52.60 54.26 81.23 53.34 -24.04 74.20 5.58 -21.67 76.16 5.44 ULMN 3 1kim_c00 THYMIDINE KINASE user 16 3 # 16 A 83 GLU D 121 GLU^? 11.70 OH7 1PE B 150 A 163 ARG D 31 ARG^? 10.57 OH7 1PE B 150 A 222 ARG D 33 ARG.? 10.45 C1 GOL D 147 coo 51.27 81.34 48.31 51.67 80.79 50.28 -20.91 85.61 9.48 -19.44 85.70 10.98 coo 48.06 78.22 50.94 48.51 78.27 53.98 -19.64 81.34 12.02 -19.24 78.87 10.07 coo 54.85 84.16 52.60 54.26 81.23 53.34 -24.75 89.49 9.81 -23.48 88.88 7.05 ULMN 3 1kim_c00 THYMIDINE KINASE user 17 3 # 17 A 83 GLU D 121 GLU^? 11.70 OH7 1PE B 150 A 163 ARG D 33 ARG.? 10.45 C1 GOL D 147 A 222 ARG D 31 ARG^? 10.57 OH7 1PE B 150 coo 51.27 81.34 48.31 51.67 80.79 50.28 -20.91 85.61 9.48 -19.44 85.70 10.98 coo 48.06 78.22 50.94 48.51 78.27 53.98 -24.75 89.49 9.81 -23.48 88.88 7.05 coo 54.85 84.16 52.60 54.26 81.23 53.34 -19.64 81.34 12.02 -19.24 78.87 10.07 1kim_c00 source 1kim THYMIDINE KINASE : 17 hits 1kim_c00 naa= 3 ULMN 3 1knp_c00 L-ASPARTATE OXIDASE user 1 3 # 1 A 290 ARG A 31 ARG^? 11.10 C1 GOL A 150 A 351 HIS A 85 HIS.? 6.69 C5 PGE A 147 A 386 LEU A 32 LEU^? 9.30 CH2 MLY D 135 coo 57.36 53.34 128.83 58.45 50.56 128.34 -18.51 63.86 1.13 -18.37 66.66 2.58 coo 60.60 50.64 133.59 60.63 48.82 132.56 -23.05 64.43 -0.55 -21.68 63.00 -1.25 coo 63.28 54.23 126.45 63.53 52.07 126.70 -19.04 56.74 3.15 -19.76 55.64 4.88 ULMN 3 1knp_c00 L-ASPARTATE OXIDASE user 2 3 # 2 A 290 ARG A 124 ARG^? 8.18 C1 GOL A 150 A 351 HIS A 4 HIS.? -3.92 C2 GOL A 150s A 386 LEU A 125 LEU^? 4.68 C17 2PE A 148 coo 57.36 53.34 128.83 58.45 50.56 128.34 -17.35 69.10 10.18 -16.14 69.37 7.36 coo 60.60 50.64 133.59 60.63 48.82 132.56 -11.85 68.18 8.83 -11.23 70.10 8.29 coo 63.28 54.23 126.45 63.53 52.07 126.70 -17.49 64.43 15.55 -17.95 62.77 16.85 ULMN 3 1knp_c00 L-ASPARTATE OXIDASE user 3 3 # 3 A 290 ARG B 31 ARG^? 11.02 C6 PGE B 147 A 351 HIS B 85 HIS.? 6.66 C6 PGE B 147 A 386 LEU B 32 LEU^? 9.36 CE MLY C 135 coo 57.36 53.34 128.83 58.45 50.56 128.34 12.15 83.61 47.77 10.36 84.10 50.21 coo 60.60 50.64 133.59 60.63 48.82 132.56 11.11 88.86 48.90 12.76 88.34 47.73 coo 63.28 54.23 126.45 63.53 52.07 126.70 12.48 84.84 40.35 10.99 84.89 38.79 ULMN 3 1knp_c00 L-ASPARTATE OXIDASE user 4 3 # 4 A 290 ARG B 124 ARG^? 8.02 O2 GOL B 149 A 351 HIS B 4 HIS.? -3.86 O2 GOL B 149s A 386 LEU B 125 LEU^? 4.86 C15 PE8 B 148 coo 57.36 53.34 128.83 58.45 50.56 128.34 3.96 78.02 49.67 6.79 78.26 50.86 coo 60.60 50.64 133.59 60.63 48.82 132.56 8.07 73.88 49.16 8.30 73.43 51.19 coo 63.28 54.23 126.45 63.53 52.07 126.70 0.84 76.40 43.40 -0.09 76.47 41.42 ULMN 3 1knp_c00 L-ASPARTATE OXIDASE user 5 3 # 5 A 290 ARG C 31 ARG^? 11.22 C3 GOL C 149 A 351 HIS C 85 HIS.? 6.34 C1 PGE C 147 A 386 LEU C 32 LEU^? 8.96 CD MLY B 135 coo 57.36 53.34 128.83 58.45 50.56 128.34 -2.17 77.49 60.72 0.17 78.08 58.83 coo 60.60 50.64 133.59 60.63 48.82 132.56 -4.08 74.18 57.17 -4.69 74.12 59.17 coo 63.28 54.23 126.45 63.53 52.07 126.70 -8.67 80.10 62.81 -9.90 81.76 62.17 ULMN 3 1knp_c00 L-ASPARTATE OXIDASE user 6 3 # 6 A 290 ARG C 124 ARG^? 7.92 C3 GOL C 149 A 351 HIS C 4 HIS.? -3.73 C3 GOL C 149s A 386 LEU C 125 LEU^? 5.17 C15 PE8 C 148 coo 57.36 53.34 128.83 58.45 50.56 128.34 2.87 85.20 55.95 3.74 82.90 57.81 coo 60.60 50.64 133.59 60.63 48.82 132.56 4.88 85.81 61.42 6.80 85.00 61.18 coo 63.28 54.23 126.45 63.53 52.07 126.70 -1.29 91.04 56.29 -2.92 92.47 56.21 ULMN 3 1knp_c00 L-ASPARTATE OXIDASE user 7 3 # 7 A 290 ARG D 31 ARG^? 10.57 OH7 1PE B 150 A 351 HIS D 85 HIS.? 4.73 OH7 1PE B 150 A 386 LEU D 32 LEU^? 9.39 CH1 MLY A 135 coo 57.36 53.34 128.83 58.45 50.56 128.34 -19.64 81.34 12.02 -19.24 78.87 10.07 coo 60.60 50.64 133.59 60.63 48.82 132.56 -18.08 79.12 16.04 -18.14 81.21 15.79 coo 63.28 54.23 126.45 63.53 52.07 126.70 -25.57 84.78 15.16 -27.60 84.30 15.68 ULMN 3 1knp_c00 L-ASPARTATE OXIDASE user 8 3 # 8 A 290 ARG D 124 ARG^? 7.97 C3 GOL D 147 A 351 HIS D 4 HIS.? 4.07 C3 GOL D 147 A 386 LEU D 125 LEU^? 4.59 C17 2PE D 146 coo 57.36 53.34 128.83 58.45 50.56 128.34 -24.04 74.20 5.58 -21.67 76.16 5.44 coo 60.60 50.64 133.59 60.63 48.82 132.56 -23.57 78.63 1.94 -22.01 77.96 0.72 coo 63.28 54.23 126.45 63.53 52.07 126.70 -31.23 74.71 6.11 -33.26 74.87 6.83 1knp_c00 source 1knp L-ASPARTATE OXIDASE : 8 hits 1knp_c00 naa= 3 ULMN 3 1kqf_c03 FORMATE DEHYDROGENASE, NITRATE-INDUCuser 1 3 # 1 A 94 LYS B 129 LYS^? 7.64 C2 PEG B 146 A 197 HIS B 4 HIS.? -3.86 O2 GOL B 149s A 446 ARG B 124 ARG^? 8.02 O2 GOL B 149 coo 3.26 62.02 109.14 4.83 57.73 107.38 -12.78 77.45 45.34 -17.39 74.89 47.84 coo 9.48 43.28 113.60 10.05 44.21 111.80 8.07 73.88 49.16 8.30 73.43 51.19 coo 12.14 46.28 115.16 13.57 43.60 115.68 3.96 78.02 49.67 6.79 78.26 50.86 ULMN 3 1kqf_c03 FORMATE DEHYDROGENASE, NITRATE-INDUCuser 2 3 # 2 A 94 LYS D 129 LYS^? 7.63 C4 PEG D 145 A 197 HIS D 4 HIS.? 4.07 C3 GOL D 147 A 446 ARG D 124 ARG^? 7.97 C3 GOL D 147 coo 3.26 62.02 109.14 4.83 57.73 107.38 -36.12 61.83 6.50 -39.41 57.83 4.09 coo 9.48 43.28 113.60 10.05 44.21 111.80 -23.57 78.63 1.94 -22.01 77.96 0.72 coo 12.14 46.28 115.16 13.57 43.60 115.68 -24.04 74.20 5.58 -21.67 76.16 5.44 1kqf_c03 source 1kqf FORMATE DEHYDROGENASE, NITRATE-INDUCIBLE, CYTO: 2 hits 1kqf_c03 naa= 3 ULMN 3 1lam_c00 LEUCINE AMINOPEPTIDASE user 1 3 # 1 255 ASP A 6 ASP.? -3.91 C9 2PE A 148s 262 LYS A 9 LYS~? 8.68 C6 2PE A 148 336 ARG A 124 ARG^? 8.18 C1 GOL A 150 coo 61.88 50.78 12.96 63.84 50.60 13.71 -8.66 61.41 13.34 -8.76 59.35 12.80 coo 63.59 44.40 18.32 63.20 49.74 17.95 -4.77 65.74 20.08 0.46 67.29 18.98 coo 72.60 57.42 15.86 71.61 56.68 18.70 -17.35 69.10 10.18 -16.14 69.37 7.36 ULMN 3 1lam_c00 LEUCINE AMINOPEPTIDASE user 2 3 # 2 255 ASP B 6 ASP.? -3.99 C6 PE8 B 148s 262 LYS B 9 LYS~? 8.12 C3 PE8 B 148 336 ARG B 124 ARG^? 8.02 O2 GOL B 149 coo 61.88 50.78 12.96 63.84 50.60 13.71 7.95 70.39 41.39 8.88 71.08 39.61 coo 63.59 44.40 18.32 63.20 49.74 17.95 3.06 63.14 43.18 6.71 59.02 44.53 coo 72.60 57.42 15.86 71.61 56.68 18.70 3.96 78.02 49.67 6.79 78.26 50.86 ULMN 3 1lam_c00 LEUCINE AMINOPEPTIDASE user 3 3 # 3 255 ASP C 6 ASP.? -4.04 C8 PE8 C 148s 262 LYS C 9 LYS~? 8.15 O4 PE8 C 148 336 ARG C 110 ARG~? -6.90 CM MLZ C 114s coo 61.88 50.78 12.96 63.84 50.60 13.71 0.53 91.96 65.64 -1.31 91.68 66.68 coo 63.59 44.40 18.32 63.20 49.74 17.95 6.41 98.82 64.59 9.45 98.54 68.92 coo 72.60 57.42 15.86 71.61 56.68 18.70 -6.95 102.53 68.25 -6.50 103.08 71.25 ULMN 3 1lam_c00 LEUCINE AMINOPEPTIDASE user 4 3 # 4 255 ASP C 6 ASP.? -4.04 C8 PE8 C 148s 262 LYS C 9 LYS~? 8.15 O4 PE8 C 148 336 ARG C 124 ARG^? 7.92 C3 GOL C 149 coo 61.88 50.78 12.96 63.84 50.60 13.71 0.53 91.96 65.64 -1.31 91.68 66.68 coo 63.59 44.40 18.32 63.20 49.74 17.95 6.41 98.82 64.59 9.45 98.54 68.92 coo 72.60 57.42 15.86 71.61 56.68 18.70 2.87 85.20 55.95 3.74 82.90 57.81 ULMN 3 1lam_c00 LEUCINE AMINOPEPTIDASE user 5 3 # 5 255 ASP D 6 ASP.? -3.77 C8 2PE D 146s 262 LYS D 9 LYS~? 7.95 C5 2PE D 146 336 ARG D 124 ARG^? 7.97 C3 GOL D 147 coo 61.88 50.78 12.96 63.84 50.60 13.71 -31.03 82.87 1.04 -31.83 84.41 2.29 coo 63.59 44.40 18.32 63.20 49.74 17.95 -34.17 79.01 -6.33 -32.19 82.24 -10.69 coo 72.60 57.42 15.86 71.61 56.68 18.70 -24.04 74.20 5.58 -21.67 76.16 5.44 1lam_c00 source 1lam LEUCINE AMINOPEPTIDASE : 5 hits 1lam_c00 naa= 3 ULMN 3 1lci_c00 LUCIFERASE user 1 3 # 1 218 ARG A 31 ARG^? 11.10 C1 GOL A 150 245 HIS A 4 HIS.? -3.92 C2 GOL A 150s 343 THR A 2 THR.? -3.85 C1 GOL A 150s coo 18.11 85.25 41.19 18.04 83.33 43.59 -18.51 63.86 1.13 -18.37 66.66 2.58 coo 5.34 86.23 43.48 6.16 87.26 45.12 -11.85 68.18 8.83 -11.23 70.10 8.29 coo 9.06 92.76 42.80 7.04 92.63 42.14 -8.70 65.75 2.39 -7.33 67.47 2.56 1lci_c00 source 1lci LUCIFERASE : 1 hits 1lci_c00 naa= 3 ULMN 3 1ldm_c01 M4 LACTATE DEHYDROGENASE user 1 3 # 1 166 ASP A 56 ASP~? 11.59 C21 2PE A 148 169 ARG A 55 ARG~? 10.23 CD MLY D 135 193 HIS A 115 HIS~? 12.27 C21 2PE A 148 coo 20.88 15.91 3.60 20.25 17.72 4.50 -16.01 45.89 15.64 -15.93 44.31 14.23 coo 17.70 17.91 -0.80 15.74 19.74 0.84 -19.70 43.33 11.87 -20.69 44.07 9.04 coo 18.81 19.85 7.63 17.55 19.89 5.97 -13.18 48.35 10.37 -12.55 46.36 10.33 ULMN 3 1ldm_c01 M4 LACTATE DEHYDROGENASE user 2 3 # 2 166 ASP B 56 ASP~? 11.45 C20 PE8 B 148 169 ARG B 55 ARG~? 9.33 CG MLY C 135 193 HIS B 115 HIS~? 12.48 C18 PE8 B 148 coo 20.88 15.91 3.60 20.25 17.72 4.50 6.80 78.21 26.00 8.47 79.07 25.03 coo 17.70 17.91 -0.80 15.74 19.74 0.84 8.78 84.29 24.99 10.39 86.20 26.77 coo 18.81 19.85 7.63 17.55 19.89 5.97 11.86 77.76 30.05 12.70 77.49 28.15 ULMN 3 1ldm_c01 M4 LACTATE DEHYDROGENASE user 3 3 # 3 166 ASP B 122 ASP^? 7.33 O2 GOL B 149 169 ARG B 31 ARG^? 11.02 C6 PGE B 147 193 HIS B 4 HIS.? -3.86 O2 GOL B 149s coo 20.88 15.91 3.60 20.25 17.72 4.50 10.89 79.68 47.57 9.75 78.80 49.16 coo 17.70 17.91 -0.80 15.74 19.74 0.84 12.15 83.61 47.77 10.36 84.10 50.21 coo 18.81 19.85 7.63 17.55 19.89 5.97 8.07 73.88 49.16 8.30 73.43 51.19 ULMN 3 1ldm_c01 M4 LACTATE DEHYDROGENASE user 4 3 # 4 166 ASP C 56 ASP~? 9.09 N MLZ C 114 169 ARG C 55 ARG~? 9.18 O MLY B 135 193 HIS C 115 HIS~? 4.72 C MLZ C 114 coo 20.88 15.91 3.60 20.25 17.72 4.50 -16.40 94.43 66.11 -17.63 93.56 67.58 coo 17.70 17.91 -0.80 15.74 19.74 0.84 -21.06 89.68 64.73 -20.37 86.74 65.24 coo 18.81 19.85 7.63 17.55 19.89 5.97 -12.99 90.00 69.08 -14.38 90.57 70.54 ULMN 3 1ldm_c01 M4 LACTATE DEHYDROGENASE user 5 3 # 5 166 ASP D 56 ASP~? 11.46 C21 2PE D 146 169 ARG D 55 ARG~? 9.16 CG MLY A 135 193 HIS D 115 HIS~? 12.18 C21 2PE D 146 coo 20.88 15.91 3.60 20.25 17.72 4.50 -41.85 87.81 13.66 -41.61 89.58 14.80 coo 17.70 17.91 -0.80 15.74 19.74 0.84 -39.98 89.02 19.79 -37.17 89.06 21.03 coo 18.81 19.85 7.63 17.55 19.89 5.97 -36.28 90.32 11.92 -37.49 91.98 12.35 1ldm_c01 source 1ldm M4 LACTATE DEHYDROGENASE : 5 hits 1ldm_c01 naa= 3 ULMN 3 1lij_c01 ADENOSINE KINASE user 1 3 # 1 A 316 ALA A 52 ALA~? 11.32 CD MLY D 135 A 317 GLY A 54 GLY~? 5.80 C21 2PE A 148 A 318 ASP A 56 ASP~? 11.59 C21 2PE A 148 coo 144.15 17.54 -4.21 144.96 16.79 -5.26 -17.75 46.92 10.26 -16.48 46.44 9.51 coo 145.79 20.97 -4.38 145.13 20.72 -3.93 -20.41 50.07 13.76 -19.88 49.43 13.69 coo 141.70 22.54 -2.23 141.09 23.62 -3.92 -16.01 45.89 15.64 -15.93 44.31 14.23 ULMN 3 1lij_c01 ADENOSINE KINASE user 2 3 # 2 A 316 ALA B 52 ALA~? 11.30 CE MLY C 135 A 317 GLY B 54 GLY~? 5.68 C20 PE8 B 148 A 318 ASP B 56 ASP~? 11.45 C20 PE8 B 148 coo 144.15 17.54 -4.21 144.96 16.79 -5.26 10.17 82.02 28.78 11.54 81.34 28.64 coo 145.79 20.97 -4.38 145.13 20.72 -3.93 5.02 82.24 30.45 5.51 81.90 29.87 coo 141.70 22.54 -2.23 141.09 23.62 -3.92 6.80 78.21 26.00 8.47 79.07 25.03 ULMN 3 1lij_c01 ADENOSINE KINASE user 3 3 # 3 A 316 ALA C 52 ALA~? 7.88 C MLZ C 114 A 317 GLY C 54 GLY~? 6.00 CH2 MLY B 135 A 318 ASP C 56 ASP~? 9.09 N MLZ C 114 coo 144.15 17.54 -4.21 144.96 16.79 -5.26 -16.51 88.80 66.17 -16.23 88.55 67.66 coo 145.79 20.97 -4.38 145.13 20.72 -3.93 -15.22 90.72 61.35 -15.47 90.98 62.07 coo 141.70 22.54 -2.23 141.09 23.62 -3.92 -16.40 94.43 66.11 -17.63 93.56 67.58 ULMN 3 1lij_c01 ADENOSINE KINASE user 4 3 # 4 A 316 ALA D 52 ALA~? 11.20 CE MLY A 135 A 317 GLY D 54 GLY~? 5.81 C23 2PE D 146 A 318 ASP D 56 ASP~? 11.46 C21 2PE D 146 coo 144.15 17.54 -4.21 144.96 16.79 -5.26 -36.92 88.76 16.36 -36.55 90.11 15.77 coo 145.79 20.97 -4.38 145.13 20.72 -3.93 -38.01 83.52 15.98 -38.33 84.28 15.84 coo 141.70 22.54 -2.23 141.09 23.62 -3.92 -41.85 87.81 13.66 -41.61 89.58 14.80 1lij_c01 source 1lij ADENOSINE KINASE : 4 hits 1lij_c01 naa= 3 ULMN 3 1lio_c01 ADENOSINE KINASE user 1 3 # 1 A 316 ALA A 52 ALA~? 11.32 CD MLY D 135 A 317 GLY A 54 GLY~? 5.80 C21 2PE A 148 A 318 ASP A 56 ASP~? 11.59 C21 2PE A 148 coo 27.04 23.54 41.85 25.72 24.19 42.18 -17.75 46.92 10.26 -16.48 46.44 9.51 coo 27.87 23.16 38.17 28.43 22.97 38.87 -20.41 50.07 13.76 -19.88 49.43 13.69 coo 32.11 22.71 40.58 33.42 24.22 39.78 -16.01 45.89 15.64 -15.93 44.31 14.23 ULMN 3 1lio_c01 ADENOSINE KINASE user 2 3 # 2 A 316 ALA B 52 ALA~? 11.30 CE MLY C 135 A 317 GLY B 54 GLY~? 5.68 C20 PE8 B 148 A 318 ASP B 56 ASP~? 11.45 C20 PE8 B 148 coo 27.04 23.54 41.85 25.72 24.19 42.18 10.17 82.02 28.78 11.54 81.34 28.64 coo 27.87 23.16 38.17 28.43 22.97 38.87 5.02 82.24 30.45 5.51 81.90 29.87 coo 32.11 22.71 40.58 33.42 24.22 39.78 6.80 78.21 26.00 8.47 79.07 25.03 ULMN 3 1lio_c01 ADENOSINE KINASE user 3 3 # 3 A 316 ALA C 52 ALA~? 7.88 C MLZ C 114 A 317 GLY C 54 GLY~? 6.00 CH2 MLY B 135 A 318 ASP C 56 ASP~? 9.09 N MLZ C 114 coo 27.04 23.54 41.85 25.72 24.19 42.18 -16.51 88.80 66.17 -16.23 88.55 67.66 coo 27.87 23.16 38.17 28.43 22.97 38.87 -15.22 90.72 61.35 -15.47 90.98 62.07 coo 32.11 22.71 40.58 33.42 24.22 39.78 -16.40 94.43 66.11 -17.63 93.56 67.58 ULMN 3 1lio_c01 ADENOSINE KINASE user 4 3 # 4 A 316 ALA D 52 ALA~? 11.20 CE MLY A 135 A 317 GLY D 54 GLY~? 5.81 C23 2PE D 146 A 318 ASP D 56 ASP~? 11.46 C21 2PE D 146 coo 27.04 23.54 41.85 25.72 24.19 42.18 -36.92 88.76 16.36 -36.55 90.11 15.77 coo 27.87 23.16 38.17 28.43 22.97 38.87 -38.01 83.52 15.98 -38.33 84.28 15.84 coo 32.11 22.71 40.58 33.42 24.22 39.78 -41.85 87.81 13.66 -41.61 89.58 14.80 1lio_c01 source 1lio ADENOSINE KINASE : 4 hits 1lio_c01 naa= 3 ULMN 3 1m53_c03 ISOMALTULOSE SYNTHASE user 1 3 # 1 A 241 ASP A 56 ASP~? 11.59 C21 2PE A 148 A 295 GLU A 111 GLU~? 12.48 C11 2PE A 148 A 369 ASP A 106 ASP~? 11.93 O22 2PE A 148 coo 11.74 38.14 80.19 10.63 36.40 80.65 -16.01 45.89 15.64 -15.93 44.31 14.23 coo 16.11 33.72 80.99 14.10 33.54 81.63 -8.13 46.06 17.22 -6.45 46.46 15.98 coo 12.19 31.08 87.29 11.13 32.66 86.38 -12.71 50.36 24.83 -13.06 48.30 25.05 ULMN 3 1m53_c03 ISOMALTULOSE SYNTHASE user 2 3 # 2 A 241 ASP A 83 ASP.? 8.52 O3 GOL D 147 A 295 GLU A 84 GLU.? 10.45 C3 GOL D 147 A 369 ASP A 122 ASP^? 7.46 C1 GOL A 150 coo 11.74 38.14 80.19 10.63 36.40 80.65 -19.46 70.43 -3.04 -19.06 72.28 -2.05 coo 16.11 33.72 80.99 14.10 33.54 81.63 -21.01 70.22 3.12 -21.10 71.95 4.30 coo 12.19 31.08 87.29 11.13 32.66 86.38 -15.41 64.92 4.51 -15.09 66.83 5.33 ULMN 3 1m53_c03 ISOMALTULOSE SYNTHASE user 3 3 # 3 A 241 ASP A 122 ASP^? 7.46 C1 GOL A 150 A 295 GLU A 84 GLU.? 10.45 C3 GOL D 147 A 369 ASP A 83 ASP.? 8.52 O3 GOL D 147 coo 11.74 38.14 80.19 10.63 36.40 80.65 -15.41 64.92 4.51 -15.09 66.83 5.33 coo 16.11 33.72 80.99 14.10 33.54 81.63 -21.01 70.22 3.12 -21.10 71.95 4.30 coo 12.19 31.08 87.29 11.13 32.66 86.38 -19.46 70.43 -3.04 -19.06 72.28 -2.05 ULMN 3 1m53_c03 ISOMALTULOSE SYNTHASE user 4 3 # 4 A 241 ASP B 56 ASP~? 11.45 C20 PE8 B 148 A 295 GLU B 111 GLU~? 12.54 O7 PE8 B 148 A 369 ASP B 106 ASP~? 11.87 OH2 1PE B 150 coo 11.74 38.14 80.19 10.63 36.40 80.65 6.80 78.21 26.00 8.47 79.07 25.03 coo 16.11 33.72 80.99 14.10 33.54 81.63 9.41 70.70 25.55 11.25 69.94 26.27 coo 12.19 31.08 87.29 11.13 32.66 86.38 -0.30 70.27 27.08 -0.10 70.78 25.05 ULMN 3 1m53_c03 ISOMALTULOSE SYNTHASE user 5 3 # 5 A 241 ASP B 83 ASP.? 9.40 O3 GOL C 149 A 295 GLU B 84 GLU.? 10.31 O3 GOL C 149 A 369 ASP B 122 ASP^? 7.33 O2 GOL B 149 coo 11.74 38.14 80.19 10.63 36.40 80.65 13.62 86.10 55.23 12.83 84.59 56.49 coo 16.11 33.72 80.99 14.10 33.54 81.63 7.66 84.31 53.13 6.13 83.49 54.35 coo 12.19 31.08 87.29 11.13 32.66 86.38 10.89 79.68 47.57 9.75 78.80 49.16 ULMN 3 1m53_c03 ISOMALTULOSE SYNTHASE user 6 3 # 6 A 241 ASP B 122 ASP^? 7.33 O2 GOL B 149 A 295 GLU B 84 GLU.? 10.31 O3 GOL C 149 A 369 ASP B 83 ASP.? 9.40 O3 GOL C 149 coo 11.74 38.14 80.19 10.63 36.40 80.65 10.89 79.68 47.57 9.75 78.80 49.16 coo 16.11 33.72 80.99 14.10 33.54 81.63 7.66 84.31 53.13 6.13 83.49 54.35 coo 12.19 31.08 87.29 11.13 32.66 86.38 13.62 86.10 55.23 12.83 84.59 56.49 ULMN 3 1m53_c03 ISOMALTULOSE SYNTHASE user 7 3 # 7 A 241 ASP C 56 ASP~? 9.09 N MLZ C 114 A 295 GLU C 111 GLU~? 3.06 NZ MLZ C 114 A 369 ASP C 106 ASP~? 12.11 C21 PE8 C 148 coo 11.74 38.14 80.19 10.63 36.40 80.65 -16.40 94.43 66.11 -17.63 93.56 67.58 coo 16.11 33.72 80.99 14.10 33.54 81.63 -12.41 98.44 71.96 -11.17 97.70 73.52 coo 12.19 31.08 87.29 11.13 32.66 86.38 -11.06 103.55 63.77 -13.00 104.00 64.35 ULMN 3 1m53_c03 ISOMALTULOSE SYNTHASE user 8 3 # 8 A 241 ASP C 83 ASP.? 8.65 O3 GOL B 149 A 295 GLU C 84 GLU.? 10.77 O2 GOL B 149 A 369 ASP C 122 ASP^? 7.22 C3 GOL C 149 coo 11.74 38.14 80.19 10.63 36.40 80.65 3.02 71.86 58.06 4.88 72.49 57.24 coo 16.11 33.72 80.99 14.10 33.54 81.63 2.34 77.12 55.01 3.46 78.21 53.60 coo 12.19 31.08 87.29 11.13 32.66 86.38 0.27 81.12 61.60 2.07 81.54 60.53 ULMN 3 1m53_c03 ISOMALTULOSE SYNTHASE user 9 3 # 9 A 241 ASP C 122 ASP^? 7.22 C3 GOL C 149 A 295 GLU C 84 GLU.? 10.77 O2 GOL B 149 A 369 ASP C 83 ASP.? 8.65 O3 GOL B 149 coo 11.74 38.14 80.19 10.63 36.40 80.65 0.27 81.12 61.60 2.07 81.54 60.53 coo 16.11 33.72 80.99 14.10 33.54 81.63 2.34 77.12 55.01 3.46 78.21 53.60 coo 12.19 31.08 87.29 11.13 32.66 86.38 3.02 71.86 58.06 4.88 72.49 57.24 ULMN 3 1m53_c03 ISOMALTULOSE SYNTHASE user 10 3 # 10 A 241 ASP D 56 ASP~? 11.46 C21 2PE D 146 A 295 GLU D 111 GLU~? 11.88 C9 2PE D 146 A 369 ASP D 106 ASP~? 11.82 O22 2PE D 146 coo 11.74 38.14 80.19 10.63 36.40 80.65 -41.85 87.81 13.66 -41.61 89.58 14.80 coo 16.11 33.72 80.99 14.10 33.54 81.63 -43.22 91.45 6.64 -41.92 92.74 5.57 coo 12.19 31.08 87.29 11.13 32.66 86.38 -46.82 82.57 5.87 -48.37 83.43 7.00 ULMN 3 1m53_c03 ISOMALTULOSE SYNTHASE user 11 3 # 11 A 241 ASP D 83 ASP.? 8.76 O1 GOL A 150 A 295 GLU D 84 GLU.? 10.79 C1 GOL A 150 A 369 ASP D 122 ASP^? 7.49 C3 GOL D 147 coo 11.74 38.14 80.19 10.63 36.40 80.65 -12.54 78.43 10.94 -12.46 77.06 9.29 coo 16.11 33.72 80.99 14.10 33.54 81.63 -17.40 74.78 10.23 -17.69 72.96 9.24 coo 12.19 31.08 87.29 11.13 32.66 86.38 -21.82 80.90 7.85 -21.38 79.32 6.51 ULMN 3 1m53_c03 ISOMALTULOSE SYNTHASE user 12 3 # 12 A 241 ASP D 122 ASP^? 7.49 C3 GOL D 147 A 295 GLU D 84 GLU.? 10.79 C1 GOL A 150 A 369 ASP D 83 ASP.? 8.76 O1 GOL A 150 coo 11.74 38.14 80.19 10.63 36.40 80.65 -21.82 80.90 7.85 -21.38 79.32 6.51 coo 16.11 33.72 80.99 14.10 33.54 81.63 -17.40 74.78 10.23 -17.69 72.96 9.24 coo 12.19 31.08 87.29 11.13 32.66 86.38 -12.54 78.43 10.94 -12.46 77.06 9.29 1m53_c03 source 1m53 ISOMALTULOSE SYNTHASE : 12 hits 1m53_c03 naa= 3 ULMN 3 1m53_c05 ISOMALTULOSE SYNTHASE user 1 3 # 1 A 241 ASP A 83 ASP.? 8.52 O3 GOL D 147 A 265 GLU A 75 GLU.? -8.03 O4 PGE A 147s A 369 ASP A 122 ASP^? 7.46 C1 GOL A 150 coo 11.74 38.14 80.19 10.63 36.40 80.65 -19.46 70.43 -3.04 -19.06 72.28 -2.05 coo 17.36 23.57 72.04 18.68 21.92 71.98 -34.40 63.01 2.19 -36.49 63.07 2.67 coo 12.19 31.08 87.29 11.13 32.66 86.38 -15.41 64.92 4.51 -15.09 66.83 5.33 ULMN 3 1m53_c05 ISOMALTULOSE SYNTHASE user 2 3 # 2 A 241 ASP A 122 ASP^? 7.46 C1 GOL A 150 A 265 GLU A 75 GLU.? -8.03 O4 PGE A 147s A 369 ASP A 83 ASP.? 8.52 O3 GOL D 147 coo 11.74 38.14 80.19 10.63 36.40 80.65 -15.41 64.92 4.51 -15.09 66.83 5.33 coo 17.36 23.57 72.04 18.68 21.92 71.98 -34.40 63.01 2.19 -36.49 63.07 2.67 coo 12.19 31.08 87.29 11.13 32.66 86.38 -19.46 70.43 -3.04 -19.06 72.28 -2.05 ULMN 3 1m53_c05 ISOMALTULOSE SYNTHASE user 3 3 # 3 A 241 ASP B 83 ASP.? 9.40 O3 GOL C 149 A 265 GLU B 75 GLU.? -3.56 CB MLZ C 129s A 369 ASP B 122 ASP^? 7.33 O2 GOL B 149 coo 11.74 38.14 80.19 10.63 36.40 80.65 13.62 86.10 55.23 12.83 84.59 56.49 coo 17.36 23.57 72.04 18.68 21.92 71.98 3.68 97.59 46.60 2.29 99.21 46.53 coo 12.19 31.08 87.29 11.13 32.66 86.38 10.89 79.68 47.57 9.75 78.80 49.16 ULMN 3 1m53_c05 ISOMALTULOSE SYNTHASE user 4 3 # 4 A 241 ASP B 122 ASP^? 7.33 O2 GOL B 149 A 265 GLU B 75 GLU.? -3.56 CB MLZ C 129s A 369 ASP B 83 ASP.? 9.40 O3 GOL C 149 coo 11.74 38.14 80.19 10.63 36.40 80.65 10.89 79.68 47.57 9.75 78.80 49.16 coo 17.36 23.57 72.04 18.68 21.92 71.98 3.68 97.59 46.60 2.29 99.21 46.53 coo 12.19 31.08 87.29 11.13 32.66 86.38 13.62 86.10 55.23 12.83 84.59 56.49 ULMN 3 1m53_c05 ISOMALTULOSE SYNTHASE user 5 3 # 5 A 241 ASP C 83 ASP.? 8.65 O3 GOL B 149 A 265 GLU C 75 GLU.? -8.81 O1 PGE C 147s A 369 ASP C 122 ASP^? 7.22 C3 GOL C 149 coo 11.74 38.14 80.19 10.63 36.40 80.65 3.02 71.86 58.06 4.88 72.49 57.24 coo 17.36 23.57 72.04 18.68 21.92 71.98 -10.84 73.75 47.59 -11.85 73.47 45.72 coo 12.19 31.08 87.29 11.13 32.66 86.38 0.27 81.12 61.60 2.07 81.54 60.53 ULMN 3 1m53_c05 ISOMALTULOSE SYNTHASE user 6 3 # 6 A 241 ASP C 122 ASP^? 7.22 C3 GOL C 149 A 265 GLU C 75 GLU.? -8.81 O1 PGE C 147s A 369 ASP C 83 ASP.? 8.65 O3 GOL B 149 coo 11.74 38.14 80.19 10.63 36.40 80.65 0.27 81.12 61.60 2.07 81.54 60.53 coo 17.36 23.57 72.04 18.68 21.92 71.98 -10.84 73.75 47.59 -11.85 73.47 45.72 coo 12.19 31.08 87.29 11.13 32.66 86.38 3.02 71.86 58.06 4.88 72.49 57.24 ULMN 3 1m53_c05 ISOMALTULOSE SYNTHASE user 7 3 # 7 A 241 ASP D 83 ASP.? 8.76 O1 GOL A 150 A 265 GLU D 75 GLU.? -3.59 CB MLZ A 129s A 369 ASP D 122 ASP^? 7.49 C3 GOL D 147 coo 11.74 38.14 80.19 10.63 36.40 80.65 -12.54 78.43 10.94 -12.46 77.06 9.29 coo 17.36 23.57 72.04 18.68 21.92 71.98 -21.02 72.19 24.99 -21.34 70.79 26.58 coo 12.19 31.08 87.29 11.13 32.66 86.38 -21.82 80.90 7.85 -21.38 79.32 6.51 ULMN 3 1m53_c05 ISOMALTULOSE SYNTHASE user 8 3 # 8 A 241 ASP D 122 ASP^? 7.49 C3 GOL D 147 A 265 GLU D 75 GLU.? -3.59 CB MLZ A 129s A 369 ASP D 83 ASP.? 8.76 O1 GOL A 150 coo 11.74 38.14 80.19 10.63 36.40 80.65 -21.82 80.90 7.85 -21.38 79.32 6.51 coo 17.36 23.57 72.04 18.68 21.92 71.98 -21.02 72.19 24.99 -21.34 70.79 26.58 coo 12.19 31.08 87.29 11.13 32.66 86.38 -12.54 78.43 10.94 -12.46 77.06 9.29 1m53_c05 source 1m53 ISOMALTULOSE SYNTHASE : 8 hits 1m53_c05 naa= 3 ULMN 3 1m53_c06 ISOMALTULOSE SYNTHASE user 1 3 # 1 A 241 ASP A 6 ASP.? -3.91 C9 2PE A 148s A 279 GLU A 102 GLU~? 6.28 O2 SO4 A 143 A 369 ASP A 122 ASP^? 7.46 C1 GOL A 150 coo 11.74 38.14 80.19 10.63 36.40 80.65 -8.66 61.41 13.34 -8.76 59.35 12.80 coo 16.54 46.37 63.94 14.77 45.79 62.95 -14.00 55.24 30.65 -12.08 54.69 31.20 coo 12.19 31.08 87.29 11.13 32.66 86.38 -15.41 64.92 4.51 -15.09 66.83 5.33 ULMN 3 1m53_c06 ISOMALTULOSE SYNTHASE user 2 3 # 2 A 241 ASP A 6 ASP.? -3.91 C9 2PE A 148s A 279 GLU B 102 GLU~? 6.18 O4 SO4 A 143 A 369 ASP A 122 ASP^? 7.46 C1 GOL A 150 coo 11.74 38.14 80.19 10.63 36.40 80.65 -8.66 61.41 13.34 -8.76 59.35 12.80 coo 16.54 46.37 63.94 14.77 45.79 62.95 -7.10 67.86 29.77 -6.34 66.05 29.12 coo 12.19 31.08 87.29 11.13 32.66 86.38 -15.41 64.92 4.51 -15.09 66.83 5.33 ULMN 3 1m53_c06 ISOMALTULOSE SYNTHASE user 3 3 # 3 A 241 ASP A 56 ASP~? 11.59 C21 2PE A 148 A 279 GLU A 43 GLU.? 22.22 CD MLY D 135 A 369 ASP A 106 ASP~? 11.93 O22 2PE A 148 coo 11.74 38.14 80.19 10.63 36.40 80.65 -16.01 45.89 15.64 -15.93 44.31 14.23 coo 16.54 46.37 63.94 14.77 45.79 62.95 -10.18 46.49 -4.16 -10.86 48.08 -5.46 coo 12.19 31.08 87.29 11.13 32.66 86.38 -12.71 50.36 24.83 -13.06 48.30 25.05 ULMN 3 1m53_c06 ISOMALTULOSE SYNTHASE user 4 3 # 4 A 241 ASP A 106 ASP~? 11.93 O22 2PE A 148 A 279 GLU B 102 GLU~? 6.18 O4 SO4 A 143 A 369 ASP A 56 ASP~? 11.59 C21 2PE A 148 coo 11.74 38.14 80.19 10.63 36.40 80.65 -12.71 50.36 24.83 -13.06 48.30 25.05 coo 16.54 46.37 63.94 14.77 45.79 62.95 -7.10 67.86 29.77 -6.34 66.05 29.12 coo 12.19 31.08 87.29 11.13 32.66 86.38 -16.01 45.89 15.64 -15.93 44.31 14.23 ULMN 3 1m53_c06 ISOMALTULOSE SYNTHASE user 5 3 # 5 A 241 ASP A 122 ASP^? 7.46 C1 GOL A 150 A 279 GLU A 10 GLU~? 8.70 C6 2PE A 148 A 369 ASP A 83 ASP.? 8.52 O3 GOL D 147 coo 11.74 38.14 80.19 10.63 36.40 80.65 -15.41 64.92 4.51 -15.09 66.83 5.33 coo 16.54 46.37 63.94 14.77 45.79 62.95 -3.10 70.57 20.07 -2.45 69.30 18.38 coo 12.19 31.08 87.29 11.13 32.66 86.38 -19.46 70.43 -3.04 -19.06 72.28 -2.05 ULMN 3 1m53_c06 ISOMALTULOSE SYNTHASE user 6 3 # 6 A 241 ASP A 122 ASP^? 7.46 C1 GOL A 150 A 279 GLU A 10 GLU~? 8.70 C6 2PE A 148 A 369 ASP A 87 ASP.? 8.49 C6 PGE A 147 coo 11.74 38.14 80.19 10.63 36.40 80.65 -15.41 64.92 4.51 -15.09 66.83 5.33 coo 16.54 46.37 63.94 14.77 45.79 62.95 -3.10 70.57 20.07 -2.45 69.30 18.38 coo 12.19 31.08 87.29 11.13 32.66 86.38 -23.17 58.67 3.55 -22.34 59.17 1.69 ULMN 3 1m53_c06 ISOMALTULOSE SYNTHASE user 7 3 # 7 A 241 ASP A 122 ASP^? 7.46 C1 GOL A 150 A 279 GLU A 75 GLU.? -8.03 O4 PGE A 147s A 369 ASP A 6 ASP.? -3.91 C9 2PE A 148s coo 11.74 38.14 80.19 10.63 36.40 80.65 -15.41 64.92 4.51 -15.09 66.83 5.33 coo 16.54 46.37 63.94 14.77 45.79 62.95 -34.40 63.01 2.19 -36.49 63.07 2.67 coo 12.19 31.08 87.29 11.13 32.66 86.38 -8.66 61.41 13.34 -8.76 59.35 12.80 ULMN 3 1m53_c06 ISOMALTULOSE SYNTHASE user 8 3 # 8 A 241 ASP B 6 ASP.? -3.99 C6 PE8 B 148s A 279 GLU B 102 GLU~? 6.18 O4 SO4 A 143 A 369 ASP B 122 ASP^? 7.33 O2 GOL B 149 coo 11.74 38.14 80.19 10.63 36.40 80.65 7.95 70.39 41.39 8.88 71.08 39.61 coo 16.54 46.37 63.94 14.77 45.79 62.95 -7.10 67.86 29.77 -6.34 66.05 29.12 coo 12.19 31.08 87.29 11.13 32.66 86.38 10.89 79.68 47.57 9.75 78.80 49.16 ULMN 3 1m53_c06 ISOMALTULOSE SYNTHASE user 9 3 # 9 A 241 ASP B 56 ASP~? 11.45 C20 PE8 B 148 A 279 GLU B 43 GLU.? 6.93 O1 PEG B 144 A 369 ASP B 106 ASP~? 11.87 OH2 1PE B 150 coo 11.74 38.14 80.19 10.63 36.40 80.65 6.80 78.21 26.00 8.47 79.07 25.03 coo 16.54 46.37 63.94 14.77 45.79 62.95 25.26 83.58 33.36 26.25 82.60 35.01 coo 12.19 31.08 87.29 11.13 32.66 86.38 -0.30 70.27 27.08 -0.10 70.78 25.05 ULMN 3 1m53_c06 ISOMALTULOSE SYNTHASE user 10 3 # 10 A 241 ASP B 122 ASP^? 7.33 O2 GOL B 149 A 279 GLU B 10 GLU~? 8.46 C3 PE8 B 148 A 369 ASP B 83 ASP.? 9.40 O3 GOL C 149 coo 11.74 38.14 80.19 10.63 36.40 80.65 10.89 79.68 47.57 9.75 78.80 49.16 coo 16.54 46.37 63.94 14.77 45.79 62.95 2.64 60.90 47.80 4.72 61.28 47.03 coo 12.19 31.08 87.29 11.13 32.66 86.38 13.62 86.10 55.23 12.83 84.59 56.49 ULMN 3 1m53_c06 ISOMALTULOSE SYNTHASE user 11 3 # 11 A 241 ASP B 122 ASP^? 7.33 O2 GOL B 149 A 279 GLU B 10 GLU~? 8.46 C3 PE8 B 148 A 369 ASP B 87 ASP.? 8.94 O4 PGE B 147 coo 11.74 38.14 80.19 10.63 36.40 80.65 10.89 79.68 47.57 9.75 78.80 49.16 coo 16.54 46.37 63.94 14.77 45.79 62.95 2.64 60.90 47.80 4.72 61.28 47.03 coo 12.19 31.08 87.29 11.13 32.66 86.38 9.49 87.97 42.02 11.31 87.98 43.09 ULMN 3 1m53_c06 ISOMALTULOSE SYNTHASE user 12 3 # 12 A 241 ASP B 122 ASP^? 7.33 O2 GOL B 149 A 279 GLU B 75 GLU.? -3.56 CB MLZ C 129s A 369 ASP B 6 ASP.? -3.99 C6 PE8 B 148s coo 11.74 38.14 80.19 10.63 36.40 80.65 10.89 79.68 47.57 9.75 78.80 49.16 coo 16.54 46.37 63.94 14.77 45.79 62.95 3.68 97.59 46.60 2.29 99.21 46.53 coo 12.19 31.08 87.29 11.13 32.66 86.38 7.95 70.39 41.39 8.88 71.08 39.61 ULMN 3 1m53_c06 ISOMALTULOSE SYNTHASE user 13 3 # 13 A 241 ASP C 6 ASP.? -4.04 C8 PE8 C 148s A 279 GLU C 102 GLU~? 5.77 O1 SO4 C 143 A 369 ASP C 122 ASP^? 7.22 C3 GOL C 149 coo 11.74 38.14 80.19 10.63 36.40 80.65 0.53 91.96 65.64 -1.31 91.68 66.68 coo 16.54 46.37 63.94 14.77 45.79 62.95 -7.47 107.78 58.43 -6.93 108.85 60.16 coo 12.19 31.08 87.29 11.13 32.66 86.38 0.27 81.12 61.60 2.07 81.54 60.53 ULMN 3 1m53_c06 ISOMALTULOSE SYNTHASE user 14 3 # 14 A 241 ASP C 122 ASP^? 7.22 C3 GOL C 149 A 279 GLU C 10 GLU~? 8.32 O4 PE8 C 148 A 369 ASP C 83 ASP.? 8.65 O3 GOL B 149 coo 11.74 38.14 80.19 10.63 36.40 80.65 0.27 81.12 61.60 2.07 81.54 60.53 coo 16.54 46.37 63.94 14.77 45.79 62.95 11.17 98.18 63.71 10.29 96.83 65.21 coo 12.19 31.08 87.29 11.13 32.66 86.38 3.02 71.86 58.06 4.88 72.49 57.24 ULMN 3 1m53_c06 ISOMALTULOSE SYNTHASE user 15 3 # 15 A 241 ASP C 122 ASP^? 7.22 C3 GOL C 149 A 279 GLU C 10 GLU~? 8.32 O4 PE8 C 148 A 369 ASP C 87 ASP.? 8.84 O1 PGE C 147 coo 11.74 38.14 80.19 10.63 36.40 80.65 0.27 81.12 61.60 2.07 81.54 60.53 coo 16.54 46.37 63.94 14.77 45.79 62.95 11.17 98.18 63.71 10.29 96.83 65.21 coo 12.19 31.08 87.29 11.13 32.66 86.38 -9.03 79.00 58.44 -8.21 77.39 59.55 ULMN 3 1m53_c06 ISOMALTULOSE SYNTHASE user 16 3 # 16 A 241 ASP C 122 ASP^? 7.22 C3 GOL C 149 A 279 GLU C 75 GLU.? -8.81 O1 PGE C 147s A 369 ASP C 6 ASP.? -4.04 C8 PE8 C 148s coo 11.74 38.14 80.19 10.63 36.40 80.65 0.27 81.12 61.60 2.07 81.54 60.53 coo 16.54 46.37 63.94 14.77 45.79 62.95 -10.84 73.75 47.59 -11.85 73.47 45.72 coo 12.19 31.08 87.29 11.13 32.66 86.38 0.53 91.96 65.64 -1.31 91.68 66.68 ULMN 3 1m53_c06 ISOMALTULOSE SYNTHASE user 17 3 # 17 A 241 ASP D 6 ASP.? -3.77 C8 2PE D 146s A 279 GLU D 102 GLU~? 11.83 O1 2PE D 146 A 369 ASP D 122 ASP^? 7.49 C3 GOL D 147 coo 11.74 38.14 80.19 10.63 36.40 80.65 -31.03 82.87 1.04 -31.83 84.41 2.29 coo 16.54 46.37 63.94 14.77 45.79 62.95 -48.79 75.67 2.61 -49.51 76.91 1.13 coo 12.19 31.08 87.29 11.13 32.66 86.38 -21.82 80.90 7.85 -21.38 79.32 6.51 ULMN 3 1m53_c06 ISOMALTULOSE SYNTHASE user 18 3 # 18 A 241 ASP D 56 ASP~? 11.46 C21 2PE D 146 A 279 GLU D 43 GLU.? 21.91 OH7 1PE B 150 A 369 ASP D 106 ASP~? 11.82 O22 2PE D 146 coo 11.74 38.14 80.19 10.63 36.40 80.65 -41.85 87.81 13.66 -41.61 89.58 14.80 coo 16.54 46.37 63.94 14.77 45.79 62.95 -25.19 99.19 16.02 -23.48 99.27 14.73 coo 12.19 31.08 87.29 11.13 32.66 86.38 -46.82 82.57 5.87 -48.37 83.43 7.00 ULMN 3 1m53_c06 ISOMALTULOSE SYNTHASE user 19 3 # 19 A 241 ASP D 122 ASP^? 7.49 C3 GOL D 147 A 279 GLU D 10 GLU~? 10.92 C5 2PE D 146 A 369 ASP D 83 ASP.? 8.76 O1 GOL A 150 coo 11.74 38.14 80.19 10.63 36.40 80.65 -21.82 80.90 7.85 -21.38 79.32 6.51 coo 16.54 46.37 63.94 14.77 45.79 62.95 -31.21 76.98 -9.53 -30.22 76.65 -11.38 coo 12.19 31.08 87.29 11.13 32.66 86.38 -12.54 78.43 10.94 -12.46 77.06 9.29 ULMN 3 1m53_c06 ISOMALTULOSE SYNTHASE user 20 3 # 20 A 241 ASP D 122 ASP^? 7.49 C3 GOL D 147 A 279 GLU D 10 GLU~? 10.92 C5 2PE D 146 A 369 ASP D 87 ASP.? 7.26 C16 1PE B 150 coo 11.74 38.14 80.19 10.63 36.40 80.65 -21.82 80.90 7.85 -21.38 79.32 6.51 coo 16.54 46.37 63.94 14.77 45.79 62.95 -31.21 76.98 -9.53 -30.22 76.65 -11.38 coo 12.19 31.08 87.29 11.13 32.66 86.38 -24.70 80.89 17.41 -22.90 81.94 17.31 ULMN 3 1m53_c06 ISOMALTULOSE SYNTHASE user 21 3 # 21 A 241 ASP D 122 ASP^? 7.49 C3 GOL D 147 A 279 GLU D 75 GLU.? -3.59 CB MLZ A 129s A 369 ASP D 6 ASP.? -3.77 C8 2PE D 146s coo 11.74 38.14 80.19 10.63 36.40 80.65 -21.82 80.90 7.85 -21.38 79.32 6.51 coo 16.54 46.37 63.94 14.77 45.79 62.95 -21.02 72.19 24.99 -21.34 70.79 26.58 coo 12.19 31.08 87.29 11.13 32.66 86.38 -31.03 82.87 1.04 -31.83 84.41 2.29 1m53_c06 source 1m53 ISOMALTULOSE SYNTHASE : 21 hits 1m53_c06 naa= 3 ULMN 3 1mpp_c04 PEPSIN (RENIN) (E.C.3.4.23.23) user 1 3 # 1 32 ASP A 19 ASP.? -3.59 O4 SO4 A 144s 35 SER B 96 SER~? 7.21 O4 SO4 A 144 215 ASP B 19 ASP.? -3.77 O3 SO4 A 144s coo 20.97 14.47 32.28 19.66 15.96 31.62 -15.01 66.98 32.71 -14.52 68.02 34.44 coo 16.04 14.72 33.82 17.27 13.71 31.95 -12.28 72.78 35.88 -11.90 71.42 33.88 coo 20.65 22.00 33.80 20.06 20.56 32.39 -12.63 65.75 40.21 -14.11 64.30 40.60 1mpp_c04 source 1mpp PEPSIN (RENIN) (E.C.3.4.23.23) : 1 hits 1mpp_c04 naa= 3 ULMN 3 1mro_c00 METHYL-COENZYME M REDUCTASE user 1 3 # 1 A 465 GLY A 72 GLY.? 8.27 O MLY D 135 A 501 ASP D 87 ASP.? 7.26 C16 1PE B 150 B 367 TYR A 38 TYR.? 14.78 C11 2PE A 148 coo 4.40 25.46 -23.33 5.00 25.87 -23.68 -31.88 60.72 9.60 -31.18 60.35 9.56 coo 13.82 6.17 -29.83 11.78 5.87 -29.33 -24.70 80.89 17.41 -22.90 81.94 17.31 coo 27.05 35.80 -12.24 28.72 34.05 -10.85 -8.94 48.99 5.06 -11.42 48.37 6.17 ULMN 3 1mro_c00 METHYL-COENZYME M REDUCTASE user 2 3 # 2 A 465 GLY A 80 GLY.? 7.76 C1 GOL D 147 A 501 ASP D 19 ASP.? -13.24 C2 PGE A 147s B 367 TYR A 94 TYR^? 4.94 CL CL A 145s coo 4.40 25.46 -23.33 5.00 25.87 -23.68 -25.41 75.48 2.13 -25.84 75.58 1.39 coo 13.82 6.17 -29.83 11.78 5.87 -29.33 -43.72 66.33 -2.80 -44.54 65.10 -4.29 coo 27.05 35.80 -12.24 28.72 34.05 -10.85 -21.59 58.91 24.53 -21.03 57.83 22.04 ULMN 3 1mro_c00 METHYL-COENZYME M REDUCTASE user 3 3 # 3 A 465 GLY A 80 GLY.? 7.76 C1 GOL D 147 A 501 ASP D 56 ASP~? 11.46 C21 2PE D 146 B 367 TYR A 94 TYR^? 4.94 CL CL A 145s coo 4.40 25.46 -23.33 5.00 25.87 -23.68 -25.41 75.48 2.13 -25.84 75.58 1.39 coo 13.82 6.17 -29.83 11.78 5.87 -29.33 -41.85 87.81 13.66 -41.61 89.58 14.80 coo 27.05 35.80 -12.24 28.72 34.05 -10.85 -21.59 58.91 24.53 -21.03 57.83 22.04 ULMN 3 1mro_c00 METHYL-COENZYME M REDUCTASE user 4 3 # 4 A 465 GLY B 22 GLY.? 4.26 C1 PEG B 146 A 501 ASP D 87 ASP.? 7.26 C16 1PE B 150 B 367 TYR B 50 TYR~? 5.52 CH1 MLY C 135 coo 4.40 25.46 -23.33 5.00 25.87 -23.68 -16.69 74.52 39.34 -16.05 74.06 39.06 coo 13.82 6.17 -29.83 11.78 5.87 -29.33 -24.70 80.89 17.41 -22.90 81.94 17.31 coo 27.05 35.80 -12.24 28.72 34.05 -10.85 8.51 83.11 35.90 5.93 82.51 36.84 ULMN 3 1mro_c00 METHYL-COENZYME M REDUCTASE user 5 3 # 5 A 465 GLY B 65 GLY.? 4.50 C13 1PE B 150 A 501 ASP A 6 ASP.? -3.91 C9 2PE A 148s B 367 TYR B 38 TYR.? 9.60 O1 PEG B 144 coo 4.40 25.46 -23.33 5.00 25.87 -23.68 -9.71 78.10 29.60 -8.92 78.05 29.76 coo 13.82 6.17 -29.83 11.78 5.87 -29.33 -8.66 61.41 13.34 -8.76 59.35 12.80 coo 27.05 35.80 -12.24 28.72 34.05 -10.85 18.19 76.55 32.34 16.15 78.24 31.46 ULMN 3 1mro_c00 METHYL-COENZYME M REDUCTASE user 6 3 # 6 A 465 GLY B 65 GLY.? 4.50 C13 1PE B 150 A 501 ASP B 6 ASP.? -3.99 C6 PE8 B 148s B 367 TYR A 109 TYR~? -5.64 O16 2PE A 148s coo 4.40 25.46 -23.33 5.00 25.87 -23.68 -9.71 78.10 29.60 -8.92 78.05 29.76 coo 13.82 6.17 -29.83 11.78 5.87 -29.33 7.95 70.39 41.39 8.88 71.08 39.61 coo 27.05 35.80 -12.24 28.72 34.05 -10.85 -13.81 52.60 20.09 -14.53 54.76 18.49 ULMN 3 1mro_c00 METHYL-COENZYME M REDUCTASE user 7 3 # 7 A 465 GLY B 66 GLY.? -2.40 N MLZ B 67s A 501 ASP D 83 ASP.? 8.76 O1 GOL A 150 B 367 TYR B 38 TYR.? 9.60 O1 PEG B 144 coo 4.40 25.46 -23.33 5.00 25.87 -23.68 -6.97 79.43 31.86 -7.37 79.83 31.22 coo 13.82 6.17 -29.83 11.78 5.87 -29.33 -12.54 78.43 10.94 -12.46 77.06 9.29 coo 27.05 35.80 -12.24 28.72 34.05 -10.85 18.19 76.55 32.34 16.15 78.24 31.46 ULMN 3 1mro_c00 METHYL-COENZYME M REDUCTASE user 8 3 # 8 A 465 GLY B 72 GLY.? 3.37 O MLZ C 129 A 501 ASP C 87 ASP.? 8.84 O1 PGE C 147 B 367 TYR B 38 TYR.? 9.60 O1 PEG B 144 coo 4.40 25.46 -23.33 5.00 25.87 -23.68 -0.49 92.37 42.04 0.02 91.83 41.70 coo 13.82 6.17 -29.83 11.78 5.87 -29.33 -9.03 79.00 58.44 -8.21 77.39 59.55 coo 27.05 35.80 -12.24 28.72 34.05 -10.85 18.19 76.55 32.34 16.15 78.24 31.46 ULMN 3 1mro_c00 METHYL-COENZYME M REDUCTASE user 9 3 # 9 A 465 GLY B 80 GLY.? 7.38 C3 GOL C 149 A 501 ASP C 19 ASP.? 9.43 O3 SO4 C 143 B 367 TYR B 94 TYR^? -5.06 CL CL B 143s coo 4.40 25.46 -23.33 5.00 25.87 -23.68 4.67 87.66 58.38 5.02 88.38 58.71 coo 13.82 6.17 -29.83 11.78 5.87 -29.33 2.21 107.45 51.42 3.36 109.08 50.82 coo 27.05 35.80 -12.24 28.72 34.05 -10.85 -6.97 76.65 35.26 -4.34 77.53 35.11 ULMN 3 1mro_c00 METHYL-COENZYME M REDUCTASE user 10 3 # 10 A 465 GLY B 80 GLY.? 7.38 C3 GOL C 149 A 501 ASP C 56 ASP~? 9.09 N MLZ C 114 B 367 TYR B 94 TYR^? -5.06 CL CL B 143s coo 4.40 25.46 -23.33 5.00 25.87 -23.68 4.67 87.66 58.38 5.02 88.38 58.71 coo 13.82 6.17 -29.83 11.78 5.87 -29.33 -16.40 94.43 66.11 -17.63 93.56 67.58 coo 27.05 35.80 -12.24 28.72 34.05 -10.85 -6.97 76.65 35.26 -4.34 77.53 35.11 ULMN 3 1mro_c00 METHYL-COENZYME M REDUCTASE user 11 3 # 11 A 465 GLY C 72 GLY.? 8.73 CH1 MLY B 135 A 501 ASP B 87 ASP.? 8.94 O4 PGE B 147 B 367 TYR C 38 TYR.? 5.20 O MLZ C 114 coo 4.40 25.46 -23.33 5.00 25.87 -23.68 -11.64 81.75 48.16 -11.60 81.98 48.95 coo 13.82 6.17 -29.83 11.78 5.87 -29.33 9.49 87.97 42.02 11.31 87.98 43.09 coo 27.05 35.80 -12.24 28.72 34.05 -10.85 -10.37 86.21 74.10 -12.04 86.61 71.91 ULMN 3 1mro_c00 METHYL-COENZYME M REDUCTASE user 12 3 # 12 A 465 GLY C 80 GLY.? 7.77 O2 GOL B 149 A 501 ASP B 19 ASP.? -3.77 O3 SO4 A 144s B 367 TYR C 94 TYR^? 5.01 CL CL C 144s coo 4.40 25.46 -23.33 5.00 25.87 -23.68 4.31 74.26 49.15 4.26 73.42 48.97 coo 13.82 6.17 -29.83 11.78 5.87 -29.33 -12.63 65.75 40.21 -14.11 64.30 40.60 coo 27.05 35.80 -12.24 28.72 34.05 -10.85 -8.07 99.17 52.54 -8.69 97.12 54.34 ULMN 3 1mro_c00 METHYL-COENZYME M REDUCTASE user 13 3 # 13 A 465 GLY C 80 GLY.? 7.77 O2 GOL B 149 A 501 ASP B 56 ASP~? 11.45 C20 PE8 B 148 B 367 TYR C 94 TYR^? 5.01 CL CL C 144s coo 4.40 25.46 -23.33 5.00 25.87 -23.68 4.31 74.26 49.15 4.26 73.42 48.97 coo 13.82 6.17 -29.83 11.78 5.87 -29.33 6.80 78.21 26.00 8.47 79.07 25.03 coo 27.05 35.80 -12.24 28.72 34.05 -10.85 -8.07 99.17 52.54 -8.69 97.12 54.34 ULMN 3 1mro_c00 METHYL-COENZYME M REDUCTASE user 14 3 # 14 A 465 GLY D 72 GLY.? 3.28 O MLZ A 129 A 501 ASP A 87 ASP.? 8.49 C6 PGE A 147 B 367 TYR D 38 TYR.? 14.74 C9 2PE D 146 coo 4.40 25.46 -23.33 5.00 25.87 -23.68 -28.40 71.61 21.66 -28.57 72.28 21.25 coo 13.82 6.17 -29.83 11.78 5.87 -29.33 -23.17 58.67 3.55 -22.34 59.17 1.69 coo 27.05 35.80 -12.24 28.72 34.05 -10.85 -31.57 94.95 9.95 -32.83 93.25 11.77 ULMN 3 1mro_c00 METHYL-COENZYME M REDUCTASE user 15 3 # 15 A 465 GLY D 80 GLY.? 7.47 C2 GOL A 150 A 501 ASP A 19 ASP.? -3.59 O4 SO4 A 144s B 367 TYR D 94 TYR^? -4.97 CL CL D 143s coo 4.40 25.46 -23.33 5.00 25.87 -23.68 -13.78 69.07 11.78 -13.14 69.11 12.34 coo 13.82 6.17 -29.83 11.78 5.87 -29.33 -15.01 66.98 32.71 -14.52 68.02 34.44 coo 27.05 35.80 -12.24 28.72 34.05 -10.85 -41.68 71.74 9.13 -40.22 73.97 9.96 ULMN 3 1mro_c00 METHYL-COENZYME M REDUCTASE user 16 3 # 16 A 465 GLY D 80 GLY.? 7.47 C2 GOL A 150 A 501 ASP A 56 ASP~? 11.59 C21 2PE A 148 B 367 TYR B 94 TYR^? -5.06 CL CL B 143s coo 4.40 25.46 -23.33 5.00 25.87 -23.68 -13.78 69.07 11.78 -13.14 69.11 12.34 coo 13.82 6.17 -29.83 11.78 5.87 -29.33 -16.01 45.89 15.64 -15.93 44.31 14.23 coo 27.05 35.80 -12.24 28.72 34.05 -10.85 -6.97 76.65 35.26 -4.34 77.53 35.11 ULMN 3 1mro_c00 METHYL-COENZYME M REDUCTASE user 17 3 # 17 A 465 GLY D 80 GLY.? 7.47 C2 GOL A 150 A 501 ASP A 56 ASP~? 11.59 C21 2PE A 148 B 367 TYR D 94 TYR^? -4.97 CL CL D 143s coo 4.40 25.46 -23.33 5.00 25.87 -23.68 -13.78 69.07 11.78 -13.14 69.11 12.34 coo 13.82 6.17 -29.83 11.78 5.87 -29.33 -16.01 45.89 15.64 -15.93 44.31 14.23 coo 27.05 35.80 -12.24 28.72 34.05 -10.85 -41.68 71.74 9.13 -40.22 73.97 9.96 1mro_c00 source 1mro METHYL-COENZYME M REDUCTASE : 17 hits 1mro_c00 naa= 3 ULMN 3 1mro_c01 METHYL-COENZYME M REDUCTASE user 1 3 # 1 D 465 GLY A 72 GLY.? 8.27 O MLY D 135 D 501 ASP D 87 ASP.? 7.26 C16 1PE B 150 E 367 TYR A 38 TYR.? 14.78 C11 2PE A 148 coo 21.60 60.44 -42.77 21.61 59.72 -42.40 -31.88 60.72 9.60 -31.18 60.35 9.56 coo 42.23 65.30 -35.49 41.21 67.05 -36.13 -24.70 80.89 17.41 -22.90 81.94 17.31 coo 28.27 36.08 -52.91 30.75 35.88 -54.18 -8.94 48.99 5.06 -11.42 48.37 6.17 ULMN 3 1mro_c01 METHYL-COENZYME M REDUCTASE user 2 3 # 2 D 465 GLY A 80 GLY.? 7.76 C1 GOL D 147 D 501 ASP D 19 ASP.? -13.24 C2 PGE A 147s E 367 TYR A 94 TYR^? 4.94 CL CL A 145s coo 21.60 60.44 -42.77 21.61 59.72 -42.40 -25.41 75.48 2.13 -25.84 75.58 1.39 coo 42.23 65.30 -35.49 41.21 67.05 -36.13 -43.72 66.33 -2.80 -44.54 65.10 -4.29 coo 28.27 36.08 -52.91 30.75 35.88 -54.18 -21.59 58.91 24.53 -21.03 57.83 22.04 ULMN 3 1mro_c01 METHYL-COENZYME M REDUCTASE user 3 3 # 3 D 465 GLY A 80 GLY.? 7.76 C1 GOL D 147 D 501 ASP D 56 ASP~? 11.46 C21 2PE D 146 E 367 TYR A 94 TYR^? 4.94 CL CL A 145s coo 21.60 60.44 -42.77 21.61 59.72 -42.40 -25.41 75.48 2.13 -25.84 75.58 1.39 coo 42.23 65.30 -35.49 41.21 67.05 -36.13 -41.85 87.81 13.66 -41.61 89.58 14.80 coo 28.27 36.08 -52.91 30.75 35.88 -54.18 -21.59 58.91 24.53 -21.03 57.83 22.04 ULMN 3 1mro_c01 METHYL-COENZYME M REDUCTASE user 4 3 # 4 D 465 GLY B 22 GLY.? 4.26 C1 PEG B 146 D 501 ASP D 87 ASP.? 7.26 C16 1PE B 150 E 367 TYR B 50 TYR~? 5.52 CH1 MLY C 135 coo 21.60 60.44 -42.77 21.61 59.72 -42.40 -16.69 74.52 39.34 -16.05 74.06 39.06 coo 42.23 65.30 -35.49 41.21 67.05 -36.13 -24.70 80.89 17.41 -22.90 81.94 17.31 coo 28.27 36.08 -52.91 30.75 35.88 -54.18 8.51 83.11 35.90 5.93 82.51 36.84 ULMN 3 1mro_c01 METHYL-COENZYME M REDUCTASE user 5 3 # 5 D 465 GLY B 65 GLY.? 4.50 C13 1PE B 150 D 501 ASP A 6 ASP.? -3.91 C9 2PE A 148s E 367 TYR B 38 TYR.? 9.60 O1 PEG B 144 coo 21.60 60.44 -42.77 21.61 59.72 -42.40 -9.71 78.10 29.60 -8.92 78.05 29.76 coo 42.23 65.30 -35.49 41.21 67.05 -36.13 -8.66 61.41 13.34 -8.76 59.35 12.80 coo 28.27 36.08 -52.91 30.75 35.88 -54.18 18.19 76.55 32.34 16.15 78.24 31.46 ULMN 3 1mro_c01 METHYL-COENZYME M REDUCTASE user 6 3 # 6 D 465 GLY B 65 GLY.? 4.50 C13 1PE B 150 D 501 ASP B 6 ASP.? -3.99 C6 PE8 B 148s E 367 TYR A 109 TYR~? -5.64 O16 2PE A 148s coo 21.60 60.44 -42.77 21.61 59.72 -42.40 -9.71 78.10 29.60 -8.92 78.05 29.76 coo 42.23 65.30 -35.49 41.21 67.05 -36.13 7.95 70.39 41.39 8.88 71.08 39.61 coo 28.27 36.08 -52.91 30.75 35.88 -54.18 -13.81 52.60 20.09 -14.53 54.76 18.49 ULMN 3 1mro_c01 METHYL-COENZYME M REDUCTASE user 7 3 # 7 D 465 GLY B 66 GLY.? -2.40 N MLZ B 67s D 501 ASP D 83 ASP.? 8.76 O1 GOL A 150 E 367 TYR B 38 TYR.? 9.60 O1 PEG B 144 coo 21.60 60.44 -42.77 21.61 59.72 -42.40 -6.97 79.43 31.86 -7.37 79.83 31.22 coo 42.23 65.30 -35.49 41.21 67.05 -36.13 -12.54 78.43 10.94 -12.46 77.06 9.29 coo 28.27 36.08 -52.91 30.75 35.88 -54.18 18.19 76.55 32.34 16.15 78.24 31.46 ULMN 3 1mro_c01 METHYL-COENZYME M REDUCTASE user 8 3 # 8 D 465 GLY B 72 GLY.? 3.37 O MLZ C 129 D 501 ASP C 87 ASP.? 8.84 O1 PGE C 147 E 367 TYR B 38 TYR.? 9.60 O1 PEG B 144 coo 21.60 60.44 -42.77 21.61 59.72 -42.40 -0.49 92.37 42.04 0.02 91.83 41.70 coo 42.23 65.30 -35.49 41.21 67.05 -36.13 -9.03 79.00 58.44 -8.21 77.39 59.55 coo 28.27 36.08 -52.91 30.75 35.88 -54.18 18.19 76.55 32.34 16.15 78.24 31.46 ULMN 3 1mro_c01 METHYL-COENZYME M REDUCTASE user 9 3 # 9 D 465 GLY B 80 GLY.? 7.38 C3 GOL C 149 D 501 ASP C 19 ASP.? 9.43 O3 SO4 C 143 E 367 TYR B 94 TYR^? -5.06 CL CL B 143s coo 21.60 60.44 -42.77 21.61 59.72 -42.40 4.67 87.66 58.38 5.02 88.38 58.71 coo 42.23 65.30 -35.49 41.21 67.05 -36.13 2.21 107.45 51.42 3.36 109.08 50.82 coo 28.27 36.08 -52.91 30.75 35.88 -54.18 -6.97 76.65 35.26 -4.34 77.53 35.11 ULMN 3 1mro_c01 METHYL-COENZYME M REDUCTASE user 10 3 # 10 D 465 GLY B 80 GLY.? 7.38 C3 GOL C 149 D 501 ASP C 56 ASP~? 9.09 N MLZ C 114 E 367 TYR B 94 TYR^? -5.06 CL CL B 143s coo 21.60 60.44 -42.77 21.61 59.72 -42.40 4.67 87.66 58.38 5.02 88.38 58.71 coo 42.23 65.30 -35.49 41.21 67.05 -36.13 -16.40 94.43 66.11 -17.63 93.56 67.58 coo 28.27 36.08 -52.91 30.75 35.88 -54.18 -6.97 76.65 35.26 -4.34 77.53 35.11 ULMN 3 1mro_c01 METHYL-COENZYME M REDUCTASE user 11 3 # 11 D 465 GLY C 72 GLY.? 8.73 CH1 MLY B 135 D 501 ASP B 87 ASP.? 8.94 O4 PGE B 147 E 367 TYR C 38 TYR.? 5.20 O MLZ C 114 coo 21.60 60.44 -42.77 21.61 59.72 -42.40 -11.64 81.75 48.16 -11.60 81.98 48.95 coo 42.23 65.30 -35.49 41.21 67.05 -36.13 9.49 87.97 42.02 11.31 87.98 43.09 coo 28.27 36.08 -52.91 30.75 35.88 -54.18 -10.37 86.21 74.10 -12.04 86.61 71.91 ULMN 3 1mro_c01 METHYL-COENZYME M REDUCTASE user 12 3 # 12 D 465 GLY C 80 GLY.? 7.77 O2 GOL B 149 D 501 ASP B 19 ASP.? -3.77 O3 SO4 A 144s E 367 TYR C 94 TYR^? 5.01 CL CL C 144s coo 21.60 60.44 -42.77 21.61 59.72 -42.40 4.31 74.26 49.15 4.26 73.42 48.97 coo 42.23 65.30 -35.49 41.21 67.05 -36.13 -12.63 65.75 40.21 -14.11 64.30 40.60 coo 28.27 36.08 -52.91 30.75 35.88 -54.18 -8.07 99.17 52.54 -8.69 97.12 54.34 ULMN 3 1mro_c01 METHYL-COENZYME M REDUCTASE user 13 3 # 13 D 465 GLY C 80 GLY.? 7.77 O2 GOL B 149 D 501 ASP B 56 ASP~? 11.45 C20 PE8 B 148 E 367 TYR C 94 TYR^? 5.01 CL CL C 144s coo 21.60 60.44 -42.77 21.61 59.72 -42.40 4.31 74.26 49.15 4.26 73.42 48.97 coo 42.23 65.30 -35.49 41.21 67.05 -36.13 6.80 78.21 26.00 8.47 79.07 25.03 coo 28.27 36.08 -52.91 30.75 35.88 -54.18 -8.07 99.17 52.54 -8.69 97.12 54.34 ULMN 3 1mro_c01 METHYL-COENZYME M REDUCTASE user 14 3 # 14 D 465 GLY D 72 GLY.? 3.28 O MLZ A 129 D 501 ASP A 87 ASP.? 8.49 C6 PGE A 147 E 367 TYR D 38 TYR.? 14.74 C9 2PE D 146 coo 21.60 60.44 -42.77 21.61 59.72 -42.40 -28.40 71.61 21.66 -28.57 72.28 21.25 coo 42.23 65.30 -35.49 41.21 67.05 -36.13 -23.17 58.67 3.55 -22.34 59.17 1.69 coo 28.27 36.08 -52.91 30.75 35.88 -54.18 -31.57 94.95 9.95 -32.83 93.25 11.77 ULMN 3 1mro_c01 METHYL-COENZYME M REDUCTASE user 15 3 # 15 D 465 GLY D 80 GLY.? 7.47 C2 GOL A 150 D 501 ASP A 19 ASP.? -3.59 O4 SO4 A 144s E 367 TYR D 94 TYR^? -4.97 CL CL D 143s coo 21.60 60.44 -42.77 21.61 59.72 -42.40 -13.78 69.07 11.78 -13.14 69.11 12.34 coo 42.23 65.30 -35.49 41.21 67.05 -36.13 -15.01 66.98 32.71 -14.52 68.02 34.44 coo 28.27 36.08 -52.91 30.75 35.88 -54.18 -41.68 71.74 9.13 -40.22 73.97 9.96 ULMN 3 1mro_c01 METHYL-COENZYME M REDUCTASE user 16 3 # 16 D 465 GLY D 80 GLY.? 7.47 C2 GOL A 150 D 501 ASP A 56 ASP~? 11.59 C21 2PE A 148 E 367 TYR B 94 TYR^? -5.06 CL CL B 143s coo 21.60 60.44 -42.77 21.61 59.72 -42.40 -13.78 69.07 11.78 -13.14 69.11 12.34 coo 42.23 65.30 -35.49 41.21 67.05 -36.13 -16.01 45.89 15.64 -15.93 44.31 14.23 coo 28.27 36.08 -52.91 30.75 35.88 -54.18 -6.97 76.65 35.26 -4.34 77.53 35.11 ULMN 3 1mro_c01 METHYL-COENZYME M REDUCTASE user 17 3 # 17 D 465 GLY D 80 GLY.? 7.47 C2 GOL A 150 D 501 ASP A 56 ASP~? 11.59 C21 2PE A 148 E 367 TYR B 109 TYR~? -5.65 O13 PE8 B 148s coo 21.60 60.44 -42.77 21.61 59.72 -42.40 -13.78 69.07 11.78 -13.14 69.11 12.34 coo 42.23 65.30 -35.49 41.21 67.05 -36.13 -16.01 45.89 15.64 -15.93 44.31 14.23 coo 28.27 36.08 -52.91 30.75 35.88 -54.18 2.41 73.03 30.76 2.68 74.03 33.35 ULMN 3 1mro_c01 METHYL-COENZYME M REDUCTASE user 18 3 # 18 D 465 GLY D 80 GLY.? 7.47 C2 GOL A 150 D 501 ASP A 56 ASP~? 11.59 C21 2PE A 148 E 367 TYR D 94 TYR^? -4.97 CL CL D 143s coo 21.60 60.44 -42.77 21.61 59.72 -42.40 -13.78 69.07 11.78 -13.14 69.11 12.34 coo 42.23 65.30 -35.49 41.21 67.05 -36.13 -16.01 45.89 15.64 -15.93 44.31 14.23 coo 28.27 36.08 -52.91 30.75 35.88 -54.18 -41.68 71.74 9.13 -40.22 73.97 9.96 1mro_c01 source 1mro METHYL-COENZYME M REDUCTASE : 18 hits 1mro_c01 naa= 3 ULMN 3 1mrq_c02 ALDO-KETO REDUCTASE FAMILY 1 MEMBER user 1 3 # 1 A 50 ASP A 56 ASP~? 11.59 C21 2PE A 148 A 55 TYR A 53 TYR~? -4.55 C21 2PE A 148s A 84 LYS A 114 LYS~? 11.27 C9 2PE A 148 coo 11.09 42.89 24.44 11.32 42.06 22.49 -16.01 45.89 15.64 -15.93 44.31 14.23 coo 4.60 40.33 20.42 7.25 39.50 20.05 -16.76 52.42 13.05 -16.88 54.33 15.10 coo 9.71 44.83 15.47 10.13 41.43 19.93 -9.49 51.50 12.13 -4.59 48.44 14.69 ULMN 3 1mrq_c02 ALDO-KETO REDUCTASE FAMILY 1 MEMBER user 2 3 # 2 A 50 ASP A 56 ASP~? 11.59 C21 2PE A 148 A 55 TYR A 109 TYR~? -5.64 O16 2PE A 148s A 84 LYS A 114 LYS~? 11.27 C9 2PE A 148 coo 11.09 42.89 24.44 11.32 42.06 22.49 -16.01 45.89 15.64 -15.93 44.31 14.23 coo 4.60 40.33 20.42 7.25 39.50 20.05 -13.81 52.60 20.09 -14.53 54.76 18.49 coo 9.71 44.83 15.47 10.13 41.43 19.93 -9.49 51.50 12.13 -4.59 48.44 14.69 ULMN 3 1mrq_c02 ALDO-KETO REDUCTASE FAMILY 1 MEMBER user 3 3 # 3 A 50 ASP B 56 ASP~? 11.45 C20 PE8 B 148 A 55 TYR B 53 TYR~? -4.63 C18 PE8 B 148s A 84 LYS B 114 LYS~? 11.34 O7 PE8 B 148 coo 11.09 42.89 24.44 11.32 42.06 22.49 6.80 78.21 26.00 8.47 79.07 25.03 coo 4.60 40.33 20.42 7.25 39.50 20.05 6.73 78.96 33.00 4.51 77.73 34.14 coo 9.71 44.83 15.47 10.13 41.43 19.93 11.35 73.22 32.47 12.65 68.43 28.61 ULMN 3 1mrq_c02 ALDO-KETO REDUCTASE FAMILY 1 MEMBER user 4 3 # 4 A 50 ASP B 56 ASP~? 11.45 C20 PE8 B 148 A 55 TYR B 109 TYR~? -5.65 O13 PE8 B 148s A 84 LYS B 114 LYS~? 11.34 O7 PE8 B 148 coo 11.09 42.89 24.44 11.32 42.06 22.49 6.80 78.21 26.00 8.47 79.07 25.03 coo 4.60 40.33 20.42 7.25 39.50 20.05 2.41 73.03 30.76 2.68 74.03 33.35 coo 9.71 44.83 15.47 10.13 41.43 19.93 11.35 73.22 32.47 12.65 68.43 28.61 ULMN 3 1mrq_c02 ALDO-KETO REDUCTASE FAMILY 1 MEMBER user 5 3 # 5 A 50 ASP D 56 ASP~? 11.46 C21 2PE D 146 A 55 TYR D 53 TYR~? -4.60 C21 2PE D 146s A 84 LYS D 114 LYS~? 10.81 C9 2PE D 146 coo 11.09 42.89 24.44 11.32 42.06 22.49 -41.85 87.81 13.66 -41.61 89.58 14.80 coo 4.60 40.33 20.42 7.25 39.50 20.05 -36.08 84.35 12.01 -36.58 82.07 10.49 coo 9.71 44.83 15.47 10.13 41.43 19.93 -35.88 89.56 6.78 -39.69 93.33 3.49 ULMN 3 1mrq_c02 ALDO-KETO REDUCTASE FAMILY 1 MEMBER user 6 3 # 6 A 50 ASP D 56 ASP~? 11.46 C21 2PE D 146 A 55 TYR D 109 TYR~? -5.82 O16 2PE D 146s A 84 LYS D 114 LYS~? 10.81 C9 2PE D 146 coo 11.09 42.89 24.44 11.32 42.06 22.49 -41.85 87.81 13.66 -41.61 89.58 14.80 coo 4.60 40.33 20.42 7.25 39.50 20.05 -41.76 82.56 7.21 -39.24 81.41 7.29 coo 9.71 44.83 15.47 10.13 41.43 19.93 -35.88 89.56 6.78 -39.69 93.33 3.49 1mrq_c02 source 1mrq ALDO-KETO REDUCTASE FAMILY 1 MEMBER C1 : 6 hits 1mrq_c02 naa= 3 ULMN 3 1n2t_c02 L-CYSTEINE-CYSTINE LYASE C-DES user 1 3 # 1 A 114 HIS A 4 HIS.? -3.92 C2 GOL A 150s A 197 ASP A 6 ASP.? -3.91 C9 2PE A 148s A 223 ALA A 119 ALA~? 10.88 CH2 MLY D 135 coo -61.68 -8.94 -28.01 -61.87 -7.73 -26.31 -11.85 68.18 8.83 -11.23 70.10 8.29 coo -57.09 -14.53 -30.28 -57.60 -13.32 -28.61 -8.66 61.41 13.34 -8.76 59.35 12.80 coo -56.49 -13.76 -16.93 -57.17 -13.93 -18.30 -14.35 54.52 5.55 -15.48 54.02 6.43 ULMN 3 1n2t_c02 L-CYSTEINE-CYSTINE LYASE C-DES user 2 3 # 2 A 114 HIS A 4 HIS.? -3.92 C2 GOL A 150s A 197 ASP A 122 ASP^? 7.46 C1 GOL A 150 A 223 ALA A 118 ALA~? 12.39 C11 2PE A 148 coo -61.68 -8.94 -28.01 -61.87 -7.73 -26.31 -11.85 68.18 8.83 -11.23 70.10 8.29 coo -57.09 -14.53 -30.28 -57.60 -13.32 -28.61 -15.41 64.92 4.51 -15.09 66.83 5.33 coo -56.49 -13.76 -16.93 -57.17 -13.93 -18.30 -10.68 53.61 6.19 -10.55 52.09 6.11 ULMN 3 1n2t_c02 L-CYSTEINE-CYSTINE LYASE C-DES user 3 3 # 3 A 114 HIS A 85 HIS.? 6.69 C5 PGE A 147 A 197 ASP A 122 ASP^? 7.46 C1 GOL A 150 A 223 ALA A 47 ALA~? 9.02 CD MLY D 135 coo -61.68 -8.94 -28.01 -61.87 -7.73 -26.31 -23.05 64.43 -0.55 -21.68 63.00 -1.25 coo -57.09 -14.53 -30.28 -57.60 -13.32 -28.61 -15.41 64.92 4.51 -15.09 66.83 5.33 coo -56.49 -13.76 -16.93 -57.17 -13.93 -18.30 -20.21 51.63 3.44 -21.40 51.48 2.53 ULMN 3 1n2t_c02 L-CYSTEINE-CYSTINE LYASE C-DES user 4 3 # 4 A 114 HIS B 4 HIS.? -3.86 O2 GOL B 149s A 197 ASP B 6 ASP.? -3.99 C6 PE8 B 148s A 223 ALA B 119 ALA~? 10.71 O16 PE8 B 148 coo -61.68 -8.94 -28.01 -61.87 -7.73 -26.31 8.07 73.88 49.16 8.30 73.43 51.19 coo -57.09 -14.53 -30.28 -57.60 -13.32 -28.61 7.95 70.39 41.39 8.88 71.08 39.61 coo -56.49 -13.76 -16.93 -57.17 -13.93 -18.30 13.47 80.03 37.47 12.33 80.66 36.69 ULMN 3 1n2t_c02 L-CYSTEINE-CYSTINE LYASE C-DES user 5 3 # 5 A 114 HIS B 4 HIS.? -3.86 O2 GOL B 149s A 197 ASP B 122 ASP^? 7.33 O2 GOL B 149 A 223 ALA B 118 ALA~? 8.74 O1 PEG B 144 coo -61.68 -8.94 -28.01 -61.87 -7.73 -26.31 8.07 73.88 49.16 8.30 73.43 51.19 coo -57.09 -14.53 -30.28 -57.60 -13.32 -28.61 10.89 79.68 47.57 9.75 78.80 49.16 coo -56.49 -13.76 -16.93 -57.17 -13.93 -18.30 15.05 76.70 36.40 15.62 76.90 35.00 ULMN 3 1n2t_c02 L-CYSTEINE-CYSTINE LYASE C-DES user 6 3 # 6 A 114 HIS B 85 HIS.? 6.66 C6 PGE B 147 A 197 ASP B 122 ASP^? 7.33 O2 GOL B 149 A 223 ALA B 47 ALA~? 9.27 CD MLY C 135 coo -61.68 -8.94 -28.01 -61.87 -7.73 -26.31 11.11 88.86 48.90 12.76 88.34 47.73 coo -57.09 -14.53 -30.28 -57.60 -13.32 -28.61 10.89 79.68 47.57 9.75 78.80 49.16 coo -56.49 -13.76 -16.93 -57.17 -13.93 -18.30 13.13 86.65 35.42 13.34 88.15 35.52 ULMN 3 1n2t_c02 L-CYSTEINE-CYSTINE LYASE C-DES user 7 3 # 7 A 114 HIS C 4 HIS.? -3.73 C3 GOL C 149s A 197 ASP C 6 ASP.? -4.04 C8 PE8 C 148s A 223 ALA C 119 ALA~? 6.80 O MLZ C 114 coo -61.68 -8.94 -28.01 -61.87 -7.73 -26.31 4.88 85.81 61.42 6.80 85.00 61.18 coo -57.09 -14.53 -30.28 -57.60 -13.32 -28.61 0.53 91.96 65.64 -1.31 91.68 66.68 coo -56.49 -13.76 -16.93 -57.17 -13.93 -18.30 -8.25 84.08 66.89 -9.22 84.66 65.88 ULMN 3 1n2t_c02 L-CYSTEINE-CYSTINE LYASE C-DES user 8 3 # 8 A 114 HIS C 4 HIS.? -3.73 C3 GOL C 149s A 197 ASP C 122 ASP^? 7.22 C3 GOL C 149 A 223 ALA C 118 ALA~? 3.71 O MLZ C 114 coo -61.68 -8.94 -28.01 -61.87 -7.73 -26.31 4.88 85.81 61.42 6.80 85.00 61.18 coo -57.09 -14.53 -30.28 -57.60 -13.32 -28.61 0.27 81.12 61.60 2.07 81.54 60.53 coo -56.49 -13.76 -16.93 -57.17 -13.93 -18.30 -7.16 85.94 70.06 -8.41 86.17 70.90 ULMN 3 1n2t_c02 L-CYSTEINE-CYSTINE LYASE C-DES user 9 3 # 9 A 114 HIS C 85 HIS.? 6.34 C1 PGE C 147 A 197 ASP C 122 ASP^? 7.22 C3 GOL C 149 A 223 ALA C 47 ALA~? 8.78 CD MLY B 135 coo -61.68 -8.94 -28.01 -61.87 -7.73 -26.31 -4.08 74.18 57.17 -4.69 74.12 59.17 coo -57.09 -14.53 -30.28 -57.60 -13.32 -28.61 0.27 81.12 61.60 2.07 81.54 60.53 coo -56.49 -13.76 -16.93 -57.17 -13.93 -18.30 -13.73 80.92 64.16 -14.51 79.74 63.61 ULMN 3 1n2t_c02 L-CYSTEINE-CYSTINE LYASE C-DES user 10 3 # 10 A 114 HIS D 4 HIS.? 4.07 C3 GOL D 147 A 197 ASP D 6 ASP.? -3.77 C8 2PE D 146s A 223 ALA D 119 ALA~? 10.88 C18 2PE D 146 coo -61.68 -8.94 -28.01 -61.87 -7.73 -26.31 -23.57 78.63 1.94 -22.01 77.96 0.72 coo -57.09 -14.53 -30.28 -57.60 -13.32 -28.61 -31.03 82.87 1.04 -31.83 84.41 2.29 coo -56.49 -13.76 -16.93 -57.17 -13.93 -18.30 -28.73 87.90 11.52 -29.74 87.21 12.41 ULMN 3 1n2t_c02 L-CYSTEINE-CYSTINE LYASE C-DES user 11 3 # 11 A 114 HIS D 4 HIS.? 4.07 C3 GOL D 147 A 197 ASP D 122 ASP^? 7.49 C3 GOL D 147 A 223 ALA D 118 ALA~? 12.42 C9 2PE D 146 coo -61.68 -8.94 -28.01 -61.87 -7.73 -26.31 -23.57 78.63 1.94 -22.01 77.96 0.72 coo -57.09 -14.53 -30.28 -57.60 -13.32 -28.61 -21.82 80.90 7.85 -21.38 79.32 6.51 coo -56.49 -13.76 -16.93 -57.17 -13.93 -18.30 -29.78 90.27 8.72 -30.62 91.39 9.36 ULMN 3 1n2t_c02 L-CYSTEINE-CYSTINE LYASE C-DES user 12 3 # 12 A 114 HIS D 85 HIS.? 4.73 OH7 1PE B 150 A 197 ASP D 122 ASP^? 7.49 C3 GOL D 147 A 223 ALA D 47 ALA~? 9.03 CG MLY A 135 coo -61.68 -8.94 -28.01 -61.87 -7.73 -26.31 -18.08 79.12 16.04 -18.14 81.21 15.79 coo -57.09 -14.53 -30.28 -57.60 -13.32 -28.61 -21.82 80.90 7.85 -21.38 79.32 6.51 coo -56.49 -13.76 -16.93 -57.17 -13.93 -18.30 -28.68 87.42 18.40 -28.00 87.29 19.73 1n2t_c02 source 1n2t L-CYSTEINE-CYSTINE LYASE C-DES : 12 hits 1n2t_c02 naa= 3 ULMN 3 1n2t_c03 L-CYSTEINE-CYSTINE LYASE C-DES user 1 3 # 1 B 114 HIS A 4 HIS.? -3.92 C2 GOL A 150s B 197 ASP A 6 ASP.? -3.91 C9 2PE A 148s B 223 ALA A 119 ALA~? 10.88 CH2 MLY D 135 coo -32.24 6.73 -26.90 -32.01 5.24 -25.44 -11.85 68.18 8.83 -11.23 70.10 8.29 coo -36.83 12.62 -28.19 -36.31 11.10 -26.78 -8.66 61.41 13.34 -8.76 59.35 12.80 coo -37.23 9.70 -15.15 -36.60 10.10 -16.48 -14.35 54.52 5.55 -15.48 54.02 6.43 ULMN 3 1n2t_c03 L-CYSTEINE-CYSTINE LYASE C-DES user 2 3 # 2 B 114 HIS A 4 HIS.? -3.92 C2 GOL A 150s B 197 ASP A 122 ASP^? 7.46 C1 GOL A 150 B 223 ALA A 118 ALA~? 12.39 C11 2PE A 148 coo -32.24 6.73 -26.90 -32.01 5.24 -25.44 -11.85 68.18 8.83 -11.23 70.10 8.29 coo -36.83 12.62 -28.19 -36.31 11.10 -26.78 -15.41 64.92 4.51 -15.09 66.83 5.33 coo -37.23 9.70 -15.15 -36.60 10.10 -16.48 -10.68 53.61 6.19 -10.55 52.09 6.11 ULMN 3 1n2t_c03 L-CYSTEINE-CYSTINE LYASE C-DES user 3 3 # 3 B 114 HIS A 85 HIS.? 6.69 C5 PGE A 147 B 197 ASP A 122 ASP^? 7.46 C1 GOL A 150 B 223 ALA A 47 ALA~? 9.02 CD MLY D 135 coo -32.24 6.73 -26.90 -32.01 5.24 -25.44 -23.05 64.43 -0.55 -21.68 63.00 -1.25 coo -36.83 12.62 -28.19 -36.31 11.10 -26.78 -15.41 64.92 4.51 -15.09 66.83 5.33 coo -37.23 9.70 -15.15 -36.60 10.10 -16.48 -20.21 51.63 3.44 -21.40 51.48 2.53 ULMN 3 1n2t_c03 L-CYSTEINE-CYSTINE LYASE C-DES user 4 3 # 4 B 114 HIS B 4 HIS.? -3.86 O2 GOL B 149s B 197 ASP B 6 ASP.? -3.99 C6 PE8 B 148s B 223 ALA B 119 ALA~? 10.71 O16 PE8 B 148 coo -32.24 6.73 -26.90 -32.01 5.24 -25.44 8.07 73.88 49.16 8.30 73.43 51.19 coo -36.83 12.62 -28.19 -36.31 11.10 -26.78 7.95 70.39 41.39 8.88 71.08 39.61 coo -37.23 9.70 -15.15 -36.60 10.10 -16.48 13.47 80.03 37.47 12.33 80.66 36.69 ULMN 3 1n2t_c03 L-CYSTEINE-CYSTINE LYASE C-DES user 5 3 # 5 B 114 HIS B 4 HIS.? -3.86 O2 GOL B 149s B 197 ASP B 122 ASP^? 7.33 O2 GOL B 149 B 223 ALA B 118 ALA~? 8.74 O1 PEG B 144 coo -32.24 6.73 -26.90 -32.01 5.24 -25.44 8.07 73.88 49.16 8.30 73.43 51.19 coo -36.83 12.62 -28.19 -36.31 11.10 -26.78 10.89 79.68 47.57 9.75 78.80 49.16 coo -37.23 9.70 -15.15 -36.60 10.10 -16.48 15.05 76.70 36.40 15.62 76.90 35.00 ULMN 3 1n2t_c03 L-CYSTEINE-CYSTINE LYASE C-DES user 6 3 # 6 B 114 HIS B 85 HIS.? 6.66 C6 PGE B 147 B 197 ASP B 122 ASP^? 7.33 O2 GOL B 149 B 223 ALA B 47 ALA~? 9.27 CD MLY C 135 coo -32.24 6.73 -26.90 -32.01 5.24 -25.44 11.11 88.86 48.90 12.76 88.34 47.73 coo -36.83 12.62 -28.19 -36.31 11.10 -26.78 10.89 79.68 47.57 9.75 78.80 49.16 coo -37.23 9.70 -15.15 -36.60 10.10 -16.48 13.13 86.65 35.42 13.34 88.15 35.52 ULMN 3 1n2t_c03 L-CYSTEINE-CYSTINE LYASE C-DES user 7 3 # 7 B 114 HIS C 4 HIS.? -3.73 C3 GOL C 149s B 197 ASP C 6 ASP.? -4.04 C8 PE8 C 148s B 223 ALA C 119 ALA~? 6.80 O MLZ C 114 coo -32.24 6.73 -26.90 -32.01 5.24 -25.44 4.88 85.81 61.42 6.80 85.00 61.18 coo -36.83 12.62 -28.19 -36.31 11.10 -26.78 0.53 91.96 65.64 -1.31 91.68 66.68 coo -37.23 9.70 -15.15 -36.60 10.10 -16.48 -8.25 84.08 66.89 -9.22 84.66 65.88 ULMN 3 1n2t_c03 L-CYSTEINE-CYSTINE LYASE C-DES user 8 3 # 8 B 114 HIS C 4 HIS.? -3.73 C3 GOL C 149s B 197 ASP C 122 ASP^? 7.22 C3 GOL C 149 B 223 ALA C 118 ALA~? 3.71 O MLZ C 114 coo -32.24 6.73 -26.90 -32.01 5.24 -25.44 4.88 85.81 61.42 6.80 85.00 61.18 coo -36.83 12.62 -28.19 -36.31 11.10 -26.78 0.27 81.12 61.60 2.07 81.54 60.53 coo -37.23 9.70 -15.15 -36.60 10.10 -16.48 -7.16 85.94 70.06 -8.41 86.17 70.90 ULMN 3 1n2t_c03 L-CYSTEINE-CYSTINE LYASE C-DES user 9 3 # 9 B 114 HIS C 85 HIS.? 6.34 C1 PGE C 147 B 197 ASP C 122 ASP^? 7.22 C3 GOL C 149 B 223 ALA C 47 ALA~? 8.78 CD MLY B 135 coo -32.24 6.73 -26.90 -32.01 5.24 -25.44 -4.08 74.18 57.17 -4.69 74.12 59.17 coo -36.83 12.62 -28.19 -36.31 11.10 -26.78 0.27 81.12 61.60 2.07 81.54 60.53 coo -37.23 9.70 -15.15 -36.60 10.10 -16.48 -13.73 80.92 64.16 -14.51 79.74 63.61 ULMN 3 1n2t_c03 L-CYSTEINE-CYSTINE LYASE C-DES user 10 3 # 10 B 114 HIS D 4 HIS.? 4.07 C3 GOL D 147 B 197 ASP D 6 ASP.? -3.77 C8 2PE D 146s B 223 ALA D 119 ALA~? 10.88 C18 2PE D 146 coo -32.24 6.73 -26.90 -32.01 5.24 -25.44 -23.57 78.63 1.94 -22.01 77.96 0.72 coo -36.83 12.62 -28.19 -36.31 11.10 -26.78 -31.03 82.87 1.04 -31.83 84.41 2.29 coo -37.23 9.70 -15.15 -36.60 10.10 -16.48 -28.73 87.90 11.52 -29.74 87.21 12.41 ULMN 3 1n2t_c03 L-CYSTEINE-CYSTINE LYASE C-DES user 11 3 # 11 B 114 HIS D 4 HIS.? 4.07 C3 GOL D 147 B 197 ASP D 122 ASP^? 7.49 C3 GOL D 147 B 223 ALA D 118 ALA~? 12.42 C9 2PE D 146 coo -32.24 6.73 -26.90 -32.01 5.24 -25.44 -23.57 78.63 1.94 -22.01 77.96 0.72 coo -36.83 12.62 -28.19 -36.31 11.10 -26.78 -21.82 80.90 7.85 -21.38 79.32 6.51 coo -37.23 9.70 -15.15 -36.60 10.10 -16.48 -29.78 90.27 8.72 -30.62 91.39 9.36 ULMN 3 1n2t_c03 L-CYSTEINE-CYSTINE LYASE C-DES user 12 3 # 12 B 114 HIS D 85 HIS.? 4.73 OH7 1PE B 150 B 197 ASP D 122 ASP^? 7.49 C3 GOL D 147 B 223 ALA D 47 ALA~? 9.03 CG MLY A 135 coo -32.24 6.73 -26.90 -32.01 5.24 -25.44 -18.08 79.12 16.04 -18.14 81.21 15.79 coo -36.83 12.62 -28.19 -36.31 11.10 -26.78 -21.82 80.90 7.85 -21.38 79.32 6.51 coo -37.23 9.70 -15.15 -36.60 10.10 -16.48 -28.68 87.42 18.40 -28.00 87.29 19.73 1n2t_c03 source 1n2t L-CYSTEINE-CYSTINE LYASE C-DES : 12 hits 1n2t_c03 naa= 3 ULMN 3 1ni4_c00 PYRUVATE DEHYDROGENASE E1 COMPONENT:user 1 3 # 1 B 59 GLU A 121 GLU^? 12.41 C1 GOL A 150 B 128 HIS A 88 HIS^? 4.20 CH2 MLY D 135 C 263 HIS A 115 HIS~? 12.27 C21 2PE A 148 coo 6.12 5.94 82.00 7.16 6.32 83.81 -13.98 61.53 0.93 -15.14 61.60 -0.79 coo 12.51 16.35 80.99 13.16 14.90 82.37 -23.95 56.87 7.77 -24.14 54.98 6.86 coo 11.58 14.94 93.26 12.25 14.03 91.50 -13.18 48.35 10.37 -12.55 46.36 10.33 ULMN 3 1ni4_c00 PYRUVATE DEHYDROGENASE E1 COMPONENT:user 2 3 # 2 B 59 GLU B 121 GLU^? 8.74 O2 PEG B 144 B 128 HIS B 88 HIS^? 4.29 CH1 MLY C 135 C 263 HIS B 115 HIS~? 12.48 C18 PE8 B 148 coo 6.12 5.94 82.00 7.16 6.32 83.81 15.37 80.83 45.64 16.23 82.69 46.15 coo 12.51 16.35 80.99 13.16 14.90 82.37 6.15 87.00 38.94 7.35 87.96 37.51 coo 11.58 14.94 93.26 12.25 14.03 91.50 11.86 77.76 30.05 12.70 77.49 28.15 ULMN 3 1ni4_c00 PYRUVATE DEHYDROGENASE E1 COMPONENT:user 3 3 # 3 B 59 GLU C 84 GLU.? 10.77 O2 GOL B 149 B 128 HIS C 4 HIS.? -3.73 C3 GOL C 149s C 263 HIS B 85 HIS.? 6.66 C6 PGE B 147 coo 6.12 5.94 82.00 7.16 6.32 83.81 2.34 77.12 55.01 3.46 78.21 53.60 coo 12.51 16.35 80.99 13.16 14.90 82.37 4.88 85.81 61.42 6.80 85.00 61.18 coo 11.58 14.94 93.26 12.25 14.03 91.50 11.11 88.86 48.90 12.76 88.34 47.73 ULMN 3 1ni4_c00 PYRUVATE DEHYDROGENASE E1 COMPONENT:user 4 3 # 4 B 59 GLU C 121 GLU^? 12.40 C3 GOL C 149 B 128 HIS C 88 HIS^? 3.86 CD MLY B 135 C 263 HIS C 115 HIS~? 4.72 C MLZ C 114 coo 6.12 5.94 82.00 7.16 6.32 83.81 -1.98 78.69 65.48 -2.54 76.71 65.06 coo 12.51 16.35 80.99 13.16 14.90 82.37 -11.00 83.03 57.18 -12.69 82.43 58.26 coo 11.58 14.94 93.26 12.25 14.03 91.50 -12.99 90.00 69.08 -14.38 90.57 70.54 ULMN 3 1ni4_c00 PYRUVATE DEHYDROGENASE E1 COMPONENT:user 5 3 # 5 B 59 GLU D 121 GLU^? 11.70 OH7 1PE B 150 B 128 HIS D 88 HIS^? 4.38 CH1 MLY A 135 C 263 HIS D 115 HIS~? 12.18 C21 2PE D 146 coo 6.12 5.94 82.00 7.16 6.32 83.81 -20.91 85.61 9.48 -19.44 85.70 10.98 coo 12.51 16.35 80.99 13.16 14.90 82.37 -29.18 79.71 17.63 -29.43 81.25 19.03 coo 11.58 14.94 93.26 12.25 14.03 91.50 -36.28 90.32 11.92 -37.49 91.98 12.35 1ni4_c00 source 1ni4 PYRUVATE DEHYDROGENASE E1 COMPONENT: ALPHA SUB: 5 hits 1ni4_c00 naa= 3 ULMN 3 1ni4_c01 PYRUVATE DEHYDROGENASE E1 COMPONENT:user 1 3 # 1 A 263 HIS A 88 HIS^? 4.20 CH2 MLY D 135 D 59 GLU A 75 GLU.? -8.03 O4 PGE A 147s D 128 HIS A 85 HIS.? 6.69 C5 PGE A 147 coo 8.65 -19.64 67.59 7.76 -17.92 68.39 -23.95 56.87 7.77 -24.14 54.98 6.86 coo 12.72 -5.58 71.72 12.08 -7.54 72.22 -34.40 63.01 2.19 -36.49 63.07 2.67 coo 4.03 -8.95 63.85 3.80 -9.89 65.71 -23.05 64.43 -0.55 -21.68 63.00 -1.25 ULMN 3 1ni4_c01 PYRUVATE DEHYDROGENASE E1 COMPONENT:user 2 3 # 2 A 263 HIS A 115 HIS~? 12.27 C21 2PE A 148 D 59 GLU A 121 GLU^? 12.41 C1 GOL A 150 D 128 HIS A 88 HIS^? 4.20 CH2 MLY D 135 coo 8.65 -19.64 67.59 7.76 -17.92 68.39 -13.18 48.35 10.37 -12.55 46.36 10.33 coo 12.72 -5.58 71.72 12.08 -7.54 72.22 -13.98 61.53 0.93 -15.14 61.60 -0.79 coo 4.03 -8.95 63.85 3.80 -9.89 65.71 -23.95 56.87 7.77 -24.14 54.98 6.86 ULMN 3 1ni4_c01 PYRUVATE DEHYDROGENASE E1 COMPONENT:user 3 3 # 3 A 263 HIS B 88 HIS^? 4.29 CH1 MLY C 135 D 59 GLU B 75 GLU.? -3.56 CB MLZ C 129s D 128 HIS B 85 HIS.? 6.66 C6 PGE B 147 coo 8.65 -19.64 67.59 7.76 -17.92 68.39 6.15 87.00 38.94 7.35 87.96 37.51 coo 12.72 -5.58 71.72 12.08 -7.54 72.22 3.68 97.59 46.60 2.29 99.21 46.53 coo 4.03 -8.95 63.85 3.80 -9.89 65.71 11.11 88.86 48.90 12.76 88.34 47.73 ULMN 3 1ni4_c01 PYRUVATE DEHYDROGENASE E1 COMPONENT:user 4 3 # 4 A 263 HIS B 115 HIS~? 12.48 C18 PE8 B 148 D 59 GLU B 121 GLU^? 8.74 O2 PEG B 144 D 128 HIS B 88 HIS^? 4.29 CH1 MLY C 135 coo 8.65 -19.64 67.59 7.76 -17.92 68.39 11.86 77.76 30.05 12.70 77.49 28.15 coo 12.72 -5.58 71.72 12.08 -7.54 72.22 15.37 80.83 45.64 16.23 82.69 46.15 coo 4.03 -8.95 63.85 3.80 -9.89 65.71 6.15 87.00 38.94 7.35 87.96 37.51 ULMN 3 1ni4_c01 PYRUVATE DEHYDROGENASE E1 COMPONENT:user 5 3 # 5 A 263 HIS C 88 HIS^? 3.86 CD MLY B 135 D 59 GLU C 75 GLU.? -8.81 O1 PGE C 147s D 128 HIS C 85 HIS.? 6.34 C1 PGE C 147 coo 8.65 -19.64 67.59 7.76 -17.92 68.39 -11.00 83.03 57.18 -12.69 82.43 58.26 coo 12.72 -5.58 71.72 12.08 -7.54 72.22 -10.84 73.75 47.59 -11.85 73.47 45.72 coo 4.03 -8.95 63.85 3.80 -9.89 65.71 -4.08 74.18 57.17 -4.69 74.12 59.17 ULMN 3 1ni4_c01 PYRUVATE DEHYDROGENASE E1 COMPONENT:user 6 3 # 6 A 263 HIS C 115 HIS~? 4.72 C MLZ C 114 D 59 GLU C 121 GLU^? 12.40 C3 GOL C 149 D 128 HIS C 88 HIS^? 3.86 CD MLY B 135 coo 8.65 -19.64 67.59 7.76 -17.92 68.39 -12.99 90.00 69.08 -14.38 90.57 70.54 coo 12.72 -5.58 71.72 12.08 -7.54 72.22 -1.98 78.69 65.48 -2.54 76.71 65.06 coo 4.03 -8.95 63.85 3.80 -9.89 65.71 -11.00 83.03 57.18 -12.69 82.43 58.26 ULMN 3 1ni4_c01 PYRUVATE DEHYDROGENASE E1 COMPONENT:user 7 3 # 7 A 263 HIS D 88 HIS^? 4.38 CH1 MLY A 135 D 59 GLU D 75 GLU.? -3.59 CB MLZ A 129s D 128 HIS D 85 HIS.? 4.73 OH7 1PE B 150 coo 8.65 -19.64 67.59 7.76 -17.92 68.39 -29.18 79.71 17.63 -29.43 81.25 19.03 coo 12.72 -5.58 71.72 12.08 -7.54 72.22 -21.02 72.19 24.99 -21.34 70.79 26.58 coo 4.03 -8.95 63.85 3.80 -9.89 65.71 -18.08 79.12 16.04 -18.14 81.21 15.79 ULMN 3 1ni4_c01 PYRUVATE DEHYDROGENASE E1 COMPONENT:user 8 3 # 8 A 263 HIS D 115 HIS~? 12.18 C21 2PE D 146 D 59 GLU D 121 GLU^? 11.70 OH7 1PE B 150 D 128 HIS D 88 HIS^? 4.38 CH1 MLY A 135 coo 8.65 -19.64 67.59 7.76 -17.92 68.39 -36.28 90.32 11.92 -37.49 91.98 12.35 coo 12.72 -5.58 71.72 12.08 -7.54 72.22 -20.91 85.61 9.48 -19.44 85.70 10.98 coo 4.03 -8.95 63.85 3.80 -9.89 65.71 -29.18 79.71 17.63 -29.43 81.25 19.03 1ni4_c01 source 1ni4 PYRUVATE DEHYDROGENASE E1 COMPONENT: ALPHA SUB: 8 hits 1ni4_c01 naa= 3 ULMN 3 1nsf_c00 N-ETHYLMALEIMIDE SENSITIVE FACTOR user 1 3 # 1 549 LYS D 129 LYS^? 7.63 C4 PEG D 145 631 LYS D 9 LYS~? 7.95 C5 2PE D 146 708 LYS D 132 LYS.? -3.69 O4 PEG D 145s coo 8.61 33.06 11.15 10.12 29.19 8.82 -36.12 61.83 6.50 -39.41 57.83 4.09 coo -11.99 27.40 17.14 -13.60 24.52 11.71 -34.17 79.01 -6.33 -32.19 82.24 -10.69 coo 18.16 32.86 9.85 16.06 28.20 13.56 -35.99 54.44 13.45 -42.83 52.94 13.30 1nsf_c00 source 1nsf N-ETHYLMALEIMIDE SENSITIVE FACTOR : 1 hits 1nsf_c00 naa= 3 ULMN 3 1nu3_c00 LIMONENE-1,2-EPOXIDE HYDROLASE user 1 3 # 1 A 99 ARG A 31 ARG^? 11.10 C1 GOL A 150 A 101 ASP A 122 ASP^? 7.46 C1 GOL A 150 A 132 ASP A 83 ASP.? 8.52 O3 GOL D 147 coo 11.61 22.83 17.30 14.06 21.71 15.78 -18.51 63.86 1.13 -18.37 66.66 2.58 coo 11.37 24.94 11.48 12.48 24.45 13.28 -15.41 64.92 4.51 -15.09 66.83 5.33 coo 16.14 18.17 13.37 15.92 19.81 14.71 -19.46 70.43 -3.04 -19.06 72.28 -2.05 ULMN 3 1nu3_c00 LIMONENE-1,2-EPOXIDE HYDROLASE user 2 3 # 2 A 99 ARG A 31 ARG^? 11.10 C1 GOL A 150 A 101 ASP A 122 ASP^? 7.46 C1 GOL A 150 A 132 ASP A 87 ASP.? 8.49 C6 PGE A 147 coo 11.61 22.83 17.30 14.06 21.71 15.78 -18.51 63.86 1.13 -18.37 66.66 2.58 coo 11.37 24.94 11.48 12.48 24.45 13.28 -15.41 64.92 4.51 -15.09 66.83 5.33 coo 16.14 18.17 13.37 15.92 19.81 14.71 -23.17 58.67 3.55 -22.34 59.17 1.69 ULMN 3 1nu3_c00 LIMONENE-1,2-EPOXIDE HYDROLASE user 3 3 # 3 A 99 ARG C 31 ARG^? 11.22 C3 GOL C 149 A 101 ASP C 122 ASP^? 7.22 C3 GOL C 149 A 132 ASP C 83 ASP.? 8.65 O3 GOL B 149 coo 11.61 22.83 17.30 14.06 21.71 15.78 -2.17 77.49 60.72 0.17 78.08 58.83 coo 11.37 24.94 11.48 12.48 24.45 13.28 0.27 81.12 61.60 2.07 81.54 60.53 coo 16.14 18.17 13.37 15.92 19.81 14.71 3.02 71.86 58.06 4.88 72.49 57.24 ULMN 3 1nu3_c00 LIMONENE-1,2-EPOXIDE HYDROLASE user 4 3 # 4 A 99 ARG C 31 ARG^? 11.22 C3 GOL C 149 A 101 ASP C 122 ASP^? 7.22 C3 GOL C 149 A 132 ASP C 87 ASP.? 8.84 O1 PGE C 147 coo 11.61 22.83 17.30 14.06 21.71 15.78 -2.17 77.49 60.72 0.17 78.08 58.83 coo 11.37 24.94 11.48 12.48 24.45 13.28 0.27 81.12 61.60 2.07 81.54 60.53 coo 16.14 18.17 13.37 15.92 19.81 14.71 -9.03 79.00 58.44 -8.21 77.39 59.55 ULMN 3 1nu3_c00 LIMONENE-1,2-EPOXIDE HYDROLASE user 5 3 # 5 A 99 ARG D 31 ARG^? 10.57 OH7 1PE B 150 A 101 ASP D 122 ASP^? 7.49 C3 GOL D 147 A 132 ASP D 83 ASP.? 8.76 O1 GOL A 150 coo 11.61 22.83 17.30 14.06 21.71 15.78 -19.64 81.34 12.02 -19.24 78.87 10.07 coo 11.37 24.94 11.48 12.48 24.45 13.28 -21.82 80.90 7.85 -21.38 79.32 6.51 coo 16.14 18.17 13.37 15.92 19.81 14.71 -12.54 78.43 10.94 -12.46 77.06 9.29 ULMN 3 1nu3_c00 LIMONENE-1,2-EPOXIDE HYDROLASE user 6 3 # 6 A 99 ARG D 31 ARG^? 10.57 OH7 1PE B 150 A 101 ASP D 122 ASP^? 7.49 C3 GOL D 147 A 132 ASP D 87 ASP.? 7.26 C16 1PE B 150 coo 11.61 22.83 17.30 14.06 21.71 15.78 -19.64 81.34 12.02 -19.24 78.87 10.07 coo 11.37 24.94 11.48 12.48 24.45 13.28 -21.82 80.90 7.85 -21.38 79.32 6.51 coo 16.14 18.17 13.37 15.92 19.81 14.71 -24.70 80.89 17.41 -22.90 81.94 17.31 1nu3_c00 source 1nu3 LIMONENE-1,2-EPOXIDE HYDROLASE : 6 hits 1nu3_c00 naa= 3 ULMN 3 1nu3_c01 LIMONENE-1,2-EPOXIDE HYDROLASE user 1 3 # 1 B 99 ARG A 31 ARG^? 11.10 C1 GOL A 150 B 101 ASP A 122 ASP^? 7.46 C1 GOL A 150 B 132 ASP A 83 ASP.? 8.52 O3 GOL D 147 coo 11.61 3.43 18.38 9.11 4.29 16.86 -18.51 63.86 1.13 -18.37 66.66 2.58 coo 11.74 0.51 12.98 10.75 1.32 14.67 -15.41 64.92 4.51 -15.09 66.83 5.33 coo 6.93 7.52 14.08 7.18 6.08 15.65 -19.46 70.43 -3.04 -19.06 72.28 -2.05 ULMN 3 1nu3_c01 LIMONENE-1,2-EPOXIDE HYDROLASE user 2 3 # 2 B 99 ARG A 31 ARG^? 11.10 C1 GOL A 150 B 101 ASP A 122 ASP^? 7.46 C1 GOL A 150 B 132 ASP A 87 ASP.? 8.49 C6 PGE A 147 coo 11.61 3.43 18.38 9.11 4.29 16.86 -18.51 63.86 1.13 -18.37 66.66 2.58 coo 11.74 0.51 12.98 10.75 1.32 14.67 -15.41 64.92 4.51 -15.09 66.83 5.33 coo 6.93 7.52 14.08 7.18 6.08 15.65 -23.17 58.67 3.55 -22.34 59.17 1.69 ULMN 3 1nu3_c01 LIMONENE-1,2-EPOXIDE HYDROLASE user 3 3 # 3 B 99 ARG B 31 ARG^? 11.02 C6 PGE B 147 B 101 ASP B 122 ASP^? 7.33 O2 GOL B 149 B 132 ASP B 83 ASP.? 9.40 O3 GOL C 149 coo 11.61 3.43 18.38 9.11 4.29 16.86 12.15 83.61 47.77 10.36 84.10 50.21 coo 11.74 0.51 12.98 10.75 1.32 14.67 10.89 79.68 47.57 9.75 78.80 49.16 coo 6.93 7.52 14.08 7.18 6.08 15.65 13.62 86.10 55.23 12.83 84.59 56.49 ULMN 3 1nu3_c01 LIMONENE-1,2-EPOXIDE HYDROLASE user 4 3 # 4 B 99 ARG B 31 ARG^? 11.02 C6 PGE B 147 B 101 ASP B 122 ASP^? 7.33 O2 GOL B 149 B 132 ASP B 87 ASP.? 8.94 O4 PGE B 147 coo 11.61 3.43 18.38 9.11 4.29 16.86 12.15 83.61 47.77 10.36 84.10 50.21 coo 11.74 0.51 12.98 10.75 1.32 14.67 10.89 79.68 47.57 9.75 78.80 49.16 coo 6.93 7.52 14.08 7.18 6.08 15.65 9.49 87.97 42.02 11.31 87.98 43.09 ULMN 3 1nu3_c01 LIMONENE-1,2-EPOXIDE HYDROLASE user 5 3 # 5 B 99 ARG C 31 ARG^? 11.22 C3 GOL C 149 B 101 ASP C 122 ASP^? 7.22 C3 GOL C 149 B 132 ASP C 83 ASP.? 8.65 O3 GOL B 149 coo 11.61 3.43 18.38 9.11 4.29 16.86 -2.17 77.49 60.72 0.17 78.08 58.83 coo 11.74 0.51 12.98 10.75 1.32 14.67 0.27 81.12 61.60 2.07 81.54 60.53 coo 6.93 7.52 14.08 7.18 6.08 15.65 3.02 71.86 58.06 4.88 72.49 57.24 ULMN 3 1nu3_c01 LIMONENE-1,2-EPOXIDE HYDROLASE user 6 3 # 6 B 99 ARG C 31 ARG^? 11.22 C3 GOL C 149 B 101 ASP C 122 ASP^? 7.22 C3 GOL C 149 B 132 ASP C 87 ASP.? 8.84 O1 PGE C 147 coo 11.61 3.43 18.38 9.11 4.29 16.86 -2.17 77.49 60.72 0.17 78.08 58.83 coo 11.74 0.51 12.98 10.75 1.32 14.67 0.27 81.12 61.60 2.07 81.54 60.53 coo 6.93 7.52 14.08 7.18 6.08 15.65 -9.03 79.00 58.44 -8.21 77.39 59.55 ULMN 3 1nu3_c01 LIMONENE-1,2-EPOXIDE HYDROLASE user 7 3 # 7 B 99 ARG D 31 ARG^? 10.57 OH7 1PE B 150 B 101 ASP D 122 ASP^? 7.49 C3 GOL D 147 B 132 ASP D 83 ASP.? 8.76 O1 GOL A 150 coo 11.61 3.43 18.38 9.11 4.29 16.86 -19.64 81.34 12.02 -19.24 78.87 10.07 coo 11.74 0.51 12.98 10.75 1.32 14.67 -21.82 80.90 7.85 -21.38 79.32 6.51 coo 6.93 7.52 14.08 7.18 6.08 15.65 -12.54 78.43 10.94 -12.46 77.06 9.29 ULMN 3 1nu3_c01 LIMONENE-1,2-EPOXIDE HYDROLASE user 8 3 # 8 B 99 ARG D 31 ARG^? 10.57 OH7 1PE B 150 B 101 ASP D 122 ASP^? 7.49 C3 GOL D 147 B 132 ASP D 87 ASP.? 7.26 C16 1PE B 150 coo 11.61 3.43 18.38 9.11 4.29 16.86 -19.64 81.34 12.02 -19.24 78.87 10.07 coo 11.74 0.51 12.98 10.75 1.32 14.67 -21.82 80.90 7.85 -21.38 79.32 6.51 coo 6.93 7.52 14.08 7.18 6.08 15.65 -24.70 80.89 17.41 -22.90 81.94 17.31 1nu3_c01 source 1nu3 LIMONENE-1,2-EPOXIDE HYDROLASE : 8 hits 1nu3_c01 naa= 3 ULMN 3 1nww_c02 LIMONENE-1,2-EPOXIDE HYDROLASE user 1 3 # 1 A 99 ARG A 31 ARG^? 11.10 C1 GOL A 150 A 101 ASP A 122 ASP^? 7.46 C1 GOL A 150 A 132 ASP A 83 ASP.? 8.52 O3 GOL D 147 coo 11.50 22.77 17.24 14.00 21.62 15.86 -18.51 63.86 1.13 -18.37 66.66 2.58 coo 11.19 25.00 11.76 12.16 24.45 13.59 -15.41 64.92 4.51 -15.09 66.83 5.33 coo 16.04 18.11 13.43 15.88 19.70 14.83 -19.46 70.43 -3.04 -19.06 72.28 -2.05 ULMN 3 1nww_c02 LIMONENE-1,2-EPOXIDE HYDROLASE user 2 3 # 2 A 99 ARG A 31 ARG^? 11.10 C1 GOL A 150 A 101 ASP A 122 ASP^? 7.46 C1 GOL A 150 A 132 ASP A 87 ASP.? 8.49 C6 PGE A 147 coo 11.50 22.77 17.24 14.00 21.62 15.86 -18.51 63.86 1.13 -18.37 66.66 2.58 coo 11.19 25.00 11.76 12.16 24.45 13.59 -15.41 64.92 4.51 -15.09 66.83 5.33 coo 16.04 18.11 13.43 15.88 19.70 14.83 -23.17 58.67 3.55 -22.34 59.17 1.69 ULMN 3 1nww_c02 LIMONENE-1,2-EPOXIDE HYDROLASE user 3 3 # 3 A 99 ARG B 31 ARG^? 11.02 C6 PGE B 147 A 101 ASP B 122 ASP^? 7.33 O2 GOL B 149 A 132 ASP B 83 ASP.? 9.40 O3 GOL C 149 coo 11.50 22.77 17.24 14.00 21.62 15.86 12.15 83.61 47.77 10.36 84.10 50.21 coo 11.19 25.00 11.76 12.16 24.45 13.59 10.89 79.68 47.57 9.75 78.80 49.16 coo 16.04 18.11 13.43 15.88 19.70 14.83 13.62 86.10 55.23 12.83 84.59 56.49 ULMN 3 1nww_c02 LIMONENE-1,2-EPOXIDE HYDROLASE user 4 3 # 4 A 99 ARG B 31 ARG^? 11.02 C6 PGE B 147 A 101 ASP B 122 ASP^? 7.33 O2 GOL B 149 A 132 ASP B 87 ASP.? 8.94 O4 PGE B 147 coo 11.50 22.77 17.24 14.00 21.62 15.86 12.15 83.61 47.77 10.36 84.10 50.21 coo 11.19 25.00 11.76 12.16 24.45 13.59 10.89 79.68 47.57 9.75 78.80 49.16 coo 16.04 18.11 13.43 15.88 19.70 14.83 9.49 87.97 42.02 11.31 87.98 43.09 ULMN 3 1nww_c02 LIMONENE-1,2-EPOXIDE HYDROLASE user 5 3 # 5 A 99 ARG C 31 ARG^? 11.22 C3 GOL C 149 A 101 ASP C 122 ASP^? 7.22 C3 GOL C 149 A 132 ASP C 83 ASP.? 8.65 O3 GOL B 149 coo 11.50 22.77 17.24 14.00 21.62 15.86 -2.17 77.49 60.72 0.17 78.08 58.83 coo 11.19 25.00 11.76 12.16 24.45 13.59 0.27 81.12 61.60 2.07 81.54 60.53 coo 16.04 18.11 13.43 15.88 19.70 14.83 3.02 71.86 58.06 4.88 72.49 57.24 ULMN 3 1nww_c02 LIMONENE-1,2-EPOXIDE HYDROLASE user 6 3 # 6 A 99 ARG C 31 ARG^? 11.22 C3 GOL C 149 A 101 ASP C 122 ASP^? 7.22 C3 GOL C 149 A 132 ASP C 87 ASP.? 8.84 O1 PGE C 147 coo 11.50 22.77 17.24 14.00 21.62 15.86 -2.17 77.49 60.72 0.17 78.08 58.83 coo 11.19 25.00 11.76 12.16 24.45 13.59 0.27 81.12 61.60 2.07 81.54 60.53 coo 16.04 18.11 13.43 15.88 19.70 14.83 -9.03 79.00 58.44 -8.21 77.39 59.55 ULMN 3 1nww_c02 LIMONENE-1,2-EPOXIDE HYDROLASE user 7 3 # 7 A 99 ARG D 31 ARG^? 10.57 OH7 1PE B 150 A 101 ASP D 122 ASP^? 7.49 C3 GOL D 147 A 132 ASP D 83 ASP.? 8.76 O1 GOL A 150 coo 11.50 22.77 17.24 14.00 21.62 15.86 -19.64 81.34 12.02 -19.24 78.87 10.07 coo 11.19 25.00 11.76 12.16 24.45 13.59 -21.82 80.90 7.85 -21.38 79.32 6.51 coo 16.04 18.11 13.43 15.88 19.70 14.83 -12.54 78.43 10.94 -12.46 77.06 9.29 ULMN 3 1nww_c02 LIMONENE-1,2-EPOXIDE HYDROLASE user 8 3 # 8 A 99 ARG D 31 ARG^? 10.57 OH7 1PE B 150 A 101 ASP D 122 ASP^? 7.49 C3 GOL D 147 A 132 ASP D 87 ASP.? 7.26 C16 1PE B 150 coo 11.50 22.77 17.24 14.00 21.62 15.86 -19.64 81.34 12.02 -19.24 78.87 10.07 coo 11.19 25.00 11.76 12.16 24.45 13.59 -21.82 80.90 7.85 -21.38 79.32 6.51 coo 16.04 18.11 13.43 15.88 19.70 14.83 -24.70 80.89 17.41 -22.90 81.94 17.31 1nww_c02 source 1nww LIMONENE-1,2-EPOXIDE HYDROLASE : 8 hits 1nww_c02 naa= 3 ULMN 3 1nww_c03 LIMONENE-1,2-EPOXIDE HYDROLASE user 1 3 # 1 B 99 ARG A 31 ARG^? 11.10 C1 GOL A 150 B 101 ASP A 122 ASP^? 7.46 C1 GOL A 150 B 132 ASP A 83 ASP.? 8.52 O3 GOL D 147 coo 11.48 3.09 18.25 9.01 4.07 16.77 -18.51 63.86 1.13 -18.37 66.66 2.58 coo 11.83 0.33 13.01 10.88 1.04 14.81 -15.41 64.92 4.51 -15.09 66.83 5.33 coo 6.85 7.33 14.07 7.10 5.88 15.60 -19.46 70.43 -3.04 -19.06 72.28 -2.05 ULMN 3 1nww_c03 LIMONENE-1,2-EPOXIDE HYDROLASE user 2 3 # 2 B 99 ARG A 31 ARG^? 11.10 C1 GOL A 150 B 101 ASP A 122 ASP^? 7.46 C1 GOL A 150 B 132 ASP A 87 ASP.? 8.49 C6 PGE A 147 coo 11.48 3.09 18.25 9.01 4.07 16.77 -18.51 63.86 1.13 -18.37 66.66 2.58 coo 11.83 0.33 13.01 10.88 1.04 14.81 -15.41 64.92 4.51 -15.09 66.83 5.33 coo 6.85 7.33 14.07 7.10 5.88 15.60 -23.17 58.67 3.55 -22.34 59.17 1.69 ULMN 3 1nww_c03 LIMONENE-1,2-EPOXIDE HYDROLASE user 3 3 # 3 B 99 ARG B 31 ARG^? 11.02 C6 PGE B 147 B 101 ASP B 122 ASP^? 7.33 O2 GOL B 149 B 132 ASP B 83 ASP.? 9.40 O3 GOL C 149 coo 11.48 3.09 18.25 9.01 4.07 16.77 12.15 83.61 47.77 10.36 84.10 50.21 coo 11.83 0.33 13.01 10.88 1.04 14.81 10.89 79.68 47.57 9.75 78.80 49.16 coo 6.85 7.33 14.07 7.10 5.88 15.60 13.62 86.10 55.23 12.83 84.59 56.49 ULMN 3 1nww_c03 LIMONENE-1,2-EPOXIDE HYDROLASE user 4 3 # 4 B 99 ARG B 31 ARG^? 11.02 C6 PGE B 147 B 101 ASP B 122 ASP^? 7.33 O2 GOL B 149 B 132 ASP B 87 ASP.? 8.94 O4 PGE B 147 coo 11.48 3.09 18.25 9.01 4.07 16.77 12.15 83.61 47.77 10.36 84.10 50.21 coo 11.83 0.33 13.01 10.88 1.04 14.81 10.89 79.68 47.57 9.75 78.80 49.16 coo 6.85 7.33 14.07 7.10 5.88 15.60 9.49 87.97 42.02 11.31 87.98 43.09 ULMN 3 1nww_c03 LIMONENE-1,2-EPOXIDE HYDROLASE user 5 3 # 5 B 99 ARG C 31 ARG^? 11.22 C3 GOL C 149 B 101 ASP C 122 ASP^? 7.22 C3 GOL C 149 B 132 ASP C 83 ASP.? 8.65 O3 GOL B 149 coo 11.48 3.09 18.25 9.01 4.07 16.77 -2.17 77.49 60.72 0.17 78.08 58.83 coo 11.83 0.33 13.01 10.88 1.04 14.81 0.27 81.12 61.60 2.07 81.54 60.53 coo 6.85 7.33 14.07 7.10 5.88 15.60 3.02 71.86 58.06 4.88 72.49 57.24 ULMN 3 1nww_c03 LIMONENE-1,2-EPOXIDE HYDROLASE user 6 3 # 6 B 99 ARG C 31 ARG^? 11.22 C3 GOL C 149 B 101 ASP C 122 ASP^? 7.22 C3 GOL C 149 B 132 ASP C 87 ASP.? 8.84 O1 PGE C 147 coo 11.48 3.09 18.25 9.01 4.07 16.77 -2.17 77.49 60.72 0.17 78.08 58.83 coo 11.83 0.33 13.01 10.88 1.04 14.81 0.27 81.12 61.60 2.07 81.54 60.53 coo 6.85 7.33 14.07 7.10 5.88 15.60 -9.03 79.00 58.44 -8.21 77.39 59.55 ULMN 3 1nww_c03 LIMONENE-1,2-EPOXIDE HYDROLASE user 7 3 # 7 B 99 ARG D 31 ARG^? 10.57 OH7 1PE B 150 B 101 ASP D 122 ASP^? 7.49 C3 GOL D 147 B 132 ASP D 83 ASP.? 8.76 O1 GOL A 150 coo 11.48 3.09 18.25 9.01 4.07 16.77 -19.64 81.34 12.02 -19.24 78.87 10.07 coo 11.83 0.33 13.01 10.88 1.04 14.81 -21.82 80.90 7.85 -21.38 79.32 6.51 coo 6.85 7.33 14.07 7.10 5.88 15.60 -12.54 78.43 10.94 -12.46 77.06 9.29 ULMN 3 1nww_c03 LIMONENE-1,2-EPOXIDE HYDROLASE user 8 3 # 8 B 99 ARG D 31 ARG^? 10.57 OH7 1PE B 150 B 101 ASP D 122 ASP^? 7.49 C3 GOL D 147 B 132 ASP D 87 ASP.? 7.26 C16 1PE B 150 coo 11.48 3.09 18.25 9.01 4.07 16.77 -19.64 81.34 12.02 -19.24 78.87 10.07 coo 11.83 0.33 13.01 10.88 1.04 14.81 -21.82 80.90 7.85 -21.38 79.32 6.51 coo 6.85 7.33 14.07 7.10 5.88 15.60 -24.70 80.89 17.41 -22.90 81.94 17.31 1nww_c03 source 1nww LIMONENE-1,2-EPOXIDE HYDROLASE : 8 hits 1nww_c03 naa= 3 ULMN 3 1o98_c00 2,3-BISPHOSPHOGLYCERATE-INDEPENDENT user 1 3 # 1 A 62 SER A 123 SER^? 7.34 C15 2PE A 148 A 154 ASP A 6 ASP.? -3.91 C9 2PE A 148s A 261 ARG A 116 ARG~? 4.70 C15 2PE A 148 coo 16.10 74.10 3.11 17.18 73.52 5.20 -17.01 64.19 8.64 -15.43 63.06 10.12 coo 16.07 84.71 8.14 15.20 82.81 8.14 -8.66 61.41 13.34 -8.76 59.35 12.80 coo 10.59 77.85 4.81 13.09 76.36 5.76 -15.13 57.15 12.87 -15.00 60.01 11.67 ULMN 3 1o98_c00 2,3-BISPHOSPHOGLYCERATE-INDEPENDENT user 2 3 # 2 A 62 SER A 123 SER^? 7.34 C15 2PE A 148 A 154 ASP A 83 ASP.? 8.52 O3 GOL D 147 A 261 ARG A 31 ARG^? 11.10 C1 GOL A 150 coo 16.10 74.10 3.11 17.18 73.52 5.20 -17.01 64.19 8.64 -15.43 63.06 10.12 coo 16.07 84.71 8.14 15.20 82.81 8.14 -19.46 70.43 -3.04 -19.06 72.28 -2.05 coo 10.59 77.85 4.81 13.09 76.36 5.76 -18.51 63.86 1.13 -18.37 66.66 2.58 ULMN 3 1o98_c00 2,3-BISPHOSPHOGLYCERATE-INDEPENDENT user 3 3 # 3 A 62 SER B 123 SER^? 7.43 C12 PE8 B 148 A 154 ASP B 6 ASP.? -3.99 C6 PE8 B 148s A 261 ARG B 116 ARG~? 4.93 C12 PE8 B 148 coo 16.10 74.10 3.11 17.18 73.52 5.20 6.88 79.31 45.54 6.79 77.45 43.98 coo 16.07 84.71 8.14 15.20 82.81 8.14 7.95 70.39 41.39 8.88 71.08 39.61 coo 10.59 77.85 4.81 13.09 76.36 5.76 6.23 77.16 37.54 6.11 77.30 40.64 ULMN 3 1o98_c00 2,3-BISPHOSPHOGLYCERATE-INDEPENDENT user 4 3 # 4 A 62 SER B 123 SER^? 7.43 C12 PE8 B 148 A 154 ASP B 83 ASP.? 9.40 O3 GOL C 149 A 261 ARG B 31 ARG^? 11.02 C6 PGE B 147 coo 16.10 74.10 3.11 17.18 73.52 5.20 6.88 79.31 45.54 6.79 77.45 43.98 coo 16.07 84.71 8.14 15.20 82.81 8.14 13.62 86.10 55.23 12.83 84.59 56.49 coo 10.59 77.85 4.81 13.09 76.36 5.76 12.15 83.61 47.77 10.36 84.10 50.21 ULMN 3 1o98_c00 2,3-BISPHOSPHOGLYCERATE-INDEPENDENT user 5 3 # 5 A 62 SER B 123 SER^? 7.43 C12 PE8 B 148 A 154 ASP B 87 ASP.? 8.94 O4 PGE B 147 A 261 ARG B 31 ARG^? 11.02 C6 PGE B 147 coo 16.10 74.10 3.11 17.18 73.52 5.20 6.88 79.31 45.54 6.79 77.45 43.98 coo 16.07 84.71 8.14 15.20 82.81 8.14 9.49 87.97 42.02 11.31 87.98 43.09 coo 10.59 77.85 4.81 13.09 76.36 5.76 12.15 83.61 47.77 10.36 84.10 50.21 ULMN 3 1o98_c00 2,3-BISPHOSPHOGLYCERATE-INDEPENDENT user 6 3 # 6 A 62 SER C 123 SER^? 7.65 C15 PE8 C 148 A 154 ASP C 6 ASP.? -4.04 C8 PE8 C 148s A 261 ARG C 116 ARG~? 4.72 C15 PE8 C 148 coo 16.10 74.10 3.11 17.18 73.52 5.20 -1.16 84.64 59.13 -1.43 86.65 60.45 coo 16.07 84.71 8.14 15.20 82.81 8.14 0.53 91.96 65.64 -1.31 91.68 66.68 coo 10.59 77.85 4.81 13.09 76.36 5.76 -6.64 90.12 62.40 -4.04 88.84 61.33 ULMN 3 1o98_c00 2,3-BISPHOSPHOGLYCERATE-INDEPENDENT user 7 3 # 7 A 62 SER C 123 SER^? 7.65 C15 PE8 C 148 A 154 ASP C 83 ASP.? 8.65 O3 GOL B 149 A 261 ARG C 31 ARG^? 11.22 C3 GOL C 149 coo 16.10 74.10 3.11 17.18 73.52 5.20 -1.16 84.64 59.13 -1.43 86.65 60.45 coo 16.07 84.71 8.14 15.20 82.81 8.14 3.02 71.86 58.06 4.88 72.49 57.24 coo 10.59 77.85 4.81 13.09 76.36 5.76 -2.17 77.49 60.72 0.17 78.08 58.83 ULMN 3 1o98_c00 2,3-BISPHOSPHOGLYCERATE-INDEPENDENT user 8 3 # 8 A 62 SER D 123 SER^? 7.59 C15 2PE D 146 A 154 ASP D 6 ASP.? -3.77 C8 2PE D 146s A 261 ARG D 116 ARG~? 4.73 C15 2PE D 146 coo 16.10 74.10 3.11 17.18 73.52 5.20 -25.59 78.45 8.19 -27.49 79.37 6.96 coo 16.07 84.71 8.14 15.20 82.81 8.14 -31.03 82.87 1.04 -31.83 84.41 2.29 coo 10.59 77.85 4.81 13.09 76.36 5.76 -33.13 82.22 8.73 -30.63 80.83 7.52 ULMN 3 1o98_c00 2,3-BISPHOSPHOGLYCERATE-INDEPENDENT user 9 3 # 9 A 62 SER D 123 SER^? 7.59 C15 2PE D 146 A 154 ASP D 83 ASP.? 8.76 O1 GOL A 150 A 261 ARG D 31 ARG^? 10.57 OH7 1PE B 150 coo 16.10 74.10 3.11 17.18 73.52 5.20 -25.59 78.45 8.19 -27.49 79.37 6.96 coo 16.07 84.71 8.14 15.20 82.81 8.14 -12.54 78.43 10.94 -12.46 77.06 9.29 coo 10.59 77.85 4.81 13.09 76.36 5.76 -19.64 81.34 12.02 -19.24 78.87 10.07 1o98_c00 source 1o98 2,3-BISPHOSPHOGLYCERATE-INDEPENDENT PHOSPHOGLY: 9 hits 1o98_c00 naa= 3 ULMN 3 1ohh_c08 ATP SYNTHASE ALPHA CHAIN HEART ISOFOuser 1 3 # 1 C 175 LYS A 9 LYS~? 8.68 C6 2PE A 148 C 208 GLN A 117 GLN~? 5.13 C9 2PE A 148 C 209 LYS A 114 LYS~? 11.27 C9 2PE A 148 coo 100.54 -2.78 25.52 103.29 2.02 24.05 -4.77 65.74 20.08 0.46 67.29 18.98 coo 111.02 -1.31 30.92 109.87 -2.78 29.89 -9.09 56.12 11.47 -7.47 55.62 12.81 coo 113.62 1.19 33.65 109.52 3.92 36.47 -9.49 51.50 12.13 -4.59 48.44 14.69 ULMN 3 1ohh_c08 ATP SYNTHASE ALPHA CHAIN HEART ISOFOuser 2 3 # 2 C 175 LYS B 9 LYS~? 8.12 C3 PE8 B 148 C 208 GLN B 117 GLN~? 5.32 C6 PE8 B 148 C 209 LYS B 114 LYS~? 11.34 O7 PE8 B 148 coo 100.54 -2.78 25.52 103.29 2.02 24.05 3.06 63.14 43.18 6.71 59.02 44.53 coo 111.02 -1.31 30.92 109.87 -2.78 29.89 10.75 72.43 36.89 10.67 70.46 36.01 coo 113.62 1.19 33.65 109.52 3.92 36.47 11.35 73.22 32.47 12.65 68.43 28.61 ULMN 3 1ohh_c08 ATP SYNTHASE ALPHA CHAIN HEART ISOFOuser 3 3 # 3 C 175 LYS D 9 LYS~? 7.95 C5 2PE D 146 C 208 GLN D 117 GLN~? 4.87 C9 2PE D 146 C 209 LYS D 114 LYS~? 10.81 C9 2PE D 146 coo 100.54 -2.78 25.52 103.29 2.02 24.05 -34.17 79.01 -6.33 -32.19 82.24 -10.69 coo 111.02 -1.31 30.92 109.87 -2.78 29.89 -32.82 87.00 4.66 -34.04 87.67 3.01 coo 113.62 1.19 33.65 109.52 3.92 36.47 -35.88 89.56 6.78 -39.69 93.33 3.49 1ohh_c08 source 1ohh ATP SYNTHASE ALPHA CHAIN HEART ISOFORM, MITOCH: 3 hits 1ohh_c08 naa= 3 ULMN 3 1ok4_c00 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 1 3 # 1 A 24 ASP A 106 ASP~? 11.93 O22 2PE A 148 A 146 TYR A 53 TYR~? -4.55 C21 2PE A 148s A 177 LYS A 114 LYS~? 11.27 C9 2PE A 148 coo -3.50 124.89 25.05 -2.25 124.77 23.26 -12.71 50.36 24.83 -13.06 48.30 25.05 coo 1.87 119.38 16.45 1.41 122.11 16.84 -16.76 52.42 13.05 -16.88 54.33 15.10 coo -2.59 124.07 12.67 -0.91 126.17 18.42 -9.49 51.50 12.13 -4.59 48.44 14.69 ULMN 3 1ok4_c00 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 2 3 # 2 A 24 ASP B 106 ASP~? 11.87 OH2 1PE B 150 A 146 TYR B 53 TYR~? -4.63 C18 PE8 B 148s A 177 LYS B 114 LYS~? 11.34 O7 PE8 B 148 coo -3.50 124.89 25.05 -2.25 124.77 23.26 -0.30 70.27 27.08 -0.10 70.78 25.05 coo 1.87 119.38 16.45 1.41 122.11 16.84 6.73 78.96 33.00 4.51 77.73 34.14 coo -2.59 124.07 12.67 -0.91 126.17 18.42 11.35 73.22 32.47 12.65 68.43 28.61 ULMN 3 1ok4_c00 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 3 3 # 3 A 24 ASP D 106 ASP~? 11.82 O22 2PE D 146 A 146 TYR D 53 TYR~? -4.60 C21 2PE D 146s A 177 LYS D 114 LYS~? 10.81 C9 2PE D 146 coo -3.50 124.89 25.05 -2.25 124.77 23.26 -46.82 82.57 5.87 -48.37 83.43 7.00 coo 1.87 119.38 16.45 1.41 122.11 16.84 -36.08 84.35 12.01 -36.58 82.07 10.49 coo -2.59 124.07 12.67 -0.91 126.17 18.42 -35.88 89.56 6.78 -39.69 93.33 3.49 1ok4_c00 source 1ok4 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASS I : 3 hits 1ok4_c00 naa= 3 ULMN 3 1ok4_c01 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 1 3 # 1 B 24 ASP A 106 ASP~? 11.93 O22 2PE A 148 B 146 TYR A 53 TYR~? -4.55 C21 2PE A 148s B 177 LYS A 114 LYS~? 11.27 C9 2PE A 148 coo -7.43 109.06 51.23 -5.84 110.54 50.86 -12.71 50.36 24.83 -13.06 48.30 25.05 coo 0.22 114.56 44.62 -0.76 115.18 47.18 -16.76 52.42 13.05 -16.88 54.33 15.10 coo -4.18 120.17 46.85 -4.02 115.31 51.00 -9.49 51.50 12.13 -4.59 48.44 14.69 ULMN 3 1ok4_c01 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 2 3 # 2 B 24 ASP B 106 ASP~? 11.87 OH2 1PE B 150 B 146 TYR B 53 TYR~? -4.63 C18 PE8 B 148s B 177 LYS B 114 LYS~? 11.34 O7 PE8 B 148 coo -7.43 109.06 51.23 -5.84 110.54 50.86 -0.30 70.27 27.08 -0.10 70.78 25.05 coo 0.22 114.56 44.62 -0.76 115.18 47.18 6.73 78.96 33.00 4.51 77.73 34.14 coo -4.18 120.17 46.85 -4.02 115.31 51.00 11.35 73.22 32.47 12.65 68.43 28.61 ULMN 3 1ok4_c01 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 3 3 # 3 B 24 ASP D 106 ASP~? 11.82 O22 2PE D 146 B 146 TYR D 53 TYR~? -4.60 C21 2PE D 146s B 177 LYS D 114 LYS~? 10.81 C9 2PE D 146 coo -7.43 109.06 51.23 -5.84 110.54 50.86 -46.82 82.57 5.87 -48.37 83.43 7.00 coo 0.22 114.56 44.62 -0.76 115.18 47.18 -36.08 84.35 12.01 -36.58 82.07 10.49 coo -4.18 120.17 46.85 -4.02 115.31 51.00 -35.88 89.56 6.78 -39.69 93.33 3.49 1ok4_c01 source 1ok4 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASS I : 3 hits 1ok4_c01 naa= 3 ULMN 3 1ok4_c02 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 1 3 # 1 C 24 ASP A 106 ASP~? 11.93 O22 2PE A 148 C 146 TYR A 53 TYR~? -4.55 C21 2PE A 148s C 177 LYS A 114 LYS~? 11.27 C9 2PE A 148 coo -13.49 79.65 43.90 -12.13 80.29 45.45 -12.71 50.36 24.83 -13.06 48.30 25.05 coo -5.65 86.78 48.49 -7.16 84.72 49.65 -16.76 52.42 13.05 -16.88 54.33 15.10 coo -11.22 87.18 53.49 -10.94 81.64 50.31 -9.49 51.50 12.13 -4.59 48.44 14.69 ULMN 3 1ok4_c02 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 2 3 # 2 C 24 ASP B 106 ASP~? 11.87 OH2 1PE B 150 C 146 TYR B 53 TYR~? -4.63 C18 PE8 B 148s C 177 LYS B 114 LYS~? 11.34 O7 PE8 B 148 coo -13.49 79.65 43.90 -12.13 80.29 45.45 -0.30 70.27 27.08 -0.10 70.78 25.05 coo -5.65 86.78 48.49 -7.16 84.72 49.65 6.73 78.96 33.00 4.51 77.73 34.14 coo -11.22 87.18 53.49 -10.94 81.64 50.31 11.35 73.22 32.47 12.65 68.43 28.61 ULMN 3 1ok4_c02 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 3 3 # 3 C 24 ASP D 106 ASP~? 11.82 O22 2PE D 146 C 146 TYR D 53 TYR~? -4.60 C21 2PE D 146s C 177 LYS D 114 LYS~? 10.81 C9 2PE D 146 coo -13.49 79.65 43.90 -12.13 80.29 45.45 -46.82 82.57 5.87 -48.37 83.43 7.00 coo -5.65 86.78 48.49 -7.16 84.72 49.65 -36.08 84.35 12.01 -36.58 82.07 10.49 coo -11.22 87.18 53.49 -10.94 81.64 50.31 -35.88 89.56 6.78 -39.69 93.33 3.49 1ok4_c02 source 1ok4 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASS I : 3 hits 1ok4_c02 naa= 3 ULMN 3 1ok4_c03 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 1 3 # 1 D 24 ASP A 106 ASP~? 11.93 O22 2PE A 148 D 146 TYR A 53 TYR~? -4.55 C21 2PE A 148s D 177 LYS A 114 LYS~? 11.27 C9 2PE A 148 coo -13.44 77.36 13.12 -12.53 75.97 14.48 -12.71 50.36 24.83 -13.06 48.30 25.05 coo -7.85 74.44 22.75 -9.22 72.86 20.89 -16.76 52.42 13.05 -16.88 54.33 15.10 coo -14.24 70.61 23.48 -12.55 71.73 17.42 -9.49 51.50 12.13 -4.59 48.44 14.69 ULMN 3 1ok4_c03 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 2 3 # 2 D 24 ASP B 106 ASP~? 11.87 OH2 1PE B 150 D 146 TYR B 53 TYR~? -4.63 C18 PE8 B 148s D 177 LYS B 114 LYS~? 11.34 O7 PE8 B 148 coo -13.44 77.36 13.12 -12.53 75.97 14.48 -0.30 70.27 27.08 -0.10 70.78 25.05 coo -7.85 74.44 22.75 -9.22 72.86 20.89 6.73 78.96 33.00 4.51 77.73 34.14 coo -14.24 70.61 23.48 -12.55 71.73 17.42 11.35 73.22 32.47 12.65 68.43 28.61 ULMN 3 1ok4_c03 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 3 3 # 3 D 24 ASP D 106 ASP~? 11.82 O22 2PE D 146 D 146 TYR D 53 TYR~? -4.60 C21 2PE D 146s D 177 LYS D 114 LYS~? 10.81 C9 2PE D 146 coo -13.44 77.36 13.12 -12.53 75.97 14.48 -46.82 82.57 5.87 -48.37 83.43 7.00 coo -7.85 74.44 22.75 -9.22 72.86 20.89 -36.08 84.35 12.01 -36.58 82.07 10.49 coo -14.24 70.61 23.48 -12.55 71.73 17.42 -35.88 89.56 6.78 -39.69 93.33 3.49 1ok4_c03 source 1ok4 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASS I : 3 hits 1ok4_c03 naa= 3 ULMN 3 1ok4_c04 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 1 3 # 1 E 24 ASP A 106 ASP~? 11.93 O22 2PE A 148 E 146 TYR A 53 TYR~? -4.55 C21 2PE A 148s E 177 LYS A 114 LYS~? 11.27 C9 2PE A 148 coo -7.12 105.25 1.43 -6.30 103.34 0.77 -12.71 50.36 24.83 -13.06 48.30 25.05 coo -3.11 94.55 3.01 -3.83 95.92 0.66 -16.76 52.42 13.05 -16.88 54.33 15.10 coo -8.77 93.34 -1.70 -6.28 99.15 -2.21 -9.49 51.50 12.13 -4.59 48.44 14.69 ULMN 3 1ok4_c04 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 2 3 # 2 E 24 ASP B 106 ASP~? 11.87 OH2 1PE B 150 E 146 TYR B 53 TYR~? -4.63 C18 PE8 B 148s E 177 LYS B 114 LYS~? 11.34 O7 PE8 B 148 coo -7.12 105.25 1.43 -6.30 103.34 0.77 -0.30 70.27 27.08 -0.10 70.78 25.05 coo -3.11 94.55 3.01 -3.83 95.92 0.66 6.73 78.96 33.00 4.51 77.73 34.14 coo -8.77 93.34 -1.70 -6.28 99.15 -2.21 11.35 73.22 32.47 12.65 68.43 28.61 ULMN 3 1ok4_c04 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 3 3 # 3 E 24 ASP D 106 ASP~? 11.82 O22 2PE D 146 E 146 TYR D 53 TYR~? -4.60 C21 2PE D 146s E 177 LYS D 114 LYS~? 10.81 C9 2PE D 146 coo -7.12 105.25 1.43 -6.30 103.34 0.77 -46.82 82.57 5.87 -48.37 83.43 7.00 coo -3.11 94.55 3.01 -3.83 95.92 0.66 -36.08 84.35 12.01 -36.58 82.07 10.49 coo -8.77 93.34 -1.70 -6.28 99.15 -2.21 -35.88 89.56 6.78 -39.69 93.33 3.49 1ok4_c04 source 1ok4 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASS I : 3 hits 1ok4_c04 naa= 3 ULMN 3 1ok4_c05 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 1 3 # 1 F 24 ASP A 106 ASP~? 11.93 O22 2PE A 148 F 146 TYR A 53 TYR~? -4.55 C21 2PE A 148s F 177 LYS A 114 LYS~? 11.27 C9 2PE A 148 coo -44.75 128.15 10.28 -45.68 129.67 11.55 -12.71 50.36 24.83 -13.06 48.30 25.05 coo -50.43 131.90 19.60 -49.04 133.31 17.60 -16.76 52.42 13.05 -16.88 54.33 15.10 coo -44.10 135.86 19.99 -45.67 134.21 14.07 -9.49 51.50 12.13 -4.59 48.44 14.69 ULMN 3 1ok4_c05 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 2 3 # 2 F 24 ASP B 106 ASP~? 11.87 OH2 1PE B 150 F 146 TYR B 53 TYR~? -4.63 C18 PE8 B 148s F 177 LYS B 114 LYS~? 11.34 O7 PE8 B 148 coo -44.75 128.15 10.28 -45.68 129.67 11.55 -0.30 70.27 27.08 -0.10 70.78 25.05 coo -50.43 131.90 19.60 -49.04 133.31 17.60 6.73 78.96 33.00 4.51 77.73 34.14 coo -44.10 135.86 19.99 -45.67 134.21 14.07 11.35 73.22 32.47 12.65 68.43 28.61 ULMN 3 1ok4_c05 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 3 3 # 3 F 24 ASP D 106 ASP~? 11.82 O22 2PE D 146 F 146 TYR D 53 TYR~? -4.60 C21 2PE D 146s F 177 LYS D 114 LYS~? 10.81 C9 2PE D 146 coo -44.75 128.15 10.28 -45.68 129.67 11.55 -46.82 82.57 5.87 -48.37 83.43 7.00 coo -50.43 131.90 19.60 -49.04 133.31 17.60 -36.08 84.35 12.01 -36.58 82.07 10.49 coo -44.10 135.86 19.99 -45.67 134.21 14.07 -35.88 89.56 6.78 -39.69 93.33 3.49 1ok4_c05 source 1ok4 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASS I : 3 hits 1ok4_c05 naa= 3 ULMN 3 1ok4_c06 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 1 3 # 1 G 24 ASP A 106 ASP~? 11.93 O22 2PE A 148 G 146 TYR A 53 TYR~? -4.55 C21 2PE A 148s G 177 LYS A 114 LYS~? 11.27 C9 2PE A 148 coo -44.97 128.78 41.20 -46.32 128.26 42.83 -12.71 50.36 24.83 -13.06 48.30 25.05 coo -52.83 122.13 46.42 -51.31 124.30 47.39 -16.76 52.42 13.05 -16.88 54.33 15.10 coo -47.30 122.24 51.49 -47.46 127.44 47.81 -9.49 51.50 12.13 -4.59 48.44 14.69 ULMN 3 1ok4_c06 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 2 3 # 2 G 24 ASP B 106 ASP~? 11.87 OH2 1PE B 150 G 146 TYR B 53 TYR~? -4.63 C18 PE8 B 148s G 177 LYS B 114 LYS~? 11.34 O7 PE8 B 148 coo -44.97 128.78 41.20 -46.32 128.26 42.83 -0.30 70.27 27.08 -0.10 70.78 25.05 coo -52.83 122.13 46.42 -51.31 124.30 47.39 6.73 78.96 33.00 4.51 77.73 34.14 coo -47.30 122.24 51.49 -47.46 127.44 47.81 11.35 73.22 32.47 12.65 68.43 28.61 ULMN 3 1ok4_c06 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 3 3 # 3 G 24 ASP D 106 ASP~? 11.82 O22 2PE D 146 G 146 TYR D 53 TYR~? -4.60 C21 2PE D 146s G 177 LYS D 114 LYS~? 10.81 C9 2PE D 146 coo -44.97 128.78 41.20 -46.32 128.26 42.83 -46.82 82.57 5.87 -48.37 83.43 7.00 coo -52.83 122.13 46.42 -51.31 124.30 47.39 -36.08 84.35 12.01 -36.58 82.07 10.49 coo -47.30 122.24 51.49 -47.46 127.44 47.81 -35.88 89.56 6.78 -39.69 93.33 3.49 1ok4_c06 source 1ok4 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASS I : 3 hits 1ok4_c06 naa= 3 ULMN 3 1ok4_c07 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 1 3 # 1 H 24 ASP A 106 ASP~? 11.93 O22 2PE A 148 H 146 TYR A 53 TYR~? -4.55 C21 2PE A 148s H 177 LYS A 114 LYS~? 11.27 C9 2PE A 148 coo -51.11 100.30 51.41 -52.67 98.82 51.12 -12.71 50.36 24.83 -13.06 48.30 25.05 coo -58.70 94.17 45.32 -57.76 93.82 47.92 -16.76 52.42 13.05 -16.88 54.33 15.10 coo -54.32 88.79 48.13 -54.61 94.04 51.74 -9.49 51.50 12.13 -4.59 48.44 14.69 ULMN 3 1ok4_c07 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 2 3 # 2 H 24 ASP B 106 ASP~? 11.87 OH2 1PE B 150 H 146 TYR B 53 TYR~? -4.63 C18 PE8 B 148s H 177 LYS B 114 LYS~? 11.34 O7 PE8 B 148 coo -51.11 100.30 51.41 -52.67 98.82 51.12 -0.30 70.27 27.08 -0.10 70.78 25.05 coo -58.70 94.17 45.32 -57.76 93.82 47.92 6.73 78.96 33.00 4.51 77.73 34.14 coo -54.32 88.79 48.13 -54.61 94.04 51.74 11.35 73.22 32.47 12.65 68.43 28.61 ULMN 3 1ok4_c07 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 3 3 # 3 H 24 ASP D 106 ASP~? 11.82 O22 2PE D 146 H 146 TYR D 53 TYR~? -4.60 C21 2PE D 146s H 177 LYS D 114 LYS~? 10.81 C9 2PE D 146 coo -51.11 100.30 51.41 -52.67 98.82 51.12 -46.82 82.57 5.87 -48.37 83.43 7.00 coo -58.70 94.17 45.32 -57.76 93.82 47.92 -36.08 84.35 12.01 -36.58 82.07 10.49 coo -54.32 88.79 48.13 -54.61 94.04 51.74 -35.88 89.56 6.78 -39.69 93.33 3.49 1ok4_c07 source 1ok4 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASS I : 3 hits 1ok4_c07 naa= 3 ULMN 3 1ok4_c08 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 1 3 # 1 I 24 ASP A 106 ASP~? 11.93 O22 2PE A 148 I 146 TYR A 53 TYR~? -4.55 C21 2PE A 148s I 177 LYS A 114 LYS~? 11.27 C9 2PE A 148 coo -54.65 81.97 26.87 -55.88 81.89 25.07 -12.71 50.36 24.83 -13.06 48.30 25.05 coo -59.92 86.62 17.74 -59.42 83.94 18.40 -16.76 52.42 13.05 -16.88 54.33 15.10 coo -55.38 81.61 14.50 -57.11 80.05 20.41 -9.49 51.50 12.13 -4.59 48.44 14.69 ULMN 3 1ok4_c08 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 2 3 # 2 I 24 ASP B 106 ASP~? 11.87 OH2 1PE B 150 I 146 TYR B 53 TYR~? -4.63 C18 PE8 B 148s I 177 LYS B 114 LYS~? 11.34 O7 PE8 B 148 coo -54.65 81.97 26.87 -55.88 81.89 25.07 -0.30 70.27 27.08 -0.10 70.78 25.05 coo -59.92 86.62 17.74 -59.42 83.94 18.40 6.73 78.96 33.00 4.51 77.73 34.14 coo -55.38 81.61 14.50 -57.11 80.05 20.41 11.35 73.22 32.47 12.65 68.43 28.61 ULMN 3 1ok4_c08 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 3 3 # 3 I 24 ASP D 106 ASP~? 11.82 O22 2PE D 146 I 146 TYR D 53 TYR~? -4.60 C21 2PE D 146s I 177 LYS D 114 LYS~? 10.81 C9 2PE D 146 coo -54.65 81.97 26.87 -55.88 81.89 25.07 -46.82 82.57 5.87 -48.37 83.43 7.00 coo -59.92 86.62 17.74 -59.42 83.94 18.40 -36.08 84.35 12.01 -36.58 82.07 10.49 coo -55.38 81.61 14.50 -57.11 80.05 20.41 -35.88 89.56 6.78 -39.69 93.33 3.49 1ok4_c08 source 1ok4 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASS I : 3 hits 1ok4_c08 naa= 3 ULMN 3 1ok4_c09 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 1 3 # 1 J 24 ASP A 106 ASP~? 11.93 O22 2PE A 148 J 146 TYR A 53 TYR~? -4.55 C21 2PE A 148s J 177 LYS A 114 LYS~? 11.27 C9 2PE A 148 coo -50.64 99.08 1.52 -51.52 100.83 0.67 -12.71 50.36 24.83 -13.06 48.30 25.05 coo -54.74 109.84 1.86 -54.04 108.22 -0.34 -16.76 52.42 13.05 -16.88 54.33 15.10 coo -49.01 110.53 -2.89 -51.59 104.72 -2.78 -9.49 51.50 12.13 -4.59 48.44 14.69 ULMN 3 1ok4_c09 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 2 3 # 2 J 24 ASP B 106 ASP~? 11.87 OH2 1PE B 150 J 146 TYR B 53 TYR~? -4.63 C18 PE8 B 148s J 177 LYS B 114 LYS~? 11.34 O7 PE8 B 148 coo -50.64 99.08 1.52 -51.52 100.83 0.67 -0.30 70.27 27.08 -0.10 70.78 25.05 coo -54.74 109.84 1.86 -54.04 108.22 -0.34 6.73 78.96 33.00 4.51 77.73 34.14 coo -49.01 110.53 -2.89 -51.59 104.72 -2.78 11.35 73.22 32.47 12.65 68.43 28.61 ULMN 3 1ok4_c09 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 3 3 # 3 J 24 ASP D 106 ASP~? 11.82 O22 2PE D 146 J 146 TYR D 53 TYR~? -4.60 C21 2PE D 146s J 177 LYS D 114 LYS~? 10.81 C9 2PE D 146 coo -50.64 99.08 1.52 -51.52 100.83 0.67 -46.82 82.57 5.87 -48.37 83.43 7.00 coo -54.74 109.84 1.86 -54.04 108.22 -0.34 -36.08 84.35 12.01 -36.58 82.07 10.49 coo -49.01 110.53 -2.89 -51.59 104.72 -2.78 -35.88 89.56 6.78 -39.69 93.33 3.49 1ok4_c09 source 1ok4 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASS I : 3 hits 1ok4_c09 naa= 3 ULMN 3 1onr_c00 TRANSALDOLASE B user 1 3 # 1 A 17 ASP A 87 ASP.? 8.49 C6 PGE A 147 A 96 GLU A 75 GLU.? -8.03 O4 PGE A 147s A 132 LYS D 129 LYS^? 7.63 C4 PEG D 145 coo 31.23 12.29 16.44 30.82 11.56 18.39 -23.17 58.67 3.55 -22.34 59.17 1.69 coo 26.82 3.20 24.36 27.99 4.86 24.98 -34.40 63.01 2.19 -36.49 63.07 2.67 coo 29.99 0.62 22.18 30.38 6.69 20.81 -36.12 61.83 6.50 -39.41 57.83 4.09 ULMN 3 1onr_c00 TRANSALDOLASE B user 2 3 # 2 A 17 ASP B 19 ASP.? -3.77 O3 SO4 A 144s A 96 GLU C 75 GLU.? -8.81 O1 PGE C 147s A 132 LYS B 129 LYS^? 7.64 C2 PEG B 146 coo 31.23 12.29 16.44 30.82 11.56 18.39 -12.63 65.75 40.21 -14.11 64.30 40.60 coo 26.82 3.20 24.36 27.99 4.86 24.98 -10.84 73.75 47.59 -11.85 73.47 45.72 coo 29.99 0.62 22.18 30.38 6.69 20.81 -12.78 77.45 45.34 -17.39 74.89 47.84 ULMN 3 1onr_c00 TRANSALDOLASE B user 3 3 # 3 A 17 ASP C 87 ASP.? 8.84 O1 PGE C 147 A 96 GLU C 75 GLU.? -8.81 O1 PGE C 147s A 132 LYS B 129 LYS^? 7.64 C2 PEG B 146 coo 31.23 12.29 16.44 30.82 11.56 18.39 -9.03 79.00 58.44 -8.21 77.39 59.55 coo 26.82 3.20 24.36 27.99 4.86 24.98 -10.84 73.75 47.59 -11.85 73.47 45.72 coo 29.99 0.62 22.18 30.38 6.69 20.81 -12.78 77.45 45.34 -17.39 74.89 47.84 ULMN 3 1onr_c00 TRANSALDOLASE B user 4 3 # 4 A 17 ASP D 19 ASP.? -13.24 C2 PGE A 147s A 96 GLU A 75 GLU.? -8.03 O4 PGE A 147s A 132 LYS D 129 LYS^? 7.63 C4 PEG D 145 coo 31.23 12.29 16.44 30.82 11.56 18.39 -43.72 66.33 -2.80 -44.54 65.10 -4.29 coo 26.82 3.20 24.36 27.99 4.86 24.98 -34.40 63.01 2.19 -36.49 63.07 2.67 coo 29.99 0.62 22.18 30.38 6.69 20.81 -36.12 61.83 6.50 -39.41 57.83 4.09 1onr_c00 source 1onr TRANSALDOLASE B : 4 hits 1onr_c00 naa= 3 ULMN 3 1onr_c01 TRANSALDOLASE B user 1 3 # 1 B 17 ASP A 87 ASP.? 8.49 C6 PGE A 147 B 96 GLU A 75 GLU.? -8.03 O4 PGE A 147s B 132 LYS D 129 LYS^? 7.63 C4 PEG D 145 coo 31.16 57.31 -0.94 30.73 56.64 1.01 -23.17 58.67 3.55 -22.34 59.17 1.69 coo 26.69 48.45 7.18 27.85 50.13 7.74 -34.40 63.01 2.19 -36.49 63.07 2.67 coo 29.82 45.80 5.07 30.26 51.81 3.56 -36.12 61.83 6.50 -39.41 57.83 4.09 ULMN 3 1onr_c01 TRANSALDOLASE B user 2 3 # 2 B 17 ASP B 19 ASP.? -3.77 O3 SO4 A 144s B 96 GLU C 75 GLU.? -8.81 O1 PGE C 147s B 132 LYS B 129 LYS^? 7.64 C2 PEG B 146 coo 31.16 57.31 -0.94 30.73 56.64 1.01 -12.63 65.75 40.21 -14.11 64.30 40.60 coo 26.69 48.45 7.18 27.85 50.13 7.74 -10.84 73.75 47.59 -11.85 73.47 45.72 coo 29.82 45.80 5.07 30.26 51.81 3.56 -12.78 77.45 45.34 -17.39 74.89 47.84 ULMN 3 1onr_c01 TRANSALDOLASE B user 3 3 # 3 B 17 ASP C 87 ASP.? 8.84 O1 PGE C 147 B 96 GLU C 75 GLU.? -8.81 O1 PGE C 147s B 132 LYS B 129 LYS^? 7.64 C2 PEG B 146 coo 31.16 57.31 -0.94 30.73 56.64 1.01 -9.03 79.00 58.44 -8.21 77.39 59.55 coo 26.69 48.45 7.18 27.85 50.13 7.74 -10.84 73.75 47.59 -11.85 73.47 45.72 coo 29.82 45.80 5.07 30.26 51.81 3.56 -12.78 77.45 45.34 -17.39 74.89 47.84 ULMN 3 1onr_c01 TRANSALDOLASE B user 4 3 # 4 B 17 ASP D 19 ASP.? -13.24 C2 PGE A 147s B 96 GLU A 75 GLU.? -8.03 O4 PGE A 147s B 132 LYS D 129 LYS^? 7.63 C4 PEG D 145 coo 31.16 57.31 -0.94 30.73 56.64 1.01 -43.72 66.33 -2.80 -44.54 65.10 -4.29 coo 26.69 48.45 7.18 27.85 50.13 7.74 -34.40 63.01 2.19 -36.49 63.07 2.67 coo 29.82 45.80 5.07 30.26 51.81 3.56 -36.12 61.83 6.50 -39.41 57.83 4.09 1onr_c01 source 1onr TRANSALDOLASE B : 4 hits 1onr_c01 naa= 3 ULMN 3 1oyg_c00 LEVANSUCRASE user 1 3 # 1 A 86 ASP A 87 ASP.? 8.49 C6 PGE A 147 A 247 ASP A 122 ASP^? 7.46 C1 GOL A 150 A 342 GLU A 121 GLU^? 12.41 C1 GOL A 150 coo 44.36 35.68 9.71 43.29 36.20 11.51 -23.17 58.67 3.55 -22.34 59.17 1.69 coo 41.40 28.81 12.91 40.82 30.90 12.97 -15.41 64.92 4.51 -15.09 66.83 5.33 coo 40.37 33.11 18.06 39.99 34.93 17.06 -13.98 61.53 0.93 -15.14 61.60 -0.79 ULMN 3 1oyg_c00 LEVANSUCRASE user 2 3 # 2 A 86 ASP B 19 ASP.? -3.77 O3 SO4 A 144s A 247 ASP A 19 ASP.? -3.59 O4 SO4 A 144s A 342 GLU B 21 GLU.? -4.32 C4 PEG B 146s coo 44.36 35.68 9.71 43.29 36.20 11.51 -12.63 65.75 40.21 -14.11 64.30 40.60 coo 41.40 28.81 12.91 40.82 30.90 12.97 -15.01 66.98 32.71 -14.52 68.02 34.44 coo 40.37 33.11 18.06 39.99 34.93 17.06 -19.10 71.22 37.43 -20.67 70.39 36.27 ULMN 3 1oyg_c00 LEVANSUCRASE user 3 3 # 3 A 86 ASP B 87 ASP.? 8.94 O4 PGE B 147 A 247 ASP B 122 ASP^? 7.33 O2 GOL B 149 A 342 GLU B 121 GLU^? 8.74 O2 PEG B 144 coo 44.36 35.68 9.71 43.29 36.20 11.51 9.49 87.97 42.02 11.31 87.98 43.09 coo 41.40 28.81 12.91 40.82 30.90 12.97 10.89 79.68 47.57 9.75 78.80 49.16 coo 40.37 33.11 18.06 39.99 34.93 17.06 15.37 80.83 45.64 16.23 82.69 46.15 ULMN 3 1oyg_c00 LEVANSUCRASE user 4 3 # 4 A 86 ASP C 87 ASP.? 8.84 O1 PGE C 147 A 247 ASP C 122 ASP^? 7.22 C3 GOL C 149 A 342 GLU C 121 GLU^? 12.40 C3 GOL C 149 coo 44.36 35.68 9.71 43.29 36.20 11.51 -9.03 79.00 58.44 -8.21 77.39 59.55 coo 41.40 28.81 12.91 40.82 30.90 12.97 0.27 81.12 61.60 2.07 81.54 60.53 coo 40.37 33.11 18.06 39.99 34.93 17.06 -1.98 78.69 65.48 -2.54 76.71 65.06 ULMN 3 1oyg_c00 LEVANSUCRASE user 5 3 # 5 A 86 ASP D 83 ASP.? 8.76 O1 GOL A 150 A 247 ASP D 122 ASP^? 7.49 C3 GOL D 147 A 342 GLU D 121 GLU^? 11.70 OH7 1PE B 150 coo 44.36 35.68 9.71 43.29 36.20 11.51 -12.54 78.43 10.94 -12.46 77.06 9.29 coo 41.40 28.81 12.91 40.82 30.90 12.97 -21.82 80.90 7.85 -21.38 79.32 6.51 coo 40.37 33.11 18.06 39.99 34.93 17.06 -20.91 85.61 9.48 -19.44 85.70 10.98 ULMN 3 1oyg_c00 LEVANSUCRASE user 6 3 # 6 A 86 ASP D 87 ASP.? 7.26 C16 1PE B 150 A 247 ASP D 122 ASP^? 7.49 C3 GOL D 147 A 342 GLU D 121 GLU^? 11.70 OH7 1PE B 150 coo 44.36 35.68 9.71 43.29 36.20 11.51 -24.70 80.89 17.41 -22.90 81.94 17.31 coo 41.40 28.81 12.91 40.82 30.90 12.97 -21.82 80.90 7.85 -21.38 79.32 6.51 coo 40.37 33.11 18.06 39.99 34.93 17.06 -20.91 85.61 9.48 -19.44 85.70 10.98 ULMN 3 1oyg_c00 LEVANSUCRASE user 7 3 # 7 A 86 ASP D 122 ASP^? 7.49 C3 GOL D 147 A 247 ASP D 83 ASP.? 8.76 O1 GOL A 150 A 342 GLU D 84 GLU.? 10.79 C1 GOL A 150 coo 44.36 35.68 9.71 43.29 36.20 11.51 -21.82 80.90 7.85 -21.38 79.32 6.51 coo 41.40 28.81 12.91 40.82 30.90 12.97 -12.54 78.43 10.94 -12.46 77.06 9.29 coo 40.37 33.11 18.06 39.99 34.93 17.06 -17.40 74.78 10.23 -17.69 72.96 9.24 1oyg_c00 source 1oyg LEVANSUCRASE : 7 hits 1oyg_c00 naa= 3 ULMN 3 1pj5_c00 N,N-DIMETHYLGLYCINE OXIDASE user 1 3 # 1 A 225 HIS A 115 HIS~? 12.27 C21 2PE A 148 A 259 TYR A 38 TYR.? 14.78 C11 2PE A 148 A 552 ASP B 56 ASP~? 11.45 C20 PE8 B 148 coo 11.34 95.90 25.54 12.13 96.42 23.67 -13.18 48.35 10.37 -12.55 46.36 10.33 coo 14.91 97.39 18.63 13.39 95.60 20.20 -8.94 48.99 5.06 -11.42 48.37 6.17 coo 46.37 82.54 38.83 45.97 84.66 38.77 6.80 78.21 26.00 8.47 79.07 25.03 ULMN 3 1pj5_c00 N,N-DIMETHYLGLYCINE OXIDASE user 2 3 # 2 A 225 HIS A 115 HIS~? 12.27 C21 2PE A 148 A 259 TYR A 38 TYR.? 14.78 C11 2PE A 148 A 552 ASP D 6 ASP.? -3.77 C8 2PE D 146s coo 11.34 95.90 25.54 12.13 96.42 23.67 -13.18 48.35 10.37 -12.55 46.36 10.33 coo 14.91 97.39 18.63 13.39 95.60 20.20 -8.94 48.99 5.06 -11.42 48.37 6.17 coo 46.37 82.54 38.83 45.97 84.66 38.77 -31.03 82.87 1.04 -31.83 84.41 2.29 ULMN 3 1pj5_c00 N,N-DIMETHYLGLYCINE OXIDASE user 3 3 # 3 A 225 HIS A 115 HIS~? 12.27 C21 2PE A 148 A 259 TYR A 38 TYR.? 14.78 C11 2PE A 148 A 552 ASP D 19 ASP.? -13.24 C2 PGE A 147s coo 11.34 95.90 25.54 12.13 96.42 23.67 -13.18 48.35 10.37 -12.55 46.36 10.33 coo 14.91 97.39 18.63 13.39 95.60 20.20 -8.94 48.99 5.06 -11.42 48.37 6.17 coo 46.37 82.54 38.83 45.97 84.66 38.77 -43.72 66.33 -2.80 -44.54 65.10 -4.29 ULMN 3 1pj5_c00 N,N-DIMETHYLGLYCINE OXIDASE user 4 3 # 4 A 225 HIS A 115 HIS~? 12.27 C21 2PE A 148 A 259 TYR A 50 TYR~? 5.51 CH2 MLY D 135 A 552 ASP B 56 ASP~? 11.45 C20 PE8 B 148 coo 11.34 95.90 25.54 12.13 96.42 23.67 -13.18 48.35 10.37 -12.55 46.36 10.33 coo 14.91 97.39 18.63 13.39 95.60 20.20 -19.50 53.98 8.67 -20.18 55.72 10.74 coo 46.37 82.54 38.83 45.97 84.66 38.77 6.80 78.21 26.00 8.47 79.07 25.03 ULMN 3 1pj5_c00 N,N-DIMETHYLGLYCINE OXIDASE user 5 3 # 5 A 225 HIS B 115 HIS~? 12.48 C18 PE8 B 148 A 259 TYR B 38 TYR.? 9.60 O1 PEG B 144 A 552 ASP C 6 ASP.? -4.04 C8 PE8 C 148s coo 11.34 95.90 25.54 12.13 96.42 23.67 11.86 77.76 30.05 12.70 77.49 28.15 coo 14.91 97.39 18.63 13.39 95.60 20.20 18.19 76.55 32.34 16.15 78.24 31.46 coo 46.37 82.54 38.83 45.97 84.66 38.77 0.53 91.96 65.64 -1.31 91.68 66.68 ULMN 3 1pj5_c00 N,N-DIMETHYLGLYCINE OXIDASE user 6 3 # 6 A 225 HIS B 115 HIS~? 12.48 C18 PE8 B 148 A 259 TYR B 38 TYR.? 9.60 O1 PEG B 144 A 552 ASP C 19 ASP.? 9.43 O3 SO4 C 143 coo 11.34 95.90 25.54 12.13 96.42 23.67 11.86 77.76 30.05 12.70 77.49 28.15 coo 14.91 97.39 18.63 13.39 95.60 20.20 18.19 76.55 32.34 16.15 78.24 31.46 coo 46.37 82.54 38.83 45.97 84.66 38.77 2.21 107.45 51.42 3.36 109.08 50.82 ULMN 3 1pj5_c00 N,N-DIMETHYLGLYCINE OXIDASE user 7 3 # 7 A 225 HIS B 115 HIS~? 12.48 C18 PE8 B 148 A 259 TYR B 50 TYR~? 5.52 CH1 MLY C 135 A 552 ASP D 122 ASP^? 7.49 C3 GOL D 147 coo 11.34 95.90 25.54 12.13 96.42 23.67 11.86 77.76 30.05 12.70 77.49 28.15 coo 14.91 97.39 18.63 13.39 95.60 20.20 8.51 83.11 35.90 5.93 82.51 36.84 coo 46.37 82.54 38.83 45.97 84.66 38.77 -21.82 80.90 7.85 -21.38 79.32 6.51 ULMN 3 1pj5_c00 N,N-DIMETHYLGLYCINE OXIDASE user 8 3 # 8 A 225 HIS B 115 HIS~? 12.48 C18 PE8 B 148 A 259 TYR B 53 TYR~? -4.63 C18 PE8 B 148s A 552 ASP A 122 ASP^? 7.46 C1 GOL A 150 coo 11.34 95.90 25.54 12.13 96.42 23.67 11.86 77.76 30.05 12.70 77.49 28.15 coo 14.91 97.39 18.63 13.39 95.60 20.20 6.73 78.96 33.00 4.51 77.73 34.14 coo 46.37 82.54 38.83 45.97 84.66 38.77 -15.41 64.92 4.51 -15.09 66.83 5.33 ULMN 3 1pj5_c00 N,N-DIMETHYLGLYCINE OXIDASE user 9 3 # 9 A 225 HIS C 115 HIS~? 4.72 C MLZ C 114 A 259 TYR C 38 TYR.? 5.20 O MLZ C 114 A 552 ASP B 6 ASP.? -3.99 C6 PE8 B 148s coo 11.34 95.90 25.54 12.13 96.42 23.67 -12.99 90.00 69.08 -14.38 90.57 70.54 coo 14.91 97.39 18.63 13.39 95.60 20.20 -10.37 86.21 74.10 -12.04 86.61 71.91 coo 46.37 82.54 38.83 45.97 84.66 38.77 7.95 70.39 41.39 8.88 71.08 39.61 ULMN 3 1pj5_c00 N,N-DIMETHYLGLYCINE OXIDASE user 10 3 # 10 A 225 HIS D 115 HIS~? 12.18 C21 2PE D 146 A 259 TYR D 38 TYR.? 14.74 C9 2PE D 146 A 552 ASP A 6 ASP.? -3.91 C9 2PE A 148s coo 11.34 95.90 25.54 12.13 96.42 23.67 -36.28 90.32 11.92 -37.49 91.98 12.35 coo 14.91 97.39 18.63 13.39 95.60 20.20 -31.57 94.95 9.95 -32.83 93.25 11.77 coo 46.37 82.54 38.83 45.97 84.66 38.77 -8.66 61.41 13.34 -8.76 59.35 12.80 ULMN 3 1pj5_c00 N,N-DIMETHYLGLYCINE OXIDASE user 11 3 # 11 A 225 HIS D 115 HIS~? 12.18 C21 2PE D 146 A 259 TYR D 38 TYR.? 14.74 C9 2PE D 146 A 552 ASP A 19 ASP.? -3.59 O4 SO4 A 144s coo 11.34 95.90 25.54 12.13 96.42 23.67 -36.28 90.32 11.92 -37.49 91.98 12.35 coo 14.91 97.39 18.63 13.39 95.60 20.20 -31.57 94.95 9.95 -32.83 93.25 11.77 coo 46.37 82.54 38.83 45.97 84.66 38.77 -15.01 66.98 32.71 -14.52 68.02 34.44 1pj5_c00 source 1pj5 N,N-DIMETHYLGLYCINE OXIDASE : 11 hits 1pj5_c00 naa= 3 ULMN 3 1pjh_c00 ENOYL-COA ISOMERASE; ECI1P user 1 3 # 1 A 70 ALA A 119 ALA~? 10.88 CH2 MLY D 135 A 126 LEU A 32 LEU^? 9.30 CH2 MLY D 135 A 158 GLU A 121 GLU^? 12.41 C1 GOL A 150 coo -2.29 37.66 144.73 -1.46 37.12 145.87 -14.35 54.52 5.55 -15.48 54.02 6.43 coo -4.62 32.83 147.14 -5.50 32.85 149.12 -19.04 56.74 3.15 -19.76 55.64 4.88 coo -0.83 29.57 149.77 -0.39 31.47 148.95 -13.98 61.53 0.93 -15.14 61.60 -0.79 ULMN 3 1pjh_c00 ENOYL-COA ISOMERASE; ECI1P user 2 3 # 2 A 70 ALA B 119 ALA~? 10.71 O16 PE8 B 148 A 126 LEU B 32 LEU^? 9.36 CE MLY C 135 A 158 GLU B 121 GLU^? 8.74 O2 PEG B 144 coo -2.29 37.66 144.73 -1.46 37.12 145.87 13.47 80.03 37.47 12.33 80.66 36.69 coo -4.62 32.83 147.14 -5.50 32.85 149.12 12.48 84.84 40.35 10.99 84.89 38.79 coo -0.83 29.57 149.77 -0.39 31.47 148.95 15.37 80.83 45.64 16.23 82.69 46.15 ULMN 3 1pjh_c00 ENOYL-COA ISOMERASE; ECI1P user 3 3 # 3 A 70 ALA C 119 ALA~? 6.80 O MLZ C 114 A 126 LEU C 32 LEU^? 8.96 CD MLY B 135 A 158 GLU C 121 GLU^? 12.40 C3 GOL C 149 coo -2.29 37.66 144.73 -1.46 37.12 145.87 -8.25 84.08 66.89 -9.22 84.66 65.88 coo -4.62 32.83 147.14 -5.50 32.85 149.12 -8.67 80.10 62.81 -9.90 81.76 62.17 coo -0.83 29.57 149.77 -0.39 31.47 148.95 -1.98 78.69 65.48 -2.54 76.71 65.06 ULMN 3 1pjh_c00 ENOYL-COA ISOMERASE; ECI1P user 4 3 # 4 A 70 ALA D 119 ALA~? 10.88 C18 2PE D 146 A 126 LEU D 32 LEU^? 9.39 CH1 MLY A 135 A 158 GLU D 121 GLU^? 11.70 OH7 1PE B 150 coo -2.29 37.66 144.73 -1.46 37.12 145.87 -28.73 87.90 11.52 -29.74 87.21 12.41 coo -4.62 32.83 147.14 -5.50 32.85 149.12 -25.57 84.78 15.16 -27.60 84.30 15.68 coo -0.83 29.57 149.77 -0.39 31.47 148.95 -20.91 85.61 9.48 -19.44 85.70 10.98 1pjh_c00 source 1pjh ENOYL-COA ISOMERASE; ECI1P : 4 hits 1pjh_c00 naa= 3 ULMN 3 1pjh_c01 ENOYL-COA ISOMERASE; ECI1P user 1 3 # 1 B 70 ALA A 119 ALA~? 10.88 CH2 MLY D 135 B 126 LEU A 32 LEU^? 9.30 CH2 MLY D 135 B 158 GLU A 121 GLU^? 12.41 C1 GOL A 150 coo -39.79 4.61 147.27 -39.61 5.56 148.47 -14.35 54.52 5.55 -15.48 54.02 6.43 coo -34.22 5.06 149.25 -33.65 4.24 151.15 -19.04 56.74 3.15 -19.76 55.64 4.88 coo -33.03 9.93 151.71 -34.98 9.38 151.11 -13.98 61.53 0.93 -15.14 61.60 -0.79 ULMN 3 1pjh_c01 ENOYL-COA ISOMERASE; ECI1P user 2 3 # 2 B 70 ALA B 119 ALA~? 10.71 O16 PE8 B 148 B 126 LEU B 32 LEU^? 9.36 CE MLY C 135 B 158 GLU B 121 GLU^? 8.74 O2 PEG B 144 coo -39.79 4.61 147.27 -39.61 5.56 148.47 13.47 80.03 37.47 12.33 80.66 36.69 coo -34.22 5.06 149.25 -33.65 4.24 151.15 12.48 84.84 40.35 10.99 84.89 38.79 coo -33.03 9.93 151.71 -34.98 9.38 151.11 15.37 80.83 45.64 16.23 82.69 46.15 ULMN 3 1pjh_c01 ENOYL-COA ISOMERASE; ECI1P user 3 3 # 3 B 70 ALA C 119 ALA~? 6.80 O MLZ C 114 B 126 LEU C 32 LEU^? 8.96 CD MLY B 135 B 158 GLU C 121 GLU^? 12.40 C3 GOL C 149 coo -39.79 4.61 147.27 -39.61 5.56 148.47 -8.25 84.08 66.89 -9.22 84.66 65.88 coo -34.22 5.06 149.25 -33.65 4.24 151.15 -8.67 80.10 62.81 -9.90 81.76 62.17 coo -33.03 9.93 151.71 -34.98 9.38 151.11 -1.98 78.69 65.48 -2.54 76.71 65.06 ULMN 3 1pjh_c01 ENOYL-COA ISOMERASE; ECI1P user 4 3 # 4 B 70 ALA D 119 ALA~? 10.88 C18 2PE D 146 B 126 LEU D 32 LEU^? 9.39 CH1 MLY A 135 B 158 GLU D 121 GLU^? 11.70 OH7 1PE B 150 coo -39.79 4.61 147.27 -39.61 5.56 148.47 -28.73 87.90 11.52 -29.74 87.21 12.41 coo -34.22 5.06 149.25 -33.65 4.24 151.15 -25.57 84.78 15.16 -27.60 84.30 15.68 coo -33.03 9.93 151.71 -34.98 9.38 151.11 -20.91 85.61 9.48 -19.44 85.70 10.98 1pjh_c01 source 1pjh ENOYL-COA ISOMERASE; ECI1P : 4 hits 1pjh_c01 naa= 3 ULMN 3 1pjh_c02 ENOYL-COA ISOMERASE; ECI1P user 1 3 # 1 C 70 ALA A 119 ALA~? 10.88 CH2 MLY D 135 C 126 LEU A 32 LEU^? 9.30 CH2 MLY D 135 C 158 GLU A 121 GLU^? 12.41 C1 GOL A 150 coo 7.77 -11.41 146.15 6.88 -11.77 147.32 -14.35 54.52 5.55 -15.48 54.02 6.43 coo 4.88 -6.81 148.13 5.33 -5.89 150.06 -19.04 56.74 3.15 -19.76 55.64 4.88 coo 0.03 -8.25 150.96 1.55 -9.64 150.41 -13.98 61.53 0.93 -15.14 61.60 -0.79 ULMN 3 1pjh_c02 ENOYL-COA ISOMERASE; ECI1P user 2 3 # 2 C 70 ALA B 119 ALA~? 10.71 O16 PE8 B 148 C 126 LEU B 32 LEU^? 9.36 CE MLY C 135 C 158 GLU B 121 GLU^? 8.74 O2 PEG B 144 coo 7.77 -11.41 146.15 6.88 -11.77 147.32 13.47 80.03 37.47 12.33 80.66 36.69 coo 4.88 -6.81 148.13 5.33 -5.89 150.06 12.48 84.84 40.35 10.99 84.89 38.79 coo 0.03 -8.25 150.96 1.55 -9.64 150.41 15.37 80.83 45.64 16.23 82.69 46.15 ULMN 3 1pjh_c02 ENOYL-COA ISOMERASE; ECI1P user 3 3 # 3 C 70 ALA C 119 ALA~? 6.80 O MLZ C 114 C 126 LEU C 32 LEU^? 8.96 CD MLY B 135 C 158 GLU C 121 GLU^? 12.40 C3 GOL C 149 coo 7.77 -11.41 146.15 6.88 -11.77 147.32 -8.25 84.08 66.89 -9.22 84.66 65.88 coo 4.88 -6.81 148.13 5.33 -5.89 150.06 -8.67 80.10 62.81 -9.90 81.76 62.17 coo 0.03 -8.25 150.96 1.55 -9.64 150.41 -1.98 78.69 65.48 -2.54 76.71 65.06 ULMN 3 1pjh_c02 ENOYL-COA ISOMERASE; ECI1P user 4 3 # 4 C 70 ALA D 119 ALA~? 10.88 C18 2PE D 146 C 126 LEU D 32 LEU^? 9.39 CH1 MLY A 135 C 158 GLU D 121 GLU^? 11.70 OH7 1PE B 150 coo 7.77 -11.41 146.15 6.88 -11.77 147.32 -28.73 87.90 11.52 -29.74 87.21 12.41 coo 4.88 -6.81 148.13 5.33 -5.89 150.06 -25.57 84.78 15.16 -27.60 84.30 15.68 coo 0.03 -8.25 150.96 1.55 -9.64 150.41 -20.91 85.61 9.48 -19.44 85.70 10.98 1pjh_c02 source 1pjh ENOYL-COA ISOMERASE; ECI1P : 4 hits 1pjh_c02 naa= 3 ULMN 3 1pjq_c02 SIROHEME SYNTHASE user 1 3 # 1 A 248 ASP A 6 ASP.? -3.91 C9 2PE A 148s A 270 LYS A 9 LYS~? 8.68 C6 2PE A 148 A 382 MET A 26 MET?? -5.64 CL CL A 145s coo -27.63 121.99 45.48 -26.66 123.86 45.68 -8.66 61.41 13.34 -8.76 59.35 12.80 coo -32.20 115.91 49.56 -31.37 121.03 53.12 -4.77 65.74 20.08 0.46 67.29 18.98 coo -23.75 127.89 58.42 -26.02 128.79 55.12 -22.65 64.00 19.64 -19.99 64.34 21.62 ULMN 3 1pjq_c02 SIROHEME SYNTHASE user 2 3 # 2 A 248 ASP A 6 ASP.? -3.91 C9 2PE A 148s A 270 LYS A 9 LYS~? 8.68 C6 2PE A 148 A 382 MET A 103 MET?? 4.67 O22 2PE A 148 coo -27.63 121.99 45.48 -26.66 123.86 45.68 -8.66 61.41 13.34 -8.76 59.35 12.80 coo -32.20 115.91 49.56 -31.37 121.03 53.12 -4.77 65.74 20.08 0.46 67.29 18.98 coo -23.75 127.89 58.42 -26.02 128.79 55.12 -15.02 54.15 24.81 -18.15 54.76 21.95 ULMN 3 1pjq_c02 SIROHEME SYNTHASE user 3 3 # 3 A 248 ASP A 6 ASP.? -3.91 C9 2PE A 148s A 270 LYS A 114 LYS~? 11.27 C9 2PE A 148 A 382 MET A 1 MET?? 7.79 C1 GOL A 150 coo -27.63 121.99 45.48 -26.66 123.86 45.68 -8.66 61.41 13.34 -8.76 59.35 12.80 coo -32.20 115.91 49.56 -31.37 121.03 53.12 -9.49 51.50 12.13 -4.59 48.44 14.69 coo -23.75 127.89 58.42 -26.02 128.79 55.12 -10.88 64.37 -0.48 -13.80 67.37 0.89 ULMN 3 1pjq_c02 SIROHEME SYNTHASE user 4 3 # 4 A 248 ASP B 6 ASP.? -3.99 C6 PE8 B 148s A 270 LYS B 9 LYS~? 8.12 C3 PE8 B 148 A 382 MET B 26 MET?? -5.63 CL CL B 143s coo -27.63 121.99 45.48 -26.66 123.86 45.68 7.95 70.39 41.39 8.88 71.08 39.61 coo -32.20 115.91 49.56 -31.37 121.03 53.12 3.06 63.14 43.18 6.71 59.02 44.53 coo -23.75 127.89 58.42 -26.02 128.79 55.12 -4.92 79.05 41.71 -5.28 75.74 41.38 ULMN 3 1pjq_c02 SIROHEME SYNTHASE user 5 3 # 5 A 248 ASP B 6 ASP.? -3.99 C6 PE8 B 148s A 270 LYS B 9 LYS~? 8.12 C3 PE8 B 148 A 382 MET B 103 MET?? 4.44 O19 PE8 B 148 coo -27.63 121.99 45.48 -26.66 123.86 45.68 7.95 70.39 41.39 8.88 71.08 39.61 coo -32.20 115.91 49.56 -31.37 121.03 53.12 3.06 63.14 43.18 6.71 59.02 44.53 coo -23.75 127.89 58.42 -26.02 128.79 55.12 -2.51 71.69 30.66 -1.87 75.61 32.28 ULMN 3 1pjq_c02 SIROHEME SYNTHASE user 6 3 # 6 A 248 ASP C 6 ASP.? -4.04 C8 PE8 C 148s A 270 LYS C 9 LYS~? 8.15 O4 PE8 C 148 A 382 MET C 26 MET?? -5.59 CL CL C 144s coo -27.63 121.99 45.48 -26.66 123.86 45.68 0.53 91.96 65.64 -1.31 91.68 66.68 coo -32.20 115.91 49.56 -31.37 121.03 53.12 6.41 98.82 64.59 9.45 98.54 68.92 coo -23.75 127.89 58.42 -26.02 128.79 55.12 -4.21 93.40 50.96 -2.58 95.97 52.33 ULMN 3 1pjq_c02 SIROHEME SYNTHASE user 7 3 # 7 A 248 ASP C 6 ASP.? -4.04 C8 PE8 C 148s A 270 LYS C 9 LYS~? 8.15 O4 PE8 C 148 A 382 MET C 103 MET?? 4.53 C21 PE8 C 148 coo -27.63 121.99 45.48 -26.66 123.86 45.68 0.53 91.96 65.64 -1.31 91.68 66.68 coo -32.20 115.91 49.56 -31.37 121.03 53.12 6.41 98.82 64.59 9.45 98.54 68.92 coo -23.75 127.89 58.42 -26.02 128.79 55.12 -8.98 102.17 60.10 -9.94 98.40 58.22 ULMN 3 1pjq_c02 SIROHEME SYNTHASE user 8 3 # 8 A 248 ASP D 6 ASP.? -3.77 C8 2PE D 146s A 270 LYS D 9 LYS~? 7.95 C5 2PE D 146 A 382 MET D 26 MET?? -5.61 CL CL D 143s coo -27.63 121.99 45.48 -26.66 123.86 45.68 -31.03 82.87 1.04 -31.83 84.41 2.29 coo -32.20 115.91 49.56 -31.37 121.03 53.12 -34.17 79.01 -6.33 -32.19 82.24 -10.69 coo -23.75 127.89 58.42 -26.02 128.79 55.12 -34.73 70.12 9.23 -36.17 70.45 6.29 ULMN 3 1pjq_c02 SIROHEME SYNTHASE user 9 3 # 9 A 248 ASP D 6 ASP.? -3.77 C8 2PE D 146s A 270 LYS D 9 LYS~? 7.95 C5 2PE D 146 A 382 MET D 103 MET?? 4.49 O22 2PE D 146 coo -27.63 121.99 45.48 -26.66 123.86 45.68 -31.03 82.87 1.04 -31.83 84.41 2.29 coo -32.20 115.91 49.56 -31.37 121.03 53.12 -34.17 79.01 -6.33 -32.19 82.24 -10.69 coo -23.75 127.89 58.42 -26.02 128.79 55.12 -44.67 78.56 5.93 -41.96 77.76 9.17 1pjq_c02 source 1pjq SIROHEME SYNTHASE : 9 hits 1pjq_c02 naa= 3 ULMN 3 1pjq_c03 SIROHEME SYNTHASE user 1 3 # 1 B 248 ASP A 6 ASP.? -3.91 C9 2PE A 148s B 270 LYS A 9 LYS~? 8.68 C6 2PE A 148 B 382 MET A 103 MET?? 4.67 O22 2PE A 148 coo -11.82 154.51 43.38 -12.86 152.74 43.79 -8.66 61.41 13.34 -8.76 59.35 12.80 coo -5.09 158.39 43.41 -0.74 158.80 47.15 -4.77 65.74 20.08 0.46 67.29 18.98 coo -2.79 145.52 50.38 -5.75 148.14 51.66 -15.02 54.15 24.81 -18.15 54.76 21.95 ULMN 3 1pjq_c03 SIROHEME SYNTHASE user 2 3 # 2 B 248 ASP B 6 ASP.? -3.99 C6 PE8 B 148s B 270 LYS B 9 LYS~? 8.12 C3 PE8 B 148 B 382 MET B 103 MET?? 4.44 O19 PE8 B 148 coo -11.82 154.51 43.38 -12.86 152.74 43.79 7.95 70.39 41.39 8.88 71.08 39.61 coo -5.09 158.39 43.41 -0.74 158.80 47.15 3.06 63.14 43.18 6.71 59.02 44.53 coo -2.79 145.52 50.38 -5.75 148.14 51.66 -2.51 71.69 30.66 -1.87 75.61 32.28 ULMN 3 1pjq_c03 SIROHEME SYNTHASE user 3 3 # 3 B 248 ASP C 6 ASP.? -4.04 C8 PE8 C 148s B 270 LYS C 9 LYS~? 8.15 O4 PE8 C 148 B 382 MET C 103 MET?? 4.53 C21 PE8 C 148 coo -11.82 154.51 43.38 -12.86 152.74 43.79 0.53 91.96 65.64 -1.31 91.68 66.68 coo -5.09 158.39 43.41 -0.74 158.80 47.15 6.41 98.82 64.59 9.45 98.54 68.92 coo -2.79 145.52 50.38 -5.75 148.14 51.66 -8.98 102.17 60.10 -9.94 98.40 58.22 ULMN 3 1pjq_c03 SIROHEME SYNTHASE user 4 3 # 4 B 248 ASP D 6 ASP.? -3.77 C8 2PE D 146s B 270 LYS D 9 LYS~? 7.95 C5 2PE D 146 B 382 MET D 103 MET?? 4.49 O22 2PE D 146 coo -11.82 154.51 43.38 -12.86 152.74 43.79 -31.03 82.87 1.04 -31.83 84.41 2.29 coo -5.09 158.39 43.41 -0.74 158.80 47.15 -34.17 79.01 -6.33 -32.19 82.24 -10.69 coo -2.79 145.52 50.38 -5.75 148.14 51.66 -44.67 78.56 5.93 -41.96 77.76 9.17 1pjq_c03 source 1pjq SIROHEME SYNTHASE : 4 hits 1pjq_c03 naa= 3 ULMN 3 1pmi_c00 PHOSPHOMANNOSE ISOMERASE user 1 3 # 1 111 GLN B 117 GLN~? 5.32 C6 PE8 B 148 294 GLU B 111 GLU~? 12.54 O7 PE8 B 148 304 ARG B 116 ARG~? 4.93 C12 PE8 B 148 coo 15.89 18.45 46.53 15.82 16.91 48.02 10.75 72.43 36.89 10.67 70.46 36.01 coo 22.84 13.44 52.91 20.84 13.18 52.38 9.41 70.70 25.55 11.25 69.94 26.27 coo 8.71 17.11 46.51 7.23 17.64 49.20 6.23 77.16 37.54 6.11 77.30 40.64 ULMN 3 1pmi_c00 PHOSPHOMANNOSE ISOMERASE user 2 3 # 2 111 GLN C 117 GLN~? 4.60 CA MLZ C 114 294 GLU C 111 GLU~? 3.06 NZ MLZ C 114 304 ARG C 116 ARG~? 4.72 C15 PE8 C 148 coo 15.89 18.45 46.53 15.82 16.91 48.02 -4.25 90.95 68.48 -3.88 92.71 69.63 coo 22.84 13.44 52.91 20.84 13.18 52.38 -12.41 98.44 71.96 -11.17 97.70 73.52 coo 8.71 17.11 46.51 7.23 17.64 49.20 -6.64 90.12 62.40 -4.04 88.84 61.33 ULMN 3 1pmi_c00 PHOSPHOMANNOSE ISOMERASE user 3 3 # 3 111 GLN D 82 GLN.? 6.38 C25 1PE B 150 294 GLU D 84 GLU.? 10.79 C1 GOL A 150 304 ARG B 63 ARG~? -8.01 OH2 1PE B 150s coo 15.89 18.45 46.53 15.82 16.91 48.02 -10.30 73.84 16.04 -11.87 72.70 17.06 coo 22.84 13.44 52.91 20.84 13.18 52.38 -17.40 74.78 10.23 -17.69 72.96 9.24 coo 8.71 17.11 46.51 7.23 17.64 49.20 -5.18 74.17 22.68 -2.11 73.83 22.90 1pmi_c00 source 1pmi PHOSPHOMANNOSE ISOMERASE : 3 hits 1pmi_c00 naa= 3 ULMN 3 1pyl_c00 RIBONUCLEASE user 1 3 # 1 A 56 GLU A 48 GLU~? 14.04 CG MLY D 135 A 67 ARG A 42 ARG.? 16.81 C11 2PE A 148 A 86 HIS A 115 HIS~? 12.27 C21 2PE A 148 coo 18.15 3.28 18.56 20.10 2.92 19.20 -19.52 46.65 2.13 -18.86 45.41 0.50 coo 21.52 6.83 26.64 21.22 5.53 23.85 -8.57 45.71 4.07 -9.11 44.76 6.92 coo 22.36 -1.88 25.52 23.57 -0.73 24.25 -13.18 48.35 10.37 -12.55 46.36 10.33 ULMN 3 1pyl_c00 RIBONUCLEASE user 2 3 # 2 A 56 GLU A 48 GLU~? 14.04 CG MLY D 135 A 67 ARG A 55 ARG~? 10.23 CD MLY D 135 A 86 HIS A 115 HIS~? 12.27 C21 2PE A 148 coo 18.15 3.28 18.56 20.10 2.92 19.20 -19.52 46.65 2.13 -18.86 45.41 0.50 coo 21.52 6.83 26.64 21.22 5.53 23.85 -19.70 43.33 11.87 -20.69 44.07 9.04 coo 22.36 -1.88 25.52 23.57 -0.73 24.25 -13.18 48.35 10.37 -12.55 46.36 10.33 ULMN 3 1pyl_c00 RIBONUCLEASE user 3 3 # 3 A 56 GLU B 48 GLU~? 13.73 O1 PEG B 144 A 67 ARG B 42 ARG.? 12.70 O1 PEG B 144 A 86 HIS B 115 HIS~? 12.48 C18 PE8 B 148 coo 18.15 3.28 18.56 20.10 2.92 19.20 16.05 87.39 31.22 18.08 87.70 30.57 coo 21.52 6.83 26.64 21.22 5.53 23.85 19.61 78.53 29.44 17.94 76.42 28.00 coo 22.36 -1.88 25.52 23.57 -0.73 24.25 11.86 77.76 30.05 12.70 77.49 28.15 ULMN 3 1pyl_c00 RIBONUCLEASE user 4 3 # 4 A 56 GLU B 48 GLU~? 13.73 O1 PEG B 144 A 67 ARG B 55 ARG~? 9.33 CG MLY C 135 A 86 HIS B 115 HIS~? 12.48 C18 PE8 B 148 coo 18.15 3.28 18.56 20.10 2.92 19.20 16.05 87.39 31.22 18.08 87.70 30.57 coo 21.52 6.83 26.64 21.22 5.53 23.85 8.78 84.29 24.99 10.39 86.20 26.77 coo 22.36 -1.88 25.52 23.57 -0.73 24.25 11.86 77.76 30.05 12.70 77.49 28.15 ULMN 3 1pyl_c00 RIBONUCLEASE user 5 3 # 5 A 56 GLU C 48 GLU~? 14.22 O MLZ C 114 A 67 ARG C 42 ARG.? 7.63 O MLZ C 114 A 86 HIS C 115 HIS~? 4.72 C MLZ C 114 coo 18.15 3.28 18.56 20.10 2.92 19.20 -17.56 80.63 67.68 -18.20 79.53 69.43 coo 21.52 6.83 26.64 21.22 5.53 23.85 -13.55 84.90 75.42 -13.77 88.03 75.38 coo 22.36 -1.88 25.52 23.57 -0.73 24.25 -12.99 90.00 69.08 -14.38 90.57 70.54 ULMN 3 1pyl_c00 RIBONUCLEASE user 6 3 # 6 A 56 GLU C 48 GLU~? 14.22 O MLZ C 114 A 67 ARG C 55 ARG~? 9.18 O MLY B 135 A 86 HIS C 115 HIS~? 4.72 C MLZ C 114 coo 18.15 3.28 18.56 20.10 2.92 19.20 -17.56 80.63 67.68 -18.20 79.53 69.43 coo 21.52 6.83 26.64 21.22 5.53 23.85 -21.06 89.68 64.73 -20.37 86.74 65.24 coo 22.36 -1.88 25.52 23.57 -0.73 24.25 -12.99 90.00 69.08 -14.38 90.57 70.54 ULMN 3 1pyl_c00 RIBONUCLEASE user 7 3 # 7 A 56 GLU D 48 GLU~? 13.85 CG MLY A 135 A 67 ARG D 42 ARG.? 16.60 C9 2PE D 146 A 86 HIS D 115 HIS~? 12.18 C21 2PE D 146 coo 18.15 3.28 18.56 20.10 2.92 19.20 -30.39 91.81 20.65 -29.75 93.83 21.10 coo 21.52 6.83 26.64 21.22 5.53 23.85 -32.78 97.24 12.74 -35.35 96.85 11.13 coo 22.36 -1.88 25.52 23.57 -0.73 24.25 -36.28 90.32 11.92 -37.49 91.98 12.35 ULMN 3 1pyl_c00 RIBONUCLEASE user 8 3 # 8 A 56 GLU D 48 GLU~? 13.85 CG MLY A 135 A 67 ARG D 55 ARG~? 9.16 CG MLY A 135 A 86 HIS D 115 HIS~? 12.18 C21 2PE D 146 coo 18.15 3.28 18.56 20.10 2.92 19.20 -30.39 91.81 20.65 -29.75 93.83 21.10 coo 21.52 6.83 26.64 21.22 5.53 23.85 -39.98 89.02 19.79 -37.17 89.06 21.03 coo 22.36 -1.88 25.52 23.57 -0.73 24.25 -36.28 90.32 11.92 -37.49 91.98 12.35 1pyl_c00 source 1pyl RIBONUCLEASE : 8 hits 1pyl_c00 naa= 3 ULMN 3 1pyl_c01 RIBONUCLEASE user 1 3 # 1 B 56 GLU A 48 GLU~? 14.04 CG MLY D 135 B 67 ARG A 42 ARG.? 16.81 C11 2PE A 148 B 86 HIS A 115 HIS~? 12.27 C21 2PE A 148 coo 33.14 -5.53 11.32 32.45 -5.14 9.39 -19.52 46.65 2.13 -18.86 45.41 0.50 coo 31.86 -4.62 2.25 31.08 -4.78 5.21 -8.57 45.71 4.07 -9.11 44.76 6.92 coo 25.42 -9.42 7.20 25.63 -7.36 7.52 -13.18 48.35 10.37 -12.55 46.36 10.33 ULMN 3 1pyl_c01 RIBONUCLEASE user 2 3 # 2 B 56 GLU A 48 GLU~? 14.04 CG MLY D 135 B 67 ARG A 55 ARG~? 10.23 CD MLY D 135 B 86 HIS A 115 HIS~? 12.27 C21 2PE A 148 coo 33.14 -5.53 11.32 32.45 -5.14 9.39 -19.52 46.65 2.13 -18.86 45.41 0.50 coo 31.86 -4.62 2.25 31.08 -4.78 5.21 -19.70 43.33 11.87 -20.69 44.07 9.04 coo 25.42 -9.42 7.20 25.63 -7.36 7.52 -13.18 48.35 10.37 -12.55 46.36 10.33 ULMN 3 1pyl_c01 RIBONUCLEASE user 3 3 # 3 B 56 GLU B 48 GLU~? 13.73 O1 PEG B 144 B 67 ARG B 42 ARG.? 12.70 O1 PEG B 144 B 86 HIS B 115 HIS~? 12.48 C18 PE8 B 148 coo 33.14 -5.53 11.32 32.45 -5.14 9.39 16.05 87.39 31.22 18.08 87.70 30.57 coo 31.86 -4.62 2.25 31.08 -4.78 5.21 19.61 78.53 29.44 17.94 76.42 28.00 coo 25.42 -9.42 7.20 25.63 -7.36 7.52 11.86 77.76 30.05 12.70 77.49 28.15 ULMN 3 1pyl_c01 RIBONUCLEASE user 4 3 # 4 B 56 GLU B 48 GLU~? 13.73 O1 PEG B 144 B 67 ARG B 55 ARG~? 9.33 CG MLY C 135 B 86 HIS B 115 HIS~? 12.48 C18 PE8 B 148 coo 33.14 -5.53 11.32 32.45 -5.14 9.39 16.05 87.39 31.22 18.08 87.70 30.57 coo 31.86 -4.62 2.25 31.08 -4.78 5.21 8.78 84.29 24.99 10.39 86.20 26.77 coo 25.42 -9.42 7.20 25.63 -7.36 7.52 11.86 77.76 30.05 12.70 77.49 28.15 ULMN 3 1pyl_c01 RIBONUCLEASE user 5 3 # 5 B 56 GLU C 48 GLU~? 14.22 O MLZ C 114 B 67 ARG C 42 ARG.? 7.63 O MLZ C 114 B 86 HIS C 115 HIS~? 4.72 C MLZ C 114 coo 33.14 -5.53 11.32 32.45 -5.14 9.39 -17.56 80.63 67.68 -18.20 79.53 69.43 coo 31.86 -4.62 2.25 31.08 -4.78 5.21 -13.55 84.90 75.42 -13.77 88.03 75.38 coo 25.42 -9.42 7.20 25.63 -7.36 7.52 -12.99 90.00 69.08 -14.38 90.57 70.54 ULMN 3 1pyl_c01 RIBONUCLEASE user 6 3 # 6 B 56 GLU C 48 GLU~? 14.22 O MLZ C 114 B 67 ARG C 55 ARG~? 9.18 O MLY B 135 B 86 HIS C 115 HIS~? 4.72 C MLZ C 114 coo 33.14 -5.53 11.32 32.45 -5.14 9.39 -17.56 80.63 67.68 -18.20 79.53 69.43 coo 31.86 -4.62 2.25 31.08 -4.78 5.21 -21.06 89.68 64.73 -20.37 86.74 65.24 coo 25.42 -9.42 7.20 25.63 -7.36 7.52 -12.99 90.00 69.08 -14.38 90.57 70.54 ULMN 3 1pyl_c01 RIBONUCLEASE user 7 3 # 7 B 56 GLU C 84 GLU.? 10.77 O2 GOL B 149 B 67 ARG C 31 ARG^? 11.22 C3 GOL C 149 B 86 HIS C 4 HIS.? -3.73 C3 GOL C 149s coo 33.14 -5.53 11.32 32.45 -5.14 9.39 2.34 77.12 55.01 3.46 78.21 53.60 coo 31.86 -4.62 2.25 31.08 -4.78 5.21 -2.17 77.49 60.72 0.17 78.08 58.83 coo 25.42 -9.42 7.20 25.63 -7.36 7.52 4.88 85.81 61.42 6.80 85.00 61.18 ULMN 3 1pyl_c01 RIBONUCLEASE user 8 3 # 8 B 56 GLU D 48 GLU~? 13.85 CG MLY A 135 B 67 ARG D 42 ARG.? 16.60 C9 2PE D 146 B 86 HIS D 115 HIS~? 12.18 C21 2PE D 146 coo 33.14 -5.53 11.32 32.45 -5.14 9.39 -30.39 91.81 20.65 -29.75 93.83 21.10 coo 31.86 -4.62 2.25 31.08 -4.78 5.21 -32.78 97.24 12.74 -35.35 96.85 11.13 coo 25.42 -9.42 7.20 25.63 -7.36 7.52 -36.28 90.32 11.92 -37.49 91.98 12.35 ULMN 3 1pyl_c01 RIBONUCLEASE user 9 3 # 9 B 56 GLU D 48 GLU~? 13.85 CG MLY A 135 B 67 ARG D 55 ARG~? 9.16 CG MLY A 135 B 86 HIS D 115 HIS~? 12.18 C21 2PE D 146 coo 33.14 -5.53 11.32 32.45 -5.14 9.39 -30.39 91.81 20.65 -29.75 93.83 21.10 coo 31.86 -4.62 2.25 31.08 -4.78 5.21 -39.98 89.02 19.79 -37.17 89.06 21.03 coo 25.42 -9.42 7.20 25.63 -7.36 7.52 -36.28 90.32 11.92 -37.49 91.98 12.35 1pyl_c01 source 1pyl RIBONUCLEASE : 9 hits 1pyl_c01 naa= 3 ULMN 3 1qb4_c01 PHOSPHOENOLPYRUVATE CARBOXYLASE user 1 3 # 1 A 396 ARG B 33 ARG.? -3.91 C3 PEG B 144s A 581 ARG B 35 ARG.? 9.50 O1 PEG B 144 A 713 ARG B 42 ARG.? 12.70 O1 PEG B 144 coo 23.94 27.00 -9.66 23.90 28.89 -12.21 17.31 79.39 40.81 17.39 77.24 43.00 coo 24.10 34.79 -11.24 24.18 32.99 -13.65 22.76 84.08 36.32 22.81 87.07 35.45 coo 24.26 28.71 -19.68 23.74 27.73 -16.81 19.61 78.53 29.44 17.94 76.42 28.00 ULMN 3 1qb4_c01 PHOSPHOENOLPYRUVATE CARBOXYLASE user 2 3 # 2 A 396 ARG B 35 ARG.? 9.50 O1 PEG B 144 A 581 ARG B 33 ARG.? -3.91 C3 PEG B 144s A 713 ARG B 42 ARG.? 12.70 O1 PEG B 144 coo 23.94 27.00 -9.66 23.90 28.89 -12.21 22.76 84.08 36.32 22.81 87.07 35.45 coo 24.10 34.79 -11.24 24.18 32.99 -13.65 17.31 79.39 40.81 17.39 77.24 43.00 coo 24.26 28.71 -19.68 23.74 27.73 -16.81 19.61 78.53 29.44 17.94 76.42 28.00 ULMN 3 1qb4_c01 PHOSPHOENOLPYRUVATE CARBOXYLASE user 3 3 # 3 A 396 ARG B 35 ARG.? 9.50 O1 PEG B 144 A 581 ARG B 42 ARG.? 12.70 O1 PEG B 144 A 713 ARG B 33 ARG.? -3.91 C3 PEG B 144s coo 23.94 27.00 -9.66 23.90 28.89 -12.21 22.76 84.08 36.32 22.81 87.07 35.45 coo 24.10 34.79 -11.24 24.18 32.99 -13.65 19.61 78.53 29.44 17.94 76.42 28.00 coo 24.26 28.71 -19.68 23.74 27.73 -16.81 17.31 79.39 40.81 17.39 77.24 43.00 ULMN 3 1qb4_c01 PHOSPHOENOLPYRUVATE CARBOXYLASE user 4 3 # 4 A 396 ARG B 42 ARG.? 12.70 O1 PEG B 144 A 581 ARG B 35 ARG.? 9.50 O1 PEG B 144 A 713 ARG B 33 ARG.? -3.91 C3 PEG B 144s coo 23.94 27.00 -9.66 23.90 28.89 -12.21 19.61 78.53 29.44 17.94 76.42 28.00 coo 24.10 34.79 -11.24 24.18 32.99 -13.65 22.76 84.08 36.32 22.81 87.07 35.45 coo 24.26 28.71 -19.68 23.74 27.73 -16.81 17.31 79.39 40.81 17.39 77.24 43.00 1qb4_c01 source 1qb4 PHOSPHOENOLPYRUVATE CARBOXYLASE : 4 hits 1qb4_c01 naa= 3 ULMN 3 1qfe_c00 3-DEHYDROQUINATE DEHYDRATASE user 1 3 # 1 A 86 GLU B 93 GLU^? 4.01 CE MLZ B 67 A 143 HIS B 25 HIS^? 5.55 C6 PG4 C 145 A 170 LYS B 129 LYS^? 7.64 C2 PEG B 146 coo -2.40 27.37 52.92 -1.22 29.09 52.71 -11.20 80.89 36.50 -12.93 82.08 36.76 coo 1.36 26.79 49.43 3.17 26.89 50.50 -10.19 81.59 41.51 -11.58 82.85 40.58 coo 7.24 31.80 48.14 6.27 25.92 49.70 -12.78 77.45 45.34 -17.39 74.89 47.84 1qfe_c00 source 1qfe 3-DEHYDROQUINATE DEHYDRATASE : 1 hits 1qfe_c00 naa= 3 ULMN 3 1qgn_c16 CYSTATHIONINE GAMMA-SYNTHASE user 1 3 # 1 A 110 ARG A 63 ARG~? 11.15 O28 2PE A 148 C 163 TYR A 109 TYR~? -5.64 O16 2PE A 148s C 236 ASP A 56 ASP~? 11.59 C21 2PE A 148 coo 39.01 29.77 22.02 37.48 31.30 19.84 -18.54 46.85 28.43 -16.64 46.31 26.03 coo 39.51 34.34 13.63 37.63 32.61 14.79 -13.81 52.60 20.09 -14.53 54.76 18.49 coo 45.78 31.11 9.51 44.25 30.06 10.53 -16.01 45.89 15.64 -15.93 44.31 14.23 ULMN 3 1qgn_c16 CYSTATHIONINE GAMMA-SYNTHASE user 2 3 # 2 A 110 ARG B 33 ARG.? -3.91 C3 PEG B 144s C 163 TYR B 38 TYR.? 9.60 O1 PEG B 144 C 236 ASP B 40 ASP.? 11.67 O1 PEG B 144 coo 39.01 29.77 22.02 37.48 31.30 19.84 17.31 79.39 40.81 17.39 77.24 43.00 coo 39.51 34.34 13.63 37.63 32.61 14.79 18.19 76.55 32.34 16.15 78.24 31.46 coo 45.78 31.11 9.51 44.25 30.06 10.53 22.51 72.75 29.32 21.02 74.20 28.79 ULMN 3 1qgn_c16 CYSTATHIONINE GAMMA-SYNTHASE user 3 3 # 3 A 110 ARG B 35 ARG.? 9.50 O1 PEG B 144 C 163 TYR B 38 TYR.? 9.60 O1 PEG B 144 C 236 ASP B 40 ASP.? 11.67 O1 PEG B 144 coo 39.01 29.77 22.02 37.48 31.30 19.84 22.76 84.08 36.32 22.81 87.07 35.45 coo 39.51 34.34 13.63 37.63 32.61 14.79 18.19 76.55 32.34 16.15 78.24 31.46 coo 45.78 31.11 9.51 44.25 30.06 10.53 22.51 72.75 29.32 21.02 74.20 28.79 ULMN 3 1qgn_c16 CYSTATHIONINE GAMMA-SYNTHASE user 4 3 # 4 A 110 ARG B 63 ARG~? -8.01 OH2 1PE B 150s C 163 TYR B 109 TYR~? -5.65 O13 PE8 B 148s C 236 ASP B 56 ASP~? 11.45 C20 PE8 B 148 coo 39.01 29.77 22.02 37.48 31.30 19.84 -5.18 74.17 22.68 -2.11 73.83 22.90 coo 39.51 34.34 13.63 37.63 32.61 14.79 2.41 73.03 30.76 2.68 74.03 33.35 coo 45.78 31.11 9.51 44.25 30.06 10.53 6.80 78.21 26.00 8.47 79.07 25.03 ULMN 3 1qgn_c16 CYSTATHIONINE GAMMA-SYNTHASE user 5 3 # 5 A 110 ARG C 63 ARG~? -11.70 O25 PE8 C 148s C 163 TYR C 109 TYR~? -5.91 C14 PE8 C 148s C 236 ASP C 56 ASP~? 9.09 N MLZ C 114 coo 39.01 29.77 22.02 37.48 31.30 19.84 -17.02 105.73 59.39 -16.53 104.08 61.96 coo 39.51 34.34 13.63 37.63 32.61 14.79 -9.64 98.32 63.33 -8.13 96.27 62.21 coo 45.78 31.11 9.51 44.25 30.06 10.53 -16.40 94.43 66.11 -17.63 93.56 67.58 ULMN 3 1qgn_c16 CYSTATHIONINE GAMMA-SYNTHASE user 6 3 # 6 A 110 ARG D 33 ARG.? 10.45 C1 GOL D 147 C 163 TYR D 38 TYR.? 14.74 C9 2PE D 146 C 236 ASP D 40 ASP.? 18.38 C9 2PE D 146 coo 39.01 29.77 22.02 37.48 31.30 19.84 -24.75 89.49 9.81 -23.48 88.88 7.05 coo 39.51 34.34 13.63 37.63 32.61 14.79 -31.57 94.95 9.95 -32.83 93.25 11.77 coo 45.78 31.11 9.51 44.25 30.06 10.53 -32.95 100.50 7.54 -33.10 99.69 9.54 ULMN 3 1qgn_c16 CYSTATHIONINE GAMMA-SYNTHASE user 7 3 # 7 A 110 ARG D 63 ARG~? -11.23 O28 2PE D 146s C 163 TYR D 109 TYR~? -5.82 O16 2PE D 146s C 236 ASP D 56 ASP~? 11.46 C21 2PE D 146 coo 39.01 29.77 22.02 37.48 31.30 19.84 -51.80 79.77 10.92 -50.17 82.42 10.63 coo 39.51 34.34 13.63 37.63 32.61 14.79 -41.76 82.56 7.21 -39.24 81.41 7.29 coo 45.78 31.11 9.51 44.25 30.06 10.53 -41.85 87.81 13.66 -41.61 89.58 14.80 1qgn_c16 source 1qgn CYSTATHIONINE GAMMA-SYNTHASE : 7 hits 1qgn_c16 naa= 3 ULMN 3 1qgn_c17 CYSTATHIONINE GAMMA-SYNTHASE user 1 3 # 1 B 110 ARG A 63 ARG~? 11.15 O28 2PE A 148 D 163 TYR A 109 TYR~? -5.64 O16 2PE A 148s D 236 ASP A 56 ASP~? 11.59 C21 2PE A 148 coo 23.05 -7.35 32.81 21.30 -7.38 35.33 -18.54 46.85 28.43 -16.64 46.31 26.03 coo 21.28 -11.43 41.42 21.14 -8.83 40.39 -13.81 52.60 20.09 -14.53 54.76 18.49 coo 28.41 -14.31 44.14 27.98 -12.36 43.41 -16.01 45.89 15.64 -15.93 44.31 14.23 ULMN 3 1qgn_c17 CYSTATHIONINE GAMMA-SYNTHASE user 2 3 # 2 B 110 ARG B 33 ARG.? -3.91 C3 PEG B 144s D 163 TYR B 38 TYR.? 9.60 O1 PEG B 144 D 236 ASP B 40 ASP.? 11.67 O1 PEG B 144 coo 23.05 -7.35 32.81 21.30 -7.38 35.33 17.31 79.39 40.81 17.39 77.24 43.00 coo 21.28 -11.43 41.42 21.14 -8.83 40.39 18.19 76.55 32.34 16.15 78.24 31.46 coo 28.41 -14.31 44.14 27.98 -12.36 43.41 22.51 72.75 29.32 21.02 74.20 28.79 ULMN 3 1qgn_c17 CYSTATHIONINE GAMMA-SYNTHASE user 3 3 # 3 B 110 ARG B 35 ARG.? 9.50 O1 PEG B 144 D 163 TYR B 38 TYR.? 9.60 O1 PEG B 144 D 236 ASP B 40 ASP.? 11.67 O1 PEG B 144 coo 23.05 -7.35 32.81 21.30 -7.38 35.33 22.76 84.08 36.32 22.81 87.07 35.45 coo 21.28 -11.43 41.42 21.14 -8.83 40.39 18.19 76.55 32.34 16.15 78.24 31.46 coo 28.41 -14.31 44.14 27.98 -12.36 43.41 22.51 72.75 29.32 21.02 74.20 28.79 ULMN 3 1qgn_c17 CYSTATHIONINE GAMMA-SYNTHASE user 4 3 # 4 B 110 ARG B 63 ARG~? -8.01 OH2 1PE B 150s D 163 TYR B 109 TYR~? -5.65 O13 PE8 B 148s D 236 ASP B 56 ASP~? 11.45 C20 PE8 B 148 coo 23.05 -7.35 32.81 21.30 -7.38 35.33 -5.18 74.17 22.68 -2.11 73.83 22.90 coo 21.28 -11.43 41.42 21.14 -8.83 40.39 2.41 73.03 30.76 2.68 74.03 33.35 coo 28.41 -14.31 44.14 27.98 -12.36 43.41 6.80 78.21 26.00 8.47 79.07 25.03 ULMN 3 1qgn_c17 CYSTATHIONINE GAMMA-SYNTHASE user 5 3 # 5 B 110 ARG C 63 ARG~? -11.70 O25 PE8 C 148s D 163 TYR C 109 TYR~? -5.91 C14 PE8 C 148s D 236 ASP C 56 ASP~? 9.09 N MLZ C 114 coo 23.05 -7.35 32.81 21.30 -7.38 35.33 -17.02 105.73 59.39 -16.53 104.08 61.96 coo 21.28 -11.43 41.42 21.14 -8.83 40.39 -9.64 98.32 63.33 -8.13 96.27 62.21 coo 28.41 -14.31 44.14 27.98 -12.36 43.41 -16.40 94.43 66.11 -17.63 93.56 67.58 ULMN 3 1qgn_c17 CYSTATHIONINE GAMMA-SYNTHASE user 6 3 # 6 B 110 ARG D 33 ARG.? 10.45 C1 GOL D 147 D 163 TYR D 38 TYR.? 14.74 C9 2PE D 146 D 236 ASP D 40 ASP.? 18.38 C9 2PE D 146 coo 23.05 -7.35 32.81 21.30 -7.38 35.33 -24.75 89.49 9.81 -23.48 88.88 7.05 coo 21.28 -11.43 41.42 21.14 -8.83 40.39 -31.57 94.95 9.95 -32.83 93.25 11.77 coo 28.41 -14.31 44.14 27.98 -12.36 43.41 -32.95 100.50 7.54 -33.10 99.69 9.54 ULMN 3 1qgn_c17 CYSTATHIONINE GAMMA-SYNTHASE user 7 3 # 7 B 110 ARG D 63 ARG~? -11.23 O28 2PE D 146s D 163 TYR D 109 TYR~? -5.82 O16 2PE D 146s D 236 ASP D 56 ASP~? 11.46 C21 2PE D 146 coo 23.05 -7.35 32.81 21.30 -7.38 35.33 -51.80 79.77 10.92 -50.17 82.42 10.63 coo 21.28 -11.43 41.42 21.14 -8.83 40.39 -41.76 82.56 7.21 -39.24 81.41 7.29 coo 28.41 -14.31 44.14 27.98 -12.36 43.41 -41.85 87.81 13.66 -41.61 89.58 14.80 1qgn_c17 source 1qgn CYSTATHIONINE GAMMA-SYNTHASE : 7 hits 1qgn_c17 naa= 3 ULMN 3 1qgn_c18 CYSTATHIONINE GAMMA-SYNTHASE user 1 3 # 1 A 163 TYR A 109 TYR~? -5.64 O16 2PE A 148s A 236 ASP A 56 ASP~? 11.59 C21 2PE A 148 C 110 ARG A 63 ARG~? 11.15 O28 2PE A 148 coo 55.48 26.51 40.65 55.39 23.99 39.43 -13.81 52.60 20.09 -14.53 54.76 18.49 coo 48.87 29.19 44.63 49.10 27.34 43.63 -16.01 45.89 15.64 -15.93 44.31 14.23 coo 52.39 23.42 32.10 54.51 23.27 34.29 -18.54 46.85 28.43 -16.64 46.31 26.03 ULMN 3 1qgn_c18 CYSTATHIONINE GAMMA-SYNTHASE user 2 3 # 2 A 163 TYR B 38 TYR.? 9.60 O1 PEG B 144 A 236 ASP B 40 ASP.? 11.67 O1 PEG B 144 C 110 ARG B 33 ARG.? -3.91 C3 PEG B 144s coo 55.48 26.51 40.65 55.39 23.99 39.43 18.19 76.55 32.34 16.15 78.24 31.46 coo 48.87 29.19 44.63 49.10 27.34 43.63 22.51 72.75 29.32 21.02 74.20 28.79 coo 52.39 23.42 32.10 54.51 23.27 34.29 17.31 79.39 40.81 17.39 77.24 43.00 ULMN 3 1qgn_c18 CYSTATHIONINE GAMMA-SYNTHASE user 3 3 # 3 A 163 TYR B 38 TYR.? 9.60 O1 PEG B 144 A 236 ASP B 40 ASP.? 11.67 O1 PEG B 144 C 110 ARG B 35 ARG.? 9.50 O1 PEG B 144 coo 55.48 26.51 40.65 55.39 23.99 39.43 18.19 76.55 32.34 16.15 78.24 31.46 coo 48.87 29.19 44.63 49.10 27.34 43.63 22.51 72.75 29.32 21.02 74.20 28.79 coo 52.39 23.42 32.10 54.51 23.27 34.29 22.76 84.08 36.32 22.81 87.07 35.45 ULMN 3 1qgn_c18 CYSTATHIONINE GAMMA-SYNTHASE user 4 3 # 4 A 163 TYR B 109 TYR~? -5.65 O13 PE8 B 148s A 236 ASP B 56 ASP~? 11.45 C20 PE8 B 148 C 110 ARG B 63 ARG~? -8.01 OH2 1PE B 150s coo 55.48 26.51 40.65 55.39 23.99 39.43 2.41 73.03 30.76 2.68 74.03 33.35 coo 48.87 29.19 44.63 49.10 27.34 43.63 6.80 78.21 26.00 8.47 79.07 25.03 coo 52.39 23.42 32.10 54.51 23.27 34.29 -5.18 74.17 22.68 -2.11 73.83 22.90 ULMN 3 1qgn_c18 CYSTATHIONINE GAMMA-SYNTHASE user 5 3 # 5 A 163 TYR C 109 TYR~? -5.91 C14 PE8 C 148s A 236 ASP C 56 ASP~? 9.09 N MLZ C 114 C 110 ARG C 63 ARG~? -11.70 O25 PE8 C 148s coo 55.48 26.51 40.65 55.39 23.99 39.43 -9.64 98.32 63.33 -8.13 96.27 62.21 coo 48.87 29.19 44.63 49.10 27.34 43.63 -16.40 94.43 66.11 -17.63 93.56 67.58 coo 52.39 23.42 32.10 54.51 23.27 34.29 -17.02 105.73 59.39 -16.53 104.08 61.96 ULMN 3 1qgn_c18 CYSTATHIONINE GAMMA-SYNTHASE user 6 3 # 6 A 163 TYR D 38 TYR.? 14.74 C9 2PE D 146 A 236 ASP D 40 ASP.? 18.38 C9 2PE D 146 C 110 ARG D 33 ARG.? 10.45 C1 GOL D 147 coo 55.48 26.51 40.65 55.39 23.99 39.43 -31.57 94.95 9.95 -32.83 93.25 11.77 coo 48.87 29.19 44.63 49.10 27.34 43.63 -32.95 100.50 7.54 -33.10 99.69 9.54 coo 52.39 23.42 32.10 54.51 23.27 34.29 -24.75 89.49 9.81 -23.48 88.88 7.05 ULMN 3 1qgn_c18 CYSTATHIONINE GAMMA-SYNTHASE user 7 3 # 7 A 163 TYR D 109 TYR~? -5.82 O16 2PE D 146s A 236 ASP D 56 ASP~? 11.46 C21 2PE D 146 C 110 ARG D 63 ARG~? -11.23 O28 2PE D 146s coo 55.48 26.51 40.65 55.39 23.99 39.43 -41.76 82.56 7.21 -39.24 81.41 7.29 coo 48.87 29.19 44.63 49.10 27.34 43.63 -41.85 87.81 13.66 -41.61 89.58 14.80 coo 52.39 23.42 32.10 54.51 23.27 34.29 -51.80 79.77 10.92 -50.17 82.42 10.63 1qgn_c18 source 1qgn CYSTATHIONINE GAMMA-SYNTHASE : 7 hits 1qgn_c18 naa= 3 ULMN 3 1qgn_c19 CYSTATHIONINE GAMMA-SYNTHASE user 1 3 # 1 B 163 TYR A 109 TYR~? -5.64 O16 2PE A 148s B 236 ASP A 56 ASP~? 11.59 C21 2PE A 148 D 110 ARG A 63 ARG~? 11.15 O28 2PE A 148 coo 32.99 -16.32 11.66 35.01 -14.70 12.72 -13.81 52.60 20.09 -14.53 54.76 18.49 coo 26.18 -12.82 8.91 27.87 -11.87 9.77 -16.01 45.89 15.64 -15.93 44.31 14.23 coo 34.79 -12.60 20.34 35.97 -13.92 17.84 -18.54 46.85 28.43 -16.64 46.31 26.03 ULMN 3 1qgn_c19 CYSTATHIONINE GAMMA-SYNTHASE user 2 3 # 2 B 163 TYR B 38 TYR.? 9.60 O1 PEG B 144 B 236 ASP B 40 ASP.? 11.67 O1 PEG B 144 D 110 ARG B 33 ARG.? -3.91 C3 PEG B 144s coo 32.99 -16.32 11.66 35.01 -14.70 12.72 18.19 76.55 32.34 16.15 78.24 31.46 coo 26.18 -12.82 8.91 27.87 -11.87 9.77 22.51 72.75 29.32 21.02 74.20 28.79 coo 34.79 -12.60 20.34 35.97 -13.92 17.84 17.31 79.39 40.81 17.39 77.24 43.00 ULMN 3 1qgn_c19 CYSTATHIONINE GAMMA-SYNTHASE user 3 3 # 3 B 163 TYR B 38 TYR.? 9.60 O1 PEG B 144 B 236 ASP B 40 ASP.? 11.67 O1 PEG B 144 D 110 ARG B 35 ARG.? 9.50 O1 PEG B 144 coo 32.99 -16.32 11.66 35.01 -14.70 12.72 18.19 76.55 32.34 16.15 78.24 31.46 coo 26.18 -12.82 8.91 27.87 -11.87 9.77 22.51 72.75 29.32 21.02 74.20 28.79 coo 34.79 -12.60 20.34 35.97 -13.92 17.84 22.76 84.08 36.32 22.81 87.07 35.45 ULMN 3 1qgn_c19 CYSTATHIONINE GAMMA-SYNTHASE user 4 3 # 4 B 163 TYR B 109 TYR~? -5.65 O13 PE8 B 148s B 236 ASP B 56 ASP~? 11.45 C20 PE8 B 148 D 110 ARG B 63 ARG~? -8.01 OH2 1PE B 150s coo 32.99 -16.32 11.66 35.01 -14.70 12.72 2.41 73.03 30.76 2.68 74.03 33.35 coo 26.18 -12.82 8.91 27.87 -11.87 9.77 6.80 78.21 26.00 8.47 79.07 25.03 coo 34.79 -12.60 20.34 35.97 -13.92 17.84 -5.18 74.17 22.68 -2.11 73.83 22.90 ULMN 3 1qgn_c19 CYSTATHIONINE GAMMA-SYNTHASE user 5 3 # 5 B 163 TYR C 38 TYR.? 5.20 O MLZ C 114 B 236 ASP C 40 ASP.? 9.64 O MLZ C 114 D 110 ARG C 33 ARG.? 10.55 C1 GOL C 149 coo 32.99 -16.32 11.66 35.01 -14.70 12.72 -10.37 86.21 74.10 -12.04 86.61 71.91 coo 26.18 -12.82 8.91 27.87 -11.87 9.77 -10.62 87.43 80.17 -12.01 86.84 78.68 coo 34.79 -12.60 20.34 35.97 -13.92 17.84 -5.11 80.73 69.28 -2.11 81.22 69.57 ULMN 3 1qgn_c19 CYSTATHIONINE GAMMA-SYNTHASE user 6 3 # 6 B 163 TYR C 109 TYR~? -5.91 C14 PE8 C 148s B 236 ASP C 56 ASP~? 9.09 N MLZ C 114 D 110 ARG C 63 ARG~? -11.70 O25 PE8 C 148s coo 32.99 -16.32 11.66 35.01 -14.70 12.72 -9.64 98.32 63.33 -8.13 96.27 62.21 coo 26.18 -12.82 8.91 27.87 -11.87 9.77 -16.40 94.43 66.11 -17.63 93.56 67.58 coo 34.79 -12.60 20.34 35.97 -13.92 17.84 -17.02 105.73 59.39 -16.53 104.08 61.96 ULMN 3 1qgn_c19 CYSTATHIONINE GAMMA-SYNTHASE user 7 3 # 7 B 163 TYR D 38 TYR.? 14.74 C9 2PE D 146 B 236 ASP D 40 ASP.? 18.38 C9 2PE D 146 D 110 ARG D 33 ARG.? 10.45 C1 GOL D 147 coo 32.99 -16.32 11.66 35.01 -14.70 12.72 -31.57 94.95 9.95 -32.83 93.25 11.77 coo 26.18 -12.82 8.91 27.87 -11.87 9.77 -32.95 100.50 7.54 -33.10 99.69 9.54 coo 34.79 -12.60 20.34 35.97 -13.92 17.84 -24.75 89.49 9.81 -23.48 88.88 7.05 ULMN 3 1qgn_c19 CYSTATHIONINE GAMMA-SYNTHASE user 8 3 # 8 B 163 TYR D 109 TYR~? -5.82 O16 2PE D 146s B 236 ASP D 56 ASP~? 11.46 C21 2PE D 146 D 110 ARG D 63 ARG~? -11.23 O28 2PE D 146s coo 32.99 -16.32 11.66 35.01 -14.70 12.72 -41.76 82.56 7.21 -39.24 81.41 7.29 coo 26.18 -12.82 8.91 27.87 -11.87 9.77 -41.85 87.81 13.66 -41.61 89.58 14.80 coo 34.79 -12.60 20.34 35.97 -13.92 17.84 -51.80 79.77 10.92 -50.17 82.42 10.63 1qgn_c19 source 1qgn CYSTATHIONINE GAMMA-SYNTHASE : 8 hits 1qgn_c19 naa= 3 ULMN 3 1qgn_c20 CYSTATHIONINE GAMMA-SYNTHASE user 1 3 # 1 E 110 ARG A 63 ARG~? 11.15 O28 2PE A 148 G 163 TYR A 109 TYR~? -5.64 O16 2PE A 148s G 236 ASP A 56 ASP~? 11.59 C21 2PE A 148 coo 60.40 -9.85 -55.76 62.00 -8.48 -58.01 -18.54 46.85 28.43 -16.64 46.31 26.03 coo 64.84 -10.79 -64.16 63.27 -8.78 -63.00 -13.81 52.60 20.09 -14.53 54.76 18.49 coo 61.22 -16.97 -68.13 60.30 -15.38 -67.08 -16.01 45.89 15.64 -15.93 44.31 14.23 ULMN 3 1qgn_c20 CYSTATHIONINE GAMMA-SYNTHASE user 2 3 # 2 E 110 ARG B 33 ARG.? -3.91 C3 PEG B 144s G 163 TYR B 38 TYR.? 9.60 O1 PEG B 144 G 236 ASP B 40 ASP.? 11.67 O1 PEG B 144 coo 60.40 -9.85 -55.76 62.00 -8.48 -58.01 17.31 79.39 40.81 17.39 77.24 43.00 coo 64.84 -10.79 -64.16 63.27 -8.78 -63.00 18.19 76.55 32.34 16.15 78.24 31.46 coo 61.22 -16.97 -68.13 60.30 -15.38 -67.08 22.51 72.75 29.32 21.02 74.20 28.79 ULMN 3 1qgn_c20 CYSTATHIONINE GAMMA-SYNTHASE user 3 3 # 3 E 110 ARG B 35 ARG.? 9.50 O1 PEG B 144 G 163 TYR B 38 TYR.? 9.60 O1 PEG B 144 G 236 ASP B 40 ASP.? 11.67 O1 PEG B 144 coo 60.40 -9.85 -55.76 62.00 -8.48 -58.01 22.76 84.08 36.32 22.81 87.07 35.45 coo 64.84 -10.79 -64.16 63.27 -8.78 -63.00 18.19 76.55 32.34 16.15 78.24 31.46 coo 61.22 -16.97 -68.13 60.30 -15.38 -67.08 22.51 72.75 29.32 21.02 74.20 28.79 ULMN 3 1qgn_c20 CYSTATHIONINE GAMMA-SYNTHASE user 4 3 # 4 E 110 ARG B 63 ARG~? -8.01 OH2 1PE B 150s G 163 TYR B 109 TYR~? -5.65 O13 PE8 B 148s G 236 ASP B 56 ASP~? 11.45 C20 PE8 B 148 coo 60.40 -9.85 -55.76 62.00 -8.48 -58.01 -5.18 74.17 22.68 -2.11 73.83 22.90 coo 64.84 -10.79 -64.16 63.27 -8.78 -63.00 2.41 73.03 30.76 2.68 74.03 33.35 coo 61.22 -16.97 -68.13 60.30 -15.38 -67.08 6.80 78.21 26.00 8.47 79.07 25.03 ULMN 3 1qgn_c20 CYSTATHIONINE GAMMA-SYNTHASE user 5 3 # 5 E 110 ARG C 63 ARG~? -11.70 O25 PE8 C 148s G 163 TYR C 109 TYR~? -5.91 C14 PE8 C 148s G 236 ASP C 56 ASP~? 9.09 N MLZ C 114 coo 60.40 -9.85 -55.76 62.00 -8.48 -58.01 -17.02 105.73 59.39 -16.53 104.08 61.96 coo 64.84 -10.79 -64.16 63.27 -8.78 -63.00 -9.64 98.32 63.33 -8.13 96.27 62.21 coo 61.22 -16.97 -68.13 60.30 -15.38 -67.08 -16.40 94.43 66.11 -17.63 93.56 67.58 ULMN 3 1qgn_c20 CYSTATHIONINE GAMMA-SYNTHASE user 6 3 # 6 E 110 ARG D 33 ARG.? 10.45 C1 GOL D 147 G 163 TYR D 38 TYR.? 14.74 C9 2PE D 146 G 236 ASP D 40 ASP.? 18.38 C9 2PE D 146 coo 60.40 -9.85 -55.76 62.00 -8.48 -58.01 -24.75 89.49 9.81 -23.48 88.88 7.05 coo 64.84 -10.79 -64.16 63.27 -8.78 -63.00 -31.57 94.95 9.95 -32.83 93.25 11.77 coo 61.22 -16.97 -68.13 60.30 -15.38 -67.08 -32.95 100.50 7.54 -33.10 99.69 9.54 ULMN 3 1qgn_c20 CYSTATHIONINE GAMMA-SYNTHASE user 7 3 # 7 E 110 ARG D 63 ARG~? -11.23 O28 2PE D 146s G 163 TYR D 109 TYR~? -5.82 O16 2PE D 146s G 236 ASP D 56 ASP~? 11.46 C21 2PE D 146 coo 60.40 -9.85 -55.76 62.00 -8.48 -58.01 -51.80 79.77 10.92 -50.17 82.42 10.63 coo 64.84 -10.79 -64.16 63.27 -8.78 -63.00 -41.76 82.56 7.21 -39.24 81.41 7.29 coo 61.22 -16.97 -68.13 60.30 -15.38 -67.08 -41.85 87.81 13.66 -41.61 89.58 14.80 1qgn_c20 source 1qgn CYSTATHIONINE GAMMA-SYNTHASE : 7 hits 1qgn_c20 naa= 3 ULMN 3 1qgn_c21 CYSTATHIONINE GAMMA-SYNTHASE user 1 3 # 1 F 110 ARG A 63 ARG~? 11.15 O28 2PE A 148 H 163 TYR A 109 TYR~? -5.64 O16 2PE A 148s H 236 ASP A 56 ASP~? 11.59 C21 2PE A 148 coo 24.62 8.71 -44.89 24.77 10.53 -42.42 -18.54 46.85 28.43 -16.64 46.31 26.03 coo 20.90 10.83 -36.23 23.51 10.75 -37.23 -13.81 52.60 20.09 -14.53 54.76 18.49 coo 17.57 3.99 -33.38 19.51 4.24 -34.16 -16.01 45.89 15.64 -15.93 44.31 14.23 ULMN 3 1qgn_c21 CYSTATHIONINE GAMMA-SYNTHASE user 2 3 # 2 F 110 ARG B 33 ARG.? -3.91 C3 PEG B 144s H 163 TYR B 38 TYR.? 9.60 O1 PEG B 144 H 236 ASP B 40 ASP.? 11.67 O1 PEG B 144 coo 24.62 8.71 -44.89 24.77 10.53 -42.42 17.31 79.39 40.81 17.39 77.24 43.00 coo 20.90 10.83 -36.23 23.51 10.75 -37.23 18.19 76.55 32.34 16.15 78.24 31.46 coo 17.57 3.99 -33.38 19.51 4.24 -34.16 22.51 72.75 29.32 21.02 74.20 28.79 ULMN 3 1qgn_c21 CYSTATHIONINE GAMMA-SYNTHASE user 3 3 # 3 F 110 ARG B 35 ARG.? 9.50 O1 PEG B 144 H 163 TYR B 38 TYR.? 9.60 O1 PEG B 144 H 236 ASP B 40 ASP.? 11.67 O1 PEG B 144 coo 24.62 8.71 -44.89 24.77 10.53 -42.42 22.76 84.08 36.32 22.81 87.07 35.45 coo 20.90 10.83 -36.23 23.51 10.75 -37.23 18.19 76.55 32.34 16.15 78.24 31.46 coo 17.57 3.99 -33.38 19.51 4.24 -34.16 22.51 72.75 29.32 21.02 74.20 28.79 ULMN 3 1qgn_c21 CYSTATHIONINE GAMMA-SYNTHASE user 4 3 # 4 F 110 ARG B 63 ARG~? -8.01 OH2 1PE B 150s H 163 TYR B 109 TYR~? -5.65 O13 PE8 B 148s H 236 ASP B 56 ASP~? 11.45 C20 PE8 B 148 coo 24.62 8.71 -44.89 24.77 10.53 -42.42 -5.18 74.17 22.68 -2.11 73.83 22.90 coo 20.90 10.83 -36.23 23.51 10.75 -37.23 2.41 73.03 30.76 2.68 74.03 33.35 coo 17.57 3.99 -33.38 19.51 4.24 -34.16 6.80 78.21 26.00 8.47 79.07 25.03 ULMN 3 1qgn_c21 CYSTATHIONINE GAMMA-SYNTHASE user 5 3 # 5 F 110 ARG C 33 ARG.? 10.55 C1 GOL C 149 H 163 TYR C 38 TYR.? 5.20 O MLZ C 114 H 236 ASP C 40 ASP.? 9.64 O MLZ C 114 coo 24.62 8.71 -44.89 24.77 10.53 -42.42 -5.11 80.73 69.28 -2.11 81.22 69.57 coo 20.90 10.83 -36.23 23.51 10.75 -37.23 -10.37 86.21 74.10 -12.04 86.61 71.91 coo 17.57 3.99 -33.38 19.51 4.24 -34.16 -10.62 87.43 80.17 -12.01 86.84 78.68 ULMN 3 1qgn_c21 CYSTATHIONINE GAMMA-SYNTHASE user 6 3 # 6 F 110 ARG C 63 ARG~? -11.70 O25 PE8 C 148s H 163 TYR C 109 TYR~? -5.91 C14 PE8 C 148s H 236 ASP C 56 ASP~? 9.09 N MLZ C 114 coo 24.62 8.71 -44.89 24.77 10.53 -42.42 -17.02 105.73 59.39 -16.53 104.08 61.96 coo 20.90 10.83 -36.23 23.51 10.75 -37.23 -9.64 98.32 63.33 -8.13 96.27 62.21 coo 17.57 3.99 -33.38 19.51 4.24 -34.16 -16.40 94.43 66.11 -17.63 93.56 67.58 ULMN 3 1qgn_c21 CYSTATHIONINE GAMMA-SYNTHASE user 7 3 # 7 F 110 ARG D 33 ARG.? 10.45 C1 GOL D 147 H 163 TYR D 38 TYR.? 14.74 C9 2PE D 146 H 236 ASP D 40 ASP.? 18.38 C9 2PE D 146 coo 24.62 8.71 -44.89 24.77 10.53 -42.42 -24.75 89.49 9.81 -23.48 88.88 7.05 coo 20.90 10.83 -36.23 23.51 10.75 -37.23 -31.57 94.95 9.95 -32.83 93.25 11.77 coo 17.57 3.99 -33.38 19.51 4.24 -34.16 -32.95 100.50 7.54 -33.10 99.69 9.54 ULMN 3 1qgn_c21 CYSTATHIONINE GAMMA-SYNTHASE user 8 3 # 8 F 110 ARG D 63 ARG~? -11.23 O28 2PE D 146s H 163 TYR D 109 TYR~? -5.82 O16 2PE D 146s H 236 ASP D 56 ASP~? 11.46 C21 2PE D 146 coo 24.62 8.71 -44.89 24.77 10.53 -42.42 -51.80 79.77 10.92 -50.17 82.42 10.63 coo 20.90 10.83 -36.23 23.51 10.75 -37.23 -41.76 82.56 7.21 -39.24 81.41 7.29 coo 17.57 3.99 -33.38 19.51 4.24 -34.16 -41.85 87.81 13.66 -41.61 89.58 14.80 1qgn_c21 source 1qgn CYSTATHIONINE GAMMA-SYNTHASE : 8 hits 1qgn_c21 naa= 3 ULMN 3 1qgn_c22 CYSTATHIONINE GAMMA-SYNTHASE user 1 3 # 1 E 163 TYR A 109 TYR~? -5.64 O16 2PE A 148s E 236 ASP A 56 ASP~? 11.59 C21 2PE A 148 G 110 ARG A 63 ARG~? 11.15 O28 2PE A 148 coo 56.39 -25.68 -36.91 53.88 -25.46 -38.13 -13.81 52.60 20.09 -14.53 54.76 18.49 coo 59.54 -19.27 -32.99 57.70 -19.44 -33.97 -16.01 45.89 15.64 -15.93 44.31 14.23 coo 53.35 -22.70 -45.35 52.95 -24.81 -43.16 -18.54 46.85 28.43 -16.64 46.31 26.03 ULMN 3 1qgn_c22 CYSTATHIONINE GAMMA-SYNTHASE user 2 3 # 2 E 163 TYR B 38 TYR.? 9.60 O1 PEG B 144 E 236 ASP B 40 ASP.? 11.67 O1 PEG B 144 G 110 ARG B 33 ARG.? -3.91 C3 PEG B 144s coo 56.39 -25.68 -36.91 53.88 -25.46 -38.13 18.19 76.55 32.34 16.15 78.24 31.46 coo 59.54 -19.27 -32.99 57.70 -19.44 -33.97 22.51 72.75 29.32 21.02 74.20 28.79 coo 53.35 -22.70 -45.35 52.95 -24.81 -43.16 17.31 79.39 40.81 17.39 77.24 43.00 ULMN 3 1qgn_c22 CYSTATHIONINE GAMMA-SYNTHASE user 3 3 # 3 E 163 TYR B 38 TYR.? 9.60 O1 PEG B 144 E 236 ASP B 40 ASP.? 11.67 O1 PEG B 144 G 110 ARG B 35 ARG.? 9.50 O1 PEG B 144 coo 56.39 -25.68 -36.91 53.88 -25.46 -38.13 18.19 76.55 32.34 16.15 78.24 31.46 coo 59.54 -19.27 -32.99 57.70 -19.44 -33.97 22.51 72.75 29.32 21.02 74.20 28.79 coo 53.35 -22.70 -45.35 52.95 -24.81 -43.16 22.76 84.08 36.32 22.81 87.07 35.45 ULMN 3 1qgn_c22 CYSTATHIONINE GAMMA-SYNTHASE user 4 3 # 4 E 163 TYR B 109 TYR~? -5.65 O13 PE8 B 148s E 236 ASP B 56 ASP~? 11.45 C20 PE8 B 148 G 110 ARG B 63 ARG~? -8.01 OH2 1PE B 150s coo 56.39 -25.68 -36.91 53.88 -25.46 -38.13 2.41 73.03 30.76 2.68 74.03 33.35 coo 59.54 -19.27 -32.99 57.70 -19.44 -33.97 6.80 78.21 26.00 8.47 79.07 25.03 coo 53.35 -22.70 -45.35 52.95 -24.81 -43.16 -5.18 74.17 22.68 -2.11 73.83 22.90 ULMN 3 1qgn_c22 CYSTATHIONINE GAMMA-SYNTHASE user 5 3 # 5 E 163 TYR C 38 TYR.? 5.20 O MLZ C 114 E 236 ASP C 40 ASP.? 9.64 O MLZ C 114 G 110 ARG C 33 ARG.? 10.55 C1 GOL C 149 coo 56.39 -25.68 -36.91 53.88 -25.46 -38.13 -10.37 86.21 74.10 -12.04 86.61 71.91 coo 59.54 -19.27 -32.99 57.70 -19.44 -33.97 -10.62 87.43 80.17 -12.01 86.84 78.68 coo 53.35 -22.70 -45.35 52.95 -24.81 -43.16 -5.11 80.73 69.28 -2.11 81.22 69.57 ULMN 3 1qgn_c22 CYSTATHIONINE GAMMA-SYNTHASE user 6 3 # 6 E 163 TYR C 109 TYR~? -5.91 C14 PE8 C 148s E 236 ASP C 56 ASP~? 9.09 N MLZ C 114 G 110 ARG C 63 ARG~? -11.70 O25 PE8 C 148s coo 56.39 -25.68 -36.91 53.88 -25.46 -38.13 -9.64 98.32 63.33 -8.13 96.27 62.21 coo 59.54 -19.27 -32.99 57.70 -19.44 -33.97 -16.40 94.43 66.11 -17.63 93.56 67.58 coo 53.35 -22.70 -45.35 52.95 -24.81 -43.16 -17.02 105.73 59.39 -16.53 104.08 61.96 ULMN 3 1qgn_c22 CYSTATHIONINE GAMMA-SYNTHASE user 7 3 # 7 E 163 TYR D 38 TYR.? 14.74 C9 2PE D 146 E 236 ASP D 40 ASP.? 18.38 C9 2PE D 146 G 110 ARG D 33 ARG.? 10.45 C1 GOL D 147 coo 56.39 -25.68 -36.91 53.88 -25.46 -38.13 -31.57 94.95 9.95 -32.83 93.25 11.77 coo 59.54 -19.27 -32.99 57.70 -19.44 -33.97 -32.95 100.50 7.54 -33.10 99.69 9.54 coo 53.35 -22.70 -45.35 52.95 -24.81 -43.16 -24.75 89.49 9.81 -23.48 88.88 7.05 ULMN 3 1qgn_c22 CYSTATHIONINE GAMMA-SYNTHASE user 8 3 # 8 E 163 TYR D 109 TYR~? -5.82 O16 2PE D 146s E 236 ASP D 56 ASP~? 11.46 C21 2PE D 146 G 110 ARG D 63 ARG~? -11.23 O28 2PE D 146s coo 56.39 -25.68 -36.91 53.88 -25.46 -38.13 -41.76 82.56 7.21 -39.24 81.41 7.29 coo 59.54 -19.27 -32.99 57.70 -19.44 -33.97 -41.85 87.81 13.66 -41.61 89.58 14.80 coo 53.35 -22.70 -45.35 52.95 -24.81 -43.16 -51.80 79.77 10.92 -50.17 82.42 10.63 1qgn_c22 source 1qgn CYSTATHIONINE GAMMA-SYNTHASE : 8 hits 1qgn_c22 naa= 3 ULMN 3 1qgn_c23 CYSTATHIONINE GAMMA-SYNTHASE user 1 3 # 1 F 163 TYR A 109 TYR~? -5.64 O16 2PE A 148s F 236 ASP A 56 ASP~? 11.59 C21 2PE A 148 H 110 ARG A 63 ARG~? 11.15 O28 2PE A 148 coo 14.88 -1.19 -65.80 16.37 -3.30 -64.72 -13.81 52.60 20.09 -14.53 54.76 18.49 coo 18.75 5.49 -68.65 19.58 3.75 -67.80 -16.01 45.89 15.64 -15.93 44.31 14.23 coo 18.56 -3.01 -57.11 17.14 -4.14 -59.58 -18.54 46.85 28.43 -16.64 46.31 26.03 ULMN 3 1qgn_c23 CYSTATHIONINE GAMMA-SYNTHASE user 2 3 # 2 F 163 TYR B 38 TYR.? 9.60 O1 PEG B 144 F 236 ASP B 40 ASP.? 11.67 O1 PEG B 144 H 110 ARG B 33 ARG.? -3.91 C3 PEG B 144s coo 14.88 -1.19 -65.80 16.37 -3.30 -64.72 18.19 76.55 32.34 16.15 78.24 31.46 coo 18.75 5.49 -68.65 19.58 3.75 -67.80 22.51 72.75 29.32 21.02 74.20 28.79 coo 18.56 -3.01 -57.11 17.14 -4.14 -59.58 17.31 79.39 40.81 17.39 77.24 43.00 ULMN 3 1qgn_c23 CYSTATHIONINE GAMMA-SYNTHASE user 3 3 # 3 F 163 TYR B 38 TYR.? 9.60 O1 PEG B 144 F 236 ASP B 40 ASP.? 11.67 O1 PEG B 144 H 110 ARG B 35 ARG.? 9.50 O1 PEG B 144 coo 14.88 -1.19 -65.80 16.37 -3.30 -64.72 18.19 76.55 32.34 16.15 78.24 31.46 coo 18.75 5.49 -68.65 19.58 3.75 -67.80 22.51 72.75 29.32 21.02 74.20 28.79 coo 18.56 -3.01 -57.11 17.14 -4.14 -59.58 22.76 84.08 36.32 22.81 87.07 35.45 ULMN 3 1qgn_c23 CYSTATHIONINE GAMMA-SYNTHASE user 4 3 # 4 F 163 TYR B 109 TYR~? -5.65 O13 PE8 B 148s F 236 ASP B 56 ASP~? 11.45 C20 PE8 B 148 H 110 ARG B 63 ARG~? -8.01 OH2 1PE B 150s coo 14.88 -1.19 -65.80 16.37 -3.30 -64.72 2.41 73.03 30.76 2.68 74.03 33.35 coo 18.75 5.49 -68.65 19.58 3.75 -67.80 6.80 78.21 26.00 8.47 79.07 25.03 coo 18.56 -3.01 -57.11 17.14 -4.14 -59.58 -5.18 74.17 22.68 -2.11 73.83 22.90 ULMN 3 1qgn_c23 CYSTATHIONINE GAMMA-SYNTHASE user 5 3 # 5 F 163 TYR C 109 TYR~? -5.91 C14 PE8 C 148s F 236 ASP C 56 ASP~? 9.09 N MLZ C 114 H 110 ARG C 63 ARG~? -11.70 O25 PE8 C 148s coo 14.88 -1.19 -65.80 16.37 -3.30 -64.72 -9.64 98.32 63.33 -8.13 96.27 62.21 coo 18.75 5.49 -68.65 19.58 3.75 -67.80 -16.40 94.43 66.11 -17.63 93.56 67.58 coo 18.56 -3.01 -57.11 17.14 -4.14 -59.58 -17.02 105.73 59.39 -16.53 104.08 61.96 ULMN 3 1qgn_c23 CYSTATHIONINE GAMMA-SYNTHASE user 6 3 # 6 F 163 TYR D 38 TYR.? 14.74 C9 2PE D 146 F 236 ASP D 40 ASP.? 18.38 C9 2PE D 146 H 110 ARG D 33 ARG.? 10.45 C1 GOL D 147 coo 14.88 -1.19 -65.80 16.37 -3.30 -64.72 -31.57 94.95 9.95 -32.83 93.25 11.77 coo 18.75 5.49 -68.65 19.58 3.75 -67.80 -32.95 100.50 7.54 -33.10 99.69 9.54 coo 18.56 -3.01 -57.11 17.14 -4.14 -59.58 -24.75 89.49 9.81 -23.48 88.88 7.05 ULMN 3 1qgn_c23 CYSTATHIONINE GAMMA-SYNTHASE user 7 3 # 7 F 163 TYR D 109 TYR~? -5.82 O16 2PE D 146s F 236 ASP D 56 ASP~? 11.46 C21 2PE D 146 H 110 ARG D 63 ARG~? -11.23 O28 2PE D 146s coo 14.88 -1.19 -65.80 16.37 -3.30 -64.72 -41.76 82.56 7.21 -39.24 81.41 7.29 coo 18.75 5.49 -68.65 19.58 3.75 -67.80 -41.85 87.81 13.66 -41.61 89.58 14.80 coo 18.56 -3.01 -57.11 17.14 -4.14 -59.58 -51.80 79.77 10.92 -50.17 82.42 10.63 1qgn_c23 source 1qgn CYSTATHIONINE GAMMA-SYNTHASE : 7 hits 1qgn_c23 naa= 3 ULMN 3 1qho_c04 ALPHA-AMYLASE user 1 3 # 1 A 228 ASP A 83 ASP.? 8.52 O3 GOL D 147 A 256 GLU A 84 GLU.? 10.45 C3 GOL D 147 A 329 ASP A 122 ASP^? 7.46 C1 GOL A 150 coo 28.46 69.88 26.74 30.40 70.70 26.53 -19.46 70.43 -3.04 -19.06 72.28 -2.05 coo 30.54 71.65 32.58 31.73 72.26 30.92 -21.01 70.22 3.12 -21.10 71.95 4.30 coo 37.87 70.12 31.80 36.61 69.74 30.15 -15.41 64.92 4.51 -15.09 66.83 5.33 ULMN 3 1qho_c04 ALPHA-AMYLASE user 2 3 # 2 A 228 ASP A 122 ASP^? 7.46 C1 GOL A 150 A 256 GLU A 84 GLU.? 10.45 C3 GOL D 147 A 329 ASP A 83 ASP.? 8.52 O3 GOL D 147 coo 28.46 69.88 26.74 30.40 70.70 26.53 -15.41 64.92 4.51 -15.09 66.83 5.33 coo 30.54 71.65 32.58 31.73 72.26 30.92 -21.01 70.22 3.12 -21.10 71.95 4.30 coo 37.87 70.12 31.80 36.61 69.74 30.15 -19.46 70.43 -3.04 -19.06 72.28 -2.05 ULMN 3 1qho_c04 ALPHA-AMYLASE user 3 3 # 3 A 228 ASP B 83 ASP.? 9.40 O3 GOL C 149 A 256 GLU B 84 GLU.? 10.31 O3 GOL C 149 A 329 ASP B 122 ASP^? 7.33 O2 GOL B 149 coo 28.46 69.88 26.74 30.40 70.70 26.53 13.62 86.10 55.23 12.83 84.59 56.49 coo 30.54 71.65 32.58 31.73 72.26 30.92 7.66 84.31 53.13 6.13 83.49 54.35 coo 37.87 70.12 31.80 36.61 69.74 30.15 10.89 79.68 47.57 9.75 78.80 49.16 ULMN 3 1qho_c04 ALPHA-AMYLASE user 4 3 # 4 A 228 ASP B 122 ASP^? 7.33 O2 GOL B 149 A 256 GLU B 84 GLU.? 10.31 O3 GOL C 149 A 329 ASP B 83 ASP.? 9.40 O3 GOL C 149 coo 28.46 69.88 26.74 30.40 70.70 26.53 10.89 79.68 47.57 9.75 78.80 49.16 coo 30.54 71.65 32.58 31.73 72.26 30.92 7.66 84.31 53.13 6.13 83.49 54.35 coo 37.87 70.12 31.80 36.61 69.74 30.15 13.62 86.10 55.23 12.83 84.59 56.49 ULMN 3 1qho_c04 ALPHA-AMYLASE user 5 3 # 5 A 228 ASP C 83 ASP.? 8.65 O3 GOL B 149 A 256 GLU C 84 GLU.? 10.77 O2 GOL B 149 A 329 ASP C 122 ASP^? 7.22 C3 GOL C 149 coo 28.46 69.88 26.74 30.40 70.70 26.53 3.02 71.86 58.06 4.88 72.49 57.24 coo 30.54 71.65 32.58 31.73 72.26 30.92 2.34 77.12 55.01 3.46 78.21 53.60 coo 37.87 70.12 31.80 36.61 69.74 30.15 0.27 81.12 61.60 2.07 81.54 60.53 ULMN 3 1qho_c04 ALPHA-AMYLASE user 6 3 # 6 A 228 ASP C 122 ASP^? 7.22 C3 GOL C 149 A 256 GLU C 84 GLU.? 10.77 O2 GOL B 149 A 329 ASP C 83 ASP.? 8.65 O3 GOL B 149 coo 28.46 69.88 26.74 30.40 70.70 26.53 0.27 81.12 61.60 2.07 81.54 60.53 coo 30.54 71.65 32.58 31.73 72.26 30.92 2.34 77.12 55.01 3.46 78.21 53.60 coo 37.87 70.12 31.80 36.61 69.74 30.15 3.02 71.86 58.06 4.88 72.49 57.24 ULMN 3 1qho_c04 ALPHA-AMYLASE user 7 3 # 7 A 228 ASP D 83 ASP.? 8.76 O1 GOL A 150 A 256 GLU D 84 GLU.? 10.79 C1 GOL A 150 A 329 ASP D 122 ASP^? 7.49 C3 GOL D 147 coo 28.46 69.88 26.74 30.40 70.70 26.53 -12.54 78.43 10.94 -12.46 77.06 9.29 coo 30.54 71.65 32.58 31.73 72.26 30.92 -17.40 74.78 10.23 -17.69 72.96 9.24 coo 37.87 70.12 31.80 36.61 69.74 30.15 -21.82 80.90 7.85 -21.38 79.32 6.51 ULMN 3 1qho_c04 ALPHA-AMYLASE user 8 3 # 8 A 228 ASP D 122 ASP^? 7.49 C3 GOL D 147 A 256 GLU D 84 GLU.? 10.79 C1 GOL A 150 A 329 ASP D 83 ASP.? 8.76 O1 GOL A 150 coo 28.46 69.88 26.74 30.40 70.70 26.53 -21.82 80.90 7.85 -21.38 79.32 6.51 coo 30.54 71.65 32.58 31.73 72.26 30.92 -17.40 74.78 10.23 -17.69 72.96 9.24 coo 37.87 70.12 31.80 36.61 69.74 30.15 -12.54 78.43 10.94 -12.46 77.06 9.29 1qho_c04 source 1qho ALPHA-AMYLASE : 8 hits 1qho_c04 naa= 3 ULMN 3 1qho_c05 ALPHA-AMYLASE user 1 3 # 1 A 228 ASP A 6 ASP.? -3.91 C9 2PE A 148s A 261 ASP D 83 ASP.? 8.76 O1 GOL A 150 A 329 ASP A 122 ASP^? 7.46 C1 GOL A 150 coo 28.46 69.88 26.74 30.40 70.70 26.53 -8.66 61.41 13.34 -8.76 59.35 12.80 coo 34.02 79.89 42.60 34.73 78.01 41.86 -12.54 78.43 10.94 -12.46 77.06 9.29 coo 37.87 70.12 31.80 36.61 69.74 30.15 -15.41 64.92 4.51 -15.09 66.83 5.33 ULMN 3 1qho_c05 ALPHA-AMYLASE user 2 3 # 2 A 228 ASP B 83 ASP.? 9.40 O3 GOL C 149 A 261 ASP C 83 ASP.? 8.65 O3 GOL B 149 A 329 ASP B 122 ASP^? 7.33 O2 GOL B 149 coo 28.46 69.88 26.74 30.40 70.70 26.53 13.62 86.10 55.23 12.83 84.59 56.49 coo 34.02 79.89 42.60 34.73 78.01 41.86 3.02 71.86 58.06 4.88 72.49 57.24 coo 37.87 70.12 31.80 36.61 69.74 30.15 10.89 79.68 47.57 9.75 78.80 49.16 ULMN 3 1qho_c05 ALPHA-AMYLASE user 3 3 # 3 A 228 ASP B 122 ASP^? 7.33 O2 GOL B 149 A 261 ASP C 122 ASP^? 7.22 C3 GOL C 149 A 329 ASP B 83 ASP.? 9.40 O3 GOL C 149 coo 28.46 69.88 26.74 30.40 70.70 26.53 10.89 79.68 47.57 9.75 78.80 49.16 coo 34.02 79.89 42.60 34.73 78.01 41.86 0.27 81.12 61.60 2.07 81.54 60.53 coo 37.87 70.12 31.80 36.61 69.74 30.15 13.62 86.10 55.23 12.83 84.59 56.49 ULMN 3 1qho_c05 ALPHA-AMYLASE user 4 3 # 4 A 228 ASP C 6 ASP.? -4.04 C8 PE8 C 148s A 261 ASP B 83 ASP.? 9.40 O3 GOL C 149 A 329 ASP C 122 ASP^? 7.22 C3 GOL C 149 coo 28.46 69.88 26.74 30.40 70.70 26.53 0.53 91.96 65.64 -1.31 91.68 66.68 coo 34.02 79.89 42.60 34.73 78.01 41.86 13.62 86.10 55.23 12.83 84.59 56.49 coo 37.87 70.12 31.80 36.61 69.74 30.15 0.27 81.12 61.60 2.07 81.54 60.53 ULMN 3 1qho_c05 ALPHA-AMYLASE user 5 3 # 5 A 228 ASP C 83 ASP.? 8.65 O3 GOL B 149 A 261 ASP B 83 ASP.? 9.40 O3 GOL C 149 A 329 ASP C 122 ASP^? 7.22 C3 GOL C 149 coo 28.46 69.88 26.74 30.40 70.70 26.53 3.02 71.86 58.06 4.88 72.49 57.24 coo 34.02 79.89 42.60 34.73 78.01 41.86 13.62 86.10 55.23 12.83 84.59 56.49 coo 37.87 70.12 31.80 36.61 69.74 30.15 0.27 81.12 61.60 2.07 81.54 60.53 ULMN 3 1qho_c05 ALPHA-AMYLASE user 6 3 # 6 A 228 ASP C 122 ASP^? 7.22 C3 GOL C 149 A 261 ASP B 122 ASP^? 7.33 O2 GOL B 149 A 329 ASP C 83 ASP.? 8.65 O3 GOL B 149 coo 28.46 69.88 26.74 30.40 70.70 26.53 0.27 81.12 61.60 2.07 81.54 60.53 coo 34.02 79.89 42.60 34.73 78.01 41.86 10.89 79.68 47.57 9.75 78.80 49.16 coo 37.87 70.12 31.80 36.61 69.74 30.15 3.02 71.86 58.06 4.88 72.49 57.24 1qho_c05 source 1qho ALPHA-AMYLASE : 6 hits 1qho_c05 naa= 3 ULMN 3 1qho_c07 ALPHA-AMYLASE user 1 3 # 1 A 228 ASP A 6 ASP.? -3.91 C9 2PE A 148s A 260 ASP D 83 ASP.? 8.76 O1 GOL A 150 A 329 ASP A 122 ASP^? 7.46 C1 GOL A 150 coo 28.46 69.88 26.74 30.40 70.70 26.53 -8.66 61.41 13.34 -8.76 59.35 12.80 coo 30.73 81.29 37.61 31.23 82.07 35.69 -12.54 78.43 10.94 -12.46 77.06 9.29 coo 37.87 70.12 31.80 36.61 69.74 30.15 -15.41 64.92 4.51 -15.09 66.83 5.33 ULMN 3 1qho_c07 ALPHA-AMYLASE user 2 3 # 2 A 228 ASP A 56 ASP~? 11.59 C21 2PE A 148 A 260 ASP A 6 ASP.? -3.91 C9 2PE A 148s A 329 ASP A 106 ASP~? 11.93 O22 2PE A 148 coo 28.46 69.88 26.74 30.40 70.70 26.53 -16.01 45.89 15.64 -15.93 44.31 14.23 coo 30.73 81.29 37.61 31.23 82.07 35.69 -8.66 61.41 13.34 -8.76 59.35 12.80 coo 37.87 70.12 31.80 36.61 69.74 30.15 -12.71 50.36 24.83 -13.06 48.30 25.05 ULMN 3 1qho_c07 ALPHA-AMYLASE user 3 3 # 3 A 228 ASP A 83 ASP.? 8.52 O3 GOL D 147 A 260 ASP D 83 ASP.? 8.76 O1 GOL A 150 A 329 ASP A 122 ASP^? 7.46 C1 GOL A 150 coo 28.46 69.88 26.74 30.40 70.70 26.53 -19.46 70.43 -3.04 -19.06 72.28 -2.05 coo 30.73 81.29 37.61 31.23 82.07 35.69 -12.54 78.43 10.94 -12.46 77.06 9.29 coo 37.87 70.12 31.80 36.61 69.74 30.15 -15.41 64.92 4.51 -15.09 66.83 5.33 ULMN 3 1qho_c07 ALPHA-AMYLASE user 4 3 # 4 A 228 ASP A 122 ASP^? 7.46 C1 GOL A 150 A 260 ASP D 122 ASP^? 7.49 C3 GOL D 147 A 329 ASP A 83 ASP.? 8.52 O3 GOL D 147 coo 28.46 69.88 26.74 30.40 70.70 26.53 -15.41 64.92 4.51 -15.09 66.83 5.33 coo 30.73 81.29 37.61 31.23 82.07 35.69 -21.82 80.90 7.85 -21.38 79.32 6.51 coo 37.87 70.12 31.80 36.61 69.74 30.15 -19.46 70.43 -3.04 -19.06 72.28 -2.05 ULMN 3 1qho_c07 ALPHA-AMYLASE user 5 3 # 5 A 228 ASP B 6 ASP.? -3.99 C6 PE8 B 148s A 260 ASP C 83 ASP.? 8.65 O3 GOL B 149 A 329 ASP B 122 ASP^? 7.33 O2 GOL B 149 coo 28.46 69.88 26.74 30.40 70.70 26.53 7.95 70.39 41.39 8.88 71.08 39.61 coo 30.73 81.29 37.61 31.23 82.07 35.69 3.02 71.86 58.06 4.88 72.49 57.24 coo 37.87 70.12 31.80 36.61 69.74 30.15 10.89 79.68 47.57 9.75 78.80 49.16 ULMN 3 1qho_c07 ALPHA-AMYLASE user 6 3 # 6 A 228 ASP B 122 ASP^? 7.33 O2 GOL B 149 A 260 ASP C 122 ASP^? 7.22 C3 GOL C 149 A 329 ASP B 83 ASP.? 9.40 O3 GOL C 149 coo 28.46 69.88 26.74 30.40 70.70 26.53 10.89 79.68 47.57 9.75 78.80 49.16 coo 30.73 81.29 37.61 31.23 82.07 35.69 0.27 81.12 61.60 2.07 81.54 60.53 coo 37.87 70.12 31.80 36.61 69.74 30.15 13.62 86.10 55.23 12.83 84.59 56.49 ULMN 3 1qho_c07 ALPHA-AMYLASE user 7 3 # 7 A 228 ASP C 6 ASP.? -4.04 C8 PE8 C 148s A 260 ASP B 83 ASP.? 9.40 O3 GOL C 149 A 329 ASP C 122 ASP^? 7.22 C3 GOL C 149 coo 28.46 69.88 26.74 30.40 70.70 26.53 0.53 91.96 65.64 -1.31 91.68 66.68 coo 30.73 81.29 37.61 31.23 82.07 35.69 13.62 86.10 55.23 12.83 84.59 56.49 coo 37.87 70.12 31.80 36.61 69.74 30.15 0.27 81.12 61.60 2.07 81.54 60.53 ULMN 3 1qho_c07 ALPHA-AMYLASE user 8 3 # 8 A 228 ASP C 56 ASP~? 9.09 N MLZ C 114 A 260 ASP C 6 ASP.? -4.04 C8 PE8 C 148s A 329 ASP C 106 ASP~? 12.11 C21 PE8 C 148 coo 28.46 69.88 26.74 30.40 70.70 26.53 -16.40 94.43 66.11 -17.63 93.56 67.58 coo 30.73 81.29 37.61 31.23 82.07 35.69 0.53 91.96 65.64 -1.31 91.68 66.68 coo 37.87 70.12 31.80 36.61 69.74 30.15 -11.06 103.55 63.77 -13.00 104.00 64.35 ULMN 3 1qho_c07 ALPHA-AMYLASE user 9 3 # 9 A 228 ASP C 122 ASP^? 7.22 C3 GOL C 149 A 260 ASP B 122 ASP^? 7.33 O2 GOL B 149 A 329 ASP C 83 ASP.? 8.65 O3 GOL B 149 coo 28.46 69.88 26.74 30.40 70.70 26.53 0.27 81.12 61.60 2.07 81.54 60.53 coo 30.73 81.29 37.61 31.23 82.07 35.69 10.89 79.68 47.57 9.75 78.80 49.16 coo 37.87 70.12 31.80 36.61 69.74 30.15 3.02 71.86 58.06 4.88 72.49 57.24 ULMN 3 1qho_c07 ALPHA-AMYLASE user 10 3 # 10 A 228 ASP D 6 ASP.? -3.77 C8 2PE D 146s A 260 ASP A 83 ASP.? 8.52 O3 GOL D 147 A 329 ASP D 122 ASP^? 7.49 C3 GOL D 147 coo 28.46 69.88 26.74 30.40 70.70 26.53 -31.03 82.87 1.04 -31.83 84.41 2.29 coo 30.73 81.29 37.61 31.23 82.07 35.69 -19.46 70.43 -3.04 -19.06 72.28 -2.05 coo 37.87 70.12 31.80 36.61 69.74 30.15 -21.82 80.90 7.85 -21.38 79.32 6.51 ULMN 3 1qho_c07 ALPHA-AMYLASE user 11 3 # 11 A 228 ASP D 83 ASP.? 8.76 O1 GOL A 150 A 260 ASP A 83 ASP.? 8.52 O3 GOL D 147 A 329 ASP D 122 ASP^? 7.49 C3 GOL D 147 coo 28.46 69.88 26.74 30.40 70.70 26.53 -12.54 78.43 10.94 -12.46 77.06 9.29 coo 30.73 81.29 37.61 31.23 82.07 35.69 -19.46 70.43 -3.04 -19.06 72.28 -2.05 coo 37.87 70.12 31.80 36.61 69.74 30.15 -21.82 80.90 7.85 -21.38 79.32 6.51 ULMN 3 1qho_c07 ALPHA-AMYLASE user 12 3 # 12 A 228 ASP D 122 ASP^? 7.49 C3 GOL D 147 A 260 ASP A 122 ASP^? 7.46 C1 GOL A 150 A 329 ASP D 83 ASP.? 8.76 O1 GOL A 150 coo 28.46 69.88 26.74 30.40 70.70 26.53 -21.82 80.90 7.85 -21.38 79.32 6.51 coo 30.73 81.29 37.61 31.23 82.07 35.69 -15.41 64.92 4.51 -15.09 66.83 5.33 coo 37.87 70.12 31.80 36.61 69.74 30.15 -12.54 78.43 10.94 -12.46 77.06 9.29 1qho_c07 source 1qho ALPHA-AMYLASE : 12 hits 1qho_c07 naa= 3 ULMN 3 1qol_c00 PROTEASE (NONSTRUCTURAL PROTEIN P20Auser 1 3 # 1 A 51 ALA A 49 ALA~? 12.15 CD MLY D 135 A 148 HIS A 115 HIS~? 12.27 C21 2PE A 148 A 163 ASP A 56 ASP~? 11.59 C21 2PE A 148 coo 1.42 19.18 21.84 1.11 19.57 23.28 -16.03 49.47 6.19 -14.84 50.27 5.67 coo 0.71 19.67 27.92 2.43 19.16 26.83 -13.18 48.35 10.37 -12.55 46.36 10.33 coo 7.15 16.22 27.50 6.15 18.00 27.94 -16.01 45.89 15.64 -15.93 44.31 14.23 ULMN 3 1qol_c00 PROTEASE (NONSTRUCTURAL PROTEIN P20Auser 2 3 # 2 A 51 ALA A 51 ALA~? 7.23 CD MLY D 135 A 148 HIS A 115 HIS~? 12.27 C21 2PE A 148 A 163 ASP A 56 ASP~? 11.59 C21 2PE A 148 coo 1.42 19.18 21.84 1.11 19.57 23.28 -20.65 48.85 8.75 -21.19 47.91 7.68 coo 0.71 19.67 27.92 2.43 19.16 26.83 -13.18 48.35 10.37 -12.55 46.36 10.33 coo 7.15 16.22 27.50 6.15 18.00 27.94 -16.01 45.89 15.64 -15.93 44.31 14.23 ULMN 3 1qol_c00 PROTEASE (NONSTRUCTURAL PROTEIN P20Auser 3 3 # 3 A 51 ALA B 49 ALA~? 10.91 O1 PEG B 144 A 148 HIS B 115 HIS~? 12.48 C18 PE8 B 148 A 163 ASP B 56 ASP~? 11.45 C20 PE8 B 148 coo 1.42 19.18 21.84 1.11 19.57 23.28 13.56 82.06 32.43 14.35 81.13 33.34 coo 0.71 19.67 27.92 2.43 19.16 26.83 11.86 77.76 30.05 12.70 77.49 28.15 coo 7.15 16.22 27.50 6.15 18.00 27.94 6.80 78.21 26.00 8.47 79.07 25.03 ULMN 3 1qol_c00 PROTEASE (NONSTRUCTURAL PROTEIN P20Auser 4 3 # 4 A 51 ALA B 51 ALA~? 7.25 CG MLY C 135 A 148 HIS B 115 HIS~? 12.48 C18 PE8 B 148 A 163 ASP B 56 ASP~? 11.45 C20 PE8 B 148 coo 1.42 19.18 21.84 1.11 19.57 23.28 9.29 84.92 31.07 10.11 86.09 30.55 coo 0.71 19.67 27.92 2.43 19.16 26.83 11.86 77.76 30.05 12.70 77.49 28.15 coo 7.15 16.22 27.50 6.15 18.00 27.94 6.80 78.21 26.00 8.47 79.07 25.03 ULMN 3 1qol_c00 PROTEASE (NONSTRUCTURAL PROTEIN P20Auser 5 3 # 5 A 51 ALA C 49 ALA~? 6.49 O MLZ C 114 A 148 HIS C 115 HIS~? 4.72 C MLZ C 114 A 163 ASP C 56 ASP~? 9.09 N MLZ C 114 coo 1.42 19.18 21.84 1.11 19.57 23.28 -13.48 85.10 67.69 -12.20 84.83 68.50 coo 0.71 19.67 27.92 2.43 19.16 26.83 -12.99 90.00 69.08 -14.38 90.57 70.54 coo 7.15 16.22 27.50 6.15 18.00 27.94 -16.40 94.43 66.11 -17.63 93.56 67.58 ULMN 3 1qol_c00 PROTEASE (NONSTRUCTURAL PROTEIN P20Auser 6 3 # 6 A 51 ALA C 51 ALA~? 7.46 CD MLY B 135 A 148 HIS C 115 HIS~? 4.72 C MLZ C 114 A 163 ASP C 56 ASP~? 9.09 N MLZ C 114 coo 1.42 19.18 21.84 1.11 19.57 23.28 -16.25 86.28 63.34 -17.35 85.28 63.69 coo 0.71 19.67 27.92 2.43 19.16 26.83 -12.99 90.00 69.08 -14.38 90.57 70.54 coo 7.15 16.22 27.50 6.15 18.00 27.94 -16.40 94.43 66.11 -17.63 93.56 67.58 ULMN 3 1qol_c00 PROTEASE (NONSTRUCTURAL PROTEIN P20Auser 7 3 # 7 A 51 ALA D 49 ALA~? 12.11 CE MLY A 135 A 148 HIS D 115 HIS~? 12.18 C21 2PE D 146 A 163 ASP D 56 ASP~? 11.46 C21 2PE D 146 coo 1.42 19.18 21.84 1.11 19.57 23.28 -32.13 89.91 15.13 -31.19 90.29 13.98 coo 0.71 19.67 27.92 2.43 19.16 26.83 -36.28 90.32 11.92 -37.49 91.98 12.35 coo 7.15 16.22 27.50 6.15 18.00 27.94 -41.85 87.81 13.66 -41.61 89.58 14.80 ULMN 3 1qol_c00 PROTEASE (NONSTRUCTURAL PROTEIN P20Auser 8 3 # 8 A 51 ALA D 51 ALA~? 6.92 CG MLY A 135 A 148 HIS D 115 HIS~? 12.18 C21 2PE D 146 A 163 ASP D 56 ASP~? 11.46 C21 2PE D 146 coo 1.42 19.18 21.84 1.11 19.57 23.28 -34.62 86.43 18.27 -34.28 87.19 19.52 coo 0.71 19.67 27.92 2.43 19.16 26.83 -36.28 90.32 11.92 -37.49 91.98 12.35 coo 7.15 16.22 27.50 6.15 18.00 27.94 -41.85 87.81 13.66 -41.61 89.58 14.80 1qol_c00 source 1qol PROTEASE (NONSTRUCTURAL PROTEIN P20A) : 8 hits 1qol_c00 naa= 3 ULMN 3 1qol_c01 PROTEASE (NONSTRUCTURAL PROTEIN P20Auser 1 3 # 1 B 51 ALA A 49 ALA~? 12.15 CD MLY D 135 B 148 HIS A 115 HIS~? 12.27 C21 2PE A 148 B 163 ASP A 56 ASP~? 11.59 C21 2PE A 148 coo -33.97 19.78 54.18 -33.40 20.11 52.82 -16.03 49.47 6.19 -14.84 50.27 5.67 coo -33.17 20.01 48.16 -34.95 19.37 49.06 -13.18 48.35 10.37 -12.55 46.36 10.33 coo -39.82 16.62 48.85 -38.59 18.24 48.48 -16.01 45.89 15.64 -15.93 44.31 14.23 ULMN 3 1qol_c01 PROTEASE (NONSTRUCTURAL PROTEIN P20Auser 2 3 # 2 B 51 ALA A 51 ALA~? 7.23 CD MLY D 135 B 148 HIS A 115 HIS~? 12.27 C21 2PE A 148 B 163 ASP A 56 ASP~? 11.59 C21 2PE A 148 coo -33.97 19.78 54.18 -33.40 20.11 52.82 -20.65 48.85 8.75 -21.19 47.91 7.68 coo -33.17 20.01 48.16 -34.95 19.37 49.06 -13.18 48.35 10.37 -12.55 46.36 10.33 coo -39.82 16.62 48.85 -38.59 18.24 48.48 -16.01 45.89 15.64 -15.93 44.31 14.23 ULMN 3 1qol_c01 PROTEASE (NONSTRUCTURAL PROTEIN P20Auser 3 3 # 3 B 51 ALA B 49 ALA~? 10.91 O1 PEG B 144 B 148 HIS B 115 HIS~? 12.48 C18 PE8 B 148 B 163 ASP B 56 ASP~? 11.45 C20 PE8 B 148 coo -33.97 19.78 54.18 -33.40 20.11 52.82 13.56 82.06 32.43 14.35 81.13 33.34 coo -33.17 20.01 48.16 -34.95 19.37 49.06 11.86 77.76 30.05 12.70 77.49 28.15 coo -39.82 16.62 48.85 -38.59 18.24 48.48 6.80 78.21 26.00 8.47 79.07 25.03 ULMN 3 1qol_c01 PROTEASE (NONSTRUCTURAL PROTEIN P20Auser 4 3 # 4 B 51 ALA B 51 ALA~? 7.25 CG MLY C 135 B 148 HIS B 115 HIS~? 12.48 C18 PE8 B 148 B 163 ASP B 56 ASP~? 11.45 C20 PE8 B 148 coo -33.97 19.78 54.18 -33.40 20.11 52.82 9.29 84.92 31.07 10.11 86.09 30.55 coo -33.17 20.01 48.16 -34.95 19.37 49.06 11.86 77.76 30.05 12.70 77.49 28.15 coo -39.82 16.62 48.85 -38.59 18.24 48.48 6.80 78.21 26.00 8.47 79.07 25.03 ULMN 3 1qol_c01 PROTEASE (NONSTRUCTURAL PROTEIN P20Auser 5 3 # 5 B 51 ALA C 49 ALA~? 6.49 O MLZ C 114 B 148 HIS C 115 HIS~? 4.72 C MLZ C 114 B 163 ASP C 56 ASP~? 9.09 N MLZ C 114 coo -33.97 19.78 54.18 -33.40 20.11 52.82 -13.48 85.10 67.69 -12.20 84.83 68.50 coo -33.17 20.01 48.16 -34.95 19.37 49.06 -12.99 90.00 69.08 -14.38 90.57 70.54 coo -39.82 16.62 48.85 -38.59 18.24 48.48 -16.40 94.43 66.11 -17.63 93.56 67.58 ULMN 3 1qol_c01 PROTEASE (NONSTRUCTURAL PROTEIN P20Auser 6 3 # 6 B 51 ALA C 51 ALA~? 7.46 CD MLY B 135 B 148 HIS C 115 HIS~? 4.72 C MLZ C 114 B 163 ASP C 56 ASP~? 9.09 N MLZ C 114 coo -33.97 19.78 54.18 -33.40 20.11 52.82 -16.25 86.28 63.34 -17.35 85.28 63.69 coo -33.17 20.01 48.16 -34.95 19.37 49.06 -12.99 90.00 69.08 -14.38 90.57 70.54 coo -39.82 16.62 48.85 -38.59 18.24 48.48 -16.40 94.43 66.11 -17.63 93.56 67.58 ULMN 3 1qol_c01 PROTEASE (NONSTRUCTURAL PROTEIN P20Auser 7 3 # 7 B 51 ALA D 49 ALA~? 12.11 CE MLY A 135 B 148 HIS D 115 HIS~? 12.18 C21 2PE D 146 B 163 ASP D 56 ASP~? 11.46 C21 2PE D 146 coo -33.97 19.78 54.18 -33.40 20.11 52.82 -32.13 89.91 15.13 -31.19 90.29 13.98 coo -33.17 20.01 48.16 -34.95 19.37 49.06 -36.28 90.32 11.92 -37.49 91.98 12.35 coo -39.82 16.62 48.85 -38.59 18.24 48.48 -41.85 87.81 13.66 -41.61 89.58 14.80 ULMN 3 1qol_c01 PROTEASE (NONSTRUCTURAL PROTEIN P20Auser 8 3 # 8 B 51 ALA D 51 ALA~? 6.92 CG MLY A 135 B 148 HIS D 115 HIS~? 12.18 C21 2PE D 146 B 163 ASP D 56 ASP~? 11.46 C21 2PE D 146 coo -33.97 19.78 54.18 -33.40 20.11 52.82 -34.62 86.43 18.27 -34.28 87.19 19.52 coo -33.17 20.01 48.16 -34.95 19.37 49.06 -36.28 90.32 11.92 -37.49 91.98 12.35 coo -39.82 16.62 48.85 -38.59 18.24 48.48 -41.85 87.81 13.66 -41.61 89.58 14.80 1qol_c01 source 1qol PROTEASE (NONSTRUCTURAL PROTEIN P20A) : 8 hits 1qol_c01 naa= 3 ULMN 3 1qol_c02 PROTEASE (NONSTRUCTURAL PROTEIN P20Auser 1 3 # 1 C 51 ALA A 49 ALA~? 12.15 CD MLY D 135 C 148 HIS A 115 HIS~? 12.27 C21 2PE A 148 C 163 ASP A 56 ASP~? 11.59 C21 2PE A 148 coo -26.36 -19.12 21.15 -25.71 -19.49 22.47 -16.03 49.47 6.19 -14.84 50.27 5.67 coo -25.01 -20.21 26.78 -26.91 -20.55 25.93 -13.18 48.35 10.37 -12.55 46.36 10.33 coo -32.17 -20.34 27.36 -30.15 -20.93 27.54 -16.01 45.89 15.64 -15.93 44.31 14.23 ULMN 3 1qol_c02 PROTEASE (NONSTRUCTURAL PROTEIN P20Auser 2 3 # 2 C 51 ALA A 51 ALA~? 7.23 CD MLY D 135 C 148 HIS A 115 HIS~? 12.27 C21 2PE A 148 C 163 ASP A 56 ASP~? 11.59 C21 2PE A 148 coo -26.36 -19.12 21.15 -25.71 -19.49 22.47 -20.65 48.85 8.75 -21.19 47.91 7.68 coo -25.01 -20.21 26.78 -26.91 -20.55 25.93 -13.18 48.35 10.37 -12.55 46.36 10.33 coo -32.17 -20.34 27.36 -30.15 -20.93 27.54 -16.01 45.89 15.64 -15.93 44.31 14.23 ULMN 3 1qol_c02 PROTEASE (NONSTRUCTURAL PROTEIN P20Auser 3 3 # 3 C 51 ALA B 49 ALA~? 10.91 O1 PEG B 144 C 148 HIS B 115 HIS~? 12.48 C18 PE8 B 148 C 163 ASP B 56 ASP~? 11.45 C20 PE8 B 148 coo -26.36 -19.12 21.15 -25.71 -19.49 22.47 13.56 82.06 32.43 14.35 81.13 33.34 coo -25.01 -20.21 26.78 -26.91 -20.55 25.93 11.86 77.76 30.05 12.70 77.49 28.15 coo -32.17 -20.34 27.36 -30.15 -20.93 27.54 6.80 78.21 26.00 8.47 79.07 25.03 ULMN 3 1qol_c02 PROTEASE (NONSTRUCTURAL PROTEIN P20Auser 4 3 # 4 C 51 ALA B 51 ALA~? 7.25 CG MLY C 135 C 148 HIS B 115 HIS~? 12.48 C18 PE8 B 148 C 163 ASP B 56 ASP~? 11.45 C20 PE8 B 148 coo -26.36 -19.12 21.15 -25.71 -19.49 22.47 9.29 84.92 31.07 10.11 86.09 30.55 coo -25.01 -20.21 26.78 -26.91 -20.55 25.93 11.86 77.76 30.05 12.70 77.49 28.15 coo -32.17 -20.34 27.36 -30.15 -20.93 27.54 6.80 78.21 26.00 8.47 79.07 25.03 ULMN 3 1qol_c02 PROTEASE (NONSTRUCTURAL PROTEIN P20Auser 5 3 # 5 C 51 ALA C 49 ALA~? 6.49 O MLZ C 114 C 148 HIS C 115 HIS~? 4.72 C MLZ C 114 C 163 ASP C 56 ASP~? 9.09 N MLZ C 114 coo -26.36 -19.12 21.15 -25.71 -19.49 22.47 -13.48 85.10 67.69 -12.20 84.83 68.50 coo -25.01 -20.21 26.78 -26.91 -20.55 25.93 -12.99 90.00 69.08 -14.38 90.57 70.54 coo -32.17 -20.34 27.36 -30.15 -20.93 27.54 -16.40 94.43 66.11 -17.63 93.56 67.58 ULMN 3 1qol_c02 PROTEASE (NONSTRUCTURAL PROTEIN P20Auser 6 3 # 6 C 51 ALA C 51 ALA~? 7.46 CD MLY B 135 C 148 HIS C 115 HIS~? 4.72 C MLZ C 114 C 163 ASP C 56 ASP~? 9.09 N MLZ C 114 coo -26.36 -19.12 21.15 -25.71 -19.49 22.47 -16.25 86.28 63.34 -17.35 85.28 63.69 coo -25.01 -20.21 26.78 -26.91 -20.55 25.93 -12.99 90.00 69.08 -14.38 90.57 70.54 coo -32.17 -20.34 27.36 -30.15 -20.93 27.54 -16.40 94.43 66.11 -17.63 93.56 67.58 ULMN 3 1qol_c02 PROTEASE (NONSTRUCTURAL PROTEIN P20Auser 7 3 # 7 C 51 ALA D 49 ALA~? 12.11 CE MLY A 135 C 148 HIS D 115 HIS~? 12.18 C21 2PE D 146 C 163 ASP D 56 ASP~? 11.46 C21 2PE D 146 coo -26.36 -19.12 21.15 -25.71 -19.49 22.47 -32.13 89.91 15.13 -31.19 90.29 13.98 coo -25.01 -20.21 26.78 -26.91 -20.55 25.93 -36.28 90.32 11.92 -37.49 91.98 12.35 coo -32.17 -20.34 27.36 -30.15 -20.93 27.54 -41.85 87.81 13.66 -41.61 89.58 14.80 ULMN 3 1qol_c02 PROTEASE (NONSTRUCTURAL PROTEIN P20Auser 8 3 # 8 C 51 ALA D 51 ALA~? 6.92 CG MLY A 135 C 148 HIS D 115 HIS~? 12.18 C21 2PE D 146 C 163 ASP D 56 ASP~? 11.46 C21 2PE D 146 coo -26.36 -19.12 21.15 -25.71 -19.49 22.47 -34.62 86.43 18.27 -34.28 87.19 19.52 coo -25.01 -20.21 26.78 -26.91 -20.55 25.93 -36.28 90.32 11.92 -37.49 91.98 12.35 coo -32.17 -20.34 27.36 -30.15 -20.93 27.54 -41.85 87.81 13.66 -41.61 89.58 14.80 1qol_c02 source 1qol PROTEASE (NONSTRUCTURAL PROTEIN P20A) : 8 hits 1qol_c02 naa= 3 ULMN 3 1qol_c03 PROTEASE (NONSTRUCTURAL PROTEIN P20Auser 1 3 # 1 D 51 ALA A 49 ALA~? 12.15 CD MLY D 135 D 148 HIS A 115 HIS~? 12.27 C21 2PE A 148 D 163 ASP A 56 ASP~? 11.59 C21 2PE A 148 coo -6.15 -19.18 55.49 -6.70 -19.60 54.15 -16.03 49.47 6.19 -14.84 50.27 5.67 coo -7.62 -20.32 49.70 -5.89 -20.86 50.74 -13.18 48.35 10.37 -12.55 46.36 10.33 coo -0.41 -20.05 49.27 -2.21 -21.16 49.24 -16.01 45.89 15.64 -15.93 44.31 14.23 ULMN 3 1qol_c03 PROTEASE (NONSTRUCTURAL PROTEIN P20Auser 2 3 # 2 D 51 ALA A 51 ALA~? 7.23 CD MLY D 135 D 148 HIS A 115 HIS~? 12.27 C21 2PE A 148 D 163 ASP A 56 ASP~? 11.59 C21 2PE A 148 coo -6.15 -19.18 55.49 -6.70 -19.60 54.15 -20.65 48.85 8.75 -21.19 47.91 7.68 coo -7.62 -20.32 49.70 -5.89 -20.86 50.74 -13.18 48.35 10.37 -12.55 46.36 10.33 coo -0.41 -20.05 49.27 -2.21 -21.16 49.24 -16.01 45.89 15.64 -15.93 44.31 14.23 ULMN 3 1qol_c03 PROTEASE (NONSTRUCTURAL PROTEIN P20Auser 3 3 # 3 D 51 ALA B 49 ALA~? 10.91 O1 PEG B 144 D 148 HIS B 115 HIS~? 12.48 C18 PE8 B 148 D 163 ASP B 56 ASP~? 11.45 C20 PE8 B 148 coo -6.15 -19.18 55.49 -6.70 -19.60 54.15 13.56 82.06 32.43 14.35 81.13 33.34 coo -7.62 -20.32 49.70 -5.89 -20.86 50.74 11.86 77.76 30.05 12.70 77.49 28.15 coo -0.41 -20.05 49.27 -2.21 -21.16 49.24 6.80 78.21 26.00 8.47 79.07 25.03 ULMN 3 1qol_c03 PROTEASE (NONSTRUCTURAL PROTEIN P20Auser 4 3 # 4 D 51 ALA B 51 ALA~? 7.25 CG MLY C 135 D 148 HIS B 115 HIS~? 12.48 C18 PE8 B 148 D 163 ASP B 56 ASP~? 11.45 C20 PE8 B 148 coo -6.15 -19.18 55.49 -6.70 -19.60 54.15 9.29 84.92 31.07 10.11 86.09 30.55 coo -7.62 -20.32 49.70 -5.89 -20.86 50.74 11.86 77.76 30.05 12.70 77.49 28.15 coo -0.41 -20.05 49.27 -2.21 -21.16 49.24 6.80 78.21 26.00 8.47 79.07 25.03 ULMN 3 1qol_c03 PROTEASE (NONSTRUCTURAL PROTEIN P20Auser 5 3 # 5 D 51 ALA C 49 ALA~? 6.49 O MLZ C 114 D 148 HIS C 115 HIS~? 4.72 C MLZ C 114 D 163 ASP C 56 ASP~? 9.09 N MLZ C 114 coo -6.15 -19.18 55.49 -6.70 -19.60 54.15 -13.48 85.10 67.69 -12.20 84.83 68.50 coo -7.62 -20.32 49.70 -5.89 -20.86 50.74 -12.99 90.00 69.08 -14.38 90.57 70.54 coo -0.41 -20.05 49.27 -2.21 -21.16 49.24 -16.40 94.43 66.11 -17.63 93.56 67.58 ULMN 3 1qol_c03 PROTEASE (NONSTRUCTURAL PROTEIN P20Auser 6 3 # 6 D 51 ALA C 51 ALA~? 7.46 CD MLY B 135 D 148 HIS C 115 HIS~? 4.72 C MLZ C 114 D 163 ASP C 56 ASP~? 9.09 N MLZ C 114 coo -6.15 -19.18 55.49 -6.70 -19.60 54.15 -16.25 86.28 63.34 -17.35 85.28 63.69 coo -7.62 -20.32 49.70 -5.89 -20.86 50.74 -12.99 90.00 69.08 -14.38 90.57 70.54 coo -0.41 -20.05 49.27 -2.21 -21.16 49.24 -16.40 94.43 66.11 -17.63 93.56 67.58 ULMN 3 1qol_c03 PROTEASE (NONSTRUCTURAL PROTEIN P20Auser 7 3 # 7 D 51 ALA D 49 ALA~? 12.11 CE MLY A 135 D 148 HIS D 115 HIS~? 12.18 C21 2PE D 146 D 163 ASP D 56 ASP~? 11.46 C21 2PE D 146 coo -6.15 -19.18 55.49 -6.70 -19.60 54.15 -32.13 89.91 15.13 -31.19 90.29 13.98 coo -7.62 -20.32 49.70 -5.89 -20.86 50.74 -36.28 90.32 11.92 -37.49 91.98 12.35 coo -0.41 -20.05 49.27 -2.21 -21.16 49.24 -41.85 87.81 13.66 -41.61 89.58 14.80 ULMN 3 1qol_c03 PROTEASE (NONSTRUCTURAL PROTEIN P20Auser 8 3 # 8 D 51 ALA D 51 ALA~? 6.92 CG MLY A 135 D 148 HIS D 115 HIS~? 12.18 C21 2PE D 146 D 163 ASP D 56 ASP~? 11.46 C21 2PE D 146 coo -6.15 -19.18 55.49 -6.70 -19.60 54.15 -34.62 86.43 18.27 -34.28 87.19 19.52 coo -7.62 -20.32 49.70 -5.89 -20.86 50.74 -36.28 90.32 11.92 -37.49 91.98 12.35 coo -0.41 -20.05 49.27 -2.21 -21.16 49.24 -41.85 87.81 13.66 -41.61 89.58 14.80 1qol_c03 source 1qol PROTEASE (NONSTRUCTURAL PROTEIN P20A) : 8 hits 1qol_c03 naa= 3 ULMN 3 1qol_c04 PROTEASE (NONSTRUCTURAL PROTEIN P20Auser 1 3 # 1 E 51 ALA A 49 ALA~? 12.15 CD MLY D 135 E 148 HIS A 115 HIS~? 12.27 C21 2PE A 148 E 163 ASP A 56 ASP~? 11.59 C21 2PE A 148 coo 5.48 -16.06 -47.92 6.03 -15.45 -46.65 -16.03 49.47 6.19 -14.84 50.27 5.67 coo 5.81 -16.05 -42.05 5.54 -17.84 -43.11 -13.18 48.35 10.37 -12.55 46.36 10.33 coo 2.75 -22.21 -43.08 4.67 -21.31 -42.96 -16.01 45.89 15.64 -15.93 44.31 14.23 ULMN 3 1qol_c04 PROTEASE (NONSTRUCTURAL PROTEIN P20Auser 2 3 # 2 E 51 ALA A 51 ALA~? 7.23 CD MLY D 135 E 148 HIS A 115 HIS~? 12.27 C21 2PE A 148 E 163 ASP A 56 ASP~? 11.59 C21 2PE A 148 coo 5.48 -16.06 -47.92 6.03 -15.45 -46.65 -20.65 48.85 8.75 -21.19 47.91 7.68 coo 5.81 -16.05 -42.05 5.54 -17.84 -43.11 -13.18 48.35 10.37 -12.55 46.36 10.33 coo 2.75 -22.21 -43.08 4.67 -21.31 -42.96 -16.01 45.89 15.64 -15.93 44.31 14.23 ULMN 3 1qol_c04 PROTEASE (NONSTRUCTURAL PROTEIN P20Auser 3 3 # 3 E 51 ALA B 49 ALA~? 10.91 O1 PEG B 144 E 148 HIS B 115 HIS~? 12.48 C18 PE8 B 148 E 163 ASP B 56 ASP~? 11.45 C20 PE8 B 148 coo 5.48 -16.06 -47.92 6.03 -15.45 -46.65 13.56 82.06 32.43 14.35 81.13 33.34 coo 5.81 -16.05 -42.05 5.54 -17.84 -43.11 11.86 77.76 30.05 12.70 77.49 28.15 coo 2.75 -22.21 -43.08 4.67 -21.31 -42.96 6.80 78.21 26.00 8.47 79.07 25.03 ULMN 3 1qol_c04 PROTEASE (NONSTRUCTURAL PROTEIN P20Auser 4 3 # 4 E 51 ALA B 51 ALA~? 7.25 CG MLY C 135 E 148 HIS B 115 HIS~? 12.48 C18 PE8 B 148 E 163 ASP B 56 ASP~? 11.45 C20 PE8 B 148 coo 5.48 -16.06 -47.92 6.03 -15.45 -46.65 9.29 84.92 31.07 10.11 86.09 30.55 coo 5.81 -16.05 -42.05 5.54 -17.84 -43.11 11.86 77.76 30.05 12.70 77.49 28.15 coo 2.75 -22.21 -43.08 4.67 -21.31 -42.96 6.80 78.21 26.00 8.47 79.07 25.03 ULMN 3 1qol_c04 PROTEASE (NONSTRUCTURAL PROTEIN P20Auser 5 3 # 5 E 51 ALA C 49 ALA~? 6.49 O MLZ C 114 E 148 HIS C 115 HIS~? 4.72 C MLZ C 114 E 163 ASP C 56 ASP~? 9.09 N MLZ C 114 coo 5.48 -16.06 -47.92 6.03 -15.45 -46.65 -13.48 85.10 67.69 -12.20 84.83 68.50 coo 5.81 -16.05 -42.05 5.54 -17.84 -43.11 -12.99 90.00 69.08 -14.38 90.57 70.54 coo 2.75 -22.21 -43.08 4.67 -21.31 -42.96 -16.40 94.43 66.11 -17.63 93.56 67.58 ULMN 3 1qol_c04 PROTEASE (NONSTRUCTURAL PROTEIN P20Auser 6 3 # 6 E 51 ALA C 51 ALA~? 7.46 CD MLY B 135 E 148 HIS C 115 HIS~? 4.72 C MLZ C 114 E 163 ASP C 56 ASP~? 9.09 N MLZ C 114 coo 5.48 -16.06 -47.92 6.03 -15.45 -46.65 -16.25 86.28 63.34 -17.35 85.28 63.69 coo 5.81 -16.05 -42.05 5.54 -17.84 -43.11 -12.99 90.00 69.08 -14.38 90.57 70.54 coo 2.75 -22.21 -43.08 4.67 -21.31 -42.96 -16.40 94.43 66.11 -17.63 93.56 67.58 ULMN 3 1qol_c04 PROTEASE (NONSTRUCTURAL PROTEIN P20Auser 7 3 # 7 E 51 ALA D 49 ALA~? 12.11 CE MLY A 135 E 148 HIS D 115 HIS~? 12.18 C21 2PE D 146 E 163 ASP D 56 ASP~? 11.46 C21 2PE D 146 coo 5.48 -16.06 -47.92 6.03 -15.45 -46.65 -32.13 89.91 15.13 -31.19 90.29 13.98 coo 5.81 -16.05 -42.05 5.54 -17.84 -43.11 -36.28 90.32 11.92 -37.49 91.98 12.35 coo 2.75 -22.21 -43.08 4.67 -21.31 -42.96 -41.85 87.81 13.66 -41.61 89.58 14.80 ULMN 3 1qol_c04 PROTEASE (NONSTRUCTURAL PROTEIN P20Auser 8 3 # 8 E 51 ALA D 51 ALA~? 6.92 CG MLY A 135 E 148 HIS D 115 HIS~? 12.18 C21 2PE D 146 E 163 ASP D 56 ASP~? 11.46 C21 2PE D 146 coo 5.48 -16.06 -47.92 6.03 -15.45 -46.65 -34.62 86.43 18.27 -34.28 87.19 19.52 coo 5.81 -16.05 -42.05 5.54 -17.84 -43.11 -36.28 90.32 11.92 -37.49 91.98 12.35 coo 2.75 -22.21 -43.08 4.67 -21.31 -42.96 -41.85 87.81 13.66 -41.61 89.58 14.80 1qol_c04 source 1qol PROTEASE (NONSTRUCTURAL PROTEIN P20A) : 8 hits 1qol_c04 naa= 3 ULMN 3 1qol_c05 PROTEASE (NONSTRUCTURAL PROTEIN P20Auser 1 3 # 1 F 51 ALA A 49 ALA~? 12.15 CD MLY D 135 F 148 HIS A 115 HIS~? 12.27 C21 2PE A 148 F 163 ASP A 56 ASP~? 11.59 C21 2PE A 148 coo 5.33 15.59 -14.28 5.80 15.15 -15.64 -16.03 49.47 6.19 -14.84 50.27 5.67 coo 5.79 15.50 -20.13 5.50 17.28 -19.05 -13.18 48.35 10.37 -12.55 46.36 10.33 coo 2.42 22.00 -18.97 4.23 20.92 -19.18 -16.01 45.89 15.64 -15.93 44.31 14.23 ULMN 3 1qol_c05 PROTEASE (NONSTRUCTURAL PROTEIN P20Auser 2 3 # 2 F 51 ALA A 51 ALA~? 7.23 CD MLY D 135 F 148 HIS A 115 HIS~? 12.27 C21 2PE A 148 F 163 ASP A 56 ASP~? 11.59 C21 2PE A 148 coo 5.33 15.59 -14.28 5.80 15.15 -15.64 -20.65 48.85 8.75 -21.19 47.91 7.68 coo 5.79 15.50 -20.13 5.50 17.28 -19.05 -13.18 48.35 10.37 -12.55 46.36 10.33 coo 2.42 22.00 -18.97 4.23 20.92 -19.18 -16.01 45.89 15.64 -15.93 44.31 14.23 ULMN 3 1qol_c05 PROTEASE (NONSTRUCTURAL PROTEIN P20Auser 3 3 # 3 F 51 ALA B 49 ALA~? 10.91 O1 PEG B 144 F 148 HIS B 115 HIS~? 12.48 C18 PE8 B 148 F 163 ASP B 56 ASP~? 11.45 C20 PE8 B 148 coo 5.33 15.59 -14.28 5.80 15.15 -15.64 13.56 82.06 32.43 14.35 81.13 33.34 coo 5.79 15.50 -20.13 5.50 17.28 -19.05 11.86 77.76 30.05 12.70 77.49 28.15 coo 2.42 22.00 -18.97 4.23 20.92 -19.18 6.80 78.21 26.00 8.47 79.07 25.03 ULMN 3 1qol_c05 PROTEASE (NONSTRUCTURAL PROTEIN P20Auser 4 3 # 4 F 51 ALA B 51 ALA~? 7.25 CG MLY C 135 F 148 HIS B 115 HIS~? 12.48 C18 PE8 B 148 F 163 ASP B 56 ASP~? 11.45 C20 PE8 B 148 coo 5.33 15.59 -14.28 5.80 15.15 -15.64 9.29 84.92 31.07 10.11 86.09 30.55 coo 5.79 15.50 -20.13 5.50 17.28 -19.05 11.86 77.76 30.05 12.70 77.49 28.15 coo 2.42 22.00 -18.97 4.23 20.92 -19.18 6.80 78.21 26.00 8.47 79.07 25.03 ULMN 3 1qol_c05 PROTEASE (NONSTRUCTURAL PROTEIN P20Auser 5 3 # 5 F 51 ALA C 49 ALA~? 6.49 O MLZ C 114 F 148 HIS C 115 HIS~? 4.72 C MLZ C 114 F 163 ASP C 56 ASP~? 9.09 N MLZ C 114 coo 5.33 15.59 -14.28 5.80 15.15 -15.64 -13.48 85.10 67.69 -12.20 84.83 68.50 coo 5.79 15.50 -20.13 5.50 17.28 -19.05 -12.99 90.00 69.08 -14.38 90.57 70.54 coo 2.42 22.00 -18.97 4.23 20.92 -19.18 -16.40 94.43 66.11 -17.63 93.56 67.58 ULMN 3 1qol_c05 PROTEASE (NONSTRUCTURAL PROTEIN P20Auser 6 3 # 6 F 51 ALA C 51 ALA~? 7.46 CD MLY B 135 F 148 HIS C 115 HIS~? 4.72 C MLZ C 114 F 163 ASP C 56 ASP~? 9.09 N MLZ C 114 coo 5.33 15.59 -14.28 5.80 15.15 -15.64 -16.25 86.28 63.34 -17.35 85.28 63.69 coo 5.79 15.50 -20.13 5.50 17.28 -19.05 -12.99 90.00 69.08 -14.38 90.57 70.54 coo 2.42 22.00 -18.97 4.23 20.92 -19.18 -16.40 94.43 66.11 -17.63 93.56 67.58 ULMN 3 1qol_c05 PROTEASE (NONSTRUCTURAL PROTEIN P20Auser 7 3 # 7 F 51 ALA D 49 ALA~? 12.11 CE MLY A 135 F 148 HIS D 115 HIS~? 12.18 C21 2PE D 146 F 163 ASP D 56 ASP~? 11.46 C21 2PE D 146 coo 5.33 15.59 -14.28 5.80 15.15 -15.64 -32.13 89.91 15.13 -31.19 90.29 13.98 coo 5.79 15.50 -20.13 5.50 17.28 -19.05 -36.28 90.32 11.92 -37.49 91.98 12.35 coo 2.42 22.00 -18.97 4.23 20.92 -19.18 -41.85 87.81 13.66 -41.61 89.58 14.80 ULMN 3 1qol_c05 PROTEASE (NONSTRUCTURAL PROTEIN P20Auser 8 3 # 8 F 51 ALA D 51 ALA~? 6.92 CG MLY A 135 F 148 HIS D 115 HIS~? 12.18 C21 2PE D 146 F 163 ASP D 56 ASP~? 11.46 C21 2PE D 146 coo 5.33 15.59 -14.28 5.80 15.15 -15.64 -34.62 86.43 18.27 -34.28 87.19 19.52 coo 5.79 15.50 -20.13 5.50 17.28 -19.05 -36.28 90.32 11.92 -37.49 91.98 12.35 coo 2.42 22.00 -18.97 4.23 20.92 -19.18 -41.85 87.81 13.66 -41.61 89.58 14.80 1qol_c05 source 1qol PROTEASE (NONSTRUCTURAL PROTEIN P20A) : 8 hits 1qol_c05 naa= 3 ULMN 3 1qol_c06 PROTEASE (NONSTRUCTURAL PROTEIN P20Auser 1 3 # 1 G 51 ALA A 49 ALA~? 12.15 CD MLY D 135 G 148 HIS A 115 HIS~? 12.27 C21 2PE A 148 G 163 ASP A 56 ASP~? 11.59 C21 2PE A 148 coo -33.28 -11.88 -14.46 -33.66 -11.38 -15.87 -16.03 49.47 6.19 -14.84 50.27 5.67 coo -34.88 -9.77 -20.15 -35.41 -11.60 -19.26 -13.18 48.35 10.37 -12.55 46.36 10.33 coo -34.41 -16.73 -21.11 -35.66 -15.03 -20.96 -16.01 45.89 15.64 -15.93 44.31 14.23 ULMN 3 1qol_c06 PROTEASE (NONSTRUCTURAL PROTEIN P20Auser 2 3 # 2 G 51 ALA A 51 ALA~? 7.23 CD MLY D 135 G 148 HIS A 115 HIS~? 12.27 C21 2PE A 148 G 163 ASP A 56 ASP~? 11.59 C21 2PE A 148 coo -33.28 -11.88 -14.46 -33.66 -11.38 -15.87 -20.65 48.85 8.75 -21.19 47.91 7.68 coo -34.88 -9.77 -20.15 -35.41 -11.60 -19.26 -13.18 48.35 10.37 -12.55 46.36 10.33 coo -34.41 -16.73 -21.11 -35.66 -15.03 -20.96 -16.01 45.89 15.64 -15.93 44.31 14.23 ULMN 3 1qol_c06 PROTEASE (NONSTRUCTURAL PROTEIN P20Auser 3 3 # 3 G 51 ALA B 49 ALA~? 10.91 O1 PEG B 144 G 148 HIS B 115 HIS~? 12.48 C18 PE8 B 148 G 163 ASP B 56 ASP~? 11.45 C20 PE8 B 148 coo -33.28 -11.88 -14.46 -33.66 -11.38 -15.87 13.56 82.06 32.43 14.35 81.13 33.34 coo -34.88 -9.77 -20.15 -35.41 -11.60 -19.26 11.86 77.76 30.05 12.70 77.49 28.15 coo -34.41 -16.73 -21.11 -35.66 -15.03 -20.96 6.80 78.21 26.00 8.47 79.07 25.03 ULMN 3 1qol_c06 PROTEASE (NONSTRUCTURAL PROTEIN P20Auser 4 3 # 4 G 51 ALA B 51 ALA~? 7.25 CG MLY C 135 G 148 HIS B 115 HIS~? 12.48 C18 PE8 B 148 G 163 ASP B 56 ASP~? 11.45 C20 PE8 B 148 coo -33.28 -11.88 -14.46 -33.66 -11.38 -15.87 9.29 84.92 31.07 10.11 86.09 30.55 coo -34.88 -9.77 -20.15 -35.41 -11.60 -19.26 11.86 77.76 30.05 12.70 77.49 28.15 coo -34.41 -16.73 -21.11 -35.66 -15.03 -20.96 6.80 78.21 26.00 8.47 79.07 25.03 ULMN 3 1qol_c06 PROTEASE (NONSTRUCTURAL PROTEIN P20Auser 5 3 # 5 G 51 ALA C 49 ALA~? 6.49 O MLZ C 114 G 148 HIS C 115 HIS~? 4.72 C MLZ C 114 G 163 ASP C 56 ASP~? 9.09 N MLZ C 114 coo -33.28 -11.88 -14.46 -33.66 -11.38 -15.87 -13.48 85.10 67.69 -12.20 84.83 68.50 coo -34.88 -9.77 -20.15 -35.41 -11.60 -19.26 -12.99 90.00 69.08 -14.38 90.57 70.54 coo -34.41 -16.73 -21.11 -35.66 -15.03 -20.96 -16.40 94.43 66.11 -17.63 93.56 67.58 ULMN 3 1qol_c06 PROTEASE (NONSTRUCTURAL PROTEIN P20Auser 6 3 # 6 G 51 ALA C 51 ALA~? 7.46 CD MLY B 135 G 148 HIS C 115 HIS~? 4.72 C MLZ C 114 G 163 ASP C 56 ASP~? 9.09 N MLZ C 114 coo -33.28 -11.88 -14.46 -33.66 -11.38 -15.87 -16.25 86.28 63.34 -17.35 85.28 63.69 coo -34.88 -9.77 -20.15 -35.41 -11.60 -19.26 -12.99 90.00 69.08 -14.38 90.57 70.54 coo -34.41 -16.73 -21.11 -35.66 -15.03 -20.96 -16.40 94.43 66.11 -17.63 93.56 67.58 ULMN 3 1qol_c06 PROTEASE (NONSTRUCTURAL PROTEIN P20Auser 7 3 # 7 G 51 ALA D 49 ALA~? 12.11 CE MLY A 135 G 148 HIS D 115 HIS~? 12.18 C21 2PE D 146 G 163 ASP D 56 ASP~? 11.46 C21 2PE D 146 coo -33.28 -11.88 -14.46 -33.66 -11.38 -15.87 -32.13 89.91 15.13 -31.19 90.29 13.98 coo -34.88 -9.77 -20.15 -35.41 -11.60 -19.26 -36.28 90.32 11.92 -37.49 91.98 12.35 coo -34.41 -16.73 -21.11 -35.66 -15.03 -20.96 -41.85 87.81 13.66 -41.61 89.58 14.80 ULMN 3 1qol_c06 PROTEASE (NONSTRUCTURAL PROTEIN P20Auser 8 3 # 8 G 51 ALA D 51 ALA~? 6.92 CG MLY A 135 G 148 HIS D 115 HIS~? 12.18 C21 2PE D 146 G 163 ASP D 56 ASP~? 11.46 C21 2PE D 146 coo -33.28 -11.88 -14.46 -33.66 -11.38 -15.87 -34.62 86.43 18.27 -34.28 87.19 19.52 coo -34.88 -9.77 -20.15 -35.41 -11.60 -19.26 -36.28 90.32 11.92 -37.49 91.98 12.35 coo -34.41 -16.73 -21.11 -35.66 -15.03 -20.96 -41.85 87.81 13.66 -41.61 89.58 14.80 1qol_c06 source 1qol PROTEASE (NONSTRUCTURAL PROTEIN P20A) : 8 hits 1qol_c06 naa= 3 ULMN 3 1qol_c07 PROTEASE (NONSTRUCTURAL PROTEIN P20Auser 1 3 # 1 H 51 ALA A 49 ALA~? 12.15 CD MLY D 135 H 148 HIS A 115 HIS~? 12.27 C21 2PE A 148 H 163 ASP A 56 ASP~? 11.59 C21 2PE A 148 coo -33.97 9.40 -47.46 -34.31 8.55 -46.23 -16.03 49.47 6.19 -14.84 50.27 5.67 coo -35.28 7.86 -41.76 -36.20 9.51 -42.67 -13.18 48.35 10.37 -12.55 46.36 10.33 coo -35.25 15.19 -41.05 -35.81 13.11 -41.05 -16.01 45.89 15.64 -15.93 44.31 14.23 ULMN 3 1qol_c07 PROTEASE (NONSTRUCTURAL PROTEIN P20Auser 2 3 # 2 H 51 ALA A 51 ALA~? 7.23 CD MLY D 135 H 148 HIS A 115 HIS~? 12.27 C21 2PE A 148 H 163 ASP A 56 ASP~? 11.59 C21 2PE A 148 coo -33.97 9.40 -47.46 -34.31 8.55 -46.23 -20.65 48.85 8.75 -21.19 47.91 7.68 coo -35.28 7.86 -41.76 -36.20 9.51 -42.67 -13.18 48.35 10.37 -12.55 46.36 10.33 coo -35.25 15.19 -41.05 -35.81 13.11 -41.05 -16.01 45.89 15.64 -15.93 44.31 14.23 ULMN 3 1qol_c07 PROTEASE (NONSTRUCTURAL PROTEIN P20Auser 3 3 # 3 H 51 ALA B 49 ALA~? 10.91 O1 PEG B 144 H 148 HIS B 115 HIS~? 12.48 C18 PE8 B 148 H 163 ASP B 56 ASP~? 11.45 C20 PE8 B 148 coo -33.97 9.40 -47.46 -34.31 8.55 -46.23 13.56 82.06 32.43 14.35 81.13 33.34 coo -35.28 7.86 -41.76 -36.20 9.51 -42.67 11.86 77.76 30.05 12.70 77.49 28.15 coo -35.25 15.19 -41.05 -35.81 13.11 -41.05 6.80 78.21 26.00 8.47 79.07 25.03 ULMN 3 1qol_c07 PROTEASE (NONSTRUCTURAL PROTEIN P20Auser 4 3 # 4 H 51 ALA B 51 ALA~? 7.25 CG MLY C 135 H 148 HIS B 115 HIS~? 12.48 C18 PE8 B 148 H 163 ASP B 56 ASP~? 11.45 C20 PE8 B 148 coo -33.97 9.40 -47.46 -34.31 8.55 -46.23 9.29 84.92 31.07 10.11 86.09 30.55 coo -35.28 7.86 -41.76 -36.20 9.51 -42.67 11.86 77.76 30.05 12.70 77.49 28.15 coo -35.25 15.19 -41.05 -35.81 13.11 -41.05 6.80 78.21 26.00 8.47 79.07 25.03 ULMN 3 1qol_c07 PROTEASE (NONSTRUCTURAL PROTEIN P20Auser 5 3 # 5 H 51 ALA C 49 ALA~? 6.49 O MLZ C 114 H 148 HIS C 115 HIS~? 4.72 C MLZ C 114 H 163 ASP C 56 ASP~? 9.09 N MLZ C 114 coo -33.97 9.40 -47.46 -34.31 8.55 -46.23 -13.48 85.10 67.69 -12.20 84.83 68.50 coo -35.28 7.86 -41.76 -36.20 9.51 -42.67 -12.99 90.00 69.08 -14.38 90.57 70.54 coo -35.25 15.19 -41.05 -35.81 13.11 -41.05 -16.40 94.43 66.11 -17.63 93.56 67.58 ULMN 3 1qol_c07 PROTEASE (NONSTRUCTURAL PROTEIN P20Auser 6 3 # 6 H 51 ALA C 51 ALA~? 7.46 CD MLY B 135 H 148 HIS C 115 HIS~? 4.72 C MLZ C 114 H 163 ASP C 56 ASP~? 9.09 N MLZ C 114 coo -33.97 9.40 -47.46 -34.31 8.55 -46.23 -16.25 86.28 63.34 -17.35 85.28 63.69 coo -35.28 7.86 -41.76 -36.20 9.51 -42.67 -12.99 90.00 69.08 -14.38 90.57 70.54 coo -35.25 15.19 -41.05 -35.81 13.11 -41.05 -16.40 94.43 66.11 -17.63 93.56 67.58 ULMN 3 1qol_c07 PROTEASE (NONSTRUCTURAL PROTEIN P20Auser 7 3 # 7 H 51 ALA D 49 ALA~? 12.11 CE MLY A 135 H 148 HIS D 115 HIS~? 12.18 C21 2PE D 146 H 163 ASP D 56 ASP~? 11.46 C21 2PE D 146 coo -33.97 9.40 -47.46 -34.31 8.55 -46.23 -32.13 89.91 15.13 -31.19 90.29 13.98 coo -35.28 7.86 -41.76 -36.20 9.51 -42.67 -36.28 90.32 11.92 -37.49 91.98 12.35 coo -35.25 15.19 -41.05 -35.81 13.11 -41.05 -41.85 87.81 13.66 -41.61 89.58 14.80 ULMN 3 1qol_c07 PROTEASE (NONSTRUCTURAL PROTEIN P20Auser 8 3 # 8 H 51 ALA D 51 ALA~? 6.92 CG MLY A 135 H 148 HIS D 115 HIS~? 12.18 C21 2PE D 146 H 163 ASP D 56 ASP~? 11.46 C21 2PE D 146 coo -33.97 9.40 -47.46 -34.31 8.55 -46.23 -34.62 86.43 18.27 -34.28 87.19 19.52 coo -35.28 7.86 -41.76 -36.20 9.51 -42.67 -36.28 90.32 11.92 -37.49 91.98 12.35 coo -35.25 15.19 -41.05 -35.81 13.11 -41.05 -41.85 87.81 13.66 -41.61 89.58 14.80 1qol_c07 source 1qol PROTEASE (NONSTRUCTURAL PROTEIN P20A) : 8 hits 1qol_c07 naa= 3 ULMN 3 1qrz_c12 PLASMINOGEN user 1 3 # 1 A 603 HIS A 4 HIS.? -3.92 C2 GOL A 150s A 646 ASP A 6 ASP.? -3.91 C9 2PE A 148s A 741 SER A 123 SER^? 7.34 C15 2PE A 148 coo -20.72 2.99 34.37 -21.94 1.82 35.61 -11.85 68.18 8.83 -11.23 70.10 8.29 coo -18.83 7.68 26.86 -20.89 7.78 26.56 -8.66 61.41 13.34 -8.76 59.35 12.80 coo -16.10 -1.48 32.49 -17.38 0.37 33.40 -17.01 64.19 8.64 -15.43 63.06 10.12 ULMN 3 1qrz_c12 PLASMINOGEN user 2 3 # 2 A 603 HIS B 4 HIS.? -3.86 O2 GOL B 149s A 646 ASP B 6 ASP.? -3.99 C6 PE8 B 148s A 741 SER B 123 SER^? 7.43 C12 PE8 B 148 coo -20.72 2.99 34.37 -21.94 1.82 35.61 8.07 73.88 49.16 8.30 73.43 51.19 coo -18.83 7.68 26.86 -20.89 7.78 26.56 7.95 70.39 41.39 8.88 71.08 39.61 coo -16.10 -1.48 32.49 -17.38 0.37 33.40 6.88 79.31 45.54 6.79 77.45 43.98 ULMN 3 1qrz_c12 PLASMINOGEN user 3 3 # 3 A 603 HIS C 4 HIS.? -3.73 C3 GOL C 149s A 646 ASP C 6 ASP.? -4.04 C8 PE8 C 148s A 741 SER C 123 SER^? 7.65 C15 PE8 C 148 coo -20.72 2.99 34.37 -21.94 1.82 35.61 4.88 85.81 61.42 6.80 85.00 61.18 coo -18.83 7.68 26.86 -20.89 7.78 26.56 0.53 91.96 65.64 -1.31 91.68 66.68 coo -16.10 -1.48 32.49 -17.38 0.37 33.40 -1.16 84.64 59.13 -1.43 86.65 60.45 ULMN 3 1qrz_c12 PLASMINOGEN user 4 3 # 4 A 603 HIS D 4 HIS.? 4.07 C3 GOL D 147 A 646 ASP D 6 ASP.? -3.77 C8 2PE D 146s A 741 SER D 123 SER^? 7.59 C15 2PE D 146 coo -20.72 2.99 34.37 -21.94 1.82 35.61 -23.57 78.63 1.94 -22.01 77.96 0.72 coo -18.83 7.68 26.86 -20.89 7.78 26.56 -31.03 82.87 1.04 -31.83 84.41 2.29 coo -16.10 -1.48 32.49 -17.38 0.37 33.40 -25.59 78.45 8.19 -27.49 79.37 6.96 1qrz_c12 source 1qrz PLASMINOGEN : 4 hits 1qrz_c12 naa= 3 ULMN 3 1qrz_c13 PLASMINOGEN user 1 3 # 1 B 603 HIS A 4 HIS.? -3.92 C2 GOL A 150s B 646 ASP A 6 ASP.? -3.91 C9 2PE A 148s B 741 SER A 123 SER^? 7.34 C15 2PE A 148 coo -48.36 3.10 -3.91 -49.78 2.04 -2.80 -11.85 68.18 8.83 -11.23 70.10 8.29 coo -46.10 7.71 -10.96 -48.16 8.01 -11.35 -8.66 61.41 13.34 -8.76 59.35 12.80 coo -43.75 -1.60 -6.12 -44.85 0.33 -5.15 -17.01 64.19 8.64 -15.43 63.06 10.12 ULMN 3 1qrz_c13 PLASMINOGEN user 2 3 # 2 B 603 HIS B 4 HIS.? -3.86 O2 GOL B 149s B 646 ASP B 6 ASP.? -3.99 C6 PE8 B 148s B 741 SER B 123 SER^? 7.43 C12 PE8 B 148 coo -48.36 3.10 -3.91 -49.78 2.04 -2.80 8.07 73.88 49.16 8.30 73.43 51.19 coo -46.10 7.71 -10.96 -48.16 8.01 -11.35 7.95 70.39 41.39 8.88 71.08 39.61 coo -43.75 -1.60 -6.12 -44.85 0.33 -5.15 6.88 79.31 45.54 6.79 77.45 43.98 ULMN 3 1qrz_c13 PLASMINOGEN user 3 3 # 3 B 603 HIS C 4 HIS.? -3.73 C3 GOL C 149s B 646 ASP C 6 ASP.? -4.04 C8 PE8 C 148s B 741 SER C 123 SER^? 7.65 C15 PE8 C 148 coo -48.36 3.10 -3.91 -49.78 2.04 -2.80 4.88 85.81 61.42 6.80 85.00 61.18 coo -46.10 7.71 -10.96 -48.16 8.01 -11.35 0.53 91.96 65.64 -1.31 91.68 66.68 coo -43.75 -1.60 -6.12 -44.85 0.33 -5.15 -1.16 84.64 59.13 -1.43 86.65 60.45 ULMN 3 1qrz_c13 PLASMINOGEN user 4 3 # 4 B 603 HIS D 4 HIS.? 4.07 C3 GOL D 147 B 646 ASP D 6 ASP.? -3.77 C8 2PE D 146s B 741 SER D 123 SER^? 7.59 C15 2PE D 146 coo -48.36 3.10 -3.91 -49.78 2.04 -2.80 -23.57 78.63 1.94 -22.01 77.96 0.72 coo -46.10 7.71 -10.96 -48.16 8.01 -11.35 -31.03 82.87 1.04 -31.83 84.41 2.29 coo -43.75 -1.60 -6.12 -44.85 0.33 -5.15 -25.59 78.45 8.19 -27.49 79.37 6.96 1qrz_c13 source 1qrz PLASMINOGEN : 4 hits 1qrz_c13 naa= 3 ULMN 3 1qrz_c14 PLASMINOGEN user 1 3 # 1 C 603 HIS A 4 HIS.? -3.92 C2 GOL A 150s C 646 ASP A 6 ASP.? -3.91 C9 2PE A 148s C 741 SER A 123 SER^? 7.34 C15 2PE A 148 coo 1.49 -9.23 8.48 -0.19 -8.40 9.43 -11.85 68.18 8.83 -11.23 70.10 8.29 coo 9.05 -13.82 8.74 8.78 -14.02 10.85 -8.66 61.41 13.34 -8.76 59.35 12.80 coo 4.71 -4.57 4.71 3.58 -6.49 5.69 -17.01 64.19 8.64 -15.43 63.06 10.12 ULMN 3 1qrz_c14 PLASMINOGEN user 2 3 # 2 C 603 HIS B 4 HIS.? -3.86 O2 GOL B 149s C 646 ASP B 6 ASP.? -3.99 C6 PE8 B 148s C 741 SER B 123 SER^? 7.43 C12 PE8 B 148 coo 1.49 -9.23 8.48 -0.19 -8.40 9.43 8.07 73.88 49.16 8.30 73.43 51.19 coo 9.05 -13.82 8.74 8.78 -14.02 10.85 7.95 70.39 41.39 8.88 71.08 39.61 coo 4.71 -4.57 4.71 3.58 -6.49 5.69 6.88 79.31 45.54 6.79 77.45 43.98 ULMN 3 1qrz_c14 PLASMINOGEN user 3 3 # 3 C 603 HIS C 4 HIS.? -3.73 C3 GOL C 149s C 646 ASP C 6 ASP.? -4.04 C8 PE8 C 148s C 741 SER C 123 SER^? 7.65 C15 PE8 C 148 coo 1.49 -9.23 8.48 -0.19 -8.40 9.43 4.88 85.81 61.42 6.80 85.00 61.18 coo 9.05 -13.82 8.74 8.78 -14.02 10.85 0.53 91.96 65.64 -1.31 91.68 66.68 coo 4.71 -4.57 4.71 3.58 -6.49 5.69 -1.16 84.64 59.13 -1.43 86.65 60.45 ULMN 3 1qrz_c14 PLASMINOGEN user 4 3 # 4 C 603 HIS D 4 HIS.? 4.07 C3 GOL D 147 C 646 ASP D 6 ASP.? -3.77 C8 2PE D 146s C 741 SER D 123 SER^? 7.59 C15 2PE D 146 coo 1.49 -9.23 8.48 -0.19 -8.40 9.43 -23.57 78.63 1.94 -22.01 77.96 0.72 coo 9.05 -13.82 8.74 8.78 -14.02 10.85 -31.03 82.87 1.04 -31.83 84.41 2.29 coo 4.71 -4.57 4.71 3.58 -6.49 5.69 -25.59 78.45 8.19 -27.49 79.37 6.96 1qrz_c14 source 1qrz PLASMINOGEN : 4 hits 1qrz_c14 naa= 3 ULMN 3 1qrz_c15 PLASMINOGEN user 1 3 # 1 D 603 HIS A 4 HIS.? -3.92 C2 GOL A 150s D 646 ASP A 6 ASP.? -3.91 C9 2PE A 148s D 741 SER A 123 SER^? 7.34 C15 2PE A 148 coo -52.57 -8.94 46.70 -54.06 -7.64 47.39 -11.85 68.18 8.83 -11.23 70.10 8.29 coo -45.30 -14.04 46.94 -45.65 -14.15 49.00 -8.66 61.41 13.34 -8.76 59.35 12.80 coo -49.16 -4.56 43.16 -50.44 -6.45 43.96 -17.01 64.19 8.64 -15.43 63.06 10.12 ULMN 3 1qrz_c15 PLASMINOGEN user 2 3 # 2 D 603 HIS B 4 HIS.? -3.86 O2 GOL B 149s D 646 ASP B 6 ASP.? -3.99 C6 PE8 B 148s D 741 SER B 123 SER^? 7.43 C12 PE8 B 148 coo -52.57 -8.94 46.70 -54.06 -7.64 47.39 8.07 73.88 49.16 8.30 73.43 51.19 coo -45.30 -14.04 46.94 -45.65 -14.15 49.00 7.95 70.39 41.39 8.88 71.08 39.61 coo -49.16 -4.56 43.16 -50.44 -6.45 43.96 6.88 79.31 45.54 6.79 77.45 43.98 ULMN 3 1qrz_c15 PLASMINOGEN user 3 3 # 3 D 603 HIS C 4 HIS.? -3.73 C3 GOL C 149s D 646 ASP C 6 ASP.? -4.04 C8 PE8 C 148s D 741 SER C 123 SER^? 7.65 C15 PE8 C 148 coo -52.57 -8.94 46.70 -54.06 -7.64 47.39 4.88 85.81 61.42 6.80 85.00 61.18 coo -45.30 -14.04 46.94 -45.65 -14.15 49.00 0.53 91.96 65.64 -1.31 91.68 66.68 coo -49.16 -4.56 43.16 -50.44 -6.45 43.96 -1.16 84.64 59.13 -1.43 86.65 60.45 ULMN 3 1qrz_c15 PLASMINOGEN user 4 3 # 4 D 603 HIS D 4 HIS.? 4.07 C3 GOL D 147 D 646 ASP D 6 ASP.? -3.77 C8 2PE D 146s D 741 SER D 123 SER^? 7.59 C15 2PE D 146 coo -52.57 -8.94 46.70 -54.06 -7.64 47.39 -23.57 78.63 1.94 -22.01 77.96 0.72 coo -45.30 -14.04 46.94 -45.65 -14.15 49.00 -31.03 82.87 1.04 -31.83 84.41 2.29 coo -49.16 -4.56 43.16 -50.44 -6.45 43.96 -25.59 78.45 8.19 -27.49 79.37 6.96 1qrz_c15 source 1qrz PLASMINOGEN : 4 hits 1qrz_c15 naa= 3 ULMN 3 1qrz_c20 PLASMINOGEN user 1 3 # 1 A 603 HIS A 85 HIS.? 6.69 C5 PGE A 147 A 646 ASP A 122 ASP^? 7.46 C1 GOL A 150 A 739 GLY A 72 GLY.? 8.27 O MLY D 135 coo -20.72 2.99 34.37 -21.94 1.82 35.61 -23.05 64.43 -0.55 -21.68 63.00 -1.25 coo -18.83 7.68 26.86 -20.89 7.78 26.56 -15.41 64.92 4.51 -15.09 66.83 5.33 coo -13.44 -7.35 30.08 -14.24 -7.41 30.34 -31.88 60.72 9.60 -31.18 60.35 9.56 ULMN 3 1qrz_c20 PLASMINOGEN user 2 3 # 2 A 603 HIS A 85 HIS.? 6.69 C5 PGE A 147 A 646 ASP A 122 ASP^? 7.46 C1 GOL A 150 A 739 GLY A 80 GLY.? 7.76 C1 GOL D 147 coo -20.72 2.99 34.37 -21.94 1.82 35.61 -23.05 64.43 -0.55 -21.68 63.00 -1.25 coo -18.83 7.68 26.86 -20.89 7.78 26.56 -15.41 64.92 4.51 -15.09 66.83 5.33 coo -13.44 -7.35 30.08 -14.24 -7.41 30.34 -25.41 75.48 2.13 -25.84 75.58 1.39 ULMN 3 1qrz_c20 PLASMINOGEN user 3 3 # 3 A 603 HIS B 85 HIS.? 6.66 C6 PGE B 147 A 646 ASP B 87 ASP.? 8.94 O4 PGE B 147 A 739 GLY B 80 GLY.? 7.38 C3 GOL C 149 coo -20.72 2.99 34.37 -21.94 1.82 35.61 11.11 88.86 48.90 12.76 88.34 47.73 coo -18.83 7.68 26.86 -20.89 7.78 26.56 9.49 87.97 42.02 11.31 87.98 43.09 coo -13.44 -7.35 30.08 -14.24 -7.41 30.34 4.67 87.66 58.38 5.02 88.38 58.71 ULMN 3 1qrz_c20 PLASMINOGEN user 4 3 # 4 A 603 HIS B 85 HIS.? 6.66 C6 PGE B 147 A 646 ASP B 122 ASP^? 7.33 O2 GOL B 149 A 739 GLY B 72 GLY.? 3.37 O MLZ C 129 coo -20.72 2.99 34.37 -21.94 1.82 35.61 11.11 88.86 48.90 12.76 88.34 47.73 coo -18.83 7.68 26.86 -20.89 7.78 26.56 10.89 79.68 47.57 9.75 78.80 49.16 coo -13.44 -7.35 30.08 -14.24 -7.41 30.34 -0.49 92.37 42.04 0.02 91.83 41.70 ULMN 3 1qrz_c20 PLASMINOGEN user 5 3 # 5 A 603 HIS B 85 HIS.? 6.66 C6 PGE B 147 A 646 ASP B 122 ASP^? 7.33 O2 GOL B 149 A 739 GLY B 80 GLY.? 7.38 C3 GOL C 149 coo -20.72 2.99 34.37 -21.94 1.82 35.61 11.11 88.86 48.90 12.76 88.34 47.73 coo -18.83 7.68 26.86 -20.89 7.78 26.56 10.89 79.68 47.57 9.75 78.80 49.16 coo -13.44 -7.35 30.08 -14.24 -7.41 30.34 4.67 87.66 58.38 5.02 88.38 58.71 ULMN 3 1qrz_c20 PLASMINOGEN user 6 3 # 6 A 603 HIS C 85 HIS.? 6.34 C1 PGE C 147 A 646 ASP C 122 ASP^? 7.22 C3 GOL C 149 A 739 GLY C 72 GLY.? 8.73 CH1 MLY B 135 coo -20.72 2.99 34.37 -21.94 1.82 35.61 -4.08 74.18 57.17 -4.69 74.12 59.17 coo -18.83 7.68 26.86 -20.89 7.78 26.56 0.27 81.12 61.60 2.07 81.54 60.53 coo -13.44 -7.35 30.08 -14.24 -7.41 30.34 -11.64 81.75 48.16 -11.60 81.98 48.95 ULMN 3 1qrz_c20 PLASMINOGEN user 7 3 # 7 A 603 HIS C 85 HIS.? 6.34 C1 PGE C 147 A 646 ASP C 122 ASP^? 7.22 C3 GOL C 149 A 739 GLY C 80 GLY.? 7.77 O2 GOL B 149 coo -20.72 2.99 34.37 -21.94 1.82 35.61 -4.08 74.18 57.17 -4.69 74.12 59.17 coo -18.83 7.68 26.86 -20.89 7.78 26.56 0.27 81.12 61.60 2.07 81.54 60.53 coo -13.44 -7.35 30.08 -14.24 -7.41 30.34 4.31 74.26 49.15 4.26 73.42 48.97 ULMN 3 1qrz_c20 PLASMINOGEN user 8 3 # 8 A 603 HIS D 85 HIS.? 4.73 OH7 1PE B 150 A 646 ASP D 122 ASP^? 7.49 C3 GOL D 147 A 739 GLY D 72 GLY.? 3.28 O MLZ A 129 coo -20.72 2.99 34.37 -21.94 1.82 35.61 -18.08 79.12 16.04 -18.14 81.21 15.79 coo -18.83 7.68 26.86 -20.89 7.78 26.56 -21.82 80.90 7.85 -21.38 79.32 6.51 coo -13.44 -7.35 30.08 -14.24 -7.41 30.34 -28.40 71.61 21.66 -28.57 72.28 21.25 ULMN 3 1qrz_c20 PLASMINOGEN user 9 3 # 9 A 603 HIS D 85 HIS.? 4.73 OH7 1PE B 150 A 646 ASP D 122 ASP^? 7.49 C3 GOL D 147 A 739 GLY D 80 GLY.? 7.47 C2 GOL A 150 coo -20.72 2.99 34.37 -21.94 1.82 35.61 -18.08 79.12 16.04 -18.14 81.21 15.79 coo -18.83 7.68 26.86 -20.89 7.78 26.56 -21.82 80.90 7.85 -21.38 79.32 6.51 coo -13.44 -7.35 30.08 -14.24 -7.41 30.34 -13.78 69.07 11.78 -13.14 69.11 12.34 1qrz_c20 source 1qrz PLASMINOGEN : 9 hits 1qrz_c20 naa= 3 ULMN 3 1qrz_c21 PLASMINOGEN user 1 3 # 1 B 603 HIS A 85 HIS.? 6.69 C5 PGE A 147 B 646 ASP A 87 ASP.? 8.49 C6 PGE A 147 B 739 GLY A 80 GLY.? 7.76 C1 GOL D 147 coo -48.36 3.10 -3.91 -49.78 2.04 -2.80 -23.05 64.43 -0.55 -21.68 63.00 -1.25 coo -46.10 7.71 -10.96 -48.16 8.01 -11.35 -23.17 58.67 3.55 -22.34 59.17 1.69 coo -41.48 -7.57 -8.71 -42.26 -7.67 -8.41 -25.41 75.48 2.13 -25.84 75.58 1.39 ULMN 3 1qrz_c21 PLASMINOGEN user 2 3 # 2 B 603 HIS A 85 HIS.? 6.69 C5 PGE A 147 B 646 ASP A 122 ASP^? 7.46 C1 GOL A 150 B 739 GLY A 72 GLY.? 8.27 O MLY D 135 coo -48.36 3.10 -3.91 -49.78 2.04 -2.80 -23.05 64.43 -0.55 -21.68 63.00 -1.25 coo -46.10 7.71 -10.96 -48.16 8.01 -11.35 -15.41 64.92 4.51 -15.09 66.83 5.33 coo -41.48 -7.57 -8.71 -42.26 -7.67 -8.41 -31.88 60.72 9.60 -31.18 60.35 9.56 ULMN 3 1qrz_c21 PLASMINOGEN user 3 3 # 3 B 603 HIS A 85 HIS.? 6.69 C5 PGE A 147 B 646 ASP A 122 ASP^? 7.46 C1 GOL A 150 B 739 GLY A 80 GLY.? 7.76 C1 GOL D 147 coo -48.36 3.10 -3.91 -49.78 2.04 -2.80 -23.05 64.43 -0.55 -21.68 63.00 -1.25 coo -46.10 7.71 -10.96 -48.16 8.01 -11.35 -15.41 64.92 4.51 -15.09 66.83 5.33 coo -41.48 -7.57 -8.71 -42.26 -7.67 -8.41 -25.41 75.48 2.13 -25.84 75.58 1.39 ULMN 3 1qrz_c21 PLASMINOGEN user 4 3 # 4 B 603 HIS B 85 HIS.? 6.66 C6 PGE B 147 B 646 ASP B 122 ASP^? 7.33 O2 GOL B 149 B 739 GLY B 72 GLY.? 3.37 O MLZ C 129 coo -48.36 3.10 -3.91 -49.78 2.04 -2.80 11.11 88.86 48.90 12.76 88.34 47.73 coo -46.10 7.71 -10.96 -48.16 8.01 -11.35 10.89 79.68 47.57 9.75 78.80 49.16 coo -41.48 -7.57 -8.71 -42.26 -7.67 -8.41 -0.49 92.37 42.04 0.02 91.83 41.70 ULMN 3 1qrz_c21 PLASMINOGEN user 5 3 # 5 B 603 HIS C 85 HIS.? 6.34 C1 PGE C 147 B 646 ASP C 87 ASP.? 8.84 O1 PGE C 147 B 739 GLY C 80 GLY.? 7.77 O2 GOL B 149 coo -48.36 3.10 -3.91 -49.78 2.04 -2.80 -4.08 74.18 57.17 -4.69 74.12 59.17 coo -46.10 7.71 -10.96 -48.16 8.01 -11.35 -9.03 79.00 58.44 -8.21 77.39 59.55 coo -41.48 -7.57 -8.71 -42.26 -7.67 -8.41 4.31 74.26 49.15 4.26 73.42 48.97 ULMN 3 1qrz_c21 PLASMINOGEN user 6 3 # 6 B 603 HIS C 85 HIS.? 6.34 C1 PGE C 147 B 646 ASP C 122 ASP^? 7.22 C3 GOL C 149 B 739 GLY C 72 GLY.? 8.73 CH1 MLY B 135 coo -48.36 3.10 -3.91 -49.78 2.04 -2.80 -4.08 74.18 57.17 -4.69 74.12 59.17 coo -46.10 7.71 -10.96 -48.16 8.01 -11.35 0.27 81.12 61.60 2.07 81.54 60.53 coo -41.48 -7.57 -8.71 -42.26 -7.67 -8.41 -11.64 81.75 48.16 -11.60 81.98 48.95 ULMN 3 1qrz_c21 PLASMINOGEN user 7 3 # 7 B 603 HIS C 85 HIS.? 6.34 C1 PGE C 147 B 646 ASP C 122 ASP^? 7.22 C3 GOL C 149 B 739 GLY C 80 GLY.? 7.77 O2 GOL B 149 coo -48.36 3.10 -3.91 -49.78 2.04 -2.80 -4.08 74.18 57.17 -4.69 74.12 59.17 coo -46.10 7.71 -10.96 -48.16 8.01 -11.35 0.27 81.12 61.60 2.07 81.54 60.53 coo -41.48 -7.57 -8.71 -42.26 -7.67 -8.41 4.31 74.26 49.15 4.26 73.42 48.97 ULMN 3 1qrz_c21 PLASMINOGEN user 8 3 # 8 B 603 HIS D 85 HIS.? 4.73 OH7 1PE B 150 B 646 ASP D 87 ASP.? 7.26 C16 1PE B 150 B 739 GLY D 80 GLY.? 7.47 C2 GOL A 150 coo -48.36 3.10 -3.91 -49.78 2.04 -2.80 -18.08 79.12 16.04 -18.14 81.21 15.79 coo -46.10 7.71 -10.96 -48.16 8.01 -11.35 -24.70 80.89 17.41 -22.90 81.94 17.31 coo -41.48 -7.57 -8.71 -42.26 -7.67 -8.41 -13.78 69.07 11.78 -13.14 69.11 12.34 ULMN 3 1qrz_c21 PLASMINOGEN user 9 3 # 9 B 603 HIS D 85 HIS.? 4.73 OH7 1PE B 150 B 646 ASP D 122 ASP^? 7.49 C3 GOL D 147 B 739 GLY D 72 GLY.? 3.28 O MLZ A 129 coo -48.36 3.10 -3.91 -49.78 2.04 -2.80 -18.08 79.12 16.04 -18.14 81.21 15.79 coo -46.10 7.71 -10.96 -48.16 8.01 -11.35 -21.82 80.90 7.85 -21.38 79.32 6.51 coo -41.48 -7.57 -8.71 -42.26 -7.67 -8.41 -28.40 71.61 21.66 -28.57 72.28 21.25 ULMN 3 1qrz_c21 PLASMINOGEN user 10 3 # 10 B 603 HIS D 85 HIS.? 4.73 OH7 1PE B 150 B 646 ASP D 122 ASP^? 7.49 C3 GOL D 147 B 739 GLY D 80 GLY.? 7.47 C2 GOL A 150 coo -48.36 3.10 -3.91 -49.78 2.04 -2.80 -18.08 79.12 16.04 -18.14 81.21 15.79 coo -46.10 7.71 -10.96 -48.16 8.01 -11.35 -21.82 80.90 7.85 -21.38 79.32 6.51 coo -41.48 -7.57 -8.71 -42.26 -7.67 -8.41 -13.78 69.07 11.78 -13.14 69.11 12.34 1qrz_c21 source 1qrz PLASMINOGEN : 10 hits 1qrz_c21 naa= 3 ULMN 3 1qrz_c22 PLASMINOGEN user 1 3 # 1 C 603 HIS A 85 HIS.? 6.69 C5 PGE A 147 C 646 ASP A 87 ASP.? 8.49 C6 PGE A 147 C 739 GLY A 80 GLY.? 7.76 C1 GOL D 147 coo 1.49 -9.23 8.48 -0.19 -8.40 9.43 -23.05 64.43 -0.55 -21.68 63.00 -1.25 coo 9.05 -13.82 8.74 8.78 -14.02 10.85 -23.17 58.67 3.55 -22.34 59.17 1.69 coo 7.82 1.25 3.03 7.30 1.31 3.65 -25.41 75.48 2.13 -25.84 75.58 1.39 ULMN 3 1qrz_c22 PLASMINOGEN user 2 3 # 2 C 603 HIS A 85 HIS.? 6.69 C5 PGE A 147 C 646 ASP A 122 ASP^? 7.46 C1 GOL A 150 C 739 GLY A 72 GLY.? 8.27 O MLY D 135 coo 1.49 -9.23 8.48 -0.19 -8.40 9.43 -23.05 64.43 -0.55 -21.68 63.00 -1.25 coo 9.05 -13.82 8.74 8.78 -14.02 10.85 -15.41 64.92 4.51 -15.09 66.83 5.33 coo 7.82 1.25 3.03 7.30 1.31 3.65 -31.88 60.72 9.60 -31.18 60.35 9.56 ULMN 3 1qrz_c22 PLASMINOGEN user 3 3 # 3 C 603 HIS A 85 HIS.? 6.69 C5 PGE A 147 C 646 ASP A 122 ASP^? 7.46 C1 GOL A 150 C 739 GLY A 80 GLY.? 7.76 C1 GOL D 147 coo 1.49 -9.23 8.48 -0.19 -8.40 9.43 -23.05 64.43 -0.55 -21.68 63.00 -1.25 coo 9.05 -13.82 8.74 8.78 -14.02 10.85 -15.41 64.92 4.51 -15.09 66.83 5.33 coo 7.82 1.25 3.03 7.30 1.31 3.65 -25.41 75.48 2.13 -25.84 75.58 1.39 ULMN 3 1qrz_c22 PLASMINOGEN user 4 3 # 4 C 603 HIS B 85 HIS.? 6.66 C6 PGE B 147 C 646 ASP B 87 ASP.? 8.94 O4 PGE B 147 C 739 GLY B 80 GLY.? 7.38 C3 GOL C 149 coo 1.49 -9.23 8.48 -0.19 -8.40 9.43 11.11 88.86 48.90 12.76 88.34 47.73 coo 9.05 -13.82 8.74 8.78 -14.02 10.85 9.49 87.97 42.02 11.31 87.98 43.09 coo 7.82 1.25 3.03 7.30 1.31 3.65 4.67 87.66 58.38 5.02 88.38 58.71 ULMN 3 1qrz_c22 PLASMINOGEN user 5 3 # 5 C 603 HIS B 85 HIS.? 6.66 C6 PGE B 147 C 646 ASP B 122 ASP^? 7.33 O2 GOL B 149 C 739 GLY B 72 GLY.? 3.37 O MLZ C 129 coo 1.49 -9.23 8.48 -0.19 -8.40 9.43 11.11 88.86 48.90 12.76 88.34 47.73 coo 9.05 -13.82 8.74 8.78 -14.02 10.85 10.89 79.68 47.57 9.75 78.80 49.16 coo 7.82 1.25 3.03 7.30 1.31 3.65 -0.49 92.37 42.04 0.02 91.83 41.70 ULMN 3 1qrz_c22 PLASMINOGEN user 6 3 # 6 C 603 HIS B 85 HIS.? 6.66 C6 PGE B 147 C 646 ASP B 122 ASP^? 7.33 O2 GOL B 149 C 739 GLY B 80 GLY.? 7.38 C3 GOL C 149 coo 1.49 -9.23 8.48 -0.19 -8.40 9.43 11.11 88.86 48.90 12.76 88.34 47.73 coo 9.05 -13.82 8.74 8.78 -14.02 10.85 10.89 79.68 47.57 9.75 78.80 49.16 coo 7.82 1.25 3.03 7.30 1.31 3.65 4.67 87.66 58.38 5.02 88.38 58.71 ULMN 3 1qrz_c22 PLASMINOGEN user 7 3 # 7 C 603 HIS C 85 HIS.? 6.34 C1 PGE C 147 C 646 ASP C 87 ASP.? 8.84 O1 PGE C 147 C 739 GLY C 80 GLY.? 7.77 O2 GOL B 149 coo 1.49 -9.23 8.48 -0.19 -8.40 9.43 -4.08 74.18 57.17 -4.69 74.12 59.17 coo 9.05 -13.82 8.74 8.78 -14.02 10.85 -9.03 79.00 58.44 -8.21 77.39 59.55 coo 7.82 1.25 3.03 7.30 1.31 3.65 4.31 74.26 49.15 4.26 73.42 48.97 ULMN 3 1qrz_c22 PLASMINOGEN user 8 3 # 8 C 603 HIS C 85 HIS.? 6.34 C1 PGE C 147 C 646 ASP C 122 ASP^? 7.22 C3 GOL C 149 C 739 GLY C 72 GLY.? 8.73 CH1 MLY B 135 coo 1.49 -9.23 8.48 -0.19 -8.40 9.43 -4.08 74.18 57.17 -4.69 74.12 59.17 coo 9.05 -13.82 8.74 8.78 -14.02 10.85 0.27 81.12 61.60 2.07 81.54 60.53 coo 7.82 1.25 3.03 7.30 1.31 3.65 -11.64 81.75 48.16 -11.60 81.98 48.95 ULMN 3 1qrz_c22 PLASMINOGEN user 9 3 # 9 C 603 HIS C 85 HIS.? 6.34 C1 PGE C 147 C 646 ASP C 122 ASP^? 7.22 C3 GOL C 149 C 739 GLY C 80 GLY.? 7.77 O2 GOL B 149 coo 1.49 -9.23 8.48 -0.19 -8.40 9.43 -4.08 74.18 57.17 -4.69 74.12 59.17 coo 9.05 -13.82 8.74 8.78 -14.02 10.85 0.27 81.12 61.60 2.07 81.54 60.53 coo 7.82 1.25 3.03 7.30 1.31 3.65 4.31 74.26 49.15 4.26 73.42 48.97 ULMN 3 1qrz_c22 PLASMINOGEN user 10 3 # 10 C 603 HIS D 85 HIS.? 4.73 OH7 1PE B 150 C 646 ASP D 87 ASP.? 7.26 C16 1PE B 150 C 739 GLY D 80 GLY.? 7.47 C2 GOL A 150 coo 1.49 -9.23 8.48 -0.19 -8.40 9.43 -18.08 79.12 16.04 -18.14 81.21 15.79 coo 9.05 -13.82 8.74 8.78 -14.02 10.85 -24.70 80.89 17.41 -22.90 81.94 17.31 coo 7.82 1.25 3.03 7.30 1.31 3.65 -13.78 69.07 11.78 -13.14 69.11 12.34 ULMN 3 1qrz_c22 PLASMINOGEN user 11 3 # 11 C 603 HIS D 85 HIS.? 4.73 OH7 1PE B 150 C 646 ASP D 122 ASP^? 7.49 C3 GOL D 147 C 739 GLY D 72 GLY.? 3.28 O MLZ A 129 coo 1.49 -9.23 8.48 -0.19 -8.40 9.43 -18.08 79.12 16.04 -18.14 81.21 15.79 coo 9.05 -13.82 8.74 8.78 -14.02 10.85 -21.82 80.90 7.85 -21.38 79.32 6.51 coo 7.82 1.25 3.03 7.30 1.31 3.65 -28.40 71.61 21.66 -28.57 72.28 21.25 ULMN 3 1qrz_c22 PLASMINOGEN user 12 3 # 12 C 603 HIS D 85 HIS.? 4.73 OH7 1PE B 150 C 646 ASP D 122 ASP^? 7.49 C3 GOL D 147 C 739 GLY D 80 GLY.? 7.47 C2 GOL A 150 coo 1.49 -9.23 8.48 -0.19 -8.40 9.43 -18.08 79.12 16.04 -18.14 81.21 15.79 coo 9.05 -13.82 8.74 8.78 -14.02 10.85 -21.82 80.90 7.85 -21.38 79.32 6.51 coo 7.82 1.25 3.03 7.30 1.31 3.65 -13.78 69.07 11.78 -13.14 69.11 12.34 1qrz_c22 source 1qrz PLASMINOGEN : 12 hits 1qrz_c22 naa= 3 ULMN 3 1qrz_c23 PLASMINOGEN user 1 3 # 1 D 603 HIS A 85 HIS.? 6.69 C5 PGE A 147 D 646 ASP A 87 ASP.? 8.49 C6 PGE A 147 D 739 GLY A 80 GLY.? 7.76 C1 GOL D 147 coo -52.57 -8.94 46.70 -54.06 -7.64 47.39 -23.05 64.43 -0.55 -21.68 63.00 -1.25 coo -45.30 -14.04 46.94 -45.65 -14.15 49.00 -23.17 58.67 3.55 -22.34 59.17 1.69 coo -45.82 1.31 41.67 -46.38 1.39 42.31 -25.41 75.48 2.13 -25.84 75.58 1.39 ULMN 3 1qrz_c23 PLASMINOGEN user 2 3 # 2 D 603 HIS A 85 HIS.? 6.69 C5 PGE A 147 D 646 ASP A 122 ASP^? 7.46 C1 GOL A 150 D 739 GLY A 72 GLY.? 8.27 O MLY D 135 coo -52.57 -8.94 46.70 -54.06 -7.64 47.39 -23.05 64.43 -0.55 -21.68 63.00 -1.25 coo -45.30 -14.04 46.94 -45.65 -14.15 49.00 -15.41 64.92 4.51 -15.09 66.83 5.33 coo -45.82 1.31 41.67 -46.38 1.39 42.31 -31.88 60.72 9.60 -31.18 60.35 9.56 ULMN 3 1qrz_c23 PLASMINOGEN user 3 3 # 3 D 603 HIS A 85 HIS.? 6.69 C5 PGE A 147 D 646 ASP A 122 ASP^? 7.46 C1 GOL A 150 D 739 GLY A 80 GLY.? 7.76 C1 GOL D 147 coo -52.57 -8.94 46.70 -54.06 -7.64 47.39 -23.05 64.43 -0.55 -21.68 63.00 -1.25 coo -45.30 -14.04 46.94 -45.65 -14.15 49.00 -15.41 64.92 4.51 -15.09 66.83 5.33 coo -45.82 1.31 41.67 -46.38 1.39 42.31 -25.41 75.48 2.13 -25.84 75.58 1.39 ULMN 3 1qrz_c23 PLASMINOGEN user 4 3 # 4 D 603 HIS B 85 HIS.? 6.66 C6 PGE B 147 D 646 ASP B 87 ASP.? 8.94 O4 PGE B 147 D 739 GLY B 80 GLY.? 7.38 C3 GOL C 149 coo -52.57 -8.94 46.70 -54.06 -7.64 47.39 11.11 88.86 48.90 12.76 88.34 47.73 coo -45.30 -14.04 46.94 -45.65 -14.15 49.00 9.49 87.97 42.02 11.31 87.98 43.09 coo -45.82 1.31 41.67 -46.38 1.39 42.31 4.67 87.66 58.38 5.02 88.38 58.71 ULMN 3 1qrz_c23 PLASMINOGEN user 5 3 # 5 D 603 HIS B 85 HIS.? 6.66 C6 PGE B 147 D 646 ASP B 122 ASP^? 7.33 O2 GOL B 149 D 739 GLY B 72 GLY.? 3.37 O MLZ C 129 coo -52.57 -8.94 46.70 -54.06 -7.64 47.39 11.11 88.86 48.90 12.76 88.34 47.73 coo -45.30 -14.04 46.94 -45.65 -14.15 49.00 10.89 79.68 47.57 9.75 78.80 49.16 coo -45.82 1.31 41.67 -46.38 1.39 42.31 -0.49 92.37 42.04 0.02 91.83 41.70 ULMN 3 1qrz_c23 PLASMINOGEN user 6 3 # 6 D 603 HIS B 85 HIS.? 6.66 C6 PGE B 147 D 646 ASP B 122 ASP^? 7.33 O2 GOL B 149 D 739 GLY B 80 GLY.? 7.38 C3 GOL C 149 coo -52.57 -8.94 46.70 -54.06 -7.64 47.39 11.11 88.86 48.90 12.76 88.34 47.73 coo -45.30 -14.04 46.94 -45.65 -14.15 49.00 10.89 79.68 47.57 9.75 78.80 49.16 coo -45.82 1.31 41.67 -46.38 1.39 42.31 4.67 87.66 58.38 5.02 88.38 58.71 ULMN 3 1qrz_c23 PLASMINOGEN user 7 3 # 7 D 603 HIS C 85 HIS.? 6.34 C1 PGE C 147 D 646 ASP C 87 ASP.? 8.84 O1 PGE C 147 D 739 GLY C 80 GLY.? 7.77 O2 GOL B 149 coo -52.57 -8.94 46.70 -54.06 -7.64 47.39 -4.08 74.18 57.17 -4.69 74.12 59.17 coo -45.30 -14.04 46.94 -45.65 -14.15 49.00 -9.03 79.00 58.44 -8.21 77.39 59.55 coo -45.82 1.31 41.67 -46.38 1.39 42.31 4.31 74.26 49.15 4.26 73.42 48.97 ULMN 3 1qrz_c23 PLASMINOGEN user 8 3 # 8 D 603 HIS C 85 HIS.? 6.34 C1 PGE C 147 D 646 ASP C 122 ASP^? 7.22 C3 GOL C 149 D 739 GLY C 72 GLY.? 8.73 CH1 MLY B 135 coo -52.57 -8.94 46.70 -54.06 -7.64 47.39 -4.08 74.18 57.17 -4.69 74.12 59.17 coo -45.30 -14.04 46.94 -45.65 -14.15 49.00 0.27 81.12 61.60 2.07 81.54 60.53 coo -45.82 1.31 41.67 -46.38 1.39 42.31 -11.64 81.75 48.16 -11.60 81.98 48.95 ULMN 3 1qrz_c23 PLASMINOGEN user 9 3 # 9 D 603 HIS C 85 HIS.? 6.34 C1 PGE C 147 D 646 ASP C 122 ASP^? 7.22 C3 GOL C 149 D 739 GLY C 80 GLY.? 7.77 O2 GOL B 149 coo -52.57 -8.94 46.70 -54.06 -7.64 47.39 -4.08 74.18 57.17 -4.69 74.12 59.17 coo -45.30 -14.04 46.94 -45.65 -14.15 49.00 0.27 81.12 61.60 2.07 81.54 60.53 coo -45.82 1.31 41.67 -46.38 1.39 42.31 4.31 74.26 49.15 4.26 73.42 48.97 ULMN 3 1qrz_c23 PLASMINOGEN user 10 3 # 10 D 603 HIS D 85 HIS.? 4.73 OH7 1PE B 150 D 646 ASP D 87 ASP.? 7.26 C16 1PE B 150 D 739 GLY D 80 GLY.? 7.47 C2 GOL A 150 coo -52.57 -8.94 46.70 -54.06 -7.64 47.39 -18.08 79.12 16.04 -18.14 81.21 15.79 coo -45.30 -14.04 46.94 -45.65 -14.15 49.00 -24.70 80.89 17.41 -22.90 81.94 17.31 coo -45.82 1.31 41.67 -46.38 1.39 42.31 -13.78 69.07 11.78 -13.14 69.11 12.34 ULMN 3 1qrz_c23 PLASMINOGEN user 11 3 # 11 D 603 HIS D 85 HIS.? 4.73 OH7 1PE B 150 D 646 ASP D 122 ASP^? 7.49 C3 GOL D 147 D 739 GLY D 72 GLY.? 3.28 O MLZ A 129 coo -52.57 -8.94 46.70 -54.06 -7.64 47.39 -18.08 79.12 16.04 -18.14 81.21 15.79 coo -45.30 -14.04 46.94 -45.65 -14.15 49.00 -21.82 80.90 7.85 -21.38 79.32 6.51 coo -45.82 1.31 41.67 -46.38 1.39 42.31 -28.40 71.61 21.66 -28.57 72.28 21.25 ULMN 3 1qrz_c23 PLASMINOGEN user 12 3 # 12 D 603 HIS D 85 HIS.? 4.73 OH7 1PE B 150 D 646 ASP D 122 ASP^? 7.49 C3 GOL D 147 D 739 GLY D 80 GLY.? 7.47 C2 GOL A 150 coo -52.57 -8.94 46.70 -54.06 -7.64 47.39 -18.08 79.12 16.04 -18.14 81.21 15.79 coo -45.30 -14.04 46.94 -45.65 -14.15 49.00 -21.82 80.90 7.85 -21.38 79.32 6.51 coo -45.82 1.31 41.67 -46.38 1.39 42.31 -13.78 69.07 11.78 -13.14 69.11 12.34 1qrz_c23 source 1qrz PLASMINOGEN : 12 hits 1qrz_c23 naa= 3 ULMN 3 1qz9_c02 KYNURENINASE user 1 3 # 1 A 129 PHE B 15 PHE~? 8.85 C11 PE8 B 148 A 201 ASP B 19 ASP.? -3.77 O3 SO4 A 144s A 227 LYS B 129 LYS^? 7.64 C2 PEG B 146 coo 23.39 49.81 32.16 21.33 51.68 32.26 -4.97 69.26 41.83 -5.66 71.31 40.07 coo 25.52 45.12 37.98 23.98 46.65 37.85 -12.63 65.75 40.21 -14.11 64.30 40.60 coo 12.68 46.83 36.69 18.26 48.67 34.51 -12.78 77.45 45.34 -17.39 74.89 47.84 ULMN 3 1qz9_c02 KYNURENINASE user 2 3 # 2 A 129 PHE D 15 PHE~? 8.99 C14 2PE D 146 A 201 ASP D 19 ASP.? -13.24 C2 PGE A 147s A 227 LYS D 129 LYS^? 7.63 C4 PEG D 145 coo 23.39 49.81 32.16 21.33 51.68 32.26 -37.50 71.61 -0.03 -38.77 71.49 2.45 coo 25.52 45.12 37.98 23.98 46.65 37.85 -43.72 66.33 -2.80 -44.54 65.10 -4.29 coo 12.68 46.83 36.69 18.26 48.67 34.51 -36.12 61.83 6.50 -39.41 57.83 4.09 1qz9_c02 source 1qz9 KYNURENINASE : 2 hits 1qz9_c02 naa= 3 ULMN 3 1req_c10 METHYLMALONYL-COA MUTASE user 1 3 # 1 A 608 ASP A 83 ASP.? 8.52 O3 GOL D 147 A 610 HIS A 85 HIS.? 6.69 C5 PGE A 147 A 661 HIS D 4 HIS.? 4.07 C3 GOL D 147 coo 75.99 81.56 1.86 73.91 81.34 2.28 -19.46 70.43 -3.04 -19.06 72.28 -2.05 coo 71.04 78.84 0.46 71.54 76.90 1.02 -23.05 64.43 -0.55 -21.68 63.00 -1.25 coo 75.40 81.38 12.06 74.88 79.42 12.63 -23.57 78.63 1.94 -22.01 77.96 0.72 ULMN 3 1req_c10 METHYLMALONYL-COA MUTASE user 2 3 # 2 A 608 ASP B 83 ASP.? 9.40 O3 GOL C 149 A 610 HIS B 85 HIS.? 6.66 C6 PGE B 147 A 661 HIS C 4 HIS.? -3.73 C3 GOL C 149s coo 75.99 81.56 1.86 73.91 81.34 2.28 13.62 86.10 55.23 12.83 84.59 56.49 coo 71.04 78.84 0.46 71.54 76.90 1.02 11.11 88.86 48.90 12.76 88.34 47.73 coo 75.40 81.38 12.06 74.88 79.42 12.63 4.88 85.81 61.42 6.80 85.00 61.18 ULMN 3 1req_c10 METHYLMALONYL-COA MUTASE user 3 3 # 3 A 608 ASP C 83 ASP.? 8.65 O3 GOL B 149 A 610 HIS C 85 HIS.? 6.34 C1 PGE C 147 A 661 HIS B 4 HIS.? -3.86 O2 GOL B 149s coo 75.99 81.56 1.86 73.91 81.34 2.28 3.02 71.86 58.06 4.88 72.49 57.24 coo 71.04 78.84 0.46 71.54 76.90 1.02 -4.08 74.18 57.17 -4.69 74.12 59.17 coo 75.40 81.38 12.06 74.88 79.42 12.63 8.07 73.88 49.16 8.30 73.43 51.19 ULMN 3 1req_c10 METHYLMALONYL-COA MUTASE user 4 3 # 4 A 608 ASP D 83 ASP.? 8.76 O1 GOL A 150 A 610 HIS D 85 HIS.? 4.73 OH7 1PE B 150 A 661 HIS A 4 HIS.? -3.92 C2 GOL A 150s coo 75.99 81.56 1.86 73.91 81.34 2.28 -12.54 78.43 10.94 -12.46 77.06 9.29 coo 71.04 78.84 0.46 71.54 76.90 1.02 -18.08 79.12 16.04 -18.14 81.21 15.79 coo 75.40 81.38 12.06 74.88 79.42 12.63 -11.85 68.18 8.83 -11.23 70.10 8.29 1req_c10 source 1req METHYLMALONYL-COA MUTASE : 4 hits 1req_c10 naa= 3 ULMN 3 1req_c11 METHYLMALONYL-COA MUTASE user 1 3 # 1 C 608 ASP A 83 ASP.? 8.52 O3 GOL D 147 C 610 HIS A 85 HIS.? 6.69 C5 PGE A 147 C 661 HIS D 4 HIS.? 4.07 C3 GOL D 147 coo -17.65 80.52 58.00 -16.23 80.79 56.41 -19.46 70.43 -3.04 -19.06 72.28 -2.05 coo -16.56 83.18 53.03 -16.33 85.18 53.60 -23.05 64.43 -0.55 -21.68 63.00 -1.25 coo -8.38 80.78 62.24 -7.53 82.67 62.02 -23.57 78.63 1.94 -22.01 77.96 0.72 ULMN 3 1req_c11 METHYLMALONYL-COA MUTASE user 2 3 # 2 C 608 ASP B 83 ASP.? 9.40 O3 GOL C 149 C 610 HIS B 85 HIS.? 6.66 C6 PGE B 147 C 661 HIS C 4 HIS.? -3.73 C3 GOL C 149s coo -17.65 80.52 58.00 -16.23 80.79 56.41 13.62 86.10 55.23 12.83 84.59 56.49 coo -16.56 83.18 53.03 -16.33 85.18 53.60 11.11 88.86 48.90 12.76 88.34 47.73 coo -8.38 80.78 62.24 -7.53 82.67 62.02 4.88 85.81 61.42 6.80 85.00 61.18 ULMN 3 1req_c11 METHYLMALONYL-COA MUTASE user 3 3 # 3 C 608 ASP C 83 ASP.? 8.65 O3 GOL B 149 C 610 HIS C 85 HIS.? 6.34 C1 PGE C 147 C 661 HIS B 4 HIS.? -3.86 O2 GOL B 149s coo -17.65 80.52 58.00 -16.23 80.79 56.41 3.02 71.86 58.06 4.88 72.49 57.24 coo -16.56 83.18 53.03 -16.33 85.18 53.60 -4.08 74.18 57.17 -4.69 74.12 59.17 coo -8.38 80.78 62.24 -7.53 82.67 62.02 8.07 73.88 49.16 8.30 73.43 51.19 ULMN 3 1req_c11 METHYLMALONYL-COA MUTASE user 4 3 # 4 C 608 ASP D 83 ASP.? 8.76 O1 GOL A 150 C 610 HIS D 85 HIS.? 4.73 OH7 1PE B 150 C 661 HIS A 4 HIS.? -3.92 C2 GOL A 150s coo -17.65 80.52 58.00 -16.23 80.79 56.41 -12.54 78.43 10.94 -12.46 77.06 9.29 coo -16.56 83.18 53.03 -16.33 85.18 53.60 -18.08 79.12 16.04 -18.14 81.21 15.79 coo -8.38 80.78 62.24 -7.53 82.67 62.02 -11.85 68.18 8.83 -11.23 70.10 8.29 1req_c11 source 1req METHYLMALONYL-COA MUTASE : 4 hits 1req_c11 naa= 3 ULMN 3 1rgq_c01 NS4A PEPTIDE user 1 3 # 1 B 60 HIS A 85 HIS.? 6.69 C5 PGE A 147 B 84 ASP A 87 ASP.? 8.49 C6 PGE A 147 B 140 GLY A 3 GLY.? -5.02 C3 GOL A 150s coo 20.71 17.85 -18.47 19.91 19.62 -17.68 -23.05 64.43 -0.55 -21.68 63.00 -1.25 coo 23.40 21.01 -22.79 22.72 19.65 -21.32 -23.17 58.67 3.55 -22.34 59.17 1.69 coo 11.52 20.17 -13.15 11.93 20.87 -13.16 -11.64 65.89 4.76 -10.88 65.57 4.96 ULMN 3 1rgq_c01 NS4A PEPTIDE user 2 3 # 2 B 60 HIS A 85 HIS.? 6.69 C5 PGE A 147 B 84 ASP A 87 ASP.? 8.49 C6 PGE A 147 B 140 GLY A 80 GLY.? 7.76 C1 GOL D 147 coo 20.71 17.85 -18.47 19.91 19.62 -17.68 -23.05 64.43 -0.55 -21.68 63.00 -1.25 coo 23.40 21.01 -22.79 22.72 19.65 -21.32 -23.17 58.67 3.55 -22.34 59.17 1.69 coo 11.52 20.17 -13.15 11.93 20.87 -13.16 -25.41 75.48 2.13 -25.84 75.58 1.39 ULMN 3 1rgq_c01 NS4A PEPTIDE user 3 3 # 3 B 60 HIS A 88 HIS^? 4.20 CH2 MLY D 135 B 84 ASP A 87 ASP.? 8.49 C6 PGE A 147 B 140 GLY A 54 GLY~? 5.80 C21 2PE A 148 coo 20.71 17.85 -18.47 19.91 19.62 -17.68 -23.95 56.87 7.77 -24.14 54.98 6.86 coo 23.40 21.01 -22.79 22.72 19.65 -21.32 -23.17 58.67 3.55 -22.34 59.17 1.69 coo 11.52 20.17 -13.15 11.93 20.87 -13.16 -20.41 50.07 13.76 -19.88 49.43 13.69 ULMN 3 1rgq_c01 NS4A PEPTIDE user 4 3 # 4 B 60 HIS A 88 HIS^? 4.20 CH2 MLY D 135 B 84 ASP A 87 ASP.? 8.49 C6 PGE A 147 B 140 GLY D 134 GLY.? 2.47 N MLY D 135 coo 20.71 17.85 -18.47 19.91 19.62 -17.68 -23.95 56.87 7.77 -24.14 54.98 6.86 coo 23.40 21.01 -22.79 22.72 19.65 -21.32 -23.17 58.67 3.55 -22.34 59.17 1.69 coo 11.52 20.17 -13.15 11.93 20.87 -13.16 -31.46 51.06 14.18 -31.60 51.74 13.54 ULMN 3 1rgq_c01 NS4A PEPTIDE user 5 3 # 5 B 60 HIS A 115 HIS~? 12.27 C21 2PE A 148 B 84 ASP A 56 ASP~? 11.59 C21 2PE A 148 B 140 GLY A 46 GLY~? 12.01 CD MLY D 135 coo 20.71 17.85 -18.47 19.91 19.62 -17.68 -13.18 48.35 10.37 -12.55 46.36 10.33 coo 23.40 21.01 -22.79 22.72 19.65 -21.32 -16.01 45.89 15.64 -15.93 44.31 14.23 coo 11.52 20.17 -13.15 11.93 20.87 -13.16 -16.75 52.82 2.36 -17.28 52.20 2.20 ULMN 3 1rgq_c01 NS4A PEPTIDE user 6 3 # 6 B 60 HIS B 85 HIS.? 6.66 C6 PGE B 147 B 84 ASP B 87 ASP.? 8.94 O4 PGE B 147 B 140 GLY B 80 GLY.? 7.38 C3 GOL C 149 coo 20.71 17.85 -18.47 19.91 19.62 -17.68 11.11 88.86 48.90 12.76 88.34 47.73 coo 23.40 21.01 -22.79 22.72 19.65 -21.32 9.49 87.97 42.02 11.31 87.98 43.09 coo 11.52 20.17 -13.15 11.93 20.87 -13.16 4.67 87.66 58.38 5.02 88.38 58.71 ULMN 3 1rgq_c01 NS4A PEPTIDE user 7 3 # 7 B 60 HIS B 88 HIS^? 4.29 CH1 MLY C 135 B 84 ASP B 87 ASP.? 8.94 O4 PGE B 147 B 140 GLY B 54 GLY~? 5.68 C20 PE8 B 148 coo 20.71 17.85 -18.47 19.91 19.62 -17.68 6.15 87.00 38.94 7.35 87.96 37.51 coo 23.40 21.01 -22.79 22.72 19.65 -21.32 9.49 87.97 42.02 11.31 87.98 43.09 coo 11.52 20.17 -13.15 11.93 20.87 -13.16 5.02 82.24 30.45 5.51 81.90 29.87 ULMN 3 1rgq_c01 NS4A PEPTIDE user 8 3 # 8 B 60 HIS B 88 HIS^? 4.29 CH1 MLY C 135 B 84 ASP B 87 ASP.? 8.94 O4 PGE B 147 B 140 GLY C 134 GLY.? 2.48 N MLY C 135 coo 20.71 17.85 -18.47 19.91 19.62 -17.68 6.15 87.00 38.94 7.35 87.96 37.51 coo 23.40 21.01 -22.79 22.72 19.65 -21.32 9.49 87.97 42.02 11.31 87.98 43.09 coo 11.52 20.17 -13.15 11.93 20.87 -13.16 -1.36 91.26 31.44 -1.10 91.64 32.26 ULMN 3 1rgq_c01 NS4A PEPTIDE user 9 3 # 9 B 60 HIS B 115 HIS~? 12.48 C18 PE8 B 148 B 84 ASP B 56 ASP~? 11.45 C20 PE8 B 148 B 140 GLY B 46 GLY~? 9.70 O1 PEG B 144 coo 20.71 17.85 -18.47 19.91 19.62 -17.68 11.86 77.76 30.05 12.70 77.49 28.15 coo 23.40 21.01 -22.79 22.72 19.65 -21.32 6.80 78.21 26.00 8.47 79.07 25.03 coo 11.52 20.17 -13.15 11.93 20.87 -13.16 15.35 83.93 36.97 15.42 84.55 36.41 ULMN 3 1rgq_c01 NS4A PEPTIDE user 10 3 # 10 B 60 HIS C 85 HIS.? 6.34 C1 PGE C 147 B 84 ASP C 87 ASP.? 8.84 O1 PGE C 147 B 140 GLY C 3 GLY.? -4.72 C3 GOL C 149s coo 20.71 17.85 -18.47 19.91 19.62 -17.68 -4.08 74.18 57.17 -4.69 74.12 59.17 coo 23.40 21.01 -22.79 22.72 19.65 -21.32 -9.03 79.00 58.44 -8.21 77.39 59.55 coo 11.52 20.17 -13.15 11.93 20.87 -13.16 2.92 82.34 64.00 3.08 82.77 64.68 ULMN 3 1rgq_c01 NS4A PEPTIDE user 11 3 # 11 B 60 HIS C 85 HIS.? 6.34 C1 PGE C 147 B 84 ASP C 87 ASP.? 8.84 O1 PGE C 147 B 140 GLY C 80 GLY.? 7.77 O2 GOL B 149 coo 20.71 17.85 -18.47 19.91 19.62 -17.68 -4.08 74.18 57.17 -4.69 74.12 59.17 coo 23.40 21.01 -22.79 22.72 19.65 -21.32 -9.03 79.00 58.44 -8.21 77.39 59.55 coo 11.52 20.17 -13.15 11.93 20.87 -13.16 4.31 74.26 49.15 4.26 73.42 48.97 ULMN 3 1rgq_c01 NS4A PEPTIDE user 12 3 # 12 B 60 HIS C 88 HIS^? 3.86 CD MLY B 135 B 84 ASP C 87 ASP.? 8.84 O1 PGE C 147 B 140 GLY B 134 GLY.? 2.46 N MLY B 135 coo 20.71 17.85 -18.47 19.91 19.62 -17.68 -11.00 83.03 57.18 -12.69 82.43 58.26 coo 23.40 21.01 -22.79 22.72 19.65 -21.32 -9.03 79.00 58.44 -8.21 77.39 59.55 coo 11.52 20.17 -13.15 11.93 20.87 -13.16 -19.59 87.32 51.84 -18.97 86.72 51.66 ULMN 3 1rgq_c01 NS4A PEPTIDE user 13 3 # 13 B 60 HIS C 88 HIS^? 3.86 CD MLY B 135 B 84 ASP C 87 ASP.? 8.84 O1 PGE C 147 B 140 GLY C 54 GLY~? 6.00 CH2 MLY B 135 coo 20.71 17.85 -18.47 19.91 19.62 -17.68 -11.00 83.03 57.18 -12.69 82.43 58.26 coo 23.40 21.01 -22.79 22.72 19.65 -21.32 -9.03 79.00 58.44 -8.21 77.39 59.55 coo 11.52 20.17 -13.15 11.93 20.87 -13.16 -15.22 90.72 61.35 -15.47 90.98 62.07 ULMN 3 1rgq_c01 NS4A PEPTIDE user 14 3 # 14 B 60 HIS C 115 HIS~? 4.72 C MLZ C 114 B 84 ASP C 56 ASP~? 9.09 N MLZ C 114 B 140 GLY C 46 GLY~? 10.04 O MLZ C 114 coo 20.71 17.85 -18.47 19.91 19.62 -17.68 -12.99 90.00 69.08 -14.38 90.57 70.54 coo 23.40 21.01 -22.79 22.72 19.65 -21.32 -16.40 94.43 66.11 -17.63 93.56 67.58 coo 11.52 20.17 -13.15 11.93 20.87 -13.16 -10.91 80.74 66.75 -11.70 80.52 66.65 ULMN 3 1rgq_c01 NS4A PEPTIDE user 15 3 # 15 B 60 HIS D 85 HIS.? 4.73 OH7 1PE B 150 B 84 ASP D 87 ASP.? 7.26 C16 1PE B 150 B 140 GLY D 3 GLY.? 4.87 C3 GOL D 147 coo 20.71 17.85 -18.47 19.91 19.62 -17.68 -18.08 79.12 16.04 -18.14 81.21 15.79 coo 23.40 21.01 -22.79 22.72 19.65 -21.32 -24.70 80.89 17.41 -22.90 81.94 17.31 coo 11.52 20.17 -13.15 11.93 20.87 -13.16 -21.40 82.14 3.97 -21.80 82.75 3.64 ULMN 3 1rgq_c01 NS4A PEPTIDE user 16 3 # 16 B 60 HIS D 85 HIS.? 4.73 OH7 1PE B 150 B 84 ASP D 87 ASP.? 7.26 C16 1PE B 150 B 140 GLY D 80 GLY.? 7.47 C2 GOL A 150 coo 20.71 17.85 -18.47 19.91 19.62 -17.68 -18.08 79.12 16.04 -18.14 81.21 15.79 coo 23.40 21.01 -22.79 22.72 19.65 -21.32 -24.70 80.89 17.41 -22.90 81.94 17.31 coo 11.52 20.17 -13.15 11.93 20.87 -13.16 -13.78 69.07 11.78 -13.14 69.11 12.34 ULMN 3 1rgq_c01 NS4A PEPTIDE user 17 3 # 17 B 60 HIS D 88 HIS^? 4.38 CH1 MLY A 135 B 84 ASP D 87 ASP.? 7.26 C16 1PE B 150 B 140 GLY A 134 GLY.? 2.47 N MLY A 135 coo 20.71 17.85 -18.47 19.91 19.62 -17.68 -29.18 79.71 17.63 -29.43 81.25 19.03 coo 23.40 21.01 -22.79 22.72 19.65 -21.32 -24.70 80.89 17.41 -22.90 81.94 17.31 coo 11.52 20.17 -13.15 11.93 20.87 -13.16 -37.57 76.13 24.20 -36.67 75.88 24.22 ULMN 3 1rgq_c01 NS4A PEPTIDE user 18 3 # 18 B 60 HIS D 88 HIS^? 4.38 CH1 MLY A 135 B 84 ASP D 87 ASP.? 7.26 C16 1PE B 150 B 140 GLY D 54 GLY~? 5.81 C23 2PE D 146 coo 20.71 17.85 -18.47 19.91 19.62 -17.68 -29.18 79.71 17.63 -29.43 81.25 19.03 coo 23.40 21.01 -22.79 22.72 19.65 -21.32 -24.70 80.89 17.41 -22.90 81.94 17.31 coo 11.52 20.17 -13.15 11.93 20.87 -13.16 -38.01 83.52 15.98 -38.33 84.28 15.84 ULMN 3 1rgq_c01 NS4A PEPTIDE user 19 3 # 19 B 60 HIS D 115 HIS~? 12.18 C21 2PE D 146 B 84 ASP D 56 ASP~? 11.46 C21 2PE D 146 B 140 GLY D 46 GLY~? 12.21 CD MLY A 135 coo 20.71 17.85 -18.47 19.91 19.62 -17.68 -36.28 90.32 11.92 -37.49 91.98 12.35 coo 23.40 21.01 -22.79 22.72 19.65 -21.32 -41.85 87.81 13.66 -41.61 89.58 14.80 coo 11.52 20.17 -13.15 11.93 20.87 -13.16 -27.16 89.12 15.33 -27.37 89.29 16.11 1rgq_c01 source 1rgq NS4A PEPTIDE : 19 hits 1rgq_c01 naa= 3 ULMN 3 1rhc_c00 F420-DEPENDENT ALCOHOL DEHYDROGENASEuser 1 3 # 1 A 39 HIS A 85 HIS.? 6.69 C5 PGE A 147 A 43 TRP A 86 TRP.? 11.27 C5 PGE A 147 A 108 GLU A 84 GLU.? 10.45 C3 GOL D 147 coo 33.67 25.97 25.39 31.70 26.60 25.75 -23.05 64.43 -0.55 -21.68 63.00 -1.25 coo 29.43 26.12 28.46 27.08 29.25 29.01 -23.97 66.49 5.70 -20.10 66.49 6.06 coo 29.13 31.14 24.26 29.28 29.08 24.66 -21.01 70.22 3.12 -21.10 71.95 4.30 ULMN 3 1rhc_c00 F420-DEPENDENT ALCOHOL DEHYDROGENASEuser 2 3 # 2 A 39 HIS B 85 HIS.? 6.66 C6 PGE B 147 A 43 TRP B 86 TRP.? 11.40 C6 PGE B 147 A 108 GLU B 84 GLU.? 10.31 O3 GOL C 149 coo 33.67 25.97 25.39 31.70 26.60 25.75 11.11 88.86 48.90 12.76 88.34 47.73 coo 29.43 26.12 28.46 27.08 29.25 29.01 5.15 86.32 48.71 6.70 82.77 48.58 coo 29.13 31.14 24.26 29.28 29.08 24.66 7.66 84.31 53.13 6.13 83.49 54.35 ULMN 3 1rhc_c00 F420-DEPENDENT ALCOHOL DEHYDROGENASEuser 3 3 # 3 A 39 HIS C 85 HIS.? 6.34 C1 PGE C 147 A 43 TRP C 86 TRP.? 11.30 C1 PGE C 147 A 108 GLU C 84 GLU.? 10.77 O2 GOL B 149 coo 33.67 25.97 25.39 31.70 26.60 25.75 -4.08 74.18 57.17 -4.69 74.12 59.17 coo 29.43 26.12 28.46 27.08 29.25 29.01 -2.64 79.47 53.33 -0.76 80.96 56.37 coo 29.13 31.14 24.26 29.28 29.08 24.66 2.34 77.12 55.01 3.46 78.21 53.60 ULMN 3 1rhc_c00 F420-DEPENDENT ALCOHOL DEHYDROGENASEuser 4 3 # 4 A 39 HIS D 85 HIS.? 4.73 OH7 1PE B 150 A 43 TRP D 86 TRP.? 10.59 OH7 1PE B 150 A 108 GLU D 84 GLU.? 10.79 C1 GOL A 150 coo 33.67 25.97 25.39 31.70 26.60 25.75 -18.08 79.12 16.04 -18.14 81.21 15.79 coo 29.43 26.12 28.46 27.08 29.25 29.01 -21.83 74.25 13.71 -22.24 76.29 10.42 coo 29.13 31.14 24.26 29.28 29.08 24.66 -17.40 74.78 10.23 -17.69 72.96 9.24 1rhc_c00 source 1rhc F420-DEPENDENT ALCOHOL DEHYDROGENASE : 4 hits 1rhc_c00 naa= 3 ULMN 3 1rne_c04 RENIN (ACTIVATED, GLYCOSYLATED, INHIuser 1 3 # 1 32 ASP A 19 ASP.? -3.59 O4 SO4 A 144s 35 SER B 96 SER~? 7.21 O4 SO4 A 144 215 ASP B 19 ASP.? -3.77 O3 SO4 A 144s coo 11.85 17.24 72.81 11.09 15.37 72.36 -15.01 66.98 32.71 -14.52 68.02 34.44 coo 12.20 12.71 75.45 13.69 13.84 74.03 -12.28 72.78 35.88 -11.90 71.42 33.88 coo 5.22 15.03 71.43 7.19 14.88 70.83 -12.63 65.75 40.21 -14.11 64.30 40.60 1rne_c04 source 1rne RENIN (ACTIVATED, GLYCOSYLATED, INHIBITED) (E.: 1 hits 1rne_c04 naa= 3 ULMN 3 1ro7_c03 ALPHA-2,3/8-SIALYLTRANSFERASE user 1 3 # 1 D 129 ARG A 42 ARG.? 16.81 C11 2PE A 148 D 156 TYR A 50 TYR~? 5.51 CH2 MLY D 135 D 188 HIS A 115 HIS~? 12.27 C21 2PE A 148 coo -19.99 -38.81 30.91 -19.99 -39.90 28.04 -8.57 45.71 4.07 -9.11 44.76 6.92 coo -32.96 -44.88 30.49 -32.31 -42.65 28.92 -19.50 53.98 8.67 -20.18 55.72 10.74 coo -25.33 -42.26 31.79 -24.77 -40.56 30.70 -13.18 48.35 10.37 -12.55 46.36 10.33 ULMN 3 1ro7_c03 ALPHA-2,3/8-SIALYLTRANSFERASE user 2 3 # 2 D 129 ARG A 55 ARG~? 10.23 CD MLY D 135 D 156 TYR A 38 TYR.? 14.78 C11 2PE A 148 D 188 HIS A 115 HIS~? 12.27 C21 2PE A 148 coo -19.99 -38.81 30.91 -19.99 -39.90 28.04 -19.70 43.33 11.87 -20.69 44.07 9.04 coo -32.96 -44.88 30.49 -32.31 -42.65 28.92 -8.94 48.99 5.06 -11.42 48.37 6.17 coo -25.33 -42.26 31.79 -24.77 -40.56 30.70 -13.18 48.35 10.37 -12.55 46.36 10.33 ULMN 3 1ro7_c03 ALPHA-2,3/8-SIALYLTRANSFERASE user 3 3 # 3 D 129 ARG B 42 ARG.? 12.70 O1 PEG B 144 D 156 TYR B 50 TYR~? 5.52 CH1 MLY C 135 D 188 HIS B 115 HIS~? 12.48 C18 PE8 B 148 coo -19.99 -38.81 30.91 -19.99 -39.90 28.04 19.61 78.53 29.44 17.94 76.42 28.00 coo -32.96 -44.88 30.49 -32.31 -42.65 28.92 8.51 83.11 35.90 5.93 82.51 36.84 coo -25.33 -42.26 31.79 -24.77 -40.56 30.70 11.86 77.76 30.05 12.70 77.49 28.15 ULMN 3 1ro7_c03 ALPHA-2,3/8-SIALYLTRANSFERASE user 4 3 # 4 D 129 ARG C 42 ARG.? 7.63 O MLZ C 114 D 156 TYR C 50 TYR~? 5.59 CE MLY B 135 D 188 HIS C 115 HIS~? 4.72 C MLZ C 114 coo -19.99 -38.81 30.91 -19.99 -39.90 28.04 -13.55 84.90 75.42 -13.77 88.03 75.38 coo -32.96 -44.88 30.49 -32.31 -42.65 28.92 -11.27 85.65 61.91 -10.18 87.09 59.78 coo -25.33 -42.26 31.79 -24.77 -40.56 30.70 -12.99 90.00 69.08 -14.38 90.57 70.54 ULMN 3 1ro7_c03 ALPHA-2,3/8-SIALYLTRANSFERASE user 5 3 # 5 D 129 ARG D 42 ARG.? 16.60 C9 2PE D 146 D 156 TYR D 50 TYR~? 5.61 CH1 MLY A 135 D 188 HIS D 115 HIS~? 12.18 C21 2PE D 146 coo -19.99 -38.81 30.91 -19.99 -39.90 28.04 -32.78 97.24 12.74 -35.35 96.85 11.13 coo -32.96 -44.88 30.49 -32.31 -42.65 28.92 -31.54 83.73 14.98 -32.20 81.17 14.09 coo -25.33 -42.26 31.79 -24.77 -40.56 30.70 -36.28 90.32 11.92 -37.49 91.98 12.35 1ro7_c03 source 1ro7 ALPHA-2,3/8-SIALYLTRANSFERASE : 5 hits 1ro7_c03 naa= 3 ULMN 3 1roz_c00 DEOXYHYPUSINE SYNTHASE user 1 3 # 1 A 137 GLU C 84 GLU.? 10.77 O2 GOL B 149 A 288 HIS C 25 HIS^? 5.68 C3 PG4 C 145 A 329 LYS C 132 LYS.? 10.46 CE MLZ C 129 coo 29.27 18.78 14.99 27.16 18.62 14.76 2.34 77.12 55.01 3.46 78.21 53.60 coo 49.52 10.06 10.36 50.99 9.65 8.92 -5.80 94.82 45.56 -7.26 95.23 44.11 coo 57.80 12.92 13.83 53.77 8.42 12.15 -3.83 95.01 34.81 -4.64 100.66 32.21 ULMN 3 1roz_c00 DEOXYHYPUSINE SYNTHASE user 2 3 # 2 A 137 GLU D 84 GLU.? 10.79 C1 GOL A 150 A 288 HIS D 25 HIS^? 5.64 C8 PG4 D 144 A 329 LYS D 132 LYS.? -3.69 O4 PEG D 145s coo 29.27 18.78 14.99 27.16 18.62 14.76 -17.40 74.78 10.23 -17.69 72.96 9.24 coo 49.52 10.06 10.36 50.99 9.65 8.92 -36.75 65.22 11.65 -37.83 64.18 13.11 coo 57.80 12.92 13.83 53.77 8.42 12.15 -35.99 54.44 13.45 -42.83 52.94 13.30 1roz_c00 source 1roz DEOXYHYPUSINE SYNTHASE : 2 hits 1roz_c00 naa= 3 ULMN 3 1roz_c01 DEOXYHYPUSINE SYNTHASE user 1 3 # 1 B 137 GLU C 84 GLU.? 10.77 O2 GOL B 149 B 288 HIS C 25 HIS^? 5.68 C3 PG4 C 145 B 329 LYS C 132 LYS.? 10.46 CE MLZ C 129 coo 51.99 -1.20 48.77 51.89 -0.93 46.67 2.34 77.12 55.01 3.46 78.21 53.60 coo 31.44 -9.36 43.35 29.98 -10.83 43.65 -5.80 94.82 45.56 -7.26 95.23 44.11 coo 23.19 -4.89 44.25 27.28 -8.41 40.97 -3.83 95.01 34.81 -4.64 100.66 32.21 ULMN 3 1roz_c01 DEOXYHYPUSINE SYNTHASE user 2 3 # 2 B 137 GLU D 84 GLU.? 10.79 C1 GOL A 150 B 288 HIS D 25 HIS^? 5.64 C8 PG4 D 144 B 329 LYS D 132 LYS.? -3.69 O4 PEG D 145s coo 51.99 -1.20 48.77 51.89 -0.93 46.67 -17.40 74.78 10.23 -17.69 72.96 9.24 coo 31.44 -9.36 43.35 29.98 -10.83 43.65 -36.75 65.22 11.65 -37.83 64.18 13.11 coo 23.19 -4.89 44.25 27.28 -8.41 40.97 -35.99 54.44 13.45 -42.83 52.94 13.30 1roz_c01 source 1roz DEOXYHYPUSINE SYNTHASE : 2 hits 1roz_c01 naa= 3 ULMN 3 1rtf_c06 TWO CHAIN TISSUE PLASMINOGEN ACTIVATuser 1 3 # 1 B 57 HIS A 88 HIS^? 4.20 CH2 MLY D 135 B 102 ASP A 87 ASP.? 8.49 C6 PGE A 147 B 193 GLY A 54 GLY~? 5.80 C21 2PE A 148 coo -4.60 27.52 42.88 -4.63 27.41 40.76 -23.95 56.87 7.77 -24.14 54.98 6.86 coo -0.27 31.24 43.51 -1.49 29.62 42.98 -23.17 58.67 3.55 -22.34 59.17 1.69 coo -6.81 22.81 34.74 -6.42 23.54 34.62 -20.41 50.07 13.76 -19.88 49.43 13.69 ULMN 3 1rtf_c06 TWO CHAIN TISSUE PLASMINOGEN ACTIVATuser 2 3 # 2 B 57 HIS A 88 HIS^? 4.20 CH2 MLY D 135 B 102 ASP A 87 ASP.? 8.49 C6 PGE A 147 B 193 GLY D 134 GLY.? 2.47 N MLY D 135 coo -4.60 27.52 42.88 -4.63 27.41 40.76 -23.95 56.87 7.77 -24.14 54.98 6.86 coo -0.27 31.24 43.51 -1.49 29.62 42.98 -23.17 58.67 3.55 -22.34 59.17 1.69 coo -6.81 22.81 34.74 -6.42 23.54 34.62 -31.46 51.06 14.18 -31.60 51.74 13.54 ULMN 3 1rtf_c06 TWO CHAIN TISSUE PLASMINOGEN ACTIVATuser 3 3 # 3 B 57 HIS A 115 HIS~? 12.27 C21 2PE A 148 B 102 ASP A 56 ASP~? 11.59 C21 2PE A 148 B 193 GLY A 46 GLY~? 12.01 CD MLY D 135 coo -4.60 27.52 42.88 -4.63 27.41 40.76 -13.18 48.35 10.37 -12.55 46.36 10.33 coo -0.27 31.24 43.51 -1.49 29.62 42.98 -16.01 45.89 15.64 -15.93 44.31 14.23 coo -6.81 22.81 34.74 -6.42 23.54 34.62 -16.75 52.82 2.36 -17.28 52.20 2.20 ULMN 3 1rtf_c06 TWO CHAIN TISSUE PLASMINOGEN ACTIVATuser 4 3 # 4 B 57 HIS B 88 HIS^? 4.29 CH1 MLY C 135 B 102 ASP B 87 ASP.? 8.94 O4 PGE B 147 B 193 GLY B 54 GLY~? 5.68 C20 PE8 B 148 coo -4.60 27.52 42.88 -4.63 27.41 40.76 6.15 87.00 38.94 7.35 87.96 37.51 coo -0.27 31.24 43.51 -1.49 29.62 42.98 9.49 87.97 42.02 11.31 87.98 43.09 coo -6.81 22.81 34.74 -6.42 23.54 34.62 5.02 82.24 30.45 5.51 81.90 29.87 ULMN 3 1rtf_c06 TWO CHAIN TISSUE PLASMINOGEN ACTIVATuser 5 3 # 5 B 57 HIS B 88 HIS^? 4.29 CH1 MLY C 135 B 102 ASP B 87 ASP.? 8.94 O4 PGE B 147 B 193 GLY C 134 GLY.? 2.48 N MLY C 135 coo -4.60 27.52 42.88 -4.63 27.41 40.76 6.15 87.00 38.94 7.35 87.96 37.51 coo -0.27 31.24 43.51 -1.49 29.62 42.98 9.49 87.97 42.02 11.31 87.98 43.09 coo -6.81 22.81 34.74 -6.42 23.54 34.62 -1.36 91.26 31.44 -1.10 91.64 32.26 ULMN 3 1rtf_c06 TWO CHAIN TISSUE PLASMINOGEN ACTIVATuser 6 3 # 6 B 57 HIS B 115 HIS~? 12.48 C18 PE8 B 148 B 102 ASP B 56 ASP~? 11.45 C20 PE8 B 148 B 193 GLY B 46 GLY~? 9.70 O1 PEG B 144 coo -4.60 27.52 42.88 -4.63 27.41 40.76 11.86 77.76 30.05 12.70 77.49 28.15 coo -0.27 31.24 43.51 -1.49 29.62 42.98 6.80 78.21 26.00 8.47 79.07 25.03 coo -6.81 22.81 34.74 -6.42 23.54 34.62 15.35 83.93 36.97 15.42 84.55 36.41 ULMN 3 1rtf_c06 TWO CHAIN TISSUE PLASMINOGEN ACTIVATuser 7 3 # 7 B 57 HIS C 88 HIS^? 3.86 CD MLY B 135 B 102 ASP C 87 ASP.? 8.84 O1 PGE C 147 B 193 GLY B 134 GLY.? 2.46 N MLY B 135 coo -4.60 27.52 42.88 -4.63 27.41 40.76 -11.00 83.03 57.18 -12.69 82.43 58.26 coo -0.27 31.24 43.51 -1.49 29.62 42.98 -9.03 79.00 58.44 -8.21 77.39 59.55 coo -6.81 22.81 34.74 -6.42 23.54 34.62 -19.59 87.32 51.84 -18.97 86.72 51.66 ULMN 3 1rtf_c06 TWO CHAIN TISSUE PLASMINOGEN ACTIVATuser 8 3 # 8 B 57 HIS C 88 HIS^? 3.86 CD MLY B 135 B 102 ASP C 87 ASP.? 8.84 O1 PGE C 147 B 193 GLY C 54 GLY~? 6.00 CH2 MLY B 135 coo -4.60 27.52 42.88 -4.63 27.41 40.76 -11.00 83.03 57.18 -12.69 82.43 58.26 coo -0.27 31.24 43.51 -1.49 29.62 42.98 -9.03 79.00 58.44 -8.21 77.39 59.55 coo -6.81 22.81 34.74 -6.42 23.54 34.62 -15.22 90.72 61.35 -15.47 90.98 62.07 ULMN 3 1rtf_c06 TWO CHAIN TISSUE PLASMINOGEN ACTIVATuser 9 3 # 9 B 57 HIS C 115 HIS~? 4.72 C MLZ C 114 B 102 ASP C 56 ASP~? 9.09 N MLZ C 114 B 193 GLY C 46 GLY~? 10.04 O MLZ C 114 coo -4.60 27.52 42.88 -4.63 27.41 40.76 -12.99 90.00 69.08 -14.38 90.57 70.54 coo -0.27 31.24 43.51 -1.49 29.62 42.98 -16.40 94.43 66.11 -17.63 93.56 67.58 coo -6.81 22.81 34.74 -6.42 23.54 34.62 -10.91 80.74 66.75 -11.70 80.52 66.65 ULMN 3 1rtf_c06 TWO CHAIN TISSUE PLASMINOGEN ACTIVATuser 10 3 # 10 B 57 HIS D 88 HIS^? 4.38 CH1 MLY A 135 B 102 ASP D 87 ASP.? 7.26 C16 1PE B 150 B 193 GLY A 134 GLY.? 2.47 N MLY A 135 coo -4.60 27.52 42.88 -4.63 27.41 40.76 -29.18 79.71 17.63 -29.43 81.25 19.03 coo -0.27 31.24 43.51 -1.49 29.62 42.98 -24.70 80.89 17.41 -22.90 81.94 17.31 coo -6.81 22.81 34.74 -6.42 23.54 34.62 -37.57 76.13 24.20 -36.67 75.88 24.22 ULMN 3 1rtf_c06 TWO CHAIN TISSUE PLASMINOGEN ACTIVATuser 11 3 # 11 B 57 HIS D 88 HIS^? 4.38 CH1 MLY A 135 B 102 ASP D 87 ASP.? 7.26 C16 1PE B 150 B 193 GLY D 54 GLY~? 5.81 C23 2PE D 146 coo -4.60 27.52 42.88 -4.63 27.41 40.76 -29.18 79.71 17.63 -29.43 81.25 19.03 coo -0.27 31.24 43.51 -1.49 29.62 42.98 -24.70 80.89 17.41 -22.90 81.94 17.31 coo -6.81 22.81 34.74 -6.42 23.54 34.62 -38.01 83.52 15.98 -38.33 84.28 15.84 ULMN 3 1rtf_c06 TWO CHAIN TISSUE PLASMINOGEN ACTIVATuser 12 3 # 12 B 57 HIS D 115 HIS~? 12.18 C21 2PE D 146 B 102 ASP D 56 ASP~? 11.46 C21 2PE D 146 B 193 GLY D 46 GLY~? 12.21 CD MLY A 135 coo -4.60 27.52 42.88 -4.63 27.41 40.76 -36.28 90.32 11.92 -37.49 91.98 12.35 coo -0.27 31.24 43.51 -1.49 29.62 42.98 -41.85 87.81 13.66 -41.61 89.58 14.80 coo -6.81 22.81 34.74 -6.42 23.54 34.62 -27.16 89.12 15.33 -27.37 89.29 16.11 1rtf_c06 source 1rtf TWO CHAIN TISSUE PLASMINOGEN ACTIVATOR : 12 hits 1rtf_c06 naa= 3 ULMN 3 1s3i_c00 10-FORMYLTETRAHYDROFOLATE DEHYDROGENuser 1 3 # 1 A 104 ILE A 5 ILE.? 7.33 C3 GOL A 150 A 106 HIS A 4 HIS.? -3.92 C2 GOL A 150s A 142 ASP A 122 ASP^? 7.46 C1 GOL A 150 coo -15.54 60.72 29.56 -16.71 61.53 30.10 -10.65 61.23 8.95 -10.30 60.36 8.03 coo -17.00 64.03 23.46 -18.21 65.65 22.90 -11.85 68.18 8.83 -11.23 70.10 8.29 coo -17.05 67.91 26.85 -18.66 66.47 26.76 -15.41 64.92 4.51 -15.09 66.83 5.33 ULMN 3 1s3i_c00 10-FORMYLTETRAHYDROFOLATE DEHYDROGENuser 2 3 # 2 A 104 ILE A 79 ILE.? 6.02 C14 2PE D 146 A 106 HIS D 4 HIS.? 4.07 C3 GOL D 147 A 142 ASP D 122 ASP^? 7.49 C3 GOL D 147 coo -15.54 60.72 29.56 -16.71 61.53 30.10 -29.50 76.99 3.78 -29.92 78.29 4.27 coo -17.00 64.03 23.46 -18.21 65.65 22.90 -23.57 78.63 1.94 -22.01 77.96 0.72 coo -17.05 67.91 26.85 -18.66 66.47 26.76 -21.82 80.90 7.85 -21.38 79.32 6.51 ULMN 3 1s3i_c00 10-FORMYLTETRAHYDROFOLATE DEHYDROGENuser 3 3 # 3 A 104 ILE B 5 ILE.? 7.08 O1 GOL B 149 A 106 HIS B 4 HIS.? -3.86 O2 GOL B 149s A 142 ASP B 122 ASP^? 7.33 O2 GOL B 149 coo -15.54 60.72 29.56 -16.71 61.53 30.10 10.64 74.11 42.59 11.89 74.33 42.08 coo -17.00 64.03 23.46 -18.21 65.65 22.90 8.07 73.88 49.16 8.30 73.43 51.19 coo -17.05 67.91 26.85 -18.66 66.47 26.76 10.89 79.68 47.57 9.75 78.80 49.16 ULMN 3 1s3i_c00 10-FORMYLTETRAHYDROFOLATE DEHYDROGENuser 4 3 # 4 A 104 ILE B 79 ILE.? 5.86 O13 PE8 C 148 A 106 HIS C 4 HIS.? -3.73 C3 GOL C 149s A 142 ASP C 122 ASP^? 7.22 C3 GOL C 149 coo -15.54 60.72 29.56 -16.71 61.53 30.10 0.87 90.20 59.31 -0.16 90.12 60.31 coo -17.00 64.03 23.46 -18.21 65.65 22.90 4.88 85.81 61.42 6.80 85.00 61.18 coo -17.05 67.91 26.85 -18.66 66.47 26.76 0.27 81.12 61.60 2.07 81.54 60.53 ULMN 3 1s3i_c00 10-FORMYLTETRAHYDROFOLATE DEHYDROGENuser 5 3 # 5 A 104 ILE C 5 ILE.? 7.14 C1 GOL C 149 A 106 HIS C 4 HIS.? -3.73 C3 GOL C 149s A 142 ASP C 122 ASP^? 7.22 C3 GOL C 149 coo -15.54 60.72 29.56 -16.71 61.53 30.10 -0.58 87.30 65.65 -1.16 86.69 66.74 coo -17.00 64.03 23.46 -18.21 65.65 22.90 4.88 85.81 61.42 6.80 85.00 61.18 coo -17.05 67.91 26.85 -18.66 66.47 26.76 0.27 81.12 61.60 2.07 81.54 60.53 ULMN 3 1s3i_c00 10-FORMYLTETRAHYDROFOLATE DEHYDROGENuser 6 3 # 6 A 104 ILE C 79 ILE.? -5.55 C12 PE8 B 148s A 106 HIS B 4 HIS.? -3.86 O2 GOL B 149s A 142 ASP B 122 ASP^? 7.33 O2 GOL B 149 coo -15.54 60.72 29.56 -16.71 61.53 30.10 3.66 74.25 44.53 4.61 74.35 43.39 coo -17.00 64.03 23.46 -18.21 65.65 22.90 8.07 73.88 49.16 8.30 73.43 51.19 coo -17.05 67.91 26.85 -18.66 66.47 26.76 10.89 79.68 47.57 9.75 78.80 49.16 ULMN 3 1s3i_c00 10-FORMYLTETRAHYDROFOLATE DEHYDROGENuser 7 3 # 7 A 104 ILE D 5 ILE.? 7.47 C1 GOL D 147 A 106 HIS D 4 HIS.? 4.07 C3 GOL D 147 A 142 ASP D 122 ASP^? 7.49 C3 GOL D 147 coo -15.54 60.72 29.56 -16.71 61.53 30.10 -27.59 83.95 4.24 -27.35 85.25 4.70 coo -17.00 64.03 23.46 -18.21 65.65 22.90 -23.57 78.63 1.94 -22.01 77.96 0.72 coo -17.05 67.91 26.85 -18.66 66.47 26.76 -21.82 80.90 7.85 -21.38 79.32 6.51 ULMN 3 1s3i_c00 10-FORMYLTETRAHYDROFOLATE DEHYDROGENuser 8 3 # 8 A 104 ILE D 79 ILE.? 5.90 C15 2PE A 148 A 106 HIS A 4 HIS.? -3.92 C2 GOL A 150s A 142 ASP A 122 ASP^? 7.46 C1 GOL A 150 coo -15.54 60.72 29.56 -16.71 61.53 30.10 -14.20 64.95 13.90 -13.86 63.61 13.51 coo -17.00 64.03 23.46 -18.21 65.65 22.90 -11.85 68.18 8.83 -11.23 70.10 8.29 coo -17.05 67.91 26.85 -18.66 66.47 26.76 -15.41 64.92 4.51 -15.09 66.83 5.33 1s3i_c00 source 1s3i 10-FORMYLTETRAHYDROFOLATE DEHYDROGENASE : 8 hits 1s3i_c00 naa= 3 ULMN 3 1sme_c05 PLASMEPSIN II user 1 3 # 1 B 34 ASP A 19 ASP.? -3.59 O4 SO4 A 144s B 37 SER B 96 SER~? 7.21 O4 SO4 A 144 B 214 ASP B 19 ASP.? -3.77 O3 SO4 A 144s coo 17.69 97.58 52.73 17.33 97.19 54.77 -15.01 66.98 32.71 -14.52 68.02 34.44 coo 20.67 100.44 55.84 20.21 98.51 54.45 -12.28 72.78 35.88 -11.90 71.42 33.88 coo 12.41 98.71 58.47 14.37 98.17 58.05 -12.63 65.75 40.21 -14.11 64.30 40.60 1sme_c05 source 1sme PLASMEPSIN II : 1 hits 1sme_c05 naa= 3 ULMN 3 1ssx_c02 ALPHA-LYTIC PROTEASE user 1 3 # 1 A 57 HIS A 88 HIS^? 4.20 CH2 MLY D 135 A 102 ASP A 87 ASP.? 8.49 C6 PGE A 147 A 193 GLY A 54 GLY~? 5.80 C21 2PE A 148 coo 15.02 29.17 19.44 15.63 29.96 17.60 -23.95 56.87 7.77 -24.14 54.98 6.86 coo 19.67 30.58 22.61 18.30 29.87 21.17 -23.17 58.67 3.55 -22.34 59.17 1.69 coo 14.52 29.10 10.01 15.08 29.66 10.19 -20.41 50.07 13.76 -19.88 49.43 13.69 ULMN 3 1ssx_c02 ALPHA-LYTIC PROTEASE user 2 3 # 2 A 57 HIS A 115 HIS~? 12.27 C21 2PE A 148 A 102 ASP A 56 ASP~? 11.59 C21 2PE A 148 A 193 GLY A 46 GLY~? 12.01 CD MLY D 135 coo 15.02 29.17 19.44 15.63 29.96 17.60 -13.18 48.35 10.37 -12.55 46.36 10.33 coo 19.67 30.58 22.61 18.30 29.87 21.17 -16.01 45.89 15.64 -15.93 44.31 14.23 coo 14.52 29.10 10.01 15.08 29.66 10.19 -16.75 52.82 2.36 -17.28 52.20 2.20 ULMN 3 1ssx_c02 ALPHA-LYTIC PROTEASE user 3 3 # 3 A 57 HIS B 88 HIS^? 4.29 CH1 MLY C 135 A 102 ASP B 87 ASP.? 8.94 O4 PGE B 147 A 193 GLY B 54 GLY~? 5.68 C20 PE8 B 148 coo 15.02 29.17 19.44 15.63 29.96 17.60 6.15 87.00 38.94 7.35 87.96 37.51 coo 19.67 30.58 22.61 18.30 29.87 21.17 9.49 87.97 42.02 11.31 87.98 43.09 coo 14.52 29.10 10.01 15.08 29.66 10.19 5.02 82.24 30.45 5.51 81.90 29.87 ULMN 3 1ssx_c02 ALPHA-LYTIC PROTEASE user 4 3 # 4 A 57 HIS B 115 HIS~? 12.48 C18 PE8 B 148 A 102 ASP B 56 ASP~? 11.45 C20 PE8 B 148 A 193 GLY B 46 GLY~? 9.70 O1 PEG B 144 coo 15.02 29.17 19.44 15.63 29.96 17.60 11.86 77.76 30.05 12.70 77.49 28.15 coo 19.67 30.58 22.61 18.30 29.87 21.17 6.80 78.21 26.00 8.47 79.07 25.03 coo 14.52 29.10 10.01 15.08 29.66 10.19 15.35 83.93 36.97 15.42 84.55 36.41 ULMN 3 1ssx_c02 ALPHA-LYTIC PROTEASE user 5 3 # 5 A 57 HIS C 88 HIS^? 3.86 CD MLY B 135 A 102 ASP C 87 ASP.? 8.84 O1 PGE C 147 A 193 GLY B 134 GLY.? 2.46 N MLY B 135 coo 15.02 29.17 19.44 15.63 29.96 17.60 -11.00 83.03 57.18 -12.69 82.43 58.26 coo 19.67 30.58 22.61 18.30 29.87 21.17 -9.03 79.00 58.44 -8.21 77.39 59.55 coo 14.52 29.10 10.01 15.08 29.66 10.19 -19.59 87.32 51.84 -18.97 86.72 51.66 ULMN 3 1ssx_c02 ALPHA-LYTIC PROTEASE user 6 3 # 6 A 57 HIS C 88 HIS^? 3.86 CD MLY B 135 A 102 ASP C 87 ASP.? 8.84 O1 PGE C 147 A 193 GLY C 54 GLY~? 6.00 CH2 MLY B 135 coo 15.02 29.17 19.44 15.63 29.96 17.60 -11.00 83.03 57.18 -12.69 82.43 58.26 coo 19.67 30.58 22.61 18.30 29.87 21.17 -9.03 79.00 58.44 -8.21 77.39 59.55 coo 14.52 29.10 10.01 15.08 29.66 10.19 -15.22 90.72 61.35 -15.47 90.98 62.07 ULMN 3 1ssx_c02 ALPHA-LYTIC PROTEASE user 7 3 # 7 A 57 HIS C 115 HIS~? 4.72 C MLZ C 114 A 102 ASP C 56 ASP~? 9.09 N MLZ C 114 A 193 GLY C 46 GLY~? 10.04 O MLZ C 114 coo 15.02 29.17 19.44 15.63 29.96 17.60 -12.99 90.00 69.08 -14.38 90.57 70.54 coo 19.67 30.58 22.61 18.30 29.87 21.17 -16.40 94.43 66.11 -17.63 93.56 67.58 coo 14.52 29.10 10.01 15.08 29.66 10.19 -10.91 80.74 66.75 -11.70 80.52 66.65 ULMN 3 1ssx_c02 ALPHA-LYTIC PROTEASE user 8 3 # 8 A 57 HIS D 88 HIS^? 4.38 CH1 MLY A 135 A 102 ASP D 87 ASP.? 7.26 C16 1PE B 150 A 193 GLY A 134 GLY.? 2.47 N MLY A 135 coo 15.02 29.17 19.44 15.63 29.96 17.60 -29.18 79.71 17.63 -29.43 81.25 19.03 coo 19.67 30.58 22.61 18.30 29.87 21.17 -24.70 80.89 17.41 -22.90 81.94 17.31 coo 14.52 29.10 10.01 15.08 29.66 10.19 -37.57 76.13 24.20 -36.67 75.88 24.22 ULMN 3 1ssx_c02 ALPHA-LYTIC PROTEASE user 9 3 # 9 A 57 HIS D 88 HIS^? 4.38 CH1 MLY A 135 A 102 ASP D 87 ASP.? 7.26 C16 1PE B 150 A 193 GLY D 54 GLY~? 5.81 C23 2PE D 146 coo 15.02 29.17 19.44 15.63 29.96 17.60 -29.18 79.71 17.63 -29.43 81.25 19.03 coo 19.67 30.58 22.61 18.30 29.87 21.17 -24.70 80.89 17.41 -22.90 81.94 17.31 coo 14.52 29.10 10.01 15.08 29.66 10.19 -38.01 83.52 15.98 -38.33 84.28 15.84 ULMN 3 1ssx_c02 ALPHA-LYTIC PROTEASE user 10 3 # 10 A 57 HIS D 115 HIS~? 12.18 C21 2PE D 146 A 102 ASP D 56 ASP~? 11.46 C21 2PE D 146 A 193 GLY D 46 GLY~? 12.21 CD MLY A 135 coo 15.02 29.17 19.44 15.63 29.96 17.60 -36.28 90.32 11.92 -37.49 91.98 12.35 coo 19.67 30.58 22.61 18.30 29.87 21.17 -41.85 87.81 13.66 -41.61 89.58 14.80 coo 14.52 29.10 10.01 15.08 29.66 10.19 -27.16 89.12 15.33 -27.37 89.29 16.11 1ssx_c02 source 1ssx ALPHA-LYTIC PROTEASE : 10 hits 1ssx_c02 naa= 3 ULMN 3 1t0u_c01 URIDINE PHOSPHORYLASE user 1 3 # 1 B 8 HIS A 25 HIS^? 6.06 C MLZ A 129 B 80 GLU A 93 GLU^? 3.90 NZ MLY A 67 B 223 ARG A 42 ARG.? 16.81 C11 2PE A 148 coo -27.29 12.84 -47.54 -26.57 10.91 -47.95 -27.47 64.89 22.81 -29.24 64.17 23.67 coo -24.01 16.61 -49.84 -25.90 15.74 -49.71 -27.37 60.67 25.57 -29.32 61.09 26.31 coo -14.82 14.90 -18.49 -14.21 12.08 -19.40 -8.57 45.71 4.07 -9.11 44.76 6.92 ULMN 3 1t0u_c01 URIDINE PHOSPHORYLASE user 2 3 # 2 B 8 HIS A 25 HIS^? 6.06 C MLZ A 129 B 80 GLU A 93 GLU^? 3.90 NZ MLY A 67 B 223 ARG B 110 ARG~? 10.12 O7 PE8 B 148 coo -27.29 12.84 -47.54 -26.57 10.91 -47.95 -27.47 64.89 22.81 -29.24 64.17 23.67 coo -24.01 16.61 -49.84 -25.90 15.74 -49.71 -27.37 60.67 25.57 -29.32 61.09 26.31 coo -14.82 14.90 -18.49 -14.21 12.08 -19.40 4.56 66.25 30.54 5.81 64.43 28.32 ULMN 3 1t0u_c01 URIDINE PHOSPHORYLASE user 3 3 # 3 B 8 HIS A 25 HIS^? 6.06 C MLZ A 129 B 80 GLU A 93 GLU^? 3.90 NZ MLY A 67 B 223 ARG D 63 ARG~? -11.23 O28 2PE D 146s coo -27.29 12.84 -47.54 -26.57 10.91 -47.95 -27.47 64.89 22.81 -29.24 64.17 23.67 coo -24.01 16.61 -49.84 -25.90 15.74 -49.71 -27.37 60.67 25.57 -29.32 61.09 26.31 coo -14.82 14.90 -18.49 -14.21 12.08 -19.40 -51.80 79.77 10.92 -50.17 82.42 10.63 ULMN 3 1t0u_c01 URIDINE PHOSPHORYLASE user 4 3 # 4 B 8 HIS A 85 HIS.? 6.69 C5 PGE A 147 B 80 GLU A 84 GLU.? 10.45 C3 GOL D 147 B 223 ARG A 105 ARG~? -3.04 O2 SO4 A 143s coo -27.29 12.84 -47.54 -26.57 10.91 -47.95 -23.05 64.43 -0.55 -21.68 63.00 -1.25 coo -24.01 16.61 -49.84 -25.90 15.74 -49.71 -21.01 70.22 3.12 -21.10 71.95 4.30 coo -14.82 14.90 -18.49 -14.21 12.08 -19.40 -8.78 56.32 28.12 -7.90 58.53 30.04 ULMN 3 1t0u_c01 URIDINE PHOSPHORYLASE user 5 3 # 5 B 8 HIS B 25 HIS^? 5.55 C6 PG4 C 145 B 80 GLU B 93 GLU^? 4.01 CE MLZ B 67 B 223 ARG B 35 ARG.? 9.50 O1 PEG B 144 coo -27.29 12.84 -47.54 -26.57 10.91 -47.95 -10.19 81.59 41.51 -11.58 82.85 40.58 coo -24.01 16.61 -49.84 -25.90 15.74 -49.71 -11.20 80.89 36.50 -12.93 82.08 36.76 coo -14.82 14.90 -18.49 -14.21 12.08 -19.40 22.76 84.08 36.32 22.81 87.07 35.45 ULMN 3 1t0u_c01 URIDINE PHOSPHORYLASE user 6 3 # 6 B 8 HIS B 25 HIS^? 5.55 C6 PG4 C 145 B 80 GLU B 93 GLU^? 4.01 CE MLZ B 67 B 223 ARG B 42 ARG.? 12.70 O1 PEG B 144 coo -27.29 12.84 -47.54 -26.57 10.91 -47.95 -10.19 81.59 41.51 -11.58 82.85 40.58 coo -24.01 16.61 -49.84 -25.90 15.74 -49.71 -11.20 80.89 36.50 -12.93 82.08 36.76 coo -14.82 14.90 -18.49 -14.21 12.08 -19.40 19.61 78.53 29.44 17.94 76.42 28.00 ULMN 3 1t0u_c01 URIDINE PHOSPHORYLASE user 7 3 # 7 B 8 HIS B 25 HIS^? 5.55 C6 PG4 C 145 B 80 GLU B 93 GLU^? 4.01 CE MLZ B 67 B 223 ARG C 63 ARG~? -11.70 O25 PE8 C 148s coo -27.29 12.84 -47.54 -26.57 10.91 -47.95 -10.19 81.59 41.51 -11.58 82.85 40.58 coo -24.01 16.61 -49.84 -25.90 15.74 -49.71 -11.20 80.89 36.50 -12.93 82.08 36.76 coo -14.82 14.90 -18.49 -14.21 12.08 -19.40 -17.02 105.73 59.39 -16.53 104.08 61.96 ULMN 3 1t0u_c01 URIDINE PHOSPHORYLASE user 8 3 # 8 B 8 HIS B 85 HIS.? 6.66 C6 PGE B 147 B 80 GLU B 84 GLU.? 10.31 O3 GOL C 149 B 223 ARG B 105 ARG~? -3.01 O4 SO4 A 143s coo -27.29 12.84 -47.54 -26.57 10.91 -47.95 11.11 88.86 48.90 12.76 88.34 47.73 coo -24.01 16.61 -49.84 -25.90 15.74 -49.71 7.66 84.31 53.13 6.13 83.49 54.35 coo -14.82 14.90 -18.49 -14.21 12.08 -19.40 -2.68 64.28 31.62 -4.52 62.28 32.99 ULMN 3 1t0u_c01 URIDINE PHOSPHORYLASE user 9 3 # 9 B 8 HIS C 25 HIS^? 5.68 C3 PG4 C 145 B 80 GLU C 93 GLU^? -3.82 CH2 MLY C 67s B 223 ARG A 20 ARG.? 4.64 CB MLZ A 129 coo -27.29 12.84 -47.54 -26.57 10.91 -47.95 -5.80 94.82 45.56 -7.26 95.23 44.11 coo -24.01 16.61 -49.84 -25.90 15.74 -49.71 -9.46 98.26 46.68 -9.97 98.34 44.62 coo -14.82 14.90 -18.49 -14.21 12.08 -19.40 -20.19 69.79 30.19 -22.38 67.97 29.03 ULMN 3 1t0u_c01 URIDINE PHOSPHORYLASE user 10 3 # 10 B 8 HIS C 25 HIS^? 5.68 C3 PG4 C 145 B 80 GLU C 93 GLU^? -3.82 CH2 MLY C 67s B 223 ARG B 63 ARG~? -8.01 OH2 1PE B 150s coo -27.29 12.84 -47.54 -26.57 10.91 -47.95 -5.80 94.82 45.56 -7.26 95.23 44.11 coo -24.01 16.61 -49.84 -25.90 15.74 -49.71 -9.46 98.26 46.68 -9.97 98.34 44.62 coo -14.82 14.90 -18.49 -14.21 12.08 -19.40 -5.18 74.17 22.68 -2.11 73.83 22.90 ULMN 3 1t0u_c01 URIDINE PHOSPHORYLASE user 11 3 # 11 B 8 HIS C 25 HIS^? 5.68 C3 PG4 C 145 B 80 GLU C 93 GLU^? -3.82 CH2 MLY C 67s B 223 ARG C 42 ARG.? 7.63 O MLZ C 114 coo -27.29 12.84 -47.54 -26.57 10.91 -47.95 -5.80 94.82 45.56 -7.26 95.23 44.11 coo -24.01 16.61 -49.84 -25.90 15.74 -49.71 -9.46 98.26 46.68 -9.97 98.34 44.62 coo -14.82 14.90 -18.49 -14.21 12.08 -19.40 -13.55 84.90 75.42 -13.77 88.03 75.38 ULMN 3 1t0u_c01 URIDINE PHOSPHORYLASE user 12 3 # 12 B 8 HIS C 85 HIS.? 6.34 C1 PGE C 147 B 80 GLU C 84 GLU.? 10.77 O2 GOL B 149 B 223 ARG A 16 ARG~? -2.82 O4 SO4 A 143s coo -27.29 12.84 -47.54 -26.57 10.91 -47.95 -4.08 74.18 57.17 -4.69 74.12 59.17 coo -24.01 16.61 -49.84 -25.90 15.74 -49.71 2.34 77.12 55.01 3.46 78.21 53.60 coo -14.82 14.90 -18.49 -14.21 12.08 -19.40 -9.29 63.37 28.06 -8.90 62.24 30.90 ULMN 3 1t0u_c01 URIDINE PHOSPHORYLASE user 13 3 # 13 B 8 HIS C 85 HIS.? 6.34 C1 PGE C 147 B 80 GLU C 84 GLU.? 10.77 O2 GOL B 149 B 223 ARG A 20 ARG.? 4.64 CB MLZ A 129 coo -27.29 12.84 -47.54 -26.57 10.91 -47.95 -4.08 74.18 57.17 -4.69 74.12 59.17 coo -24.01 16.61 -49.84 -25.90 15.74 -49.71 2.34 77.12 55.01 3.46 78.21 53.60 coo -14.82 14.90 -18.49 -14.21 12.08 -19.40 -20.19 69.79 30.19 -22.38 67.97 29.03 ULMN 3 1t0u_c01 URIDINE PHOSPHORYLASE user 14 3 # 14 B 8 HIS C 85 HIS.? 6.34 C1 PGE C 147 B 80 GLU C 84 GLU.? 10.77 O2 GOL B 149 B 223 ARG C 105 ARG~? -3.12 O1 SO4 C 143s coo -27.29 12.84 -47.54 -26.57 10.91 -47.95 -4.08 74.18 57.17 -4.69 74.12 59.17 coo -24.01 16.61 -49.84 -25.90 15.74 -49.71 2.34 77.12 55.01 3.46 78.21 53.60 coo -14.82 14.90 -18.49 -14.21 12.08 -19.40 -3.93 106.64 63.12 -1.78 108.52 62.12 ULMN 3 1t0u_c01 URIDINE PHOSPHORYLASE user 15 3 # 15 B 8 HIS D 25 HIS^? 5.64 C8 PG4 D 144 B 80 GLU D 93 GLU^? -3.68 CE MLY D 67s B 223 ARG A 63 ARG~? 11.15 O28 2PE A 148 coo -27.29 12.84 -47.54 -26.57 10.91 -47.95 -36.75 65.22 11.65 -37.83 64.18 13.11 coo -24.01 16.61 -49.84 -25.90 15.74 -49.71 -41.50 66.77 12.62 -41.92 65.02 13.75 coo -14.82 14.90 -18.49 -14.21 12.08 -19.40 -18.54 46.85 28.43 -16.64 46.31 26.03 ULMN 3 1t0u_c01 URIDINE PHOSPHORYLASE user 16 3 # 16 B 8 HIS D 25 HIS^? 5.64 C8 PG4 D 144 B 80 GLU D 93 GLU^? -3.68 CE MLY D 67s B 223 ARG D 42 ARG.? 16.60 C9 2PE D 146 coo -27.29 12.84 -47.54 -26.57 10.91 -47.95 -36.75 65.22 11.65 -37.83 64.18 13.11 coo -24.01 16.61 -49.84 -25.90 15.74 -49.71 -41.50 66.77 12.62 -41.92 65.02 13.75 coo -14.82 14.90 -18.49 -14.21 12.08 -19.40 -32.78 97.24 12.74 -35.35 96.85 11.13 ULMN 3 1t0u_c01 URIDINE PHOSPHORYLASE user 17 3 # 17 B 8 HIS D 85 HIS.? 4.73 OH7 1PE B 150 B 80 GLU D 84 GLU.? 10.79 C1 GOL A 150 B 223 ARG B 16 ARG~? -3.64 O1 SO4 A 143s coo -27.29 12.84 -47.54 -26.57 10.91 -47.95 -18.08 79.12 16.04 -18.14 81.21 15.79 coo -24.01 16.61 -49.84 -25.90 15.74 -49.71 -17.40 74.78 10.23 -17.69 72.96 9.24 coo -14.82 14.90 -18.49 -14.21 12.08 -19.40 -4.85 63.18 38.40 -7.23 62.95 36.44 ULMN 3 1t0u_c01 URIDINE PHOSPHORYLASE user 18 3 # 18 B 8 HIS D 85 HIS.? 4.73 OH7 1PE B 150 B 80 GLU D 84 GLU.? 10.79 C1 GOL A 150 B 223 ARG B 110 ARG~? 10.12 O7 PE8 B 148 coo -27.29 12.84 -47.54 -26.57 10.91 -47.95 -18.08 79.12 16.04 -18.14 81.21 15.79 coo -24.01 16.61 -49.84 -25.90 15.74 -49.71 -17.40 74.78 10.23 -17.69 72.96 9.24 coo -14.82 14.90 -18.49 -14.21 12.08 -19.40 4.56 66.25 30.54 5.81 64.43 28.32 ULMN 3 1t0u_c01 URIDINE PHOSPHORYLASE user 19 3 # 19 B 8 HIS D 85 HIS.? 4.73 OH7 1PE B 150 B 80 GLU D 84 GLU.? 10.79 C1 GOL A 150 B 223 ARG D 105 ARG~? -8.15 O1 2PE D 146s coo -27.29 12.84 -47.54 -26.57 10.91 -47.95 -18.08 79.12 16.04 -18.14 81.21 15.79 coo -24.01 16.61 -49.84 -25.90 15.74 -49.71 -17.40 74.78 10.23 -17.69 72.96 9.24 coo -14.82 14.90 -18.49 -14.21 12.08 -19.40 -46.14 79.22 -1.30 -46.45 77.32 -3.67 1t0u_c01 source 1t0u URIDINE PHOSPHORYLASE : 19 hits 1t0u_c01 naa= 3 ULMN 3 1t4c_c02 FORMYL-COENZYME A TRANSFERASE user 1 3 # 1 A 261 GLY A 80 GLY.? 7.76 C1 GOL D 147 B 17 GLN A 82 GLN.? 6.12 C4 PGE A 147 B 140 GLU A 84 GLU.? 10.45 C3 GOL D 147 coo 61.49 19.86 5.96 61.52 19.46 5.16 -25.41 75.48 2.13 -25.84 75.58 1.39 coo 63.76 11.90 7.93 65.18 13.07 6.77 -26.22 72.35 -4.39 -27.71 71.44 -3.07 coo 66.44 19.00 7.38 67.69 17.67 8.37 -21.01 70.22 3.12 -21.10 71.95 4.30 ULMN 3 1t4c_c02 FORMYL-COENZYME A TRANSFERASE user 2 3 # 2 A 261 GLY B 80 GLY.? 7.38 C3 GOL C 149 B 17 GLN B 82 GLN.? 6.18 C4 PGE B 147 B 140 GLU B 84 GLU.? 10.31 O3 GOL C 149 coo 61.49 19.86 5.96 61.52 19.46 5.16 4.67 87.66 58.38 5.02 88.38 58.71 coo 63.76 11.90 7.93 65.18 13.07 6.77 10.55 92.05 57.61 8.91 92.76 56.34 coo 66.44 19.00 7.38 67.69 17.67 8.37 7.66 84.31 53.13 6.13 83.49 54.35 ULMN 3 1t4c_c02 FORMYL-COENZYME A TRANSFERASE user 3 3 # 3 A 261 GLY C 80 GLY.? 7.77 O2 GOL B 149 B 17 GLN C 82 GLN.? 6.72 C3 PGE C 147 B 140 GLU C 84 GLU.? 10.77 O2 GOL B 149 coo 61.49 19.86 5.96 61.52 19.46 5.16 4.31 74.26 49.15 4.26 73.42 48.97 coo 63.76 11.90 7.93 65.18 13.07 6.77 1.33 68.31 52.03 0.02 69.55 50.77 coo 66.44 19.00 7.38 67.69 17.67 8.37 2.34 77.12 55.01 3.46 78.21 53.60 ULMN 3 1t4c_c02 FORMYL-COENZYME A TRANSFERASE user 4 3 # 4 A 261 GLY D 80 GLY.? 7.47 C2 GOL A 150 B 17 GLN D 82 GLN.? 6.38 C25 1PE B 150 B 140 GLU D 84 GLU.? 10.79 C1 GOL A 150 coo 61.49 19.86 5.96 61.52 19.46 5.16 -13.78 69.07 11.78 -13.14 69.11 12.34 coo 63.76 11.90 7.93 65.18 13.07 6.77 -10.30 73.84 16.04 -11.87 72.70 17.06 coo 66.44 19.00 7.38 67.69 17.67 8.37 -17.40 74.78 10.23 -17.69 72.96 9.24 1t4c_c02 source 1t4c FORMYL-COENZYME A TRANSFERASE : 4 hits 1t4c_c02 naa= 3 ULMN 3 1ti6_c06 PYROGALLOL HYDROXYTRANSFERASE SMALL user 1 3 # 1 A 144 HIS A 115 HIS~? 12.27 C21 2PE A 148 A 174 ASP A 40 ASP.? 18.50 C9 2PE A 148 A 404 TYR A 50 TYR~? 5.51 CH2 MLY D 135 coo 18.51 -77.38 -39.07 19.76 -78.71 -38.04 -13.18 48.35 10.37 -12.55 46.36 10.33 coo 27.58 -77.64 -39.00 25.78 -78.57 -39.64 -5.23 45.83 3.63 -5.09 44.63 5.33 coo 14.43 -85.16 -40.78 16.47 -83.93 -39.31 -19.50 53.98 8.67 -20.18 55.72 10.74 1ti6_c06 source 1ti6 PYROGALLOL HYDROXYTRANSFERASE SMALL SUBUNIT : 1 hits 1ti6_c06 naa= 3 ULMN 3 1ti6_c07 PYROGALLOL HYDROXYTRANSFERASE SMALL user 1 3 # 1 C 144 HIS A 115 HIS~? 12.27 C21 2PE A 148 C 174 ASP A 40 ASP.? 18.50 C9 2PE A 148 C 404 TYR A 50 TYR~? 5.51 CH2 MLY D 135 coo -15.55 89.08 -13.38 -16.05 90.98 -14.11 -13.18 48.35 10.37 -12.55 46.36 10.33 coo -23.98 91.31 -16.16 -21.94 90.86 -16.65 -5.23 45.83 3.63 -5.09 44.63 5.33 coo -8.89 91.06 -18.89 -11.23 91.99 -17.67 -19.50 53.98 8.67 -20.18 55.72 10.74 1ti6_c07 source 1ti6 PYROGALLOL HYDROXYTRANSFERASE SMALL SUBUNIT : 1 hits 1ti6_c07 naa= 3 ULMN 3 1ti6_c08 PYROGALLOL HYDROXYTRANSFERASE SMALL user 1 3 # 1 E 144 HIS A 115 HIS~? 12.27 C21 2PE A 148 E 174 ASP A 40 ASP.? 18.50 C9 2PE A 148 E 404 TYR A 50 TYR~? 5.51 CH2 MLY D 135 coo -7.53-107.59 75.19 -8.14-106.04 76.47 -13.18 48.35 10.37 -12.55 46.36 10.33 coo -3.55-105.39 83.13 -5.21-106.24 82.09 -5.23 45.83 3.63 -5.09 44.63 5.33 coo -16.31-108.78 75.35 -14.20-107.14 76.16 -19.50 53.98 8.67 -20.18 55.72 10.74 1ti6_c08 source 1ti6 PYROGALLOL HYDROXYTRANSFERASE SMALL SUBUNIT : 1 hits 1ti6_c08 naa= 3 ULMN 3 1ti6_c09 PYROGALLOL HYDROXYTRANSFERASE SMALL user 1 3 # 1 G 144 HIS A 115 HIS~? 12.27 C21 2PE A 148 G 174 ASP A 40 ASP.? 18.50 C9 2PE A 148 G 404 TYR A 50 TYR~? 5.51 CH2 MLY D 135 coo 60.48-101.16 45.95 60.56-101.20 43.85 -13.18 48.35 10.37 -12.55 46.36 10.33 coo 58.10-108.15 40.62 59.57-106.86 41.51 -5.23 45.83 3.63 -5.09 44.63 5.33 coo 68.57 -97.60 44.49 66.22 -98.53 43.28 -19.50 53.98 8.67 -20.18 55.72 10.74 1ti6_c09 source 1ti6 PYROGALLOL HYDROXYTRANSFERASE SMALL SUBUNIT : 1 hits 1ti6_c09 naa= 3 ULMN 3 1ti6_c10 PYROGALLOL HYDROXYTRANSFERASE SMALL user 1 3 # 1 I 144 HIS A 115 HIS~? 12.27 C21 2PE A 148 I 174 ASP A 40 ASP.? 18.50 C9 2PE A 148 I 404 TYR A 50 TYR~? 5.51 CH2 MLY D 135 coo -12.68 -17.50 91.59 -12.79 -19.47 92.31 -13.18 48.35 10.37 -12.55 46.36 10.33 coo -20.27 -21.99 93.95 -18.47 -20.99 94.50 -5.23 45.83 3.63 -5.09 44.63 5.33 coo -5.95 -17.59 97.43 -7.86 -19.17 96.13 -19.50 53.98 8.67 -20.18 55.72 10.74 1ti6_c10 source 1ti6 PYROGALLOL HYDROXYTRANSFERASE SMALL SUBUNIT : 1 hits 1ti6_c10 naa= 3 ULMN 3 1ti6_c11 PYROGALLOL HYDROXYTRANSFERASE SMALL user 1 3 # 1 K 144 HIS A 115 HIS~? 12.27 C21 2PE A 148 K 174 ASP A 40 ASP.? 18.50 C9 2PE A 148 K 404 TYR A 50 TYR~? 5.51 CH2 MLY D 135 coo 100.18 26.45 -1.32 99.24 26.12 0.53 -13.18 48.35 10.37 -12.55 46.36 10.33 coo 102.36 30.86 6.31 102.45 29.08 5.12 -5.23 45.83 3.63 -5.09 44.63 5.33 coo 99.93 17.48 -0.85 99.14 19.86 0.39 -19.50 53.98 8.67 -20.18 55.72 10.74 1ti6_c11 source 1ti6 PYROGALLOL HYDROXYTRANSFERASE SMALL SUBUNIT : 1 hits 1ti6_c11 naa= 3 ULMN 3 1tz3_c02 PUTATIVE SUGAR KINASE user 1 3 # 1 A 250 ALA A 52 ALA~? 11.32 CD MLY D 135 A 251 GLY A 54 GLY~? 5.80 C21 2PE A 148 A 252 ASP A 56 ASP~? 11.59 C21 2PE A 148 coo 27.46 -16.39 -4.13 28.50 -15.30 -4.20 -17.75 46.92 10.26 -16.48 46.44 9.51 coo 24.64 -14.61 -2.31 24.63 -15.34 -2.63 -20.41 50.07 13.76 -19.88 49.43 13.69 coo 21.52 -17.78 -4.15 20.67 -16.16 -5.23 -16.01 45.89 15.64 -15.93 44.31 14.23 ULMN 3 1tz3_c02 PUTATIVE SUGAR KINASE user 2 3 # 2 A 250 ALA B 52 ALA~? 11.30 CE MLY C 135 A 251 GLY B 54 GLY~? 5.68 C20 PE8 B 148 A 252 ASP B 56 ASP~? 11.45 C20 PE8 B 148 coo 27.46 -16.39 -4.13 28.50 -15.30 -4.20 10.17 82.02 28.78 11.54 81.34 28.64 coo 24.64 -14.61 -2.31 24.63 -15.34 -2.63 5.02 82.24 30.45 5.51 81.90 29.87 coo 21.52 -17.78 -4.15 20.67 -16.16 -5.23 6.80 78.21 26.00 8.47 79.07 25.03 ULMN 3 1tz3_c02 PUTATIVE SUGAR KINASE user 3 3 # 3 A 250 ALA C 52 ALA~? 7.88 C MLZ C 114 A 251 GLY C 54 GLY~? 6.00 CH2 MLY B 135 A 252 ASP C 56 ASP~? 9.09 N MLZ C 114 coo 27.46 -16.39 -4.13 28.50 -15.30 -4.20 -16.51 88.80 66.17 -16.23 88.55 67.66 coo 24.64 -14.61 -2.31 24.63 -15.34 -2.63 -15.22 90.72 61.35 -15.47 90.98 62.07 coo 21.52 -17.78 -4.15 20.67 -16.16 -5.23 -16.40 94.43 66.11 -17.63 93.56 67.58 ULMN 3 1tz3_c02 PUTATIVE SUGAR KINASE user 4 3 # 4 A 250 ALA D 52 ALA~? 11.20 CE MLY A 135 A 251 GLY D 54 GLY~? 5.81 C23 2PE D 146 A 252 ASP D 56 ASP~? 11.46 C21 2PE D 146 coo 27.46 -16.39 -4.13 28.50 -15.30 -4.20 -36.92 88.76 16.36 -36.55 90.11 15.77 coo 24.64 -14.61 -2.31 24.63 -15.34 -2.63 -38.01 83.52 15.98 -38.33 84.28 15.84 coo 21.52 -17.78 -4.15 20.67 -16.16 -5.23 -41.85 87.81 13.66 -41.61 89.58 14.80 1tz3_c02 source 1tz3 PUTATIVE SUGAR KINASE : 4 hits 1tz3_c02 naa= 3 ULMN 3 1tz3_c03 PUTATIVE SUGAR KINASE user 1 3 # 1 B 250 ALA A 52 ALA~? 11.32 CD MLY D 135 B 251 GLY A 54 GLY~? 5.80 C21 2PE A 148 B 252 ASP A 56 ASP~? 11.59 C21 2PE A 148 coo 16.60 -23.26 -48.35 15.78 -24.48 -48.70 -17.75 46.92 10.26 -16.48 46.44 9.51 coo 14.17 -20.48 -49.26 14.89 -20.41 -48.91 -20.41 50.07 13.76 -19.88 49.43 13.69 coo 16.67 -17.59 -46.30 15.00 -17.34 -45.02 -16.01 45.89 15.64 -15.93 44.31 14.23 ULMN 3 1tz3_c03 PUTATIVE SUGAR KINASE user 2 3 # 2 B 250 ALA B 52 ALA~? 11.30 CE MLY C 135 B 251 GLY B 54 GLY~? 5.68 C20 PE8 B 148 B 252 ASP B 56 ASP~? 11.45 C20 PE8 B 148 coo 16.60 -23.26 -48.35 15.78 -24.48 -48.70 10.17 82.02 28.78 11.54 81.34 28.64 coo 14.17 -20.48 -49.26 14.89 -20.41 -48.91 5.02 82.24 30.45 5.51 81.90 29.87 coo 16.67 -17.59 -46.30 15.00 -17.34 -45.02 6.80 78.21 26.00 8.47 79.07 25.03 ULMN 3 1tz3_c03 PUTATIVE SUGAR KINASE user 3 3 # 3 B 250 ALA C 52 ALA~? 7.88 C MLZ C 114 B 251 GLY C 54 GLY~? 6.00 CH2 MLY B 135 B 252 ASP C 56 ASP~? 9.09 N MLZ C 114 coo 16.60 -23.26 -48.35 15.78 -24.48 -48.70 -16.51 88.80 66.17 -16.23 88.55 67.66 coo 14.17 -20.48 -49.26 14.89 -20.41 -48.91 -15.22 90.72 61.35 -15.47 90.98 62.07 coo 16.67 -17.59 -46.30 15.00 -17.34 -45.02 -16.40 94.43 66.11 -17.63 93.56 67.58 ULMN 3 1tz3_c03 PUTATIVE SUGAR KINASE user 4 3 # 4 B 250 ALA D 52 ALA~? 11.20 CE MLY A 135 B 251 GLY D 54 GLY~? 5.81 C23 2PE D 146 B 252 ASP D 56 ASP~? 11.46 C21 2PE D 146 coo 16.60 -23.26 -48.35 15.78 -24.48 -48.70 -36.92 88.76 16.36 -36.55 90.11 15.77 coo 14.17 -20.48 -49.26 14.89 -20.41 -48.91 -38.01 83.52 15.98 -38.33 84.28 15.84 coo 16.67 -17.59 -46.30 15.00 -17.34 -45.02 -41.85 87.81 13.66 -41.61 89.58 14.80 1tz3_c03 source 1tz3 PUTATIVE SUGAR KINASE : 4 hits 1tz3_c03 naa= 3 ULMN 3 1uf7_c00 N-CARBAMYL-D-AMINO ACID AMIDOHYDROLAuser 1 3 # 1 A 46 GLU B 102 GLU~? 6.18 O4 SO4 A 143 A 126 LYS A 9 LYS~? 8.68 C6 2PE A 148 A 171 ALA A 13 ALA~? 8.48 C3 2PE A 148 coo 52.87 81.38 -9.32 53.05 81.09 -7.22 -7.10 67.86 29.77 -6.34 66.05 29.12 coo 51.43 89.29 -7.19 53.08 83.69 -4.74 -4.77 65.74 20.08 0.46 67.29 18.98 coo 48.80 81.73 -5.45 50.30 81.43 -5.45 -7.72 67.72 25.29 -6.32 68.40 25.30 1uf7_c00 source 1uf7 N-CARBAMYL-D-AMINO ACID AMIDOHYDROLASE : 1 hits 1uf7_c00 naa= 3 ULMN 3 1uf7_c01 N-CARBAMYL-D-AMINO ACID AMIDOHYDROLAuser 1 3 # 1 B 46 GLU B 102 GLU~? 6.18 O4 SO4 A 143 B 126 LYS A 9 LYS~? 8.68 C6 2PE A 148 B 171 ALA A 13 ALA~? 8.48 C3 2PE A 148 coo 20.47 87.42 16.54 20.16 87.17 14.45 -7.10 67.86 29.77 -6.34 66.05 29.12 coo 24.73 94.37 14.59 21.08 89.84 11.98 -4.77 65.74 20.08 0.46 67.29 18.98 coo 24.38 86.32 12.71 22.88 86.54 12.71 -7.72 67.72 25.29 -6.32 68.40 25.30 1uf7_c01 source 1uf7 N-CARBAMYL-D-AMINO ACID AMIDOHYDROLASE : 1 hits 1uf7_c01 naa= 3 ULMN 3 1uk7_c00 3.07.01.0009 user 1 3 # 1 A 103 ALA A 49 ALA~? 12.15 CD MLY D 135 A 224 ASP A 56 ASP~? 11.59 C21 2PE A 148 A 252 HIS A 115 HIS~? 12.27 C21 2PE A 148 coo 10.74 41.88 -3.62 10.55 41.61 -5.11 -16.03 49.47 6.19 -14.84 50.27 5.67 coo 7.52 49.49 -8.72 7.95 47.43 -8.44 -16.01 45.89 15.64 -15.93 44.31 14.23 coo 9.83 44.81 -9.44 9.32 43.66 -7.77 -13.18 48.35 10.37 -12.55 46.36 10.33 ULMN 3 1uk7_c00 3.07.01.0009 user 2 3 # 2 A 103 ALA A 51 ALA~? 7.23 CD MLY D 135 A 224 ASP A 56 ASP~? 11.59 C21 2PE A 148 A 252 HIS A 115 HIS~? 12.27 C21 2PE A 148 coo 10.74 41.88 -3.62 10.55 41.61 -5.11 -20.65 48.85 8.75 -21.19 47.91 7.68 coo 7.52 49.49 -8.72 7.95 47.43 -8.44 -16.01 45.89 15.64 -15.93 44.31 14.23 coo 9.83 44.81 -9.44 9.32 43.66 -7.77 -13.18 48.35 10.37 -12.55 46.36 10.33 ULMN 3 1uk7_c00 3.07.01.0009 user 3 3 # 3 A 103 ALA B 49 ALA~? 10.91 O1 PEG B 144 A 224 ASP B 56 ASP~? 11.45 C20 PE8 B 148 A 252 HIS B 115 HIS~? 12.48 C18 PE8 B 148 coo 10.74 41.88 -3.62 10.55 41.61 -5.11 13.56 82.06 32.43 14.35 81.13 33.34 coo 7.52 49.49 -8.72 7.95 47.43 -8.44 6.80 78.21 26.00 8.47 79.07 25.03 coo 9.83 44.81 -9.44 9.32 43.66 -7.77 11.86 77.76 30.05 12.70 77.49 28.15 ULMN 3 1uk7_c00 3.07.01.0009 user 4 3 # 4 A 103 ALA B 51 ALA~? 7.25 CG MLY C 135 A 224 ASP B 56 ASP~? 11.45 C20 PE8 B 148 A 252 HIS B 115 HIS~? 12.48 C18 PE8 B 148 coo 10.74 41.88 -3.62 10.55 41.61 -5.11 9.29 84.92 31.07 10.11 86.09 30.55 coo 7.52 49.49 -8.72 7.95 47.43 -8.44 6.80 78.21 26.00 8.47 79.07 25.03 coo 9.83 44.81 -9.44 9.32 43.66 -7.77 11.86 77.76 30.05 12.70 77.49 28.15 ULMN 3 1uk7_c00 3.07.01.0009 user 5 3 # 5 A 103 ALA C 49 ALA~? 6.49 O MLZ C 114 A 224 ASP C 56 ASP~? 9.09 N MLZ C 114 A 252 HIS C 115 HIS~? 4.72 C MLZ C 114 coo 10.74 41.88 -3.62 10.55 41.61 -5.11 -13.48 85.10 67.69 -12.20 84.83 68.50 coo 7.52 49.49 -8.72 7.95 47.43 -8.44 -16.40 94.43 66.11 -17.63 93.56 67.58 coo 9.83 44.81 -9.44 9.32 43.66 -7.77 -12.99 90.00 69.08 -14.38 90.57 70.54 ULMN 3 1uk7_c00 3.07.01.0009 user 6 3 # 6 A 103 ALA C 51 ALA~? 7.46 CD MLY B 135 A 224 ASP C 56 ASP~? 9.09 N MLZ C 114 A 252 HIS C 115 HIS~? 4.72 C MLZ C 114 coo 10.74 41.88 -3.62 10.55 41.61 -5.11 -16.25 86.28 63.34 -17.35 85.28 63.69 coo 7.52 49.49 -8.72 7.95 47.43 -8.44 -16.40 94.43 66.11 -17.63 93.56 67.58 coo 9.83 44.81 -9.44 9.32 43.66 -7.77 -12.99 90.00 69.08 -14.38 90.57 70.54 ULMN 3 1uk7_c00 3.07.01.0009 user 7 3 # 7 A 103 ALA D 47 ALA~? 9.03 CG MLY A 135 A 224 ASP D 87 ASP.? 7.26 C16 1PE B 150 A 252 HIS D 88 HIS^? 4.38 CH1 MLY A 135 coo 10.74 41.88 -3.62 10.55 41.61 -5.11 -28.68 87.42 18.40 -28.00 87.29 19.73 coo 7.52 49.49 -8.72 7.95 47.43 -8.44 -24.70 80.89 17.41 -22.90 81.94 17.31 coo 9.83 44.81 -9.44 9.32 43.66 -7.77 -29.18 79.71 17.63 -29.43 81.25 19.03 ULMN 3 1uk7_c00 3.07.01.0009 user 8 3 # 8 A 103 ALA D 49 ALA~? 12.11 CE MLY A 135 A 224 ASP D 56 ASP~? 11.46 C21 2PE D 146 A 252 HIS D 115 HIS~? 12.18 C21 2PE D 146 coo 10.74 41.88 -3.62 10.55 41.61 -5.11 -32.13 89.91 15.13 -31.19 90.29 13.98 coo 7.52 49.49 -8.72 7.95 47.43 -8.44 -41.85 87.81 13.66 -41.61 89.58 14.80 coo 9.83 44.81 -9.44 9.32 43.66 -7.77 -36.28 90.32 11.92 -37.49 91.98 12.35 ULMN 3 1uk7_c00 3.07.01.0009 user 9 3 # 9 A 103 ALA D 51 ALA~? 6.92 CG MLY A 135 A 224 ASP D 56 ASP~? 11.46 C21 2PE D 146 A 252 HIS D 115 HIS~? 12.18 C21 2PE D 146 coo 10.74 41.88 -3.62 10.55 41.61 -5.11 -34.62 86.43 18.27 -34.28 87.19 19.52 coo 7.52 49.49 -8.72 7.95 47.43 -8.44 -41.85 87.81 13.66 -41.61 89.58 14.80 coo 9.83 44.81 -9.44 9.32 43.66 -7.77 -36.28 90.32 11.92 -37.49 91.98 12.35 1uk7_c00 source 1uk7 3.07.01.0009 : 9 hits 1uk7_c00 naa= 3 ULMN 3 1ula_c00 PURINE NUCLEOSIDE PHOSPHORYLASE (E.Cuser 1 3 # 1 86 HIS A 25 HIS^? 6.06 C MLZ A 129 89 GLU A 93 GLU^? 3.90 NZ MLY A 67 243 ASN D 28 ASN^? 3.51 CL CL D 143s coo 5.83 15.74 17.38 6.41 17.70 17.86 -27.47 64.89 22.81 -29.24 64.17 23.67 coo 3.11 16.19 13.44 4.96 17.09 13.42 -27.37 60.67 25.57 -29.32 61.09 26.31 coo 0.53 21.81 31.33 1.05 20.47 29.70 -31.24 74.87 11.89 -33.01 75.13 10.75 ULMN 3 1ula_c00 PURINE NUCLEOSIDE PHOSPHORYLASE (E.Cuser 2 3 # 2 86 HIS B 25 HIS^? 5.55 C6 PG4 C 145 89 GLU B 93 GLU^? 4.01 CE MLZ B 67 243 ASN C 28 ASN^? 3.42 CL CL C 144s coo 5.83 15.74 17.38 6.41 17.70 17.86 -10.19 81.59 41.51 -11.58 82.85 40.58 coo 3.11 16.19 13.44 4.96 17.09 13.42 -11.20 80.89 36.50 -12.93 82.08 36.76 coo 0.53 21.81 31.33 1.05 20.47 29.70 -6.06 88.35 54.50 -6.05 90.38 55.16 ULMN 3 1ula_c00 PURINE NUCLEOSIDE PHOSPHORYLASE (E.Cuser 3 3 # 3 86 HIS C 25 HIS^? 5.68 C3 PG4 C 145 89 GLU C 93 GLU^? -3.82 CH2 MLY C 67s 243 ASN B 28 ASN^? 3.43 CL CL B 143s coo 5.83 15.74 17.38 6.41 17.70 17.86 -5.80 94.82 45.56 -7.26 95.23 44.11 coo 3.11 16.19 13.44 4.96 17.09 13.42 -9.46 98.26 46.68 -9.97 98.34 44.62 coo 0.53 21.81 31.33 1.05 20.47 29.70 0.96 81.77 41.38 0.26 80.18 40.18 ULMN 3 1ula_c00 PURINE NUCLEOSIDE PHOSPHORYLASE (E.Cuser 4 3 # 4 86 HIS D 25 HIS^? 5.64 C8 PG4 D 144 89 GLU D 93 GLU^? -3.68 CE MLY D 67s 243 ASN A 28 ASN^? 3.50 CL CL A 145s coo 5.83 15.74 17.38 6.41 17.70 17.86 -36.75 65.22 11.65 -37.83 64.18 13.11 coo 3.11 16.19 13.44 4.96 17.09 13.42 -41.50 66.77 12.62 -41.92 65.02 13.75 coo 0.53 21.81 31.33 1.05 20.47 29.70 -22.13 61.51 13.69 -20.95 60.87 15.35 1ula_c00 source 1ula PURINE NUCLEOSIDE PHOSPHORYLASE (E.C.2.4.2.1) : 4 hits 1ula_c00 naa= 3 ULMN 3 1uok_c03 OLIGO-1,6-GLUCOSIDASE user 1 3 # 1 199 ASP A 83 ASP.? 8.52 O3 GOL D 147 255 GLU A 84 GLU.? 10.45 C3 GOL D 147 329 ASP A 122 ASP^? 7.46 C1 GOL A 150 coo 49.16 35.16 15.19 51.08 34.43 15.65 -19.46 70.43 -3.04 -19.06 72.28 -2.05 coo 52.57 37.12 10.17 53.37 35.95 11.75 -21.01 70.22 3.12 -21.10 71.95 4.30 coo 59.16 37.82 13.95 57.63 37.03 15.12 -15.41 64.92 4.51 -15.09 66.83 5.33 ULMN 3 1uok_c03 OLIGO-1,6-GLUCOSIDASE user 2 3 # 2 199 ASP A 122 ASP^? 7.46 C1 GOL A 150 255 GLU A 84 GLU.? 10.45 C3 GOL D 147 329 ASP A 83 ASP.? 8.52 O3 GOL D 147 coo 49.16 35.16 15.19 51.08 34.43 15.65 -15.41 64.92 4.51 -15.09 66.83 5.33 coo 52.57 37.12 10.17 53.37 35.95 11.75 -21.01 70.22 3.12 -21.10 71.95 4.30 coo 59.16 37.82 13.95 57.63 37.03 15.12 -19.46 70.43 -3.04 -19.06 72.28 -2.05 ULMN 3 1uok_c03 OLIGO-1,6-GLUCOSIDASE user 3 3 # 3 199 ASP B 83 ASP.? 9.40 O3 GOL C 149 255 GLU B 84 GLU.? 10.31 O3 GOL C 149 329 ASP B 122 ASP^? 7.33 O2 GOL B 149 coo 49.16 35.16 15.19 51.08 34.43 15.65 13.62 86.10 55.23 12.83 84.59 56.49 coo 52.57 37.12 10.17 53.37 35.95 11.75 7.66 84.31 53.13 6.13 83.49 54.35 coo 59.16 37.82 13.95 57.63 37.03 15.12 10.89 79.68 47.57 9.75 78.80 49.16 ULMN 3 1uok_c03 OLIGO-1,6-GLUCOSIDASE user 4 3 # 4 199 ASP B 122 ASP^? 7.33 O2 GOL B 149 255 GLU B 84 GLU.? 10.31 O3 GOL C 149 329 ASP B 83 ASP.? 9.40 O3 GOL C 149 coo 49.16 35.16 15.19 51.08 34.43 15.65 10.89 79.68 47.57 9.75 78.80 49.16 coo 52.57 37.12 10.17 53.37 35.95 11.75 7.66 84.31 53.13 6.13 83.49 54.35 coo 59.16 37.82 13.95 57.63 37.03 15.12 13.62 86.10 55.23 12.83 84.59 56.49 ULMN 3 1uok_c03 OLIGO-1,6-GLUCOSIDASE user 5 3 # 5 199 ASP C 83 ASP.? 8.65 O3 GOL B 149 255 GLU C 84 GLU.? 10.77 O2 GOL B 149 329 ASP C 122 ASP^? 7.22 C3 GOL C 149 coo 49.16 35.16 15.19 51.08 34.43 15.65 3.02 71.86 58.06 4.88 72.49 57.24 coo 52.57 37.12 10.17 53.37 35.95 11.75 2.34 77.12 55.01 3.46 78.21 53.60 coo 59.16 37.82 13.95 57.63 37.03 15.12 0.27 81.12 61.60 2.07 81.54 60.53 ULMN 3 1uok_c03 OLIGO-1,6-GLUCOSIDASE user 6 3 # 6 199 ASP C 122 ASP^? 7.22 C3 GOL C 149 255 GLU C 84 GLU.? 10.77 O2 GOL B 149 329 ASP C 83 ASP.? 8.65 O3 GOL B 149 coo 49.16 35.16 15.19 51.08 34.43 15.65 0.27 81.12 61.60 2.07 81.54 60.53 coo 52.57 37.12 10.17 53.37 35.95 11.75 2.34 77.12 55.01 3.46 78.21 53.60 coo 59.16 37.82 13.95 57.63 37.03 15.12 3.02 71.86 58.06 4.88 72.49 57.24 ULMN 3 1uok_c03 OLIGO-1,6-GLUCOSIDASE user 7 3 # 7 199 ASP D 83 ASP.? 8.76 O1 GOL A 150 255 GLU D 84 GLU.? 10.79 C1 GOL A 150 329 ASP D 122 ASP^? 7.49 C3 GOL D 147 coo 49.16 35.16 15.19 51.08 34.43 15.65 -12.54 78.43 10.94 -12.46 77.06 9.29 coo 52.57 37.12 10.17 53.37 35.95 11.75 -17.40 74.78 10.23 -17.69 72.96 9.24 coo 59.16 37.82 13.95 57.63 37.03 15.12 -21.82 80.90 7.85 -21.38 79.32 6.51 ULMN 3 1uok_c03 OLIGO-1,6-GLUCOSIDASE user 8 3 # 8 199 ASP D 122 ASP^? 7.49 C3 GOL D 147 255 GLU D 84 GLU.? 10.79 C1 GOL A 150 329 ASP D 83 ASP.? 8.76 O1 GOL A 150 coo 49.16 35.16 15.19 51.08 34.43 15.65 -21.82 80.90 7.85 -21.38 79.32 6.51 coo 52.57 37.12 10.17 53.37 35.95 11.75 -17.40 74.78 10.23 -17.69 72.96 9.24 coo 59.16 37.82 13.95 57.63 37.03 15.12 -12.54 78.43 10.94 -12.46 77.06 9.29 1uok_c03 source 1uok OLIGO-1,6-GLUCOSIDASE : 8 hits 1uok_c03 naa= 3 ULMN 3 1uok_c04 OLIGO-1,6-GLUCOSIDASE user 1 3 # 1 199 ASP A 6 ASP.? -3.91 C9 2PE A 148s 218 GLU D 93 GLU^? -3.68 CE MLY D 67s 329 ASP A 122 ASP^? 7.46 C1 GOL A 150 coo 49.16 35.16 15.19 51.08 34.43 15.65 -8.66 61.41 13.34 -8.76 59.35 12.80 coo 70.09 11.71 8.46 70.56 12.89 6.77 -41.50 66.77 12.62 -41.92 65.02 13.75 coo 59.16 37.82 13.95 57.63 37.03 15.12 -15.41 64.92 4.51 -15.09 66.83 5.33 ULMN 3 1uok_c04 OLIGO-1,6-GLUCOSIDASE user 2 3 # 2 199 ASP A 83 ASP.? 8.52 O3 GOL D 147 218 GLU B 62 GLU~? 5.14 OH2 1PE B 150 329 ASP A 122 ASP^? 7.46 C1 GOL A 150 coo 49.16 35.16 15.19 51.08 34.43 15.65 -19.46 70.43 -3.04 -19.06 72.28 -2.05 coo 70.09 11.71 8.46 70.56 12.89 6.77 -5.99 81.74 25.38 -5.29 83.68 24.76 coo 59.16 37.82 13.95 57.63 37.03 15.12 -15.41 64.92 4.51 -15.09 66.83 5.33 ULMN 3 1uok_c04 OLIGO-1,6-GLUCOSIDASE user 3 3 # 3 199 ASP A 106 ASP~? 11.93 O22 2PE A 148 218 GLU A 75 GLU.? -8.03 O4 PGE A 147s 329 ASP A 56 ASP~? 11.59 C21 2PE A 148 coo 49.16 35.16 15.19 51.08 34.43 15.65 -12.71 50.36 24.83 -13.06 48.30 25.05 coo 70.09 11.71 8.46 70.56 12.89 6.77 -34.40 63.01 2.19 -36.49 63.07 2.67 coo 59.16 37.82 13.95 57.63 37.03 15.12 -16.01 45.89 15.64 -15.93 44.31 14.23 ULMN 3 1uok_c04 OLIGO-1,6-GLUCOSIDASE user 4 3 # 4 199 ASP A 106 ASP~? 11.93 O22 2PE A 148 218 GLU A 84 GLU.? 10.45 C3 GOL D 147 329 ASP A 56 ASP~? 11.59 C21 2PE A 148 coo 49.16 35.16 15.19 51.08 34.43 15.65 -12.71 50.36 24.83 -13.06 48.30 25.05 coo 70.09 11.71 8.46 70.56 12.89 6.77 -21.01 70.22 3.12 -21.10 71.95 4.30 coo 59.16 37.82 13.95 57.63 37.03 15.12 -16.01 45.89 15.64 -15.93 44.31 14.23 ULMN 3 1uok_c04 OLIGO-1,6-GLUCOSIDASE user 5 3 # 5 199 ASP A 122 ASP^? 7.46 C1 GOL A 150 218 GLU A 21 GLU.? -3.95 C2 PEG A 146s 329 ASP A 6 ASP.? -3.91 C9 2PE A 148s coo 49.16 35.16 15.19 51.08 34.43 15.65 -15.41 64.92 4.51 -15.09 66.83 5.33 coo 70.09 11.71 8.46 70.56 12.89 6.77 -23.01 65.38 36.24 -23.03 64.85 38.31 coo 59.16 37.82 13.95 57.63 37.03 15.12 -8.66 61.41 13.34 -8.76 59.35 12.80 ULMN 3 1uok_c04 OLIGO-1,6-GLUCOSIDASE user 6 3 # 6 199 ASP A 122 ASP^? 7.46 C1 GOL A 150 218 GLU B 21 GLU.? -4.32 C4 PEG B 146s 329 ASP A 6 ASP.? -3.91 C9 2PE A 148s coo 49.16 35.16 15.19 51.08 34.43 15.65 -15.41 64.92 4.51 -15.09 66.83 5.33 coo 70.09 11.71 8.46 70.56 12.89 6.77 -19.10 71.22 37.43 -20.67 70.39 36.27 coo 59.16 37.82 13.95 57.63 37.03 15.12 -8.66 61.41 13.34 -8.76 59.35 12.80 ULMN 3 1uok_c04 OLIGO-1,6-GLUCOSIDASE user 7 3 # 7 199 ASP A 122 ASP^? 7.46 C1 GOL A 150 218 GLU D 21 GLU.? -13.48 O4 PEG D 145s 329 ASP A 83 ASP.? 8.52 O3 GOL D 147 coo 49.16 35.16 15.19 51.08 34.43 15.65 -15.41 64.92 4.51 -15.09 66.83 5.33 coo 70.09 11.71 8.46 70.56 12.89 6.77 -47.50 61.07 3.30 -49.50 60.44 2.88 coo 59.16 37.82 13.95 57.63 37.03 15.12 -19.46 70.43 -3.04 -19.06 72.28 -2.05 ULMN 3 1uok_c04 OLIGO-1,6-GLUCOSIDASE user 8 3 # 8 199 ASP B 6 ASP.? -3.99 C6 PE8 B 148s 218 GLU C 93 GLU^? -3.82 CH2 MLY C 67s 329 ASP B 122 ASP^? 7.33 O2 GOL B 149 coo 49.16 35.16 15.19 51.08 34.43 15.65 7.95 70.39 41.39 8.88 71.08 39.61 coo 70.09 11.71 8.46 70.56 12.89 6.77 -9.46 98.26 46.68 -9.97 98.34 44.62 coo 59.16 37.82 13.95 57.63 37.03 15.12 10.89 79.68 47.57 9.75 78.80 49.16 ULMN 3 1uok_c04 OLIGO-1,6-GLUCOSIDASE user 9 3 # 9 199 ASP B 106 ASP~? 11.87 OH2 1PE B 150 218 GLU B 75 GLU.? -3.56 CB MLZ C 129s 329 ASP B 56 ASP~? 11.45 C20 PE8 B 148 coo 49.16 35.16 15.19 51.08 34.43 15.65 -0.30 70.27 27.08 -0.10 70.78 25.05 coo 70.09 11.71 8.46 70.56 12.89 6.77 3.68 97.59 46.60 2.29 99.21 46.53 coo 59.16 37.82 13.95 57.63 37.03 15.12 6.80 78.21 26.00 8.47 79.07 25.03 ULMN 3 1uok_c04 OLIGO-1,6-GLUCOSIDASE user 10 3 # 10 199 ASP B 106 ASP~? 11.87 OH2 1PE B 150 218 GLU B 84 GLU.? 10.31 O3 GOL C 149 329 ASP B 56 ASP~? 11.45 C20 PE8 B 148 coo 49.16 35.16 15.19 51.08 34.43 15.65 -0.30 70.27 27.08 -0.10 70.78 25.05 coo 70.09 11.71 8.46 70.56 12.89 6.77 7.66 84.31 53.13 6.13 83.49 54.35 coo 59.16 37.82 13.95 57.63 37.03 15.12 6.80 78.21 26.00 8.47 79.07 25.03 ULMN 3 1uok_c04 OLIGO-1,6-GLUCOSIDASE user 11 3 # 11 199 ASP B 122 ASP^? 7.33 O2 GOL B 149 218 GLU A 10 GLU~? 8.70 C6 2PE A 148 329 ASP B 87 ASP.? 8.94 O4 PGE B 147 coo 49.16 35.16 15.19 51.08 34.43 15.65 10.89 79.68 47.57 9.75 78.80 49.16 coo 70.09 11.71 8.46 70.56 12.89 6.77 -3.10 70.57 20.07 -2.45 69.30 18.38 coo 59.16 37.82 13.95 57.63 37.03 15.12 9.49 87.97 42.02 11.31 87.98 43.09 ULMN 3 1uok_c04 OLIGO-1,6-GLUCOSIDASE user 12 3 # 12 199 ASP B 122 ASP^? 7.33 O2 GOL B 149 218 GLU B 21 GLU.? -4.32 C4 PEG B 146s 329 ASP B 6 ASP.? -3.99 C6 PE8 B 148s coo 49.16 35.16 15.19 51.08 34.43 15.65 10.89 79.68 47.57 9.75 78.80 49.16 coo 70.09 11.71 8.46 70.56 12.89 6.77 -19.10 71.22 37.43 -20.67 70.39 36.27 coo 59.16 37.82 13.95 57.63 37.03 15.12 7.95 70.39 41.39 8.88 71.08 39.61 ULMN 3 1uok_c04 OLIGO-1,6-GLUCOSIDASE user 13 3 # 13 199 ASP B 122 ASP^? 7.33 O2 GOL B 149 218 GLU C 21 GLU.? -6.38 O2 PEG C 146s 329 ASP B 83 ASP.? 9.40 O3 GOL C 149 coo 49.16 35.16 15.19 51.08 34.43 15.65 10.89 79.68 47.57 9.75 78.80 49.16 coo 70.09 11.71 8.46 70.56 12.89 6.77 -3.17 108.79 44.43 -3.64 110.82 43.98 coo 59.16 37.82 13.95 57.63 37.03 15.12 13.62 86.10 55.23 12.83 84.59 56.49 ULMN 3 1uok_c04 OLIGO-1,6-GLUCOSIDASE user 14 3 # 14 199 ASP C 6 ASP.? -4.04 C8 PE8 C 148s 218 GLU B 93 GLU^? 4.01 CE MLZ B 67 329 ASP C 122 ASP^? 7.22 C3 GOL C 149 coo 49.16 35.16 15.19 51.08 34.43 15.65 0.53 91.96 65.64 -1.31 91.68 66.68 coo 70.09 11.71 8.46 70.56 12.89 6.77 -11.20 80.89 36.50 -12.93 82.08 36.76 coo 59.16 37.82 13.95 57.63 37.03 15.12 0.27 81.12 61.60 2.07 81.54 60.53 ULMN 3 1uok_c04 OLIGO-1,6-GLUCOSIDASE user 15 3 # 15 199 ASP C 106 ASP~? 12.11 C21 PE8 C 148 218 GLU C 75 GLU.? -8.81 O1 PGE C 147s 329 ASP C 56 ASP~? 9.09 N MLZ C 114 coo 49.16 35.16 15.19 51.08 34.43 15.65 -11.06 103.55 63.77 -13.00 104.00 64.35 coo 70.09 11.71 8.46 70.56 12.89 6.77 -10.84 73.75 47.59 -11.85 73.47 45.72 coo 59.16 37.82 13.95 57.63 37.03 15.12 -16.40 94.43 66.11 -17.63 93.56 67.58 ULMN 3 1uok_c04 OLIGO-1,6-GLUCOSIDASE user 16 3 # 16 199 ASP C 106 ASP~? 12.11 C21 PE8 C 148 218 GLU C 84 GLU.? 10.77 O2 GOL B 149 329 ASP C 56 ASP~? 9.09 N MLZ C 114 coo 49.16 35.16 15.19 51.08 34.43 15.65 -11.06 103.55 63.77 -13.00 104.00 64.35 coo 70.09 11.71 8.46 70.56 12.89 6.77 2.34 77.12 55.01 3.46 78.21 53.60 coo 59.16 37.82 13.95 57.63 37.03 15.12 -16.40 94.43 66.11 -17.63 93.56 67.58 ULMN 3 1uok_c04 OLIGO-1,6-GLUCOSIDASE user 17 3 # 17 199 ASP C 122 ASP^? 7.22 C3 GOL C 149 218 GLU B 21 GLU.? -4.32 C4 PEG B 146s 329 ASP C 83 ASP.? 8.65 O3 GOL B 149 coo 49.16 35.16 15.19 51.08 34.43 15.65 0.27 81.12 61.60 2.07 81.54 60.53 coo 70.09 11.71 8.46 70.56 12.89 6.77 -19.10 71.22 37.43 -20.67 70.39 36.27 coo 59.16 37.82 13.95 57.63 37.03 15.12 3.02 71.86 58.06 4.88 72.49 57.24 ULMN 3 1uok_c04 OLIGO-1,6-GLUCOSIDASE user 18 3 # 18 199 ASP C 122 ASP^? 7.22 C3 GOL C 149 218 GLU C 21 GLU.? -6.38 O2 PEG C 146s 329 ASP C 6 ASP.? -4.04 C8 PE8 C 148s coo 49.16 35.16 15.19 51.08 34.43 15.65 0.27 81.12 61.60 2.07 81.54 60.53 coo 70.09 11.71 8.46 70.56 12.89 6.77 -3.17 108.79 44.43 -3.64 110.82 43.98 coo 59.16 37.82 13.95 57.63 37.03 15.12 0.53 91.96 65.64 -1.31 91.68 66.68 ULMN 3 1uok_c04 OLIGO-1,6-GLUCOSIDASE user 19 3 # 19 199 ASP D 6 ASP.? -3.77 C8 2PE D 146s 218 GLU A 93 GLU^? 3.90 NZ MLY A 67 329 ASP D 122 ASP^? 7.49 C3 GOL D 147 coo 49.16 35.16 15.19 51.08 34.43 15.65 -31.03 82.87 1.04 -31.83 84.41 2.29 coo 70.09 11.71 8.46 70.56 12.89 6.77 -27.37 60.67 25.57 -29.32 61.09 26.31 coo 59.16 37.82 13.95 57.63 37.03 15.12 -21.82 80.90 7.85 -21.38 79.32 6.51 ULMN 3 1uok_c04 OLIGO-1,6-GLUCOSIDASE user 20 3 # 20 199 ASP D 106 ASP~? 11.82 O22 2PE D 146 218 GLU D 75 GLU.? -3.59 CB MLZ A 129s 329 ASP D 56 ASP~? 11.46 C21 2PE D 146 coo 49.16 35.16 15.19 51.08 34.43 15.65 -46.82 82.57 5.87 -48.37 83.43 7.00 coo 70.09 11.71 8.46 70.56 12.89 6.77 -21.02 72.19 24.99 -21.34 70.79 26.58 coo 59.16 37.82 13.95 57.63 37.03 15.12 -41.85 87.81 13.66 -41.61 89.58 14.80 ULMN 3 1uok_c04 OLIGO-1,6-GLUCOSIDASE user 21 3 # 21 199 ASP D 106 ASP~? 11.82 O22 2PE D 146 218 GLU D 84 GLU.? 10.79 C1 GOL A 150 329 ASP D 56 ASP~? 11.46 C21 2PE D 146 coo 49.16 35.16 15.19 51.08 34.43 15.65 -46.82 82.57 5.87 -48.37 83.43 7.00 coo 70.09 11.71 8.46 70.56 12.89 6.77 -17.40 74.78 10.23 -17.69 72.96 9.24 coo 59.16 37.82 13.95 57.63 37.03 15.12 -41.85 87.81 13.66 -41.61 89.58 14.80 ULMN 3 1uok_c04 OLIGO-1,6-GLUCOSIDASE user 22 3 # 22 199 ASP D 122 ASP^? 7.49 C3 GOL D 147 218 GLU A 21 GLU.? -3.95 C2 PEG A 146s 329 ASP D 83 ASP.? 8.76 O1 GOL A 150 coo 49.16 35.16 15.19 51.08 34.43 15.65 -21.82 80.90 7.85 -21.38 79.32 6.51 coo 70.09 11.71 8.46 70.56 12.89 6.77 -23.01 65.38 36.24 -23.03 64.85 38.31 coo 59.16 37.82 13.95 57.63 37.03 15.12 -12.54 78.43 10.94 -12.46 77.06 9.29 ULMN 3 1uok_c04 OLIGO-1,6-GLUCOSIDASE user 23 3 # 23 199 ASP D 122 ASP^? 7.49 C3 GOL D 147 218 GLU B 21 GLU.? -4.32 C4 PEG B 146s 329 ASP D 83 ASP.? 8.76 O1 GOL A 150 coo 49.16 35.16 15.19 51.08 34.43 15.65 -21.82 80.90 7.85 -21.38 79.32 6.51 coo 70.09 11.71 8.46 70.56 12.89 6.77 -19.10 71.22 37.43 -20.67 70.39 36.27 coo 59.16 37.82 13.95 57.63 37.03 15.12 -12.54 78.43 10.94 -12.46 77.06 9.29 ULMN 3 1uok_c04 OLIGO-1,6-GLUCOSIDASE user 24 3 # 24 199 ASP D 122 ASP^? 7.49 C3 GOL D 147 218 GLU D 21 GLU.? -13.48 O4 PEG D 145s 329 ASP D 6 ASP.? -3.77 C8 2PE D 146s coo 49.16 35.16 15.19 51.08 34.43 15.65 -21.82 80.90 7.85 -21.38 79.32 6.51 coo 70.09 11.71 8.46 70.56 12.89 6.77 -47.50 61.07 3.30 -49.50 60.44 2.88 coo 59.16 37.82 13.95 57.63 37.03 15.12 -31.03 82.87 1.04 -31.83 84.41 2.29 1uok_c04 source 1uok OLIGO-1,6-GLUCOSIDASE : 24 hits 1uok_c04 naa= 3 ULMN 3 1uok_c05 OLIGO-1,6-GLUCOSIDASE user 1 3 # 1 199 ASP A 56 ASP~? 11.59 C21 2PE A 148 242 GLU A 43 GLU.? 22.22 CD MLY D 135 329 ASP A 106 ASP~? 11.93 O22 2PE A 148 coo 49.16 35.16 15.19 51.08 34.43 15.65 -16.01 45.89 15.64 -15.93 44.31 14.23 coo 30.42 34.74 5.00 29.09 35.09 3.38 -10.18 46.49 -4.16 -10.86 48.08 -5.46 coo 59.16 37.82 13.95 57.63 37.03 15.12 -12.71 50.36 24.83 -13.06 48.30 25.05 ULMN 3 1uok_c05 OLIGO-1,6-GLUCOSIDASE user 2 3 # 2 199 ASP A 106 ASP~? 11.93 O22 2PE A 148 242 GLU A 21 GLU.? -3.95 C2 PEG A 146s 329 ASP A 56 ASP~? 11.59 C21 2PE A 148 coo 49.16 35.16 15.19 51.08 34.43 15.65 -12.71 50.36 24.83 -13.06 48.30 25.05 coo 30.42 34.74 5.00 29.09 35.09 3.38 -23.01 65.38 36.24 -23.03 64.85 38.31 coo 59.16 37.82 13.95 57.63 37.03 15.12 -16.01 45.89 15.64 -15.93 44.31 14.23 ULMN 3 1uok_c05 OLIGO-1,6-GLUCOSIDASE user 3 3 # 3 199 ASP A 122 ASP^? 7.46 C1 GOL A 150 242 GLU A 10 GLU~? 8.70 C6 2PE A 148 329 ASP A 83 ASP.? 8.52 O3 GOL D 147 coo 49.16 35.16 15.19 51.08 34.43 15.65 -15.41 64.92 4.51 -15.09 66.83 5.33 coo 30.42 34.74 5.00 29.09 35.09 3.38 -3.10 70.57 20.07 -2.45 69.30 18.38 coo 59.16 37.82 13.95 57.63 37.03 15.12 -19.46 70.43 -3.04 -19.06 72.28 -2.05 ULMN 3 1uok_c05 OLIGO-1,6-GLUCOSIDASE user 4 3 # 4 199 ASP A 122 ASP^? 7.46 C1 GOL A 150 242 GLU A 10 GLU~? 8.70 C6 2PE A 148 329 ASP A 87 ASP.? 8.49 C6 PGE A 147 coo 49.16 35.16 15.19 51.08 34.43 15.65 -15.41 64.92 4.51 -15.09 66.83 5.33 coo 30.42 34.74 5.00 29.09 35.09 3.38 -3.10 70.57 20.07 -2.45 69.30 18.38 coo 59.16 37.82 13.95 57.63 37.03 15.12 -23.17 58.67 3.55 -22.34 59.17 1.69 ULMN 3 1uok_c05 OLIGO-1,6-GLUCOSIDASE user 5 3 # 5 199 ASP B 56 ASP~? 11.45 C20 PE8 B 148 242 GLU B 43 GLU.? 6.93 O1 PEG B 144 329 ASP B 106 ASP~? 11.87 OH2 1PE B 150 coo 49.16 35.16 15.19 51.08 34.43 15.65 6.80 78.21 26.00 8.47 79.07 25.03 coo 30.42 34.74 5.00 29.09 35.09 3.38 25.26 83.58 33.36 26.25 82.60 35.01 coo 59.16 37.82 13.95 57.63 37.03 15.12 -0.30 70.27 27.08 -0.10 70.78 25.05 ULMN 3 1uok_c05 OLIGO-1,6-GLUCOSIDASE user 6 3 # 6 199 ASP B 106 ASP~? 11.87 OH2 1PE B 150 242 GLU A 102 GLU~? 6.28 O2 SO4 A 143 329 ASP B 56 ASP~? 11.45 C20 PE8 B 148 coo 49.16 35.16 15.19 51.08 34.43 15.65 -0.30 70.27 27.08 -0.10 70.78 25.05 coo 30.42 34.74 5.00 29.09 35.09 3.38 -14.00 55.24 30.65 -12.08 54.69 31.20 coo 59.16 37.82 13.95 57.63 37.03 15.12 6.80 78.21 26.00 8.47 79.07 25.03 ULMN 3 1uok_c05 OLIGO-1,6-GLUCOSIDASE user 7 3 # 7 199 ASP B 106 ASP~? 11.87 OH2 1PE B 150 242 GLU B 21 GLU.? -4.32 C4 PEG B 146s 329 ASP B 56 ASP~? 11.45 C20 PE8 B 148 coo 49.16 35.16 15.19 51.08 34.43 15.65 -0.30 70.27 27.08 -0.10 70.78 25.05 coo 30.42 34.74 5.00 29.09 35.09 3.38 -19.10 71.22 37.43 -20.67 70.39 36.27 coo 59.16 37.82 13.95 57.63 37.03 15.12 6.80 78.21 26.00 8.47 79.07 25.03 ULMN 3 1uok_c05 OLIGO-1,6-GLUCOSIDASE user 8 3 # 8 199 ASP B 106 ASP~? 11.87 OH2 1PE B 150 242 GLU D 75 GLU.? -3.59 CB MLZ A 129s 329 ASP B 56 ASP~? 11.45 C20 PE8 B 148 coo 49.16 35.16 15.19 51.08 34.43 15.65 -0.30 70.27 27.08 -0.10 70.78 25.05 coo 30.42 34.74 5.00 29.09 35.09 3.38 -21.02 72.19 24.99 -21.34 70.79 26.58 coo 59.16 37.82 13.95 57.63 37.03 15.12 6.80 78.21 26.00 8.47 79.07 25.03 ULMN 3 1uok_c05 OLIGO-1,6-GLUCOSIDASE user 9 3 # 9 199 ASP B 122 ASP^? 7.33 O2 GOL B 149 242 GLU B 10 GLU~? 8.46 C3 PE8 B 148 329 ASP B 83 ASP.? 9.40 O3 GOL C 149 coo 49.16 35.16 15.19 51.08 34.43 15.65 10.89 79.68 47.57 9.75 78.80 49.16 coo 30.42 34.74 5.00 29.09 35.09 3.38 2.64 60.90 47.80 4.72 61.28 47.03 coo 59.16 37.82 13.95 57.63 37.03 15.12 13.62 86.10 55.23 12.83 84.59 56.49 ULMN 3 1uok_c05 OLIGO-1,6-GLUCOSIDASE user 10 3 # 10 199 ASP B 122 ASP^? 7.33 O2 GOL B 149 242 GLU B 10 GLU~? 8.46 C3 PE8 B 148 329 ASP B 87 ASP.? 8.94 O4 PGE B 147 coo 49.16 35.16 15.19 51.08 34.43 15.65 10.89 79.68 47.57 9.75 78.80 49.16 coo 30.42 34.74 5.00 29.09 35.09 3.38 2.64 60.90 47.80 4.72 61.28 47.03 coo 59.16 37.82 13.95 57.63 37.03 15.12 9.49 87.97 42.02 11.31 87.98 43.09 ULMN 3 1uok_c05 OLIGO-1,6-GLUCOSIDASE user 11 3 # 11 199 ASP B 122 ASP^? 7.33 O2 GOL B 149 242 GLU C 75 GLU.? -8.81 O1 PGE C 147s 329 ASP B 83 ASP.? 9.40 O3 GOL C 149 coo 49.16 35.16 15.19 51.08 34.43 15.65 10.89 79.68 47.57 9.75 78.80 49.16 coo 30.42 34.74 5.00 29.09 35.09 3.38 -10.84 73.75 47.59 -11.85 73.47 45.72 coo 59.16 37.82 13.95 57.63 37.03 15.12 13.62 86.10 55.23 12.83 84.59 56.49 ULMN 3 1uok_c05 OLIGO-1,6-GLUCOSIDASE user 12 3 # 12 199 ASP C 106 ASP~? 12.11 C21 PE8 C 148 242 GLU C 21 GLU.? -6.38 O2 PEG C 146s 329 ASP C 56 ASP~? 9.09 N MLZ C 114 coo 49.16 35.16 15.19 51.08 34.43 15.65 -11.06 103.55 63.77 -13.00 104.00 64.35 coo 30.42 34.74 5.00 29.09 35.09 3.38 -3.17 108.79 44.43 -3.64 110.82 43.98 coo 59.16 37.82 13.95 57.63 37.03 15.12 -16.40 94.43 66.11 -17.63 93.56 67.58 ULMN 3 1uok_c05 OLIGO-1,6-GLUCOSIDASE user 13 3 # 13 199 ASP C 122 ASP^? 7.22 C3 GOL C 149 242 GLU C 10 GLU~? 8.32 O4 PE8 C 148 329 ASP C 87 ASP.? 8.84 O1 PGE C 147 coo 49.16 35.16 15.19 51.08 34.43 15.65 0.27 81.12 61.60 2.07 81.54 60.53 coo 30.42 34.74 5.00 29.09 35.09 3.38 11.17 98.18 63.71 10.29 96.83 65.21 coo 59.16 37.82 13.95 57.63 37.03 15.12 -9.03 79.00 58.44 -8.21 77.39 59.55 ULMN 3 1uok_c05 OLIGO-1,6-GLUCOSIDASE user 14 3 # 14 199 ASP D 56 ASP~? 11.46 C21 2PE D 146 242 GLU D 43 GLU.? 21.91 OH7 1PE B 150 329 ASP D 106 ASP~? 11.82 O22 2PE D 146 coo 49.16 35.16 15.19 51.08 34.43 15.65 -41.85 87.81 13.66 -41.61 89.58 14.80 coo 30.42 34.74 5.00 29.09 35.09 3.38 -25.19 99.19 16.02 -23.48 99.27 14.73 coo 59.16 37.82 13.95 57.63 37.03 15.12 -46.82 82.57 5.87 -48.37 83.43 7.00 ULMN 3 1uok_c05 OLIGO-1,6-GLUCOSIDASE user 15 3 # 15 199 ASP D 83 ASP.? 8.76 O1 GOL A 150 242 GLU B 102 GLU~? 6.18 O4 SO4 A 143 329 ASP D 122 ASP^? 7.49 C3 GOL D 147 coo 49.16 35.16 15.19 51.08 34.43 15.65 -12.54 78.43 10.94 -12.46 77.06 9.29 coo 30.42 34.74 5.00 29.09 35.09 3.38 -7.10 67.86 29.77 -6.34 66.05 29.12 coo 59.16 37.82 13.95 57.63 37.03 15.12 -21.82 80.90 7.85 -21.38 79.32 6.51 ULMN 3 1uok_c05 OLIGO-1,6-GLUCOSIDASE user 16 3 # 16 199 ASP D 87 ASP.? 7.26 C16 1PE B 150 242 GLU B 21 GLU.? -4.32 C4 PEG B 146s 329 ASP D 122 ASP^? 7.49 C3 GOL D 147 coo 49.16 35.16 15.19 51.08 34.43 15.65 -24.70 80.89 17.41 -22.90 81.94 17.31 coo 30.42 34.74 5.00 29.09 35.09 3.38 -19.10 71.22 37.43 -20.67 70.39 36.27 coo 59.16 37.82 13.95 57.63 37.03 15.12 -21.82 80.90 7.85 -21.38 79.32 6.51 ULMN 3 1uok_c05 OLIGO-1,6-GLUCOSIDASE user 17 3 # 17 199 ASP D 106 ASP~? 11.82 O22 2PE D 146 242 GLU D 21 GLU.? -13.48 O4 PEG D 145s 329 ASP D 56 ASP~? 11.46 C21 2PE D 146 coo 49.16 35.16 15.19 51.08 34.43 15.65 -46.82 82.57 5.87 -48.37 83.43 7.00 coo 30.42 34.74 5.00 29.09 35.09 3.38 -47.50 61.07 3.30 -49.50 60.44 2.88 coo 59.16 37.82 13.95 57.63 37.03 15.12 -41.85 87.81 13.66 -41.61 89.58 14.80 1uok_c05 source 1uok OLIGO-1,6-GLUCOSIDASE : 17 hits 1uok_c05 naa= 3 ULMN 3 1v0e_c00 ENDO-ALPHA-SIALIDASE user 1 3 # 1 A 581 GLU A 102 GLU~? 6.28 O2 SO4 A 143 A 596 ARG A 105 ARG~? -3.04 O2 SO4 A 143s A 647 ARG A 16 ARG~? -2.82 O4 SO4 A 143s coo 69.13 32.20 28.58 68.39 32.96 30.44 -14.00 55.24 30.65 -12.08 54.69 31.20 coo 70.89 37.31 29.70 69.54 36.29 32.39 -8.78 56.32 28.12 -7.90 58.53 30.04 coo 66.09 40.54 34.70 66.92 37.69 35.49 -9.29 63.37 28.06 -8.90 62.24 30.90 ULMN 3 1v0e_c00 ENDO-ALPHA-SIALIDASE user 2 3 # 2 A 581 GLU A 102 GLU~? 6.28 O2 SO4 A 143 A 596 ARG A 105 ARG~? -3.04 O2 SO4 A 143s A 647 ARG A 110 ARG~? -3.66 O1 2PE A 148s coo 69.13 32.20 28.58 68.39 32.96 30.44 -14.00 55.24 30.65 -12.08 54.69 31.20 coo 70.89 37.31 29.70 69.54 36.29 32.39 -8.78 56.32 28.12 -7.90 58.53 30.04 coo 66.09 40.54 34.70 66.92 37.69 35.49 -6.91 52.41 21.82 -5.61 55.22 21.43 ULMN 3 1v0e_c00 ENDO-ALPHA-SIALIDASE user 3 3 # 3 A 581 GLU B 43 GLU.? 6.93 O1 PEG B 144 A 596 ARG B 35 ARG.? 9.50 O1 PEG B 144 A 647 ARG B 33 ARG.? -3.91 C3 PEG B 144s coo 69.13 32.20 28.58 68.39 32.96 30.44 25.26 83.58 33.36 26.25 82.60 35.01 coo 70.89 37.31 29.70 69.54 36.29 32.39 22.76 84.08 36.32 22.81 87.07 35.45 coo 66.09 40.54 34.70 66.92 37.69 35.49 17.31 79.39 40.81 17.39 77.24 43.00 ULMN 3 1v0e_c00 ENDO-ALPHA-SIALIDASE user 4 3 # 4 A 581 GLU B 102 GLU~? 6.18 O4 SO4 A 143 A 596 ARG A 16 ARG~? -2.82 O4 SO4 A 143s A 647 ARG A 105 ARG~? -3.04 O2 SO4 A 143s coo 69.13 32.20 28.58 68.39 32.96 30.44 -7.10 67.86 29.77 -6.34 66.05 29.12 coo 70.89 37.31 29.70 69.54 36.29 32.39 -9.29 63.37 28.06 -8.90 62.24 30.90 coo 66.09 40.54 34.70 66.92 37.69 35.49 -8.78 56.32 28.12 -7.90 58.53 30.04 ULMN 3 1v0e_c00 ENDO-ALPHA-SIALIDASE user 5 3 # 5 A 581 GLU B 102 GLU~? 6.18 O4 SO4 A 143 A 596 ARG B 105 ARG~? -3.01 O4 SO4 A 143s A 647 ARG B 16 ARG~? -3.64 O1 SO4 A 143s coo 69.13 32.20 28.58 68.39 32.96 30.44 -7.10 67.86 29.77 -6.34 66.05 29.12 coo 70.89 37.31 29.70 69.54 36.29 32.39 -2.68 64.28 31.62 -4.52 62.28 32.99 coo 66.09 40.54 34.70 66.92 37.69 35.49 -4.85 63.18 38.40 -7.23 62.95 36.44 ULMN 3 1v0e_c00 ENDO-ALPHA-SIALIDASE user 6 3 # 6 A 581 GLU B 102 GLU~? 6.18 O4 SO4 A 143 A 596 ARG B 105 ARG~? -3.01 O4 SO4 A 143s A 647 ARG B 110 ARG~? 10.12 O7 PE8 B 148 coo 69.13 32.20 28.58 68.39 32.96 30.44 -7.10 67.86 29.77 -6.34 66.05 29.12 coo 70.89 37.31 29.70 69.54 36.29 32.39 -2.68 64.28 31.62 -4.52 62.28 32.99 coo 66.09 40.54 34.70 66.92 37.69 35.49 4.56 66.25 30.54 5.81 64.43 28.32 ULMN 3 1v0e_c00 ENDO-ALPHA-SIALIDASE user 7 3 # 7 A 581 GLU B 121 GLU^? 8.74 O2 PEG B 144 A 596 ARG B 33 ARG.? -3.91 C3 PEG B 144s A 647 ARG B 35 ARG.? 9.50 O1 PEG B 144 coo 69.13 32.20 28.58 68.39 32.96 30.44 15.37 80.83 45.64 16.23 82.69 46.15 coo 70.89 37.31 29.70 69.54 36.29 32.39 17.31 79.39 40.81 17.39 77.24 43.00 coo 66.09 40.54 34.70 66.92 37.69 35.49 22.76 84.08 36.32 22.81 87.07 35.45 ULMN 3 1v0e_c00 ENDO-ALPHA-SIALIDASE user 8 3 # 8 A 581 GLU C 102 GLU~? 5.77 O1 SO4 C 143 A 596 ARG C 105 ARG~? -3.12 O1 SO4 C 143s A 647 ARG C 16 ARG~? -2.96 O3 SO4 C 143s coo 69.13 32.20 28.58 68.39 32.96 30.44 -7.47 107.78 58.43 -6.93 108.85 60.16 coo 70.89 37.31 29.70 69.54 36.29 32.39 -3.93 106.64 63.12 -1.78 108.52 62.12 coo 66.09 40.54 34.70 66.92 37.69 35.49 1.87 105.73 59.26 1.00 108.67 58.94 ULMN 3 1v0e_c00 ENDO-ALPHA-SIALIDASE user 9 3 # 9 A 581 GLU C 102 GLU~? 5.77 O1 SO4 C 143 A 596 ARG C 105 ARG~? -3.12 O1 SO4 C 143s A 647 ARG C 110 ARG~? -6.90 CM MLZ C 114s coo 69.13 32.20 28.58 68.39 32.96 30.44 -7.47 107.78 58.43 -6.93 108.85 60.16 coo 70.89 37.31 29.70 69.54 36.29 32.39 -3.93 106.64 63.12 -1.78 108.52 62.12 coo 66.09 40.54 34.70 66.92 37.69 35.49 -6.95 102.53 68.25 -6.50 103.08 71.25 ULMN 3 1v0e_c00 ENDO-ALPHA-SIALIDASE user 10 3 # 10 A 581 GLU D 102 GLU~? 11.83 O1 2PE D 146 A 596 ARG D 105 ARG~? -8.15 O1 2PE D 146s A 647 ARG D 16 ARG~? -9.70 O1 2PE D 146s coo 69.13 32.20 28.58 68.39 32.96 30.44 -48.79 75.67 2.61 -49.51 76.91 1.13 coo 70.89 37.31 29.70 69.54 36.29 32.39 -46.14 79.22 -1.30 -46.45 77.32 -3.67 coo 66.09 40.54 34.70 66.92 37.69 35.49 -42.18 74.28 -4.52 -45.10 73.30 -4.28 ULMN 3 1v0e_c00 ENDO-ALPHA-SIALIDASE user 11 3 # 11 A 581 GLU D 102 GLU~? 11.83 O1 2PE D 146 A 596 ARG D 105 ARG~? -8.15 O1 2PE D 146s A 647 ARG D 110 ARG~? 8.08 C9 2PE D 146 coo 69.13 32.20 28.58 68.39 32.96 30.44 -48.79 75.67 2.61 -49.51 76.91 1.13 coo 70.89 37.31 29.70 69.54 36.29 32.39 -46.14 79.22 -1.30 -46.45 77.32 -3.67 coo 66.09 40.54 34.70 66.92 37.69 35.49 -43.46 85.72 1.13 -42.23 87.94 -0.73 1v0e_c00 source 1v0e ENDO-ALPHA-SIALIDASE : 11 hits 1v0e_c00 naa= 3 ULMN 3 1v0e_c01 ENDO-ALPHA-SIALIDASE user 1 3 # 1 B 581 GLU A 102 GLU~? 6.28 O2 SO4 A 143 B 596 ARG A 105 ARG~? -3.04 O2 SO4 A 143s B 647 ARG A 16 ARG~? -2.82 O4 SO4 A 143s coo 38.22 57.83 70.36 36.82 56.74 69.18 -14.00 55.24 30.65 -12.08 54.69 31.20 coo 34.24 60.89 68.08 33.31 57.93 67.63 -8.78 56.32 28.12 -7.90 58.53 30.04 coo 31.43 57.38 61.97 31.90 55.58 64.41 -9.29 63.37 28.06 -8.90 62.24 30.90 ULMN 3 1v0e_c01 ENDO-ALPHA-SIALIDASE user 2 3 # 2 B 581 GLU A 102 GLU~? 6.28 O2 SO4 A 143 B 596 ARG A 105 ARG~? -3.04 O2 SO4 A 143s B 647 ARG A 110 ARG~? -3.66 O1 2PE A 148s coo 38.22 57.83 70.36 36.82 56.74 69.18 -14.00 55.24 30.65 -12.08 54.69 31.20 coo 34.24 60.89 68.08 33.31 57.93 67.63 -8.78 56.32 28.12 -7.90 58.53 30.04 coo 31.43 57.38 61.97 31.90 55.58 64.41 -6.91 52.41 21.82 -5.61 55.22 21.43 ULMN 3 1v0e_c01 ENDO-ALPHA-SIALIDASE user 3 3 # 3 B 581 GLU B 43 GLU.? 6.93 O1 PEG B 144 B 596 ARG B 35 ARG.? 9.50 O1 PEG B 144 B 647 ARG B 33 ARG.? -3.91 C3 PEG B 144s coo 38.22 57.83 70.36 36.82 56.74 69.18 25.26 83.58 33.36 26.25 82.60 35.01 coo 34.24 60.89 68.08 33.31 57.93 67.63 22.76 84.08 36.32 22.81 87.07 35.45 coo 31.43 57.38 61.97 31.90 55.58 64.41 17.31 79.39 40.81 17.39 77.24 43.00 ULMN 3 1v0e_c01 ENDO-ALPHA-SIALIDASE user 4 3 # 4 B 581 GLU B 102 GLU~? 6.18 O4 SO4 A 143 B 596 ARG A 16 ARG~? -2.82 O4 SO4 A 143s B 647 ARG A 105 ARG~? -3.04 O2 SO4 A 143s coo 38.22 57.83 70.36 36.82 56.74 69.18 -7.10 67.86 29.77 -6.34 66.05 29.12 coo 34.24 60.89 68.08 33.31 57.93 67.63 -9.29 63.37 28.06 -8.90 62.24 30.90 coo 31.43 57.38 61.97 31.90 55.58 64.41 -8.78 56.32 28.12 -7.90 58.53 30.04 ULMN 3 1v0e_c01 ENDO-ALPHA-SIALIDASE user 5 3 # 5 B 581 GLU B 102 GLU~? 6.18 O4 SO4 A 143 B 596 ARG B 105 ARG~? -3.01 O4 SO4 A 143s B 647 ARG B 16 ARG~? -3.64 O1 SO4 A 143s coo 38.22 57.83 70.36 36.82 56.74 69.18 -7.10 67.86 29.77 -6.34 66.05 29.12 coo 34.24 60.89 68.08 33.31 57.93 67.63 -2.68 64.28 31.62 -4.52 62.28 32.99 coo 31.43 57.38 61.97 31.90 55.58 64.41 -4.85 63.18 38.40 -7.23 62.95 36.44 ULMN 3 1v0e_c01 ENDO-ALPHA-SIALIDASE user 6 3 # 6 B 581 GLU B 102 GLU~? 6.18 O4 SO4 A 143 B 596 ARG B 105 ARG~? -3.01 O4 SO4 A 143s B 647 ARG B 110 ARG~? 10.12 O7 PE8 B 148 coo 38.22 57.83 70.36 36.82 56.74 69.18 -7.10 67.86 29.77 -6.34 66.05 29.12 coo 34.24 60.89 68.08 33.31 57.93 67.63 -2.68 64.28 31.62 -4.52 62.28 32.99 coo 31.43 57.38 61.97 31.90 55.58 64.41 4.56 66.25 30.54 5.81 64.43 28.32 ULMN 3 1v0e_c01 ENDO-ALPHA-SIALIDASE user 7 3 # 7 B 581 GLU B 121 GLU^? 8.74 O2 PEG B 144 B 596 ARG B 33 ARG.? -3.91 C3 PEG B 144s B 647 ARG B 35 ARG.? 9.50 O1 PEG B 144 coo 38.22 57.83 70.36 36.82 56.74 69.18 15.37 80.83 45.64 16.23 82.69 46.15 coo 34.24 60.89 68.08 33.31 57.93 67.63 17.31 79.39 40.81 17.39 77.24 43.00 coo 31.43 57.38 61.97 31.90 55.58 64.41 22.76 84.08 36.32 22.81 87.07 35.45 ULMN 3 1v0e_c01 ENDO-ALPHA-SIALIDASE user 8 3 # 8 B 581 GLU C 102 GLU~? 5.77 O1 SO4 C 143 B 596 ARG C 105 ARG~? -3.12 O1 SO4 C 143s B 647 ARG C 16 ARG~? -2.96 O3 SO4 C 143s coo 38.22 57.83 70.36 36.82 56.74 69.18 -7.47 107.78 58.43 -6.93 108.85 60.16 coo 34.24 60.89 68.08 33.31 57.93 67.63 -3.93 106.64 63.12 -1.78 108.52 62.12 coo 31.43 57.38 61.97 31.90 55.58 64.41 1.87 105.73 59.26 1.00 108.67 58.94 ULMN 3 1v0e_c01 ENDO-ALPHA-SIALIDASE user 9 3 # 9 B 581 GLU C 102 GLU~? 5.77 O1 SO4 C 143 B 596 ARG C 105 ARG~? -3.12 O1 SO4 C 143s B 647 ARG C 110 ARG~? -6.90 CM MLZ C 114s coo 38.22 57.83 70.36 36.82 56.74 69.18 -7.47 107.78 58.43 -6.93 108.85 60.16 coo 34.24 60.89 68.08 33.31 57.93 67.63 -3.93 106.64 63.12 -1.78 108.52 62.12 coo 31.43 57.38 61.97 31.90 55.58 64.41 -6.95 102.53 68.25 -6.50 103.08 71.25 ULMN 3 1v0e_c01 ENDO-ALPHA-SIALIDASE user 10 3 # 10 B 581 GLU D 102 GLU~? 11.83 O1 2PE D 146 B 596 ARG D 105 ARG~? -8.15 O1 2PE D 146s B 647 ARG D 16 ARG~? -9.70 O1 2PE D 146s coo 38.22 57.83 70.36 36.82 56.74 69.18 -48.79 75.67 2.61 -49.51 76.91 1.13 coo 34.24 60.89 68.08 33.31 57.93 67.63 -46.14 79.22 -1.30 -46.45 77.32 -3.67 coo 31.43 57.38 61.97 31.90 55.58 64.41 -42.18 74.28 -4.52 -45.10 73.30 -4.28 ULMN 3 1v0e_c01 ENDO-ALPHA-SIALIDASE user 11 3 # 11 B 581 GLU D 102 GLU~? 11.83 O1 2PE D 146 B 596 ARG D 105 ARG~? -8.15 O1 2PE D 146s B 647 ARG D 110 ARG~? 8.08 C9 2PE D 146 coo 38.22 57.83 70.36 36.82 56.74 69.18 -48.79 75.67 2.61 -49.51 76.91 1.13 coo 34.24 60.89 68.08 33.31 57.93 67.63 -46.14 79.22 -1.30 -46.45 77.32 -3.67 coo 31.43 57.38 61.97 31.90 55.58 64.41 -43.46 85.72 1.13 -42.23 87.94 -0.73 1v0e_c01 source 1v0e ENDO-ALPHA-SIALIDASE : 11 hits 1v0e_c01 naa= 3 ULMN 3 1v0e_c02 ENDO-ALPHA-SIALIDASE user 1 3 # 1 C 581 GLU A 102 GLU~? 6.28 O2 SO4 A 143 C 596 ARG A 105 ARG~? -3.04 O2 SO4 A 143s C 647 ARG A 16 ARG~? -2.82 O4 SO4 A 143s coo 11.31 31.26 27.00 13.31 30.71 26.58 -14.00 55.24 30.65 -12.08 54.69 31.20 coo 13.44 32.78 22.07 15.56 30.91 23.37 -8.78 56.32 28.12 -7.90 58.53 30.04 coo 21.00 33.35 22.82 19.83 30.82 24.09 -9.29 63.37 28.06 -8.90 62.24 30.90 ULMN 3 1v0e_c02 ENDO-ALPHA-SIALIDASE user 2 3 # 2 C 581 GLU A 102 GLU~? 6.28 O2 SO4 A 143 C 596 ARG A 105 ARG~? -3.04 O2 SO4 A 143s C 647 ARG A 110 ARG~? -3.66 O1 2PE A 148s coo 11.31 31.26 27.00 13.31 30.71 26.58 -14.00 55.24 30.65 -12.08 54.69 31.20 coo 13.44 32.78 22.07 15.56 30.91 23.37 -8.78 56.32 28.12 -7.90 58.53 30.04 coo 21.00 33.35 22.82 19.83 30.82 24.09 -6.91 52.41 21.82 -5.61 55.22 21.43 ULMN 3 1v0e_c02 ENDO-ALPHA-SIALIDASE user 3 3 # 3 C 581 GLU B 43 GLU.? 6.93 O1 PEG B 144 C 596 ARG B 35 ARG.? 9.50 O1 PEG B 144 C 647 ARG B 33 ARG.? -3.91 C3 PEG B 144s coo 11.31 31.26 27.00 13.31 30.71 26.58 25.26 83.58 33.36 26.25 82.60 35.01 coo 13.44 32.78 22.07 15.56 30.91 23.37 22.76 84.08 36.32 22.81 87.07 35.45 coo 21.00 33.35 22.82 19.83 30.82 24.09 17.31 79.39 40.81 17.39 77.24 43.00 ULMN 3 1v0e_c02 ENDO-ALPHA-SIALIDASE user 4 3 # 4 C 581 GLU B 102 GLU~? 6.18 O4 SO4 A 143 C 596 ARG A 16 ARG~? -2.82 O4 SO4 A 143s C 647 ARG A 105 ARG~? -3.04 O2 SO4 A 143s coo 11.31 31.26 27.00 13.31 30.71 26.58 -7.10 67.86 29.77 -6.34 66.05 29.12 coo 13.44 32.78 22.07 15.56 30.91 23.37 -9.29 63.37 28.06 -8.90 62.24 30.90 coo 21.00 33.35 22.82 19.83 30.82 24.09 -8.78 56.32 28.12 -7.90 58.53 30.04 ULMN 3 1v0e_c02 ENDO-ALPHA-SIALIDASE user 5 3 # 5 C 581 GLU B 102 GLU~? 6.18 O4 SO4 A 143 C 596 ARG B 105 ARG~? -3.01 O4 SO4 A 143s C 647 ARG B 16 ARG~? -3.64 O1 SO4 A 143s coo 11.31 31.26 27.00 13.31 30.71 26.58 -7.10 67.86 29.77 -6.34 66.05 29.12 coo 13.44 32.78 22.07 15.56 30.91 23.37 -2.68 64.28 31.62 -4.52 62.28 32.99 coo 21.00 33.35 22.82 19.83 30.82 24.09 -4.85 63.18 38.40 -7.23 62.95 36.44 ULMN 3 1v0e_c02 ENDO-ALPHA-SIALIDASE user 6 3 # 6 C 581 GLU B 102 GLU~? 6.18 O4 SO4 A 143 C 596 ARG B 105 ARG~? -3.01 O4 SO4 A 143s C 647 ARG B 110 ARG~? 10.12 O7 PE8 B 148 coo 11.31 31.26 27.00 13.31 30.71 26.58 -7.10 67.86 29.77 -6.34 66.05 29.12 coo 13.44 32.78 22.07 15.56 30.91 23.37 -2.68 64.28 31.62 -4.52 62.28 32.99 coo 21.00 33.35 22.82 19.83 30.82 24.09 4.56 66.25 30.54 5.81 64.43 28.32 ULMN 3 1v0e_c02 ENDO-ALPHA-SIALIDASE user 7 3 # 7 C 581 GLU B 121 GLU^? 8.74 O2 PEG B 144 C 596 ARG B 33 ARG.? -3.91 C3 PEG B 144s C 647 ARG B 35 ARG.? 9.50 O1 PEG B 144 coo 11.31 31.26 27.00 13.31 30.71 26.58 15.37 80.83 45.64 16.23 82.69 46.15 coo 13.44 32.78 22.07 15.56 30.91 23.37 17.31 79.39 40.81 17.39 77.24 43.00 coo 21.00 33.35 22.82 19.83 30.82 24.09 22.76 84.08 36.32 22.81 87.07 35.45 ULMN 3 1v0e_c02 ENDO-ALPHA-SIALIDASE user 8 3 # 8 C 581 GLU C 102 GLU~? 5.77 O1 SO4 C 143 C 596 ARG C 105 ARG~? -3.12 O1 SO4 C 143s C 647 ARG C 16 ARG~? -2.96 O3 SO4 C 143s coo 11.31 31.26 27.00 13.31 30.71 26.58 -7.47 107.78 58.43 -6.93 108.85 60.16 coo 13.44 32.78 22.07 15.56 30.91 23.37 -3.93 106.64 63.12 -1.78 108.52 62.12 coo 21.00 33.35 22.82 19.83 30.82 24.09 1.87 105.73 59.26 1.00 108.67 58.94 ULMN 3 1v0e_c02 ENDO-ALPHA-SIALIDASE user 9 3 # 9 C 581 GLU C 102 GLU~? 5.77 O1 SO4 C 143 C 596 ARG C 105 ARG~? -3.12 O1 SO4 C 143s C 647 ARG C 110 ARG~? -6.90 CM MLZ C 114s coo 11.31 31.26 27.00 13.31 30.71 26.58 -7.47 107.78 58.43 -6.93 108.85 60.16 coo 13.44 32.78 22.07 15.56 30.91 23.37 -3.93 106.64 63.12 -1.78 108.52 62.12 coo 21.00 33.35 22.82 19.83 30.82 24.09 -6.95 102.53 68.25 -6.50 103.08 71.25 ULMN 3 1v0e_c02 ENDO-ALPHA-SIALIDASE user 10 3 # 10 C 581 GLU D 102 GLU~? 11.83 O1 2PE D 146 C 596 ARG D 105 ARG~? -8.15 O1 2PE D 146s C 647 ARG D 16 ARG~? -9.70 O1 2PE D 146s coo 11.31 31.26 27.00 13.31 30.71 26.58 -48.79 75.67 2.61 -49.51 76.91 1.13 coo 13.44 32.78 22.07 15.56 30.91 23.37 -46.14 79.22 -1.30 -46.45 77.32 -3.67 coo 21.00 33.35 22.82 19.83 30.82 24.09 -42.18 74.28 -4.52 -45.10 73.30 -4.28 ULMN 3 1v0e_c02 ENDO-ALPHA-SIALIDASE user 11 3 # 11 C 581 GLU D 102 GLU~? 11.83 O1 2PE D 146 C 596 ARG D 105 ARG~? -8.15 O1 2PE D 146s C 647 ARG D 110 ARG~? 8.08 C9 2PE D 146 coo 11.31 31.26 27.00 13.31 30.71 26.58 -48.79 75.67 2.61 -49.51 76.91 1.13 coo 13.44 32.78 22.07 15.56 30.91 23.37 -46.14 79.22 -1.30 -46.45 77.32 -3.67 coo 21.00 33.35 22.82 19.83 30.82 24.09 -43.46 85.72 1.13 -42.23 87.94 -0.73 1v0e_c02 source 1v0e ENDO-ALPHA-SIALIDASE : 11 hits 1v0e_c02 naa= 3 ULMN 3 1v0e_c03 ENDO-ALPHA-SIALIDASE user 1 3 # 1 D 581 GLU A 102 GLU~? 6.28 O2 SO4 A 143 D 596 ARG A 105 ARG~? -3.04 O2 SO4 A 143s D 647 ARG A 16 ARG~? -2.82 O4 SO4 A 143s coo -44.60 -18.05 21.23 -43.91 -19.28 22.81 -14.00 55.24 30.65 -12.08 54.69 31.20 coo -46.27 -23.29 20.77 -45.12 -23.03 23.65 -8.78 56.32 28.12 -7.90 58.53 30.04 coo -41.59 -27.81 24.72 -42.43 -25.21 26.20 -9.29 63.37 28.06 -8.90 62.24 30.90 ULMN 3 1v0e_c03 ENDO-ALPHA-SIALIDASE user 2 3 # 2 D 581 GLU A 102 GLU~? 6.28 O2 SO4 A 143 D 596 ARG A 105 ARG~? -3.04 O2 SO4 A 143s D 647 ARG A 110 ARG~? -3.66 O1 2PE A 148s coo -44.60 -18.05 21.23 -43.91 -19.28 22.81 -14.00 55.24 30.65 -12.08 54.69 31.20 coo -46.27 -23.29 20.77 -45.12 -23.03 23.65 -8.78 56.32 28.12 -7.90 58.53 30.04 coo -41.59 -27.81 24.72 -42.43 -25.21 26.20 -6.91 52.41 21.82 -5.61 55.22 21.43 ULMN 3 1v0e_c03 ENDO-ALPHA-SIALIDASE user 3 3 # 3 D 581 GLU B 43 GLU.? 6.93 O1 PEG B 144 D 596 ARG B 35 ARG.? 9.50 O1 PEG B 144 D 647 ARG B 33 ARG.? -3.91 C3 PEG B 144s coo -44.60 -18.05 21.23 -43.91 -19.28 22.81 25.26 83.58 33.36 26.25 82.60 35.01 coo -46.27 -23.29 20.77 -45.12 -23.03 23.65 22.76 84.08 36.32 22.81 87.07 35.45 coo -41.59 -27.81 24.72 -42.43 -25.21 26.20 17.31 79.39 40.81 17.39 77.24 43.00 ULMN 3 1v0e_c03 ENDO-ALPHA-SIALIDASE user 4 3 # 4 D 581 GLU B 102 GLU~? 6.18 O4 SO4 A 143 D 596 ARG A 16 ARG~? -2.82 O4 SO4 A 143s D 647 ARG A 105 ARG~? -3.04 O2 SO4 A 143s coo -44.60 -18.05 21.23 -43.91 -19.28 22.81 -7.10 67.86 29.77 -6.34 66.05 29.12 coo -46.27 -23.29 20.77 -45.12 -23.03 23.65 -9.29 63.37 28.06 -8.90 62.24 30.90 coo -41.59 -27.81 24.72 -42.43 -25.21 26.20 -8.78 56.32 28.12 -7.90 58.53 30.04 ULMN 3 1v0e_c03 ENDO-ALPHA-SIALIDASE user 5 3 # 5 D 581 GLU B 102 GLU~? 6.18 O4 SO4 A 143 D 596 ARG B 105 ARG~? -3.01 O4 SO4 A 143s D 647 ARG B 16 ARG~? -3.64 O1 SO4 A 143s coo -44.60 -18.05 21.23 -43.91 -19.28 22.81 -7.10 67.86 29.77 -6.34 66.05 29.12 coo -46.27 -23.29 20.77 -45.12 -23.03 23.65 -2.68 64.28 31.62 -4.52 62.28 32.99 coo -41.59 -27.81 24.72 -42.43 -25.21 26.20 -4.85 63.18 38.40 -7.23 62.95 36.44 ULMN 3 1v0e_c03 ENDO-ALPHA-SIALIDASE user 6 3 # 6 D 581 GLU B 102 GLU~? 6.18 O4 SO4 A 143 D 596 ARG B 105 ARG~? -3.01 O4 SO4 A 143s D 647 ARG B 110 ARG~? 10.12 O7 PE8 B 148 coo -44.60 -18.05 21.23 -43.91 -19.28 22.81 -7.10 67.86 29.77 -6.34 66.05 29.12 coo -46.27 -23.29 20.77 -45.12 -23.03 23.65 -2.68 64.28 31.62 -4.52 62.28 32.99 coo -41.59 -27.81 24.72 -42.43 -25.21 26.20 4.56 66.25 30.54 5.81 64.43 28.32 ULMN 3 1v0e_c03 ENDO-ALPHA-SIALIDASE user 7 3 # 7 D 581 GLU B 121 GLU^? 8.74 O2 PEG B 144 D 596 ARG B 33 ARG.? -3.91 C3 PEG B 144s D 647 ARG B 35 ARG.? 9.50 O1 PEG B 144 coo -44.60 -18.05 21.23 -43.91 -19.28 22.81 15.37 80.83 45.64 16.23 82.69 46.15 coo -46.27 -23.29 20.77 -45.12 -23.03 23.65 17.31 79.39 40.81 17.39 77.24 43.00 coo -41.59 -27.81 24.72 -42.43 -25.21 26.20 22.76 84.08 36.32 22.81 87.07 35.45 ULMN 3 1v0e_c03 ENDO-ALPHA-SIALIDASE user 8 3 # 8 D 581 GLU C 102 GLU~? 5.77 O1 SO4 C 143 D 596 ARG C 105 ARG~? -3.12 O1 SO4 C 143s D 647 ARG C 16 ARG~? -2.96 O3 SO4 C 143s coo -44.60 -18.05 21.23 -43.91 -19.28 22.81 -7.47 107.78 58.43 -6.93 108.85 60.16 coo -46.27 -23.29 20.77 -45.12 -23.03 23.65 -3.93 106.64 63.12 -1.78 108.52 62.12 coo -41.59 -27.81 24.72 -42.43 -25.21 26.20 1.87 105.73 59.26 1.00 108.67 58.94 ULMN 3 1v0e_c03 ENDO-ALPHA-SIALIDASE user 9 3 # 9 D 581 GLU C 102 GLU~? 5.77 O1 SO4 C 143 D 596 ARG C 105 ARG~? -3.12 O1 SO4 C 143s D 647 ARG C 110 ARG~? -6.90 CM MLZ C 114s coo -44.60 -18.05 21.23 -43.91 -19.28 22.81 -7.47 107.78 58.43 -6.93 108.85 60.16 coo -46.27 -23.29 20.77 -45.12 -23.03 23.65 -3.93 106.64 63.12 -1.78 108.52 62.12 coo -41.59 -27.81 24.72 -42.43 -25.21 26.20 -6.95 102.53 68.25 -6.50 103.08 71.25 ULMN 3 1v0e_c03 ENDO-ALPHA-SIALIDASE user 10 3 # 10 D 581 GLU D 102 GLU~? 11.83 O1 2PE D 146 D 596 ARG D 105 ARG~? -8.15 O1 2PE D 146s D 647 ARG D 16 ARG~? -9.70 O1 2PE D 146s coo -44.60 -18.05 21.23 -43.91 -19.28 22.81 -48.79 75.67 2.61 -49.51 76.91 1.13 coo -46.27 -23.29 20.77 -45.12 -23.03 23.65 -46.14 79.22 -1.30 -46.45 77.32 -3.67 coo -41.59 -27.81 24.72 -42.43 -25.21 26.20 -42.18 74.28 -4.52 -45.10 73.30 -4.28 ULMN 3 1v0e_c03 ENDO-ALPHA-SIALIDASE user 11 3 # 11 D 581 GLU D 102 GLU~? 11.83 O1 2PE D 146 D 596 ARG D 105 ARG~? -8.15 O1 2PE D 146s D 647 ARG D 110 ARG~? 8.08 C9 2PE D 146 coo -44.60 -18.05 21.23 -43.91 -19.28 22.81 -48.79 75.67 2.61 -49.51 76.91 1.13 coo -46.27 -23.29 20.77 -45.12 -23.03 23.65 -46.14 79.22 -1.30 -46.45 77.32 -3.67 coo -41.59 -27.81 24.72 -42.43 -25.21 26.20 -43.46 85.72 1.13 -42.23 87.94 -0.73 1v0e_c03 source 1v0e ENDO-ALPHA-SIALIDASE : 11 hits 1v0e_c03 naa= 3 ULMN 3 1v0e_c04 ENDO-ALPHA-SIALIDASE user 1 3 # 1 E 581 GLU A 102 GLU~? 6.28 O2 SO4 A 143 E 596 ARG A 105 ARG~? -3.04 O2 SO4 A 143s E 647 ARG A 16 ARG~? -2.82 O4 SO4 A 143s coo 13.14 -15.80 20.26 11.08 -15.36 20.42 -14.00 55.24 30.65 -12.08 54.69 31.20 coo 10.98 -16.04 15.26 8.84 -14.68 17.08 -8.78 56.32 28.12 -7.90 58.53 30.04 coo 3.51 -16.91 15.71 4.51 -14.91 17.79 -9.29 63.37 28.06 -8.90 62.24 30.90 ULMN 3 1v0e_c04 ENDO-ALPHA-SIALIDASE user 2 3 # 2 E 581 GLU A 102 GLU~? 6.28 O2 SO4 A 143 E 596 ARG A 105 ARG~? -3.04 O2 SO4 A 143s E 647 ARG A 110 ARG~? -3.66 O1 2PE A 148s coo 13.14 -15.80 20.26 11.08 -15.36 20.42 -14.00 55.24 30.65 -12.08 54.69 31.20 coo 10.98 -16.04 15.26 8.84 -14.68 17.08 -8.78 56.32 28.12 -7.90 58.53 30.04 coo 3.51 -16.91 15.71 4.51 -14.91 17.79 -6.91 52.41 21.82 -5.61 55.22 21.43 ULMN 3 1v0e_c04 ENDO-ALPHA-SIALIDASE user 3 3 # 3 E 581 GLU B 43 GLU.? 6.93 O1 PEG B 144 E 596 ARG B 35 ARG.? 9.50 O1 PEG B 144 E 647 ARG B 33 ARG.? -3.91 C3 PEG B 144s coo 13.14 -15.80 20.26 11.08 -15.36 20.42 25.26 83.58 33.36 26.25 82.60 35.01 coo 10.98 -16.04 15.26 8.84 -14.68 17.08 22.76 84.08 36.32 22.81 87.07 35.45 coo 3.51 -16.91 15.71 4.51 -14.91 17.79 17.31 79.39 40.81 17.39 77.24 43.00 ULMN 3 1v0e_c04 ENDO-ALPHA-SIALIDASE user 4 3 # 4 E 581 GLU B 102 GLU~? 6.18 O4 SO4 A 143 E 596 ARG A 16 ARG~? -2.82 O4 SO4 A 143s E 647 ARG A 105 ARG~? -3.04 O2 SO4 A 143s coo 13.14 -15.80 20.26 11.08 -15.36 20.42 -7.10 67.86 29.77 -6.34 66.05 29.12 coo 10.98 -16.04 15.26 8.84 -14.68 17.08 -9.29 63.37 28.06 -8.90 62.24 30.90 coo 3.51 -16.91 15.71 4.51 -14.91 17.79 -8.78 56.32 28.12 -7.90 58.53 30.04 ULMN 3 1v0e_c04 ENDO-ALPHA-SIALIDASE user 5 3 # 5 E 581 GLU B 102 GLU~? 6.18 O4 SO4 A 143 E 596 ARG B 105 ARG~? -3.01 O4 SO4 A 143s E 647 ARG B 16 ARG~? -3.64 O1 SO4 A 143s coo 13.14 -15.80 20.26 11.08 -15.36 20.42 -7.10 67.86 29.77 -6.34 66.05 29.12 coo 10.98 -16.04 15.26 8.84 -14.68 17.08 -2.68 64.28 31.62 -4.52 62.28 32.99 coo 3.51 -16.91 15.71 4.51 -14.91 17.79 -4.85 63.18 38.40 -7.23 62.95 36.44 ULMN 3 1v0e_c04 ENDO-ALPHA-SIALIDASE user 6 3 # 6 E 581 GLU B 102 GLU~? 6.18 O4 SO4 A 143 E 596 ARG B 105 ARG~? -3.01 O4 SO4 A 143s E 647 ARG B 110 ARG~? 10.12 O7 PE8 B 148 coo 13.14 -15.80 20.26 11.08 -15.36 20.42 -7.10 67.86 29.77 -6.34 66.05 29.12 coo 10.98 -16.04 15.26 8.84 -14.68 17.08 -2.68 64.28 31.62 -4.52 62.28 32.99 coo 3.51 -16.91 15.71 4.51 -14.91 17.79 4.56 66.25 30.54 5.81 64.43 28.32 ULMN 3 1v0e_c04 ENDO-ALPHA-SIALIDASE user 7 3 # 7 E 581 GLU B 121 GLU^? 8.74 O2 PEG B 144 E 596 ARG B 33 ARG.? -3.91 C3 PEG B 144s E 647 ARG B 35 ARG.? 9.50 O1 PEG B 144 coo 13.14 -15.80 20.26 11.08 -15.36 20.42 15.37 80.83 45.64 16.23 82.69 46.15 coo 10.98 -16.04 15.26 8.84 -14.68 17.08 17.31 79.39 40.81 17.39 77.24 43.00 coo 3.51 -16.91 15.71 4.51 -14.91 17.79 22.76 84.08 36.32 22.81 87.07 35.45 ULMN 3 1v0e_c04 ENDO-ALPHA-SIALIDASE user 8 3 # 8 E 581 GLU C 102 GLU~? 5.77 O1 SO4 C 143 E 596 ARG C 105 ARG~? -3.12 O1 SO4 C 143s E 647 ARG C 16 ARG~? -2.96 O3 SO4 C 143s coo 13.14 -15.80 20.26 11.08 -15.36 20.42 -7.47 107.78 58.43 -6.93 108.85 60.16 coo 10.98 -16.04 15.26 8.84 -14.68 17.08 -3.93 106.64 63.12 -1.78 108.52 62.12 coo 3.51 -16.91 15.71 4.51 -14.91 17.79 1.87 105.73 59.26 1.00 108.67 58.94 ULMN 3 1v0e_c04 ENDO-ALPHA-SIALIDASE user 9 3 # 9 E 581 GLU C 102 GLU~? 5.77 O1 SO4 C 143 E 596 ARG C 105 ARG~? -3.12 O1 SO4 C 143s E 647 ARG C 110 ARG~? -6.90 CM MLZ C 114s coo 13.14 -15.80 20.26 11.08 -15.36 20.42 -7.47 107.78 58.43 -6.93 108.85 60.16 coo 10.98 -16.04 15.26 8.84 -14.68 17.08 -3.93 106.64 63.12 -1.78 108.52 62.12 coo 3.51 -16.91 15.71 4.51 -14.91 17.79 -6.95 102.53 68.25 -6.50 103.08 71.25 ULMN 3 1v0e_c04 ENDO-ALPHA-SIALIDASE user 10 3 # 10 E 581 GLU D 102 GLU~? 11.83 O1 2PE D 146 E 596 ARG D 105 ARG~? -8.15 O1 2PE D 146s E 647 ARG D 16 ARG~? -9.70 O1 2PE D 146s coo 13.14 -15.80 20.26 11.08 -15.36 20.42 -48.79 75.67 2.61 -49.51 76.91 1.13 coo 10.98 -16.04 15.26 8.84 -14.68 17.08 -46.14 79.22 -1.30 -46.45 77.32 -3.67 coo 3.51 -16.91 15.71 4.51 -14.91 17.79 -42.18 74.28 -4.52 -45.10 73.30 -4.28 ULMN 3 1v0e_c04 ENDO-ALPHA-SIALIDASE user 11 3 # 11 E 581 GLU D 102 GLU~? 11.83 O1 2PE D 146 E 596 ARG D 105 ARG~? -8.15 O1 2PE D 146s E 647 ARG D 110 ARG~? 8.08 C9 2PE D 146 coo 13.14 -15.80 20.26 11.08 -15.36 20.42 -48.79 75.67 2.61 -49.51 76.91 1.13 coo 10.98 -16.04 15.26 8.84 -14.68 17.08 -46.14 79.22 -1.30 -46.45 77.32 -3.67 coo 3.51 -16.91 15.71 4.51 -14.91 17.79 -43.46 85.72 1.13 -42.23 87.94 -0.73 1v0e_c04 source 1v0e ENDO-ALPHA-SIALIDASE : 11 hits 1v0e_c04 naa= 3 ULMN 3 1v0e_c05 ENDO-ALPHA-SIALIDASE user 1 3 # 1 F 581 GLU A 102 GLU~? 6.28 O2 SO4 A 143 F 596 ARG A 105 ARG~? -3.04 O2 SO4 A 143s F 647 ARG A 16 ARG~? -2.82 O4 SO4 A 143s coo -13.62 -54.34 53.96 -12.26 -52.95 53.12 -14.00 55.24 30.65 -12.08 54.69 31.20 coo -9.88 -56.64 50.98 -8.81 -53.71 51.30 -8.78 56.32 28.12 -7.90 58.53 30.04 coo -6.86 -51.53 46.20 -7.51 -50.44 49.00 -9.29 63.37 28.06 -8.90 62.24 30.90 ULMN 3 1v0e_c05 ENDO-ALPHA-SIALIDASE user 2 3 # 2 F 581 GLU A 102 GLU~? 6.28 O2 SO4 A 143 F 596 ARG A 105 ARG~? -3.04 O2 SO4 A 143s F 647 ARG A 110 ARG~? -3.66 O1 2PE A 148s coo -13.62 -54.34 53.96 -12.26 -52.95 53.12 -14.00 55.24 30.65 -12.08 54.69 31.20 coo -9.88 -56.64 50.98 -8.81 -53.71 51.30 -8.78 56.32 28.12 -7.90 58.53 30.04 coo -6.86 -51.53 46.20 -7.51 -50.44 49.00 -6.91 52.41 21.82 -5.61 55.22 21.43 ULMN 3 1v0e_c05 ENDO-ALPHA-SIALIDASE user 3 3 # 3 F 581 GLU B 43 GLU.? 6.93 O1 PEG B 144 F 596 ARG B 35 ARG.? 9.50 O1 PEG B 144 F 647 ARG B 33 ARG.? -3.91 C3 PEG B 144s coo -13.62 -54.34 53.96 -12.26 -52.95 53.12 25.26 83.58 33.36 26.25 82.60 35.01 coo -9.88 -56.64 50.98 -8.81 -53.71 51.30 22.76 84.08 36.32 22.81 87.07 35.45 coo -6.86 -51.53 46.20 -7.51 -50.44 49.00 17.31 79.39 40.81 17.39 77.24 43.00 ULMN 3 1v0e_c05 ENDO-ALPHA-SIALIDASE user 4 3 # 4 F 581 GLU B 102 GLU~? 6.18 O4 SO4 A 143 F 596 ARG A 16 ARG~? -2.82 O4 SO4 A 143s F 647 ARG A 105 ARG~? -3.04 O2 SO4 A 143s coo -13.62 -54.34 53.96 -12.26 -52.95 53.12 -7.10 67.86 29.77 -6.34 66.05 29.12 coo -9.88 -56.64 50.98 -8.81 -53.71 51.30 -9.29 63.37 28.06 -8.90 62.24 30.90 coo -6.86 -51.53 46.20 -7.51 -50.44 49.00 -8.78 56.32 28.12 -7.90 58.53 30.04 ULMN 3 1v0e_c05 ENDO-ALPHA-SIALIDASE user 5 3 # 5 F 581 GLU B 102 GLU~? 6.18 O4 SO4 A 143 F 596 ARG B 105 ARG~? -3.01 O4 SO4 A 143s F 647 ARG B 16 ARG~? -3.64 O1 SO4 A 143s coo -13.62 -54.34 53.96 -12.26 -52.95 53.12 -7.10 67.86 29.77 -6.34 66.05 29.12 coo -9.88 -56.64 50.98 -8.81 -53.71 51.30 -2.68 64.28 31.62 -4.52 62.28 32.99 coo -6.86 -51.53 46.20 -7.51 -50.44 49.00 -4.85 63.18 38.40 -7.23 62.95 36.44 ULMN 3 1v0e_c05 ENDO-ALPHA-SIALIDASE user 6 3 # 6 F 581 GLU B 102 GLU~? 6.18 O4 SO4 A 143 F 596 ARG B 105 ARG~? -3.01 O4 SO4 A 143s F 647 ARG B 110 ARG~? 10.12 O7 PE8 B 148 coo -13.62 -54.34 53.96 -12.26 -52.95 53.12 -7.10 67.86 29.77 -6.34 66.05 29.12 coo -9.88 -56.64 50.98 -8.81 -53.71 51.30 -2.68 64.28 31.62 -4.52 62.28 32.99 coo -6.86 -51.53 46.20 -7.51 -50.44 49.00 4.56 66.25 30.54 5.81 64.43 28.32 ULMN 3 1v0e_c05 ENDO-ALPHA-SIALIDASE user 7 3 # 7 F 581 GLU B 121 GLU^? 8.74 O2 PEG B 144 F 596 ARG B 33 ARG.? -3.91 C3 PEG B 144s F 647 ARG B 35 ARG.? 9.50 O1 PEG B 144 coo -13.62 -54.34 53.96 -12.26 -52.95 53.12 15.37 80.83 45.64 16.23 82.69 46.15 coo -9.88 -56.64 50.98 -8.81 -53.71 51.30 17.31 79.39 40.81 17.39 77.24 43.00 coo -6.86 -51.53 46.20 -7.51 -50.44 49.00 22.76 84.08 36.32 22.81 87.07 35.45 ULMN 3 1v0e_c05 ENDO-ALPHA-SIALIDASE user 8 3 # 8 F 581 GLU C 102 GLU~? 5.77 O1 SO4 C 143 F 596 ARG C 105 ARG~? -3.12 O1 SO4 C 143s F 647 ARG C 16 ARG~? -2.96 O3 SO4 C 143s coo -13.62 -54.34 53.96 -12.26 -52.95 53.12 -7.47 107.78 58.43 -6.93 108.85 60.16 coo -9.88 -56.64 50.98 -8.81 -53.71 51.30 -3.93 106.64 63.12 -1.78 108.52 62.12 coo -6.86 -51.53 46.20 -7.51 -50.44 49.00 1.87 105.73 59.26 1.00 108.67 58.94 ULMN 3 1v0e_c05 ENDO-ALPHA-SIALIDASE user 9 3 # 9 F 581 GLU C 102 GLU~? 5.77 O1 SO4 C 143 F 596 ARG C 105 ARG~? -3.12 O1 SO4 C 143s F 647 ARG C 110 ARG~? -6.90 CM MLZ C 114s coo -13.62 -54.34 53.96 -12.26 -52.95 53.12 -7.47 107.78 58.43 -6.93 108.85 60.16 coo -9.88 -56.64 50.98 -8.81 -53.71 51.30 -3.93 106.64 63.12 -1.78 108.52 62.12 coo -6.86 -51.53 46.20 -7.51 -50.44 49.00 -6.95 102.53 68.25 -6.50 103.08 71.25 ULMN 3 1v0e_c05 ENDO-ALPHA-SIALIDASE user 10 3 # 10 F 581 GLU D 102 GLU~? 11.83 O1 2PE D 146 F 596 ARG D 105 ARG~? -8.15 O1 2PE D 146s F 647 ARG D 16 ARG~? -9.70 O1 2PE D 146s coo -13.62 -54.34 53.96 -12.26 -52.95 53.12 -48.79 75.67 2.61 -49.51 76.91 1.13 coo -9.88 -56.64 50.98 -8.81 -53.71 51.30 -46.14 79.22 -1.30 -46.45 77.32 -3.67 coo -6.86 -51.53 46.20 -7.51 -50.44 49.00 -42.18 74.28 -4.52 -45.10 73.30 -4.28 ULMN 3 1v0e_c05 ENDO-ALPHA-SIALIDASE user 11 3 # 11 F 581 GLU D 102 GLU~? 11.83 O1 2PE D 146 F 596 ARG D 105 ARG~? -8.15 O1 2PE D 146s F 647 ARG D 110 ARG~? 8.08 C9 2PE D 146 coo -13.62 -54.34 53.96 -12.26 -52.95 53.12 -48.79 75.67 2.61 -49.51 76.91 1.13 coo -9.88 -56.64 50.98 -8.81 -53.71 51.30 -46.14 79.22 -1.30 -46.45 77.32 -3.67 coo -6.86 -51.53 46.20 -7.51 -50.44 49.00 -43.46 85.72 1.13 -42.23 87.94 -0.73 1v0e_c05 source 1v0e ENDO-ALPHA-SIALIDASE : 11 hits 1v0e_c05 naa= 3 ULMN 3 1vzx_c02 2.04.01.0087 user 1 3 # 1 A 314 TYR B 94 TYR^? -5.06 CL CL B 143s A 317 GLU B 93 GLU^? 4.01 CE MLZ B 67 A 365 ARG B 63 ARG~? -8.01 OH2 1PE B 150s coo 1.77 6.56 57.05 3.05 7.44 59.37 -6.97 76.65 35.26 -4.34 77.53 35.11 coo 3.06 2.85 52.79 4.83 3.89 53.24 -11.20 80.89 36.50 -12.93 82.08 36.76 coo 3.82 17.09 49.56 4.09 14.32 50.84 -5.18 74.17 22.68 -2.11 73.83 22.90 ULMN 3 1vzx_c02 2.04.01.0087 user 2 3 # 2 A 314 TYR C 94 TYR^? 5.01 CL CL C 144s A 317 GLU C 93 GLU^? -3.82 CH2 MLY C 67s A 365 ARG C 63 ARG~? -11.70 O25 PE8 C 148s coo 1.77 6.56 57.05 3.05 7.44 59.37 -8.07 99.17 52.54 -8.69 97.12 54.34 coo 3.06 2.85 52.79 4.83 3.89 53.24 -9.46 98.26 46.68 -9.97 98.34 44.62 coo 3.82 17.09 49.56 4.09 14.32 50.84 -17.02 105.73 59.39 -16.53 104.08 61.96 1vzx_c02 source 1vzx 2.04.01.0087 : 2 hits 1vzx_c02 naa= 3 ULMN 3 1vzx_c03 2.04.01.0087 user 1 3 # 1 B1314 TYR A 94 TYR^? 4.94 CL CL A 145s B1317 GLU A 93 GLU^? 3.90 NZ MLY A 67 B1365 ARG A 63 ARG~? 11.15 O28 2PE A 148 coo 13.32 10.15 -9.20 12.07 11.36 -11.38 -21.59 58.91 24.53 -21.03 57.83 22.04 coo 12.13 5.84 -5.49 10.31 6.88 -5.76 -27.37 60.67 25.57 -29.32 61.09 26.31 coo 11.24 19.69 -0.67 10.92 17.07 -2.21 -18.54 46.85 28.43 -16.64 46.31 26.03 ULMN 3 1vzx_c03 2.04.01.0087 user 2 3 # 2 B1314 TYR B 94 TYR^? -5.06 CL CL B 143s B1317 GLU B 93 GLU^? 4.01 CE MLZ B 67 B1365 ARG B 63 ARG~? -8.01 OH2 1PE B 150s coo 13.32 10.15 -9.20 12.07 11.36 -11.38 -6.97 76.65 35.26 -4.34 77.53 35.11 coo 12.13 5.84 -5.49 10.31 6.88 -5.76 -11.20 80.89 36.50 -12.93 82.08 36.76 coo 11.24 19.69 -0.67 10.92 17.07 -2.21 -5.18 74.17 22.68 -2.11 73.83 22.90 ULMN 3 1vzx_c03 2.04.01.0087 user 3 3 # 3 B1314 TYR C 94 TYR^? 5.01 CL CL C 144s B1317 GLU C 93 GLU^? -3.82 CH2 MLY C 67s B1365 ARG C 63 ARG~? -11.70 O25 PE8 C 148s coo 13.32 10.15 -9.20 12.07 11.36 -11.38 -8.07 99.17 52.54 -8.69 97.12 54.34 coo 12.13 5.84 -5.49 10.31 6.88 -5.76 -9.46 98.26 46.68 -9.97 98.34 44.62 coo 11.24 19.69 -0.67 10.92 17.07 -2.21 -17.02 105.73 59.39 -16.53 104.08 61.96 ULMN 3 1vzx_c03 2.04.01.0087 user 4 3 # 4 B1314 TYR D 94 TYR^? -4.97 CL CL D 143s B1317 GLU D 93 GLU^? -3.68 CE MLY D 67s B1365 ARG D 63 ARG~? -11.23 O28 2PE D 146s coo 13.32 10.15 -9.20 12.07 11.36 -11.38 -41.68 71.74 9.13 -40.22 73.97 9.96 coo 12.13 5.84 -5.49 10.31 6.88 -5.76 -41.50 66.77 12.62 -41.92 65.02 13.75 coo 11.24 19.69 -0.67 10.92 17.07 -2.21 -51.80 79.77 10.92 -50.17 82.42 10.63 1vzx_c03 source 1vzx 2.04.01.0087 : 4 hits 1vzx_c03 naa= 3 ULMN 3 1vzz_c00 STEROID DELTA-ISOMERASE user 1 3 # 1 A 16 TYR A 50 TYR~? 5.51 CH2 MLY D 135 A 40 ASP A 122 ASP^? 7.46 C1 GOL A 150 A 103 LEU A 32 LEU^? 9.30 CH2 MLY D 135 coo 12.09 16.13 10.57 11.28 18.80 10.73 -19.50 53.98 8.67 -20.18 55.72 10.74 coo 7.55 25.51 14.34 9.65 25.73 14.24 -15.41 64.92 4.51 -15.09 66.83 5.33 coo 11.83 18.73 16.99 10.99 19.71 15.26 -19.04 56.74 3.15 -19.76 55.64 4.88 ULMN 3 1vzz_c00 STEROID DELTA-ISOMERASE user 2 3 # 2 A 16 TYR A 94 TYR^? 4.94 CL CL A 145s A 40 ASP A 106 ASP~? 11.93 O22 2PE A 148 A 103 LEU A 64 LEU~? 9.53 N MLY A 67 coo 12.09 16.13 10.57 11.28 18.80 10.73 -21.59 58.91 24.53 -21.03 57.83 22.04 coo 7.55 25.51 14.34 9.65 25.73 14.24 -12.71 50.36 24.83 -13.06 48.30 25.05 coo 11.83 18.73 16.99 10.99 19.71 15.26 -19.44 53.00 27.96 -17.35 52.32 28.29 ULMN 3 1vzz_c00 STEROID DELTA-ISOMERASE user 3 3 # 3 A 16 TYR B 50 TYR~? 5.52 CH1 MLY C 135 A 40 ASP B 122 ASP^? 7.33 O2 GOL B 149 A 103 LEU B 32 LEU^? 9.36 CE MLY C 135 coo 12.09 16.13 10.57 11.28 18.80 10.73 8.51 83.11 35.90 5.93 82.51 36.84 coo 7.55 25.51 14.34 9.65 25.73 14.24 10.89 79.68 47.57 9.75 78.80 49.16 coo 11.83 18.73 16.99 10.99 19.71 15.26 12.48 84.84 40.35 10.99 84.89 38.79 ULMN 3 1vzz_c00 STEROID DELTA-ISOMERASE user 4 3 # 4 A 16 TYR B 94 TYR^? -5.06 CL CL B 143s A 40 ASP B 106 ASP~? 11.87 OH2 1PE B 150 A 103 LEU B 64 LEU~? 7.06 OH4 1PE B 150 coo 12.09 16.13 10.57 11.28 18.80 10.73 -6.97 76.65 35.26 -4.34 77.53 35.11 coo 7.55 25.51 14.34 9.65 25.73 14.24 -0.30 70.27 27.08 -0.10 70.78 25.05 coo 11.83 18.73 16.99 10.99 19.71 15.26 -6.99 74.17 28.56 -6.11 72.35 27.70 ULMN 3 1vzz_c00 STEROID DELTA-ISOMERASE user 5 3 # 5 A 16 TYR C 50 TYR~? 5.59 CE MLY B 135 A 40 ASP C 122 ASP^? 7.22 C3 GOL C 149 A 103 LEU C 32 LEU^? 8.96 CD MLY B 135 coo 12.09 16.13 10.57 11.28 18.80 10.73 -11.27 85.65 61.91 -10.18 87.09 59.78 coo 7.55 25.51 14.34 9.65 25.73 14.24 0.27 81.12 61.60 2.07 81.54 60.53 coo 11.83 18.73 16.99 10.99 19.71 15.26 -8.67 80.10 62.81 -9.90 81.76 62.17 ULMN 3 1vzz_c00 STEROID DELTA-ISOMERASE user 6 3 # 6 A 16 TYR C 94 TYR^? 5.01 CL CL C 144s A 40 ASP C 106 ASP~? 12.11 C21 PE8 C 148 A 103 LEU C 64 LEU~? 9.53 N MLY C 67 coo 12.09 16.13 10.57 11.28 18.80 10.73 -8.07 99.17 52.54 -8.69 97.12 54.34 coo 7.55 25.51 14.34 9.65 25.73 14.24 -11.06 103.55 63.77 -13.00 104.00 64.35 coo 11.83 18.73 16.99 10.99 19.71 15.26 -12.15 104.00 55.88 -11.78 105.13 57.73 ULMN 3 1vzz_c00 STEROID DELTA-ISOMERASE user 7 3 # 7 A 16 TYR D 50 TYR~? 5.61 CH1 MLY A 135 A 40 ASP D 122 ASP^? 7.49 C3 GOL D 147 A 103 LEU D 32 LEU^? 9.39 CH1 MLY A 135 coo 12.09 16.13 10.57 11.28 18.80 10.73 -31.54 83.73 14.98 -32.20 81.17 14.09 coo 7.55 25.51 14.34 9.65 25.73 14.24 -21.82 80.90 7.85 -21.38 79.32 6.51 coo 11.83 18.73 16.99 10.99 19.71 15.26 -25.57 84.78 15.16 -27.60 84.30 15.68 ULMN 3 1vzz_c00 STEROID DELTA-ISOMERASE user 8 3 # 8 A 16 TYR D 94 TYR^? -4.97 CL CL D 143s A 40 ASP D 106 ASP~? 11.82 O22 2PE D 146 A 103 LEU D 64 LEU~? 9.61 N MLY D 67 coo 12.09 16.13 10.57 11.28 18.80 10.73 -41.68 71.74 9.13 -40.22 73.97 9.96 coo 7.55 25.51 14.34 9.65 25.73 14.24 -46.82 82.57 5.87 -48.37 83.43 7.00 coo 11.83 18.73 16.99 10.99 19.71 15.26 -47.94 75.35 8.95 -48.64 76.82 7.45 1vzz_c00 source 1vzz STEROID DELTA-ISOMERASE : 8 hits 1vzz_c00 naa= 3 ULMN 3 1vzz_c01 STEROID DELTA-ISOMERASE user 1 3 # 1 B 16 TYR A 50 TYR~? 5.51 CH2 MLY D 135 B 40 ASP A 122 ASP^? 7.46 C1 GOL A 150 B 103 LEU A 32 LEU^? 9.30 CH2 MLY D 135 coo 14.25 20.09 37.35 13.48 17.40 37.38 -19.50 53.98 8.67 -20.18 55.72 10.74 coo 9.39 10.77 34.53 11.50 10.63 34.41 -15.41 64.92 4.51 -15.09 66.83 5.33 coo 12.89 17.60 31.13 12.34 16.51 32.90 -19.04 56.74 3.15 -19.76 55.64 4.88 ULMN 3 1vzz_c01 STEROID DELTA-ISOMERASE user 2 3 # 2 B 16 TYR A 94 TYR^? 4.94 CL CL A 145s B 40 ASP A 106 ASP~? 11.93 O22 2PE A 148 B 103 LEU A 64 LEU~? 9.53 N MLY A 67 coo 14.25 20.09 37.35 13.48 17.40 37.38 -21.59 58.91 24.53 -21.03 57.83 22.04 coo 9.39 10.77 34.53 11.50 10.63 34.41 -12.71 50.36 24.83 -13.06 48.30 25.05 coo 12.89 17.60 31.13 12.34 16.51 32.90 -19.44 53.00 27.96 -17.35 52.32 28.29 ULMN 3 1vzz_c01 STEROID DELTA-ISOMERASE user 3 3 # 3 B 16 TYR B 50 TYR~? 5.52 CH1 MLY C 135 B 40 ASP B 122 ASP^? 7.33 O2 GOL B 149 B 103 LEU B 32 LEU^? 9.36 CE MLY C 135 coo 14.25 20.09 37.35 13.48 17.40 37.38 8.51 83.11 35.90 5.93 82.51 36.84 coo 9.39 10.77 34.53 11.50 10.63 34.41 10.89 79.68 47.57 9.75 78.80 49.16 coo 12.89 17.60 31.13 12.34 16.51 32.90 12.48 84.84 40.35 10.99 84.89 38.79 ULMN 3 1vzz_c01 STEROID DELTA-ISOMERASE user 4 3 # 4 B 16 TYR B 94 TYR^? -5.06 CL CL B 143s B 40 ASP B 106 ASP~? 11.87 OH2 1PE B 150 B 103 LEU B 64 LEU~? 7.06 OH4 1PE B 150 coo 14.25 20.09 37.35 13.48 17.40 37.38 -6.97 76.65 35.26 -4.34 77.53 35.11 coo 9.39 10.77 34.53 11.50 10.63 34.41 -0.30 70.27 27.08 -0.10 70.78 25.05 coo 12.89 17.60 31.13 12.34 16.51 32.90 -6.99 74.17 28.56 -6.11 72.35 27.70 ULMN 3 1vzz_c01 STEROID DELTA-ISOMERASE user 5 3 # 5 B 16 TYR C 50 TYR~? 5.59 CE MLY B 135 B 40 ASP C 122 ASP^? 7.22 C3 GOL C 149 B 103 LEU C 32 LEU^? 8.96 CD MLY B 135 coo 14.25 20.09 37.35 13.48 17.40 37.38 -11.27 85.65 61.91 -10.18 87.09 59.78 coo 9.39 10.77 34.53 11.50 10.63 34.41 0.27 81.12 61.60 2.07 81.54 60.53 coo 12.89 17.60 31.13 12.34 16.51 32.90 -8.67 80.10 62.81 -9.90 81.76 62.17 ULMN 3 1vzz_c01 STEROID DELTA-ISOMERASE user 6 3 # 6 B 16 TYR C 94 TYR^? 5.01 CL CL C 144s B 40 ASP C 106 ASP~? 12.11 C21 PE8 C 148 B 103 LEU C 64 LEU~? 9.53 N MLY C 67 coo 14.25 20.09 37.35 13.48 17.40 37.38 -8.07 99.17 52.54 -8.69 97.12 54.34 coo 9.39 10.77 34.53 11.50 10.63 34.41 -11.06 103.55 63.77 -13.00 104.00 64.35 coo 12.89 17.60 31.13 12.34 16.51 32.90 -12.15 104.00 55.88 -11.78 105.13 57.73 ULMN 3 1vzz_c01 STEROID DELTA-ISOMERASE user 7 3 # 7 B 16 TYR D 50 TYR~? 5.61 CH1 MLY A 135 B 40 ASP D 122 ASP^? 7.49 C3 GOL D 147 B 103 LEU D 32 LEU^? 9.39 CH1 MLY A 135 coo 14.25 20.09 37.35 13.48 17.40 37.38 -31.54 83.73 14.98 -32.20 81.17 14.09 coo 9.39 10.77 34.53 11.50 10.63 34.41 -21.82 80.90 7.85 -21.38 79.32 6.51 coo 12.89 17.60 31.13 12.34 16.51 32.90 -25.57 84.78 15.16 -27.60 84.30 15.68 ULMN 3 1vzz_c01 STEROID DELTA-ISOMERASE user 8 3 # 8 B 16 TYR D 94 TYR^? -4.97 CL CL D 143s B 40 ASP D 106 ASP~? 11.82 O22 2PE D 146 B 103 LEU D 64 LEU~? 9.61 N MLY D 67 coo 14.25 20.09 37.35 13.48 17.40 37.38 -41.68 71.74 9.13 -40.22 73.97 9.96 coo 9.39 10.77 34.53 11.50 10.63 34.41 -46.82 82.57 5.87 -48.37 83.43 7.00 coo 12.89 17.60 31.13 12.34 16.51 32.90 -47.94 75.35 8.95 -48.64 76.82 7.45 1vzz_c01 source 1vzz STEROID DELTA-ISOMERASE : 8 hits 1vzz_c01 naa= 3 ULMN 3 1xny_c01 PROPIONYL-COA CARBOXYLASE COMPLEX B user 1 3 # 1 A 420 ALA A 17 ALA~? 6.78 C24 1PE B 150 B 182 GLY B 66 GLY.? -2.40 N MLZ B 67s B 183 GLY B 65 GLY.? 4.50 C13 1PE B 150 coo 38.36-101.47-135.52 39.62-101.29-136.35 -11.11 69.66 29.83 -10.38 70.82 29.22 coo 41.93-102.35-126.87 41.52-101.89-126.30 -6.97 79.43 31.86 -7.37 79.83 31.22 coo 38.37-101.99-128.11 38.63-102.24-127.37 -9.71 78.10 29.60 -8.92 78.05 29.76 ULMN 3 1xny_c01 PROPIONYL-COA CARBOXYLASE COMPLEX B user 2 3 # 2 A 420 ALA A 52 ALA~? 11.32 CD MLY D 135 B 182 GLY A 58 GLY~? 4.50 C27 2PE A 148 B 183 GLY A 54 GLY~? 5.80 C21 2PE A 148 coo 38.36-101.47-135.52 39.62-101.29-136.35 -17.75 46.92 10.26 -16.48 46.44 9.51 coo 41.93-102.35-126.87 41.52-101.89-126.30 -21.53 48.90 19.09 -20.88 48.61 19.49 coo 38.37-101.99-128.11 38.63-102.24-127.37 -20.41 50.07 13.76 -19.88 49.43 13.69 ULMN 3 1xny_c01 PROPIONYL-COA CARBOXYLASE COMPLEX B user 3 3 # 3 A 420 ALA A 92 ALA^? 3.73 CL CL A 145 B 182 GLY A 65 GLY.? 5.39 N MLY A 67 B 183 GLY A 66 GLY.? -2.41 N MLY A 67s coo 38.36-101.47-135.52 39.62-101.29-136.35 -25.37 59.69 19.81 -24.01 59.02 19.51 coo 41.93-102.35-126.87 41.52-101.89-126.30 -24.17 54.15 28.06 -23.78 54.05 27.41 coo 38.37-101.99-128.11 38.63-102.24-127.37 -23.99 55.25 24.44 -24.50 54.68 24.81 ULMN 3 1xny_c01 PROPIONYL-COA CARBOXYLASE COMPLEX B user 4 3 # 4 A 420 ALA A 99 ALA~? 9.01 N MLY A 67 B 182 GLY A 66 GLY.? -2.41 N MLY A 67s B 183 GLY A 65 GLY.? 5.39 N MLY A 67 coo 38.36-101.47-135.52 39.62-101.29-136.35 -18.17 57.51 29.32 -19.70 57.46 29.31 coo 41.93-102.35-126.87 41.52-101.89-126.30 -23.99 55.25 24.44 -24.50 54.68 24.81 coo 38.37-101.99-128.11 38.63-102.24-127.37 -24.17 54.15 28.06 -23.78 54.05 27.41 ULMN 3 1xny_c01 PROPIONYL-COA CARBOXYLASE COMPLEX B user 5 3 # 5 A 420 ALA A 112 ALA~? 8.20 C21 2PE A 148 B 182 GLY A 54 GLY~? 5.80 C21 2PE A 148 B 183 GLY A 58 GLY~? 4.50 C27 2PE A 148 coo 38.36-101.47-135.52 39.62-101.29-136.35 -12.94 48.96 15.36 -14.23 48.99 16.18 coo 41.93-102.35-126.87 41.52-101.89-126.30 -20.41 50.07 13.76 -19.88 49.43 13.69 coo 38.37-101.99-128.11 38.63-102.24-127.37 -21.53 48.90 19.09 -20.88 48.61 19.49 ULMN 3 1xny_c01 PROPIONYL-COA CARBOXYLASE COMPLEX B user 6 3 # 6 A 420 ALA A 112 ALA~? 8.20 C21 2PE A 148 B 182 GLY A 58 GLY~? 4.50 C27 2PE A 148 B 183 GLY A 54 GLY~? 5.80 C21 2PE A 148 coo 38.36-101.47-135.52 39.62-101.29-136.35 -12.94 48.96 15.36 -14.23 48.99 16.18 coo 41.93-102.35-126.87 41.52-101.89-126.30 -21.53 48.90 19.09 -20.88 48.61 19.49 coo 38.37-101.99-128.11 38.63-102.24-127.37 -20.41 50.07 13.76 -19.88 49.43 13.69 ULMN 3 1xny_c01 PROPIONYL-COA CARBOXYLASE COMPLEX B user 7 3 # 7 A 420 ALA B 52 ALA~? 11.30 CE MLY C 135 B 182 GLY B 58 GLY~? 4.95 C24 PE8 B 148 B 183 GLY B 54 GLY~? 5.68 C20 PE8 B 148 coo 38.36-101.47-135.52 39.62-101.29-136.35 10.17 82.02 28.78 11.54 81.34 28.64 coo 41.93-102.35-126.87 41.52-101.89-126.30 0.41 80.81 27.68 0.49 80.12 27.29 coo 38.37-101.99-128.11 38.63-102.24-127.37 5.02 82.24 30.45 5.51 81.90 29.87 ULMN 3 1xny_c01 PROPIONYL-COA CARBOXYLASE COMPLEX B user 8 3 # 8 A 420 ALA B 92 ALA^? 3.81 CL CL B 143 B 182 GLY B 65 GLY.? 4.50 C13 1PE B 150 B 183 GLY B 66 GLY.? -2.40 N MLZ B 67s coo 38.36-101.47-135.52 39.62-101.29-136.35 -5.22 82.02 37.59 -4.12 81.09 37.06 coo 41.93-102.35-126.87 41.52-101.89-126.30 -9.71 78.10 29.60 -8.92 78.05 29.76 coo 38.37-101.99-128.11 38.63-102.24-127.37 -6.97 79.43 31.86 -7.37 79.83 31.22 ULMN 3 1xny_c01 PROPIONYL-COA CARBOXYLASE COMPLEX B user 9 3 # 9 A 420 ALA B 99 ALA~? 8.23 C24 1PE B 150 B 182 GLY B 66 GLY.? -2.40 N MLZ B 67s B 183 GLY B 65 GLY.? 4.50 C13 1PE B 150 coo 38.36-101.47-135.52 39.62-101.29-136.35 -8.65 71.66 32.40 -9.35 73.01 32.38 coo 41.93-102.35-126.87 41.52-101.89-126.30 -6.97 79.43 31.86 -7.37 79.83 31.22 coo 38.37-101.99-128.11 38.63-102.24-127.37 -9.71 78.10 29.60 -8.92 78.05 29.76 ULMN 3 1xny_c01 PROPIONYL-COA CARBOXYLASE COMPLEX B user 10 3 # 10 A 420 ALA B 112 ALA~? 8.38 O19 PE8 B 148 B 182 GLY B 54 GLY~? 5.68 C20 PE8 B 148 B 183 GLY B 58 GLY~? 4.95 C24 PE8 B 148 coo 38.36-101.47-135.52 39.62-101.29-136.35 7.70 75.11 29.02 6.38 75.83 28.78 coo 41.93-102.35-126.87 41.52-101.89-126.30 5.02 82.24 30.45 5.51 81.90 29.87 coo 38.37-101.99-128.11 38.63-102.24-127.37 0.41 80.81 27.68 0.49 80.12 27.29 ULMN 3 1xny_c01 PROPIONYL-COA CARBOXYLASE COMPLEX B user 11 3 # 11 A 420 ALA B 112 ALA~? 8.38 O19 PE8 B 148 B 182 GLY B 58 GLY~? 4.95 C24 PE8 B 148 B 183 GLY B 54 GLY~? 5.68 C20 PE8 B 148 coo 38.36-101.47-135.52 39.62-101.29-136.35 7.70 75.11 29.02 6.38 75.83 28.78 coo 41.93-102.35-126.87 41.52-101.89-126.30 0.41 80.81 27.68 0.49 80.12 27.29 coo 38.37-101.99-128.11 38.63-102.24-127.37 5.02 82.24 30.45 5.51 81.90 29.87 ULMN 3 1xny_c01 PROPIONYL-COA CARBOXYLASE COMPLEX B user 12 3 # 12 A 420 ALA C 92 ALA^? 3.74 CL CL C 144 B 182 GLY C 65 GLY.? 5.43 N MLY C 67 B 183 GLY C 66 GLY.? 2.42 N MLY C 67 coo 38.36-101.47-135.52 39.62-101.29-136.35 -9.27 93.54 50.71 -9.15 93.80 52.25 coo 41.93-102.35-126.87 41.52-101.89-126.30 -13.50 102.51 51.50 -13.37 102.01 52.12 coo 38.37-101.99-128.11 38.63-102.24-127.37 -12.43 98.97 52.37 -13.17 99.25 52.09 ULMN 3 1xny_c01 PROPIONYL-COA CARBOXYLASE COMPLEX B user 13 3 # 13 A 420 ALA C 99 ALA~? 8.97 N MLY C 67 B 182 GLY C 66 GLY.? 2.42 N MLY C 67 B 183 GLY C 65 GLY.? 5.43 N MLY C 67 coo 38.36-101.47-135.52 39.62-101.29-136.35 -7.58 104.86 54.49 -8.41 104.39 53.32 coo 41.93-102.35-126.87 41.52-101.89-126.30 -12.43 98.97 52.37 -13.17 99.25 52.09 coo 38.37-101.99-128.11 38.63-102.24-127.37 -13.50 102.51 51.50 -13.37 102.01 52.12 ULMN 3 1xny_c01 PROPIONYL-COA CARBOXYLASE COMPLEX B user 14 3 # 14 A 420 ALA C 112 ALA~? 5.54 N MLZ C 114 B 182 GLY C 54 GLY~? 6.00 CH2 MLY B 135 B 183 GLY C 58 GLY~? 5.12 O25 PE8 C 148 coo 38.36-101.47-135.52 39.62-101.29-136.35 -12.31 94.71 67.32 -12.91 95.14 66.01 coo 41.93-102.35-126.87 41.52-101.89-126.30 -15.22 90.72 61.35 -15.47 90.98 62.07 coo 38.37-101.99-128.11 38.63-102.24-127.37 -16.70 95.68 59.15 -16.57 96.27 59.66 ULMN 3 1xny_c01 PROPIONYL-COA CARBOXYLASE COMPLEX B user 15 3 # 15 A 420 ALA C 112 ALA~? 5.54 N MLZ C 114 B 182 GLY C 58 GLY~? 5.12 O25 PE8 C 148 B 183 GLY C 54 GLY~? 6.00 CH2 MLY B 135 coo 38.36-101.47-135.52 39.62-101.29-136.35 -12.31 94.71 67.32 -12.91 95.14 66.01 coo 41.93-102.35-126.87 41.52-101.89-126.30 -16.70 95.68 59.15 -16.57 96.27 59.66 coo 38.37-101.99-128.11 38.63-102.24-127.37 -15.22 90.72 61.35 -15.47 90.98 62.07 ULMN 3 1xny_c01 PROPIONYL-COA CARBOXYLASE COMPLEX B user 16 3 # 16 A 420 ALA D 92 ALA^? 3.79 CL CL D 143 B 182 GLY D 65 GLY.? 5.41 N MLY D 67 B 183 GLY D 66 GLY.? -2.41 N MLY D 67s coo 38.36-101.47-135.52 39.62-101.29-136.35 -37.38 71.28 13.39 -37.58 72.62 12.67 coo 41.93-102.35-126.87 41.52-101.89-126.30 -47.31 71.82 12.27 -46.82 72.43 12.21 coo 38.37-101.99-128.11 38.63-102.24-127.37 -43.71 72.89 12.82 -44.34 72.79 13.37 ULMN 3 1xny_c01 PROPIONYL-COA CARBOXYLASE COMPLEX B user 17 3 # 17 A 420 ALA D 99 ALA~? 8.96 N MLY D 67 B 182 GLY D 66 GLY.? -2.41 N MLY D 67s B 183 GLY D 65 GLY.? 5.41 N MLY D 67 coo 38.36-101.47-135.52 39.62-101.29-136.35 -46.31 72.48 5.36 -46.32 71.68 6.65 coo 41.93-102.35-126.87 41.52-101.89-126.30 -43.71 72.89 12.82 -44.34 72.79 13.37 coo 38.37-101.99-128.11 38.63-102.24-127.37 -47.31 71.82 12.27 -46.82 72.43 12.21 ULMN 3 1xny_c01 PROPIONYL-COA CARBOXYLASE COMPLEX B user 18 3 # 18 A 420 ALA D 112 ALA~? 8.09 C21 2PE D 146 B 182 GLY D 54 GLY~? 5.81 C23 2PE D 146 B 183 GLY D 58 GLY~? 4.33 O28 2PE D 146 coo 38.36-101.47-135.52 39.62-101.29-136.35 -39.97 87.72 9.79 -40.62 86.60 10.56 coo 41.93-102.35-126.87 41.52-101.89-126.30 -38.01 83.52 15.98 -38.33 84.28 15.84 coo 38.37-101.99-128.11 38.63-102.24-127.37 -43.01 81.01 15.62 -43.47 81.37 15.05 ULMN 3 1xny_c01 PROPIONYL-COA CARBOXYLASE COMPLEX B user 19 3 # 19 A 420 ALA D 112 ALA~? 8.09 C21 2PE D 146 B 182 GLY D 58 GLY~? 4.33 O28 2PE D 146 B 183 GLY D 54 GLY~? 5.81 C23 2PE D 146 coo 38.36-101.47-135.52 39.62-101.29-136.35 -39.97 87.72 9.79 -40.62 86.60 10.56 coo 41.93-102.35-126.87 41.52-101.89-126.30 -43.01 81.01 15.62 -43.47 81.37 15.05 coo 38.37-101.99-128.11 38.63-102.24-127.37 -38.01 83.52 15.98 -38.33 84.28 15.84 1xny_c01 source 1xny PROPIONYL-COA CARBOXYLASE COMPLEX B SUBUNIT : 19 hits 1xny_c01 naa= 3 ULMN 3 1xqw_c00 PROLINE IMINOPEPTIDASE user 1 3 # 1 A 105 ALA A 47 ALA~? 9.02 CD MLY D 135 A 244 ASP A 87 ASP.? 8.49 C6 PGE A 147 A 271 HIS A 88 HIS^? 4.20 CH2 MLY D 135 coo 15.05 3.71 6.93 14.58 4.88 7.78 -20.21 51.63 3.44 -21.40 51.48 2.53 coo 9.85 8.15 0.76 10.61 7.04 2.39 -23.17 58.67 3.55 -22.34 59.17 1.69 coo 10.61 7.65 6.01 12.39 6.55 6.23 -23.95 56.87 7.77 -24.14 54.98 6.86 ULMN 3 1xqw_c00 PROLINE IMINOPEPTIDASE user 2 3 # 2 A 105 ALA A 49 ALA~? 12.15 CD MLY D 135 A 244 ASP A 56 ASP~? 11.59 C21 2PE A 148 A 271 HIS A 115 HIS~? 12.27 C21 2PE A 148 coo 15.05 3.71 6.93 14.58 4.88 7.78 -16.03 49.47 6.19 -14.84 50.27 5.67 coo 9.85 8.15 0.76 10.61 7.04 2.39 -16.01 45.89 15.64 -15.93 44.31 14.23 coo 10.61 7.65 6.01 12.39 6.55 6.23 -13.18 48.35 10.37 -12.55 46.36 10.33 ULMN 3 1xqw_c00 PROLINE IMINOPEPTIDASE user 3 3 # 3 A 105 ALA A 51 ALA~? 7.23 CD MLY D 135 A 244 ASP A 56 ASP~? 11.59 C21 2PE A 148 A 271 HIS A 115 HIS~? 12.27 C21 2PE A 148 coo 15.05 3.71 6.93 14.58 4.88 7.78 -20.65 48.85 8.75 -21.19 47.91 7.68 coo 9.85 8.15 0.76 10.61 7.04 2.39 -16.01 45.89 15.64 -15.93 44.31 14.23 coo 10.61 7.65 6.01 12.39 6.55 6.23 -13.18 48.35 10.37 -12.55 46.36 10.33 ULMN 3 1xqw_c00 PROLINE IMINOPEPTIDASE user 4 3 # 4 A 105 ALA B 47 ALA~? 9.27 CD MLY C 135 A 244 ASP B 87 ASP.? 8.94 O4 PGE B 147 A 271 HIS B 88 HIS^? 4.29 CH1 MLY C 135 coo 15.05 3.71 6.93 14.58 4.88 7.78 13.13 86.65 35.42 13.34 88.15 35.52 coo 9.85 8.15 0.76 10.61 7.04 2.39 9.49 87.97 42.02 11.31 87.98 43.09 coo 10.61 7.65 6.01 12.39 6.55 6.23 6.15 87.00 38.94 7.35 87.96 37.51 ULMN 3 1xqw_c00 PROLINE IMINOPEPTIDASE user 5 3 # 5 A 105 ALA B 49 ALA~? 10.91 O1 PEG B 144 A 244 ASP B 56 ASP~? 11.45 C20 PE8 B 148 A 271 HIS B 115 HIS~? 12.48 C18 PE8 B 148 coo 15.05 3.71 6.93 14.58 4.88 7.78 13.56 82.06 32.43 14.35 81.13 33.34 coo 9.85 8.15 0.76 10.61 7.04 2.39 6.80 78.21 26.00 8.47 79.07 25.03 coo 10.61 7.65 6.01 12.39 6.55 6.23 11.86 77.76 30.05 12.70 77.49 28.15 ULMN 3 1xqw_c00 PROLINE IMINOPEPTIDASE user 6 3 # 6 A 105 ALA B 51 ALA~? 7.25 CG MLY C 135 A 244 ASP B 56 ASP~? 11.45 C20 PE8 B 148 A 271 HIS B 115 HIS~? 12.48 C18 PE8 B 148 coo 15.05 3.71 6.93 14.58 4.88 7.78 9.29 84.92 31.07 10.11 86.09 30.55 coo 9.85 8.15 0.76 10.61 7.04 2.39 6.80 78.21 26.00 8.47 79.07 25.03 coo 10.61 7.65 6.01 12.39 6.55 6.23 11.86 77.76 30.05 12.70 77.49 28.15 ULMN 3 1xqw_c00 PROLINE IMINOPEPTIDASE user 7 3 # 7 A 105 ALA C 47 ALA~? 8.78 CD MLY B 135 A 244 ASP C 87 ASP.? 8.84 O1 PGE C 147 A 271 HIS C 88 HIS^? 3.86 CD MLY B 135 coo 15.05 3.71 6.93 14.58 4.88 7.78 -13.73 80.92 64.16 -14.51 79.74 63.61 coo 9.85 8.15 0.76 10.61 7.04 2.39 -9.03 79.00 58.44 -8.21 77.39 59.55 coo 10.61 7.65 6.01 12.39 6.55 6.23 -11.00 83.03 57.18 -12.69 82.43 58.26 ULMN 3 1xqw_c00 PROLINE IMINOPEPTIDASE user 8 3 # 8 A 105 ALA C 49 ALA~? 6.49 O MLZ C 114 A 244 ASP C 56 ASP~? 9.09 N MLZ C 114 A 271 HIS C 115 HIS~? 4.72 C MLZ C 114 coo 15.05 3.71 6.93 14.58 4.88 7.78 -13.48 85.10 67.69 -12.20 84.83 68.50 coo 9.85 8.15 0.76 10.61 7.04 2.39 -16.40 94.43 66.11 -17.63 93.56 67.58 coo 10.61 7.65 6.01 12.39 6.55 6.23 -12.99 90.00 69.08 -14.38 90.57 70.54 ULMN 3 1xqw_c00 PROLINE IMINOPEPTIDASE user 9 3 # 9 A 105 ALA C 51 ALA~? 7.46 CD MLY B 135 A 244 ASP C 56 ASP~? 9.09 N MLZ C 114 A 271 HIS C 115 HIS~? 4.72 C MLZ C 114 coo 15.05 3.71 6.93 14.58 4.88 7.78 -16.25 86.28 63.34 -17.35 85.28 63.69 coo 9.85 8.15 0.76 10.61 7.04 2.39 -16.40 94.43 66.11 -17.63 93.56 67.58 coo 10.61 7.65 6.01 12.39 6.55 6.23 -12.99 90.00 69.08 -14.38 90.57 70.54 ULMN 3 1xqw_c00 PROLINE IMINOPEPTIDASE user 10 3 # 10 A 105 ALA D 47 ALA~? 9.03 CG MLY A 135 A 244 ASP D 87 ASP.? 7.26 C16 1PE B 150 A 271 HIS D 88 HIS^? 4.38 CH1 MLY A 135 coo 15.05 3.71 6.93 14.58 4.88 7.78 -28.68 87.42 18.40 -28.00 87.29 19.73 coo 9.85 8.15 0.76 10.61 7.04 2.39 -24.70 80.89 17.41 -22.90 81.94 17.31 coo 10.61 7.65 6.01 12.39 6.55 6.23 -29.18 79.71 17.63 -29.43 81.25 19.03 ULMN 3 1xqw_c00 PROLINE IMINOPEPTIDASE user 11 3 # 11 A 105 ALA D 49 ALA~? 12.11 CE MLY A 135 A 244 ASP D 56 ASP~? 11.46 C21 2PE D 146 A 271 HIS D 115 HIS~? 12.18 C21 2PE D 146 coo 15.05 3.71 6.93 14.58 4.88 7.78 -32.13 89.91 15.13 -31.19 90.29 13.98 coo 9.85 8.15 0.76 10.61 7.04 2.39 -41.85 87.81 13.66 -41.61 89.58 14.80 coo 10.61 7.65 6.01 12.39 6.55 6.23 -36.28 90.32 11.92 -37.49 91.98 12.35 ULMN 3 1xqw_c00 PROLINE IMINOPEPTIDASE user 12 3 # 12 A 105 ALA D 51 ALA~? 6.92 CG MLY A 135 A 244 ASP D 56 ASP~? 11.46 C21 2PE D 146 A 271 HIS D 115 HIS~? 12.18 C21 2PE D 146 coo 15.05 3.71 6.93 14.58 4.88 7.78 -34.62 86.43 18.27 -34.28 87.19 19.52 coo 9.85 8.15 0.76 10.61 7.04 2.39 -41.85 87.81 13.66 -41.61 89.58 14.80 coo 10.61 7.65 6.01 12.39 6.55 6.23 -36.28 90.32 11.92 -37.49 91.98 12.35 1xqw_c00 source 1xqw PROLINE IMINOPEPTIDASE : 12 hits 1xqw_c00 naa= 3 ULMN 3 1xs1_c07 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 1 3 # 1 B 124 ALA A 13 ALA~? 8.48 C3 2PE A 148 B 126 ARG B 105 ARG~? -3.01 O4 SO4 A 143s B 138 GLU A 10 GLU~? 8.70 C6 2PE A 148 coo 2.11 4.00 19.31 3.14 4.86 19.99 -7.72 67.72 25.29 -6.32 68.40 25.30 coo 2.45 5.53 11.28 3.59 7.56 13.29 -2.68 64.28 31.62 -4.52 62.28 32.99 coo 6.10 2.00 25.24 6.12 1.84 23.13 -3.10 70.57 20.07 -2.45 69.30 18.38 ULMN 3 1xs1_c07 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 2 3 # 2 B 124 ALA A 112 ALA~? 8.20 C21 2PE A 148 B 126 ARG A 55 ARG~? 10.23 CD MLY D 135 B 138 GLU A 111 GLU~? 12.48 C11 2PE A 148 coo 2.11 4.00 19.31 3.14 4.86 19.99 -12.94 48.96 15.36 -14.23 48.99 16.18 coo 2.45 5.53 11.28 3.59 7.56 13.29 -19.70 43.33 11.87 -20.69 44.07 9.04 coo 6.10 2.00 25.24 6.12 1.84 23.13 -8.13 46.06 17.22 -6.45 46.46 15.98 ULMN 3 1xs1_c07 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 3 3 # 3 B 124 ALA A 112 ALA~? 8.20 C21 2PE A 148 B 126 ARG A 116 ARG~? 4.70 C15 2PE A 148 B 138 GLU A 111 GLU~? 12.48 C11 2PE A 148 coo 2.11 4.00 19.31 3.14 4.86 19.99 -12.94 48.96 15.36 -14.23 48.99 16.18 coo 2.45 5.53 11.28 3.59 7.56 13.29 -15.13 57.15 12.87 -15.00 60.01 11.67 coo 6.10 2.00 25.24 6.12 1.84 23.13 -8.13 46.06 17.22 -6.45 46.46 15.98 ULMN 3 1xs1_c07 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 4 3 # 4 B 124 ALA B 49 ALA~? 10.91 O1 PEG B 144 B 126 ARG B 116 ARG~? 4.93 C12 PE8 B 148 B 138 GLU B 48 GLU~? 13.73 O1 PEG B 144 coo 2.11 4.00 19.31 3.14 4.86 19.99 13.56 82.06 32.43 14.35 81.13 33.34 coo 2.45 5.53 11.28 3.59 7.56 13.29 6.23 77.16 37.54 6.11 77.30 40.64 coo 6.10 2.00 25.24 6.12 1.84 23.13 16.05 87.39 31.22 18.08 87.70 30.57 ULMN 3 1xs1_c07 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 5 3 # 5 B 124 ALA B 112 ALA~? 8.38 O19 PE8 B 148 B 126 ARG B 55 ARG~? 9.33 CG MLY C 135 B 138 GLU B 111 GLU~? 12.54 O7 PE8 B 148 coo 2.11 4.00 19.31 3.14 4.86 19.99 7.70 75.11 29.02 6.38 75.83 28.78 coo 2.45 5.53 11.28 3.59 7.56 13.29 8.78 84.29 24.99 10.39 86.20 26.77 coo 6.10 2.00 25.24 6.12 1.84 23.13 9.41 70.70 25.55 11.25 69.94 26.27 ULMN 3 1xs1_c07 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 6 3 # 6 B 124 ALA B 112 ALA~? 8.38 O19 PE8 B 148 B 126 ARG B 116 ARG~? 4.93 C12 PE8 B 148 B 138 GLU B 111 GLU~? 12.54 O7 PE8 B 148 coo 2.11 4.00 19.31 3.14 4.86 19.99 7.70 75.11 29.02 6.38 75.83 28.78 coo 2.45 5.53 11.28 3.59 7.56 13.29 6.23 77.16 37.54 6.11 77.30 40.64 coo 6.10 2.00 25.24 6.12 1.84 23.13 9.41 70.70 25.55 11.25 69.94 26.27 ULMN 3 1xs1_c07 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 7 3 # 7 B 124 ALA C 49 ALA~? 6.49 O MLZ C 114 B 126 ARG C 116 ARG~? 4.72 C15 PE8 C 148 B 138 GLU C 48 GLU~? 14.22 O MLZ C 114 coo 2.11 4.00 19.31 3.14 4.86 19.99 -13.48 85.10 67.69 -12.20 84.83 68.50 coo 2.45 5.53 11.28 3.59 7.56 13.29 -6.64 90.12 62.40 -4.04 88.84 61.33 coo 6.10 2.00 25.24 6.12 1.84 23.13 -17.56 80.63 67.68 -18.20 79.53 69.43 ULMN 3 1xs1_c07 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 8 3 # 8 B 124 ALA C 112 ALA~? 5.54 N MLZ C 114 B 126 ARG C 116 ARG~? 4.72 C15 PE8 C 148 B 138 GLU C 111 GLU~? 3.06 NZ MLZ C 114 coo 2.11 4.00 19.31 3.14 4.86 19.99 -12.31 94.71 67.32 -12.91 95.14 66.01 coo 2.45 5.53 11.28 3.59 7.56 13.29 -6.64 90.12 62.40 -4.04 88.84 61.33 coo 6.10 2.00 25.24 6.12 1.84 23.13 -12.41 98.44 71.96 -11.17 97.70 73.52 ULMN 3 1xs1_c07 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 9 3 # 9 B 124 ALA C 119 ALA~? 6.80 O MLZ C 114 B 126 ARG C 42 ARG.? 7.63 O MLZ C 114 B 138 GLU C 121 GLU^? 12.40 C3 GOL C 149 coo 2.11 4.00 19.31 3.14 4.86 19.99 -8.25 84.08 66.89 -9.22 84.66 65.88 coo 2.45 5.53 11.28 3.59 7.56 13.29 -13.55 84.90 75.42 -13.77 88.03 75.38 coo 6.10 2.00 25.24 6.12 1.84 23.13 -1.98 78.69 65.48 -2.54 76.71 65.06 ULMN 3 1xs1_c07 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 10 3 # 10 B 124 ALA D 49 ALA~? 12.11 CE MLY A 135 B 126 ARG D 116 ARG~? 4.73 C15 2PE D 146 B 138 GLU D 48 GLU~? 13.85 CG MLY A 135 coo 2.11 4.00 19.31 3.14 4.86 19.99 -32.13 89.91 15.13 -31.19 90.29 13.98 coo 2.45 5.53 11.28 3.59 7.56 13.29 -33.13 82.22 8.73 -30.63 80.83 7.52 coo 6.10 2.00 25.24 6.12 1.84 23.13 -30.39 91.81 20.65 -29.75 93.83 21.10 ULMN 3 1xs1_c07 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 11 3 # 11 B 124 ALA D 112 ALA~? 8.09 C21 2PE D 146 B 126 ARG D 55 ARG~? 9.16 CG MLY A 135 B 138 GLU D 111 GLU~? 11.88 C9 2PE D 146 coo 2.11 4.00 19.31 3.14 4.86 19.99 -39.97 87.72 9.79 -40.62 86.60 10.56 coo 2.45 5.53 11.28 3.59 7.56 13.29 -39.98 89.02 19.79 -37.17 89.06 21.03 coo 6.10 2.00 25.24 6.12 1.84 23.13 -43.22 91.45 6.64 -41.92 92.74 5.57 ULMN 3 1xs1_c07 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 12 3 # 12 B 124 ALA D 112 ALA~? 8.09 C21 2PE D 146 B 126 ARG D 116 ARG~? 4.73 C15 2PE D 146 B 138 GLU D 111 GLU~? 11.88 C9 2PE D 146 coo 2.11 4.00 19.31 3.14 4.86 19.99 -39.97 87.72 9.79 -40.62 86.60 10.56 coo 2.45 5.53 11.28 3.59 7.56 13.29 -33.13 82.22 8.73 -30.63 80.83 7.52 coo 6.10 2.00 25.24 6.12 1.84 23.13 -43.22 91.45 6.64 -41.92 92.74 5.57 1xs1_c07 source 1xs1 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASE : 12 hits 1xs1_c07 naa= 3 ULMN 3 1xs1_c08 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 1 3 # 1 C 124 ALA A 13 ALA~? 8.48 C3 2PE A 148 C 126 ARG B 105 ARG~? -3.01 O4 SO4 A 143s C 138 GLU A 10 GLU~? 8.70 C6 2PE A 148 coo -4.54 -7.50 19.94 -4.33 -8.73 20.82 -7.72 67.72 25.29 -6.32 68.40 25.30 coo -3.14 -9.40 12.05 -1.75 -11.23 14.08 -2.68 64.28 31.62 -4.52 62.28 32.99 coo -8.56 -9.50 25.72 -8.77 -9.47 23.62 -3.10 70.57 20.07 -2.45 69.30 18.38 ULMN 3 1xs1_c08 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 2 3 # 2 C 124 ALA A 49 ALA~? 12.15 CD MLY D 135 C 126 ARG A 33 ARG.? 10.19 C3 GOL A 150 C 138 GLU A 48 GLU~? 14.04 CG MLY D 135 coo -4.54 -7.50 19.94 -4.33 -8.73 20.82 -16.03 49.47 6.19 -14.84 50.27 5.67 coo -3.14 -9.40 12.05 -1.75 -11.23 14.08 -11.76 56.72 1.51 -9.97 59.19 1.86 coo -8.56 -9.50 25.72 -8.77 -9.47 23.62 -19.52 46.65 2.13 -18.86 45.41 0.50 ULMN 3 1xs1_c08 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 3 3 # 3 C 124 ALA A 112 ALA~? 8.20 C21 2PE A 148 C 126 ARG A 55 ARG~? 10.23 CD MLY D 135 C 138 GLU A 111 GLU~? 12.48 C11 2PE A 148 coo -4.54 -7.50 19.94 -4.33 -8.73 20.82 -12.94 48.96 15.36 -14.23 48.99 16.18 coo -3.14 -9.40 12.05 -1.75 -11.23 14.08 -19.70 43.33 11.87 -20.69 44.07 9.04 coo -8.56 -9.50 25.72 -8.77 -9.47 23.62 -8.13 46.06 17.22 -6.45 46.46 15.98 ULMN 3 1xs1_c08 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 4 3 # 4 C 124 ALA A 112 ALA~? 8.20 C21 2PE A 148 C 126 ARG A 116 ARG~? 4.70 C15 2PE A 148 C 138 GLU A 111 GLU~? 12.48 C11 2PE A 148 coo -4.54 -7.50 19.94 -4.33 -8.73 20.82 -12.94 48.96 15.36 -14.23 48.99 16.18 coo -3.14 -9.40 12.05 -1.75 -11.23 14.08 -15.13 57.15 12.87 -15.00 60.01 11.67 coo -8.56 -9.50 25.72 -8.77 -9.47 23.62 -8.13 46.06 17.22 -6.45 46.46 15.98 ULMN 3 1xs1_c08 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 5 3 # 5 C 124 ALA A 119 ALA~? 10.88 CH2 MLY D 135 C 126 ARG A 116 ARG~? 4.70 C15 2PE A 148 C 138 GLU A 121 GLU^? 12.41 C1 GOL A 150 coo -4.54 -7.50 19.94 -4.33 -8.73 20.82 -14.35 54.52 5.55 -15.48 54.02 6.43 coo -3.14 -9.40 12.05 -1.75 -11.23 14.08 -15.13 57.15 12.87 -15.00 60.01 11.67 coo -8.56 -9.50 25.72 -8.77 -9.47 23.62 -13.98 61.53 0.93 -15.14 61.60 -0.79 ULMN 3 1xs1_c08 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 6 3 # 6 C 124 ALA B 49 ALA~? 10.91 O1 PEG B 144 C 126 ARG B 116 ARG~? 4.93 C12 PE8 B 148 C 138 GLU B 48 GLU~? 13.73 O1 PEG B 144 coo -4.54 -7.50 19.94 -4.33 -8.73 20.82 13.56 82.06 32.43 14.35 81.13 33.34 coo -3.14 -9.40 12.05 -1.75 -11.23 14.08 6.23 77.16 37.54 6.11 77.30 40.64 coo -8.56 -9.50 25.72 -8.77 -9.47 23.62 16.05 87.39 31.22 18.08 87.70 30.57 ULMN 3 1xs1_c08 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 7 3 # 7 C 124 ALA B 112 ALA~? 8.38 O19 PE8 B 148 C 126 ARG B 55 ARG~? 9.33 CG MLY C 135 C 138 GLU B 111 GLU~? 12.54 O7 PE8 B 148 coo -4.54 -7.50 19.94 -4.33 -8.73 20.82 7.70 75.11 29.02 6.38 75.83 28.78 coo -3.14 -9.40 12.05 -1.75 -11.23 14.08 8.78 84.29 24.99 10.39 86.20 26.77 coo -8.56 -9.50 25.72 -8.77 -9.47 23.62 9.41 70.70 25.55 11.25 69.94 26.27 ULMN 3 1xs1_c08 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 8 3 # 8 C 124 ALA B 112 ALA~? 8.38 O19 PE8 B 148 C 126 ARG B 116 ARG~? 4.93 C12 PE8 B 148 C 138 GLU B 111 GLU~? 12.54 O7 PE8 B 148 coo -4.54 -7.50 19.94 -4.33 -8.73 20.82 7.70 75.11 29.02 6.38 75.83 28.78 coo -3.14 -9.40 12.05 -1.75 -11.23 14.08 6.23 77.16 37.54 6.11 77.30 40.64 coo -8.56 -9.50 25.72 -8.77 -9.47 23.62 9.41 70.70 25.55 11.25 69.94 26.27 ULMN 3 1xs1_c08 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 9 3 # 9 C 124 ALA B 119 ALA~? 10.71 O16 PE8 B 148 C 126 ARG B 116 ARG~? 4.93 C12 PE8 B 148 C 138 GLU B 121 GLU^? 8.74 O2 PEG B 144 coo -4.54 -7.50 19.94 -4.33 -8.73 20.82 13.47 80.03 37.47 12.33 80.66 36.69 coo -3.14 -9.40 12.05 -1.75 -11.23 14.08 6.23 77.16 37.54 6.11 77.30 40.64 coo -8.56 -9.50 25.72 -8.77 -9.47 23.62 15.37 80.83 45.64 16.23 82.69 46.15 ULMN 3 1xs1_c08 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 10 3 # 10 C 124 ALA C 49 ALA~? 6.49 O MLZ C 114 C 126 ARG C 116 ARG~? 4.72 C15 PE8 C 148 C 138 GLU C 48 GLU~? 14.22 O MLZ C 114 coo -4.54 -7.50 19.94 -4.33 -8.73 20.82 -13.48 85.10 67.69 -12.20 84.83 68.50 coo -3.14 -9.40 12.05 -1.75 -11.23 14.08 -6.64 90.12 62.40 -4.04 88.84 61.33 coo -8.56 -9.50 25.72 -8.77 -9.47 23.62 -17.56 80.63 67.68 -18.20 79.53 69.43 ULMN 3 1xs1_c08 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 11 3 # 11 C 124 ALA C 112 ALA~? 5.54 N MLZ C 114 C 126 ARG C 116 ARG~? 4.72 C15 PE8 C 148 C 138 GLU C 111 GLU~? 3.06 NZ MLZ C 114 coo -4.54 -7.50 19.94 -4.33 -8.73 20.82 -12.31 94.71 67.32 -12.91 95.14 66.01 coo -3.14 -9.40 12.05 -1.75 -11.23 14.08 -6.64 90.12 62.40 -4.04 88.84 61.33 coo -8.56 -9.50 25.72 -8.77 -9.47 23.62 -12.41 98.44 71.96 -11.17 97.70 73.52 ULMN 3 1xs1_c08 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 12 3 # 12 C 124 ALA C 119 ALA~? 6.80 O MLZ C 114 C 126 ARG C 42 ARG.? 7.63 O MLZ C 114 C 138 GLU C 121 GLU^? 12.40 C3 GOL C 149 coo -4.54 -7.50 19.94 -4.33 -8.73 20.82 -8.25 84.08 66.89 -9.22 84.66 65.88 coo -3.14 -9.40 12.05 -1.75 -11.23 14.08 -13.55 84.90 75.42 -13.77 88.03 75.38 coo -8.56 -9.50 25.72 -8.77 -9.47 23.62 -1.98 78.69 65.48 -2.54 76.71 65.06 ULMN 3 1xs1_c08 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 13 3 # 13 C 124 ALA C 119 ALA~? 6.80 O MLZ C 114 C 126 ARG C 116 ARG~? 4.72 C15 PE8 C 148 C 138 GLU C 121 GLU^? 12.40 C3 GOL C 149 coo -4.54 -7.50 19.94 -4.33 -8.73 20.82 -8.25 84.08 66.89 -9.22 84.66 65.88 coo -3.14 -9.40 12.05 -1.75 -11.23 14.08 -6.64 90.12 62.40 -4.04 88.84 61.33 coo -8.56 -9.50 25.72 -8.77 -9.47 23.62 -1.98 78.69 65.48 -2.54 76.71 65.06 ULMN 3 1xs1_c08 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 14 3 # 14 C 124 ALA D 49 ALA~? 12.11 CE MLY A 135 C 126 ARG D 116 ARG~? 4.73 C15 2PE D 146 C 138 GLU D 48 GLU~? 13.85 CG MLY A 135 coo -4.54 -7.50 19.94 -4.33 -8.73 20.82 -32.13 89.91 15.13 -31.19 90.29 13.98 coo -3.14 -9.40 12.05 -1.75 -11.23 14.08 -33.13 82.22 8.73 -30.63 80.83 7.52 coo -8.56 -9.50 25.72 -8.77 -9.47 23.62 -30.39 91.81 20.65 -29.75 93.83 21.10 ULMN 3 1xs1_c08 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 15 3 # 15 C 124 ALA D 112 ALA~? 8.09 C21 2PE D 146 C 126 ARG D 55 ARG~? 9.16 CG MLY A 135 C 138 GLU D 111 GLU~? 11.88 C9 2PE D 146 coo -4.54 -7.50 19.94 -4.33 -8.73 20.82 -39.97 87.72 9.79 -40.62 86.60 10.56 coo -3.14 -9.40 12.05 -1.75 -11.23 14.08 -39.98 89.02 19.79 -37.17 89.06 21.03 coo -8.56 -9.50 25.72 -8.77 -9.47 23.62 -43.22 91.45 6.64 -41.92 92.74 5.57 ULMN 3 1xs1_c08 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 16 3 # 16 C 124 ALA D 112 ALA~? 8.09 C21 2PE D 146 C 126 ARG D 116 ARG~? 4.73 C15 2PE D 146 C 138 GLU D 111 GLU~? 11.88 C9 2PE D 146 coo -4.54 -7.50 19.94 -4.33 -8.73 20.82 -39.97 87.72 9.79 -40.62 86.60 10.56 coo -3.14 -9.40 12.05 -1.75 -11.23 14.08 -33.13 82.22 8.73 -30.63 80.83 7.52 coo -8.56 -9.50 25.72 -8.77 -9.47 23.62 -43.22 91.45 6.64 -41.92 92.74 5.57 ULMN 3 1xs1_c08 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 17 3 # 17 C 124 ALA D 119 ALA~? 10.88 C18 2PE D 146 C 126 ARG D 116 ARG~? 4.73 C15 2PE D 146 C 138 GLU D 121 GLU^? 11.70 OH7 1PE B 150 coo -4.54 -7.50 19.94 -4.33 -8.73 20.82 -28.73 87.90 11.52 -29.74 87.21 12.41 coo -3.14 -9.40 12.05 -1.75 -11.23 14.08 -33.13 82.22 8.73 -30.63 80.83 7.52 coo -8.56 -9.50 25.72 -8.77 -9.47 23.62 -20.91 85.61 9.48 -19.44 85.70 10.98 1xs1_c08 source 1xs1 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASE : 17 hits 1xs1_c08 naa= 3 ULMN 3 1xs1_c09 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 1 3 # 1 D 124 ALA A 13 ALA~? 8.48 C3 2PE A 148 D 126 ARG B 105 ARG~? -3.01 O4 SO4 A 143s D 138 GLU A 10 GLU~? 8.70 C6 2PE A 148 coo 2.08 -1.49 62.94 3.12 -2.39 62.28 -7.72 67.72 25.29 -6.32 68.40 25.30 coo 2.52 -3.11 70.84 3.63 -5.24 68.92 -2.68 64.28 31.62 -4.52 62.28 32.99 coo 6.23 0.50 57.10 5.93 0.72 59.19 -3.10 70.57 20.07 -2.45 69.30 18.38 ULMN 3 1xs1_c09 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 2 3 # 2 D 124 ALA A 49 ALA~? 12.15 CD MLY D 135 D 126 ARG A 33 ARG.? 10.19 C3 GOL A 150 D 138 GLU A 48 GLU~? 14.04 CG MLY D 135 coo 2.08 -1.49 62.94 3.12 -2.39 62.28 -16.03 49.47 6.19 -14.84 50.27 5.67 coo 2.52 -3.11 70.84 3.63 -5.24 68.92 -11.76 56.72 1.51 -9.97 59.19 1.86 coo 6.23 0.50 57.10 5.93 0.72 59.19 -19.52 46.65 2.13 -18.86 45.41 0.50 ULMN 3 1xs1_c09 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 3 3 # 3 D 124 ALA A 112 ALA~? 8.20 C21 2PE A 148 D 126 ARG A 55 ARG~? 10.23 CD MLY D 135 D 138 GLU A 111 GLU~? 12.48 C11 2PE A 148 coo 2.08 -1.49 62.94 3.12 -2.39 62.28 -12.94 48.96 15.36 -14.23 48.99 16.18 coo 2.52 -3.11 70.84 3.63 -5.24 68.92 -19.70 43.33 11.87 -20.69 44.07 9.04 coo 6.23 0.50 57.10 5.93 0.72 59.19 -8.13 46.06 17.22 -6.45 46.46 15.98 ULMN 3 1xs1_c09 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 4 3 # 4 D 124 ALA A 112 ALA~? 8.20 C21 2PE A 148 D 126 ARG A 116 ARG~? 4.70 C15 2PE A 148 D 138 GLU A 111 GLU~? 12.48 C11 2PE A 148 coo 2.08 -1.49 62.94 3.12 -2.39 62.28 -12.94 48.96 15.36 -14.23 48.99 16.18 coo 2.52 -3.11 70.84 3.63 -5.24 68.92 -15.13 57.15 12.87 -15.00 60.01 11.67 coo 6.23 0.50 57.10 5.93 0.72 59.19 -8.13 46.06 17.22 -6.45 46.46 15.98 ULMN 3 1xs1_c09 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 5 3 # 5 D 124 ALA A 119 ALA~? 10.88 CH2 MLY D 135 D 126 ARG A 116 ARG~? 4.70 C15 2PE A 148 D 138 GLU A 121 GLU^? 12.41 C1 GOL A 150 coo 2.08 -1.49 62.94 3.12 -2.39 62.28 -14.35 54.52 5.55 -15.48 54.02 6.43 coo 2.52 -3.11 70.84 3.63 -5.24 68.92 -15.13 57.15 12.87 -15.00 60.01 11.67 coo 6.23 0.50 57.10 5.93 0.72 59.19 -13.98 61.53 0.93 -15.14 61.60 -0.79 ULMN 3 1xs1_c09 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 6 3 # 6 D 124 ALA B 112 ALA~? 8.38 O19 PE8 B 148 D 126 ARG B 55 ARG~? 9.33 CG MLY C 135 D 138 GLU B 111 GLU~? 12.54 O7 PE8 B 148 coo 2.08 -1.49 62.94 3.12 -2.39 62.28 7.70 75.11 29.02 6.38 75.83 28.78 coo 2.52 -3.11 70.84 3.63 -5.24 68.92 8.78 84.29 24.99 10.39 86.20 26.77 coo 6.23 0.50 57.10 5.93 0.72 59.19 9.41 70.70 25.55 11.25 69.94 26.27 ULMN 3 1xs1_c09 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 7 3 # 7 D 124 ALA B 112 ALA~? 8.38 O19 PE8 B 148 D 126 ARG B 116 ARG~? 4.93 C12 PE8 B 148 D 138 GLU B 111 GLU~? 12.54 O7 PE8 B 148 coo 2.08 -1.49 62.94 3.12 -2.39 62.28 7.70 75.11 29.02 6.38 75.83 28.78 coo 2.52 -3.11 70.84 3.63 -5.24 68.92 6.23 77.16 37.54 6.11 77.30 40.64 coo 6.23 0.50 57.10 5.93 0.72 59.19 9.41 70.70 25.55 11.25 69.94 26.27 ULMN 3 1xs1_c09 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 8 3 # 8 D 124 ALA B 119 ALA~? 10.71 O16 PE8 B 148 D 126 ARG B 116 ARG~? 4.93 C12 PE8 B 148 D 138 GLU B 121 GLU^? 8.74 O2 PEG B 144 coo 2.08 -1.49 62.94 3.12 -2.39 62.28 13.47 80.03 37.47 12.33 80.66 36.69 coo 2.52 -3.11 70.84 3.63 -5.24 68.92 6.23 77.16 37.54 6.11 77.30 40.64 coo 6.23 0.50 57.10 5.93 0.72 59.19 15.37 80.83 45.64 16.23 82.69 46.15 ULMN 3 1xs1_c09 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 9 3 # 9 D 124 ALA C 49 ALA~? 6.49 O MLZ C 114 D 126 ARG C 116 ARG~? 4.72 C15 PE8 C 148 D 138 GLU C 48 GLU~? 14.22 O MLZ C 114 coo 2.08 -1.49 62.94 3.12 -2.39 62.28 -13.48 85.10 67.69 -12.20 84.83 68.50 coo 2.52 -3.11 70.84 3.63 -5.24 68.92 -6.64 90.12 62.40 -4.04 88.84 61.33 coo 6.23 0.50 57.10 5.93 0.72 59.19 -17.56 80.63 67.68 -18.20 79.53 69.43 ULMN 3 1xs1_c09 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 10 3 # 10 D 124 ALA C 112 ALA~? 5.54 N MLZ C 114 D 126 ARG C 116 ARG~? 4.72 C15 PE8 C 148 D 138 GLU C 111 GLU~? 3.06 NZ MLZ C 114 coo 2.08 -1.49 62.94 3.12 -2.39 62.28 -12.31 94.71 67.32 -12.91 95.14 66.01 coo 2.52 -3.11 70.84 3.63 -5.24 68.92 -6.64 90.12 62.40 -4.04 88.84 61.33 coo 6.23 0.50 57.10 5.93 0.72 59.19 -12.41 98.44 71.96 -11.17 97.70 73.52 ULMN 3 1xs1_c09 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 11 3 # 11 D 124 ALA C 119 ALA~? 6.80 O MLZ C 114 D 126 ARG C 42 ARG.? 7.63 O MLZ C 114 D 138 GLU C 121 GLU^? 12.40 C3 GOL C 149 coo 2.08 -1.49 62.94 3.12 -2.39 62.28 -8.25 84.08 66.89 -9.22 84.66 65.88 coo 2.52 -3.11 70.84 3.63 -5.24 68.92 -13.55 84.90 75.42 -13.77 88.03 75.38 coo 6.23 0.50 57.10 5.93 0.72 59.19 -1.98 78.69 65.48 -2.54 76.71 65.06 ULMN 3 1xs1_c09 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 12 3 # 12 D 124 ALA C 119 ALA~? 6.80 O MLZ C 114 D 126 ARG C 116 ARG~? 4.72 C15 PE8 C 148 D 138 GLU C 121 GLU^? 12.40 C3 GOL C 149 coo 2.08 -1.49 62.94 3.12 -2.39 62.28 -8.25 84.08 66.89 -9.22 84.66 65.88 coo 2.52 -3.11 70.84 3.63 -5.24 68.92 -6.64 90.12 62.40 -4.04 88.84 61.33 coo 6.23 0.50 57.10 5.93 0.72 59.19 -1.98 78.69 65.48 -2.54 76.71 65.06 ULMN 3 1xs1_c09 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 13 3 # 13 D 124 ALA D 49 ALA~? 12.11 CE MLY A 135 D 126 ARG D 116 ARG~? 4.73 C15 2PE D 146 D 138 GLU D 48 GLU~? 13.85 CG MLY A 135 coo 2.08 -1.49 62.94 3.12 -2.39 62.28 -32.13 89.91 15.13 -31.19 90.29 13.98 coo 2.52 -3.11 70.84 3.63 -5.24 68.92 -33.13 82.22 8.73 -30.63 80.83 7.52 coo 6.23 0.50 57.10 5.93 0.72 59.19 -30.39 91.81 20.65 -29.75 93.83 21.10 ULMN 3 1xs1_c09 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 14 3 # 14 D 124 ALA D 112 ALA~? 8.09 C21 2PE D 146 D 126 ARG D 55 ARG~? 9.16 CG MLY A 135 D 138 GLU D 111 GLU~? 11.88 C9 2PE D 146 coo 2.08 -1.49 62.94 3.12 -2.39 62.28 -39.97 87.72 9.79 -40.62 86.60 10.56 coo 2.52 -3.11 70.84 3.63 -5.24 68.92 -39.98 89.02 19.79 -37.17 89.06 21.03 coo 6.23 0.50 57.10 5.93 0.72 59.19 -43.22 91.45 6.64 -41.92 92.74 5.57 ULMN 3 1xs1_c09 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 15 3 # 15 D 124 ALA D 112 ALA~? 8.09 C21 2PE D 146 D 126 ARG D 116 ARG~? 4.73 C15 2PE D 146 D 138 GLU D 111 GLU~? 11.88 C9 2PE D 146 coo 2.08 -1.49 62.94 3.12 -2.39 62.28 -39.97 87.72 9.79 -40.62 86.60 10.56 coo 2.52 -3.11 70.84 3.63 -5.24 68.92 -33.13 82.22 8.73 -30.63 80.83 7.52 coo 6.23 0.50 57.10 5.93 0.72 59.19 -43.22 91.45 6.64 -41.92 92.74 5.57 ULMN 3 1xs1_c09 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 16 3 # 16 D 124 ALA D 119 ALA~? 10.88 C18 2PE D 146 D 126 ARG D 116 ARG~? 4.73 C15 2PE D 146 D 138 GLU D 121 GLU^? 11.70 OH7 1PE B 150 coo 2.08 -1.49 62.94 3.12 -2.39 62.28 -28.73 87.90 11.52 -29.74 87.21 12.41 coo 2.52 -3.11 70.84 3.63 -5.24 68.92 -33.13 82.22 8.73 -30.63 80.83 7.52 coo 6.23 0.50 57.10 5.93 0.72 59.19 -20.91 85.61 9.48 -19.44 85.70 10.98 1xs1_c09 source 1xs1 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASE : 16 hits 1xs1_c09 naa= 3 ULMN 3 1xs1_c10 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 1 3 # 1 E 124 ALA A 13 ALA~? 8.48 C3 2PE A 148 E 126 ARG B 105 ARG~? -3.01 O4 SO4 A 143s E 138 GLU A 10 GLU~? 8.70 C6 2PE A 148 coo -4.56 10.03 62.36 -4.38 11.31 61.55 -7.72 67.72 25.29 -6.32 68.40 25.30 coo -3.02 12.00 70.07 -1.94 13.84 67.82 -2.68 64.28 31.62 -4.52 62.28 32.99 coo -8.67 12.22 56.54 -8.68 12.09 58.65 -3.10 70.57 20.07 -2.45 69.30 18.38 ULMN 3 1xs1_c10 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 2 3 # 2 E 124 ALA A 49 ALA~? 12.15 CD MLY D 135 E 126 ARG A 33 ARG.? 10.19 C3 GOL A 150 E 138 GLU A 48 GLU~? 14.04 CG MLY D 135 coo -4.56 10.03 62.36 -4.38 11.31 61.55 -16.03 49.47 6.19 -14.84 50.27 5.67 coo -3.02 12.00 70.07 -1.94 13.84 67.82 -11.76 56.72 1.51 -9.97 59.19 1.86 coo -8.67 12.22 56.54 -8.68 12.09 58.65 -19.52 46.65 2.13 -18.86 45.41 0.50 ULMN 3 1xs1_c10 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 3 3 # 3 E 124 ALA A 112 ALA~? 8.20 C21 2PE A 148 E 126 ARG A 55 ARG~? 10.23 CD MLY D 135 E 138 GLU A 111 GLU~? 12.48 C11 2PE A 148 coo -4.56 10.03 62.36 -4.38 11.31 61.55 -12.94 48.96 15.36 -14.23 48.99 16.18 coo -3.02 12.00 70.07 -1.94 13.84 67.82 -19.70 43.33 11.87 -20.69 44.07 9.04 coo -8.67 12.22 56.54 -8.68 12.09 58.65 -8.13 46.06 17.22 -6.45 46.46 15.98 ULMN 3 1xs1_c10 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 4 3 # 4 E 124 ALA A 112 ALA~? 8.20 C21 2PE A 148 E 126 ARG A 116 ARG~? 4.70 C15 2PE A 148 E 138 GLU A 111 GLU~? 12.48 C11 2PE A 148 coo -4.56 10.03 62.36 -4.38 11.31 61.55 -12.94 48.96 15.36 -14.23 48.99 16.18 coo -3.02 12.00 70.07 -1.94 13.84 67.82 -15.13 57.15 12.87 -15.00 60.01 11.67 coo -8.67 12.22 56.54 -8.68 12.09 58.65 -8.13 46.06 17.22 -6.45 46.46 15.98 ULMN 3 1xs1_c10 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 5 3 # 5 E 124 ALA A 119 ALA~? 10.88 CH2 MLY D 135 E 126 ARG A 116 ARG~? 4.70 C15 2PE A 148 E 138 GLU A 121 GLU^? 12.41 C1 GOL A 150 coo -4.56 10.03 62.36 -4.38 11.31 61.55 -14.35 54.52 5.55 -15.48 54.02 6.43 coo -3.02 12.00 70.07 -1.94 13.84 67.82 -15.13 57.15 12.87 -15.00 60.01 11.67 coo -8.67 12.22 56.54 -8.68 12.09 58.65 -13.98 61.53 0.93 -15.14 61.60 -0.79 ULMN 3 1xs1_c10 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 6 3 # 6 E 124 ALA B 112 ALA~? 8.38 O19 PE8 B 148 E 126 ARG B 55 ARG~? 9.33 CG MLY C 135 E 138 GLU B 111 GLU~? 12.54 O7 PE8 B 148 coo -4.56 10.03 62.36 -4.38 11.31 61.55 7.70 75.11 29.02 6.38 75.83 28.78 coo -3.02 12.00 70.07 -1.94 13.84 67.82 8.78 84.29 24.99 10.39 86.20 26.77 coo -8.67 12.22 56.54 -8.68 12.09 58.65 9.41 70.70 25.55 11.25 69.94 26.27 ULMN 3 1xs1_c10 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 7 3 # 7 E 124 ALA B 112 ALA~? 8.38 O19 PE8 B 148 E 126 ARG B 116 ARG~? 4.93 C12 PE8 B 148 E 138 GLU B 111 GLU~? 12.54 O7 PE8 B 148 coo -4.56 10.03 62.36 -4.38 11.31 61.55 7.70 75.11 29.02 6.38 75.83 28.78 coo -3.02 12.00 70.07 -1.94 13.84 67.82 6.23 77.16 37.54 6.11 77.30 40.64 coo -8.67 12.22 56.54 -8.68 12.09 58.65 9.41 70.70 25.55 11.25 69.94 26.27 ULMN 3 1xs1_c10 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 8 3 # 8 E 124 ALA B 119 ALA~? 10.71 O16 PE8 B 148 E 126 ARG B 116 ARG~? 4.93 C12 PE8 B 148 E 138 GLU B 121 GLU^? 8.74 O2 PEG B 144 coo -4.56 10.03 62.36 -4.38 11.31 61.55 13.47 80.03 37.47 12.33 80.66 36.69 coo -3.02 12.00 70.07 -1.94 13.84 67.82 6.23 77.16 37.54 6.11 77.30 40.64 coo -8.67 12.22 56.54 -8.68 12.09 58.65 15.37 80.83 45.64 16.23 82.69 46.15 ULMN 3 1xs1_c10 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 9 3 # 9 E 124 ALA C 36 ALA.? 7.94 O MLZ C 114 E 126 ARG C 42 ARG.? 7.63 O MLZ C 114 E 138 GLU C 121 GLU^? 12.40 C3 GOL C 149 coo -4.56 10.03 62.36 -4.38 11.31 61.55 -9.24 81.26 70.91 -10.47 82.16 70.81 coo -3.02 12.00 70.07 -1.94 13.84 67.82 -13.55 84.90 75.42 -13.77 88.03 75.38 coo -8.67 12.22 56.54 -8.68 12.09 58.65 -1.98 78.69 65.48 -2.54 76.71 65.06 ULMN 3 1xs1_c10 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 10 3 # 10 E 124 ALA C 49 ALA~? 6.49 O MLZ C 114 E 126 ARG C 116 ARG~? 4.72 C15 PE8 C 148 E 138 GLU C 48 GLU~? 14.22 O MLZ C 114 coo -4.56 10.03 62.36 -4.38 11.31 61.55 -13.48 85.10 67.69 -12.20 84.83 68.50 coo -3.02 12.00 70.07 -1.94 13.84 67.82 -6.64 90.12 62.40 -4.04 88.84 61.33 coo -8.67 12.22 56.54 -8.68 12.09 58.65 -17.56 80.63 67.68 -18.20 79.53 69.43 ULMN 3 1xs1_c10 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 11 3 # 11 E 124 ALA C 112 ALA~? 5.54 N MLZ C 114 E 126 ARG C 116 ARG~? 4.72 C15 PE8 C 148 E 138 GLU C 111 GLU~? 3.06 NZ MLZ C 114 coo -4.56 10.03 62.36 -4.38 11.31 61.55 -12.31 94.71 67.32 -12.91 95.14 66.01 coo -3.02 12.00 70.07 -1.94 13.84 67.82 -6.64 90.12 62.40 -4.04 88.84 61.33 coo -8.67 12.22 56.54 -8.68 12.09 58.65 -12.41 98.44 71.96 -11.17 97.70 73.52 ULMN 3 1xs1_c10 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 12 3 # 12 E 124 ALA C 119 ALA~? 6.80 O MLZ C 114 E 126 ARG C 42 ARG.? 7.63 O MLZ C 114 E 138 GLU C 121 GLU^? 12.40 C3 GOL C 149 coo -4.56 10.03 62.36 -4.38 11.31 61.55 -8.25 84.08 66.89 -9.22 84.66 65.88 coo -3.02 12.00 70.07 -1.94 13.84 67.82 -13.55 84.90 75.42 -13.77 88.03 75.38 coo -8.67 12.22 56.54 -8.68 12.09 58.65 -1.98 78.69 65.48 -2.54 76.71 65.06 ULMN 3 1xs1_c10 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 13 3 # 13 E 124 ALA C 119 ALA~? 6.80 O MLZ C 114 E 126 ARG C 116 ARG~? 4.72 C15 PE8 C 148 E 138 GLU C 121 GLU^? 12.40 C3 GOL C 149 coo -4.56 10.03 62.36 -4.38 11.31 61.55 -8.25 84.08 66.89 -9.22 84.66 65.88 coo -3.02 12.00 70.07 -1.94 13.84 67.82 -6.64 90.12 62.40 -4.04 88.84 61.33 coo -8.67 12.22 56.54 -8.68 12.09 58.65 -1.98 78.69 65.48 -2.54 76.71 65.06 ULMN 3 1xs1_c10 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 14 3 # 14 E 124 ALA D 49 ALA~? 12.11 CE MLY A 135 E 126 ARG D 116 ARG~? 4.73 C15 2PE D 146 E 138 GLU D 48 GLU~? 13.85 CG MLY A 135 coo -4.56 10.03 62.36 -4.38 11.31 61.55 -32.13 89.91 15.13 -31.19 90.29 13.98 coo -3.02 12.00 70.07 -1.94 13.84 67.82 -33.13 82.22 8.73 -30.63 80.83 7.52 coo -8.67 12.22 56.54 -8.68 12.09 58.65 -30.39 91.81 20.65 -29.75 93.83 21.10 ULMN 3 1xs1_c10 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 15 3 # 15 E 124 ALA D 112 ALA~? 8.09 C21 2PE D 146 E 126 ARG D 55 ARG~? 9.16 CG MLY A 135 E 138 GLU D 111 GLU~? 11.88 C9 2PE D 146 coo -4.56 10.03 62.36 -4.38 11.31 61.55 -39.97 87.72 9.79 -40.62 86.60 10.56 coo -3.02 12.00 70.07 -1.94 13.84 67.82 -39.98 89.02 19.79 -37.17 89.06 21.03 coo -8.67 12.22 56.54 -8.68 12.09 58.65 -43.22 91.45 6.64 -41.92 92.74 5.57 ULMN 3 1xs1_c10 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 16 3 # 16 E 124 ALA D 112 ALA~? 8.09 C21 2PE D 146 E 126 ARG D 116 ARG~? 4.73 C15 2PE D 146 E 138 GLU D 111 GLU~? 11.88 C9 2PE D 146 coo -4.56 10.03 62.36 -4.38 11.31 61.55 -39.97 87.72 9.79 -40.62 86.60 10.56 coo -3.02 12.00 70.07 -1.94 13.84 67.82 -33.13 82.22 8.73 -30.63 80.83 7.52 coo -8.67 12.22 56.54 -8.68 12.09 58.65 -43.22 91.45 6.64 -41.92 92.74 5.57 ULMN 3 1xs1_c10 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 17 3 # 17 E 124 ALA D 119 ALA~? 10.88 C18 2PE D 146 E 126 ARG D 116 ARG~? 4.73 C15 2PE D 146 E 138 GLU D 121 GLU^? 11.70 OH7 1PE B 150 coo -4.56 10.03 62.36 -4.38 11.31 61.55 -28.73 87.90 11.52 -29.74 87.21 12.41 coo -3.02 12.00 70.07 -1.94 13.84 67.82 -33.13 82.22 8.73 -30.63 80.83 7.52 coo -8.67 12.22 56.54 -8.68 12.09 58.65 -20.91 85.61 9.48 -19.44 85.70 10.98 1xs1_c10 source 1xs1 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASE : 17 hits 1xs1_c10 naa= 3 ULMN 3 1xs1_c11 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 1 3 # 1 F 124 ALA A 13 ALA~? 8.48 C3 2PE A 148 F 126 ARG B 105 ARG~? -3.01 O4 SO4 A 143s F 138 GLU A 10 GLU~? 8.70 C6 2PE A 148 coo -11.15 -1.53 62.85 -12.44 -2.03 62.23 -7.72 67.72 25.29 -6.32 68.40 25.30 coo -13.16 -0.52 70.77 -15.41 -0.40 68.66 -2.68 64.28 31.62 -4.52 62.28 32.99 coo -11.26 -6.31 57.37 -11.02 -6.31 59.47 -3.10 70.57 20.07 -2.45 69.30 18.38 ULMN 3 1xs1_c11 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 2 3 # 2 F 124 ALA A 49 ALA~? 12.15 CD MLY D 135 F 126 ARG A 33 ARG.? 10.19 C3 GOL A 150 F 138 GLU A 48 GLU~? 14.04 CG MLY D 135 coo -11.15 -1.53 62.85 -12.44 -2.03 62.23 -16.03 49.47 6.19 -14.84 50.27 5.67 coo -13.16 -0.52 70.77 -15.41 -0.40 68.66 -11.76 56.72 1.51 -9.97 59.19 1.86 coo -11.26 -6.31 57.37 -11.02 -6.31 59.47 -19.52 46.65 2.13 -18.86 45.41 0.50 ULMN 3 1xs1_c11 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 3 3 # 3 F 124 ALA A 112 ALA~? 8.20 C21 2PE A 148 F 126 ARG A 55 ARG~? 10.23 CD MLY D 135 F 138 GLU A 111 GLU~? 12.48 C11 2PE A 148 coo -11.15 -1.53 62.85 -12.44 -2.03 62.23 -12.94 48.96 15.36 -14.23 48.99 16.18 coo -13.16 -0.52 70.77 -15.41 -0.40 68.66 -19.70 43.33 11.87 -20.69 44.07 9.04 coo -11.26 -6.31 57.37 -11.02 -6.31 59.47 -8.13 46.06 17.22 -6.45 46.46 15.98 ULMN 3 1xs1_c11 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 4 3 # 4 F 124 ALA A 112 ALA~? 8.20 C21 2PE A 148 F 126 ARG A 116 ARG~? 4.70 C15 2PE A 148 F 138 GLU A 111 GLU~? 12.48 C11 2PE A 148 coo -11.15 -1.53 62.85 -12.44 -2.03 62.23 -12.94 48.96 15.36 -14.23 48.99 16.18 coo -13.16 -0.52 70.77 -15.41 -0.40 68.66 -15.13 57.15 12.87 -15.00 60.01 11.67 coo -11.26 -6.31 57.37 -11.02 -6.31 59.47 -8.13 46.06 17.22 -6.45 46.46 15.98 ULMN 3 1xs1_c11 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 5 3 # 5 F 124 ALA A 119 ALA~? 10.88 CH2 MLY D 135 F 126 ARG A 116 ARG~? 4.70 C15 2PE A 148 F 138 GLU A 121 GLU^? 12.41 C1 GOL A 150 coo -11.15 -1.53 62.85 -12.44 -2.03 62.23 -14.35 54.52 5.55 -15.48 54.02 6.43 coo -13.16 -0.52 70.77 -15.41 -0.40 68.66 -15.13 57.15 12.87 -15.00 60.01 11.67 coo -11.26 -6.31 57.37 -11.02 -6.31 59.47 -13.98 61.53 0.93 -15.14 61.60 -0.79 ULMN 3 1xs1_c11 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 6 3 # 6 F 124 ALA B 49 ALA~? 10.91 O1 PEG B 144 F 126 ARG B 116 ARG~? 4.93 C12 PE8 B 148 F 138 GLU B 48 GLU~? 13.73 O1 PEG B 144 coo -11.15 -1.53 62.85 -12.44 -2.03 62.23 13.56 82.06 32.43 14.35 81.13 33.34 coo -13.16 -0.52 70.77 -15.41 -0.40 68.66 6.23 77.16 37.54 6.11 77.30 40.64 coo -11.26 -6.31 57.37 -11.02 -6.31 59.47 16.05 87.39 31.22 18.08 87.70 30.57 ULMN 3 1xs1_c11 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 7 3 # 7 F 124 ALA B 112 ALA~? 8.38 O19 PE8 B 148 F 126 ARG B 55 ARG~? 9.33 CG MLY C 135 F 138 GLU B 111 GLU~? 12.54 O7 PE8 B 148 coo -11.15 -1.53 62.85 -12.44 -2.03 62.23 7.70 75.11 29.02 6.38 75.83 28.78 coo -13.16 -0.52 70.77 -15.41 -0.40 68.66 8.78 84.29 24.99 10.39 86.20 26.77 coo -11.26 -6.31 57.37 -11.02 -6.31 59.47 9.41 70.70 25.55 11.25 69.94 26.27 ULMN 3 1xs1_c11 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 8 3 # 8 F 124 ALA B 112 ALA~? 8.38 O19 PE8 B 148 F 126 ARG B 116 ARG~? 4.93 C12 PE8 B 148 F 138 GLU B 111 GLU~? 12.54 O7 PE8 B 148 coo -11.15 -1.53 62.85 -12.44 -2.03 62.23 7.70 75.11 29.02 6.38 75.83 28.78 coo -13.16 -0.52 70.77 -15.41 -0.40 68.66 6.23 77.16 37.54 6.11 77.30 40.64 coo -11.26 -6.31 57.37 -11.02 -6.31 59.47 9.41 70.70 25.55 11.25 69.94 26.27 ULMN 3 1xs1_c11 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 9 3 # 9 F 124 ALA B 119 ALA~? 10.71 O16 PE8 B 148 F 126 ARG B 116 ARG~? 4.93 C12 PE8 B 148 F 138 GLU B 121 GLU^? 8.74 O2 PEG B 144 coo -11.15 -1.53 62.85 -12.44 -2.03 62.23 13.47 80.03 37.47 12.33 80.66 36.69 coo -13.16 -0.52 70.77 -15.41 -0.40 68.66 6.23 77.16 37.54 6.11 77.30 40.64 coo -11.26 -6.31 57.37 -11.02 -6.31 59.47 15.37 80.83 45.64 16.23 82.69 46.15 ULMN 3 1xs1_c11 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 10 3 # 10 F 124 ALA C 49 ALA~? 6.49 O MLZ C 114 F 126 ARG C 116 ARG~? 4.72 C15 PE8 C 148 F 138 GLU C 48 GLU~? 14.22 O MLZ C 114 coo -11.15 -1.53 62.85 -12.44 -2.03 62.23 -13.48 85.10 67.69 -12.20 84.83 68.50 coo -13.16 -0.52 70.77 -15.41 -0.40 68.66 -6.64 90.12 62.40 -4.04 88.84 61.33 coo -11.26 -6.31 57.37 -11.02 -6.31 59.47 -17.56 80.63 67.68 -18.20 79.53 69.43 ULMN 3 1xs1_c11 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 11 3 # 11 F 124 ALA C 112 ALA~? 5.54 N MLZ C 114 F 126 ARG C 116 ARG~? 4.72 C15 PE8 C 148 F 138 GLU C 111 GLU~? 3.06 NZ MLZ C 114 coo -11.15 -1.53 62.85 -12.44 -2.03 62.23 -12.31 94.71 67.32 -12.91 95.14 66.01 coo -13.16 -0.52 70.77 -15.41 -0.40 68.66 -6.64 90.12 62.40 -4.04 88.84 61.33 coo -11.26 -6.31 57.37 -11.02 -6.31 59.47 -12.41 98.44 71.96 -11.17 97.70 73.52 ULMN 3 1xs1_c11 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 12 3 # 12 F 124 ALA C 119 ALA~? 6.80 O MLZ C 114 F 126 ARG C 42 ARG.? 7.63 O MLZ C 114 F 138 GLU C 121 GLU^? 12.40 C3 GOL C 149 coo -11.15 -1.53 62.85 -12.44 -2.03 62.23 -8.25 84.08 66.89 -9.22 84.66 65.88 coo -13.16 -0.52 70.77 -15.41 -0.40 68.66 -13.55 84.90 75.42 -13.77 88.03 75.38 coo -11.26 -6.31 57.37 -11.02 -6.31 59.47 -1.98 78.69 65.48 -2.54 76.71 65.06 ULMN 3 1xs1_c11 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 13 3 # 13 F 124 ALA C 119 ALA~? 6.80 O MLZ C 114 F 126 ARG C 116 ARG~? 4.72 C15 PE8 C 148 F 138 GLU C 121 GLU^? 12.40 C3 GOL C 149 coo -11.15 -1.53 62.85 -12.44 -2.03 62.23 -8.25 84.08 66.89 -9.22 84.66 65.88 coo -13.16 -0.52 70.77 -15.41 -0.40 68.66 -6.64 90.12 62.40 -4.04 88.84 61.33 coo -11.26 -6.31 57.37 -11.02 -6.31 59.47 -1.98 78.69 65.48 -2.54 76.71 65.06 ULMN 3 1xs1_c11 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 14 3 # 14 F 124 ALA D 49 ALA~? 12.11 CE MLY A 135 F 126 ARG D 116 ARG~? 4.73 C15 2PE D 146 F 138 GLU D 48 GLU~? 13.85 CG MLY A 135 coo -11.15 -1.53 62.85 -12.44 -2.03 62.23 -32.13 89.91 15.13 -31.19 90.29 13.98 coo -13.16 -0.52 70.77 -15.41 -0.40 68.66 -33.13 82.22 8.73 -30.63 80.83 7.52 coo -11.26 -6.31 57.37 -11.02 -6.31 59.47 -30.39 91.81 20.65 -29.75 93.83 21.10 ULMN 3 1xs1_c11 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 15 3 # 15 F 124 ALA D 112 ALA~? 8.09 C21 2PE D 146 F 126 ARG D 55 ARG~? 9.16 CG MLY A 135 F 138 GLU D 111 GLU~? 11.88 C9 2PE D 146 coo -11.15 -1.53 62.85 -12.44 -2.03 62.23 -39.97 87.72 9.79 -40.62 86.60 10.56 coo -13.16 -0.52 70.77 -15.41 -0.40 68.66 -39.98 89.02 19.79 -37.17 89.06 21.03 coo -11.26 -6.31 57.37 -11.02 -6.31 59.47 -43.22 91.45 6.64 -41.92 92.74 5.57 ULMN 3 1xs1_c11 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 16 3 # 16 F 124 ALA D 112 ALA~? 8.09 C21 2PE D 146 F 126 ARG D 116 ARG~? 4.73 C15 2PE D 146 F 138 GLU D 111 GLU~? 11.88 C9 2PE D 146 coo -11.15 -1.53 62.85 -12.44 -2.03 62.23 -39.97 87.72 9.79 -40.62 86.60 10.56 coo -13.16 -0.52 70.77 -15.41 -0.40 68.66 -33.13 82.22 8.73 -30.63 80.83 7.52 coo -11.26 -6.31 57.37 -11.02 -6.31 59.47 -43.22 91.45 6.64 -41.92 92.74 5.57 ULMN 3 1xs1_c11 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 17 3 # 17 F 124 ALA D 119 ALA~? 10.88 C18 2PE D 146 F 126 ARG D 116 ARG~? 4.73 C15 2PE D 146 F 138 GLU D 121 GLU^? 11.70 OH7 1PE B 150 coo -11.15 -1.53 62.85 -12.44 -2.03 62.23 -28.73 87.90 11.52 -29.74 87.21 12.41 coo -13.16 -0.52 70.77 -15.41 -0.40 68.66 -33.13 82.22 8.73 -30.63 80.83 7.52 coo -11.26 -6.31 57.37 -11.02 -6.31 59.47 -20.91 85.61 9.48 -19.44 85.70 10.98 1xs1_c11 source 1xs1 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASE : 17 hits 1xs1_c11 naa= 3 ULMN 3 1xva_c03 GLYCINE N-METHYLTRANSFERASE user 1 3 # 1 B 137 GLY A 22 GLY.? 4.28 C3 PEG A 146 B 175 ARG A 127 ARG^? 7.47 N MLZ A 129 B 242 TYR A 94 TYR^? 4.94 CL CL A 145s coo 99.45 58.28 3.33 99.57 58.61 4.10 -24.67 65.84 32.25 -23.92 65.53 31.96 coo 106.37 63.53 0.89 108.02 63.40 -1.62 -18.44 68.25 24.06 -17.70 68.37 27.04 coo 100.93 69.04 4.38 99.52 68.48 2.09 -21.59 58.91 24.53 -21.03 57.83 22.04 ULMN 3 1xva_c03 GLYCINE N-METHYLTRANSFERASE user 2 3 # 2 B 137 GLY A 54 GLY~? 5.80 C21 2PE A 148 B 175 ARG A 116 ARG~? 4.70 C15 2PE A 148 B 242 TYR A 109 TYR~? -5.64 O16 2PE A 148s coo 99.45 58.28 3.33 99.57 58.61 4.10 -20.41 50.07 13.76 -19.88 49.43 13.69 coo 106.37 63.53 0.89 108.02 63.40 -1.62 -15.13 57.15 12.87 -15.00 60.01 11.67 coo 100.93 69.04 4.38 99.52 68.48 2.09 -13.81 52.60 20.09 -14.53 54.76 18.49 ULMN 3 1xva_c03 GLYCINE N-METHYLTRANSFERASE user 3 3 # 3 B 137 GLY B 22 GLY.? 4.26 C1 PEG B 146 B 175 ARG B 127 ARG^? 9.26 O4 SO4 A 144 B 242 TYR B 94 TYR^? -5.06 CL CL B 143s coo 99.45 58.28 3.33 99.57 58.61 4.10 -16.69 74.52 39.34 -16.05 74.06 39.06 coo 106.37 63.53 0.89 108.02 63.40 -1.62 -7.64 72.55 44.16 -9.78 70.52 43.36 coo 100.93 69.04 4.38 99.52 68.48 2.09 -6.97 76.65 35.26 -4.34 77.53 35.11 ULMN 3 1xva_c03 GLYCINE N-METHYLTRANSFERASE user 4 3 # 4 B 137 GLY B 46 GLY~? 9.70 O1 PEG B 144 B 175 ARG B 35 ARG.? 9.50 O1 PEG B 144 B 242 TYR B 38 TYR.? 9.60 O1 PEG B 144 coo 99.45 58.28 3.33 99.57 58.61 4.10 15.35 83.93 36.97 15.42 84.55 36.41 coo 106.37 63.53 0.89 108.02 63.40 -1.62 22.76 84.08 36.32 22.81 87.07 35.45 coo 100.93 69.04 4.38 99.52 68.48 2.09 18.19 76.55 32.34 16.15 78.24 31.46 ULMN 3 1xva_c03 GLYCINE N-METHYLTRANSFERASE user 5 3 # 5 B 137 GLY B 54 GLY~? 5.68 C20 PE8 B 148 B 175 ARG B 116 ARG~? 4.93 C12 PE8 B 148 B 242 TYR B 109 TYR~? -5.65 O13 PE8 B 148s coo 99.45 58.28 3.33 99.57 58.61 4.10 5.02 82.24 30.45 5.51 81.90 29.87 coo 106.37 63.53 0.89 108.02 63.40 -1.62 6.23 77.16 37.54 6.11 77.30 40.64 coo 100.93 69.04 4.38 99.52 68.48 2.09 2.41 73.03 30.76 2.68 74.03 33.35 ULMN 3 1xva_c03 GLYCINE N-METHYLTRANSFERASE user 6 3 # 6 B 137 GLY C 22 GLY.? 6.89 CD MLZ C 129 B 175 ARG C 127 ARG^? 7.44 N MLZ C 129 B 242 TYR C 94 TYR^? 5.01 CL CL C 144s coo 99.45 58.28 3.33 99.57 58.61 4.10 -3.53 104.38 44.27 -3.45 104.39 45.13 coo 106.37 63.53 0.89 108.02 63.40 -1.62 1.53 98.09 50.88 2.14 101.05 50.40 coo 100.93 69.04 4.38 99.52 68.48 2.09 -8.07 99.17 52.54 -8.69 97.12 54.34 ULMN 3 1xva_c03 GLYCINE N-METHYLTRANSFERASE user 7 3 # 7 B 137 GLY C 54 GLY~? 6.00 CH2 MLY B 135 B 175 ARG C 116 ARG~? 4.72 C15 PE8 C 148 B 242 TYR C 109 TYR~? -5.91 C14 PE8 C 148s coo 99.45 58.28 3.33 99.57 58.61 4.10 -15.22 90.72 61.35 -15.47 90.98 62.07 coo 106.37 63.53 0.89 108.02 63.40 -1.62 -6.64 90.12 62.40 -4.04 88.84 61.33 coo 100.93 69.04 4.38 99.52 68.48 2.09 -9.64 98.32 63.33 -8.13 96.27 62.21 ULMN 3 1xva_c03 GLYCINE N-METHYLTRANSFERASE user 8 3 # 8 B 137 GLY D 22 GLY.? 9.04 C3 PEG D 145 B 175 ARG D 127 ARG^? 9.31 O3 PGE A 147 B 242 TYR D 94 TYR^? -4.97 CL CL D 143s coo 99.45 58.28 3.33 99.57 58.61 4.10 -43.93 61.79 5.73 -43.90 62.56 5.37 coo 106.37 63.53 0.89 108.02 63.40 -1.62 -35.94 67.72 2.28 -38.25 66.55 0.66 coo 100.93 69.04 4.38 99.52 68.48 2.09 -41.68 71.74 9.13 -40.22 73.97 9.96 ULMN 3 1xva_c03 GLYCINE N-METHYLTRANSFERASE user 9 3 # 9 B 137 GLY D 54 GLY~? 5.81 C23 2PE D 146 B 175 ARG D 116 ARG~? 4.73 C15 2PE D 146 B 242 TYR D 109 TYR~? -5.82 O16 2PE D 146s coo 99.45 58.28 3.33 99.57 58.61 4.10 -38.01 83.52 15.98 -38.33 84.28 15.84 coo 106.37 63.53 0.89 108.02 63.40 -1.62 -33.13 82.22 8.73 -30.63 80.83 7.52 coo 100.93 69.04 4.38 99.52 68.48 2.09 -41.76 82.56 7.21 -39.24 81.41 7.29 1xva_c03 source 1xva GLYCINE N-METHYLTRANSFERASE : 9 hits 1xva_c03 naa= 3 ULMN 3 2ag0_c04 BENZALDEHYDE LYASE user 1 3 # 1 B 29 HIS A 88 HIS^? 4.20 CH2 MLY D 135 B 50 GLU A 75 GLU.? -8.03 O4 PGE A 147s B 113 GLN A 71 GLN.? 3.67 CA MLY D 135 coo 37.74 -17.01 11.59 38.11 -17.83 13.49 -23.95 56.87 7.77 -24.14 54.98 6.86 coo 46.64 -18.37 3.41 46.45 -20.27 4.34 -34.40 63.01 2.19 -36.49 63.07 2.67 coo 42.38 -20.40 13.90 41.08 -20.72 12.22 -29.94 57.42 11.87 -29.23 55.39 12.09 ULMN 3 2ag0_c04 BENZALDEHYDE LYASE user 2 3 # 2 B 29 HIS B 88 HIS^? 4.29 CH1 MLY C 135 B 50 GLU B 75 GLU.? -3.56 CB MLZ C 129s B 113 GLN B 71 GLN.? 3.79 NZ MLY C 135 coo 37.74 -17.01 11.59 38.11 -17.83 13.49 6.15 87.00 38.94 7.35 87.96 37.51 coo 46.64 -18.37 3.41 46.45 -20.27 4.34 3.68 97.59 46.60 2.29 99.21 46.53 coo 42.38 -20.40 13.90 41.08 -20.72 12.22 -0.31 89.93 38.21 0.60 89.72 36.30 ULMN 3 2ag0_c04 BENZALDEHYDE LYASE user 3 3 # 3 B 29 HIS C 88 HIS^? 3.86 CD MLY B 135 B 50 GLU C 75 GLU.? -8.81 O1 PGE C 147s B 113 GLN C 71 GLN.? 3.66 CB MLY B 135 coo 37.74 -17.01 11.59 38.11 -17.83 13.49 -11.00 83.03 57.18 -12.69 82.43 58.26 coo 46.64 -18.37 3.41 46.45 -20.27 4.34 -10.84 73.75 47.59 -11.85 73.47 45.72 coo 42.38 -20.40 13.90 41.08 -20.72 12.22 -13.54 84.96 50.60 -14.77 85.74 52.17 ULMN 3 2ag0_c04 BENZALDEHYDE LYASE user 4 3 # 4 B 29 HIS D 88 HIS^? 4.38 CH1 MLY A 135 B 50 GLU D 75 GLU.? -3.59 CB MLZ A 129s B 113 GLN D 71 GLN.? 3.86 NZ MLY A 135 coo 37.74 -17.01 11.59 38.11 -17.83 13.49 -29.18 79.71 17.63 -29.43 81.25 19.03 coo 46.64 -18.37 3.41 46.45 -20.27 4.34 -21.02 72.19 24.99 -21.34 70.79 26.58 coo 42.38 -20.40 13.90 41.08 -20.72 12.22 -32.07 73.89 20.70 -33.31 75.61 20.99 2ag0_c04 source 2ag0 BENZALDEHYDE LYASE : 4 hits 2ag0_c04 naa= 3 ULMN 3 2ag0_c08 BENZALDEHYDE LYASE user 1 3 # 1 B 29 HIS A 88 HIS^? 4.20 CH2 MLY D 135 B 50 GLU A 75 GLU.? -8.03 O4 PGE A 147s B 113 GLN A 71 GLN.? 3.67 CA MLY D 135 coo 37.74 -17.01 11.59 38.11 -17.83 13.49 -23.95 56.87 7.77 -24.14 54.98 6.86 coo 46.64 -18.37 3.41 46.45 -20.27 4.34 -34.40 63.01 2.19 -36.49 63.07 2.67 coo 42.38 -20.40 13.90 41.08 -20.72 12.22 -29.94 57.42 11.87 -29.23 55.39 12.09 ULMN 3 2ag0_c08 BENZALDEHYDE LYASE user 2 3 # 2 B 29 HIS B 88 HIS^? 4.29 CH1 MLY C 135 B 50 GLU B 75 GLU.? -3.56 CB MLZ C 129s B 113 GLN B 71 GLN.? 3.79 NZ MLY C 135 coo 37.74 -17.01 11.59 38.11 -17.83 13.49 6.15 87.00 38.94 7.35 87.96 37.51 coo 46.64 -18.37 3.41 46.45 -20.27 4.34 3.68 97.59 46.60 2.29 99.21 46.53 coo 42.38 -20.40 13.90 41.08 -20.72 12.22 -0.31 89.93 38.21 0.60 89.72 36.30 ULMN 3 2ag0_c08 BENZALDEHYDE LYASE user 3 3 # 3 B 29 HIS C 88 HIS^? 3.86 CD MLY B 135 B 50 GLU C 75 GLU.? -8.81 O1 PGE C 147s B 113 GLN C 71 GLN.? 3.66 CB MLY B 135 coo 37.74 -17.01 11.59 38.11 -17.83 13.49 -11.00 83.03 57.18 -12.69 82.43 58.26 coo 46.64 -18.37 3.41 46.45 -20.27 4.34 -10.84 73.75 47.59 -11.85 73.47 45.72 coo 42.38 -20.40 13.90 41.08 -20.72 12.22 -13.54 84.96 50.60 -14.77 85.74 52.17 ULMN 3 2ag0_c08 BENZALDEHYDE LYASE user 4 3 # 4 B 29 HIS D 88 HIS^? 4.38 CH1 MLY A 135 B 50 GLU D 75 GLU.? -3.59 CB MLZ A 129s B 113 GLN D 71 GLN.? 3.86 NZ MLY A 135 coo 37.74 -17.01 11.59 38.11 -17.83 13.49 -29.18 79.71 17.63 -29.43 81.25 19.03 coo 46.64 -18.37 3.41 46.45 -20.27 4.34 -21.02 72.19 24.99 -21.34 70.79 26.58 coo 42.38 -20.40 13.90 41.08 -20.72 12.22 -32.07 73.89 20.70 -33.31 75.61 20.99 2ag0_c08 source 2ag0 BENZALDEHYDE LYASE : 4 hits 2ag0_c08 naa= 3 ULMN 3 2ag0_c09 BENZALDEHYDE LYASE user 1 3 # 1 A 29 HIS A 88 HIS^? 4.20 CH2 MLY D 135 A 50 GLU A 75 GLU.? -8.03 O4 PGE A 147s A 113 GLN A 71 GLN.? 3.67 CA MLY D 135 coo 73.37 -13.43 4.64 73.06 -11.77 3.39 -23.95 56.87 7.77 -24.14 54.98 6.86 coo 63.97 -21.08 5.81 64.12 -20.78 3.71 -34.40 63.01 2.19 -36.49 63.07 2.67 coo 68.60 -11.76 1.04 69.76 -13.55 1.03 -29.94 57.42 11.87 -29.23 55.39 12.09 ULMN 3 2ag0_c09 BENZALDEHYDE LYASE user 2 3 # 2 A 29 HIS B 88 HIS^? 4.29 CH1 MLY C 135 A 50 GLU B 75 GLU.? -3.56 CB MLZ C 129s A 113 GLN B 71 GLN.? 3.79 NZ MLY C 135 coo 73.37 -13.43 4.64 73.06 -11.77 3.39 6.15 87.00 38.94 7.35 87.96 37.51 coo 63.97 -21.08 5.81 64.12 -20.78 3.71 3.68 97.59 46.60 2.29 99.21 46.53 coo 68.60 -11.76 1.04 69.76 -13.55 1.03 -0.31 89.93 38.21 0.60 89.72 36.30 ULMN 3 2ag0_c09 BENZALDEHYDE LYASE user 3 3 # 3 A 29 HIS C 88 HIS^? 3.86 CD MLY B 135 A 50 GLU C 75 GLU.? -8.81 O1 PGE C 147s A 113 GLN C 71 GLN.? 3.66 CB MLY B 135 coo 73.37 -13.43 4.64 73.06 -11.77 3.39 -11.00 83.03 57.18 -12.69 82.43 58.26 coo 63.97 -21.08 5.81 64.12 -20.78 3.71 -10.84 73.75 47.59 -11.85 73.47 45.72 coo 68.60 -11.76 1.04 69.76 -13.55 1.03 -13.54 84.96 50.60 -14.77 85.74 52.17 ULMN 3 2ag0_c09 BENZALDEHYDE LYASE user 4 3 # 4 A 29 HIS D 88 HIS^? 4.38 CH1 MLY A 135 A 50 GLU D 75 GLU.? -3.59 CB MLZ A 129s A 113 GLN D 71 GLN.? 3.86 NZ MLY A 135 coo 73.37 -13.43 4.64 73.06 -11.77 3.39 -29.18 79.71 17.63 -29.43 81.25 19.03 coo 63.97 -21.08 5.81 64.12 -20.78 3.71 -21.02 72.19 24.99 -21.34 70.79 26.58 coo 68.60 -11.76 1.04 69.76 -13.55 1.03 -32.07 73.89 20.70 -33.31 75.61 20.99 2ag0_c09 source 2ag0 BENZALDEHYDE LYASE : 4 hits 2ag0_c09 naa= 3 ULMN 3 2ag0_c10 BENZALDEHYDE LYASE user 1 3 # 1 C 29 HIS A 88 HIS^? 4.20 CH2 MLY D 135 C 50 GLU A 75 GLU.? -8.03 O4 PGE A 147s C 113 GLN A 71 GLN.? 3.67 CA MLY D 135 coo 74.92 8.52 28.42 74.88 6.86 29.70 -23.95 56.87 7.77 -24.14 54.98 6.86 coo 65.25 15.95 28.73 65.73 15.63 30.78 -34.40 63.01 2.19 -36.49 63.07 2.67 coo 70.80 6.73 32.72 71.88 8.55 32.53 -29.94 57.42 11.87 -29.23 55.39 12.09 ULMN 3 2ag0_c10 BENZALDEHYDE LYASE user 2 3 # 2 C 29 HIS B 88 HIS^? 4.29 CH1 MLY C 135 C 50 GLU B 75 GLU.? -3.56 CB MLZ C 129s C 113 GLN B 71 GLN.? 3.79 NZ MLY C 135 coo 74.92 8.52 28.42 74.88 6.86 29.70 6.15 87.00 38.94 7.35 87.96 37.51 coo 65.25 15.95 28.73 65.73 15.63 30.78 3.68 97.59 46.60 2.29 99.21 46.53 coo 70.80 6.73 32.72 71.88 8.55 32.53 -0.31 89.93 38.21 0.60 89.72 36.30 ULMN 3 2ag0_c10 BENZALDEHYDE LYASE user 3 3 # 3 C 29 HIS C 88 HIS^? 3.86 CD MLY B 135 C 50 GLU C 75 GLU.? -8.81 O1 PGE C 147s C 113 GLN C 71 GLN.? 3.66 CB MLY B 135 coo 74.92 8.52 28.42 74.88 6.86 29.70 -11.00 83.03 57.18 -12.69 82.43 58.26 coo 65.25 15.95 28.73 65.73 15.63 30.78 -10.84 73.75 47.59 -11.85 73.47 45.72 coo 70.80 6.73 32.72 71.88 8.55 32.53 -13.54 84.96 50.60 -14.77 85.74 52.17 ULMN 3 2ag0_c10 BENZALDEHYDE LYASE user 4 3 # 4 C 29 HIS D 88 HIS^? 4.38 CH1 MLY A 135 C 50 GLU D 75 GLU.? -3.59 CB MLZ A 129s C 113 GLN D 71 GLN.? 3.86 NZ MLY A 135 coo 74.92 8.52 28.42 74.88 6.86 29.70 -29.18 79.71 17.63 -29.43 81.25 19.03 coo 65.25 15.95 28.73 65.73 15.63 30.78 -21.02 72.19 24.99 -21.34 70.79 26.58 coo 70.80 6.73 32.72 71.88 8.55 32.53 -32.07 73.89 20.70 -33.31 75.61 20.99 2ag0_c10 source 2ag0 BENZALDEHYDE LYASE : 4 hits 2ag0_c10 naa= 3 ULMN 3 2ag0_c11 BENZALDEHYDE LYASE user 1 3 # 1 D 29 HIS A 88 HIS^? 4.20 CH2 MLY D 135 D 50 GLU A 75 GLU.? -8.03 O4 PGE A 147s D 113 GLN A 71 GLN.? 3.67 CA MLY D 135 coo 38.66 11.31 27.15 38.67 12.13 25.22 -23.95 56.87 7.77 -24.14 54.98 6.86 coo 48.72 12.85 33.83 48.36 14.77 32.95 -34.40 63.01 2.19 -36.49 63.07 2.67 coo 42.85 14.77 24.15 41.85 15.11 26.02 -29.94 57.42 11.87 -29.23 55.39 12.09 ULMN 3 2ag0_c11 BENZALDEHYDE LYASE user 2 3 # 2 D 29 HIS B 88 HIS^? 4.29 CH1 MLY C 135 D 50 GLU B 75 GLU.? -3.56 CB MLZ C 129s D 113 GLN B 71 GLN.? 3.79 NZ MLY C 135 coo 38.66 11.31 27.15 38.67 12.13 25.22 6.15 87.00 38.94 7.35 87.96 37.51 coo 48.72 12.85 33.83 48.36 14.77 32.95 3.68 97.59 46.60 2.29 99.21 46.53 coo 42.85 14.77 24.15 41.85 15.11 26.02 -0.31 89.93 38.21 0.60 89.72 36.30 ULMN 3 2ag0_c11 BENZALDEHYDE LYASE user 3 3 # 3 D 29 HIS C 88 HIS^? 3.86 CD MLY B 135 D 50 GLU C 75 GLU.? -8.81 O1 PGE C 147s D 113 GLN C 71 GLN.? 3.66 CB MLY B 135 coo 38.66 11.31 27.15 38.67 12.13 25.22 -11.00 83.03 57.18 -12.69 82.43 58.26 coo 48.72 12.85 33.83 48.36 14.77 32.95 -10.84 73.75 47.59 -11.85 73.47 45.72 coo 42.85 14.77 24.15 41.85 15.11 26.02 -13.54 84.96 50.60 -14.77 85.74 52.17 ULMN 3 2ag0_c11 BENZALDEHYDE LYASE user 4 3 # 4 D 29 HIS D 88 HIS^? 4.38 CH1 MLY A 135 D 50 GLU D 75 GLU.? -3.59 CB MLZ A 129s D 113 GLN D 71 GLN.? 3.86 NZ MLY A 135 coo 38.66 11.31 27.15 38.67 12.13 25.22 -29.18 79.71 17.63 -29.43 81.25 19.03 coo 48.72 12.85 33.83 48.36 14.77 32.95 -21.02 72.19 24.99 -21.34 70.79 26.58 coo 42.85 14.77 24.15 41.85 15.11 26.02 -32.07 73.89 20.70 -33.31 75.61 20.99 2ag0_c11 source 2ag0 BENZALDEHYDE LYASE : 4 hits 2ag0_c11 naa= 3 ULMN 3 2amg_c02 1,4-ALPHA-D-GLUCAN MALTOTETRAHYDROLAuser 1 3 # 1 193 ASP A 19 ASP.? -3.59 O4 SO4 A 144s 219 GLU B 21 GLU.? -4.32 C4 PEG B 146s 294 ASP B 19 ASP.? -3.77 O3 SO4 A 144s coo 27.89 102.52 14.98 29.35 101.92 13.57 -15.01 66.98 32.71 -14.52 68.02 34.44 coo 25.84 105.87 9.06 27.86 105.55 8.74 -19.10 71.22 37.43 -20.67 70.39 36.27 coo 33.16 106.80 7.72 33.34 104.87 6.92 -12.63 65.75 40.21 -14.11 64.30 40.60 ULMN 3 2amg_c02 1,4-ALPHA-D-GLUCAN MALTOTETRAHYDROLAuser 2 3 # 2 193 ASP A 83 ASP.? 8.52 O3 GOL D 147 219 GLU A 84 GLU.? 10.45 C3 GOL D 147 294 ASP A 122 ASP^? 7.46 C1 GOL A 150 coo 27.89 102.52 14.98 29.35 101.92 13.57 -19.46 70.43 -3.04 -19.06 72.28 -2.05 coo 25.84 105.87 9.06 27.86 105.55 8.74 -21.01 70.22 3.12 -21.10 71.95 4.30 coo 33.16 106.80 7.72 33.34 104.87 6.92 -15.41 64.92 4.51 -15.09 66.83 5.33 ULMN 3 2amg_c02 1,4-ALPHA-D-GLUCAN MALTOTETRAHYDROLAuser 3 3 # 3 193 ASP A 122 ASP^? 7.46 C1 GOL A 150 219 GLU A 84 GLU.? 10.45 C3 GOL D 147 294 ASP A 83 ASP.? 8.52 O3 GOL D 147 coo 27.89 102.52 14.98 29.35 101.92 13.57 -15.41 64.92 4.51 -15.09 66.83 5.33 coo 25.84 105.87 9.06 27.86 105.55 8.74 -21.01 70.22 3.12 -21.10 71.95 4.30 coo 33.16 106.80 7.72 33.34 104.87 6.92 -19.46 70.43 -3.04 -19.06 72.28 -2.05 ULMN 3 2amg_c02 1,4-ALPHA-D-GLUCAN MALTOTETRAHYDROLAuser 4 3 # 4 193 ASP B 19 ASP.? -3.77 O3 SO4 A 144s 219 GLU B 21 GLU.? -4.32 C4 PEG B 146s 294 ASP A 19 ASP.? -3.59 O4 SO4 A 144s coo 27.89 102.52 14.98 29.35 101.92 13.57 -12.63 65.75 40.21 -14.11 64.30 40.60 coo 25.84 105.87 9.06 27.86 105.55 8.74 -19.10 71.22 37.43 -20.67 70.39 36.27 coo 33.16 106.80 7.72 33.34 104.87 6.92 -15.01 66.98 32.71 -14.52 68.02 34.44 ULMN 3 2amg_c02 1,4-ALPHA-D-GLUCAN MALTOTETRAHYDROLAuser 5 3 # 5 193 ASP B 83 ASP.? 9.40 O3 GOL C 149 219 GLU B 84 GLU.? 10.31 O3 GOL C 149 294 ASP B 122 ASP^? 7.33 O2 GOL B 149 coo 27.89 102.52 14.98 29.35 101.92 13.57 13.62 86.10 55.23 12.83 84.59 56.49 coo 25.84 105.87 9.06 27.86 105.55 8.74 7.66 84.31 53.13 6.13 83.49 54.35 coo 33.16 106.80 7.72 33.34 104.87 6.92 10.89 79.68 47.57 9.75 78.80 49.16 ULMN 3 2amg_c02 1,4-ALPHA-D-GLUCAN MALTOTETRAHYDROLAuser 6 3 # 6 193 ASP B 122 ASP^? 7.33 O2 GOL B 149 219 GLU B 84 GLU.? 10.31 O3 GOL C 149 294 ASP B 83 ASP.? 9.40 O3 GOL C 149 coo 27.89 102.52 14.98 29.35 101.92 13.57 10.89 79.68 47.57 9.75 78.80 49.16 coo 25.84 105.87 9.06 27.86 105.55 8.74 7.66 84.31 53.13 6.13 83.49 54.35 coo 33.16 106.80 7.72 33.34 104.87 6.92 13.62 86.10 55.23 12.83 84.59 56.49 ULMN 3 2amg_c02 1,4-ALPHA-D-GLUCAN MALTOTETRAHYDROLAuser 7 3 # 7 193 ASP C 83 ASP.? 8.65 O3 GOL B 149 219 GLU C 84 GLU.? 10.77 O2 GOL B 149 294 ASP C 122 ASP^? 7.22 C3 GOL C 149 coo 27.89 102.52 14.98 29.35 101.92 13.57 3.02 71.86 58.06 4.88 72.49 57.24 coo 25.84 105.87 9.06 27.86 105.55 8.74 2.34 77.12 55.01 3.46 78.21 53.60 coo 33.16 106.80 7.72 33.34 104.87 6.92 0.27 81.12 61.60 2.07 81.54 60.53 ULMN 3 2amg_c02 1,4-ALPHA-D-GLUCAN MALTOTETRAHYDROLAuser 8 3 # 8 193 ASP C 122 ASP^? 7.22 C3 GOL C 149 219 GLU C 84 GLU.? 10.77 O2 GOL B 149 294 ASP C 83 ASP.? 8.65 O3 GOL B 149 coo 27.89 102.52 14.98 29.35 101.92 13.57 0.27 81.12 61.60 2.07 81.54 60.53 coo 25.84 105.87 9.06 27.86 105.55 8.74 2.34 77.12 55.01 3.46 78.21 53.60 coo 33.16 106.80 7.72 33.34 104.87 6.92 3.02 71.86 58.06 4.88 72.49 57.24 ULMN 3 2amg_c02 1,4-ALPHA-D-GLUCAN MALTOTETRAHYDROLAuser 9 3 # 9 193 ASP D 83 ASP.? 8.76 O1 GOL A 150 219 GLU D 84 GLU.? 10.79 C1 GOL A 150 294 ASP D 122 ASP^? 7.49 C3 GOL D 147 coo 27.89 102.52 14.98 29.35 101.92 13.57 -12.54 78.43 10.94 -12.46 77.06 9.29 coo 25.84 105.87 9.06 27.86 105.55 8.74 -17.40 74.78 10.23 -17.69 72.96 9.24 coo 33.16 106.80 7.72 33.34 104.87 6.92 -21.82 80.90 7.85 -21.38 79.32 6.51 ULMN 3 2amg_c02 1,4-ALPHA-D-GLUCAN MALTOTETRAHYDROLAuser 10 3 # 10 193 ASP D 122 ASP^? 7.49 C3 GOL D 147 219 GLU D 84 GLU.? 10.79 C1 GOL A 150 294 ASP D 83 ASP.? 8.76 O1 GOL A 150 coo 27.89 102.52 14.98 29.35 101.92 13.57 -21.82 80.90 7.85 -21.38 79.32 6.51 coo 25.84 105.87 9.06 27.86 105.55 8.74 -17.40 74.78 10.23 -17.69 72.96 9.24 coo 33.16 106.80 7.72 33.34 104.87 6.92 -12.54 78.43 10.94 -12.46 77.06 9.29 2amg_c02 source 2amg 1,4-ALPHA-D-GLUCAN MALTOTETRAHYDROLASE : 10 hits 2amg_c02 naa= 3 ULMN 3 2amg_c06 1,4-ALPHA-D-GLUCAN MALTOTETRAHYDROLAuser 1 3 # 1 193 ASP A 56 ASP~? 11.59 C21 2PE A 148 231 ASP A 122 ASP^? 7.46 C1 GOL A 150 294 ASP A 106 ASP~? 11.93 O22 2PE A 148 coo 27.89 102.52 14.98 29.35 101.92 13.57 -16.01 45.89 15.64 -15.93 44.31 14.23 coo 14.74 93.05 -1.00 14.30 94.22 0.73 -15.41 64.92 4.51 -15.09 66.83 5.33 coo 33.16 106.80 7.72 33.34 104.87 6.92 -12.71 50.36 24.83 -13.06 48.30 25.05 ULMN 3 2amg_c06 1,4-ALPHA-D-GLUCAN MALTOTETRAHYDROLAuser 2 3 # 2 193 ASP A 122 ASP^? 7.46 C1 GOL A 150 231 ASP D 6 ASP.? -3.77 C8 2PE D 146s 294 ASP A 87 ASP.? 8.49 C6 PGE A 147 coo 27.89 102.52 14.98 29.35 101.92 13.57 -15.41 64.92 4.51 -15.09 66.83 5.33 coo 14.74 93.05 -1.00 14.30 94.22 0.73 -31.03 82.87 1.04 -31.83 84.41 2.29 coo 33.16 106.80 7.72 33.34 104.87 6.92 -23.17 58.67 3.55 -22.34 59.17 1.69 ULMN 3 2amg_c06 1,4-ALPHA-D-GLUCAN MALTOTETRAHYDROLAuser 3 3 # 3 193 ASP A 122 ASP^? 7.46 C1 GOL A 150 231 ASP D 87 ASP.? 7.26 C16 1PE B 150 294 ASP A 6 ASP.? -3.91 C9 2PE A 148s coo 27.89 102.52 14.98 29.35 101.92 13.57 -15.41 64.92 4.51 -15.09 66.83 5.33 coo 14.74 93.05 -1.00 14.30 94.22 0.73 -24.70 80.89 17.41 -22.90 81.94 17.31 coo 33.16 106.80 7.72 33.34 104.87 6.92 -8.66 61.41 13.34 -8.76 59.35 12.80 ULMN 3 2amg_c06 1,4-ALPHA-D-GLUCAN MALTOTETRAHYDROLAuser 4 3 # 4 193 ASP A 122 ASP^? 7.46 C1 GOL A 150 231 ASP D 87 ASP.? 7.26 C16 1PE B 150 294 ASP A 83 ASP.? 8.52 O3 GOL D 147 coo 27.89 102.52 14.98 29.35 101.92 13.57 -15.41 64.92 4.51 -15.09 66.83 5.33 coo 14.74 93.05 -1.00 14.30 94.22 0.73 -24.70 80.89 17.41 -22.90 81.94 17.31 coo 33.16 106.80 7.72 33.34 104.87 6.92 -19.46 70.43 -3.04 -19.06 72.28 -2.05 ULMN 3 2amg_c06 1,4-ALPHA-D-GLUCAN MALTOTETRAHYDROLAuser 5 3 # 5 193 ASP A 122 ASP^? 7.46 C1 GOL A 150 231 ASP D 87 ASP.? 7.26 C16 1PE B 150 294 ASP A 87 ASP.? 8.49 C6 PGE A 147 coo 27.89 102.52 14.98 29.35 101.92 13.57 -15.41 64.92 4.51 -15.09 66.83 5.33 coo 14.74 93.05 -1.00 14.30 94.22 0.73 -24.70 80.89 17.41 -22.90 81.94 17.31 coo 33.16 106.80 7.72 33.34 104.87 6.92 -23.17 58.67 3.55 -22.34 59.17 1.69 ULMN 3 2amg_c06 1,4-ALPHA-D-GLUCAN MALTOTETRAHYDROLAuser 6 3 # 6 193 ASP B 19 ASP.? -3.77 O3 SO4 A 144s 231 ASP B 6 ASP.? -3.99 C6 PE8 B 148s 294 ASP A 19 ASP.? -3.59 O4 SO4 A 144s coo 27.89 102.52 14.98 29.35 101.92 13.57 -12.63 65.75 40.21 -14.11 64.30 40.60 coo 14.74 93.05 -1.00 14.30 94.22 0.73 7.95 70.39 41.39 8.88 71.08 39.61 coo 33.16 106.80 7.72 33.34 104.87 6.92 -15.01 66.98 32.71 -14.52 68.02 34.44 ULMN 3 2amg_c06 1,4-ALPHA-D-GLUCAN MALTOTETRAHYDROLAuser 7 3 # 7 193 ASP B 56 ASP~? 11.45 C20 PE8 B 148 231 ASP B 122 ASP^? 7.33 O2 GOL B 149 294 ASP B 106 ASP~? 11.87 OH2 1PE B 150 coo 27.89 102.52 14.98 29.35 101.92 13.57 6.80 78.21 26.00 8.47 79.07 25.03 coo 14.74 93.05 -1.00 14.30 94.22 0.73 10.89 79.68 47.57 9.75 78.80 49.16 coo 33.16 106.80 7.72 33.34 104.87 6.92 -0.30 70.27 27.08 -0.10 70.78 25.05 ULMN 3 2amg_c06 1,4-ALPHA-D-GLUCAN MALTOTETRAHYDROLAuser 8 3 # 8 193 ASP B 83 ASP.? 9.40 O3 GOL C 149 231 ASP C 87 ASP.? 8.84 O1 PGE C 147 294 ASP B 122 ASP^? 7.33 O2 GOL B 149 coo 27.89 102.52 14.98 29.35 101.92 13.57 13.62 86.10 55.23 12.83 84.59 56.49 coo 14.74 93.05 -1.00 14.30 94.22 0.73 -9.03 79.00 58.44 -8.21 77.39 59.55 coo 33.16 106.80 7.72 33.34 104.87 6.92 10.89 79.68 47.57 9.75 78.80 49.16 ULMN 3 2amg_c06 1,4-ALPHA-D-GLUCAN MALTOTETRAHYDROLAuser 9 3 # 9 193 ASP B 87 ASP.? 8.94 O4 PGE B 147 231 ASP B 40 ASP.? 11.67 O1 PEG B 144 294 ASP B 122 ASP^? 7.33 O2 GOL B 149 coo 27.89 102.52 14.98 29.35 101.92 13.57 9.49 87.97 42.02 11.31 87.98 43.09 coo 14.74 93.05 -1.00 14.30 94.22 0.73 22.51 72.75 29.32 21.02 74.20 28.79 coo 33.16 106.80 7.72 33.34 104.87 6.92 10.89 79.68 47.57 9.75 78.80 49.16 ULMN 3 2amg_c06 1,4-ALPHA-D-GLUCAN MALTOTETRAHYDROLAuser 10 3 # 10 193 ASP B 106 ASP~? 11.87 OH2 1PE B 150 231 ASP D 83 ASP.? 8.76 O1 GOL A 150 294 ASP B 56 ASP~? 11.45 C20 PE8 B 148 coo 27.89 102.52 14.98 29.35 101.92 13.57 -0.30 70.27 27.08 -0.10 70.78 25.05 coo 14.74 93.05 -1.00 14.30 94.22 0.73 -12.54 78.43 10.94 -12.46 77.06 9.29 coo 33.16 106.80 7.72 33.34 104.87 6.92 6.80 78.21 26.00 8.47 79.07 25.03 ULMN 3 2amg_c06 1,4-ALPHA-D-GLUCAN MALTOTETRAHYDROLAuser 11 3 # 11 193 ASP B 122 ASP^? 7.33 O2 GOL B 149 231 ASP B 40 ASP.? 11.67 O1 PEG B 144 294 ASP B 87 ASP.? 8.94 O4 PGE B 147 coo 27.89 102.52 14.98 29.35 101.92 13.57 10.89 79.68 47.57 9.75 78.80 49.16 coo 14.74 93.05 -1.00 14.30 94.22 0.73 22.51 72.75 29.32 21.02 74.20 28.79 coo 33.16 106.80 7.72 33.34 104.87 6.92 9.49 87.97 42.02 11.31 87.98 43.09 ULMN 3 2amg_c06 1,4-ALPHA-D-GLUCAN MALTOTETRAHYDROLAuser 12 3 # 12 193 ASP B 122 ASP^? 7.33 O2 GOL B 149 231 ASP C 6 ASP.? -4.04 C8 PE8 C 148s 294 ASP B 87 ASP.? 8.94 O4 PGE B 147 coo 27.89 102.52 14.98 29.35 101.92 13.57 10.89 79.68 47.57 9.75 78.80 49.16 coo 14.74 93.05 -1.00 14.30 94.22 0.73 0.53 91.96 65.64 -1.31 91.68 66.68 coo 33.16 106.80 7.72 33.34 104.87 6.92 9.49 87.97 42.02 11.31 87.98 43.09 ULMN 3 2amg_c06 1,4-ALPHA-D-GLUCAN MALTOTETRAHYDROLAuser 13 3 # 13 193 ASP B 122 ASP^? 7.33 O2 GOL B 149 231 ASP C 87 ASP.? 8.84 O1 PGE C 147 294 ASP B 6 ASP.? -3.99 C6 PE8 B 148s coo 27.89 102.52 14.98 29.35 101.92 13.57 10.89 79.68 47.57 9.75 78.80 49.16 coo 14.74 93.05 -1.00 14.30 94.22 0.73 -9.03 79.00 58.44 -8.21 77.39 59.55 coo 33.16 106.80 7.72 33.34 104.87 6.92 7.95 70.39 41.39 8.88 71.08 39.61 ULMN 3 2amg_c06 1,4-ALPHA-D-GLUCAN MALTOTETRAHYDROLAuser 14 3 # 14 193 ASP B 122 ASP^? 7.33 O2 GOL B 149 231 ASP C 87 ASP.? 8.84 O1 PGE C 147 294 ASP B 83 ASP.? 9.40 O3 GOL C 149 coo 27.89 102.52 14.98 29.35 101.92 13.57 10.89 79.68 47.57 9.75 78.80 49.16 coo 14.74 93.05 -1.00 14.30 94.22 0.73 -9.03 79.00 58.44 -8.21 77.39 59.55 coo 33.16 106.80 7.72 33.34 104.87 6.92 13.62 86.10 55.23 12.83 84.59 56.49 ULMN 3 2amg_c06 1,4-ALPHA-D-GLUCAN MALTOTETRAHYDROLAuser 15 3 # 15 193 ASP B 122 ASP^? 7.33 O2 GOL B 149 231 ASP C 87 ASP.? 8.84 O1 PGE C 147 294 ASP B 87 ASP.? 8.94 O4 PGE B 147 coo 27.89 102.52 14.98 29.35 101.92 13.57 10.89 79.68 47.57 9.75 78.80 49.16 coo 14.74 93.05 -1.00 14.30 94.22 0.73 -9.03 79.00 58.44 -8.21 77.39 59.55 coo 33.16 106.80 7.72 33.34 104.87 6.92 9.49 87.97 42.02 11.31 87.98 43.09 ULMN 3 2amg_c06 1,4-ALPHA-D-GLUCAN MALTOTETRAHYDROLAuser 16 3 # 16 193 ASP C 56 ASP~? 9.09 N MLZ C 114 231 ASP C 122 ASP^? 7.22 C3 GOL C 149 294 ASP C 106 ASP~? 12.11 C21 PE8 C 148 coo 27.89 102.52 14.98 29.35 101.92 13.57 -16.40 94.43 66.11 -17.63 93.56 67.58 coo 14.74 93.05 -1.00 14.30 94.22 0.73 0.27 81.12 61.60 2.07 81.54 60.53 coo 33.16 106.80 7.72 33.34 104.87 6.92 -11.06 103.55 63.77 -13.00 104.00 64.35 ULMN 3 2amg_c06 1,4-ALPHA-D-GLUCAN MALTOTETRAHYDROLAuser 17 3 # 17 193 ASP C 83 ASP.? 8.65 O3 GOL B 149 231 ASP B 87 ASP.? 8.94 O4 PGE B 147 294 ASP C 122 ASP^? 7.22 C3 GOL C 149 coo 27.89 102.52 14.98 29.35 101.92 13.57 3.02 71.86 58.06 4.88 72.49 57.24 coo 14.74 93.05 -1.00 14.30 94.22 0.73 9.49 87.97 42.02 11.31 87.98 43.09 coo 33.16 106.80 7.72 33.34 104.87 6.92 0.27 81.12 61.60 2.07 81.54 60.53 ULMN 3 2amg_c06 1,4-ALPHA-D-GLUCAN MALTOTETRAHYDROLAuser 18 3 # 18 193 ASP C 122 ASP^? 7.22 C3 GOL C 149 231 ASP B 6 ASP.? -3.99 C6 PE8 B 148s 294 ASP C 87 ASP.? 8.84 O1 PGE C 147 coo 27.89 102.52 14.98 29.35 101.92 13.57 0.27 81.12 61.60 2.07 81.54 60.53 coo 14.74 93.05 -1.00 14.30 94.22 0.73 7.95 70.39 41.39 8.88 71.08 39.61 coo 33.16 106.80 7.72 33.34 104.87 6.92 -9.03 79.00 58.44 -8.21 77.39 59.55 ULMN 3 2amg_c06 1,4-ALPHA-D-GLUCAN MALTOTETRAHYDROLAuser 19 3 # 19 193 ASP C 122 ASP^? 7.22 C3 GOL C 149 231 ASP B 87 ASP.? 8.94 O4 PGE B 147 294 ASP C 6 ASP.? -4.04 C8 PE8 C 148s coo 27.89 102.52 14.98 29.35 101.92 13.57 0.27 81.12 61.60 2.07 81.54 60.53 coo 14.74 93.05 -1.00 14.30 94.22 0.73 9.49 87.97 42.02 11.31 87.98 43.09 coo 33.16 106.80 7.72 33.34 104.87 6.92 0.53 91.96 65.64 -1.31 91.68 66.68 ULMN 3 2amg_c06 1,4-ALPHA-D-GLUCAN MALTOTETRAHYDROLAuser 20 3 # 20 193 ASP C 122 ASP^? 7.22 C3 GOL C 149 231 ASP B 87 ASP.? 8.94 O4 PGE B 147 294 ASP C 83 ASP.? 8.65 O3 GOL B 149 coo 27.89 102.52 14.98 29.35 101.92 13.57 0.27 81.12 61.60 2.07 81.54 60.53 coo 14.74 93.05 -1.00 14.30 94.22 0.73 9.49 87.97 42.02 11.31 87.98 43.09 coo 33.16 106.80 7.72 33.34 104.87 6.92 3.02 71.86 58.06 4.88 72.49 57.24 ULMN 3 2amg_c06 1,4-ALPHA-D-GLUCAN MALTOTETRAHYDROLAuser 21 3 # 21 193 ASP C 122 ASP^? 7.22 C3 GOL C 149 231 ASP B 87 ASP.? 8.94 O4 PGE B 147 294 ASP C 87 ASP.? 8.84 O1 PGE C 147 coo 27.89 102.52 14.98 29.35 101.92 13.57 0.27 81.12 61.60 2.07 81.54 60.53 coo 14.74 93.05 -1.00 14.30 94.22 0.73 9.49 87.97 42.02 11.31 87.98 43.09 coo 33.16 106.80 7.72 33.34 104.87 6.92 -9.03 79.00 58.44 -8.21 77.39 59.55 ULMN 3 2amg_c06 1,4-ALPHA-D-GLUCAN MALTOTETRAHYDROLAuser 22 3 # 22 193 ASP C 122 ASP^? 7.22 C3 GOL C 149 231 ASP C 40 ASP.? 9.64 O MLZ C 114 294 ASP C 87 ASP.? 8.84 O1 PGE C 147 coo 27.89 102.52 14.98 29.35 101.92 13.57 0.27 81.12 61.60 2.07 81.54 60.53 coo 14.74 93.05 -1.00 14.30 94.22 0.73 -10.62 87.43 80.17 -12.01 86.84 78.68 coo 33.16 106.80 7.72 33.34 104.87 6.92 -9.03 79.00 58.44 -8.21 77.39 59.55 ULMN 3 2amg_c06 1,4-ALPHA-D-GLUCAN MALTOTETRAHYDROLAuser 23 3 # 23 193 ASP D 56 ASP~? 11.46 C21 2PE D 146 231 ASP D 122 ASP^? 7.49 C3 GOL D 147 294 ASP D 106 ASP~? 11.82 O22 2PE D 146 coo 27.89 102.52 14.98 29.35 101.92 13.57 -41.85 87.81 13.66 -41.61 89.58 14.80 coo 14.74 93.05 -1.00 14.30 94.22 0.73 -21.82 80.90 7.85 -21.38 79.32 6.51 coo 33.16 106.80 7.72 33.34 104.87 6.92 -46.82 82.57 5.87 -48.37 83.43 7.00 ULMN 3 2amg_c06 1,4-ALPHA-D-GLUCAN MALTOTETRAHYDROLAuser 24 3 # 24 193 ASP D 83 ASP.? 8.76 O1 GOL A 150 231 ASP A 87 ASP.? 8.49 C6 PGE A 147 294 ASP D 122 ASP^? 7.49 C3 GOL D 147 coo 27.89 102.52 14.98 29.35 101.92 13.57 -12.54 78.43 10.94 -12.46 77.06 9.29 coo 14.74 93.05 -1.00 14.30 94.22 0.73 -23.17 58.67 3.55 -22.34 59.17 1.69 coo 33.16 106.80 7.72 33.34 104.87 6.92 -21.82 80.90 7.85 -21.38 79.32 6.51 ULMN 3 2amg_c06 1,4-ALPHA-D-GLUCAN MALTOTETRAHYDROLAuser 25 3 # 25 193 ASP D 122 ASP^? 7.49 C3 GOL D 147 231 ASP A 6 ASP.? -3.91 C9 2PE A 148s 294 ASP D 87 ASP.? 7.26 C16 1PE B 150 coo 27.89 102.52 14.98 29.35 101.92 13.57 -21.82 80.90 7.85 -21.38 79.32 6.51 coo 14.74 93.05 -1.00 14.30 94.22 0.73 -8.66 61.41 13.34 -8.76 59.35 12.80 coo 33.16 106.80 7.72 33.34 104.87 6.92 -24.70 80.89 17.41 -22.90 81.94 17.31 ULMN 3 2amg_c06 1,4-ALPHA-D-GLUCAN MALTOTETRAHYDROLAuser 26 3 # 26 193 ASP D 122 ASP^? 7.49 C3 GOL D 147 231 ASP A 87 ASP.? 8.49 C6 PGE A 147 294 ASP D 6 ASP.? -3.77 C8 2PE D 146s coo 27.89 102.52 14.98 29.35 101.92 13.57 -21.82 80.90 7.85 -21.38 79.32 6.51 coo 14.74 93.05 -1.00 14.30 94.22 0.73 -23.17 58.67 3.55 -22.34 59.17 1.69 coo 33.16 106.80 7.72 33.34 104.87 6.92 -31.03 82.87 1.04 -31.83 84.41 2.29 ULMN 3 2amg_c06 1,4-ALPHA-D-GLUCAN MALTOTETRAHYDROLAuser 27 3 # 27 193 ASP D 122 ASP^? 7.49 C3 GOL D 147 231 ASP A 87 ASP.? 8.49 C6 PGE A 147 294 ASP D 83 ASP.? 8.76 O1 GOL A 150 coo 27.89 102.52 14.98 29.35 101.92 13.57 -21.82 80.90 7.85 -21.38 79.32 6.51 coo 14.74 93.05 -1.00 14.30 94.22 0.73 -23.17 58.67 3.55 -22.34 59.17 1.69 coo 33.16 106.80 7.72 33.34 104.87 6.92 -12.54 78.43 10.94 -12.46 77.06 9.29 ULMN 3 2amg_c06 1,4-ALPHA-D-GLUCAN MALTOTETRAHYDROLAuser 28 3 # 28 193 ASP D 122 ASP^? 7.49 C3 GOL D 147 231 ASP A 87 ASP.? 8.49 C6 PGE A 147 294 ASP D 87 ASP.? 7.26 C16 1PE B 150 coo 27.89 102.52 14.98 29.35 101.92 13.57 -21.82 80.90 7.85 -21.38 79.32 6.51 coo 14.74 93.05 -1.00 14.30 94.22 0.73 -23.17 58.67 3.55 -22.34 59.17 1.69 coo 33.16 106.80 7.72 33.34 104.87 6.92 -24.70 80.89 17.41 -22.90 81.94 17.31 ULMN 3 2amg_c06 1,4-ALPHA-D-GLUCAN MALTOTETRAHYDROLAuser 29 3 # 29 193 ASP D 122 ASP^? 7.49 C3 GOL D 147 231 ASP D 40 ASP.? 18.38 C9 2PE D 146 294 ASP D 87 ASP.? 7.26 C16 1PE B 150 coo 27.89 102.52 14.98 29.35 101.92 13.57 -21.82 80.90 7.85 -21.38 79.32 6.51 coo 14.74 93.05 -1.00 14.30 94.22 0.73 -32.95 100.50 7.54 -33.10 99.69 9.54 coo 33.16 106.80 7.72 33.34 104.87 6.92 -24.70 80.89 17.41 -22.90 81.94 17.31 2amg_c06 source 2amg 1,4-ALPHA-D-GLUCAN MALTOTETRAHYDROLASE : 29 hits 2amg_c06 naa= 3 ULMN 3 2apr_c04 ACID PROTEINASE (RHIZOPUSPEPSIN) (E.user 1 3 # 1 35 ASP A 19 ASP.? -3.59 O4 SO4 A 144s 38 SER B 96 SER~? 7.21 O4 SO4 A 144 218 ASP B 19 ASP.? -3.77 O3 SO4 A 144s coo 41.14 58.72 105.19 42.39 59.85 103.92 -15.01 66.98 32.71 -14.52 68.02 34.44 coo 46.04 57.35 103.96 44.97 58.52 105.78 -12.28 72.78 35.88 -11.90 71.42 33.88 coo 41.33 60.20 97.63 42.00 60.96 99.49 -12.63 65.75 40.21 -14.11 64.30 40.60 2apr_c04 source 2apr ACID PROTEINASE (RHIZOPUSPEPSIN) (E.C.3.4.23.6: 1 hits 2apr_c04 naa= 3 ULMN 3 2c7v_c08 PTERIDINE REDUCTASE user 1 3 # 1 A 14 ARG A 16 ARG~? -2.82 O4 SO4 A 143s A 161 ASP A 106 ASP~? 11.93 O22 2PE A 148 A 174 TYR A 109 TYR~? -5.64 O16 2PE A 148s coo 14.43 -13.26 8.40 11.75 -14.25 9.60 -9.29 63.37 28.06 -8.90 62.24 30.90 coo 3.82 -4.94 15.61 3.37 -6.97 16.02 -12.71 50.36 24.83 -13.06 48.30 25.05 coo 8.61 -7.11 20.41 7.51 -6.92 17.85 -13.81 52.60 20.09 -14.53 54.76 18.49 ULMN 3 2c7v_c08 PTERIDINE REDUCTASE user 2 3 # 2 A 14 ARG A 42 ARG.? 16.81 C11 2PE A 148 A 161 ASP A 56 ASP~? 11.59 C21 2PE A 148 A 174 TYR A 53 TYR~? -4.55 C21 2PE A 148s coo 14.43 -13.26 8.40 11.75 -14.25 9.60 -8.57 45.71 4.07 -9.11 44.76 6.92 coo 3.82 -4.94 15.61 3.37 -6.97 16.02 -16.01 45.89 15.64 -15.93 44.31 14.23 coo 8.61 -7.11 20.41 7.51 -6.92 17.85 -16.76 52.42 13.05 -16.88 54.33 15.10 ULMN 3 2c7v_c08 PTERIDINE REDUCTASE user 3 3 # 3 A 14 ARG A 55 ARG~? 10.23 CD MLY D 135 A 161 ASP A 106 ASP~? 11.93 O22 2PE A 148 A 174 TYR A 109 TYR~? -5.64 O16 2PE A 148s coo 14.43 -13.26 8.40 11.75 -14.25 9.60 -19.70 43.33 11.87 -20.69 44.07 9.04 coo 3.82 -4.94 15.61 3.37 -6.97 16.02 -12.71 50.36 24.83 -13.06 48.30 25.05 coo 8.61 -7.11 20.41 7.51 -6.92 17.85 -13.81 52.60 20.09 -14.53 54.76 18.49 ULMN 3 2c7v_c08 PTERIDINE REDUCTASE user 4 3 # 4 A 14 ARG A 124 ARG^? 8.18 C1 GOL A 150 A 161 ASP A 87 ASP.? 8.49 C6 PGE A 147 A 174 TYR A 50 TYR~? 5.51 CH2 MLY D 135 coo 14.43 -13.26 8.40 11.75 -14.25 9.60 -17.35 69.10 10.18 -16.14 69.37 7.36 coo 3.82 -4.94 15.61 3.37 -6.97 16.02 -23.17 58.67 3.55 -22.34 59.17 1.69 coo 8.61 -7.11 20.41 7.51 -6.92 17.85 -19.50 53.98 8.67 -20.18 55.72 10.74 ULMN 3 2c7v_c08 PTERIDINE REDUCTASE user 5 3 # 5 A 14 ARG B 16 ARG~? -3.64 O1 SO4 A 143s A 161 ASP B 106 ASP~? 11.87 OH2 1PE B 150 A 174 TYR B 109 TYR~? -5.65 O13 PE8 B 148s coo 14.43 -13.26 8.40 11.75 -14.25 9.60 -4.85 63.18 38.40 -7.23 62.95 36.44 coo 3.82 -4.94 15.61 3.37 -6.97 16.02 -0.30 70.27 27.08 -0.10 70.78 25.05 coo 8.61 -7.11 20.41 7.51 -6.92 17.85 2.41 73.03 30.76 2.68 74.03 33.35 ULMN 3 2c7v_c08 PTERIDINE REDUCTASE user 6 3 # 6 A 14 ARG B 35 ARG.? 9.50 O1 PEG B 144 A 161 ASP B 87 ASP.? 8.94 O4 PGE B 147 A 174 TYR B 50 TYR~? 5.52 CH1 MLY C 135 coo 14.43 -13.26 8.40 11.75 -14.25 9.60 22.76 84.08 36.32 22.81 87.07 35.45 coo 3.82 -4.94 15.61 3.37 -6.97 16.02 9.49 87.97 42.02 11.31 87.98 43.09 coo 8.61 -7.11 20.41 7.51 -6.92 17.85 8.51 83.11 35.90 5.93 82.51 36.84 ULMN 3 2c7v_c08 PTERIDINE REDUCTASE user 7 3 # 7 A 14 ARG B 55 ARG~? 9.33 CG MLY C 135 A 161 ASP B 106 ASP~? 11.87 OH2 1PE B 150 A 174 TYR B 109 TYR~? -5.65 O13 PE8 B 148s coo 14.43 -13.26 8.40 11.75 -14.25 9.60 8.78 84.29 24.99 10.39 86.20 26.77 coo 3.82 -4.94 15.61 3.37 -6.97 16.02 -0.30 70.27 27.08 -0.10 70.78 25.05 coo 8.61 -7.11 20.41 7.51 -6.92 17.85 2.41 73.03 30.76 2.68 74.03 33.35 ULMN 3 2c7v_c08 PTERIDINE REDUCTASE user 8 3 # 8 A 14 ARG B 124 ARG^? 8.02 O2 GOL B 149 A 161 ASP B 87 ASP.? 8.94 O4 PGE B 147 A 174 TYR B 50 TYR~? 5.52 CH1 MLY C 135 coo 14.43 -13.26 8.40 11.75 -14.25 9.60 3.96 78.02 49.67 6.79 78.26 50.86 coo 3.82 -4.94 15.61 3.37 -6.97 16.02 9.49 87.97 42.02 11.31 87.98 43.09 coo 8.61 -7.11 20.41 7.51 -6.92 17.85 8.51 83.11 35.90 5.93 82.51 36.84 ULMN 3 2c7v_c08 PTERIDINE REDUCTASE user 9 3 # 9 A 14 ARG C 16 ARG~? -2.96 O3 SO4 C 143s A 161 ASP C 106 ASP~? 12.11 C21 PE8 C 148 A 174 TYR C 109 TYR~? -5.91 C14 PE8 C 148s coo 14.43 -13.26 8.40 11.75 -14.25 9.60 1.87 105.73 59.26 1.00 108.67 58.94 coo 3.82 -4.94 15.61 3.37 -6.97 16.02 -11.06 103.55 63.77 -13.00 104.00 64.35 coo 8.61 -7.11 20.41 7.51 -6.92 17.85 -9.64 98.32 63.33 -8.13 96.27 62.21 ULMN 3 2c7v_c08 PTERIDINE REDUCTASE user 10 3 # 10 A 14 ARG C 42 ARG.? 7.63 O MLZ C 114 A 161 ASP C 56 ASP~? 9.09 N MLZ C 114 A 174 TYR C 53 TYR~? -4.98 C18 PE8 C 148s coo 14.43 -13.26 8.40 11.75 -14.25 9.60 -13.55 84.90 75.42 -13.77 88.03 75.38 coo 3.82 -4.94 15.61 3.37 -6.97 16.02 -16.40 94.43 66.11 -17.63 93.56 67.58 coo 8.61 -7.11 20.41 7.51 -6.92 17.85 -11.26 90.80 63.43 -9.63 92.35 61.80 ULMN 3 2c7v_c08 PTERIDINE REDUCTASE user 11 3 # 11 A 14 ARG C 55 ARG~? 9.18 O MLY B 135 A 161 ASP C 106 ASP~? 12.11 C21 PE8 C 148 A 174 TYR C 109 TYR~? -5.91 C14 PE8 C 148s coo 14.43 -13.26 8.40 11.75 -14.25 9.60 -21.06 89.68 64.73 -20.37 86.74 65.24 coo 3.82 -4.94 15.61 3.37 -6.97 16.02 -11.06 103.55 63.77 -13.00 104.00 64.35 coo 8.61 -7.11 20.41 7.51 -6.92 17.85 -9.64 98.32 63.33 -8.13 96.27 62.21 ULMN 3 2c7v_c08 PTERIDINE REDUCTASE user 12 3 # 12 A 14 ARG C 124 ARG^? 7.92 C3 GOL C 149 A 161 ASP C 87 ASP.? 8.84 O1 PGE C 147 A 174 TYR C 50 TYR~? 5.59 CE MLY B 135 coo 14.43 -13.26 8.40 11.75 -14.25 9.60 2.87 85.20 55.95 3.74 82.90 57.81 coo 3.82 -4.94 15.61 3.37 -6.97 16.02 -9.03 79.00 58.44 -8.21 77.39 59.55 coo 8.61 -7.11 20.41 7.51 -6.92 17.85 -11.27 85.65 61.91 -10.18 87.09 59.78 ULMN 3 2c7v_c08 PTERIDINE REDUCTASE user 13 3 # 13 A 14 ARG D 16 ARG~? -9.70 O1 2PE D 146s A 161 ASP D 106 ASP~? 11.82 O22 2PE D 146 A 174 TYR D 109 TYR~? -5.82 O16 2PE D 146s coo 14.43 -13.26 8.40 11.75 -14.25 9.60 -42.18 74.28 -4.52 -45.10 73.30 -4.28 coo 3.82 -4.94 15.61 3.37 -6.97 16.02 -46.82 82.57 5.87 -48.37 83.43 7.00 coo 8.61 -7.11 20.41 7.51 -6.92 17.85 -41.76 82.56 7.21 -39.24 81.41 7.29 ULMN 3 2c7v_c08 PTERIDINE REDUCTASE user 14 3 # 14 A 14 ARG D 55 ARG~? 9.16 CG MLY A 135 A 161 ASP D 106 ASP~? 11.82 O22 2PE D 146 A 174 TYR D 109 TYR~? -5.82 O16 2PE D 146s coo 14.43 -13.26 8.40 11.75 -14.25 9.60 -39.98 89.02 19.79 -37.17 89.06 21.03 coo 3.82 -4.94 15.61 3.37 -6.97 16.02 -46.82 82.57 5.87 -48.37 83.43 7.00 coo 8.61 -7.11 20.41 7.51 -6.92 17.85 -41.76 82.56 7.21 -39.24 81.41 7.29 ULMN 3 2c7v_c08 PTERIDINE REDUCTASE user 15 3 # 15 A 14 ARG D 124 ARG^? 7.97 C3 GOL D 147 A 161 ASP D 87 ASP.? 7.26 C16 1PE B 150 A 174 TYR D 50 TYR~? 5.61 CH1 MLY A 135 coo 14.43 -13.26 8.40 11.75 -14.25 9.60 -24.04 74.20 5.58 -21.67 76.16 5.44 coo 3.82 -4.94 15.61 3.37 -6.97 16.02 -24.70 80.89 17.41 -22.90 81.94 17.31 coo 8.61 -7.11 20.41 7.51 -6.92 17.85 -31.54 83.73 14.98 -32.20 81.17 14.09 2c7v_c08 source 2c7v PTERIDINE REDUCTASE : 15 hits 2c7v_c08 naa= 3 ULMN 3 2c7v_c09 PTERIDINE REDUCTASE user 1 3 # 1 B 14 ARG A 16 ARG~? -2.82 O4 SO4 A 143s B 161 ASP A 106 ASP~? 11.93 O22 2PE A 148 B 174 TYR A 109 TYR~? -5.64 O16 2PE A 148s coo -18.34 17.48 -4.91 -16.98 18.69 -2.39 -9.29 63.37 28.06 -8.90 62.24 30.90 coo -14.86 10.19 8.14 -14.82 12.31 8.42 -12.71 50.36 24.83 -13.06 48.30 25.05 coo -21.46 12.70 8.53 -19.04 12.30 7.24 -13.81 52.60 20.09 -14.53 54.76 18.49 ULMN 3 2c7v_c09 PTERIDINE REDUCTASE user 2 3 # 2 B 14 ARG A 42 ARG.? 16.81 C11 2PE A 148 B 161 ASP A 56 ASP~? 11.59 C21 2PE A 148 B 174 TYR A 53 TYR~? -4.55 C21 2PE A 148s coo -18.34 17.48 -4.91 -16.98 18.69 -2.39 -8.57 45.71 4.07 -9.11 44.76 6.92 coo -14.86 10.19 8.14 -14.82 12.31 8.42 -16.01 45.89 15.64 -15.93 44.31 14.23 coo -21.46 12.70 8.53 -19.04 12.30 7.24 -16.76 52.42 13.05 -16.88 54.33 15.10 ULMN 3 2c7v_c09 PTERIDINE REDUCTASE user 3 3 # 3 B 14 ARG A 55 ARG~? 10.23 CD MLY D 135 B 161 ASP A 106 ASP~? 11.93 O22 2PE A 148 B 174 TYR A 109 TYR~? -5.64 O16 2PE A 148s coo -18.34 17.48 -4.91 -16.98 18.69 -2.39 -19.70 43.33 11.87 -20.69 44.07 9.04 coo -14.86 10.19 8.14 -14.82 12.31 8.42 -12.71 50.36 24.83 -13.06 48.30 25.05 coo -21.46 12.70 8.53 -19.04 12.30 7.24 -13.81 52.60 20.09 -14.53 54.76 18.49 ULMN 3 2c7v_c09 PTERIDINE REDUCTASE user 4 3 # 4 B 14 ARG A 124 ARG^? 8.18 C1 GOL A 150 B 161 ASP A 87 ASP.? 8.49 C6 PGE A 147 B 174 TYR A 50 TYR~? 5.51 CH2 MLY D 135 coo -18.34 17.48 -4.91 -16.98 18.69 -2.39 -17.35 69.10 10.18 -16.14 69.37 7.36 coo -14.86 10.19 8.14 -14.82 12.31 8.42 -23.17 58.67 3.55 -22.34 59.17 1.69 coo -21.46 12.70 8.53 -19.04 12.30 7.24 -19.50 53.98 8.67 -20.18 55.72 10.74 ULMN 3 2c7v_c09 PTERIDINE REDUCTASE user 5 3 # 5 B 14 ARG B 16 ARG~? -3.64 O1 SO4 A 143s B 161 ASP B 106 ASP~? 11.87 OH2 1PE B 150 B 174 TYR B 109 TYR~? -5.65 O13 PE8 B 148s coo -18.34 17.48 -4.91 -16.98 18.69 -2.39 -4.85 63.18 38.40 -7.23 62.95 36.44 coo -14.86 10.19 8.14 -14.82 12.31 8.42 -0.30 70.27 27.08 -0.10 70.78 25.05 coo -21.46 12.70 8.53 -19.04 12.30 7.24 2.41 73.03 30.76 2.68 74.03 33.35 ULMN 3 2c7v_c09 PTERIDINE REDUCTASE user 6 3 # 6 B 14 ARG B 35 ARG.? 9.50 O1 PEG B 144 B 161 ASP B 87 ASP.? 8.94 O4 PGE B 147 B 174 TYR B 50 TYR~? 5.52 CH1 MLY C 135 coo -18.34 17.48 -4.91 -16.98 18.69 -2.39 22.76 84.08 36.32 22.81 87.07 35.45 coo -14.86 10.19 8.14 -14.82 12.31 8.42 9.49 87.97 42.02 11.31 87.98 43.09 coo -21.46 12.70 8.53 -19.04 12.30 7.24 8.51 83.11 35.90 5.93 82.51 36.84 ULMN 3 2c7v_c09 PTERIDINE REDUCTASE user 7 3 # 7 B 14 ARG B 55 ARG~? 9.33 CG MLY C 135 B 161 ASP B 106 ASP~? 11.87 OH2 1PE B 150 B 174 TYR B 109 TYR~? -5.65 O13 PE8 B 148s coo -18.34 17.48 -4.91 -16.98 18.69 -2.39 8.78 84.29 24.99 10.39 86.20 26.77 coo -14.86 10.19 8.14 -14.82 12.31 8.42 -0.30 70.27 27.08 -0.10 70.78 25.05 coo -21.46 12.70 8.53 -19.04 12.30 7.24 2.41 73.03 30.76 2.68 74.03 33.35 ULMN 3 2c7v_c09 PTERIDINE REDUCTASE user 8 3 # 8 B 14 ARG B 124 ARG^? 8.02 O2 GOL B 149 B 161 ASP B 87 ASP.? 8.94 O4 PGE B 147 B 174 TYR B 50 TYR~? 5.52 CH1 MLY C 135 coo -18.34 17.48 -4.91 -16.98 18.69 -2.39 3.96 78.02 49.67 6.79 78.26 50.86 coo -14.86 10.19 8.14 -14.82 12.31 8.42 9.49 87.97 42.02 11.31 87.98 43.09 coo -21.46 12.70 8.53 -19.04 12.30 7.24 8.51 83.11 35.90 5.93 82.51 36.84 ULMN 3 2c7v_c09 PTERIDINE REDUCTASE user 9 3 # 9 B 14 ARG C 16 ARG~? -2.96 O3 SO4 C 143s B 161 ASP C 106 ASP~? 12.11 C21 PE8 C 148 B 174 TYR C 109 TYR~? -5.91 C14 PE8 C 148s coo -18.34 17.48 -4.91 -16.98 18.69 -2.39 1.87 105.73 59.26 1.00 108.67 58.94 coo -14.86 10.19 8.14 -14.82 12.31 8.42 -11.06 103.55 63.77 -13.00 104.00 64.35 coo -21.46 12.70 8.53 -19.04 12.30 7.24 -9.64 98.32 63.33 -8.13 96.27 62.21 ULMN 3 2c7v_c09 PTERIDINE REDUCTASE user 10 3 # 10 B 14 ARG C 42 ARG.? 7.63 O MLZ C 114 B 161 ASP C 56 ASP~? 9.09 N MLZ C 114 B 174 TYR C 53 TYR~? -4.98 C18 PE8 C 148s coo -18.34 17.48 -4.91 -16.98 18.69 -2.39 -13.55 84.90 75.42 -13.77 88.03 75.38 coo -14.86 10.19 8.14 -14.82 12.31 8.42 -16.40 94.43 66.11 -17.63 93.56 67.58 coo -21.46 12.70 8.53 -19.04 12.30 7.24 -11.26 90.80 63.43 -9.63 92.35 61.80 ULMN 3 2c7v_c09 PTERIDINE REDUCTASE user 11 3 # 11 B 14 ARG C 55 ARG~? 9.18 O MLY B 135 B 161 ASP C 106 ASP~? 12.11 C21 PE8 C 148 B 174 TYR C 109 TYR~? -5.91 C14 PE8 C 148s coo -18.34 17.48 -4.91 -16.98 18.69 -2.39 -21.06 89.68 64.73 -20.37 86.74 65.24 coo -14.86 10.19 8.14 -14.82 12.31 8.42 -11.06 103.55 63.77 -13.00 104.00 64.35 coo -21.46 12.70 8.53 -19.04 12.30 7.24 -9.64 98.32 63.33 -8.13 96.27 62.21 ULMN 3 2c7v_c09 PTERIDINE REDUCTASE user 12 3 # 12 B 14 ARG C 124 ARG^? 7.92 C3 GOL C 149 B 161 ASP C 87 ASP.? 8.84 O1 PGE C 147 B 174 TYR C 50 TYR~? 5.59 CE MLY B 135 coo -18.34 17.48 -4.91 -16.98 18.69 -2.39 2.87 85.20 55.95 3.74 82.90 57.81 coo -14.86 10.19 8.14 -14.82 12.31 8.42 -9.03 79.00 58.44 -8.21 77.39 59.55 coo -21.46 12.70 8.53 -19.04 12.30 7.24 -11.27 85.65 61.91 -10.18 87.09 59.78 ULMN 3 2c7v_c09 PTERIDINE REDUCTASE user 13 3 # 13 B 14 ARG D 16 ARG~? -9.70 O1 2PE D 146s B 161 ASP D 106 ASP~? 11.82 O22 2PE D 146 B 174 TYR D 109 TYR~? -5.82 O16 2PE D 146s coo -18.34 17.48 -4.91 -16.98 18.69 -2.39 -42.18 74.28 -4.52 -45.10 73.30 -4.28 coo -14.86 10.19 8.14 -14.82 12.31 8.42 -46.82 82.57 5.87 -48.37 83.43 7.00 coo -21.46 12.70 8.53 -19.04 12.30 7.24 -41.76 82.56 7.21 -39.24 81.41 7.29 ULMN 3 2c7v_c09 PTERIDINE REDUCTASE user 14 3 # 14 B 14 ARG D 55 ARG~? 9.16 CG MLY A 135 B 161 ASP D 106 ASP~? 11.82 O22 2PE D 146 B 174 TYR D 109 TYR~? -5.82 O16 2PE D 146s coo -18.34 17.48 -4.91 -16.98 18.69 -2.39 -39.98 89.02 19.79 -37.17 89.06 21.03 coo -14.86 10.19 8.14 -14.82 12.31 8.42 -46.82 82.57 5.87 -48.37 83.43 7.00 coo -21.46 12.70 8.53 -19.04 12.30 7.24 -41.76 82.56 7.21 -39.24 81.41 7.29 ULMN 3 2c7v_c09 PTERIDINE REDUCTASE user 15 3 # 15 B 14 ARG D 124 ARG^? 7.97 C3 GOL D 147 B 161 ASP D 87 ASP.? 7.26 C16 1PE B 150 B 174 TYR D 50 TYR~? 5.61 CH1 MLY A 135 coo -18.34 17.48 -4.91 -16.98 18.69 -2.39 -24.04 74.20 5.58 -21.67 76.16 5.44 coo -14.86 10.19 8.14 -14.82 12.31 8.42 -24.70 80.89 17.41 -22.90 81.94 17.31 coo -21.46 12.70 8.53 -19.04 12.30 7.24 -31.54 83.73 14.98 -32.20 81.17 14.09 2c7v_c09 source 2c7v PTERIDINE REDUCTASE : 15 hits 2c7v_c09 naa= 3 ULMN 3 2c7v_c10 PTERIDINE REDUCTASE user 1 3 # 1 C 14 ARG A 16 ARG~? -2.82 O4 SO4 A 143s C 161 ASP A 106 ASP~? 11.93 O22 2PE A 148 C 174 TYR A 109 TYR~? -5.64 O16 2PE A 148s coo 2.84 19.43 40.34 1.59 20.35 37.65 -9.29 63.37 28.06 -8.90 62.24 30.90 coo -0.62 11.10 28.05 -0.65 13.15 27.46 -12.71 50.36 24.83 -13.06 48.30 25.05 coo 5.94 13.28 27.17 3.53 13.05 28.58 -13.81 52.60 20.09 -14.53 54.76 18.49 ULMN 3 2c7v_c10 PTERIDINE REDUCTASE user 2 3 # 2 C 14 ARG A 42 ARG.? 16.81 C11 2PE A 148 C 161 ASP A 56 ASP~? 11.59 C21 2PE A 148 C 174 TYR A 53 TYR~? -4.55 C21 2PE A 148s coo 2.84 19.43 40.34 1.59 20.35 37.65 -8.57 45.71 4.07 -9.11 44.76 6.92 coo -0.62 11.10 28.05 -0.65 13.15 27.46 -16.01 45.89 15.64 -15.93 44.31 14.23 coo 5.94 13.28 27.17 3.53 13.05 28.58 -16.76 52.42 13.05 -16.88 54.33 15.10 ULMN 3 2c7v_c10 PTERIDINE REDUCTASE user 3 3 # 3 C 14 ARG A 55 ARG~? 10.23 CD MLY D 135 C 161 ASP A 40 ASP.? 18.50 C9 2PE A 148 C 174 TYR A 38 TYR.? 14.78 C11 2PE A 148 coo 2.84 19.43 40.34 1.59 20.35 37.65 -19.70 43.33 11.87 -20.69 44.07 9.04 coo -0.62 11.10 28.05 -0.65 13.15 27.46 -5.23 45.83 3.63 -5.09 44.63 5.33 coo 5.94 13.28 27.17 3.53 13.05 28.58 -8.94 48.99 5.06 -11.42 48.37 6.17 ULMN 3 2c7v_c10 PTERIDINE REDUCTASE user 4 3 # 4 C 14 ARG A 55 ARG~? 10.23 CD MLY D 135 C 161 ASP A 106 ASP~? 11.93 O22 2PE A 148 C 174 TYR A 109 TYR~? -5.64 O16 2PE A 148s coo 2.84 19.43 40.34 1.59 20.35 37.65 -19.70 43.33 11.87 -20.69 44.07 9.04 coo -0.62 11.10 28.05 -0.65 13.15 27.46 -12.71 50.36 24.83 -13.06 48.30 25.05 coo 5.94 13.28 27.17 3.53 13.05 28.58 -13.81 52.60 20.09 -14.53 54.76 18.49 ULMN 3 2c7v_c10 PTERIDINE REDUCTASE user 5 3 # 5 C 14 ARG A 124 ARG^? 8.18 C1 GOL A 150 C 161 ASP A 87 ASP.? 8.49 C6 PGE A 147 C 174 TYR A 50 TYR~? 5.51 CH2 MLY D 135 coo 2.84 19.43 40.34 1.59 20.35 37.65 -17.35 69.10 10.18 -16.14 69.37 7.36 coo -0.62 11.10 28.05 -0.65 13.15 27.46 -23.17 58.67 3.55 -22.34 59.17 1.69 coo 5.94 13.28 27.17 3.53 13.05 28.58 -19.50 53.98 8.67 -20.18 55.72 10.74 ULMN 3 2c7v_c10 PTERIDINE REDUCTASE user 6 3 # 6 C 14 ARG B 16 ARG~? -3.64 O1 SO4 A 143s C 161 ASP B 106 ASP~? 11.87 OH2 1PE B 150 C 174 TYR B 109 TYR~? -5.65 O13 PE8 B 148s coo 2.84 19.43 40.34 1.59 20.35 37.65 -4.85 63.18 38.40 -7.23 62.95 36.44 coo -0.62 11.10 28.05 -0.65 13.15 27.46 -0.30 70.27 27.08 -0.10 70.78 25.05 coo 5.94 13.28 27.17 3.53 13.05 28.58 2.41 73.03 30.76 2.68 74.03 33.35 ULMN 3 2c7v_c10 PTERIDINE REDUCTASE user 7 3 # 7 C 14 ARG B 35 ARG.? 9.50 O1 PEG B 144 C 161 ASP B 87 ASP.? 8.94 O4 PGE B 147 C 174 TYR B 50 TYR~? 5.52 CH1 MLY C 135 coo 2.84 19.43 40.34 1.59 20.35 37.65 22.76 84.08 36.32 22.81 87.07 35.45 coo -0.62 11.10 28.05 -0.65 13.15 27.46 9.49 87.97 42.02 11.31 87.98 43.09 coo 5.94 13.28 27.17 3.53 13.05 28.58 8.51 83.11 35.90 5.93 82.51 36.84 ULMN 3 2c7v_c10 PTERIDINE REDUCTASE user 8 3 # 8 C 14 ARG B 42 ARG.? 12.70 O1 PEG B 144 C 161 ASP B 56 ASP~? 11.45 C20 PE8 B 148 C 174 TYR B 53 TYR~? -4.63 C18 PE8 B 148s coo 2.84 19.43 40.34 1.59 20.35 37.65 19.61 78.53 29.44 17.94 76.42 28.00 coo -0.62 11.10 28.05 -0.65 13.15 27.46 6.80 78.21 26.00 8.47 79.07 25.03 coo 5.94 13.28 27.17 3.53 13.05 28.58 6.73 78.96 33.00 4.51 77.73 34.14 ULMN 3 2c7v_c10 PTERIDINE REDUCTASE user 9 3 # 9 C 14 ARG B 55 ARG~? 9.33 CG MLY C 135 C 161 ASP B 106 ASP~? 11.87 OH2 1PE B 150 C 174 TYR B 109 TYR~? -5.65 O13 PE8 B 148s coo 2.84 19.43 40.34 1.59 20.35 37.65 8.78 84.29 24.99 10.39 86.20 26.77 coo -0.62 11.10 28.05 -0.65 13.15 27.46 -0.30 70.27 27.08 -0.10 70.78 25.05 coo 5.94 13.28 27.17 3.53 13.05 28.58 2.41 73.03 30.76 2.68 74.03 33.35 ULMN 3 2c7v_c10 PTERIDINE REDUCTASE user 10 3 # 10 C 14 ARG B 124 ARG^? 8.02 O2 GOL B 149 C 161 ASP B 87 ASP.? 8.94 O4 PGE B 147 C 174 TYR B 50 TYR~? 5.52 CH1 MLY C 135 coo 2.84 19.43 40.34 1.59 20.35 37.65 3.96 78.02 49.67 6.79 78.26 50.86 coo -0.62 11.10 28.05 -0.65 13.15 27.46 9.49 87.97 42.02 11.31 87.98 43.09 coo 5.94 13.28 27.17 3.53 13.05 28.58 8.51 83.11 35.90 5.93 82.51 36.84 ULMN 3 2c7v_c10 PTERIDINE REDUCTASE user 11 3 # 11 C 14 ARG C 16 ARG~? -2.96 O3 SO4 C 143s C 161 ASP C 106 ASP~? 12.11 C21 PE8 C 148 C 174 TYR C 109 TYR~? -5.91 C14 PE8 C 148s coo 2.84 19.43 40.34 1.59 20.35 37.65 1.87 105.73 59.26 1.00 108.67 58.94 coo -0.62 11.10 28.05 -0.65 13.15 27.46 -11.06 103.55 63.77 -13.00 104.00 64.35 coo 5.94 13.28 27.17 3.53 13.05 28.58 -9.64 98.32 63.33 -8.13 96.27 62.21 ULMN 3 2c7v_c10 PTERIDINE REDUCTASE user 12 3 # 12 C 14 ARG C 42 ARG.? 7.63 O MLZ C 114 C 161 ASP C 56 ASP~? 9.09 N MLZ C 114 C 174 TYR C 53 TYR~? -4.98 C18 PE8 C 148s coo 2.84 19.43 40.34 1.59 20.35 37.65 -13.55 84.90 75.42 -13.77 88.03 75.38 coo -0.62 11.10 28.05 -0.65 13.15 27.46 -16.40 94.43 66.11 -17.63 93.56 67.58 coo 5.94 13.28 27.17 3.53 13.05 28.58 -11.26 90.80 63.43 -9.63 92.35 61.80 ULMN 3 2c7v_c10 PTERIDINE REDUCTASE user 13 3 # 13 C 14 ARG C 55 ARG~? 9.18 O MLY B 135 C 161 ASP C 106 ASP~? 12.11 C21 PE8 C 148 C 174 TYR C 109 TYR~? -5.91 C14 PE8 C 148s coo 2.84 19.43 40.34 1.59 20.35 37.65 -21.06 89.68 64.73 -20.37 86.74 65.24 coo -0.62 11.10 28.05 -0.65 13.15 27.46 -11.06 103.55 63.77 -13.00 104.00 64.35 coo 5.94 13.28 27.17 3.53 13.05 28.58 -9.64 98.32 63.33 -8.13 96.27 62.21 ULMN 3 2c7v_c10 PTERIDINE REDUCTASE user 14 3 # 14 C 14 ARG C 124 ARG^? 7.92 C3 GOL C 149 C 161 ASP C 87 ASP.? 8.84 O1 PGE C 147 C 174 TYR C 50 TYR~? 5.59 CE MLY B 135 coo 2.84 19.43 40.34 1.59 20.35 37.65 2.87 85.20 55.95 3.74 82.90 57.81 coo -0.62 11.10 28.05 -0.65 13.15 27.46 -9.03 79.00 58.44 -8.21 77.39 59.55 coo 5.94 13.28 27.17 3.53 13.05 28.58 -11.27 85.65 61.91 -10.18 87.09 59.78 ULMN 3 2c7v_c10 PTERIDINE REDUCTASE user 15 3 # 15 C 14 ARG D 16 ARG~? -9.70 O1 2PE D 146s C 161 ASP D 106 ASP~? 11.82 O22 2PE D 146 C 174 TYR D 109 TYR~? -5.82 O16 2PE D 146s coo 2.84 19.43 40.34 1.59 20.35 37.65 -42.18 74.28 -4.52 -45.10 73.30 -4.28 coo -0.62 11.10 28.05 -0.65 13.15 27.46 -46.82 82.57 5.87 -48.37 83.43 7.00 coo 5.94 13.28 27.17 3.53 13.05 28.58 -41.76 82.56 7.21 -39.24 81.41 7.29 ULMN 3 2c7v_c10 PTERIDINE REDUCTASE user 16 3 # 16 C 14 ARG D 55 ARG~? 9.16 CG MLY A 135 C 161 ASP D 106 ASP~? 11.82 O22 2PE D 146 C 174 TYR D 109 TYR~? -5.82 O16 2PE D 146s coo 2.84 19.43 40.34 1.59 20.35 37.65 -39.98 89.02 19.79 -37.17 89.06 21.03 coo -0.62 11.10 28.05 -0.65 13.15 27.46 -46.82 82.57 5.87 -48.37 83.43 7.00 coo 5.94 13.28 27.17 3.53 13.05 28.58 -41.76 82.56 7.21 -39.24 81.41 7.29 ULMN 3 2c7v_c10 PTERIDINE REDUCTASE user 17 3 # 17 C 14 ARG D 124 ARG^? 7.97 C3 GOL D 147 C 161 ASP D 87 ASP.? 7.26 C16 1PE B 150 C 174 TYR D 50 TYR~? 5.61 CH1 MLY A 135 coo 2.84 19.43 40.34 1.59 20.35 37.65 -24.04 74.20 5.58 -21.67 76.16 5.44 coo -0.62 11.10 28.05 -0.65 13.15 27.46 -24.70 80.89 17.41 -22.90 81.94 17.31 coo 5.94 13.28 27.17 3.53 13.05 28.58 -31.54 83.73 14.98 -32.20 81.17 14.09 2c7v_c10 source 2c7v PTERIDINE REDUCTASE : 17 hits 2c7v_c10 naa= 3 ULMN 3 2c7v_c11 PTERIDINE REDUCTASE user 1 3 # 1 D 14 ARG A 16 ARG~? -2.82 O4 SO4 A 143s D 161 ASP A 106 ASP~? 11.93 O22 2PE A 148 D 174 TYR A 109 TYR~? -5.64 O16 2PE A 148s coo -30.56 -11.62 29.88 -27.98 -12.86 28.66 -9.29 63.37 28.06 -8.90 62.24 30.90 coo -19.83 -4.38 21.99 -19.35 -6.45 21.76 -12.71 50.36 24.83 -13.06 48.30 25.05 coo -24.51 -6.92 17.31 -23.48 -6.50 19.84 -13.81 52.60 20.09 -14.53 54.76 18.49 ULMN 3 2c7v_c11 PTERIDINE REDUCTASE user 2 3 # 2 D 14 ARG A 42 ARG.? 16.81 C11 2PE A 148 D 161 ASP A 56 ASP~? 11.59 C21 2PE A 148 D 174 TYR A 53 TYR~? -4.55 C21 2PE A 148s coo -30.56 -11.62 29.88 -27.98 -12.86 28.66 -8.57 45.71 4.07 -9.11 44.76 6.92 coo -19.83 -4.38 21.99 -19.35 -6.45 21.76 -16.01 45.89 15.64 -15.93 44.31 14.23 coo -24.51 -6.92 17.31 -23.48 -6.50 19.84 -16.76 52.42 13.05 -16.88 54.33 15.10 ULMN 3 2c7v_c11 PTERIDINE REDUCTASE user 3 3 # 3 D 14 ARG A 55 ARG~? 10.23 CD MLY D 135 D 161 ASP A 106 ASP~? 11.93 O22 2PE A 148 D 174 TYR A 109 TYR~? -5.64 O16 2PE A 148s coo -30.56 -11.62 29.88 -27.98 -12.86 28.66 -19.70 43.33 11.87 -20.69 44.07 9.04 coo -19.83 -4.38 21.99 -19.35 -6.45 21.76 -12.71 50.36 24.83 -13.06 48.30 25.05 coo -24.51 -6.92 17.31 -23.48 -6.50 19.84 -13.81 52.60 20.09 -14.53 54.76 18.49 ULMN 3 2c7v_c11 PTERIDINE REDUCTASE user 4 3 # 4 D 14 ARG A 124 ARG^? 8.18 C1 GOL A 150 D 161 ASP A 87 ASP.? 8.49 C6 PGE A 147 D 174 TYR A 50 TYR~? 5.51 CH2 MLY D 135 coo -30.56 -11.62 29.88 -27.98 -12.86 28.66 -17.35 69.10 10.18 -16.14 69.37 7.36 coo -19.83 -4.38 21.99 -19.35 -6.45 21.76 -23.17 58.67 3.55 -22.34 59.17 1.69 coo -24.51 -6.92 17.31 -23.48 -6.50 19.84 -19.50 53.98 8.67 -20.18 55.72 10.74 ULMN 3 2c7v_c11 PTERIDINE REDUCTASE user 5 3 # 5 D 14 ARG B 16 ARG~? -3.64 O1 SO4 A 143s D 161 ASP B 106 ASP~? 11.87 OH2 1PE B 150 D 174 TYR B 109 TYR~? -5.65 O13 PE8 B 148s coo -30.56 -11.62 29.88 -27.98 -12.86 28.66 -4.85 63.18 38.40 -7.23 62.95 36.44 coo -19.83 -4.38 21.99 -19.35 -6.45 21.76 -0.30 70.27 27.08 -0.10 70.78 25.05 coo -24.51 -6.92 17.31 -23.48 -6.50 19.84 2.41 73.03 30.76 2.68 74.03 33.35 ULMN 3 2c7v_c11 PTERIDINE REDUCTASE user 6 3 # 6 D 14 ARG B 35 ARG.? 9.50 O1 PEG B 144 D 161 ASP B 87 ASP.? 8.94 O4 PGE B 147 D 174 TYR B 50 TYR~? 5.52 CH1 MLY C 135 coo -30.56 -11.62 29.88 -27.98 -12.86 28.66 22.76 84.08 36.32 22.81 87.07 35.45 coo -19.83 -4.38 21.99 -19.35 -6.45 21.76 9.49 87.97 42.02 11.31 87.98 43.09 coo -24.51 -6.92 17.31 -23.48 -6.50 19.84 8.51 83.11 35.90 5.93 82.51 36.84 ULMN 3 2c7v_c11 PTERIDINE REDUCTASE user 7 3 # 7 D 14 ARG B 42 ARG.? 12.70 O1 PEG B 144 D 161 ASP B 56 ASP~? 11.45 C20 PE8 B 148 D 174 TYR B 53 TYR~? -4.63 C18 PE8 B 148s coo -30.56 -11.62 29.88 -27.98 -12.86 28.66 19.61 78.53 29.44 17.94 76.42 28.00 coo -19.83 -4.38 21.99 -19.35 -6.45 21.76 6.80 78.21 26.00 8.47 79.07 25.03 coo -24.51 -6.92 17.31 -23.48 -6.50 19.84 6.73 78.96 33.00 4.51 77.73 34.14 ULMN 3 2c7v_c11 PTERIDINE REDUCTASE user 8 3 # 8 D 14 ARG B 55 ARG~? 9.33 CG MLY C 135 D 161 ASP B 106 ASP~? 11.87 OH2 1PE B 150 D 174 TYR B 109 TYR~? -5.65 O13 PE8 B 148s coo -30.56 -11.62 29.88 -27.98 -12.86 28.66 8.78 84.29 24.99 10.39 86.20 26.77 coo -19.83 -4.38 21.99 -19.35 -6.45 21.76 -0.30 70.27 27.08 -0.10 70.78 25.05 coo -24.51 -6.92 17.31 -23.48 -6.50 19.84 2.41 73.03 30.76 2.68 74.03 33.35 ULMN 3 2c7v_c11 PTERIDINE REDUCTASE user 9 3 # 9 D 14 ARG B 124 ARG^? 8.02 O2 GOL B 149 D 161 ASP B 87 ASP.? 8.94 O4 PGE B 147 D 174 TYR B 50 TYR~? 5.52 CH1 MLY C 135 coo -30.56 -11.62 29.88 -27.98 -12.86 28.66 3.96 78.02 49.67 6.79 78.26 50.86 coo -19.83 -4.38 21.99 -19.35 -6.45 21.76 9.49 87.97 42.02 11.31 87.98 43.09 coo -24.51 -6.92 17.31 -23.48 -6.50 19.84 8.51 83.11 35.90 5.93 82.51 36.84 ULMN 3 2c7v_c11 PTERIDINE REDUCTASE user 10 3 # 10 D 14 ARG C 16 ARG~? -2.96 O3 SO4 C 143s D 161 ASP C 106 ASP~? 12.11 C21 PE8 C 148 D 174 TYR C 109 TYR~? -5.91 C14 PE8 C 148s coo -30.56 -11.62 29.88 -27.98 -12.86 28.66 1.87 105.73 59.26 1.00 108.67 58.94 coo -19.83 -4.38 21.99 -19.35 -6.45 21.76 -11.06 103.55 63.77 -13.00 104.00 64.35 coo -24.51 -6.92 17.31 -23.48 -6.50 19.84 -9.64 98.32 63.33 -8.13 96.27 62.21 ULMN 3 2c7v_c11 PTERIDINE REDUCTASE user 11 3 # 11 D 14 ARG C 42 ARG.? 7.63 O MLZ C 114 D 161 ASP C 56 ASP~? 9.09 N MLZ C 114 D 174 TYR C 53 TYR~? -4.98 C18 PE8 C 148s coo -30.56 -11.62 29.88 -27.98 -12.86 28.66 -13.55 84.90 75.42 -13.77 88.03 75.38 coo -19.83 -4.38 21.99 -19.35 -6.45 21.76 -16.40 94.43 66.11 -17.63 93.56 67.58 coo -24.51 -6.92 17.31 -23.48 -6.50 19.84 -11.26 90.80 63.43 -9.63 92.35 61.80 ULMN 3 2c7v_c11 PTERIDINE REDUCTASE user 12 3 # 12 D 14 ARG C 55 ARG~? 9.18 O MLY B 135 D 161 ASP C 106 ASP~? 12.11 C21 PE8 C 148 D 174 TYR C 109 TYR~? -5.91 C14 PE8 C 148s coo -30.56 -11.62 29.88 -27.98 -12.86 28.66 -21.06 89.68 64.73 -20.37 86.74 65.24 coo -19.83 -4.38 21.99 -19.35 -6.45 21.76 -11.06 103.55 63.77 -13.00 104.00 64.35 coo -24.51 -6.92 17.31 -23.48 -6.50 19.84 -9.64 98.32 63.33 -8.13 96.27 62.21 ULMN 3 2c7v_c11 PTERIDINE REDUCTASE user 13 3 # 13 D 14 ARG C 124 ARG^? 7.92 C3 GOL C 149 D 161 ASP C 87 ASP.? 8.84 O1 PGE C 147 D 174 TYR C 50 TYR~? 5.59 CE MLY B 135 coo -30.56 -11.62 29.88 -27.98 -12.86 28.66 2.87 85.20 55.95 3.74 82.90 57.81 coo -19.83 -4.38 21.99 -19.35 -6.45 21.76 -9.03 79.00 58.44 -8.21 77.39 59.55 coo -24.51 -6.92 17.31 -23.48 -6.50 19.84 -11.27 85.65 61.91 -10.18 87.09 59.78 ULMN 3 2c7v_c11 PTERIDINE REDUCTASE user 14 3 # 14 D 14 ARG D 16 ARG~? -9.70 O1 2PE D 146s D 161 ASP D 106 ASP~? 11.82 O22 2PE D 146 D 174 TYR D 109 TYR~? -5.82 O16 2PE D 146s coo -30.56 -11.62 29.88 -27.98 -12.86 28.66 -42.18 74.28 -4.52 -45.10 73.30 -4.28 coo -19.83 -4.38 21.99 -19.35 -6.45 21.76 -46.82 82.57 5.87 -48.37 83.43 7.00 coo -24.51 -6.92 17.31 -23.48 -6.50 19.84 -41.76 82.56 7.21 -39.24 81.41 7.29 ULMN 3 2c7v_c11 PTERIDINE REDUCTASE user 15 3 # 15 D 14 ARG D 55 ARG~? 9.16 CG MLY A 135 D 161 ASP D 106 ASP~? 11.82 O22 2PE D 146 D 174 TYR D 109 TYR~? -5.82 O16 2PE D 146s coo -30.56 -11.62 29.88 -27.98 -12.86 28.66 -39.98 89.02 19.79 -37.17 89.06 21.03 coo -19.83 -4.38 21.99 -19.35 -6.45 21.76 -46.82 82.57 5.87 -48.37 83.43 7.00 coo -24.51 -6.92 17.31 -23.48 -6.50 19.84 -41.76 82.56 7.21 -39.24 81.41 7.29 ULMN 3 2c7v_c11 PTERIDINE REDUCTASE user 16 3 # 16 D 14 ARG D 124 ARG^? 7.97 C3 GOL D 147 D 161 ASP D 87 ASP.? 7.26 C16 1PE B 150 D 174 TYR D 50 TYR~? 5.61 CH1 MLY A 135 coo -30.56 -11.62 29.88 -27.98 -12.86 28.66 -24.04 74.20 5.58 -21.67 76.16 5.44 coo -19.83 -4.38 21.99 -19.35 -6.45 21.76 -24.70 80.89 17.41 -22.90 81.94 17.31 coo -24.51 -6.92 17.31 -23.48 -6.50 19.84 -31.54 83.73 14.98 -32.20 81.17 14.09 2c7v_c11 source 2c7v PTERIDINE REDUCTASE : 16 hits 2c7v_c11 naa= 3 ULMN 3 2dbt_c00 CHITINASE C user 1 3 # 1 A 147 GLU A 84 GLU.? 10.45 C3 GOL D 147 A 156 GLU A 121 GLU^? 12.41 C1 GOL A 150 A 194 ASN A 28 ASN^? 3.50 CL CL A 145s coo 74.14 15.91 8.55 72.08 15.36 8.63 -21.01 70.22 3.12 -21.10 71.95 4.30 coo 67.47 20.07 1.34 65.99 20.06 2.88 -13.98 61.53 0.93 -15.14 61.60 -0.79 coo 67.44 25.26 13.91 67.54 23.65 15.28 -22.13 61.51 13.69 -20.95 60.87 15.35 ULMN 3 2dbt_c00 CHITINASE C user 2 3 # 2 A 147 GLU A 84 GLU.? 10.45 C3 GOL D 147 A 156 GLU D 84 GLU.? 10.79 C1 GOL A 150 A 194 ASN A 28 ASN^? 3.50 CL CL A 145s coo 74.14 15.91 8.55 72.08 15.36 8.63 -21.01 70.22 3.12 -21.10 71.95 4.30 coo 67.47 20.07 1.34 65.99 20.06 2.88 -17.40 74.78 10.23 -17.69 72.96 9.24 coo 67.44 25.26 13.91 67.54 23.65 15.28 -22.13 61.51 13.69 -20.95 60.87 15.35 ULMN 3 2dbt_c00 CHITINASE C user 3 3 # 3 A 147 GLU A 84 GLU.? 10.45 C3 GOL D 147 A 156 GLU D 84 GLU.? 10.79 C1 GOL A 150 A 194 ASN D 28 ASN^? 3.51 CL CL D 143s coo 74.14 15.91 8.55 72.08 15.36 8.63 -21.01 70.22 3.12 -21.10 71.95 4.30 coo 67.47 20.07 1.34 65.99 20.06 2.88 -17.40 74.78 10.23 -17.69 72.96 9.24 coo 67.44 25.26 13.91 67.54 23.65 15.28 -31.24 74.87 11.89 -33.01 75.13 10.75 ULMN 3 2dbt_c00 CHITINASE C user 4 3 # 4 A 147 GLU B 62 GLU~? 5.14 OH2 1PE B 150 A 156 GLU B 93 GLU^? 4.01 CE MLZ B 67 A 194 ASN A 18 ASN~? 7.05 CM MLZ A 129 coo 74.14 15.91 8.55 72.08 15.36 8.63 -5.99 81.74 25.38 -5.29 83.68 24.76 coo 67.47 20.07 1.34 65.99 20.06 2.88 -11.20 80.89 36.50 -12.93 82.08 36.76 coo 67.44 25.26 13.91 67.54 23.65 15.28 -15.51 71.08 28.46 -17.41 71.81 28.97 ULMN 3 2dbt_c00 CHITINASE C user 5 3 # 5 A 147 GLU B 84 GLU.? 10.31 O3 GOL C 149 A 156 GLU B 121 GLU^? 8.74 O2 PEG B 144 A 194 ASN B 28 ASN^? 3.43 CL CL B 143s coo 74.14 15.91 8.55 72.08 15.36 8.63 7.66 84.31 53.13 6.13 83.49 54.35 coo 67.47 20.07 1.34 65.99 20.06 2.88 15.37 80.83 45.64 16.23 82.69 46.15 coo 67.44 25.26 13.91 67.54 23.65 15.28 0.96 81.77 41.38 0.26 80.18 40.18 ULMN 3 2dbt_c00 CHITINASE C user 6 3 # 6 A 147 GLU B 84 GLU.? 10.31 O3 GOL C 149 A 156 GLU C 84 GLU.? 10.77 O2 GOL B 149 A 194 ASN B 28 ASN^? 3.43 CL CL B 143s coo 74.14 15.91 8.55 72.08 15.36 8.63 7.66 84.31 53.13 6.13 83.49 54.35 coo 67.47 20.07 1.34 65.99 20.06 2.88 2.34 77.12 55.01 3.46 78.21 53.60 coo 67.44 25.26 13.91 67.54 23.65 15.28 0.96 81.77 41.38 0.26 80.18 40.18 ULMN 3 2dbt_c00 CHITINASE C user 7 3 # 7 A 147 GLU B 84 GLU.? 10.31 O3 GOL C 149 A 156 GLU C 84 GLU.? 10.77 O2 GOL B 149 A 194 ASN C 28 ASN^? 3.42 CL CL C 144s coo 74.14 15.91 8.55 72.08 15.36 8.63 7.66 84.31 53.13 6.13 83.49 54.35 coo 67.47 20.07 1.34 65.99 20.06 2.88 2.34 77.12 55.01 3.46 78.21 53.60 coo 67.44 25.26 13.91 67.54 23.65 15.28 -6.06 88.35 54.50 -6.05 90.38 55.16 ULMN 3 2dbt_c00 CHITINASE C user 8 3 # 8 A 147 GLU B 93 GLU^? 4.01 CE MLZ B 67 A 156 GLU B 62 GLU~? 5.14 OH2 1PE B 150 A 194 ASN A 18 ASN~? 7.05 CM MLZ A 129 coo 74.14 15.91 8.55 72.08 15.36 8.63 -11.20 80.89 36.50 -12.93 82.08 36.76 coo 67.47 20.07 1.34 65.99 20.06 2.88 -5.99 81.74 25.38 -5.29 83.68 24.76 coo 67.44 25.26 13.91 67.54 23.65 15.28 -15.51 71.08 28.46 -17.41 71.81 28.97 ULMN 3 2dbt_c00 CHITINASE C user 9 3 # 9 A 147 GLU C 84 GLU.? 10.77 O2 GOL B 149 A 156 GLU B 84 GLU.? 10.31 O3 GOL C 149 A 194 ASN B 28 ASN^? 3.43 CL CL B 143s coo 74.14 15.91 8.55 72.08 15.36 8.63 2.34 77.12 55.01 3.46 78.21 53.60 coo 67.47 20.07 1.34 65.99 20.06 2.88 7.66 84.31 53.13 6.13 83.49 54.35 coo 67.44 25.26 13.91 67.54 23.65 15.28 0.96 81.77 41.38 0.26 80.18 40.18 ULMN 3 2dbt_c00 CHITINASE C user 10 3 # 10 A 147 GLU C 84 GLU.? 10.77 O2 GOL B 149 A 156 GLU B 84 GLU.? 10.31 O3 GOL C 149 A 194 ASN C 28 ASN^? 3.42 CL CL C 144s coo 74.14 15.91 8.55 72.08 15.36 8.63 2.34 77.12 55.01 3.46 78.21 53.60 coo 67.47 20.07 1.34 65.99 20.06 2.88 7.66 84.31 53.13 6.13 83.49 54.35 coo 67.44 25.26 13.91 67.54 23.65 15.28 -6.06 88.35 54.50 -6.05 90.38 55.16 ULMN 3 2dbt_c00 CHITINASE C user 11 3 # 11 A 147 GLU C 84 GLU.? 10.77 O2 GOL B 149 A 156 GLU C 121 GLU^? 12.40 C3 GOL C 149 A 194 ASN C 28 ASN^? 3.42 CL CL C 144s coo 74.14 15.91 8.55 72.08 15.36 8.63 2.34 77.12 55.01 3.46 78.21 53.60 coo 67.47 20.07 1.34 65.99 20.06 2.88 -1.98 78.69 65.48 -2.54 76.71 65.06 coo 67.44 25.26 13.91 67.54 23.65 15.28 -6.06 88.35 54.50 -6.05 90.38 55.16 ULMN 3 2dbt_c00 CHITINASE C user 12 3 # 12 A 147 GLU D 84 GLU.? 10.79 C1 GOL A 150 A 156 GLU A 84 GLU.? 10.45 C3 GOL D 147 A 194 ASN A 28 ASN^? 3.50 CL CL A 145s coo 74.14 15.91 8.55 72.08 15.36 8.63 -17.40 74.78 10.23 -17.69 72.96 9.24 coo 67.47 20.07 1.34 65.99 20.06 2.88 -21.01 70.22 3.12 -21.10 71.95 4.30 coo 67.44 25.26 13.91 67.54 23.65 15.28 -22.13 61.51 13.69 -20.95 60.87 15.35 ULMN 3 2dbt_c00 CHITINASE C user 13 3 # 13 A 147 GLU D 84 GLU.? 10.79 C1 GOL A 150 A 156 GLU A 84 GLU.? 10.45 C3 GOL D 147 A 194 ASN D 28 ASN^? 3.51 CL CL D 143s coo 74.14 15.91 8.55 72.08 15.36 8.63 -17.40 74.78 10.23 -17.69 72.96 9.24 coo 67.47 20.07 1.34 65.99 20.06 2.88 -21.01 70.22 3.12 -21.10 71.95 4.30 coo 67.44 25.26 13.91 67.54 23.65 15.28 -31.24 74.87 11.89 -33.01 75.13 10.75 ULMN 3 2dbt_c00 CHITINASE C user 14 3 # 14 A 147 GLU D 84 GLU.? 10.79 C1 GOL A 150 A 156 GLU D 121 GLU^? 11.70 OH7 1PE B 150 A 194 ASN D 28 ASN^? 3.51 CL CL D 143s coo 74.14 15.91 8.55 72.08 15.36 8.63 -17.40 74.78 10.23 -17.69 72.96 9.24 coo 67.47 20.07 1.34 65.99 20.06 2.88 -20.91 85.61 9.48 -19.44 85.70 10.98 coo 67.44 25.26 13.91 67.54 23.65 15.28 -31.24 74.87 11.89 -33.01 75.13 10.75 2dbt_c00 source 2dbt CHITINASE C : 14 hits 2dbt_c00 naa= 3 ULMN 3 2dbt_c01 CHITINASE C user 1 3 # 1 B 147 GLU A 84 GLU.? 10.45 C3 GOL D 147 B 156 GLU A 121 GLU^? 12.41 C1 GOL A 150 B 194 ASN A 28 ASN^? 3.50 CL CL A 145s coo 45.64 63.11 17.20 47.48 62.43 16.45 -21.01 70.22 3.12 -21.10 71.95 4.30 coo 54.43 67.89 19.82 55.62 67.90 18.07 -13.98 61.53 0.93 -15.14 61.60 -0.79 coo 49.79 70.75 7.78 50.10 68.90 6.86 -22.13 61.51 13.69 -20.95 60.87 15.35 ULMN 3 2dbt_c01 CHITINASE C user 2 3 # 2 B 147 GLU A 84 GLU.? 10.45 C3 GOL D 147 B 156 GLU D 84 GLU.? 10.79 C1 GOL A 150 B 194 ASN A 28 ASN^? 3.50 CL CL A 145s coo 45.64 63.11 17.20 47.48 62.43 16.45 -21.01 70.22 3.12 -21.10 71.95 4.30 coo 54.43 67.89 19.82 55.62 67.90 18.07 -17.40 74.78 10.23 -17.69 72.96 9.24 coo 49.79 70.75 7.78 50.10 68.90 6.86 -22.13 61.51 13.69 -20.95 60.87 15.35 ULMN 3 2dbt_c01 CHITINASE C user 3 3 # 3 B 147 GLU A 84 GLU.? 10.45 C3 GOL D 147 B 156 GLU D 84 GLU.? 10.79 C1 GOL A 150 B 194 ASN D 28 ASN^? 3.51 CL CL D 143s coo 45.64 63.11 17.20 47.48 62.43 16.45 -21.01 70.22 3.12 -21.10 71.95 4.30 coo 54.43 67.89 19.82 55.62 67.90 18.07 -17.40 74.78 10.23 -17.69 72.96 9.24 coo 49.79 70.75 7.78 50.10 68.90 6.86 -31.24 74.87 11.89 -33.01 75.13 10.75 ULMN 3 2dbt_c01 CHITINASE C user 4 3 # 4 B 147 GLU B 84 GLU.? 10.31 O3 GOL C 149 B 156 GLU B 121 GLU^? 8.74 O2 PEG B 144 B 194 ASN B 28 ASN^? 3.43 CL CL B 143s coo 45.64 63.11 17.20 47.48 62.43 16.45 7.66 84.31 53.13 6.13 83.49 54.35 coo 54.43 67.89 19.82 55.62 67.90 18.07 15.37 80.83 45.64 16.23 82.69 46.15 coo 49.79 70.75 7.78 50.10 68.90 6.86 0.96 81.77 41.38 0.26 80.18 40.18 ULMN 3 2dbt_c01 CHITINASE C user 5 3 # 5 B 147 GLU B 84 GLU.? 10.31 O3 GOL C 149 B 156 GLU C 84 GLU.? 10.77 O2 GOL B 149 B 194 ASN B 28 ASN^? 3.43 CL CL B 143s coo 45.64 63.11 17.20 47.48 62.43 16.45 7.66 84.31 53.13 6.13 83.49 54.35 coo 54.43 67.89 19.82 55.62 67.90 18.07 2.34 77.12 55.01 3.46 78.21 53.60 coo 49.79 70.75 7.78 50.10 68.90 6.86 0.96 81.77 41.38 0.26 80.18 40.18 ULMN 3 2dbt_c01 CHITINASE C user 6 3 # 6 B 147 GLU B 84 GLU.? 10.31 O3 GOL C 149 B 156 GLU C 84 GLU.? 10.77 O2 GOL B 149 B 194 ASN C 28 ASN^? 3.42 CL CL C 144s coo 45.64 63.11 17.20 47.48 62.43 16.45 7.66 84.31 53.13 6.13 83.49 54.35 coo 54.43 67.89 19.82 55.62 67.90 18.07 2.34 77.12 55.01 3.46 78.21 53.60 coo 49.79 70.75 7.78 50.10 68.90 6.86 -6.06 88.35 54.50 -6.05 90.38 55.16 ULMN 3 2dbt_c01 CHITINASE C user 7 3 # 7 B 147 GLU C 84 GLU.? 10.77 O2 GOL B 149 B 156 GLU B 84 GLU.? 10.31 O3 GOL C 149 B 194 ASN B 28 ASN^? 3.43 CL CL B 143s coo 45.64 63.11 17.20 47.48 62.43 16.45 2.34 77.12 55.01 3.46 78.21 53.60 coo 54.43 67.89 19.82 55.62 67.90 18.07 7.66 84.31 53.13 6.13 83.49 54.35 coo 49.79 70.75 7.78 50.10 68.90 6.86 0.96 81.77 41.38 0.26 80.18 40.18 ULMN 3 2dbt_c01 CHITINASE C user 8 3 # 8 B 147 GLU C 84 GLU.? 10.77 O2 GOL B 149 B 156 GLU B 84 GLU.? 10.31 O3 GOL C 149 B 194 ASN C 28 ASN^? 3.42 CL CL C 144s coo 45.64 63.11 17.20 47.48 62.43 16.45 2.34 77.12 55.01 3.46 78.21 53.60 coo 54.43 67.89 19.82 55.62 67.90 18.07 7.66 84.31 53.13 6.13 83.49 54.35 coo 49.79 70.75 7.78 50.10 68.90 6.86 -6.06 88.35 54.50 -6.05 90.38 55.16 ULMN 3 2dbt_c01 CHITINASE C user 9 3 # 9 B 147 GLU C 84 GLU.? 10.77 O2 GOL B 149 B 156 GLU C 121 GLU^? 12.40 C3 GOL C 149 B 194 ASN C 28 ASN^? 3.42 CL CL C 144s coo 45.64 63.11 17.20 47.48 62.43 16.45 2.34 77.12 55.01 3.46 78.21 53.60 coo 54.43 67.89 19.82 55.62 67.90 18.07 -1.98 78.69 65.48 -2.54 76.71 65.06 coo 49.79 70.75 7.78 50.10 68.90 6.86 -6.06 88.35 54.50 -6.05 90.38 55.16 ULMN 3 2dbt_c01 CHITINASE C user 10 3 # 10 B 147 GLU D 84 GLU.? 10.79 C1 GOL A 150 B 156 GLU A 84 GLU.? 10.45 C3 GOL D 147 B 194 ASN A 28 ASN^? 3.50 CL CL A 145s coo 45.64 63.11 17.20 47.48 62.43 16.45 -17.40 74.78 10.23 -17.69 72.96 9.24 coo 54.43 67.89 19.82 55.62 67.90 18.07 -21.01 70.22 3.12 -21.10 71.95 4.30 coo 49.79 70.75 7.78 50.10 68.90 6.86 -22.13 61.51 13.69 -20.95 60.87 15.35 ULMN 3 2dbt_c01 CHITINASE C user 11 3 # 11 B 147 GLU D 84 GLU.? 10.79 C1 GOL A 150 B 156 GLU A 84 GLU.? 10.45 C3 GOL D 147 B 194 ASN D 28 ASN^? 3.51 CL CL D 143s coo 45.64 63.11 17.20 47.48 62.43 16.45 -17.40 74.78 10.23 -17.69 72.96 9.24 coo 54.43 67.89 19.82 55.62 67.90 18.07 -21.01 70.22 3.12 -21.10 71.95 4.30 coo 49.79 70.75 7.78 50.10 68.90 6.86 -31.24 74.87 11.89 -33.01 75.13 10.75 ULMN 3 2dbt_c01 CHITINASE C user 12 3 # 12 B 147 GLU D 84 GLU.? 10.79 C1 GOL A 150 B 156 GLU D 121 GLU^? 11.70 OH7 1PE B 150 B 194 ASN D 28 ASN^? 3.51 CL CL D 143s coo 45.64 63.11 17.20 47.48 62.43 16.45 -17.40 74.78 10.23 -17.69 72.96 9.24 coo 54.43 67.89 19.82 55.62 67.90 18.07 -20.91 85.61 9.48 -19.44 85.70 10.98 coo 49.79 70.75 7.78 50.10 68.90 6.86 -31.24 74.87 11.89 -33.01 75.13 10.75 2dbt_c01 source 2dbt CHITINASE C : 12 hits 2dbt_c01 naa= 3 ULMN 3 2dbt_c02 CHITINASE C user 1 3 # 1 C 147 GLU A 84 GLU.? 10.45 C3 GOL D 147 C 156 GLU A 121 GLU^? 12.41 C1 GOL A 150 C 194 ASN A 28 ASN^? 3.50 CL CL A 145s coo 41.23 29.31 13.28 43.03 29.85 12.29 -21.01 70.22 3.12 -21.10 71.95 4.30 coo 44.75 23.09 5.51 46.77 22.91 6.12 -13.98 61.53 0.93 -15.14 61.60 -0.79 coo 49.75 21.00 18.12 50.45 23.02 18.26 -22.13 61.51 13.69 -20.95 60.87 15.35 ULMN 3 2dbt_c02 CHITINASE C user 2 3 # 2 C 147 GLU A 84 GLU.? 10.45 C3 GOL D 147 C 156 GLU D 84 GLU.? 10.79 C1 GOL A 150 C 194 ASN A 28 ASN^? 3.50 CL CL A 145s coo 41.23 29.31 13.28 43.03 29.85 12.29 -21.01 70.22 3.12 -21.10 71.95 4.30 coo 44.75 23.09 5.51 46.77 22.91 6.12 -17.40 74.78 10.23 -17.69 72.96 9.24 coo 49.75 21.00 18.12 50.45 23.02 18.26 -22.13 61.51 13.69 -20.95 60.87 15.35 ULMN 3 2dbt_c02 CHITINASE C user 3 3 # 3 C 147 GLU A 84 GLU.? 10.45 C3 GOL D 147 C 156 GLU D 84 GLU.? 10.79 C1 GOL A 150 C 194 ASN D 28 ASN^? 3.51 CL CL D 143s coo 41.23 29.31 13.28 43.03 29.85 12.29 -21.01 70.22 3.12 -21.10 71.95 4.30 coo 44.75 23.09 5.51 46.77 22.91 6.12 -17.40 74.78 10.23 -17.69 72.96 9.24 coo 49.75 21.00 18.12 50.45 23.02 18.26 -31.24 74.87 11.89 -33.01 75.13 10.75 ULMN 3 2dbt_c02 CHITINASE C user 4 3 # 4 C 147 GLU B 62 GLU~? 5.14 OH2 1PE B 150 C 156 GLU B 93 GLU^? 4.01 CE MLZ B 67 C 194 ASN A 18 ASN~? 7.05 CM MLZ A 129 coo 41.23 29.31 13.28 43.03 29.85 12.29 -5.99 81.74 25.38 -5.29 83.68 24.76 coo 44.75 23.09 5.51 46.77 22.91 6.12 -11.20 80.89 36.50 -12.93 82.08 36.76 coo 49.75 21.00 18.12 50.45 23.02 18.26 -15.51 71.08 28.46 -17.41 71.81 28.97 ULMN 3 2dbt_c02 CHITINASE C user 5 3 # 5 C 147 GLU B 84 GLU.? 10.31 O3 GOL C 149 C 156 GLU B 121 GLU^? 8.74 O2 PEG B 144 C 194 ASN B 28 ASN^? 3.43 CL CL B 143s coo 41.23 29.31 13.28 43.03 29.85 12.29 7.66 84.31 53.13 6.13 83.49 54.35 coo 44.75 23.09 5.51 46.77 22.91 6.12 15.37 80.83 45.64 16.23 82.69 46.15 coo 49.75 21.00 18.12 50.45 23.02 18.26 0.96 81.77 41.38 0.26 80.18 40.18 ULMN 3 2dbt_c02 CHITINASE C user 6 3 # 6 C 147 GLU B 84 GLU.? 10.31 O3 GOL C 149 C 156 GLU C 84 GLU.? 10.77 O2 GOL B 149 C 194 ASN B 28 ASN^? 3.43 CL CL B 143s coo 41.23 29.31 13.28 43.03 29.85 12.29 7.66 84.31 53.13 6.13 83.49 54.35 coo 44.75 23.09 5.51 46.77 22.91 6.12 2.34 77.12 55.01 3.46 78.21 53.60 coo 49.75 21.00 18.12 50.45 23.02 18.26 0.96 81.77 41.38 0.26 80.18 40.18 ULMN 3 2dbt_c02 CHITINASE C user 7 3 # 7 C 147 GLU B 84 GLU.? 10.31 O3 GOL C 149 C 156 GLU C 84 GLU.? 10.77 O2 GOL B 149 C 194 ASN C 28 ASN^? 3.42 CL CL C 144s coo 41.23 29.31 13.28 43.03 29.85 12.29 7.66 84.31 53.13 6.13 83.49 54.35 coo 44.75 23.09 5.51 46.77 22.91 6.12 2.34 77.12 55.01 3.46 78.21 53.60 coo 49.75 21.00 18.12 50.45 23.02 18.26 -6.06 88.35 54.50 -6.05 90.38 55.16 ULMN 3 2dbt_c02 CHITINASE C user 8 3 # 8 C 147 GLU B 93 GLU^? 4.01 CE MLZ B 67 C 156 GLU B 62 GLU~? 5.14 OH2 1PE B 150 C 194 ASN A 18 ASN~? 7.05 CM MLZ A 129 coo 41.23 29.31 13.28 43.03 29.85 12.29 -11.20 80.89 36.50 -12.93 82.08 36.76 coo 44.75 23.09 5.51 46.77 22.91 6.12 -5.99 81.74 25.38 -5.29 83.68 24.76 coo 49.75 21.00 18.12 50.45 23.02 18.26 -15.51 71.08 28.46 -17.41 71.81 28.97 ULMN 3 2dbt_c02 CHITINASE C user 9 3 # 9 C 147 GLU C 84 GLU.? 10.77 O2 GOL B 149 C 156 GLU B 84 GLU.? 10.31 O3 GOL C 149 C 194 ASN B 28 ASN^? 3.43 CL CL B 143s coo 41.23 29.31 13.28 43.03 29.85 12.29 2.34 77.12 55.01 3.46 78.21 53.60 coo 44.75 23.09 5.51 46.77 22.91 6.12 7.66 84.31 53.13 6.13 83.49 54.35 coo 49.75 21.00 18.12 50.45 23.02 18.26 0.96 81.77 41.38 0.26 80.18 40.18 ULMN 3 2dbt_c02 CHITINASE C user 10 3 # 10 C 147 GLU C 84 GLU.? 10.77 O2 GOL B 149 C 156 GLU B 84 GLU.? 10.31 O3 GOL C 149 C 194 ASN C 28 ASN^? 3.42 CL CL C 144s coo 41.23 29.31 13.28 43.03 29.85 12.29 2.34 77.12 55.01 3.46 78.21 53.60 coo 44.75 23.09 5.51 46.77 22.91 6.12 7.66 84.31 53.13 6.13 83.49 54.35 coo 49.75 21.00 18.12 50.45 23.02 18.26 -6.06 88.35 54.50 -6.05 90.38 55.16 ULMN 3 2dbt_c02 CHITINASE C user 11 3 # 11 C 147 GLU C 84 GLU.? 10.77 O2 GOL B 149 C 156 GLU C 121 GLU^? 12.40 C3 GOL C 149 C 194 ASN C 28 ASN^? 3.42 CL CL C 144s coo 41.23 29.31 13.28 43.03 29.85 12.29 2.34 77.12 55.01 3.46 78.21 53.60 coo 44.75 23.09 5.51 46.77 22.91 6.12 -1.98 78.69 65.48 -2.54 76.71 65.06 coo 49.75 21.00 18.12 50.45 23.02 18.26 -6.06 88.35 54.50 -6.05 90.38 55.16 ULMN 3 2dbt_c02 CHITINASE C user 12 3 # 12 C 147 GLU D 84 GLU.? 10.79 C1 GOL A 150 C 156 GLU A 84 GLU.? 10.45 C3 GOL D 147 C 194 ASN A 28 ASN^? 3.50 CL CL A 145s coo 41.23 29.31 13.28 43.03 29.85 12.29 -17.40 74.78 10.23 -17.69 72.96 9.24 coo 44.75 23.09 5.51 46.77 22.91 6.12 -21.01 70.22 3.12 -21.10 71.95 4.30 coo 49.75 21.00 18.12 50.45 23.02 18.26 -22.13 61.51 13.69 -20.95 60.87 15.35 ULMN 3 2dbt_c02 CHITINASE C user 13 3 # 13 C 147 GLU D 84 GLU.? 10.79 C1 GOL A 150 C 156 GLU A 84 GLU.? 10.45 C3 GOL D 147 C 194 ASN D 28 ASN^? 3.51 CL CL D 143s coo 41.23 29.31 13.28 43.03 29.85 12.29 -17.40 74.78 10.23 -17.69 72.96 9.24 coo 44.75 23.09 5.51 46.77 22.91 6.12 -21.01 70.22 3.12 -21.10 71.95 4.30 coo 49.75 21.00 18.12 50.45 23.02 18.26 -31.24 74.87 11.89 -33.01 75.13 10.75 ULMN 3 2dbt_c02 CHITINASE C user 14 3 # 14 C 147 GLU D 84 GLU.? 10.79 C1 GOL A 150 C 156 GLU D 121 GLU^? 11.70 OH7 1PE B 150 C 194 ASN D 28 ASN^? 3.51 CL CL D 143s coo 41.23 29.31 13.28 43.03 29.85 12.29 -17.40 74.78 10.23 -17.69 72.96 9.24 coo 44.75 23.09 5.51 46.77 22.91 6.12 -20.91 85.61 9.48 -19.44 85.70 10.98 coo 49.75 21.00 18.12 50.45 23.02 18.26 -31.24 74.87 11.89 -33.01 75.13 10.75 2dbt_c02 source 2dbt CHITINASE C : 14 hits 2dbt_c02 naa= 3 ULMN 3 2gsa_c04 GLUTAMATE SEMIALDEHYDE AMINOTRANSFERuser 1 3 # 1 A 157 PHE A 12 PHE~? 4.69 O4 2PE A 148 A 245 ASP A 6 ASP.? -3.91 C9 2PE A 148s A 273 LYS A 114 LYS~? 11.27 C9 2PE A 148 coo 9.49 9.24 -34.27 7.12 7.86 -33.75 -9.56 63.64 22.60 -10.98 61.59 23.81 coo 1.75 12.92 -36.29 2.66 14.31 -34.97 -8.66 61.41 13.34 -8.76 59.35 12.80 coo -0.09 22.51 -29.56 4.47 22.51 -33.59 -9.49 51.50 12.13 -4.59 48.44 14.69 ULMN 3 2gsa_c04 GLUTAMATE SEMIALDEHYDE AMINOTRANSFERuser 2 3 # 2 A 157 PHE A 100 PHE~? 5.47 CL CL A 145 A 245 ASP A 106 ASP~? 11.93 O22 2PE A 148 A 273 LYS A 114 LYS~? 11.27 C9 2PE A 148 coo 9.49 9.24 -34.27 7.12 7.86 -33.75 -17.05 60.16 23.87 -16.37 60.41 21.18 coo 1.75 12.92 -36.29 2.66 14.31 -34.97 -12.71 50.36 24.83 -13.06 48.30 25.05 coo -0.09 22.51 -29.56 4.47 22.51 -33.59 -9.49 51.50 12.13 -4.59 48.44 14.69 ULMN 3 2gsa_c04 GLUTAMATE SEMIALDEHYDE AMINOTRANSFERuser 3 3 # 3 A 157 PHE B 12 PHE~? 4.57 O1 PE8 B 148 A 245 ASP B 6 ASP.? -3.99 C6 PE8 B 148s A 273 LYS B 114 LYS~? 11.34 O7 PE8 B 148 coo 9.49 9.24 -34.27 7.12 7.86 -33.75 -0.75 66.38 40.39 -1.89 67.28 38.03 coo 1.75 12.92 -36.29 2.66 14.31 -34.97 7.95 70.39 41.39 8.88 71.08 39.61 coo -0.09 22.51 -29.56 4.47 22.51 -33.59 11.35 73.22 32.47 12.65 68.43 28.61 ULMN 3 2gsa_c04 GLUTAMATE SEMIALDEHYDE AMINOTRANSFERuser 4 3 # 4 A 157 PHE D 12 PHE~? 4.72 C2 2PE D 146 A 245 ASP D 6 ASP.? -3.77 C8 2PE D 146s A 273 LYS D 114 LYS~? 10.81 C9 2PE D 146 coo 9.49 9.24 -34.27 7.12 7.86 -33.75 -37.40 76.40 -2.23 -39.62 76.38 -0.57 coo 1.75 12.92 -36.29 2.66 14.31 -34.97 -31.03 82.87 1.04 -31.83 84.41 2.29 coo -0.09 22.51 -29.56 4.47 22.51 -33.59 -35.88 89.56 6.78 -39.69 93.33 3.49 2gsa_c04 source 2gsa GLUTAMATE SEMIALDEHYDE AMINOTRANSFERASE : 4 hits 2gsa_c04 naa= 3 ULMN 3 2jxr_c04 LIGAND CP-081282 user 1 3 # 1 A 32 ASP A 19 ASP.? -3.59 O4 SO4 A 144s A 35 SER B 96 SER~? 7.21 O4 SO4 A 144 A 215 ASP B 19 ASP.? -3.77 O3 SO4 A 144s coo -14.00 61.45 43.99 -14.19 63.14 42.84 -15.01 66.98 32.71 -14.52 68.02 34.44 coo -13.21 66.21 45.84 -15.49 65.90 45.84 -12.28 72.78 35.88 -11.90 71.42 33.88 coo -10.72 64.19 37.77 -12.20 64.43 39.15 -12.63 65.75 40.21 -14.11 64.30 40.60 2jxr_c04 source 2jxr LIGAND CP-081282 : 1 hits 2jxr_c04 naa= 3 ULMN 3 2lpr_c02 ALPHA-LYTIC PROTEASE user 1 3 # 1 A 57 HIS A 88 HIS^? 4.20 CH2 MLY D 135 A 102 ASP A 87 ASP.? 8.49 C6 PGE A 147 A 193 GLY A 54 GLY~? 5.80 C21 2PE A 148 coo 14.96 29.22 19.55 15.62 29.93 17.67 -23.95 56.87 7.77 -24.14 54.98 6.86 coo 19.64 30.69 22.61 18.18 29.94 21.25 -23.17 58.67 3.55 -22.34 59.17 1.69 coo 14.54 28.99 9.76 15.06 29.59 10.02 -20.41 50.07 13.76 -19.88 49.43 13.69 ULMN 3 2lpr_c02 ALPHA-LYTIC PROTEASE user 2 3 # 2 A 57 HIS A 88 HIS^? 4.20 CH2 MLY D 135 A 102 ASP A 87 ASP.? 8.49 C6 PGE A 147 A 193 GLY D 134 GLY.? 2.47 N MLY D 135 coo 14.96 29.22 19.55 15.62 29.93 17.67 -23.95 56.87 7.77 -24.14 54.98 6.86 coo 19.64 30.69 22.61 18.18 29.94 21.25 -23.17 58.67 3.55 -22.34 59.17 1.69 coo 14.54 28.99 9.76 15.06 29.59 10.02 -31.46 51.06 14.18 -31.60 51.74 13.54 ULMN 3 2lpr_c02 ALPHA-LYTIC PROTEASE user 3 3 # 3 A 57 HIS A 115 HIS~? 12.27 C21 2PE A 148 A 102 ASP A 56 ASP~? 11.59 C21 2PE A 148 A 193 GLY A 46 GLY~? 12.01 CD MLY D 135 coo 14.96 29.22 19.55 15.62 29.93 17.67 -13.18 48.35 10.37 -12.55 46.36 10.33 coo 19.64 30.69 22.61 18.18 29.94 21.25 -16.01 45.89 15.64 -15.93 44.31 14.23 coo 14.54 28.99 9.76 15.06 29.59 10.02 -16.75 52.82 2.36 -17.28 52.20 2.20 ULMN 3 2lpr_c02 ALPHA-LYTIC PROTEASE user 4 3 # 4 A 57 HIS B 88 HIS^? 4.29 CH1 MLY C 135 A 102 ASP B 87 ASP.? 8.94 O4 PGE B 147 A 193 GLY B 54 GLY~? 5.68 C20 PE8 B 148 coo 14.96 29.22 19.55 15.62 29.93 17.67 6.15 87.00 38.94 7.35 87.96 37.51 coo 19.64 30.69 22.61 18.18 29.94 21.25 9.49 87.97 42.02 11.31 87.98 43.09 coo 14.54 28.99 9.76 15.06 29.59 10.02 5.02 82.24 30.45 5.51 81.90 29.87 ULMN 3 2lpr_c02 ALPHA-LYTIC PROTEASE user 5 3 # 5 A 57 HIS B 88 HIS^? 4.29 CH1 MLY C 135 A 102 ASP B 87 ASP.? 8.94 O4 PGE B 147 A 193 GLY C 134 GLY.? 2.48 N MLY C 135 coo 14.96 29.22 19.55 15.62 29.93 17.67 6.15 87.00 38.94 7.35 87.96 37.51 coo 19.64 30.69 22.61 18.18 29.94 21.25 9.49 87.97 42.02 11.31 87.98 43.09 coo 14.54 28.99 9.76 15.06 29.59 10.02 -1.36 91.26 31.44 -1.10 91.64 32.26 ULMN 3 2lpr_c02 ALPHA-LYTIC PROTEASE user 6 3 # 6 A 57 HIS B 115 HIS~? 12.48 C18 PE8 B 148 A 102 ASP B 56 ASP~? 11.45 C20 PE8 B 148 A 193 GLY B 46 GLY~? 9.70 O1 PEG B 144 coo 14.96 29.22 19.55 15.62 29.93 17.67 11.86 77.76 30.05 12.70 77.49 28.15 coo 19.64 30.69 22.61 18.18 29.94 21.25 6.80 78.21 26.00 8.47 79.07 25.03 coo 14.54 28.99 9.76 15.06 29.59 10.02 15.35 83.93 36.97 15.42 84.55 36.41 ULMN 3 2lpr_c02 ALPHA-LYTIC PROTEASE user 7 3 # 7 A 57 HIS C 88 HIS^? 3.86 CD MLY B 135 A 102 ASP C 87 ASP.? 8.84 O1 PGE C 147 A 193 GLY B 134 GLY.? 2.46 N MLY B 135 coo 14.96 29.22 19.55 15.62 29.93 17.67 -11.00 83.03 57.18 -12.69 82.43 58.26 coo 19.64 30.69 22.61 18.18 29.94 21.25 -9.03 79.00 58.44 -8.21 77.39 59.55 coo 14.54 28.99 9.76 15.06 29.59 10.02 -19.59 87.32 51.84 -18.97 86.72 51.66 ULMN 3 2lpr_c02 ALPHA-LYTIC PROTEASE user 8 3 # 8 A 57 HIS C 88 HIS^? 3.86 CD MLY B 135 A 102 ASP C 87 ASP.? 8.84 O1 PGE C 147 A 193 GLY C 54 GLY~? 6.00 CH2 MLY B 135 coo 14.96 29.22 19.55 15.62 29.93 17.67 -11.00 83.03 57.18 -12.69 82.43 58.26 coo 19.64 30.69 22.61 18.18 29.94 21.25 -9.03 79.00 58.44 -8.21 77.39 59.55 coo 14.54 28.99 9.76 15.06 29.59 10.02 -15.22 90.72 61.35 -15.47 90.98 62.07 ULMN 3 2lpr_c02 ALPHA-LYTIC PROTEASE user 9 3 # 9 A 57 HIS C 115 HIS~? 4.72 C MLZ C 114 A 102 ASP C 56 ASP~? 9.09 N MLZ C 114 A 193 GLY C 46 GLY~? 10.04 O MLZ C 114 coo 14.96 29.22 19.55 15.62 29.93 17.67 -12.99 90.00 69.08 -14.38 90.57 70.54 coo 19.64 30.69 22.61 18.18 29.94 21.25 -16.40 94.43 66.11 -17.63 93.56 67.58 coo 14.54 28.99 9.76 15.06 29.59 10.02 -10.91 80.74 66.75 -11.70 80.52 66.65 ULMN 3 2lpr_c02 ALPHA-LYTIC PROTEASE user 10 3 # 10 A 57 HIS D 88 HIS^? 4.38 CH1 MLY A 135 A 102 ASP D 87 ASP.? 7.26 C16 1PE B 150 A 193 GLY A 134 GLY.? 2.47 N MLY A 135 coo 14.96 29.22 19.55 15.62 29.93 17.67 -29.18 79.71 17.63 -29.43 81.25 19.03 coo 19.64 30.69 22.61 18.18 29.94 21.25 -24.70 80.89 17.41 -22.90 81.94 17.31 coo 14.54 28.99 9.76 15.06 29.59 10.02 -37.57 76.13 24.20 -36.67 75.88 24.22 ULMN 3 2lpr_c02 ALPHA-LYTIC PROTEASE user 11 3 # 11 A 57 HIS D 88 HIS^? 4.38 CH1 MLY A 135 A 102 ASP D 87 ASP.? 7.26 C16 1PE B 150 A 193 GLY D 54 GLY~? 5.81 C23 2PE D 146 coo 14.96 29.22 19.55 15.62 29.93 17.67 -29.18 79.71 17.63 -29.43 81.25 19.03 coo 19.64 30.69 22.61 18.18 29.94 21.25 -24.70 80.89 17.41 -22.90 81.94 17.31 coo 14.54 28.99 9.76 15.06 29.59 10.02 -38.01 83.52 15.98 -38.33 84.28 15.84 ULMN 3 2lpr_c02 ALPHA-LYTIC PROTEASE user 12 3 # 12 A 57 HIS D 115 HIS~? 12.18 C21 2PE D 146 A 102 ASP D 56 ASP~? 11.46 C21 2PE D 146 A 193 GLY D 46 GLY~? 12.21 CD MLY A 135 coo 14.96 29.22 19.55 15.62 29.93 17.67 -36.28 90.32 11.92 -37.49 91.98 12.35 coo 19.64 30.69 22.61 18.18 29.94 21.25 -41.85 87.81 13.66 -41.61 89.58 14.80 coo 14.54 28.99 9.76 15.06 29.59 10.02 -27.16 89.12 15.33 -27.37 89.29 16.11 2lpr_c02 source 2lpr ALPHA-LYTIC PROTEASE : 12 hits 2lpr_c02 naa= 3 ULMN 3 2oat_c03 ORNITHINE AMINOTRANSFERASE user 1 3 # 1 A 177 PHE A 90 PHE^? 4.08 CH1 MLY D 135 A 263 ASP A 87 ASP.? 8.49 C6 PGE A 147 A 292 LYS D 129 LYS^? 7.63 C4 PEG D 145 coo 51.51 50.32 16.39 52.13 49.68 13.75 -25.59 59.02 13.87 -22.88 58.27 14.15 coo 54.43 44.82 23.74 55.21 45.06 21.80 -23.17 58.67 3.55 -22.34 59.17 1.69 coo 63.95 45.30 16.71 59.11 49.15 16.05 -36.12 61.83 6.50 -39.41 57.83 4.09 ULMN 3 2oat_c03 ORNITHINE AMINOTRANSFERASE user 2 3 # 2 A 177 PHE B 15 PHE~? 8.85 C11 PE8 B 148 A 263 ASP B 19 ASP.? -3.77 O3 SO4 A 144s A 292 LYS B 129 LYS^? 7.64 C2 PEG B 146 coo 51.51 50.32 16.39 52.13 49.68 13.75 -4.97 69.26 41.83 -5.66 71.31 40.07 coo 54.43 44.82 23.74 55.21 45.06 21.80 -12.63 65.75 40.21 -14.11 64.30 40.60 coo 63.95 45.30 16.71 59.11 49.15 16.05 -12.78 77.45 45.34 -17.39 74.89 47.84 ULMN 3 2oat_c03 ORNITHINE AMINOTRANSFERASE user 3 3 # 3 A 177 PHE B 100 PHE~? 5.44 CL CL B 143 A 263 ASP B 19 ASP.? -3.77 O3 SO4 A 144s A 292 LYS B 129 LYS^? 7.64 C2 PEG B 146 coo 51.51 50.32 16.39 52.13 49.68 13.75 -4.47 72.85 36.74 -1.98 73.56 37.79 coo 54.43 44.82 23.74 55.21 45.06 21.80 -12.63 65.75 40.21 -14.11 64.30 40.60 coo 63.95 45.30 16.71 59.11 49.15 16.05 -12.78 77.45 45.34 -17.39 74.89 47.84 ULMN 3 2oat_c03 ORNITHINE AMINOTRANSFERASE user 4 3 # 4 A 177 PHE C 90 PHE^? 3.87 CH1 MLY B 135 A 263 ASP C 87 ASP.? 8.84 O1 PGE C 147 A 292 LYS B 129 LYS^? 7.64 C2 PEG B 146 coo 51.51 50.32 16.39 52.13 49.68 13.75 -9.96 87.99 52.84 -9.24 88.98 55.39 coo 54.43 44.82 23.74 55.21 45.06 21.80 -9.03 79.00 58.44 -8.21 77.39 59.55 coo 63.95 45.30 16.71 59.11 49.15 16.05 -12.78 77.45 45.34 -17.39 74.89 47.84 ULMN 3 2oat_c03 ORNITHINE AMINOTRANSFERASE user 5 3 # 5 A 177 PHE D 15 PHE~? 8.99 C14 2PE D 146 A 263 ASP D 19 ASP.? -13.24 C2 PGE A 147s A 292 LYS D 129 LYS^? 7.63 C4 PEG D 145 coo 51.51 50.32 16.39 52.13 49.68 13.75 -37.50 71.61 -0.03 -38.77 71.49 2.45 coo 54.43 44.82 23.74 55.21 45.06 21.80 -43.72 66.33 -2.80 -44.54 65.10 -4.29 coo 63.95 45.30 16.71 59.11 49.15 16.05 -36.12 61.83 6.50 -39.41 57.83 4.09 ULMN 3 2oat_c03 ORNITHINE AMINOTRANSFERASE user 6 3 # 6 A 177 PHE D 100 PHE~? 5.42 CL CL D 143 A 263 ASP D 19 ASP.? -13.24 C2 PGE A 147s A 292 LYS D 129 LYS^? 7.63 C4 PEG D 145 coo 51.51 50.32 16.39 52.13 49.68 13.75 -40.31 73.86 4.98 -37.99 75.35 5.35 coo 54.43 44.82 23.74 55.21 45.06 21.80 -43.72 66.33 -2.80 -44.54 65.10 -4.29 coo 63.95 45.30 16.71 59.11 49.15 16.05 -36.12 61.83 6.50 -39.41 57.83 4.09 2oat_c03 source 2oat ORNITHINE AMINOTRANSFERASE : 6 hits 2oat_c03 naa= 3 ULMN 3 2oat_c04 ORNITHINE AMINOTRANSFERASE user 1 3 # 1 B 177 PHE A 90 PHE^? 4.08 CH1 MLY D 135 B 263 ASP A 87 ASP.? 8.49 C6 PGE A 147 B 292 LYS D 129 LYS^? 7.63 C4 PEG D 145 coo 49.99 26.05 6.28 51.46 26.87 8.49 -25.59 59.02 13.87 -22.88 58.27 14.15 coo 49.07 31.32 -1.50 50.64 31.29 -0.07 -23.17 58.67 3.55 -22.34 59.17 1.69 coo 60.53 31.67 0.97 57.79 27.51 3.63 -36.12 61.83 6.50 -39.41 57.83 4.09 ULMN 3 2oat_c04 ORNITHINE AMINOTRANSFERASE user 2 3 # 2 B 177 PHE B 15 PHE~? 8.85 C11 PE8 B 148 B 263 ASP B 19 ASP.? -3.77 O3 SO4 A 144s B 292 LYS B 129 LYS^? 7.64 C2 PEG B 146 coo 49.99 26.05 6.28 51.46 26.87 8.49 -4.97 69.26 41.83 -5.66 71.31 40.07 coo 49.07 31.32 -1.50 50.64 31.29 -0.07 -12.63 65.75 40.21 -14.11 64.30 40.60 coo 60.53 31.67 0.97 57.79 27.51 3.63 -12.78 77.45 45.34 -17.39 74.89 47.84 ULMN 3 2oat_c04 ORNITHINE AMINOTRANSFERASE user 3 3 # 3 B 177 PHE B 100 PHE~? 5.44 CL CL B 143 B 263 ASP B 19 ASP.? -3.77 O3 SO4 A 144s B 292 LYS B 129 LYS^? 7.64 C2 PEG B 146 coo 49.99 26.05 6.28 51.46 26.87 8.49 -4.47 72.85 36.74 -1.98 73.56 37.79 coo 49.07 31.32 -1.50 50.64 31.29 -0.07 -12.63 65.75 40.21 -14.11 64.30 40.60 coo 60.53 31.67 0.97 57.79 27.51 3.63 -12.78 77.45 45.34 -17.39 74.89 47.84 ULMN 3 2oat_c04 ORNITHINE AMINOTRANSFERASE user 4 3 # 4 B 177 PHE D 15 PHE~? 8.99 C14 2PE D 146 B 263 ASP D 19 ASP.? -13.24 C2 PGE A 147s B 292 LYS D 129 LYS^? 7.63 C4 PEG D 145 coo 49.99 26.05 6.28 51.46 26.87 8.49 -37.50 71.61 -0.03 -38.77 71.49 2.45 coo 49.07 31.32 -1.50 50.64 31.29 -0.07 -43.72 66.33 -2.80 -44.54 65.10 -4.29 coo 60.53 31.67 0.97 57.79 27.51 3.63 -36.12 61.83 6.50 -39.41 57.83 4.09 ULMN 3 2oat_c04 ORNITHINE AMINOTRANSFERASE user 5 3 # 5 B 177 PHE D 100 PHE~? 5.42 CL CL D 143 B 263 ASP D 19 ASP.? -13.24 C2 PGE A 147s B 292 LYS D 129 LYS^? 7.63 C4 PEG D 145 coo 49.99 26.05 6.28 51.46 26.87 8.49 -40.31 73.86 4.98 -37.99 75.35 5.35 coo 49.07 31.32 -1.50 50.64 31.29 -0.07 -43.72 66.33 -2.80 -44.54 65.10 -4.29 coo 60.53 31.67 0.97 57.79 27.51 3.63 -36.12 61.83 6.50 -39.41 57.83 4.09 2oat_c04 source 2oat ORNITHINE AMINOTRANSFERASE : 5 hits 2oat_c04 naa= 3 ULMN 3 2oat_c05 ORNITHINE AMINOTRANSFERASE user 1 3 # 1 C 177 PHE A 90 PHE^? 4.08 CH1 MLY D 135 C 263 ASP A 87 ASP.? 8.49 C6 PGE A 147 C 292 LYS D 129 LYS^? 7.63 C4 PEG D 145 coo 21.96 11.84 -0.03 20.04 11.74 -2.01 -25.59 59.02 13.87 -22.88 58.27 14.15 coo 19.84 12.02 9.33 18.68 11.23 7.75 -23.17 58.67 3.55 -22.34 59.17 1.69 coo 12.82 3.49 4.98 17.80 5.59 1.90 -36.12 61.83 6.50 -39.41 57.83 4.09 ULMN 3 2oat_c05 ORNITHINE AMINOTRANSFERASE user 2 3 # 2 C 177 PHE B 15 PHE~? 8.85 C11 PE8 B 148 C 263 ASP B 19 ASP.? -3.77 O3 SO4 A 144s C 292 LYS B 129 LYS^? 7.64 C2 PEG B 146 coo 21.96 11.84 -0.03 20.04 11.74 -2.01 -4.97 69.26 41.83 -5.66 71.31 40.07 coo 19.84 12.02 9.33 18.68 11.23 7.75 -12.63 65.75 40.21 -14.11 64.30 40.60 coo 12.82 3.49 4.98 17.80 5.59 1.90 -12.78 77.45 45.34 -17.39 74.89 47.84 ULMN 3 2oat_c05 ORNITHINE AMINOTRANSFERASE user 3 3 # 3 C 177 PHE B 100 PHE~? 5.44 CL CL B 143 C 263 ASP B 19 ASP.? -3.77 O3 SO4 A 144s C 292 LYS B 129 LYS^? 7.64 C2 PEG B 146 coo 21.96 11.84 -0.03 20.04 11.74 -2.01 -4.47 72.85 36.74 -1.98 73.56 37.79 coo 19.84 12.02 9.33 18.68 11.23 7.75 -12.63 65.75 40.21 -14.11 64.30 40.60 coo 12.82 3.49 4.98 17.80 5.59 1.90 -12.78 77.45 45.34 -17.39 74.89 47.84 ULMN 3 2oat_c05 ORNITHINE AMINOTRANSFERASE user 4 3 # 4 C 177 PHE C 90 PHE^? 3.87 CH1 MLY B 135 C 263 ASP C 87 ASP.? 8.84 O1 PGE C 147 C 292 LYS B 129 LYS^? 7.64 C2 PEG B 146 coo 21.96 11.84 -0.03 20.04 11.74 -2.01 -9.96 87.99 52.84 -9.24 88.98 55.39 coo 19.84 12.02 9.33 18.68 11.23 7.75 -9.03 79.00 58.44 -8.21 77.39 59.55 coo 12.82 3.49 4.98 17.80 5.59 1.90 -12.78 77.45 45.34 -17.39 74.89 47.84 ULMN 3 2oat_c05 ORNITHINE AMINOTRANSFERASE user 5 3 # 5 C 177 PHE D 15 PHE~? 8.99 C14 2PE D 146 C 263 ASP D 19 ASP.? -13.24 C2 PGE A 147s C 292 LYS D 129 LYS^? 7.63 C4 PEG D 145 coo 21.96 11.84 -0.03 20.04 11.74 -2.01 -37.50 71.61 -0.03 -38.77 71.49 2.45 coo 19.84 12.02 9.33 18.68 11.23 7.75 -43.72 66.33 -2.80 -44.54 65.10 -4.29 coo 12.82 3.49 4.98 17.80 5.59 1.90 -36.12 61.83 6.50 -39.41 57.83 4.09 ULMN 3 2oat_c05 ORNITHINE AMINOTRANSFERASE user 6 3 # 6 C 177 PHE D 100 PHE~? 5.42 CL CL D 143 C 263 ASP D 19 ASP.? -13.24 C2 PGE A 147s C 292 LYS D 129 LYS^? 7.63 C4 PEG D 145 coo 21.96 11.84 -0.03 20.04 11.74 -2.01 -40.31 73.86 4.98 -37.99 75.35 5.35 coo 19.84 12.02 9.33 18.68 11.23 7.75 -43.72 66.33 -2.80 -44.54 65.10 -4.29 coo 12.82 3.49 4.98 17.80 5.59 1.90 -36.12 61.83 6.50 -39.41 57.83 4.09 2oat_c05 source 2oat ORNITHINE AMINOTRANSFERASE : 6 hits 2oat_c05 naa= 3 ULMN 3 2pth_c00 PEPTIDYL-TRNA HYDROLASE user 1 3 # 1 10 ASN A 28 ASN^? 3.50 CL CL A 145s 20 HIS A 88 HIS^? 4.20 CH2 MLY D 135 93 ASP A 87 ASP.? 8.49 C6 PGE A 147 coo 45.21 45.27 48.24 46.79 44.92 46.88 -22.13 61.51 13.69 -20.95 60.87 15.35 coo 47.05 39.55 45.24 48.99 39.30 44.46 -23.95 56.87 7.77 -24.14 54.98 6.86 coo 46.96 34.22 47.29 47.91 35.95 46.52 -23.17 58.67 3.55 -22.34 59.17 1.69 ULMN 3 2pth_c00 PEPTIDYL-TRNA HYDROLASE user 2 3 # 2 10 ASN B 28 ASN^? 3.43 CL CL B 143s 20 HIS B 88 HIS^? 4.29 CH1 MLY C 135 93 ASP B 87 ASP.? 8.94 O4 PGE B 147 coo 45.21 45.27 48.24 46.79 44.92 46.88 0.96 81.77 41.38 0.26 80.18 40.18 coo 47.05 39.55 45.24 48.99 39.30 44.46 6.15 87.00 38.94 7.35 87.96 37.51 coo 46.96 34.22 47.29 47.91 35.95 46.52 9.49 87.97 42.02 11.31 87.98 43.09 ULMN 3 2pth_c00 PEPTIDYL-TRNA HYDROLASE user 3 3 # 3 10 ASN C 28 ASN^? 3.42 CL CL C 144s 20 HIS C 88 HIS^? 3.86 CD MLY B 135 93 ASP C 87 ASP.? 8.84 O1 PGE C 147 coo 45.21 45.27 48.24 46.79 44.92 46.88 -6.06 88.35 54.50 -6.05 90.38 55.16 coo 47.05 39.55 45.24 48.99 39.30 44.46 -11.00 83.03 57.18 -12.69 82.43 58.26 coo 46.96 34.22 47.29 47.91 35.95 46.52 -9.03 79.00 58.44 -8.21 77.39 59.55 ULMN 3 2pth_c00 PEPTIDYL-TRNA HYDROLASE user 4 3 # 4 10 ASN D 28 ASN^? 3.51 CL CL D 143s 20 HIS D 88 HIS^? 4.38 CH1 MLY A 135 93 ASP D 87 ASP.? 7.26 C16 1PE B 150 coo 45.21 45.27 48.24 46.79 44.92 46.88 -31.24 74.87 11.89 -33.01 75.13 10.75 coo 47.05 39.55 45.24 48.99 39.30 44.46 -29.18 79.71 17.63 -29.43 81.25 19.03 coo 46.96 34.22 47.29 47.91 35.95 46.52 -24.70 80.89 17.41 -22.90 81.94 17.31 2pth_c00 source 2pth PEPTIDYL-TRNA HYDROLASE : 4 hits 2pth_c00 naa= 3 ULMN 3 2tdt_c00 TETRAHYDRODIPICOLINATE N-SUCCINYLTRAuser 1 3 # 1 141 ASP A 6 ASP.? -3.91 C9 2PE A 148s 166 GLY A 46 GLY~? 12.01 CD MLY D 135 169 GLU A 43 GLU.? 22.22 CD MLY D 135 coo 8.28 6.87 1.62 10.08 5.77 1.34 -8.66 61.41 13.34 -8.76 59.35 12.80 coo -8.58 13.22 3.21 -8.90 13.15 4.05 -16.75 52.82 2.36 -17.28 52.20 2.20 coo -16.67 7.89 2.78 -17.65 6.56 1.49 -10.18 46.49 -4.16 -10.86 48.08 -5.46 ULMN 3 2tdt_c00 TETRAHYDRODIPICOLINATE N-SUCCINYLTRAuser 2 3 # 2 141 ASP A 83 ASP.? 8.52 O3 GOL D 147 166 GLY A 46 GLY~? 12.01 CD MLY D 135 169 GLU A 43 GLU.? 22.22 CD MLY D 135 coo 8.28 6.87 1.62 10.08 5.77 1.34 -19.46 70.43 -3.04 -19.06 72.28 -2.05 coo -8.58 13.22 3.21 -8.90 13.15 4.05 -16.75 52.82 2.36 -17.28 52.20 2.20 coo -16.67 7.89 2.78 -17.65 6.56 1.49 -10.18 46.49 -4.16 -10.86 48.08 -5.46 ULMN 3 2tdt_c00 TETRAHYDRODIPICOLINATE N-SUCCINYLTRAuser 3 3 # 3 141 ASP B 6 ASP.? -3.99 C6 PE8 B 148s 166 GLY B 41 GLY.? 7.26 O1 PEG B 144 169 GLU B 43 GLU.? 6.93 O1 PEG B 144 coo 8.28 6.87 1.62 10.08 5.77 1.34 7.95 70.39 41.39 8.88 71.08 39.61 coo -8.58 13.22 3.21 -8.90 13.15 4.05 24.21 75.61 32.92 24.20 75.73 32.15 coo -16.67 7.89 2.78 -17.65 6.56 1.49 25.26 83.58 33.36 26.25 82.60 35.01 ULMN 3 2tdt_c00 TETRAHYDRODIPICOLINATE N-SUCCINYLTRAuser 4 3 # 4 141 ASP B 83 ASP.? 9.40 O3 GOL C 149 166 GLY B 46 GLY~? 9.70 O1 PEG B 144 169 GLU B 43 GLU.? 6.93 O1 PEG B 144 coo 8.28 6.87 1.62 10.08 5.77 1.34 13.62 86.10 55.23 12.83 84.59 56.49 coo -8.58 13.22 3.21 -8.90 13.15 4.05 15.35 83.93 36.97 15.42 84.55 36.41 coo -16.67 7.89 2.78 -17.65 6.56 1.49 25.26 83.58 33.36 26.25 82.60 35.01 ULMN 3 2tdt_c00 TETRAHYDRODIPICOLINATE N-SUCCINYLTRAuser 5 3 # 5 141 ASP D 83 ASP.? 8.76 O1 GOL A 150 166 GLY D 46 GLY~? 12.21 CD MLY A 135 169 GLU D 43 GLU.? 21.91 OH7 1PE B 150 coo 8.28 6.87 1.62 10.08 5.77 1.34 -12.54 78.43 10.94 -12.46 77.06 9.29 coo -8.58 13.22 3.21 -8.90 13.15 4.05 -27.16 89.12 15.33 -27.37 89.29 16.11 coo -16.67 7.89 2.78 -17.65 6.56 1.49 -25.19 99.19 16.02 -23.48 99.27 14.73 ULMN 3 2tdt_c00 TETRAHYDRODIPICOLINATE N-SUCCINYLTRAuser 6 3 # 6 141 ASP D 87 ASP.? 7.26 C16 1PE B 150 166 GLY B 65 GLY.? 4.50 C13 1PE B 150 169 GLU B 102 GLU~? 6.18 O4 SO4 A 143 coo 8.28 6.87 1.62 10.08 5.77 1.34 -24.70 80.89 17.41 -22.90 81.94 17.31 coo -8.58 13.22 3.21 -8.90 13.15 4.05 -9.71 78.10 29.60 -8.92 78.05 29.76 coo -16.67 7.89 2.78 -17.65 6.56 1.49 -7.10 67.86 29.77 -6.34 66.05 29.12 2tdt_c00 source 2tdt TETRAHYDRODIPICOLINATE N-SUCCINYLTRANSFERASE : 6 hits 2tdt_c00 naa= 3 ULMN 3 2tmd_c00 TRIMETHYLAMINE DEHYDROGENASE user 1 3 # 1 A 169 TYR A 38 TYR.? 14.78 C11 2PE A 148 A 172 HIS A 115 HIS~? 12.27 C21 2PE A 148 A 267 ASP A 56 ASP~? 11.59 C21 2PE A 148 coo 26.78 20.44 0.03 28.51 18.26 0.09 -8.94 48.99 5.06 -11.42 48.37 6.17 coo 29.39 14.39 -1.75 31.15 15.06 -2.66 -13.18 48.35 10.37 -12.55 46.36 10.33 coo 33.26 12.70 -5.86 33.92 14.66 -5.47 -16.01 45.89 15.64 -15.93 44.31 14.23 ULMN 3 2tmd_c00 TRIMETHYLAMINE DEHYDROGENASE user 2 3 # 2 A 169 TYR A 50 TYR~? 5.51 CH2 MLY D 135 A 172 HIS A 115 HIS~? 12.27 C21 2PE A 148 A 267 ASP A 56 ASP~? 11.59 C21 2PE A 148 coo 26.78 20.44 0.03 28.51 18.26 0.09 -19.50 53.98 8.67 -20.18 55.72 10.74 coo 29.39 14.39 -1.75 31.15 15.06 -2.66 -13.18 48.35 10.37 -12.55 46.36 10.33 coo 33.26 12.70 -5.86 33.92 14.66 -5.47 -16.01 45.89 15.64 -15.93 44.31 14.23 ULMN 3 2tmd_c00 TRIMETHYLAMINE DEHYDROGENASE user 3 3 # 3 A 169 TYR B 38 TYR.? 9.60 O1 PEG B 144 A 172 HIS B 115 HIS~? 12.48 C18 PE8 B 148 A 267 ASP B 56 ASP~? 11.45 C20 PE8 B 148 coo 26.78 20.44 0.03 28.51 18.26 0.09 18.19 76.55 32.34 16.15 78.24 31.46 coo 29.39 14.39 -1.75 31.15 15.06 -2.66 11.86 77.76 30.05 12.70 77.49 28.15 coo 33.26 12.70 -5.86 33.92 14.66 -5.47 6.80 78.21 26.00 8.47 79.07 25.03 ULMN 3 2tmd_c00 TRIMETHYLAMINE DEHYDROGENASE user 4 3 # 4 A 169 TYR B 50 TYR~? 5.52 CH1 MLY C 135 A 172 HIS B 115 HIS~? 12.48 C18 PE8 B 148 A 267 ASP B 56 ASP~? 11.45 C20 PE8 B 148 coo 26.78 20.44 0.03 28.51 18.26 0.09 8.51 83.11 35.90 5.93 82.51 36.84 coo 29.39 14.39 -1.75 31.15 15.06 -2.66 11.86 77.76 30.05 12.70 77.49 28.15 coo 33.26 12.70 -5.86 33.92 14.66 -5.47 6.80 78.21 26.00 8.47 79.07 25.03 ULMN 3 2tmd_c00 TRIMETHYLAMINE DEHYDROGENASE user 5 3 # 5 A 169 TYR C 38 TYR.? 5.20 O MLZ C 114 A 172 HIS C 115 HIS~? 4.72 C MLZ C 114 A 267 ASP C 56 ASP~? 9.09 N MLZ C 114 coo 26.78 20.44 0.03 28.51 18.26 0.09 -10.37 86.21 74.10 -12.04 86.61 71.91 coo 29.39 14.39 -1.75 31.15 15.06 -2.66 -12.99 90.00 69.08 -14.38 90.57 70.54 coo 33.26 12.70 -5.86 33.92 14.66 -5.47 -16.40 94.43 66.11 -17.63 93.56 67.58 ULMN 3 2tmd_c00 TRIMETHYLAMINE DEHYDROGENASE user 6 3 # 6 A 169 TYR C 50 TYR~? 5.59 CE MLY B 135 A 172 HIS C 115 HIS~? 4.72 C MLZ C 114 A 267 ASP C 56 ASP~? 9.09 N MLZ C 114 coo 26.78 20.44 0.03 28.51 18.26 0.09 -11.27 85.65 61.91 -10.18 87.09 59.78 coo 29.39 14.39 -1.75 31.15 15.06 -2.66 -12.99 90.00 69.08 -14.38 90.57 70.54 coo 33.26 12.70 -5.86 33.92 14.66 -5.47 -16.40 94.43 66.11 -17.63 93.56 67.58 ULMN 3 2tmd_c00 TRIMETHYLAMINE DEHYDROGENASE user 7 3 # 7 A 169 TYR D 38 TYR.? 14.74 C9 2PE D 146 A 172 HIS D 115 HIS~? 12.18 C21 2PE D 146 A 267 ASP D 56 ASP~? 11.46 C21 2PE D 146 coo 26.78 20.44 0.03 28.51 18.26 0.09 -31.57 94.95 9.95 -32.83 93.25 11.77 coo 29.39 14.39 -1.75 31.15 15.06 -2.66 -36.28 90.32 11.92 -37.49 91.98 12.35 coo 33.26 12.70 -5.86 33.92 14.66 -5.47 -41.85 87.81 13.66 -41.61 89.58 14.80 ULMN 3 2tmd_c00 TRIMETHYLAMINE DEHYDROGENASE user 8 3 # 8 A 169 TYR D 50 TYR~? 5.61 CH1 MLY A 135 A 172 HIS D 115 HIS~? 12.18 C21 2PE D 146 A 267 ASP D 56 ASP~? 11.46 C21 2PE D 146 coo 26.78 20.44 0.03 28.51 18.26 0.09 -31.54 83.73 14.98 -32.20 81.17 14.09 coo 29.39 14.39 -1.75 31.15 15.06 -2.66 -36.28 90.32 11.92 -37.49 91.98 12.35 coo 33.26 12.70 -5.86 33.92 14.66 -5.47 -41.85 87.81 13.66 -41.61 89.58 14.80 2tmd_c00 source 2tmd TRIMETHYLAMINE DEHYDROGENASE : 8 hits 2tmd_c00 naa= 3 ULMN 3 2tmd_c01 TRIMETHYLAMINE DEHYDROGENASE user 1 3 # 1 B 169 TYR A 38 TYR.? 14.78 C11 2PE A 148 B 172 HIS A 115 HIS~? 12.27 C21 2PE A 148 B 267 ASP A 56 ASP~? 11.59 C21 2PE A 148 coo 44.86 1.98 33.27 42.75 1.12 31.67 -8.94 48.99 5.06 -11.42 48.37 6.17 coo 40.83 -2.48 29.90 39.16 -2.39 31.17 -13.18 48.35 10.37 -12.55 46.36 10.33 coo 36.38 -5.89 31.55 36.22 -4.28 32.93 -16.01 45.89 15.64 -15.93 44.31 14.23 ULMN 3 2tmd_c01 TRIMETHYLAMINE DEHYDROGENASE user 2 3 # 2 B 169 TYR A 50 TYR~? 5.51 CH2 MLY D 135 B 172 HIS A 115 HIS~? 12.27 C21 2PE A 148 B 267 ASP A 56 ASP~? 11.59 C21 2PE A 148 coo 44.86 1.98 33.27 42.75 1.12 31.67 -19.50 53.98 8.67 -20.18 55.72 10.74 coo 40.83 -2.48 29.90 39.16 -2.39 31.17 -13.18 48.35 10.37 -12.55 46.36 10.33 coo 36.38 -5.89 31.55 36.22 -4.28 32.93 -16.01 45.89 15.64 -15.93 44.31 14.23 ULMN 3 2tmd_c01 TRIMETHYLAMINE DEHYDROGENASE user 3 3 # 3 B 169 TYR B 38 TYR.? 9.60 O1 PEG B 144 B 172 HIS B 115 HIS~? 12.48 C18 PE8 B 148 B 267 ASP B 56 ASP~? 11.45 C20 PE8 B 148 coo 44.86 1.98 33.27 42.75 1.12 31.67 18.19 76.55 32.34 16.15 78.24 31.46 coo 40.83 -2.48 29.90 39.16 -2.39 31.17 11.86 77.76 30.05 12.70 77.49 28.15 coo 36.38 -5.89 31.55 36.22 -4.28 32.93 6.80 78.21 26.00 8.47 79.07 25.03 ULMN 3 2tmd_c01 TRIMETHYLAMINE DEHYDROGENASE user 4 3 # 4 B 169 TYR B 50 TYR~? 5.52 CH1 MLY C 135 B 172 HIS B 115 HIS~? 12.48 C18 PE8 B 148 B 267 ASP B 56 ASP~? 11.45 C20 PE8 B 148 coo 44.86 1.98 33.27 42.75 1.12 31.67 8.51 83.11 35.90 5.93 82.51 36.84 coo 40.83 -2.48 29.90 39.16 -2.39 31.17 11.86 77.76 30.05 12.70 77.49 28.15 coo 36.38 -5.89 31.55 36.22 -4.28 32.93 6.80 78.21 26.00 8.47 79.07 25.03 ULMN 3 2tmd_c01 TRIMETHYLAMINE DEHYDROGENASE user 5 3 # 5 B 169 TYR C 38 TYR.? 5.20 O MLZ C 114 B 172 HIS C 115 HIS~? 4.72 C MLZ C 114 B 267 ASP C 56 ASP~? 9.09 N MLZ C 114 coo 44.86 1.98 33.27 42.75 1.12 31.67 -10.37 86.21 74.10 -12.04 86.61 71.91 coo 40.83 -2.48 29.90 39.16 -2.39 31.17 -12.99 90.00 69.08 -14.38 90.57 70.54 coo 36.38 -5.89 31.55 36.22 -4.28 32.93 -16.40 94.43 66.11 -17.63 93.56 67.58 ULMN 3 2tmd_c01 TRIMETHYLAMINE DEHYDROGENASE user 6 3 # 6 B 169 TYR C 50 TYR~? 5.59 CE MLY B 135 B 172 HIS C 115 HIS~? 4.72 C MLZ C 114 B 267 ASP C 56 ASP~? 9.09 N MLZ C 114 coo 44.86 1.98 33.27 42.75 1.12 31.67 -11.27 85.65 61.91 -10.18 87.09 59.78 coo 40.83 -2.48 29.90 39.16 -2.39 31.17 -12.99 90.00 69.08 -14.38 90.57 70.54 coo 36.38 -5.89 31.55 36.22 -4.28 32.93 -16.40 94.43 66.11 -17.63 93.56 67.58 ULMN 3 2tmd_c01 TRIMETHYLAMINE DEHYDROGENASE user 7 3 # 7 B 169 TYR D 38 TYR.? 14.74 C9 2PE D 146 B 172 HIS D 115 HIS~? 12.18 C21 2PE D 146 B 267 ASP D 56 ASP~? 11.46 C21 2PE D 146 coo 44.86 1.98 33.27 42.75 1.12 31.67 -31.57 94.95 9.95 -32.83 93.25 11.77 coo 40.83 -2.48 29.90 39.16 -2.39 31.17 -36.28 90.32 11.92 -37.49 91.98 12.35 coo 36.38 -5.89 31.55 36.22 -4.28 32.93 -41.85 87.81 13.66 -41.61 89.58 14.80 ULMN 3 2tmd_c01 TRIMETHYLAMINE DEHYDROGENASE user 8 3 # 8 B 169 TYR D 50 TYR~? 5.61 CH1 MLY A 135 B 172 HIS D 115 HIS~? 12.18 C21 2PE D 146 B 267 ASP D 56 ASP~? 11.46 C21 2PE D 146 coo 44.86 1.98 33.27 42.75 1.12 31.67 -31.54 83.73 14.98 -32.20 81.17 14.09 coo 40.83 -2.48 29.90 39.16 -2.39 31.17 -36.28 90.32 11.92 -37.49 91.98 12.35 coo 36.38 -5.89 31.55 36.22 -4.28 32.93 -41.85 87.81 13.66 -41.61 89.58 14.80 2tmd_c01 source 2tmd TRIMETHYLAMINE DEHYDROGENASE : 8 hits 2tmd_c01 naa= 3 ULMN 3 2tmd_c02 TRIMETHYLAMINE DEHYDROGENASE user 1 3 # 1 A 169 TYR A 50 TYR~? 5.51 CH2 MLY D 135 A 172 HIS A 115 HIS~? 12.27 C21 2PE A 148 A 174 TYR A 53 TYR~? -4.55 C21 2PE A 148s coo 26.78 20.44 0.03 28.51 18.26 0.09 -19.50 53.98 8.67 -20.18 55.72 10.74 coo 29.39 14.39 -1.75 31.15 15.06 -2.66 -13.18 48.35 10.37 -12.55 46.36 10.33 coo 24.73 15.69 1.93 26.72 14.32 3.31 -16.76 52.42 13.05 -16.88 54.33 15.10 ULMN 3 2tmd_c02 TRIMETHYLAMINE DEHYDROGENASE user 2 3 # 2 A 169 TYR B 50 TYR~? 5.52 CH1 MLY C 135 A 172 HIS B 115 HIS~? 12.48 C18 PE8 B 148 A 174 TYR B 53 TYR~? -4.63 C18 PE8 B 148s coo 26.78 20.44 0.03 28.51 18.26 0.09 8.51 83.11 35.90 5.93 82.51 36.84 coo 29.39 14.39 -1.75 31.15 15.06 -2.66 11.86 77.76 30.05 12.70 77.49 28.15 coo 24.73 15.69 1.93 26.72 14.32 3.31 6.73 78.96 33.00 4.51 77.73 34.14 ULMN 3 2tmd_c02 TRIMETHYLAMINE DEHYDROGENASE user 3 3 # 3 A 169 TYR C 50 TYR~? 5.59 CE MLY B 135 A 172 HIS C 115 HIS~? 4.72 C MLZ C 114 A 174 TYR C 53 TYR~? -4.98 C18 PE8 C 148s coo 26.78 20.44 0.03 28.51 18.26 0.09 -11.27 85.65 61.91 -10.18 87.09 59.78 coo 29.39 14.39 -1.75 31.15 15.06 -2.66 -12.99 90.00 69.08 -14.38 90.57 70.54 coo 24.73 15.69 1.93 26.72 14.32 3.31 -11.26 90.80 63.43 -9.63 92.35 61.80 ULMN 3 2tmd_c02 TRIMETHYLAMINE DEHYDROGENASE user 4 3 # 4 A 169 TYR D 50 TYR~? 5.61 CH1 MLY A 135 A 172 HIS D 115 HIS~? 12.18 C21 2PE D 146 A 174 TYR D 53 TYR~? -4.60 C21 2PE D 146s coo 26.78 20.44 0.03 28.51 18.26 0.09 -31.54 83.73 14.98 -32.20 81.17 14.09 coo 29.39 14.39 -1.75 31.15 15.06 -2.66 -36.28 90.32 11.92 -37.49 91.98 12.35 coo 24.73 15.69 1.93 26.72 14.32 3.31 -36.08 84.35 12.01 -36.58 82.07 10.49 2tmd_c02 source 2tmd TRIMETHYLAMINE DEHYDROGENASE : 4 hits 2tmd_c02 naa= 3 ULMN 3 2tmd_c03 TRIMETHYLAMINE DEHYDROGENASE user 1 3 # 1 B 169 TYR A 50 TYR~? 5.51 CH2 MLY D 135 B 172 HIS A 115 HIS~? 12.27 C21 2PE A 148 B 174 TYR A 53 TYR~? -4.55 C21 2PE A 148s coo 44.86 1.98 33.27 42.75 1.12 31.67 -19.50 53.98 8.67 -20.18 55.72 10.74 coo 40.83 -2.48 29.90 39.16 -2.39 31.17 -13.18 48.35 10.37 -12.55 46.36 10.33 coo 45.95 0.11 28.25 43.87 0.82 26.55 -16.76 52.42 13.05 -16.88 54.33 15.10 ULMN 3 2tmd_c03 TRIMETHYLAMINE DEHYDROGENASE user 2 3 # 2 B 169 TYR B 50 TYR~? 5.52 CH1 MLY C 135 B 172 HIS B 115 HIS~? 12.48 C18 PE8 B 148 B 174 TYR B 53 TYR~? -4.63 C18 PE8 B 148s coo 44.86 1.98 33.27 42.75 1.12 31.67 8.51 83.11 35.90 5.93 82.51 36.84 coo 40.83 -2.48 29.90 39.16 -2.39 31.17 11.86 77.76 30.05 12.70 77.49 28.15 coo 45.95 0.11 28.25 43.87 0.82 26.55 6.73 78.96 33.00 4.51 77.73 34.14 ULMN 3 2tmd_c03 TRIMETHYLAMINE DEHYDROGENASE user 3 3 # 3 B 169 TYR C 50 TYR~? 5.59 CE MLY B 135 B 172 HIS C 115 HIS~? 4.72 C MLZ C 114 B 174 TYR C 53 TYR~? -4.98 C18 PE8 C 148s coo 44.86 1.98 33.27 42.75 1.12 31.67 -11.27 85.65 61.91 -10.18 87.09 59.78 coo 40.83 -2.48 29.90 39.16 -2.39 31.17 -12.99 90.00 69.08 -14.38 90.57 70.54 coo 45.95 0.11 28.25 43.87 0.82 26.55 -11.26 90.80 63.43 -9.63 92.35 61.80 ULMN 3 2tmd_c03 TRIMETHYLAMINE DEHYDROGENASE user 4 3 # 4 B 169 TYR D 50 TYR~? 5.61 CH1 MLY A 135 B 172 HIS D 115 HIS~? 12.18 C21 2PE D 146 B 174 TYR D 53 TYR~? -4.60 C21 2PE D 146s coo 44.86 1.98 33.27 42.75 1.12 31.67 -31.54 83.73 14.98 -32.20 81.17 14.09 coo 40.83 -2.48 29.90 39.16 -2.39 31.17 -36.28 90.32 11.92 -37.49 91.98 12.35 coo 45.95 0.11 28.25 43.87 0.82 26.55 -36.08 84.35 12.01 -36.58 82.07 10.49 2tmd_c03 source 2tmd TRIMETHYLAMINE DEHYDROGENASE : 4 hits 2tmd_c03 naa= 3 ULMN 3 2xis_c00 XYLOSE ISOMERASE (E.C.5.3.1.5) COMPLuser 1 3 # 1 183 LYS A 114 LYS~? 11.27 C9 2PE A 148 220 HIS A 115 HIS~? 12.27 C21 2PE A 148 255 ASP A 56 ASP~? 11.59 C21 2PE A 148 coo 11.94 40.77 50.56 7.67 36.15 49.76 -9.49 51.50 12.13 -4.59 48.44 14.69 coo 10.50 40.09 46.76 10.54 37.99 46.56 -13.18 48.35 10.37 -12.55 46.36 10.33 coo 4.47 38.05 47.65 5.63 36.87 46.50 -16.01 45.89 15.64 -15.93 44.31 14.23 ULMN 3 2xis_c00 XYLOSE ISOMERASE (E.C.5.3.1.5) COMPLuser 2 3 # 2 183 LYS B 114 LYS~? 11.34 O7 PE8 B 148 220 HIS B 115 HIS~? 12.48 C18 PE8 B 148 255 ASP B 56 ASP~? 11.45 C20 PE8 B 148 coo 11.94 40.77 50.56 7.67 36.15 49.76 11.35 73.22 32.47 12.65 68.43 28.61 coo 10.50 40.09 46.76 10.54 37.99 46.56 11.86 77.76 30.05 12.70 77.49 28.15 coo 4.47 38.05 47.65 5.63 36.87 46.50 6.80 78.21 26.00 8.47 79.07 25.03 ULMN 3 2xis_c00 XYLOSE ISOMERASE (E.C.5.3.1.5) COMPLuser 3 3 # 3 183 LYS D 114 LYS~? 10.81 C9 2PE D 146 220 HIS D 115 HIS~? 12.18 C21 2PE D 146 255 ASP D 56 ASP~? 11.46 C21 2PE D 146 coo 11.94 40.77 50.56 7.67 36.15 49.76 -35.88 89.56 6.78 -39.69 93.33 3.49 coo 10.50 40.09 46.76 10.54 37.99 46.56 -36.28 90.32 11.92 -37.49 91.98 12.35 coo 4.47 38.05 47.65 5.63 36.87 46.50 -41.85 87.81 13.66 -41.61 89.58 14.80 2xis_c00 source 2xis XYLOSE ISOMERASE (E.C.5.3.1.5) COMPLEX WITH XY: 3 hits 2xis_c00 naa= 3 ULMN 3 3cla_c00 TYPE III CHLORAMPHENICOL ACETYLTRANSuser 1 3 # 1 18 ARG A 55 ARG~? 10.23 CD MLY D 135 195 HIS A 115 HIS~? 12.27 C21 2PE A 148 199 ASP A 56 ASP~? 11.59 C21 2PE A 148 coo 21.96 2.03 15.24 19.33 1.86 13.55 -19.70 43.33 11.87 -20.69 44.07 9.04 coo 13.48 -0.87 14.56 14.47 -2.14 15.92 -13.18 48.35 10.37 -12.55 46.36 10.33 coo 17.92 -0.05 18.55 18.90 -0.38 16.73 -16.01 45.89 15.64 -15.93 44.31 14.23 ULMN 3 3cla_c00 TYPE III CHLORAMPHENICOL ACETYLTRANSuser 2 3 # 2 18 ARG B 31 ARG^? 11.02 C6 PGE B 147 195 HIS B 4 HIS.? -3.86 O2 GOL B 149s 199 ASP B 122 ASP^? 7.33 O2 GOL B 149 coo 21.96 2.03 15.24 19.33 1.86 13.55 12.15 83.61 47.77 10.36 84.10 50.21 coo 13.48 -0.87 14.56 14.47 -2.14 15.92 8.07 73.88 49.16 8.30 73.43 51.19 coo 17.92 -0.05 18.55 18.90 -0.38 16.73 10.89 79.68 47.57 9.75 78.80 49.16 ULMN 3 3cla_c00 TYPE III CHLORAMPHENICOL ACETYLTRANSuser 3 3 # 3 18 ARG B 55 ARG~? 9.33 CG MLY C 135 195 HIS B 115 HIS~? 12.48 C18 PE8 B 148 199 ASP B 56 ASP~? 11.45 C20 PE8 B 148 coo 21.96 2.03 15.24 19.33 1.86 13.55 8.78 84.29 24.99 10.39 86.20 26.77 coo 13.48 -0.87 14.56 14.47 -2.14 15.92 11.86 77.76 30.05 12.70 77.49 28.15 coo 17.92 -0.05 18.55 18.90 -0.38 16.73 6.80 78.21 26.00 8.47 79.07 25.03 ULMN 3 3cla_c00 TYPE III CHLORAMPHENICOL ACETYLTRANSuser 4 3 # 4 18 ARG C 31 ARG^? 11.22 C3 GOL C 149 195 HIS C 4 HIS.? -3.73 C3 GOL C 149s 199 ASP C 122 ASP^? 7.22 C3 GOL C 149 coo 21.96 2.03 15.24 19.33 1.86 13.55 -2.17 77.49 60.72 0.17 78.08 58.83 coo 13.48 -0.87 14.56 14.47 -2.14 15.92 4.88 85.81 61.42 6.80 85.00 61.18 coo 17.92 -0.05 18.55 18.90 -0.38 16.73 0.27 81.12 61.60 2.07 81.54 60.53 ULMN 3 3cla_c00 TYPE III CHLORAMPHENICOL ACETYLTRANSuser 5 3 # 5 18 ARG C 55 ARG~? 9.18 O MLY B 135 195 HIS C 115 HIS~? 4.72 C MLZ C 114 199 ASP C 56 ASP~? 9.09 N MLZ C 114 coo 21.96 2.03 15.24 19.33 1.86 13.55 -21.06 89.68 64.73 -20.37 86.74 65.24 coo 13.48 -0.87 14.56 14.47 -2.14 15.92 -12.99 90.00 69.08 -14.38 90.57 70.54 coo 17.92 -0.05 18.55 18.90 -0.38 16.73 -16.40 94.43 66.11 -17.63 93.56 67.58 ULMN 3 3cla_c00 TYPE III CHLORAMPHENICOL ACETYLTRANSuser 6 3 # 6 18 ARG D 55 ARG~? 9.16 CG MLY A 135 195 HIS D 115 HIS~? 12.18 C21 2PE D 146 199 ASP D 56 ASP~? 11.46 C21 2PE D 146 coo 21.96 2.03 15.24 19.33 1.86 13.55 -39.98 89.02 19.79 -37.17 89.06 21.03 coo 13.48 -0.87 14.56 14.47 -2.14 15.92 -36.28 90.32 11.92 -37.49 91.98 12.35 coo 17.92 -0.05 18.55 18.90 -0.38 16.73 -41.85 87.81 13.66 -41.61 89.58 14.80 3cla_c00 source 3cla TYPE III CHLORAMPHENICOL ACETYLTRANSFERASE ( C: 6 hits 3cla_c00 naa= 3 ULMN 3 4mdh_c02 CYTOPLASMIC MALATE DEHYDROGENASE (E.user 1 3 # 1 A 158 ASP A 56 ASP~? 11.59 C21 2PE A 148 A 161 ARG A 55 ARG~? 10.23 CD MLY D 135 A 186 HIS A 115 HIS~? 12.27 C21 2PE A 148 coo 18.62 26.83 58.17 18.48 28.64 57.08 -16.01 45.89 15.64 -15.93 44.31 14.23 coo 23.76 27.69 57.88 24.05 29.81 55.69 -19.70 43.33 11.87 -20.69 44.07 9.04 coo 16.67 31.22 54.64 18.74 31.15 54.14 -13.18 48.35 10.37 -12.55 46.36 10.33 ULMN 3 4mdh_c02 CYTOPLASMIC MALATE DEHYDROGENASE (E.user 2 3 # 2 A 158 ASP B 56 ASP~? 11.45 C20 PE8 B 148 A 161 ARG B 55 ARG~? 9.33 CG MLY C 135 A 186 HIS B 115 HIS~? 12.48 C18 PE8 B 148 coo 18.62 26.83 58.17 18.48 28.64 57.08 6.80 78.21 26.00 8.47 79.07 25.03 coo 23.76 27.69 57.88 24.05 29.81 55.69 8.78 84.29 24.99 10.39 86.20 26.77 coo 16.67 31.22 54.64 18.74 31.15 54.14 11.86 77.76 30.05 12.70 77.49 28.15 ULMN 3 4mdh_c02 CYTOPLASMIC MALATE DEHYDROGENASE (E.user 3 3 # 3 A 158 ASP C 56 ASP~? 9.09 N MLZ C 114 A 161 ARG C 55 ARG~? 9.18 O MLY B 135 A 186 HIS C 115 HIS~? 4.72 C MLZ C 114 coo 18.62 26.83 58.17 18.48 28.64 57.08 -16.40 94.43 66.11 -17.63 93.56 67.58 coo 23.76 27.69 57.88 24.05 29.81 55.69 -21.06 89.68 64.73 -20.37 86.74 65.24 coo 16.67 31.22 54.64 18.74 31.15 54.14 -12.99 90.00 69.08 -14.38 90.57 70.54 ULMN 3 4mdh_c02 CYTOPLASMIC MALATE DEHYDROGENASE (E.user 4 3 # 4 A 158 ASP D 56 ASP~? 11.46 C21 2PE D 146 A 161 ARG D 55 ARG~? 9.16 CG MLY A 135 A 186 HIS D 115 HIS~? 12.18 C21 2PE D 146 coo 18.62 26.83 58.17 18.48 28.64 57.08 -41.85 87.81 13.66 -41.61 89.58 14.80 coo 23.76 27.69 57.88 24.05 29.81 55.69 -39.98 89.02 19.79 -37.17 89.06 21.03 coo 16.67 31.22 54.64 18.74 31.15 54.14 -36.28 90.32 11.92 -37.49 91.98 12.35 4mdh_c02 source 4mdh CYTOPLASMIC MALATE DEHYDROGENASE (E.C.1.1.1.37: 4 hits 4mdh_c02 naa= 3 ULMN 3 4mdh_c03 CYTOPLASMIC MALATE DEHYDROGENASE (E.user 1 3 # 1 B 158 ASP A 56 ASP~? 11.59 C21 2PE A 148 B 161 ARG A 55 ARG~? 10.23 CD MLY D 135 B 186 HIS A 115 HIS~? 12.27 C21 2PE A 148 coo 44.53 16.44 28.54 44.89 18.45 28.77 -16.01 45.89 15.64 -15.93 44.31 14.23 coo 39.64 19.27 28.15 40.19 21.74 29.94 -19.70 43.33 11.87 -20.69 44.07 9.04 coo 48.32 20.00 31.44 46.45 20.91 31.50 -13.18 48.35 10.37 -12.55 46.36 10.33 ULMN 3 4mdh_c03 CYTOPLASMIC MALATE DEHYDROGENASE (E.user 2 3 # 2 B 158 ASP A 87 ASP.? 8.49 C6 PGE A 147 B 161 ARG A 31 ARG^? 11.10 C1 GOL A 150 B 186 HIS A 88 HIS^? 4.20 CH2 MLY D 135 coo 44.53 16.44 28.54 44.89 18.45 28.77 -23.17 58.67 3.55 -22.34 59.17 1.69 coo 39.64 19.27 28.15 40.19 21.74 29.94 -18.51 63.86 1.13 -18.37 66.66 2.58 coo 48.32 20.00 31.44 46.45 20.91 31.50 -23.95 56.87 7.77 -24.14 54.98 6.86 ULMN 3 4mdh_c03 CYTOPLASMIC MALATE DEHYDROGENASE (E.user 3 3 # 3 B 158 ASP A 122 ASP^? 7.46 C1 GOL A 150 B 161 ARG A 31 ARG^? 11.10 C1 GOL A 150 B 186 HIS A 4 HIS.? -3.92 C2 GOL A 150s coo 44.53 16.44 28.54 44.89 18.45 28.77 -15.41 64.92 4.51 -15.09 66.83 5.33 coo 39.64 19.27 28.15 40.19 21.74 29.94 -18.51 63.86 1.13 -18.37 66.66 2.58 coo 48.32 20.00 31.44 46.45 20.91 31.50 -11.85 68.18 8.83 -11.23 70.10 8.29 ULMN 3 4mdh_c03 CYTOPLASMIC MALATE DEHYDROGENASE (E.user 4 3 # 4 B 158 ASP B 56 ASP~? 11.45 C20 PE8 B 148 B 161 ARG B 55 ARG~? 9.33 CG MLY C 135 B 186 HIS B 115 HIS~? 12.48 C18 PE8 B 148 coo 44.53 16.44 28.54 44.89 18.45 28.77 6.80 78.21 26.00 8.47 79.07 25.03 coo 39.64 19.27 28.15 40.19 21.74 29.94 8.78 84.29 24.99 10.39 86.20 26.77 coo 48.32 20.00 31.44 46.45 20.91 31.50 11.86 77.76 30.05 12.70 77.49 28.15 ULMN 3 4mdh_c03 CYTOPLASMIC MALATE DEHYDROGENASE (E.user 5 3 # 5 B 158 ASP B 87 ASP.? 8.94 O4 PGE B 147 B 161 ARG B 31 ARG^? 11.02 C6 PGE B 147 B 186 HIS B 88 HIS^? 4.29 CH1 MLY C 135 coo 44.53 16.44 28.54 44.89 18.45 28.77 9.49 87.97 42.02 11.31 87.98 43.09 coo 39.64 19.27 28.15 40.19 21.74 29.94 12.15 83.61 47.77 10.36 84.10 50.21 coo 48.32 20.00 31.44 46.45 20.91 31.50 6.15 87.00 38.94 7.35 87.96 37.51 ULMN 3 4mdh_c03 CYTOPLASMIC MALATE DEHYDROGENASE (E.user 6 3 # 6 B 158 ASP B 122 ASP^? 7.33 O2 GOL B 149 B 161 ARG B 31 ARG^? 11.02 C6 PGE B 147 B 186 HIS B 4 HIS.? -3.86 O2 GOL B 149s coo 44.53 16.44 28.54 44.89 18.45 28.77 10.89 79.68 47.57 9.75 78.80 49.16 coo 39.64 19.27 28.15 40.19 21.74 29.94 12.15 83.61 47.77 10.36 84.10 50.21 coo 48.32 20.00 31.44 46.45 20.91 31.50 8.07 73.88 49.16 8.30 73.43 51.19 ULMN 3 4mdh_c03 CYTOPLASMIC MALATE DEHYDROGENASE (E.user 7 3 # 7 B 158 ASP C 56 ASP~? 9.09 N MLZ C 114 B 161 ARG C 55 ARG~? 9.18 O MLY B 135 B 186 HIS C 115 HIS~? 4.72 C MLZ C 114 coo 44.53 16.44 28.54 44.89 18.45 28.77 -16.40 94.43 66.11 -17.63 93.56 67.58 coo 39.64 19.27 28.15 40.19 21.74 29.94 -21.06 89.68 64.73 -20.37 86.74 65.24 coo 48.32 20.00 31.44 46.45 20.91 31.50 -12.99 90.00 69.08 -14.38 90.57 70.54 ULMN 3 4mdh_c03 CYTOPLASMIC MALATE DEHYDROGENASE (E.user 8 3 # 8 B 158 ASP C 87 ASP.? 8.84 O1 PGE C 147 B 161 ARG C 31 ARG^? 11.22 C3 GOL C 149 B 186 HIS C 88 HIS^? 3.86 CD MLY B 135 coo 44.53 16.44 28.54 44.89 18.45 28.77 -9.03 79.00 58.44 -8.21 77.39 59.55 coo 39.64 19.27 28.15 40.19 21.74 29.94 -2.17 77.49 60.72 0.17 78.08 58.83 coo 48.32 20.00 31.44 46.45 20.91 31.50 -11.00 83.03 57.18 -12.69 82.43 58.26 ULMN 3 4mdh_c03 CYTOPLASMIC MALATE DEHYDROGENASE (E.user 9 3 # 9 B 158 ASP C 122 ASP^? 7.22 C3 GOL C 149 B 161 ARG C 31 ARG^? 11.22 C3 GOL C 149 B 186 HIS C 4 HIS.? -3.73 C3 GOL C 149s coo 44.53 16.44 28.54 44.89 18.45 28.77 0.27 81.12 61.60 2.07 81.54 60.53 coo 39.64 19.27 28.15 40.19 21.74 29.94 -2.17 77.49 60.72 0.17 78.08 58.83 coo 48.32 20.00 31.44 46.45 20.91 31.50 4.88 85.81 61.42 6.80 85.00 61.18 ULMN 3 4mdh_c03 CYTOPLASMIC MALATE DEHYDROGENASE (E.user 10 3 # 10 B 158 ASP D 56 ASP~? 11.46 C21 2PE D 146 B 161 ARG D 55 ARG~? 9.16 CG MLY A 135 B 186 HIS D 115 HIS~? 12.18 C21 2PE D 146 coo 44.53 16.44 28.54 44.89 18.45 28.77 -41.85 87.81 13.66 -41.61 89.58 14.80 coo 39.64 19.27 28.15 40.19 21.74 29.94 -39.98 89.02 19.79 -37.17 89.06 21.03 coo 48.32 20.00 31.44 46.45 20.91 31.50 -36.28 90.32 11.92 -37.49 91.98 12.35 ULMN 3 4mdh_c03 CYTOPLASMIC MALATE DEHYDROGENASE (E.user 11 3 # 11 B 158 ASP D 87 ASP.? 7.26 C16 1PE B 150 B 161 ARG D 31 ARG^? 10.57 OH7 1PE B 150 B 186 HIS D 88 HIS^? 4.38 CH1 MLY A 135 coo 44.53 16.44 28.54 44.89 18.45 28.77 -24.70 80.89 17.41 -22.90 81.94 17.31 coo 39.64 19.27 28.15 40.19 21.74 29.94 -19.64 81.34 12.02 -19.24 78.87 10.07 coo 48.32 20.00 31.44 46.45 20.91 31.50 -29.18 79.71 17.63 -29.43 81.25 19.03 ULMN 3 4mdh_c03 CYTOPLASMIC MALATE DEHYDROGENASE (E.user 12 3 # 12 B 158 ASP D 122 ASP^? 7.49 C3 GOL D 147 B 161 ARG D 31 ARG^? 10.57 OH7 1PE B 150 B 186 HIS D 4 HIS.? 4.07 C3 GOL D 147 coo 44.53 16.44 28.54 44.89 18.45 28.77 -21.82 80.90 7.85 -21.38 79.32 6.51 coo 39.64 19.27 28.15 40.19 21.74 29.94 -19.64 81.34 12.02 -19.24 78.87 10.07 coo 48.32 20.00 31.44 46.45 20.91 31.50 -23.57 78.63 1.94 -22.01 77.96 0.72 4mdh_c03 source 4mdh CYTOPLASMIC MALATE DEHYDROGENASE (E.C.1.1.1.37: 12 hits 4mdh_c03 naa= 3 ULMN 3 5cpa_c01 CARBOXYPEPTIDASE A=ALPHA= (COX) (E.Cuser 1 3 # 1 71 ARG A 16 ARG~? -2.82 O4 SO4 A 143s 127 ARG B 105 ARG~? -3.01 O4 SO4 A 143s 270 GLU A 10 GLU~? 8.70 C6 2PE A 148 coo -1.14 25.72 1.64 0.76 28.10 1.50 -9.29 63.37 28.06 -8.90 62.24 30.90 coo 2.87 25.67 -2.58 1.96 27.95 -4.18 -2.68 64.28 31.62 -4.52 62.28 32.99 coo -7.41 30.69 -7.56 -5.96 29.61 -6.39 -3.10 70.57 20.07 -2.45 69.30 18.38 ULMN 3 5cpa_c01 CARBOXYPEPTIDASE A=ALPHA= (COX) (E.Cuser 2 3 # 2 71 ARG A 20 ARG.? 4.64 CB MLZ A 129 127 ARG A 127 ARG^? 7.47 N MLZ A 129 270 GLU A 93 GLU^? 3.90 NZ MLY A 67 coo -1.14 25.72 1.64 0.76 28.10 1.50 -20.19 69.79 30.19 -22.38 67.97 29.03 coo 2.87 25.67 -2.58 1.96 27.95 -4.18 -18.44 68.25 24.06 -17.70 68.37 27.04 coo -7.41 30.69 -7.56 -5.96 29.61 -6.39 -27.37 60.67 25.57 -29.32 61.09 26.31 ULMN 3 5cpa_c01 CARBOXYPEPTIDASE A=ALPHA= (COX) (E.Cuser 3 3 # 3 71 ARG A 20 ARG.? 4.64 CB MLZ A 129 127 ARG A 127 ARG^? 7.47 N MLZ A 129 270 GLU B 102 GLU~? 6.18 O4 SO4 A 143 coo -1.14 25.72 1.64 0.76 28.10 1.50 -20.19 69.79 30.19 -22.38 67.97 29.03 coo 2.87 25.67 -2.58 1.96 27.95 -4.18 -18.44 68.25 24.06 -17.70 68.37 27.04 coo -7.41 30.69 -7.56 -5.96 29.61 -6.39 -7.10 67.86 29.77 -6.34 66.05 29.12 ULMN 3 5cpa_c01 CARBOXYPEPTIDASE A=ALPHA= (COX) (E.Cuser 4 3 # 4 71 ARG A 127 ARG^? 7.47 N MLZ A 129 127 ARG A 20 ARG.? 4.64 CB MLZ A 129 270 GLU A 93 GLU^? 3.90 NZ MLY A 67 coo -1.14 25.72 1.64 0.76 28.10 1.50 -18.44 68.25 24.06 -17.70 68.37 27.04 coo 2.87 25.67 -2.58 1.96 27.95 -4.18 -20.19 69.79 30.19 -22.38 67.97 29.03 coo -7.41 30.69 -7.56 -5.96 29.61 -6.39 -27.37 60.67 25.57 -29.32 61.09 26.31 ULMN 3 5cpa_c01 CARBOXYPEPTIDASE A=ALPHA= (COX) (E.Cuser 5 3 # 5 71 ARG A 127 ARG^? 7.47 N MLZ A 129 127 ARG A 20 ARG.? 4.64 CB MLZ A 129 270 GLU B 102 GLU~? 6.18 O4 SO4 A 143 coo -1.14 25.72 1.64 0.76 28.10 1.50 -18.44 68.25 24.06 -17.70 68.37 27.04 coo 2.87 25.67 -2.58 1.96 27.95 -4.18 -20.19 69.79 30.19 -22.38 67.97 29.03 coo -7.41 30.69 -7.56 -5.96 29.61 -6.39 -7.10 67.86 29.77 -6.34 66.05 29.12 ULMN 3 5cpa_c01 CARBOXYPEPTIDASE A=ALPHA= (COX) (E.Cuser 6 3 # 6 71 ARG B 20 ARG.? 7.28 C1 PEG B 146 127 ARG B 127 ARG^? 9.26 O4 SO4 A 144 270 GLU B 93 GLU^? 4.01 CE MLZ B 67 coo -1.14 25.72 1.64 0.76 28.10 1.50 -14.05 70.97 43.62 -13.60 73.76 42.39 coo 2.87 25.67 -2.58 1.96 27.95 -4.18 -7.64 72.55 44.16 -9.78 70.52 43.36 coo -7.41 30.69 -7.56 -5.96 29.61 -6.39 -11.20 80.89 36.50 -12.93 82.08 36.76 ULMN 3 5cpa_c01 CARBOXYPEPTIDASE A=ALPHA= (COX) (E.Cuser 7 3 # 7 71 ARG B 105 ARG~? -3.01 O4 SO4 A 143s 127 ARG A 16 ARG~? -2.82 O4 SO4 A 143s 270 GLU A 10 GLU~? 8.70 C6 2PE A 148 coo -1.14 25.72 1.64 0.76 28.10 1.50 -2.68 64.28 31.62 -4.52 62.28 32.99 coo 2.87 25.67 -2.58 1.96 27.95 -4.18 -9.29 63.37 28.06 -8.90 62.24 30.90 coo -7.41 30.69 -7.56 -5.96 29.61 -6.39 -3.10 70.57 20.07 -2.45 69.30 18.38 ULMN 3 5cpa_c01 CARBOXYPEPTIDASE A=ALPHA= (COX) (E.Cuser 8 3 # 8 71 ARG B 105 ARG~? -3.01 O4 SO4 A 143s 127 ARG B 110 ARG~? 10.12 O7 PE8 B 148 270 GLU A 10 GLU~? 8.70 C6 2PE A 148 coo -1.14 25.72 1.64 0.76 28.10 1.50 -2.68 64.28 31.62 -4.52 62.28 32.99 coo 2.87 25.67 -2.58 1.96 27.95 -4.18 4.56 66.25 30.54 5.81 64.43 28.32 coo -7.41 30.69 -7.56 -5.96 29.61 -6.39 -3.10 70.57 20.07 -2.45 69.30 18.38 ULMN 3 5cpa_c01 CARBOXYPEPTIDASE A=ALPHA= (COX) (E.Cuser 9 3 # 9 71 ARG B 110 ARG~? 10.12 O7 PE8 B 148 127 ARG B 105 ARG~? -3.01 O4 SO4 A 143s 270 GLU A 10 GLU~? 8.70 C6 2PE A 148 coo -1.14 25.72 1.64 0.76 28.10 1.50 4.56 66.25 30.54 5.81 64.43 28.32 coo 2.87 25.67 -2.58 1.96 27.95 -4.18 -2.68 64.28 31.62 -4.52 62.28 32.99 coo -7.41 30.69 -7.56 -5.96 29.61 -6.39 -3.10 70.57 20.07 -2.45 69.30 18.38 ULMN 3 5cpa_c01 CARBOXYPEPTIDASE A=ALPHA= (COX) (E.Cuser 10 3 # 10 71 ARG B 127 ARG^? 9.26 O4 SO4 A 144 127 ARG B 20 ARG.? 7.28 C1 PEG B 146 270 GLU B 93 GLU^? 4.01 CE MLZ B 67 coo -1.14 25.72 1.64 0.76 28.10 1.50 -7.64 72.55 44.16 -9.78 70.52 43.36 coo 2.87 25.67 -2.58 1.96 27.95 -4.18 -14.05 70.97 43.62 -13.60 73.76 42.39 coo -7.41 30.69 -7.56 -5.96 29.61 -6.39 -11.20 80.89 36.50 -12.93 82.08 36.76 ULMN 3 5cpa_c01 CARBOXYPEPTIDASE A=ALPHA= (COX) (E.Cuser 11 3 # 11 71 ARG C 20 ARG.? 4.54 CB MLZ C 129 127 ARG C 127 ARG^? 7.44 N MLZ C 129 270 GLU C 93 GLU^? -3.82 CH2 MLY C 67s coo -1.14 25.72 1.64 0.76 28.10 1.50 2.03 103.13 46.63 -0.64 101.63 46.15 coo 2.87 25.67 -2.58 1.96 27.95 -4.18 1.53 98.09 50.88 2.14 101.05 50.40 coo -7.41 30.69 -7.56 -5.96 29.61 -6.39 -9.46 98.26 46.68 -9.97 98.34 44.62 ULMN 3 5cpa_c01 CARBOXYPEPTIDASE A=ALPHA= (COX) (E.Cuser 12 3 # 12 71 ARG C 127 ARG^? 7.44 N MLZ C 129 127 ARG C 20 ARG.? 4.54 CB MLZ C 129 270 GLU C 93 GLU^? -3.82 CH2 MLY C 67s coo -1.14 25.72 1.64 0.76 28.10 1.50 1.53 98.09 50.88 2.14 101.05 50.40 coo 2.87 25.67 -2.58 1.96 27.95 -4.18 2.03 103.13 46.63 -0.64 101.63 46.15 coo -7.41 30.69 -7.56 -5.96 29.61 -6.39 -9.46 98.26 46.68 -9.97 98.34 44.62 ULMN 3 5cpa_c01 CARBOXYPEPTIDASE A=ALPHA= (COX) (E.Cuser 13 3 # 13 71 ARG D 20 ARG.? 10.31 C3 PEG D 145 127 ARG D 127 ARG^? 9.31 O3 PGE A 147 270 GLU D 93 GLU^? -3.68 CE MLY D 67s coo -1.14 25.72 1.64 0.76 28.10 1.50 -40.03 62.67 1.01 -40.08 63.13 4.08 coo 2.87 25.67 -2.58 1.96 27.95 -4.18 -35.94 67.72 2.28 -38.25 66.55 0.66 coo -7.41 30.69 -7.56 -5.96 29.61 -6.39 -41.50 66.77 12.62 -41.92 65.02 13.75 ULMN 3 5cpa_c01 CARBOXYPEPTIDASE A=ALPHA= (COX) (E.Cuser 14 3 # 14 71 ARG D 127 ARG^? 9.31 O3 PGE A 147 127 ARG D 20 ARG.? 10.31 C3 PEG D 145 270 GLU D 93 GLU^? -3.68 CE MLY D 67s coo -1.14 25.72 1.64 0.76 28.10 1.50 -35.94 67.72 2.28 -38.25 66.55 0.66 coo 2.87 25.67 -2.58 1.96 27.95 -4.18 -40.03 62.67 1.01 -40.08 63.13 4.08 coo -7.41 30.69 -7.56 -5.96 29.61 -6.39 -41.50 66.77 12.62 -41.92 65.02 13.75 5cpa_c01 source 5cpa CARBOXYPEPTIDASE A=ALPHA= (COX) (E.C.3.4.17.1): 14 hits 5cpa_c01 naa= 3 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 1 1 # 1 A 461 ASN A 18 ASN~? 7.05 CM MLZ A 129 coo 5.80 63.03 55.85 5.52 65.03 56.45 -15.51 71.08 28.46 -17.41 71.81 28.97 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 2 1 # 2 A 461 ASN A 28 ASN^? 3.50 CL CL A 145s coo 5.80 63.03 55.85 5.52 65.03 56.45 -22.13 61.51 13.69 -20.95 60.87 15.35 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 3 1 # 3 A 461 ASN B 18 ASN~? 7.46 O3 PGE C 147 coo 5.80 63.03 55.85 5.52 65.03 56.45 -10.56 67.47 45.50 -12.09 68.82 46.03 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 4 1 # 4 A 461 ASN B 28 ASN^? 3.43 CL CL B 143s coo 5.80 63.03 55.85 5.52 65.03 56.45 0.96 81.77 41.38 0.26 80.18 40.18 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 5 1 # 5 A 461 ASN C 18 ASN~? 7.71 C3 PGE B 147 coo 5.80 63.03 55.85 5.52 65.03 56.45 5.53 102.64 50.54 5.25 102.39 48.47 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 6 1 # 6 A 461 ASN C 28 ASN^? 3.42 CL CL C 144s coo 5.80 63.03 55.85 5.52 65.03 56.45 -6.06 88.35 54.50 -6.05 90.38 55.16 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 7 1 # 7 A 461 ASN D 18 ASN~? 7.72 O4 PGE A 147 coo 5.80 63.03 55.85 5.52 65.03 56.45 -37.88 65.32 -2.95 -37.84 63.53 -1.86 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 8 1 # 8 A 461 ASN D 28 ASN^? 3.51 CL CL D 143s coo 5.80 63.03 55.85 5.52 65.03 56.45 -31.24 74.87 11.89 -33.01 75.13 10.75 1kbk_p00 source 1kbk ALPHA-AMYLASE, PANCREATIC : 8 hits 1kbk_p00 naa= 1 ULMN 3 1o8s_p00 PUTATIVE ENDO-XYLANASE user 1 3 # 1 A 56 TYR A 50 TYR~? 5.51 CH2 MLY D 135 A 112 PHE A 90 PHE^? 4.08 CH1 MLY D 135 A 140 ASN A 28 ASN^? 3.50 CL CL A 145s coo -6.29 44.15 17.65 -9.00 44.92 17.68 -19.50 53.98 8.67 -20.18 55.72 10.74 coo -7.38 52.77 16.75 -5.54 52.71 18.82 -25.59 59.02 13.87 -22.88 58.27 14.15 coo -4.46 50.64 12.29 -5.69 49.89 13.85 -22.13 61.51 13.69 -20.95 60.87 15.35 ULMN 3 1o8s_p00 PUTATIVE ENDO-XYLANASE user 2 3 # 2 A 56 TYR B 50 TYR~? 5.52 CH1 MLY C 135 A 112 PHE B 90 PHE^? 3.94 CH1 MLY C 135 A 140 ASN B 28 ASN^? 3.43 CL CL B 143s coo -6.29 44.15 17.65 -9.00 44.92 17.68 8.51 83.11 35.90 5.93 82.51 36.84 coo -7.38 52.77 16.75 -5.54 52.71 18.82 -0.26 85.08 38.94 1.10 82.78 38.09 coo -4.46 50.64 12.29 -5.69 49.89 13.85 0.96 81.77 41.38 0.26 80.18 40.18 ULMN 3 1o8s_p00 PUTATIVE ENDO-XYLANASE user 3 3 # 3 A 56 TYR C 50 TYR~? 5.59 CE MLY B 135 A 112 PHE C 90 PHE^? 3.87 CH1 MLY B 135 A 140 ASN C 28 ASN^? 3.42 CL CL C 144s coo -6.29 44.15 17.65 -9.00 44.92 17.68 -11.27 85.65 61.91 -10.18 87.09 59.78 coo -7.38 52.77 16.75 -5.54 52.71 18.82 -9.96 87.99 52.84 -9.24 88.98 55.39 coo -4.46 50.64 12.29 -5.69 49.89 13.85 -6.06 88.35 54.50 -6.05 90.38 55.16 ULMN 3 1o8s_p00 PUTATIVE ENDO-XYLANASE user 4 3 # 4 A 56 TYR D 50 TYR~? 5.61 CH1 MLY A 135 A 112 PHE D 90 PHE^? 4.00 CH1 MLY A 135 A 140 ASN D 28 ASN^? 3.51 CL CL D 143s coo -6.29 44.15 17.65 -9.00 44.92 17.68 -31.54 83.73 14.98 -32.20 81.17 14.09 coo -7.38 52.77 16.75 -5.54 52.71 18.82 -32.92 74.43 15.81 -33.53 76.42 13.90 coo -4.46 50.64 12.29 -5.69 49.89 13.85 -31.24 74.87 11.89 -33.01 75.13 10.75 1o8s_p00 source 1o8s PUTATIVE ENDO-XYLANASE : 4 hits 1o8s_p00 naa= 3 ULMN 4 2cl8_p00 DECTIN-1 user 1 4 # 1 A 145 ARG A 20 ARG.? 4.64 CB MLZ A 129 A 148 SER B 96 SER~? 7.21 O4 SO4 A 144 A 152 ALA B 99 ALA~? 8.23 C24 1PE B 150 A 194 GLU B 93 GLU^? 4.01 CE MLZ B 67 coo -29.52 -1.51 -10.80 -29.25 -1.07 -13.87 -20.19 69.79 30.19 -22.38 67.97 29.03 coo -35.30 0.90 -4.91 -36.19 -1.20 -5.57 -12.28 72.78 35.88 -11.90 71.42 33.88 coo -37.81 4.22 -2.30 -36.99 5.43 -2.37 -8.65 71.66 32.40 -9.35 73.01 32.38 coo -43.25 5.44 -9.45 -44.36 4.89 -7.68 -11.20 80.89 36.50 -12.93 82.08 36.76 2cl8_p00 source 2cl8 DECTIN-1 : 1 hits 2cl8_p00 naa= 4 ULMN 3 2p3i_p00 VP4 user 1 3 # 1 A 101 ARG A 20 ARG.? 4.64 CB MLZ A 129 A 188 TYR A 94 TYR^? 4.94 CL CL A 145s A 190 SER A 96 SER~? 7.38 O1 SO4 A 144 coo 37.69 7.64 13.51 38.82 8.84 16.11 -20.19 69.79 30.19 -22.38 67.97 29.03 coo 47.14 12.10 13.73 48.75 12.33 16.01 -21.59 58.91 24.53 -21.03 57.83 22.04 coo 43.77 6.93 15.46 45.49 7.21 17.11 -20.86 61.67 30.54 -19.56 59.85 31.49 ULMN 3 2p3i_p00 VP4 user 2 3 # 2 A 101 ARG A 63 ARG~? 11.15 O28 2PE A 148 A 188 TYR A 109 TYR~? -5.64 O16 2PE A 148s A 190 SER A 61 SER~? -2.92 O25 2PE A 148s coo 37.69 7.64 13.51 38.82 8.84 16.11 -18.54 46.85 28.43 -16.64 46.31 26.03 coo 47.14 12.10 13.73 48.75 12.33 16.01 -13.81 52.60 20.09 -14.53 54.76 18.49 coo 43.77 6.93 15.46 45.49 7.21 17.11 -20.68 51.98 23.20 -22.01 53.58 22.10 ULMN 3 2p3i_p00 VP4 user 3 3 # 3 A 101 ARG B 20 ARG.? 7.28 C1 PEG B 146 A 188 TYR B 94 TYR^? -5.06 CL CL B 143s A 190 SER B 96 SER~? 7.21 O4 SO4 A 144 coo 37.69 7.64 13.51 38.82 8.84 16.11 -14.05 70.97 43.62 -13.60 73.76 42.39 coo 47.14 12.10 13.73 48.75 12.33 16.01 -6.97 76.65 35.26 -4.34 77.53 35.11 coo 43.77 6.93 15.46 45.49 7.21 17.11 -12.28 72.78 35.88 -11.90 71.42 33.88 ULMN 3 2p3i_p00 VP4 user 4 3 # 4 A 101 ARG B 63 ARG~? -8.01 OH2 1PE B 150s A 188 TYR B 109 TYR~? -5.65 O13 PE8 B 148s A 190 SER B 61 SER~? -3.13 O22 PE8 B 148s coo 37.69 7.64 13.51 38.82 8.84 16.11 -5.18 74.17 22.68 -2.11 73.83 22.90 coo 47.14 12.10 13.73 48.75 12.33 16.01 2.41 73.03 30.76 2.68 74.03 33.35 coo 43.77 6.93 15.46 45.49 7.21 17.11 -3.39 77.64 29.23 -3.48 78.95 31.25 ULMN 3 2p3i_p00 VP4 user 5 3 # 5 A 101 ARG C 20 ARG.? 4.54 CB MLZ C 129 A 188 TYR C 94 TYR^? 5.01 CL CL C 144s A 190 SER C 96 SER~? 11.39 N MLY C 67 coo 37.69 7.64 13.51 38.82 8.84 16.11 2.03 103.13 46.63 -0.64 101.63 46.15 coo 47.14 12.10 13.73 48.75 12.33 16.01 -8.07 99.17 52.54 -8.69 97.12 54.34 coo 43.77 6.93 15.46 45.49 7.21 17.11 -5.29 104.57 49.79 -6.22 106.17 51.38 ULMN 3 2p3i_p00 VP4 user 6 3 # 6 A 101 ARG C 63 ARG~? -11.70 O25 PE8 C 148s A 188 TYR C 109 TYR~? -5.91 C14 PE8 C 148s A 190 SER C 61 SER~? -3.32 C24 PE8 C 148s coo 37.69 7.64 13.51 38.82 8.84 16.11 -17.02 105.73 59.39 -16.53 104.08 61.96 coo 47.14 12.10 13.73 48.75 12.33 16.01 -9.64 98.32 63.33 -8.13 96.27 62.21 coo 43.77 6.93 15.46 45.49 7.21 17.11 -13.57 99.31 57.04 -12.74 97.63 55.62 ULMN 3 2p3i_p00 VP4 user 7 3 # 7 A 101 ARG D 20 ARG.? 10.31 C3 PEG D 145 A 188 TYR D 94 TYR^? -4.97 CL CL D 143s A 190 SER D 96 SER~? 11.44 N MLY D 67 coo 37.69 7.64 13.51 38.82 8.84 16.11 -40.03 62.67 1.01 -40.08 63.13 4.08 coo 47.14 12.10 13.73 48.75 12.33 16.01 -41.68 71.74 9.13 -40.22 73.97 9.96 coo 43.77 6.93 15.46 45.49 7.21 17.11 -44.97 67.48 5.17 -46.83 69.00 4.60 ULMN 3 2p3i_p00 VP4 user 8 3 # 8 A 101 ARG D 63 ARG~? -11.23 O28 2PE D 146s A 188 TYR D 109 TYR~? -5.82 O16 2PE D 146s A 190 SER D 61 SER~? -3.17 O25 2PE D 146s coo 37.69 7.64 13.51 38.82 8.84 16.11 -51.80 79.77 10.92 -50.17 82.42 10.63 coo 47.14 12.10 13.73 48.75 12.33 16.01 -41.76 82.56 7.21 -39.24 81.41 7.29 coo 43.77 6.93 15.46 45.49 7.21 17.11 -44.62 77.53 12.06 -42.61 76.31 12.46 2p3i_p00 source 2p3i VP4 : 8 hits 2p3i_p00 naa= 3 ULMN 3 1bdv_d00 GENE REGULATION/DNA user 1 3 # 1 A 9 GLN A 14 GLN~? 4.09 C14 1PE B 150 A 11 ASN A 18 ASN~? 7.05 CM MLZ A 129 A 13 ARG A 20 ARG.? 4.64 CB MLZ A 129 coo 33.45 2.10 7.21 34.51 1.09 5.67 -9.40 72.50 23.82 -9.67 73.73 22.10 coo 38.37 -1.60 11.46 39.03 -3.43 10.75 -15.51 71.08 28.46 -17.41 71.81 28.97 coo 41.73 -6.32 12.94 43.25 -5.49 10.40 -20.19 69.79 30.19 -22.38 67.97 29.03 ULMN 3 1bdv_d00 GENE REGULATION/DNA user 2 3 # 2 A 9 GLN B 14 GLN~? 3.86 C4 PGE C 147 A 11 ASN B 18 ASN~? 7.46 O3 PGE C 147 A 13 ARG B 20 ARG.? 7.28 C1 PEG B 146 coo 33.45 2.10 7.21 34.51 1.09 5.67 -4.26 64.23 48.43 -3.20 64.97 50.12 coo 38.37 -1.60 11.46 39.03 -3.43 10.75 -10.56 67.47 45.50 -12.09 68.82 46.03 coo 41.73 -6.32 12.94 43.25 -5.49 10.40 -14.05 70.97 43.62 -13.60 73.76 42.39 ULMN 3 1bdv_d00 GENE REGULATION/DNA user 3 3 # 3 A 9 GLN B 71 GLN.? 3.79 NZ MLY C 135 A 11 ASN B 28 ASN^? 3.43 CL CL B 143s A 13 ARG B 116 ARG~? 4.93 C12 PE8 B 148 coo 33.45 2.10 7.21 34.51 1.09 5.67 -0.31 89.93 38.21 0.60 89.72 36.30 coo 38.37 -1.60 11.46 39.03 -3.43 10.75 0.96 81.77 41.38 0.26 80.18 40.18 coo 41.73 -6.32 12.94 43.25 -5.49 10.40 6.23 77.16 37.54 6.11 77.30 40.64 ULMN 3 1bdv_d00 GENE REGULATION/DNA user 4 3 # 4 A 9 GLN C 14 GLN~? 4.10 C4 PGE B 147 A 11 ASN C 18 ASN~? 7.71 C3 PGE B 147 A 13 ARG C 20 ARG.? 4.54 CB MLZ C 129 coo 33.45 2.10 7.21 34.51 1.09 5.67 9.82 99.77 56.17 10.76 97.86 56.11 coo 38.37 -1.60 11.46 39.03 -3.43 10.75 5.53 102.64 50.54 5.25 102.39 48.47 coo 41.73 -6.32 12.94 43.25 -5.49 10.40 2.03 103.13 46.63 -0.64 101.63 46.15 ULMN 3 1bdv_d00 GENE REGULATION/DNA user 5 3 # 5 A 9 GLN D 14 GLN~? 4.36 C3 PGE A 147 A 11 ASN D 18 ASN~? 7.72 O4 PGE A 147 A 13 ARG D 20 ARG.? 10.31 C3 PEG D 145 coo 33.45 2.10 7.21 34.51 1.09 5.67 -33.25 70.00 -6.94 -31.12 69.90 -6.76 coo 38.37 -1.60 11.46 39.03 -3.43 10.75 -37.88 65.32 -2.95 -37.84 63.53 -1.86 coo 41.73 -6.32 12.94 43.25 -5.49 10.40 -40.03 62.67 1.01 -40.08 63.13 4.08 1bdv_d00 source 1bdv GENE REGULATION/DNA : 5 hits 1bdv_d00 naa= 3 ULMN 4 1cf7_d00 TRANSCRIPTION/DNA user 1 4 # 1 A 17 ARG A 105 ARG~? -3.04 O2 SO4 A 143s A 56 ARG B 110 ARG~? 10.12 O7 PE8 B 148 A 57 ARG B 105 ARG~? -3.01 O4 SO4 A 143s A 59 TYR B 109 TYR~? -5.65 O13 PE8 B 148s coo 23.81 34.86 13.48 26.88 35.12 13.67 -8.78 56.32 28.12 -7.90 58.53 30.04 coo 34.72 21.75 14.37 35.68 23.54 16.67 4.56 66.25 30.54 5.81 64.43 28.32 coo 28.85 24.84 16.33 31.23 25.02 14.35 -2.68 64.28 31.62 -4.52 62.28 32.99 coo 34.87 18.31 18.80 34.65 15.66 17.89 2.41 73.03 30.76 2.68 74.03 33.35 ULMN 4 1cf7_d00 TRANSCRIPTION/DNA user 2 4 # 2 A 17 ARG B 105 ARG~? -3.01 O4 SO4 A 143s A 56 ARG A 110 ARG~? -3.66 O1 2PE A 148s A 57 ARG A 105 ARG~? -3.04 O2 SO4 A 143s A 59 TYR A 109 TYR~? -5.64 O16 2PE A 148s coo 23.81 34.86 13.48 26.88 35.12 13.67 -2.68 64.28 31.62 -4.52 62.28 32.99 coo 34.72 21.75 14.37 35.68 23.54 16.67 -6.91 52.41 21.82 -5.61 55.22 21.43 coo 28.85 24.84 16.33 31.23 25.02 14.35 -8.78 56.32 28.12 -7.90 58.53 30.04 coo 34.87 18.31 18.80 34.65 15.66 17.89 -13.81 52.60 20.09 -14.53 54.76 18.49 1cf7_d00 source 1cf7 TRANSCRIPTION/DNA : 2 hits 1cf7_d00 naa= 4 ULMN 3 1cqt_d00 GENE REGULATION/DNA user 1 3 # 1 I 303 TYR A 50 TYR~? 5.51 CH2 MLY D 135 I 306 VAL A 30 VAL^? 7.63 CH2 MLY D 135 I 308 VAL A 89 VAL^? 7.52 CH2 MLY D 135 coo 26.18 35.24 6.87 24.33 35.18 8.97 -19.50 53.98 8.67 -20.18 55.72 10.74 coo 23.55 29.53 9.81 23.15 27.39 10.24 -20.36 61.41 7.82 -19.79 59.66 8.98 coo 16.43 30.18 9.35 15.05 30.67 11.01 -26.37 61.75 10.01 -26.94 63.64 9.20 ULMN 3 1cqt_d00 GENE REGULATION/DNA user 2 3 # 2 I 303 TYR A 53 TYR~? -4.55 C21 2PE A 148s I 306 VAL A 113 VAL~? 5.20 C11 2PE A 148 I 308 VAL A 108 VAL~? 12.10 O22 2PE A 148 coo 26.18 35.24 6.87 24.33 35.18 8.97 -16.76 52.42 13.05 -16.88 54.33 15.10 coo 23.55 29.53 9.81 23.15 27.39 10.24 -12.07 52.60 14.69 -11.15 54.36 15.66 coo 16.43 30.18 9.35 15.05 30.67 11.01 -11.85 46.69 21.24 -13.33 45.13 21.50 ULMN 3 1cqt_d00 GENE REGULATION/DNA user 3 3 # 3 I 303 TYR B 50 TYR~? 5.52 CH1 MLY C 135 I 306 VAL B 30 VAL^? 7.57 CH1 MLY C 135 I 308 VAL B 89 VAL^? 7.46 CH1 MLY C 135 coo 26.18 35.24 6.87 24.33 35.18 8.97 8.51 83.11 35.90 5.93 82.51 36.84 coo 23.55 29.53 9.81 23.15 27.39 10.24 6.53 83.10 43.29 6.37 82.28 41.30 coo 16.43 30.18 9.35 15.05 30.67 11.01 1.72 87.18 42.85 1.64 87.82 44.92 ULMN 3 1cqt_d00 GENE REGULATION/DNA user 4 3 # 4 I 303 TYR B 53 TYR~? -4.63 C18 PE8 B 148s I 306 VAL B 113 VAL~? 5.33 C8 PE8 B 148 I 308 VAL B 108 VAL~? 12.14 O19 PE8 B 148 coo 26.18 35.24 6.87 24.33 35.18 8.97 6.73 78.96 33.00 4.51 77.73 34.14 coo 23.55 29.53 9.81 23.15 27.39 10.24 7.66 74.10 32.67 6.84 72.58 34.05 coo 16.43 30.18 9.35 15.05 30.67 11.01 4.18 71.84 24.83 3.58 73.22 23.25 ULMN 3 1cqt_d00 GENE REGULATION/DNA user 5 3 # 5 I 303 TYR C 50 TYR~? 5.59 CE MLY B 135 I 306 VAL C 30 VAL^? 7.69 CH1 MLY B 135 I 308 VAL C 89 VAL^? 7.43 CH1 MLY B 135 coo 26.18 35.24 6.87 24.33 35.18 8.97 -11.27 85.65 61.91 -10.18 87.09 59.78 coo 23.55 29.53 9.81 23.15 27.39 10.24 -5.27 83.40 57.91 -6.48 84.91 58.88 coo 16.43 30.18 9.35 15.05 30.67 11.01 -8.00 83.59 52.13 -6.58 82.28 51.11 ULMN 3 1cqt_d00 GENE REGULATION/DNA user 6 3 # 6 I 303 TYR C 53 TYR~? -4.98 C18 PE8 C 148s I 306 VAL C 113 VAL~? 2.88 N MLZ C 114 I 308 VAL C 108 VAL~? 10.09 N MLZ C 114 coo 26.18 35.24 6.87 24.33 35.18 8.97 -11.26 90.80 63.43 -9.63 92.35 61.80 coo 23.55 29.53 9.81 23.15 27.39 10.24 -8.75 93.66 66.57 -6.75 94.54 66.21 coo 16.43 30.18 9.35 15.05 30.67 11.01 -13.79 100.83 67.38 -15.88 100.95 66.81 ULMN 3 1cqt_d00 GENE REGULATION/DNA user 7 3 # 7 I 303 TYR D 50 TYR~? 5.61 CH1 MLY A 135 I 306 VAL D 30 VAL^? 7.69 CH1 MLY A 135 I 308 VAL D 89 VAL^? 7.52 CH1 MLY A 135 coo 26.18 35.24 6.87 24.33 35.18 8.97 -31.54 83.73 14.98 -32.20 81.17 14.09 coo 23.55 29.53 9.81 23.15 27.39 10.24 -26.56 78.72 12.45 -28.51 79.69 12.51 coo 16.43 30.18 9.35 15.05 30.67 11.01 -28.14 73.97 16.47 -26.28 72.79 16.34 1cqt_d00 source 1cqt GENE REGULATION/DNA : 7 hits 1cqt_d00 naa= 3 ULMN 3 1emh_d00 HYDROLASE/DNA user 1 3 # 1 A 271 PRO A 7 PRO.? -4.58 O7 2PE A 148s A 272 LEU A 125 LEU^? 4.68 C17 2PE A 148 A 276 ARG A 124 ARG^? 8.18 C1 GOL A 150 coo 16.45 -2.42 17.59 14.58 -2.74 16.47 -10.40 62.69 17.37 -9.93 63.97 15.68 coo 10.97 0.43 16.73 11.31 2.11 18.06 -17.49 64.43 15.55 -17.95 62.77 16.85 coo 5.13 -4.12 13.47 2.16 -3.72 14.17 -17.35 69.10 10.18 -16.14 69.37 7.36 ULMN 3 1emh_d00 HYDROLASE/DNA user 2 3 # 2 A 271 PRO A 7 PRO.? -4.58 O7 2PE A 148s A 272 LEU A 125 LEU^? 4.68 C17 2PE A 148 A 276 ARG A 127 ARG^? 7.47 N MLZ A 129 coo 16.45 -2.42 17.59 14.58 -2.74 16.47 -10.40 62.69 17.37 -9.93 63.97 15.68 coo 10.97 0.43 16.73 11.31 2.11 18.06 -17.49 64.43 15.55 -17.95 62.77 16.85 coo 5.13 -4.12 13.47 2.16 -3.72 14.17 -18.44 68.25 24.06 -17.70 68.37 27.04 ULMN 3 1emh_d00 HYDROLASE/DNA user 3 3 # 3 A 271 PRO A 7 PRO.? -4.58 O7 2PE A 148s A 272 LEU D 78 LEU.? 6.76 C14 2PE A 148 A 276 ARG A 124 ARG^? 8.18 C1 GOL A 150 coo 16.45 -2.42 17.59 14.58 -2.74 16.47 -10.40 62.69 17.37 -9.93 63.97 15.68 coo 10.97 0.43 16.73 11.31 2.11 18.06 -14.99 66.37 18.84 -13.83 65.06 20.07 coo 5.13 -4.12 13.47 2.16 -3.72 14.17 -17.35 69.10 10.18 -16.14 69.37 7.36 ULMN 3 1emh_d00 HYDROLASE/DNA user 4 3 # 4 A 271 PRO A 7 PRO.? -4.58 O7 2PE A 148s A 272 LEU D 78 LEU.? 6.76 C14 2PE A 148 A 276 ARG A 127 ARG^? 7.47 N MLZ A 129 coo 16.45 -2.42 17.59 14.58 -2.74 16.47 -10.40 62.69 17.37 -9.93 63.97 15.68 coo 10.97 0.43 16.73 11.31 2.11 18.06 -14.99 66.37 18.84 -13.83 65.06 20.07 coo 5.13 -4.12 13.47 2.16 -3.72 14.17 -18.44 68.25 24.06 -17.70 68.37 27.04 ULMN 3 1emh_d00 HYDROLASE/DNA user 5 3 # 5 A 271 PRO A 95 PRO.? 7.34 CD MLY A 67 A 272 LEU A 64 LEU~? 9.53 N MLY A 67 A 276 ARG A 63 ARG~? 11.15 O28 2PE A 148 coo 16.45 -2.42 17.59 14.58 -2.74 16.47 -23.59 57.70 30.16 -23.92 59.73 29.24 coo 10.97 0.43 16.73 11.31 2.11 18.06 -19.44 53.00 27.96 -17.35 52.32 28.29 coo 5.13 -4.12 13.47 2.16 -3.72 14.17 -18.54 46.85 28.43 -16.64 46.31 26.03 ULMN 3 1emh_d00 HYDROLASE/DNA user 6 3 # 6 A 271 PRO B 7 PRO.? -4.74 C6 PE8 B 148s A 272 LEU B 125 LEU^? 4.86 C15 PE8 B 148 A 276 ARG B 124 ARG^? 8.02 O2 GOL B 149 coo 16.45 -2.42 17.59 14.58 -2.74 16.47 3.39 69.73 41.22 4.67 69.93 42.99 coo 10.97 0.43 16.73 11.31 2.11 18.06 0.84 76.40 43.40 -0.09 76.47 41.42 coo 5.13 -4.12 13.47 2.16 -3.72 14.17 3.96 78.02 49.67 6.79 78.26 50.86 ULMN 3 1emh_d00 HYDROLASE/DNA user 7 3 # 7 A 271 PRO B 7 PRO.? -4.74 C6 PE8 B 148s A 272 LEU B 125 LEU^? 4.86 C15 PE8 B 148 A 276 ARG B 127 ARG^? 9.26 O4 SO4 A 144 coo 16.45 -2.42 17.59 14.58 -2.74 16.47 3.39 69.73 41.22 4.67 69.93 42.99 coo 10.97 0.43 16.73 11.31 2.11 18.06 0.84 76.40 43.40 -0.09 76.47 41.42 coo 5.13 -4.12 13.47 2.16 -3.72 14.17 -7.64 72.55 44.16 -9.78 70.52 43.36 ULMN 3 1emh_d00 HYDROLASE/DNA user 8 3 # 8 A 271 PRO B 7 PRO.? -4.74 C6 PE8 B 148s A 272 LEU C 78 LEU.? 6.59 C11 PE8 B 148 A 276 ARG B 124 ARG^? 8.02 O2 GOL B 149 coo 16.45 -2.42 17.59 14.58 -2.74 16.47 3.39 69.73 41.22 4.67 69.93 42.99 coo 10.97 0.43 16.73 11.31 2.11 18.06 -1.13 72.41 44.19 -1.22 71.01 42.54 coo 5.13 -4.12 13.47 2.16 -3.72 14.17 3.96 78.02 49.67 6.79 78.26 50.86 ULMN 3 1emh_d00 HYDROLASE/DNA user 9 3 # 9 A 271 PRO B 7 PRO.? -4.74 C6 PE8 B 148s A 272 LEU C 78 LEU.? 6.59 C11 PE8 B 148 A 276 ARG B 127 ARG^? 9.26 O4 SO4 A 144 coo 16.45 -2.42 17.59 14.58 -2.74 16.47 3.39 69.73 41.22 4.67 69.93 42.99 coo 10.97 0.43 16.73 11.31 2.11 18.06 -1.13 72.41 44.19 -1.22 71.01 42.54 coo 5.13 -4.12 13.47 2.16 -3.72 14.17 -7.64 72.55 44.16 -9.78 70.52 43.36 ULMN 3 1emh_d00 HYDROLASE/DNA user 10 3 # 10 A 271 PRO B 95 PRO.? 7.58 CE MLZ B 67 A 272 LEU B 64 LEU~? 7.06 OH4 1PE B 150 A 276 ARG B 63 ARG~? -8.01 OH2 1PE B 150s coo 16.45 -2.42 17.59 14.58 -2.74 16.47 -12.20 75.89 32.26 -12.22 76.36 34.46 coo 10.97 0.43 16.73 11.31 2.11 18.06 -6.99 74.17 28.56 -6.11 72.35 27.70 coo 5.13 -4.12 13.47 2.16 -3.72 14.17 -5.18 74.17 22.68 -2.11 73.83 22.90 ULMN 3 1emh_d00 HYDROLASE/DNA user 11 3 # 11 A 271 PRO C 7 PRO.? -4.63 C6 PE8 C 148s A 272 LEU B 78 LEU.? 6.77 C12 PE8 C 148 A 276 ARG C 124 ARG^? 7.92 C3 GOL C 149 coo 16.45 -2.42 17.59 14.58 -2.74 16.47 0.88 95.09 62.29 2.19 93.37 62.62 coo 10.97 0.43 16.73 11.31 2.11 18.06 1.69 94.40 56.33 1.23 96.16 57.46 coo 5.13 -4.12 13.47 2.16 -3.72 14.17 2.87 85.20 55.95 3.74 82.90 57.81 ULMN 3 1emh_d00 HYDROLASE/DNA user 12 3 # 12 A 271 PRO C 7 PRO.? -4.63 C6 PE8 C 148s A 272 LEU B 78 LEU.? 6.77 C12 PE8 C 148 A 276 ARG C 127 ARG^? 7.44 N MLZ C 129 coo 16.45 -2.42 17.59 14.58 -2.74 16.47 0.88 95.09 62.29 2.19 93.37 62.62 coo 10.97 0.43 16.73 11.31 2.11 18.06 1.69 94.40 56.33 1.23 96.16 57.46 coo 5.13 -4.12 13.47 2.16 -3.72 14.17 1.53 98.09 50.88 2.14 101.05 50.40 ULMN 3 1emh_d00 HYDROLASE/DNA user 13 3 # 13 A 271 PRO C 7 PRO.? -4.63 C6 PE8 C 148s A 272 LEU C 125 LEU^? 5.17 C15 PE8 C 148 A 276 ARG C 124 ARG^? 7.92 C3 GOL C 149 coo 16.45 -2.42 17.59 14.58 -2.74 16.47 0.88 95.09 62.29 2.19 93.37 62.62 coo 10.97 0.43 16.73 11.31 2.11 18.06 -1.29 91.04 56.29 -2.92 92.47 56.21 coo 5.13 -4.12 13.47 2.16 -3.72 14.17 2.87 85.20 55.95 3.74 82.90 57.81 ULMN 3 1emh_d00 HYDROLASE/DNA user 14 3 # 14 A 271 PRO C 7 PRO.? -4.63 C6 PE8 C 148s A 272 LEU C 125 LEU^? 5.17 C15 PE8 C 148 A 276 ARG C 127 ARG^? 7.44 N MLZ C 129 coo 16.45 -2.42 17.59 14.58 -2.74 16.47 0.88 95.09 62.29 2.19 93.37 62.62 coo 10.97 0.43 16.73 11.31 2.11 18.06 -1.29 91.04 56.29 -2.92 92.47 56.21 coo 5.13 -4.12 13.47 2.16 -3.72 14.17 1.53 98.09 50.88 2.14 101.05 50.40 ULMN 3 1emh_d00 HYDROLASE/DNA user 15 3 # 15 A 271 PRO C 95 PRO.? 7.43 NZ MLY C 67 A 272 LEU C 64 LEU~? 9.53 N MLY C 67 A 276 ARG C 63 ARG~? -11.70 O25 PE8 C 148s coo 16.45 -2.42 17.59 14.58 -2.74 16.47 -10.11 104.13 49.66 -8.57 102.82 48.75 coo 10.97 0.43 16.73 11.31 2.11 18.06 -12.15 104.00 55.88 -11.78 105.13 57.73 coo 5.13 -4.12 13.47 2.16 -3.72 14.17 -17.02 105.73 59.39 -16.53 104.08 61.96 ULMN 3 1emh_d00 HYDROLASE/DNA user 16 3 # 16 A 271 PRO D 7 PRO.? -4.52 O4 2PE D 146s A 272 LEU A 78 LEU.? 6.71 C14 2PE D 146 A 276 ARG D 124 ARG^? 7.97 C3 GOL D 147 coo 16.45 -2.42 17.59 14.58 -2.74 16.47 -33.61 79.01 0.51 -31.47 79.31 0.12 coo 10.97 0.43 16.73 11.31 2.11 18.06 -32.71 73.24 2.11 -34.50 74.18 1.33 coo 5.13 -4.12 13.47 2.16 -3.72 14.17 -24.04 74.20 5.58 -21.67 76.16 5.44 ULMN 3 1emh_d00 HYDROLASE/DNA user 17 3 # 17 A 271 PRO D 7 PRO.? -4.52 O4 2PE D 146s A 272 LEU A 78 LEU.? 6.71 C14 2PE D 146 A 276 ARG D 127 ARG^? 9.31 O3 PGE A 147 coo 16.45 -2.42 17.59 14.58 -2.74 16.47 -33.61 79.01 0.51 -31.47 79.31 0.12 coo 10.97 0.43 16.73 11.31 2.11 18.06 -32.71 73.24 2.11 -34.50 74.18 1.33 coo 5.13 -4.12 13.47 2.16 -3.72 14.17 -35.94 67.72 2.28 -38.25 66.55 0.66 ULMN 3 1emh_d00 HYDROLASE/DNA user 18 3 # 18 A 271 PRO D 7 PRO.? -4.52 O4 2PE D 146s A 272 LEU D 125 LEU^? 4.59 C17 2PE D 146 A 276 ARG D 124 ARG^? 7.97 C3 GOL D 147 coo 16.45 -2.42 17.59 14.58 -2.74 16.47 -33.61 79.01 0.51 -31.47 79.31 0.12 coo 10.97 0.43 16.73 11.31 2.11 18.06 -31.23 74.71 6.11 -33.26 74.87 6.83 coo 5.13 -4.12 13.47 2.16 -3.72 14.17 -24.04 74.20 5.58 -21.67 76.16 5.44 ULMN 3 1emh_d00 HYDROLASE/DNA user 19 3 # 19 A 271 PRO D 7 PRO.? -4.52 O4 2PE D 146s A 272 LEU D 125 LEU^? 4.59 C17 2PE D 146 A 276 ARG D 127 ARG^? 9.31 O3 PGE A 147 coo 16.45 -2.42 17.59 14.58 -2.74 16.47 -33.61 79.01 0.51 -31.47 79.31 0.12 coo 10.97 0.43 16.73 11.31 2.11 18.06 -31.23 74.71 6.11 -33.26 74.87 6.83 coo 5.13 -4.12 13.47 2.16 -3.72 14.17 -35.94 67.72 2.28 -38.25 66.55 0.66 ULMN 3 1emh_d00 HYDROLASE/DNA user 20 3 # 20 A 271 PRO D 95 PRO.? 7.26 CE MLY D 67 A 272 LEU D 64 LEU~? 9.61 N MLY D 67 A 276 ARG D 63 ARG~? -11.23 O28 2PE D 146s coo 16.45 -2.42 17.59 14.58 -2.74 16.47 -46.96 68.69 9.47 -45.03 67.63 9.07 coo 10.97 0.43 16.73 11.31 2.11 18.06 -47.94 75.35 8.95 -48.64 76.82 7.45 coo 5.13 -4.12 13.47 2.16 -3.72 14.17 -51.80 79.77 10.92 -50.17 82.42 10.63 1emh_d00 source 1emh HYDROLASE/DNA : 20 hits 1emh_d00 naa= 3 ULMN 3 1hwt_d00 GENE REGULATION/DNA user 1 3 # 1 C 70 ARG A 116 ARG~? 4.70 C15 2PE A 148 C 71 LYS A 114 LYS~? 11.27 C9 2PE A 148 C 72 VAL A 113 VAL~? 5.20 C11 2PE A 148 coo 23.89 33.54 29.21 26.59 34.86 28.68 -15.13 57.15 12.87 -15.00 60.01 11.67 coo 25.82 26.89 29.68 23.33 22.98 25.84 -9.49 51.50 12.13 -4.59 48.44 14.69 coo 28.86 29.08 30.37 28.04 31.02 29.93 -12.07 52.60 14.69 -11.15 54.36 15.66 ULMN 3 1hwt_d00 GENE REGULATION/DNA user 2 3 # 2 C 70 ARG B 63 ARG~? -8.01 OH2 1PE B 150s C 71 LYS A 9 LYS~? 8.68 C6 2PE A 148 C 72 VAL A 11 VAL~? 7.91 C14 1PE B 150 coo 23.89 33.54 29.21 26.59 34.86 28.68 -5.18 74.17 22.68 -2.11 73.83 22.90 coo 25.82 26.89 29.68 23.33 22.98 25.84 -4.77 65.74 20.08 0.46 67.29 18.98 coo 28.86 29.08 30.37 28.04 31.02 29.93 -8.93 69.43 20.51 -10.10 70.00 18.77 ULMN 3 1hwt_d00 GENE REGULATION/DNA user 3 3 # 3 C 70 ARG B 116 ARG~? 4.93 C12 PE8 B 148 C 71 LYS B 114 LYS~? 11.34 O7 PE8 B 148 C 72 VAL B 113 VAL~? 5.33 C8 PE8 B 148 coo 23.89 33.54 29.21 26.59 34.86 28.68 6.23 77.16 37.54 6.11 77.30 40.64 coo 25.82 26.89 29.68 23.33 22.98 25.84 11.35 73.22 32.47 12.65 68.43 28.61 coo 28.86 29.08 30.37 28.04 31.02 29.93 7.66 74.10 32.67 6.84 72.58 34.05 ULMN 3 1hwt_d00 GENE REGULATION/DNA user 4 3 # 4 C 70 ARG D 116 ARG~? 4.73 C15 2PE D 146 C 71 LYS D 114 LYS~? 10.81 C9 2PE D 146 C 72 VAL D 113 VAL~? 5.49 C11 2PE D 146 coo 23.89 33.54 29.21 26.59 34.86 28.68 -33.13 82.22 8.73 -30.63 80.83 7.52 coo 25.82 26.89 29.68 23.33 22.98 25.84 -35.88 89.56 6.78 -39.69 93.33 3.49 coo 28.86 29.08 30.37 28.04 31.02 29.93 -37.26 86.14 7.64 -37.00 84.99 5.73 1hwt_d00 source 1hwt GENE REGULATION/DNA : 4 hits 1hwt_d00 naa= 3 ULMN 3 1id3_d00 STRUCTURAL PROTEIN/DNA user 1 3 # 1 E 40 ARG A 110 ARG~? -3.66 O1 2PE A 148s E 41 TYR A 109 TYR~? -5.64 O16 2PE A 148s E 83 ARG D 42 ARG.? 16.60 C9 2PE D 146 coo 41.16 -25.11 -82.73 40.81 -22.13 -82.13 -6.91 52.41 21.82 -5.61 55.22 21.43 coo 40.04 -30.19 -77.46 41.62 -32.14 -76.20 -13.81 52.60 20.09 -14.53 54.76 18.49 coo 33.18 -0.85 -38.14 36.12 -0.03 -38.44 -32.78 97.24 12.74 -35.35 96.85 11.13 ULMN 3 1id3_d00 STRUCTURAL PROTEIN/DNA user 2 3 # 2 E 40 ARG A 116 ARG~? 4.70 C15 2PE A 148 E 41 TYR A 109 TYR~? -5.64 O16 2PE A 148s E 83 ARG B 31 ARG^? 11.02 C6 PGE B 147 coo 41.16 -25.11 -82.73 40.81 -22.13 -82.13 -15.13 57.15 12.87 -15.00 60.01 11.67 coo 40.04 -30.19 -77.46 41.62 -32.14 -76.20 -13.81 52.60 20.09 -14.53 54.76 18.49 coo 33.18 -0.85 -38.14 36.12 -0.03 -38.44 12.15 83.61 47.77 10.36 84.10 50.21 ULMN 3 1id3_d00 STRUCTURAL PROTEIN/DNA user 3 3 # 3 E 40 ARG A 116 ARG~? 4.70 C15 2PE A 148 E 41 TYR A 109 TYR~? -5.64 O16 2PE A 148s E 83 ARG B 35 ARG.? 9.50 O1 PEG B 144 coo 41.16 -25.11 -82.73 40.81 -22.13 -82.13 -15.13 57.15 12.87 -15.00 60.01 11.67 coo 40.04 -30.19 -77.46 41.62 -32.14 -76.20 -13.81 52.60 20.09 -14.53 54.76 18.49 coo 33.18 -0.85 -38.14 36.12 -0.03 -38.44 22.76 84.08 36.32 22.81 87.07 35.45 ULMN 3 1id3_d00 STRUCTURAL PROTEIN/DNA user 4 3 # 4 E 40 ARG B 33 ARG.? -3.91 C3 PEG B 144s E 41 TYR B 38 TYR.? 9.60 O1 PEG B 144 E 83 ARG D 33 ARG.? 10.45 C1 GOL D 147 coo 41.16 -25.11 -82.73 40.81 -22.13 -82.13 17.31 79.39 40.81 17.39 77.24 43.00 coo 40.04 -30.19 -77.46 41.62 -32.14 -76.20 18.19 76.55 32.34 16.15 78.24 31.46 coo 33.18 -0.85 -38.14 36.12 -0.03 -38.44 -24.75 89.49 9.81 -23.48 88.88 7.05 ULMN 3 1id3_d00 STRUCTURAL PROTEIN/DNA user 5 3 # 5 E 40 ARG B 110 ARG~? 10.12 O7 PE8 B 148 E 41 TYR B 109 TYR~? -5.65 O13 PE8 B 148s E 83 ARG C 42 ARG.? 7.63 O MLZ C 114 coo 41.16 -25.11 -82.73 40.81 -22.13 -82.13 4.56 66.25 30.54 5.81 64.43 28.32 coo 40.04 -30.19 -77.46 41.62 -32.14 -76.20 2.41 73.03 30.76 2.68 74.03 33.35 coo 33.18 -0.85 -38.14 36.12 -0.03 -38.44 -13.55 84.90 75.42 -13.77 88.03 75.38 ULMN 3 1id3_d00 STRUCTURAL PROTEIN/DNA user 6 3 # 6 E 40 ARG B 110 ARG~? 10.12 O7 PE8 B 148 E 41 TYR B 109 TYR~? -5.65 O13 PE8 B 148s E 83 ARG D 127 ARG^? 9.31 O3 PGE A 147 coo 41.16 -25.11 -82.73 40.81 -22.13 -82.13 4.56 66.25 30.54 5.81 64.43 28.32 coo 40.04 -30.19 -77.46 41.62 -32.14 -76.20 2.41 73.03 30.76 2.68 74.03 33.35 coo 33.18 -0.85 -38.14 36.12 -0.03 -38.44 -35.94 67.72 2.28 -38.25 66.55 0.66 ULMN 3 1id3_d00 STRUCTURAL PROTEIN/DNA user 7 3 # 7 E 40 ARG B 116 ARG~? 4.93 C12 PE8 B 148 E 41 TYR B 50 TYR~? 5.52 CH1 MLY C 135 E 83 ARG D 42 ARG.? 16.60 C9 2PE D 146 coo 41.16 -25.11 -82.73 40.81 -22.13 -82.13 6.23 77.16 37.54 6.11 77.30 40.64 coo 40.04 -30.19 -77.46 41.62 -32.14 -76.20 8.51 83.11 35.90 5.93 82.51 36.84 coo 33.18 -0.85 -38.14 36.12 -0.03 -38.44 -32.78 97.24 12.74 -35.35 96.85 11.13 ULMN 3 1id3_d00 STRUCTURAL PROTEIN/DNA user 8 3 # 8 E 40 ARG B 116 ARG~? 4.93 C12 PE8 B 148 E 41 TYR B 50 TYR~? 5.52 CH1 MLY C 135 E 83 ARG D 55 ARG~? 9.16 CG MLY A 135 coo 41.16 -25.11 -82.73 40.81 -22.13 -82.13 6.23 77.16 37.54 6.11 77.30 40.64 coo 40.04 -30.19 -77.46 41.62 -32.14 -76.20 8.51 83.11 35.90 5.93 82.51 36.84 coo 33.18 -0.85 -38.14 36.12 -0.03 -38.44 -39.98 89.02 19.79 -37.17 89.06 21.03 ULMN 3 1id3_d00 STRUCTURAL PROTEIN/DNA user 9 3 # 9 E 40 ARG C 110 ARG~? -6.90 CM MLZ C 114s E 41 TYR C 109 TYR~? -5.91 C14 PE8 C 148s E 83 ARG B 42 ARG.? 12.70 O1 PEG B 144 coo 41.16 -25.11 -82.73 40.81 -22.13 -82.13 -6.95 102.53 68.25 -6.50 103.08 71.25 coo 40.04 -30.19 -77.46 41.62 -32.14 -76.20 -9.64 98.32 63.33 -8.13 96.27 62.21 coo 33.18 -0.85 -38.14 36.12 -0.03 -38.44 19.61 78.53 29.44 17.94 76.42 28.00 ULMN 3 1id3_d00 STRUCTURAL PROTEIN/DNA user 10 3 # 10 E 40 ARG C 116 ARG~? 4.72 C15 PE8 C 148 E 41 TYR C 50 TYR~? 5.59 CE MLY B 135 E 83 ARG D 31 ARG^? 10.57 OH7 1PE B 150 coo 41.16 -25.11 -82.73 40.81 -22.13 -82.13 -6.64 90.12 62.40 -4.04 88.84 61.33 coo 40.04 -30.19 -77.46 41.62 -32.14 -76.20 -11.27 85.65 61.91 -10.18 87.09 59.78 coo 33.18 -0.85 -38.14 36.12 -0.03 -38.44 -19.64 81.34 12.02 -19.24 78.87 10.07 ULMN 3 1id3_d00 STRUCTURAL PROTEIN/DNA user 11 3 # 11 E 40 ARG D 110 ARG~? 8.08 C9 2PE D 146 E 41 TYR D 109 TYR~? -5.82 O16 2PE D 146s E 83 ARG A 42 ARG.? 16.81 C11 2PE A 148 coo 41.16 -25.11 -82.73 40.81 -22.13 -82.13 -43.46 85.72 1.13 -42.23 87.94 -0.73 coo 40.04 -30.19 -77.46 41.62 -32.14 -76.20 -41.76 82.56 7.21 -39.24 81.41 7.29 coo 33.18 -0.85 -38.14 36.12 -0.03 -38.44 -8.57 45.71 4.07 -9.11 44.76 6.92 1id3_d00 source 1id3 STRUCTURAL PROTEIN/DNA : 11 hits 1id3_d00 naa= 3 ULMN 3 1r4i_d00 TRANSCRIPTION/DNA user 1 3 # 1 A 563 LYS A 9 LYS~? 8.68 C6 2PE A 148 A 564 VAL A 11 VAL~? 7.91 C14 1PE B 150 A 568 ARG B 63 ARG~? -8.01 OH2 1PE B 150s coo -6.60 80.79 55.64 -8.55 79.48 61.01 -4.77 65.74 20.08 0.46 67.29 18.98 coo -9.25 78.14 55.31 -11.11 77.94 56.39 -8.93 69.43 20.51 -10.10 70.00 18.77 coo -12.31 74.86 52.32 -13.99 74.91 54.92 -5.18 74.17 22.68 -2.11 73.83 22.90 ULMN 3 1r4i_d00 TRANSCRIPTION/DNA user 2 3 # 2 A 563 LYS A 114 LYS~? 11.27 C9 2PE A 148 A 564 VAL A 113 VAL~? 5.20 C11 2PE A 148 A 568 ARG A 116 ARG~? 4.70 C15 2PE A 148 coo -6.60 80.79 55.64 -8.55 79.48 61.01 -9.49 51.50 12.13 -4.59 48.44 14.69 coo -9.25 78.14 55.31 -11.11 77.94 56.39 -12.07 52.60 14.69 -11.15 54.36 15.66 coo -12.31 74.86 52.32 -13.99 74.91 54.92 -15.13 57.15 12.87 -15.00 60.01 11.67 ULMN 3 1r4i_d00 TRANSCRIPTION/DNA user 3 3 # 3 A 563 LYS B 114 LYS~? 11.34 O7 PE8 B 148 A 564 VAL B 113 VAL~? 5.33 C8 PE8 B 148 A 568 ARG B 116 ARG~? 4.93 C12 PE8 B 148 coo -6.60 80.79 55.64 -8.55 79.48 61.01 11.35 73.22 32.47 12.65 68.43 28.61 coo -9.25 78.14 55.31 -11.11 77.94 56.39 7.66 74.10 32.67 6.84 72.58 34.05 coo -12.31 74.86 52.32 -13.99 74.91 54.92 6.23 77.16 37.54 6.11 77.30 40.64 ULMN 3 1r4i_d00 TRANSCRIPTION/DNA user 4 3 # 4 A 563 LYS D 114 LYS~? 10.81 C9 2PE D 146 A 564 VAL D 113 VAL~? 5.49 C11 2PE D 146 A 568 ARG D 116 ARG~? 4.73 C15 2PE D 146 coo -6.60 80.79 55.64 -8.55 79.48 61.01 -35.88 89.56 6.78 -39.69 93.33 3.49 coo -9.25 78.14 55.31 -11.11 77.94 56.39 -37.26 86.14 7.64 -37.00 84.99 5.73 coo -12.31 74.86 52.32 -13.99 74.91 54.92 -33.13 82.22 8.73 -30.63 80.83 7.52 1r4i_d00 source 1r4i TRANSCRIPTION/DNA : 4 hits 1r4i_d00 naa= 3 ULMN 4 1v15_d00 HYDROLASE user 1 4 # 1 D 5 ARG A 127 ARG^? 7.47 N MLZ A 129 D 51 ASP A 19 ASP.? -3.59 O4 SO4 A 144s D 54 ARG A 16 ARG~? -2.82 O4 SO4 A 143s D 96 ARG B 63 ARG~? -8.01 OH2 1PE B 150s coo 26.68 123.37 35.42 27.02 123.02 38.47 -18.44 68.25 24.06 -17.70 68.37 27.04 coo 28.85 117.12 30.52 26.97 118.21 30.78 -15.01 66.98 32.71 -14.52 68.02 34.44 coo 27.03 113.91 36.12 26.66 115.85 33.77 -9.29 63.37 28.06 -8.90 62.24 30.90 coo 15.69 117.00 39.50 16.92 119.48 40.82 -5.18 74.17 22.68 -2.11 73.83 22.90 1v15_d00 source 1v15 HYDROLASE : 1 hits 1v15_d00 naa= 4 ULMN 4 1z1c_d00 VIRUS/DNA user 1 4 # 1 A 52 HIS A 25 HIS^? 6.06 C MLZ A 129 A 53 TYR A 94 TYR^? 4.94 CL CL A 145s A 54 ARG A 127 ARG^? 7.47 N MLZ A 129 A 55 PHE A 100 PHE~? 5.47 CL CL A 145 coo -51.92 14.77 71.82 -52.52 16.69 71.24 -27.47 64.89 22.81 -29.24 64.17 23.67 coo -53.17 8.84 75.64 -53.81 9.66 78.23 -21.59 58.91 24.53 -21.03 57.83 22.04 coo -46.84 9.39 68.38 -45.10 9.66 65.86 -18.44 68.25 24.06 -17.70 68.37 27.04 coo -51.87 3.84 71.46 -53.47 4.35 73.68 -17.05 60.16 23.87 -16.37 60.41 21.18 ULMN 4 1z1c_d00 VIRUS/DNA user 2 4 # 2 A 52 HIS B 25 HIS^? 5.55 C6 PG4 C 145 A 53 TYR B 94 TYR^? -5.06 CL CL B 143s A 54 ARG B 127 ARG^? 9.26 O4 SO4 A 144 A 55 PHE B 100 PHE~? 5.44 CL CL B 143 coo -51.92 14.77 71.82 -52.52 16.69 71.24 -10.19 81.59 41.51 -11.58 82.85 40.58 coo -53.17 8.84 75.64 -53.81 9.66 78.23 -6.97 76.65 35.26 -4.34 77.53 35.11 coo -46.84 9.39 68.38 -45.10 9.66 65.86 -7.64 72.55 44.16 -9.78 70.52 43.36 coo -51.87 3.84 71.46 -53.47 4.35 73.68 -4.47 72.85 36.74 -1.98 73.56 37.79 ULMN 4 1z1c_d00 VIRUS/DNA user 3 4 # 3 A 52 HIS C 25 HIS^? 5.68 C3 PG4 C 145 A 53 TYR C 94 TYR^? 5.01 CL CL C 144s A 54 ARG C 127 ARG^? 7.44 N MLZ C 129 A 55 PHE C 100 PHE~? 5.49 CL CL C 144 coo -51.92 14.77 71.82 -52.52 16.69 71.24 -5.80 94.82 45.56 -7.26 95.23 44.11 coo -53.17 8.84 75.64 -53.81 9.66 78.23 -8.07 99.17 52.54 -8.69 97.12 54.34 coo -46.84 9.39 68.38 -45.10 9.66 65.86 1.53 98.09 50.88 2.14 101.05 50.40 coo -51.87 3.84 71.46 -53.47 4.35 73.68 -4.65 99.62 55.88 -4.08 97.24 57.19 ULMN 4 1z1c_d00 VIRUS/DNA user 4 4 # 4 A 52 HIS D 25 HIS^? 5.64 C8 PG4 D 144 A 53 TYR D 94 TYR^? -4.97 CL CL D 143s A 54 ARG D 127 ARG^? 9.31 O3 PGE A 147 A 55 PHE D 100 PHE~? 5.42 CL CL D 143 coo -51.92 14.77 71.82 -52.52 16.69 71.24 -36.75 65.22 11.65 -37.83 64.18 13.11 coo -53.17 8.84 75.64 -53.81 9.66 78.23 -41.68 71.74 9.13 -40.22 73.97 9.96 coo -46.84 9.39 68.38 -45.10 9.66 65.86 -35.94 67.72 2.28 -38.25 66.55 0.66 coo -51.87 3.84 71.46 -53.47 4.35 73.68 -40.31 73.86 4.98 -37.99 75.35 5.35 1z1c_d00 source 1z1c VIRUS/DNA : 4 hits 1z1c_d00 naa= 4 ULMN 3 2bsq_d00 TRANSCRIPTION user 1 3 # 1 E 3 SER A 57 SER~? 3.96 C21 2PE A 148 E 5 VAL A 60 VAL~? 8.17 O22 2PE A 148 E 7 ARG A 63 ARG~? 11.15 O28 2PE A 148 coo -3.82 -25.91 35.53 -5.28 -27.06 37.10 -17.83 49.34 18.20 -18.57 51.11 16.71 coo -8.42 -21.09 33.22 -10.34 -21.69 33.92 -18.47 48.97 23.63 -16.33 49.16 23.32 coo -12.01 -17.19 33.96 -11.18 -17.21 36.88 -18.54 46.85 28.43 -16.64 46.31 26.03 ULMN 3 2bsq_d00 TRANSCRIPTION user 2 3 # 2 E 3 SER A 96 SER~? 7.38 O1 SO4 A 144 E 5 VAL A 101 VAL~? 7.61 O4 SO4 A 143 E 7 ARG A 16 ARG~? -2.82 O4 SO4 A 143s coo -3.82 -25.91 35.53 -5.28 -27.06 37.10 -20.86 61.67 30.54 -19.56 59.85 31.49 coo -8.42 -21.09 33.22 -10.34 -21.69 33.92 -13.38 58.79 26.81 -11.99 60.19 27.79 coo -12.01 -17.19 33.96 -11.18 -17.21 36.88 -9.29 63.37 28.06 -8.90 62.24 30.90 ULMN 3 2bsq_d00 TRANSCRIPTION user 3 3 # 3 E 3 SER A 96 SER~? 7.38 O1 SO4 A 144 E 5 VAL A 101 VAL~? 7.61 O4 SO4 A 143 E 7 ARG A 105 ARG~? -3.04 O2 SO4 A 143s coo -3.82 -25.91 35.53 -5.28 -27.06 37.10 -20.86 61.67 30.54 -19.56 59.85 31.49 coo -8.42 -21.09 33.22 -10.34 -21.69 33.92 -13.38 58.79 26.81 -11.99 60.19 27.79 coo -12.01 -17.19 33.96 -11.18 -17.21 36.88 -8.78 56.32 28.12 -7.90 58.53 30.04 ULMN 3 2bsq_d00 TRANSCRIPTION user 4 3 # 4 E 3 SER A 123 SER^? 7.34 C15 2PE A 148 E 5 VAL A 120 VAL^? 9.31 C15 2PE A 148 E 7 ARG A 33 ARG.? 10.19 C3 GOL A 150 coo -3.82 -25.91 35.53 -5.28 -27.06 37.10 -17.01 64.19 8.64 -15.43 63.06 10.12 coo -8.42 -21.09 33.22 -10.34 -21.69 33.92 -14.62 58.24 6.05 -15.39 59.15 7.91 coo -12.01 -17.19 33.96 -11.18 -17.21 36.88 -11.76 56.72 1.51 -9.97 59.19 1.86 ULMN 3 2bsq_d00 TRANSCRIPTION user 5 3 # 5 E 3 SER B 57 SER~? 3.95 C20 PE8 B 148 E 5 VAL B 60 VAL~? 8.38 O19 PE8 B 148 E 7 ARG B 63 ARG~? -8.01 OH2 1PE B 150s coo -3.82 -25.91 35.53 -5.28 -27.06 37.10 2.89 78.00 28.42 3.14 79.13 30.54 coo -8.42 -21.09 33.22 -10.34 -21.69 33.92 -1.80 76.03 26.21 -0.59 74.27 26.57 coo -12.01 -17.19 33.96 -11.18 -17.21 36.88 -5.18 74.17 22.68 -2.11 73.83 22.90 ULMN 3 2bsq_d00 TRANSCRIPTION user 6 3 # 6 E 3 SER B 96 SER~? 7.21 O4 SO4 A 144 E 5 VAL B 101 VAL~? 7.65 O1 SO4 A 143 E 7 ARG B 16 ARG~? -3.64 O1 SO4 A 143s coo -3.82 -25.91 35.53 -5.28 -27.06 37.10 -12.28 72.78 35.88 -11.90 71.42 33.88 coo -8.42 -21.09 33.22 -10.34 -21.69 33.92 -4.62 68.54 34.45 -5.22 66.70 35.46 coo -12.01 -17.19 33.96 -11.18 -17.21 36.88 -4.85 63.18 38.40 -7.23 62.95 36.44 ULMN 3 2bsq_d00 TRANSCRIPTION user 7 3 # 7 E 3 SER B 96 SER~? 7.21 O4 SO4 A 144 E 5 VAL B 101 VAL~? 7.65 O1 SO4 A 143 E 7 ARG B 105 ARG~? -3.01 O4 SO4 A 143s coo -3.82 -25.91 35.53 -5.28 -27.06 37.10 -12.28 72.78 35.88 -11.90 71.42 33.88 coo -8.42 -21.09 33.22 -10.34 -21.69 33.92 -4.62 68.54 34.45 -5.22 66.70 35.46 coo -12.01 -17.19 33.96 -11.18 -17.21 36.88 -2.68 64.28 31.62 -4.52 62.28 32.99 ULMN 3 2bsq_d00 TRANSCRIPTION user 8 3 # 8 E 3 SER B 123 SER^? 7.43 C12 PE8 B 148 E 5 VAL B 120 VAL^? 9.59 O13 PE8 B 148 E 7 ARG B 33 ARG.? -3.91 C3 PEG B 144s coo -3.82 -25.91 35.53 -5.28 -27.06 37.10 6.88 79.31 45.54 6.79 77.45 43.98 coo -8.42 -21.09 33.22 -10.34 -21.69 33.92 11.80 79.44 40.75 9.68 79.12 40.98 coo -12.01 -17.19 33.96 -11.18 -17.21 36.88 17.31 79.39 40.81 17.39 77.24 43.00 ULMN 3 2bsq_d00 TRANSCRIPTION user 9 3 # 9 E 3 SER C 57 SER~? 4.15 C20 PE8 C 148 E 5 VAL C 60 VAL~? 8.15 C21 PE8 C 148 E 7 ARG C 63 ARG~? -11.70 O25 PE8 C 148s coo -3.82 -25.91 35.53 -5.28 -27.06 37.10 -14.48 95.85 62.27 -13.19 94.01 61.32 coo -8.42 -21.09 33.22 -10.34 -21.69 33.92 -15.08 100.84 60.11 -13.84 101.15 61.85 coo -12.01 -17.19 33.96 -11.18 -17.21 36.88 -17.02 105.73 59.39 -16.53 104.08 61.96 ULMN 3 2bsq_d00 TRANSCRIPTION user 10 3 # 10 E 3 SER C 57 SER~? 4.15 C20 PE8 C 148 E 5 VAL C 108 VAL~? 10.09 N MLZ C 114 E 7 ARG C 110 ARG~? -6.90 CM MLZ C 114s coo -3.82 -25.91 35.53 -5.28 -27.06 37.10 -14.48 95.85 62.27 -13.19 94.01 61.32 coo -8.42 -21.09 33.22 -10.34 -21.69 33.92 -13.79 100.83 67.38 -15.88 100.95 66.81 coo -12.01 -17.19 33.96 -11.18 -17.21 36.88 -6.95 102.53 68.25 -6.50 103.08 71.25 ULMN 3 2bsq_d00 TRANSCRIPTION user 11 3 # 11 E 3 SER C 96 SER~? 11.39 N MLY C 67 E 5 VAL C 101 VAL~? 7.57 O1 SO4 C 143 E 7 ARG C 16 ARG~? -2.96 O3 SO4 C 143s coo -3.82 -25.91 35.53 -5.28 -27.06 37.10 -5.29 104.57 49.79 -6.22 106.17 51.38 coo -8.42 -21.09 33.22 -10.34 -21.69 33.92 -4.07 103.71 58.59 -2.16 104.76 58.71 coo -12.01 -17.19 33.96 -11.18 -17.21 36.88 1.87 105.73 59.26 1.00 108.67 58.94 ULMN 3 2bsq_d00 TRANSCRIPTION user 12 3 # 12 E 3 SER C 96 SER~? 11.39 N MLY C 67 E 5 VAL C 101 VAL~? 7.57 O1 SO4 C 143 E 7 ARG C 105 ARG~? -3.12 O1 SO4 C 143s coo -3.82 -25.91 35.53 -5.28 -27.06 37.10 -5.29 104.57 49.79 -6.22 106.17 51.38 coo -8.42 -21.09 33.22 -10.34 -21.69 33.92 -4.07 103.71 58.59 -2.16 104.76 58.71 coo -12.01 -17.19 33.96 -11.18 -17.21 36.88 -3.93 106.64 63.12 -1.78 108.52 62.12 ULMN 3 2bsq_d00 TRANSCRIPTION user 13 3 # 13 E 3 SER C 123 SER^? 7.65 C15 PE8 C 148 E 5 VAL C 120 VAL^? 8.92 O MLZ C 114 E 7 ARG C 33 ARG.? 10.55 C1 GOL C 149 coo -3.82 -25.91 35.53 -5.28 -27.06 37.10 -1.16 84.64 59.13 -1.43 86.65 60.45 coo -8.42 -21.09 33.22 -10.34 -21.69 33.92 -5.18 83.90 64.73 -4.80 85.24 63.07 coo -12.01 -17.19 33.96 -11.18 -17.21 36.88 -5.11 80.73 69.28 -2.11 81.22 69.57 ULMN 3 2bsq_d00 TRANSCRIPTION user 14 3 # 14 E 3 SER D 57 SER~? 3.84 C21 2PE D 146 E 5 VAL D 60 VAL~? 8.01 O22 2PE D 146 E 7 ARG D 63 ARG~? -11.23 O28 2PE D 146s coo -3.82 -25.91 35.53 -5.28 -27.06 37.10 -42.08 83.25 12.68 -39.78 82.38 12.84 coo -8.42 -21.09 33.22 -10.34 -21.69 33.92 -46.69 80.64 11.49 -46.27 81.87 9.75 coo -12.01 -17.19 33.96 -11.18 -17.21 36.88 -51.80 79.77 10.92 -50.17 82.42 10.63 ULMN 3 2bsq_d00 TRANSCRIPTION user 15 3 # 15 E 3 SER D 96 SER~? 11.44 N MLY D 67 E 5 VAL D 101 VAL~? 8.08 O1 2PE D 146 E 7 ARG D 16 ARG~? -9.70 O1 2PE D 146s coo -3.82 -25.91 35.53 -5.28 -27.06 37.10 -44.97 67.48 5.17 -46.83 69.00 4.60 coo -8.42 -21.09 33.22 -10.34 -21.69 33.92 -43.60 75.52 1.72 -43.54 74.79 -0.36 coo -12.01 -17.19 33.96 -11.18 -17.21 36.88 -42.18 74.28 -4.52 -45.10 73.30 -4.28 ULMN 3 2bsq_d00 TRANSCRIPTION user 16 3 # 16 E 3 SER D 96 SER~? 11.44 N MLY D 67 E 5 VAL D 101 VAL~? 8.08 O1 2PE D 146 E 7 ARG D 105 ARG~? -8.15 O1 2PE D 146s